PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gibson, SZ				Gibson, Sarah Z.			Redescription and Phylogenetic Placement of dagger Hemicalypterus weiri Schaeffer, 1967 (Actinopterygii, Neopterygii) from the Triassic Chinle Formation, Southwestern United States: New Insights into Morphology, Ecological Niche, and Phylogeny	PLOS ONE			English	Article							GINGLYMODIAN FISH; SEMIONOTIFORMES; EVOLUTION	The actinopterygian fish dagger Hemicalypterus weiri Schaeffer, 1967 is herein redescribed and rediagnosed based on new information collected from reexamination of museum specimens as well as examination of recently collected specimens from the Upper Triassic Chinle Formation of San Juan County, Utah, United States. dagger Hemicalypterus is distinguishable by its deep, disc-shaped compressed body; ganoid-scaled anterior half and scaleless posterior half; spinose, prominent dorsal and ventral ridge scales anterior to dorsal and anal fins; hem-like dorsal and anal fins with rounded distal margins; small mouth gape; and specialized, multicuspid dentition. This type of dentition, when observed in extant fishes, is often associated with herbivory, and dagger Hemicalypterus represents the oldest known ray-finned fish to have possibly exploited an herbivorous trophic feeding niche. A phylogenetic analysis infers a placement of dagger Hemicalypterus within dagger Dapediiformes, with dagger Dapediiformes being recovered as sister to Ginglymodi within holostean actinopterygians.	[Gibson, Sarah Z.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Gibson, Sarah Z.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Gibson, SZ (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.; Gibson, SZ (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	szgibson@ku.edu		Gibson, Sarah Z./0000-0002-6784-3980	University of Kansas Biodiversity Institute Panorama Grant; University of Kansas Department of Geology; National Geographic Society [9071-12]; Geological Society of America Student Research Grants program; National Science Foundation [DEB-1502005]; University of Kansas Department of Geology and Biodiversity Institute; University of Utah; Utah Geological Survey; St. George Dinosaur Discovery Site; Direct For Biological Sciences [1502005] Funding Source: National Science Foundation	University of Kansas Biodiversity Institute Panorama Grant; University of Kansas Department of Geology; National Geographic Society(National Geographic Society); Geological Society of America Student Research Grants program; National Science Foundation(National Science Foundation (NSF)); University of Kansas Department of Geology and Biodiversity Institute; University of Utah; Utah Geological Survey; St. George Dinosaur Discovery Site; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded in part by the University of Kansas Biodiversity Institute Panorama Grant, the University of Kansas Department of Geology, National Geographic Society (www.nationalgeographic.com) Grant #9071-12, the Geological Society of America Student Research Grants program, and National Science Foundation (www.nsf.gov) Doctoral Dissertation Improvement Grant #DEB-1502005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I thank H.-P. Schultze and M. P. Davis for their comments on the manuscript, M. P. Davis for assistance with phylogenetic methods, and W. L. Smith for photographic assistance. I thank A. R. C. Milner, J. I. Kirkland, R. Irmis, and volunteers from the Utah Friends of Paleontology for their efforts in fieldwork, specimen collection, and fossil preparation. R. Irmis, C. Levitt-Bussian, J. Maisey, A. Gishlik, A. Millhouse, and M. Brett-Surman are responsible for loaning or providing access to fossil specimens from their respective institutions. I thank the University of Kansas Department of Geology and Biodiversity Institute, the University of Utah, the Utah Geological Survey, and the St. George Dinosaur Discovery Site for their support of this research.	[Anonymous], TRAITE PALEONTOLOGIE; [Anonymous], 1983, RIV ITALIANA PALEONT; [Anonymous], 2011, RISE FISHES 500 MILL; [Anonymous], 1895, CATALOGUE FOSSIL FIS; Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; ARRATIA G, 2008, MESOZOIC FISHES, P40; Arratia G, 2013, SOC VERTEBR PALEONTO, V13, P1; Arratia Gloria, 1999, P265; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood DR, 2003, PALEOBIOLOGY, V29, P71, DOI 10.1666/0094-8373(2003)029<0071:OAEOHI>2.0.CO;2; Bermudez-Rochas DD, 2015, J SYST PALAEONTOL, V13, P265, DOI 10.1080/14772019.2014.881928; Blakey R.C., 1983, MESOZOIC PALEOGEOGRA, P57; Cope E.D, 1871, T AM PHILOS SOC, V14, P445, DOI [10.2307/1005256, DOI 10.2307/1005256]; DUBIEL R F, 1991, Palaios, V6, P347, DOI 10.2307/3514963; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDINER BRIAN GEORGE, 1960, BULL BRIT MUS [NAT HIST] GEOL, V4, P239; Gibson SZ, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1262-y; Gibson SZ, 2013, COPEIA, P582, DOI 10.1643/CI-12-028; Gibson SZ, 2013, J VERTEBR PALEONTOL, V33, P1037, DOI 10.1080/02724634.2013.758125; Grande L, 2010, COPEIA, P1; HODYCH JP, 1992, GEOLOGY, V20, P51, DOI 10.1130/0091-7613(1992)020<0051:DTMITE>2.3.CO;2; HUXLEY T. H., 1880, P ZOOL SOC LOND, P649; JAIN S L, 1973, Palaeontology (Oxford), V16, P149; JOHNSON SC, 2002, NEW MEXICO MUSEUM NA, V21, P107; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lopez-Arbarello A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108665; Lopez-Arbarello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039370; Maddison WP., 2021, MESQUITE MODULAR SYS; Martz JW, 2014, GEOLOGY UTAHS FAR S, V43, P397; Milner A. R. C., 2006, MUSEUM NO ARIZONA B, V62, P163; MILNER ARC, 2006, NEW MEXICO MUSEUM NA, V37, P522; Mo JY, 2016, GEOL MAG, V153, P143, DOI 10.1017/S0016756815000394; Muller J., 1845, BERICHT AKAD WISSENS, P416; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Olsen P.E., 1991, Journal of Vertebrate Paleontology, V11, P269; Parker WG, 2010, EARTH ENV SCI T R SO, V101, P231, DOI 10.1017/S1755691011020020; PATTERSON C, 1975, PHILOS T R SOC B, V269, P275, DOI 10.1098/rstb.1975.0001; Regan CT, 1923, P ZOOL SOC LOND, V1923, P445; Schaeffer B., 1967, Bulletin of the American Museum of Natural History, V135, P285; Schultze Hans-Peter, 2008, P23; STEWART J.H., 1972, US GEOLOGICAL SURVEY, V690, P1; Stromer E, 1930, ABH BAYR AKAD MATH N, V7, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thies D., 1991, Geologica et Palaeontologica, V25, P251; THIES D., 1989, NEUES JB GEOLOGIE PA, V44, P692; Thies D, 2016, J SYST PALAEONTOL, V14, P339, DOI 10.1080/14772019.2015.1043361; Thies Detlev, 2011, Palaeodiversity, P185; Thies Detlev, 1999, P143; Wenz S, 1968, CAHIERS PALEONTOLOGI, P1; Wiley E.O., 2008, P9; Woodward AS, 1928, P PETERBOROUGH NAT H, V56, P56; Woodward AS, 1929, P ZOOL SOC LOND, p[561, 1]; Woodward AS, 1895, MEM GEOL SURV NEW S, V9, p[I, 1]; Xu GH, 2012, CHINESE SCI BULL, V57, P111, DOI 10.1007/s11434-011-4719-1; Zwickl DJ., 2006, GENETIC ALGORITHM AP	57	15	15	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							0163657	10.1371/journal.pone.0163657	http://dx.doi.org/10.1371/journal.pone.0163657			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657923	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200158
J	Wan, ZZ; Chen, QQ; Chen, X; Duo, L; Li, PL; Zheng, YT; Zhang, CY				Wan, Zhenzhou; Chen, Qianqian; Chen, Xin; Duo, Lin; Li, Peilu; Zheng, Yong-Tang; Zhang, Chiyu			HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INJECTION-DRUG USERS; SOUTH-EAST ASIA; GENOTYPE 6; SUBTYPE; INFECTION; HIV-1; EPIDEMIOLOGY; TRANSMISSION; COINFECTION	HCV transmission is closely associated with drug-trafficking routes in China. Dehong, a prefecture of Yunnan, is the important trade transfer station linking Southeast Asia and China, as well as the drug-trafficking channel linking "Golden triangle" and other regions of China and surrounding countries. In this study, we investigated the HCV genotype diversity among IDUs in Dehong based on 259 HCV positive samples from 118 Chinese and 141 Burmese IDUs. HCV genotypes were determined based on the phylogenies of C/E2 and NS5B genomic sequences. Six HCV subtypes, including 1a, 1b, 3a, 3b, 6n and 6u, were detected. Interestingly, 4 HCV sequences from Burmese IDUs did not cluster with any known HCV subtypes, but formed a well-supported independent clade in the phylogenetic trees of both C/E2 and NS5B, suggesting a potential new HCV subtype circulating in Dehong. Subtype 3b was the predominant subtype, followed by subtypes 6n and 6u. Comparison showed that Dehong had a unique pattern of HCV subtype distribution, obviously different from other regions of China. In particular, HCV subtypes 6u and the potential new HCV subtype had a relatively high prevalence in Dehong, but were rarely detected in other regions of China. There was no significant difference in HCV subtype distribution between Burmese and Chinese IDUs. Few HCV sequences from Burmese and Chinese IDUs clustered together to form transmission clusters. Furthermore, about half of HCV sequences from Burmese IDUs formed small transmission clusters, significantly higher than that from Chinese IDUs (p < 0.01). These suggest that the Chinese and Burmese IDUs were relatively isolated from each other in injection drug use behavior and the Burmese IDUs might prefer to inject drugs themselves together. The unique genotype distribution and complex diversity of genotype 6 among IDUs may be associated with the special geographical position of Dehong.	[Wan, Zhenzhou; Chen, Qianqian; Li, Peilu; Zhang, Chiyu] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Chen, Xin; Zheng, Yong-Tang] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Chen, Xin; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Peoples R China; [Wan, Zhenzhou] Taizhou Fourth Peoples Hosp, Med Lab, Taizhou 225300, Jiangsu, Peoples R China; [Duo, Lin] Second Peoples Hosp Yunnan Prov, Kunming 650031, Yunnan, Peoples R China; [Chen, Xin] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, CY (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Zheng, YT (corresponding author), Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China.; Zheng, YT (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Peoples R China.	zhengyt@mail.kiz.ac.cn; zhangcy1999@ips.ac.cn	Xin, Chen/AAV-6405-2021; wan, zhenzhou/GZL-3245-2022	Chen, Xin/0000-0002-8980-7032	NSFC [U1302224, 81271888, 81271892]; Key Scientific and Technological Program of China [2012ZX10001-006]; Science and Technology Support Foundations of Taizhou City [TS201613]	NSFC(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Program of China; Science and Technology Support Foundations of Taizhou City	This work was supported by grants from the NSFC (U1302224, 81271888, and 81271892), Key Scientific and Technological Program of China (2012ZX10001-006) and in part by the Science and Technology Support Foundations of Taizhou City (TS201613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2010, J MED VIROL, V82, P257, DOI 10.1002/jmv.21680; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142543; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Du H, 2012, J CLIN VIROL, V54, P207, DOI 10.1016/j.jcv.2012.04.017; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Forns X, 1999, CLIN LIVER DIS, V3, pvii; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Han XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065337; Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583; Liu J, 2012, INFECT GENET EVOL, V12, P1944, DOI 10.1016/j.meegid.2012.08.001; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Qi YL, 2016, J MED VIROL, V88, P498, DOI 10.1002/jmv.24356; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sy Theodore, 2006, Int J Med Sci, V3, P41; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050343; Thong VD, 2014, WORLD J GASTROENTERO, V20, P2927, DOI 10.3748/wjg.v20.i11.2927; Wang HR, 2013, J GEN VIROL, V94, P76, DOI 10.1099/vir.0.047506-0; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598; Zhao R, 2013, J MED VIROL, V85, P1712, DOI 10.1002/jmv.23650; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016349	37	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163062	10.1371/journal.pone.0163062	http://dx.doi.org/10.1371/journal.pone.0163062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657722	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200061
J	He, M; Wang, W; Ding, H; Zhong, XW				He, Miao; Wang, Wei; Ding, Hui; Zhong, Xingwu			Comparison of Two Cap Thickness in Small Incision Lenticule Extraction: 100 mu m versus 160 mu m	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; CORNEAL DEFORMATION; TENSILE-STRENGTH; LASIK; REPEATABILITY; DEVICE; SMILE	Purpose To compare the changes of biomechanical properties, endothelial cell density (ECD), and posterior corneal elevation (PCE) after femtosecond small incision lenticule extractions (SMILEs) with 100 mu m versus 160 mu m cap thicknesses. Methods A total of 12 rabbits were randomly assigned into two groups of 6 each. SMILE was performed at a depth of either 160 mu m (160-cap group) or 100 mu m (100-cap group). Corneal biomechanics, PCE, ECD were evaluated pre-operatively, 1week, 1 month, 2 months, 3 months, and 4 months post-operatively by Pentacam, Corvis ST, in vivo confocal microscopy (IVCM) respectively. The Young's modulus was obtained by strip-extensometry test 4 months after surgery. Results At each time point, the second applanation time (A2T) was similar between the groups with the exception of 4 months after surgery (22.66 +/- 0.16 ms in the 160-cap group versus 21.75 +/- 0.29 ms in the 100-cap group, p = 0.004). Neither deformation amplitude (DA) nor the first applanationtime (A1T) were significantly different between the two groups. The postoperative posterior surface did not shift forward, the changes of PCE and ECD were not significantly different between the two groups at any observation time. Young's modulus was higher in the 160-cap group than that in the 100-cap group with no statistical significance (P>0.05). Regression analyses showed that the PCE changes and Young's modulus were not affected by cap thickness (CT) or residual stromal bed thickness (RBT) (All P>0.05). Conclusions The differences of corneal biomechanics, posterior surface elevation, or ECD changes were quite small when using 100 mu m or 160 mu m cap thicknesses in SMILE.	[He, Miao; Wang, Wei; Zhong, Xingwu] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Ding, Hui; Zhong, Xingwu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Hainan Eye Hosp, Haikou, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhong, XW (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China.; Zhong, XW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Hainan Eye Hosp, Haikou, Hainan, Peoples R China.	zhongxwu@mail.sysu.edu.cn			Science and Technology Planning Project of Guangdong [2013B090200057]; National Natural Science Foundation of China [81371046]	Science and Technology Planning Project of Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Science and Technology Planning Project of Guangdong (2013B090200057) and the National Natural Science Foundation of China (81371046).	Bak-Nielsen S, 2015, CORNEA, V34, P71, DOI 10.1097/ICO.0000000000000293; Buzard K A, 1992, Refract Corneal Surg, V8, P127; Chen XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109577; Ciolino JB, 2006, J CATARACT REFR SURG, V32, P1426, DOI 10.1016/j.jcrs.2006.03.037; El-Massry AA, 2015, CORNEA, V34, P1272, DOI 10.1097/ICO.0000000000000571; Ganesh S, 2015, CLIN OPHTHALMOL, V9, P1359, DOI 10.2147/OPTH.S84354; Guell JL, 2015, J REFRACT SURG, V31, P579, DOI 10.3928/1081597X-20150820-02; Hatami-Marbini H, 2014, ANN BIOMED ENG, V42, P1740, DOI 10.1007/s10439-014-0996-6; Hatami-Marbini H, 2013, EXP EYE RES, V116, P47, DOI 10.1016/j.exer.2013.07.016; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Leung CKS, 2013, INVEST OPHTH VIS SCI, V54, P2885, DOI 10.1167/iovs.12-11563; Mastropasqua L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290619; MCPHEE TJ, 1985, INVEST OPHTH VIS SCI, V26, P869; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Reinstein DZ, 2013, J REFRACT SURG, V29, P454, DOI 10.3928/1081597X-20130617-03; Salvetat ML, 2015, J GLAUCOMA, V24, P568, DOI 10.1097/IJG.0000000000000133; Schmack I, 2005, J REFRACT SURG, V21, P433; Seiler T, 1992, Refract Corneal Surg, V8, P139; Tejwani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097591; Tian L, 2016, ACTA OPHTHALMOL, V94, pe317, DOI 10.1111/aos.12672; Wang DY, 2014, J REFRACT SURG, V30, P702, DOI 10.3928/1081597X-20140903-09; Wang Z, 1999, OPHTHALMOLOGY, V106, P406, DOI 10.1016/S0161-6420(99)90083-0; Wilson SE, 2000, CORNEA, V19, P417, DOI 10.1097/00003226-200007000-00001; Wu D, 2014, J CATARACT REFR SURG, V40, P954, DOI 10.1016/j.jcrs.2013.07.056; Zhang H, 2015, CONTACT LENS ANTERIO, V38, P334, DOI 10.1016/j.clae.2015.03.011	27	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163259	10.1371/journal.pone.0163259	http://dx.doi.org/10.1371/journal.pone.0163259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655417	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892700047
J	Song, DS; Chang, UI; Choi, S; Jung, YD; Han, K; Ko, SH; Ahn, YB; Yang, JM				Song, Do Seon; Chang, U. Im; Choi, Sooa; Jung, Yun Duk; Han, Kyungdo; Ko, Seung-Hyun; Ahn, Yu-Bae; Yang, Jin Mo			Heavy Alcohol Consumption with Alcoholic Liver Disease Accelerates Sarcopenia in Elderly Korean Males: The Korean National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; GLOBAL BURDEN; RISK-FACTOR; MYOPATHY; MEN; MORTALITY; CIRRHOSIS	Background and Aim Although a few studies have reported that sarcopenia is associated with alcoholic liver disease (ALD), no studies have investigated this association in a large sample representative of the elderly Korean population. Methods This was a cross-sectional study that used data from the Fourth and Fifth Korean National Health and Nutrition Examination Surveys (KNHANES) on subjects aged 65 years and older. Sarcopenia was defined as a skeletal muscle index (SMI) more than 1 SD below the gender-specific mean for young adults; SMI was calculated as the appendicular muscle mass divided by height squared (ASM/Ht(2)). Heavy alcohol consumption was defined as consuming at least 210 g/week, and elevated liver enzymes were defined as alanine aminotransferase levels of at least 32 U/L or aspartate aminotransferase levels of at least 34 U/L. ALD was defined as heavy alcohol consumption and elevated liver enzymes. Results The mean age of the 1,151 elderly males was 71.6 +/- 0.2 years, and the prevalence of heavy alcohol consumption was 11.8% (136 subjects). SMI did not differ between the nonheavy and heavy alcohol consumer groups (7.1 +/- 0.0 kg/m(2) vs. 7.3 +/- 0.1 kg/m(2), respectively, P = 0.145). However, after stratifying by the presence of liver disease and heavy alcohol consumption and adjusting for other confounders in the multivariate logisticregression, SMI was significantly lower among heavy alcohol consumers with ALD (all P < 0.05). Additionally, two-way ANOVA showed a significant interaction between heavy alcohol consumption and liver disease (P = 0.011). Conclusion Sarcopenia was accelerated in the elderly male ALD group, with a significant interaction between alcohol consumption and liver disease.	[Song, Do Seon; Chang, U. Im; Choi, Sooa; Jung, Yun Duk; Yang, Jin Mo] Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Hepatol,Dept Internal Med, Suwon, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Ko, Seung-Hyun; Ahn, Yu-Bae] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Yang, JM (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Div Hepatol,Dept Internal Med, Suwon, South Korea.; Ahn, YB (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Suwon, South Korea.	ybahn@catholic.ac.kr; jmyangdr@catholic.ac.kr		Song, Do Seon/0000-0002-8278-4878				Adachi J, 2003, J NUTR BIOCHEM, V14, P616, DOI 10.1016/S0955-2863(03)00114-1; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Baek SJ, 2014, J ENDOCRINOL INVEST, V37, P247, DOI 10.1007/s40618-013-0011-3; CAPOCACCIA L, 1994, J HEPATOL, V21, P317; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DUANE P, 1987, CLIN SCI, V73, P601, DOI 10.1042/cs0730601; DUANE P, 1988, ALCOHOL ALCOHOLISM, V23, P271; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Hanck C, 2000, J HEPATOL, V32, P51, DOI 10.1016/S0168-8278(00)80189-0; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Hill DB, 2000, J LAB CLIN MED, V135, P387, DOI 10.1067/mlc.2000.106451; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Huisman EJ, 2011, EUR J GASTROEN HEPAT, V23, P982, DOI 10.1097/MEG.0b013e32834aa4bb; Ishii S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112718; Kim SH, 2013, ARCH GERONTOL GERIAT, V56, P472, DOI 10.1016/j.archger.2012.12.009; Kim TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146745; Kim TY, 2014, J KOREAN MED SCI, V29, P1253, DOI 10.3346/jkms.2014.29.9.1253; Ko MJ, 2015, BRIT J NUTR, V114, P1838, DOI 10.1017/S0007114515003633; Landi F, 2014, CURR OPIN CLIN NUTR, V17, P25, DOI 10.1097/MCO.0000000000000018; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MARTIN F, 1985, Q J MED, V55, P233; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McClain CJ, 2011, ALCOHOL CLIN EXP RES, V35, P815, DOI 10.1111/j.1530-0277.2010.01405.x; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; MILLS KR, 1986, ALCOHOL ALCOHOLISM, V21, P357; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Preedy VR, 2001, DRUG ALCOHOL DEPEN, V63, P199, DOI 10.1016/S0376-8716(00)00219-2; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Singal AK, 2012, CLIN LIVER DIS, V16, P805, DOI 10.1016/j.cld.2012.08.009; Sohn W, 2013, J GASTROEN HEPATOL, V28, P522, DOI 10.1111/j.1440-1746.2012.07143.x; Steffl M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0270-x; Steiner JL, 2014, J APPL PHYSIOL, V117, P1170, DOI 10.1152/japplphysiol.00180.2014; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Thapaliya S, 2014, AUTOPHAGY, V10, P677, DOI 10.4161/auto.27918; Vargas R, 2008, ALCOHOL CLIN EXP RES, V32, P128, DOI 10.1111/j.1530-0277.2007.00548.x; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326	43	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163222	10.1371/journal.pone.0163222	http://dx.doi.org/10.1371/journal.pone.0163222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655344	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700044
J	Borowski, Z; Swislocka, M; Matosiuk, M; Mirski, P; Krysiuk, K; Czajkowska, M; Borkowska, A; Ratkiewicz, M				Borowski, Zbigniew; Swislocka, Magdalena; Matosiuk, Maciej; Mirski, Pawel; Krysiuk, Kamil; Czajkowska, Magdalena; Borkowska, Anetta; Ratkiewicz, Miroslaw			Purifying Selection, Density Blocking and Unnoticed Mitochondrial DNA Diversity in the Red Deer, Cervus elaphus	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; GENETIC-STRUCTURE; PHYLOGEOGRAPHY; IDENTIFICATION; RESPONSES; CERVIDAE; SEQUENCE; ANCIENT; HISTORY; CLIMATE	The trajectories of postglacial range expansions, the occurrence of lineage patches and the formation and maintenance of secondary contact between lineages may mostly reflect neutral demographic processes, including density blocking, that may leave long-lasting genetic signatures. However, a few studies have recently shown that climate may also play a role. We used red deer, a large, mobile herbivore that is assumed to be sensitive to climate change, to test hypotheses of possible selection on the mitochondrial DNA cytochrome b gene (mtDNA cytb) and competitive and/or density-blocking (using mtDNA control region). We searched for a possible link between the phylogeographic structure and abiotic climatic variables. Finally, we tested for isolation by distance and isolation by environment and assessed the impact of human-mediated translocations on the genetic structure of red deer. Our analysis of 30 red deer populations in Poland using the mtDNA control region (N = 357) and cytochrome b (N = 50) markers not only confirmed the presence of the Western and South-Eastern lineages of the species but also indicated the presence of a previously unnoticed, rare relic haplotype that grouped together C. e. italicus from Italy (the Mesola deer). No significant signs of positive selection were detected for the mtDNA cytb gene in the studied red deer. However, a significant signal for purifying selection was found in our study that may explain the narrowness of the contact zone because gene flow between the Western and South-Eastern lineages should drive relatively strong mito-nuclear incompatibilities. MtDNA control region differentiation among red deer populations in Poland correlated with different abiotic climatic variables. Strikingly, the southernmost ice sheet limits during the Elsterian was the most important factor, and it explained the largest amount of variation. However, neither isolation by distance (IBD) nor isolation by environment (IBE) were recorded, and a very limited impact of human translocations was evident. The abovementioned results suggest that in contemporary red deer populations in Poland, the phylogeographic pattern is well preserved, and long-term processes (density and/or competitive blocking) still play a major role.	[Borowski, Zbigniew; Krysiuk, Kamil] Forest Res Inst, Dept Forest Ecol, Raszyn, Poland; [Swislocka, Magdalena; Matosiuk, Maciej; Mirski, Pawel; Czajkowska, Magdalena; Borkowska, Anetta; Ratkiewicz, Miroslaw] Univ Bialystok, Inst Biol, Bialystok, Poland	Forest Research Institute; University of Bialystok	Swislocka, M (corresponding author), Univ Bialystok, Inst Biol, Bialystok, Poland.	magdaswi@uwb.edu.pl	Ratkiewicz, Mirosław/AAI-9035-2020; Borowski, Zbigniew/AAL-6483-2021; Borowski, Zbigniew/AAI-6571-2020; Mirski, Paweł/GXM-8764-2022; Borowski, Zbigniew/AAF-5230-2020	Ratkiewicz, Mirosław/0000-0003-2929-3612; Borowski, Zbigniew/0000-0003-4109-5205; Matosiuk, Maciej/0000-0001-9595-690X; Swislocka, Magdalena/0000-0002-1808-9037; Mirski, Pawel/0000-0003-1251-6365; Czajkowska, Magdalena/0000-0001-8851-9664; Borkowska, Anetta/0000-0002-8711-454X	Forest Research Institute [24-01-08]; General Directorate of Polish Forestry [500-430]; University of Bialystok [BST-102]	Forest Research Institute; General Directorate of Polish Forestry; University of Bialystok	Funded by Forest Research Institute, grant no. 24-01-08 to ZB; General Directorate of Polish Forestry (grant no. 500-430 to ZB; University of Bialystok, BST-102 to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Anderson M. J, 2004, DISTLM V 5 FORTRAN C, P10; Balloux F, 2009, P ROY SOC B-BIOL SCI, V276, P3447, DOI 10.1098/rspb.2009.0752; Borowik T, 2013, ACTA THERIOL, V58, P403, DOI 10.1007/s13364-013-0153-x; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Chikuni K, 1995, J MOL EVOL, V41, P859, DOI 10.1007/BF00173165; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehlers J, 2004, DEV QUA SCI, V2, P135; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feulner PGD, 2004, HEREDITY, V93, P299, DOI 10.1038/sj.hdy.6800504; Filipi K, 2015, MOL PHYLOGENET EVOL, V82, P245, DOI 10.1016/j.ympev.2014.10.016; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Krojerova-Prokesova J, 2015, J HERED, V106, P375, DOI 10.1093/jhered/esv018; Lorenc H., 2005, ATLAS KLIMATU POLSKI, P116; Lorenzini R, 2015, J ZOOL SYST EVOL RES, V53, P340, DOI 10.1111/jzs.12104; Matosiuk M, 2014, MOL ECOL, V23, P2559, DOI 10.1111/mec.12745; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Meiri M, 2013, MOL ECOL, V22, P4711, DOI 10.1111/mec.12420; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Niedzialkowska M, 2012, CAN J ZOOL, V90, P150, DOI [10.1139/Z11-122, 10.1139/z11-122]; Niedzialkowska M, 2011, ACTA THERIOL, V56, P1, DOI 10.1007/s13364-010-0002-0; Pakeman RJ, 2004, J ECOL, V92, P893, DOI 10.1111/j.0022-0477.2004.00928.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Searle JB, 2009, P ROY SOC LOND B BIO, DOI [10.1098/j.666.2009.1422, DOI 10.1098/4666.2009.1422]; Skog A, 2009, J BIOGEOGR, V36, P66, DOI 10.1111/j.1365-2699.2008.01986.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stojak J, 2015, BIOL J LINN SOC, V115, P927, DOI 10.1111/bij.12535; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wojcik JM, 2010, J ZOOL, V281, P249, DOI 10.1111/j.1469-7998.2010.00699.x; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zachos FE, 2014, ITAL J ZOOL, V81, P136, DOI 10.1080/11250003.2014.895060; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	45	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163191	10.1371/journal.pone.0163191	http://dx.doi.org/10.1371/journal.pone.0163191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649313	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100065
J	Bourgeois, JS; Jacob, J; Garewal, A; Ndahayo, R; Paxson, J				Bourgeois, Jeffrey S.; Jacob, Jeeva; Garewal, Aram; Ndahayo, Renata; Paxson, Julia			The Bioavailability of Soluble Cigarette Smoke Extract Is Reduced through Interactions with Cells and Affects the Cellular Response to CSE Exposure	PLOS ONE			English	Article							IN-VITRO; LUNG FIBROBLASTS; OXIDATIVE STRESS; DISEASE; VIVO; TOXICITY; DAMAGE; COPD	Cellular exposure to cigarette smoke leads to an array of complex responses including apoptosis, cellular senescence, telomere dysfunction, cellular aging, and neoplastic transformation. To study the cellular response to cigarette smoke, a common in vitro model exposes cultured cells to a nominal concentration (i.e. initial concentration) of soluble cigarette smoke extract (CSE). However, we report that use of the nominal concentration of CSE as the only measure of cellular exposure is inadequate. Instead, we demonstrate that cellular response to CSE exposure is dependent not only on the nominal concentration of CSE, but also on specific experimental variables, including the total cell number, and the volume of CSE solution used. As found in other similar xenobiotic assays, our work suggests that the effective dose of CSE is more accurately related to the amount of bioavailable chemicals per cell. In particular, interactions of CSE components both with cells and other physical factors limit CSE bioavailability, as demonstrated by a quantifiably reduced cellular response to CSE that is first modified by such interactions. This has broad implications for the nature of cellular response to CSE exposure, and for the design of in vitro assays using CSE.	[Bourgeois, Jeffrey S.; Jacob, Jeeva; Garewal, Aram; Ndahayo, Renata; Paxson, Julia] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA	College of the Holy Cross	Paxson, J (corresponding author), Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA.	jpaxson@holycross.edu		Bourgeois, Jeffrey/0000-0001-9037-8418	College of the Holy Cross; Holy Cross Summer Research Fund	College of the Holy Cross; Holy Cross Summer Research Fund	Funding was provided by the College of the Holy Cross, and by the Holy Cross Summer Research Fund.	Ahmed A, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-25; Birch J, 2015, AM J PHYSIOL-LUNG C, V309, pL1124, DOI 10.1152/ajplung.00293.2015; Burney P, 2015, INT J TUBERC LUNG D, V19, P10, DOI 10.5588/ijtld.14.0446; Camlin NJ, 2014, TOXICOL APPL PHARM, V281, P266, DOI 10.1016/j.taap.2014.10.010; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Doskey CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132572; Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001; Fowles J, 2003, TOB CONTROL, V12, P424, DOI 10.1136/tc.12.4.424; Franks TJ, 2015, ARCH PATHOL LAB MED, V139, P974, DOI 10.5858/arpa.2013-0384-RA; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Gulden M, 2015, TOXICOLOGY, V332, P41, DOI 10.1016/j.tox.2013.11.006; Higashi T, 2016, BIOL PHARM BULL, V39, P898, DOI 10.1248/bpb.b16-00062; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jack J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-109; Jennings P, 2015, TOXICOL IN VITRO, V29, P1217, DOI 10.1016/j.tiv.2014.08.011; Jiang B, 2013, J MED FOOD, V16, P481, DOI 10.1089/jmf.2012.2686; Johnson MD, 2009, CANCER EPIDEM BIOMAR, V18, P3263, DOI [10.1158/1055-9965.EPI-09-0965, DOI 10.1158/1055-9965.EPI-09-0965]; Kanaji N, 2014, AM J PHYSIOL-LUNG C, V307, pL364, DOI 10.1152/ajplung.00041.2014; Kim SY, 2012, AM J PHYSIOL-LUNG C, V302, pL891, DOI 10.1152/ajplung.00288.2011; Lallier TE, 2015, J PERIODONTOL, V86, P91, DOI 10.1902/jop.2014.140319; Lee CH, 2015, ONCOTARGET, V6, P25188, DOI 10.18632/oncotarget.4512; Lee H, 2016, TOXICOL LETT, V240, P140, DOI 10.1016/j.toxlet.2015.10.030; Lemaitre V, 2011, TOXICOL SCI, V123, P542, DOI 10.1093/toxsci/kfr181; Lu B, 2007, TOXICOL SCI, V98, P469, DOI 10.1093/toxsci/kfm112; Marcilla A, 2012, FOOD CHEM TOXICOL, V50, P1317, DOI 10.1016/j.fct.2012.01.046; Ojo O, 2014, PULM PHARMACOL THER, V29, P121, DOI 10.1016/j.pupt.2014.04.004; SHERMAN CB, 1991, CLIN CHEST MED, V12, P643; Stewart R, 2014, EUR HEART J, V35, P2265; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Zuo L, 2014, AM J PHYSIOL-LUNG C, V307, pL205, DOI 10.1152/ajplung.00330.2013	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163182	10.1371/journal.pone.0163182	http://dx.doi.org/10.1371/journal.pone.0163182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649082	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100064
J	Dawson, KS; Bryant, RA				Dawson, Katie S.; Bryant, Richard A.			Children's Vantage Point of Recalling Traumatic Events	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MATERNAL REMINISCING STYLE; LONG-TERM RETENTION; AUTOBIOGRAPHICAL MEMORY; FOLLOW-UP; GENDER-DIFFERENCES; EARLIEST MEMORIES; SELF-DESCRIPTION; ADOLESCENTS; EMERGENCE	This study investigated the recollections of child survivors of the 2004 Asian tsunami in terms of their vantage point and posttraumatic stress disorder (PTSD) responses. Five years after the tsunami, 110 children (aged 7-13 years) living in Aceh, Indonesia were assessed for source of memories of the tsunami (personal memory or second-hand source), vantage point of the memory, and were administered the Children's Revised Impact of Event Scale-13. Fifty-three children (48%) met criteria for PTSD. Two-thirds of children reported direct memories of the tsunami and one-third reported having memories based on reports from other people. More children (97%) who reported an indirect memory of the tsunami recalled the event from an onlooker's perspective to some extent than those who recalled the event directly (63%). Boys were more likely to rely on stories from others to reconstruct their memory of the tsunami, and to adopt an observer perspective. Boys who adopted an observer's perspective had less severe PTSD than those who adopted a field perspective. These findings suggest that, at least in the case of boys, an observer perspectives of trauma can be associated with levels of PTSD.	[Dawson, Katie S.; Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Bryant, RA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	Australian Research Council Linkage Grant [LP100100702]	Australian Research Council Linkage Grant(Australian Research Council)	This project was funded by the Australian Research Council Linkage Grant (LP100100702) awarded to RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by an ARC Linkage Grant (LP100100702).	Bauer P.J., 2007, REMEMBERING TIMES OU; Bauer PJ, 2007, CURR DIR PSYCHOL SCI, V16, P142, DOI 10.1111/j.1467-8721.2007.00492.x; Bauer PJ, 2003, MEMORY, V11, P27, DOI 10.1080/741938176; Berntsen D, 2006, PSYCHOL AGING, V21, P127, DOI 10.1037/0882-7974.21.1.127; Berntsen D, 2006, COGNITION EMOTION, V20, P1193, DOI 10.1080/02699930500371190; BRAINERD CJ, 1990, MONOGR SOC RES CHILD, V55, P1, DOI 10.1111/j.1540-5834.1990.tb00287.x; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Correa S, 2014, APA HDB SEXUALITY PS, V2, P267; Dawson K, 2014, E SUSSEX ROUTLEDGE, P210; Dawson KS, 2014, PSYCHOL TRAUMA-US, V6, P580, DOI 10.1037/a0037140; Dawson KS, TRANSCULT P IN PRESS; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fivush R, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P149; Fivush R, 2006, CHILD DEV, V77, P1568, DOI 10.1111/j.1467-8624.2006.00960.x; Fivush R, 2011, ANNU REV PSYCHOL, V62, P559, DOI 10.1146/annurev.psych.121208.131702; Fletcher Kenneth E., 1996, P242; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; GREEN BL, 1994, J AM ACAD CHILD PSY, V33, P71, DOI 10.1097/00004583-199401000-00011; Grysman A, 2013, DEV REV, V33, P239, DOI 10.1016/j.dr.2013.07.004; HOWE ML, 1994, CONSCIOUS COGN, V3, P327, DOI 10.1006/ccog.1994.1019; HOWE ML, 1995, DEV PSYCHOL, V31, P579, DOI 10.1037/0012-1649.31.4.579; Jack F, 2009, CHILD DEV, V80, P496, DOI 10.1111/j.1467-8624.2009.01274.x; Jobson L, 2008, BRIT J CLIN PSYCHOL, V47, P95, DOI 10.1348/014466507X235953; Kenny LM, 2007, BEHAV RES THER, V45, P1915, DOI 10.1016/j.brat.2006.09.004; Kenny LM, 2009, PSYCHOL SCI, V20, P1049, DOI 10.1111/j.1467-9280.2009.02393.x; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; MacDonald S, 2000, MEMORY, V8, P365, DOI 10.1080/09658210050156822; McAdams D.P., 2001, REV GEN PSYCHOL, V5, P100, DOI [10.1037/1089-2680.5.2.100, DOI 10.1037/1089-2680.5.2.100]; McIsaac H. K., 2002, PSYCHONOMIC B REV, V9, P409; McIsaac HK, 2004, PSYCHOL SCI, V15, P248, DOI 10.1111/j.0956-7976.2004.00660.x; McNally Richard J., 2003, REMEMBERING TRAUMA; Meiser-Stedman R, 2002, CLIN CHILD FAM PSYCH, V5, P217, DOI 10.1023/A:1020982122107; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Tan NT, 2007, J SOC WORK DISABIL R, V5, P43, DOI 10.1300/J198v05n03_03; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norton GR, 2004, COGNITIVE BEHAV THER, V33, P112; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Peterson C, 2011, CHILD DEV, V82, P1092, DOI 10.1111/j.1467-8624.2011.01597.x; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pohl RF, 2005, APPL COGNITIVE PSYCH, V19, P745, DOI 10.1002/acp.1104; ROSENHECK R, 1985, HOSP COMMUNITY PSYCH, V36, P538; Rubin DC, 2000, MEMORY, V8, P265, DOI 10.1080/096582100406810; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Shaw JA, 1996, J AM ACAD CHILD PSY, V35, P359, DOI 10.1097/00004583-199603000-00018; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Smith P, 2001, J CHILD PSYCHOL PSYC, V42, P395, DOI 10.1017/S0021963001007065; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Wang Q, 2004, DEV PSYCHOL, V40, P3, DOI 10.1037/0012-1649.40.1.3; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Wickrama KAS, 2007, SOC SCI MED, V64, P713, DOI 10.1016/j.socscimed.2006.09.031; Williams AD, 2007, BEHAV RES THER, V45, P1141, DOI 10.1016/j.brat.2006.09.005	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162030	10.1371/journal.pone.0162030	http://dx.doi.org/10.1371/journal.pone.0162030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649299	Green Published, gold			2022-12-27	WOS:000383892100011
J	McCarthy, D; Windsor, PA; Harris, C; Lomax, S; White, PJ				McCarthy, Dominique; Windsor, Peter Andrew; Harris, Charissa; Lomax, Sabrina; White, Peter John			Effect of Topically Applied Anaesthetic Formulation on the Sensitivity of Scoop Dehorning Wounds in Calves	PLOS ONE			English	Article							CORTISOL RESPONSES; LOCAL-ANESTHESIA; TAIL DOCKING; BEEF-CATTLE; PAIN; ALLEVIATION; DURATION; LAMBS	The post-operative effects of three formulations of topical anaesthetic and a cornual nerve block on the sensitivity of scoop dehorning wounds in calves were compared in two trials. In Trial 1, 21 female Holstein dairy calves aged 8 to 24 weeks were randomly allocated to two groups: (1) scoop dehorning with a post-operative application of a novel topical anaesthetic powder (DTAP, n = 10); and (2) scoop dehorning with a post-operative application of a novel topical anaesthetic ethanol liquid (DTAE, n = 11). In Trial 2, 18 castrated male and 18 female Hereford beef calves aged 16 to 20 weeks were randomly allocated to four groups: (1) scoop dehorning with a pre-operative cornual nerve block of lignocaine (DCB, n = 9); (2) scoop dehorning with a post-operative application of the novel topical anaesthetic ethanol liquid from Trial 1 (DTAE, n = 9); (3) scoop dehorning with a post-operative application of a topical anaesthetic gel (DTAG, n = 9); and (4) sham dehorning (CON, n = 9). Sensitivity was assessed by scoring the behavioural response of calves to stimulation of the wound or skin at time points before and after treatment. In Trial 1, DTAP calves had a greater probability of displaying more severe responses than DTAE calves at 90 and 180 min (P < 0.001). In Trial 2, at 1 h, DTAG calves had a greater probability of displaying more severe responses than CON calves. At 2 h onwards, all dehorned calves had a greater probability of displaying more severe responses than CON calves (P < 0.001). There were no differences between the responses of DCB, DTAG and DTAE calves at any time point. Topical anaesthetic formulations result in almost immediate but temporary anaesthesia of the wound following scoop dehorning in calves and may provide a practical option for pain relief on-farm.	[McCarthy, Dominique; Windsor, Peter Andrew; Harris, Charissa; Lomax, Sabrina; White, Peter John] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Sydney	McCarthy, D (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	dominique.mccarthy@sydney.edu.au	White, Peter J/B-5208-2013; Van der Saag, Dominique/Z-2878-2019	Van der Saag, Dominique/0000-0002-1127-7529; Lomax, Sabrina/0000-0002-6417-5788	Meat and Livestock Australia [P.PSH.0654]	Meat and Livestock Australia(Meat and Livestock Australia)	This work was funded by Meat and Livestock Australia (http://www.mla.com.au/Home). The grant number for this funding is P.PSH.0654. Topical anaesthetic products were supplied by Bayer Animal Health Australia (https://www.bayer.com.au/en/about/profile-and-organisation/animal-health/). Meat and Livestock Australia and Bayer Animal Health Australia had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Meat and Livestock Australia approves the publication of this manuscript.	Brofeldt B T, 1989, J Burn Care Rehabil, V10, P63, DOI 10.1097/00004630-198901000-00009; Clarke K. W., 2014, VET ANAESTHESIA, P313; CSIRO, 2015, BREED HORNL CATTL; Edmondson MA, 2014, FARM ANIMAL ANESTHESIA: CATTLE, SMALL RUMINANTS, CAMELIDS, AND PIGS, P136; Espinoza C, 2013, J DAIRY SCI, V96, P2894, DOI 10.3168/jds.2012-5954; Espinoza C., 2015, ANIM PROD SCI; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Irwin J, 1998, DEHORNING CATTLE; Kupczynski R, 2014, ANN ANIM SCI, V14, P231, DOI 10.2478/aoas-2014-0016; Lomax S, 2008, AUST VET J, V86, P159, DOI 10.1111/j.1751-0813.2008.00285.x; Lomax S, 2013, J ANIM SCI, V91, P4945, DOI 10.2527/jas.2012-5984; Lomax S, 2013, AUST VET J, V91, P160, DOI 10.1111/avj.12031; Lomax S, 2010, AUST VET J, V88, P67, DOI 10.1111/j.1751-0813.2009.00546.x; McMeekan CM, 1998, AUST VET J, V76, P281, DOI 10.1111/j.1751-0813.1998.tb10160.x; Meyer RA, 2005, J HOPKINS APL TECH D, V26, P56; Petherick JC, 2005, APPL ANIM BEHAV SCI, V92, P211, DOI 10.1016/j.applanim.2005.05.009; Petrie NJ, 1996, NEW ZEAL VET J, V44, P4, DOI 10.1080/00480169.1996.35923; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Redua MA, 2002, VET ANAESTH ANALG, V29, P200, DOI 10.1046/j.1467-2995.2002.00083.x; Stafford K. J., 2009, Improving animal welfare: a practical approach, P88, DOI 10.1079/9781845935412.0088; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Sutherland MA, 2002, RES VET SCI, V73, P115, DOI 10.1016/S0034-5288(02)00005-X; Sylvester SP, 2004, AUST VET J, V82, P697, DOI 10.1111/j.1751-0813.2004.tb12162.x; Sylvester SP, 1998, AUST VET J, V76, P118, DOI 10.1111/j.1751-0813.1998.tb14542.x; Thompson T., 2015, ABARES RES REPORT PR; Windsor PA, 2016, SMALL RUMIN IN PRESS	26	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163181	10.1371/journal.pone.0163181	http://dx.doi.org/10.1371/journal.pone.0163181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648948	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100063
J	Nayir, T; Uskun, E; Yurekli, MV; Devran, H; Celik, A; Okyay, RA				Nayir, Tufan; Uskun, Ersin; Yurekli, Mustafa Volkan; Devran, Hacer; Celik, Ayse; Okyay, Ramazan Azim			Does Body Image Affect Quality of Life?: A Population Based Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MARITAL-STATUS; ADOLESCENT FEMALES; NUTRITIONAL-STATUS; WEIGHT CONTROL; HEALTH; DISSATISFACTION; BEHAVIORS; EXERCISE; ADULTS	Body image (BI) can be described as the assessment of both positive and negative emotion for one's own body parts and their characteristics by himself or herself. Current research has concentrated mostly on the status of negative BI as a risk factor for mental health problems rather than as a public health problem, thereby little is known about the effects of BI on quality of life. Thus, the purpose of this study was to assess the BI and Quality of Life (QoL) of individuals and to investigate the relationship between the two. Individuals over 15 living in Isparta city center constitute the universe of this cross-sectional analytical study, carried out in 2014. The BI of individuals was measured by the Body Image Scale and The QoL of individuals was measured using the World Health Organization (WHO) Quality of Life Scale Short Form. The mean age of the participants was 31.9 +/- 13.0 and 56.0% were female, 36.8% were married and 81.7% had education above high school. 25.7% had at least one chronic disease and 17.7% received medication regularly. Having good-very good health perception, having higher income than expenses, making regular exercises were predictors in enhancing the quality of life in certain aspects, however having a good body image came out as a predictor enhancing the quality of life in all sub-domains. BI was found closely related with QoL in all sub-domains. Our findings suggest that greater attention should be to be given to BI as a strong predictor of QoL.	[Nayir, Tufan] Mersin Publ Hlth Directorate, Dept Adm, Mersin, Turkey; [Uskun, Ersin; Yurekli, Mustafa Volkan; Devran, Hacer; Celik, Ayse] Suleyman Demirel Univ, Dept Publ Hlth, Fac Med, Isparta, Turkey; [Okyay, Ramazan Azim] Ceyhan Community Hlth Ctr, Dept Communicable Dis, Adana, Turkey	Mersin State Hospital; Suleyman Demirel University	Okyay, RA (corresponding author), Ceyhan Community Hlth Ctr, Dept Communicable Dis, Adana, Turkey.	razim01@gmail.com	Nayir, Tufan/HHS-7629-2022; Okyay, Ramazan A./C-9299-2016; Okyay, Ramazan Azim/AAC-5703-2020	Nayir, Tufan/0000-0003-4810-5410; 				Adeyemo TA, 2015, PEDIATR BLOOD CANCER, V62, P1245, DOI 10.1002/pbc.25503; Hidalgo-Rasmussen CA, 2011, CAD SAUDE PUBLICA, V27, P67, DOI 10.1590/S0102-311X2011000100007; Alleva JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139177; [Anonymous], 1993, PSIKIYATRI PSIKOLOJI, V1, P26; Appleton KM, 2013, J HEALTH PSYCHOL, V18, P110, DOI 10.1177/1359105311434756; Asian D., 2004, STED, V13, P326; Bardone AM, 2000, BEHAV THER, V31, P265, DOI 10.1016/S0005-7894(00)80015-5; Bergstrom E, 2000, J ADOLESCENT HEALTH, V26, P43, DOI DOI 10.1016/S1054-139X(99)00058-0; Bodnar R, 2015, ADV CLIN EXP MED, V24, P487, DOI 10.17219/acem/24991; Campbell A, 2009, J HEALTH PSYCHOL, V14, P780, DOI 10.1177/1359105309338977; Chung H, 2005, STAT MED, V24, P2895, DOI 10.1002/sim.2148; Clark Matthew M, 2005, Body Image, V2, P263, DOI 10.1016/j.bodyim.2005.05.002; Donaghue N, 2009, BODY IMAGE, V6, P37, DOI 10.1016/j.bodyim.2008.08.002; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Eser E., 1999, DERGISI, V7, P23; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; Friedman KE, 2002, OBES RES, V10, P33, DOI 10.1038/oby.2002.5; Hall EE, 2011, J HEALTH PSYCHOL, V16, P938, DOI 10.1177/1359105310396394; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Hardoy Maria Carolina, 2011, Clin Pract Epidemiol Ment Health, V7, P157, DOI 10.2174/1745017901107010157; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holmqvist K, 2010, EUR EAT DISORD REV, V18, P133, DOI 10.1002/erv.965; Jaworowska A, 2009, BIOMED PHARMACOTHER, V63, P679, DOI 10.1016/j.biopha.2008.08.005; Kenny C, 2005, SOC INDIC RES, V73, P199, DOI 10.1007/s11205-004-0986-4; Kim HK, 2002, J FAM ISSUES, V23, P885, DOI 10.1177/019251302237296; Kim K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119245; Kotsis K, 2014, EXPERT REV PHARM OUT, V14, P857, DOI 10.1586/14737167.2014.957679; Meland E, 2007, HEALTH EDUC RES, V22, P342, DOI 10.1093/her/cyl085; Mond J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-920; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; Muennig P, 2008, AM J PUBLIC HEALTH, V98, P501, DOI 10.2105/AJPH.2007.114769; Mummery K, 2004, AUST NZ J PUBL HEAL, V28, P188, DOI 10.1111/j.1467-842X.2004.tb00934.x; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Okano Y, 2004, CLIN EXP HYPERTENS, V26, P145, DOI 10.1081/CEH-120028553; Pienta AM, 2000, J FAM ISSUES, V21, P559, DOI 10.1177/019251300021005003; Pinar R., 2002, CUMHURIYET HEM DER, V6, P30; Porto Denilson Braga, 2015, Rev. bras. cineantropom. desempenho hum., V17, P175, DOI 10.5007/1980-0037.2015v17n2p175; Saatcioglu O, 2008, DRUG ALCOHOL REV, V27, P83, DOI 10.1080/09595230701711140; Salehi A, 2015, IRAN J PUBLIC HEALTH, V44, P332; Silva DAS, 2011, BODY IMAGE, V8, P427, DOI 10.1016/j.bodyim.2011.05.009; Schuler BR, 2015, HEALTH SOC WORK, V40, P225, DOI 10.1093/hsw/hlv045; SECORD PF, 1953, J CONSULT PSYCHOL, V17, P343; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Shoff SM, 2013, J CYST FIBROS, V12, P746, DOI 10.1016/j.jcf.2013.01.006; Stewart K, 2005, SOC INDIC RES, V73, P221, DOI 10.1007/s11205-005-2922-7; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; stun E, 2010, U UST DUZEY FUTBOLCU, V2, P157; Tabolli S, 2012, EUR J DERMATOL, V22, P672, DOI 10.1684/ejd.2012.1822; Umberson D, 2009, J HEALTH SOC BEHAV, V50, P327, DOI 10.1177/002214650905000306; Unterhalter Gina, 2007, Eat Behav, V8, P382, DOI 10.1016/j.eatbeh.2006.11.015; Van Dijk AP, 2004, J STUD ALCOHOL, V65, P241, DOI 10.15288/jsa.2004.65.241; Voelker DK, 2015, ADOLESC HEALTH MED T, V6, P149, DOI 10.2147/AHMT.S68344; White MA, 2012, COMPR PSYCHIAT, V53, P403, DOI 10.1016/j.comppsych.2011.05.007; WHO, 1998, WHOQ US MAN; World Health Organization (WHO), 1996, WHOQ BREF INTRO ADM; Yalcin SE, 1999, PSIKIYATRI PSIKOL S2, V7, P5; Ziolkowski A, 2015, ANN AGR ENV MED, V22, P147, DOI 10.5604/12321966.1141385	57	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163290	10.1371/journal.pone.0163290	http://dx.doi.org/10.1371/journal.pone.0163290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649389	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100075
J	Peng, YF; Chen, WC; Xiao, K; Xu, L; Wang, L; Wan, X				Peng, Yun-Feng; Chen, Wen-Chao; Xiao, Kang; Xu, Lin; Wang, Lian; Wan, Xia			DHA Production in Escherichia coli by Expressing Reconstituted Key Genes of Polyketide Synthase Pathway from Marine Bacteria	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PHOSPHOPANTETHEINYL TRANSFERASE GENE; PHOTOBACTERIUM-PROFUNDUM SS9; CUNNINGHAMELLA-ECHINULATA; RECOMBINANT PRODUCTION; DOCOSAHEXAENOIC ACID; STRAIN MP-1; BIOSYNTHESIS; OMEGA-3-FATTY-ACIDS; CERULENIN	The gene encoding phosphopantetheinyl transferase (PPTase), pfaE, a component of the polyketide synthase (PKS) pathway, is crucial for the production of docosahexaenoic acid (DHA, 22: 6 omega 3), along with the other pfa cluster members pfaA, pfaB, pfaC and pfaD. DHA was produced in Escherichia coli by co-expressing pfaABCD from DHA-producing Colwellia psychrerythraea34H with one of four pfaE genes from bacteria producing arachidonic acid (ARA, 20: 4 omega 6), eicosapentaenoic acid (EPA, 20: 5 omega 3) or DHA, respectively. Substitution of the pfaE gene from different strain source in E. coli did not influence the function of the PKS pathway producing DHA, although they led to different DHA yields and fatty acid profiles. This result suggested that the pfaE gene could be switchable between these strains for the production of DHA. The DHA production by expressing the reconstituted PKS pathway was also investigated in different E. coli strains, at different temperatures, or with the treatment of cerulenin. The highest DHA production, 2.2 mg of DHA per gram of dry cell weight or 4.1% of total fatty acids, was obtained by co-expressing pfaE(EPA) from the EPA-producing strain Shewanella baltica with pfaABCD in DH5 alpha. Incubation at low temperature (10-15 degrees C) resulted in higher accumulation of DHA compared to higher temperatures. The addition of cerulenin to the medium increased the proportion of DHA and saturated fatty acids, including C12:0, C14:0 and C16:0, at the expense of monounsaturated fatty acids, including C16: 1 and C18:1. Supplementation with 1 mg/L cerulenin resulted in the highest DHA yield of 2.4 mg/L upon co-expression of pfaE(DHA) from C. psychrerythraea.	[Peng, Yun-Feng; Chen, Wen-Chao; Xiao, Kang; Xu, Lin; Wang, Lian; Wan, Xia] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Wan, Xia] Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wan, X (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.; Wan, X (corresponding author), Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China.	wanxia@oilcrops.cn			National Natural Science Foundation of China [3100078]; 948 project [2015-Z3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 project(Ministry of Agriculture & Rural Affairs)	Support was provided by the National Natural Science Foundation of China (3100078) and 948 project (2015-Z3) to XW.	Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Amiri-Jami M, 2010, J APPL MICROBIOL, V109, P1897, DOI 10.1111/j.1365-2672.2010.04817.x; Amiri-Jami M, 2014, APPL MICROBIOL BIOT, V98, P3071, DOI 10.1007/s00253-013-5381-0; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bunet R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087607; Dubois N, 2006, EUR J LIPID SCI TECH, V108, P28, DOI 10.1002/ejlt.200501217; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gong YM, 2014, PROG LIPID RES, V56, P19, DOI 10.1016/j.plipres.2014.07.001; Guan X, 2015, PLANT J, V84, P718, DOI 10.1111/tpj.13034; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Matsuda T, 2012, J LIPID RES, V53, P2806, DOI 10.1194/jlr.M024935ERR; Morita N, 2005, BIOTECHNOL LETT, V27, P389, DOI 10.1007/s10529-005-1532-4; Napier JA, 2002, TRENDS PLANT SCI, V7, P51, DOI 10.1016/S1360-1385(01)02191-4; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Orikasa Y, 2006, BIOTECHNOL LETT, V28, P1841, DOI 10.1007/s10529-006-9168-6; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Song XJ, 2013, J AGR FOOD CHEM, V61, P9876, DOI 10.1021/jf403153p; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Timmusk S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00387; Trajtenberg F, 2014, FEBS J, V281, P2324, DOI 10.1111/febs.12785; Ujihara T, 2014, FEBS LETT, V588, P4032, DOI 10.1016/j.febslet.2014.09.023; Wan X, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0431-9; Wan X, 2013, MOL BIOL REP, V40, P4483, DOI 10.1007/s11033-013-2540-4; Wan X, 2009, J MICROBIOL BIOTECHN, V19, P1098, DOI 10.4014/jmb.0902.071; Zhou XR, 2013, PHYTOCHEMISTRY, V92, P42, DOI 10.1016/j.phytochem.2013.05.006	32	15	19	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162861	10.1371/journal.pone.0162861	http://dx.doi.org/10.1371/journal.pone.0162861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649078	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100037
J	Dao, TT; Sehgal, P; Tung, TT; Moller, JV; Nielsen, J; Palmgren, M; Christensen, SB; Fuglsang, AT				Dao, Trong Tuan; Sehgal, Pankaj; Tung, Truong Thanh; Moller, Jesper Vuust; Nielsen, John; Palmgren, Michael; Christensen, Soren Brogger; Fuglsang, Anja Thoe			DemethoxycurcuminIs A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM; ANTIFUNGAL TARGET; REGULATORY DOMAIN; DELETION ANALYSIS; INNATE IMMUNITY; CURCUMA-LONGA; CALCIUM-PUMP; YEAST	P-type ATPases catalyze the active transport of cations and phospholipids across biological membranes. Members of this large family are involved in a range of fundamental cellular processes. To date, a substantial number of P-type ATPase inhibitors have been characterized, some of which are used as drugs. In this work a library of natural compounds was screened and we first identified curcuminoids as plasma membrane H+-ATPases inhibitors in plant and fungal cells. We also found that some of the commercial curcumins contain several curcuminoids. Three of these were purified and, among the curcuminoids, demethoxycurcumin was the most potent inhibitor of all tested P-type ATPases from fungal (Pma1p; H+-ATPase), plant (AHA2; H+-ATPase) and animal (SERCA; Ca2+-ATPase) cells. All three curcuminoids acted as non-competitive antagonist to ATP and hence may bind to a highly conserved allosteric site of these pumps. Future research on biological effects of commercial preparations of curcumin should consider the heterogeneity of the material.	[Dao, Trong Tuan; Palmgren, Michael; Fuglsang, Anja Thoe] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Dao, Trong Tuan; Tung, Truong Thanh; Nielsen, John; Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Sehgal, Pankaj; Moller, Jesper Vuust] Univ Aarhus, Dept Biomed, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Fuglsang, AT (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark.	atf@plen.ku.dk	Palmgren, Michael/A-9808-2013; Fuglsang, Anja Thoe/A-6733-2015; Truong, Tung/L-2664-2019; Christensen, Søren Brøgger/H-4526-2019	Palmgren, Michael/0000-0002-9982-6114; Fuglsang, Anja Thoe/0000-0003-1153-8394; Truong, Tung/0000-0002-5263-203X; Christensen, Søren Brøgger/0000-0002-5773-6874; Nielsen, John/0000-0002-2854-8188; Dao, Trong Tuan/0000-0003-4741-1678	University of Copenhagen's Excellency Program KU; Danish National Research Foundation [DNRF85]	University of Copenhagen's Excellency Program KU; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the University of Copenhagen's Excellency Program KU2016 "Plants for a changing world" (SBC, MP) and the Danish National Research Foundation through the "PUMPKIN Center of Excellence" (DNRF85) (JVM, ATF, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Ashraf K, 2015, J CHROMATOGR SCI; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; Billack B, 2010, J ENZYM INHIB MED CH, V25, P312, DOI 10.3109/14756360903179419; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; BRISKIN DP, 1986, ARCH BIOCHEM BIOPHYS, V248, P106, DOI 10.1016/0003-9861(86)90406-6; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; Chauhan S. K., 1999, Indian Journal of Pharmaceutical Sciences, V61, P58; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Dao TT, 2012, FOOD CHEM, V134, P21, DOI 10.1016/j.foodchem.2012.02.015; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Fan L, 2014, BIOMED PHARMACOTHER, V68, P1141, DOI 10.1016/j.biopha.2014.10.014; Fournet A., 2002, TOP MED CHEM, V2, P1215, DOI DOI 10.2174/1568026023393011; Ganiger S, 2007, FOOD CHEM TOXICOL, V45, P64, DOI 10.1016/j.fct.2006.07.016; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Huang K.C., 1998, PHARM CHINESE HERBS; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Kim MK, 2003, J AGR FOOD CHEM, V51, P1578, DOI 10.1021/jf0210369; KIUCHI F, 1993, CHEM PHARM BULL, V41, P1640, DOI 10.1248/cpb.41.1640; Kongstad KT, 2015, FITOTERAPIA, V105, P102, DOI 10.1016/j.fitote.2015.06.013; Kongstad KT, 2014, J AGR FOOD CHEM, V62, P5595, DOI 10.1021/jf501605z; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; Lund Anette, 2012, Methods Mol Biol, V913, P217, DOI 10.1007/978-1-61779-986-0_14; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Moller JV, 2016, METHODS MOL BIOL, V1377, P11, DOI 10.1007/978-1-4939-3179-8_3; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MONK BC, 1994, CRIT REV MICROBIOL, V20, P209, DOI 10.3109/10408419409114555; Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117; Doan NTQ, 2015, CURR PHARM DESIGN, V21, P5501, DOI 10.2174/1381612821666151002112824; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Ostrowski W, 2013, J SPECTROSC, V2013, DOI 10.1155/2013/749641; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; PALMGREN MG, 1993, FEBS LETT, V317, P216, DOI 10.1016/0014-5793(93)81279-9; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmgren MG, 2011, PLANT CELL MONOGR, V19, P177, DOI 10.1007/978-3-642-13431-9_7; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Pfeiffer E, 2003, J FOOD ENG, V56, P257, DOI 10.1016/S0260-8774(02)00264-9; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; Rasmussen HB, 2000, PLANTA MED, V66, P396, DOI 10.1055/s-2000-8533; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SCHULTHEIS PJ, 1993, J BIOL CHEM, V268, P22686; Sehgal P, 2016, METHODS MOL BIOL, V1377, P105, DOI 10.1007/978-1-4939-3179-8_11; SetoYoung D, 1997, BBA-BIOMEMBRANES, V1326, P249, DOI 10.1016/S0005-2736(97)00028-X; Sharma M, 2010, FEMS YEAST RES, V10, P570, DOI 10.1111/j.1567-1364.2010.00637.x; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shukla A, 2012, CELL MOL BIOL, V58, P182, DOI 10.1170/T939; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Soteropoulos P, 2000, ANTIMICROB AGENTS CH, V44, P2349, DOI 10.1128/AAC.44.9.2349-2355.2000; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; Takeuchi T, 2006, GENES CELLS, V11, P223, DOI 10.1111/j.1365-2443.2006.00937.x; Tao Zhou, 2009, PROGR NATURAL SCI, V01, P1, DOI DOI 10.1371/J0URNAL.PBI0.1000139; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsao SM, 2000, J FOOD DRUG ANAL, V8, P208; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	86	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163260	10.1371/journal.pone.0163260	http://dx.doi.org/10.1371/journal.pone.0163260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644036	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900039
J	Boswihi, SS; Udo, EE; Al-Sweih, N				Boswihi, Samar S.; Udo, Edet E.; Al-Sweih, Noura			Shifts in the Clonal Distribution of Methicillin-Resistant Staphylococcus aureus in Kuwait Hospitals: 1992-2010	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; ASIAN COUNTRIES; COMMUNITY; MRSA; STRAINS; SEQUENCE; EPIDEMIOLOGY; EMERGENCE	Background As the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is constantly changing globally, determining the prevailing MRSA clones in a local healthcare facility is important for better management of infections. This study investigated clonal composition and distribution of MRSA isolates in Kuwait's hospitals using a combination of molecular typing methods. Materials and Methods In total, 400 non-repeatMRSA isolates were obtained between 1992 and 2010 in 13 public hospitals and were characterized using antibiogram, SCCmec typing, spa typing, and multilocus-sequence typing. Clonal assignment and detection of virulence factors and antibiotic resistance genes were performed by DNA microarray. Results The isolates were resistant to kanamycin (74.2%), erythromycin (69.5%), tetracycline (66.7%), gentamicin (61%), ciprofloxacin, (61%), fusidic acid (53.5%), clindamycin (41.5%), high-level mupirocin resistance (5.2%) and carried aphA3, aacA-aphD, ermA, ermC, mupA, tetK, tetM, fusC and far1. Molecular typing revealed 31 different MRSA clones consisting of ST239-MRSA-III (52.2%), ST22-MRSA-IV (9.2%), ST80-MRSA-IV (7.5%), ST5-MRSA-II/IV/V/VI (6.5%), ST30-MRSA-IV (3.5%), ST241-MRSA-III (2.7%), ST6-MRSA-IV (2.2%), ST36-MRSA-II (2%) and ST772-MRSA-V (1.75%). The isolates differed in the carriage of genes for enterotoxins, Panton-Valentine leukocidin (PVL), toxic shock syndrome toxin (tst-1), arginine catabolic mobile element (ACME) and exfoliative toxins. The number of clones increased from one (ST239-III-t037) in 1992 to 30 in 2010 including ST8-IV-t008 [PVL+] [ACME+] (USA300), ST772-V (Bengal Bay clone) and ST2816 identified for the first time in Kuwait. Conclusion The study revealed that the MRSA isolates belonged to diverse clones that changed in numbers and diversity overtime. Although ST239-MRSA-III, a healthcare-associated clone remained the dominant MRSA clone overtime, the newly emerged clones consisted mostly of community-associated.	[Boswihi, Samar S.; Udo, Edet E.; Al-Sweih, Noura] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University Research Sector [YM 02/12, SRUL02/13]; College of Graduate Studies, Kuwait University, Kuwait	Kuwait University Research Sector; College of Graduate Studies, Kuwait University, Kuwait	This study was supported by grant YM 02/12 and Research Core Facility project no. SRUL02/13 from Kuwait University Research Sector. S. Boswihi received a graduate student fellowship from the College of Graduate Studies, Kuwait University, Kuwait.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; Afroz S, 2008, JPN J INFECT DIS, V61, P393; Ahmad N, 2009, J MED MICROBIOL, V58, P1213, DOI 10.1099/jmm.0.011353-0; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Al-Haddad AM, 2001, J MED MICROBIOL, V50, P558, DOI 10.1099/0022-1317-50-6-558; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chatterjee S.S., 2013, CLIN EPIDEMIOL, V5, P205, DOI [10.2147/CLEP.S37071, DOI 10.2147/CLEP.S37071]; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; CLSI, 2012, CLSI DOCUMENT M100 S; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espedido BA, 2012, ANTIMICROB AGENTS CH, V56, P3380, DOI 10.1128/AAC.00013-12; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Hon PY, 2013, ANTIMICROB AGENTS CH, V57, P1563, DOI 10.1128/AAC.02518-12; Hsu LY, 2005, CLIN INFECT DIS, V40, P486, DOI 10.1086/427033; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kawaguchiya M, 2013, J MED MICROBIOL, V62, P1852, DOI 10.1099/jmm.0.062125-0; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Melter O, 2006, EUROSURVEILLANCE, P1; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Oksuz L, 2013, INT J MED SCI, V10, P1740, DOI 10.7150/ijms.6438; Que Y.A., 2010, MANDELL DOUGLAS BENN, P2543; RICHARDSON JF, 1993, J HOSP INFECT, V25, P45, DOI 10.1016/0195-6701(93)90007-M; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Udo E E, 2014, New Microbes New Infect, V2, P100, DOI 10.1002/nmi2.47; Udo EE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-168; Udo EE, 2011, J MED MICROBIOL, V60, P600, DOI 10.1099/jmm.0.028381-0; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Udo EE, 2000, J MED MICROBIOL, V49, P419, DOI 10.1099/0022-1317-49-5-419; Udo EE, 2016, HIGH PREVALENCE TOXI; Wang SH, 2012, EMERG INFECT DIS, V18, P1557, DOI 10.3201/eid1810.120468; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	70	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162744	10.1371/journal.pone.0162744	http://dx.doi.org/10.1371/journal.pone.0162744			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631623	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900072
J	Lleo, A; Bian, ZL; Zhang, HY; Miao, Q; Yang, F; Peng, YS; Chen, XY; Tang, RQ; Wang, QX; Qiu, DK; Fang, JY; Sobacchi, C; Villa, A; Di Tommaso, L; Roncalli, M; Gershwin, ME; Ma, X; Invernizzi, P				Lleo, Ana; Bian, Zhaolian; Zhang, Haiyan; Miao, Qi; Yang, Fang; Peng, Yanshen; Chen, Xiaoyu; Tang, Ruqi; Wang, Qixia; Qiu, Dekai; Fang, Jingyuan; Sobacchi, Cristina; Villa, Anna; Di Tommaso, Luca; Roncalli, Massimo; Gershwin, M. Eric; Ma, Xiong; Invernizzi, Pietro			Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis	PLOS ONE			English	Article							KAPPA-B LIGAND; CELL IMMUNE-RESPONSES; RECEPTOR ACTIVATOR; AUTOIMMUNE CHOLANGITIS; DIFFERENTIATION FACTOR; OSTEOCLAST FORMATION; OSTEOPROTEGERIN; BONE; CIRRHOSIS; INFLAMMATION	There is substantial data that suggests an abnormality of innate immunity in patients with primary biliary cholangitis (PBC) which includes the transcription factor nuclear factor-kB (NF-kB) and well as downstream inflammatory signaling pathways. In addition, Immuno-Chip analysis has identified a novel PBC-associated locus near the receptor activator of NF-kB ligand (RANKL) gene. Based on these observations, we investigated the role of the RANKL axis in the liver of patients with PBC compared to controls. We used immunohistochemistry to quantitate liver expression of RANKL, its receptor (RANK), and importantly the decoy receptor osteoprotegerin (OPG), including a total of 122 liver samples (PBC = 37, primary sclerosing cholangitis = 20, autoimmune hepatitis = 26, chronic hepatitis B = 32 and unaffected controls = 7). In addition, we studied RANKL-RANK-OPG co-localization in CD4 and CD8 T cells, B cells, dendritic cells, macrophages, NK, NKT cells, hepatocytes, and cholangiocytes. We report herein that RANK is constitutively expressed by cholangiocytes in both unaffected and diseased liver. However, cholangiocytes from PBC express significantly higher levers of RANK than either the unaffected controls or liver diseased controls. CD4, CD8 and CD19 cells with in the portal areas around bile ducts in PBC express significantly higher levels of RANKL compared to controls. Importantly, the overall hepatic RANKL level and the ratio of hepatic RANKL/OPG correlated with disease severity in PBC. In conclusion, our data indicate a role of RANK-RANKL axis in the innate immune activation in PBC and we hypothesize that the damaged cholangiocytes, which express high levels of RANK, lead to the recruitment of RANKL positive cells and ultimately the classic portal tract infiltrates.	[Lleo, Ana; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Liver Unit, Milan, Italy; [Lleo, Ana; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy; [Bian, Zhaolian; Zhang, Haiyan; Miao, Qi; Yang, Fang; Peng, Yanshen; Chen, Xiaoyu; Tang, Ruqi; Wang, Qixia; Qiu, Dekai; Fang, Jingyuan; Ma, Xiong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Div Gastroenterol & Hepatol,Ren Ji Hosp,Sch Med,M, Shanghai, Peoples R China; [Sobacchi, Cristina; Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan, Italy; [Sobacchi, Cristina; Villa, Anna] Humanitas Clin & Res Ctr, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Humanitas Clin & Res Ctr, Pathol Unit, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Gershwin, M. Eric; Invernizzi, Pietro] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Invernizzi, Pietro] Univ Milano Bicocca, Int Ctr Digest Hlth, Dept Med & Surg, Milan, Italy	Shanghai Jiao Tong University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Humanitas University; University of California System; University of California Davis; University of Milano-Bicocca	Invernizzi, P (corresponding author), Humanitas Clin & Res Ctr, Liver Unit, Milan, Italy.; Invernizzi, P (corresponding author), Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy.; Ma, X (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Div Gastroenterol & Hepatol,Ren Ji Hosp,Sch Med,M, Shanghai, Peoples R China.; Gershwin, ME; Invernizzi, P (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.; Invernizzi, P (corresponding author), Univ Milano Bicocca, Int Ctr Digest Hlth, Dept Med & Surg, Milan, Italy.	megershwin@ucdavis.edu; maxiongmd@163.com; pietro.invernizzi@unimib.it	Lleo, Ana/AAA-5759-2019; Invernizzi, Pietro/AAB-8367-2022; SOBACCHI, CRISTINA/J-9345-2018	Lleo, Ana/0000-0002-0561-7902; Invernizzi, Pietro/0000-0003-3262-1998; SOBACCHI, CRISTINA/0000-0002-2684-7184; Ma, Xiong/0000-0001-9616-4672; di tommaso, luca/0000-0002-9013-4728; Roncalli, Massimo/0000-0002-7901-8910	National Natural Science Foundation of China [81170380, 81325002, 81421001, 81400608, 81200293]; Shanghai Jiaotong University School of Medicine [BXJ201321]; National Institutes of Health [DK39588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039588] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the National Natural Science Foundation of China (#81170380 and #81325002 to Xiong Ma, #81421001 to Jingyuan Fang, #81400608 to Ruqi Tang and #81200293 to Qi Miao), the Doctoral Innovation Fund Projects from Shanghai Jiaotong University School of Medicine (BXJ201321 to Zhaolian Bian), and the National Institutes of Health grant (MEG), DK39588.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Akiyama T, 2012, WORLD J ORTHOP, V3, P142, DOI 10.5312/wjo.v3.i9.142; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Beuers U, 2015, HEPATOLOGY, V62, P1620, DOI 10.1002/hep.28140; Beuers U, 2015, CLIN REV ALLERG IMMU, V48, P127, DOI 10.1007/s12016-015-8484-9; Bianchi I, 2014, SEMIN LIVER DIS, V34, P255, DOI 10.1055/s-0034-1383725; Bowlus CL, 2014, AUTOIMMUN REV, V13, P441, DOI 10.1016/j.autrev.2014.01.041; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Chan AWH, 2014, HISTOPATHOLOGY, V65, P174, DOI 10.1111/his.12384; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Floreani A, 2015, CLIN REV ALLERG IMMU, V48, P263, DOI 10.1007/s12016-014-8456-5; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Guanabens N, 2009, J BONE MINER METAB, V27, P347, DOI 10.1007/s00774-009-0042-1; Guerrini MM, 2014, ARCH BIOCHEM BIOPHYS, V561, P118, DOI 10.1016/j.abb.2014.06.003; Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Huang WT, 2014, J AUTOIMMUN, V50, P123, DOI 10.1016/j.jaut.2014.01.034; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kar SP, 2013, GENES IMMUN, V14, P179, DOI 10.1038/gene.2013.1; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li YY, 2015, HEPATOLOGY, V61, P1998, DOI 10.1002/hep.27725; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lleo A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0098-9; Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Mousa HS, 2015, EXPERT OPIN PHARMACO, V16, P633, DOI 10.1517/14656566.2015.998650; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Shimoda S, 2015, HEPATOLOGY, V62, P1817, DOI 10.1002/hep.28122; Shimoda S, 2010, HEPATOLOGY, V51, P567, DOI 10.1002/hep.23318; Sirinian C, 2013, GENE, V525, P124, DOI 10.1016/j.gene.2013.04.075; Spanjol J, 2013, TRANSPL P, V45, P1766, DOI 10.1016/j.transproceed.2012.10.065; Stolina M, 2007, J IMMUNOL, V179, P7497, DOI 10.4049/jimmunol.179.11.7497; Sun Y, 2015, CLIN REV ALLERG IMMU, V48, P285, DOI 10.1007/s12016-014-8449-4; Szalay F, 2003, J HEPATOL, V38, P395, DOI 10.1016/S0168-8278(02)00435-X; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tanaka H, 2015, CLIN EXP IMMUNOL, V180, P371, DOI 10.1111/cei.12581; Tanaka H, 2014, CLIN EXP IMMUNOL, V178, P253, DOI 10.1111/cei.12415; Tsushima H, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0532-6; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Wang YH, 2015, J AUTOIMMUN, V59, P26, DOI 10.1016/j.jaut.2015.01.011; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wright HL, 2009, CURR REV MUSCULOSKE, V2, P56, DOI 10.1007/s12178-009-9046-7; Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009; You ZR, 2012, J AUTOIMMUN, V39, P216, DOI 10.1016/j.jaut.2012.05.022; Zhang HY, 2015, DIGEST DIS, V33, P94, DOI 10.1159/000440754; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313; Ziolkowska M, 2002, ARTHRITIS RHEUM-US, V46, P1744, DOI 10.1002/art.10388	56	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159612	10.1371/journal.pone.0159612	http://dx.doi.org/10.1371/journal.pone.0159612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631617	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900002
J	Rabellino, D; Densmore, M; Frewen, PA; Theberge, J; McKinnon, MC; Lanius, RA				Rabellino, Daniela; Densmore, Maria; Frewen, Paul A.; Theberge, Jean; McKinnon, Margaret C.; Lanius, Ruth A.			Aberrant Functional Connectivity of the Amygdala Complexes in PTSD during Conscious and Subconscious Processing of Trauma-Related Stimuli	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANXIETY DISORDER; FEAR; RESPONSES; CORTEX; BRAIN; ACTIVATION; METAANALYSIS; SUBREGIONS; WOMEN	Post-traumatic stress disorder (PTSD) is characterized by altered functional connectivity of the amygdala complexes at rest. However, amygdala complex connectivity during conscious and subconscious threat processing remains to be elucidated. Here, we investigate specific connectivity of the centromedial amygdala (CMA) and basolateral amygdala (BLA) during conscious and subconscious processing of trauma-related words among individuals with PTSD (n = 26) as compared to non-trauma-exposed controls (n = 20). Psycho-physiological interaction analyses were performed using the right and left amygdala complexes as regions of interest during conscious and subconscious trauma word processing. These analyses revealed a differential, context-dependent responses by each amygdala seed during trauma processing in PTSD. Specifically, relative to controls, during subconscious processing, individuals with PTSD demonstrated increased connectivity of the CMA with the superior frontal gyrus, accompanied by a pattern of decreased connectivity between the BLA and the superior colliculus. During conscious processing, relative to controls, individuals with PTSD showed increased connectivity between the CMA and the pulvinar. These findings demonstrate alterations in amygdala subregion functional connectivity in PTSD and highlight the disruption of the innate alarm network during both conscious and subconscious trauma processing in this disorder.	[Rabellino, Daniela; Densmore, Maria; Frewen, Paul A.; Theberge, Jean; Lanius, Ruth A.] Univ Western Ontario, Dept Psychiat, London, ON, Canada; [Densmore, Maria; Theberge, Jean; Lanius, Ruth A.] Lawson Hlth Res Inst, Imaging Div, London, ON, Canada; [Frewen, Paul A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Frewen, Paul A.; Lanius, Ruth A.] Univ Western Ontario, Dept Neurosci, London, ON, Canada; [Theberge, Jean] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [McKinnon, Margaret C.] St Josephs Healthcare, Mood Disorders Program, Hamilton, ON, Canada; [McKinnon, Margaret C.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [McKinnon, Margaret C.] Homewood Res Inst, Guelph, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Lanius, RA (corresponding author), Univ Western Ontario, Dept Psychiat, London, ON, Canada.; Lanius, RA (corresponding author), Lawson Hlth Res Inst, Imaging Div, London, ON, Canada.; Lanius, RA (corresponding author), Univ Western Ontario, Dept Neurosci, London, ON, Canada.	ruth.lanius@lhsc.on.ca	McKinnon, Margaret/AAT-5821-2021; Lanius, Ruth A/J-6961-2015; Theberge, Jean/A-3087-2008	McKinnon, Margaret/0000-0002-8315-7657; Lanius, Ruth A/0000-0002-3758-1393; Theberge, Jean/0000-0001-7578-4469	Canadian Institutes of Health Research [MOP97914]; MITACS; Homewood Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MITACS; Homewood Research Institute	This study was supported by the Canadian Institutes of Health Research (#MOP97914). Daniela Rabellino was supported by fellowship from MITACS and Homewood Research Institute. Canadian Institutes of Health Research: http://www.cihr-irsc.gc.ca/e/193.html. RL MITACS http://www.mitacs.ca/en. DR. Homewood Research Institute http://www.homewoodresearch.org/DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Briere J., 2002, MULTISCALE DISSOCIAT; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Felmingham K, 2008, PSYCHOL MED, V38, P1771, DOI 10.1017/S0033291708002742; First MB, 2002, STRUCTURED CLIN INTE; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fruhholz S, 2013, CORTEX, V49, P1394, DOI 10.1016/j.cortex.2012.08.003; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kemp AH, 2009, PSYCHIAT RES-NEUROIM, V174, P158, DOI 10.1016/j.pscychresns.2009.04.012; Kozlowska K, 2015, HARVARD REV PSYCHIAT, V23, P263, DOI 10.1097/HRP.0000000000000065; Lanius UF, 2014, NEUROBIOLOGY TREATM; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nicholson AA, 2015, NEUROPSYCHOPHARMACOL, V40, P2317, DOI 10.1038/npp.2015.79; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Rabellino D, 2015, ACTA PSYCHIAT SCAND, V132, P365, DOI 10.1111/acps.12418; Rabellino D, 2016, PSYCHIAT RES-NEUROIM, V248, P142, DOI 10.1016/j.pscychresns.2015.12.005; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Reber TP, 2012, J NEUROSCI, V32, P6138, DOI 10.1523/JNEUROSCI.5639-11.2012; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Steuwe C, 2014, SOC COGN AFFECT NEUR, V9, P88, DOI 10.1093/scan/nss105; Steuwe C, 2015, PSYCHIAT RES-NEUROIM, V232, P162, DOI 10.1016/j.pscychresns.2015.02.010; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Williams LM, 2006, HUM BRAIN MAPP, V27, P652, DOI 10.1002/hbm.20208; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	52	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163097	10.1371/journal.pone.0163097	http://dx.doi.org/10.1371/journal.pone.0163097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631496	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900131
J	Nagl, M; Hilbert, A; de Zwaan, M; Braehler, E; Kersting, A				Nagl, Michaela; Hilbert, Anja; de Zwaan, Martina; Braehler, Elmar; Kersting, Anette			The German Version of the Dutch Eating Behavior Questionnaire: Psychometric Properties, Measurement Invariance, and Population-Based Norms	PLOS ONE			English	Article							TESTING MEASUREMENT INVARIANCE; BODY-MASS INDEX; FIT INDEXES; FOLLOW-UP; VALIDATION; DEBQ; OBESITY; ADULTS; OVERWEIGHT; CHILDREN	The Dutch Eating Behavior Questionnaire is an internationally widely used instrument assessing different eating styles that may contribute to weight gain and overweight: emotional eating, external eating, and restraint. This study aimed to evaluate the psychometric properties of the 30-item German version of the DEBQ including its measurement invariance across gender, age, and BMI-status in a representative German population sample. Furthermore, we examined the distribution of eating styles in the general population and provide population-based norms for DEBQ scales. A representative sample of the German general population (N = 2513, age >= 14 years) was assessed with the German version of the DEBQ along with information on sociodemographic characteristics and body weight and height. The German version of the DEQB demonstrates good item characteristics and reliability (restraint: alpha = .92, emotional eating: alpha = .94, external eating: alpha = .89). The 3-factor structure of the DEBQ could be replicated in exploratory and confirmatory factor analyses and results of multi-group confirmatory factor analyses supported its metric and scalar measurement invariance across gender, age, and BMI-status. External eating was the most prevalent eating style in the German general population. Women scored higher on emotional and restrained eating scales than men, and overweight individuals scored higher in all three eating styles compared to normal weight individuals. Small differences across age were found for external eating. Norms were provided according to gender, age, and BMI-status. Our findings suggest that the German version of the DEBQ has good reliability and construct validity, and is suitable to reliably measure eating styles across age, gender, and BMI-status. Furthermore, the results demonstrate a considerable variation of eating styles across gender and BMI-status.	[Nagl, Michaela; Kersting, Anette] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, Leipzig, Germany; [Hilbert, Anja] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Med Ctr, Leipzig, Germany; [Hilbert, Anja; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [de Zwaan, Martina] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Braehler, Elmar] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Mainz, Germany	Leipzig University; Leipzig University; Leipzig University; Hannover Medical School; Johannes Gutenberg University of Mainz	Nagl, M (corresponding author), Univ Leipzig, Dept Psychosomat Med & Psychotherapy, Leipzig, Germany.	michaela.nagl@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	German Federal Ministry of Education and Research [01E01501]; German Research Foundation (DFG); Universitat Leipzig	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	AH was supported by the German Federal Ministry of Education and Research (grant 01E01501). We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The external funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly N, 2012, APPETITE, V59, P853, DOI 10.1016/j.appet.2012.08.029; Banos RM, 2011, NUTR HOSP, V26, P890, DOI [10.3305/nh.2011.26.4.5238, 10.1590/S0212-16112011000400032]; Bozan N, 2011, APPETITE, V56, P564, DOI 10.1016/j.appet.2011.01.025; Braet C, 1997, BEHAV RES THER, V35, P863, DOI 10.1016/S0005-7967(97)00045-4; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Brunault P, 2015, PRESSE MED, V44, pE363, DOI 10.1016/j.lpm.2015.03.028; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; Canetti L, 2002, BEHAV PROCESS, V60, P157, DOI 10.1016/S0376-6357(02)00082-7; Cebolla A, 2014, APPETITE, V73, P58, DOI 10.1016/j.appet.2013.10.014; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dakanalis A, 2013, APPETITE, V71, P187, DOI 10.1016/j.appet.2013.08.010; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Grunert SC., 1989, DIAGNOSTICA, V2, P167; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037/0033-2909.110.1.86; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KAPLAN HI, 1957, J NERV MENT DIS, V125, P181, DOI 10.1097/00005053-195704000-00004; Larsen JK, 2006, J PSYCHOSOM RES, V60, P237, DOI 10.1016/j.jpsychores.2005.07.006; Lluch A, 1996, EUR PSYCHIAT, V11, P198, DOI 10.1016/0924-9338(96)88391-X; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Meule A, 2012, DIAGNOSTICA, V58, P115, DOI 10.1026/0012-1924/a000047; Muller J, 2008, APPETITE, V50, P499, DOI 10.1016/j.appet.2007.10.008; POLIVY J, 1985, AM PSYCHOL, V40, P193, DOI 10.1037/0003-066X.40.2.193; Pook M, 2003, VERHALTENSTHERAPIE, V13, P40, DOI 10.1159/000070498; SCHACHTER S, 1971, AM PSYCHOL, V26, P129, DOI 10.1037/h0030817; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; TUSCHENCAFFIER B, 2005, DIAGNOSTIK ESSSTORUN; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Van Strien T, 2008, APPETITE, V50, P544, DOI 10.1016/j.appet.2007.08.005; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; van Strien T, 2007, APPETITE, V49, P109, DOI 10.1016/j.appet.2007.01.003; van Strien T, 2012, APPETITE, V59, P782, DOI 10.1016/j.appet.2012.08.009; van Strien T, 2012, INT J EAT DISORDER, V45, P257, DOI 10.1002/eat.20940; van Strien T, 2009, APPETITE, V52, P380, DOI 10.1016/j.appet.2008.11.010; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WARDLE J, 1987, J PSYCHOSOM RES, V31, P161, DOI 10.1016/0022-3999(87)90072-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; *WHO GLOB INFOBASE, 2005, 2 SURF WHO GLOB INFO	40	47	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162510	10.1371/journal.pone.0162510	http://dx.doi.org/10.1371/journal.pone.0162510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27656879	gold, Green Published			2022-12-27	WOS:000383893200027
J	Wang, H; Li, PY; Fan, ZH; Li, ZQ; Wei, XH				Wang Hui; Li Peiyu; Fan Zhihui; Li Zheqing; Wei Xuhui			Enhancing the Flexibility of TCP in Heterogeneous Network	PLOS ONE			English	Article								Due to a set of constant initial values, the performance of conventional TCP drops significantly encountering heterogeneous network, showing low throughput and unfairness. This paper firstly demonstrates the chaotic character of TCP congestion control in heterogeneous network, especially the sensitivity to initial value. Inspired by merit of nature-inspired algorithm, a novel structure of TCP congestion control (IPPM, Internet Prey-Predator Model) is proposed. Parameters such as available link capacity(C), congestion window (W) and queue length (Q) are collected by IPPM, which calculates the max value of C according to the interacting relationship existing in C, Wand Q, and IPPM initiates the TCP ssthresh with the calculated value. Plenty of simulation results show that the modified TCP can effectively avoid network congestion and packet loss. Besides, it holds high resource utilization, convergence speeds, fairness and stability.	[Wang Hui; Li Peiyu; Fan Zhihui; Li Zheqing] Henan Univ Sci & Technol, Network Informat Ctr, Luoyang 471003, Peoples R China; [Wei Xuhui] Henan Univ Sci & Technol, Informat Engn Coll, Luoyang 471003, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology	Li, PY (corresponding author), Henan Univ Sci & Technol, Network Informat Ctr, Luoyang 471003, Peoples R China.	lpy@haust.edu.cn			National Natural Science Foundation of China [61070247]; scientific and technological project of Henan province [132102210246, 13B510001, 14A510015, NGII20150311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological project of Henan province	This work is supported by the National Natural Science Foundation of China under Grant No. 61070247, the scientific and technological project of Henan province under Grant No. 132102210246, No.13B510001, No.14A510015, and No.NGII20150311.	Awrejcewicz J., 2014, CHAOS SYNCHRONIZATIO, P527; Chandra E, 2010, GLOBAL J COMPUTER SC, V1, P82; Liu F, 2011, NONLINEAR ANAL-REAL, V12, P353, DOI 10.1016/j.nonrwa.2010.06.021; Lotka A. J., 1956, ELEMENTS MATH BIOL; Mao P, 2015, 3 INT C MAN, V74, P179; Mirjalili S, 2015, PHYS REV C, V49, P1; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Shivamoggi B. K., 2014, NONLINEAR DYNAMICS C, V103, P189, DOI 10.1007/978-94-007-7094-2_6; Stuart Milner, 2012, IEEE T MOBILE COMPUT, V11, P1207; Veres A, 2000, P IEEE INFOCOM, V3, P1715; Wang JS, 2011, CHINESE PHYS B, V20; Wei J, 2015, IEEE T SMART GRID, V6, P178, DOI 10.1109/TSG.2014.2341213; Wu RQ, 2014, J COMMUNICATIONS, V9, P792; Zhao H, 2013, IEEE T INF FOREN SEC, V8, P273, DOI 10.1109/TIFS.2012.2231861; Zhen Yanxiang, 2010, 2010 WRI INT C COMM, V1, P453	15	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161249	10.1371/journal.pone.0161249	http://dx.doi.org/10.1371/journal.pone.0161249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657890	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200006
J	Lian, S; Xia, Y; Nguyen, TT; Ung, TT; Yoon, HJ; Kim, NH; Kim, KK; Jung, YD				Lian, Sen; Xia, Yong; Thi Thinh Nguyen; Trong Thuan Ung; Yoon, Hyun Joong; Kim, Nam Ho; Kim, Kyung Keun; Jung, Young Do			Docosahexaenoic Acid Inhibits Tumor Promoter-Induced Urokinase-Type Plasminogen Activator Receptor by Suppressing PKCd- and MAPKs-Mediated Pathways in ECV304 Human Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR; UP-REGULATION; MATRIX-METALLOPROTEINASE-9 EXPRESSION; GLIOMA-CELLS; CANCER; AP-1; MIGRATION; ALPHA	The overexpression of urokinase-type plasminogen activator receptor (uPAR) is associated with inflammation and virtually all human cancers. Despite the fact that docosahexaenoic acid (DHA) has been reported to possess anti-inflammatory and anti-tumor properties, the negative regulation of uPAR by DHA is still undefined. Here, we investigated the effect of DHA on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced uPAR expression and the underlying molecular mechanisms in ECV304 human endothelial cells. DHA concentration-dependently inhibited TPA-induced uPAR. Specific inhibitors and mutagenesis studies showed that PKC gamma, JNK1/2, Erk1/2, NF-kappa B, and AP-1 were critical for TPA-induced uPAR expression. Application of DHA suppressed TPA-induced translocation of PKC gamma, activation of the JNK1/2 and Erk1/2 signaling pathways, and subsequent AP-1 and NF-kappa B transactivation. In conclusion, these observations suggest a novel role for DHA in reducing uPAR expression and cell invasion by inhibition of PKCd, JNK1/2, and Erk1/2, and the reduction of AP-1 and NF-kappa B activation in ECV304 human endothelial cells.	[Lian, Sen; Xia, Yong; Thi Thinh Nguyen; Trong Thuan Ung; Yoon, Hyun Joong; Kim, Nam Ho; Kim, Kyung Keun; Jung, Young Do] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju 501190, South Korea	Chonnam National University	Jung, YD (corresponding author), Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Gwangju 501190, South Korea.	ydjung@chonnam.ac.kr	Xia, Yong/L-1618-2019		National Cancer Center [0720570]; Basic Science Research Program grant through the National Research Foundation of Korea (NRF) - ministry of Education, Science, and Technology [2015R1D1A1A09057240]; Medical Research Center grant from the Korean Science and Engineering Education [2012-000-9442]	National Cancer Center; Basic Science Research Program grant through the National Research Foundation of Korea (NRF) - ministry of Education, Science, and Technology(National Research Foundation of Korea); Medical Research Center grant from the Korean Science and Engineering Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by a Research grant (0720570) from the National Cancer Center (www.ncc.re.kr), Basic Science Research Program grant through the National Research Foundation of Korea (NRF) funded by the ministry of Education, Science, and Technology (2015R1D1A1A09057240, www.moe.go.kr), and a Medical Research Center (2012-000-9442) grant from the Korean Science and Engineering Education (www.nrf.re.kr). All above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant (0720570) from the National Cancer Center, by a Basic Science Research Program grant through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2015R1D1A1A09057240), and by a Medical Research Center (2012-000-9442) grant from the Korean Science and Engineering Foundation.	Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Ashour AA, 2014, J CELL MOL MED, V18, P2235, DOI 10.1111/jcmm.12361; Baek MK, 2008, ONCOL REP, V20, P1569, DOI 10.3892/or_00000181; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baker EA, 2000, J CLIN PATHOL-MOL PA, V53, P307; Beit-Yannai E, 2007, MED HYPOTHESES, V68, P299, DOI 10.1016/j.mehy.2006.05.067; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Chang HJ, 2007, ANTICANCER RES, V27, P3411; Chao CY, 2014, J AGR FOOD CHEM, V62, P4152, DOI 10.1021/jf5007165; Chen HW, 2013, ARCH TOXICOL, V87, P857, DOI 10.1007/s00204-012-1003-3; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Cho YM, 2014, EXP BIOL MED, V239, P302, DOI 10.1177/1535370213514927; Chong EWT, 2006, CLIN EXP OPHTHALMOL, V34, P464, DOI 10.1111/j.1442-9071.2006.01250.x; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fang IM, 2014, MOL NUTR FOOD RES, V58, P2053, DOI 10.1002/mnfr.201400196; Garcia M., 2007, GLOBAL CANC FACTS FI, V1, P1; Hildenbrand R, 2008, UROKINASE SYSTEM ROL; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Johnson MR, 2000, ANAL BIOCHEM, V278, P175, DOI 10.1006/abio.1999.4461; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kobayashi H, 2002, EUR J BIOCHEM, V269, P3945, DOI 10.1046/j.1432-1033.2002.03068.x; Kolb TM, 2004, TOXICOL SCI, V81, P233, DOI 10.1093/toxsci/kfh183; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Lian S, 2015, TOXICOLOGY, V338, P104, DOI 10.1016/j.tox.2015.10.008; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Michael J Morgan, 2011, Cell Research, V21, P103; Mori T, 2000, J NEURO-ONCOL, V46, P115, DOI 10.1023/A:1006339717748; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nishimura K, 2003, INT J ANDROL, V26, P175, DOI 10.1046/j.1365-2605.2003.00413.x; Park Hyeli, 2014, Chonnam Med J, V50, P96, DOI 10.4068/cmj.2014.50.3.96; Park JS, 2011, CARCINOGENESIS, V32, P175, DOI 10.1093/carcin/bgq241; Resh MD, 2008, CANCER CELL, V13, P469, DOI 10.1016/j.ccr.2008.05.011; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Song NY, 2014, BIOCHEM PHARMACOL, V92, P142, DOI 10.1016/j.bcp.2014.08.030; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Wang Y, 2001, INT J CANCER, V92, P257; Whyte C, 2012, J NUTR BIOCHEM, V23, P1378, DOI 10.1016/j.jnutbio.2011.08.005; Ye S, 2010, PROSTAG LEUKOTR ESS, V83, P37, DOI 10.1016/j.plefa.2010.02.002; Zannetti A, 2000, CANCER RES, V60, P1546	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163395	10.1371/journal.pone.0163395	http://dx.doi.org/10.1371/journal.pone.0163395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654969	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700056
J	Thomann, AK; Thomann, PA; Wolf, RC; Hirjak, D; Schmahl, C; Ebert, MP; Szabo, K; Reindl, W; Griebe, M				Thomann, Anne K.; Thomann, Philipp A.; Wolf, Robert C.; Hirjak, Dusan; Schmahl, Christian; Ebert, Matthias P.; Szabo, Kristina; Reindl, Wolfgang; Griebe, Martin			Altered Markers of Brain Development in Crohn's Disease with Extraintestinal Manifestations - A Pilot Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SURFACE-BASED ANALYSIS; GEOMETRICALLY ACCURATE; CLINICAL-PATTERNS; CEREBRAL-CORTEX; GUT MICROBIOTA; GYRIFICATION; THICKNESS; AREA; ABNORMALITIES	Background and Objective Alterations of brain morphology in Crohn's disease have been reported, but data is scarce and heterogenous and the possible impact of disease predisposition on brain development is unknown. Assuming a systemic course of the disease, brain involvement seems more probable in presence of extraintestinal manifestations, but this question has not yet been addressed. The present study examined the relationship between Crohn's disease and brain structure and focused on the connection with extraintestinal manifestations and markers of brain development. Methods In a pilot study, brains of 15 patients with Crohn's disease (of which 9 had a history of extraintestinal manifestations, i.e. arthritis, erythema nodosum and primary sclerosing cholangitis) were compared to matched healthy controls using high resolution magnetic resonance imaging. Patients and controls were tested for depression, fatigue and global cognitive function. Cortical thickness, surface area and folding were determined via cortical surface modeling. Results The overall group comparison (i.e. all patients vs. controls) yielded no significant results. In the patient subgroup with extraintestinal manifestations, changes in cortical area and folding, but not thickness, were identified: Patients showed elevated cortical surface area in the left middle frontal lobe (p < 0.05) and hypergyrification in the left lingual gyrus (p < 0.001) compared to healthy controls. Hypogyrification of the right insular cortex (p < 0.05) and hypergyrification of the right anterior cingulate cortex (p < 0.001) were detected in the subgroup comparison of patients with against without extraintestinal manifestations. P-values are corrected for multiple comparisons. Conclusions Our findings lend further support to the hypothesis that Crohn's disease is associated with aberrant brain structure and preliminary support for the hypothesis that these changes are associated with a systemic course of the disease as indicated by extraintestinal manifestations. Changes in cortical surface area and folding suggest a possible involvement of Crohn's disease or its predisposition during brain development.	[Thomann, Anne K.; Ebert, Matthias P.; Reindl, Wolfgang] Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Mannheim, Germany; [Thomann, Philipp A.; Hirjak, Dusan] Univ Heidelberg Hosp, Dept Psychiat, Heidelberg, Germany; [Wolf, Robert C.] Univ Saarland, Dept Psychiat Psychotherapy & Psychosomat, Homburg, Germany; [Hirjak, Dusan] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Schmahl, Christian] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychosomat Med, Mannheim, Germany; [Szabo, Kristina; Griebe, Martin] Heidelberg Univ, Med Fac Mannheim, Dept Neurol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Saarland University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Thomann, AK (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Mannheim, Germany.	anne.thomann@umm.de	Hirjak, Dusan/P-2777-2018; Szabo, Kristina/AAE-7978-2021; Wolf, Robert Christian/AAG-9142-2020; Hirjak, Dusan/W-2126-2019	Wolf, Robert Christian/0000-0002-5358-5212; Schmahl, Christian/0000-0003-0141-0821				Agostini A, 2013, NEUROGASTROENT MOTIL, V25, P147, DOI 10.1111/nmo.12017; Bao CH, 2015, J CROHNS COLITIS, V9, P532, DOI 10.1093/ecco-jcc/jjv057; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Caprilli R, 2006, GUT, V55, DOI 10.1136/gut.2005.081950c; Chen M, 2012, J NEUROIMAGING, V22, P38, DOI 10.1111/j.1552-6569.2010.00538.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Eyler LT, 2012, TWIN RES HUM GENET, V15, P304, DOI 10.1017/thg.2012.3; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flachenecker R, 2006, NERVENARZT, V77, P165, DOI 10.1007/s00115-005-1990-x; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Goyal MS, 2015, P NATL ACAD SCI USA, V112, P14105, DOI 10.1073/pnas.1511465112; Hirjak D, 2015, BEHAV BRAIN RES, V292, P19, DOI 10.1016/j.bbr.2015.05.048; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Klein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084914; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lakatos PL, 2005, HEPATO-GASTROENTEROL, V52, P817; Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551; Long MD, 2010, AM J GASTROENTEROL, V105, P1796, DOI 10.1038/ajg.2010.162; Ma XS, 2016, BEHAV GENET, V46, P205, DOI 10.1007/s10519-015-9755-1; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mee S, 2006, J PSYCHIATR RES, V40, P680, DOI 10.1016/j.jpsychires.2006.03.003; Moris G, 2014, WORLD J GASTROENTERO, V20, P1228, DOI 10.3748/wjg.v20.i5.1228; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nesvag R, 2014, SCHIZOPHR RES, V152, P333, DOI 10.1016/j.schres.2013.11.032; O'Mahony SM, 2017, NEUROSCIENCE, V342, P37, DOI 10.1016/j.neuroscience.2015.09.068; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palaniyappan L, 2015, BRAIN STRUCT FUNCT, V220, P2059, DOI 10.1007/s00429-014-0772-2; Palaniyappan L, 2014, SCHIZOPHRENIA BULL, V40, P675, DOI 10.1093/schbul/sbt050; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RANKIN GB, 1979, GASTROENTEROLOGY, V77, P914; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Satsangi J, 1996, GUT, V38, P738, DOI 10.1136/gut.38.5.738; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00750; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stovicek J, 2014, SCAND J GASTROENTERO, V49, P173, DOI 10.3109/00365521.2013.867358; Su CYG, 2002, GASTROENTEROL CLIN N, V31, P307, DOI 10.1016/S0889-8553(01)00019-X; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vogt BA, 2013, NEUROGASTROENT MOTIL, V25, P93, DOI 10.1111/nmo.12067; Vuoksimaa E, 2015, CEREB CORTEX, V25, P2127, DOI 10.1093/cercor/bhu018; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yang X, 2015, NEUROPSYCH DIS TREAT, V11, P2415, DOI 10.2147/NDT.S93055; Zikou AK, 2014, EUR RADIOL, V24, P2499, DOI 10.1007/s00330-014-3242-6; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006; Zippi M, 2014, WORLD J GASTROENTERO, V20, P17463, DOI 10.3748/wjg.v20.i46.17463	62	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163202	10.1371/journal.pone.0163202	http://dx.doi.org/10.1371/journal.pone.0163202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655165	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700040
J	Burian, A; Wang, KL; Finton, KAK; Lee, N; Ishitani, A; Strong, RK; Geraghty, DE				Burian, Aura; Wang, Kevin L.; Finton, Kathryn A. K.; Lee, Ni; Ishitani, Akiko; Strong, Roland K.; Geraghty, Daniel E.			HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1	PLOS ONE			English	Article							NK CELLS; RECOGNITION; EXPRESSION; MOLECULES; ACTIVATION; LIGANDS; COMPLEX; PROTEIN; SURFACE; ALLELE	Based on previous findings supporting HLA-F as a ligand for KIR3DL2 and KIR2DS4, we investigated the potential for MHC-I open conformers (OCs) as ligands for KIR3DS1 and KIR3DL1 through interactions measured by surface plasmon resonance. These measurements showed physical binding of KIR3DS1 but not KIR3DL1 with HLA-F and other MHC-I OC while also confirming the allotype specific binding of KIR3DL1 with MHC-I peptide complex. Concordant results were obtained with biochemical pull-down from cell lines and biochemical heterodimerization experiments with recombinant proteins. In addition, surface binding of HLA-F and KIR3DS1 to native and activated NK and T cells was coincident with specific expression of the putative ligand or receptor. A functional response of KIR3DS1 was indicated by increased granule exocytosis in activated cells incubated with HLA-F bound to surfaces. The data extend a model for interaction between MHC-I open conformers and activating KIR receptors expressed during an inflammatory response, potentially contributing to communication between the innate and adaptive immune response.	[Burian, Aura; Wang, Kevin L.; Lee, Ni; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Finton, Kathryn A. K.; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Ishitani, Akiko] Nara Med Univ, Kashihara, Nara 634, Japan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Nara Medical University	Geraghty, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA.	geraghty@fhcrc.org			NICHD [HD45813]; University of Washington Center for AIDS Research (CFAR); NIH [P30 AI027757]; NIH Institute and Center (NIAID); NIH Institute and Center (NCI); NIH Institute and Center (NIMH); NIH Institute and Center (NIDA); NIH Institute and Center (NICHD); NIH Institute and Center (NHLBI); NIH Institute and Center (NCCAM); Clinical Research Division at the Fred Hutchinson Cancer Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institute and Center (NIAID); NIH Institute and Center (NCI); NIH Institute and Center (NIMH); NIH Institute and Center (NIDA); NIH Institute and Center (NICHD); NIH Institute and Center (NHLBI); NIH Institute and Center (NCCAM); Clinical Research Division at the Fred Hutchinson Cancer Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support from NICHD (www.nichd.nih.gov) grant HD45813 to D.E.G. is acknowledged. Support from the University of Washington Center for AIDS Research (CFAR-depts.washington.edu/cfar/home), a NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) also contributed to this work. Interim funding support from the Clinical Research Division at the Fred Hutchinson Cancer Research Center (fredhutch.org) to D.E.G. is gratefully acknowledged.; Support from NICHD grant HD45813 to D.E.G. is acknowledged. Support from the University of Washington Center for AIDS Research (CFAR), a NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) also contributed to this work. Interim funding support from the Clinical Research Division at the Fred Hutchinson Cancer Research Center to D.E.G. is gratefully acknowledged.	Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Finton KA, 2012, IMMUNOL REV, V250, P239, DOI 10.1111/j.1600-065X.2012.01168.x; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2013, J IMMUNOL, V191, P1567, DOI 10.4049/jimmunol.1300080; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Ishitani A, 2003, J IMMUNOL, V171, P1376, DOI 10.4049/jimmunol.171.3.1376; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Male V, 2010, METHODS MOL BIOL, V612, P447, DOI 10.1007/978-1-60761-362-6_30; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Pascal V, 2007, J IMMUNOL, V179, P1625, DOI 10.4049/jimmunol.179.3.1625; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Velardi A, 2012, CURR OPIN HEMATOL, V19, P319, DOI 10.1097/MOH.0b013e32835423c3; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517	27	81	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163297	10.1371/journal.pone.0163297	http://dx.doi.org/10.1371/journal.pone.0163297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649529	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100077
J	Castro, F; Zuniga, J; Higuera, G; Donderis, MC; Gomez, B; Motta, J				Castro, Franz; Zuniga, Julio; Higuera, Gladys; Carrion Donderis, Maria; Gomez, Beatriz; Motta, Jorge			Indigenous Ethnicity and Low Maternal Education Are Associated with Delayed Diagnosis and Mortality in Infants with Congenital Heart Defects in Panama	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; CURRENT KNOWLEDGE; DISPARITIES; COUNCIL; HEALTH; TRENDS; RISK; CARE	Background This is the first study in Panama and Central America that has included indigenous populations in an assessment of the association between socioeconomic variables with delayed diagnosis and mortality due to congenital heart defects (CHD). Methods A retrospective observational study was conducted. A sample calculation was performed and 954 infants born from 2010 to 2014 were randomly selected from clinical records of all Panamanian public health institutions with paediatric cardiologists. Critical CHD was defined according to the defects listed as targets of newborn pulse oximetry screening. Diagnoses were considered delayed when made after the third day of life for the critical CHD and after the twentieth day of life for the non-critical. A logistic regression model was performed to examine the association between socioeconomic variables and delayed diagnosis. A Cox proportional hazards model was used to assess the relationship between socioeconomic features and mortality. Results An increased risk of delayed diagnosis was observed in infants with indigenous ethnicity (AOR, 1.56; 95% CI, 1.03-2.37), low maternal education (AOR, 1.57; 95% CI, 1.09-2.25) and homebirth (AOR, 4.32; 95% CI, 1.63-11.48). Indigenous infants had a higher risk of dying due to CHD (HR, 1.43; 95% CI, 1.03-1.99), as did those with low maternal education (HR, 1.95; 95% CI, 1.45-2.62). Conclusion Inequalities in access to health care, conditioned by unfavourable socioeconomic features, may play a key role in delayed diagnosis and mortality of CHD patients. Further studies are required to study the relationship between indigenous ethnicity and these adverse health outcomes.	[Castro, Franz; Zuniga, Julio; Higuera, Gladys; Carrion Donderis, Maria; Gomez, Beatriz; Motta, Jorge] Inst Conmemorat Gorgas Estudios Salud, Dept Res & Hlth Technol Assessment, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud	Castro, F (corresponding author), Inst Conmemorat Gorgas Estudios Salud, Dept Res & Hlth Technol Assessment, Panama City, Panama.	franzcastro@hotmail.fr	Motta, Jorge Alejandro/ABI-6006-2020	Carrion Donderis, Maria Teresa/0000-0001-5129-860X; Zuniga Cisneros, Julio/0000-0002-4659-3468				*AG HEALTHC RES QU, 2007, HEALTHC COST UT PROJ; [Anonymous], 2017, SA HEART, DOI DOI 10.24170/7-1-1964; Bank World, 2015, GINI IND WORLD BANK; Bank World, 2015, COUNTR LEND GROUPS; Benavidez OJ, 2006, PEDIATR CARDIOL, V27, P321, DOI 10.1007/s00246-005-7121-4; Boneva RS, 2001, CIRCULATION, V103, P2376; Dawson AL, 2013, PEDIATRICS, V132, pE604, DOI 10.1542/peds.2013-1002; Garg LF, 2013, PEDIATRICS, V132, pE314, DOI 10.1542/peds.2013-0269; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hoffman JIE, 2011, NEONATOLOGY, V99, P1, DOI 10.1159/000311216; Hoffman JI, 2013, CARDIOVASC J AFR, V24, P141, DOI 10.5830/CVJA-2013-028; Irvine B, 2015, HEALTH PROMOT CHRON, V35, P21, DOI 10.24095/hpcdp.35.1.04; Irvine J, 2012, PAED CHILD HEALT-CAN, V17, P363, DOI 10.1093/pch/17.7.363; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Leon-Wyss Juan R, 2009, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P8, DOI 10.1053/j.pcsu.2009.01.003; Liberman RF, 2014, PEDIATRICS, V134, pE373, DOI 10.1542/peds.2013-3949; MELNIKOW J, 1993, J FAM PRACTICE, V37, P575; Ministry of Health of Panama, 2016, BAS HLTH IND; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; National Institute of Statistics and Census, 2010, DISTR IND POP ETHN G; Nembhard WN, 2008, ETHNIC DIS, V18, P442; Nguyen N, 2015, ARCH DIS CHILD, V100, P1156, DOI 10.1136/archdischild-2015-308173; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Pan American Health Organization, 2007, REG GOALS REG HUM HL; Pasquali SK, 2013, WORLD J PEDIATR CONG, V4, P139, DOI 10.1177/2150135113480221; Pasquali SK, 2011, CIRC-CARDIOVASC QUAL, V4, P306, DOI 10.1161/CIRCOUTCOMES.110.958959; Peterson C, 2014, JAMA PEDIATR, V168, P361, DOI 10.1001/jamapediatrics.2013.4779; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Shieh JTC, 2012, AM J MED GENET A, V158A, P1236, DOI 10.1002/ajmg.a.35272; Snijder CA, 2012, HUM REPROD, V27, P1510, DOI 10.1093/humrep/des043; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Yacoub MH, 2007, CIRCULATION, V116, P1876, DOI 10.1161/CIRCULATIONAHA.107.726265	32	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163168	10.1371/journal.pone.0163168	http://dx.doi.org/10.1371/journal.pone.0163168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648568	gold, Green Submitted, Green Published			2022-12-27	WOS:000383892100061
J	Ng, HKH; Harikumar, KG; Miller, LJ; Chow, BKC				Ng, Hans K. H.; Harikumar, Kaleeckal G.; Miller, Laurence J.; Chow, Billy K. C.			Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus	PLOS ONE			English	Article							COUPLED RECEPTOR DIMERIZATION; V2 VASOPRESSIN RECEPTORS; BODY-WATER HOMEOSTASIS; FUNCTIONAL-CHARACTERIZATION; INAPPROPRIATE ANTIDIURESIS; SECRETIN RECEPTOR; BETA-ARRESTINS; RAT-KIDNEY; AQUAPORIN-2; MUTATIONS	The involvement of secretin (SCT) and secretin receptor (SCTR) in regulating body water homeostasis is well established. Identified as one of the vasopressin (Vp)-independent mechanisms in fluid balance, SCT regulates aquaporin 2 (AQP2) in the kidney distal collecting duct cells through activating intracellular cAMP production. This ability to bypass Vp-mediated water reabsorption in kidney implicates SCT's potential to treat nephrogenic diabetes insipidus (NDI). Research on NDI in the past has largely been focused on the searching for mutations in vasopressin receptor 2 (AVPR2), while the functional relationship between SCTR, AVPR2 and NDI remains unclear. Here, we demonstrate the interaction between SCTR and AVPR2 to modulate cellular signaling in vitro. Interestingly, we show in this report that upon heteromer formation with SCTR, R137H, a NDI-causing AVPR2 mutant that is defective in trafficking to cell surface, can functionally be rescued. Our data may provide an explanation for this clinically mild case of NDI, and insights into the pathological development of NDI in the future.	[Ng, Hans K. H.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	University of Hong Kong; Mayo Clinic; Mayo Clinic Phoenix	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government Research Grants Council [HKU 765011M, 764812M, 765113M, HKU6/CRF/11G]	Hong Kong Government Research Grants Council(Hong Kong Research Grants Council)	This project was supported by the Hong Kong Government Research Grants Council grants (http://www.ugc.edu.hk/eng/rgc/) HKU 765011M, 764812M, 765113M and HKU6/CRF/11G to BKCC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065885; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Bockenhauer D, 2010, NEPHRON PHYSIOL, V114, P1, DOI 10.1159/000245059; Boselt I, 2012, NEPHROL DIAL TRANSPL, V27, P1521, DOI 10.1093/ndt/gfr487; Cheng CYY, 2009, J MOL ENDOCRINOL, V43, P81, DOI 10.1677/JME-08-0123; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; Kim S, 2015, AM J PHYSIOL-RENAL, V309, pF474, DOI 10.1152/ajprenal.00477.2014; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lemaire M, 2009, CLIN KIDNEY J, V2, P20, DOI 10.1093/ndtplus/sfn163; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Michimata M, 2003, KIDNEY INT, V64, P933, DOI 10.1046/j.1523-1755.2003.00182.x; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Neocleous V, 2012, METABOLISM, V61, P922, DOI 10.1016/j.metabol.2012.01.005; Okamoto Takayuki, 2006, Clin Pediatr Endocrinol, V15, P41, DOI 10.1297/cpe.15.41; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Pendergraft WF, 2016, BRENNER RECTORS KIDN, V1, P1072; Procino G, 2014, KIDNEY INT, V86, P127, DOI 10.1038/ki.2014.10; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; Schoneberg T, 1997, J CLIN INVEST, V100, P1547, DOI 10.1172/JCI119678; Shoji Y, 1998, HUM MUTAT, pS278; Siu FKY, 2006, REGUL PEPTIDES, V137, P95, DOI 10.1016/j.regpep.2006.02.011; Spanakis E, 2008, J CELL PHYSIOL, V217, P605, DOI 10.1002/jcp.21552; Tajima Asako, 2005, Clin Pediatr Endocrinol, V14, P27, DOI 10.1297/cpe.14.27; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; VargasPoussou R, 1997, J AM SOC NEPHROL, V8, P1855; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; Wilke C, 2005, KIDNEY INT, V67, P201, DOI 10.1111/j.1523-1755.2005.00071.x	39	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163086	10.1371/journal.pone.0163086	http://dx.doi.org/10.1371/journal.pone.0163086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649563	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100051
J	Paramanandam, M; O'Byrne, M; Ghosh, B; Mammen, JJ; Manipadam, MT; Thamburaj, R; Pakrashi, V				Paramanandam, Maqlin; O'Byrne, Michael; Ghosh, Bidisha; Mammen, Joy John; Manipadam, Marie Therese; Thamburaj, Robinson; Pakrashi, Vikram			Automated Segmentation of Nuclei in Breast Cancer Histopathology Images	PLOS ONE			English	Article							ACTIVE CONTOUR; BOUNDARY	The process of Nuclei detection in high-grade breast cancer images is quite challenging in the case of image processing techniques due to certain heterogeneous characteristics of cancer nuclei such as enlarged and irregularly shaped nuclei, highly coarse chromatin marginalized to the nuclei periphery and visible nucleoli. Recent reviews state that existing techniques show appreciable segmentation accuracy on breast histopathology images whose nuclei are dispersed and regular in texture and shape; however, typical cancer nuclei are often clustered and have irregular texture and shape properties. This paper proposes a novel segmentation algorithm for detecting individual nuclei from Hematoxylin and Eosin (H&E) stained breast histopathology images. This detection framework estimates a nuclei saliency map using tensor voting followed by boundary extraction of the nuclei on the saliency map using a Loopy Back Propagation (LBP) algorithm on a Markov Random Field (MRF). The method was tested on both whole-slide images and frames of breast cancer histopathology images. Experimental results demonstrate high segmentation performance with efficient precision, recall and dice-coefficient rates, upon testing high-grade breast cancer images containing several thousand nuclei. In addition to the optimal performance on the highly complex images presented in this paper, this method also gave appreciable results in comparison with two recently published methods-Wienert et al. (2012) and Veta et al. (2013), which were tested using their own datasets.	[Paramanandam, Maqlin; Thamburaj, Robinson] Madras Christian Coll, Dept Math, Chennai, Tamil Nadu, India; [O'Byrne, Michael; Pakrashi, Vikram] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Ghosh, Bidisha] Trinity Coll Dublin, Dept Civil Struct & Environm Engn, Dublin, Ireland; [Mammen, Joy John] Christian Med Coll & Hosp, Dept Transfus Med & Immunohematol, Vellore, Tamil Nadu, India; [Manipadam, Marie Therese] Christian Med Coll & Hosp, Dept Pathol, Vellore, Tamil Nadu, India	University College Dublin; Trinity College Dublin; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Ghosh, B (corresponding author), Trinity Coll Dublin, Dept Civil Struct & Environm Engn, Dublin, Ireland.	BGHOSH@tcd.ie	Thamburaj, Robinson/AAY-1062-2020; Ghosh, Bidisha/Y-8034-2018	Thamburaj, Robinson/0000-0001-8507-4196; Pakrashi, Vikram/0000-0002-8318-3521; Ghosh, Bidisha/0000-0002-1924-3040; Mammen, Joy/0000-0002-7349-5660	SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program [12/ISCA/2493]	SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program(Science Foundation Ireland)	The study was supported by SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program grant no. 12/ISCA/2493 to BG and VP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305; Breen EJ, 1996, COMPUT VIS IMAGE UND, V64, P377, DOI 10.1006/cviu.1996.0066; Ciresan DC, 2013, LECT NOTES COMPUTER; Cosatto E, 2008, INT C PATT RECOG, P672; Cucoranu IC, 2014, J PATHOL INFORM, V5; Dalle JR., 2009, WACV; Elston C W, 2002, Histopathology, V41, P154; Fatakdawala H, 2010, IEEE T BIO-MED ENG, V57, P1676, DOI 10.1109/TBME.2010.2041232; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Gelasca ED, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-368; Guy G, 1997, IEEE T PATTERN ANAL, V19, P1265, DOI 10.1109/34.632985; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Meijer GA, 1997, J CLIN PATHOL, V50, P365, DOI 10.1136/jcp.50.5.365; Paramanandam M, 2014, LECT NOTES COMPUT SC, V8466, P250, DOI 10.1007/978-3-319-07148-0_22; Qi X, 2012, IEEE T BIO-MED ENG, V59, P754, DOI 10.1109/TBME.2011.2179298; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Veta M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070221, DOI 10.1371/J0URNAL.P0NE.0070221]; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Xu J, 2011, MED IMAGE ANAL, V15, P851, DOI 10.1016/j.media.2011.04.002	24	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162053	10.1371/journal.pone.0162053	http://dx.doi.org/10.1371/journal.pone.0162053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649496	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100013
J	Koram, KA; Adu, B; Ocran, J; Karikari, YS; Adu-Amankwah, S; Ntiri, M; Abuaku, B; Dodoo, D; Gyan, B; Kronmann, KC; Nkrumah, F				Koram, Kwadwo A.; Adu, Bright; Ocran, Josephine; Karikari, Yaa S.; Adu-Amankwah, Susan; Ntiri, Michael; Abuaku, Benjamin; Dodoo, Daniel; Gyan, Ben; Kronmann, Karl C.; Nkrumah, Francis			Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; BINDING ANTIGEN 175; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR HETEROGENEITY; FUNCTIONAL ANTIBODIES; MOZAMBICAN CHILDREN; MALIAN CHILDREN; ERYTHROCYTES; INVASION; PROTECTION	The erythrocyte binding antigen region II (EBA-175 RII) is a Plasmodium falciparum ligand that mediates erythrocyte invasion and is considered an important malaria vaccine candidate. A phase Ia trial in malaria naive adults living in the United States found the recombinant non-glycosylated vaccine antigen, EBA-175 RII-NG adjuvanted with aluminium phosphate to be safe, immunogenic and capable of inducing biologically active antibodies that can inhibit parasite growth in vitro. The aim of the current study was to assess the safety and immunogenicity of this vaccine in malaria exposed semi-immune healthy adults living in a malaria endemic country, Ghana. In this double-blinded, placebo controlled, dose escalation phase I trial, eighteen subjects per group received ascending dose concentrations (5 mu g, 20 mu g or 80 mu g) of the vaccine intramuscularly at 0, 1 and 6 months, while 6 subjects received placebo (normal saline). The primary end point was the number of subjects experiencing Grade 3 systemic or local adverse events within 14 days post-vaccination. Serious adverse events were assessed throughout the study period. Blood samples for immunological analyses were collected at days 0, 14, 28, 42, 180 and 194. A total of 52 subjects received three doses of the vaccine in the respective groups. No serious adverse events were reported. The majority of all adverse events reported were mild to moderate in severity, with local pain and tenderness being the most common. All adverse events, irrespective of severity, resolved without any sequelae. Subjects who received any of the EBA-175 RII-NG doses had high immunoglobulin G levels which moderately inhibited P. falciparum growth in vitro, compared to those in the placebo group. In conclusion, the EBA-175 RII-NG vaccine was safe, well tolerated and immunogenic in malaria semi-immune Ghanaian adults. Its further development is recommended.	[Koram, Kwadwo A.; Ocran, Josephine; Karikari, Yaa S.; Adu-Amankwah, Susan; Ntiri, Michael; Abuaku, Benjamin; Kronmann, Karl C.; Nkrumah, Francis] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Ghana; [Adu, Bright; Dodoo, Daniel; Gyan, Ben] Univ Ghana, Noguchi Mem Inst Med Res, Coll Hlth Sci, Dept Immunol, Legon, Ghana; [Kronmann, Karl C.] US Naval Med Res Unit 3, Ghana Detachment, Cantonments, Accra, Ghana; [Ocran, Josephine] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Karikari, Yaa S.] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Kronmann, Karl C.] Naval Med Ctr, Portsmouth, VA USA	University of Ghana; University of Ghana; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Harvard University; Harvard T.H. Chan School of Public Health; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koram, KA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Ghana.	KKoram@noguchi.ug.edu.gh	Adu, Bright/ABA-8631-2020; Abuaku, Benjamin/AAG-1113-2020	Adu, Bright/0000-0002-3622-2137; Abuaku, Benjamin/0000-0002-1840-6979; Kronmann, Karl/0000-0003-1783-7061	National Institute of Allergy and Infectious Diseases (NIAID) [N01-AI-05421]; Division of Microbiology and Infectious Diseases (DMID), NIAID/US NIH [HHSN266200400016C]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Microbiology and Infectious Diseases (DMID), NIAID/US NIH	The study product was developed by Leidos with support from National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov) [contract N01-AI-05421 awarded to Leidos]. The study was sponsored by the Division of Microbiology and Infectious Diseases (DMID), NIAID/US NIH (https://www.niaid.nih.gov) under Contract No. HHSN266200400016C awarded to Noguchi Memorial Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Dobano C, 2012, CLIN VACCINE IMMUNOL, V19, P157, DOI 10.1128/CVI.05523-11; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Esen M, 2009, VACCINE, V27, P6862, DOI 10.1016/j.vaccine.2009.09.011; HADLEY TJ, 1987, J CLIN INVEST, V80, P1190, DOI 10.1172/JCI113178; Irani V, 2015, CLIN INFECT DIS, V61, P1244, DOI 10.1093/cid/civ525; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Koram Ka, 2007, Ghana Med J, V41, P160; Lusingu JPA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-163; mal ERACGoV, 2011, PLOS MED, V8, DOI [10.1371/ journal. pmed. 1000398, DOI 10.1371/J0URNAL.PMED.1000398]; MITCHELL GH, 1986, BLOOD, V67, P1519; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Theisen M, 2014, VACCINE, V32, P2623, DOI 10.1016/j.vaccine.2014.03.020; Thera MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009041; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Wanaguru M, 2013, J BIOL CHEM, V288, P32106, DOI 10.1074/jbc.M113.484840; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; WHO, 2015, WORLD MAL REP 2015	39	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163066	10.1371/journal.pone.0163066	http://dx.doi.org/10.1371/journal.pone.0163066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644034	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900030
J	Kinoshita, T; Mitamura, Y; Mori, T; Akaiwa, K; Semba, K; Egawa, M; Mori, J; Sonoda, S; Sakamoto, T				Kinoshita, Takamasa; Mitamura, Yoshinori; Mori, Terumi; Akaiwa, Kei; Semba, Kentaro; Egawa, Mariko; Mori, Junya; Sonoda, Shozo; Sakamoto, Taiji			Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INDOCYANINE GREEN ANGIOGRAPHY; KOYANAGI-HARADA DISEASE; STROMAL AREAS; VISUAL-ACUITY; BINARIZATION; VERTEPORFIN; IMAGES; THICKNESS; ASSOCIATION	Purpose To determine the structural changes in the choroid after half-dose photodynamic therapy (hPDT) in eyes with chronic central serous chorioretinopathy (CSC). Methods This was a retrospective interventional study of 29 eyes of 29 patients who underwent hPDT for chronic CSC with serous retinal detachment (SRD) and were followed for >= 3 months. Enhanced depth imaging optical coherence tomographic (EDI-OCT) images of the subfoveal choroid were converted to binary images. The central choroidal thickness (CCT), the cross sectional subfoveal choroidal area, the hyporeflective and hyperreflective areas of the inner, outer, and whole choroid were determined at the baseline, and at 1, 3, and 12 months after the hPDT. Results The SRDs were resolved in 26 (89.7%) eyes at 3 months after the hPDT. The mean CCT (P = 0.001), the total choroidal area (P = 0.001), and the hypo-reflective area (P = 0.003) of the whole choroid were significantly decreased from the baseline at 3 months. The hyperreflective area of whole choroid was not significantly changed during the study period (P = 0.083). The hyperreflective but not the hyporeflective area of the inner choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively). The hyporeflective but not the hyperreflective area of the outer choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively). Conclusions The hyperreflective area of the inner choroid and hyporeflective area of the outer choroid were significantly decreased after hPDT for chronic CSC. Because the hyperreflective and hyporeflective area correspond to the choroidal stroma and vessels, respectively, the decreased CCT and subfoveal choroidal area after hPDT may be attributed to a decrease in the exudative changes in the inner choroidal stroma and the reduction of the dilation of the outer choroidal vessels.	[Kinoshita, Takamasa; Mitamura, Yoshinori; Mori, Terumi; Akaiwa, Kei; Semba, Kentaro; Egawa, Mariko] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan; [Kinoshita, Takamasa; Mori, Junya] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Tokushima University; Sapporo City General Hospital; Kagoshima University	Kinoshita, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan.; Kinoshita, T (corresponding author), Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	knst129@gmail.com	Kinoshita, Takamasa/S-9174-2019	Kinoshita, Takamasa/0000-0002-0465-2140	Ministry of Education, Culture, Sports, Science and Technology, Japan [16K11288]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grant-in-aid 16K11288 (to YM) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2016, RETINA; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan WM, 2008, OPHTHALMOLOGY, V115, P1756, DOI 10.1016/j.ophtha.2008.04.014; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Egawa M, 2016, BRIT J OPHTHALMOL, V100, P1646, DOI 10.1136/bjophthalmol-2015-307734; Egawa M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0127-7; Fujita K, 2015, OPHTHALMOLOGY, V122, P555, DOI 10.1016/j.ophtha.2014.09.034; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Inoue R, 2010, AM J OPHTHALMOL, V149, P441, DOI 10.1016/j.ajo.2009.10.011; Iwata A, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0014-2; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Kawano H, 2016, GRAEF ARCH CLIN EXP, V254, P421, DOI 10.1007/s00417-016-3283-4; Kinoshita T, 2017, BRIT J OPHTHALMOL, V101, P360, DOI 10.1136/bjophthalmol-2016-308594; Lai TYY, 2006, BRIT J OPHTHALMOL, V90, P869, DOI 10.1136/bjo.2006.090282; Loo RH, 2002, RETINA-J RET VIT DIS, V22, P19, DOI 10.1097/00006982-200202000-00004; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Nakayama M, 2012, RETINA-J RET VIT DIS, V32, P2061, DOI 10.1097/IAE.0b013e318256205a; Nicolo M, 2014, AM J OPHTHALMOL, V157, P1033, DOI 10.1016/j.ajo.2014.01.022; Nicolo M, 2012, AM J OPHTHALMOL, V153, P474, DOI 10.1016/j.ajo.2011.08.015; PICCOLINO FC, 1995, EYE, V9, P324, DOI 10.1038/eye.1995.63; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Razavi S, 2014, AM J OPHTHALMOL, V157, P852, DOI 10.1016/j.ajo.2013.12.029; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Reibaldi M, 2010, AM J OPHTHALMOL, V149, P307, DOI 10.1016/j.ajo.2009.08.026; Schmidt-Erfurth U, 2002, ARCH OPHTHALMOL-CHIC, V120, P835; Smretschnig E, 2013, RETINA-J RET VIT DIS, V33, P316, DOI 10.1097/IAE.0b013e318280769c; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 1996, OPHTHALMOLOGY, V103, P2070, DOI 10.1016/S0161-6420(96)30386-2; Spaide RF, 2015, AM J OPHTHALMOL, V160, P1211, DOI 10.1016/j.ajo.2015.08.018; Yang LH, 2013, INVEST OPHTH VIS SCI, V54, P4659, DOI 10.1167/iovs.12-10991; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; YOSHIOKA H, 1982, JPN J OPHTHALMOL, V26, P397	41	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163104	10.1371/journal.pone.0163104	http://dx.doi.org/10.1371/journal.pone.0163104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636093	gold, Green Submitted, Green Published			2022-12-27	WOS:000383723700033
J	Sluka, JP; Fu, X; Swat, M; Belmonte, JM; Cosmanescu, A; Clendenon, SG; Wambaugh, JF; Glazier, JA				Sluka, James P.; Fu, Xiao; Swat, Maciej; Belmonte, Julio M.; Cosmanescu, Alin; Clendenon, Sherry G.; Wambaugh, John F.; Glazier, James A.			A Liver-Centric Multiscale Modeling Framework for Xenobiotics	PLOS ONE			English	Article							BIOLOGY MARKUP LANGUAGE; HEPATIC STELLATE CELLS; IN-VIVO EXTRAPOLATION; SYSTEMS BIOLOGY; GLUTATHIONE METABOLISM; INDUCED HEPATOTOXICITY; ACETAMINOPHEN; PARACETAMOL; SIMULATION; HUMANS	We describe a multi-scale, liver-centric in silico modeling framework for acetaminophen pharmacology and metabolism. We focus on a computational model to characterize whole body uptake and clearance, liver transport and phase I and phase II metabolism. We do this by incorporating sub-models that span three scales; Physiologically Based Pharmacokinetic (PBPK) modeling of acetaminophen uptake and distribution at the whole body level, cell and blood flow modeling at the tissue/organ level and metabolism at the sub-cellular level. We have used standard modeling modalities at each of the three scales. In particular, we have used the Systems Biology Markup Language (SBML) to create both the whole-body and sub-cellular scales. Our modeling approach allows us to run the individual sub-models separately and allows us to easily exchange models at a particular scale without the need to extensively rework the sub-models at other scales. In addition, the use of SBML greatly facilitates the inclusion of biological annotations directly in the model code. The model was calibrated using human in vivo data for acetaminophen and its sulfate and glucuronate metabolites. We then carried out extensive parameter sensitivity studies including the pairwise interaction of parameters. We also simulated population variation of exposure and sensitivity to acetaminophen. Our modeling framework can be extended to the prediction of liver toxicity following acetaminophen overdose, or used as a general purpose pharmacokinetic model for xenobiotics.	[Sluka, James P.; Fu, Xiao; Swat, Maciej; Belmonte, Julio M.; Cosmanescu, Alin; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ Bloomington, Biocomplex Inst, Bloomington, IN 47405 USA; [Wambaugh, John F.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Indiana University System; Indiana University Bloomington; United States Environmental Protection Agency	Sluka, JP; Glazier, JA (corresponding author), Indiana Univ Bloomington, Biocomplex Inst, Bloomington, IN 47405 USA.	JSluka@Indiana.edu; JGlazier@Indiana.edu	Belmonte, Julio/J-8696-2013; Clendenon, Sherry G/F-7651-2010; Wambaugh, John/AAM-4487-2020; Belmonte, Julio M/AAB-6434-2020; Sluka, James P/AAL-9294-2021; Clendenon, Sherry/AAG-6655-2019	Belmonte, Julio/0000-0002-4315-9631; Clendenon, Sherry G/0000-0002-3353-0919; Wambaugh, John/0000-0002-4024-534X; Belmonte, Julio M/0000-0002-4315-9631; Sluka, James P/0000-0002-5901-1404; Clendenon, Sherry/0000-0002-3353-0919; Fu, Xiao/0000-0002-8611-891X; Glazier, James Alexander/0000-0003-3634-190X	US Environmental Protection Agency [R835001]; National Institute of Health, National Institute of General Medical Sciences [GM077138, GM111243]; Indiana University; Lilly Endowment; Indiana METACyt Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM111243] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indiana University; Lilly Endowment; Indiana METACyt Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the US Environmental Protection Agency (www3.epa.gov), grant number R835001 (JAG, JFW, JPS, AC), The National Institute of Health, National Institute of General Medical Sciences (www.nih.gov), grant numbers GM077138 (JAG, JPS, MS, JMB) and GM111243 (JAG, JPS, XF, SGC), by Indiana University (www.indiana.edu) (JAG, XF, MS, JMB, AC, SGC), the Lilly Endowment (JAG), and Indiana METACyt Initiative (JAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ME, 1997, TOXICOL APPL PHARM, V144, P135, DOI 10.1006/taap.1996.8066; BAGNALL WE, 1979, J PHARM PHARMACOL, V31, P157, DOI 10.1111/j.2042-7158.1979.tb13459.x; Ben-Shachar R, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-55; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Critchley JAJH, 2005, J CLIN PHARM THER, V30, P179, DOI 10.1111/j.1365-2710.2004.00626.x; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Drasdo D, 2014, J HEPATOL, V61, P951, DOI 10.1016/j.jhep.2014.06.013; FAHRAEUS R, 1931, THE AMERICAN JOURNAL, V96, P562; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Geenen S, 2013, INTEGR BIOL-UK, V5, P877, DOI 10.1039/c3ib20245c; Ghallab A, 2016, J HEPATOLOG IN PRESS, P1; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Groneberg DA, 2002, TOXICOL PATHOL, V30, P394, DOI 10.1080/01926230252929972; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; GWILT JR, 1963, J PHARM PHARMACOL, V15, P440, DOI 10.1111/j.2042-7158.1963.tb12811.x; Hester SD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002155; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jiang XL, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.55; KATZ NR, 1992, J NUTR, V122, P843, DOI 10.1093/jn/122.suppl_3.843; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Leclerc E, 2015, CELL BIOL TOXICOL, V31, P173, DOI 10.1007/s10565-015-9302-0; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mazaleuskaya LL, 2015, PHARMACOGENET GENOM, V25, P416, DOI 10.1097/FPC.0000000000000150; Nishii K, 2016, J MECH BEHAV BIOMED, V57, P201, DOI 10.1016/j.jmbbm.2015.11.033; Ochoa JGD, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00204; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Pery ARR, 2013, TOXICOL LETT, V220, P26, DOI 10.1016/j.toxlet.2013.03.032; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Nicolas R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-79; Sauro HM, 2000, 9 INT BIOTHERMOKINET, P221; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schwen LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133653; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Shiran MR, 2006, XENOBIOTICA, V36, P567, DOI 10.1080/00498250600761662; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Somogyi ET, 2015, BIOINFORMATICS, V31, P3315, DOI 10.1093/bioinformatics/btv363; Stahl Simone H, 2015, Drug Discov Today Technol, V15, P9, DOI 10.1016/j.ddtec.2015.06.003; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Trettin A, 2011, J CHROMATOGR B, V879, P2274, DOI 10.1016/j.jchromb.2011.06.012; Vallabhajosyula RR, 2007, BIOINFORMATICS, V23, P1859, DOI 10.1093/bioinformatics/btm231; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Ward B., 1999, ACUTE PAIN, V2, P139, DOI DOI 10.1016/S1366-0071(99)80006-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yan L, 2008, PHARM RES, V25, P1023, DOI 10.1007/s11095-007-9494-y; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023; Zurlinden TJ, 2015, BRIT J CLIN PHARMACO, P1	63	34	34	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162428	10.1371/journal.pone.0162428	http://dx.doi.org/10.1371/journal.pone.0162428			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636091	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700006
J	Beeftink, MMA; Spiering, W; Bots, ML; Verloop, WL; De Jager, RL; Sanders, MF; Vonken, EJ; Blankestijn, PJ; Voskuil, M				Beeftink, Martine M. A.; Spiering, Wilko; Bots, Michiel L.; Verloop, Willemien L.; De Jager, Rosa L.; Sanders, Margreet F.; Vonken, Evert-jan; Blankestijn, Peter J.; Voskuil, Michiel			Renal Denervation in a Real Life Setting: A Gradual Decrease in Home Blood Pressure	PLOS ONE			English	Article							RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; EUROPEAN-SOCIETY; CONTROLLED-TRIAL; MANAGEMENT; PATIENT; SAFETY	Objectives To investigate the blood pressure dynamics after renal denervation through monthly home blood pressure measurements throughout the first 12 months. Methods A cohort of 70 patients performed highly standardized monthly home blood pressure monitoring during the first year after denervation according to the European Society of Hypertension guidelines. At baseline and 12 months follow-up, office and ambulatory blood pressure as well as routine physical and laboratory assessment was performed. Results Home blood pressure decreased with a rate of 0.53 mmHg/month (95% CI 0.20 to 0.86) systolic and 0.26 mmHg/month (95% CI 0.08 to 0.44) diastolic throughout 12 months of follow-up, while the use of antihypertensive medication remained stable (+ 0.03 daily defined doses/month, 95% CI -0.01 to 0.08). On average, a 12 month reduction of 8.1 mmHg (95% CI 4.2 to 12.0) was achieved in home systolic blood pressure, 9.3 mmHg (95% CI -14.2 to -4.4) as measured by 24-hour ambulatory blood pressure monitoring and 15.9 mmHg (95% CI -23.8 to -7.9) on office measurements. Conclusion Blood pressure reduction after renal denervation occurs as a gradual decrease that extends to at least one-year follow-up. Home monitoring seems a suitable alternative for ambulatory blood pressure monitoring after renal denervation.	[Beeftink, Martine M. A.; Verloop, Willemien L.; Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & PrimaryCare, Utrecht, Netherlands; [De Jager, Rosa L.; Sanders, Margreet F.; Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Vonken, Evert-jan] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voskuil, M (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	m.voskuil@umcutrecht.nl			Netherlands Organisation for Health Research and Development (ZonMw); Dutch Kidney Foundation [NCT02482103]; Medtronic	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation; Medtronic(Medtronic)	RLD and MS are supported by grants from The Netherlands Organisation for Health Research and Development (ZonMw), the Dutch Kidney Foundation and an unrestricted grant from Medtronic (Sympathy trial). MMB is supported by an unrestricted grant from Medtronic (DIASTOLE trial). MLB has obtained grants from non-profit organisations such as The Netherlands Organisation for Health Research and Development (ZonMw) and the Dutch Kidney Foundation for conducting studies into renal denervation. For the remaining authors none were declared. The Dutch National Renal Denervation Registry is partly supported by a grant from the Dutch Kidney Foundation (NCT02482103).	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Ali S, 2002, J HUM HYPERTENS, V16, P359, DOI 10.1038/sj.jhh.1001384; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; De Jager RL, 2016, CLIN RES CARDIOL, V105, P755, DOI 10.1007/s00392-016-0984-y; Desch S, 2015, HYPERTENSION, V65, P1202, DOI 10.1161/HYPERTENSIONAHA.115.05283; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Hering D, 2014, HYPERTENSION, V64, P118, DOI 10.1161/HYPERTENSIONAHA.113.03098; Kaiser L, 2014, EUROINTERVENTION, V10, P157, DOI 10.4244/EIJV10I1A24; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; Mc Namara KP, 2014, FAM PRACT, V31, P437, DOI 10.1093/fampra/cmu026; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Persu A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0460-x; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickering TG, 2010, J AM SOC HYPERTENS, V4, P56, DOI 10.1016/j.jash.2010.03.003; REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.1995.03520390071036; Rosa J, 2015, HYPERTENSION, V65, P407, DOI 10.1161/HYPERTENSIONAHA.114.04019; Rumke CL, REGRESSION MEAN, V128, P158; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Sanders MF, 2016, NETH J MED, V74, P5; Tzafriri AR, 2014, J AM COLL CARDIOL, V64, P1079, DOI 10.1016/j.jacc.2014.07.937; Verberk WJ, 2007, HYPERTENSION, V50, P1019, DOI 10.1161/HYPERTENSIONAHA.107.094193; Verloop WL, 2015, EUR J PREV CARDIOL, V22, P558, DOI 10.1177/2047487314556003; Verloop WL, 2013, J HYPERTENS, V31, P1662, DOI 10.1097/HJH.0b013e328362152e; Vink EE, 2014, J HYPERTENS, V32, P2045, DOI 10.1097/HJH.0000000000000282; WHO Collaborating Centre for Drug Statistics Methodology, 2014, GUID ATC CLASS DDD A; World Health Organization, 2013, GLOBAL BRIEF HYPERTE; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162251	10.1371/journal.pone.0162251	http://dx.doi.org/10.1371/journal.pone.0162251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631608	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900032
J	Chai, YW; Lee, EH; Gubbe, JD; Brekke, JH				Chai, Yi Wen; Lee, Eu Han; Gubbe, John D.; Brekke, John H.			3D Cell Culture in a Self-Assembled Nanofiber Environment	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CHITOSAN; TUMOR; DIFFERENTIATION; MIGRATION; CARTILAGE; HYDROGELS; PROTEIN; MICROENVIRONMENTS; BIOMATERIALS	The development and utilization of three-dimensional cell culture platforms has been gaining more traction. Three-dimensional culture platforms are capable of mimicking in vivo microenvironments, which provide greater physiological relevance in comparison to conventional two-dimensional cultures. The majority of three-dimensional culture platforms are challenged by the lack of cell attachment, long polymerization times, and inclusion of undefined xenobiotics, and cytotoxic cross-linkers. In this study, we review the use of a highly defined material composed of naturally occurring compounds, hyaluronic acid and chitosan, known as Cell-Mate3D (TM). Moreover, we provide an original measurement of Young's modulus using a uniaxial unconfined compression method to elucidate the difference in microenvironment rigidity for acellular and cellular conditions. When hydrated into a tissue-like hybrid hydrocolloid/hydrogel, Cell-Mate3D (TM) is a highly versatile three-dimensional culture platform that enables downstream applications such as flow cytometry, immunostaining, histological staining, and functional studies to be applied with relative ease.	[Chai, Yi Wen; Lee, Eu Han; Gubbe, John D.; Brekke, John H.] BRTI Life Sci, Two Harbors, MN 55616 USA		Chai, YW (corresponding author), BRTI Life Sci, Two Harbors, MN 55616 USA.	wchai@brtilifesciences.com						Amann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092511; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619; BENZEEV A, 1991, BIOESSAYS, V13, P207, DOI 10.1002/bies.950130502; BISSELL MJ, 1987, J CELL SCI, P327; Brekke JH, 2011, INTRO BIOMATERIALS, P331; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; CANCEDDA FD, 1992, J CELL BIOL, V117, P427, DOI 10.1083/jcb.117.2.427; Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6; Chun SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128739; Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067; Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Didenko LV, 2005, B EXP BIOL MED+, V140, P356, DOI 10.1007/s10517-005-0489-6; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gill BJ, 2014, J BIOMECH, V47, P1969, DOI 10.1016/j.jbiomech.2013.09.029; Goessler UR, 2004, INT J MOL MED, V13, P505; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; HAY ED, 1989, AM J MED GENET, V34, P14, DOI 10.1002/ajmg.1320340107; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hu T, 2004, LECT NOTES COMPUT SC, V3078, P28; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; HUGHES WL, 1958, P NATL ACAD SCI USA, V44, P476, DOI 10.1073/pnas.44.5.476; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; INGBER DE, 1994, INT REV CYTOL, V150, P173; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kisiday J, BIOPOLYMER METHODS T, P239, DOI [10.1385/1-1016/j.tips.2015.03.003, DOI 10.1385/1-1016/J.TIPS.2015.03.003]; LI J, 2011, BMC CANCER, V11, DOI DOI 10.1186/1471-2407-; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lindborg BA, 2015, TISSUE ENG PT A, V21, P1952, DOI [10.1089/ten.TEA.2014.0335, 10.1089/ten.tea.2014.0335]; Lovitt Carrie J, 2014, Biology (Basel), V3, P345, DOI 10.3390/biology3020345; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; MCELWAIN DLS, 1977, MATH BIOSCI, V35, P267, DOI 10.1016/0025-5564(77)90028-1; Miller K, 2000, CONSTITUTIVE MODELLI, V33, DOI [10.1016/S0021-9290(99), DOI 10.1016/S0021-9290(99)]; Monica A, 2008, METHODS, V45, P93; Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002; Nagahara S, 1996, J BIOMED MATER RES, V32, P677, DOI 10.1002/(SICI)1097-4636(199612)32:4<677::AID-JBM22>3.0.CO;2-9; Nema R., 2012, ADV BIOSCIENCE BIOTE, V3, P219, DOI [10.4236/abb.2012.33030, DOI 10.4236/ABB.2012.33030]; Nerem RM, 2007, BIOMATERIALS, V28, P5074, DOI 10.1016/j.biomaterials.2007.07.032; Neumann S, 2014, CANC BIOL NUCL ENV R, P484; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peng G, 2015, TRENDS PHARMACOL SCI, V36, P374, DOI 10.1016/j.tips.2015.03.003; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224; RODFORD RA, 1993, BIOMATERIALS, V14, P781, DOI 10.1016/0142-9612(93)90044-3; Roeder RK, 2013, CHARACTERIZATION OF BIOMATERIALS, P49, DOI 10.1016/B978-0-12-415800-9.00003-6; Saggar JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00154; Sawada D, 2012, BIOMACROMOLECULES, V13, P288, DOI 10.1021/bm201512t; Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786+; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Soares CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038147; Stamenovic D, 1996, J THEOR BIOL, V181, P125, DOI 10.1006/jtbi.1996.0120; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Tai BCU, 2010, BIOMATERIALS, V31, P48, DOI 10.1016/j.biomaterials.2009.09.022; Tannock IF, 2001, CANCER METAST REV, V20, P123, DOI 10.1023/A:1013125027697; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075727; Whittaker JL, 2015, J MATER CHEM B, V3, P6576, DOI 10.1039/c5tb00970g; Whittaker J, 2014, POLYM INT, V63, P1545, DOI 10.1002/pi.4670; Xiong W, 2016, ASIAN J PHARM SCI, V11, P439, DOI 10.1016/j.ajps.2015.10.064; Yang C., 2014, J BOT, V2014, P9, DOI [10.1155/2014/181727, DOI 10.1155/2014/181727]; Yim EKF, 2006, BIOMATERIALS, V27, P6111, DOI 10.1016/j.biomaterials.2006.07.037; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279	75	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162853	10.1371/journal.pone.0162853	http://dx.doi.org/10.1371/journal.pone.0162853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632425	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900087
J	Devisscher, T; Anderson, LO; Aragao, LEOC; Galvan, L; Malhi, Y				Devisscher, Tahia; Anderson, Liana O.; Aragao, Luiz E. O. C.; Galvan, Luis; Malhi, Yadvinder			Increased Wildfire Risk Driven by Climate and Development Interactions in the Bolivian Chiquitania, Southern Amazonia	PLOS ONE			English	Article							FIRE REGIMES; LAND-USE; TROPICAL FORESTS; SPATIAL-PATTERNS; CARBON-DENSITY; DEFORESTATION; SUSCEPTIBILITY; PREVENTION; FUTURE; LANDSCAPES	Wildfires are becoming increasingly dominant in tropical landscapes due to reinforcing feed-backs between land cover change and more severe dry conditions. This study focused on the Bolivian Chiquitania, a region located at the southern edge of Amazonia. The extensive, unique and well-conserved tropical dry forest in this region is susceptible to wildfires due to a marked seasonality. We used a novel approach to assess fire risk at the regional level driven by different development trajectories interacting with changing climatic conditions. Possible future risk scenarios were simulated using maximum entropy modelling with presence-only data, combining land cover, anthropogenic and climatic variables. We found that important determinants of fire risk in the region are distance to roads, recent deforestation and density of human settlements. Severely dry conditions alone increased the area of high fire risk by 69%, affecting all categories of land use and land cover. Interactions between extreme dry conditions and rapid frontier expansion further increased fire risk, resulting in potential biomass loss of 2.44 +/- 0.8 Tg in high risk area, about 1.8 times higher than the estimates for the 2010 drought. These interactions showed particularly high fire risk in land used for 'extensive cattle ranching', 'agro-silvopastoral use' and 'intensive cattle ranching and agriculture'. These findings have serious implications for subsistence activities and the economy in the Chiquitania, which greatly depend on the forestry, agriculture and livestock sectors. Results are particularly concerning if considering the current development policies promoting frontier expansion. Departmental protected areas inhibited wildfires when strategically established in areas of high risk, even under drought conditions. However, further research is needed to assess their effectiveness accounting for more specific contextual factors. This novel and simple modelling approach can inform fire and land management decisions in the Chiquitania and other tropical forest landscapes to better anticipate and manage large wildfires in the future.	[Devisscher, Tahia; Anderson, Liana O.; Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Devisscher, Tahia] Stockholm Environm Inst, Oxford, England; [Anderson, Liana O.] Natl Ctr Monitoring & Early Warning Nat Disasters, Sao Jose Dos Campos, Brazil; [Anderson, Liana O.; Aragao, Luiz E. O. C.] Natl Inst Space Res, Remote Sensing Div, Sao Jose Dos Campos, Brazil; [Aragao, Luiz E. O. C.] Univ Exeter, Geog, Coll Life & Environm Sci, Exeter, Devon, England; [Galvan, Luis] Univ Nacl Autonoma Mexico, Inst Geog, Posgrad Geog, Mexico City, DF, Mexico	University of Oxford; Instituto Nacional de Pesquisas Espaciais (INPE); University of Exeter; Universidad Nacional Autonoma de Mexico	Devisscher, T (corresponding author), Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England.; Devisscher, T (corresponding author), Stockholm Environm Inst, Oxford, England.	tahia.devisscher@ouce.ox.ac.uk	aragao, luiz eoc/G-8387-2012	aragao, luiz eoc/0000-0002-4134-6708	Santander Academic Travel Award; FCBC; FAN; INPE	Santander Academic Travel Award; FCBC; FAN; INPE	The author(s) received no specific funding for this research. The study was mostly self-funded by the corresponding author TD as part of her PhD thesis. TD was supported by the Santander Academic Travel Award to visit INPE as part of this study.r This study was conducted with support from the FCBC, FAN and INPE. Special thanks to R. Anivarro and L. Saldana Moron at the FCBC, A.M. Rodriguez-Montellano and C. Pinto at the FAN, A. Lima, M. Gesteira Fonseca, E. Arai and G. Tejada Pinell at the INPE, and Y. Yu and S. Saatchi at the JPL-NASA for their important support in data compilation and advice in data processing. We are grateful also to J. Barlow and anonymous reviewers whose comments improved the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Alencar AAC, 2004, ECOL APPL, V14, pS139; Alencar A, 2006, EARTH INTERACT, V10; Anderson LO, 2015, GLOBAL BIOGEOCHEM CY, V29, P1739, DOI 10.1002/2014GB005008; [Anonymous], 2006, NEOTROPICAL SAVANNAS; Aragao LEOC, 2014, BIOL REV, V89, P913, DOI 10.1111/brv.12088; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Armenteras D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035288; Arnold JD, 2014, FIRE ECOL, V10, P64, DOI 10.4996/fireecology.1002064; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Balch JK, 2015, BIOSCIENCE, V65, P893, DOI 10.1093/biosci/biv106; Bar Massada A., 2012, INT J WILDLAND FIRE, V22, P174, DOI DOI 10.1071/WF11178; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Bilbao BA, 2010, HUM ECOL, V38, P663, DOI 10.1007/s10745-010-9344-0; Bowman MS, 2008, ECOL ECON, V67, P117, DOI 10.1016/j.ecolecon.2007.12.003; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Cardoso MF, 2003, GLOBAL CHANGE BIOL, V9, P656, DOI 10.1046/j.1365-2486.2003.00607.x; Carmenta R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149292; Carmenta R, 2011, ECOL SOC, V16; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Chumacero JP, 2010, FUNDACION TIERRA INF; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cochrane MA, 2009, GLOBAL CHANGE BIOL, V15, P601, DOI 10.1111/j.1365-2486.2008.01786.x; Cochrane MA, 2008, AMBIO, V37, P522, DOI 10.1579/0044-7447-37.7.522; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; de Mendonca MJC, 2004, ECOL ECON, V49, P89, DOI 10.1016/j.ecolecon.2003.11.011; Devisscher T, 2016, ECOLOGY SOC IN PRESS; Devisscher T, 2016, FOREST ECOL MANAG, V360, P273, DOI 10.1016/j.foreco.2015.10.033; Dexter KG, 2015, INT FORESTRY REV, V17; Diaz-Delgado R, 2004, LANDSCAPE ECOL, V19, P731, DOI 10.1007/s10980-005-0183-1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO, 2011, 5 INT WILDL FIR C SU; Ferrarini A., 2012, ENV SKEPTICS CRITICS, V1, P56; Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140389; Fundacion Amigos de la Naturaleza (FAN), 2012, MAP DEF TIERR BAJ YU; Fundacion para la Conservacion del Bosque Chiquitano (FCBC), 2012, DAT SHAR I; Fundacion Tierra, 2015, CUMBR AGR SEMBR BOL; Giglio L, 2020, COLLECTION 6 MODIS B; Gutierrez-Velez VH, 2014, ECOL APPL, V24, P1323, DOI 10.1890/13-2101.1; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Hardy CC, 2005, FOREST ECOL MANAG, V211, P73, DOI 10.1016/j.foreco.2005.01.029; Instituto Boliviano de Comercio Exterior (IBCE), 2013, ENC AGR PROD MAS INV; Instituto Nacional de Estadistica de Bolivia (INE), 2010, DAT DE POBL; International Model Forest Network (IMFN), 2013, CHIQ MOD FOR; Jimenez G, 2013, TERRITORIOS INDIGENA; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Justiniano H, 2014, EXPERIENCIAS BOSQUES; Killeen TJ, 1998, J TROP ECOL, V14, P803, DOI 10.1017/S0266467498000583; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lima A, 2012, APPL GEOGR, V34, P239, DOI 10.1016/j.apgeog.2011.10.013; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; McDaniel J, 2005, SOC NATUR RESOUR, V18, P921, DOI 10.1080/08941920500248921; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Muller R, 2013, LAND USE POLICY, V30, P895, DOI 10.1016/j.landusepol.2012.06.019; Muller R., 2014, 108 CIFOR, DOI 10.17528/cifor/004600; National Aeronautics and Space Administration and the U.S. Geological Survey (NASA USGS), 2014, MOD TERR LAND SURF T; National Aeronautics and Space Administration Fire Information for Resource Management System (NASA FIRMS), 2014, AQ TERR MCD14ML HOTS; National Aeronautics and Space Administration Tropical Rainfall Measuring Mission (NASA TRMM), 2014, PREC DAT DOWNL CHIQ; Nazeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048104; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Oliveras I, 2014, GLOBAL BIOGEOCHEM CY, V28, P480, DOI 10.1002/2013GB004664; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto C., 2007, CHAQUEOS INCENDIOS F; Redo D, 2011, LAND USE POLICY, V28, P227, DOI 10.1016/j.landusepol.2010.06.004; Renard Q, 2012, INT J WILDLAND FIRE, V21, P368, DOI 10.1071/WF10109; Rodriguez-Montellano A.M., 2014, INCENDIOS QUEMAS BOL; Roy DP, 2016, EUR SPAC AG LIV PLAN; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Schroeder W, 2008, REMOTE SENS ENVIRON, V112, P2711, DOI 10.1016/j.rse.2008.01.005; Schroeder W, 2014, REMOTE SENS ENVIRON, V143, P85, DOI 10.1016/j.rse.2013.12.008; Seiler C., 2009, IMPLEMENTATION VALID; Seiler C, 2013, J APPL METEOROL CLIM, V52, P1303, DOI 10.1175/JAMC-D-12-0224.1; Seiler C, 2013, J APPL METEOROL CLIM, V52, P130, DOI 10.1175/JAMC-D-12-0105.1; Shimabukuro YE, 2009, INT J REMOTE SENS, V30, P1537, DOI 10.1080/01431160802509058; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; Sletto B, 2013, J ENVIRON MANAGE, V115, P155, DOI 10.1016/j.jenvman.2012.10.041; Smith HG, 2014, J HYDROL, V396, P170; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Soares B, 2012, LANDSCAPE ECOL, V27, P585, DOI 10.1007/s10980-012-9723-6; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; STAR SL, 1989, SOC STUD SCI, V19, P387, DOI 10.1177/030631289019003001; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; Tejada G, 2016, ENVIRON RES, V144, P49, DOI 10.1016/j.envres.2015.10.010; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; Uriarte M, 2012, P NATL ACAD SCI USA, V109, P21546, DOI 10.1073/pnas.1215567110; UTNIT, 2010, MAP COB US ACT TIERR; Veldman J.W, 2008, REV B ECO CONS AMB, V24, P65; Veldman JW, 2011, BIOL CONSERV, V144, P1419, DOI 10.1016/j.biocon.2011.01.011; Vides-Almonacid R., 2007, PLANIFICACION ECORRE	99	22	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161323	10.1371/journal.pone.0161323	http://dx.doi.org/10.1371/journal.pone.0161323			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632528	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900018
J	Murray, CC; Mach, ME; Martone, RG; Singh, GG; Miriam, O; Chan, KMA				Murray, Cathryn Clarke; Mach, Megan E.; Martone, Rebecca G.; Singh, Gerald G.; Miriam, O.; Chan, Kai M. A.			Supporting Risk Assessment: Accounting for Indirect Risk to Ecosystem Components	PLOS ONE			English	Article							CUMULATIVE HUMAN IMPACTS; BRITISH-COLUMBIA; MARINE SYSTEMS; KILLER WHALES; DYNAMICS; SPECIALIZATION; STRESSORS; WATERS; WEBS	The multi-scalar complexity of social-ecological systems makes it challenging to quantify impacts from human activities on ecosystems, inspiring risk-based approaches to assessments of potential effects of human activities on valued ecosystem components. Risk assessments do not commonly include the risk from indirect effects as mediated via habitat and prey. In this case study from British Columbia, Canada, we illustrate how such "indirect risks" can be incorporated into risk assessments for seventeen ecosystem components. We ask whether (i) the addition of indirect risk changes the at-risk ranking of the seventeen ecosystem components and if (ii) risk scores correlate with trophic prey and habitat linkages in the food web. Even with conservative assumptions about the transfer of impacts or risks from prey species and habitats, the addition of indirect risks in the cumulative risk score changes the ranking of priorities for management. In particular, resident orca, Steller sea lion, and Pacific herring all increase in relative risk, more closely aligning these species with their "at-risk status" designations. Risk assessments are not a replacement for impact assessments, but-by considering the potential for indirect risks as we demonstrate here-they offer a crucial complementary perspective for the management of ecosystems and the organisms within.	[Murray, Cathryn Clarke; Mach, Megan E.; Singh, Gerald G.; Chan, Kai M. A.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Murray, Cathryn Clarke] North Pacific Marine Sci Org PICES, Sidney, BC, Canada; [Mach, Megan E.; Martone, Rebecca G.] Ctr Ocean Solut, Monterey, CA USA; [Miriam, O.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	University of British Columbia; Fisheries & Oceans Canada	Murray, CC (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.; Murray, CC (corresponding author), North Pacific Marine Sci Org PICES, Sidney, BC, Canada.	cclarke@eos.ubc.ca	Chan, Kai M A/C-1682-2009	Chan, Kai M A/0000-0002-7804-3276	David and Lucille Packard Foundation [F08-00136]; Canada Research Chair program; NSERC Discovery grant [06-5566]	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Canada Research Chair program(Canada Research Chairs); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was conducted with support from the David and Lucille Packard Foundation (Grant #F08-00136) (https://www.packard.org/), the Canada Research Chair program (http://www.chairschaires.gc.ca/home-accueil-eng.aspx), and an NSERC Discovery grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGPPSIGP_eng.asp) (#06-5566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Adams SM, 1998, MULTIPLE STRESSES EC, P13; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Barnthouse L., 1986, USERS MANUAL ECOLOGI; BRYAN GW, 1979, PHILOS T ROY SOC B, V286, P483, DOI 10.1098/rstb.1979.0042; Chapman PM, 2004, MAR POLLUT BULL, V48, P411, DOI 10.1016/j.marpolbul.2003.11.005; COSEWIC, 2003, COSEWIC ASS STAT REP; COSEWIC, 2008, COSEWIC ASS UPD STAT; COSEWIC, 2011, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2013, COSEWIC ASS STAT REP; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crisp DJ., 1972, PRODUCTIVITY WORLD E, P71; Dahlstrom A, 2011, MAR POLICY, V35, P208, DOI 10.1016/j.marpol.2010.10.001; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Espinosa-Romero MJ, 2011, ECOL MODEL, V222, P1569, DOI 10.1016/j.ecolmodel.2011.02.008; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fisheries & Oceans Canada, 2015, 2015037 DFO CAN SCI; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Gallagher AJ, 2014, BIOSCIENCE, V64, P619, DOI 10.1093/biosci/biu071; Giakoumi S, 2015, CONSERV BIOL, V29, P1228, DOI 10.1111/cobi.12468; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Heise Kathy, 2003, Aquatic Mammals, V29, P325, DOI 10.1578/01675420360736497; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Lucas B. G., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2667, P1; MacConnachie S., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2677, P1; Martone R, 2015, DFO CAN SCI ADVIS SE; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Murray CC, 2015, GLOB ECOL CONSERV, V4, P110, DOI 10.1016/j.gecco.2015.06.003; Murray CC, 2016, DFO CAN SCI ADVIS SE; Pastorok RA, 2003, HUM ECOL RISK ASSESS, V9, P939, DOI 10.1080/713610017; Preston BL, 2002, ENVIRON MANAGE, V29, P311, DOI 10.1007/s00267-001-0023-1; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Singh GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065435; Suter Glenn W. III, 2008, Integrated Environmental Assessment and Management, V4, P285, DOI 10.1897/IEAM_2007-062; Therriault TW, 2008, ICES J MAR SCI, V65, P781, DOI 10.1093/icesjms/fsn059; Trites AW, 2007, MAR MAMMAL SCI, V23, P751, DOI 10.1111/j.1748-7692.2006.00076.x; Walker C.H., 2013, PERSISTENT POLLUTANT; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162932	10.1371/journal.pone.0162932	http://dx.doi.org/10.1371/journal.pone.0162932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632287	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900097
J	Solaro, C; Trabucco, E; Signori, A; Martinelli, V; Radaelli, M; Centonze, D; Rossi, S; Grasso, MG; Clemenzi, A; Bonavita, S; D'Ambrosio, A; Patti, F; D'Amico, E; Cruccu, G; Truini, A				Solaro, C.; Trabucco, E.; Signori, A.; Martinelli, V.; Radaelli, M.; Centonze, D.; Rossi, S.; Grasso, M. G.; Clemenzi, A.; Bonavita, S.; D'Ambrosio, A.; Patti, F.; D'Amico, E.; Cruccu, G.; Truini, A.			Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; MAJOR DEPRESSION; INDIVIDUALS; IMPAIRMENT; SEVERITY; ILLNESS; LESIONS; SCALE	Background Depression occurs in about 50% of patients with multiple sclerosis. The aims of this study was to investigate the prevalence of depressive symptoms in a multicenter MS population using the Beck Depression Inventory II (BDI II) and to identify possible correlations between the BDI II score and demographic and clinical variables. Methods Data were collected in a multi-center, cross-sectional study over a period of six months in six MS centers in Italy using BDI II. Results 1,011 MS patients participated in the study. 676 subjects were female, with a mean age of 34 years (SD 10.8), mean EDSS of 3.3 (0-8.5) and mean disease duration of 10.3 years (range 1-50 years). 668 (%) subjects scored lower than 14 on the BDI II and 343 (33.9%) scored greater than 14 (14 cut-off score). For patients with BDI> 14 multivariate analysis showed a significant difference between EDSS and disease course. BDI II scores for subjects with secondary progressive (SP) MS were significantly different from primary progressive (PP) patients (p < 0.001) but similar to relapsing-remitting (RR) patients. Considering subjects with moderate to severe depressive symptoms (BDI II score from 20-63), in relation to disease course, 11.7% (83/710) had RR MS, 40.7% (96/236) SP and 13.6% (6/44) PP. Conclusions Using the BDI II, 30% of the current sample had depressive symptoms. BDI II score correlates with disability and disease course, particularly in subjects with SP MS. The BDI II scale can be a useful tool in clinical practice to screen depressive symptoms in people with MS.	[Solaro, C.; Trabucco, E.] ASL 3 Genovese, Head & Neck Dept, Neurol Unit, Genoa, Italy; [Trabucco, E.] Univ Genoa, Sect Diagnost Radiol, Dept Expt Med, Genoa, Italy; [Signori, A.] Univ Genoa, Sect Biostat, Dept Hlth Sci, Genoa, Italy; [Martinelli, V.; Radaelli, M.] Ist Sci San Raffaele, Dept Neurol, Milan, Italy; [Centonze, D.; Rossi, S.] Tor Vergata Univ, Dept Syst Med, Neurol Clin, Rome, Italy; [Centonze, D.; Rossi, S.] IRCCS Neuromed, Rome, Italy; [Centonze, D.; Rossi, S.] IRCCS, Ist Neurol Mediterraneo Neuromed, Rome, Italy; [Grasso, M. G.; Clemenzi, A.] Santa Lucia Fdn, IRCCS, Rome, Italy; [Bonavita, S.; D'Ambrosio, A.] Univ Naples 2, Neurol Clin, Naples, Italy; [Patti, F.; D'Amico, E.] Univ Catania, Multiple Sclerosis Ctr, Neurosci Sect, Dept DANA,GF Ingrassia, Catania, Italy; [Cruccu, G.; Truini, A.] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy	University of Genoa; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Rome Tor Vergata; IRCCS Neuromed; IRCCS Neuromed; IRCCS Santa Lucia; Universita della Campania Vanvitelli; University of Catania; Sapienza University Rome	Solaro, C (corresponding author), ASL 3 Genovese, Head & Neck Dept, Neurol Unit, Genoa, Italy.	csolaro@libero.it	Bonavita, Simona/AGN-5124-2022; Centonze, Diego/J-7767-2016; Signori, Alessio/L-3081-2016; D'Amico, Emanuele/N-5568-2019; Martinelli, Vittorio/AAN-7240-2020; Solaro, Claudio Marcello/AAL-2402-2021	Bonavita, Simona/0000-0002-8561-9720; Centonze, Diego/0000-0002-8390-8545; Signori, Alessio/0000-0001-6289-9144; D'Amico, Emanuele/0000-0001-7494-9057; Solaro, Claudio Marcello/0000-0002-6713-4623; patti, francesco/0000-0002-6923-0846; truini, andrea/0000-0002-2630-7647	FISM (Fondazione Italiana Sclerosi Multipla); Merck-Serono; Teva; Genzyme; Bayer Schering; Biogen Idec; Novartis; Almirall; GW Pharmaceuticals; FISM; MIUR	FISM (Fondazione Italiana Sclerosi Multipla)(Fondazione Italiana Sclerosi Multipla (FISM)); Merck-Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Genzyme(Sanofi-AventisGenzyme Corporation); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Novartis(Novartis); Almirall(Almirall); GW Pharmaceuticals; FISM(Fondazione Italiana Sclerosi Multipla (FISM)); MIUR(Ministry of Education, Universities and Research (MIUR))	Dr. Solaro served as advisory board the following companies: Biogen Idec, Merck Serono. He received speaking honoraria from Bayer Schering, Biogen Idec, Merck Serono, Almirall, Teva, Genzyme. He received research grants and support by the FISM (Fondazione Italiana Sclerosi Multipla). Dr. Centonze acted as an Advisory Board member of, and received funding for traveling and honoraria for speaking or consultation fees from Merck-Serono, Teva, Genzyme, Bayer Schering, Biogen Idec, Novartis, Almirall, GW Pharmaceuticals. He is the principal investigator in clinical trials for Novartis, Merck Serono, Teva, Bayer Schering, Sanofi-aventis, Biogen Idec, Roche. Dr. Bonavita received honoraria for advisory board and speaking activities from Biogen-Idec, Merck Serono and Novartis. Dr. Patti received honoraria for advisory board and speaking activities from Almirall, Bayer, Biogen, Merck Serono, Novartis, Sanofi Genzyme and TEVA; he also received research grants from FISM and MIUR. Dr. Cruccu received honoraria for advisory board and speaking activities from Astellas, Convergence, Eli Lilly e Pfizer. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Askari Fariba, 2014, Acta Med Iran, V52, P889; Bakshi R, 2000, NEUROREPORT, V11, P1153, DOI 10.1097/00001756-200004270-00003; Bamer AM, 2008, GEN HOSP PSYCHIAT, V30, P311, DOI 10.1016/j.genhosppsych.2008.04.006; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berg D, 2000, MULT SCLER J, V6, P156, DOI 10.1191/135245800701566016; Brown-DeGagne AM, 1998, J OCCUP ENVIRON MED, V40, P862, DOI 10.1097/00043764-199810000-00005; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Dalton EJ, 2005, NEUROPSYCHOLOGY, V19, P152, DOI 10.1037/0894-4105.19.2.152; Deckx N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/705232; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Feinstein A, 2014, NAT REV NEUROL, V10, P507, DOI 10.1038/nrneurol.2014.139; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Foley G, 1972, N Z Nurs J, V65, P24; Goretti B, 2009, NEUROL SCI, V30, P15, DOI 10.1007/s10072-008-0009-3; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; JOFFE RT, 1987, J AFFECT DISORDERS, V12, P63, DOI 10.1016/0165-0327(87)90062-0; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; MINDEN SL, 1987, GEN HOSP PSYCHIAT, V9, P426, DOI 10.1016/0163-8343(87)90052-1; Mohr DC, 1997, MULT SCLER J, V3, P254, DOI 10.1177/135245859700300408; Montalban X, 2011, MULT SCLER J, V17, P1341, DOI 10.1177/1352458511411061; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Patten SB, 1997, PSYCHOTHER PSYCHOSOM, V66, P286, DOI 10.1159/000289150; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Patten SB, 2000, MULT SCLER, V6, P115, DOI 10.1191/135245800678827536; Polman CH, 2011, ANN NEUROL; Pujol J, 1997, NEUROLOGY, V49, P1105, DOI 10.1212/WNL.49.4.1105; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sadovnick AD, 1996, NEUROLOGY, V46, P628, DOI 10.1212/WNL.46.3.628; SCHIFFER RB, 1983, AM J PSYCHIAT, V140, P1498; Silberman CD, 2006, ARQ NEURO-PSIQUIAT, V64, P407, DOI 10.1590/S0004-282X2006000300011; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; THOMPSON AJ, 1991, ANN NEUROL, V29, P53, DOI 10.1002/ana.410290111; Watson Tessa M, 2014, Int J MS Care, V16, P105, DOI 10.7224/1537-2073.2013-013; Wilson KG, 2001, PAIN, V91, P227, DOI 10.1016/S0304-3959(00)00440-1; Zabad RK, 2005, NEUROLOGY, V64, P359, DOI 10.1212/01.WNL.0000149760.64921.AA; Ziemssen T, 2009, J NEUROL SCI, V277, pS37, DOI 10.1016/S0022-510X(09)70011-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160261	10.1371/journal.pone.0160261	http://dx.doi.org/10.1371/journal.pone.0160261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632167	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900005
J	Wu, LG; Hu, ZX; Huang, YY; Yu, YT; Liang, W; Zheng, QH; Huang, XN; Huang, Y; Lu, XL; Zhao, YX				Wu, Lige; Hu, Zixi; Huang, Yingying; Yu, Yating; Liang, Wei; Zheng, Qinghui; Huang, Xianing; Huang, Yong; Lu, Xiaoling; Zhao, Yongxiang			Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16	PLOS ONE			English	Article							IONIZING-RADIATION; RADIOSENSITIZATION; RADIORESISTANCE; BIOMARKER; CYCLE	Radiation therapy can be an effective way to kill cancer cells using ionizing radiation, but some tumors are resistant to radiation therapy and the underlying mechanism still remains elusive. It is therefore necessary to establish an appropriate working model to study and monitor radiation-mediated cancer therapy. In response to cellular stress, the metabolome is the integrated profiling of changes in all metabolites in cells, which can be used to investigate radiation tolerance mechanisms and identify targets for cancer radiation sensibilization. In this study, using H-1 nuclear magnetic resonance for untargeted metabolic profiling in radiation-tolerant mouse melanoma cell line B16, we comprehensively investigated changes in metabolites and metabolic network in B16 cells in response to radiation. Principal component analysis and partial least squares discriminant analysis indicated the difference in cellular metabolites between the untreated cells and X-ray radiated cells. In radiated cells, the content of alanine, glutamate, glycine and choline was increased, while the content of leucine, lactate, creatine and creatine phosphate was decreased. Enrichment analysis of metabolic pathway showed that the changes in metabolites were related to multiple metabolic pathways including the metabolism of glycine, arginine, taurine, glycolysis, and gluconeogenesis. Taken together, with cellular metabolome study followed by bioinformatic analysis to profile specific metabolic pathways in response to radiation, we deepened our understanding of radiation-resistant mechanisms and radiation sensibilization in cancer, which may further provide a theoretical and practical basis for personalized cancer therapy.	[Wu, Lige; Hu, Zixi; Huang, Yingying; Yu, Yating; Liang, Wei; Zheng, Qinghui; Huang, Xianing; Huang, Yong; Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Collaborat Innovat Ctr Targeting Tumor Diag & The, Nanning 530021, Guangxi, Peoples R China; [Lu, Xiaoling] Guangxi Med Univ, Dept Immunol, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Huang, Y; Lu, XL; Zhao, YX (corresponding author), Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Collaborat Innovat Ctr Targeting Tumor Diag & The, Nanning 530021, Guangxi, Peoples R China.; Lu, XL (corresponding author), Guangxi Med Univ, Dept Immunol, Nanning 530021, Guangxi, Peoples R China.	yonghuang503@126.com; luwuliu@163.com; yongxiang_zhao@126.com	lu, xl/HDO-8340-2022; wu, lige/X-1422-2019	wu, lige/0000-0002-9388-6706	National Natural Scientific Foundation of China [81430055, 81372452]; Programs for Changjiang Scholars and Innovative Research Team in University [IRT_15R13]; International Cooperation Project of the Ministry of Science and Technology of China [2015DFA31320]; Project for Innovative Research Team in Guangxi Natural Science Foundation [2015GX NSFFA139001, 2015GXNSFFA139001]; Project of Science and Technology of Guangxi [14125008-2-12, 1599005-2-10]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); International Cooperation Project of the Ministry of Science and Technology of China; Project for Innovative Research Team in Guangxi Natural Science Foundation; Project of Science and Technology of Guangxi	The present study was supported, in part, by grants from the National Natural Scientific Foundation of China (nos. 81430055 and 81372452), Programs for Changjiang Scholars and Innovative Research Team in University (No.IRT_15R13), the International Cooperation Project of the Ministry of Science and Technology of China (no. 2015DFA31320), the Project for Innovative Research Team in Guangxi Natural Science Foundation (2015GX NSFFA139001), and the Project of Science and Technology of Guangxi (nos. 14125008-2-12 and 1599005-2-10).; The authors are grateful to Dr. Donghai Lin and Dr. Caihua Huang (College of Chemistry and Chemical Engineering, Xiamen University) for instructions and assistance in data analysis. The authors also want to thank Jinping Gu (College of Chemistry and Chemical Engineering, Xiamen University) for MATLAB script writing. This work was supported, in part, by grants from the National Natural Scientific Foundation of China (Nos. 81430055, 81372452); Programs for Changjiang Scholars and Innovative Research Team in University (No.IRT_15R13); International Cooperation Project of the Ministry of Science and Technology of China (No. 2015DFA31320); Project for Innovative Research Team in Guangxi Natural Science Foundation (2015GXNSFFA139001); Project of Science and Technology of Guangxi (Nos. 14125008-2-12, 1599005-2-10).	Bartel J, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301009; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; BIAGLOW JE, 1983, INT J RADIAT BIOL, V44, P489, DOI 10.1080/09553008314551491; Bibault JE, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-12; Boccard J, 2013, ANAL CHIM ACTA, V769, P30, DOI 10.1016/j.aca.2013.01.022; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chen XY, 2016, BIOCHEM BIOPH RES CO, V473, P296, DOI 10.1016/j.bbrc.2016.03.099; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2013, EXPERT REV MOL DIAGN, V13, P737, DOI 10.1586/14737159.2013.835570; GILLETTE EL, 1995, SEMIN VET MED SURG, V10, P129; Hong A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/294735; Huber SM, 2015, BBA-BIOMEMBRANES, V1848, P2657, DOI 10.1016/j.bbamem.2014.11.004; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kruger M, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9013; Li L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060839; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Matchuk O, 2013, CELL TISSUE BIOL, V7, P556; Ni XH, 2015, MOL CANCER THER, V14, P2797, DOI 10.1158/1535-7163.MCT-15-0291-T; Purnell PR, 2009, J THORAC ONCOL, V4, P448, DOI 10.1097/JTO.0b013e31819c78fb; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tan J, 2015, CELL COMMUNICAITONS, V2, P36; Tarish FL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5671; Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Werthmoller N, 2016, INT J HYPERTHER, V32, P23, DOI 10.3109/02656736.2015.1106011; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Willers H, 2013, CANCER J, V19, P200, DOI 10.1097/PPO.0b013e318292e4e3; Williams TM, 2013, TRANSL ONCOL, V6, P133, DOI 10.1593/tlo.13214; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiao CN, 2009, ANALYST, V134, P916, DOI 10.1039/b818802e; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162917	10.1371/journal.pone.0162917	http://dx.doi.org/10.1371/journal.pone.0162917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631970	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900094
J	Yuan, JW; Ren, JP; Wang, Y; He, X; Zhao, YW				Yuan, Jiawen; Ren, Jinpeng; Wang, Ying; He, Xiao; Zhao, Yuwu			Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PRIMARY CULTURES; MOUSE MODEL; DEATH; PATHOGENESIS; NEURONS; PROTECT; INJURY; CELLS	Parkinson's disease (PD) is characterized by the progressive degeneration of the dopaminergic neurons in the substantia nigra (SN) region. Acteoside has displayed multiple biological functions. Its potential role against PD and the underlying signaling mechanisms are largely unknown. Here, we showed that oral administration of acteoside significantly attenuated parkinsonism symptoms in rotenone-induced PD rats. Further, acteoside inhibited rotenone-induced alpha-synuclein, caspase-3 upregulation and microtubule-associated protein 2 (MAP2) downregulation in PD rats. The molecular docking and molecular dynamics (MD) simulation results indicated that acteoside may directly bind to and inhibit caspase-3. Acteoside formed hydrogen bonds with at least six residues of caspase-3: ThrA177, SerA178, GlyA238, SerB339, ArgB341 and TrpB348. In addition, a pi-pi interaction was formed between acteoside and caspase-3's HisA237, which might further stabilize the complex. MD simulation results demonstrated that the binding affinity of the caspase-3-acteoside complex was higher than that of caspase-3 and its native ligand inhibitor. Together, we show that acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of PD.	[Yuan, Jiawen; Ren, Jinpeng; Zhao, Yuwu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China; [Wang, Ying; He, Xiao] East China Normal Univ, State Key Lab Precis Spect, Shanghai, Peoples R China; [Wang, Ying; He, Xiao] East China Normal Univ, Dept Phys, Shanghai, Peoples R China; [He, Xiao] NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai, Peoples R China	Shanghai Jiao Tong University; East China Normal University; East China Normal University; NYU Shanghai	Zhao, YW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China.	yuwu_zhao359@163.com	He, Xiao/G-3114-2016	He, Xiao/0000-0002-4199-8175	Shanghai Sixth People's Hospital [2014-015]	Shanghai Sixth People's Hospital	This study was funded by the the research fund of Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University (2014-015, to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen J, 1998, J NEUROSCI, V18, P4914; Chompoopong S, 2016, NEUROMOLECULAR MED; D'Andrea MR, 2001, NEUROSCI LETT, V306, P137, DOI 10.1016/S0304-3940(01)01811-0; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaki GS, 2014, NEUROMOL MED, V16, P217, DOI 10.1007/s12017-014-8294-x; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; He J, 2011, J ASIAN NAT PROD RES, V13, P449, DOI 10.1080/10286020.2011.568940; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Li YY, 2008, EUR J PHARMACOL, V579, P134, DOI 10.1016/j.ejphar.2007.10.052; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Marchisella F, 2016, CYTOSKELETON HOBOKEN; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P119, DOI 10.1097/NEN.0b013e3182801cde; Peng XM, 2015, PHYTOTHER RES, V29, P1137, DOI 10.1002/ptr.5358; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Rodriguez-Nogales C, 2016, MATURITAS, V84, P25, DOI 10.1016/j.maturitas.2015.11.009; Shin J, 2009, J NEUROSCI, V29, P15375, DOI 10.1523/JNEUROSCI.3126-09.2009; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wang HQ, 2009, BRAIN RES, V1283, P139, DOI 10.1016/j.brainres.2009.05.101; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Xiong LN, 2016, J MED FOOD, V19, P54, DOI 10.1089/jmf.2015.3462	30	28	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162696	10.1371/journal.pone.0162696	http://dx.doi.org/10.1371/journal.pone.0162696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632381	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900067
J	Bacheler, NM; Schobernd, ZH; Berrane, DJ; Schobernd, CM; Mitchell, WA; Teer, BZ; Gregalis, KC; Glasgow, DM				Bacheler, Nathan M.; Schobernd, Zebulon H.; Berrane, David J.; Schobernd, Christina M.; Mitchell, Warren A.; Teer, Bradford Z.; Gregalis, Kevan C.; Glasgow, Dawn M.			Spatial Distribution of Reef Fish Species along the Southeast US Atlantic Coast Inferred from Underwater Video Survey Data	PLOS ONE			English	Article							TRAP; HABITAT; ASSEMBLAGES; POPULATIONS; PREDATION; ABUNDANCE; STATIONS; BIGHT	Marine fish abundance and distribution often varies across spatial scales for a variety of reasons, and this variability has significant ecological and management consequences. We quantified the distribution of reef-associated fish species along the southeast United States Atlantic coast using underwater video survey samples (N = 4,855 in 2011-2014) to elucidate variability within species across space, depths, and habitats, as well as describe broad-scale patterns in species richness. Thirty-two species were seen at least 10 times on video, and the most commonly observed species were red porgy (Pagrus pagrus; 41.4% of videos), gray triggerfish (Balistes capriscus; 31.0%), black sea bass (Centropristis striata; 29.1%), vermilion snapper (Rhomboplites aurorubens; 27.7%), and red snapper (Lutjanus campechanus; 22.6%). Using generalized additive models, we found that most species were non-randomly distributed across space, depths, and habitats. Most rare species were observed along the continental shelf break, except for goliath grouper (Epinephelus itajara), which was found on the continental shelf in Florida and Georgia. We also observed higher numbers of species in shelf-break habitats from southern North Carolina to Georgia, and fewer in shallower water and at the northern and southern ends of the southeast United States Atlantic coast. Our study provides the first broad-scale description of the spatial distribution of reef fish in the region to be based on fishery-independent data, reinforces the utility of underwater video to survey reef fish, and can help improve the management of reef fish in the SEUS, for example, by improving indices of abundance.	[Bacheler, Nathan M.; Schobernd, Zebulon H.; Berrane, David J.; Schobernd, Christina M.; Mitchell, Warren A.; Teer, Bradford Z.; Gregalis, Kevan C.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, 101 Pivers Isl Rd, Beaufort, NC 28516 USA; [Glasgow, Dawn M.] Marine Resources Res Inst, South Carolina Dept Nat Resources, 217 Ft Johnson Rd, Charleston, SC 29412 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Bacheler, NM (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, 101 Pivers Isl Rd, Beaufort, NC 28516 USA.	nate.bacheler@noaa.gov	Schobernd, Zeb/V-4379-2019		National Marine Fisheries Service	National Marine Fisheries Service	The survey is funded through the National Marine Fisheries Service, but authors received no specific funding for the analyses.	[Anonymous], 1989, APPL LINEAR REGRESSI; [Anonymous], 2014, R LANG ENV STAT COMP; Bacheler NM, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2774-x; Bacheler NM, 2015, FISH B-NOAA, V113, P15, DOI 10.7755/FB.113.1.2; Bacheler NM, 2014, MAR ECOL PROG SER, V517, P1, DOI 10.3354/meps11094; Bacheler NM, 2013, FISH B-NOAA, V111, P218, DOI 10.7755/FB.111.3.2; Bacheler NM, 2013, FISH RES, V143, P81, DOI 10.1016/j.fishres.2013.01.013; Bartolino V, 2012, MAR ECOL PROG SER, V444, P251, DOI 10.3354/meps09434; Bartolino V, 2011, ECOLOGY, V92, P189, DOI 10.1890/09-1129.1; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Ciannelli L, 2008, J MARINE SYST, V71, P223, DOI 10.1016/j.jmarsys.2007.02.031; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Coggins LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108302; COLLINS MR, 1990, FISH RES, V9, P325, DOI 10.1016/0165-7836(90)90051-V; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Geraldi NR, 2009, CAN J FISH AQUAT SCI, V66, P460, DOI 10.1139/F09-011; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HILBORN R, 1992; Hjort J., 1914, RAPPORTS PROCES VERB, V20, P1; Hyun KH, 2010, J MARINE SYST, V83, P1, DOI 10.1016/j.jmarsys.2010.05.014; Kendall MS, 2008, T AM FISH SOC, V137, P1134, DOI 10.1577/T07-210.1; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; NMFS (National Marine Fisheries Service), 2014, FISH STOCK SUST IND; Pitcher T.J., 1986, P294; SAFMC, 2007, AM 14 FISH MAN PLAN; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Saul SE, 2013, FISH RES, V143, P12, DOI 10.1016/j.fishres.2013.01.002; Schobernd CM, 2009, B MAR SCI, V84, P67; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; SEDBERRY GR, 1984, ENVIRON BIOL FISH, V11, P241, DOI 10.1007/BF00001372; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Whitfield PE, 2014, MAR ECOL PROG SER, V509, P241, DOI 10.3354/meps10882; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wootton R.J., 1990, ECOLOGY TELEOST FISH; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	39	21	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162653	10.1371/journal.pone.0162653	http://dx.doi.org/10.1371/journal.pone.0162653			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655268	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700027
J	Blanchard, AA; Zelinski, T; Xie, JY; Cooper, S; Penner, C; Leygue, E; Myal, Y				Blanchard, Anne A.; Zelinski, Teresa; Xie, Jiuyong; Cooper, Steven; Penner, Carla; Leygue, Etienne; Myal, Yvonne			Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TIGHT JUNCTION; UP-REGULATION; COLORECTAL-CANCER; PARACELLULAR PERMEABILITY; DECREASED EXPRESSION; RECURRENCE STATUS; PROTEIN; CLDN1; OVEREXPRESSION	Background The claudin 1 tight junction protein, solely responsible for the barrier function of epithelial cells, is frequently down regulated in invasive human breast cancer. The underlying mechanism is largely unknown, and no obvious mutations in the claudin 1 gene (CLDN1) have been identified to date in breast cancer. Since many genes have been shown to undergo deregulation through splicing and mis-splicing events in cancer, the current study was undertaken to investigate the occurrence of transcript variants for CLDN1 in human invasive breast cancer. Methods RT-PCR analysis of CLDN1 transcripts was conducted on RNA isolated from 12 human invasive breast tumors. The PCR products from each tumor were resolved by agarose gel electrophoresis, cloned and sequenced. Genomic DNA was also isolated from each of the 12 tumors and amplified using PCR CLDN1 specific primers. Sanger sequencing and single nucleotide polymorphism (SNP) analyses were conducted. Results A number of CLDN1 transcript variants were identified in these breast tumors. All variants were shorter than the classical CLDN1 transcript. Sequence analysis of the PCR products revealed several splice variants, primarily in exon 1 of CLDN1; resulting in truncated proteins. One variant, V1, resulted in a premature stop codon and thus likely led to nonsense mediated decay. Interestingly, another transcript variant, V2, was not detected in normal breast tissue samples. Further, sequence analysis of the tumor genomic DNA revealed SNPs in 3 of the 4 coding exons, including a rare missense SNP (rs140846629) in exon 2 which represents an Ala124Thr substitution. To our knowledge this is the first report of CLDN1 transcript variants in human invasive breast cancer. These studies suggest that alternate splicing may also be a mechanism by which claudin 1 is down regulated at both the mRNA and protein levels in invasive breast cancer and may provide novel insights into how CLDN1 is reduced or silenced in human breast cancer.	[Blanchard, Anne A.; Cooper, Steven; Penner, Carla; Myal, Yvonne] Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; [Blanchard, Anne A.; Xie, Jiuyong; Myal, Yvonne] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Zelinski, Teresa] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Zelinski, Teresa; Leygue, Etienne] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Leygue, Etienne; Myal, Yvonne] Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Myal, Y (corresponding author), Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada.; Myal, Y (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.; Myal, Y (corresponding author), Manitoba Inst Cell Biol, Winnipeg, MB, Canada.	yvonne.myal@umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; , Anne/0000-0002-6752-6280	Canadian Breast Cancer Foundation; Winnipeg RH Institute Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Winnipeg RH Institute Foundation	This study was supported by a grant from the Canadian Breast Cancer Foundation (to YM) and a grant from the Winnipeg RH Institute Foundation (to TZ).; The authors would like to thank the personnel at the Manitoba Breast Tumor Bank for technical support, particularly Andrea Fritensky and Michelle Parisien. This study was supported by a grant from the Canadian Breast Cancer Foundation (to YM) and a grant from the Winnipeg Rh Institute Foundation (to TZ).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; [Anonymous], 2016, EX VAR SERV; [Anonymous], 2016, UCSC GEN BIOINF UCSC; [Anonymous], 2016, CBIO PORT CANC GEN; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Balda MS, 1998, J CELL SCI, V111, P541; Bekker V, 2010, J VIRAL HEPATITIS, V17, P192, DOI 10.1111/j.1365-2893.2009.01166.x; Blanchard AA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-268; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen JJ, 2015, INT J CLIN EXP MED, V8, P1247; Cohn ML, 2005, J CUTAN PATHOL, V32, P533, DOI 10.1111/j.0303-6987.2005.00324.x; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Di Cello F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068630; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Higashi Y, 2007, J SURG RES, V139, P68, DOI 10.1016/j.jss.2006.08.038; Ho MF, 2016, MOL ENDOCRINOL, V30, P382, DOI 10.1210/me.2015-1267; Ingr M, 2015, J THEOR BIOL, V382, P178, DOI 10.1016/j.jtbi.2015.06.048; Katz TA, 2014, ANN MED, V46, P397, DOI 10.3109/07853890.2014.923740; Kinugasa T, 2007, ANTICANCER RES, V27, P3729; Kleinberg L, 2008, HUM PATHOL, V39, P747, DOI 10.1016/j.humpath.2007.10.002; Kominsky SL, 2004, AM J PATHOL, V164, P1627, DOI 10.1016/S0002-9440(10)63721-2; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Liu M, 2013, MOL ENDOCRINOL, V27, P657, DOI 10.1210/me.2012-1397; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Miyamoto K, 2008, BIOMED RES-TOKYO, V29, P71, DOI 10.2220/biomedres.29.71; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2012, TIGHT JUNCTIONS CANC; Nemeth J, 2009, PATHOLONCOLRES; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Pope JL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-167; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Takehara M, 2009, BIOL PHARM BULL, V32, P825, DOI 10.1248/bpb.32.825; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; van Voss MRH, 2014, HISTOPATHOLOGY, V65, P814, DOI 10.1111/his.12490; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu YL, 2008, WORLD J GASTROENTERO, V14, P4943, DOI 10.3748/wjg.14.4943; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yadav BK, 2015, J STROKE CEREBROVASC, V24, P1662, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.038; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	51	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163387	10.1371/journal.pone.0163387	http://dx.doi.org/10.1371/journal.pone.0163387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649506	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100085
J	Brink, H; Smith, RJ; Skinner, K; Leader-Williams, N				Brink, Henry; Smith, Robert J.; Skinner, Kirsten; Leader-Williams, Nigel			Sustainability and Long Term-Tenure: Lion Trophy Hunting in Tanzania	PLOS ONE			English	Article							PROTECTED AREAS; PANTHERA-LEO; CONSERVATION; POPULATIONS; MANAGEMENT; PRIVATE; HELP	It is argued that trophy hunting of large, charismatic mammal species can have considerable conservation benefits but only if undertaken sustainably. Social-ecological theory suggests such sustainability only results from developing governance systems that balance financial and biological requirements. Here we use lion (Panthera leo) trophy hunting data from Tanzania to investigate how resource ownership patterns influence hunting revenue and offtake levels. Tanzania contains up to half of the global population of free-ranging lions and is also the main location for lion trophy hunting in Africa. However, there are concerns that current hunting levels are unsustainable. The lion hunting industry in Tanzania is run by the private sector, although the government leases each hunting block to companies, enforces hunting regulation, and allocates them a species-specific annual quota per block. The length of these leases varies and theories surrounding property rights and tenure suggest hunting levels would be less sustainable in blocks experiencing a high turnover of short-termleases. We explored this issue using lion data collected from 1996 to 2008 in the Selous Game Reserve (SGR), the most important trophy hunting destination in Tanzania. We found that blocks in SGR with the highest lion hunting offtake were also those that experienced the steepest declines in trophy offtake. In addition, we found this high hunting offtake and the resultant offtake decline tended to be in blocks under short-termtenure. In contrast, lion hunting levels in blocks under long-termtenure matched more closely the recommended sustainable offtake of 0.92 lions per 1000 km(2). However, annual financial returnswere higher from blocks under short-termtenure, providing $ 133 per km(2) of government revenue as compared to $ 62 per km(2) from long-termtenure blocks. Our results provide evidence for the importance of property rights in conservation, and support calls for an overhaul of the system in Tanzania by developing competitive market-based approaches for block allocation based on long-termtenure of ten years.	[Brink, Henry; Skinner, Kirsten] Selous Lion Project, POB 34514, Dar Es Salaam, Tanzania; [Brink, Henry; Smith, Robert J.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Skinner, Kirsten] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Leader-Williams, Nigel] Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England	University of Kent; University of Queensland; University of Cambridge	Brink, H (corresponding author), Selous Lion Project, POB 34514, Dar Es Salaam, Tanzania.; Brink, H (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England.	selouslion@gmail.com	Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171	National Geographic [EC0274-06]; Panthera	National Geographic(National Geographic Society); Panthera	The research has been made possible by grants from National Geographic (Grant # EC0274-06) and Panthera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2004, EXTINCTION STORY CON, DOI 10.4324/9781849770415; Agrawal A, 2011, ENVIRON CONSERV, V38, P199, DOI 10.1017/S0376892910000925; [Anonymous], 2012, COMMUNITY RIGHTS CON; [Anonymous], 2009, RECREATIONAL HUNTING; Ayre G, 2005, GOVERNANCE SUSTAINAB; Baldus RD, 2004, LION CONSERVATION TA; Baldus RD, 2004, TOURIST HUNTING ITS; Baldus RD, 2006, CRUCIAL ROLE GOVERNA; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Berkes F., 2002, LINKING SOCIAL ECOLO; Booth Vernon R, 2009, RECREATIONAL HUNTING, P282; Bouche P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155763; Breakthrough Attorneys, 2015, INV WILDL SECT NEW H; Brink H, 2013, AFR J ECOL, V51, P366, DOI 10.1111/aje.12051; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Caro T, 2016, CONSERV BIOL, V30, P716, DOI 10.1111/cobi.12658; Carter E, 2008, ORYX, V42, P177, DOI 10.1017/S0030605308007655; Chapron G, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2939; Chardonnet P., 2002, CONSERVATION AFRICAN; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; Edwards CTT, 2014, P NATL ACAD SCI USA, V111, P539, DOI 10.1073/pnas.1219615110; Fitzherbert E, 2014, BIOL CONSERV, V174, P84, DOI 10.1016/j.biocon.2014.03.012; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Githiru M, 2015, BIOL CONSERV, V191, P819, DOI 10.1016/j.biocon.2015.07.033; Group ICS, 2006, CONSERVATION STRATEG; Harris RB, 2013, CONSERV BIOL, V27, P945, DOI 10.1111/cobi.12115; IUCN, 2008, RED LIST THREATENED; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Jones T. B., 2009, RECREATIONAL HUNTING, P157; Kiffner C, 2009, ORYX, V43, P52, DOI 10.1017/S0030605307002335; Langholz JA, 2001, BIOSCIENCE, V51, P1079, DOI 10.1641/0006-3568(2001)051[1079:PAPOPO]2.0.CO;2; Leader-Williams N, 2005, PEOPLE WILDLIFE CONF, P150; Leader-Williams N., 2009, RECREATIONAL HUNTING, P9; Leader-Williams N, 1996, TOURIST HUNTING TANZ; Lewis D, 2005, CONSERV BIOL SER, V9, P239; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Ministry of Natural Resources and Tourism, 1995, POL MAN PLAN TOUR HU; Mitchell B, 2005, PARKS, V15, P1; Naidoo R, 2016, CONSERV BIOL, V30, P628, DOI 10.1111/cobi.12643; Nelson F., 2007, CONSERV SOC, V5, P232; Nelson F, 2013, ORYX, V47, P509, DOI 10.1017/S0030605313001178; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rohwer R, 2009, WILD HEART AFRICA SE, P189; Tucker CM, 1999, HUM ECOL, V27, P201, DOI 10.1023/A:1018721826964; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395	62	12	12	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162610	10.1371/journal.pone.0162610	http://dx.doi.org/10.1371/journal.pone.0162610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648566	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000383892100025
J	Lee, MY; Chang, WJ; Kim, HS; Lee, JY; Lim, SH; Lee, JE; Kim, SW; Nam, SJ; Ahn, JS; Im, YH; Park, YH				Lee, Min-Young; Chang, Won Jin; Kim, Hae Su; Lee, Ji Yun; Lim, Sung Hee; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee			Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR RECURRENCE; CONSERVING THERAPY; LOCAL RECURRENCE; MASTECTOMY; CHEMOTHERAPY; SURGERY; RELAPSE; TRIAL	Purpose The purpose of this study was to investigate the clinicopathologic features and prognostic factors affecting outcome in patients with isolated locoregional recurrence of breast cancer (ILRR). Methods We retrospectively analyzed the medical records of 104 patients who were diagnosed with ILRR and underwent curative surgery from January 2000 to December 2010 at Samsung Medical Center. Results Among 104 patients, 43 (41%) underwent total mastectomy and 61 (59%) underwent breast-conserving surgery for primary breast cancer. The median time from initial operation to ILRR was 35.7 months (4.5-132.3 months). After diagnosis of ILRR, 45 (43%) patients were treated with mastectomy, 41 (39%) with excision of recurred lesion, and 18 (17%) with node dissection. During a median follow-up of 8.9 years, the 5-year overall survival was 77% and 5-year distant metastasis-free survival (DMFS) was 54%. On multivariate analysis, younger age (< 35 years), higher stage, early onset of elapse (<= 24 months), lymph node recurrences, and subtype of triple negative breast cancer (TNBC) were found to be independently associated with DMFS. Patients in the no chemotherapy group showed a longer DMFS after surgery for ILRR than those treated with chemotherapy (median 101.5 vs. 48.0 months, p = 0.072) but without statistical significance. Conclusion Our analysis showed that younger age (< 35 years), higher stage, early onset of relapse (<= 24 months), lymph node recurrence, and subtype of TNBC are the worst prognostic factors for ILRR.	[Lee, Min-Young; Chang, Won Jin; Kim, Hae Su; Lee, Ji Yun; Lim, Sung Hee; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol,Dept Med, Seoul, South Korea; [Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol,Dept Med, Seoul, South Korea.	yhparkhmo@skku.edu						Abe O, 2005, LANCET, V366, P2087; Aebi S, 2014, LANCET ONCOL, V15, P156, DOI 10.1016/S1470-2045(13)70589-8; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Botteri E, 2009, ANN ONCOL, V20, P1008, DOI 10.1093/annonc/mdn732; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Clemons M, 2001, CANCER TREAT REV, V27, P67, DOI 10.1053/ctrv.2000.0204; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Freedman GM, 2000, ONCOLOGY-NY, V14, P1561; Gentilini O, 2007, ANN ONCOL, V18, P468, DOI 10.1093/annonc/mdl424; Gentilini O, 2012, ANN SURG ONCOL, V19, P3771, DOI 10.1245/s10434-012-2404-5; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; HAFFTY BG, 1991, INT J RADIAT ONCOL, V21, P293, DOI 10.1016/0360-3016(91)90774-X; Huang E, 2002, CANCER, V95, P2059, DOI 10.1002/cncr.10952; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Shikama N, 2011, BREAST CANCER-TOKYO, V18, P252, DOI 10.1007/s12282-010-0206-9; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273; Wapnir IL, 2008, CLIN BREAST CANCER, V8, P287, DOI 10.3816/CBC.2008.n.035; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163254	10.1371/journal.pone.0163254	http://dx.doi.org/10.1371/journal.pone.0163254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648567	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100070
J	Mizzi, C; Dalabira, E; Kumuthini, J; Dzimiri, N; Balogh, I; Basak, N; Bohm, R; Borg, J; Borgiani, P; Bozina, N; Bruckmueller, H; Burzynska, B; Carracedo, A; Cascorbi, I; Deltas, C; Dolzan, V; Fenech, A; Grech, G; Kasiulevicius, V; Kadasi, L; Kucinskas, V; Khusnutdinova, E; Loukas, YL; Macek, M; Makukh, H; Mathijssen, R; Mitropoulos, K; Mitropoulou, C; Novelli, G; Papantoni, I; Pavlovic, S; Saglio, G; Setric, J; Stojiljkovic, M; Stubbs, AP; Squassina, A; Torres, M; Turnovec, M; van Schaik, RH; Voskarides, K; Wakil, SM; Werk, A; del Zompo, M; Zukic, B; Katsila, T; Lee, MTM; Motsinger-Rief, A; Mc Leod, HL; van der Spek, PJ; Patrinos, GP				Mizzi, Clint; Dalabira, Eleni; Kumuthini, Judit; Dzimiri, Nduna; Balogh, Istvan; Basak, Nazli; Boehm, Ruwen; Borg, Joseph; Borgiani, Paola; Bozina, Nada; Bruckmueller, Henrike; Burzynska, Beata; Carracedo, Angel; Cascorbi, Ingolf; Deltas, Constantinos; Dolzan, Vita; Fenech, Anthony; Grech, Godfrey; Kasiulevicius, Vytautas; Kadasi, L'udevit; Kucinskas, Vaidutis; Khusnutdinova, Elza; Loukas, Yiannis L.; Macek, Milan, Jr.; Makukh, Halyna; Mathijssen, Ron; Mitropoulos, Konstantinos; Mitropoulou, Christina; Novelli, Giuseppe; Papantoni, Ioanna; Pavlovic, Sonja; Saglio, Giuseppe; Setric, Jadranka; Stojiljkovic, Maja; Stubbs, Andrew P.; Squassina, Alessio; Torres, Maria; Turnovec, Marek; van Schaik, Ron H.; Voskarides, Konstantinos; Wakil, Salma M.; Werk, Anneke; del Zompo, Maria; Zukic, Branka; Katsila, Theodora; Lee, Ming Ta Michael; Motsinger-Rief, Alison; Mc Leod, Howard L.; van der Spek, Peter J.; Patrinos, George P.			A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics	PLOS ONE			English	Article							SIMVASTATIN-INDUCED MYOPATHY; GENETIC-VARIATION; POPULATION-STRUCTURE; DECISION-MAKING; UNITED-STATES; DRUG; MICROATTRIBUTION; CHALLENGES; GUIDELINE; MEDICINE	Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity with the underlying genetic composition, particularly in genes encoding for protein factors and enzymes involved in drug metabolism and transport. In several European populations, particularly in countries with lower income, information related to the prevalence of pharmacogenomic biomarkers is incomplete or lacking. Here, we have implemented the microattribution approach to assess the pharmacogenomic biomarkers allelic spectrum in 18 European populations, mostly from developing European countries, by analyzing 1,931 pharmacogenomics biomarkers in 231 genes. Our data show significant interpopulation pharmacogenomic biomarker allele frequency differences, particularly in 7 clinically actionable pharmacogenomic biomarkers in 7 European populations, affecting drug efficacy and/ or toxicity of 51 medication treatment modalities. These data also reflect on the differences observed in the prevalence of high-risk genotypes in these populations, as far as common markers in the CYP2C9, CYP2C19, CYP3A5, VKORC1, SLCO1B1 and TPMT pharmacogenes are concerned. Also, our data demonstrate notable differences in predicted genotype-based warfarin dosing among these populations. Our findings can be exploited not only to develop guidelines for medical prioritization, but most importantly to facilitate integration of pharmacogenomics and to support pre-emptive pharmacogenomic testing. This may subsequently contribute towards significant cost-savings in the overall healthcare expenditure in the participating countries, where pharmacogenomics implementation proves to be cost-effective.	[Mizzi, Clint; Stubbs, Andrew P.; van der Spek, Peter J.; Patrinos, George P.] Erasmus Univ, Fac Med, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Mizzi, Clint] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Msida, Malta; [Dalabira, Eleni; Papantoni, Ioanna; Katsila, Theodora; Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Kumuthini, Judit] Ctr Prote & Genom Res, Observ, Cape Town, South Africa; [Dzimiri, Nduna; Wakil, Salma M.] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Balogh, Istvan] Univ Debrecen, Debrecen, Hungary; [Basak, Nazli] Bogazici Univ, Istanbul, Turkey; [Boehm, Ruwen; Bruckmueller, Henrike; Cascorbi, Ingolf; Werk, Anneke] Univ Kiel, Inst Expt & Clin Pharmacol, Kiel, Germany; [Borg, Joseph] Univ Malta, Fac Hlth Sci, Dept Appl Biomed Sci, Msida, Malta; [Borgiani, Paola; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Bozina, Nada; Setric, Jadranka] Univ Hosp Ctr, Zagreb, Croatia; [Burzynska, Beata] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Carracedo, Angel; Torres, Maria] Univ Santiago de Compostela, Santiago, Spain; [Deltas, Constantinos; Voskarides, Konstantinos] Univ Cyprus, Dept Biol Sci, Mol Med Res Ctr, Nicosia, Cyprus; [Dolzan, Vita] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Fenech, Anthony; Grech, Godfrey] Univ Malta, Fac Med, Dept Surg, Msida, Malta; [Kasiulevicius, Vytautas; Kucinskas, Vaidutis] Vilnius Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania; [Kadasi, L'udevit] Comenius Univ, Fac Nat Sci, Bratislava, Slovakia; [Kadasi, L'udevit] Slovak Acad Sci, Ctr Mol Med, Bratislava, Slovakia; [Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa, Russia; [Loukas, Yiannis L.] Univ Athens, Fac Pharm, Dept Pharmaceut Chem, Athens, Greece; [Macek, Milan, Jr.; Turnovec, Marek] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Macek, Milan, Jr.; Turnovec, Marek] Univ Hosp Motol, Prague, Czech Republic; [Makukh, Halyna] Ukrainian Natl Acad Med Sci, Inst Hereditary Pathol, Lvov, Ukraine; [Mathijssen, Ron; Mitropoulou, Christina; van Schaik, Ron H.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Mitropoulos, Konstantinos] Golden Helix Fdn, London, England; [Pavlovic, Sonja; Stojiljkovic, Maja; Zukic, Branka] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia; [Saglio, Giuseppe] Univ Turin, Sch Med, Turin, Italy; [Setric, Jadranka] Univ Zagreb, Sch Med, Zagreb, Croatia; [Squassina, Alessio; del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Lee, Ming Ta Michael] Riken Inst Phys & Chem Res, Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan; [Motsinger-Rief, Alison] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Mc Leod, Howard L.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Dalabira, Eleni] Univ Lausanne Hosp, Lausanne, Switzerland; [Lee, Ming Ta Michael] Geisinger Genom Med Inst, Danville, PA USA	Erasmus University Rotterdam; Erasmus MC; University of Malta; University of Patras; King Faisal Specialist Hospital & Research Center; University of Debrecen; Bogazici University; University of Kiel; University of Malta; University of Rome Tor Vergata; University of Zagreb; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Universidade de Santiago de Compostela; University of Cyprus; University of Ljubljana; University of Malta; Vilnius University; Comenius University Bratislava; Slovak Academy of Sciences; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; National & Kapodistrian University of Athens; Charles University Prague; Motol University Hospital; National Academy of Medical Sciences of Ukraine; Institute of Hereditary Pathology; National Academy of Sciences Ukraine; Erasmus University Rotterdam; Erasmus MC; University of Belgrade; University of Turin; University of Zagreb; University of Cagliari; RIKEN; University of North Carolina; North Carolina State University; H Lee Moffitt Cancer Center & Research Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Patrinos, GP (corresponding author), Erasmus Univ, Fac Med, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands.; Patrinos, GP (corresponding author), Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece.	gpatrinos@upatras.gr	Carracedo, Angel/D-4257-2012; Mitropoulou, Christina/C-2851-2009; Majid, Salma/AAT-6166-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Burzynska, Beata/A-4691-2013; Kadasi, Ludevit/A-4677-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Torres, Maria/R-5162-2019; KUČINSKAS, Vaidutis/A-4798-2013; McLeod, Howard/ABD-8364-2021; Balogh, Istvan/N-2990-2019; van Schaik, Ron H.N./G-6816-2013; Voskarides, Konstantinos/A-4669-2013; Grech, Godfrey/AAD-1303-2020; Majid, Salma/AAT-2616-2020; Katsila, Theodora/O-3228-2015; Cascorbi, Ingolf/AAT-1927-2021; Deltas, Constantinos/A-4936-2013; Novelli, Giuseppe/GQB-3329-2022; Bruckmüller, Henrike/B-6830-2015; Kasiulevicius, Vytautas/P-6819-2014	Carracedo, Angel/0000-0003-1085-8986; Majid, Salma/0000-0002-7883-2515; Novelli, Giuseppe/0000-0002-7781-602X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Torres, Maria/0000-0002-2658-0133; McLeod, Howard/0000-0002-9004-9232; Balogh, Istvan/0000-0003-3397-2829; Voskarides, Konstantinos/0000-0002-3705-3451; Grech, Godfrey/0000-0003-4502-8237; Majid, Salma/0000-0002-1724-5405; Katsila, Theodora/0000-0002-6263-4231; Cascorbi, Ingolf/0000-0002-2182-9534; Deltas, Constantinos/0000-0001-5549-9169; Novelli, Giuseppe/0000-0002-7781-602X; Bruckmüller, Henrike/0000-0002-6027-253X; Burzynska, Beata/0000-0003-1595-0036; Kasiulevicius, Vytautas/0000-0001-9967-8257; Bohm, Ruwen/0000-0003-1007-3011; Kumuthini, Judit/0000-0002-8008-1917; Saglio, Giuseppe/0000-0002-1046-3514; Squassina, Alessio/0000-0001-7415-7607	European grant (RD-Connect) [FP7-305444]; Golden Helix Foundation; LITGEN project - European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-01-013]; National Institutes of Health Common Fund Award NHGRI Grant [U41HG006941];  [00064203];  [LN14073];  [LM2015091];  [NF-CZ11-PDP-3-003-2014];  [CZ.2.16/3.1.00/24022OPPK]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006941] Funding Source: NIH RePORTER	European grant (RD-Connect); Golden Helix Foundation; LITGEN project - European Social Fund under the Global Grant Measure; National Institutes of Health Common Fund Award NHGRI Grant; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Euro-PGx project was partly funded by European grant (RD-Connect; FP7-305444) and the Golden Helix Foundation and encouraged by the Genomic Medicine Alliance Pharmacogenomics Working group. The Lithuanian segment of the project was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. The Czech segment of the project was supported by 00064203, LN14073, LM2015091, NF-CZ11-PDP-3-003-2014 and CZ.2.16/3.1.00/24022OPPK grants to MM. JK was funded by the National Institutes of Health Common Fund Award NHGRI Grant Number U41HG006941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Euro-PGx project was partly funded by European grant (RD-Connect; FP7-305444) and the Golden Helix Foundation and encouraged by the Genomic Medicine Alliance Pharmacogenomics Working group. The Lithuanian segment of the project was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. The Czech segment of the project was supported by 00064203, LN14073, LM2015091, NF-CZ11-PDP-3-003-2014 and CZ.2.16/3.1.00/24022OPPK grants to MM. JK was funded by the National Institutes of Health Common Fund Award NHGRI Grant Number U41HG006941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interests.	Arnold FL, 2014, CLIN PHARMACOL THER, V95, P542, DOI 10.1038/clpt.2013.231; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; Chen JM, 2010, PHARMACOGENOMICS, V11, P1077, DOI 10.2217/PGS.10.79; Davies EC, 2010, BRIT J CLIN PHARMACO, V70, P102, DOI 10.1111/j.1365-2125.2010.03671.x; Delser PM, 2013, HUM GENET, V132, P563, DOI 10.1007/s00439-013-1268-5; Ehmann F, 2015, PHARMACOGENOMICS J, V15, P201, DOI 10.1038/tpj.2014.86; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jackson JN, 2016, PHARMACOGEN IN PRESS; Jittikoon J, 2016, J HUM GENET, V61, P119, DOI 10.1038/jhg.2015.115; Kampourakis K, 2014, EMBO REP, V15, P472, DOI 10.1002/embr.201438641; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Limdi NA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00183; Mitropoulou C, 2014, PUBLIC HEALTH GENOM, V17, P280, DOI 10.1159/000365896; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Papadopoulos P, 2014, NUCLEIC ACIDS RES, V42, pD1020, DOI 10.1093/nar/gkt1125; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Potamias G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140071; Pritchard JK, 2000, GENETICS, V155, P945; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Ramsey LB, 2014, CLIN PHARMACOL THER, V96, P423, DOI 10.1038/clpt.2014.125; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Schildcrout JS, 2012, CLIN PHARMACOL THER, V92, P235, DOI 10.1038/clpt.2012.66; Snyder SR, 2014, PUBLIC HEALTH GENOM, V17, P256, DOI 10.1159/000366177; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI [10.2217/pgs.10.97, 10.2217/PGS.10.97]; Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Wilke RA, 2012, CLIN PHARMACOL THER, V92, P112, DOI 10.1038/clpt.2012.57; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Zineh I, 2011, PHARMACOTHERAPY, V31, P729, DOI 10.1592/phco.31.8.729	32	72	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162866	10.1371/journal.pone.0162866	http://dx.doi.org/10.1371/journal.pone.0162866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636550	gold, Green Published, Green Submitted			2022-12-27	WOS:000383723700018
J	Zhang, XL; Shen, ZW; Zhang, GS; Shen, YY; Chen, MM; Zhao, JX; Wu, RH				Zhang, Xiaolei; Shen, Zhiwei; Zhang, Guishan; Shen, Yuanyu; Chen, Miaomiao; Zhao, Jiaxiang; Wu, Renhua			Short Exon Detection via Wavelet Transform Modulus Maxima	PLOS ONE			English	Article							PROTEIN-CODING REGIONS; LONG-RANGE CORRELATIONS; SEQUENCE-ANALYSIS; GENE PREDICTION; HUMAN GENOME; BRCA1 GENE; DNA; IDENTIFICATION; REPLICATION; PERIODICITY	The detection of short exons is a challenging open problem in the field of bioinformatics. Due to the fact that the weakness of existing model-independent methods lies in their inability to reliably detect small exons, a model-independent method based on the singularity detection with wavelet transform modulus maxima has been developed for detecting short coding sequences (exons) in eukaryotic DNA sequences. In the analysis of our method, the local maxima can capture and characterize singularities of short exons, which helps to yield significant patterns that are rarely observed with the traditional methods. In order to get some information about singularities on the differences between the exon signal and the background noise, the noise level is estimated by filtering the genomic sequence through a notch filter. Meanwhile, a fast method based on a piecewise cubic Hermite interpolating polynomial is applied to reconstruct the wavelet coefficients for improving the computational efficiency. In addition, the output measure of a paired-numerical representation calculated in both forward and reverse directions is used to incorporate a useful DNA structural property. The performances of our approach and other techniques are evaluated on two benchmark data sets. Experimental results demonstrate that the proposed method outperforms all assessed model-independent methods for detecting short exons in terms of evaluation metrics.	[Zhang, Xiaolei] Shantou Univ, Coll Med, Shantou, Peoples R China; [Shen, Zhiwei; Shen, Yuanyu; Chen, Miaomiao; Wu, Renhua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Peoples R China; [Zhang, Guishan] Shantou Univ, Coll Engn, Shantou, Peoples R China; [Zhao, Jiaxiang] Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin, Peoples R China	Shantou University; Shantou University; Shantou University; Nankai University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Peoples R China.; Zhao, JX (corresponding author), Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin, Peoples R China.	zhaojx@nankai.edu.cn; cjr.wurenhua@vip.163.com		Zhang, Xiaolei/0000-0002-5909-5820	National Natural Science Foundation of China [81471730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China: http://www.nsfc.gov.cn/ (Grant No. 81471730, RHW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; [Anonymous], 1995, WAVELETS STAT, DOI [DOI 10.1007/978-1-4612-2544-7_17, 10.1007/978-1-4612-2544-7_17]; Arneodo A, 1996, PHYSICA D, V96, P291, DOI 10.1016/0167-2789(96)00029-2; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Audit B, 2002, J MOL BIOL, V316, P903, DOI 10.1006/jmbi.2001.5363; Audit B, 2001, PHYS REV LETT, V86, P2471, DOI 10.1103/PhysRevLett.86.2471; Audit B, 2013, NAT PROTOC, V8, P98, DOI 10.1038/nprot.2012.145; Bergen SW, 2005, 2005 IEEE PAC RIM C; Brodie EB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248103; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CHECHETKIN VR, 1995, PHYS LETT A, V199, P75, DOI 10.1016/0375-9601(95)00047-7; Ciernikova S, 2003, NEOPLASMA, V50, P403; Datta S, 2004, P IEEE 6 INT S MULT; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Fan ZC, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/4/045007; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Fowler JE, 2005, IEEE SIGNAL PROC LET, V12, P629, DOI 10.1109/LSP.2005.853048; Gao F, 2004, BIOINFORMATICS, V20, P673, DOI 10.1093/bioinformatics/btg467; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Guigo R, 1997, GENETIC DATABASES, P53; Han Min, 2005, Journal of System Simulation, V17, P2616; Jain D., 2014, SURVEY RES PROPOSAL; Jiang R, 2008, PHYSICA A, V387, P4223, DOI 10.1016/j.physa.2008.02.076; Jiang R, 2008, INT J DATA MIN BIOIN, V2, P15, DOI 10.1504/IJDMB.2008.016754; Jleed H, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTER APPLICATIONS TECHNOLOGY (ICCAT); Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MALLAT S, 1992, IEEE T INFORM THEORY, V38, P617, DOI 10.1109/18.119727; Marhon SA, 2016, IEEE ACM T COMPUT BI, V13, P742, DOI 10.1109/TCBB.2015.2476789; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Mena-Chalco JP, 2008, IEEE ACM T COMPUT BI, V5, P198, DOI 10.1109/TCBB.2007.70259; Mikels A., 2003, CAN HMMGENE NET GENE; Nedelcu R, 2002, EUR J HUM GENET, V10, P150, DOI 10.1038/sj.ejhg.5200755; Nicolay S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.032902; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pesquet JC, 1996, IEEE T SIGNAL PROCES, V44, P1964, DOI 10.1109/78.533717; Ramachandran P, 2009, 2009 IEEE INT S CIRC; Rao N, 2004, 2004 INT C COMM CIRC; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; Saberkari Hamidreza, 2013, J Med Signals Sens, V3, P139; Saeys Y, 2007, BIOINFORMATICS, V23, P414, DOI 10.1093/bioinformatics/btl639; Saleh-Gohari N, 2012, IRAN J CANCER PREV, V5, P210; Salzberg S, 1998, J COMPUT BIOL, V5, P667, DOI 10.1089/cmb.1998.5.667; Shakya DK, 2013, IEEE ACM T COMPUT BI, V10, P1241, DOI 10.1109/TCBB.2013.76; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; TSONIS AA, 1991, J THEOR BIOL, V151, P323, DOI 10.1016/S0022-5193(05)80381-9; Vaidyanathan PP, 2004, J FRANKLIN I, V341, P111, DOI 10.1016/j.jfranklin.2003.12.001; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Wang Zhuo, 2004, Genomics Proteomics & Bioinformatics, V2, P216; Windsor AJ, 2006, CURR OPIN BIOTECH, V17, P161, DOI 10.1016/j.copbio.2006.01.007; Wu YH, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061916; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; Zhang WF, 2012, PATTERN RECOGN, V45, P947, DOI 10.1016/j.patcog.2011.08.016	63	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163088	10.1371/journal.pone.0163088	http://dx.doi.org/10.1371/journal.pone.0163088			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635656	gold, Green Submitted, Green Published			2022-12-27	WOS:000383723700032
J	Bickel, WK; Wilson, AG; Chen, C; Koffarnus, MN; Franck, CT				Bickel, Warren K.; Wilson, A. George; Chen, Chen; Koffarnus, Mikhail N.; Franck, Christopher T.			Stuck in Time: Negative Income Shock Constricts the Temporal Window of Valuation Spanning the Future and the Past	PLOS ONE			English	Article							CIGARETTE SMOKERS; POVERTY; REWARDS; CHOICE; REAL	Insufficient resources are associated with negative consequences including decreased valuation of future reinforcers. To determine if these effects result from scarcity, we examined the consequences of acute, abrupt changes in resource availability on delay discounting-the subjective devaluation of rewards as delay to receipt increases. In the current study, 599 individuals recruited from Amazon Mechanical Turk read a narrative of a sudden change (positive, neutral, or negative) to one's hypothetical future income and completed a delay discounting task examining future and past monetary gains and losses. The effects of the explicit zero procedure, a framing manipulation, was also examined. Negative income shock significantly increased discounting rates for gains and loses occurring both in the future and the past. Positive income windfalls significantly decreased discounting to a lesser extent. The framing procedure significantly reduced discounting under all conditions. Negative income shocks may result in short-term choices.	[Bickel, Warren K.; Koffarnus, Mikhail N.] Virginia Tech, Carilion Res Inst, Roanoke, VA 24016 USA; [Wilson, A. George] Univ Kentucky, Lexington, KY USA; [Chen, Chen; Franck, Christopher T.] Virginia Tech, Dept Stat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University of Kentucky; Virginia Polytechnic Institute & State University	Bickel, WK (corresponding author), Virginia Tech, Carilion Res Inst, Roanoke, VA 24016 USA.	wkbickel@vtc.vt.edu	Bickel, Warren/M-5413-2019; Bickel, Warren/D-8898-2011	Bickel, Warren/0000-0002-1048-7372	National Institute on Alcohol Abuse and Alcoholism [R01AA021529]; National Institute on Drug Abuse [R01DA034755]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The grants that supported the project were provided by the National Institute on Alcohol Abuse and Alcoholism (www.NIAAA.nih.gov) No. R01AA021529 and the National Institute on Drug Abuse (www.drugabuse.gov) No. R01DA034755.	Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Bickel WK, 2014, PREV MED, V68, P37, DOI 10.1016/j.ypmed.2014.06.032; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V96, P256, DOI 10.1016/j.drugalcdep.2008.03.009; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; Haushofer J, 2013, NEGATIVE IN IN PRESS; Haushofer J, 2014, SCIENCE, V344, P862, DOI 10.1126/science.1232491; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Kahneman D., 2011, THINKING FAST SLOW; Koffarnus MN, 2014, EXP CLIN PSYCHOPHARM, V22, P222, DOI 10.1037/a0035973; Krosch AR, 2014, P NATL ACAD SCI USA, V111, P9079, DOI 10.1073/pnas.1404448111; LAWRANCE EC, 1991, J POLIT ECON, V99, P54, DOI 10.1086/261740; Magen E, 2008, PSYCHOL SCI, V19, P648, DOI 10.1111/j.1467-9280.2008.02137.x; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Radu PT, 2011, J EXP ANAL BEHAV, V96, P363, DOI 10.1901/jeab.2011.96-363; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Schwarz G, 1978, ESTIMATING THE DIMEN; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Yoon JH, 2008, DRUG ALCOHOL DEPEN, V95, P169, DOI 10.1016/j.drugalcdep.2007.12.011	24	48	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163051	10.1371/journal.pone.0163051	http://dx.doi.org/10.1371/journal.pone.0163051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631760	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900123
J	Chuan, LM; He, P; Zhao, TK; Zheng, HG; Xu, XP				Chuan, Limin; He, Ping; Zhao, Tongke; Zheng, Huaiguo; Xu, Xinpeng			Agronomic Characteristics Related to Grain Yield and Nutrient Use Efficiency for Wheat Production in China	PLOS ONE			English	Article							REQUIREMENTS; NITROGEN; MAIZE	In order to make clear the recent status and trend of wheat (Triticum aestivum L.) production in China, datasets from multiple field experiments and published literature were collected to study the agronomic characteristics related to grain yield, fertilizer application and nutrient use efficiency from the year 2000 to 2011. The results showed that the mean grain yield of wheat in 2000-2011 was 5950 kg/ha, while the N, P2O5 and K2O application rates were 172, 102 and 91 kg/ha on average, respectively. The decrease in N and P2O5 and increase in K2O balanced the nutrient supply and was the main reason for yield increase. The partial factor productivity (PFP, kg grain yield produced per unit of N, P2O5 or K2O applied) values of N (PFP-N), P (PFP-P) and K (PFP-K) were in the ranges of 29.5 similar to 39.6, 43.4 similar to 74.9 and 44.1 similar to 76.5 kg/kg, respectively. While PFP-N showed no significant changes from 2000 to 2010, both PFP-P and PFP-K showed an increased trend over this period. The mean agronomic efficiency (AE, kg grain yield increased per unit of N, P2O5 or K2O applied) values of N (AEN), P (AEP) and K (AEK) were 9.4, 10.2 and 6.5 kg/kg, respectively. The AE values demonstrated marked inter-annual fluctuations, with the amplitude of fluctuation for AEN greater than those for AEP and AEK. The mean fertilizer recovery efficiency (RE, the fraction of nutrient uptake in aboveground plant dry matter to the nutrient of fertilizer application) values of N, P and K in the aboveground biomass were 33.1%, 24.3% and 28.4%, respectively. It was also revealed that different wheat ecological regions differ greatly in wheat productivity, fertilizer application and nutrient use efficiency. In summary, it was suggested that best nutrient management practices, i.e. fertilizer recommendation applied based on soil testing or yield response, with strategies to match the nutrient input with realistic yield and demand, or provided with the 4R's nutrient management (right time, right rate, right site and right fertilizer) should be adopted widely to improve the yield production and nutrient use efficiency.	[Chuan, Limin; Zheng, Huaiguo] Beijing Acad Agr & Forestry Sci, Inst Informat Sci & Technol Agr, Beijing, Peoples R China; [He, Ping] Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Nutr & Fertilizat, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [He, Ping] Int Plant Nutr Inst China Program, Beijing, Peoples R China; [Zhao, Tongke; Xu, Xinpeng] Beijing Acad Agr & Forestry Sci, Inst Plant Nutr & Resources, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry	He, P (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Nutr & Fertilizat, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; He, P (corresponding author), Int Plant Nutr Inst China Program, Beijing, Peoples R China.; Zhao, TK (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant Nutr & Resources, Beijing, Peoples R China.	phe@ipni.net; tkzhao@126.com	He, Ping/HGD-5389-2022		Innovation Program of Beijing Academy of Agricultural and Forestry Sciences [KJCX20140207, KJCX20160503]; National Basic Research Program of China [2013CB127405, 2016YFDO200103]; International Plant Nutrition Institute (IPNI)	Innovation Program of Beijing Academy of Agricultural and Forestry Sciences; National Basic Research Program of China(National Basic Research Program of China); International Plant Nutrition Institute (IPNI)	Funding for this research is provided by the Innovation Program of Beijing Academy of Agricultural and Forestry Sciences (KJCX20140207 and KJCX20160503), the National Basic Research Program of China (2013CB127405, 2016YFDO200103), and International Plant Nutrition Institute (IPNI).	Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chinese Society of Soil Science, 2000, METH SOIL PLANT AN; Chuan LM, 2013, FIELD CROP RES, V146, P96, DOI 10.1016/j.fcr.2013.02.015; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Cui Z., 2008, ACTA AGR BOREALI SIN, V23, P224; Dobermann A., 2007, FERTILIZER BEST MANA; Fixen P. E., 2009, Better Crops with Plant Food, V93, P12; Fixen PE, 2007, P S INF TECH SOIL FE, P52; [郭战玲 GUO Zhan-ling], 2009, [华北农学报, Acta Agriculturae Boreali-Sinica], V24, P185; He P, 2009, AGRON J, V101, P1489, DOI 10.2134/agronj2009.0099; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; LIN B, 1989, Acta Pedologica Sinica, V26, P273; Liu MQ, 2006, NUTR CYCL AGROECOSYS, V74, P245, DOI 10.1007/s10705-006-9002-5; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; [何萍 He Ping], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P499; Snyder C.S., 2007, NUTRIENT USE EFFICIE; Wang FH, 1995, SHANDONG AGR SCI, V1, P4; [王激清 WANG Jiqing], 2008, [资源科学, Resources Science], V30, P415; Wei ZA, 2002, CHEM FERT IND, V29, P32; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhou Yang, 2007, Acta Agronomica Sinica, V33, P1530; Zhu Z.L., 1992, SOIL NITROGEN CHINA; ZHU ZL, 1998, FERTILIZER PROBLEMS, P38	23	13	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162802	10.1371/journal.pone.0162802	http://dx.doi.org/10.1371/journal.pone.0162802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631468	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900081
J	Jiang, HJ; Xie, YF; Li, XC; Ge, HJ; Deng, YQ; Mu, HF; Feng, XL; Yin, L; Du, Z; Chen, F; He, NY				Jiang, Haojun; Xie, Yifan; Li, Xuchao; Ge, Huijuan; Deng, Yongqiang; Mu, Haofang; Feng, Xiaoli; Yin, Lu; Du, Zhou; Chen, Fang; He, Nongyue			Noninvasive Prenatal Paternity Testing (NIPAT) through Maternal Plasma DNA Sequencing: A Pilot Study	PLOS ONE			English	Article							PREGNANCY; ASSAY	Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) have been already used to performnoninvasive prenatal paternity testing from maternal plasma DNA. The frequently used technologies were PCR followed by capillary electrophoresis and SNP typing array, respectively. Here, we developed a noninvasive prenatal paternity testing (NIPAT) based on SNP typing with maternal plasma DNA sequencing. We evaluated the influence factors (minor allele frequency (MAF), the number of total SNP, fetal fraction and effective sequencing depth) and designed three different selective SNP panels in order to verify the performance in clinical cases. Combining targeted deep sequencing of selective SNP and informative bioinformatics pipeline, we calculated the combined paternity index (CPI) of 17 cases to determine paternity. Sequencing-based NIPAT results fully agreed with invasive prenatal paternity test using STR multiplex system. Our study here proved that the maternal plasma DNA sequencing-based technology is feasible and accurate in determining paternity, which may provide an alternative in forensic application in the future.	[Jiang, Haojun; He, Nongyue] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Xie, Yifan; Li, Xuchao; Ge, Huijuan; Mu, Haofang; Feng, Xiaoli; Chen, Fang] Univ Chinese Acad Sci, BGI Educ Ctr, Beijing 100049, Peoples R China; [Jiang, Haojun; Xie, Yifan] BGI Shenzhen, Shenzhen 518000, Peoples R China; [Deng, Yongqiang] Second Peoples Hosp Shenzhen, Dept Stomatol, Shenzhen 518000, Peoples R China; [Mu, Haofang; Feng, Xiaoli] Beijing Genom Inst, Ctr Forens Sci, Beijing 100049, Peoples R China; [Yin, Lu; Du, Zhou; Chen, Fang] Publ Secur Bur Shenzhen Municipal, Shenzhen 518000, Peoples R China; [Yin, Lu; Du, Zhou; Chen, Fang] Joint Lab Gene Associated Applicat Res Forens, Shenzhen 518000, Peoples R China; [Chen, Fang] BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen 518000, Peoples R China; [Chen, Fang] BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen 518000, Peoples R China; [Chen, Fang] Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, Dept Vet Dis Biol, DK-1165 Copenhagen K, Kobenhavn, Denmark	Southeast University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Second People's Hospital of Shenzhen; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); University of Copenhagen	He, NY (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.; Chen, F (corresponding author), Univ Chinese Acad Sci, BGI Educ Ctr, Beijing 100049, Peoples R China.; Chen, F (corresponding author), Publ Secur Bur Shenzhen Municipal, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), Joint Lab Gene Associated Applicat Res Forens, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, Dept Vet Dis Biol, DK-1165 Copenhagen K, Kobenhavn, Denmark.	fangchen@genomics.cn; nyhe1958@163.com			Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology [201510208]; Shenzhen Municipal Government of China [JCYJ20140414170821214, ZDSYS20140509153457495, CXZZ20140808170655268]; BGI-Shenzhen	Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology; Shenzhen Municipal Government of China; BGI-Shenzhen	Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology (201510208), Shenzhen Municipal Government of China (NO. JCYJ20140414170821214), Shenzhen Municipal Government of China (NO. ZDSYS20140509153457495) and Shenzhen Municipal Government of China (NO. CXZZ20140808170655268) supported this study. BGI-Shenzhen provided support in the form of salaries for F. Chen, H. J. Ge, and X. C. Li. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsting C, 2008, FORENSIC SCI INT-GEN, V2, P292, DOI 10.1016/j.fsigen.2008.03.007; Dorum G, 2014, FORENSIC SCI INT-GEN, V9, P93, DOI 10.1016/j.fsigen.2013.11.008; Guo X, 2012, NEW ENGL J MED, V366, P1743, DOI 10.1056/NEJMc1113044; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Ou XL, 2014, TRANSFUSION, V54, P2523, DOI 10.1111/trf.12659; Ou XL, 2013, TRANSFUSION, V53, P1856, DOI 10.1111/trf.12246; Ryan A, 2013, GENET MED, V15, P473, DOI 10.1038/gim.2012.155; Tynan JA, 2011, J MOL DIAGN, V13, P382, DOI 10.1016/j.jmoldx.2011.02.001; Wagner J, 2009, INT J LEGAL MED, V123, P75, DOI 10.1007/s00414-008-0292-9	12	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159385	10.1371/journal.pone.0159385	http://dx.doi.org/10.1371/journal.pone.0159385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631491	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900001
J	Nakamura, E; Kinoshita, H; Feng, GG; Hayashi, H; Satomoto, M; Sato, M; Fujiwara, Y				Nakamura, Emi; Kinoshita, Hiroyuki; Feng, Guo-Gang; Hayashi, Hisaki; Satomoto, Maiko; Sato, Motohiko; Fujiwara, Yoshihiro			Sevoflurane Inhalation Accelerates the Long-Term Memory Consolidation via Small GTPase Overexpression in the Hippocampus of Mice in Adolescence	PLOS ONE			English	Article							K+ CHANNEL FUNCTION; ACTIN CYTOSKELETON; NADPH OXIDASE; HIGH GLUCOSE; ISOFLURANE; IMPAIRMENT; ANESTHESIA; ADULT; NEUROGENESIS; EXPOSURE	Sevoflurane exposure impairs the long-term memory in neonates. Whether the exposure to animals in adolescence affects the memory, however, has been unclear. A small hydrolase enzyme of guanosine triphosphate (GTPase) rac1 plays a role in the F-actin dynamics related to the synaptic plasticity, as well as superoxide production via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation. The current study was designed to examine whether sevoflurane exposure to mice in early adolescence modifies the long-term learning ability concomitantly with the changes in F-actin constitution as well as superoxide production in the hippocampus according to the levels of rac1 protein expression. Four-week-old mice were subjected to the evaluation of long-term learning ability for three days. On day one, each mouse was allowed to enter a dark chamber for five min to acclimatization. On day two, the procedure was repeated with the addition of an electric shock as soon as a mouse entered the dark chamber. All mice subsequently inhaled 2 L/min air with (Sevoflurane group) and without (Control group) 2.5% sevoflurane for three hours. On day three, each mouse was placed on the platform and retention time, which is the latency to enter the dark chamber, was examined. The brain removed after the behavior test, was used for analyses of immunofluorescence, Western immunoblotting and intracellular levels of superoxide. Sevoflurane exposure significantly prolonged retention time, indicating the enhanced long-term memory. Sevoflurane inhalation augmented F-actin constitution coexisting with the rac1 protein overexpression in the hippocampus whereas it did not alter the levels of superoxide. Sevoflurane exposure to 4-week-old mice accelerates the long-term memory concomitantly with the enhanced F-actin constitution coexisting with the small GTPase rac1 overexpression in the hippocampus. These results suggest that sevoflurane inhalation may amplify long-term memory consolidation via the increased cytoskeleton constitution in the hippocampus of animals in early adolescence.	[Nakamura, Emi; Kinoshita, Hiroyuki; Fujiwara, Yoshihiro] Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi, Japan; [Feng, Guo-Gang] Aichi Med Univ, Dept Pharmacol, Sch Med, Nagakute, Aichi, Japan; [Hayashi, Hisaki; Sato, Motohiko] Aichi Med Univ, Dept Physiol, Sch Med, Nagakute, Aichi, Japan; [Satomoto, Maiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan	Aichi Medical University; Aichi Medical University; Aichi Medical University; Tokyo Medical & Dental University (TMDU)	Kinoshita, H (corresponding author), Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi, Japan.	hkinoshi@aichi-med-u.ac.jp	Kinoshita, Hiroyuki/AFC-8806-2022	Satomoto, Maiko/0000-0003-2768-7482	Japan Society for the Promotion of Science [KAKENHI] [15K15575]; Grants-in-Aid for Scientific Research [16K08600, 16K08508] Funding Source: KAKEN	Japan Society for the Promotion of Science [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science [KAKENHI Grant no. 15K15575]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behr J, 2009, PROG NEUROBIOL, V89, P334, DOI 10.1016/j.pneurobio.2009.09.002; Callaway JK, 2012, ANESTHESIOLOGY, V117, P1091, DOI 10.1097/ALN.0b013e31826cb228; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Fidalgo AR, 2012, ACTA ANAESTH SCAND, V56, P1052, DOI 10.1111/j.1399-6576.2012.02691.x; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Franklin K., 2007, MOUSE BRAIN STEREOTA; Guo DW, 2012, APMIS, V120, P469, DOI 10.1111/j.1600-0463.2011.02855.x; Haditsch U, 2013, J NEUROSCI, V33, P12229, DOI 10.1523/JNEUROSCI.2939-12.2013; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; Kinoshita H, 2012, ANESTH ANALG, V115, P54, DOI 10.1213/ANE.0b013e318254270d; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kojima N, 2016, NEUROSCIENCE, V324, P218, DOI 10.1016/j.neuroscience.2016.03.015; Komatsu T, 2008, EXP GERONTOL, V43, P339, DOI 10.1016/j.exger.2008.01.008; Lamprecht R, 2014, PROG NEUROBIOL, V117, P1, DOI 10.1016/j.pneurobio.2014.02.001; Liao M, 2006, ANESTH ANALG, V102, P1452, DOI 10.1213/01.ane.0000204254.87933.f6; Mceown K, 2013, NEUROSCIENCE, V252, P169, DOI 10.1016/j.neuroscience.2013.08.012; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Sun Z, 2016, BRIT J ANAESTH, V117, P80, DOI 10.1093/bja/aew064; Tejada-Simon MV, 2015, J NEUROCHEM, V133, P767, DOI 10.1111/jnc.13100; Vizcaychipi MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026394; Yasuda Y, 2016, PFLUG ARCH EUR J PHY, V468, P1555, DOI 10.1007/s00424-016-1857-y; Yin J, 2014, ANAESTHESIA, V69, P118, DOI 10.1111/anae.12504; York JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50252; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	32	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163151	10.1371/journal.pone.0163151	http://dx.doi.org/10.1371/journal.pone.0163151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632208	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900136
J	Shu, CW; Chang, HT; Wu, CS; Chen, CH; Wu, S; Chang, HW; Kuo, SY; Fu, E; Liu, PF; Hsieh, YD				Shu, Chih-Wen; Chang, Hong-Tai; Wu, Chieh-Shan; Chen, Chien-Hsun; Wu, Sam; Chang, Hsueh-Wei; Kuo, Soong-Yu; Fu, Earl; Liu, Pei-Feng; Hsieh, Yao-Dung			RelA-Mediated BECN1 Expression Is Required for Reactive Oxygen Species-Induced Autophagy in Oral Cancer Cells Exposed to Low-Power Laser Irradiation	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; IONIZING-RADIATION; NECK-CANCER; IN-VITRO; ACTIVATION; THERAPY; DEGRADATION; RESISTANCE; INHIBITION	Low-power laser irradiation (LPLI) is a non-invasive and safe method for cancer treatment that alters a variety of physiological processes in the cells. Autophagy can play either a cytoprotective role or a detrimental role in cancer cells exposed to stress. The detailed mechanisms of autophagy and its role on cytotoxicity in oral cancer cells exposed to LPLI remain unclear. In this study, we showed that LPLI at 810 nm with energy density 60 J/cm(2) increased the number of microtubule associated protein 1 light chain 3 (MAP1LC3) puncta and increased autophagic flux in oral cancer cells. Moreover, reactive oxygen species (ROS) production was induced, which increased RelA transcriptional activity and beclin 1 (BECN1) expression in oral cancer cells irradiated with LPLI. Furthermore, ROS scavenger or knockdown of RelA diminished LPLI-induced BECN1 expression and MAP1LC3-II conversion. In addition, pharmacological and genetic ablation of autophagy significantly enhanced the effects of LPLI-induced apoptosis in oral cancer cells. These results suggest that autophagy may be a resistant mechanism for LPLI-induced apoptosis in oral cancer cells.	[Shu, Chih-Wen; Liu, Pei-Feng] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chang, Hong-Tai] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Chieh-Shan] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Chien-Hsun] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Wu, Sam] Samwell Testing INC, Taipei, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Kuo, Soong-Yu] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Fu, Earl] Natl Def Med Ctr, Sch Dent, Dept Periodontol, Taipei, Taiwan; [Fu, Earl] Triserv Gen Hosp, Taipei, Taiwan; [Liu, Pei-Feng] Fooyin Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Hsieh, Yao-Dung] Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Fooyin University; National Defense Medical Center; Tri-Service General Hospital; Fooyin University; Kaohsiung Veterans General Hospital	Liu, PF (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.; Liu, PF (corresponding author), Fooyin Univ, Dept Biotechnol, Kaohsiung, Taiwan.; Hsieh, YD (corresponding author), Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan.	d908203@gmail.com; mrusmrus@gmail.com	Shu, Chih-Wen/AAE-9652-2019; Chang, Hsueh-Wei/C-9654-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Liu, Pei-Feng/0000-0002-7849-8940; Fu, Earl/0000-0003-0637-0208; Shu, Chih-Wen/0000-0002-7774-0002	National Science Council [NSC 101, 102-2311-B-075B-001]; Kaohsiung Veterans General Hospital [VGHKS99-072, VGHKS102-007]; Kaohsiung Veterans General Hospital, Pingtung Branch [P-001]; Samwell Testing INC	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital, Pingtung Branch; Samwell Testing INC	This work was supported by National Science Council (NSC 101 and 102-2311-B-075B-001 to C.W. Shu), Kaohsiung Veterans General Hospital (VGHKS99-072 to Y.D. Hsieh and VGHKS102-007 to C.W. Shu), and Kaohsiung Veterans General Hospital, Pingtung Branch (P-001 to Y.D. Hsieh). Co-author Sam Wu is employed by Samwell Testing INC. Samwell Testing INC provided support in the form of salary for author SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Ahn MY, 2013, J ORAL PATHOL MED, V42, P17, DOI 10.1111/j.1600-0714.2012.01187.x; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chu JR, 2010, CANCER LETT, V297, P207, DOI 10.1016/j.canlet.2010.05.013; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Han MW, 2014, ANTICANCER RES, V34, P1449; Huang L, 2015, J CELL BIOCHEM, V116, P1741, DOI 10.1002/jcb.25133; Huang L, 2011, J CELL PHYSIOL, V226, P588, DOI 10.1002/jcp.22367; Jiang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133940; Kim J, 2014, J ORAL PATHOL MED, V43, P675, DOI 10.1111/jop.12195; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Ko A, 2014, CELL DEATH DIFFER, V21, P92, DOI 10.1038/cdd.2013.124; Krmpot AJ, 2010, LASER SURG MED, V42, P338, DOI 10.1002/lsm.20911; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Liang N, 2013, CELL SIGNAL, V25, P2530, DOI 10.1016/j.cellsig.2013.08.010; Liang WZ, 2015, LASER SURG MED, V47, P756, DOI 10.1002/lsm.22419; Liu PF, 2015, J INVEST DERMATOL, V135, P2714, DOI 10.1038/jid.2015.254; Liu PF, 2014, AUTOPHAGY, V10, P1454, DOI 10.4161/auto.29556; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Luo LY, 2013, CANCER LETT, V328, P114, DOI 10.1016/j.canlet.2012.08.034; Marocchio Luciana S, 2010, J Oral Sci, V52, P267; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morgan-Bathke M, 2015, J DENT RES, V94, P1035, DOI 10.1177/0022034515590796; Murayama H, 2012, LASER MED SCI, V27, P87, DOI 10.1007/s10103-011-0924-z; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Palumbo S, 2013, J CELL PHYSIOL, V228, P1, DOI 10.1002/jcp.24118; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Prajna NV, 2013, JAMA OPHTHALMOL, V131, P422, DOI 10.1001/jamaophthalmol.2013.1497; Ryter SW, 2014, INT J CELL BIOL, V2014; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shu CW, 2011, J BIOMOL SCREEN, V16, P174, DOI 10.1177/1087057110392996; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Trocoli A, 2011, AM J CANCER RES, V1, P629; Wang F, 2005, LASER SURG MED, V36, P2, DOI 10.1002/lsm.20130; Wu HJ, 2014, INT J BIOL SCI, V10, P1072, DOI 10.7150/ijbs.9719; Wu SA, 2014, ANTIOXID REDOX SIGN, V20, P733, DOI 10.1089/ars.2013.5229; Yeh CC, 2009, MOL CANCER THER, V8, P2718, DOI 10.1158/1535-7163.MCT-09-0211	45	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160586	10.1371/journal.pone.0160586	http://dx.doi.org/10.1371/journal.pone.0160586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632526	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900008
J	Chen, M; Yang, CM; Sui, C; Jin, Y; Wei, JH				Chen, Meng; Yang, Chengmin; Sui, Chun; Jin, Yue; Wei, Jianhe			Zhongdanyaozhi No. 1 and Zhongdanyaozhi No. 2 Are Hybrid Cultivars of Salvia miltiorrhiza with High Yield and Active Compounds Content	PLOS ONE			English	Article							DANSHEN; PERFORMANCE; EXTRACT; BUNGE	Salvia miltiorrhiza Bunge is an important medicinal plant used for the treatment of cardiovascular disease. Intraspecific hybridization between a male sterile line and inbred lines was followed by 39 F1 crossings. Cultivars "Zhongdanyaozhi No. 1" (ZD1) and "Zhongdanyaozhi No. 2" (ZD2) were obtained. In 2012 and 2013 tests in Beijing, the two cultivars were compared with three widely accepted types, SDCK, SXCK and HNCK from Shandong, Shanxi and Henan provinces. The yield of ZD1 and ZD2 exceeded the three CKs by more than 48.2% and 39.2%, respectively; the composition of the two hybrid cultivars was similar to the control, although the content of some compounds varied to some extent. The content of salvianolic acid B and tanshinone II A of both ZD1 and ZD2 could measure up the requirement of Chinese Pharmacopoeia. The former showed no obvious advantage than the three CKs, while the later's tanshinone II A was 29.6% higher than the three CKs. Taken together, ZD1 is a high yielding and thick-root-type cultivar which is suitable for decoction pieces; while ZD2 is suitable for component especially lipophilic component extraction. ZD1 and ZD2 reported here are the first cultivars obtained by the hybridization of S. miltiorrhiza.	[Yang, Chengmin; Wei, Jianhe] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, CM; Wei, JH (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.	cmyang@implda.ac.cn; wjianh@263.net			National Natural Science Foundation of China [81303212]; National Specialized Research Fund for the Doctoral Program of Higher Education [20131106110033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Natural Science Foundation of China, No. 81303212, http://www.nsfc.gov.cn/, to Chengmin Yang; and the National Specialized Research Fund for the Doctoral Program of Higher Education, No. 20131106110033, http://www.cutech.edu.cn/cn/, to Jianhe Wei.; This work was supported by the National Natural Science Foundation of China (No. 81303212) and the National Specialized Research Fund for the Doctoral Program of Higher Education (No. 20131106110033).	Baydar H, 2003, PLANT BREEDING, V122, P459, DOI 10.1046/j.1439-0523.2003.00901.x; Bomme U, 2009, Z ARZNEI- GEWURZPFLA, V14, P25; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Chizzola R., 2002, Journal of Herbs, Spices & Medicinal Plants, V9, P39, DOI 10.1300/J044v09n02_06; Dorman HJD, 2003, J AGR FOOD CHEM, V51, P4563, DOI 10.1021/jf034108k; He YL, 2007, THESIS; Hung YC, 2009, J ETHNOPHARMACOL, V124, P463, DOI 10.1016/j.jep.2009.05.020; JIANG CZ, 2002, WORLD SCI TECH MODER, V4, P75; KIM YOUNG GUK, 2013, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V21, P179, DOI 10.7783/KJMCS.2013.21.3.179; Kwak HB, 2008, EUR J PHARMACOL, V601, P30, DOI 10.1016/j.ejphar.2008.10.034; Li CG, 2009, CHEM BIODIVERS, V6, P170, DOI 10.1002/cbdv.200700441; Lin WL, 2008, CHIN MED MAT, V31, P338; Liu M, 2007, J CHROMATOGR A, V1157, P51, DOI 10.1016/j.chroma.2007.05.018; Lu L. L., 2013, Australian Journal of Crop Science, V7, P152; Pank F., 2002, Journal of Herbs, Spices & Medicinal Plants, V9, P31, DOI 10.1300/J044v09n02_05; Roberts AT, 2007, J MED FOOD, V10, P184, DOI 10.1089/jmf.2006.272; SHARMA J R, 1988, Indian Journal of Genetics and Plant Breeding, V48, P261; Shen WJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003646; Sheng S, 2007, THESIS; Shi FH, 2011, J MED PLANTS RES, V5, P3488; Shi FH, 2014, J AM SOC HORTIC SCI, V139, P442, DOI 10.21273/JASHS.139.4.442; The Pharmacopoeia Commission of PRC, 2010, PHARM PEOPL REP CH 1; Townsend T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061989; Wang YJ, 2013, MICROSC RES TECHNIQ, V76, P947, DOI 10.1002/jemt.22253; Yadav HK, 2007, EUPHYTICA, V157, P123, DOI 10.1007/s10681-007-9402-x; Yan YP, 2007, LISHIZHEN MED MAT ME, V18, P1882; Yang CM, 2013, MOD CHIN MED, V9, P727; Zhang DanYan, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P996; Zhang Y, 2012, PHARM RES-DORDR, V29, P1595, DOI 10.1007/s11095-012-0670-3; Zhao JL, 2011, MOLECULES, V16, P2259, DOI 10.3390/molecules16032259; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou R, 2012, J ETHNOPHARMACOL, V139, P440, DOI 10.1016/j.jep.2011.11.030	32	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162691	10.1371/journal.pone.0162691	http://dx.doi.org/10.1371/journal.pone.0162691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658029	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200031
J	Otsuki, S; Nishiura, H				Otsuki, Shiori; Nishiura, Hiroshi			Reduced Risk of Importing Ebola Virus Disease because of Travel Restrictions in 2014: A Retrospective Epidemiological Modeling Study	PLOS ONE			English	Article							INTERNATIONAL SPREAD; TRANSMISSION; NETWORK; PREDICTABILITY; DISSEMINATION	Background An epidemic of Ebola virus disease (EVD) from 2013-16 posed a serious risk of global spread during its early growth phase. A post-epidemic evaluation of the effectiveness of travel restrictions has yet to be conducted. The present study aimed to estimate the effectiveness of travel restrictions in reducing the risk of importation from mid-August to September, 2014, using a simple hazard-based statistical model. Methodology/Principal Findings The hazard rate was modeled as an inverse function of the effective distance, an excellent predictor of disease spread, which was calculated from the airline transportation network. By analyzing datasets of the date of EVD case importation from the 15 th of July to the 15 th of September 2014, and assuming that the network structure changed from the 8 th of August 2014 because of travel restrictions, parameters that characterized the hazard rate were estimated. The absolute risk reduction and relative risk reductions due to travel restrictions were estimated to be less than 1% and about 20%, respectively, for all models tested. Effectiveness estimates among African countries were greater than those for other countries outside Africa. Conclusions The travel restrictions were not effective enough to expect the prevention of global spread of Ebola virus disease. It is more efficient to control the spread of disease locally during an early phase of an epidemic than to attempt to control the epidemic at international borders. Capacity building for local containment and coordinated and expedited international cooperation are essential to reduce the risk of global transmission.	[Otsuki, Shiori; Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Otsuki, Shiori; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Hokkaido University	Nishiura, H (corresponding author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.; Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.	nishiurah@med.hokudai.ac.jp			Japan Agency for Medical Research and Development; Japan Science and Technology Agency (JST) CREST program; Japan Science and Technology Agency (JST) RISTEX program for Science of Science, Technology and Innovation Policy; Japan Society for the Promotion of Science (JSPS) [16K15356, 26700028]; Grants-in-Aid for Scientific Research [26700028] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Science and Technology Agency (JST) CREST program; Japan Science and Technology Agency (JST) RISTEX program for Science of Science, Technology and Innovation Policy; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HN received funding support from Japan Agency for Medical Research and Development, the Japan Science and Technology Agency (JST) CREST program and RISTEX program for Science of Science, Technology and Innovation Policy, and Japan Society for the Promotion of Science (JSPS) Grant-in-Aid (Kakenhi) 16K15356 and 26700028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TRAV DOC HLTH ADV; [Anonymous], 2013, OBSERVATORY EC COMPL; [Anonymous], 2012, REL COMP BY COUNTR; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Camacho A., 2015, PLOS CURR, V7; Central Intelligence Agency (CIA), 2015, WORLD FACTBOOK; Chowell G, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002057, 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261]; Chowell G, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0196-0; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2015, LANCET, V385, P7, DOI 10.1016/S0140-6736(14)61895-X; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gomes MF, 2014, PLOS CURR, V6; Grais RF, 2003, EPIDEMIOL INFECT, V131, P849, DOI 10.1017/S0950268803008811; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Huang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064317; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Kucharski AJ, 2015, EMERG INFECT DIS, V21, P393, DOI 10.3201/eid2103.141892; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Nah K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1675-z; Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017; Nishiura H, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/1742-4682-12-1; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; OpenFlights. org, 2014, AIRPORT AIRLINE AND; Poletto C, 2014, EUR SURVEILL, V19; Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; The World Bank, 2014, EC IMP 2014 EB EP; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992; World Bank, 2013, INT MIGR STOCK TOT; World Health Organization, 2015, WHO EB SIT REP; World Health Organization, 2008, STAT 1 M IHR EM COMM; World Health Organization, 2015, ESS VACC THER DIAGN; World Health Organization (WHO), 2016, INT HLTH REG 2005	41	11	11	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163418	10.1371/journal.pone.0163418	http://dx.doi.org/10.1371/journal.pone.0163418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657544	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200116
J	Tewes, S; Mokov, N; Hartung, D; Schick, V; Peters, I; Schedl, P; Pertschy, S; Wacker, F; Voshage, G; Hueper, K				Tewes, Susanne; Mokov, Nikolaj; Hartung, Dagmar; Schick, Volker; Peters, Inga; Schedl, Peter; Pertschy, Stefanie; Wacker, Frank; Voshage, Goetz; Hueper, Katja			Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2	PLOS ONE			English	Article							SCORING SYSTEM; MULTIPARAMETRIC MRI; GUIDED BIOPSY; CANCER; VALIDATION; GUIDELINES; AGREEMENT; DIAGNOSIS	Introduction Objective of our study was to determine the agreement between version 1 (v1) and v2 of the Prostate Imaging Reporting and Data System (PI-RADS) for evaluation of multiparametric prostate MRI (mpMRI) and to compare their diagnostic accuracy, their inter-observer agreement and practicability. Material and Methods mpMRI including T2-weighted imaging, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE) of 54 consecutive patients, who subsequently underwent MRI-guided in-bore biopsy were re-analyzed according to PI-RADS v1 and v2 by two independent readers. Diagnostic accuracy for detection of prostate cancer (PCa) was assessed using ROC-curve analysis. Agreement between PI-RADS versions and observers was calculated and the time needed for scoring was determined. Results MRI-guided biopsy revealed PCa in 31 patients. Diagnostic accuracy for detection of PCa was equivalent with both PI-RADS versions for reader 1 with sensitivities and specificities of 84%/91% (AUC = 0.91 95% CI[0.8-1]) for PI-RADS v1 and 100%/74% (AUC = 0.92 95% CI[0.8-1]) for PI-RADS v2. Reader 2 achieved similar diagnostic accuracy with sensitivity and specificity of 74%/91% (AUC = 0.88 95% CI[0.8-1]) for PI-RADS v1 and 81%/91% (AUC = 0.91 95% CI[0.8-1]) for PI-RADS v2. Agreement between scores determined with different PI-RADS versions was good (reader 1: kappa = 0.62, reader 2: kappa = 0.64). Inter-observer agreement was moderate with PI-RADS v2 (kappa = 0.56) and fair with v1 (kappa = 0.39). The time required for building the PI-RADS score was significantly lower with PI-RADS v2 compared to v1 ( 24.7 +/- 2.3 s vs. 41.9 +/- 2.6 s, p<0.001). Conclusion Agreement between PI-RADS versions was high and both versions revealed high diagnostic accuracy for detection of PCa. Due to better inter-observer agreement for malignant lesions and less time demand, the new PI-RADS version could be more practicable for clinical routine.	[Tewes, Susanne; Hartung, Dagmar; Pertschy, Stefanie; Wacker, Frank; Hueper, Katja] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Mokov, Nikolaj; Voshage, Goetz] Klinikum Reg Hannover, Inst Diagnost & Intervent Radiol, Hannover, Gehrden, Germany; [Schick, Volker; Schedl, Peter] Klinikum Reg Hannover, Urol Clin, Hannover, Gehrden, Germany; [Peters, Inga] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Tewes, S (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	Tewes.Susanne@mh-hannover.de			Junge Akademie program Hannover Medical School	Junge Akademie program Hannover Medical School	KH and ST received funding from the Junge Akademie program Hannover Medical School. KH has a research collaboration with Siemens Healthcare outside the work submitted. FW receives institutional grants from Siemens Healthcare and Promedicus Ltd and Delcath Systems Inc. outside the work submitted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2009, NAT REV CLIN ONCOL, V6, P197, DOI 10.1038/nrclinonc.2009.18; Baco E, 2015, EUR UROL, V67, P787, DOI 10.1016/j.eururo.2014.08.077; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Delongchamps NB, 2011, BJU INT, V107, P1411, DOI 10.1111/j.1464-410X.2010.09808.x; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Hamoen EH, 2014, EUROPEAN UROLOGY; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Hoeks CMA, 2012, EUR UROL, V62, P902, DOI 10.1016/j.eururo.2012.01.047; Junker D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/252939; Komai Y, 2013, J UROLOGY, V190, P867, DOI 10.1016/j.juro.2013.03.078; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mazaheri Y, 2008, MAGN RESON MATER PHY, V21, P379, DOI 10.1007/s10334-008-0138-y; Muller BG, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.2015142818; Nagel KNA, 2013, RADIOLOGY, V267, P164, DOI 10.1148/radiol.12111683; Osugi K, 2013, MAGN RESON MED SCI, V12, P271, DOI 10.2463/mrms.2012-0054; Portalez D, 2012, EUR UROL, V62, P986, DOI 10.1016/j.eururo.2012.06.044; Quentin M, 2013, ACTA RADIOL, V54, P1224, DOI 10.1177/0284185113492972; Radiology ACo, MR PROST IM REP DAT; Rastinehad AR, 2011, J UROLOGY, V185, P815, DOI 10.1016/j.juro.2010.10.076; Rothke M, 2013, ROFO-FORTSCHR RONTG, V185, P253, DOI 10.1055/s-0032-1330270; Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5; Rosenkrantz Andrew B, 2013, Radiology, V269, P482, DOI 10.1148/radiol.13122233; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, pW612, DOI 10.2214/AJR.12.10173; Schimmoller L, 2013, EUR RADIOL, V23, P3185, DOI 10.1007/s00330-013-2922-y; Schimmoller L, 2014, EUR RADIOL, V24, P2582, DOI 10.1007/s00330-014-3276-9; Schools I. G., 2014, EUROPEAN UROLOGY; Tewes S, 2015, WORLD J UROLOGY; Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; Valerio M, 2014, EUROPEAN UROLOGY; Vargas HA, 2015, EUROPEAN RADIOLOGY	31	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162879	10.1371/journal.pone.0162879	http://dx.doi.org/10.1371/journal.pone.0162879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657729	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200037
J	Bouchebti, S; Durier, V; Pasquaretta, C; Rivault, C; Lihoreau, M				Bouchebti, Sofia; Durier, Virginie; Pasquaretta, Cristian; Rivault, Colette; Lihoreau, Mathieu			Subsocial Cockroaches Nauphoeta cinerea Mate Indiscriminately with Kin Despite High Costs of Inbreeding	PLOS ONE			English	Article							DEPENDENT NESTMATE-DISCRIMINATION; MALE LOBSTER COCKROACH; SEXUAL CONFLICT; BIASED DISPERSAL; INCEST AVOIDANCE; MATING-BEHAVIOR; NO EVIDENCE; RECOGNITION; FEMALES; CHOICE	Many animals have evolved strategies to reduce risks of inbreeding and its deleterious effects on the progeny. In social arthropods, such as the eusocial ants and bees, inbreeding avoidance is typically achieved by the dispersal of breeders from their native colony. However studies in presocial insects suggest that kin discrimination during mate choice may be a more common mechanism in socially simpler species with no reproductive division of labour. Here we examined this possibility in the subsocial cockroach Nauphoeta cinerea, a model species for research in sexual selection, where males establish dominance hierarchies to access females and control breeding territories. When given a binary choice between a sibling male and a non-sibling male that had the opportunity to establish a hierarchy prior to the tests, females mated preferentially with the dominant male, irrespective of kinship or body size. Despite the lack of kin discrimination during mate choice, inbredmated females incurred significant fitness costs, producing 20% less offspring than outbred-mated females. We discuss how the social mating system of this territorial cockroach may naturally limit the probability of siblings to encounter and reproduce, without the need for evolving active inbreeding avoidance mechanisms, such as kin recognition.	[Bouchebti, Sofia; Pasquaretta, Cristian; Lihoreau, Mathieu] Univ Toulouse, Ctr Integrat Biol CBI, Res Ctr Anim Cognit CRCA, CNRS,UPS, Toulouse, France; [Durier, Virginie; Rivault, Colette] Univ Rennes 1, CNRS UMR Ethol Anim & Humaine 6552, Ave Gen Leclerc, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Rennes	Bouchebti, S (corresponding author), Univ Toulouse, Ctr Integrat Biol CBI, Res Ctr Anim Cognit CRCA, CNRS,UPS, Toulouse, France.	sofia.bouchebti@gmail.com	Pasquaretta, Cristian/AAA-3364-2021	Pasquaretta, Cristian/0000-0001-8308-9968; Lihoreau, Mathieu/0000-0002-2463-2040	CNRS; Federal University of Toulouse; Fyssen foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); Federal University of Toulouse; Fyssen foundation	This work was funded by the CNRS. While writing, ML was supported by two IDEX grants of the Federal University of Toulouse and a research grant from the Fyssen foundation.	Aguilera-Olivares D, 2015, INSECT SOC, V62, P237, DOI 10.1007/s00040-015-0399-1; Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; [Anonymous], 1971, INSECT SOC; Atwell A, 2014, ANIM BEHAV, V98, P177, DOI 10.1016/j.anbehav.2014.10.007; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bayoumy MH, 2015, ECOL ENTOMOL, V40, P596, DOI 10.1111/een.12230; Beaurepaire AL, 2014, ECOL EVOL, V4, P4669, DOI 10.1002/ece3.1284; BELL WJ, 1978, BEHAVIOUR, V67, P217, DOI 10.1163/156853978X00341; Bell WJ, 2007, COCKROACHES ECOLOGY; Billing AM, 2012, MOL ECOL, V21, P1487, DOI 10.1111/j.1365-294X.2012.05490.x; Blatrix R, 2002, ANIM BEHAV, V64, P261, DOI 10.1006/anbe.2002.3048; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; BREED MD, 1980, ANIM BEHAV, V28, P130, DOI 10.1016/S0003-3472(80)80017-0; Breed MD, 2014, ANIM BEHAV, V92, P271, DOI 10.1016/j.anbehav.2014.02.030; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Buczkowski G, 2005, ANIM BEHAV, V69, P741, DOI 10.1016/j.anbehav.2004.06.027; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen SC, 2007, NATURWISSENSCHAFTEN, V94, P927, DOI 10.1007/s00114-007-0265-8; Chou SY, 2007, HORM BEHAV, V52, P252, DOI 10.1016/j.yhbeh.2007.04.013; Costa J., 2006, OTHER INSECT SOC; DEWSBURY DA, 1988, BEHAV GENET, V18, P525, DOI 10.1007/BF01065519; Dronnet S, 2006, J CHEM ECOL, V32, P1027, DOI 10.1007/s10886-006-9043-x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2008, BEHAV ECOL, V19, P854, DOI 10.1093/beheco/arn047; EWING LS, 1972, BEHAVIOUR, V42, P152, DOI 10.1163/156853972X00158; EWING LS, 1973, BEHAVIOUR, V45, P282, DOI 10.1163/156853974X00688; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P223, DOI 10.1046/j.1365-2311.1998.00128.x; Firman RC, 2015, ECOL LETT, V18, P937, DOI 10.1111/ele.12471; FOSTER RL, 1992, J KANSAS ENTOMOL SOC, V65, P238; Frere CH, 2010, P ROY SOC B-BIOL SCI, V277, P2667, DOI 10.1098/rspb.2010.0039; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Guillaume F, 2009, AM NAT, V173, P536, DOI 10.1086/597218; Harano T, 2012, ANIM BEHAV, V83, P1007, DOI 10.1016/j.anbehav.2012.01.022; Harris WE, 2005, AM NAT, V165, pS64, DOI 10.1086/429352; Hepper P.G., 1991, P259, DOI 10.1017/CBO9780511525414.011; Hothorn T., 2008, MULTCOMP SIMULTANEOU; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KOEHLER PG, 1987, ANN ENTOMOL SOC AM, V80, P820, DOI 10.1093/aesa/80.6.820; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; LEFEUVRE JC, 1966, ANN SOC ENTOMOL FR, V2, P731; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Lihoreau M, 2012, INSECT SOC, V59, P445, DOI 10.1007/s00040-012-0234-x; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lihoreau M, 2016, BEHAV ECOL, V27, P1694, DOI 10.1093/beheco/arw099; Lihoreau M, 2010, ANIM BEHAV, V80, P303, DOI 10.1016/j.anbehav.2010.05.011; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Liu XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094389; Lize A, 2014, ISME J, V8, P469, DOI 10.1038/ismej.2013.157; Loyau A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051293; Montrose VT, 2004, J EVOLUTION BIOL, V17, P443, DOI 10.1046/j.1420-9101.2003.00654.x; MOORE AJ, 1988, ANIM BEHAV, V36, P303, DOI 10.1016/S0003-3472(88)80278-1; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; Moore AJ, 2003, J EVOLUTION BIOL, V16, P523, DOI 10.1046/j.1420-9101.2003.00527.x; MOORE AJ, 1990, ANIM BEHAV, V39, P388, DOI 10.1016/S0003-3472(05)80886-3; Moore AJ, 1999, P ROY SOC B-BIOL SCI, V266, P711, DOI 10.1098/rspb.1999.0694; MOORE AJ, 1989, BEHAV GENET, V19, P717, DOI 10.1007/BF01066033; MOORE AJ, 1986, ANIM BEHAV, V34, P1160, DOI 10.1016/S0003-3472(86)80175-0; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Morbey YE, 2001, ECOL LETT, V4, P663, DOI 10.1046/j.1461-0248.2001.00265.x; MOTRO U, 1991, AM NAT, V137, P108, DOI 10.1086/285148; Olson LE, 2012, MOL ECOL, V21, P562, DOI 10.1111/j.1365-294X.2011.05389.x; Panhuis TM, 2007, J EVOLUTION BIOL, V20, P1988, DOI 10.1111/j.1420-9101.2007.01363.x; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; R Core Team, 2021, R LANGUAGE ENV STAT; Randall DA, 2007, BEHAV ECOL, V18, P579, DOI 10.1093/beheco/arm010; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Robinson SP, 2012, J EVOLUTION BIOL, V25, P716, DOI 10.1111/j.1420-9101.2012.02466.x; ROTH LM, 1966, J INSECT PHYSIOL, V12, P255, DOI 10.1016/0022-1910(66)90140-5; ROTH LM, 1962, SCIENCE, V138, P1267, DOI 10.1126/science.138.3546.1267; ROTH LM, 1964, J INSECT PHYSIOL, V10, P915, DOI 10.1016/0022-1910(64)90082-4; SCHAL C, 1984, BIOL REV, V59, P209, DOI 10.1111/j.1469-185X.1984.tb00408.x; SCHAL C, 1983, BIOL BEHAV, V8, P117; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; SEELINGER G, 1983, Z TIERPSYCHOL, V61, P315; Shilpa MC, 2010, BEHAV PROCESS, V85, P42, DOI 10.1016/j.beproc.2010.06.004; Starks PT, 1998, ANIM BEHAV, V56, P449, DOI 10.1006/anbe.1998.0778; Szulkin M, 2007, J EVOLUTION BIOL, V20, P1531, DOI 10.1111/j.1420-9101.2007.01325.x; Szulkin M, 2009, J ANIM ECOL, V78, P778, DOI 10.1111/j.1365-2656.2009.01544.x; Tabadkani SM, 2012, NATURWISSENSCHAFTEN, V99, P779, DOI 10.1007/s00114-012-0961-x; Tan CKW, 2012, ANIM BEHAV, V83, P1433, DOI 10.1016/j.anbehav.2012.03.015; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas ML, 2011, J EVOLUTION BIOL, V24, P1793, DOI 10.1111/j.1420-9101.2011.02319.x; Tien NSH, 2011, EXP APPL ACAROL, V54, P119, DOI 10.1007/s10493-011-9431-y; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Tuni C, 2013, J EVOLUTION BIOL, V26, P1261, DOI 10.1111/jeb.12118; Vitikainen EIK, 2015, AM NAT, V186, P716, DOI 10.1086/683799; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050; Wong JWY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1236	102	6	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162548	10.1371/journal.pone.0162548	http://dx.doi.org/10.1371/journal.pone.0162548			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655156	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700025
J	Doerschner, N; Fitzsimmons, KE; Ditchfield, P; McLaren, SJ; Steele, TE; Zielhofer, C; McPherron, SP; Bouzouggar, A; Hublin, JJ				Doerschner, Nina; Fitzsimmons, Kathryn E.; Ditchfield, Peter; McLaren, Sue J.; Steele, Teresa E.; Zielhofer, Christoph; McPherron, Shannon P.; Bouzouggar, Abdeljalil; Hublin, Jean-Jacques			A New Chronology for Rhafas, Northeast Morocco, Spanning the North African Middle Stone Age through to the Neolithic	PLOS ONE			English	Article							JINMIUM ROCK SHELTER; INDIVIDUAL GRAINS; MULTIPLE GRAINS; ATERIAN LEVELS; DOSE-RATES; SINGLE; LUMINESCENCE; QUARTZ; CAVE; PLEISTOCENE	Archaeological sites in northern Africa provide a rich record of increasing importance for the origins of modern human behaviour and for understanding human dispersal out of Africa. However, the timing and nature of Palaeolithic human behaviour and dispersal across north-western Africa (the Maghreb), and their relationship to local environmental conditions, remain poorly understood. The cave of Rhafas (northeast Morocco) provides valuable chronological information about cultural changes in the Maghreb during the Palaeolithic due to its long stratified archaeological sequence comprising Middle Stone Age (MSA), Later Stone Age (LSA) and Neolithic occupation layers. In this study, we apply optically stimulated luminescence (OSL) dating on sand-sized quartz grains to the cave deposits of Rhafas, as well as to a recently excavated section on the terrace in front of the cave entrance. We hereby provide a revised chronostratigraphy for the archaeological sequence at the site. We combine these results with geological and sedimentological multi-proxy investigations to gain insights into site formation processes and the palaeoenvironmental record of the region. The older sedimentological units at Rhafas were deposited between 135 ka and 57 ka (MIS 6 -MIS 3) and are associated with the MSA technocomplex. Tanged pieces start to occur in the archaeological layers around 109 ka, which is consistent with previously published chronological data from the Maghreb. A well indurated duricrust indicates favourable climatic conditions for the pedogenic cementation by carbonates of sediment layers at the site after 57 ka. Overlying deposits attributed to the LSA technocomplex yield ages of similar to 21 ka and similar to 15 ka, corresponding to the last glacial period, and fall well within the previously established occupation phase in the Maghreb. The last occupation phase at Rhafas took place during the Neolithic and is dated to similar to 7.8 ka.	[Doerschner, Nina; Fitzsimmons, Kathryn E.; Steele, Teresa E.; McPherron, Shannon P.; Bouzouggar, Abdeljalil; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Ditchfield, Peter] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [McLaren, Sue J.] Univ Leicester, Dept Geog, Leicester, Leics, England; [Steele, Teresa E.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Zielhofer, Christoph] Univ Leipzig, Inst Geog, Leipzig, Germany; [Bouzouggar, Abdeljalil] Inst Natl Sci Archeol & Patrimoine, Rabat, Morocco; [Bouzouggar, Abdeljalil] Aix Marseille Univ, Inst Adv Study, Marseille, France	Max Planck Society; University of Oxford; University of Leicester; University of California System; University of California Davis; Leipzig University; UDICE-French Research Universities; Aix-Marseille Universite	Doerschner, N (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	nina_doerschner@eva.mpg.de	Fitzsimmons, Kathryn/U-3565-2018; Bouzouggar, Abdeljalil/AAD-3608-2022	Fitzsimmons, Kathryn/0000-0002-9337-0793; Bouzouggar, Abdeljalil/0000-0002-4332-4385; Dorschner, Nina/0000-0002-4714-2693; McLaren, Sue/0000-0002-0051-7400; Zielhofer, Christoph/0000-0001-9551-4466; Steele, Teresa/0000-0002-3091-6488	Max Planck Society; Aix-Marseille University, IMeRA; LabexMed of Labex RFIEA; ANR - Investissements d'Avenir	Max Planck Society(Max Planck SocietyFoundation CELLEX); Aix-Marseille University, IMeRA; LabexMed of Labex RFIEA; ANR - Investissements d'Avenir(French National Research Agency (ANR))	This study was funded by the Max Planck Society. A. Bouzouggar's work was also supported by Aix-Marseille University, IMeRA, with the support of LabexMed, of Labex RFIEA and ANR - Investissements d'Avenir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson K, 2015, QUATERNARY RES, V84, P272, DOI 10.1016/j.yqres.2015.05.002; Aitken M.J., 1998, INTRO OPTICAL DATING; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; Ballarini M, 2007, RADIAT MEAS, V42, P360, DOI 10.1016/j.radmeas.2006.12.016; Barich BE, 2008, AFR ARCHAEOL REV, V25, P87, DOI 10.1007/s10437-008-9020-6; Barton N., 2005, AFR ARCHAEOL REV, V22, P77; Barton RNE, 2013, J HUM EVOL, V65, P266, DOI 10.1016/j.jhevol.2013.06.003; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Barton R.N.E., 2007, RETHINKING HUMAN REV, P177; Barton RNE, 2015, QUATERNARY IN PRESS; Betrouni M, 2001, HOMME MAGHREBIN SON, P101; Betrouni M, 1997, MON MEDITERRANI DESP, V17, P57; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Botter-Jensen L, 1997, RADIAT MEAS, V27, P749, DOI 10.1016/S1350-4487(97)00206-0; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; BOTTERJENSEN L, 1985, NUCL TRACKS RAD MEAS, V10, P663, DOI 10.1016/0735-245X(85)90073-0; Bouzouggar A, 2008, AFR ARCHAEOL REV, V25, P3, DOI 10.1007/s10437-008-9023-3; Bouzouggar A., 2012, MODERN ORIGINS N AFR, P93; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Braham L, 2008, 1 AFRICANS AFRICAN A; Brookins D.G., 1988, EH PH DIAGRAMS GEOCH; Camps G., 1974, CIVILISATIONS PREHIS; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Clark-Balzan LA, 2012, QUAT GEOCHRONOL, V12, P53, DOI 10.1016/j.quageo.2012.06.006; Cunningham AC, 2009, RADIAT MEAS, V44, P423, DOI 10.1016/j.radmeas.2009.02.014; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; DEBENATH A, 1986, ANTHROPOLOGIE, V90, P233; DEBENATH A, 1992, ANTHROPOLOGIE, V96, P711; di Lernia S., 1998, WADI TESHUINAT PALAE, P123; Dibble H.L., 2012, PALEOANTHROPOLOGY, V2012, P145, DOI DOI 10.4207/PA.2012.ART74; Dibble HL, 2013, J HUM EVOL, V64, P194, DOI 10.1016/j.jhevol.2012.10.010; Douka K, 2014, J HUM EVOL, V66, P39, DOI 10.1016/j.jhevol.2013.10.001; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Duller GAT, 1999, NUCL INSTRUM METH B, V155, P506, DOI 10.1016/S0168-583X(99)00488-7; Galbraith R.F., 2005, STAT FISSION TRACK A, DOI [10.1201/9781420034929, DOI 10.1201/9781420034929]; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Garcea E.A.A., 2012, MODERN ORIGINS N AFR, P127; Garcea E.A.A., 2010, S E MEDITERRANEAN PE, P37; Garcea EAA, 1996, PREHISTORY AFRICA, P183; GARCEA EAA, 1998, WADI TESHUINAT PALAE, P155; Garcea EAA, SE MEDITERRANEAN PEO; Garcea EAA, 2006, J HUM EVOL, V51, P411, DOI 10.1016/j.jhevol.2006.05.002; Garcea EAA, 2012, QUATERN INT, V270, P119, DOI 10.1016/j.quaint.2011.06.034; Giraudi C, 2010, LIBYA ANTIQUA, P237; Grubbs FE, 1950, SAMPLE CRITERIA TEST, P27, DOI 10.1214/aoms/1177729885; Guerin G, 2011, ANCIENT TL, V29, P5; Hogue J., 2014, THESIS; Hogue JT, QUATERNARY IN PRESS; Humphrey L, 2012, J HUM EVOL, V62, P261, DOI 10.1016/j.jhevol.2011.11.003; Iovita R., 2011, PLOS ONE, V6, DOI [10.1371/ journal.6646.0029029, DOI 10.1371/J0URNAL.6646.0029029]; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Jacobs Z, 2011, J ARCHAEOL SCI, V38, P3631, DOI 10.1016/j.jas.2011.08.033; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1808, DOI 10.1016/j.jas.2007.11.027; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jacobs Z, 2012, J HUM EVOL, V62, P377, DOI 10.1016/j.jhevol.2011.12.001; KOWALSKI K, 1989, QUATERNARY RES, V32, P335, DOI 10.1016/0033-5894(89)90099-9; Larrasoana J.C., 2012, MODERN ORIGINS N AFR, P19; Linstadter J., 2008, QUARTAR, V55, P41; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; Martini M., 1998, WADI TESHUINAT PALAE, P67; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McBurney C.B.M., 1967, HAUA FTEAH CYRENAICA; McLaren S, 2007, GEOCHEMICAL SEDIMENT, P443; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mercier N, 2007, QUAT GEOCHRONOL, V2, P309, DOI 10.1016/j.quageo.2006.03.010; MICHEL P, 1992, ANTHROPOLOGIE, V96, P643; Moreno A, 2002, QUATERNARY RES, V58, P318, DOI 10.1006/qres.2002.2383; Moreno A., 2012, MULTIPROXY PALEOCLIM, P3, DOI DOI 10.1007/978-94-007-2929-23; Moser J, 2003, GROTTE IFRI AMMAR, V1; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Occhietti S, 1993, AMINOSTRATIGRAPHIE D, P1625; Olley JM, 1996, QUATERNARY SCI REV, V15, P751, DOI 10.1016/0277-3791(96)00026-1; Olley JM, 1997, RADIAT MEAS, V27, P433, DOI 10.1016/S1350-4487(96)00114-X; PRENTICE IC, 1992, NATURE, V360, P658, DOI 10.1038/360658a0; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramos J, 2008, QUATERNARY SCI REV, V27, P2210, DOI 10.1016/j.quascirev.2008.08.030; Ramos Munoz J, 2007, REV PREHISTORIA ARQU, V60, P27; Rhodes EJ, 2006, QUATERNARY SCI REV, V25, P2569, DOI 10.1016/j.quascirev.2005.09.010; Richter D., 2012, MODERN ORIGINS N AFR, P61; Richter D, 2010, J HUM EVOL, V59, P672, DOI 10.1016/j.jhevol.2010.07.024; Roberts RG, 1999, ARCHAEOMETRY, V41, P365, DOI 10.1111/j.1475-4754.1999.tb00988.x; Roberts RG, 2000, RADIAT MEAS, V32, P459, DOI 10.1016/S1350-4487(00)00104-9; Roche J, 1963, EPIPALEOLITHIQUE MAR; Rodnight H., 2008, ANCIENT TL, V26, P3; Roset J-P, 2007, SITE ARCHEOLOGIQUE P; Sari L, 2014, QUATERN INT, V320, P131, DOI 10.1016/j.quaint.2013.04.014; Saxon E.C., 1974, LIBYCA, V22, P49; Schwenninger J.L., 2010, S E MEDITERRANEAN PE, P18; Smith J.R., 2010, S E MEDITERRANEAN PE, P6; Smith TM, 2007, P NATL ACAD SCI USA, V104, P6128, DOI 10.1073/pnas.0700747104; Smits JM, 2012, MIND AND METHOD OF THE LEGAL ACADEMIC, P35; Stoetzel E, 2011, J HUM EVOL, V60, P1, DOI 10.101651.939991.2010.07.016; Stoetzel E, 2014, QUATERN INT, V320, P143, DOI 10.1016/j.quaint.2013.05.017; Talbi EH, 2012, REPORT GEOLOGY RHAFA; Texier J-P, 1988, CR HEBD ACAD SCI, P827; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Wallinga J, 2002, BOREAS, V31, P303; Wendorf F., 1993, EGYPT LAST INTERGLAC; Wengler L, 1997, ANTHROPOLOGIE, V101, P448; Wengler L., 2002, QUATERNAIRE, V13, P179, DOI [10.3406/quate.2002.1710, DOI 10.3406/QUATE.2002.1710]; Wengler L, 2006, PALEOLITHIQUE MOYEN; Wengler L, 1993, THESIS U BORDEAUX 1; Wintle AG, 2006, RADIAT MEAS, V41, P369, DOI 10.1016/j.radmeas.2005.11.001; Wrinn PJ, 2003, J ARCHAEOL SCI, V30, P123, DOI 10.1006/jasc.2002.0813	109	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162280	10.1371/journal.pone.0162280	http://dx.doi.org/10.1371/journal.pone.0162280			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DW8GK	27654350	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700018
J	Proverbio, AM; La Mastra, F; Zani, A				Proverbio, Alice Mado; La Mastra, Francesca; Zani, Alberto			How Negative Social Bias Affects Memory for Faces: An Electrical Neuroimaging Study	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; AMYGDALA-HIPPOCAMPAL CONNECTIVITY; EVENT-RELATED POTENTIALS; RECOGNITION MEMORY; EPISODIC MEMORY; PREFRONTAL ACTIVATION; EMOTIONAL MEMORY; RETRIEVAL MODE; FAMILIARITY; RECOLLECTION	During social interactions, we make inferences about people's personal characteristics based on their appearance. These inferences form a potential prejudice that can positively or negatively bias our interaction with them. Not much is known about the effects of negative bias on face perception and the ability to recognize people faces. This ability was investigated by recording event-related potentials (ERPs) from 128 sites in 16 volunteers. In the first session (encoding), they viewed 200 faces associated with a short fictional story that described anecdotal positive or negative characteristics about each person. In the second session (recognition), they underwent an old/new memory test, in which they had to distinguish 100 new faces from the previously shown faces. ERP data relative to the encoding phase showed a larger anterior negativity in response to negatively (vs. positively) biased faces, indicating an additional processing of faces with unpleasant social traits. In the recognition task, ERPs recorded in response to new faces elicited a larger FN400 than to old faces, and to positive than negative faces. Additionally, old faces elicited a larger Old-New parietal response than new faces, in the form of an enlarged late positive (LPC) component. An inverse solution SwLORETA (450-550 ms) indicated that remembering old faces was associated with the activation of right superior frontal gyrus (SFG), left medial temporal gyrus, and right fusiform gyrus. Only negatively connoted faces strongly activated the limbic and parahippocampal areas and the left SFG. A dissociation was found between familiarity (modulated by negative bias) and recollection (distinguishing old from new faces).	[Proverbio, Alice Mado; La Mastra, Francesca] Univ Milano Bicocca, Dept Psychol, NeuroMi Milan Ctr Neurosci, Milan, Italy; [Zani, Alberto] IBFM CNR, Inst Bioimaging & Mol Physiol, Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, NeuroMi Milan Ctr Neurosci, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020	Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca [9928 2013-ATE-0037, 2012FAR]	University of Milano-Bicocca	This work was supported by the 9928 2013-ATE-0037 grant from University of Milano-Bicocca.; Supported by 2012FAR grant from University of Milano-Bicocca to AMP. We wish to thank Federica Riva and Roberta Adorni for their help with the EEG recordings.	Addante RJ, 2012, NEUROIMAGE, V62, P439, DOI 10.1016/j.neuroimage.2012.04.031; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allport G., 1979, NATURE PREJUDICE, V25th; Arcurio LR, 2012, NEUROPSYCHOLOGIA, V50, P2454, DOI 10.1016/j.neuropsychologia.2012.06.016; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Bell R, 2016, PSYCHOPHYSIOLOGY, V53, P216, DOI 10.1111/psyp.12561; Bell R, 2010, MEM COGNITION, V38, P29, DOI 10.3758/MC.38.1.29; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bero AW, 2014, P NATL ACAD SCI USA, V111, P11852, DOI 10.1073/pnas.1408378111; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; Chiu YC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00103; CHRISTIANSON SA, 1992, PSYCHOL BULL, V112, P284, DOI 10.1037/0033-2909.112.2.284; Curran T, 2003, COGNITIVE BRAIN RES, V15, P191, DOI 10.1016/S0926-6410(02)00192-1; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T, 2007, NEUROIMAGE, V36, P464, DOI 10.1016/j.neuroimage.2006.12.016; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dolcos F., 2008, CELL SCI REV, V5, P78; Dolcos F, 2012, PSYCHOLOGIA, V55, P80, DOI 10.2117/psysoc.2012.80; Duarte A, 2004, COGNITIVE BRAIN RES, V18, P255, DOI 10.1016/j.cogbrainres.2003.10.010; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Evans LH, 2012, J NEUROSCI, V32, P7253, DOI 10.1523/JNEUROSCI.6396-11.2012; Fastenrath M, 2014, J NEUROSCI, V34, P13935, DOI 10.1523/JNEUROSCI.0786-14.2014; Martinez-Galindo JG, 2015, BEHAV BRAIN RES, V291, P89, DOI 10.1016/j.bbr.2015.05.018; Guillaume F, 2013, BRAIN COGNITION, V81, P73, DOI 10.1016/j.bandc.2012.10.007; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hietanen JK, 2013, BIOL PSYCHOL, V92, P114, DOI 10.1016/j.biopsycho.2012.10.005; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188; Keightley ML, 2011, SOC COGN AFFECT NEUR, V6, P24, DOI 10.1093/scan/nsq003; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; LIGHT LL, 1979, J EXP PSYCHOL-HUM L, V5, P212, DOI 10.1037/0278-7393.5.3.212; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Murty VP, 2011, NEUROPSYCHOLOGIA, V49, P695, DOI 10.1016/j.neuropsychologia.2011.02.031; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2011, J COGNITIVE NEUROSCI, V23, P3197, DOI 10.1162/jocn_a_00041; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; Rugg MD, 1996, COGNITIVE BRAIN RES, V4, P297, DOI 10.1016/S0926-6410(96)00067-5; Rule NO, 2012, COGNITION, V125, P207, DOI 10.1016/j.cognition.2012.06.017; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sergerie K, 2006, J COGNITIVE NEUROSCI, V18, P1359, DOI 10.1162/jocn.2006.18.8.1359; Shafer AT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00177; Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tsivilis D, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00532; Tulving E, 1985, CAN J PSYCHOL, V32, P130; Vallesi A, 2006, BRAIN RES, V1124, P111, DOI 10.1016/j.brainres.2006.09.076; VOKEY JR, 1992, MEM COGNITION, V20, P291, DOI 10.3758/BF03199666; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; Wilding E. L., 2003, COGNITIVE ELECTROPHY, P169, DOI DOI 10.1016/B978-012775421-5/50009-1; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005	73	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162671	10.1371/journal.pone.0162671	http://dx.doi.org/10.1371/journal.pone.0162671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655327	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892700028
J	Bock, O; Akpinar, S				Bock, Otmar; Akpinar, Selcuk			Performance of Older Persons in a Simulated Shopping Task Is Influenced by Priming with Age Stereotypes	PLOS ONE			English	Article							ECOLOGICAL VALIDITY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; SUPERMARKET; BEHAVIOR; MATTER	Previous research suggests that older persons show cognitive deficits in standardized laboratory tests, but not in more natural tests such as the Multiple Errands Task (MET). The absence of deficits in the latter tests has been attributed to the compensation of deficits by strategies based on life-long experience. To scrutinize this view, we primed older participants with positive or negative stereotypes about old age before administering MET. We found that compared to unprimed controls, priming with positive age stereotypes reduced the number of errors without changing response times, while priming with negative stereotypes changed neither errors not response times. We interpret our findings as evidence that positive age priming improved participants' cognitive functions while leaving intact their experience-based compensation, and that negative age priming degraded participants' cognitive functions which, however, was balanced by an even stronger experience-based compensation.	[Bock, Otmar] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Akpinar, Selcuk] Nevsehir Haci Bektas Veli Univ, Dept Phys Educ & Sport Educ, Nevsehir Merkez Nevsehir, Turkey	German Sport University Cologne; Nevsehir Haci Bektas Veli University	Bock, O (corresponding author), German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany.	bock@dshs-koeln.de	Akpinar, Selcuk/M-5579-2018	Bock, Otmar/0000-0003-0485-6765	Deutsche Forschungsgemeinschaft [BO 649/21-1]; German Research Foundation (DFG) [BO 649/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Grant BO 649/21-1 by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by travel grant BO 649/21-1 from the German Research Foundation (DFG). We thank Thomas Kesnerus for programming the tablet version of the MET.	Abrams D., 2011, 735 DEP WORK PENS; Akozer M, 2011, AILE TOPLUM, V12, P103; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bock O, 2012, AGEING RES, V3, P48; Bock O, 2010, GAIT POSTURE, V32, P645, DOI 10.1016/j.gaitpost.2010.09.009; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Farrimond S, 2006, APPL COGNITIVE PSYCH, V20, P533, DOI 10.1002/acp.1202; Garden SE, 2001, NEUROPSYCHOLOGY, V15, P472, DOI 10.1037//0894-4105.15.4.472; Hausdorff JM, 1999, J AM GERIATR SOC, V47, P1346, DOI 10.1111/j.1532-5415.1999.tb07437.x; Ilieva, 2013, PSYCHOLOGY, V04, P1014, DOI [10.4236/psych.2013.412147, DOI 10.4236/PSYCH.2013.412147]; Jerusalem M., 1992, SELF EFFICACY THOUGH, P195, DOI DOI 10.4324/9781315800820; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Kirchner C, 2015, PSYCHOLOGY, V6, P133, DOI DOI 10.4236/PSYCH.2015.62012; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Levy B., 2000, J GERIATR PSYCHIAT, V33, P81; Levy BR, 2009, PSYCHOL AGING, V24, P230, DOI 10.1037/a0014563; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Levy BR, 2000, J GERONTOL B-PSYCHOL, V55, pP205, DOI 10.1093/geronb/55.4.P205; Meisner BA, 2012, J GERONTOL B-PSYCHOL, V67, P13, DOI 10.1093/geronb/gbr062; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Phillips LH, 2006, INT J AGING HUM DEV, V62, P175, DOI 10.2190/EM1W-HAYC-TMLM-WW8X; Raspelli S, 2010, STUD HEALTH TECHNOL, V154, P115, DOI 10.3233/978-1-60750-561-7-115; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Shah A, 2007, MED SCI LAW, V47, P244, DOI 10.1258/rsmmsl.47.3.244; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Slobounov S, 1997, J APPL SPORT PSYCHOL, V9, P171, DOI 10.1080/10413209708406480; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; World Health Organization, 2002, COMMON LANGUAGE FUNC	35	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0160739	10.1371/journal.pone.0160739	http://dx.doi.org/10.1371/journal.pone.0160739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649296	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100002
J	Civardi, C; Van den Bulcke, J; Schubert, M; Michel, E; Butron, MI; Boone, MN; Dierick, M; Van Acker, J; Wick, P; Schwarze, FWMR				Civardi, Chiara; Van den Bulcke, Jan; Schubert, Mark; Michel, Elisabeth; Butron, Maria Isabel; Boone, Matthieu N.; Dierick, Manuel; Van Acker, Joris; Wick, Peter; Schwarze, Francis W. M. R.			Penetration and Effectiveness of Micronized Copper in Refractory Wood Species	PLOS ONE			English	Article							PHASE; IMAGE; FLOW	The North American wood decking market mostly relies on easily treatable Southern yellow pine (SYP), which is being impregnated with micronized copper (MC) wood preservatives since 2006. These formulations are composed of copper (Cu) carbonate particles (CuCO3 center dot Cu(OH)(2)), with sizes ranging from 1 nm to 250 mu m, according to manufacturers. MC-treated SYP wood is protected against decay by solubilized Cu2+ ions and unreacted CuCO3 center dot Cu(OH)(2) particles that successively release Cu2+ ions (reservoir effect). The wood species used for the European wood decking market differ from the North American SYP. One of the most common species is Norway spruce wood, which is poorly treatable i.e. refractory due to the anatomical properties, like pore size and structure, and chemical composition, like pit membrane components or presence of wood extractives. Therefore, MC formulations may not suitable for refractory wood species common in the European market, despite their good performance in SYP. We evaluated the penetration effectiveness of MC azole (MCA) in easily treatable Scots pine and in refractory Norway spruce wood. We assessed the effectiveness against the Cu-tolerant wood-destroying fungus Rhodonia placenta. Our findings show that MCA cannot easily penetrate refractory wood species and could not confirm the presence of a reservoir effect.	[Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Civardi, Chiara; Schubert, Mark; Butron, Maria Isabel; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, Dubendorf, Switzerland; Univ Ghent, Fac Biosci Engn, Dept Forest & Water Management, UGCT Woodlab UGent,Lab Wood Technol, Ghent, Belgium; Empa, Adv Fibers, St Gallen, Switzerland; [Boone, Matthieu N.; Dierick, Manuel] Univ Ghent, Dept Phys & Astron, UGCT Radiat Phys, Proeftuinstr 86-N12, B-9000 Ghent, Belgium; [Wick, Peter] Empa, Particles Biol Interact, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Ghent University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Ghent University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Civardi, C (corresponding author), ETH, Inst Bldg Mat, Zurich, Switzerland.; Civardi, C; Schwarze, FWMR (corresponding author), Empa, Appl Wood Mat, Dubendorf, Switzerland.	civardic@student.ethz.ch; francis.schwarze@empa.ch	Boone, Matthieu N/I-2664-2013; Van Acker, Joris/AAS-6030-2020; Schwarze, Francis/Y-2157-2018	Boone, Matthieu N/0000-0002-5478-4141; Van Acker, Joris/0000-0002-8961-0176; Schwarze, Francis/0000-0003-3306-8303; Schubert, Mark/0000-0002-6900-0370	Swiss National Research Foundation [406440_141618]; EC [284181]	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); EC(European CommissionEuropean Commission Joint Research Centre)	The work is financially supported by the Swiss National Research Foundation (http://www.nrp64.ch/en, Grant No. 406440_141618) and the Transnational Access to Research Infrastructures activity in the 7th Framework Program of the EC under the Trees4Future project (Trees4Future, http://www.trees4future.eu/, 284181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Daniel Heer for the technical assistance. The work is financially supported by the Swiss National Research Foundation (Grant No. 406440_141618) and the Transnational Access to Research Infrastructures activity in the 7th Framework Program of the EC under the Trees4Future project (Trees4Future, 284181).	[Anonymous], 1994, 3502 EN; [Anonymous], 2013, 335 EN; Arsenault RD, 1973, WOOD DETERIORATION I, V2, P121; Baines EF, 1981, BIODETERIORATION, V5, P26; Berger M., 1998, NIST STAND REF DATAB, V8, P3587; Boone MN, 2012, J OPT SOC AM A, V29, P2667, DOI 10.1364/JOSAA.29.002667; Boone MN, 2012, MICROSC MICROANAL, V18, P399, DOI 10.1017/S1431927611012529; Brabant L, 2011, MICROSC MICROANAL, V17, P252, DOI 10.1017/S1431927610094389; Civardi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142578; Courtois H., 1964, Holzforschung und Holzverwertung, V16, P21; Dierick M, 2010, J X-RAY SCI TECHNOL, V18, P451, DOI 10.3233/XST-2010-0268; Dierick M, 2014, NUCL INSTRUM METH B, V324, P35, DOI 10.1016/j.nimb.2013.10.051; European Committee for Standardization, 1997, 113 EN; Evans P, 2012, P IRG ANN M 2012 MAY; Evans P, 2013, P IRG ANN M 2013 JUN; FLYNN KA, 1995, WOOD FIBER SCI, V27, P278; Freeman M, 2013, P IRG ANN M 2013 JUN; Habicht J, 2008, NORD WOOD PRES M; HALE MD, 1986, T BRIT MYCOL SOC, V86, P585, DOI 10.1016/S0007-1536(86)80060-2; Hughes A., 2006, P FIN C 2004 MAR 22; LEACH RM, 2005, Patent No. 2005104841; LEACH RM, 2004, Patent No. 2004091875; Lee MJ, 2014, HOLZFORSCHUNG, V68, P477, DOI 10.1515/hf-2013-0088; Matsunaga H, 2007, P IRG ANN M 2007 MAY; Matsunaga H, 2010, P IRG ANN M 2010 MAY; Matsunaga H, 2009, J NANOPART RES, V11, P1087, DOI 10.1007/s11051-008-9512-y; McIntyre C, 2010, P IRG ANN M 2010 MAY; Morris PI, 1994, P IRG ANN M 1994 MAY; Olsson T, 2001, J WOOD SCI, V47, P282, DOI 10.1007/BF00766714; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; PERRIN PW, 1978, FOREST PROD J, V28, P27; Platten WE, 2014, EPA600R14365; Ray M, 2010, P IRG ANN M 2010 MAY; Ryan K. G., 1988, Journal of the Institute of Wood Science, V11, P108; SIMPSON WT, 1987, WOOD FIBER SCI, V19, P9; Southern Pine Council, 2002, SURV 2000 TREAT SO P; Stirling R, 2008, P IRG ANN M 2008 MAY; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Usta Ilker, 2005, Maderas, Cienc. tecnol., V7, P121, DOI 10.4067/S0718-221X2005000200006; Usta I., 2004, P IRG ANN M 2004 JUN; Vidondo, 2014, 4 NATL FOREST INVENT; Vlassenbroeck J, 2007, NUCL INSTRUM METH A, V580, P442, DOI 10.1016/j.nima.2007.05.073; Xue W, 2014, P IRG ANN M 2014 MAY; Xue W, 2015, HOLZFORSCHUNG, V69, P509, DOI 10.1515/hf-2014-0128	44	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163124	10.1371/journal.pone.0163124	http://dx.doi.org/10.1371/journal.pone.0163124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649315	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100056
J	Gill, C; van de Wijgert, JHHM; Blow, F; Darby, AC				Gill, Christina; van de Wijgert, Janneke H. H. M.; Blow, Frances; Darby, Alistair C.			Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIOLYTIC AGENT; VAGINOSIS; WOMEN; HIV; ASSOCIATION; DIVERSITY; ALGORITHM; BIAS	Background Recent studies on the vaginal microbiota have employed molecular techniques such as 16S rRNA gene sequencing to describe the bacterial community as a whole. These techniques require the lysis of bacterial cells to release DNA before purification and PCR amplification of the 16S rRNA gene. Currently, methods for the lysis of bacterial cells are not standardised and there is potential for introducing bias into the results if some bacterial species are lysed less efficiently than others. This study aimed to compare the results of vaginal microbiota profiling using four different pretreatment methods for the lysis of bacterial samples (30 min of lysis with lysozyme, 16 hours of lysis with lysozyme, 60 min of lysis with a mixture of lysozyme, mutanolysin and lysostaphin and 30 min of lysis with lysozyme followed by bead beating) prior to chemical and enzyme-based DNA extraction with a commercial kit. Results After extraction, DNA yield did not significantly differ between methods with the exception of lysis with lysozyme combined with bead beating which produced significantly lower yields when compared to lysis with the enzyme cocktail or 30 min lysis with lysozyme only. However, this did not result in a statistically significant difference in the observed alpha diversity of samples. The beta diversity (Bray-Curtis dissimilarity) between different lysis methods was statistically significantly different, but this difference was small compared to differences between samples, and did not affect the grouping of samples with similar vaginal bacterial community structure by hierarchical clustering. Conclusions An understanding of how laboratory methods affect the results of microbiota studies is vital in order to accurately interpret the results and make valid comparisons between studies. Our results indicate that the choice of lysis method does not prevent the detection of effects relating to the type of vaginal bacterial community one of the main outcome measures of epidemiological studies. However, we recommend that the same method is used on all samples within a particular study.	[Gill, Christina; van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England; [Blow, Frances; Darby, Alistair C.] Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Blow, Frances; Darby, Alistair C.] Univ Liverpool, Ctr Genom Res, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England.	j.vandewijgert@liverpool.ac.uk	Darby, Alistair/I-6485-2012	Darby, Alistair/0000-0002-3786-6209; Gill, Christina/0000-0002-1714-1761; Blow, Frances/0000-0003-3064-5160; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Institute of Infection and Global Health, University of Liverpool	Institute of Infection and Global Health, University of Liverpool	This work was funded by the Institute of Infection and Global Health, University of Liverpool. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Abusleme L, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23990; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Brotman RM, 2014, J INFECT DIS, V210, P1723, DOI 10.1093/infdis/jiu330; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Delmont TO, 2013, BIOESSAYS, V35, P744, DOI 10.1002/bies.201200155; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faircloth B.C., 2014, FAIRCLOTH LAB SERAPU; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Hemme CL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01205; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang YE, 2015, MICROB ECOL, V69, P407, DOI 10.1007/s00248-014-0487-1; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jayaram A, 2014, PATHOG DIS, V72, P161, DOI 10.1111/2049-632X.12197; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mehta SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116894; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Oksanen J., 2019, VEGAN COMMUNITY ECOL; R Core Team, 2013, R LANG ENV STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROSENTHAL RS, 1982, INFECT IMMUN, V37, P826, DOI 10.1128/IAI.37.2.826-829.1982; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van den Heuvel RN, 2010, ENVIRON MICROBIOL, V12, P3264, DOI 10.1111/j.1462-2920.2010.02301.x; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Weng SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110152; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163148	10.1371/journal.pone.0163148	http://dx.doi.org/10.1371/journal.pone.0163148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643503	gold, Green Submitted, Green Published			2022-12-27	WOS:000383891900033
J	Sayah, MY; Chabir, R; Benyahia, H; Kandri, YR; Chahdi, FO; Touzani, H; Errachidi, F				Sayah, Mohamed Yassine; Chabir, Rachida; Benyahia, Hamid; Kandri, Youssef Rodi; Chahdi, Fouad Ouazzani; Touzani, Hanan; Errachidi, Faouzi			Yield, Esterification Degree and Molecular Weight Evaluation of Pectins Isolated from Orange and Grapefruit Peels under Different Conditions	PLOS ONE			English	Article							MODIFIED CITRUS PECTIN; RHEOLOGICAL PROPERTIES; EXTRACTION; VISCOSITY; ACID; FRUIT; MICROWAVE; GROWTH; SUGARS; CONFORMATION	Orange (Citrus sinensis) and grapefruit (Citrus paradise) peels were used as a source of pectin, which was extracted under different conditions. The peels are used under two states: fresh and residual (after essential oil extraction). Organic acid (citric acid) and mineral acid (sulfuric acid) were used in the pectin extraction. The aim of this study is the evaluation the effect of extraction conditions on pectin yield, degree of esterification "DE" and on molecular weight "Mw". Results showed that the pectin yield was higher using the residual peels. Moreover, both peels allow the obtainment of a high methoxyl pectin with DE >50%. The molecular weight was calculated using Mark-Houwink-Sakurada equation which describes its relationship with intrinsic viscosity. This later was determined using four equations; Huggins equation, kramer, Schulz-Blaschke and Martin equation. The molecular weight varied from 1.538x10(05) to 2.47x10(05) g/mol for grapefruit pectin and from 1.639x10(05) to 2.471x10(05) g/mol for orange pectin.	[Sayah, Mohamed Yassine; Kandri, Youssef Rodi; Chahdi, Fouad Ouazzani; Touzani, Hanan] Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Appl Organ Chem, Fes, Morocco; [Chabir, Rachida] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Lab Pathophysiol & Nutr, Fes, Morocco; [Benyahia, Hamid] INRA, Lab Ameliorat & Biotechnol Agrumes, Kenitra, Morocco; [Errachidi, Faouzi] Univ Hassan II Ain Chock, Fac Sci, Lab Physiol & Mol Genet, Casablanca, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University of Casablanca	Sayah, MY (corresponding author), Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Appl Organ Chem, Fes, Morocco.	mohamedyassine.sayah@usmba.ac.ma						Bagherian H, 2011, CHEM ENG PROCESS, V50, P1237, DOI 10.1016/j.cep.2011.08.002; BATISSE C, 1994, J FOOD SCI, V59, P389, DOI 10.1111/j.1365-2621.1994.tb06974.x; Brain C, 1985, US patents, Patent No. [4,532,143, 4532143]; Brown L, 1999, AM J CLIN NUTR, V69, P30; Chamberlain EK, 2000, FOOD HYDROCOLLOID, V14, P163, DOI 10.1016/S0268-005X(99)00063-6; Chen CH, 2006, BIOCHEM PHARMACOL, V72, P1001, DOI 10.1016/j.bcp.2006.07.001; CHEN TS, 1967, J COLLOID INTERF SCI, V25, P346, DOI 10.1016/0021-9797(67)90040-9; CHOU TD, 1987, J FOOD SCI, V52, P1658, DOI 10.1111/j.1365-2621.1987.tb05900.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eddy NO, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/254347; El Madani, 2014, INT J INNOV RES SCI, V03, P15658, DOI DOI 10.15680/IJIRSET.2014.0308078; Eliaz I, 2006, PHYTOTHER RES, V20, P859, DOI 10.1002/ptr.1953; Evageliou V, 2005, FOOD HYDROCOLLOID, V19, P1032, DOI 10.1016/j.foodhyd.2005.01.004; Fishman ML, 2003, BIOMACROMOLECULES, V4, P880, DOI 10.1021/bm020122e; Fishman ML, 2000, CARBOHYD RES, V323, P126; Guo XF, 2012, CARBOHYD POLYM, V88, P441, DOI 10.1016/j.carbpol.2011.12.026; HARDING SE, 1991, CARBOHYD POLYM, V16, P1, DOI 10.1016/0144-8617(91)90069-O; Higiro J, 2007, FOOD RES INT, V40, P435, DOI 10.1016/j.foodres.2006.02.002; HM Shekhar Pandharipande, 2012, ENG RES STUD; Hua X, 2015, FOOD HYDROCOLLOID, V44, P122, DOI 10.1016/j.foodhyd.2014.09.026; Hwang J, 1998, J FOOD SCI, V63, P10, DOI [10.1111/j.1365-2621.1998.tb17911.x, DOI 10.1111/J.1365-2621]; Iacomini M, 2005, FITOTERAPIA, V76, P676, DOI 10.1016/j.fitote.2005.08.017; Kanmani P., 2014, IRANICA J ENERGY ENV, V5, P303, DOI DOI 10.5829/IDOSI.IJEE.2014.05.03.10; Kar F, 1999, CARBOHYD POLYM, V40, P285, DOI 10.1016/S0144-8617(99)00063-6; Kar F, 1999, CARBOHYD POLYM, V40, P277, DOI 10.1016/S0144-8617(99)00062-4; KRATCHANOVA M, 1994, CARBOHYD POLYM, V25, P141, DOI 10.1016/0144-8617(94)90197-X; Kurita O, 2008, CARBOHYD POLYM, V74, P725, DOI 10.1016/j.carbpol.2008.04.033; Kuuva T, 2003, FOOD HYDROCOLLOID, V17, P679, DOI 10.1016/S0268-005X(03)00034-1; Lapasin R., 1995, RHEOLOGY IND POLYSAC, P134, DOI DOI 10.1007/978-1-4615-2185-3_2; Liu Y, 2002, J SCI FOOD AGR, V82, P469, DOI 10.1002/jsfa.1037; Liu Y, 2001, J AGR FOOD CHEM, V49, P3051, DOI 10.1021/jf001020n; Methacanon P, 2014, FOOD HYDROCOLLOID, V35, P383, DOI 10.1016/j.foodhyd.2013.06.018; Minjares-Fuentes R, 2014, CARBOHYD POLYM, V106, P179, DOI 10.1016/j.carbpol.2014.02.013; Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4; Morris GA, 2000, FOOD HYDROCOLLOID, V14, P227, DOI 10.1016/S0268-005X(00)00007-2; Morris GA, 2008, FOOD HYDROCOLLOID, V22, P1435, DOI 10.1016/j.foodhyd.2007.09.005; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2002, TRENDS MOL MED, V8, P187, DOI 10.1016/S1471-4914(02)02295-5; Niture S. K., 2013, American Journal of Pharmacology and Toxicology, V8, P9; PANCHEV I, 1988, INT J FOOD SCI TECH, V23, P337; PHATAK L, 1988, J FOOD SCI, V53, P830, DOI 10.1111/j.1365-2621.1988.tb08964.x; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Popov SV, 1999, INT J IMMUNOPHARMACO, V21, P617, DOI 10.1016/S0192-0561(99)00032-6; Ralet MC, 2001, CARBOHYD RES, V336, P117, DOI 10.1016/S0008-6215(01)00248-8; Rao DG, 1993, J FOOD SCI TECHNOLOG, P66; Rlcxiillan DE, 1974, COMP 5 METHODS OBTAI, V13, P1367; Ross-Murphy S.B., 1994, PHYS TECHNIQUES STUD, DOI [10.1007/978-1-4615-2101-3, DOI 10.1007/978-1-4615-2101-3]; SABIR MA, 1976, J AGR FOOD CHEM, V24, P348, DOI 10.1021/jf60204a049; Santos JDG, 2013, CARBOHYD POLYM, V92, P1997, DOI 10.1016/j.carbpol.2012.11.089; Sayah M. Y., 2014, International Journal of Innovation and Applied Studies, V7, P1642; SMIDSROD O, 1971, BIOPOLYMERS, V10, P1213, DOI 10.1002/bip.360100711; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Wai WW, 2010, FOOD BIOPROD PROCESS, V88, P209, DOI 10.1016/j.fbp.2010.01.010; Wanchoo RK, 2003, EUR POLYM J, V39, P1481, DOI 10.1016/S0014-3057(02)00386-5; Wang XS, 2005, CARBOHYD POLYM, V60, P95, DOI 10.1016/j.carbpol.2004.11.031; Yapo BM, 2009, J AGR FOOD CHEM, V57, P1572, DOI 10.1021/jf802969m; Yoo SH, 2006, FOOD HYDROCOLLOID, V20, P62, DOI 10.1016/j.foodhyd.2005.03.003; Zhou JH, 2008, J CENT SOUTH UNIV T, V15, P520, DOI 10.1007/s11771-008-0413-0	58	59	60	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0161751	10.1371/journal.pone.0161751	http://dx.doi.org/10.1371/journal.pone.0161751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644093	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900004
J	Ceppi, F; Duval, M; Leclerc, JM; Laverdiere, C; Delva, YL; Cellot, S; Teira, P; Bittencourt, H				Ceppi, Francesco; Duval, Michel; Leclerc, Jean-Marie; Laverdiere, Caroline; Delva, Yves-Line; Cellot, Sonia; Teira, Pierre; Bittencourt, Henrique			Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ONCOLOGY-GROUP; MARROW RELAPSE; REMISSION; CHEMOTHERAPY; RESISTANCE; THERAPY	Relapsed/refractory acute lymphoblastic leukemia (ALL) is a leading cause of death by cancer in children. Our institution has switched relapse treatment strategy to improve survival. We reviewed records of first relapse/refractory childhood ALL between 1996 and 2012. Based on length of first remission, relapse site and immunophenotype, patients were classified into two groups: standard-risk relapse (SRR) and high-risk relapse and refractory (HRRR). Before 2007, all patients were uniformly treated with the same induction as at presentation, followed by hematopoietic stem cell transplantation (HSCT). Since 2007, treatment was given according to risk of failure: SRR were mostly treated with chemotherapy; HRRR patients underwent HSCT after intensive chemotherapy, aiming reduction of pre-transplant disease burden. Sixty-four patients were included. Thirty (47%) were SRR and 34 (53%) HRRR, including 11 with refractory ALL. Five-years overall survival (OS) and event-free survival (EFS) were similar for SRR, but were significantly higher with new risk-based strategy for HRRR: 56% versus 17% (P = 0.03) for OS, and 56% vs 11% for EFS (P = 0.008), respectively. In multivariate analysis, treatment strategy was significantly associated with survival. In conclusion, change for a risk-based strategy in our institution increased survival of high-risk patients to levels similar of those of standard-risk patients.	[Ceppi, Francesco; Duval, Michel; Leclerc, Jean-Marie; Laverdiere, Caroline; Delva, Yves-Line; Cellot, Sonia; Teira, Pierre; Bittencourt, Henrique] Univ Montreal, CHU Ste Justine, Charles Bruneau Canc Res Ctr, Hematooncol Div,Dept Pediat, Montreal, PQ, Canada	Universite de Montreal	Bittencourt, H (corresponding author), Univ Montreal, CHU Ste Justine, Charles Bruneau Canc Res Ctr, Hematooncol Div,Dept Pediat, Montreal, PQ, Canada.	henrique.bittencourt.hsj@ssss.gouv.qc.ca		Ceppi, Francesco/0000-0002-9665-3190				Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Coustan-Smith E, 2004, LEUKEMIA, V18, P499, DOI 10.1038/sj.leu.2403283; Dalle JH, 2005, J PEDIAT HEMATOL ONC, V27, P73, DOI 10.1097/01.mph.0000152860.97998.32; Domenech C, 2008, EUR J CANCER, V44, P2461, DOI 10.1016/j.ejca.2008.08.007; Duval M, 2010, J CLIN ONCOL, V28, P3730, DOI 10.1200/JCO.2010.28.8852; Eapen M, 2006, BLOOD, V107, P4961, DOI 10.1182/blood-2005-12-4942; Eckert C, 2001, LANCET, V358, P1239, DOI 10.1016/S0140-6736(01)06355-3; Gaynon PS, 2006, J CLIN ONCOL, V24, P3150, DOI 10.1200/JCO.2005.04.5856; Goulden N, 2002, BEST PRACT RES CL HA, V15, P59, DOI 10.1053/beha.2002.0185; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; KLUMPER E, 1995, BRIT J CANCER, V71, P1188, DOI 10.1038/bjc.1995.231; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Lee DW, 2012, CLIN CANCER RES, V18, P2780, DOI 10.1158/1078-0432.CCR-11-1920; Leung W, 2011, BRIT J HAEMATOL, V155, P14, DOI 10.1111/j.1365-2141.2011.08823.x; Lew G, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.684.684; Loh ML, 2013, BLOOD, V121, P485, DOI 10.1182/blood-2012-04-422691; Mateos MK, 2013, PEDIATR BLOOD CANCER, V60, P1520, DOI 10.1002/pbc.24559; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; Ruggeri A, 2012, LEUKEMIA, V26, P2455, DOI 10.1038/leu.2012.123; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; van den Berg H, 2011, PEDIATR BLOOD CANCER, V57, P210, DOI 10.1002/pbc.22946; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Weston BW, 2013, J CLIN ONCOL, V31, pE413, DOI 10.1200/JCO.2012.47.6770	33	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160310	10.1371/journal.pone.0160310	http://dx.doi.org/10.1371/journal.pone.0160310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632202	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900006
J	Rathod, SD; De Silva, MJ; Ssebunnya, J; Breuer, E; Murhar, V; Luitel, NP; Medhin, G; Kigozi, F; Shidhaye, R; Fekadu, A; Jordans, M; Patel, V; Tomlinson, M; Lund, C				Rathod, Sujit D.; De Silva, Mary J.; Ssebunnya, Joshua; Breuer, Erica; Murhar, Vaibhav; Luitel, Nagendra P.; Medhin, Girmay; Kigozi, Fred; Shidhaye, Rahul; Fekadu, Abebaw; Jordans, Mark; Patel, Vikram; Tomlinson, Mark; Lund, Crick			Treatment Contact Coverage for Probable Depressive and Probable Alcohol Use Disorders in Four Low- and Middle-Income Country Districts: The PRIME Cross-Sectional Community Surveys	PLOS ONE			English	Article							MENTAL-DISORDERS; PSYCHOMETRIC PROPERTIES; IDENTIFICATION TEST; PREVALENCE; SEVERITY; VALIDITY; PHQ-9; CARE	Context A robust evidence base is now emerging that indicates that treatment for depression and alcohol use disorders (AUD) delivered in low and middle-income countries (LMIC) can be effective. However, the coverage of services for these conditions in most LMIC settings remains unknown. Objective To describe the methods of a repeat cross-sectional survey to determine changes in treatment contact coverage for probable depression and for probable AUD in four LMIC districts, and to present the baseline findings regarding treatment contact coverage. Methods Population-based cross-sectional surveys with structured questionnaires, which included validated screening tools to identify probable cases. We defined contact coverage as being the proportion of cases who sought professional help in the past 12 months. Setting Sodo District, Ethiopia; Sehore District, India; Chitwan District, Nepal; and Kamuli District, Uganda Participants 8036 adults residing in these districts between May 2013 and May 2014 Main Outcome Measures Treatment contact coverage was defined as having sought care from a specialist, generalist, or other health care provider for symptoms related to depression or AUD. Results The proportion of adults who screened positive for depression over the past 12 months ranged from 11.2% in Nepal to 29.7% in India and treatment contact coverage over the past 12 months ranged between 8.1% in Nepal to 23.5% in India. In Ethiopia, lifetime contact coverage for probable depression was 23.7%. The proportion of adults who screened positive for AUD over the past 12 months ranged from 1.7% in Uganda to 13.9% in Ethiopia and treatment contact coverage over the past 12 months ranged from 2.8% in India to 5.1% in Nepal. In Ethiopia, lifetime contact coverage for probable AUD was 13.1%. Conclusions Our findings are consistent with and contribute to the limited evidence base which indicates low treatment contact coverage for depression and for AUD in LMIC. The planned follow up surveys will be used to estimate the change in contact coverage coinciding with the implementation of district-level mental health care plans.	[Rathod, Sujit D.; De Silva, Mary J.; Patel, Vikram] London Sch Hyg & Trop Med, Dept Populat Hlth, Ctr Global Mental Hlth, London, England; [Ssebunnya, Joshua; Kigozi, Fred] Makerere Univ, Butabika Natl Referral & Teaching Hosp, Kampala, Uganda; [Breuer, Erica; Tomlinson, Mark; Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Cape Town, South Africa; [Murhar, Vaibhav; Patel, Vikram] Sangath, Bhopal, India; [Luitel, Nagendra P.] Transcultural Psychosocial Org TPO Nepal, Kathmandu, Nepal; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Shidhaye, Rahul; Patel, Vikram] Publ Hlth Fdn India, Ctr Mental Hlth, New Delhi, India; [Shidhaye, Rahul] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Fekadu, Abebaw] Univ Addis Ababa, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Kings Coll London, Ctr Affect Disorders, London, England; [Fekadu, Abebaw] Kings Coll London, Inst Psychiat Psychol & Neurosci, Affect Disorders Res Grp, London, England; [Jordans, Mark] HealthNet TPO Amsterdam, Dept Res & Dev, Amsterdam, Netherlands; [Jordans, Mark; Lund, Crick] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London, England; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Alan J Flisher Ctr Publ Mental Hlth, Stellenbosch, South Africa	University of London; London School of Hygiene & Tropical Medicine; Makerere University; University of Cape Town; Addis Ababa University; Public Health Foundation of India; Maastricht University; Addis Ababa University; University of London; King's College London; University of London; King's College London; University of London; King's College London; Stellenbosch University	Rathod, SD (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, Ctr Global Mental Hlth, London, England.	sujit.rathod@lshtm.ac.uk	Shidhaye, Rahul/I-1329-2019; Rathod, Sujit D/M-9298-2014	Shidhaye, Rahul/0000-0001-9365-7164; Rathod, Sujit D/0000-0001-8783-7724; Medhin, Girmay/0000-0003-2146-4261; Breuer, Erica/0000-0003-0952-6650; Lund, Crick/0000-0002-5159-8220; Murhar, Vaibhav/0000-0002-1028-0363; Wassie, Abebaw Fekadu/0000-0003-2219-0952	UK aid from the UK Government; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017104] Funding Source: NIH RePORTER; Department for International Development (DFID) [201446] Funding Source: researchfish	UK aid from the UK Government(CGIAR); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department for International Development (DFID)	This study is an output of the PRogramme for Improving Mental health carE (PRIME). The material has been funded by UK aid from the UK Government, however the views expressed do not necessarily reflect the UK Government's official policies. The financial assistance of the South Africa National Research Foundation (NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at, are those of the authors and are not necessarily to be attributed to the NRF (URL: http://r4d.dfid.gov.uk/Project/60851/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Beecham J., 2001, MEASURING MENTAL HLT, P200; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Bennett LA, 1998, ALCOHOL HEALTH RES W, V22, P243; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Bohra P, 2009, INT MIGR REV, V43, P621, DOI 10.1111/j.1747-7379.2009.00779.x; Breuer E, 2016, BRIT J PSYCHIAT, V208, pS55, DOI 10.1192/bjp.bp.114.153841; Central Bureau of Statistics, 2011, NPHC2011 GOV NEP CEN; De Silva MJ, 2016, BRIT J PSYCHIAT, V208, pS63, DOI 10.1192/bjp.bp.114.153858; De Silva MJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-267; De Silva MJ, 2014, INT J EPIDEMIOL, V43, P341, DOI 10.1093/ije/dyt191; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Desjarlais R., 1996, WORLD MENTAL HLTH PR; Evans-Lacko S, 2011, EPIDEMIOL PSYCH SCI, V20, P263, DOI 10.1017/S2045796011000308; Evans-Lacko S, 2010, CAN J PSYCHIAT, V55, P440, DOI 10.1177/070674371005500707; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hanlon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088437; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Jordans MJD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-332; Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004; Kohrt BA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0768-y; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Lund C, 2016, BRIT J PSYCHIAT, V208, pS1, DOI 10.1192/bjp.bp.114.153668; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Nakku E, 2016, GLOB MENT HEALTH, DOI [10.1017/gmh.2026.14, DOI 10.1017/GMH.2026.14]; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sinha S., 2014, DISTRICT CENSUS H 24; StataCorp, 2013, STATA STAT SOFTW REL; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Ustun B., 2010, MEASURING HLTH DISAB; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 1991, TRAIN MIDL MAN EPI C	46	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162038	10.1371/journal.pone.0162038	http://dx.doi.org/10.1371/journal.pone.0162038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632166	Green Accepted, Green Published, gold			2022-12-27	WOS:000383706900025
J	te Molder, M; de Hoog, MLA; Uiterwaal, CSPM; van der Ent, CK; Smit, HA; Schilder, AGM; Damoiseaux, RAMJ; Venekamp, RP				te Molder, Marthe; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; van der Ent, Cornelis K.; Smit, Henriette A.; Schilder, Anne G. M.; Damoiseaux, Roger A. M. J.; Venekamp, Roderick P.			Antibiotic Treatment for First Episode of Acute Otitis Media Is Not Associated with Future Recurrences	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONTROLLED-TRIAL; PRIMARY-CARE; CHILDREN; COHORT; THERAPY; CONSULTATIONS; MASTOIDITIS	Objective Antibiotic treatment of acute otitis media (AOM) has been suggested to increase the risk of future AOM episodes by causing unfavorable shifts in microbial flora. Because current evidence on this topic is inconclusive and long-term follow-up data are scarce, we wanted to estimate the effect of antibiotic treatment for a first AOM episode occurring during infancy on AOM recurrences and AOM-related health care utilization later in life. Methods We obtained demographic information and risk factors from data of the Wheezing Illnesses Study Leidsche Rijn, a prospective birth cohort study in which all healthy newborns born in Leidsche Rijn (between 2001 and 2012), The Netherlands, were enrolled. These data were linked to children's primary care electronic health records up to the age of four. Children with at least one family physician-diagnosed AOM episode before the age of two were included in analyses. The exposure of interest was the prescription of oral antibiotics (yes vs no) for a child's first AOM episode before the age of two years. Results 848 children were included in analyses and 512 (60%) children were prescribed antibiotics for their first AOM episode. Antibiotic treatmentwas not associated with an increased risk of total AOM recurrences (adjusted rate ratio: 0.94, 95% CI: 0.78-1.13), recurrent AOM (>= 3 episodes in 6 months or >= 4 in one year; adjusted risk ratio: 0.79, 95% CI: 0.57-1.11), or with increased AOM-related health care utilization during children's first four years of life. Conclusions Oral antibiotic treatment of a first AOM episode occurring during infancy does not affect the number of AOM recurrences and AOM-related health care utilization later in life. This information can be used when weighing the pros and cons of various AOM treatment options.	[te Molder, Marthe; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; Smit, Henriette A.; Schilder, Anne G. M.; Damoiseaux, Roger A. M. J.; Venekamp, Roderick P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [Schilder, Anne G. M.; Venekamp, Roderick P.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Utrecht, Netherlands; [Schilder, Anne G. M.] UCL, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of London; University College London	de Hoog, MLA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	M.L.A.deHoog@umcutrecht.nl		Schilder, Anne/0000-0002-5496-4580; Van der Ent, Cornelis/0000-0002-2501-4121; Damoiseaux, Roger/0000-0001-8052-0302; Venekamp, Roderick P/0000-0002-1446-9614	Netherlands Organization for Health Research and Development (ZonMw) [20010101322]; University Medical Center Utrecht; GlaxoSmithKline, The Netherlands; National Institute for Health Research (NIHR); National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The WHISTLER-project was supported by grants from The Netherlands Organization for Health Research and Development (ZonMw; Grant No.: 20010101322), by the University Medical Center Utrecht, and by an unrestricted grant from GlaxoSmithKline, The Netherlands. The evidENT team at UCL, United Kingdom, is supported by a National Institute for Health Research (NIHR), Research Professorship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman AE, 2005, BRIT J GEN PRACT, V55, P114; American Academy of Pediatrics American Academy of Family Physicians, 2013, PEDIATRICS, V131, P964; Bakaletz LO, 2012, PAEDIATR RESPIR REV, V13, P154, DOI 10.1016/j.prrv.2012.03.001; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; Bezakova N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2525; Brook I, 2005, J MED MICROBIOL, V54, P83, DOI 10.1099/jmm.0.45819-0; Cohen R, 1997, PEDIATR INFECT DIS J, V16, P555, DOI 10.1097/00006454-199706000-00004; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Damoiseaux RAMJ, 2006, FAM PRACT, V23, P40, DOI 10.1093/fampra/cmi083; Damoiseaux RAMJ, 2014, HUISARTS WET, V57, P648; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fortanier AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121572; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Ghaffar F, 2002, CLIN INFECT DIS, V34, P1301, DOI 10.1086/340054; Grossman Z, 2016, PEDIATR INFECT DIS J, V35, P162, DOI 10.1097/INF.0000000000000951; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hoppe JE, 1999, PEDIATR INFECT DIS J, V18, P1085, DOI 10.1097/00006454-199912000-00012; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Rovers MM, 2008, FAM PRACT, V25, P233, DOI 10.1093/fampra/cmn030; Rubin DB, 2004, MULTIPLE IMPUTATION; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; Thompson PL, 2009, PEDIATRICS, V123, P424, DOI 10.1542/peds.2007-3349; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; Venekamp RP, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000219.pub4, 10.1002/14651858.CD000219.pub3]; Williamson I, 2006, BRIT J GEN PRACT, V56, P170; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160560	10.1371/journal.pone.0160560	http://dx.doi.org/10.1371/journal.pone.0160560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632355	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900007
J	Kolonko, M; Ozga, K; Holubowicz, R; Taube, M; Kozak, M; Ozyhar, A; Greb-Markiewicz, B				Kolonko, Marta; Ozga, Katarzyna; Holubowicz, Rafal; Taube, Michal; Kozak, Maciej; Ozyhar, Andrzej; Greb-Markiewicz, Beata			Intrinsic Disorder of the C-Terminal Domain of Drosophila Methoprene-Tolerant Protein	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; CIRCULAR-DICHROISM SPECTRA; JUVENILE-HORMONE RECEPTOR; BHLH-PAS FAMILY; BINDING; FTZ-F1; MET; ULTRACENTRIFUGATION; MACROMOLECULES; ACTIVATION	Methoprene tolerant protein (Met) has recently been confirmed as the long-sought juvenile hormone (JH) receptor. This protein plays a significant role in the cross-talk of the 20-hydroxyecdysone (20E) and JH signalling pathways, which are important for control of insect development and maturation. Met belongs to the basic helix-loop-helix/Per-Arnt-Sim (bHLH-PAS) family of transcription factors. In these proteins, bHLH domains are typically responsible for DNA binding and dimerization, whereas the PAS domains are crucial for the choice of dimerization partner and the specificity of target gene activation. The C-terminal region is usually responsible for the regulation of protein complex activity. The sequence of the Met C-terminal region (MetC) is not homologous to any sequence deposited in the Protein Data Bank (PDB) and has not been structurally characterized to date. In this study, we show that the MetC exhibits properties typical for an intrinsically disordered protein (IDP). The final averaged structure obtained with small angle X-ray scattering (SAXS) experiments indicates that intrinsically disordered MetC exists in an extended conformation. This extended shape and the long unfolded regions characterise proteins with high flexibility and dynamics. Therefore, we suggest that the multiplicity of conformations adopted by the disordered MetC is crucial for its activity as a biological switch modulating the cross-talk of different signalling pathways in insects.	[Kolonko, Marta; Ozga, Katarzyna; Holubowicz, Rafal; Ozyhar, Andrzej; Greb-Markiewicz, Beata] Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Taube, Michal; Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Joint Lab SAXS Studies, Umultowska 85, PL-61614 Poznan, Poland; [Kozak, Maciej] Adam Mickiewicz Univ, Dept Macromol Phys, Fac Phys, Umultowska 85, PL-61614 Poznan, Poland	Wroclaw University of Science & Technology; Adam Mickiewicz University; Adam Mickiewicz University	Greb-Markiewicz, B (corresponding author), Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	beata.greb-markiewicz@pwr.edu.pl	Greb-Markiewicz, Beata/AAB-5246-2020; Holubowicz, Rafal/AAB-7552-2020; Ozga, Katarzyna/O-1156-2017	Greb-Markiewicz, Beata/0000-0002-2831-439X; Holubowicz, Rafal/0000-0002-2555-2069; Taube, Michal/0000-0002-8876-929X; Ozga, Katarzyna/0000-0002-4936-2278; Ozga, Katarzyna/0000-0002-2837-283X; OZYHAR, Andrzej/0000-0002-5874-784X; Kozak, Maciej/0000-0003-3312-6518; Kolonko, Marta/0000-0003-4153-3391	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Technology	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Technology	This work and publication were supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018. This work was supported by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Technology.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; AYER S, 1992, MOL CELL BIOL, V12, P661, DOI 10.1128/MCB.12.2.661; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bernado A P, 2012, ROYAL SOC CHEM, V8, P151, DOI [10.1039/c1mb05275f, DOI 10.1039/C1MB05275F]; Bernado P., 2010, INSTRUMENTAL ANAL IN, P451; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bernardo Travis J., 2012, Insects, V3, P324, DOI 10.3390/insects3010324; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brewer AK, 2011, ANALYST, V136, P515, DOI 10.1039/c0an00738b; Brunelle JL, 2014, METHOD ENZYMOL, V541, P151, DOI 10.1016/B978-0-12-420119-4.00012-4; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Greb-Markiewicz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133307; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; HOLZWARTH G, 1965, J AM CHEM SOC, V87, P218, DOI 10.1021/ja01080a015; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]; McDowell GS, 2014, BMC BIOCHEM, V15, DOI 10.1186/s12858-014-0024-3; Michael A.K., 2013, OA BIOCH, V1, P16, DOI [10.13172/2052-9651-1-2-1123, DOI 10.13172/2052-9651-1-2-1123]; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Permyakov SE, 2003, PROTEINS, V53, P855, DOI 10.1002/prot.10481; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sultan ARS, 2014, DEV GROWTH DIFFER, V56, P245, DOI 10.1111/dgd.12125; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2009, STRUCTURE FUNCTION I; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	89	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162950	10.1371/journal.pone.0162950	http://dx.doi.org/10.1371/journal.pone.0162950			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657508	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200044
J	Moisset, X; Calbacho, V; Torres, P; Gremeau-Richard, C; Dallel, R				Moisset, Xavier; Calbacho, Valentina; Torres, Pilar; Gremeau-Richard, Christelle; Dallel, Radhouane			Co-occurrence of Pain Symptoms and Somatosensory Sensitivity in Burning Mouth Syndrome: A Systematic Review	PLOS ONE			English	Review							IDIOPATHIC OROFACIAL PAIN; TEMPOROMANDIBULAR DISORDERS; GENERAL-POPULATION; PREVALENCE; FIBROMYALGIA; STIMULATION; DYSFUNCTION; THRESHOLDS; VULVODYNIA; MECHANISMS	Background Burning mouth syndrome (BMS) is a chronic and spontaneous oral pain with burning quality in the tongue or other oral mucosa without any identifiable oral lesion or laboratory finding. Pathogenesis and etiology of BMS are still unknown. However, BMS has been associated with other chronic pain syndromes including other idiopathic orofacial pain, the dynias group and the family of central sensitivity syndromes. This would imply that BMS shares common mechanisms with other cephalic and/or extracephalic chronic pains. The primary aim of this systematic review was to determine whether BMS is actually associated with other pain syndromes, and to analyze cephalic and extracephalic somatosensory sensitivity in these patients. Methods This report followed the PRISMA Statement. An electronic search was performed until January 2015 in PubMed, Cochrane library, Wiley and ScienceDirect. Searched terms included "burning mouth syndrome OR stomatodynia OR glossodynia OR burning tongue OR oral burning". Studies were selected according to predefined inclusion criteria (report of an association between BMS and other pain(s) symptoms or of cutaneous cephalic and/or extracephalic quantitative sensory testing in BMS patients), and a descriptive analysis conducted. Results The search retrieved 1512 reports. Out of these, twelve articles met criteria for co-occurring pain symptoms and nine studies for quantitative sensory testing (QST) in BMS patients. The analysis reveals that in BMS patients co-occurring pain symptoms are rare, assessed by only 0.8% (12 of 1512) of the retrieved studies. BMS was associated with headaches, TMD, atypical facial pain, trigeminal neuralgia, post-herpetic facial pain, back pain, fibromyalgia, joint pain, abdominal pain, rectal pain or vulvodynia. However, the prevalence of pain symptoms in BMS patients is not different from that in the age-matched general population. QST studies reveal no or inconsistent evidence of abnormal cutaneous cephalic and extracephalic somatosensory sensitivity. Conclusions There is no evidence for a high rate of other pain symptoms or somatosensory impairments co-occurring with BMS. These results thus suggest that BMS rather depends on specific mechanisms, likely at the trigeminal level. Nevertheless, more thoroughly conducted research is required to draw definitive conclusion.	[Moisset, Xavier; Gremeau-Richard, Christelle; Dallel, Radhouane] Univ Auvergne, Clermont Univ, Neurodol, Clermont Ferrand, France; [Moisset, Xavier; Gremeau-Richard, Christelle; Dallel, Radhouane] Inserm U1107, Clermont Ferrand, France; [Gremeau-Richard, Christelle; Dallel, Radhouane] CHU Clermont Ferrand, Serv Odontol, Clermont Ferrand, France; [Moisset, Xavier] CHU Clermont Ferrand, Serv Neurol, Clermont Ferrand, France; [Calbacho, Valentina; Torres, Pilar] Univ San Sebastian, Fac Odontol, Santiago, Chile	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; CHU Clermont Ferrand; Universidad San Sebastian	Dallel, R (corresponding author), Univ Auvergne, Clermont Univ, Neurodol, Clermont Ferrand, France.; Dallel, R (corresponding author), Inserm U1107, Clermont Ferrand, France.; Dallel, R (corresponding author), CHU Clermont Ferrand, Serv Odontol, Clermont Ferrand, France.	radhouane.dallel@udamail.fr	Moisset, Xavier/H-2862-2019; Dallel, Radhouane/W-4599-2017	Moisset, Xavier/0000-0002-8799-0750; Dallel, Radhouane/0000-0001-7494-116X; , Gremeau-Richard/0000-0003-4654-7290	Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Clermont 1 (France); Facultad De Odontologia, Universidad San Sebast ian, Santiago (Chile)	Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Clermont 1 (France); Facultad De Odontologia, Universidad San Sebast ian, Santiago (Chile)	This work was supported by funding from Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Clermont 1 (France) and Facultad De Odontologia, Universidad San Sebast ian, Santiago (Chile).	Albuquerque RJC, 2006, PAIN, V122, P223, DOI 10.1016/j.pain.2006.01.020; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; Bartoshuk LM, 2005, CHEM SENSES, V30, pI218, DOI 10.1093/chemse/bjh192; Bennett G, 2002, BEST PRACT RES CL GA, V16, P63, DOI 10.1053/bega.2001.0266; BERGDAHL J, 1994, SCAND J DENT RES, V102, P299; Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Clauw DJ, 2003, BEST PRACT RES CL RH, V17, P685, DOI 10.1016/S1521-6942(03)00035-4; Corsalini M, 2013, INT J MED SCI, V10, P1784, DOI 10.7150/ijms.6327; da Silva LA, 2014, ORAL DIS, V20, pe103, DOI 10.1111/odi.12145; de Siqueira SRDT, 2013, OR SURG OR MED OR PA, V115, pE37, DOI 10.1016/j.oooo.2013.02.014; DEKANTER RJAM, 1993, J DENT RES, V72, P1509, DOI 10.1177/00220345930720110901; ELI I, 1994, J DENT RES, V73, P567, DOI 10.1177/00220345940730021301; Eliav E, 2007, J AM DENT ASSOC, V138, P628, DOI 10.14219/jada.archive.2007.0234; Forssell H, 2015, J ORAL REHABIL, V42, P300, DOI 10.1111/joor.12256; Forssell H, 2002, PAIN, V99, P41, DOI 10.1016/S0304-3959(02)00052-0; Forssell H, 2012, J OROFAC PAIN, V26, P117; Gesch D, 2004, QUINTESSENCE INT, V35, P143; Netto FOG, 2011, CLIN ORAL INVEST, V15, P571, DOI 10.1007/s00784-010-0419-5; Granot M, 2005, J PAIN, V6, P581, DOI 10.1016/j.jpain.2005.03.010; Gremeau-Richard C, 2010, PAIN, V149, P27, DOI 10.1016/j.pain.2009.11.016; GRUSHKA M, 1987, PAIN, V28, P169, DOI 10.1016/0304-3959(87)90114-X; GRUSHKA M, 1987, ORAL SURG ORAL MED O, V63, P30, DOI 10.1016/0030-4220(87)90336-7; Grushka M, 1984, PAIN; Hakeberg M, 1997, EUR J ORAL SCI, V105, P539, DOI 10.1111/j.1600-0722.1997.tb00214.x; Harlow BL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.033; Ito M, 2002, PSYCHIAT CLIN NEUROS, V56, P161, DOI 10.1046/j.1440-1819.2002.00950.x; Jaaskelainen SK, 2012, CLIN NEUROPHYSIOL, V123, P71, DOI 10.1016/j.clinph.2011.07.054; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kaplan I, 2011, SKIN RES TECHNOL, V17, P196, DOI 10.1111/j.1600-0846.2010.00483.x; Kohorst JJ, 2015, BRIT J DERMATOL, V172, P1654, DOI 10.1111/bjd.13613; Kutscher A, 1952, NEW YORK STATE DENT, P31; Lamey PJ, 2005, ORAL SURG ORAL MED O, V99, P48, DOI 10.1016/j.tripleo.2004.01.021; Lamey PJ, 1996, J ORAL PATHOL MED, V25, P420, DOI 10.1111/j.1600-0714.1996.tb00290.x; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mignogna MD, 2011, J OROFAC PAIN, V25, P131; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nasri C, 2007, CLINICS, V62, P561, DOI 10.1590/S1807-59322007000500005; Nguyen RHN, 2013, J PAIN RES, V6, P303, DOI 10.2147/JPR.S42940; Pokupec-Gruden JS, 2000, COLLEGIUM ANTROPOL, V24, P119; Reed BD, 2012, OBSTET GYNECOL, V120, P145, DOI 10.1097/AOG.0b013e31825957cf; Savage NW, 1996, AUST DENT J, V41, P363, DOI 10.1111/j.1834-7819.1996.tb06019.x; Siviero M, 2011, CLINICS, V66, P509, DOI 10.1590/S1807-59322011000300026; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; SVENSSON P, 1993, CLIN J PAIN, V9, P207, DOI 10.1097/00002508-199309000-00009; Thorstensson B, 1996, ACTA ODONTOL SCAND, V54, P257, DOI 10.3109/00016359609003534; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wesselmann U, 1996, SEMIN NEUROL, V16, P63, DOI 10.1055/s-2008-1040961; Woda A, 1998, J OROFAC PAIN, V12, P272; Woda A, 1999, J OROFAC PAIN, V13, P172; Woda A, 2009, J OROFAC PAIN, V23, P202; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003; Yunus MB, 2015, CURR RHEUMATOL REV, V11, P70, DOI 10.2174/157339711102150702112236; Zakrzewska JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002779.pub2; Zolnoun DA, 2008, CLIN J PAIN, V24, P187, DOI 10.1097/AJP.0b013e318159f976	56	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163449	10.1371/journal.pone.0163449	http://dx.doi.org/10.1371/journal.pone.0163449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657531	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200124
J	Nuzzio, KM; Watt, ED; Boettcher, JM; Gajsiewicz, JM; Morrissey, JH; Rienstra, CM				Nuzzio, Kristin M.; Watt, Eric D.; Boettcher, John M.; Gajsiewicz, Joshua M.; Morrissey, James H.; Rienstra, Chad M.			High-Resolution NMR Studies of Human Tissue Factor	PLOS ONE			English	Article							ANGLE-SPINNING NMR; SOLID-STATE; PROCOAGULANT ACTIVITY; EXTRACELLULAR DOMAIN; LARGE PROTEINS; VIIA COMPLEX; RESONANCE; PURIFICATION; SPECTROSCOPY; EXPRESSION	In normal hemostasis, the blood clotting cascade is initiated when factor VIIa (fVIIa, other clotting factors are named similarly) binds to the integral membrane protein, human tissue factor (TF). The TF/fVIIa complex in turn activates fX and fIX, eventually concluding with clot formation. Several X-ray crystal structures of the soluble extracellular domain of TF (sTF) exist; however, these structures are missing electron density in functionally relevant regions of the protein. In this context, NMR can provide complementary structural information as well as dynamic insights into enzyme activity. The resolution and sensitivity for NMR studies are greatly enhanced by the ability to prepare multiple milligrams of protein with various isotopic labeling patterns. Here, we demonstrate high-yield production of several isotopically labeled forms of recombinant sTF, allowing for high-resolution NMR studies both in the solid and solution state. We also report solution NMR spectra at sub-mM concentrations of sTF, ensuring the presence of dispersed monomer, as well as the first solid-state NMR spectra of sTF. Our improved sample preparation and precipitation conditions have enabled the acquisition of multidimensional NMR data sets for TF chemical shift assignment and provide a benchmark for TF structure elucidation.	[Nuzzio, Kristin M.; Watt, Eric D.; Boettcher, John M.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gajsiewicz, Joshua M.; Morrissey, James H.; Rienstra, Chad M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rienstra, CM (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Rienstra, CM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Rienstra, CM (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	rienstra@illinois.edu	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569; Watt, Eric/0000-0002-1211-0229	National Science Foundation; American Heart Association; National Institutes of Health [R01HL103999]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103999] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Science Foundation Graduate Research Fellowship to KMN; American Heart Association Postdoctoral Fellowship to EDW; National Institutes of Health Grant R01HL103999 to JHM and CMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Isotech Laboratories, Inc (JMB present affiliation) did not have any financial role in this work, and the work completed by JMB was performed at the University of Illinois at Urbana Champaign.	Boettcher JM, 2010, BIOMOL NMR ASSIGN, V4, P183, DOI 10.1007/s12104-010-9233-x; Butenas Saulius, 2012, Front Biosci (Elite Ed), V4, P381; Carlsson K, 2011, BIOCHEM BIOPH RES CO, V413, P545, DOI 10.1016/j.bbrc.2011.08.135; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gajsiewicz JM, 2015, BIOCHEMISTRY-US, V54, P4665, DOI 10.1021/acs.biochem.5b00608; Gao M, 2013, J AM CHEM SOC, V135, P15278, DOI 10.1021/ja407526s; Gardiennet C, 2012, ANGEW CHEM INT EDIT, V51, P7855, DOI 10.1002/anie.201200779; Goddard T. D., 2006, SPARKY; Han Y, 2010, J AM CHEM SOC, V132, P1976, DOI 10.1021/ja908687k; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Higman VA, 2009, J BIOMOL NMR, V44, P245, DOI 10.1007/s10858-009-9338-7; Huang MD, 1998, J MOL BIOL, V275, P873, DOI 10.1006/jmbi.1997.1512; Kothari H, 2013, J THROMB HAEMOST, V11, P2066, DOI 10.1111/jth.12407; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Morrissey JH, 2004, INT J HEMATOL, V79, P103, DOI 10.1532/IJH97.03167; MULLER YA, 1994, BIOCHEMISTRY-US, V33, P10864, DOI 10.1021/bi00202a003; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; RUF W, 1991, J BIOL CHEM, V266, P2158; Shi LC, 2009, BBA-BIOMEMBRANES, V1788, P2563, DOI 10.1016/j.bbamem.2009.09.011; Sperling LJ, 2010, J MOL BIOL, V399, P268, DOI 10.1016/j.jmb.2010.04.012; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; Stringer JA, 2005, J MAGN RESON, V173, P40, DOI 10.1016/j.jmr.2004.11.015; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163206	10.1371/journal.pone.0163206	http://dx.doi.org/10.1371/journal.pone.0163206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657719	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200085
J	Cuadrado, I; Castejon, B; Martin, AM; Saura, M; Reventun-Torralba, P; Zamorano, JL; Zaragoza, C				Cuadrado, Irene; Castejon, Borja; Martin, Ana M.; Saura, Marta; Reventun-Torralba, Paula; Luis Zamorano, Jose; Zaragoza, Carlos			Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes	PLOS ONE			English	Article							DIABETIC-RATS; CAVEOLIN-1; EXPRESSION; EMMPRIN; CD147; DYSFUNCTION; ACTIVATION; ISCHEMIA; RECEPTOR; ARTERY	Inhibition of Extracellular Matrix degradation by nitric oxide (NO) induces cardiac protection against coronary ischemia/reperfusion (IR). Glycosylation of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) stimulates enzymatic activation of matrix metalloproteinases (MMPs) in the heart, although the mechanisms leading to EMMPRIN glycosylation are poorly understood. We sought to determine if NO may induce cardiac protection by preventing glycosylation of EMMPRIN in a mouse model of IR. Here we found that Caveolin-3 binds to low glycosylated EMMPRIN (LG-EMMPRIN) in cardiac cells and in the hearts of healthy mice, whereas IR disrupted the complex in nitric oxide synthase 2 (NOS2) knockout (KO) mice. By contrast, the binding was partially restored when mice were fed with an NO donor (DEA-NO) in the drinking water, showing a significant reduction on infarct size (NOS2KO: 34.6 +/- 5 vs NOS2KO+DEA-NO:20.7 +/- 9), in expression of matrix metalloproteinases, and cardiac performance was improved (left ventricular ejection fraction (LVEF). NOS2KO: 31 +/- 4 vs NOS2KO+DEA-NO:46 +/- 6). The role of Caveolin-3/EMMPRIN in NO-mediated cardiac protection was further assayed in Caveolin-3 KO mice, showing no significant improvement on infarct size (Caveolin-3 KO:34.8 +/- 3 vs Caveolin-3 KO+DEA-NO:33.7 +/- 5), or in the expression of MMPs, suggesting that stabilization of the complex Caveolin-3/LG-EMMPRIN may play a significant role in the cardioprotective effect of NO against IR.	[Castejon, Borja; Martin, Ana M.; Zaragoza, Carlos] Univ Francisco Vitoria, Hosp Ramon y Cajal Res Unit IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain; [Cuadrado, Irene; Saura, Marta; Reventun-Torralba, Paula] Univ Alcala, Dept Syst Biol Physiol, Ctra Madrid Barcelona,Km 3,300, Madrid 28875, Spain; [Luis Zamorano, Jose] Univ Hosp Ramon y Cajal IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain	Universidad Francisco de Vitoria; Universidad de Alcala	Zaragoza, C (corresponding author), Univ Francisco Vitoria, Hosp Ramon y Cajal Res Unit IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain.	c.zaragoza.prof@ufv.es	Reventun, Paula/C-7764-2018; Reventun, Paula/AAK-9265-2020; Cuadrado-Berrocal, Irene/P-1360-2014; Cuadrado-Berrocal, Irene/AAZ-1917-2021; Zaragoza, Carlos/AAH-9275-2019	Reventun, Paula/0000-0002-6221-8780; Reventun, Paula/0000-0002-6221-8780; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Zaragoza, Carlos/0000-0002-1706-8592	Instituto de Salud Carlos III (Plan Estatal de I+D+i) [PI14/02022]; European Development Regional Fund "A way to achieve Europe'' (ERDF); Ministerio de Economia y Competitividad [SAF 2012-35141]	Instituto de Salud Carlos III (Plan Estatal de I+D+i); European Development Regional Fund "A way to achieve Europe'' (ERDF)(European Commission); Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016) PI14/02022, and cofinanced by the European Development Regional Fund "A way to achieve Europe'' (ERDF), and Ministerio de Economia y Competitividad SAF 2012-35141.	Chen DB, 2006, BIOL REPROD, V74, P832, DOI 10.1095/biolreprod.105.049700; Chen ZF, 2015, INT J CLIN EXP PATHO, V8, P4614; Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463; Horikawa YT, 2008, J MOL CELL CARDIOL, V44, P123, DOI 10.1016/j.yjmcc.2007.10.003; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu Y, 2015, CLIN SCI, V129, P331, DOI 10.1042/CS20140789; Lizarbe TR, 2008, FASEB J, V22, P3207, DOI 10.1096/fj.07-103804; Lizarbe TR, 2009, AM J PATHOL, V175, P1421, DOI 10.2353/ajpath.2009.080845; Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102; Matsunaga T, 2005, INT J CARDIOL, V105, P203, DOI 10.1016/j.ijcard.2005.01.011; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Rodriguez-Feo JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002612; Sangwung P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031564; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schmidt R, 2008, CIRC RES, V102, P302, DOI 10.1161/CIRCRESAHA.107.157990; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; Sellers SL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00280; Sturhan H, 2015, THROMB RES, V135, P1160, DOI 10.1016/j.thromres.2015.03.022; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tarin C, 2011, FREE RADICAL BIO MED, V51, P387, DOI 10.1016/j.freeradbiomed.2011.04.021; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Tsutsumi YM, 2010, ANESTHESIOLOGY, V112, P1136, DOI 10.1097/ALN.0b013e3181d3d624; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162912	10.1371/journal.pone.0162912	http://dx.doi.org/10.1371/journal.pone.0162912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649573	Green Published, gold			2022-12-27	WOS:000383892100042
J	Gong, YC; Ai, ZJ; Sun, X; Fu, BW				Gong, Yinchun; Ai, Zhijiu; Sun, Xu; Fu, Biwei			The Effects of Boundary Conditions and Friction on the Helical Buckling of Coiled Tubing in an Inclined Wellbore	PLOS ONE			English	Article							CYLINDER-IN-CYLINDER; HORIZONTAL CYLINDER; LOCK-UP; WELLS; BEHAVIOR	Analytical buckling models are important for down-hole operations to ensure the structural integrity of the drill string. A literature survey shows that most published analytical buckling models do not address the effects of inclination angle, boundary conditions or friction. The objective of this paper is to study the effects of boundary conditions, friction and angular inclination on the helical buckling of coiled tubing in an inclined wellbore. In this paper, a new theoretical model is established to describe the buckling behavior of coiled tubing. The buckling equations are derived by applying the principles of virtualwork and minimum potential energy. The proper solution for the post-buckling configuration is determined based on geometric and natural boundary conditions. The effects of angular inclination and boundary conditions on the helical buckling of coiled tubing are considered. Many significant conclusions are obtained from this study. When the dimensionless length of the coiled tubing is greater than 40, the effects of the boundary conditions can be ignored. The critical load required for helical buckling increases as the angle of inclination and the friction coefficient increase. The post-buckling behavior of coiled tubing in different configurations and for different axial loads is determined using the proposed analytical method. Practical examples are provided that illustrate the influence of the angular inclination on the axial force. The rate of change of the axial force decreases with increasing angular inclination. Moreover, the total axial friction also decreases with an increasing inclination angle. These results will help researchers to better understand helical buckling in coiled tubing. Using this knowledge, measures can be taken to prevent buckling in coiled tubing during down-hole operations.	[Gong, Yinchun; Ai, Zhijiu; Fu, Biwei] Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China; [Sun, Xu] China Natl Offshore Oil Corp, Shenzhen Ltd, Shenzhen, Peoples R China	Southwest Petroleum University; China National Offshore Oil Corporation (CNOOC)	Gong, YC (corresponding author), Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China.	gongyinchun@126.com			National Natural Science Foundation of China [51074132]; Shenzen Limited	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzen Limited	This study is supported by National Natural Science Foundation of China (grant no. 51074132). Shenzen Limited provided funding via salary to Xu Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheatham J. B., 1984, HELICAL POSTBUCKLING, DOI [10.2118/10854-PA, DOI 10.2118/10854-PA]; CHEN YC, 1990, J PETROL TECHNOL, V42, P140, DOI 10.2118/19176-PA; Chen YC, 2015, MEASUREMENT, V65, P227, DOI 10.1016/j.measurement.2015.01.008; DAWSON R, 1984, J PETROL TECHNOL, V36, P1734, DOI 10.2118/11167-PA; Gao D., 2002, PROGR NATURALENCE, V12; Gao G., 2010, SPE PROD OP S 4 8 AP; Guan F, 2014, APPL OCEAN RES, V44, P13, DOI 10.1016/j.apor.2013.10.009; Gulyaev VI, 2008, STRENGTH MATER+, V40, P648, DOI 10.1007/s11223-008-9083-2; HE XJ, 1995, SPE DRILL COMPLETION, V10, P10, DOI 10.2118/25370-PA; Huang GX, 2016, SHIPS OFFSHORE STRUC, V11, P561, DOI 10.1080/17445302.2015.1038867; Huang N. C., 2000, SAUDI MED J, V33, P367; Lubinski A., 1962, J PET TECHNOL, V14, P655, DOI DOI 10.2118/178-PA; McCann R.C., 1994, OFFSH TECHN C HOUST; Miller JT, 2015, EXTREME MECH LETT, V3, P36, DOI 10.1016/j.eml.2015.03.002; Miller JT, 2015, INT J SOLIDS STRUCT, V72, P153, DOI 10.1016/j.ijsolstr.2015.07.025; Miska S., 1995, ANAL HELICAL BUCKLIN, DOI [10.2118/29460-MS, DOI 10.2118/29460-MS]; Mitchell R. F., 2013, SPE DRILL COMPLETION, V12, P63; Mitchell R. F., 2002, NEW BUCKLING SOLUTIO, DOI [10.2118/74566-MS, DOI 10.2118/74566-MS]; Mitchell R.F., 1986, SPE DRILL ENG, V1, P457, DOI DOI 10.2118/13064-PA; Mitchell R.F., 1988, SPE DRILL ENG, V3, P303, DOI DOI 10.2118/15470-PA; Paslay P. R., 1964, J APPL MECH, V31; Qin X, 2016, J NAT GAS SCI ENG, V30, P182, DOI 10.1016/j.jngse.2016.02.016; Wicks N, 2008, INT J MECH SCI, V50, P538, DOI 10.1016/j.ijmecsci.2007.08.005; Wu J., 1993, SPE PROD OP S OKL US, P10; Yuan Z, 2012, INT J NONLIN MECH, V47, P699, DOI 10.1016/j.ijnonlinmec.2011.11.008	25	1	1	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162741	10.1371/journal.pone.0162741	http://dx.doi.org/10.1371/journal.pone.0162741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649535	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100032
J	Tao, Z; Kokas, A; Zhang, R; Cohan, DS; Wallach, D				Tao, Zhu; Kokas, Aynne; Zhang, Rui; Cohan, Daniel S.; Wallach, Dan			Inferring Atmospheric Particulate Matter Concentrations from Chinese Social Media Data	PLOS ONE			English	Article							TWITTER	Although studies have increasingly linked air pollution to specific health outcomes, less well understood is how public perceptions of air quality respond to changing pollutant levels. The growing availability of air pollution measurements and the proliferation of social media provide an opportunity to gauge public discussion of air quality conditions. In this paper, we consider particulate matter (PM) measurements from four Chinese megacities (Beijing, Shanghai, Guangzhou, and Chengdu) together with 112 million posts on Weibo (a popular Chinese microblogging system) from corresponding days in 2011-2013 to identify terms whose frequency was most correlated with PM levels. These correlations are used to construct an Air Discussion Index (ADI) for estimating daily PM based on the content of Weibo posts. In Beijing, the Chinese city with the most PM as measured by U.S. Embassy monitor stations, we found a strong correlation (R = 0.88) between the ADI and measured PM. In other Chinese cities with lower pollution levels, the correlation was weaker. Nonetheless, our results show that social media may be a useful proxy measurement for pollution, particularly when traditional measurement stations are unavailable, censored or misreported.	[Tao, Zhu; Wallach, Dan] Rice Univ, Dept Comp Sci, Houston, TX 77005 USA; [Kokas, Aynne] Univ Virginia, Dept Media Studies, Charlottesville, VA USA; [Zhang, Rui; Cohan, Daniel S.] Rice Univ, Dept Civil & Environm Engn, Houston, TX USA; [Tao, Zhu] Googleplex, Mountain View, CA USA	Rice University; University of Virginia; Rice University	Wallach, D (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77005 USA.	dwallach@rice.edu	Cohan, Daniel S/E-6595-2010	Cohan, Daniel S/0000-0003-0415-7980				Ao J, 2014, PROCEDIA COMPUT SCI, V31, P731, DOI 10.1016/j.procs.2014.05.321; Cao B, 2012, BLOOMBERG       0228; Chen JY, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P505, DOI 10.1145/2567948.2576941; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; Dhar V, 2009, J INTERACT MARK, V23, P300, DOI 10.1016/j.intmar.2009.07.004; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Economy E, 2014, ALL MEANS NECESSARY; Forman C, 2008, INFORM SYST RES, V19, P291, DOI 10.1287/isre.1080.0193; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; HBase Development Team, 2012, HBASE DISTR DAT LARG; Hsu A, 2012, ENVIRON DEV, V3, P39, DOI 10.1016/j.envdev.2012.05.001; Huilei He, 2013, Advanced Data Mining and Applications. 9th International Conference, ADMA 2013. Proceedings: LNCS 8346, P372, DOI 10.1007/978-3-642-53914-5_32; Jiang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134142; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Kreyszig E, 1993, ADV ENG MATH, V1022; Lampos V, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337557; Lin MY, 1993, P ROCLING 6, P119; Liu LX, 2012, ENVIRON SCI POLICY, V21, P106, DOI 10.1016/j.envsci.2012.05.001; Martin RV, 2008, ATMOS ENVIRON, V42, P7823, DOI 10.1016/j.atmosenv.2008.07.018; Mendoza M, 2010, ACM 2010, P71; Mishne G., 2006, AAAI SPRING S COMP A, P155; Miyabe M, 2012, USE TREND ANAL TWITT, P175, DOI [10.1145/2141512.2141571, DOI 10.1145/2141512.2141571]; Muralidharan S, 2011, PUBLIC RELAT REV, V37, P175, DOI 10.1016/j.pubrev.2011.01.010; Power R., 2013, P AUSTR LANG TECHN A, P80; RIVEST R, 1992, MD5 MESSAGE DIGEST A; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shvachko Konstantin, 2010, MSST, DOI [10.1109/MSST.2010.5496972, DOI 10.1109/MSST.2010.5496972]; Song P, 2012, P 2012 INT C NAT LAN; Spann M, 2003, MANAGE SCI, V49, P1310, DOI 10.1287/mnsc.49.10.1310.17314; The-Minh Nguyen, 2011, 2011 IEEE International Conference on Granular Computing, P496, DOI 10.1109/GRC.2011.6122647; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; World Health Organization, 2014, BURD DIS AMB AIR POL; Xinjiang Lu, 2013, 2013 IEEE International Conference on Green Computing and Communications (GreenCom) and IEEE Internet of Things (iThings) and IEEE Cyber, Physical and Social Computing (CPSCom), P962, DOI 10.1109/GreenCom-iThings-CPSCom.2013.166; Zhang HP, 2014, INT J AUTOM COMPUT, V11, P119, DOI 10.1007/s11633-014-0774-9; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhu T, 2013, 22 USENIX SEC S USEN, P227; Zhuang XL, 2014, J ENVIRON SCI, V26, P2, DOI 10.1016/S1001-0742(13)60376-9	39	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161389	10.1371/journal.pone.0161389	http://dx.doi.org/10.1371/journal.pone.0161389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649530	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100005
J	Trotta, A; Iyegbe, C; Di Forti, M; Sham, PC; Campbell, DD; Cherny, SS; Mondelli, V; Aitchison, KJ; Murray, RM; Vassos, E; Fisher, HL				Trotta, Antonella; Iyegbe, Conrad; Di Forti, Marta; Sham, Pak C.; Campbell, Desmond D.; Cherny, Stacey S.; Mondelli, Valeria; Aitchison, Katherine J.; Murray, Robin M.; Vassos, Evangelos; Fisher, Helen L.			Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study	PLOS ONE			English	Article							ABUSE QUESTIONNAIRE CECA.Q; FAMILIAL RISK; TRAUMA; ASSOCIATION; ENVIRONMENT; PSYCHOPATHOLOGY; STRATIFICATION; METAANALYSIS; VALIDATION; EXPERIENCE	A history of childhood adversity is associated with psychotic disorder, with an increase in risk according to number or severity of exposures. However, it is not known why only some exposed individuals go on to develop psychosis. One possibility is pre-existing genetic vulnerability. Research on gene-environment interaction in psychosis has primarily focused on candidate genes, although the genetic effects are now known to be polygenic. This pilot study investigated whether the effect of childhood adversity on psychosis is moderated by the polygenic risk score for schizophrenia (PRS). Data were utilised from the Genes and Psychosis (GAP) study set in South London, UK. The GAP sample comprises 285 first-presentation psychosis cases and 256 unaffected controls with information on childhood adversity. We studied only white subjects (80 cases and 110 controls) with PRS data, as the PRS has limited predictive ability in patients of African ancestry. The occurrence of childhood adversity was assessed with the Childhood Experience of Care and Abuse Questionnaire (CECA.Q) and the PRS was based on genome-wide meta-analysis results for schizophrenia from the Psychiatric Genomics Consortium. Higher schizophrenia PRS and childhood adversities each predicted psychosis status. Nevertheless, no evidence was found for interaction as departure from additivity, indicating that the effect of polygenic risk scores on psychosis was not increased in the presence of a history of childhood adversity. These findings are compatible with a multifactorial threshold model in which both genetic liability and exposure to environmental risk contribute independently to the etiology of psychosis.	[Trotta, Antonella; Iyegbe, Conrad; Murray, Robin M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Di Forti, Marta; Aitchison, Katherine J.; Vassos, Evangelos; Fisher, Helen L.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Sham, Pak C.; Campbell, Desmond D.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Campbell, Desmond D.; Cherny, Stacey S.] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Mondelli, Valeria] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England; [Aitchison, Katherine J.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Aitchison, Katherine J.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of London; King's College London; University of London; King's College London; University of Hong Kong; University of Hong Kong; University of London; King's College London; University of Alberta; University of Alberta	Fisher, HL (corresponding author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England.	helen.2.fisher@kcl.ac.uk	Aitchison, Katherine J/G-4476-2013; Fisher, Helen L/A-7178-2010; Cherny, Stacey S/B-3315-2008; Vassos, Evangelos/F-9825-2013; murray, robin/F-8658-2012	Aitchison, Katherine J/0000-0002-1107-3024; Fisher, Helen L/0000-0003-4174-2126; Cherny, Stacey S/0000-0002-0269-3352; Vassos, Evangelos/0000-0001-6363-0438; Mondelli, Valeria/0000-0001-8690-6839; Di Forti, Marta/0000-0002-3218-6925; Campbell, Desmond/0000-0003-1085-714X; murray, robin/0000-0003-0829-0519; Trotta, Antonella/0000-0001-7538-6145	Maudsley Charitable Fund; United Kingdom (UK) National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health grant (BRC-SLAM); NIHR BRC-SLAM; Psychiatry Research Trust studentship; Brain & Behaviour Research Foundation [22604]; UK Medical Research Council Population Health Scientist award [G1002366]; MQ: Transforming Mental Health Fellows Award [MQ14F40]; Government of Alberta; MRC [MR/K004867/1, MR/K013807/1, MR/M008436/1, G1002366, G1100583, G0600972, G0700995] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Mondelli] Funding Source: researchfish; Medical Research Council [G0600972, MR/K013807/1, MR/M008436/1, G0700995, MR/K004867/1, G1002366, G1100583] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10110, RP-PG-0606-1049, CL-2008-17-005] Funding Source: researchfish; MQ: Transforming Mental Health [MQ14F40] Funding Source: researchfish	Maudsley Charitable Fund; United Kingdom (UK) National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health grant (BRC-SLAM); NIHR BRC-SLAM; Psychiatry Research Trust studentship; Brain & Behaviour Research Foundation; UK Medical Research Council Population Health Scientist award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MQ: Transforming Mental Health Fellows Award; Government of Alberta; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MQ: Transforming Mental Health	The work was supported by the Maudsley Charitable Fund and the United Kingdom (UK) National Institute of Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health grant (BRC-SLAM). RMM receives salary support from the NIHR BRC-SLAM. AT was funded by a Psychiatry Research Trust studentship. CI is funded by a NARSAD Young Investigator award [22604] from the Brain & Behaviour Research Foundation. HLF was funded by a UK Medical Research Council Population Health Scientist award [G1002366] and an MQ: Transforming Mental Health Fellows Award [MQ14F40]. KJA holds an Alberta Centennial Addiction and Mental Health Research Chair, funded by the Government of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas M, 2014, J PSYCHIATR RES, V59, P14, DOI 10.1016/j.jpsychires.2014.08.011; Aas M, 2013, PROG NEURO-PSYCHOPH, V46, P181, DOI 10.1016/j.pnpbp.2013.07.008; Ajnakina O, 2016, PSYCHOL MED, V46, P317, DOI 10.1017/S0033291715001816; Ajnakina O, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00084; Alemany S, 2013, EUR PSYCHIAT, V28, P207, DOI 10.1016/j.eurpsy.2012.03.001; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Asarnow RF, 2001, ARCH GEN PSYCHIAT, V58, P581, DOI 10.1001/archpsyc.58.6.581; Beards S, 2013, SCHIZOPHRENIA BULL, V39, P740, DOI 10.1093/schbul/sbt065; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Collip D, 2013, BRIT J PSYCHIAT, V202, P261, DOI 10.1192/bjp.bp.112.115972; DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227; DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Fisher HL, 2011, SCHIZOPHRENIA BULL, V37, P546, DOI 10.1093/schbul/sbp103; Fisher HL, 2014, SCHIZOPHRENIA BULL, V40, P1443, DOI 10.1093/schbul/sbt201; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Iyegbe C, 2014, SOC PSYCH PSYCH EPID, V49, P169, DOI 10.1007/s00127-014-0823-2; Jaffee SR, 2012, DEV PSYCHOPATHOL, V24, P1253, DOI 10.1017/S0954579412000685; Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Kendler KS, 2010, BRIT J PSYCHIAT, V197, P170, DOI 10.1192/bjp.bp.110.081331; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Meyers JL, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.63; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Mullins N, 2016, PSYCHOL MED, V46, P759, DOI 10.1017/S0033291715002172; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Peyrot WJ, 2014, BRIT J PSYCHIAT, V205, P113, DOI 10.1192/bjp.bp.113.143081; Pfeifer S, 2010, PSYCHOSIS, V2, P1, DOI 10.1080/17522430903197384; Porta M, 2008, DICT EPIDEMIOLOGY; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004; Rajkumar RP, 2014, MED HYPOTHESES, V83, P276, DOI 10.1016/j.mehy.2014.05.017; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salvatore JE, 2014, GENES-BASEL, V5, P330, DOI 10.3390/genes5020330; Schafer Ingo, 2011, Dialogues Clin Neurosci, V13, P360; Shevlin M, 2008, SCHIZOPHRENIA BULL, V34, P193, DOI 10.1093/schbul/sbm069; Smith N, 2002, SOC PSYCH PSYCH EPID, V37, P572, DOI 10.1007/s00127-002-0589-9; Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670; Trotta A, 2016, SCHIZOPHRENIA BULL, V42, P464, DOI 10.1093/schbul/sbv131; Trotta A, 2015, BJPSYCH OPEN, V1, P6, DOI 10.1192/bjpo.bp.115.000158; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vassos E, 2017, BIOL PSYCHIAT, V81, P470, DOI 10.1016/j.biopsych.2016.06.028; Vinkhuyzen AAE, 2015, EPIDEMIOL PSYCH SCI, V24, P12, DOI 10.1017/S2045796014000584; Wickrama K, 2014, J YOUTH ADOLESCENCE, V43, P1096, DOI 10.1007/s10964-014-0109-8; Wigman JTW, 2012, ACTA PSYCHIAT SCAND, V126, P266, DOI 10.1111/j.1600-0447.2012.01857.x; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization (WHO) Division of Mental Health, 1994, SCHED CLIN ASS NEUR; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Wray NR, 2010, SCHIZOPHRENIA BULL, V36, P14, DOI 10.1093/schbul/sbp137; Zammit S, 2010, BRIT J PSYCHIAT, V197, P207, DOI 10.1192/bjp.bp.109.070904	59	41	41	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163319	10.1371/journal.pone.0163319	http://dx.doi.org/10.1371/journal.pone.0163319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27648571	Green Published, Green Accepted, gold			2022-12-27	WOS:000383892100079
J	Spence, JR; Stanley, DJ				Spence, Jeffrey R.; Stanley, David J.			Prediction Interval: What to Expect When You're Expecting . . . A Replication	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; PSYCHOLOGICAL SCIENCE; CUMULATIVE KNOWLEDGE; REPLICABILITY; ASSOCIATION; RESEARCHERS; CANCER	A challenge when interpreting replications is determining whether the results of a replication "successfully" replicate the original study. Looking for consistency between two studies is challenging because individual studies are susceptible to many sources of error that can cause study results to deviate from each other and the population effect in unpredictable directions and magnitudes. In the current paper, we derive methods to compute a prediction interval, a range of results that can be expected in a replication due to chance (i.e., sampling error), for means and commonly used indexes of effect size: correlations and d-values. The prediction interval is calculable based on objective study characteristics (i.e., effect size of the original study and sample sizes of the original study and planned replication) even when sample sizes across studies are unequal. The prediction interval provides an a priori method for assessing if the difference between an original and replication result is consistent with what can be expected due to sample error alone. We provide opensource software tools that allow researchers, reviewers, replicators, and editors to easily calculate prediction intervals.	[Spence, Jeffrey R.; Stanley, David J.] Univ Guelph, Dept Psychol, Guelph, ON, Canada	University of Guelph	Spence, JR (corresponding author), Univ Guelph, Dept Psychol, Guelph, ON, Canada.	spencejr@uoguelph.ca			University of Guelph	University of Guelph	This work was supported by an internal research grant at the University of Guelph [no grant number]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2012, PERSPECT PSYCHOL SCI, V7, P657, DOI 10.1177/1745691612462588; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; BAKAN D, 1966, PSYCHOL BULL, V66, P423, DOI 10.1037/h0020412; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Black L., 2003, THE WHITE ALBUM; Borenstein M, 2009, INTRO META ANAL; Boyle P, 2008, ANN ONCOL, V19, P1665, DOI 10.1093/annonc/mdn561; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; CARVER RP, 1978, HARVARD EDUC REV, V48, P378, DOI 10.17763/haer.48.3.t490261645281841; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cooper H, 2009, HDB RES SYNTHESIS ME; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/00131640121971374; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Cumming G., 2004, UNDERSTANDING STAT, V3, P299, DOI DOI 10.1207/S15328031US0304_; Cumming G, 2006, PSYCHOL METHODS, V11, P217, DOI 10.1037/1082-989X.11.3.217; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; Estes WK, 1997, PSYCHON B REV, V4, P330, DOI 10.3758/BF03210790; FISHER RA, 1959, STAT METHODS SCI INF; Glass G.V., 1976, ED RES, V5, P3, DOI [10.2307/1174772, DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Gorroochurn P, 2007, GENET MED, V9, P325, DOI 10.1097/GIM.0b013e3180676d79; Greiner A, 2010, PUBLIC HEALTH NUTR, V13, P1786, DOI 10.1017/S1368980010000923; Zou GY, 2007, PSYCHOL METHODS, V12, P399, DOI 10.1037/1082-989X.12.4.399; HAHN GJ, 1969, J AM STAT ASSOC, V64, P878, DOI 10.2307/2283469; Hahn GJ, 1970, J AM STAT ASSOC, V65, P1668; Hedges L. V., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoekstra R, 2014, PSYCHON B REV, V21, P1157, DOI 10.3758/s13423-013-0572-3; Hunter J.E., 2004, METHODS META ANAL CO; Hunter J.E., 1982, STUDYING ORG INNOVAT, V4; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Kahneman D., NEW ETIQUETTE REPLIC; Kant I., 1781, CRITIQUE PURE REASON; Kelley K, 2007, BEHAV RES METHODS, V39, P979, DOI 10.3758/BF03192993; Kelley K, 2007, J STAT SOFTW, V20, P1; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; OLKIN I, 1995, PSYCHOL BULL, V118, P155, DOI 10.1037/0033-2909.118.1.155; Patil P, 2016, PERSPECT PSYCHOL SCI, V11, P539, DOI 10.1177/1745691616646366; Rosenthal R., 1993, HDB DATA ANAL BEHAV, P519; Schmidt FL, 1996, PSYCHOL METHODS, V1, P115, DOI 10.1037/1082-989X.1.2.115; SCHMIDT FL, 1992, AM PSYCHOL, V47, P1173, DOI 10.1037/0003-066X.47.10.1173; SCHMIDT FL, 1985, PERS PSYCHOL, V38, P509, DOI 10.1111/j.1744-6570.1985.tb00557.x; Schnall S., 2015, S SCHNALL HER EXPERI; Stanley DJ, 2014, PERSPECT PSYCHOL SCI, V9, P305, DOI 10.1177/1745691614528518; Stroebe W, 2014, PERSPECT PSYCHOL SCI, V9, P59, DOI 10.1177/1745691613514450	45	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162874	10.1371/journal.pone.0162874	http://dx.doi.org/10.1371/journal.pone.0162874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27644090	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900022
J	Choo, JM; Cheung, JK; Wisniewski, JA; Steer, DL; Bulach, DM; Hiscox, TJ; Chakravorty, A; Smith, AI; Gell, DA; Rood, JI; Awad, MM				Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Steer, David L.; Bulach, Dieter M.; Hiscox, Thomas J.; Chakravorty, Anjana; Smith, A. Ian; Gell, David A.; Rood, Julian I.; Awad, Milena M.			The NEAT Domain-Containing Proteins of Clostridium perfringens Bind Heme	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; DETERMINANT ISD PROTEINS; GRAM-POSITIVE BACTERIA; MEDIATED GAS-GANGRENE; GROUP-A STREPTOCOCCUS; STAPHYLOCOCCUS-AUREUS; LISTERIA-MONOCYTOGENES; BACILLUS-ANTHRACIS; IRON ACQUISITION; HEMOGLOBIN RECEPTOR	The ability of a pathogenic bacterium to scavenge iron from its host is important for its growth and survival during an infection. Our studies on C. perfringens gas gangrene strain JIR325, a derivative of strain 13, showed that it is capable of utilizing both human hemoglobin and ferric chloride, but not human holo-transferrin, as an iron source for in vitro growth. Analysis of the C. perfringens strain 13 genome sequence identified a putative heme acquisition system encoded by an iron-regulated surface gene region that we have named the Cht (Clostridium perfringens heme transport) locus. This locus comprises eight genes that are co-transcribed and includes genes that encode NEAT domain-containing proteins (ChtD and ChtE) and a putative sortase (Srt). The ChtD, ChtE and Srt proteins were shown to be expressed in JIR325 cells grown under iron-limited conditions and were localized to the cell envelope. Moreover, the NEAT proteins, ChtD and ChtE, were found to bind heme. Both chtDE and srt mutants were constructed, but these mutants were not defective in hemoglobin or ferric chloride utilization. They were, however, attenuated for virulence when tested in a mouse myonecrosis model, although the virulence phenotype could not be restored via complementation and, as is common with such systems, secondary mutations were identified in these strains. In summary, this study provides evidence for the functional redundancies that occur in the heme transport pathways of this life threatening pathogen.	[Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Hiscox, Thomas J.; Chakravorty, Anjana; Rood, Julian I.; Awad, Milena M.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Hiscox, Thomas J.; Chakravorty, Anjana; Rood, Julian I.; Awad, Milena M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Steer, David L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bulach, Dieter M.; Smith, A. Ian] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Gell, David A.] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia	Monash University; Monash University; Monash University; Monash University; University of Tasmania	Awad, MM (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Awad, MM (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	milena.awad@monash.edu	Bulach, Dieter M/D-5793-2011; Rood, Julian I/A-4858-2008	Bulach, Dieter M/0000-0001-9823-6078; Rood, Julian I/0000-0003-2126-7209; Awad, Milena/0000-0002-9275-3979; Hiscox, Thomas/0000-0003-2182-2874	Australian National Health and Medical Research Council [GNT1005991]; Monash Graduate Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Graduate Scholarship(Monash University)	This work was supported by the Australian National Health and Medical Research Council (Project Grant GNT1005991) (https://www.nhmrc.gov.au/). Jocelyn M. Choo was the recipient of a Monash Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.We acknowledge the Australian National Health and Medical Research Council for supporting this work (Project Grant GNT1005991). Jocelyn M. Choo was the recipient of a Monash Graduate Scholarship.	Ahn SH, 2005, INFECT IMMUN, V73, P722, DOI 10.1128/IAI.73.2.722-729.2005; Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Awad MM, 2016, ANAEROBE, V41, P10, DOI 10.1016/j.anaerobe.2016.05.005; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dumas Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1055; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fisher M, 2008, INFECT IMMUN, V76, P5006, DOI 10.1128/IAI.00300-08; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hassan S, 2010, J MICROBIOL, V48, P96, DOI 10.1007/s12275-009-0384-3; HEBBEL RP, 1988, AM J HEMATOL, V29, P222, DOI 10.1002/ajh.2830290409; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Hurd AF, 2012, FEMS MICROBIOL LETT, V329, P93, DOI 10.1111/j.1574-6968.2012.02502.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Kennedy CL, 2009, MICROBES INFECT, V11, P413, DOI 10.1016/j.micinf.2009.01.002; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Kirillina O, 2006, INFECT IMMUN, V74, P6171, DOI 10.1128/IAI.00874-06; Kok M, 2003, MICROBIOL-SGM, V149, P2645, DOI 10.1099/mic.0.26406-0; LABRUDE P, 1984, CRYOBIOLOGY, V21, P33, DOI 10.1016/0011-2240(84)90020-8; LEE BC, 1992, J GEN MICROBIOL, V138, P2647, DOI 10.1099/00221287-138-12-2647; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Merkley ED, 2012, J PROTEOME RES, V11, P6147, DOI 10.1021/pr3007914; Miller CE, 2009, MICROBIOL-SGM, V155, P3157, DOI 10.1099/mic.0.032425-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morelle G, 1989, FOCUS, V11, P7; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pishchany G, 2013, JOVE-J VIS EXP, DOI 10.3791/50072; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; RODKEY FL, 1974, CLIN CHEM, V20, P83; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Suryadinata R, 2015, ACTA CRYSTALLOGR D, V71, P1505, DOI 10.1107/S1399004715009219; TAI SS, 1993, INFECT IMMUN, V61, P5401, DOI 10.1128/IAI.61.12.5401-5405.1993; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wright JA, 2012, FEMS MICROBIOL LETT, V329, P177, DOI 10.1111/j.1574-6968.2012.02519.x; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	91	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162981	10.1371/journal.pone.0162981	http://dx.doi.org/10.1371/journal.pone.0162981			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637108	gold, Green Published			2022-12-27	WOS:000383723700022
J	Chanthavilay, P; Reinharz, D; Mayxay, M; Phongsavan, K; Marsden, DE; Moore, L; White, LJ				Chanthavilay, Phetsavanh; Reinharz, Daniel; Mayxay, Mayfong; Phongsavan, Keokedthong; Marsden, Donald E.; Moore, Lynne; White, Lisa J.			Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR	PLOS ONE			English	Article							COST-EFFECTIVENESS; VISUAL INSPECTION; ACETIC-ACID; NATURAL-HISTORY; DNA TEST; ACCURACY; TECHNOLOGIES; MANAGEMENT; DIAGNOSIS; CYTOLOGY	Background Several approaches to reduce the incidence of invasive cervical cancers exist. The approach adopted should take into account contextual factors that influence the cost-effectiveness of the available options. Objective To determine the cost-effectiveness of screening strategies combined with a vaccination program for 10-year old girls for cervical cancer prevention in Vientiane, Lao PDR. Methods A population-based dynamic compartment model was constructed. The interventions consisted of a 10-year old girl vaccination program only, or this program combined with screening strategies, i.e., visual inspection with acetic acid (VIA), cytology-based screening, rapid human papillomavirus (HPV) DNA testing, or combined VIA and cytology testing. Simulations were run over 100 years. In base-case scenario analyses, we assumed a 70% vaccination coverage with lifelong protection and a 50% screening coverage. The outcome of interest was the incremental cost per Disability-Adjusted Life Year (DALY) averted. Results In base-case scenarios, compared to the next best strategy, the model predicted that VIA screening of women aged 30-65 years old every three years, combined with vaccination, was the most attractive option, costing 2 544 international dollars (I$) per DALY averted. Meanwhile, rapid HPV DNA testing was predicted to be more attractive than cytology-based screening or its combination with VIA. Among cytology-based screening options, combined VIA with conventional cytology testing was predicted to be the most attractive option. Multi-way sensitivity analyses did not change the results. Compared to rapid HPV DNA testing, VIA had a probability of cost-effectiveness of 73%. Compared to the vaccination only option, the probability that a program consisting of screening women every five years would be cost-effective was around 60% and 80% if the willingness-to-pay threshold is fixed at one and three GDP per capita, respectively. Conclusions A VIA screening program in addition to a girl vaccination program was predicted to be the most attractive option in the health care context of Lao PDR. When compared with other screening methods, VIA was the primary recommended method for combination with vaccination in Lao PDR.	[Chanthavilay, Phetsavanh; Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Chanthavilay, Phetsavanh; Reinharz, Daniel; Moore, Lynne] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Reinharz, Daniel] Inst Francophonie Med Trop, Viangchan, Laos; [Mayxay, Mayfong] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [Mayxay, Mayfong; Marsden, Donald E.] Univ Oxford, Ctr Trop Med & Global Hlth, Churchill Hosp, Oxford, England; [Phongsavan, Keokedthong] Setthathirath Hosp, Gynecol Oncol Unit, Viangchan, Laos; [White, Lisa J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand; [White, Lisa J.] Univ Oxford, Nuffield Dept Med, Oxford, England	Laval University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Chanthavilay, P (corresponding author), Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos.; Chanthavilay, P (corresponding author), Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada.	phetsavanh456@gmail.com		White, Lisa/0000-0002-6523-185X	Agence Universitaire de la Francophonie; Wellcome-Trust Major Oversees Programme in SE Asia [077166/Z/05/Z]; Global Health Research Capacity Strengthening Programme	Agence Universitaire de la Francophonie; Wellcome-Trust Major Oversees Programme in SE Asia; Global Health Research Capacity Strengthening Programme	Funding for PC was approved by the Agence Universitaire de la Francophonie, Global Health Research Capacity Strengthening Programme [http://www.pifrsm-ghrcaps.org/home.html]. Funding for LJW was provided by the Wellcome-Trust Major Oversees Programme in SE Asia (grant number 077166/Z/05/Z) [http://www.wellcome.ac.uk/Funding/Biomedical-science/Funded-projects/Major-initiatives/Major-Overseas-Programmes/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T., 2003, MAKING CHOICES HLTH; American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], 1986, BMJ-BRIT MED J, V293, P659; [Anonymous], LIF TABL WHO MEM STA; [Anonymous], 2013, WORLD POP PROSP 2012; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bank World, GDP PER CAP PPP CURR; Bosch FX, 2011, EXPERT OPIN PHARMACO, V12, P2189, DOI 10.1517/14656566.2011.596527; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Bruni L, 2019, ICO IARC INFORM CTR; Chanthavilay Phetsavanh, 2015, Asian Pac J Cancer Prev, V16, P5889; Chen CX, 2012, INT J GYNECOL CANCER, V22, P908, DOI 10.1097/IGC.0b013e318256e5e4; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Gravitt PE, 2008, VACCINE, V26, pK42, DOI 10.1016/j.vaccine.2008.05.002; Guerrero AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2046-1; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; JONES HW, 1995, BAILLIERE CLIN OB GY, V9, P221, DOI 10.1016/S0950-3552(05)80367-0; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Macey RI., 2010, BERKELEY MADONNA VER; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Praditsitthikorn N, 2011, PHARMACOECONOMICS, V29, P781, DOI 10.2165/11586560-000000000-00000; Qiao L, 2015, J OBSTET GYNAECOLOGY; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sauvaget C, 2013, INT J GYNECOL OBSTET, V120, P218, DOI 10.1016/j.ijgo.2012.10.014; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Sharma M, 2012, BJOG-INT J OBSTET GY, V119, P166, DOI 10.1111/j.1471-0528.2011.02974.x; Shelbaya SG, 2009, GLOBAL GUIDANCE CERV, P11; Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]; Shi JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-123; Sritipsukho Paskorn, 2010, J Med Assoc Thai, V93 Suppl 7, pS254; Steele H, MACROECONOMICS HLTH; Suprasert P, 2009, ASIAN PAC J CANCER P, V10, P587; Wang KL, 2010, J PSYCHOSOM OBST GYN, V31, P16, DOI 10.3109/01674820903564440; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2012, HEALTH SERVICE DELIV; World Bank, PPP CONV FACT GDP LC; [No title captured]	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162915	10.1371/journal.pone.0162915	http://dx.doi.org/10.1371/journal.pone.0162915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631732	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900093
J	Hailu, FB; Kassahun, CW; Kerie, MW				Hailu, Fikadu Balcha; Kassahun, Chanyalew Worku; Kerie, Mirkuzie Woldie			Perceived Nurse-Physician Communication in Patient Care and Associated Factors in Public Hospitals of Jimma Zone, South West Ethiopia: Cross Sectional Study	PLOS ONE			English	Article							COLLABORATION; TEAMWORK; STIGMA; SAFETY; HIV	Background Nurse-physician communication has been shown to have a significant impact on the job satisfaction and retention of staff. In areas where it has been studied, communication failure between nurses and physicians was found to be one of the leading causes of preventable patient injuries, complications, death and medical malpractice claims. Objective The objective of this study is to determine perception of nurses and physicians towards nurse-physician communication in patient care and associated factors in public hospitals of Jimma zone, southwest Ethiopia. Methods Institution based cross-sectional survey was conducted from March 10 to April 16, 2014 among 341 nurses and 168 physicians working in public hospitals in Jimma zone. Data was collected using a pre-tested self-administered questionnaire; entered into EpiData version 3.1 and exported to Statistical Package for Social Sciences (SPSS) version 16.0 for analysis. Factor analysis was carried out. Descriptive statistics, independent sample t-test, linear regression and one way analysis of variance were used. Variables with P-value < 0.05 were considered as statistically significant. Results The response rate of the study was 91.55%. The mean perceived nurse-physician communication scores were 50.88 +/- 19.7% for perceived professional respect and satisfaction, and 48.52 +/- 19.7% for perceived openness and sharing of patient information on nurse-physician communication. Age, salary and organizational factors were statistically significant predictors for perceived respect and satisfaction. Whereas sex, working hospital, work attitude individual factors and organizational factors were significant predictors of perceived openness and sharing of patient information in nurse-physician communication during patient care. Conclusion Perceived level of nurse-physician communication mean score was low among nurses than physicians and it is attention seeking gap. Hence, the finding of our study suggests the need for developing and implementing nurse-physician communication improvement strategies to solve communication mishaps in patient care.	[Hailu, Fikadu Balcha] Jimma Univ, Dept Nursing, Jimma, Ethiopia; [Kassahun, Chanyalew Worku] Mada Walabu Univ, Dept Nursing, Basel, Switzerland; [Kerie, Mirkuzie Woldie] Jimma Univ, Dept Hlth Econ Management & Policy, Jimma, Ethiopia	Jimma University; Jimma University	Hailu, FB (corresponding author), Jimma Univ, Dept Nursing, Jimma, Ethiopia.	fb.hailu@studmed.uio.no	Kassahun, Chanyalew Worku/HHN-6462-2022; Hailu, Fikadu Balcha/ABA-5004-2020; Woldie, Mirkuzie/S-4086-2017	Hailu, Fikadu Balcha/0000-0002-1201-7139; Woldie, Mirkuzie/0000-0002-1777-0816	Jimma University	Jimma University	This work was supported by Jimma University, https://www.ju.edu.et/.; First our thanks go to Jimma University Specialized Hospital, Shenen Gibe Hospital and Limmu Genet Hospital staff and administration for their help in providing necessary information for this study. Then, we would like to acknowledge Jimma University for sponsoring the study and for using internet and other facilities.	Aghamolaei T, 2012, INT J HOSP RES, V1; Baiyekusi I., 2010, PHYS NURSE RELATIONS; Bryon E, 2012, J CLIN NURS, V21, P2975, DOI 10.1111/j.1365-2702.2011.04029.x; Casanova J, 2007, J NURS ADMIN, V37, P68, DOI 10.1097/00005110-200702000-00007; Chang L, 2010, W INDIAN MED J, V59; Cherie A, 2006, LECT NOTE PROFESSION; Commission J., 2013, SENTINEL EVENT DATA, V2, P2014; Council VQ, 2010, PROM EFF COMM HEALTH; Daniels C, ENHANCE COMMUNICATIO; Elbialy GG, 2011, J AM SCI, V7, P750; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Haftel HM, 2011, PEDIATRICS, V127, P601, DOI 10.1542/peds.2010-3767; Hassankhani H ZV, 2013, INT J BASIC SCI APPL, V2, P45; Manojlovich M, 2010, MED CARE, V48, P941, DOI 10.1097/MLR.0b013e3181eb31bd; Martin JS, 2010, SWISS MED WKLY, V140, P33, DOI 10.4414/smw.2010.13062; Minamizono Sachiko, 2013, J Clin Med Res, V5, P350, DOI 10.4021/jocmr1474w; Nair DM, 2012, J INTERPROF CARE, V26, P115, DOI 10.3109/13561820.2011.637647; O'Daniel M, PROFESSIONAL COMMUNI, V2; Ogbimi RI, 2006, BMC NURS, V5, DOI 10.1186/1472-6955-5-2; Othman EH, 2009, NURSE PHYS COMMUNICA; Reidpath DD, 2005, AIDS CARE, V17, P425, DOI 10.1080/09540120412331319769; Renz SM, 2013, GERIATR NURS, V34, P295, DOI 10.1016/j.gerinurse.2013.04.010; Robinson L, 2013, EFFECTIVE COMMUNICAT; Rosenstein AH, 2002, AM J NURS, V102, P26, DOI 10.1097/00000446-200206000-00040; Scalise D, 2006, HOSP HEALTH NETWORK, V80, P40; Shannon D, 2012, PATIENT SAFETY QUALI, V9, P19; Simpson KR, 2006, JOGNN-J OBST GYN NEO, V35, P547, DOI 10.1111/J.1552-6909.2006.00075.x; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; Tjia Jennifer, 2009, J Patient Saf, V5, P145, DOI 10.1097/PTS.0b013e3181b53f9b; Tschannen D, 2012, NURSING RES PRACTICE, V2012; Ushiro R, 2009, J ADV NURS, V65, P1497, DOI 10.1111/j.1365-2648.2009.05011.x; Vaismoradi M, 2011, JPN J NURS SCI, V8, P184, DOI 10.1111/j.1742-7924.2011.00173.x; Varpio L, 2008, ACAD MED, V83, pS76, DOI 10.1097/ACM.0b013e318183e67b	34	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162264	10.1371/journal.pone.0162264	http://dx.doi.org/10.1371/journal.pone.0162264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632162	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900035
J	Ko, CC; Tai, MH; Li, CF; Chen, TY; Chen, JH; Shu, G; Kuo, YT; Lee, YC				Ko, Ching Chung; Tai, Ming Hong; Li, Chien Feng; Chen, Tai Yuan; Chen, Jeon Hor; Shu, Ginger; Kuo, Yu Ting; Lee, Yu Chang			Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging	PLOS ONE			English	Article							SOLITARY METASTATIC LESIONS; NERVOUS-SYSTEM LYMPHOMA; PRIMARY CNS LYMPHOMA; BRAIN-TUMORS; PERITUMORAL EDEMA; COEFFICIENT; PERFUSION; GLIOMA	The differentiation between glioblastomamultiforme (GBM) and primary cerebral lymphoma (PCL) is importantbecause the treatments are substantially different. The purpose of this article is to describe the MR imaging characteristics of GBM and PCL with emphasis on the quantitative ADC analysis in the tumor necrosis, the most strongly-enhanced tumor area, and the peritumoral edema. This retrospective cohort study collected 104 GBM (WHO grade IV) patients and 22 immune-competent PCL (diffuse large B cell lymphoma) patients. All these patients had pretreatment brain MR DWI and ADC imaging. Analysis of conventional-MR imaging and quantitative ADC measurement including the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe) were done. ROC analysis with optimal cut-off values and area-under-the ROC curve (AUC) was performed. For conventional MR imaging, there are statistical differences in tumor size, tumor location, tumor margin, and the presence of tumor necrosis between GBM and PCL. Quantitative ADC analysis shows that GBM tended to have significantly (P<0.05) higher ADC in the most strongly-enhanced area (ADCt) and lower ADC in the peritumoral edema (ADCe) as compared with PCL. Excellent AUC (0.94) with optimal sensitivity of 90% and specificity of 86% for differentiating between GBM and PCL was obtained by combination of ADC in the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe). Besides, there are positive ADC gradients in the peritumoral edema in a subset of GBMs but not in the PCLs. Quantitative ADC analysis in these three areas can thus be implemented to improve diagnostic accuracy for these two brain tumor types. The histological correlation of the ADC difference deserves further investigation.	[Ko, Ching Chung; Chen, Tai Yuan; Shu, Ginger; Kuo, Yu Ting] Chi Mei Med Ctr, Dept Med Imaging, Tainan, Taiwan; [Ko, Ching Chung; Tai, Ming Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Li, Chien Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan; [Chen, Tai Yuan] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan; [Chen, Jeon Hor; Lee, Yu Chang] I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan	Chi Mei Hospital; National Sun Yat Sen University; Chi Mei Hospital; Chang Jung Christian University; E-Da Hospital; I Shou University	Lee, YC (corresponding author), I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan.	drtimlee@ms54.hinet.net		Li, Chien-Feng/0000-0002-9527-7576				Ahn SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112948; Batra A, 2004, Australas Radiol, V48, P388, DOI 10.1111/j.0004-8461.2004.01324.x; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Giese A, 2001, J CANCER RES CLIN, V127, P217, DOI 10.1007/s004320000188; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171; Horger M, 2009, AM J ROENTGENOL, V193, P1384, DOI 10.2214/AJR.09.2486; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Koeller KK, 1997, RADIOGRAPHICS, V17, P1497, DOI 10.1148/radiographics.17.6.9397461; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1; Matsushima N, 2012, ANN NUCL MED, V26, P262, DOI 10.1007/s12149-012-0570-y; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Peters S, 2012, ROFO-FORTSCHR RONTG, V184, P713, DOI 10.1055/s-0032-1312862; Rollin N, 2006, NEURORADIOLOGY, V48, P150, DOI 10.1007/s00234-005-0030-7; Schlegel Uwe, 2009, Ther Adv Neurol Disord, V2, P93, DOI 10.1177/1756285608101222; Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Toh CH, 2006, J NEUROSURG, V105, P132, DOI 10.3171/jns.2006.105.1.132; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6	32	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162565	10.1371/journal.pone.0162565	http://dx.doi.org/10.1371/journal.pone.0162565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631626	gold, Green Submitted, Green Published			2022-12-27	WOS:000383706900052
J	McEwan, P; Bennett, H; Fellows, J; Priaulx, J; Bergenheim, K				McEwan, Phil; Bennett, Hayley; Fellows, Jonathan; Priaulx, Jennifer; Bergenheim, Klas			The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus	PLOS ONE			English	Article							COST-UTILITY MODEL; QUALITY-OF-LIFE; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; RISK-FACTORS; NPH INSULIN; CARDIOVASCULAR-DISEASE; POLICY MODEL; INTERVENTIONS; OUTCOMES; PEOPLE	Aims Therapy-related consequences of treatment for type 1 diabetes mellitus (T1DM), such as weight gain and hypoglycaemia, act as a barrier to attaining optimal glycaemic control, indirectly influencing the incidence of vascular complications and associated morbidity and mortality. This study quantifies the individual and combined contribution of changes in hypoglycaemia frequency, weight and HbA1c to predicted quality-adjusted life-years (QALYs) within a T1DM population. Materials and methods We describe the Cardiff Type 1 Diabetes (CT1DM) Model, originally informed by the Diabetes Control and Complications Trial (DCCT) and updated with the Epidemiology of Diabetes Interventions and Complications (EDIC) study and Swedish National Diabetes Registry for microvascular and cardiovascular complications respectively. We report model validation results and the QALY impact of HbA1c, weight and hypoglycaemia changes. Results Validation results demonstrated coefficients of determination for clinical endpoints of R-2 = 0.863 (internal R-2 = 0.999; external R2 = 0.823), costs R-2 = 0.980 and QALYs R2 = 0.951. Achieving and maintaining a 1% HbA1c reduction was estimated to provide 0.61 additional discounted QALYs. Weight changes of +/-1kg, +/-2kg or +/-3kg led to discounted QALY changes of +/-0.03, +/-0.07 and +/-0.10 respectively, while modifying hypoglycaemia frequency by -10%, -20% or -30% resulted in changes of -0.05, -0.11 and -0.17. The differences in discounted costs, life-years and QALYs associated with HbA1c 6% versus 10% were -19,037 pound, 2.49 and 2.35 respectively. Conclusions Using a model updated with contemporary epidemiological data, this study presents an outcome-focused perspective to assessing the health economic consequences of differing levels of glycaemic control in T1DM with and without weight and hypoglycaemia effects.	[McEwan, Phil; Bennett, Hayley; Fellows, Jonathan] Hlth Econ & Outcomes Res Ltd, Mulberry Dr, Cardiff, S Glam, Wales; [Priaulx, Jennifer] AstraZeneca, Global Hlth Econ & Outcomes Res, London, England; [Bergenheim, Klas] AstraZeneca, Global Hlth Econ & Outcomes Res, Molndal, Sweden	Health Economics & Outcomes Research Ltd; AstraZeneca; AstraZeneca	McEwan, P (corresponding author), Hlth Econ & Outcomes Res Ltd, Mulberry Dr, Cardiff, S Glam, Wales.	phil.mcewan@heor.co.uk			AstraZeneca plc; AstraZeneca plc.; HEOR Ltd.	AstraZeneca plc(AstraZeneca); AstraZeneca plc.(AstraZeneca); HEOR Ltd.	Funding for the study has been provided by AstraZeneca plc; no other funding sources were received for this study. The funder provided support in the form of salaries for authors JP and KB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. PM, HB and JF are employed by HEOR Ltd., which received funding support in the form of a grant from AstraZeneca plc. HEOR Ltd. provided support in the form of salaries for authors PM, HB and JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the Response to Reviewers and cover letter manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amiel SA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4188; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 1996, DIABETES, V45, P1289; Apelqvist J, 2001, DIABETOLOGIA, V44, P2077, DOI DOI 10.1007/S001250100013; Bagust A, 2005, HEALTH ECON, V14, P217, DOI 10.1002/hec.910; Beaudet A, 2014, VALUE HEALTH, V17, P462, DOI 10.1016/j.jval.2014.03.003; Cederholm J, 2011, DIABETIC MED, V28, P1213, DOI 10.1111/j.1464-5491.2011.03342.x; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Conway B, 2010, DIABETIC MED, V27, P398, DOI 10.1111/j.1464-5491.2010.02956.x; Cryer PE, 2010, ENDOCRIN METAB CLIN, V39, P641, DOI 10.1016/j.ecl.2010.05.003; Currie CJ, 2006, CURR MED RES OPIN, V22, P1523, DOI 10.1185/030079906X115757; de Boer IH, 2014, DIABETES CARE, V37, P24, DOI 10.2337/dc13-2113; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Dennett SL, 2008, VALUE HEALTH, V11, P478, DOI 10.1111/j.1524-4733.2007.00260.x; Gilg J, 2015, NEPHRON, V129, P1, DOI 10.1159/000370271; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Guillermin Anne-Laure, 2011, J Med Econ, V14, P207, DOI 10.3111/13696998.2011.561390; Hammer Mette, 2009, J Med Econ, V12, P281, DOI 10.3111/13696990903336597; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Henriksson M, 2016, PHARMACOECONOMICS, V34, P569, DOI 10.1007/s40273-015-0374-8; Holman N, 2015, DIABETIC MED, V32, P1119, DOI 10.1111/dme.12791; Kiberd BA, 1995, BRIT MED J, V311, P1595, DOI 10.1136/bmj.311.7020.1595; Kruger J, 2013, DIABETIC MED, V30, P1236, DOI 10.1111/dme.12270; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Lauridsen JT, 2014, QUAL LIFE RES, V23, P2645, DOI 10.1007/s11136-014-0712-x; Lee JM, 2011, MED CARE, V49, P924, DOI 10.1097/MLR.0b013e318216592c; Lloyd A, 2008, DIABETIC MED, V25, P618, DOI 10.1111/j.1464-5491.2008.02430.x; Lung TWC, 2013, PHARMACOECONOMICS, V31, P509, DOI 10.1007/s40273-013-0047-4; Lung TWC, 2011, QUAL LIFE RES, V20, P1669, DOI 10.1007/s11136-011-9902-y; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; McEwan P, 2006, CURR MED RES OPIN, V22, P121, DOI 10.1185/030079906X80350; McEwan P, 2010, DIABETES OBES METAB, V12, P623, DOI 10.1111/j.1463-1326.2010.01198.x; McEwan P, 2010, DIABETES OBES METAB, V12, P431, DOI 10.1111/j.1463-1326.2009.01184.x; McEwan P, 2010, 46 EASD M STOCKH SWE; McEwan P, 2007, CURR MED RES OPIN, V23, pS21, DOI 10.1185/030079907X167570; McEwan P, 2010, PHARMACOECONOMICS, V28, P665, DOI 10.2165/11535350-000000000-00000; McQueen R Brett, 2011, Cost Eff Resour Alloc, V9, P13, DOI 10.1186/1478-7547-9-13; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Institute for Health and Care Excellence, 2015, NIC GUID NG 17; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Palmer AJ, 2007, CURR MED RES OPIN, V23, P895, DOI 10.1185/030079907X182194; Personal Social Services Research Unit, 2014, UNIT COSTS HLTH SOCI; Pfohl Martin, 2012, J Med Econ, V15 Suppl 2, P14, DOI 10.3111/13696998.2012.713879; Rawshani A, 2015, DIABETES CARE, V38, P1518, DOI 10.2337/dc15-0145; Saunders SA, 2009, QJM-INT J MED, V102, P29, DOI 10.1093/qjmed/hcn125; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Snoek FJ, 2000, INT J OBESITY, V24, pS12, DOI 10.1038/sj.ijo.0801421; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Steenkamp R, 2015, NEPHRON, V129, P99, DOI 10.1159/000370275; Taber DJ, 2013, CLIN TRANSPLANT, V27, P274, DOI 10.1111/ctr.12080; Thokala P, 2014, DIABETIC MED, V31, P477, DOI 10.1111/dme.12371; Tunis SL, 2009, CURR MED RES OPIN, V25, P1273, DOI [10.1185/03007990902869169, 10.1185/03007990902869169 ]; Valentine WJ, 2011, SCAND J PUBLIC HEALT, V39, P79, DOI 10.1177/1403494810379290; Wang ZH, 2008, DIABETIC MED, V25, P867, DOI 10.1111/j.1464-5491.2008.02461.x; Wolowacz S, 2015, DIABETIC MED, V32, P1023, DOI 10.1111/dme.12663	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162441	10.1371/journal.pone.0162441	http://dx.doi.org/10.1371/journal.pone.0162441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632534	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900047
J	Rodriguez-Cuenca, S; Whyte, L; Hagen, R; Vidal-Puig, A; Fuller, M				Rodriguez-Cuenca, Sergio; Whyte, Lauren; Hagen, Rachel; Vidal-Puig, Antonio; Fuller, Maria			Stearoyl-CoA Desaturase 1 Is a Key Determinant of Membrane Lipid Composition in 3T3-L1 Adipocytes	PLOS ONE			English	Article							GAUCHER-DISEASE; PROTECTS MICE; SCD1; CHOLESTEROL; OBESITY; TRIACYLGLYCEROL; PURIFICATION; INHIBITION; FLUIDITY; POTENT	Stearoyl-CoA desaturase 1 (SCD1) is a lipogenic enzyme important for the regulation of membrane lipid homeostasis; dysregulation likely contributes to obesity associated metabolic disturbances. SCD1 catalyses the Delta 9 desaturation of 12-19 carbon saturated fatty acids to monounsaturated fatty acids. To understand its influence in cellular lipid composition we investigated the effect of genetic ablation of SCD1 in 3T3-L1 adipocytes on membrane microdomain lipid composition at the species-specific level. Using liquid chromatography/electrospray ionisation-tandem mass spectrometry, we quantified 70 species of ceramide, mono-, di- and trihexosylceramide, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, bis(monoacylglycero) phosphate, phosphatidylinositol and cholesterol in 3T3-L1 adipocytes in which a 90% reduction in scd1 mRNA expression was achieved with siRNA. Cholesterol content was unchanged although decreases in other lipids resulted in cholesterol accounting for a higher proportion of lipid in the membranes. This was associated with decreased membrane lateral diffusion. An increased ratio of 24: 0 to 24: 1 in ceramide, mono-and dihexosylceramide, and sphingomyelin likely also contributed to this decrease in lateral diffusion. Of particular interest, we observed a decrease in phospholipids containing arachidonic acid. Given the high degree of structural flexibility of this acyl chain this will influence membrane lateral diffusion, and is likely responsible for the transcriptional activation of Lands' cycle enzymes lpcat3 and mboat7. Of relevance these profound changes in the lipidome were not accompanied by dramatic changes in gene expression in mature differentiated adipocytes, suggesting that adaptive homeostatic mechanisms to ensure partial maintenance of the biophysical properties of membranes likely occur at a post-transcriptional level.	[Rodriguez-Cuenca, Sergio; Hagen, Rachel; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Whyte, Lauren; Fuller, Maria] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Hinxton, England; [Fuller, Maria] Univ Adelaide, North Terrace, Adelaide, SA 5000, Australia	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SA Pathology; Wellcome Trust Sanger Institute; University of Adelaide	Fuller, M (corresponding author), SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia.; Fuller, M (corresponding author), Univ Adelaide, North Terrace, Adelaide, SA 5000, Australia.	maria.fuller@adelaide.edu.au		Vidal-Puig, Antonio/0000-0003-4220-9577	Biotechnology and Biological Sciences Research Council [BB/H002731/1] Funding Source: Medline; British Heart Foundation [PG/12/53/29714, RG/12/13/29853] Funding Source: Medline; Medical Research Council [MC_UU_12012/2, G0400192, G0802051] Funding Source: Medline; Medical Research Council [MC_UU_12012/5/B] Funding Source: researchfish; BBSRC [BB/H002731/1] Funding Source: UKRI; MRC [G0802051, G0400192, MC_UU_12012/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calder P. C., 2006, Scandinavian Journal of Food & Nutrition, V50, P54, DOI [10.1080/17482970601066389, 10.1080/17482970600786821]; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; FEWSTER ME, 1975, J NEUROCHEM, V25, P207, DOI 10.1111/j.1471-4159.1975.tb06954.x; Hattersley KJ, 2013, BIOCHEM BIOPH RES CO, V442, P62, DOI 10.1016/j.bbrc.2013.11.009; Hein LK, 2013, J LIPID RES, V54, P1691, DOI 10.1194/jlr.M038232; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; LISANTI MP, 1995, METHOD ENZYMOL, V250, P655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA M, 1987, J IMMUNOL METHODS, V96, P225, DOI 10.1016/0022-1759(87)90318-8; Mobius W, 2003, TRAFFIC, V4, P222; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ortinau LC, 2013, OBESITY, V21, P344, DOI 10.1002/oby.20040; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Ralston JC, 2015, PROSTAG LEUKOTR ESS, V98, P29, DOI 10.1016/j.plefa.2015.04.008; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; Rogowski MP, 2013, J LIPID RES, V54, P2636, DOI 10.1194/jlr.M035865; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Yang SM, 2014, BIOORG MED CHEM LETT, V24, P1437, DOI 10.1016/j.bmcl.2013.12.075; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255; Zhang ZH, 2013, J MED CHEM, V56, P568, DOI 10.1021/jm301661h	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162047	10.1371/journal.pone.0162047	http://dx.doi.org/10.1371/journal.pone.0162047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632198	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900026
J	Thengone, D; Gagnidze, K; Pfaff, D; Proekt, A				Thengone, Daniel; Gagnidze, Khatuna; Pfaff, Donald; Proekt, Alex			Phase-Amplitude Coupling in Spontaneous Mouse Behavior	PLOS ONE			English	Article							GROWTH-HORMONE SECRETION; CIRCADIAN-RHYTHMS; LOCOMOTOR-ACTIVITY; ULTRADIAN RHYTHMS; WAVELET ANALYSIS; CLOCK MUTANTS; RAT; DYNAMICS; HAMSTER; ORGANIZATION	The level of activity of many animals including humans rises and falls with a period of similar to 24 hours. The intrinsic biological oscillator that gives rise to this circadian oscillation is driven by a molecular feedback loop with an approximately 24 hour cycle period and is influenced by the environment, most notably the light: dark cycle. In addition to the circadian oscillations, behavior of many animals is influenced by multiple oscillations occurring at fasterultradian-time scales. These ultradian oscillations are also thought to be driven by feedback loops. While many studies have focused on identifying such ultradian oscillations, less is known about how the ultradian behavioral oscillations interact with each other and with the circadian oscillation. Decoding the coupling among the various physiological oscillators may be important for understanding how they conspire together to regulate the normal activity levels, as well in disease states in which such rhythmic fluctuations in behavior may be disrupted. Here, we use a wavelet-based cross-frequency analysis to show that different oscillations identified in spontaneous mouse behavior are coupled such that the amplitude of oscillations occurring at higher frequencies are modulated by the phase of the slower oscillations. The patterns of these interactions are different among different individuals. Yet this variability is not random. Differences in the pattern of interactions are confined to a low dimensional subspace where different patterns of interactions formclusters. These clusters expose the differences among individuals-males and females are preferentially segregated into different clusters. These sex-specific features of spontaneous behavior were not apparent in the spectra. Thus, our methodology reveals novel aspects of the structure of spontaneous animal behavior that are not observable using conventional methodology.	[Thengone, Daniel] Weill Cornell Grad Sch Med Sci, Feil Family Brain & Mind Res Inst, New York, NY USA; [Gagnidze, Khatuna] Rockefeller Univ, Neuroendocrinol Lab, New York, NY USA; [Gagnidze, Khatuna; Pfaff, Donald; Proekt, Alex] Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA; [Proekt, Alex] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rockefeller University; Rockefeller University; University of Pennsylvania	Proekt, A (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.; Proekt, A (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	proekt@gmail.com		Proekt, Alexander/0000-0002-9272-5337	National Institutes of Health [K08 GM106144-02]; FAER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAER	This work was supported by the National Institutes of Health K08 GM106144-02 (Alex Proekt) and FAER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; BUTTNER D, 1984, BEHAV GENET, V14, P137, DOI 10.1007/BF01076410; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CARMICHAEL MS, 1981, P NATL ACAD SCI-BIOL, V78, P7830, DOI 10.1073/pnas.78.12.7830; Chui C.K., 2014, INTRO WAVELETS, V1; DELGADOGARCIA JM, 1976, EXP BRAIN RES, V25, P79, DOI 10.1007/BF00237327; Dowse H, 2010, J EXP BIOL, V213, P1788, DOI 10.1242/jeb.038877; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P17; FELDMAN JF, 1976, GENETICS, V82, P9; FITZGERALD KM, 1976, P NATL ACAD SCI USA, V73, P2923, DOI 10.1073/pnas.73.8.2923; Golani I, 2004, BEHAV LAB RAT HDB TE, V171; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; HONMA KI, 1978, AM J PHYSIOL, V235, pR250, DOI 10.1152/ajpregu.1978.235.5.R250; JILGE B, 1986, J INTERDISCIPL CYCLE, V17, P7; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P37, DOI 10.1177/0748730409352843; KIMURA F, 1984, J PHYSIOL-LONDON, V353, P305, DOI 10.1113/jphysiol.1984.sp015337; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819, DOI 10.1152/ajpregu.1994.267.3.R819; Leise Tanya L, 2013, J Circadian Rhythms, V11, P5, DOI 10.1186/1740-3391-11-5; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MORIN LP, 1977, SCIENCE, V196, P305, DOI 10.1126/science.557840; Mukamel EA, 2011, IEEE ENG MED BIO, P1981, DOI 10.1109/IEMBS.2011.6090558; Nakamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058884; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Steele AD, 2015, ELIFE, V4, DOI 10.7554/eLife.06351; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; Tchernichovski O, 1998, BIOL CYBERN, V78, P423, DOI 10.1007/s004220050446; Thomson DJ, 2000, NONLINEAR AND NONSTATIONARY SIGNAL PROCESSING, P317; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	40	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162262	10.1371/journal.pone.0162262	http://dx.doi.org/10.1371/journal.pone.0162262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631971	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900034
J	Wesener, T; Conrad, C				Wesener, Thomas; Conrad, Cathrin			Local Hotspots of Endemism or Artifacts of Incorrect Taxonomy? The Status of Microendemic Pill Millipede Species of the Genus Glomeris in Northern Italy (Diplopoda, Glomerida)	PLOS ONE			English	Article							INTEGRATIVE REDESCRIPTION; MITOCHONDRIAL-DNA; PHYLOGENY; KOCH; ARTHROPODA; SEQUENCES; IDENTITY; VERHOEFF; ALLOZYME	Local endemic species with their unique evolutionary history always stirred the interest of scientists. One such area especially rich in endemics is northern Italy. In case of pill millipedes of the genus Glomeris Latreille, 1803, only a single species is found in northern Europe, while 22 country-endemics alone are known from Italy. Many of these endemics, however, have not been studied in several decades; therefore we aimed to determine whether this diversity is the result of overlooked synonymies or natural processes. A focus was placed on the local endemics that are in some aspects morphologically similar to the widespread and variable G. klugii Brandt, 1833. The local endemics Glomeris larii Verhoeff, 1921, G. primordialis Verhoeff, 1930, G. oblongoguttata Verhoeff, 1894, G. oropensis Verhoeff, 1936, G. transalpina Koch, 1836, G. romana Verhoeff, 1900, G. ligurica Latzel, 1884 and G. apuana Verhoeff, 1911 were included in a molecular analysis incorporating ribosomal nuclear (28S) and mitochondrial (COI) genes. Individuals were sequenced and compared to 31 specimens from 18 localities of G. klugii. The final dataset included 657 base pairs for 56 terminals in the COI, and 14 terminals with 1068 base pairs in the combined 28S and COI analysis. Our analysis shows intraspecific distances of up to 5% in the COI gene in G. klugii that are not strictly correlated to geography or color pattern. G. larii is discovered to be genetically and morphologically identical to G. klugii and is synonymised with the latter. Interspecific distances in our dataset vary between 6.7 to 15.9%, with the lowest (6.7-9.0%) between G. primordialis and G. klugii. Our analysis confirmsthe species status of the local endemics G. primordialis, G. oblongoguttata, G. oropensis, G. transalpina, G. ligurica and G. apuana. We also confirm the synonymy of G. undulata Koch, 1844 under G. klugii. G. genuensis Latzel, 1886 is indistinguishable from G. ligurica.	[Wesener, Thomas; Conrad, Cathrin] Leibniz Inst Anim Biodivers, Sect Myriapoda, Ctr Taxon & Evolutionary Res, Zool Res Museum A Koenig, Bonn, Germany		Wesener, T (corresponding author), Leibniz Inst Anim Biodivers, Sect Myriapoda, Ctr Taxon & Evolutionary Res, Zool Res Museum A Koenig, Bonn, Germany.	t.wesener@zfmk.de						Ahrens D, 2013, MOL PHYLOGENET EVOL, V69, P83, DOI 10.1016/j.ympev.2013.05.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez N, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-21; Attems C., 1927, ABHANDLUNGEN SENCKEN, V39, P233; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Daavalos LM, 2014, J MAMMAL, V95, P781, DOI 10.1644/14-MAMM-A-107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foddai D., 1995, CHECKLIST SPECIE FAU, V32/33, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Golovatch SI, 2009, ZOOKEYS, P47, DOI 10.3897/zookeys.12.179; Golovatch SI, 2003, ARTHROPODA SEL, V11, P255; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoess R, 2001, ZOOL ANZ, V240, P15, DOI 10.1078/0044-5231-00003; Hoess R, 1997, ENTOMOL SCAND, P133; Hoess R, 1999, REV SUISSE ZOOL, V106, P643, DOI 10.5962/bhl.part.80100; Hoess R, 1999, REV SUISSE ZOOL, V106, P1013, DOI 10.5962/bhl.part.80113; Hoess R., 2000, JB NATURHISTORISCHEN, V13, P3; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Kime R. Desmond, 2000, Fragmenta Faunistica (Warsaw), V43, P281; Kime RD, 2011, ATLAS EUROPEAN MILLI, V1; Latzel R, 1886, B SOC ENTOMOL ITAL, V18, P308; Latzel R, 1884, MYRIOPODEN OSTERREIC, V2; Mauries Jean-Paul, 2005, Arthropoda Selecta, V14, P241; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Oeyen JP, 2015, ZOOKEYS, P49, DOI 10.3897/zookeys.510.8675; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Schubart O., 1934, TAUSENDFUSSLER ODER, P28; Shelley Rowland M., 2011, Insecta Mundi, V0158, P1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Strasser K., 1984, SOC VENEZIANA SCI NA, V9, P193; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VERHOEFF K. W., 1921, Archiv fuer Naturgeschichte Berlin, V87, P1; Verhoeff K. W., 1937, Zoologische Jahrbuecher Jena Systematik, V70, P87; VERHOEFF KARL W., 1930, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V59, P387; VERHOEFF KARL W., 1936, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V68, P353; Verhoeff Karl W., 1911, Jahresheft des Vereins fuer Naturkunde Stuttgart, V67; Wesener T, 2016, ZOOKEYS, P21, DOI 10.3897/zookeys.564.7535; Wesener T, 2015, ZOOTAXA, V4039, P391, DOI 10.11646/zootaxa.4039.2.11; Wesener T, 2015, ZOOTAXA, V3999, P571, DOI 10.11646/zootaxa.3999.4.7; Wesener T, 2015, ZOOKEYS, P15, DOI 10.3897/zookeys.510.8852; Wesener Thomas, 2012, Zootaxa, V3258, P58; Wesener Thomas, 2010, Zootaxa, V2725, P28; Wilbrandt J, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e5176	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162284	10.1371/journal.pone.0162284	http://dx.doi.org/10.1371/journal.pone.0162284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632210	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900036
J	Cai, JY; Li, MJ; Huang, QY; Fu, XQ; Wu, HM				Cai, JunYing; Li, MuJun; Huang, QianYi; Fu, XiaoQian; Wu, HuiMei			Differences in Cytokine Expression and STAT3 Activation between Healthy Controls and Patients of Unexplained Recurrent Spontaneous Abortion (URSA) during Early Pregnancy	PLOS ONE			English	Article							REGULATORY T-CELLS; TH17 CELLS; SPONTANEOUS MISCARRIAGE; RECEPTOR SUBUNIT; PATHWAY; POLYMORPHISMS; WOMEN	Unexplained recurrent spontaneous abortion (URSA) is a common complication of pregnancy. Although tolerance of the maternal immune system is considered to be essential for a normal pregnancy, the precise mechanism underlying the pathogenesis of URSA remains to be fully elucidated, albeit it is known to involve inflammation. Here, we examine the relationship between the expression of inflammatory cytokines and the activation of downstream signaling pathways in URSA patients. Decidual and peripheral blood samples were collected from 30 URSA patients and from 30 women with normal early pregnancies. Western blot analysis was used to measure the expression levels of signal transducers and activators of transcription 3(STAT3), phosphorylated STAT3(p-STAT3), and interleukin-17 receptor(IL-17R) in the decidual samples. Enzyme-linked immunosorbent assay was used to assess the levels of IL-17, IL-10, IL-6, and IL-23 in the peripheral blood and decidual samples. In the URSA patients, the IL-10 expression levels were lower than those in the control subjects (P<0.05), whereas IL-6, IL-17, and IL-23 were all expressed at higher levels( P<0.05). Furthermore, the expression levels of IL-17R and p-STAT3 were higher in the URSA patients, exhibiting a trend similar to that of IL-23. Our finding of increased IL-23 expression in the deciduae and peripheral blood of patients with URSA suggest that this maybe a contributing factor to the pathogenesis of this disease. Likewise, STAT3 activation through its phosphorylation, which was associated with the IL-23 increase, may also be involved in URSA pathogenesis. However, the precise pathogenic mechanism requires further study.	[Cai, JunYing; Li, MuJun; Huang, QianYi; Fu, XiaoQian; Wu, HuiMei] Guangxi Med Univ, Affiliated Hosp 1, Dept Reprod Ctr, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Li, MJ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Reprod Ctr, Nanning, Guangxi, Peoples R China.	lmj20051699@126.com			National Natural Science Foundation of China [81360101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (81360101) to MJL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bao SH, 2013, CLIN EXP IMMUNOL, V172, P437, DOI 10.1111/cei.12066; Choi YK, 2008, AM J REPROD IMMUNOL, V60, P91, DOI 10.1111/j.1600-0897.2008.00602.x; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Heo YJ, 2010, IMMUNOL LETT, V127, P150, DOI 10.1016/j.imlet.2009.10.006; Hu WT, 2015, J REPROD IMMUNOL, V109, P52, DOI 10.1016/j.jri.2015.01.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee SK, 2011, HUM REPROD, V26, P2964, DOI 10.1093/humrep/der301; Lee SY, 2014, IMMUNOLOGY, V141, P353, DOI 10.1111/imm.12196; Li FJ, 2010, SURG-J R COLL SURG E, V8, P262, DOI 10.1016/j.surge.2010.03.003; Liu YS, 2011, AM J REPROD IMMUNOL, V65, P503, DOI 10.1111/j.1600-0897.2010.00921.x; Mat NFC, 2011, J INTERF CYTOK RES, V31, P363, DOI 10.1089/jir.2010.0083; Mesquita D, 2009, BRAZ J MED BIOL RES, V42, P476, DOI 10.1590/S0100-879X2009000600002; Messaoudi S, 2013, GENET TEST MOL BIOMA, V17, P35, DOI 10.1089/gtmb.2012.0201; Nakashima A, 2010, AM J REPROD IMMUNOL, V64, P4, DOI 10.1111/j.1600-0897.2010.00812.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Qaddourah RH, 2014, HUM REPROD, V29, P1025, DOI 10.1093/humrep/deu043; Rafa H, 2003, PLOS PATHOG, V9; Rafa H, 2013, J INTERF CYTOK RES, V33, P355, DOI 10.1089/jir.2012.0063; Saifi B, 2014, REPROD BIOMED ONLINE, V29, P481, DOI 10.1016/j.rbmo.2014.06.008; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Tulunay A, 2015, GENES IMMUN, V16, P170, DOI 10.1038/gene.2014.64; Wang WJ, 2013, J REPROD IMMUNOL, V99, P39, DOI 10.1016/j.jri.2013.04.002; Wang WJ, 2010, J REPROD IMMUNOL, V84, P164, DOI 10.1016/j.jri.2009.12.003; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu ZG, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/896458; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yue CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128219; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	33	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163252	10.1371/journal.pone.0163252	http://dx.doi.org/10.1371/journal.pone.0163252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657728	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200093
J	Cinque, B; La Torre, C; Lombardi, F; Palumbo, P; Van der Rest, M; Cifone, MG				Cinque, Benedetta; La Torre, Cristina; Lombardi, Francesca; Palumbo, Paola; Van der Rest, Michel; Cifone, Maria Grazia			Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							VSLNUMBER-3; PREBIOTICS; FORMULATION; INDUCTION; SAFETY	A careful selection of the probiotic agent, standardization of the dose and detailed characterization of the beneficial effects are essential when considering use of a probiotic for the dietary management of serious diseases. However, changes in the manufacturing processes, equipment or facilities can result in differences in the product itself due to the live nature of probiotics. The need to reconfirm safety and/or efficacy for any probiotic product made at a different factory is therefore mandatory. Recently, under the brand VSL#3 (R), a formulation produced by a manufacturer different from the previous one, has been commercialized in some European countries (the UK and Holland). VSL#3 is a high concentration multi-strain preparation which has been recognized by the main Gastroenterology Associations for the dietary management of pouchitis as well as ulcerative colitis. We have compared the "original" VSL#3 produced in USA with the "newfound" VSL#3 produced in Italy. According to our results, the "newfound" VSL#3 has 130-150% more "dead bacteria" compared to the "original" product, raising concerns for the well-known association between dead microbes with adverse effects. The abilities of bacterial lysates from the two formulations to influence in vitro viability and proliferation of different tumor cell lines also resulted different. The repair of previously scratched monolayers of various adherent tumor cell lines (i.e. HT1080, and Caco-2 cells) was inhibited more significantly by the "original" VSL#3 when compared to the "newfound" VSL#3. Tumor cell cycle profile, in particular cell cycle arrest and apoptotic death of the cancer cells, further confirms that the "original " VSL#3 has a better functional profile than the "newfound " VSL#3, at least in in vitro. Our data stress the importance of the production conditions for the "newfound " VSL#3 considering that this product is intended to be used for the dietary management of patients with very serious diseases, such as chronic inflammatory bowel diseases.	[Cinque, Benedetta; La Torre, Cristina; Lombardi, Francesca; Palumbo, Paola; Cifone, Maria Grazia] Univ Aquila, Dept Life Hlth & Environm Sci, Bldg Delta 6, Laquila, Italy; [Van der Rest, Michel] BioVisible BV, Groningen, Netherlands	University of L'Aquila	Cifone, MG (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Bldg Delta 6, Laquila, Italy.	cifone@univaq.it	Cifone, Maria Grazia/I-3750-2019; Cifone, Maria Grazia/ABH-1984-2021	Cifone, Maria Grazia/0000-0002-9923-5445; Lombardi, Francesca/0000-0002-0551-5076; palumbo, paola/0000-0001-7027-2691	Authors Institution (University of L'Aquila-Department of Life, Health Environmental Sciences); "Abruzzo earthquake relief fund" (Toronto, Ontario)	Authors Institution (University of L'Aquila-Department of Life, Health Environmental Sciences); "Abruzzo earthquake relief fund" (Toronto, Ontario)	Dr. Van der Rest is the owner of BioVisible BV and receives a salary. The specific role of this author is articulated in the "author contributions" section. The study was supported by Authors Institution (University of L'Aquila-Department of Life, Health Environmental Sciences). The funder (University of L'Aquila) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study has been performed in the framework of the "Research Center for Molecular Diagnostics and Advanced Therapies" supported by the "Abruzzo earthquake relief fund" (Toronto, Ontario). The Authors thank Gasperina De Nuntiis (Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy) for technical assistance.	Angulo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016953; [Anonymous], 2011, AHRQ PUBL 11 E007 AP, V11-E007; Biordi L, 2001, NUTR CANC, V40, P185; Chapman TM, 2006, DRUGS, V66, P1371, DOI 10.2165/00003495-200666100-00006; D'Mello C, 2015, J NEUROSCI, V35, P10821, DOI 10.1523/JNEUROSCI.0575-15.2015; Derikx LAAP, 2016, BEST PRACT RES CL GA, V30, P55, DOI 10.1016/j.bpg.2016.02.005; Dhiman RK, 2014, GASTROENTEROLOGY, V147, P1327, DOI 10.1053/j.gastro.2014.08.031; Distrutti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106503; Donelli Gianfranco, 2013, Microbial Ecology in Health and Disease, V24, P20105, DOI 10.3402/mehd.v24i0.20105; FAO/WHO, 2002, FOOD AGR ORG UN WHO; FDA, 2015, SCI CONS DEM BIOS RE; Floch MH, 2015, J CLIN GASTROENTEROL, V49, pS69, DOI 10.1097/MCG.0000000000000420; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Hungin APS, 2013, ALIMENT PHARM THER, V38, P864, DOI 10.1111/apt.12460; Jeong SY, 2008, J APPL MICROBIOL, V104, P796, DOI 10.1111/j.1365-2672.2007.03615.x; Kimoto-Nira H, 2008, J FOOD PROTECT, V71, P2124, DOI 10.4315/0362-028X-71.10.2124; Kumar M, 2013, NUTR REV, V71, P23, DOI 10.1111/j.1753-4887.2012.00542.x; La Torre C, 2016, J CELL PHYSL, V999, P1; Lichtenstein L, 2016, BEST PRACT RES CL GA, V30, P81, DOI 10.1016/j.bpg.2016.02.002; Loguercio C, 2005, J CLIN GASTROENTEROL, V39, P540, DOI 10.1097/01.mcg.0000165671.25272.0f; Mittal VV, 2011, EUR J GASTROEN HEPAT, V23, P725, DOI 10.1097/MEG.0b013e32834696f5; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Orel R, 2014, WORLD J GASTROENTERO, V20, P11505, DOI 10.3748/wjg.v20.i33.11505; Saarela MH, 2009, J APPL MICROBIOL, V106, P1204, DOI 10.1111/j.1365-2672.2008.04089.x; Sanders ME, 2014, ANN NY ACAD SCI, V1309, P1, DOI 10.1111/nyas.12363; Sanders ME, 2010, GUT MICROBES, V1, P164, DOI 10.4161/gmic.1.3.12127; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Ulisse S, 2001, AM J GASTROENTEROL, V96, P2691, DOI 10.1111/j.1572-0241.2001.04139.x; Ullal AJ, 2010, CYTOM PART A, V77A, P294, DOI 10.1002/cyto.a.20833; Urbanska AM, 2009, DIGEST DIS SCI, V54, P264, DOI 10.1007/s10620-008-0363-2; Zacarias MF, 2011, INT DAIRY J, V21, P548, DOI 10.1016/j.idairyj.2011.03.007	33	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163216	10.1371/journal.pone.0163216	http://dx.doi.org/10.1371/journal.pone.0163216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657913	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200086
J	Clavarino, G; Delouche, N; Vettier, C; Laurin, D; Pernollet, M; Raskovalova, T; Cesbron, JY; Dumestre-Perard, C; Jacob, MC				Clavarino, Giovanna; Delouche, Noemie; Vettier, Claire; Laurin, David; Pernollet, Martine; Raskovalova, Tatiana; Cesbron, Jean-Yves; Dumestre-Perard, Chantal; Jacob, Marie-Christine			Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry	PLOS ONE			English	Article							HUMAN-BONE-MARROW; IMMUNOPHENOTYPIC ANALYSIS; PERIPHERAL-BLOOD; PLASMA-CELLS; HEMATOGONES; SUBSETS; HETEROGENEITY; FEATURES; DISEASE; COMMON	A precise identification and phenotypic characterization of human B-cell subsets is of crucial importance in both basic research and medicine. In the literature, flow cytometry studies for the phenotypic characterization of B-lymphocytes are mainly focused on the description of a particular cell stage, or of specific cell stages observed in a single type of sample. In the present work, we propose a backbone of 6 antibodies (CD38, CD27, CD10, CD19, CD5 and CD45) and an efficient gating strategy to identify, in a single analysis tube, a large number of B-cell subsets covering the whole B-cell differentiation from precursors to memory and plasma cells. Furthermore, by adding two antibodies in an 8-color combination, our approach allows the analysis of the modulation of any cell surface marker of interest along B-cell differentiation. We thus developed a panel of seven 8-colour antibody combinations to phenotypically characterize B-cell subpopulations in bone marrow, peripheral blood, lymph node and cord blood samples. Beyond qualitative information provided by biparametric representations, we also quantified antigen expression on each of the identified B-cell subsets and we proposed a series of informative curves showing the modulation of seventeen cell surface markers along B-cell differentiation. Our approach by flow cytometry provides an efficient tool to obtain quantitative data on B-cell surface markers expression with a relative easy-to-handle technique that can be applied in routine explorations.	[Clavarino, Giovanna; Delouche, Noemie; Pernollet, Martine; Raskovalova, Tatiana; Cesbron, Jean-Yves; Dumestre-Perard, Chantal; Jacob, Marie-Christine] Grenoble Univ Hosp, Lab Immunol, Dept Hematol Oncogenet & Immunol, Pole Biol, Grenoble, France; [Clavarino, Giovanna; Cesbron, Jean-Yves; Dumestre-Perard, Chantal] TIMC IMAG, UMR 5525 CNRS, BNI, Grenoble, France; [Clavarino, Giovanna; Laurin, David; Cesbron, Jean-Yves; Dumestre-Perard, Chantal; Jacob, Marie-Christine] Univ Grenoble Alpes, Grenoble, France; [Vettier, Claire] Grenoble Univ Hosp, Lab Hematol, Dept Hematol Oncogenet & Immunol, Pole Biol, Grenoble, France; [Laurin, David] TIMC IMAG, UMR 5525 CNRS, TheREx, Grenoble, France; [Laurin, David] Etab Francais Sang Rhones Alpes Auvergne, La Tronche, France; [Jacob, Marie-Christine] Inst Albert Bonniot, CNRS UMR 5309, Grenoble, France; [Jacob, Marie-Christine] Inst Albert Bonniot, INSERM U1209, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Clavarino, G (corresponding author), Grenoble Univ Hosp, Lab Immunol, Dept Hematol Oncogenet & Immunol, Pole Biol, Grenoble, France.; Clavarino, G (corresponding author), TIMC IMAG, UMR 5525 CNRS, BNI, Grenoble, France.; Clavarino, G (corresponding author), Univ Grenoble Alpes, Grenoble, France.	gclavarino@chu-grenoble.fr	marie-christine, JACOB/G-7322-2014; Laurin, David/M-7895-2014	Laurin, David/0000-0001-9339-8369; Clavarino, Giovanna/0000-0003-1778-1352				Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Arnoulet C, 2010, CYTOM PART B-CLIN CY, V78B, P3, DOI 10.1002/cyto.b.20484; Aspord C, 2016, PLOS ONE, V11; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Bohnhorst JO, 2001, J IMMUNOL, V167, P3610, DOI 10.4049/jimmunol.167.7.3610; CAMPANA D, 1985, J IMMUNOL, V134, P1524; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; Espeli M, 2006, SEMIN IMMUNOL, V18, P56, DOI 10.1016/j.smim.2005.11.002; Ha YJ, 2008, J LEUKOCYTE BIOL, V84, P1557, DOI 10.1189/jlb.0706457; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; LOKEN MR, 1988, PATHOL IMMUNOPATH R, V7, P357, DOI 10.1159/000157129; LOKEN MR, 1987, BLOOD, V70, P1316; Lougaris V, 2016, CLIN IMMUNOL, V163, P10, DOI 10.1016/j.clim.2015.12.006; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Marie-Cardine A, 2008, CLIN IMMUNOL, V127, P14, DOI 10.1016/j.clim.2007.11.013; McKenna RW, 2001, BLOOD, V98, P2498, DOI 10.1182/blood.V98.8.2498; McKenna RW, 2004, LEUKEMIA LYMPHOMA, V45, P277, DOI 10.1080/1042819031000151950; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Neumann B, 2015, CYTOM PART A, V87A, P800, DOI 10.1002/cyto.a.22712; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Salameire D, 2009, CYTOM PART A, V75A, P743, DOI 10.1002/cyto.a.20767; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sevilla DW, 2010, LEUKEMIA LYMPHOMA, V51, P10, DOI 10.3109/10428190903370346; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Suryani S, 2010, BLOOD, V115, P519, DOI 10.1182/blood-2009-07-234799; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Wei CW, 2011, CYTOM PART A, V79A, P894, DOI 10.1002/cyto.a.21112; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346	33	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162209	10.1371/journal.pone.0162209	http://dx.doi.org/10.1371/journal.pone.0162209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657694	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200021
J	Grin'kina, NM; Li, Y; Haber, M; Sangobowale, M; Nikulina, E; Le'Pre, C; El Sehamy, AM; Dugue, R; Ho, JS; Bergold, PJ				Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Sangobowale, Michael; Nikulina, Elena; Le'Pre, Charm; El Sehamy, Alexander M.; Dugue, Rachelle; Ho, Johnson S.; Bergold, Peter J.			Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury	PLOS ONE			English	Article								Blunt impact produces a heterogeneous brain injury in people and in animal models of traumatic brain injury. We report that a single closed head impact to adult C57/BL6 mice produced two injury syndromes (CHI-1 and CHI-2). CHI-1 mice spontaneously reinitiated breathing after injury while CHI-2 mice had prolonged apnea and regained breathing only after cardiopulmonary resuscitation and supplementation of 100% O-2. The CHI-1 group significantly regained righting reflex more rapidly than the CHI-2 group. At 7 days postinjury, CHI-1, but not CHI-2 mice, acquired but had no long-term retention of an active place avoidance task. The behavioral deficits of CHI-1 and CHI-2 mice were retained one-month after the injury. CHI-1 mice had loss of hippocampal neurons and localized white matter injury at one month after injury. CHI-2 had a larger loss of hippocampal neurons and more widespread loss of myelin and axons. High-speed videos made during the injury were followed by assessment of breathing and righting reflex. These videos show that CHI-2 mice experienced a larger vertical g-force than CHI-1 mice. Time to regain righting reflex in CHI-2 mice significantly correlated with vertical g-force. Thus, physiological responses occurring immediately after injury can be valuable surrogate markers of subsequent behavioral and histological deficits.	[Haber, Margalit; Sangobowale, Michael; Le'Pre, Charm; Dugue, Rachelle; Bergold, Peter J.] Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Li, Yang; Haber, Margalit; Nikulina, Elena; El Sehamy, Alexander M.; Ho, Johnson S.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Nikulina, Elena; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Li, Yang] New York Psychiat Inst, 1051 Riverside Dr,Kolb Annex 669, New York, NY 10032 USA; [Haber, Margalit] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rm 227,12725 Twinbrook Pkwy, Rockville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York State Psychiatry Institute; Uniformed Services University of the Health Sciences - USA	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.; Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Dugue, Rachelle/0000-0002-5179-4424; Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Material Command [W81XWH-10-2-0171]	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was supported by the award number: W81XWH-10-2-0171, http://mrmc.amedd.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the invaluable assistance of Mr. Polaris and Hilarion Banks in assisting with the high-speed video recordings of the head movements and Ms. Kristen Whitney for critically reading the manuscript. This work was funded by an award from the United States Army Medical Research and Material Command (W81XWH-10-2-0171) to P.J.B.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	24	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161053	10.1371/journal.pone.0161053	http://dx.doi.org/10.1371/journal.pone.0161053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657499	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200004
J	Uchida, TK; Seth, A; Pouya, S; Dembia, CL; Hicks, JL; Delp, SL				Uchida, Thomas K.; Seth, Ajay; Pouya, Soha; Dembia, Christopher L.; Hicks, Jennifer L.; Delp, Scott L.			Simulating Ideal Assistive Devices to Reduce the Metabolic Cost of Running	PLOS ONE			English	Article							MUSCLE CONTRIBUTIONS; DYNAMIC SIMULATIONS; HUMAN WALKING; ENERGETIC COST; EXOSKELETON; MECHANICS; SUPPORT; TENDON; MASS; BIOMECHANICS	Tools have been used for millions of years to augment the capabilities of the human body, allowing us to accomplish tasks that would otherwise be difficult or impossible. Powered exoskeletons and other assistive devices are sophisticated modern tools that have restored bipedal locomotion in individuals with paraplegia and have endowed unimpaired individuals with superhuman strength. Despite these successes, designing assistive devices that reduce energy consumption during running remains a substantial challenge, in part because these devices disrupt the dynamics of a complex, finely tuned biological system. Furthermore, designers have hitherto relied primarily on experiments, which cannot report muscle-level energy consumption and are fraught with practical challenges. In this study, we use OpenSim to generate muscle-driven simulations of 10 human subjects running at 2 and 5 m/s. We then add ideal, massless assistive devices to our simulations and examine the predicted changes in muscle recruitment patterns and metabolic power consumption. Our simulations suggest that an assistive device should not necessarily apply the net joint moment generated by muscles during unassisted running, and an assistive device can reduce the activity of muscles that do not cross the assisted joint. Our results corroborate and suggest biomechanical explanations for similar effects observed by experimentalists, and can be used to form hypotheses for future experimental studies. The models, simulations, and software used in this study are freely available at simtk.org and can provide insight into assistive device design that complements experimental approaches.	[Uchida, Thomas K.; Seth, Ajay; Pouya, Soha; Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dembia, Christopher L.; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Uchida, TK (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	tkuchida@stanford.edu		Hicks, Jennifer/0000-0002-2516-9334; Delp, Scott/0000-0002-9643-7551; Seth, Ajay/0000-0003-4217-1580; Uchida, Thomas/0000-0002-7700-7476; Dembia, Christopher/0000-0002-7759-7146	Defense Advanced Research Projects Agency (DARPA) [W911QX-12-C-0018]; National Institutes of Health (NIH) [R24 HD065690, P2C HD065690, U54 EB020405, U54 GM072970]; National Science Foundation (NSF) [DGE-114747]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065690, R24HD065690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided to all authors by Defense Advanced Research Projects Agency (DARPA) contract W911QX-12-C-0018 (Warrior Web) and by National Institutes of Health (NIH) grants R24 HD065690 and P2C HD065690 (NIH National Center for Simulation in Rehabilitation Research), U54 EB020405 (Mobilize Center NIH Big Data to Knowledge Center of Excellence), and U54 GM072970 (NIH National Center for Physics Based Simulation of Biological Structures). CLD also received funding from National Science Foundation (NSF) Graduate Research Fellowship DGE-114747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033177; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bogue R, 2009, IND ROBOT, V36, P421, DOI 10.1108/01439910910980141; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Caputo JM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026225; Carrier DR, 2011, P NATL ACAD SCI USA, V108, P18631, DOI 10.1073/pnas.1105277108; Cenciarini M., 2011, IEEE INT C REH ROB P, V2011, P1, DOI [10.1109/ICORR.2011.5975366, DOI 10.1109/ICORR.2011.5975366]; Cherry MS, 2010, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, VOL 7, PTS A AND B, P727; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dollar AM, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P747, DOI 10.1109/IROS.2008.4651202; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Elliott G., 2013, IEEE INT C REHABIL R, P1; Farris DJ, 2012, J APPL PHYSIOL, V113, P1862, DOI 10.1152/japplphysiol.00802.2012; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; GARRETT WE, 1984, AM J SPORT MED, V12, P98, DOI 10.1177/036354658401200202; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Grabowski AM, 2009, J APPL PHYSIOL, V107, P670, DOI 10.1152/japplphysiol.91609.2008; Gruber AH, 2013, J APPL PHYSIOL, V115, P194, DOI 10.1152/japplphysiol.01437.2012; Hamner SR, 2013, J BIOMECH, V46, P780, DOI 10.1016/j.jbiomech.2012.11.024; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Homayouni T, 2015, IEEE T BIO-MED ENG, V62, P2208, DOI 10.1109/TBME.2015.2419223; Ikeuchi Y, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P4073, DOI 10.1109/IROS.2009.5354543; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Kazerooni H, 2005, IEEE INT CONF ROBOT, P4353; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; LAPRE AK, 2014, P 2014 INT C IEEE EN, P1618; Lenzi T, 2013, IEEE T NEUR SYS REH, V21, P938, DOI 10.1109/TNSRE.2013.2248749; Lichtwark GA, 2008, J THEOR BIOL, V252, P662, DOI 10.1016/j.jtbi.2008.01.018; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Miller RH, 2012, P ROY SOC B-BIOL SCI, V279, P1498, DOI 10.1098/rspb.2011.2015; Minetti AE, 2013, J APPL PHYSIOL, V114, P498, DOI 10.1152/japplphysiol.00959.2012; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; NEWHAM DJ, 1983, CLIN SCI, V64, P55, DOI 10.1042/cs0640055; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; Pires NJ, 2014, J EXP BIOL, V217, P3519, DOI 10.1242/jeb.107599; Pratt JE, 2004, IEEE INT CONF ROBOT, P2430, DOI 10.1109/ROBOT.2004.1307425; Riener R, 2010, J HEALTHC ENG, V1, P197, DOI 10.1260/2040-2295.1.2.197; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Sawicki GS, 2015, IEEE T BIOMED ENG, VPP, P1; SEABURY JJ, 1977, ERGONOMICS, V20, P491, DOI 10.1080/00140137708931658; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Shamaei K, 2015, IEEE T BIO-MED ENG, V62, P2389, DOI 10.1109/TBME.2015.2428636; Sherman MA, 2011, PROC IUTAM, V2, P241, DOI 10.1016/j.piutam.2011.04.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Strausser K. A., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4911, DOI 10.1109/IROS.2011.6048674; Sugar TG, 2015, ASME J MECH ROBOT, V7, DOI [10.1115/1, DOI 10.1151/1.]; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Thelen DG, 2003, J BIOMECH ENG-T ASME, V125, P70, DOI 10.1115/1.1531112; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150378; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Vanderpool MT, 2008, GAIT POSTURE, V28, P427, DOI 10.1016/j.gaitpost.2008.01.016; Viteckova S, 2013, BIOCYBERN BIOMED ENG, V33, P96, DOI 10.1016/j.bbe.2013.03.005; Walsh CJ, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P1410, DOI 10.1109/IROS.2006.281932; Yagn N, 1890, US Patent, Patent No. [420,179, 420173]; Yan TF, 2015, ROBOT AUTON SYST, V64, P120, DOI 10.1016/j.robot.2014.09.032; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	64	66	66	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163417	10.1371/journal.pone.0163417	http://dx.doi.org/10.1371/journal.pone.0163417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656901	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200115
J	Gatta, G; Cortesi, M; Zamparo, P				Gatta, Giorgio; Cortesi, Matteo; Zamparo, Paola			The Relationship between Power Generated by Thrust and Power to Overcome Drag in Elite Short Distance Swimmers	PLOS ONE			English	Article							PASSIVE DRAG; SWIMMING STROKES; ACTIVE DRAG; CRAWL; PERFORMANCE; ENERGETICS; VELOCITY; FORCES; OUTPUT	At constant average speed (v), a balance between thrust force (Ft) and drag force (Fd) should occur: Ft-Fd = 0; hence the power generated by thrust forces (Pt = Ft.v) should be equal to the power needed to overcome drag forces at that speed (Pd = Fd.v); the aim of this study was to measure Pt (tethered swims), to estimate Pd in active conditions (at sprint speed) and to compare these values. 10 front crawl male elite swimmers (expertise: 93.1 +/- 2.4% of 50 m world record) participated to the study; their sprint speed was measured during a 30 m maximal trial. Ft was assessed during a 15 s tethered effort; passive towing measurement were performed to determine speed specific drag in passive conditions (k(P) = passive drag force/v(2)); drag force in active conditions (Fd = kA.v(2)) was calculated assuming that kA = 1.5.kP. Average sprint speed was 2.20 +/- 0.07 m.s(-1); k(A), at this speed, was 37.2 +/- 2.7 N.s(2).m(-2). No significant differences (paired t-test: p > 0.8) were observed between Pt (399 +/- 56 W) and Pd (400 +/- 57 W) and a strong correlation (R = 0.95, p < 0.001) was observed between these two parameters. The Bland-Altman plot indicated a good agreement and a small, acceptable, error (bias: -0.89 W, limits of agreement: -25.5 and 23.7 W). Power thrust experiments can thus be suggested as a valid tool for estimating a swimmer's power propulsion.	[Gatta, Giorgio; Cortesi, Matteo] Dept Life Qual Studies, Rimini, Italy; [Gatta, Giorgio; Cortesi, Matteo] Univ Bologna, Sch Pharm Biotechnol & Sport Sci, Bologna, Italy; [Zamparo, Paola] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy	University of Bologna; University of Verona	Gatta, G (corresponding author), Dept Life Qual Studies, Rimini, Italy.; Gatta, G (corresponding author), Univ Bologna, Sch Pharm Biotechnol & Sport Sci, Bologna, Italy.	m.cortesi@unibo.it	Zamparo, Paola/AAF-7700-2020; Cortesi, Matteo/AAA-7263-2021	Zamparo, Paola/0000-0002-6919-6721; GATTA, GIORGIO/0000-0001-6322-7761				Barbosa TM, 2015, J STRENGTH COND RES, V29, P440, DOI 10.1519/JSC.0000000000000626; Barlett R., 2007, INTRO SPORTS BIOMECH; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ceseracciu E, 2011, J BIOMECH, V44, P2236, DOI 10.1016/j.jbiomech.2011.06.003; CLARYS JP, 1979, SWIMMING, V3, P3; Cortesi M, 2014, J STRENGTH COND RES, V28, P3164, DOI 10.1519/JSC.0000000000000508; CRAIG AB, 1979, MED SCI SPORT EXER, V11, P278; DIPRAMPE.PE, 1974, J APPL PHYSIOL, V37, P1; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Dominguez-Castells R, 2013, INT J SPORTS MED, V34, P324, DOI 10.1055/s-0032-1323721; Fomitchenko TG, 1999, P 8 INT S BIOM MED S, P209; Gatta G, 2015, HUM MOVEMENT SCI, V39, P41, DOI 10.1016/j.humov.2014.06.010; Gatta G, 2013, J STRENGTH COND RES, V27, P2904, DOI 10.1519/JSC.0b013e318280cc3a; Havriluk R, 2007, RES Q EXERCISE SPORT, V78, P32, DOI 10.1080/02701367.2007.10599401; HOLMER I, 1974, ACTA PHYSIOL SCAND, P1; KESKINEN K L, 1989, Scandinavian Journal of Sports Sciences, V11, P87; Knuttgen H.G., 1987, J APPL SPORT RES, V1, P1, DOI DOI 10.1519/00124278-198702000-00001; KOLMOGOROV SV, 1992, J BIOMECH, V25, P311, DOI 10.1016/0021-9290(92)90028-Y; Lecrivain G, 2010, J BIOMECH, V43, P1111, DOI 10.1016/j.jbiomech.2009.12.014; Lyttle A, 2011, WORLD BOOK SWIMMING, P425; MAGEL JR, 1970, RES QUART, V41, P68, DOI 10.1080/10671188.1970.10614948; Morouco PG, 2014, J STRENGTH COND RES, V28, P3093, DOI 10.1519/JSC.0000000000000509; MOSTERD W. L., 1964, INTERNATIONALE Z ANGEW PHYSIOL, V20, P288; Schleihauf RE, 1979, SWIMMING, V8, P70; Shionoya Akira, 1999, Applied Human Science, V18, P13, DOI 10.2114/jpa.18.13; Taylor S, 2001, J SPORTS SCI, V19, P12; Toussaint HM, 2004, J BIOMECH, V37, P1655, DOI 10.1016/j.jbiomech.2004.02.020; TOUSSAINT HM, 1992, SPORTS MED, V13, P8, DOI 10.2165/00007256-199213010-00002; Vorontsov A., 2011, WORLD BOOK SWIMMING, P313; Wilson B, 2003, BIOMECHANICS MED SWI, P15; YEATER RA, 1981, J BIOMECH, V14, P527, DOI 10.1016/0021-9290(81)90002-6; Zamparo P, 2011, EUR J APPL PHYSIOL, V111, P367, DOI [10.1007/s00421-010-1433-7, 10.1007/s00421-010-1396-8]; Zamparo P, 2002, J BIOMECH, V35, P1387, DOI 10.1016/S0021-9290(02)00071-4; Zamparo P, 2009, EUR J APPL PHYSIOL, V106, P195, DOI 10.1007/s00421-009-1007-8	35	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162387	10.1371/journal.pone.0162387	http://dx.doi.org/10.1371/journal.pone.0162387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654992	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700022
J	Fu, T; Sharmab, A; Xie, F; Liu, YL; Li, K; Wan, WW; Baylin, SB; Wolfgang, CL; Ahuja, N				Fu, Tao; Sharmab, Anup; Xie, Fei; Liu, Yanliang; Li, Kai; Wan, Weiwei; Baylin, Stephen B.; Wolfgang, Christopher L.; Ahuja, Nita			Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE MGMT; SMALL-BOWEL ADENOCARCINOMA; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; COLORECTAL-CANCER; K-RAS; LUNG-CANCER; GENE; HYPERMETHYLATION; GLIOBLASTOMA	Background O-6-methylguanine-DNA methyltransferase (MGMT) methylation status has not been extensively investigated in duodenal adenocarcinoma (DA). The aim of this study was to evaluate the MGMT methylation status and examine its possible prognostic value in patients with stage III DA. Methods Demographics, tumor characteristics and survival were available for 64 patients with stage III DA. MGMT methylation was detected by using MethyLight. A Cox proportional hazard model was built to predict survival, adjusted for clinicopathological characteristics and tumor molecular features, including the CpG island methylator phenotype (CIMP), microsatellite instability (MSI), and KRAS mutations. Results MGMT methylation was detected in 17 of 64 (26.6%) patients, and was not correlated with sex, age, tumor differentiation, CIMP, MSI, or KRAS mutations. MGMT methylation was the only one factor associated with both overall survival (OS) and disease-free survival (DFS) on both univariate and multivariate analyses. In patients treated with surgery alone, MGMT-methylated group had worse OS and DFS when compared with MGMT-unmethylated group. However, in patients treated with chemotherapy/radiotherapy, outcomes became comparable between the two groups. Conclusions Our results demonstrate MGMT methylation is a reliable and independent prognostic factor in DAs. Methylation of MGMT is associated with poor prognosis in patients with stage III DAs.	[Fu, Tao; Xie, Fei; Liu, Yanliang; Li, Kai; Wan, Weiwei] Wuhan Univ, Renmin Hosp, Dept Gastrointestinal Surg 2, Key Lab Hubei Prov Digest Syst Dis, Wuhan, Peoples R China; [Sharmab, Anup; Wolfgang, Christopher L.; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Baylin, Stephen B.; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Wuhan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fu, T (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastrointestinal Surg 2, Key Lab Hubei Prov Digest Syst Dis, Wuhan, Peoples R China.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.	futao1975@tom.com; nahuja1@jhmi.edu	Wolfgang, Christopher/HGD-0863-2022	Fu, Tao/0000-0003-4713-7269	National Institutes of Health [CA140599, CA127141]; National Natural Science Foundation of China [81000898, 81472289]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by National Institutes of Health grants CA140599 and CA127141, National Natural Science Foundation of China grants 81000898 and 81472289, and sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China.	ALWMARK A, 1980, ANN SURG, V191, P13, DOI 10.1097/00000658-198001000-00003; Baumann S, 2006, INT J CANCER, V119, P264, DOI 10.1002/ijc.21848; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI 10.1097/SLA.0b013e31818e4641; Brabender J, 2003, CLIN CANCER RES, V9, P223; Cecchini S, 2012, J GASTROINTEST SURG, V16, P113, DOI 10.1007/s11605-011-1704-6; Chalmers AJ, 2009, INT J RADIAT ONCOL, V75, P1511, DOI 10.1016/j.ijrobp.2009.07.1703; Christmann M, 2011, BBA-REV CANCER, V1816, P179, DOI 10.1016/j.bbcan.2011.06.002; Cloyd JM, 2014, ANN SURG ONCOL, DOI [10.1245/1208250, DOI 10.1245/1208250]; Dietmaier W, 1997, CANCER RES, V57, P4749; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, CANCER RES, V60, P2368; Fu T, 2013, INT J CANCER, V132, P2502, DOI 10.1002/ijc.27910; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Fumagalli C, 2014, CLIN BREAST CANCER, V14, P285, DOI 10.1016/j.clbc.2014.02.010; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hibi K, 2009, ANTICANCER RES, V29, P5053; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Jesien-Lewandowicz E, 2009, CANCER GENET CYTOGEN, V188, P77, DOI 10.1016/j.cancergencyto.2008.09.015; Kelsey CR, 2007, INT J RADIAT ONCOL, V69, P1436, DOI 10.1016/j.ijrobp.2007.05.006; Kim JI, 2009, HUM PATHOL, V40, P934, DOI 10.1016/j.humpath.2009.01.005; Kim SG, 2003, GASTROENTEROLOGY, V124, P1300, DOI 10.1016/S0016-5085(03)00278-6; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Laforest A, 2014, EUR J CANCER, V50, P1740, DOI 10.1016/j.ejca.2014.04.007; Liu Y, 2006, NEOPLASIA, V8, P46, DOI 10.1593/neo.05586; Murakami J, 2007, ONCOL REP, V17, P1461; Nagasaka T, 2003, CLIN CANCER RES, V9, P5306; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Nagy E, 2014, BRIT J CANCER, V110, P2874, DOI 10.1038/bjc.2014.263; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Overman MJ, 2010, BRIT J CANCER, V102, P144, DOI 10.1038/sj.bjc.6605449; Overman MJ, 2012, ANN SURG ONCOL, V19, P1439, DOI 10.1245/s10434-011-2173-6; Overman MJ, 2010, CANCER-AM CANCER SOC, V116, P5374, DOI 10.1002/cncr.25324; Poultsides GA, 2012, ANN SURG ONCOL, V19, P1928, DOI 10.1245/s10434-011-2168-3; Raghav K, 2013, NAT REV CLIN ONCOL, V10, P534, DOI 10.1038/nrclinonc.2013.132; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Singhal N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005202.pub2; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swartz MJ, 2007, ARCH SURG-CHICAGO, V142, P285, DOI 10.1001/archsurg.142.3.285; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wu Ming, 2004, Gastric Cancer, V7, P246, DOI 10.1007/s10120-004-0300-9; Yachida S, 2009, AM J SURG PATHOL, V33, P1823, DOI 10.1097/PAS.0b013e3181b6da19; Yan L, 2005, ONCOGENE, V24, P2175, DOI 10.1038/sj.onc.1208250; Zhang Y, 2014, CELL DEATH DIFFER, V21, P720, DOI 10.1038/cdd.2013.196; Zhao JJ, 2014, TUMOUR BIOL J INT SO, DOI [10.1007/s13277-014-2276-3, DOI 10.1007/S13277-014-2276-3.IJC.23398]	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162929	10.1371/journal.pone.0162929	http://dx.doi.org/10.1371/journal.pone.0162929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643594	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900025
J	Morey, F; Hambleton, IR; Unwin, N; Samuels, TA				Morey, Francis; Hambleton, Ian R.; Unwin, Nigel; Samuels, T. Alafia			Ethnic and Gender Disparities in Premature Adult Mortality in Belize 2008-2010	PLOS ONE			English	Article							ALL-CAUSE; DETERMINANTS; TRINIDAD; MEN	Background Data on disparities in mortality within low and middle income countries are limited, with little published data from the Caribbean or Central America. Our aim was to investigate disparities in overall and cause specific premature adult mortality in the multi-ethnic middle income country of Belize. Methods Mortality data from Belize 2008-2010 classified using the International Classification of Diseases 10 and the 2010 census stratified by age and ethnicity were used to calculate age, sex, and ethnic specific mortality rates for those 15-59 years, and life table analysis was used to estimate the probability of death between the ages of 15 and 59 (45q15). Results The probability of death among those aged 15 to 59 years was 18.1% (women 13.5%, men 22.7%). Creole and Garifuna ethnic groups have three times the 45q15 probability of death compared to Mayan and Mestizo groups (Creole 31.2%, Garifuna 31.1%, Mayan 10.2%, Mestizo 12.0%). This pattern of ethnic disparity existed in both sexes but was greater in men. The probability of death from injurieswas 14.8% among Creole men, more than twice the rate of other ethnicities and peaks among young Creole men. These deaths are dominated by homicides and unspecified deaths involving firearms Conclusions Marked disparities in mortality between ethnic groups exist in this Central American/Caribbean country, from rates that are typical of high-income countries to those of low-income countries. The pattern of these extreme differences likely suggests that they reflect underlying social determinants rooted in the country's colonial past.	[Morey, Francis] Minist Hlth, Dept Hlth Serv, Belmopan, Belize; [Hambleton, Ian R.; Unwin, Nigel; Samuels, T. Alafia] Univ West Indies, Caribbean Inst Hlth Res, Chron Dis Res Ctr, Bridgetown, Barbados; [Unwin, Nigel] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	University West Indies Mona Jamaica; University of the West Indies Open Campus; University of Cambridge	Samuels, TA (corresponding author), Univ West Indies, Caribbean Inst Hlth Res, Chron Dis Res Ctr, Bridgetown, Barbados.	Alafia.samuels@cavehill.uwi.edu	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794; Unwin, Nigel/0000-0002-1368-1648	National Institute On Minority Health And Health Disparities [U24MD006959]	National Institute On Minority Health And Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	IH was supported by Grant Number U24MD006959 from the National Institute On Minority Health And Health Disparities (http://www.nimhd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Chevannes B, 1999, G KENNEDY FDN LECT S, V1999; Community C, 2016, MEMB STAT ASS MEMB; Crime UNOoDa, 2010, WORLD DRUG REP 2010; Epidemiology Unit MoH, 2011, BEL BAS IND 2010; Evans H., 1999, GENDER DIFFERENCES E; Fay MP, 1997, STAT MED, V16, P791; Feachem RGA, 1992, HLTH ADULTS DEV WORL; Gayle Herbert., 2010, MALE SOCIAL PARTICIP; Government of Belize and the Caribbean Development Bank, 2010, COUNTR POV ASS FIN R, V1; IHME, 2010, GBD PROF; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Miller GJ, 2005, INT J EPIDEMIOL, V34, P1387, DOI 10.1093/ije/dyi193; MILLER GJ, 1988, INT J EPIDEMIOL, V17, P62, DOI 10.1093/ije/17.1.62; Ministry of Health GoB, 2006, VIT REG BEL MEM UND; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Mwakikagile G., 2010, BELIZE ITS IDENTITY; Odedina Folakemi T, 2009, Infect Agent Cancer, V4 Suppl 1, pS2, DOI 10.1186/1750-9378-4-S1-S2; Organization PAH, 2011, REG MORT DAT; PAHO (Pan American Health Organization), 2012, HLTH AM 2012 ED REG; Pan American Health Organization, 2013, HLTH SIT AM BAS IND; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Ramsay-Johnson Edith M, 2006, ABNF J, V17, P44; SELVIN S, 1991, STAT ANAL EPIDEMIOLO; Statistical Institute of Belize, 2012, ABSTR STAT; Thomas CN, 2000, W INDIAN MED J, V49, P112; United Nations, 1982, MOD LIF TABL DEV COU; United Nations DoEaSA Population Division, 2012, WORLD MORT REP 2011; United Nations DoEaSA Population Division, 2013, ESAPWP228 UN DOEASA; United Nations DoEaSA Population Division Changing Levels and Trends in Mortality: the role of patterns of death by cause New York United Nations, 2012, STESASERA318 UN DOEA; United Nations DoEaSA Statistics Division, 2016, WORLD STAT POCK BOOK; World Health Organization, 2012, LANDM C ENDS AD RIO	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163172	10.1371/journal.pone.0163172	http://dx.doi.org/10.1371/journal.pone.0163172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643696	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900035
J	Smith-Brown, P; Morrison, M; Krause, L; Davies, PSW				Smith-Brown, Paula; Morrison, Mark; Krause, Lutz; Davies, Peter S. W.			Mothers Secretor Status Affects Development of Childrens Microbiota Composition and Function: A Pilot Study	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; CELIAC-DISEASE; GUT MICROBIOME; BLOOD-GROUP; MILK GROUPS; DIET; BIFIDOBACTERIA; COMMUNITIES; FREQUENCY; BACTERIA	Background One mechanism by which early life environment may influence long term health is through modulation of the gut microbiota. It is widely accepted that the optimal source of nutrition in early life is breast milk, with Human Milk Oligosaccharides (HMOs) thought to play an important role in nourishing the developing microbiota. However, mothers with inactive secretor genes have altered HMO composition and quantities in their breast milk. In this pilot study we examine the influence of secretor status and breast-feeding on microbiota composition at 2 to 3 years of age. Methods 37 children and 17 eligible mothers were recruited. Secretor status was determined from blood and saliva samples using hemagglutination inhibition technique and faecal microbiota composition was examined by 16S rRNA gene sequencing. Results Secretor status was determined for 28 eligible children with 20 being secretors (S, 71.4%). Eleven of the 17 mothers were secretors (S, 64.7%). Unweighted UniFrac distances were significantly associated with child secretor status (R-2 = 0.069, p = 0.030) and with mother secretor status in children exclusively breastfed for at least 4 months (R-2 = 0.167, p = 0.028), suggesting an influence on the presence/absence of microbes, with Prevotella not detected in samples from secretor children and children of secretor mothers. In children who were exclusively breast-fed for at least 4 months of life the abundance of the known HMO consumers Bifidobacterium were increased in the children of secretor mothers compared to non-secretor mothers. The relative abundance of an OTU related to Bacteroides plebeius, a bacterium noted for its capacity to utilise sulphated polysaccharides for growth, was decreased in these children. Conclusions Child and mothers' secretor status have an impact on childrens' microbiota composition at 2 to 3 years of age.	[Smith-Brown, Paula; Davies, Peter S. W.] Univ Queensland, Child Hlth Res Ctr, Childrens Nutr Res Ctr, Brisbane, Qld, Australia; [Morrison, Mark; Krause, Lutz] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Smith-Brown, P (corresponding author), Univ Queensland, Child Hlth Res Ctr, Childrens Nutr Res Ctr, Brisbane, Qld, Australia.	p.brown1@uq.edu.au	Morrison, Mark/C-9707-2013; Krause, Lutz/G-6283-2013	Morrison, Mark/0000-0001-9257-9133; Krause, Lutz/0000-0003-3806-0845	Danone Nutricia, Australia; Australian Government	Danone Nutricia, Australia; Australian Government(Australian GovernmentCGIAR)	PSB received Ph.D. living allowance stipend from Danone Nutricia, Australia, and data analysis funded by Danone Nutricia, Australia (PSB, PSWD). No grant number associated with this funding. URL: www.nutricia.com.au. The Translation Research Institute is supported by a grant from the Australian Government (LK, MM). No grant number supplied. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14; Bondue P, 2015, KOREAN J FOOD SCI AN, V35, P1, DOI 10.5851/kosfa.2015.35.1.1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Combs M R, 2009, Immunohematology, V25, P112; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Goehring KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101692; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langley-Evans SC, 2015, J HUM NUTR DIET, V28, P1, DOI 10.1111/jhn.12212; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Liu SL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0362-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Newby R, 2014, BREASTFEED MED, V9, P266, DOI 10.1089/bfm.2014.0012; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Rho JH, 2005, J BACTERIOL, V187, P1543, DOI 10.1128/JB.187.5.1543-1551.2005; Saboor M, 2014, PAK J MED SCI, V30, P189, DOI 10.12669/pjms.301.4194; SAMUELSSON B, 1991, Z RHEUMATOL, V50, P3; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schroeder P., CLIN MICROBIOLOGY LA; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Thurl S, 1997, GLYCOCONJUGATE J, V14, P795, DOI 10.1023/A:1018529703106; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; Tong M, 2014, ISME J, V8, P2193, DOI 10.1038/ismej.2014.64; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	53	46	49	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0161211	10.1371/journal.pone.0161211	http://dx.doi.org/10.1371/journal.pone.0161211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644050	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900003
J	Dietrich, JF; Huber, S; Klein, E; Willmes, K; Pixner, S; Moeller, K				Dietrich, Julia Felicitas; Huber, Stefan; Klein, Elise; Willmes, Klaus; Pixner, Silvia; Moeller, Korbinian			A Systematic Investigation of Accuracy and Response Time Based Measures Used to Index ANS Acuity	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; NUMERICAL MAGNITUDE REPRESENTATIONS; INDIVIDUAL-DIFFERENCES; ACHIEVEMENT EVIDENCE; MATH ACHIEVEMENT; INTUITIVE SENSE; NEURAL BASIS; RELIABILITY; CHILDREN; MODEL	The approximate number system (ANS) was proposed to be a building block for later mathematical abilities. Several measures have been used interchangeably to assess ANS acuity. Some of these measures were based on accuracy data, whereas others relied on response time (RT) data or combined accuracy and RT data. Previous studies challenged the view that all these measures can be used interchangeably, because low correlations between some of the measures had been observed. These low correlations might be due to poor reliability of some of the measures, since the majority of these measures are mathematically related. Here we systematically investigated the relationship between common ANS measures while avoiding the potential confound of poor reliability. Our first experiment revealed high correlations between all accuracy based measures supporting the assumption that all of them can be used interchangeably. In contrast, not all RT based measures were highly correlated. Additionally, our results revealed a speed-accuracy trade-off. Thus, accuracy and RT based measures provided conflicting conclusions regarding ANS acuity. Therefore, we investigated in two further experiments which type of measure (accuracy or RT) is more informative about the underlying ANS acuity, depending on participants' preferences for accuracy or speed. To this end, we manipulated participants' preferences for accuracy or speed both explicitly using different task instructions and implicitly varying presentation duration. Accuracy based measures were more informative about the underlying ANS acuity than RT based measures. Moreover, the influence of the underlying representations on accuracy data was more pronounced when participants preferred accuracy over speed after the accuracy instruction as well as for long or unlimited presentation durations. Implications regarding the diffusion model as a theoretical framework of dot comparison as well as regarding the relationship between ANS acuity and math performance are discussed.	[Dietrich, Julia Felicitas; Huber, Stefan; Klein, Elise; Moeller, Korbinian] Leibniz Inst Fuer Wissensmedien, Tubingen, Germany; [Dietrich, Julia Felicitas; Moeller, Korbinian] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany; [Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurol, Sect Neuropsychol, Aachen, Germany; [Pixner, Silvia] UMIT Hlth & Life Sci Univ, Inst Appl Psychol, Hall In Tirol, Austria; [Moeller, Korbinian] Eberhard Karls Univ Tubingen, LEAD Grad Sch, Tubingen, Germany	Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen	Dietrich, JF (corresponding author), Leibniz Inst Fuer Wissensmedien, Tubingen, Germany.; Dietrich, JF (corresponding author), Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany.	julia.dietrich@iwm-tuebingen.de	Moeller, Korbinian/AAC-6387-2020; Willmes, Klaus F/A-1268-2014	Willmes, Klaus F/0000-0002-9012-0553; Pixner, Silvia/0000-0001-5605-8576	German Research Foundation (DFG) [MO 2525/2-1]; Leibniz-Competition Fund [SAW-2014-IWM-4]; Ministery Science, Research and Arts Baden-Wuerttemberg; European Social Fonds (ESF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz-Competition Fund; Ministery Science, Research and Arts Baden-Wuerttemberg; European Social Fonds (ESF)	Julia Dietrich was supported by the German Research Foundation (DFG) providing funding to Korbinian Moeller and Elise Klein (MO 2525/2-1) (http://www.dfg.de/). Stefan Huber was supported by the Leibniz-Competition Fund providing funding to Elise Klein (SAW-2014-IWM-4) (http://www.leibniz-gemeinschaft.de/ueber-uns/leibniz-wettbewerb/). Elise Klein was supported by the Margarete von-Wrangell Fellowship of the Ministery Science, Research and Arts Baden-Wuerttemberg and the European Social Fonds (ESF) (http://margarete-von-wrangell.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-26; Anobile G, 2013, J EXP CHILD PSYCHOL, V116, P380, DOI 10.1016/j.jecp.2013.06.006; Baguley T, 2012, SERIOUS STATS GUIDE; Bartelet D, 2014, J EXP CHILD PSYCHOL, V117, P12, DOI 10.1016/j.jecp.2013.08.010; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Barton K., 2016, MUMIN MULTIMODEL INF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Brankaer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093565; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 2011, NUMBER SENSE MIND CR; DEHAENE S, 2007, ATTENTION PERFORMANC; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; DeWind NK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00310; DeWind NK, 2015, COGNITION, V142, P247, DOI 10.1016/j.cognition.2015.05.016; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Dietrich JF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00295; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2013, CHILD DEV PERSPECT, V7, P74, DOI 10.1111/cdep.12019; Ferreira Fernanda de Oliveira, 2012, Psychol. Neurosci., V5, P037, DOI 10.3922/j.psns.2012.1.06; FITTS PM, 1966, J EXP PSYCHOL, V71, P849, DOI 10.1037/h0023232; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gandini D, 2008, ACTA PSYCHOL, V129, P175, DOI 10.1016/j.actpsy.2008.05.009; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gilmore C, 2014, LEARN INDIVID DIFFER, V29, P50, DOI 10.1016/j.lindif.2013.10.004; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Goodwin LD, 2006, J EXP EDUC, V74, P251, DOI 10.3200/jexe.74.3.249-266; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gullick MM, 2011, LEARN INDIVID DIFFER, V21, P644, DOI 10.1016/j.lindif.2010.10.003; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Heitz RP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00150; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huber S, 2014, PSYCHOL RES-PSYCH FO, V78, P539, DOI 10.1007/s00426-013-0504-x; Huber S., 2013, P 12 INT C COGN MOD, P185; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Inglis M, 2013, COGNITION, V129, P63, DOI 10.1016/j.cognition.2013.06.003; KOPRIVA RJ, 1991, EDUC PSYCHOL MEAS, V51, P585, DOI 10.1177/0013164491513006; Krinzinger H, 2011, DEV NEUROPSYCHOL, V36, P721, DOI 10.1080/87565641.2010.549882; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Lindskog M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00510; Linsen S, 2014, ACTA PSYCHOL, V145, P75, DOI 10.1016/j.actpsy.2013.10.008; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; Lyons IM, 2015, J EXP PSYCHOL GEN, V144, P1021, DOI 10.1037/xge0000094; Lyons IM, 2015, HUM BRAIN MAPP, V36, P475, DOI 10.1002/hbm.22641; Macizo P, 2013, PSYCHOL RES-PSYCH FO, V77, P651, DOI 10.1007/s00426-012-0456-6; Macizo P, 2011, ACTA PSYCHOL, V136, P112, DOI 10.1016/j.actpsy.2010.10.008; Maloney EA, 2010, ACTA PSYCHOL, V134, P154, DOI 10.1016/j.actpsy.2010.01.006; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Moeller K, 2011, RES DEV DISABIL, V32, P1837, DOI 10.1016/j.ridd.2011.03.012; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Murphy K. R., 1988, PSYCHOL TESTING PRIN; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2015, OXFORD HDB NUMERICAL, P456; Nieder A, 2007, J NEUROSCI, V27, P5986, DOI 10.1523/JNEUROSCI.1056-07.2007; Nieder A, 2013, J COMP PHYSIOL A, V199, P1, DOI 10.1007/s00359-012-0763-9; Nieder A, 2011, ATTENTION PERFORM, P103, DOI 10.1016/B978-0-12-385948-8.00008-6; Nieder A, 2012, P NATL ACAD SCI USA, V109, P11860, DOI 10.1073/pnas.1204580109; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Park J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01955; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; POLTROCK SE, 1989, J MATH PSYCHOL, V33, P131, DOI 10.1016/0022-2496(89)90027-8; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratclifff R, 2015, COGNITION, V137, P115, DOI 10.1016/j.cognition.2014.12.004; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Sasanguie D, 2012, MIND BRAIN EDUC, V6, P119, DOI 10.1111/j.1751-228X.2012.01147.x; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Sasanguie D, 2011, ACTA PSYCHOL, V136, P73, DOI 10.1016/j.actpsy.2010.10.004; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simon TJ, 2008, NEUROPSYCHOLOGIA, V46, P82, DOI 10.1016/j.neuropsychologia.2007.08.016; Singmann H., 2015, AFEX ANAL FACTORIAL; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Stoianov I, 2012, NAT NEUROSCI, V15, P194, DOI 10.1038/nn.2996; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Townsend J., 1978, COGNITIVE THEORY; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Willse JT, 2014, CTT CLASSICAL TEST T	113	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163076	10.1371/journal.pone.0163076	http://dx.doi.org/10.1371/journal.pone.0163076			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5YN	27637109	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700031
J	Garganese, F; Schena, L; Siciliano, I; Prigigallo, MI; Spadaro, D; De Grassi, A; Ippolito, A; Sanzani, SM				Garganese, Francesca; Schena, Leonardo; Siciliano, Ilenia; Prigigallo, Maria Isabella; Spadaro, Davide; De Grassi, Anna; Ippolito, Antonio; Sanzani, Simona Marianna			Characterization of Citrus-Associated Alternaria Species in Mediterranean Areas	PLOS ONE			English	Article							HOST-SELECTIVE TOXINS; BROWN SPOT; TANGERINE PATHOTYPE; BIOSYNTHESIS; IDENTIFICATION; PATHOGENICITY; METABOLITES; MYCOTOXINS; DISEASES; TOMATO	Alternaria brown spot is one of the most important diseases of tangerines and their hybrids worldwide. Recently, outbreaks in Mediterranean areas related to susceptible cultivars, refocused attention on the disease. Twenty representatives were selected from a collection of 180 isolates of Alternaria spp. from citrus leaves and fruit. They were characterized along with reference strains of Alternaria spp. Micro-and macroscopic characteristics separated most Alternaria isolates into six morphotypes referable to A. alternata (5) and A. arborescens (1). Phylogenetic analyses, based on endopolygalacturonase (endopg) and internal transcribed spacer (ITS), confirmedthis finding. Moreover, a five-gene phylogeny including two anonymous genomics regions (OPA 1-3 and OPA 2-1), and the beta-tubulin gene (beta-tub), produced a further clustering of A. alternata into three clades. This analysis suggested the existence of intra-species molecular variability. Investigated isolates showed different levels of virulence on leaves and fruit. In particular, the pathogenicity on fruit seemed to be correlated with the tissue of isolation and the clade. The toxigenic behavior of Alternaria isolates was also investigated, with tenuazonic acid (TeA) being the most abundant mycotoxin (0.2-20 mg/L). Isolates also synthesized the mycotoxins alternariol(AOH), its derivate alternariol monomethyl ether (AME), and altenuene (ALT), although to a lesser extent. AME production significantly varied among the six morphotypes. The expression of pksJ/pksH, biosynthetic genes of AOH/AME, was not correlated with actual toxin production, but it was significantly different between the two genotypes and among the four clades. Finally, ten isolates proved to express the biosynthetic genes of ACTT1 phytotoxin, and thus to be included in the Alternaria pathotype tangerine. A significant correlation between pathogenicity on leaves and ACTT1 gene expression was recorded. The latter was significantly dependent on geographical origin. The widespread occurrence of Alternaria spp. on citrus fruit and their ability to producemycotoxins might represent a serious concern for producers and consumers.	[Garganese, Francesca; Ippolito, Antonio; Sanzani, Simona Marianna] Univ Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Schena, Leonardo; Prigigallo, Maria Isabella] Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy; [Siciliano, Ilenia; Spadaro, Davide] Univ Torino, Ctr Competenza Innovaz Campo Agroambientle, AGROINNOVA, Grugliasco, TO, Italy; [Spadaro, Davide] Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, TO, Italy; [De Grassi, Anna] Univ Aldo Moro, Dipartimentodi Biosci Biotecnol & Biofarmaceut, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita Mediterranea di Reggio Calabria; University of Turin; University of Turin; Universita degli Studi di Bari Aldo Moro	Sanzani, SM (corresponding author), Univ Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.	simonamarianna.sanzani@uniba.it	Prigigallo, Maria Isabella/A-1935-2019; Spadaro, Davide/F-1994-2011; SANZANI, Simona Marianna/AAE-2175-2022; Sanzani, Simona Marianna/B-9233-2019; Schena, Leonardo/A-7492-2018; Garganese, Francesca/AAC-2152-2020; De Grassi, Anna/AAE-6036-2020	Prigigallo, Maria Isabella/0000-0002-6913-5232; Spadaro, Davide/0000-0001-5207-9345; SANZANI, Simona Marianna/0000-0002-1631-638X; Schena, Leonardo/0000-0002-9737-2593; Garganese, Francesca/0000-0002-7386-8543; De Grassi, Anna/0000-0001-7273-4263; Siciliano, Ilenia/0000-0002-9258-0107	grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita [PON03PE_00090_03]	grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita	This work was partially funded by grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03).; This work was partially funded by grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee"-PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03). We thank Dr. Sylvia Stastny for her critical English revision.	Ajiro N, 2010, PHYTOPATHOLOGY, V100, P120, DOI 10.1094/PHYTO-100-2-0120; Akimitsu KA, 2003, MOL PLANT PATHOL, V4, P435, DOI 10.1046/j.1364-3703.2003.00189.X; Akimitsu K, 2014, J GEN PLANT PATHOL, V80, P109, DOI 10.1007/s10327-013-0498-7; Andersen B, 2008, MYCOL RES, V112, P241, DOI 10.1016/j.mycres.2007.09.004; Andersen B, 2006, INT J FOOD MICROBIOL, V111, P105, DOI 10.1016/j.ijfoodmicro.2006.04.021; Andersen B, 2015, INT J FOOD MICROBIOL, V196, P1, DOI 10.1016/j.ijfoodmicro.2014.11.029; Asam S, 2013, EUR FOOD RES TECHNOL, V236, P491, DOI 10.1007/s00217-012-1901-x; Bella P., 2001, Journal of Plant Pathology, V83, P231; Brun S, 2013, FUNGAL BIOL-UK, V117, P32, DOI 10.1016/j.funbio.2012.11.003; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; EFSA, 2011, EFSA J, V2011, P97; Elena K, 2006, EUR J PLANT PATHOL, V115, P259, DOI 10.1007/s10658-006-9005-8; Fleck SC, 2012, TOXICOL LETT, V214, P27, DOI 10.1016/j.toxlet.2012.08.003; GATENBEC.S, 1965, ACTA CHEM SCAND, V19, P65, DOI 10.3891/acta.chem.scand.19-0065; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Graf E, 2012, INT J FOOD MICROBIOL, V157, P353, DOI 10.1016/j.ijfoodmicro.2012.06.004; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Howlett BJ, 2006, CURR OPIN PLANT BIOL, V9, P371, DOI 10.1016/j.pbi.2006.05.004; Huang F, 2015, FUNGAL BIOL-UK, V119, P320, DOI 10.1016/j.funbio.2014.09.006; Isshiki A, 1997, PHYSIOL MOL PLANT P, V51, P155, DOI 10.1006/pmpp.1997.0106; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; Logrieco A, 2003, EUR J PLANT PATHOL, V109, P645, DOI 10.1023/A:1026033021542; Logrieco A, 2009, WORLD MYCOTOXIN J, V2, P129, DOI 10.3920/WMJ2009.1145; Markham JE, 2001, MOL PLANT PATHOL, V2, P229, DOI 10.1046/j.1464-6722.2001.00066.x; Masunaka A, 2000, PHYTOPATHOLOGY, V90, P762, DOI 10.1094/PHYTO.2000.90.7.762; Ntasiou P, 2015, INT J FOOD MICROBIOL, V197, P22, DOI 10.1016/j.ijfoodmicro.2014.12.008; Peever TL, 2002, PHYTOPATHOLOGY, V92, P794, DOI 10.1094/PHYTO.2002.92.7.794; Peever TL, 2005, PHYTOPATHOLOGY, V95, P512, DOI 10.1094/PHYTO-95-0512; Peever TL, 2004, MYCOLOGIA, V96, P119, DOI 10.2307/3761993; Perrone G, 2013, FOOD ADDIT CONTAM A, V30, P1339, DOI 10.1080/19440049.2013.796594; Prelle A, 2013, FOOD CHEM, V140, P161, DOI 10.1016/j.foodchem.2012.12.065; Pruss S, 2014, APPL ENVIRON MICROB, V80, P2582, DOI 10.1128/AEM.00327-14; Pryor BM, 2002, PHYTOPATHOLOGY, V92, P406, DOI 10.1094/PHYTO.2002.92.4.406; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Saha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040564; Sanzani SM, 2012, INT J FOOD MICROBIOL, V153, P323, DOI 10.1016/j.ijfoodmicro.2011.11.021; Sanzani SM, 2012, POSTHARVEST BIOL TEC, V68, P64, DOI 10.1016/j.postharvbio.2012.02.003; Schwarz C, 2012, ARCH TOXICOL, V86, P1911, DOI 10.1007/s00204-012-0958-4; Scott P. M., 2004, Mycotoxins in food: detection and control, P406, DOI 10.1533/9781855739086.3.406; Siciliano I, 2015, TOXINS, V7, P743, DOI 10.3390/toxins7030743; Stewart JE, 2014, BMC EVOLUTIONARY BIO, V14, P1; THOMAS R, 1961, BIOCHEM J, V80, P234, DOI 10.1042/bj0800234; Timmer Lavern W., 2003, Phytopathologia Mediterranea, V42, P99; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Van de Perre E, 2014, FOOD CONTROL, V37, P165, DOI 10.1016/j.foodcont.2013.09.034; Vicent A., 2000, Plant Disease, V84, P1044, DOI 10.1094/PDIS.2000.84.9.1044B; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Woudenberg JHC, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2015.07.001	48	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163255	10.1371/journal.pone.0163255	http://dx.doi.org/10.1371/journal.pone.0163255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636202	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700043
J	Petticrew, M; Fitzgerald, N; Durand, MA; Knai, C; Davoren, M; Perry, I				Petticrew, Mark; Fitzgerald, Niamh; Durand, Mary Alison; Knai, Cecile; Davoren, Martin; Perry, Ivan			Diageo's 'Stop Out of Control Drinking' Campaign in Ireland: An Analysis	PLOS ONE			English	Article							PUBLIC-HEALTH; ADDICTION RESEARCH; VESTED INTERESTS; ALCOHOL; INDUSTRY; SCIENCE	Background It has been argued that the alcohol industry uses corporate social responsibility activities to influence policy and undermine public health, and that every opportunity should be taken to scrutinise such activities. This study analyses a controversial Diageo-funded 'responsible drinking' campaign ("Stop out of Control Drinking", or SOOCD) in Ireland. The study aims to identify how the campaign and its advisory board members frame and define (i) alcohol-related harms, and their causes, and (ii) possible solutions. Methods Documentary analysis of SOOCD campaign material. This includes newspaper articles (n = 9), media interviews (n = 11), Facebook posts (n = 92), and Tweets (n = 340) produced by the campaign and by board members. All material was coded inductively, and a thematic analysis undertaken, with codes aggregated into sub-themes. Results The SOOCD campaign utilises vague or self-defined concepts of 'out of control' and 'moderate' drinking, tending to present alcohol problems as behavioural rather than health issues. These are also unquantified with respect to actual drinking levels. It emphasises alcohol-related antisocial behaviour among young people, particularly young women. In discussing solutions to alcohol-related problems, it focuses on public opinion rather than on scientific evidence, and on educational approaches and information provision, misrepresenting these as effective. "Moderate drinking" is presented as a behavioural issue ("negative drinking behaviours"), rather than as a health issue. Conclusions The 'Stop Out of Control Drinking' campaign frames alcohol problems and solutions in ways unfavourable to public health, and closely reflects other Diageo Corporate Social Responsibility (CSR) activity, as well as alcohol and tobacco industry strategies more generally. This framing, and in particular the framing of alcohol harms as a behavioural issue, with the implication that consumption should be guided only by self-defined limits, may not have been recognised by all board members. It suggests a need for awareness-raising efforts among the public, third sector and policymakers about alcohol industry strategies.	[Petticrew, Mark; Durand, Mary Alison; Knai, Cecile] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England; [Fitzgerald, Niamh] Univ Stirling, Inst Social Mkt, UK Ctr Tobacco & Alcohol Studies, Stirling FK9 4LA, Scotland; [Davoren, Martin; Perry, Ivan] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Western Gateway Bldg, Cork, Ireland	University of London; London School of Hygiene & Tropical Medicine; University of Stirling; University College Cork	Petticrew, M (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	mark.petticrew@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021	Perry, Ivan/0000-0002-4965-9792; Davoren, Martin/0000-0001-5076-5923; Knai, Cecile/0000-0001-6663-7379; Durand, Mary Alison/0000-0003-2205-4002; Fitzgerald, Niamh/0000-0002-3643-8165	Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2015, IRISH TIMES; [Anonymous], 2012, STEER GROUP NAT SUBS; [Anonymous], 2015, SCOTTISH LICENS 0611; [Anonymous], 2015, IRISH EXAMINER  0312; [Anonymous], 2015, IRISH EXAMINER  0219; [Anonymous], 2011, INQ BEH CHANG EV SES; [Anonymous], 2015, STOP OUT CONTR DRINK; [Anonymous], 2015, MEM UND; [Anonymous], 2015, LIMERICK LEADER 0319; [Anonymous], 2015, IRISH INDEPENDENT; [Anonymous], 2006, IRISH TIMES; Ascough Jackie, 2015, COMMUNICATION; Babor T., 2010, ALCOHOL NO ORDINARY, V2nd; Babor TF, 2006, ADDICTION, V101, P1375, DOI 10.1111/j.1360-2006.01638.x; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Bakke O, 2010, ADDICTION, V105, P22, DOI 10.1111/j.1360-0443.2009.02695.x; Brennan A, 2014, BMJ-BRIT MED J, V2014, P349; Casswell S, 2013, ADDICTION, V108, P680, DOI 10.1111/add.12011; Collin J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6087; Cooper Matt, 2015, COMMUNICATION; Defending Stance on Alcohol and Sport, 2015, DEF STANC ALC SPORT; Finlay Fergus, 2015, IRISH EXAMINER  0217; Finlay Fergus, IRISH TIMES; Finlay Fergus, 2015, COMMUNICATION; Finnegan Keith, 2015, COMMUNICATION; Forster N, 1994, QUALITATIVE METHODS; Fortune Joanna, 2015, GALWAY INDEPEND 0422; Grant M, 2005, ICAP SERIES ALCOHOL; Hall WD, 2006, MED J AUSTRALIA, V185, P635, DOI 10.5694/j.1326-5377.2006.tb00736.x; Hawkins B, 2013, CRIT POLICY STUD, V7, P53, DOI 10.1080/19460171.2013.766023; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Kelly Ciara, 2015, SUNDAY INDEPENDENT; Kelly Ciara, 2015, COMMUNICATION; Knai C, 2015, ADDICTION, V110, P1232, DOI 10.1111/add.12855; Long J, 2014, ALCOHOL CONSUMPTION; Martineau F, 2013, PREV MED, V57, P278, DOI 10.1016/j.ypmed.2013.06.019; McCambridge J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001767; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; McCambridge J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001431; Miller P, 2009, DRUG ALCOHOL REV, V28, P324, DOI 10.1111/j.1465-3362.2009.00072.x; Munro G, 2008, DRUG ALCOHOL REV, V27, P204, DOI 10.1080/09595230701827136; Patil S, 2014, EUR J PUBLIC HEALTH, V24, P561, DOI 10.1093/eurpub/cku060; Petticrew MP, 2012, AM J PUBLIC HEALTH, V102, P2018, DOI 10.2105/AJPH.2012.300816; Petticrew MP, 2011, AM J PUBLIC HEALTH, V101, P411, DOI 10.2105/AJPH.2009.177634; Savell E, 2016, ADDICTION, V111, P18, DOI 10.1111/add.13048; Smith D, 2015, COMMUNICATION; Smith EA, 2007, EUR J PUBLIC HEALTH, V17, P162, DOI 10.1093/eurpub/ckl097; The Advisory Board Company, 2015, JOURNAL; Ulucanlar S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001629; World Health Organization, 2010, GLOB STRAT RED HARMF; Yoon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-630	51	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0160379	10.1371/journal.pone.0160379	http://dx.doi.org/10.1371/journal.pone.0160379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5YN	27636883	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000383723700002
J	Coombe, L; Warren, RL; Jackman, SD; Yang, C; Vandervalk, BP; Moore, RA; Pleasance, S; Coope, RJ; Bohlmann, J; Holt, RA; Jones, SJM; Birol, I				Coombe, Lauren; Warren, Rene L.; Jackman, Shaun D.; Yang, Chen; Vandervalk, Benjamin P.; Moore, Richard A.; Pleasance, Stephen; Coope, Robin J.; Bohlmann, Joerg; Holt, Robert A.; Jones, Steven J. M.; Birol, Inanc			Assembly of the Complete Sitka Spruce Chloroplast Genome Using 10X Genomics' GemCode Sequencing Data	PLOS ONE			English	Article							DRAFT GENOMES; LONG READS; TOOL; ALIGNMENT; DNA; ANNOTATION; GENERATION; NUMBER; PLANTS	The linked read sequencing library preparation platformby 10X Genomics produces barcoded sequencing libraries, which are subsequently sequenced using the Illumina short read sequencing technology. In this new approach, long fragments of DNA are partitioned into separate micro-reactions, where the same index sequence is incorporated into each of the sequencing fragment inserts derived from a given long fragment. In this study, we exploited this property by using reads from index sequences associated with a large number of reads, to assemble the chloroplast genome of the Sitka spruce tree (Picea sitchensis). Here we report on the first Sitka spruce chloroplast genome assembled exclusively from P. sitchensis genomic libraries prepared using the 10X Genomics protocol. We show that the resulting 124,049 base pair long genome shares high sequence similarity with the related white spruce and Norway spruce chloroplast genomes, but diverges substantially from a previously published P. sitchensis-P. thunbergii chimeric genome. The use of reads from high-frequency indices enabled separation of the nuclear genome reads from that of the chloroplast, which resulted in the simplification of the de Bruijn graphs used at the various stages of assembly.	[Coombe, Lauren; Warren, Rene L.; Jackman, Shaun D.; Yang, Chen; Vandervalk, Benjamin P.; Moore, Richard A.; Pleasance, Stephen; Coope, Robin J.; Holt, Robert A.; Jones, Steven J. M.; Birol, Inanc] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Warren, RL; Birol, I (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	rwarren@bcgsc.ca; ibirol@bcgsc.ca	Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011; Holt, Robert A/C-3303-2009; Warren, Rene/R-7681-2016; Jackman, Shaun/G-9622-2013	Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Holt, Robert A/0000-0002-7259-1247; Coombe, Lauren/0000-0002-7518-2326; Vandervalk, Ben/0000-0002-3082-3476; Warren, Rene/0000-0002-9890-2293; Jackman, Shaun/0000-0002-9275-5966	BC Cancer Foundation; Genome BC; Genome Canada [212SEQ]	BC Cancer Foundation; Genome BC; Genome Canada(Genome Canada)	This study was supported by the BC Cancer Foundation, Genome BC and Genome Canada under grant award 212SEQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; De La Torre AR, 2014, PLANT PHYSIOL, V166, P1724, DOI 10.1104/pp.114.248708; Eisenstein M, 2015, NAT BIOTECHNOL, V33, P433, DOI 10.1038/nbt0515-433; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hall DE, 2011, PLANT J, V65, P936, DOI 10.1111/j.1365-313X.2010.04478.x; Hamilton JA, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0817-y; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jackman SD, 2016, GENOME BIOL EVOL, V8, P29, DOI 10.1093/gbe/evv244; Kubinova Z, 2014, J EXP BOT, V65, P609, DOI 10.1093/jxb/ert407; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Li H., 2013, ARXIV13033997 Q BIO; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAVARD L, 1994, P NATL ACAD SCI USA, V91, P5163, DOI 10.1073/pnas.91.11.5163; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vandervalk BP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S3-S1; Vieira Ldo N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, DOI 10.1371/JOURNAL.PONE.0084792]; Vieira LD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, 10.1371/journal.pone.0090618]; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163059	10.1371/journal.pone.0163059	http://dx.doi.org/10.1371/journal.pone.0163059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632164	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900125
J	Hu, GY; Tao, F; Ji, KW; Wang, W				Hu, Geng-yuan; Tao, Feng; Ji, Ke-wei; Wang, Wei			Comparison of Delta-Shape Anastomosis and Extracorporeal Billroth I Anastomosis after Laparoscopic Distal Gastrectomy for Gastric Cancer: A Systematic Review with Meta-Analysis of Short-Term Outcomes	PLOS ONE			English	Review							SURGICAL OUTCOMES; GASTRODUODENOSTOMY; SURGERY; COMPLICATIONS; MULTICENTER; EXPERIENCE; TRIALS	Objective The aim of this systematic review and meta-analysis is to evaluate the safety and relative benefits of delta-shape anastomosis (DA) by comparing to conventional laparoscopy-assisted distal gastrectomy with Billroth I gastroduodenostomy (LADG BI). Methods Studies and relevant literature regarding DA versus LADG BI were searched in the electronic databases. Operation time, postoperative complications, estimated blood loss, number of retrieved lymph nodes, time to first flatus, time to oral intake, length of postoperative hospitalization in DA and LADG BI were pooled and compared using meta-analysis. Weighted mean differences (WMDs) and odds ratios (ORs) were calculated with 95% confidence intervals (CIs) to evaluate the effect of DA. Results Eight studies of 1739 patients were included in the meta-analysis. Compared with LADG BI, DA had shorter postoperative hospitalization(WMD = -0.47, 95% CI: -0.69 to -0.25, P< 0.01), less blood loss (WMD = -25.90, 95% CI: -43.11 to -8.70, P< 0.01), shorter time to oral intake (WMD = -0.25, 95% CI: -0.49 to -0.01, P = 0.04), and more retrieved lymph nodes (WMD = 1.36, 95% CI: 0.30 to 2.43, P = 0.01). Operation time (WMD = -0.07, 95% CI -15.58 to 15.43, P = 0.99), overall postoperative complication rate (OR = 1.05, 95% CI: 0.74 to 1.49, P = 0.63), surgical complication rate (OR = 1.02, 95% CI: 0.70 to 1.49, P = 0.90), nonsurgical complication rate (OR = 1.21, 95% CI: 0.54 to 2.72, P = 0.64), leakage rate (OR = 2.54, 95% CI: 0.92 to 7.01, P = 0.07), stricture rate (OR = 0.36, 95% CI: 0.09 to 1.44, P = 0.15), wound complication rate (OR = 0.71, 95% CI: 0.33 to 1.55, P = 0.39), time to first flatus (WMD = -0.10, 95% CI: -0.27 to 0.07, P = 0.26), and proximal surgical margin (WMD = -0.25, 95% CI: -1.14 to 0.65, P = 0.59) was not statistically different. Conclusion Compared with LADG BI, DA is a safe and feasible procedure, with significantly reduced blood loss, time to oral intake, and postoperative hospitalization.	[Hu, Geng-yuan; Tao, Feng; Ji, Ke-wei; Wang, Wei] Zhejiang Univ, Shaoxing Hosp, Dept Gastrointestinal Surg, Shaoxing Peoples Hosp, Shaoxing, Peoples R China	Zhejiang University	Ji, KW (corresponding author), Zhejiang Univ, Shaoxing Hosp, Dept Gastrointestinal Surg, Shaoxing Peoples Hosp, Shaoxing, Peoples R China.	jikewei_sxph@163.com						Abraham NS, 2010, J CLIN EPIDEMIOL, V63, P238, DOI 10.1016/j.jclinepi.2009.04.005; Ahn HS, 2008, ANN SURG ONCOL, V15, P1632, DOI 10.1245/s10434-008-9871-8; Bamboat ZM, 2013, J SURG ONCOL, V107, P271, DOI 10.1002/jso.23237; Chen K, 2015, J SURG RES, V194, P367, DOI 10.1016/j.jss.2014.10.020; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gao J, 2013, J LAPAROENDOSC ADV S, V23, P693, DOI 10.1089/lap.2012.0580; Goh P, 1992, Surg Laparosc Endosc, V2, P258; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu YF, 2014, SURG ENDOSC, V28, P2048, DOI 10.1007/s00464-014-3426-9; Huang CM, 2014, WORLD J GASTROENTERO, V20, P10478, DOI 10.3748/wjg.v20.i30.10478; Huang CM, 2015, ANN SURG ONCOL, V22, P247, DOI 10.1245/s10434-014-3862-8; Huang CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102736; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jeong O, 2015, SURG ENDOSC, V29, P1522, DOI 10.1007/s00464-014-3836-8; Jung MR, 2012, WORLD J SURG, V36, P2400, DOI 10.1007/s00268-012-1693-y; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; Kanaya S, 2011, GASTRIC CANCER, V14, P365, DOI 10.1007/s10120-011-0054-0; Kim DG, 2013, SURG ENDOSC, V27, P3153, DOI 10.1007/s00464-013-2869-8; Kim HH, 2014, J CLIN ONCOL, V32, P627, DOI 10.1200/JCO.2013.48.8551; Kim MG, 2011, SURG ENDOSC, V25, P1076, DOI 10.1007/s00464-010-1319-0; Kinoshita T, 2011, SURG ENDOSC, V25, P1395, DOI 10.1007/s00464-010-1402-6; Kitagami H, 2014, SURG ENDOSC, V28, P2137, DOI 10.1007/s00464-014-3445-6; Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9; Lee HH, 2015, SURG ENDOSC, V29, P2545, DOI 10.1007/s00464-014-3966-z; Lee SH, 2015, ANN SURG TREAT RES, V89, P176, DOI 10.4174/astr.2015.89.4.176; Lin M, 2016, SURG ENDOSC; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maruyama K, 2014, CHIRURGIA-BUCHAREST, V109, P722; Park KB, 2016, SURG ENDOSC; Park YS, 2015, SURG ENDOSC; Postlewait LM, 2016, J SURG ONCOL, V113, P277, DOI 10.1002/jso.24110; Shinohara T, 2015, SURG ENDOSC; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; STEICHEN FM, 1968, SURGERY, V64, P948; Strong VE, 2010, ANN SURG, V251, P640, DOI 10.1097/SLA.0b013e3181d3d29b; Sugita H, 2015, J SURG RES, V193, P190, DOI 10.1016/j.jss.2014.07.040; Takeno S, 2006, EJSO-EUR J SURG ONC, V32, P1191, DOI 10.1016/j.ejso.2006.04.018; Umemura A, 2015, ASIAN J SURG, V38, P102, DOI 10.1016/j.asjsur.2014.09.006; Wang Nan, 2014, Zhonghua Wei Chang Wai Ke Za Zhi, V17, P1111; Zhang YX, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0532-7; Zhou JF, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0573-3	41	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162720	10.1371/journal.pone.0162720	http://dx.doi.org/10.1371/journal.pone.0162720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631378	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900070
J	Kok, LM; Haitjema, S; Groenewegen, KA; Rietveld, ABM				Kok, Laura M.; Haitjema, Saskia; Groenewegen, Karlijn A.; Rietveld, A. Boni M.			The Influence of a Sudden Increase in Playing Time on Playing-Related Musculoskeletal Complaints in High-Level Amateur Musicians in a Longitudinal Cohort Study	PLOS ONE			English	Article							PROFESSIONAL ORCHESTRAL MUSICIANS; CLASSICAL MUSICIANS; RISK-FACTORS; DISORDERS; PAIN; INSTRUMENTALISTS	Background Several studies in the domain of professional musicians describe the relation between playing time and the occurrence of musculoskeletal complaints in professional musicians. To date, no longitudinal cohort study into this relationship has been performed and no amateur musicians were studied. Therefore, the aim of this study is to examine the causal relationship between a sudden increase in playing time among amateur musicians on the occurrence of musculoskeletal complaints in a prospective cohort study. Methods All members of two national Dutch Students Orchestras were asked to participate in the study. These project-based orchestras, consisting of high-level amateurs, followed a nine-hour rehearsing schedule for ten consecutive days. On the first day (t(0)) and after one week (t(1)) the subjects were asked to complete a paper-based questionnaire including sociodemographic characteristics, music-related questions, questions regarding playing-related musculoskeletal complaints and the music module of the disabilities of arm, shoulder and hand questionnaire. Results The NSO consisted of 85 and the NESKO of 41 members during the study period. 59 subjects completed the questionnaire at both timepoints (response rate 47%). 9 subjects were excluded for being a music academy student, leaving 50 subjects (mean age 22.1, 72% female) suitable for analysis. During the rehearsal week, the prevalence of at least one playing-related musculoskeletal complaint increased from 28% to 80%. The most frequently affected areas were the neck, upper and lower back, hand/and or wrists and shoulders. The DASH music module score increased from 14 at t(0) to 23 at t(1). Conclusion A point prevalence of 28% at the start of the study that increased remarkably to 80% within a one-week period. Future research should evaluate other risk factors for musculoskeletal complaints in amateur musicians. These risk factors should be the base for the development of preventive measures.	[Kok, Laura M.] NoordWest Ziekenhuis Groep, Dept Orthoped, Alkmaar, Netherlands; [Haitjema, Saskia; Rietveld, A. Boni M.] Med Ctr Haaglanden, Med Ctr Dancers & Musicians, The Hague, Netherlands; [Groenewegen, Karlijn A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kok, Laura M.] Leiden Univ Med Ctr, Dept Orthoped, Leiden, Netherlands	Medical Center Of Alkmaar; Haaglanden Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC)	Kok, LM (corresponding author), NoordWest Ziekenhuis Groep, Dept Orthoped, Alkmaar, Netherlands.; Kok, LM (corresponding author), Leiden Univ Med Ctr, Dept Orthoped, Leiden, Netherlands.	laura.m.kok@gmail.com	Kok, Laura/J-9667-2016	Kok, Laura/0000-0002-2821-9309	Nederlandse Vereniging voor Dans- en Muziekgeneeskunde	Nederlandse Vereniging voor Dans- en Muziekgeneeskunde	All authors were supported by Nederlandse Vereniging voor Dans- en Muziekgeneeskunde.	Ackermann B, 2012, MED PROBL PERFORM AR, V27, P181; [Anonymous], 2012, THE DASH AND QUICK D; Buckley T, 2006, MED PROBL PERFORM AR, V21, P80; Chan C, 2014, OCCUP MED-OXFORD, V64, P23, DOI 10.1093/occmed/kqt117; Chan C, 2014, MED PROBL PERFORM AR, V29, P181, DOI 10.21091/mppa.2014.4038; Dawson WJ, 2001, MED PROBL PERFORM AR, V16, P152; Foxman Irina, 2006, AAOHN J, V54, P309; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Kaufman-Cohen Y, 2011, OCCUP MED-OXFORD, V61, P90, DOI 10.1093/occmed/kqq196; Kok LM, 2016, INT ARCH OCC ENV HEA, V89, P373, DOI 10.1007/s00420-015-1090-6; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; NEWMARK J, 1987, MED PROBL PERFORM AR, V2, P142; Sataloff RT, 2013, SCI MED; Volz L, 2014, FACTSHEET AMATEURKUN; Wilke C, 2011, MED PROBL PERFORM AR, V26, P24; Yoshimura E, 2008, MED PROBL PERFORM AR, V23, P107; Zaza C, 1998, SOC SCI MED, V47, P2013, DOI 10.1016/S0277-9536(98)00307-4	19	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163472	10.1371/journal.pone.0163472	http://dx.doi.org/10.1371/journal.pone.0163472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657537	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200132
J	Mainassara, HB; Paireau, J; Idi, I; Jusot, JF; Pelat, JPM; Oukem-Boyer, OOM; Fontanet, A; Mueller, JE				Mainassara, Halima Boubacar; Paireau, Juliette; Idi, Issa; Jusot, Jean-Francois; Pelat, Jean-Paul Moulia; Oukem-Boyer, Odile Ouwe Missi; Fontanet, Arnaud; Mueller, Judith E.			Serogroup-Specific Characteristics of Localized Meningococcal Meningitis Epidemics in Niger 2002-2012 and 2015: Analysis of Health Center Level Surveillance Data	PLOS ONE			English	Article							BURKINA-FASO; IMMUNITY	To compare dynamics of localized meningitis epidemics (LE) by meningococcal (Nm) serogroup, we analyzed a surveillance database of suspected and laboratory-confirmed Nm cases from 373 health areas (HA) of three regions in Niger during 2002-2012 and one region concerned by NmC epidemics during 2015. We defined LE as HA weekly incidence rates of >= 20 suspected cases per 100,000 during >= 2 weeks and assigned the predominant serogroup based on polymerase chain reaction testing of cerebrospinal fluid. Among the 175 LE, median peak weekly incidence rate in LE due to NmA, W, X and C were 54, 39, 109 and 46 per 100,000, respectively. These differences impacted ability of the epidemic to be detected at the district level. While this analysis is limited by the small number of LE due to NmX (N = 4) and NmW (N = 5), further research should explore whether strategies for prevention and response to meningitis epidemics need to be adapted according to predominant meningococcal serogroups.	[Mainassara, Halima Boubacar; Idi, Issa; Jusot, Jean-Francois; Pelat, Jean-Paul Moulia; Oukem-Boyer, Odile Ouwe Missi] Ctr Rech Med & Sanit, Niamey, Niger; [Mainassara, Halima Boubacar; Paireau, Juliette; Fontanet, Arnaud; Mueller, Judith E.] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Mainassara, Halima Boubacar; Paireau, Juliette] Univ Paris 06, Cellule Pasteur, Paris, France; [Paireau, Juliette] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Fontanet, Arnaud] Conservat Natl Arts & Metiers Chaire Sante & Dev, Paris, France; [Mueller, Judith E.] EHESP French Sch Publ Hlth, Sorbonne Paris Cite, Rennes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Princeton University	Mainassara, HB (corresponding author), Ctr Rech Med & Sanit, Niamey, Niger.; Mainassara, HB (corresponding author), Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.; Mainassara, HB (corresponding author), Univ Paris 06, Cellule Pasteur, Paris, France.	amhalima@gmail.com		, arnaud/0000-0002-5239-6110	Office of International Cooperation of the Principality of Monaco; Ministere Francais des Affaires Etrangeres (Fonds de Solidarite Prioritaire); Sanofi Pasteur; Ministere de la Sante Publique du Niger/Fonds commun; CDC/MenAfriNet; Cooperation Technique Belge	Office of International Cooperation of the Principality of Monaco; Ministere Francais des Affaires Etrangeres (Fonds de Solidarite Prioritaire); Sanofi Pasteur; Ministere de la Sante Publique du Niger/Fonds commun; CDC/MenAfriNet; Cooperation Technique Belge	This work was supported by the Office of International Cooperation of the Principality of Monaco. Surveillance activities were funded by the Ministere Francais des Affaires Etrangeres (Fonds de Solidarite Prioritaire), Sanofi Pasteur and the "Ministere de la Sante Publique du Niger/Fonds commun" and CDC/MenAfriNet. The "Cooperation Technique Belge" funded the first health area map's support.	[Anonymous], 2003, B WORLD HEAL ORGAN; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P123; Boisier P, 2007, VACCINE, V25, pA24, DOI 10.1016/j.vaccine.2007.04.036; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; BROOME CV, 1983, B WORLD HEALTH ORGAN, V61, P325; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Collard JM, 2014, T ROY SOC TROP MED H, V108, P6, DOI 10.1093/trstmh/trt104; Collard JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-576; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; Etienne J, 1990, Med Trop (Mars), V50, P227; Funk Anna, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; MacNeil JR, 2014, EMERG INFECT DIS, V20, P394, DOI 10.3201/eid2003.131407; Mainassara HB, 2015, EMERG INFECT DIS, V21, P1322, DOI 10.3201/eid2108.141361; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Paireau J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001577; QGIS, 2020, QGIS GEOGR INF SYST; R Core Team, 2012, R LANG ENV STAT COMP; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Tall H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-2; World Health Organization, 2014, WHO GUID MEN OUTBR R	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163110	10.1371/journal.pone.0163110	http://dx.doi.org/10.1371/journal.pone.0163110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657530	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200068
J	Pallares, JG; Moran-Navarro, R; Ortega, JF; Fernandez-Elias, VE; Mora-Rodriguez, R				Pallares, Jesus G.; Moran-Navarro, Ricardo; Fernando Ortega, Juan; Emilio Fernandez-Elias, Valentin; Mora-Rodriguez, Ricardo			Validity and Reliability of Ventilatory and Blood Lactate Thresholds in Well-Trained Cyclists	PLOS ONE			English	Article							ANAEROBIC THRESHOLD; STEADY-STATE; RUNNING PERFORMANCE; ELITE CYCLISTS; GAS-EXCHANGE; HEART-RATE; EXERCISE; PARAMETERS; REPRODUCIBILITY; ACCUMULATION	Purpose The purpose of this study was to determine, i) the reliability of blood lactate and ventilatory-based thresholds, ii) the lactate threshold that corresponds with each ventilatory threshold (VT1 and VT2) and with maximal lactate steady state test (MLSS) as a proxy of cycling performance. Methods Fourteen aerobically-trained male cyclists (VO2max 62.1 +/- 4.6 ml.kg(-1).min(-1)) performed two graded exercise tests (50 W warm-up followed by 25 W.min(-1)) to exhaustion. Blood lactate, VO2 and VCO2 data were collected at every stage. Workloads at VT1 (rise in V-E/VO2;) and VT2 (rise in V-E/VCO2) were compared with workloads at lactate thresholds. Several continuous tests were needed to detect the MLSS workload. Agreement and differences among tests were assessed with ANOVA, ICC and Bland-Altman. Reliability of each test was evaluated using ICC, CV and Bland-Altman plots. Results Workloads at lactate threshold (LT) and LT+2.0 mMol.L-1 matched the ones for VT1 and VT2, respectively (p = 0.147 and 0.539; r = 0.72 and 0.80; Bias = -13.6 and 2.8, respectively). Furthermore, workload at LT+0.5 mMol.L-1 coincided with MLSS workload (p = 0.449; r = 0.78; Bias = -4.5). Lactate threshold tests had high reliability (CV = 3.4-3.7%; r = 0.85-0.89; Bias = -2.1-3.0) except for D-MAX method (CV = 10.3%; r = 0.57; Bias = 15.4). Ventilatory thresholds show high reliability (CV = 1.6%-3.5%; r = 0.90-0.96; Bias = -1.8-2.9) except for RER = 1 and V-Slope (CV = 5.0-6.4%; r = 0.79; Bias = -5.6-12.4). Conclusions Lactate threshold tests can be a valid and reliable alternative to ventilatory thresholds to identify the workloads at the transition from aerobic to anaerobic metabolism.	[Pallares, Jesus G.; Moran-Navarro, Ricardo; Fernando Ortega, Juan; Emilio Fernandez-Elias, Valentin; Mora-Rodriguez, Ricardo] Univ Castilla La Mancha, Exercise Physiol Lab Toledo, Toledo, Spain; [Pallares, Jesus G.; Moran-Navarro, Ricardo] Univ Murcia, Fac Sport Sci, Human Performance & Sports Sci Lab, Murcia, Spain	Universidad de Castilla-La Mancha; University of Murcia	Mora-Rodriguez, R (corresponding author), Univ Castilla La Mancha, Exercise Physiol Lab Toledo, Toledo, Spain.	ricardo.mora@uclm.es	Pallarés, Jesús G/J-3054-2016; Mora-Rodriguez, Ricardo/AAC-9096-2022; Fernández-Elías, Valentín E./ABD-7398-2021; Morán-Navarro, Ricardo/AAB-4361-2020; PALLARES, JESUS G./AAW-3182-2020; Ortega, Juan Fernando F/L-4973-2014	Pallarés, Jesús G/0000-0002-6087-1583; Fernández-Elías, Valentín E./0000-0002-1459-5442; PALLARES, JESUS G./0000-0002-6087-1583; Ortega, Juan Fernando F/0000-0003-3884-923X; Moran-Navarro, Ricardo/0000-0002-0991-9203; Mora-Rodriguez, Ricardo/0000-0001-9252-4933				Amann M, 2006, SCAND J MED SCI SPOR, V16, P27, DOI 10.1111/j.1600-0838.2004.00424.x; AUNOLA S, 1984, EUR J APPL PHYSIOL O, V53, P260, DOI 10.1007/BF00776600; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beneke R, 1996, MED SCI SPORT EXER, V28, P241, DOI 10.1097/00005768-199602000-00013; Beneke R, 2000, MED SCI SPORT EXER, V32, P1135, DOI 10.1097/00005768-200006000-00016; BENEKE R, 1995, MED SCI SPORT EXER, V27, P863; Billat LV, 1996, SPORTS MED, V22, P157, DOI 10.2165/00007256-199622030-00003; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Borg G., 1998, BORGS PERCEIVED EXER; Cannon DT, 2013, J APPL PHYSIOL, V115, P839, DOI 10.1152/japplphysiol.00510.2013; CHENG B, 1992, INT J SPORTS MED, V13, P518, DOI 10.1055/s-2007-1021309; Chicharro J.L., 2013, FISIOLOGIA ENTRENAMI; Copp SW, 2010, J PHYSIOL-LONDON, V588, P5077, DOI 10.1113/jphysiol.2010.198382; COYLE EF, 1983, J APPL PHYSIOL, V54, P18, DOI 10.1152/jappl.1983.54.1.18; COYLE EF, 1991, MED SCI SPORT EXER, V23, P93; DAVIS JA, 1976, J APPL PHYSIOL, V41, P544, DOI 10.1152/jappl.1976.41.4.544; Del Coso J, 2009, EUR J APPL PHYSIOL, V107, P83, DOI 10.1007/s00421-009-1101-y; Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Foster C, 1983, J SPORT SCI, V1, P13, DOI 10.1080/02640418308729657; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; Garcia-Pallares J, 2010, MED SCI SPORT EXER, V42, P1209, DOI 10.1249/MSS.0b013e3181c9228c; Garcia-Pallares J, 2009, EUR J APPL PHYSIOL, V106, P629, DOI 10.1007/s00421-009-1061-2; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Gripp F, 2009, J STRENGTH COND RES, V23, P632, DOI 10.1519/JSC.0b013e318196b8b6; Hauser T, 2014, INT J SPORTS MED, V35, P517, DOI 10.1055/s-0033-1353176; Izquierdo-Gabarren M, 2010, MED SCI SPORT EXER, V42, P1191, DOI 10.1249/MSS.0b013e3181c67eec; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Lucia A, 2000, MED SCI SPORT EXER, V32, P1777; Lucia A, 1999, BRIT J SPORT MED, V33, P178, DOI 10.1136/bjsm.33.3.178; Mora-Rodriguez R, 2015, J SCI MED SPORT, V18, P338, DOI 10.1016/j.jsams.2014.04.010; Pallares JG, 2012, J SPORT HEALTH RES, V4, P119; Pfitzinger P, 1998, INT J SPORTS MED, V19, P349, DOI 10.1055/s-2007-971929; Prud'Homme D, 1984, J SPORT SCI, V2, P13, DOI 10.1080/02640418408729692; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P327, DOI 10.1111/sms.12016; SJODIN B, 1981, INT J SPORTS MED, V2, P23, DOI 10.1055/s-2008-1034579; SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285; Smekal G, 2012, EUR J APPL PHYSIOL, V112, P3079, DOI 10.1007/s00421-011-2283-7; Vincent JW, 2005, STAT KINESIOLOGY; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; WELTMAN A, 1990, INT J SPORTS MED, V11, P26, DOI 10.1055/s-2007-1024757; Weston SB, 2001, J SCI MED SPORT, V4, P357, DOI 10.1016/S1440-2440(01)80044-X	43	74	78	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163389	10.1371/journal.pone.0163389	http://dx.doi.org/10.1371/journal.pone.0163389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657502	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200108
J	Sherchand, SP; Ibana, JA; Zea, AH; Quayle, AJ; Aiyar, A				Sherchand, Shardulendra P.; Ibana, Joyce A.; Zea, Arnold H.; Quayle, Alison J.; Aiyar, Ashok			The High-Risk Human Papillomavirus E6 Oncogene Exacerbates the Negative Effect of Tryptophan Starvation on the Development of Chlamydia trachomatis	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; AMINO-ACID-REQUIREMENTS; HUMAN EPITHELIAL-CELLS; GAMMA-INTERFERON; HELA-CELLS; IN-VITRO; PERSISTENCE; INFECTION; GROWTH; INHIBITION	Chlamydia trachomatis is an obligate intracellular pathogen that requires specific essential nutrients from the host cell, one of which is the amino acid tryptophan. In this context interferon gamma (IFN gamma) is the major host protective cytokine against chlamydial infections because it induces the expression of the host enzyme, indoleamine 2,3-dioxygenase 1, that degrades tryptophan, thereby restricting bacterial replication. The mechanism by which IFN gamma acts has been dissected in vitro using epithelial cell-lines such as HeLa, HEp-2, or the primary-like endocervical cell-line A2EN. All these cell-lines express the high-risk human papillomavirus oncogenes E6 & E7. While screening cell-lines to identify those suitable for C. trachomatis co-infections with other genital pathogens, we unexpectedly found that tryptophan starvation did not completely block chlamydial development in cell-lines that were HR-HPV negative, such as C33A and 293. Therefore, we tested the hypothesis that HR-HPV oncogenes modulate the effect of tryptophan starvation on chlamydial development by comparing chlamydial development in HeLa and C33A cell-lines that were both derived from cervical carcinomas. Our results indicate that during tryptophan depletion, unlike HeLa, C33A cells generate sufficient intracellular tryptophan via proteasomal activity to permit C. trachomatis replication. By generating stable derivatives of C33A that expressed HPV16 E6, E7 or E6 & E7, we found that E6 expression alone was sufficient to convert C33A cells to behave like HeLa during tryptophan starvation. The reduced tryptophan levels in HeLa cells have a biological consequence; akin to the previously described effect of IFN gamma, tryptophan starvation protects C. trachomatis from clearance by doxycycline in HeLa but not C33A cells. Curiously, when compared to the known Homo sapiens proteome, the representation of tryptophan in the HR-HPV E6 & E6AP degradome is substantially lower, possibly providing a mechanism that underlies the lowered intracellular free tryptophan levels in E6-expressing cells during starvation.	[Sherchand, Shardulendra P.; Zea, Arnold H.; Quayle, Alison J.; Aiyar, Ashok] LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, 1901 Perdido St, New Orleans, LA 70112 USA; [Ibana, Joyce A.] Univ Philippines, Inst Biol, Quezon City 1101, PH, Philippines	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of the Philippines System; University of the Philippines Diliman	Aiyar, A (corresponding author), LSU Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, 1901 Perdido St, New Orleans, LA 70112 USA.	aaiyar@lsuhsc.edu			National Institutes of Health (US) [AI095859]	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (US). Grant number AI095859, http://www.nih.gov, awarded to AA AJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aiyar A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00072; AUERSPERG N, 1964, J NATL CANCER I, V32, P135; Balanda M, 2016, MED MICROBIOL IMMUN, V205, P585, DOI 10.1007/s00430-016-0473-y; BEATTY WL, 1995, INFECT IMMUN, V63, P199, DOI 10.1128/IAI.63.1.199-205.1995; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P15971, DOI 10.1073/pnas.2535394100; Braley AE, 1938, AM J OPHTHALMOL, V21, P1203; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Buckner LR, 2011, J REPROD IMMUNOL, V92, P8, DOI 10.1016/j.jri.2011.08.002; Caldwell HD, 2003, J CLIN INVEST, V111, P1757, DOI [10.1172/JCI200317993, 10.1172/JCI17993]; Camargo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095977; CARLIN JM, 1989, J LEUKOCYTE BIOL, V45, P29, DOI 10.1002/jlb.45.1.29; CARLIN JM, 1989, J INTERFERON RES, V9, P329, DOI 10.1089/jir.1989.9.329; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; COLES AM, 1987, J GEN MICROBIOL, V133, P701; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Duncan KJ, 2009, J PHARMACOL EXP THER, V330, P359, DOI 10.1124/jpet.108.149765; DUNLOP EMC, 1989, GENITOURIN MED, V65, P22; EAGLE H, 1959, J BIOL CHEM, V234, P592; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Fabunmi RP, 2001, J CELL SCI, V114, P29; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Fougeray S, 2012, J IMMUNOL, V189, P2954, DOI 10.4049/jimmunol.1201214; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Gourronc FA, 2013, VIROLOGY, V446, P325, DOI 10.1016/j.virol.2013.08.015; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Ibana JA, 2011, INFECT DIS OBSTET GY, V2011, DOI [10.1155/2011/420905, DOI 10.1155/2011, DOI 10.1155/2011/420905]; Ibana JA, 2011, INFECT IMMUN, V79, P4425, DOI 10.1128/IAI.05659-11; James MA, 2006, INT J CANCER, V119, P1878, DOI 10.1002/ijc.22064; Julianelle LA, 1938, AM J PATHOL, V14, P579; Kane CD, 1999, INFECT IMMUN, V67, P1666; KARAYIANNIS P, 1981, J CLIN MICROBIOL, V13, P427, DOI 10.1128/JCM.13.3.427-432.1981; Keller MJ, 2015, CLIN INFECT DIS, V61, P1573, DOI 10.1093/cid/civ569; Kokab A, 2010, MICROB PATHOGENESIS, V49, P217, DOI 10.1016/j.micpath.2010.06.002; KUO CC, 1990, J CLIN MICROBIOL, V28, P1098, DOI 10.1128/JCM.28.6.1098-1100.1990; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Lindh M, 2007, J CLIN VIROL, V40, P321, DOI 10.1016/j.jcv.2007.09.009; MADEN BEH, 1971, BIOCHEM J, V123, pP36; MADEN BEH, 1968, J MOL BIOL, V38, P431, DOI 10.1016/0022-2836(68)90398-7; Malisic E, 2014, J BUON, V19, P973; Mendoza L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-531; MITAO M, 1984, GYNECOL ONCOL, V19, P90, DOI 10.1016/0090-8258(84)90163-X; Morrison RP, 2000, INFECT IMMUN, V68, P6038, DOI 10.1128/IAI.68.10.6038-6040.2000; Mortensen F, 2015, P NATL ACAD SCI USA, V112, P9872, DOI 10.1073/pnas.1505923112; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Puddu P, 1999, LAB INVEST, V79, P1299; Reveneau N, 2005, ANTIMICROB AGENTS CH, V49, P1787, DOI 10.1128/AAC.49.5.1787-1793.2005; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Roshick C, 2006, INFECT IMMUN, V74, P225, DOI 10.1128/IAI.74.1.225-238.2006; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHIMKE RT, 1964, J BIOL CHEM, V239, P136; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sukhai M, 2000, J PHARM PHARM SCI, V3, P268; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; SWANSON J, 1975, J INFECT DIS, V131, P678, DOI 10.1093/infdis/131.6.678; Tomaic V, 2013, VIROLOGY, V446, P389, DOI 10.1016/j.virol.2013.08.016; TREUHAFT MW, 1968, J BACTERIOL, V96, P2004, DOI 10.1128/JB.96.6.2004-2011.1968; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wehenkel M, 2012, BRIT J CANCER, V107, P53, DOI 10.1038/bjc.2012.243; Wheatley DN, 2000, CELL PHYSIOL BIOCHEM, V10, P37, DOI 10.1159/000016333; Wolf K, 2000, INFECT IMMUN, V68, P2379, DOI 10.1128/IAI.68.4.2379-2385.2000; Wood H, 2003, MOL MICROBIOL, V49, P1347, DOI 10.1046/j.1365-2958.2003.03638.x; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; YEE C, 1985, AM J PATHOL, V119, P361; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014; Zoa-Assoumou S, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0091-8	73	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163174	10.1371/journal.pone.0163174	http://dx.doi.org/10.1371/journal.pone.0163174			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658027	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200079
J	Sobrevals, L; Enguita, M; Quiroga, J; Prieto, J; Fortes, P				Sobrevals, Luciano; Enguita, Monica; Quiroga, Jorge; Prieto, Jesus; Fortes, Puri			Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; REDUCES FIBROGENESIS; NONPARENCHYMAL CELLS; GENE-EXPRESSION; HEPATITIS B; HEPATOCYTES; REGRESSION; FIBROSIS; THERAPY; PROTEIN	IGF-I modulates liver tissue homeostasis. It is produced by hepatocytes and signals within the liver through IGF-I receptor expressed on hepatic stellate cells (HSCs). Liver cirrhosis is characterized by marked IGF-I deficiency. Here we compared the effect of two different gene therapy vectors encoding IGF-I as a potential treatment for cirrhotic patients. Rats with carbon tetrachloride-induced liver cirrhosis were treated with controls or with adeno-associated virus 1 (AAV) or simian virus 40 (SV40) vectors expressing IGF-I (AAVIGF-I or SVIGF-I) and molecular and histological studies were performed at 4 days, 8 weeks and 16 weeks. Increased levels of IGF-I were observed in the liver as soon as 4 days after vector administration. Control cirrhotic rats showed increased hepatic expression of pro-inflammatory and pro-fibrogenic factors including transforming growth factor beta (TGF beta), tumor necrosis factor-alpha (TNF alpha), connective tissue growth factor (CTGF), and vascular endothelial growth factor (VEGF) together with upregulation of alpha-smooth muscle actin (alpha SMA), a marker of HSC activation. In IGF-I-treated rats the levels of all these molecules were similar to those of healthy controls by week 8 post-therapy. Of note, the decline of TGF beta, CTGF, VEGF and aSMA expression was more rapid in AAVIGF-I treated animals reaching statistical significance by day 4 post-therapy. IGF-I-treated rats showed similar improvement of liver function tests in parallel with upregulation of hepatocyte nuclear factor 4 alpha (HNF4 alpha), a factor that promotes hepatocellular differentiation. A significant decrease of liver fibrosis, accompanied by upregulation of the hepatoprotective and anti-fibrogenic hepatocyte growth factor (HGF), occurred in all IGF-I-treated rats but complete reversal of liver cirrhosis took place only in AAVIGF-I group. Therefore, AAVIGF-I reverts liver cirrhosis in rats, a capability which deserves clinical testing.	[Sobrevals, Luciano; Enguita, Monica; Prieto, Jesus; Fortes, Puri] Univ Navarra, Ctr Appl Med Res CIMA, Dept Gene Therapy & Hepatol, Pamplona, Spain; [Quiroga, Jorge; Prieto, Jesus] Univ Navarra Clin CUN, Pamplona, Spain; [Quiroga, Jorge] Univ Navarra, Navarra Inst Hlth Res, Ctr Invest Biomed Red Enfermedades Hepat & Digest, IdiSNA, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra	Fortes, P (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Dept Gene Therapy & Hepatol, Pamplona, Spain.	pfortes@unav.es	Enguita, Mónica/H-7650-2015; Fortes, Puri/J-7872-2016	Enguita, Mónica/0000-0002-2890-1252; Fortes, Puri/0000-0001-7571-6220	Ministry of Science and Innovation [SAF2012-40003, SAF2015-70971-R]; CIBERehd; Fondo de Investigacion Sanitaria [PI14/01442]; Institute de Salud Carlos III; Fundacio La Marato de TV3 [20132132]; Caja Navarra Foundation [70020]; European FEDER; project RNAREG [CSD2009-00080]; Ministry of Science and Innovation under the program CONSOLIDER INGENIO	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERehd; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fundacio La Marato de TV3; Caja Navarra Foundation; European FEDER(European Commission); project RNAREG; Ministry of Science and Innovation under the program CONSOLIDER INGENIO	This study was supported by grants from the Ministry of Science and Innovation (SAF2012-40003 and SAF2015-70971-R), CIBERehd and Fondo de Investigacion Sanitaria (PI14/01442), financed by the Institute de Salud Carlos III, Fundacio La Marato de TV3 (20132132), Caja Navarra Foundation (70020), European FEDER funding and by the project RNAREG [CSD2009-00080], funded by the Ministry of Science and Innovation under the program CONSOLIDER INGENIO 2010. The funders had no role in study design, data collection and analysis, decision to publish or preparation if the manuscript.	Aghemo Alessio, 2009, Gastroenterology, V136, P1447, DOI 10.1053/j.gastro.2009.02.033; Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Berasain C, 2003, HEPATOLOGY, V38, P148, DOI 10.1053/jhep.2003.50269; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BOUWENS L, 1992, ENZYME, V46, P155, DOI 10.1159/000468782; Brown A, 2012, EXPERT REV GASTROENT, V6, P187, DOI [10.1586/EGH.12.4, 10.1586/egh.12.4]; CASTELEIJN E, 1988, BIOCHEM J, V252, P601, DOI 10.1042/bj2520601; Castilla-Cortazar I, 2000, HEPATOLOGY, V31, P592, DOI 10.1002/hep.510310308; Chandok N, 2012, LIVER TRANSPLANT, V18, P1277, DOI 10.1002/lt.23531; Conchillo M, 2007, REV ESP ENFERM DIG, V99, P156, DOI 10.4321/s1130-01082007000300007; Conchillo M, 2005, J HEPATOL, V43, P630, DOI 10.1016/j.jhep.2005.03.025; Elizalde M, 2014, J CLIN INVEST, V124, P2909, DOI 10.1172/JCI74382; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Enguita-German M, 2014, WORLD J HEPATOL, V6, P716, DOI 10.4254/wjh.v6.i10.716; Fernandez-Rodriguez CM, 2001, DIGEST DIS SCI, V46, P1313, DOI 10.1023/A:1010631800505; Fiore EJ, 2015, STEM CELLS DEV, V24, P791, DOI 10.1089/scd.2014.0174; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Issa DH, 2015, CLEV CLIN J MED, V82, P361, DOI 10.3949/ccjm.82a.14072; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kramer MG, 2003, MOL THER, V7, P375, DOI 10.1016/S1525-0016(02)00060-6; Lorenzo-Zuniga V, 2006, GUT, V55, P1306, DOI 10.1136/gut.2005.079988; Manne V, 2014, J CLIN GASTROENTEROL, V48, pE76, DOI 10.1097/MCG.0000000000000162; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Perugorria MJ, 2009, CANCER RES, V69, P1358, DOI 10.1158/0008-5472.CAN-08-2545; Rodriguez-Peralvarez M, 2014, CURR OPIN ORGAN TRAN, V19, P253, DOI 10.1097/MOT.0000000000000069; Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505; SCOTT CD, 1985, ENDOCRINOLOGY, V116, P1102, DOI 10.1210/endo-116-3-1102; Seppen J, 2006, MOL THER, V13, P1085, DOI 10.1016/j.ymthe.2006.01.014; Sobrevals L, 2012, GENE THER, V19, P411, DOI 10.1038/gt.2011.119; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Stone D, 2010, VIRUSES-BASEL, V2, P1002, DOI 10.3390/v2041002; SU TS, 1989, CANCER RES, V49, P1773; Vera M, 2007, GENE THER, V14, P203, DOI 10.1038/sj.gt.3302858; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zinchenko YS, 2006, TISSUE ENG, V12, P2241, DOI 10.1089/ten.2006.12.2241	39	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162955	10.1371/journal.pone.0162955	http://dx.doi.org/10.1371/journal.pone.0162955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658043	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200047
J	Uekawa, K; Koizumi, K; Hwang, J; Brunier, N; Hattori, Y; Zhou, P; Park, L				Uekawa, Ken; Koizumi, Kenzo; Hwang, Jason; Brunier, Nathalie; Hattori, Yorito; Zhou, Ping; Park, Laibaik			Obligatory Role of EP1 Receptors in the Increase in Cerebral Blood Flow Produced by Hypercapnia in the Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTAGLANDIN E-2; INTRACEREBRAL HEMORRHAGE; VASODILATOR RESPONSES; FUNCTIONAL HYPEREMIA; PROSTANOID RECEPTORS; POTASSIUM CHANNELS; ANGIOTENSIN-II; ACTIVATION; DYSFUNCTION	Hypercapnia induces potent vasodilation in the cerebral circulation. Although it has long been known that prostanoids participate in the cerebrovascular effects of hypercapnia, the role of prostaglandin E2 (PGE(2)) and PGE(2) receptors have not been fully investigated. In this study, we sought to determine whether cyclooxygenase-1 (COX-1)-derived PGE(2) and EP1 receptors are involved in the cerebrovascular response induced by hypercapnia. Cerebral blood flow (CBF) was recorded by laser-Doppler flowmetry in the somatosenasory cortex of anesthetized male EP1(-/-) mice and wild type (WT) littermates. In WT mice, neocortical application of the EP1 receptor antagonist SC-51089 attenuated the increase in CBF elicited by systemic hypercapnia (pCO(2) = 50-60 mmHg). SC-51089 also attenuated the increase in CBF produced by neocortical treatment of arachidonic acid or PGE(2). These CBF responses were also attenuated in EP1(-/-) mice. In WT mice, the COX-1 inhibitor SC-560, but not the COX-2 inhibitor NS-398, attenuated the hypercapnic CBF increase. Neocortical application of exogenous PGE(2) restored the attenuation in resting CBF and the hypercapnic response induced by SC-560. In contrast, exogenous PGE(2) failed to rescue the attenuation both in WT mice induced by SC-51089 and EP1(-/-) mice, attesting to the obligatory role of EP1 receptors in the response. These findings indicate that the hypercapnic vasodilatation depends on COX-1-derived PGE(2) acting on EP1 receptors and highlight the critical role that COX-1-derived PGE(2) and EP1 receptors play in the hypercapnic regulation of the cerebral circulation.	[Uekawa, Ken; Koizumi, Kenzo; Hwang, Jason; Brunier, Nathalie; Hattori, Yorito; Zhou, Ping; Park, Laibaik] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Park, L (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.	lap2003@med.cornell.edu		PARK, LAIBAIK/0000-0001-7601-663X	Feil Family Foundation; National Institutes of Health [NS37853]; American Heart Association [09SDG2060701]	Feil Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health Grant NS37853, American Heart Association Grant 09SDG2060701. The generous support of the Feil Family Foundation is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The generous support of the Feil Family Foundation is greatly acknowledged. The authors wish to thank Dr. Costantino Iadecola for his critical proofreading of the manuscript and Dr. Diane Lane for her advice of the statistical analysis.	Barnes JN, 2012, J APPL PHYSIOL, V112, P1884, DOI 10.1152/japplphysiol.01270.2011; Bassil AK, 2008, BRIT J PHARMACOL, V154, P126, DOI 10.1038/bjp.2008.84; Capone C, 2010, HYPERTENSION, V55, P911, DOI 10.1161/HYPERTENSIONAHA.109.145813; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; DALKARA T, 1995, J CEREBR BLOOD F MET, V15, P631, DOI 10.1038/jcbfm.1995.78; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Faraco G, 2016, J CEREBR BLOOD F MET, V36, P241, DOI 10.1038/jcbfm.2015.79; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; HALLINAN EA, 1993, J MED CHEM, V36, P3293, DOI 10.1021/jm00074a010; Hristovska AM, 2007, HYPERTENSION, V50, P525, DOI 10.1161/HYPERTENSIONAHA.107.088948; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; IADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913, DOI 10.1073/pnas.89.9.3913; Jadhav V, 2004, J CEREBR BLOOD F MET, V24, P1305, DOI 10.1097/01.WCB.0000139446.61789.14; Jadhav V, 2009, STROKE, V40, P261, DOI 10.1161/STROKEAHA.108.516104; Juteau HN, 2001, BIOORGAN MED CHEM, V9, P1977, DOI 10.1016/S0968-0896(01)00110-9; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; LEFFLER CW, 1989, PEDIATR RES, V25, P180; Lindauer U, 2003, J CEREBR BLOOD F MET, V23, P1227, DOI 10.1097/01.WCB.0000088764.02615.B7; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Park L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6318; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Park L, 2013, P NATL ACAD SCI USA, V110, P3089, DOI 10.1073/pnas.1300021110; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; Saleem S, 2007, J NEUROSCI RES, V85, P2433, DOI 10.1002/jnr.21399; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; Stock JL, 2001, J CLIN INVEST, V107, P325, DOI 10.1172/JCI6749; WAGERLE LC, 1991, AM J PHYSIOL, V260, pH1313, DOI 10.1152/ajpheart.1991.260.4.H1313; WAGERLE LC, 1994, AM J PHYSIOL, V266, pH1332, DOI 10.1152/ajpheart.1994.266.4.H1332; Wang G, 2013, AM J PHYSIOL-HEART C, V305, pH1451, DOI 10.1152/ajpheart.00238.2013; Wright DH, 2001, AM J PHYSIOL-REG I, V281, pR1343, DOI 10.1152/ajpregu.2001.281.5.R1343; Zhao XC, 2015, BRAIN BEHAV IMMUN, V46, P293, DOI 10.1016/j.bbi.2015.02.011	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163329	10.1371/journal.pone.0163329	http://dx.doi.org/10.1371/journal.pone.0163329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657726	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200101
J	Rainey, JJ; Kenney, J; Wilburn, B; Putman, A; Zheteyeva, Y; O'Sullivan, M				Rainey, Jeanette J.; Kenney, Jasmine; Wilburn, Ben; Putman, Ami; Zheteyeva, Yenlik; O'Sullivan, Megan			OnlineWork Force Analyzes Social Media to Identify Consequences of an Unplanned School Closure - Using Technology to Prepare for the Next Pandemic	PLOS ONE			English	Article							INFLUENZA-A H1N1; SURVEILLANCE	Background During an influenza pandemic, the United States Centers for Disease Control and Prevention (CDC) may recommend school closures. These closures could have unintended consequences for students and their families. Publicly available social media could be analyzed to identify the consequences of an unplanned school closure. Methods As a proxy for an unplanned, pandemic-related school closure, we used the district-wide school closure due to the September 10 - 18, 2012 teachers' strike in Chicago, Illinois. We captured social media posts about the school closure using the Radian6 social media-monitoring platform. An online workforce from Amazon Mechanical Turk categorized each post into one of two groups. The first group included relevant posts that described the impact of the closure on students and their families. The second group included irrelevant posts that described the political aspects of the strike or topics unrelated to the school closure. All relevant posts were further categorized as expressing a positive, negative, or neutral sentiment. We analyzed patterns of relevant posts and sentiment over time and compared our findings to household surveys conducted after other unplanned school closures. Results We captured 4,546 social media posts about the district-wide school closure using our search criteria. Of these, 930 (20%) were categorized as relevant by the online workforce. Of the relevant posts, 619 (67%) expressed a negative sentiment, 51 (5%) expressed a positive sentiment, and 260 (28%) were neutral. The number of relevant posts, and especially those with a negative sentiment, peaked on day 1 of the strike. Negative sentiment expressed concerns about childcare, missed school lunches, and the lack of class time for students. This was consistent with findings from previously conducted household surveys. Conclusion Social media are publicly available and can readily provide information on the impact of an unplanned school closure on students and their families. Using social media to assess the impact of an unplanned school closure due to a public health event would be informative. An online workforce can effectively assist with the review process.	[Rainey, Jeanette J.; Kenney, Jasmine; Putman, Ami; Zheteyeva, Yenlik; O'Sullivan, Megan] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30329 USA; [Wilburn, Ben] ORISE, Oak Ridge, TN USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Rainey, JJ (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30329 USA.	jkr7@cdc.gov						Agolory SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050916; Black David R, 2015, J Emerg Manag, V13, P217, DOI 10.5055/jem.2015.0235; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chicago Public Schools, SCH DAT DEM SCH YEAR; Copeland DL, 2013, CLIN INFECT DIS, V56, P509, DOI 10.1093/cid/cis890; Dooyema CA, 2014, J SCHOOL HEALTH, V84, P56, DOI 10.1111/josh.12113; Dyar OJ, 2014, J ANTIMICROB CHEMOTH, V69, P2568, DOI 10.1093/jac/dku165; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Epson EE, 2015, DISASTER MED PUBLIC, V9, P4, DOI 10.1017/dmp.2015.3; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x; Gift TL, 2010, EMERG INFECT DIS, V16, P1315, DOI 10.3201/eid1608.091827; Harris JK, 2014, J MED INTERNET RES, V16, DOI [10.2196/jmir.2972, 10.2196/jmir.3622]; Holloway R, 2014, MMWR RECOMM REP, V63, P1; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Kiviniemi MT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-152; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Ramagopalan S., 2014, F1000RESEARCH, V216, P1; Russell ES, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw113; Salathe A M, 2001, PLOS COMPUTATIONAL B, V7; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Steelfisher G. K., 2010, Morbidity and Mortality Weekly Report, V59, P1131; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; Tuarob S, 2014, J BIOMED INFORM, V49, P255, DOI 10.1016/j.jbi.2014.03.005	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163207	10.1371/journal.pone.0163207	http://dx.doi.org/10.1371/journal.pone.0163207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655229	gold, Green Submitted, Green Published			2022-12-27	WOS:000383892700041
J	Wood, R; Jacobs, Z; Vannieuwenhuyse, D; Balme, J; O'Connor, S; Whitau, R				Wood, Rachel; Jacobs, Zenobia; Vannieuwenhuyse, Dorcas; Balme, Jane; O'Connor, Sue; Whitau, Rose			Towards an Accurate and Precise Chronology for the Colonization of Australia: The Example of Riwi, Kimberley, Western Australia	PLOS ONE			English	Article							MIDDLE STONE-AGE; HUMAN OCCUPATION; LAKE MUNGO; SINGLE; LUMINESCENCE; QUARTZ; EXCAVATIONS; TRANSITION; SETTLEMENT; AFRICA	An extensive series of 44 radiocarbon (C-14) and 37 optically stimulated luminescence (OSL) ages have been obtained from the site of Riwi, south central Kimberley (NW Australia). As one of the earliest known Pleistocene sites in Australia, with archaeologically sterile sediment beneath deposits containing occupation, the chronology of the site is important in renewed debates surrounding the colonization of Sahul. Charcoal is preserved throughout the sequence and withinmultiple discrete hearth features. Prior to C-14 dating, charcoal has been pretreated with both acid-base-acid (ABA) and acid base oxidation-stepped combustion (ABOx-SC) methods at multiple laboratories. Ages are consistent between laboratories and also between the two pretreatment methods, suggesting that contamination is easily removed from charcoal at Riwi and the Pleistocene ages are likely to be accurate. Whilst some charcoal samples recovered from outside hearth features are identified as outliers within a Bayesian model, all ages on charcoal within hearth features are consistent with stratigraphy. OSL dating has been undertaken using single quartz grains from the sandy matrix. The majority of samples show D-e distributions that are well-bleached but that also include evidence for mixing as a result of post-depositional bioturbation of the sediment. The results of the two techniques are compared and evaluated within a Bayesian model. Consistency between the two methods is good, and we demonstrate human occupation at this site from 46.4-44.6 cal kBP (95.4% probability range). Importantly, the lowest archaeological horizon at Riwi is underlain by sterile sediments which have been dated by OSL making it possible to demonstrate the absence of human occupation for between 0.9-5.2 ka (68.2% probability range) prior to occupation.	[Wood, Rachel] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Jacobs, Zenobia] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Vannieuwenhuyse, Dorcas; Balme, Jane] Univ Western Australia, Sch Social Sci, Crawley, WA 6009, Australia; [O'Connor, Sue; Whitau, Rose] Australian Natl Univ, Res Sch Pacific & Asian Studies, Dept Archaeol & Nat Hist, Canberra, ACT 2601, Australia	Australian National University; University of Wollongong; University of Western Australia; Australian National University	Wood, R (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia.	rachel.wood@anu.edu.au	Jacobs, Zenobia/B-2721-2012; Balme, Jane/H-8787-2014; Wood, Rachel/K-5577-2016	Jacobs, Zenobia/0000-0001-5424-5837; Balme, Jane/0000-0003-1387-9379; O'Connor, Sue/0000-0001-9381-078X; Wood, Rachel/0000-0002-1694-3295	Australian Research Council [DE150100070]; Kimberley Foundation Australia; Commonwealth Department of the Environment [LP100200415]; ARC [LP100200415]; ARC DECRA fellowship [DE150100070]	Australian Research Council(Australian Research Council); Kimberley Foundation Australia; Commonwealth Department of the Environment; ARC(Australian Research Council); ARC DECRA fellowship(Australian Research Council)	The Australian Research Council (http://www.arc.gov.au), with the Kimberley Foundation Australia (http://www.kimberleyfoundation.org.au) and the Commonwealth Department of the Environment (http://www.environment.gov.au) provided funding for the research (Linkage Grant LP100200415, awarded to JB, SO'C). REW wrote this paper whilst funded by an Australian Research Council Discovery Early Career Award (DE150100070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Gooniyandi community are thanked for allowing and aiding access to the material from Riwi Cave. Funding was provided by ARC (Linkage Grant LP100200415), with the Kimberley Foundation Australia and the Commonwealth Department of the Environment. R. Wood wrote this paper whilst funded by an ARC DECRA fellowship (DE150100070). The excavation permit was provided by the Department of Aboriginal Affairs (Section 16 permit no. 499). Stewart Fallon is thanked for help with AMS. Richard Staff read an earlier draft of this paper. All errors are, of course, our own.	Aitken MJ, 1985, THERMOLUMINESCENCE D; Allen J, 2014, AUST ARCHAEOL, P86; Balme J., 2000, AUST ARCHAEOL, V51, P105; BELL WT, 1978, ARCHAEOMETRY, V20, P63, DOI 10.1111/j.1475-4754.1978.tb00213.x; Bird MI, 1999, RADIOCARBON, V41, P127, DOI 10.1017/S0033822200019482; Bird MI, 2014, QUAT GEOCHRONOL, V22, P25, DOI 10.1016/j.quageo.2014.02.003; Blinkhorn J, 2015, QUATERN INT, V382, P237, DOI 10.1016/j.quaint.2015.02.027; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; David B, AUSTR ARCHAEOLOGY; Davidson I, 2013, QUATERN INT, V285, P1, DOI 10.1016/j.quaint.2012.09.023; Demeter F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121193; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Duller G.A.T., 2007, ANCIENT TL, V25, P15; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P898, DOI 10.1016/j.nimb.2009.10.059; Fifield LK, 2001, RADIOCARBON, V43, P1139; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Hiscock P., 2015, CAMBRIDGE WORLD HIST, P433; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Kumar S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-173; Langley MC, 2016, AUSTR ARCHAEOLOGY; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mercier N., 2007, TECHNIQUE, V25, P1; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Muscheler R, 2014, EARTH PLANET SC LETT, V394, P209, DOI 10.1016/j.epsl.2014.03.024; O'Connell JF, 2015, J ARCHAEOL SCI, V56, P73, DOI 10.1016/j.jas.2015.02.020; OConnor Sue, 2015, EMERGENCE DIVERSITY, P214; Olley JM, 2006, QUATERNARY SCI REV, V25, P2469, DOI 10.1016/j.quascirev.2005.07.022; Powell R, 2002, CHEM GEOL, V185, P191, DOI 10.1016/S0009-2541(01)00403-X; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rebollo NR, 2011, J ARCHAEOL SCI, V38, P2424, DOI 10.1016/j.jas.2011.05.010; Rhodes E., 2007, ANCIENT TL, V25, P5; Rhodes EJ, 2003, QUATERNARY SCI REV, V22, P1231, DOI 10.1016/S0277-3791(03)00046-5; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Rousseeuw PJ, 2006, CRIT REV ANAL CHEM, V36, P221, DOI 10.1080/10408340600969403; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Smith M., 2013, ARCHAEOLOGY AUSTR DE; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; Veth P., 2006, ARCHAEOL OCEAN, P31; Veth P, 2009, AUST ARCHAEOL, P1; Whitau R, QUATERNARY IN PRESS; Whitau R, 2016, J ARCHAEOL SCI-REP, V6, P536, DOI 10.1016/j.jasrep.2016.03.021; Wintle AG, 1997, RADIAT MEAS, V27, P769, DOI 10.1016/S1350-4487(97)00220-5; Wood RE, 2012, QUAT GEOCHRONOL, V9, P16, DOI 10.1016/j.quageo.2012.02.003	64	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0160123	10.1371/journal.pone.0160123	http://dx.doi.org/10.1371/journal.pone.0160123			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655174	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700004
J	Klingler, JJ				Klingler, Jeremy J.			On the Morphological Description of Tracheal and Esophageal Displacement and Its Phylogenetic Distribution in Avialae	PLOS ONE			English	Article							BIRDS; EVOLUTION; MUSCLES; SPHENODON; ANATOMY	This research examines the evolution and phylogenetic distribution of a peculiar and often overlooked character seen in birds, herein called tracheal and esophageal displacement. Tracheal and esophageal displacement refers to an asymmetrically situated trachea and/or esophagus along the length of the neck. This contrasts with what would be perceived as the "normal" (midsagittal) placement of these organs, wherein the two organs are situated along the ventral midline of the neck with no deviation. A total of forty-two bird species were examined (thirty-six of which came from dissections whereas six came from comments from previous literature or personal observations), as well as turtles, lizards, crocodylians, and mammals. This study found that essentially all birds have a laterally displaced trachea and/or esophagus. Lizards and mammals were seen to have normal, midsagittally placed tracheae and esophagi. Crocodylians were interesting in that alligators were defined by a normally situated trachea and esophagus whereas some crocodiles were characterized by displacement. In birds, the displacement may occur gradually along the neck, or it may happen immediately upon exiting the oropharynx. Displacement of these organs in birds is the result of a heavily modified neck whereinmuscles that restrict mobility of the trachea and esophagus in lizards, alligators, and mammals (e.g., m. episternocleidomastoideus, m. omohyoideus, and m. sternohyoideus) no longer substantially restrict positions of the trachea and esophagus in birds. Rather, thesemuscles are modified in ways which may assist with making tracheal movements. The implications of this study may provide interesting insights for future comparisons in extinct taxa.	[Klingler, Jeremy J.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Klingler, Jeremy J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Northern Illinois University; Utah System of Higher Education; University of Utah	Klingler, JJ (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.; Klingler, JJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jeremy.j.klingler@gmail.com						Al-Hassawi A.M.A., 2004, DISCOVERY; Ashley LM, 1962, LAB ANATOMY TURTLE; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; BEEBE WILLIAM, 1926, ZOOLOGICA, V7, P1; BEZUIDENHOUT AJ, 1986, ONDERSTEPOORT J VET, V53, P111; Bezuidenhout AJ, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P13; Blache D, 2005, ENCY ANIMAL SCI, P763; Boker H., 1931, Gegenbaurs Morphologisches Jahrbuch, V66, P220; Britton SW, 1941, Q REV BIOL, V16, P13, DOI 10.1086/394620; Britton WS, 1941, Q REV BIOL, V16, P190, DOI 10.1086/394628; Cong L., 1998, GROSS ANATOMY ALLIGA; Deeming DC, 1996, P RAT C MANCH ENGL, P1; Ehrat H, 1943, Z WISS ZOOL, V156, P290; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fuarbringer M., 1902, JENA Z NATURW, V36, P289; Furbringer M, 1900, JENAISCHE Z NATURWIS, V36, P289; Furbringer M, 1876, MORPHOLOGISCHES JB, V1, P636; G- H Schumacher, 1973, MORPHOLOGY, V4, P101; GADOW H, 1891, KLASSEN ORDNUNGEN TH; Gans C., 1976, P357; George JC, 1966, AVIAN MYOLOGY; Goffart M., 1971, FUNCTION FORM SLOTH; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harmon L, 2015, PACKAGE GEIGER R PAC; Hass G, 1973, BIOL REPTILIA, V4, P285; Hayssen Virginia, 2009, Mammalian Species, P1, DOI 10.1644/839.1; HOMBERGER DG, 1989, AM J ANAT, V186, P217, DOI 10.1002/aja.1001860302; HUCHZERMEYER FW, 1998, DIS OSTRICHES OTHER; Huelsenbeck JP, 2003, SYST BIOL, V52, P131, DOI 10.1080/10635150309342; HUMPHREY PHILIP S., 1958, CONDOR, V60, P303, DOI 10.2307/1365156; Jones MEH, 2009, PALAEONTOL ELECTRON, V12; King AS, 1984, BIRDS THEIR STRUCTUR, P334; Lubosch W., 1933, Gegenbaurs Morphologisches Jahrbuch, V72, P584; MACALISTER A, 1864, P ROY IRISH ACAD, V9, P1; MCLELLAND J, 1989, FORM FUNCTION BIRDS, V0004, P00069; Niethammer G, 1933, Z WISS ZOOL ABT A, V144, P12; Owen R, 1876, CLASSIFICATION MAMMA; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poglayen-Neuwall I., 1953, Zeitschrift fuer Wissenschaftliche Zoologie, V157, P57; Rathke C, 1866, UNTERSUCHUNGEN ENTWI; Reese A. M., 1915, ALLIGATOR ITS ALLIES; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RIEPPEL O, 1978, ANAT ANZEIGER, V144, P429; Sakas PS, 2002, ESSENTIALS AVIAN MED, V2nd; Sawaya P, 1936, REV OTOLARYNG SAO PA, V4, P1; Schachner ER, 2013, PEERJ, V1, DOI 10.7717/peerj.60; Shane S. M., 1996, RATITE MANAGEMENT ME; Simon L, 1902, ARCH NATURGESCH, V68, P239; Snively E, 2006, THESIS; Tivane C, 2008, THESIS, P99; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Valente ALS, 2007, VET J, V174, P362, DOI 10.1016/j.tvjl.2006.08.018; van der Leeuw AHJ, 2001, AM ZOOL, V41, P1352, DOI 10.1668/0003-1569(2001)041[1352:COTCCS]2.0.CO;2; Vanden Berge JC, 1975, SISSON GROSSMANS ANA, P1802; Versluys J., 1898, ZOOL JB CHER ABTEILU, V12, P161; WALLACH V, 1998, BIOL REPTILIA, V19, P93; Weber M, 1928, DIE SAUGETIERE; Weber M, 1904, DIE SAUGETIERE; Wislocki GB, 1928, J MORPHOL PHYSIOL, V46, P317, DOI 10.1002/jmor.1050460202; Zehtabvar O., 2014, Iranian Journal of Veterinary Surgery, V9, P9; [No title captured]; [No title captured]; [No title captured]	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163348	10.1371/journal.pone.0163348	http://dx.doi.org/10.1371/journal.pone.0163348			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648952	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100081
J	Koch, M; Lunde, LK; Gjulem, T; Knardahl, S; Veiersted, KB				Koch, Markus; Lunde, Lars-Kristian; Gjulem, Tonje; Knardahl, Stein; Veiersted, Kaj Bo			Validity of Questionnaire and Representativeness of Objective Methods for Measurements of Mechanical Exposures in Construction and Health Care Work	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; HEART-RATE; MUSCULOSKELETAL DISORDERS; RISK-FACTORS; SELF-REPORTS; EPIDEMIOLOGY; RELIABILITY; MOVEMENT; POSTURES; CLEANERS	Objectives To determine the criterion validity of a questionnaire on physical exposures compared to objective measurements at construction and health care sites and to examine exposure variation over several working days. Methods Five hundred ninety-four construction and health care workers answered a baseline questionnaire. The daily activities (standing, moving, sitting, number of steps), postures (inclination of the arm and the trunk), and relative heart rate of 125 participants were recorded continuously over 3-4 working days. At the end of the first measurement day, the participants answered a second questionnaire (workday questionnaire). Results All objective activity measurements had significant correlations to their respective questions. Among health care workers, there were no correlations between postures and relative heart rate and the baseline questionnaire. The questionnaires overestimated the exposure durations. The highest explained variance in the adjusted models with self-reported variables were found for objectively measured sitting (R-2 = 0.559) and arm inclination >60 degrees (R-2 = 0.420). Objective measurements over several days showed a higher reliability compared to single day measurements. Conclusions Questionnaires cannot provide an accurate description of mechanical exposures. Objective measurements over several days are recommended in occupations with varying tasks.	[Koch, Markus; Lunde, Lars-Kristian; Gjulem, Tonje; Knardahl, Stein; Veiersted, Kaj Bo] Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway; [Gjulem, Tonje] Oslo Univ Hosp, Oslo, Norway	University of Oslo	Koch, M (corresponding author), Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway.	Markus.Koch@stami.no			Research Council of Norway; Norwegian Research council	Research Council of Norway(Research Council of Norway); Norwegian Research council(Research Council of NorwayEuropean Commission)	This project was funded by a grant from the Research Council of Norway (www.forskningsradet.no). No individuals employed or contracted by the funder played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The Norwegian Research council supported this study. Gunn-Helen Moen, Therese N. Hanvold, Elisabeth Petersen, Daniel Pietz Jacobsen, Monica Wigemyr and Morten Waersted provided technical assistance.	Barrero LH, 2009, SCAND J WORK ENV HEA, V35, P245, DOI 10.5271/sjweh.1335; Bernal D, 2015, INT J NURS STUD, V52, P635, DOI 10.1016/j.ijnurstu.2014.11.003; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; David GC, 2005, OCCUP MED-OXFORD, V55, P190, DOI 10.1093/occmed/kqi082; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Gupta N, 2016, SCAND J WORK ENV HEA, V42, P237, DOI 10.5271/sjweh.3561; Hansson GA, 2001, SCAND J WORK ENV HEA, V27, P30, DOI 10.5271/sjweh.584; KARVONEN J, 1988, SPORTS MED, V5, P303, DOI 10.2165/00007256-198805050-00002; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Korshoj M, 2013, ERGONOMICS, V56, P935, DOI 10.1080/00140139.2013.782427; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lunde LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1075; Magnusson ML, 1998, J SOUND VIB, V215, P965, DOI 10.1006/jsvi.1998.1677; Mathiassen SE, 2003, AIHA J-J SCI OCCUP E, V64, P196, DOI 10.1202/1542-8125(2003)64<196:EOSOMJ>2.0.CO;2; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Shimaoka M, 1998, EUR J APPL PHYSIOL O, V77, P10; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Statistics Norway, 2009, STAT NORW LEV 2009; Steingrimsdottir OA, 2004, PAIN, V110, P130, DOI 10.1016/j.pain.2004.03.016; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Stock SR, 2005, SCAND J WORK ENV HEA, V31, P409, DOI 10.5271/sjweh.947; Takala EP, 2010, SCAND J WORK ENV HEA, V36, P3, DOI 10.5271/sjweh.2876; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Teschke K, 2009, ERGONOMICS, V52, P1067, DOI 10.1080/00140130902912811; Unge J, 2005, ERGONOMICS, V48, P12, DOI 10.1080/00140130412331293364; van der Beek AJ, 1998, OCCUP ENVIRON MED, V55, P291, DOI 10.1136/oem.55.5.291; Veiersted KB, 1996, ERGONOMICS, V39, P797, DOI 10.1080/00140139608964499; Westgaard RH, 1996, APPL ERGON, V27, P79, DOI 10.1016/0003-6870(95)00062-3; Wu HC, 2002, ERGONOMICS, V45, P280, DOI 10.1080/00140130210123499; Yassi A, 2013, INT J OCCUP ENV HEAL, V19, P223, DOI 10.1179/2049396713Y.0000000027	37	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162881	10.1371/journal.pone.0162881	http://dx.doi.org/10.1371/journal.pone.0162881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649499	gold, Green Published, Green Accepted			2022-12-27	WOS:000383892100040
J	Nascimento, FF; Rodrigo, AG				Nascimento, Fabricia F.; Rodrigo, Allen G.			Computational Evaluation of the Strict Master and Random Template Models of Endogenous Retrovirus Evolution	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; HUMAN GENOME; PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCES; VIRAL EVOLUTION; COPY NUMBER; DYNAMICS; GENES; TREES; RETROTRANSPOSONS	Transposable elements (TEs) are DNA sequences that are able to replicate and move within and between host genomes. Their mechanism of replication is also shared with endogenous retroviruses (ERVs), which are also a type of TE that represent an ancient retroviral infection within animal genomes. Two models have been proposed to explain TE proliferation in host genomes: the strict master model (SMM), and the random template (or transposon) model (TM). In SMM only a single copy of a given TE lineage is able to replicate, and all other genomic copies of TEs are derived from that master copy. In TM, any element of a given family is able to replicate in the host genome. In this paper, we simulated ERV phylogenetic trees under variations of SMM and TM. To test whether current phylogenetic programs can recover the simulated ERV phylogenies, DNA sequence alignments were simulated and maximum likelihood trees were reconstructed and compared to the simulated phylogenies. Results indicate that visual inspection of phylogenetic trees alone can be misleading. However, if a set of statistical summaries is calculated, we are able to distinguish between models with high accuracy by using a data mining algorithm that we introduce here. We also demonstrate the use of our data mining algorithm with empirical data for the porcine endogenous retrovirus (PERV), an ERV that is able to replicate in human and pig cells in vitro.	[Nascimento, Fabricia F.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [Nascimento, Fabricia F.] Univ Oxford, Dept Zool, Oxford, England; [Rodrigo, Allen G.] Australian Natl Univ, Res Sch Biol, Acton, Australia	The National Evolutionary Synthesis Center; University of Oxford; Australian National University	Nascimento, FF (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC 27705 USA.; Nascimento, FF (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	fabricia.nascimento@zoo.ox.ac.uk	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317; Nascimento, Fabricia/0000-0001-9426-6835	National Evolutionary Synthesis Center-National Science Foundation [EF-0905606]; Royal Society; British Academy-Newton International Fellowship [NF 140338]	National Evolutionary Synthesis Center-National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); British Academy-Newton International Fellowship	This work was supported by the National Evolutionary Synthesis Center-National Science Foundation grant number EF-0905606 (http://www.nsf.gov/) to FFN and AR, and The Royal Society and British Academy-Newton International Fellowship NF 140338 to FFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Barrio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019832; Belancio VP, 2009, GENOME MED, V1, DOI 10.1186/gm97; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Boeke JD, 1997, RETROVIRUSES; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Bouckaert R.R., 2013, WEKA MANUAL VERSION; Boyd M, 2015, PHYLOTOP PHYLOGENETI; Buzdin A, 2003, GENOMICS, V81, P149, DOI 10.1016/S0888-7543(02)00027-7; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Clough JE, 1996, J MOL EVOL, V42, P52, DOI 10.1007/BF00163211; Coffin JM, 1996, FIELDS VIROLOGY, P1767; Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Costas J, 2001, J MOL EVOL, V53, P237, DOI 10.1007/s002390010213; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; do Nascimento FF, 2011, INFECT GENET EVOL, V11, P686, DOI 10.1016/j.meegid.2011.01.010; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabryova H, 2015, VIROLOGY, V485, P96, DOI 10.1016/j.virol.2015.07.003; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Flutre Timothee, 2011, Mob Genet Elements, V1, P151; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hayward A, 2013, P NATL ACAD SCI USA, V110, P20146, DOI 10.1073/pnas.1315419110; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Johnson WE, 2015, ANNU REV VIROL, V2, P135, DOI 10.1146/annurev-virology-100114-054945; JUKES T H, 1969, P21; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Klymiuk N, 2006, J GEN VIROL, V87, P977, DOI 10.1099/vir.0.81552-0; Kurth R, 2010, INT J CANCER, V126, P306, DOI 10.1002/ijc.24902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Magiorkinis G, 2012, P NATL ACAD SCI USA, V109, P7385, DOI 10.1073/pnas.1200913109; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; McKenzie A, 2000, MATH BIOSCI, V164, P81, DOI 10.1016/S0025-5564(99)00060-7; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Nascimento FF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-139; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; R Core Team, 2014, R LANG ENV STAT COMP; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rein A, 2011, ADV VIROL, V2011, DOI 10.1155/2011/403419; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Solyom S, 2012, GENOME MED, V4, DOI 10.1186/gm311; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Weiss RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0494; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZB, 1994, J MOL EVOL, V39, P105; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	87	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162454	10.1371/journal.pone.0162454	http://dx.doi.org/10.1371/journal.pone.0162454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649303	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100020
J	Pelusi, S; Petta, S; Rosso, C; Borroni, V; Fracanzani, AL; Dongiovanni, P; Craxi, A; Bugianesi, E; Fargion, S; Valenti, L				Pelusi, Serena; Petta, Salvatore; Rosso, Chiara; Borroni, Vittorio; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Craxi, Antonio; Bugianesi, Elisabetta; Fargion, Silvia; Valenti, Luca			Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							FOLLOW-UP; INSULIN-RESISTANCE; RECEPTOR BLOCKER; STEATOHEPATITIS; NAFLD; RISK; IRON	Background The clinical determinants of fibrosis progression in nonalcoholic fatty liver disease (NAFLD) are still under definition. Aim To assess the clinical determinants of fibrosis progression rate (FPR) in NAFLD patients with baseline and follow-up histological evaluation, with a special focus on the impact of pharmacological therapy. Methods In an observational cohort of 118 Italian patients from tertiaryreferral centers, liver histology was evaluated according to Kleiner. Independent predictors of FPR were selected by a stepwise regression approach. Results Median follow-up was 36 months (IQR 24-77). Twenty-five patients (18%) showed some amelioration, 63 (53%) had stability, 30 (25%) had progression of fibrosis. Patients with nonalcoholic steatohepatitis (NASH) had similar demographic and anthropometric features, but a higher prevalence of type 2 diabetes (T2D; p = 0.010), and use of renin-angiotensin axis system (RAS) inhibitors (p = 0.005). Fibrosis progression was dependent of the length of follow-up, and was associated with, but did not require, the presence of NASH (p<0.05). Both fibrosis progression and faster FPR were independently associated with higher APRI score at follow-up, absence of treatment with RAS inhibitors, and T2D diagnosis at baseline (p<0.05). There was a significant interaction between use of RAS inhibitors and T2D on FPR (p = 0.002). RAS inhibitors were associated with slower FPR in patients with (p = 0.011), but not in those without (p = NS) T2D. Conclusions NASH is not required for fibrosis progression in NAFLD, whereas T2D seems to drive fibrogenesis independently of hepatic inflammation. Use of RAS inhibitors may contrast fibrosis progression especially in high-risk patients affected by T2D.	[Pelusi, Serena; Borroni, Vittorio; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Fargion, Silvia; Valenti, Luca] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med & Metab Dis, Milan, Italy; [Petta, Salvatore; Craxi, Antonio] Univ Palermo, Gastroenterol, Palermo, Italy; [Rosso, Chiara; Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Gastroenterol, Turin, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Palermo; University of Turin	Valenti, L (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med & Metab Dis, Milan, Italy.	luca.valenti@unimi.it	Dongiovanni, Paola/AAC-9965-2019; pelusi, serena/AAC-2725-2022; Rosso, Chiara/AAY-4336-2021; Valenti, Luca/B-3695-2009	Dongiovanni, Paola/0000-0003-4343-7213; Rosso, Chiara/0000-0001-6518-7089; Valenti, Luca/0000-0001-8909-0345	MyFirst AIRC (Italian Association for Cancer Research) grant [16888]; Ricerca corrente Fondazione IRCCS Ca Granda Milano, Molecular Medicine Grant Fondazione-INGM	MyFirst AIRC (Italian Association for Cancer Research) grant; Ricerca corrente Fondazione IRCCS Ca Granda Milano, Molecular Medicine Grant Fondazione-INGM	LV was funded by MyFirst AIRC (Italian Association for Cancer Research) grant n. 16888 and Ricerca corrente Fondazione IRCCS Ca Granda Milano, Molecular Medicine Grant Fondazione-INGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Dongiovanni P., 2015, METABOLISM; Dongiovanni P, 2015, EXPERT REV GASTROENT, V10, P1; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Ekstedt M, 2007, J HEPATOL, V47, P135, DOI 10.1016/j.jhep.2007.02.013; European Association for the Study of the Liver, 2016, J HEPATOL; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Goh GB, 2015, LIVER INT, V35, P979, DOI 10.1111/liv.12611; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Jonsson JR, 2001, GASTROENTEROLOGY, V121, P148, DOI 10.1053/gast.2001.25480; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Morris EM, 2013, MOL CELL ENDOCRINOL, V378, P29, DOI 10.1016/j.mce.2012.04.013; Orlic L, 2015, WIEN KLIN WOCHENSCHR, V127, P355, DOI 10.1007/s00508-014-0661-y; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Petta S, 2016, J HEPATOL, V64, P682, DOI 10.1016/j.jhep.2015.10.016; Petta S, 2016, DIGEST LIVER DIS, V48, P333, DOI 10.1016/j.dld.2015.10.027; Rosso C, 2016, HEPATOLOGY, V63, P107, DOI 10.1002/hep.28287; Singh S, 2015, HEPATOLOGY; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Sturzeneker MCS, 2011, ATHEROSCLEROSIS, V216, P97, DOI 10.1016/j.atherosclerosis.2011.01.047; Torres DM, 2011, HEPATOLOGY, V54, P1631, DOI 10.1002/hep.24558; Valenti L, 2014, WORLD J GASTROENTERO, V20, P3002, DOI 10.3748/wjg.v20.i11.3002; Wu Y, 2016, LIVER INT; Yang L, 2005, J HEPATOL, V43, P317, DOI 10.1016/j.jhep.2005.02.034; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	37	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163069	10.1371/journal.pone.0163069	http://dx.doi.org/10.1371/journal.pone.0163069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649410	Green Published, gold			2022-12-27	WOS:000383892100048
J	Myat, MM; Patel, U				Myat, Monn Monn; Patel, Unisha			Receptor-Type Guanylyl Cyclase at 76C (Gyc76C) Regulates De Novo Lumen Formation during Drosophila Tracheal Development	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; TUBE FUSION; GTPASE; CGMP; PROTEIN; ACTIN; MIGRATION; SIZE; RHO	Lumen formation and maintenance are important for the development and function of essential organs such as the lung, kidney and vasculature. In the Drosophila embryonic trachea, lumena form de novo to connect the different tracheal branches into an interconnected network of tubes. Here, we identify a novel role for the receptor type guanylyl cyclase at 76C (Gyc76C) in de novo lumen formation in the Drosophila trachea. We show that in embryos mutant for gyc76C or its downsteam effector protein kinase G (PKG) 1, tracheal lumena are disconnected. Dorsal trunk (DT) cells of gyc76C mutant embryos migrate to contact each other and complete the initial steps of lumen formation, such as the accumulation of E-cadherin (E-cad) and formation of an actin track at the site of lumen formation. However, the actin track and E-cad contact site of gyc76C mutant embryos did not mature to become a new lumen and DT lumena did not fuse. We also observed failure of the luminal protein Vermiform to be secreted into the site of new lumen formation in gyc76C mutant trachea. These DT lumen formation defects were accompanied by altered localization of the Arf-like 3 GTPase (Arl3), a known regulator of vesicle-vesicle and vesicle-membrane fusion. In addition to the DT lumen defect, lumena of gyc76C mutant terminal cells were shorter compared to wild-type cells. These studies show that Gyc76C and downstream PKG-dependent signaling regulate de novo lumen formation in the tracheal DT and terminal cells, most likely by affecting Arl3-mediated luminal secretion.	[Myat, Monn Monn; Patel, Unisha] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Myat, Monn Monn] City Univ New York, Medgar Evers College, Dept Biol, Brooklyn, NY USA	Cornell University; City University of New York (CUNY) System	Myat, MM (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.; Myat, MM (corresponding author), City Univ New York, Medgar Evers College, Dept Biol, Brooklyn, NY USA.	mmyat@mec.cuny.edu			NIH [GM082996]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grant GM082996 to M.M.M. There was no additional external funding received for this study.	Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6; Caviglia S, 2014, SEMIN CELL DEV BIOL, V31, P82, DOI 10.1016/j.semcdb.2014.03.018; Chak K, 2014, DEVELOPMENT, V141, P136, DOI 10.1242/dev.095968; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Eguchi K, 2012, NEURON, V74, P517, DOI 10.1016/j.neuron.2012.03.028; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; GIGLIOTTI S, 1993, DEV BIOL, V159, P450, DOI 10.1006/dbio.1993.1255; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Jones TA, 2014, DEV BIOL, V390, P41, DOI 10.1016/j.ydbio.2014.02.021; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; KALDERON D, 1989, J BIOL CHEM, V264, P10738; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Liao WT, 2015, J MOL MED, V93, P523, DOI 10.1007/s00109-014-1236-0; Lucas KA, 2000, PHARMACOL REV, V52, P375; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Myat MM, 2005, DEV BIOL, V281, P38, DOI 10.1016/j.ydbio.2005.02.005; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Overend G, 2012, PEPTIDES, V34, P209, DOI 10.1016/j.peptides.2011.08.019; Patel U, 2013, BIOL OPEN, V000, P1; Patel U, 2012, BIOL OPEN, V1, P507, DOI 10.1242/bio.2012943; Peng QL, 2016, J NEUROSCI, V36, P4635, DOI 10.1523/JNEUROSCI.3726-15.2016; Petrov AM, 2008, J NEUROSCI, V28, P13216, DOI 10.1523/JNEUROSCI.2947-08.2008; Pirraglia C, 2013, DEV BIOL, V377, P21, DOI 10.1016/j.ydbio.2013.02.020; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Schleede J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005576; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Vermehren-Schmaedick A, 2010, GENETICS, V186, P183, DOI 10.1534/genetics.110.118166; Xu N, 2011, DEVELOPMENT, V138, P5415, DOI 10.1242/dev.069831	33	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0161865	10.1371/journal.pone.0161865	http://dx.doi.org/10.1371/journal.pone.0161865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642749	Green Published, gold			2022-12-27	WOS:000383891900005
J	Dorado, EJ; Okoth, SA; Montenegro, LM; Diaz, G; Barnwell, JW; Udhayakumar, V; Solano, CM				Jimena Dorado, Erika; Okoth, Sheila Akinyi; Madeline Montenegro, Lidia; Diaz, Gustavo; Barnwell, John W.; Udhayakumar, Venkatachalam; Murillo Solano, Claribel			Genetic Characterisation of Plasmodium falciparum Isolates with Deletion of the pfhrp2 and/or pfhrp3 Genes in Colombia: The Amazon Region, a Challenge for Malaria Diagnosis and Control	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; MICROSATELLITE MARKERS; SEQUENCE VARIATION; TESTS; PARASITES; PERFORMANCE	Most Plasmodium falciparum-detecting rapid diagnostic tests (RDTs) target histidine-rich protein 2 (PfHRP2). However, P. falciparum isolates with deletion of the pfhrp2 gene and its homolog gene, pfhrp3, have been detected. We carried out an extensive investigation on 365 P. falciparum dried blood samples collected from seven P. falciparum endemic sites in Colombia between 2003 and 2012 to genetically characterise and geographically map pfhrp2-and/or pfhrp3-negative P. falciparum parasites in the country. We found a high proportion of pfhrp2-negative parasites only in Amazonas (15/39; 38.5%), and these parasites were also pfhrp3-negative. These parasites were collected between 2008 and 2009 in Amazonas, while pfhrp3-negative parasites (157/365, 43%) were found in all the sites and from each of the sample collection years evaluated (2003 to 2012). We also found that all pfhrp2-and/or pfhrp3-negative parasites were also negative for one or both flanking genes. Six sub-population clusters were established with 93.3% (14/15) of the pfhrp2-negative parasites grouped in the same cluster and sharing the same haplotype. This haplotype corresponded with the genetic lineage B-V1, a multidrug resistant strain that caused two outbreaks reported in Peru between 2010 and 2013. We found this B-V1 lineage in the Colombian Amazon as early as 2006. Two new clonal lineages were identified in these parasites from Colombia: the genetic lineages E-V1 and F. PfHRP2 sequence analysis revealed high genetic diversity at the amino acid level, with 17 unique sequences identified among 53 PfHRP2 sequences analysed. The use of PfHRP2-based RDTs is not recommended in Amazonas because of the high proportion of parasites with pfhrp2 deletion (38.5%), and implementation of new strategies for malaria diagnosis and control in Amazonas must be prioritised. Moreover, studies to monitor and genetically characterise pfhrp2-negative P. falciparum parasites in the Americas are warranted, given the extensive human migration occurring in the region.	[Jimena Dorado, Erika; Madeline Montenegro, Lidia; Diaz, Gustavo; Murillo Solano, Claribel] Ctr Int Entrenamiento & Invest Med CIDEIM, Malaria Res Grp, Cali, Valle, Colombia; [Okoth, Sheila Akinyi; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA; [Okoth, Sheila Akinyi] Atlanta Res & Educ Fdn, Decatur, GA USA	Centers for Disease Control & Prevention - USA	Dorado, EJ; Solano, CM (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Malaria Res Grp, Cali, Valle, Colombia.	erika.dorado@gmail.com; claribel.murillo@gmail.com		DIAZ, GUSTAVO/0000-0002-9313-1936	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS [222951928929]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS (www.colciencias.gov.co), Grant 222951928929. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the patients who participated at each site studied. We thank the microscopists, the healthcare workers from the ColombianMalaria Project supported by The Global Fund Project, the Colombian National Institute of Health (INS), Hospital Divino Nino-Tumaco, Instituto Departamental de Salud de Narino-IDSN, Laboratorio de Salud Publica del Amazonas, Hospital San Sebastian de Uraba-Necocli, Hospital Nuestra Senora del Carmen-El Bagre, Laboratorio de Salud Publica del Choco-DASALUD and other institutions from our previous studies for their support in the collection of the samples. We thank Olga L. Murillo and Nancy E. Molina for their assistance in establishing the study sites in Antioquia, Choco, Cauca and Valle. We thank Alvaro M. Lasso, AngelicaMera, Katherine Navarro, Jonathan A. Mora, Paula Castaneda, Javier Martinez, Samanda Aponte, Catalina Alvarez, Cesar Restrepo andMelissa Rios for their assistance with the sample collection in Narino, Choco, Guaviare and Amazonas. We also thank Dragan Ljolje and LindsayMorton for their support in sample handling at the CDC in Atlanta, USA.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2015, B EP I NAC SAL; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Baldeviano GC, 2015, EMERG INFECT DIS, V21, P797, DOI 10.3201/eid2105.141427; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Solano CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131576; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Okoth SA, 2016, AM J TROP MED HYG, V94, P128, DOI 10.4269/ajtmh.15-0442; Okoth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126805; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Pritchard JK, 2000, GENETICS, V155, P945; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Silbergeld Ellen K., 2002, Rev. Soc. Bras. Med. Trop., V35, P421, DOI 10.1590/S0037-86822002000500001; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Trouvay M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074269; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2015, WORLD MAL REP 2015; WHO-WPRO website, MAL RAP DIAGN TESTS; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	39	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163137	10.1371/journal.pone.0163137	http://dx.doi.org/10.1371/journal.pone.0163137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636709	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700037
J	Liu, LN; Wang, YJ; Li, Y; Lin, Y; Hou, Y; Zhang, Y; Wei, SG; Zhao, P; Zhao, P; He, HW				Liu, Lina; Wang, Yejing; Li, Yu; Lin, Ying; Hou, Yong; Zhang, Yan; Wei, Shuguang; Zhao, Peng; Zhao, Ping; He, Huawei			LBD1 of Vitellogenin Receptor Specifically Binds to the Female-Specific Storage Protein SP1 via LBR1 and LBR3	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; RNA INTERFERENCE ANALYSIS; LARVAL SERUM-PROTEIN; CYSTEINE-RICH REPEAT; BOMBYX-MORI; FAT-BODY; LIGAND-BINDING; MEDIATED ENDOCYTOSIS; MOLECULAR-CLONING; FAMILIAL HYPERCHOLESTEROLEMIA	Storage proteins are the major protein synthesized in the fat body, released into hemolymph and re-sequestered into the fat body before pupation in most insect species. Storage proteins are important amino acid and nutrition resources during the non-feeding pupal period and play essential roles for the metamorphosis and oogenesis of insects. The sequestration of storage protein is a selective, specific receptor-mediated process. However, to date, the potential receptor mediating the sequestration of storage protein has not been determined in Bombyx mori. In this study, we expressed and purified the first ligand binding domain of Bombyx mori vitellogenin receptor (BmVgR), LBD1, and found LBD1 could bind with an unknown protein from the hemolymph of the ultimate silkworm larval instar via pull-down assay. This unknown protein was subsequently identified to be the female-specific storage protein SP1 by mass spectrometry. Furthermore, far western blotting assay, immunoprecipitation and isothermal titration calorimetry analysis demonstrated LBD1 specifically bound with the female-specific SP1, rather than another unisex storage protein SP2. The specific binding of LBD1 with SP1 was dependent on the presence of Ca2+ as it was essential for the proper conformation of LBD1. Deletion mutagenesis and ITC analysis revealed the first and third ligand binding repeats LBR1 and LBR3 were indispensable for the binding of LBD1 with SP1, and LBR2 and LBR4 also had a certain contribution to the specific binding. Our results implied BmVgR may mediate the sequestration of SP1 from hemolymph into the fat body during the larval-pupal transformation of Bombyx mori.	[Liu, Lina; Wang, Yejing; Li, Yu; Lin, Ying; Hou, Yong; Zhang, Yan; Wei, Shuguang; Zhao, Peng; Zhao, Ping; He, Huawei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Wang, Yejing; He, Huawei] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Coll Biotechnol, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Wang, YJ; He, HW (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.; Wang, YJ; He, HW (corresponding author), Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Coll Biotechnol, Chongqing 400715, Peoples R China.	yjwang@swu.edu.cn; hehuawei@swu.edu.cn		Liu, Lina/0000-0002-1035-9821	National Basic Research Program of China [2012CB114602]; State Key Program of National Natural Science of China [31530071]; National Natural Science Foundation of China [31572465, 31402139]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjA00040, cstc2015jcyjBX0035]; Fundamental Research Funds for the Central Universities [XDJK2013A019, XDJK2016E02 0]; Graduate Research and Innovation Project of Chongqing [CYS16074]; Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials [silkgczx2016003]; Start-up Grant from Southwest University [SWU112111]	National Basic Research Program of China(National Basic Research Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Graduate Research and Innovation Project of Chongqing; Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials; Start-up Grant from Southwest University	This work was supported by National Basic Research Program of China (2012CB114602), State Key Program of National Natural Science of China (31530071), National Natural Science Foundation of China (31572465, 31402139), Chongqing Research Program of Basic Research and Frontier Technology (cstc2015jcyjA00040, cstc2015jcyjBX0035), Fundamental Research Funds for the Central Universities (XDJK2013A019, XDJK2016E02 0), Graduate Research and Innovation Project of Chongqing (CYS16074), Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials (silkgczx2016003) and Start-up Grant from Southwest University (SWU112111).	Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; ANDREASEN PA, 1994, FEBS LETT, V338, P239, DOI 10.1016/0014-5793(94)80276-9; Bajari TM, 1998, BIOL CHEM, V379, P1053, DOI 10.1515/bchm.1998.379.8-9.1053; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Burmester T, 1998, J MOL EVOL, V47, P93, DOI 10.1007/PL00006366; BURMESTER T, 1992, INSECT BIOCHEM MOLEC, V22, P211, DOI 10.1016/0965-1748(92)90057-L; Burmester T, 1997, EUR J BIOCHEM, V247, P695, DOI 10.1111/j.1432-1033.1997.00695.x; Burmester T, 1997, EUR J BIOCHEM, V244, P713, DOI 10.1111/j.1432-1033.1997.00713.x; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; Chandrasekar R, 2008, ARCH INSECT BIOCHEM, V69, P70, DOI 10.1002/arch.20266; Chen JQ, 2015, PROTEIN J, V34, P256, DOI 10.1007/s10930-015-9619-9; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Duan J, 2009, NUCLEIC ACIDS RES; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FUJII T, 1989, J BIOL CHEM, V264, P11020; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; JONES G, 1990, J BIOL CHEM, V265, P8596; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Lin WJ, 2015, ARCH INSECT BIOCHEM, V90, P169, DOI 10.1002/arch.21252; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Liu LN, 2016, INT J BIOL MACROMOL, V86, P701, DOI 10.1016/j.ijbiomac.2016.02.016; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; Mikhailenko I, 1999, J CELL SCI, V112, P3269; MINE E, 1983, DEV BIOL, V97, P329, DOI 10.1016/0012-1606(83)90090-8; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; OGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P288, DOI 10.1303/aez.16.288; PAN ML, 1992, ARCH INSECT BIOCHEM, V19, P203, DOI 10.1002/arch.940190306; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SAKURAI H, 1988, J BIOL CHEM, V263, P7876; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; Schneider WJ, 1996, INT REV CYTOL, V166, P103, DOI 10.1016/S0074-7696(08)62507-3; Shu YH, 2011, INSECT MOL BIOL, V20, P61, DOI 10.1111/j.1365-2583.2010.01054.x; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; TOJO S, 1980, INSECT BIOCHEM, V10, P289, DOI 10.1016/0020-1790(80)90024-4; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, INSECT BIOCHEM MOLEC, V37, P235, DOI 10.1016/j.ibmb.2006.11.007; WANG ZX, 1994, CELL TISSUE RES, V278, P107, DOI 10.1007/s004410050197; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WILLOTT E, 1989, J BIOL CHEM, V264, P19052; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	58	4	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162317	10.1371/journal.pone.0162317	http://dx.doi.org/10.1371/journal.pone.0162317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637099	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700004
J	Noronha, V; Ramaswamy, A; Patil, VM; Joshi, A; Chougule, A; Kane, S; Kumar, R; Sahu, A; Doshi, V; Nayak, L; Mahajan, A; Janu, A; Prabhash, K				Noronha, Vanita; Ramaswamy, Anant; Patil, Vijay M.; Joshi, Amit; Chougule, Anuradha; Kane, Subhadha; Kumar, Rajiv; Sahu, Arvind; Doshi, Vipul; Nayak, Lingaraj; Mahajan, Abhishek; Janu, Amit; Prabhash, Kumar			ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country	PLOS ONE			English	Article							1ST-LINE CRIZOTINIB; GENE; CHEMOTHERAPY; SURVIVAL; REARRANGEMENTS; MUTATIONS	Objectives To evaluate the performance and treatment profile of advanced EML4-ALK positive Non-small cell lung cancer (NSCLC) patients in a developing country with potentially restricted access to Crizotinib. Materials and Methods A retrospective analysis of advanced ALK positive NSCLC patients who were treated from June 2012 to September 2015 was conducted. The primary goal was to evaluate outcomes of advanced ALK positive NSCLC in our practice and examine the logistic constraints in procuring Crizotinib. Results 94 patients were available for analysis. 21 (22.3%) patients were started on Crizotinib upfront, 60 (63.8%) on chemotherapy, 10 (10.6%) on Tyrosine kinase inhibitors (in view of poor PS) and 3 (3.2%) patients were offered best supportive care. Reasons for not starting Crizotinib upfront included symptomatic patients needing early initiation of therapy (23.3%), ALK not tested upfront (23.3%) and financial constraints (21.9%). 69 patients (73.4%) received Crizotinib at some stage during treatment. Dose interruptions (> 1 week) with Crizotinib were seen in 20 patients (29%), with drug toxicity being the commonest reason (85%). Median Progression free survival (PFS) on first line therapy for the entire cohort was 10 months, with a significant difference between patients receiving Crizotinib and those who did not ever receive Crizotinib (10 months vs. 2 months, p = 0.028). Median Overall Survival (OS) was not reached for the entire cohort, with 1 year survival being 81.2%. Patients with an ECOG Performance Status (PS) of > 2 had a significantly reduced PFS compared to patients with PS < = 2 (1.5 months vs. 11 months, p < 0.001). 47 patients with financial constraints (68.1%) received Crizotinib completely free via various extramural support schemes. Conclusion A majority of our ALK positive NSCLC patients were exposed to Crizotinib through the help of various support mechanisms and these patients had similar outcomes to that reported from previously published literature.	[Noronha, Vanita; Ramaswamy, Anant; Patil, Vijay M.; Joshi, Amit; Chougule, Anuradha; Sahu, Arvind; Doshi, Vipul; Nayak, Lingaraj; Prabhash, Kumar] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India; [Kane, Subhadha; Kumar, Rajiv] Tata Mem Hosp, Dept Pathol, Bombay, Maharashtra, India; [Mahajan, Abhishek; Janu, Amit] Tata Mem Hosp, Dept Radiol, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	Prabhash, K (corresponding author), Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India.	kprabhash1@gmail.com	Nayak, Lingaraj/Q-5997-2019; Mahajan, Abhishek/AAO-1329-2021	Nayak, Lingaraj/0000-0001-9520-795X; Mahajan, Abhishek/0000-0001-6606-6537				Ahn HK, 2013, J THORAC ONCOL, V8, P250, DOI 10.1097/JTO.0b013e3182746772; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Cui SH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0626-7; Djalalov S, 2014, J CLIN ONCOL, V32, P1012, DOI 10.1200/JCO.2013.53.1186; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lilenbaum RC, 2004, ONCOLOGY-NY, V18, P1321; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Park S, 2015, CLIN LUNG CANCER, V16, pE83, DOI 10.1016/j.cllc.2015.01.003; Shaw AT, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mds242; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; STANLEY KE, 1980, J NATL CANCER I, V65, P25; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tamai K, 2013, RESPIR INVESTIG, V51, P46, DOI 10.1016/j.resinv.2012.12.001; Teixido C, 2014, TRANSL LUNG CANCER R, V3, P70, DOI 10.3978/j.issn.2218-6751.2014.02.02; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101551; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9	24	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0160752	10.1371/journal.pone.0160752	http://dx.doi.org/10.1371/journal.pone.0160752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637025	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700003
J	Zeng, XQ; Li, N; Ma, LL; Tseng, YJ; Zhao, NQ; Chen, SY				Zeng, Xiao-Qing; Li, Na; Ma, Li-Li; Tseng, Yu-Jen; Zhao, Nai-Qing; Chen, Shi-Yao			Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CLINICAL-SIGNIFICANCE; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; OVARIAN-CANCER; PP125(FAK) EXPRESSION; OVEREXPRESSION; BREAST; PROGRESSION; SURVIVAL	Background Recently, the number of reports on focal adhesion kinase (FAK) as a vital therapeutic target in solid carcinomas has increased; however, the prognostic role of FAK status remains poorly understood. This study aims to evaluate the prognostic effect of FAK by means of a meta-analysis. Methods We performed a systematic literature search in order to examine the correlation between expression of FAK and overall survival (OS). The hazard ratio (HR) of OS was used to measure survival. A random-effects model was used to pool study statistics. Sensitivity and publication bias analyses were also conducted. Results Thirty eligible studies involving 4702 patients were included. The median expression rate of FAK was 54%. Meta-analysis of the HRs demonstrated that high FAK expression was associated with worse OS (average HR = 2.073, 95% confidence interval [CI]: 1.712-2.510, p = 0.000). Regarding cancer type, FAK was associated with worse OS in gastric cancer (HR = 2.646,95% CI: 1.743-4.017, p = 0.000), hepatocellular carcinoma (HR = 1.788,95% CI: 1.228-2.602, p = 0.002), ovarian cancer (HR = 1.815, 95% CI: 1.193-2.762, p = 0.005), endometrial cancer (HR = 4.149, 95% CI: 2.832-6.079, p = 0.000), gliomas (HR = 2.650, 95% CI: 1.205-5.829, p = 0.015), and squamous cell carcinoma (HR = 1,696, 95% CI: 1.030-2.793, p = 0.038). No association was found between HR and disease staging according to our meta-regression analysis. Conclusions Our study shows that high expression of FAK is associated with a worse OS in patients with carcinomas, but the association between FAK and prognosis varies according to cancer type. The value of FAK status in clinical prognosis in cancer needs further research.	[Zeng, Xiao-Qing; Li, Na; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Ma, Li-Li; Tseng, Yu-Jen; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai, Peoples R China; [Ma, Li-Li; Tseng, Yu-Jen; Chen, Shi-Yao] Fudan Univ, Zhongshan Hosp, Endoscopy Res Inst, Shanghai, Peoples R China; [Zhao, Nai-Qing] Fudan Univ, Dept Biostat, Shanghai, Peoples R China; [Zhao, Nai-Qing; Chen, Shi-Yao] Fudan Univ, Evidence Based Med Ctr, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Chen, SY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai, Peoples R China.; Chen, SY (corresponding author), Fudan Univ, Zhongshan Hosp, Endoscopy Ctr, Shanghai, Peoples R China.; Chen, SY (corresponding author), Fudan Univ, Zhongshan Hosp, Endoscopy Res Inst, Shanghai, Peoples R China.; Chen, SY (corresponding author), Fudan Univ, Evidence Based Med Ctr, Shanghai, Peoples R China.	chen.shiyao@zs-hospital.sh.cn			Natural Science Foundation of Shanghai [14ZR1406600]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Natural Science Foundation of Shanghai (Grant no. 14ZR1406600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2014, ANTICANCER RES, V34, P3969; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Canel M, 2006, CLIN CANCER RES, V12, P3272, DOI 10.1158/1078-0432.CCR-05-1583; Carelli S, 2006, LUNG CANCER, V53, P263, DOI 10.1016/j.lungcan.2006.06.001; de Vicente JC, 2013, HEAD NECK-J SCI SPEC, V35, P826, DOI 10.1002/hed.23038; Chatzizacharias NA, 2010, PANCREAS, V39, P930, DOI 10.1097/MPA.0b013e3181d7abcc; Chen YS, 2013, J GASTROENTEROL, V48, P1034, DOI 10.1007/s00535-012-0724-7; Chen YJ, 1999, J TUMOR MARKER ONCOL, V14, P19; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Dy GK, 2014, J THORAC ONCOL, V9, P1278, DOI 10.1097/JTO.0000000000000248; Fan DM, 2011, INT J MOL SCI, V12, P8489, DOI 10.3390/ijms12128489; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Furuyama K, 2006, WORLD J SURG, V30, P219, DOI 10.1007/s00268-005-0165-z; Gabriel B, 2006, CLIN CANCER RES, V12, P2476, DOI 10.1158/1078-0432.CCR-05-1867; Gabriel B, 2009, INT J GYNECOL CANCER, V19, P1221, DOI 10.1111/IGC.0b013e3181b33c61; Gao S, 2014, INT J MED SCI, V11, P268, DOI 10.7150/ijms.7769; Garouniatis A, 2013, INT J COLORECTAL DIS, V28, P9, DOI 10.1007/s00384-012-1520-9; Giaginis CT, 2009, PATHOL ONCOL RES, V15, P173, DOI 10.1007/s12253-008-9120-2; del Pulgar TG, 2016, J CELL MOL MED, V20, P1729, DOI 10.1111/jcmm.12879; Hayashi A, 2010, HUM PATHOL, V41, P859, DOI 10.1016/j.humpath.2009.09.018; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Jan YJ, 2009, HUM PATHOL, V40, P1384, DOI 10.1016/j.humpath.2009.03.006; Ji HF, 2013, J CANCER RES CLIN, V139, P429, DOI 10.1007/s00432-012-1342-8; Jones G, 2001, CANCER RES, V61, P5688; Judson PL, 1999, CANCER, V86, P1551, DOI 10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P; Kim SJ, 2004, J KOREAN MED SCI, V19, P710, DOI 10.3346/jkms.2004.19.5.710; Kim YN, 2012, KOREAN J PATHOL, V46, P454, DOI 10.4132/KoreanJPathol.2012.46.5.454; Lai IR, 2010, AM J PATHOL, V177, P1629, DOI 10.2353/ajpath.2010.100172; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Li DW, 2012, J LARYNGOL OTOL, V126, P1127, DOI 10.1017/S0022215112001971; Li MQ, 2015, ONCOL LETT, V10, P1003, DOI 10.3892/ol.2015.3278; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Livasy CA, 2004, APPL IMMUNOHISTO M M, V12, P342, DOI 10.1097/00129039-200412000-00009; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Ocak S, 2012, CANCER-AM CANCER SOC, V118, P1293, DOI 10.1002/cncr.26382; Ohta R, 2006, ONCOLOGY-BASEL, V71, P417, DOI 10.1159/000107109; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Omura G, 2016, HEAD NECK-J SCI SPEC, V38, P1164, DOI 10.1002/hed.24176; OWENS LV, 1995, CANCER RES, V55, P2752; Park JM, 2010, BIOCHEM BIOPH RES CO, V403, P329, DOI 10.1016/j.bbrc.2010.11.028; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Qayyum T, 2012, BRIT J CANCER, V107, P856, DOI 10.1038/bjc.2012.314; Rodrigo JP, 2011, CANCER PREV RES, V4, P1333, DOI 10.1158/1940-6207.CAPR-10-0338; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schmitz KJ, 2005, BREAST CANCER RES, V7, pR194, DOI 10.1186/bcr977; Sheen-Chen SM, 2013, ANTICANCER RES, V33, P1169; Skinner HD, 2016, CLIN CANCER RES, V22, P4643, DOI 10.1158/1078-0432.CCR-15-2785; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Su JM, 2002, WORLD J GASTROENTERO, V8, P613, DOI 10.3748/wjg.v8.i4.613; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun CK, 2007, BRIT J CANCER, V97, P50, DOI 10.1038/sj.bjc.6603827; Tai YL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690690; Theocharis SE, 2003, EUR J SURG ONCOL, V29, P571, DOI 10.1016/S0748-7983(03)00120-3; Theocharis S, 2012, J CANCER RES CLIN, V138, P1369, DOI 10.1007/s00432-012-1215-1; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Wang BC, 2016, ONCOL LETT, V11, P979, DOI 10.3892/ol.2015.3992; Wang CL, 2009, LUNG, V187, P104, DOI 10.1007/s00408-008-9130-6; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Yom CK, 2011, BREAST CANCER RES TR, V128, P647, DOI 10.1007/s10549-010-1150-2; Yuan Z, 2010, J CANCER RES CLIN, V136, P1489, DOI 10.1007/s00432-010-0806-y; Zhang Q, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0033-5; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou J, 2013, GYNECOL ONCOL, V128, P344, DOI 10.1016/j.ygyno.2012.07.128	73	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162666	10.1371/journal.pone.0162666	http://dx.doi.org/10.1371/journal.pone.0162666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637100	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700013
J	Zhou, ZM; Hu, Z; Li, M; Zhu, FX; Zhang, H; Nie, J; Ai, J				Zhou, Zhanmei; Hu, Zheng; Li, Mei; Zhu, Fengxin; Zhang, Hao; Nie, Jing; Ai, Jun			QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of beta-Catenin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; UNILATERAL URETERAL OBSTRUCTION; P38 MAP KINASE; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; EPITHELIAL-CELLS; UNITED-STATES; NEPHROPATHY; SMAD3	Chronic kidney disease (CKD) is becoming a worldwide problem. However, current treatment options are limited. In the current study we showed that QiShenYiQi (QSYQ), a water-ethanol extract from several Chinese medicines, is a potent inhibitor of renal interstitial fibrosis. QSYQ inhibited transforming growth factor-beta 1 (TGF-beta 1)-responsive alpha-smoothmuscle actin (alpha-SMA), collagen I, and fibronectin up-regulation in obstructive nephropathy and cultured cells. Administration of QSYQ also inhibited the established renal interstitial fibrosis in obstructive nephropathy. Interestingly, QSYQ selectively inhibited TGF-beta 1-induced beta-catenin up-regulation and downstream gene transcription. Taken together, our study suggests that QSYQ selectively inhibits TGF-beta 1-induced beta-catenin up-regulation and might have significant therapeutic potential for the treatment of renal fibrosis.	[Zhou, Zhanmei; Hu, Zheng; Li, Mei; Zhu, Fengxin; Nie, Jing; Ai, Jun] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao] Tasly R&D Inst, Tianjin, Peoples R China	Southern Medical University - China	Ai, J (corresponding author), Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	aij1980@163.com			Nanfang Hospital Fundation, Southern Medical University [2012C08]; Tasly RD Institute; Nanfang Hospital Foundation of Southern Medical University [2012C08]	Nanfang Hospital Fundation, Southern Medical University; Tasly RD Institute; Nanfang Hospital Foundation of Southern Medical University	This work was supported by the Nanfang Hospital Fundation, Southern Medical University (2012C08) to Dr. Ai. Tasly R&D Institute provided support in the form of salaries for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Nanfang Hospital Foundation of Southern Medical University (2012C08) to Dr. Ai.	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cassidy Hilary, 2012, J Signal Transduct, V2012, P463617, DOI 10.1155/2012/463617; Chevalier RL, 1999, PEDIATR NEPHROL, V13, P612, DOI 10.1007/s004670050756; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Ely JJ, 2010, COMPARATIVE MED, V60, P154; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hong Chengtao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1018; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Ina K, 2011, HISTOL HISTOPATHOL, V26, P855, DOI 10.14670/HH-26.855; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Komesli S, 1998, EUR J BIOCHEM, V254, P505, DOI 10.1046/j.1432-1327.1998.2540505.x; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Li YC, 2012, CLIN HEMORHEOL MICRO, V51, P177, DOI 10.3233/CH-2011-1523; Lin SQ, 2013, INT J CARDIOL, V168, P967, DOI 10.1016/j.ijcard.2012.10.042; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lv SC, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/415068; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Moll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056575; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Ning XH, 2013, INT IMMUNOPHARMACOL, V15, P406, DOI 10.1016/j.intimp.2012.12.019; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Shang HC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/738391; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Thornhill Barbara A, 2012, Methods Mol Biol, V886, P381, DOI 10.1007/978-1-61779-851-1_33; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; VIEDT C, 1995, KIDNEY INT, V48, P1810, DOI 10.1038/ki.1995.479; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeisberg M, 2005, METH MOLEC MED, V117, P261; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	44	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162873	10.1371/journal.pone.0162873	http://dx.doi.org/10.1371/journal.pone.0162873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636716	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700019
J	Buijze, GA; Sierevelt, IN; van der Heijden, BCJM; Dijkgraaf, MG; Frings-Dresen, MHW				Buijze, Geert A.; Sierevelt, Inger N.; van der Heijden, Bas C. J. M.; Dijkgraaf, Marcel G.; Frings-Dresen, Monique H. W.			The Effect of Cold Showering on Health and Work: A Randomized Controlled Trial	PLOS ONE			English	Article							WHOLE-BODY CRYOTHERAPY; INNATE IMMUNE-RESPONSE; NERVOUS-SYSTEM; INITIAL RESPONSES; WATER IMMERSION; EXPOSURE; HUMANS; SF-36; INFECTION; RECOVERY	Purpose The aim of this study was to determine the cumulative effect of a routine (hot-to-) cold shower on sickness, quality of life and work productivity. Methods Between January and March 2015, 3018 participants between 18 and 65 years without severe comorbidity and no routine experience of cold showering were randomized (1: 1: 1: 1) to a (hot-to-) cold shower for 30, 60, 90 seconds or a control group during 30 consecutive days followed by 60 days of showering cold at their own discretion for the intervention groups. The primary outcome was illness days and related sickness absence from work. Secondary outcomes were quality of life, work productivity, anxiety, thermal sensation and adverse reactions. Results 79% of participants in the interventions groups completed the 30 consecutive days protocol. A negative binomial regression model showed a 29% reduction in sickness absence for (hot-to-) cold shower regimen compared to the control group (incident rate ratio: 0.71, P = 0.003). For illness days there was no significant group effect. No related serious advents events were reported. Conclusion A routine (hot-to-) cold shower resulted in a statistical reduction of self-reported sickness absence but not illness days in adults without severe comorbidity.	[Buijze, Geert A.] Acad Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands; [Sierevelt, Inger N.] Med Ctr Slotervaart, Dept Orthopaed Surg, Amsterdam, Netherlands; [van der Heijden, Bas C. J. M.] Achmea, Risk Management, Zeist, Netherlands; [Dijkgraaf, Marcel G.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Frings-Dresen, Monique H. W.] Acad Med Ctr, Inst Occupat Hlth, Dept Coronel, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Buijze, GA (corresponding author), Acad Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands.	g.a.buijze@amc.nl						Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; [Anonymous], 2004, GEDRAG ORGAN, DOI DOI 10.5117/2004.017.002.002; Banerjee SK, 1999, J PARASITOL, V85, P442, DOI 10.2307/3285776; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Bleakley CM, 2014, OPEN ACCESS J SPORTS, V5, P25, DOI 10.2147/OAJSM.S41655; Brenner IKM, 1999, J APPL PHYSIOL, V87, P699, DOI 10.1152/jappl.1999.87.2.699; Castellani JW, 2002, MED SCI SPORT EXER, V34, P2013, DOI 10.1097/00005768-200212000-00023; Centraal Bureau voor de Statistiek (CBS), 2016, NATIONAL STATISTICS; Claridge RT, 1843, HYDROPATHY OR THE CO; Cold Showers, THE DEFINITIVE GUIDE; Costello JT, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010789; Crowe MJ, 2007, INT J SPORTS MED, V28, P994, DOI 10.1055/s-2007-965118; de Beurs E, 2006, MAANDBLAD GEESTELIJK, P120; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Eglin CM, 2005, EUR J APPL PHYSIOL, V93, P624, DOI 10.1007/s00421-004-1239-6; Evans JDR, 2013, COMPANION ARCHAEOLOG; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gagnon DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110774; Hendriksen IJM, 2010, PREV MED, V51, P132, DOI 10.1016/j.ypmed.2010.05.007; Huffman GR, 2008, J BONE JOINT SURG AM, V90A, P471, DOI 10.2106/JBJS.G.00325; Jansky L, 1996, EUR J APPL PHYSIOL O, V72, P445, DOI 10.1007/BF00242274; Jastrzabek R, 2013, RHEUMATOL INT, V33, P2053, DOI 10.1007/s00296-013-2692-5; Juliff LE, 2014, J STRENGTH COND RES, V28, P2353, DOI 10.1519/JSC.0000000000000417; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; Kox M, 2012, PSYCHOSOM MED, V74, P489, DOI 10.1097/PSY.0b013e3182583c6d; Lee HK, 2014, KOREAN J FAM MED, V35, P119, DOI 10.4082/kjfm.2014.35.3.119; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nieman DC, 2011, BRIT J SPORT MED, V45, P987, DOI 10.1136/bjsm.2010.077875; Shephard RJ, 1998, CAN J PHYSIOL PHARM, V76, P828, DOI 10.1139/cjpp-76-9-828; Sramek P, 2000, EUR J APPL PHYSIOL, V81, P436, DOI 10.1007/s004210050065; Teirlinck AC, 2015, REPORT OF THE NATION, P1; Tiessen-Raaphorst A, 2015, REPORT OF THE NETHER, P1; Tipton MJ, 1998, J PHYSIOL-LONDON, V512, P621, DOI 10.1111/j.1469-7793.1998.621be.x; van Middendorp H, 2016, CLIN RHEUMATOL, V35, P1081, DOI 10.1007/s10067-015-3009-8; VASWANI KK, 1988, PHARMACOL BIOCHEM BE, V29, P163, DOI 10.1016/0091-3057(88)90290-0; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	8	10	9	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161749	10.1371/journal.pone.0161749	http://dx.doi.org/10.1371/journal.pone.0161749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631616	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900022
J	Liu, JC; Hsu, YP; Wu, SY				Liu, Ju-Chi; Hsu, Yi-Ping; Wu, Szu-Yuan			Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING ENZYME-INHIBITORS; COA REDUCTASE INHIBITORS; RENAL-DISEASE; TASK-FORCE; CARDIOVASCULAR-DISEASE; PERITONEAL-DIALYSIS; AMERICAN-COLLEGE; HEART-FAILURE; PROGRESSION	Background Taiwan has the highest renal disease incidence and prevalence in the world. We evaluated the association of statin and renin-angiotensin system inhibitor (RASI) use with dialysis risk in hypertensive patients. Methods Of 248,797 patients who received a hypertension diagnosis in Taiwan during 2001-2012, our cohort contained 110,829 hypertensive patients: 44,764 who used RASIs alone; 7,606 who used statins alone; 27,836 who used both RASIs and statins; and 33,716 who used neither RASIs or statins. We adjusted for the following factors to reduce selection bias by using propensity scores (PSs): age; sex; comorbidities; urbanization level; monthly income; and use of nonstatin lipid-lowering drugs, metformin, aspirin, antihypertensives, diuretics, and beta and calcium channel blockers. The statin and RASI use index dates were considered the hypertension confirmation dates. To examine the dose-response relationship, we categorized only statin or RASI use into four groups in each cohort: < 28 (nonusers), 28-90, 91-365, and > 365 cumulative defined daily doses (cDDDs). Results In the main model, PS-adjusted hazard ratios (aHRs; 95% confidence intervals [CIs]) for dialysis risk were 0.57 (0.50-0.65), 0.72 (0.53-0.98), and 0.47 (0.41-0.54) in the only RASI, only statin, and RASI + statin users, respectively. RASIs dose-dependently reduced dialysis risk in most subgroups and in the main model. RASI use significantly reduced dialysis risk in most subgroups, regardless of comorbidities or other drug use (P < 0.001). Statins at > 365 cDDDs protected hypertensive patients against dialysis risk in the main model (aHR = 0.62, 95% CI: 0.54-0.71), regardless of whether a high cDDD of RASIs, metformin, or aspirin was used. Conclusion Statins and RASIs independently have a significant dose-dependent protective effect against dialysis risk in hypertensive patients. The combination of statins and RASIs can additively protect hypertensive patients against dialysis risk.	[Liu, Ju-Chi; Hsu, Yi-Ping] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiovasc Med, New Taipei, Taiwan; [Wu, Szu-Yuan] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Wu, Szu-Yuan] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Liu, Ju-Chi; Wu, Szu-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Wu, Szu-Yuan] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Hungkuang University	Wu, SY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan.; Wu, SY (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan.; Wu, SY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.; Wu, SY (corresponding author), Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan.	szuyuanwu5399@gmail.com		Wu, Szu-Yuan/0000-0001-5637-558X	Wan Fang Hospital	Wan Fang Hospital	This work was supported by Wan Fang Hospital.	Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Bakris GL, 2009, KIDNEY INT, V75, P449, DOI 10.1038/ki.2008.694; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Blacher J, 2002, CURR OPIN NEPHROL HY, V11, P629, DOI 10.1097/00041552-200211000-00010; Campese VM, 2007, CLIN J AM SOC NEPHRO, V2, P1100, DOI 10.2215/CJN.04060907; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; Chang YK, 2012, MEDICINE, V91, P144, DOI 10.1097/MD.0b013e318256538e; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; CHEN JH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Chen JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002845; Chiang CE, 2015, J CHIN MED ASSOC, V78, P1, DOI 10.1016/j.jcma.2014.11.005; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; DIAMOND JR, 1987, KIDNEY INT, V32, P671, DOI 10.1038/ki.1987.259; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fried LF, 2008, KIDNEY INT, V74, P571, DOI 10.1038/ki.2008.231; Grone EF, 2008, NAT CLIN PRACT NEPHR, V4, P424, DOI 10.1038/ncpneph0863; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Jayatilake N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-180; Kao TW, 2013, PERITON DIALYSIS INT, V33, P671, DOI 10.3747/pdi.2012.00081; KEANE WF, 1994, KIDNEY INT, V46, P910, DOI 10.1038/ki.1994.349; Kent DM, 2007, J AM SOC NEPHROL, V18, P1959, DOI 10.1681/ASN.2006101081; KIM SY, 1995, KIDNEY INT, V48, P363, DOI 10.1038/ki.1995.304; Konstadinidou I, 2003, TRANSPLANT P, V35, P1364, DOI 10.1016/S0041-1345(03)00376-2; Landray MJ, 2001, AM J KIDNEY DIS, V38, P537, DOI 10.1053/ajkd.2001.26850; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Michel O, 1997, KIDNEY INT, V52, P1532, DOI 10.1038/ki.1997.483; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Ozsoy RC, 2007, NEPHROL DIAL TRANSPL, V22, P1578, DOI 10.1093/ndt/gfl790; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; PARRA G, 1988, CLIN NEPHROL, V29, P58; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; RODRIGUEZITURBE B, 1990, KIDNEY INT, V38, P512, DOI 10.1038/ki.1990.233; RUBIN R, 1994, HYPERTENSION, V23, P92, DOI 10.1161/01.HYP.23.1.92; Ruggenenti P, 2010, CLIN J AM SOC NEPHRO, V5, P1928, DOI 10.2215/CJN.03380410; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sarafidis PA, 2009, ANN INTERN MED, V150, P731, DOI 10.7326/0003-4819-150-10-200905190-00014; Schaeffner ES, 2003, J AM SOC NEPHROLOGY, V14, P2084; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shao JYH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001801; Shepherd J, 2007, CLIN J AM SOC NEPHRO, V2, P1131, DOI 10.2215/CJN.04371206; Singh S, 2014, HEPATOLOGY, V59, P735, DOI [10.1002/hep.26575, 10.1002/hep.26614]; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; Weiner DE, 2004, J GEN INTERN MED, V19, P1045, DOI 10.1111/j.1525-1497.2004.40049.x; Whaley-Connell AT, 2008, AM J KIDNEY DIS, V51, pS13, DOI 10.1053/j.ajkd.2007.12.016; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P04; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162588	10.1371/journal.pone.0162588	http://dx.doi.org/10.1371/journal.pone.0162588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632175	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900055
J	Lazarova, T; Mlynarczyk, K; Querol, E; Tenchov, B; Filipek, S; Padros, E				Lazarova, Tzvetana; Mlynarczyk, Krzysztof; Querol, Enric; Tenchov, Boris; Filipek, Slawomir; Padros, Esteve			Identification of Specific Effect of Chloride on the Spectral Properties and Structural Stability of Multiple Extracellular Glutamic Acid Mutants of Bacteriorhodopsin	PLOS ONE			English	Article							DARK-ADAPTED BACTERIORHODOPSIN; PURPLE MEMBRANE; THERMAL-ISOMERIZATION; BIOLOGICAL MEMBRANE; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; HELIX INTERACTIONS; CATION-BINDING; PROTEIN; PHOTOCYCLE	In the present work we combine spectroscopic, DSC and computational approaches to examine the multiple extracellular Glu mutants E204Q/E194Q, E204Q/E194Q/E9Q and E204Q/E194Q/E9Q/E74Q of bacteriorhodopsin by varying solvent ionic strength and composition. Absorption spectroscopy data reveal that the absorption maxima of multiple EC Glu mutants can be tuned by the chloride concentration in the solution. Visible Circular dichroism spectra imply that the specific binding of Cl- can modulate weakened exciton chromophore coupling and reestablish wild type-like bilobe spectral features of the mutants. The DSC data display reappearance of the reversible thermal transition, higher T-m of denaturation and an increase in the enthalpy of unfolding of the mutants in 1 M KCl solutions. Molecular dynamics simulations indicate high affinity binding of Cl- to Arg82 and to Gln204 and Gln194 residues in the mutants. Analysis of the experimental data suggests that simultaneous elimination of the negatively charged side chain of Glu194 and Glu204 is the major cause for mutants' alterations. Specific Cl- binding efficiently coordinates distorted hydrogen bonding interactions of the EC region and reconstitutes the conformation and structure stability of mutated bR in WT-like fashion.	[Lazarova, Tzvetana; Padros, Esteve] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Med, Unitat Biofis, Barcelona, Spain; [Lazarova, Tzvetana; Padros, Esteve] Univ Autonoma Barcelona, Ctr Estudis Biofis, Barcelona, Spain; [Mlynarczyk, Krzysztof; Filipek, Slawomir] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland; [Querol, Enric] Univ Autonoma Barcelona, Inst Biomed & Biotecnol, Barcelona, Spain; [Tenchov, Boris] Med Univ Sofia, Dept Med Phys & Biophys, Fac Med, Sofia, Bulgaria	Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; University of Warsaw; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Medical University Sofia	Lazarova, T; Padros, E (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Med, Unitat Biofis, Barcelona, Spain.; Lazarova, T; Padros, E (corresponding author), Univ Autonoma Barcelona, Ctr Estudis Biofis, Barcelona, Spain.	tzvetana.lazarova@uab.cat; esteve.padros@uab.cat	Tenchov, Boris/W-5547-2019; Filipek, Slawomir/A-2985-2008	Mlynarczyk, Krzysztof/0000-0001-9032-0574; Filipek, Slawomir/0000-0003-3147-3858	Ministerio de Ciencia e Innovacion [BFU2012-40137-C02-01]; FEDER (Fondo Europeo de Desarrollo Regional); Medical University-Sofia [1-/2012 - 2015]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Medical University-Sofia	This work was funded by grant BFU2012-40137-C02-01 from the Ministerio de Ciencia e Innovacion and FEDER (Fondo Europeo de Desarrollo Regional) to EP, http://www.idi.mineco.gob.es/portal/site/MICINN/; and grant 1-/2012 - 2015 from the Medical University-Sofia to BT, http://mu-sofia.bg/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; BALASHOV SP, 1991, BIOPHYS J, V60, P475, DOI 10.1016/S0006-3495(91)82074-4; BALASHOV SP, 1995, BIOCHEMISTRY-US, V34, P8820, DOI 10.1021/bi00027a034; Baudry J, 1999, BIOPHYS J, V76, P1909, DOI 10.1016/S0006-3495(99)77349-2; Booth PJ, 2012, CURR OPIN STRUC BIOL, V22, P469, DOI 10.1016/j.sbi.2012.03.008; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5902, DOI 10.1021/bi960129e; Bowie JU, 2011, CURR OPIN STRUC BIOL, V21, P42, DOI 10.1016/j.sbi.2010.10.003; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Cartailler JP, 2003, ANNU REV BIOPH BIOM, V32, P285, DOI 10.1146/annurev.biophys.32.110601.142516; Cladera J, 1996, BIOPHYS J, V70, P2882, DOI 10.1016/S0006-3495(96)79858-2; CLADERA J, 1992, EUR J BIOCHEM, V207, P581, DOI 10.1111/j.1432-1033.1992.tb17084.x; Corcelli A, 2002, J LIPID RES, V43, P132; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Dioumaev AK, 1999, BIOCHEMISTRY-US, V38, P10070, DOI 10.1021/bi990873+; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Heyden M, 2012, SOFT MATTER, V8, P7742, DOI 10.1039/c2sm25402f; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACKSON MB, 1978, BIOCHEMISTRY-US, V17, P911, DOI 10.1021/bi00598a026; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kates M, 1988, Prog Clin Biol Res, V282, P357; Krebs MP, 2000, BBA-BIOENERGETICS, V1460, P15, DOI 10.1016/S0005-2728(00)00126-2; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lanyi JK, 2000, BBA-BIOENERGETICS, V1460, P1, DOI 10.1016/S0005-2728(00)00124-9; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lazarova T, 2002, BIOCHEMISTRY-US, V41, P8176, DOI 10.1021/bi025654u; Lazarova T, 2014, FEBS J, V281, P1181, DOI 10.1111/febs.12694; Lazarova T, 2009, PHOTOCHEM PHOTOBIOL, V85, P617, DOI 10.1111/j.1751-1097.2008.00534.x; LOGUNOV I, 1995, BIOPHYS J, V68, P1270, DOI 10.1016/S0006-3495(95)80301-2; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAKHATADZE GI, 1994, BIOPHYS CHEM, V51, P291, DOI 10.1016/0301-4622(94)00050-6; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Moller C, 2000, J MOL BIOL, V301, P869, DOI 10.1006/jmbi.2000.3995; Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Padros E, 2001, NATO SCI SER I LIFE, V335, P120; Pescitelli G, 2012, J PHYS CHEM B, V116, P6751, DOI 10.1021/jp212166k; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reat V, 1998, P NATL ACAD SCI USA, V95, P4970, DOI 10.1073/pnas.95.9.4970; Rhinow D, 2010, J PHYS CHEM B, V114, P15424, DOI 10.1021/jp108502p; Ryazantsev MN, 2012, J AM CHEM SOC, V134, P5520, DOI 10.1021/ja3009117; Saito H, 2002, BBA-BIOMEMBRANES, V1565, P97, DOI 10.1016/S0005-2736(02)00513-8; Sanz C, 1999, FEBS LETT, V456, P191, DOI 10.1016/S0014-5793(99)00950-3; Sanz C, 2001, J BIOL CHEM, V276, P40788, DOI 10.1074/jbc.M104836200; Sapra KT, 2008, BIOPHYS J, V95, P3407, DOI 10.1529/biophysj.108.131904; SMITH SO, 1989, BIOCHEMISTRY-US, V28, P8897, DOI 10.1021/bi00448a032; Song YF, 2003, BIOCHEMISTRY-US, V42, P9875, DOI 10.1021/bi034482d; Takashima K, 1998, MASS SPECTROM REV, V17, P409, DOI 10.1002/(SICI)1098-2787(1998)17:6<409::AID-MAS2>3.0.CO;2-J; Thavasi V, 2009, J NANOSCI NANOTECHNO, V9, P1679, DOI 10.1166/jnn.2009.SI07; Wang JP, 2001, PHOTOCHEM PHOTOBIOL, V73, P564, DOI 10.1562/0031-8655(2001)073<0564:TEOMCB>2.0.CO;2; WATTS A, 1995, BIOPHYS CHEM, V55, P137, DOI 10.1016/0301-4622(94)00147-C; Yokoyama Y, 2004, PROTEINS, V54, P442, DOI 10.1002/prot.10615	56	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162952	10.1371/journal.pone.0162952	http://dx.doi.org/10.1371/journal.pone.0162952			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657718	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200045
J	Wong, LP; Yusoff, RNARM; Edib, Z; Sam, IC; Zimet, GD				Wong, Li Ping; Yusoff, Raja Nur Amalina Raja Muhammad; Edib, Zobaida; Sam, I-Ching; Zimet, Gregory D.			Nationwide Survey of Knowledge and Health Beliefs regarding Human Papillomavirus among HPV-Vaccinated Female Students in Malaysia	PLOS ONE			English	Article							SECONDARY-SCHOOL STUDENTS; CERVICAL-CANCER; MULTIETHNIC POPULATIONS; DEVELOPING-COUNTRY; ACCEPTANCE; WOMEN; ACCEPTABILITY; INFECTION; AWARENESS; EDUCATION	The National HPV Immunization Programme, which offers free human papillomavirus (HPV) vaccines to teenaged female students, was launched in Malaysia in 2010. HPV vaccination paired with adequate knowledge about HPV infection provides the best protection against cervical cancer. To identify the level of knowledge and the health beliefs towards HPV and the HPV vaccine among HPV-vaccinated female students in Malaysia. A nationwide cross-sectional survey among 14 years old female students who had received three doses of the HPV vaccine was conducted in 32 randomly selected schools from 13 states and 3 federal territories in Malaysia between February 2013 and April 2013. Among 2482 respondents, knowledge about HPV infection and the HPV vaccine was extremely poor. The mean total knowledge score was only 3.56 (SD +/- 1.76), out of a possible score of 10. The majority of respondents were unaware that vaccinating boys with HPV can help protect girls against HPV infection (91.6%), HPV cannot be cured (81.6%) and that HPV is a sexually transmitted infection (70.3%). Most of the respondents had the misconception that only females get HPV (95.1%), and that the HPV vaccine eliminates the need for Pap smear tests (68.3%). Most respondents (91.6%) believed that they would not get an HPV infection. Almost half of the respondents (42.9%) held the misconception that HPV infection could not lead to serious illness. Findings revealed poor knowledge about both HPV and the HPV vaccine, low perceived susceptibility to HPV infection and misinformation about HPV infection among HPV-vaccinated girls. Therefore, it is essential to increase the knowledge and awareness of health risks regarding HPV infection among teenaged girls who have received the HPV vaccine.	[Wong, Li Ping; Yusoff, Raja Nur Amalina Raja Muhammad; Edib, Zobaida] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia; [Sam, I-Ching] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Zimet, Gregory D.] Indiana Univ, Sch Med, Dept Pediat, 410 W,10th St,HS 1001, Indianapolis, IN 46202 USA	Universiti Malaya; Universiti Malaya; Indiana University System; Indiana University-Purdue University Indianapolis	Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.	wonglp@ummc.edu.my	Sam, Jamal I-Ching/B-8688-2010; WONG, LI PING/B-2782-2010	Sam, Jamal I-Ching/0000-0002-1296-7898; WONG, LI PING/0000-0002-0107-0532; Edib, Zobaida/0000-0001-7381-7351	WLP University of Malaya Research Grant [RG 411-12 HTM]; WLP ICS Sanofi-Aventis; University of Malaya Research Grant [RG 411-12 HTM]	WLP University of Malaya Research Grant; WLP ICS Sanofi-Aventis; University of Malaya Research Grant	This work was supported by WLP University of Malaya Research Grant (grant no: RG 411-12 HTM), and WLP ICS Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The contributions of all participants in this study are greatly appreciated. The research was supported and funded by University of Malaya Research Grant (grant no: RG 411-12 HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; African Parks, 2011, ANN REP 2011; Agius PA, 2010, VACCINE, V28, P4416, DOI 10.1016/j.vaccine.2010.04.038; Allen JD, 2010, CANCER EPIDEM BIOMAR, V19, P2187, DOI 10.1158/1055-9965.EPI-10-0217; Arca E, 2011, ADV NURSING RES, V3; Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; de Visser R, 2008, SEX HEALTH, V5, P331, DOI 10.1071/SH08042; Dempsey AF, 2010, VACCINE, V28, P7179, DOI 10.1016/j.vaccine.2010.08.066; Donders GGG, 2009, EUR J OBSTET GYN R B, V145, P93, DOI 10.1016/j.ejogrb.2009.04.003; Ferlay J., 2013, INT AGENCY RES CANC; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Glanz K., 2008, HLTH BEHAV HLTH ED T; Goldie SJ, 2003, INT J CANCER, V106, P896, DOI 10.1002/ijc.11334; Gottvall M, 2009, EUR J CONTRACEP REPR, V14, P399, DOI 10.3109/13625180903229605; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; Kollar LM, 2008, CURR OPIN OBSTET GYN, V20, P479, DOI 10.1097/GCO.0b013e32830d0cf6; Marlow LAV, 2013, VACCINE, V31, P763, DOI 10.1016/j.vaccine.2012.11.083; Montgomery K, 2012, GENDER MED, V9, pS55, DOI 10.1016/j.genm.2011.11.002; Painter JE, 2008, ANN BEHAV MED, V35, P358, DOI 10.1007/s12160-008-9042-y; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Paul P, 2012, ASIAN PAC J CANCER P, V13, P2587, DOI 10.7314/APJCP.2012.13.6.2587; Rashwan H, 2011, ASIAN PAC J CANCER P, V12, P1837; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Rose SB, 2011, J SCHOOL HEALTH, V81, P680, DOI 10.1111/j.1746-1561.2011.00644.x; Scaparrotta A, 2013, ATTITUDES HPV VACCIN; Sopracordevole F, 2013, INT J GYNECOL OBSTET, V122, P48, DOI 10.1016/j.ijgo.2013.02.011; Wong LP, 2011, INT J BEHAV MED, V18, P105, DOI 10.1007/s12529-010-9104-y; Wong LP, 2009, J LOW GENIT TRACT DI, V13, P85, DOI 10.1097/LGT.0b013e3181865f44; Wong LP, 2009, VACCINE, V27, P1410, DOI 10.1016/j.vaccine.2008.12.045; Wong LP, 2009, VACCINE, V27, P1622, DOI 10.1016/j.vaccine.2008.11.107	33	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163156	10.1371/journal.pone.0163156	http://dx.doi.org/10.1371/journal.pone.0163156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27656876	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200075
J	Xu, Z; Zhang, ML; Cohen, JI				Xu, Zhe; Zhang, Ming-Li; Cohen, James I.			Phylogeographic History of Atraphaxis Plants in Arid Northern China and the Origin of A. bracteata in the Loess Plateau	PLOS ONE			English	Article							CHLOROPLAST DNA; TIBETAN PLATEAU; CLIMATIC OSCILLATIONS; MOLECULAR PHYLOGENY; SEQUENCE VARIATION; GENETIC DIVERSITY; CPDNA SEQUENCES; NORTHWEST CHINA; WESTERN CHINA; EARLY MIOCENE	In China, species of Atraphaxis (Polygonaceae) primarily inhabit arid zones across temperate steppe and desert regions. The complex geologic history (e.g., expansion of deserts) and extreme climate shifts of the region appear to have played an important role in shaping the phylogeography of Atraphaxis. The present study focuses on species-level phylogeo-graphic patterns of Atraphaxis in China, with the goal of determining the impact of past environmental changes, in northern China, on the evolutionary history of the genus. Five hundred and sixty-four individuals distributed among 71 populations of 11 species of Atraphaxis from across the geographic range of the genus were studied using sequence data from two plastid spacers, psbK-psbI and psbB-psbH. The results demonstrate that most chloroplast haplotypes are species-specific, except for some present among widespread species. The phylogeny of Atraphaxis was well structured, and molecular dating analyses suggest that the main divergence events occurred during the late Pliocene and Pleistocene (5.73-0.03 million years ago). The statistical dispersal-vicariance analysis (S-DIVA) results provide evidence that phylogeographic patterns for the genus were characterized by both vicariance events and regional dispersal. The presented data suggest that the rapid expansion of deserts and climatic changes in northern China during the late Pliocene and Pleistocene have driven the diversification and spread of Atraphaxis in the region. The expansion of the Tengger Desert provided appropriate conditions for the origin of A. bracteata. Additionally, a contact zone in the north of the Hexi Corridor was identified as having played a significant role as a migratory route for species in adjacent areas.	[Xu, Zhe; Zhang, Ming-Li] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Cohen, James I.] Kettering Univ, Appl Biol, 1700 Univ Ave, Flint, MI 48504 USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Kettering University	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Zhang, ML (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	zhangml@ibcas.ac.cn		Cohen, James/0000-0002-4755-7370	China National Basic Research Program [2014CB954201]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Basic Research Program(National Basic Research Program of China); Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the China National Basic Research Program (2014CB954201) and Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences.	Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baird KE, 2010, J SYST EVOL, V48, P161, DOI 10.1111/j.1759-6831.2010.00077.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bao BJ, 1993, ACTA PHYTOTAX SINICA, V31, P127; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Dang RL, 2001, B BOT RES, V4, P520; Ding ZL, 2005, EARTH PLANET SC LETT, V237, P45, DOI 10.1016/j.epsl.2005.06.036; Dong Y, 2006, MARINE GEOLOGY QUATE, V26, P93; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang XM, 2002, SCI CHINA SER D, V45, P289, DOI 10.1360/02yd9031; Gao XY, 2014, BIOCHEM SYST ECOL, V55, P93, DOI 10.1016/j.bse.2014.03.002; Garrick RC, 2009, MOL ECOL, V18, P1916, DOI 10.1111/j.1365-294X.2009.04148.x; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Guest HJ, 2014, J BIOGEOGR, V41, P1070, DOI 10.1111/jbi.12267; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo Z.T., 1999, QUAT SCI, V19, P556; Hardy ME, 2002, MOL ECOL, V11, P2393, DOI 10.1046/j.1365-294X.2002.01616.x; Harris AJ, 2013, J SYST EVOL, V51, P117, DOI 10.1111/jse.12007; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YF, 2009, MOL ECOL, V18, P2700, DOI 10.1111/j.1365-294X.2009.04214.x; Liu YX, 1995, ACTA PHYTOTAXON SIN, V33, P133; Ma SM, 2012, CONSERV GENET, V13, P1531, DOI 10.1007/s10592-012-0397-z; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Nason JD, 2002, EVOLUTION, V56, P2214, DOI 10.1111/j.0014-3820.2002.tb00146.x; Nishizawa T, 2011, MOL PHYLOGENET EVOL, V59, P139, DOI 10.1016/j.ympev.2011.01.015; Ossa PG, 2013, J BIOGEOGR, V40, P2191, DOI 10.1111/jbi.12152; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pons O, 1996, GENETICS, V144, P1237; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schaal BA, 2000, P NATL ACAD SCI USA, V97, P7024, DOI 10.1073/pnas.97.13.7024; Shafer ABA, 2011, EVOLUTION, V65, P125, DOI 10.1111/j.1558-5646.2010.01109.x; Shi Y.F., 2005, QUATERNARY GLACIATIO; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Su ZH, 2013, BIOL J LINN SOC, V109, P757, DOI 10.1111/bij.12088; Sun YX, 2012, J ARID LAND, V4, P180, DOI 10.3724/SP.J.1227.2012.00180; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Tavakkoli S, 2015, PLANT SYST EVOL, V301, P1157, DOI 10.1007/s00606-014-1140-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang Q, 2013, NEW PHYTOL, V199, P277, DOI 10.1111/nph.12241; Williams MA, 1993, QUATERNARY ENV; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387; Wu ZH, 2008, GEOL SOC AM BULL, V120, P1326, DOI 10.1130/B26043.1; Wulff E, 1944, HIST PLANT GEOGRAPHY; Xu DH, 2000, THEOR APPL GENET, V101, P724, DOI 10.1007/s001220051537; Xu XK, 2010, BOREAS, V39, P215, DOI 10.1111/j.1502-3885.2009.00118.x; Xu XY, 1995, CHINA BIOSPHERE RESE, V2, P37; Xu Z, 2015, BIOCHEM SYST ECOL, V60, P88, DOI 10.1016/j.bse.2015.04.003; Xu Z, 2015, J HERED, V106, P184, DOI 10.1093/jhered/esu078; Yang XP, 2004, QUATERN INT, V118, P69, DOI 10.1016/S1040-6182(03)00131-9; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang ML, 2014, J INTEGR PLANT BIOL, V56, P1125, DOI 10.1111/jipb.12226; Zhao YZ, 1997, ACTA SCI NATURALIUM, P4	67	7	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163243	10.1371/journal.pone.0163243	http://dx.doi.org/10.1371/journal.pone.0163243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656885	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200091
J	Zolea, F; Biamonte, F; Battaglia, AM; Faniello, MC; Cuda, G; Costanzo, F				Zolea, Fabiana; Biamonte, Flavia; Battaglia, Anna Martina; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco			Caffeine Positively Modulates Ferritin Heavy Chain Expression in H460 Cells: Effects on Cell Proliferation	PLOS ONE			English	Article							ENCODING GENE FERH; CANCER CELLS; XANTHINE DERIVATIVES; OXIDATIVE DAMAGE; IRON HOMEOSTASIS; HELA-CELLS; IN-VIVO; H-CHAIN; MECHANISM; PROTEIN	Both the methylxanthine caffeine and the heavy subunit of ferritin molecule (FHC) are able to control the proliferation rate of several cancer cell lines. While caffeine acts exclusively as a negative modulator of cell proliferation, FHC might reduce or enhance cell viability depending upon the different cell type. In this work we have demonstrated that physiological concentrations of caffeine reduce the proliferation rate of H460 cells: along with the modulation of p53, pAKT and Cyclin D1, caffeine also determines a significant FHC up-regulation through the activation of its transcriptional efficiency. FHC plays a central role in the molecular pathways modulated by caffeine, ending in a reduced cell growth, since its specific silencing by siRNA almost completely abolishes caffeine effects on H460 cell proliferation. These results allow the inclusion of ferritin heavy subunits among the multiple molecular targets of caffeine and open the way for studying the relationship between caffeine and intracellular iron metabolism.	[Zolea, Fabiana; Biamonte, Flavia; Battaglia, Anna Martina; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco] Magna Graecia Univ Catanzaro, Res Ctr Adv Biochem & Mol Biol, Dept Expt & Clin Med, Salvatore Venuta Campus,Viale Europa, I-88100 Catanzaro, Italy	Magna Graecia University of Catanzaro	Costanzo, F (corresponding author), Magna Graecia Univ Catanzaro, Res Ctr Adv Biochem & Mol Biol, Dept Expt & Clin Med, Salvatore Venuta Campus,Viale Europa, I-88100 Catanzaro, Italy.	fsc@unicz.it	Cuda, Giovanni/AAC-2821-2019; Biamonte, Flavia/AAF-2092-2020; Costanzo, Francesco Saverio/K-3168-2018; Biamonte, Flavia/AAC-4934-2019; Battaglia, Anna Martina/AFQ-3299-2022	Cuda, Giovanni/0000-0001-6313-1866; Costanzo, Francesco Saverio/0000-0002-3096-9416; Biamonte, Flavia/0000-0003-3248-3863; FANIELLO, Concetta Maria/0000-0001-6938-2754	Prometeo grant [PON01_02834, PON03PE_00009_2]	Prometeo grant	This work was supported by Prometeo grant to GC PON01_02834 (Design and Development of innovative technological Platforms for tissue regeneration in the Oral Maxillo facial, heamatopoietic, neuronal and cardiac system) and PON03PE_00009_2 ICaRe - Infrastruttura Calabrese per la medicina Rigenerativa: generazione di biocanche per la criopreservazione di cellule staminali umane e di tessuto osseo per use clinico e design e sviluppo di bioscaffold innovative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989; Al-Ansari MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090907; Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bache M, 2001, INT J CANCER, V96, P110, DOI 10.1002/ijc.1002; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bevilacqua MA, 1997, J BIOL CHEM, V272, P20736, DOI 10.1074/jbc.272.33.20736; BEVILACQUA MA, 1994, GENE, V141, P287, DOI 10.1016/0378-1119(94)90587-8; BEVILACQUA MA, 1992, GENE, V111, P255, DOI 10.1016/0378-1119(92)90696-M; Biamonte F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122105; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Chanvorachote P, 2016, AM J PHYSIOL-CELL PH, V310, pC728, DOI 10.1152/ajpcell.00322.2015; Chimento A, 2015, ONCOTARGET, V6, P19190, DOI 10.18632/oncotarget.4241; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; DEGUBAREFF T, 1965, J PHARMACOL EXP THER, V148, P202; Di Sanzo M, 2011, J PROTEOME RES, V10, P5444, DOI 10.1021/pr200705z; Faniello MC, 2002, BIOCHEM J, V363, P53, DOI 10.1042/0264-6021:3630053; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Gabrielli B, 2007, J BIOL CHEM, V282, P6954, DOI 10.1074/jbc.M610104200; Gururajanna B, 1999, INT J MOL MED, V4, P501; Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453; Jang MH, 2002, J KOREAN MED SCI, V17, P674, DOI 10.3346/jkms.2002.17.5.674; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kakhlon O, 2002, BIOCHEM J, V363, P431, DOI 10.1042/0264-6021:3630431; Lee JH, 2009, BIOCHEM BIOPH RES CO, V389, P399, DOI 10.1016/j.bbrc.2009.08.125; LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; LIAU G, 1991, J BIOL CHEM, V266, P18819; Lobello N., 2016, ONCOTARGET; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x; Ravi D, 2008, MOL CELL BIOCHEM, V308, P193, DOI 10.1007/s11010-007-9628-x; Santamaria R, 2006, BBA-MOL CELL RES, V1763, P815, DOI 10.1016/j.bbamcr.2006.03.010; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; WHARTON W, 1979, BIOCHEM PHARMACOL, V28, P763, DOI 10.1016/0006-2952(79)90356-3; Zolea F, 2015, FREE RADICAL BIO MED, V89, P614, DOI 10.1016/j.freeradbiomed.2015.07.161	43	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163078	10.1371/journal.pone.0163078	http://dx.doi.org/10.1371/journal.pone.0163078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657916	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200062
J	Al-Samman, AM; Rahman, TA; Azmi, MH; Hindia, MN; Khan, I; Hanafi, E				Al-Samman, A. M.; Rahman, T. A.; Azmi, M. H.; Hindia, M. N.; Khan, I.; Hanafi, E.			Statistical Modelling and Characterization of Experimental mm-Wave Indoor Channels for Future 5G Wireless Communication Networks	PLOS ONE			English	Article							PATH LOSS MODELS; PROPAGATION MEASUREMENTS; 28 GHZ; PHYSICAL IMPAIRMENTS; ANTENNA	This paper presents an experimental characterization of millimeter-wave (mm-wave) channels in the 6.5 GHz, 10.5 GHz, 15 GHz, 19 GHz, 28 GHz and 38 GHz frequency bands in an indoor corridor environment. More than 4,000 power delay profiles were measured across the bands using an omnidirectional transmitter antenna and a highly directional horn receiver antenna for both co- and cross-polarized antenna configurations. This paper develops a new path-loss model to account for the frequency attenuation with distance, which we term the frequency attenuation (FA) path-loss model and introduce a frequency-dependent attenuation factor. The large-scale path loss was characterized based on both new and well-known path-loss models. A general and less complex method is also proposed to estimate the cross-polarization discrimination (XPD) factor of close-in reference distance with the XPD (CIX) and ABG with the XPD (ABGX) path-loss models to avoid the computational complexity of minimum mean square error (MMSE) approach. Moreover, small-scale parameters such as root mean square (RMS) delay spread, mean excess (MN-EX) delay, dispersion factors and maximum excess (MAX-EX) delay parameters were used to characterize the multipath channel dispersion. Multiple statistical distributions for RMS delay spread were also investigated. The results show that our proposed models are simpler and more physically-based than other well-known models. The path-loss exponents for all studied models are smaller than that of the free-space model by values in the range of 0.1 to 1.4 for all measured frequencies. The RMS delay spread values varied between 0.2 ns and 13.8 ns, and the dispersion factor values were less than 1 for all measured frequencies. The exponential and Weibull probability distribution models best fit the RMS delay spread empirical distribution for all of the measured frequencies in all scenarios.	[Al-Samman, A. M.; Rahman, T. A.; Azmi, M. H.; Hindia, M. N.] Univ Teknol Malaysia, Fac Elect Engn, Dept Wireless Commun Ctr, Johor Baharu 81310, Malaysia; [Khan, I.] Islamic Univ Madinah, Dept Elect Engn, Madinah, Saudi Arabia; [Hanafi, E.] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Khan, I.] COMSATS Inst Informat Technol, Abbottabad, Pakistan	Universiti Teknologi Malaysia; Islamic University of Al Madinah; Universiti Malaya; COMSATS University Islamabad (CUI)	Al-Samman, AM (corresponding author), Univ Teknol Malaysia, Fac Elect Engn, Dept Wireless Commun Ctr, Johor Baharu 81310, Malaysia.	Ahmedsecure99@gmail.com	Khan, Imdad/F-4199-2015; HINDIA, MHD NOUR/AAE-3805-2020; M. AL-SAMMAN, AHMED/S-5101-2017; Hanafi, Effariza/N-1534-2015	Khan, Imdad/0000-0001-7430-9738; M. AL-SAMMAN, AHMED/0000-0001-5183-7810; Hanafi, Effariza/0000-0001-6384-0435	Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE) of Pusat Komunikasi Wayarles (WCC) [A.J090601.5357.07085];  [BK012-2015]	Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE) of Pusat Komunikasi Wayarles (WCC); 	The authors would like to acknowledge the grant number A.J090601.5357.07085 by the Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE) of grant number, Pusat Komunikasi Wayarles (WCC) managed by the research management center, Universiti Teknologi Malaysia. Also, the authors would like to acknowledge the grant number BK012-2015.	Akdeniz MR, 2014, IEEE J SEL AREA COMM, V32, P1164, DOI 10.1109/JSAC.2014.2328154; Al-Samman AM, 2015, WIRELESS PERS COMMUN, V83, P3103, DOI 10.1007/s11277-015-2585-x; [Anonymous], 2016, 20161035 USGS, DOI [10. 1109/ EuCAP. 2016.7481708, DOI 10.1109/EUCAP.2016.7481708]; Azar Y, 2013, IEEE ICC, P5143, DOI 10.1109/ICC.2013.6655399; Bhushan N, 2014, IEEE COMMUN MAG, V52, P82, DOI 10.1109/MCOM.2014.6736747; Blumenstein J, 2014, 2014 IEEE 80TH VEHICULAR TECHNOLOGY CONFERENCE (VTC FALL), DOI 10.1109/VTCFall.2014.6966022; Cassioli D, 2002, IEEE J SEL AREA COMM, V20, P1247, DOI 10.1109/JSAC.2002.801228.; Chitra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116326; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Deng S, 2016, 2016 IEEE 83 V UNPUB; Deng SJ, 2015, IEEE INT CONF COMM, P1244, DOI 10.1109/ICCW.2015.7247348; Du QH, 2015, PERS UBIQUIT COMPUT, V19, P1033, DOI 10.1007/s00779-015-0872-x; Elkashlan M, 2015, IEEE COMMUN MAG, V53, P166, DOI 10.1109/MCOM.2015.7010530; Elkashlan M, 2014, IEEE COMMUN MAG, V52, P52, DOI 10.1109/MCOM.2014.6894452; Eras LC, ANT PROP EUCAP 2015, P1; Ghosh A, 2014, IEEE J SEL AREA COMM, V32, P1152, DOI 10.1109/JSAC.2014.2328111; Haneda K, 2014, PROC EUR CONF ANTENN, P634, DOI 10.1109/EuCAP.2014.6901839; HASHEMI H, 1994, IEEE T VEH TECHNOL, V43, P110, DOI 10.1109/25.282271; He HL, 2015, IEEE ICC, P617, DOI 10.1109/ICC.2015.7248390; Hindia MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155077; Hindia MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121901; Hur S, 2014, INT BLACK SEA CONF, P83, DOI 10.1109/BlackSeaCom.2014.6849010; Kim M, 2015, 2015 IEEE 26TH ANNUAL INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P764, DOI 10.1109/PIMRC.2015.7343400; Kim M, 2014, IEEE T ANTENN PROPAG, V62, P430, DOI 10.1109/TAP.2013.2288633; Koymen OH, 2015, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2015.7417720; Lei MY, 2014, 2014 IEEE 25TH ANNUAL INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATION (PIMRC), P208, DOI 10.1109/PIMRC.2014.7136161; Liao SH, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-96; Liu DT, 2016, IEEE COMMUN SURV TUT, V18, P1018, DOI 10.1109/COMST.2016.2516538; MacCartney GR, 2015, IEEE ACCESS, V3, P2388, DOI 10.1109/ACCESS.2015.2486778; MacCartney GR, 2014, 2014 IEEE 25TH ANNUAL INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATION (PIMRC), P227, DOI 10.1109/PIMRC.2014.7136165; MacCartney GR, 2014, IEEE ICC, P4862, DOI 10.1109/ICC.2014.6884090; MacCartney GR, 2013, IEEE GLOB COMM CONF, P3948, DOI 10.1109/GLOCOM.2013.6831690; Mo YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142775; Mohapatra S.K., 2014, T MACH LEARN ARTIF I, V2, P48, DOI [10.14738/tmlai.23.256, DOI 10.14738/TMLAI.23.256, 10. 14738/M28723.256, DOI 10.14738/M28723.256]; Moraitis N, 2006, IEEE T WIREL COMMUN, V5, P880, DOI [10.1109/TWC.2006.1618937, 10.1109/TWC.2006.04022]; Nie S, 2013, 2013 IEEE 24TH INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P2429, DOI 10.1109/PIMRC.2013.6666553; Pi ZY, 2011, IEEE COMMUN MAG, V49, P101, DOI 10.1109/MCOM.2011.5783993; Rangan S, 2014, P IEEE, V102, P366, DOI 10.1109/JPROC.2014.2299397; Rappaport T. S., 2002, WIRELESS COMMUNICATI; Rappaport TS, 2012, IEEE ICC; Rappaport TS, 2015, IEEE INT CONF COMM, P1238, DOI 10.1109/ICCW.2015.7247347; Rappaport TS, 2015, IEEE T COMMUN, V63, P3029, DOI 10.1109/TCOMM.2015.2434384; Rappaport TS, 2013, IEEE ACCESS, V1, P335, DOI 10.1109/ACCESS.2013.2260813; Rappaport TS, 2011, P IEEE, V99, P1390, DOI 10.1109/JPROC.2011.2143650; Samimi M., 2013, P IEEE 77 VEH TECHN, P1, DOI [10.1109/VTCSpring.2013.6691812, DOI 10.1109/VTCSPRING.2013.6691812]; Samimi M. K., 2015, P IEEE GLOB WORKSH G, P1, DOI [10.1109/GLOCOMW.2015.7414164, DOI 10.1109/GLOCOMW.2015.7414164]; Samimi MK, 2016, IEEE VTS VEH TECHNOL, DOI 10.1109/VTCSpring.2016.7503970; Samimi MK, 2015, IEEE ICC, P2430, DOI 10.1109/ICC.2015.7248689; Samimi MK, 2014, IEEE GLOB COMM CONF, P3483, DOI 10.1109/GLOCOM.2014.7037347; Samimi MK, 2015, 10 EUR C ANT P UNPUB; Seidel SY, 1995, GLOB TELECOMM CONF, P754, DOI 10.1109/GLOCOM.1995.502029; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Smulders PFM, 2009, IEEE T ANTENN PROPAG, V57, P2820, DOI 10.1109/TAP.2009.2030524; Song HT, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P1; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; Sulyman AI, 2014, IEEE COMMUN MAG, V52, P78, DOI 10.1109/MCOM.2014.6894456; Sun S., 2015, P IEEE GLOB WORKSH G, P1, DOI 10.1109/GLOCOMW.2015.7414036; Sun S, 2015, 10 EUR C ANT P UNPUB; Sun S, 2013, IEEE GLOB COMM CONF, P3760; Sun S, 2015, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2015.7417335; Sun S, 2016, IEEE VTS VEH TECHNOL, DOI 10.1109/VTCSpring.2016.7504435; Sun S, 2016, IEEE T VEH TECHNOL, V65, P2843, DOI 10.1109/TVT.2016.2543139; Sun S, 2014, IEEE ICC, P5468, DOI 10.1109/ICC.2014.6884191; Syed Hassan Ahmed SHB, 2016, IEEE COMSOC MMTC E L, V11, P57; Wang Y, 2012, INT J ANTENN PROPAG, V2012, DOI 10.1155/2012/636349; Wu X., 2015, P 9 EUR C ANT PROP E, P1; Xu DT, 2016, IET COMMUN, V10, P292, DOI 10.1049/iet-com.2015.0229; Zhou X, 2015, INT J ANTENN PROPAG, V2015, DOI 10.1155/2015/601835	69	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163034	10.1371/journal.pone.0163034	http://dx.doi.org/10.1371/journal.pone.0163034			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654703	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700034
J	Campos, CM; Campos, VE; Miguel, F; Cona, MI				Campos, Claudia M.; Campos, Valeria E.; Miguel, Florencia; Cona, Monica I.			Management of Protected Areas and Its Effect on an Ecosystem Function: Removal of Prosopis flexuosa Seeds by Mammals in Argentinian Drylands	PLOS ONE			English	Article							MONTE DESERT; IMAGE TEXTURE; TROPICAL FOREST; LAND-USE; DISPERSAL; BIODIVERSITY; DEFAUNATION; CONSERVATION; DIVERSITY; PREDATION	The ecological function of animal seed dispersal depends on species interactions and can be affected by drivers such as the management interventions applied to protected areas. This study was conducted in two protected areas in the Monte Desert: a fenced reserve with grazing exclusion and absence of large native mammals (the Man and Biosphere Nacunan Reserve; FR) and an unfenced reserve with low densities of large native and domestic animals (Ischigualasto Park; UFR). The study focuses on Prosopis flexuosa seed removal by different functional mammal groups: "seed predators", "scatter-hoarders", and "opportunistic frugivores". Under both interventions, the relative contribution to seed removal by different functional mammal groups was assessed, as well as how these groups respond to habitat heterogeneity (i.e. vegetation structure) at different spatial scales. Camera traps were used to identify mammal species removing P. flexuosa seeds and to quantify seed removal; remote sensing data helped analyze habitat heterogeneity. In the FR, the major fruit removers were a seed predator (Graomys griseoflavus) and a scatter-hoarder (Microcavia asutralis). In the UFR, the main seed removers were the opportunistic frugivores (Lycalopex griseus and Dolichotis patagonum), who removed more seeds than the seed predator in the FR. The FR shows higher habitat homogeneity than the UFR, and functional groups respond differently to habitat heterogeneity at different spatial scales. In the FR, because large herbivores are locally extinct (e.g. Lama guanicoe) and domestic herbivores are excluded, important functions of large herbivores are missing, such as the maintenance of habitat heterogeneity, which provides habitats for medium-sized opportunistic frugivores with consequent improvement of quality and quantity of seed dispersal services. In the UFR, with low densities of large herbivores, probably one important ecosystem function this group performs is to increase habitat heterogeneity, allowing for the activity of medium-sized mammals who, behaving as opportunistic frugivores, did the most significant seed removal.	[Campos, Claudia M.; Miguel, Florencia; Cona, Monica I.] Inst Argentino Invest Zonas Aridas UNCuyo Gobiern, Mendoza, Argentina; [Campos, Valeria E.] Interacc Biol Desierto INTERBIODES, Ctr Invest Geosfera & Biosfera UNSJ CONICET, San Juan, Argentina		Campos, CM (corresponding author), Inst Argentino Invest Zonas Aridas UNCuyo Gobiern, Mendoza, Argentina.	ccampos@mendoza-conicet.gob.ar	Campos, Claudia Monica/U-9704-2019; Campos, Valeria/K-6637-2019; Miguel, Florencia/M-4074-2019	Campos, Claudia Monica/0000-0002-4978-5449; Miguel, Florencia/0000-0002-6951-1576	Consejo Nacional de Investigaciones Cientificas y Tecnologicas [CONICET- PIP 112-201101-00601]; Proyecto de Bosques Nativos (Presidencia de la Nacion y Gobierno de San Juan); Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2013-0478]	Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Proyecto de Bosques Nativos (Presidencia de la Nacion y Gobierno de San Juan); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported in part by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET- PIP 112-201101-00601, http://www.conicet.gov.ar/), Proyecto de Bosques Nativos (Presidencia de la Nacion y Gobierno de San Juan, http://ambiente.sanjuan.gov.ar/), and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2013-0478, http://www.agencia.mincyt.gob.ar/) to CMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET- PIP 112-201101-00601 http://www.conicet.gov.ar/), Proyecto de Bosques Nativos (Presidencia de la Nacion y Gobierno de San Juan http://ambiente.sanjuan.gov.ar/), and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2013-0478 http://www.agencia.mincyt.gob.ar/) to CMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the administration and all the staff of the Ischigualasto Provincial Park and Nacunan Reserve for their cooperation and help. Nelida Horak assisted us in drafting the English version.	Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; BARALDI A, 1995, IEEE T GEOSCI REMOTE, V33, P293, DOI 10.1109/36.377929; Beckman NG, 2007, BIOTROPICA, V39, P328, DOI 10.1111/j.1744-7429.2007.00273.x; Bellis LM, 2008, ECOL APPL, V18, P1956, DOI 10.1890/07-0243.1; Bjornstad O. N., 2016, PACKAGE NCF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cabrera A.L, 1976, REGIONES FITOGEOGR F; Cambi F, 2001, FONDAMENTI INTERCULT; Campos C, 2016, AUSTRAL ECOL, DOI [10.1111/j.1442-9993.2012.02438.x, DOI 10.1111/J.1442-9993.2012.02438.X]; Campos C.M., 2015, Ecosistemas, V24, P28, DOI 10.7818/ECOS.2015.24-3.05; Campos C. M., 2014, REV FORESTAL BARACOA, V33, P431; Campos CM, 2008, SEED SCI RES, V18, P91, DOI 10.1017/S0960258508940344; Campos CM, 2011, REV CHIL HIST NAT, V84, P289, DOI 10.4067/S0716-078X2011000200013; Campos Claudia M., 2001, Mammalian Species, V652, P1, DOI 10.1644/1545-1410(2001)652<0001:DP>2.0.CO;2; Campos CM, 1997, J ARID ENVIRON, V35, P707, DOI 10.1006/jare.1996.0196; Campos VE, 2016, J VEG SCI, V27, P200, DOI 10.1111/jvs.12328; Campos VE, 2015, MAMMAL RES, V60, P117, DOI 10.1007/s13364-015-0215-3; Cao L, 2011, INTEGR ZOOL, V6, P227, DOI 10.1111/j.1749-4877.2011.00248.x; Chillo V, 2012, J ARID ENVIRON, V87, P95, DOI 10.1016/j.jaridenv.2012.06.016; Chillo V, 2015, ECOL INDIC, V50, P69, DOI 10.1016/j.ecolind.2014.10.009; Corbalan V, 2006, J ARID ENVIRON, V65, P102, DOI 10.1016/j.jaridenv.2005.07.006; Corlett RT, 2013, BIOL CONSERV, V163, P13, DOI 10.1016/j.biocon.2012.11.012; Crawley M.J., 2007, R BOOK; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Durant SM, 2015, J APPL ECOL, V52, P544, DOI 10.1111/1365-2664.12415; ENVI, 2004, ENVI GIS; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Galetti M, 2015, GLOB ECOL CONSERV, V3, P824, DOI 10.1016/j.gecco.2015.04.008; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Giannoni SM, 2013, AUSTRAL ECOL, V38, P485, DOI 10.1111/j.1442-9993.2012.02438.x; Gitay H., 1997, PLANT FUNCTIONAL TYP, P3; Goiran SB, 2012, J ARID ENVIRON, V87, P188, DOI 10.1016/j.jaridenv.2012.07.011; Grunewald C, 2010, BASIC APPL ECOL, V11, P532, DOI 10.1016/j.baae.2010.07.007; Guariguata MR, 2000, CONSERV BIOL, V14, P1046, DOI 10.1046/j.1523-1739.2000.99148.x; Hampe A, 2011, ACTA OECOL, V37, P666, DOI 10.1016/j.actao.2011.05.001; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; Howe HF, 2004, BIOSCIENCE, V54, P651, DOI 10.1641/0006-3568(2004)054[0651:WSDM]2.0.CO;2; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jimenez J, 2008, IUCN RED LIST THREAT; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; KUFNER MB, 1991, STUD NEOTROP FAUNA E, V26, P249, DOI 10.1080/01650529109360860; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Marsett RC, 2006, RANGELAND ECOL MANAG, V59, P530, DOI 10.2111/05-201R.1; McCullagh P., 1989, GEN LINEAR MODELS; McCulloch C. E., 2009, GEN LINEAR MIXED MOD; Ojeda RA, 1998, J ARID ENVIRON, V39, P299, DOI 10.1006/jare.1998.0398; Oksanen J, 2016, PACKAGE VEGAN, P4; Orrock JL, 2000, ECOL APPL, V10, P1356, DOI 10.1890/1051-0761(2000)010[1356:PPAAOA]2.0.CO;2; Parsons EWR, 2013, J ANIM ECOL, V82, P459, DOI 10.1111/1365-2656.12009; Periago ME, 2015, MAMMAL REV, V45, P41, DOI 10.1111/mam.12031; POLIS GA, 1991, ECOLOGY DESERT COMMU; Quantum GIS Development Team, 2012, QUANT GIS GEOGR INF; R Core T, 2015, LANG ENV STAT COMP; Rodriguez D, 2009, J ARID ENVIRON, V73, P444, DOI 10.1016/j.jaridenv.2008.12.010; Roig-Junent S, 2001, J ARID ENVIRON, V47, P77, DOI 10.1006/jare.2000.0688; Rossi B. E, 2004, FLORA VEGETACION RES; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Shenbrot GI., 1999, SPATIAL ECOLOGY DESE, P25; Silva SI, 2005, AUSTRAL ECOL, V30, P739, DOI 10.1111/j.1442-9993.2005.01449.x; Skaug H. J., 2014, GEN LINEAR MIXED MOD; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Tabeni S, 2005, J ARID ENVIRON, V63, P244, DOI 10.1016/j.jaridenv.2005.03.009; Tabeni S, 2013, J ARID ENVIRON, V88, P250, DOI 10.1016/j.jaridenv.2012.07.003; Tabeni S, 2007, ACTA OECOL, V31, P259, DOI 10.1016/j.actao.2006.11.002; Taylor MFJ, 2011, BIODIVERS CONSERV, V20, P767, DOI 10.1007/s10531-010-9977-8; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tognelli Marcelo F., 2001, Mammalian Species, V648, P1, DOI 10.1644/1545-1410(2001)648<0001:MA>2.0.CO;2; Tognelli MF, 1995, MAMMALIA, V59, P327, DOI 10.1515/mamm.1995.59.3.327; Tuceryan M., 1998, HDB PATTERN RECOGNIT, V2/e, P207; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Villagra PE, 2009, J ARID ENVIRON, V73, P202, DOI 10.1016/j.jaridenv.2008.08.002; Villagra PE, 2002, AUSTRAL ECOL, V27, P416, DOI 10.1046/j.1442-9993.2002.01195.x; Wiens J.A., 1985, P169; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	82	16	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162551	10.1371/journal.pone.0162551	http://dx.doi.org/10.1371/journal.pone.0162551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655222	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700026
J	Covi, JA; Hutchison, ER; Neumeyer, CH; Gunderson, MD				Covi, Joseph A.; Hutchison, Evan R.; Neumeyer, Courtney H.; Gunderson, Matthew D.			Rotenone Decreases Hatching Success in Brine Shrimp Embryos by Blocking Development: Implications for Zooplankton Egg Banks	PLOS ONE			English	Article							ARTEMIA-FRANCISCANA EMBRYOS; CALANOID RESTING EGGS; ABUNDANCE; AGE; EMERGENCE; SEDIMENT; DORMANT; FISHES; ANOXIA; INVERTEBRATES	While many zooplankton species recover quickly after the treatment of water resources with the piscicide, rotenone, some fail to reach pretreatment population density or, in rare cases, do not reappear at all. The variable impact of rotenone on zooplankton populations could stem from differences in the capacity of species to switch entirely to anaerobic catabolic pathways in the presence of rotenone, which blocks mitochondrial electron transport. Alternatively, variable responses among species could originate from differences in permeability of dormant life-stages to lipophilic chemicals like rotenone. The purpose of the present study was to determine the effects of rotenone on development, emergence and hatching of zooplankton embryos that lack both the anaerobic capacity to develop in the presence of rotenone and a permeability barrier to prevent the entry of rotenone during dormancy. Post-diapause embryos of the brine shrimp, Artemia franciscana, were employed as a model system, because they are permeable to lipophilic compounds when dechorionated and require aerobic conditions to support development. Early development in this species is also well characterized in the literature. Brine shrimp embryos were exposed to rotenone while development was either slowed by chilling or suspended by anoxia. Development, emergence and hatching were then observed in rotenone-free artificial seawater. The data presented demonstrate that rotenone freely diffuses across the embryonic cuticle in a matter of hours, and prevents development and emergence after brief exposures to ecologically relevant concentrations (0.025 - 0.5 mg L (-1)) of the piscicide. Neither the removal of rotenone from the environment, nor the removal of embryonic water with a hypertonic solution, are sufficient to reverse this block on development and emergence. These data indicate that rotenone could impair recruitment from egg banks for species of zooplankton that lack both an embryonic barrier to the entry of lipophilic compounds and the anaerobic capacity to develop when NADH: ubiquinone oxidoreductase activity is inhibited by rotenone.	[Covi, Joseph A.; Neumeyer, Courtney H.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA; [Covi, Joseph A.; Hutchison, Evan R.; Gunderson, Matthew D.] Univ Wisconsin Stevens Point, Dept Biol, Stevens Point, WI USA; [Hutchison, Evan R.] Agro Biosci Inc, Wauwatosa, WI USA; [Neumeyer, Courtney H.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	University of North Carolina; University of North Carolina Wilmington; University of Wisconsin System; University of Wisconsin Stevens Point; James Madison University	Covi, JA (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.; Covi, JA (corresponding author), Univ Wisconsin Stevens Point, Dept Biol, Stevens Point, WI USA.	covij@uncw.edu		Neumeyer, Courtney/0000-0002-7394-9079; Covi, Joseph/0000-0001-5668-4577	University of Wisconsin - Stevens Point; University of North Carolina at Wilmington; University of Wisconsin, Stevens Point, (Stevens Point, Wisconsin, USA); University of North Carolina at Wilmington (Wilmington, North Carolina, USA)	University of Wisconsin - Stevens Point; University of North Carolina at Wilmington; University of Wisconsin, Stevens Point, (Stevens Point, Wisconsin, USA); University of North Carolina at Wilmington (Wilmington, North Carolina, USA)	Funding used for this work was awarded to JAC by the University of Wisconsin - Stevens Point and the University of North Carolina at Wilmington.; This work was funded by the University of Wisconsin, Stevens Point, (Stevens Point, Wisconsin, USA) and the University of North Carolina at Wilmington (Wilmington, North Carolina, USA).	Almquist E., 1959, Report Institute of Freshwater Research Drottningholm, VNo. 40, P146; ANDERSON RS, 1970, J FISH RES BOARD CAN, V27, P1335, DOI 10.1139/f70-159; BEAL DL, 1993, B ENVIRON CONTAM TOX, V51, P551; BUSA WB, 1982, ARCH BIOCHEM BIOPHYS, V216, P711, DOI 10.1016/0003-9861(82)90261-2; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.2307/176789; Caceres CE, 1998, ERGEB LIMNOL, V52, P163; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; CLEGG JS, 1964, J EXP BIOL, V41, P879; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; Clegg JS, 1997, J EXP BIOL, V200, P467; Covi JA, 2005, J EXP BIOL, V208, P2783, DOI 10.1242/jeb.01680; Covi JA, 2005, J EXP BIOL, V208, P2799, DOI 10.1242/jeb.01681; Covi JA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P422, DOI 10.1086/518344; Dalu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142140; Dawson V. K., 1986, ADSORPTION DESORPTIO; Fang NB, 1999, J AGR FOOD CHEM, V47, P2130, DOI 10.1021/jf981188x; Finlayson B., 2010, PLANNING STANDARD OP; Finlayson BJ, 2001, ROTENONE IN FISHERIES: ARE THE REWARDS WORTH THE RISKS?, P1; Finlayson BJ, 2014, ENVIRON TOXICOL CHEM, V33, P1650, DOI 10.1002/etc.2608; Finlayson J, 2001, ROTENONE IN FISHERIES: ARE THE REWARDS WORTH THE RISKS?, P37; Gilderhus P.A., 1988, INVESTIGATIONS FISH, V95; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hairston NG, 2002, INTEGR COMP BIOL, V42, P481, DOI 10.1093/icb/42.3.481; Hand SC, 1998, J EXP BIOL, V201, P1233; Hand SC, 2011, J INSECT PHYSIOL, V57, P584, DOI 10.1016/j.jinsphys.2011.02.010; HEGEN H E, 1985, North American Journal of Fisheries Management, V5, P500, DOI 10.1577/1548-8659(1985)5<500:UORAPP>2.0.CO;2; Hooper F., 1948, P MINN ACAD SCI, V16, P29; Jiang XD, 2004, J EXP MAR BIOL ECOL, V312, P89, DOI 10.1016/j.jembe.2004.06.004; Jiang XD, 2012, POLAR BIOL, V35, P1525, DOI 10.1007/s00300-012-1192-5; Ley JA, 1999, ESTUAR COAST SHELF S, V48, P701, DOI 10.1006/ecss.1998.0459; MARCUS NH, 1994, LIMNOL OCEANOGR, V39, P154, DOI 10.4319/lo.1994.39.1.0154; MATLOCK GC, 1982, T AM FISH SOC, V111, P326, DOI 10.1577/1548-8659(1982)111<326:SNEFWR>2.0.CO;2; McClay W, 2005, FISHERIES, V30, P29, DOI 10.1577/1548-8446(2005)30[29:RUINA]2.0.CO;2; Melaas CL, 2001, HYDROBIOLOGIA, V459, P177, DOI 10.1023/A:1012514124430; MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7; Mueller CA, 2016, J EXP BIOL, V219, P571, DOI 10.1242/jeb.125823; NAESS T, 1991, MAR BIOL, V111, P455, DOI 10.1007/BF01319418; NAESS T, 1991, MAR BIOL, V110, P261, DOI 10.1007/BF01313712; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; Navis S, 2015, AQUAT TOXICOL, V159, P176, DOI 10.1016/j.aquatox.2014.12.016; Neumeyer CH, 2015, J MORPHOL, V276, P342, DOI 10.1002/jmor.20344; Nico LG, 2015, MANAG BIOL INVASION, V6, P83, DOI 10.3391/mbi.2015.6.1.07; Radzikowski J, 2013, J PLANKTON RES, V35, P707, DOI 10.1093/plankt/fbt032; Rozas LP, 1997, ESTUARIES, V20, P199, DOI 10.2307/1352731; Spare W., 1983, 82E76M BIOSPH; Spare W., 1982, 2214701 LITT BION; Thomas R., 1983, 0301A BORR LAB; Uye S., 1984, Crustaceana Supplement (Leiden), P390; Van Stappen G, 1998, ERGEB LIMNOL, V52, P281; Vasquez ME, 2012, ENVIRON TOXICOL CHEM, V31, P1032, DOI 10.1002/etc.1795; Vinson MR, 2010, FISHERIES, V35, P61, DOI 10.1577/1548-8446-35.2.61	51	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163231	10.1371/journal.pone.0163231	http://dx.doi.org/10.1371/journal.pone.0163231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655396	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700046
J	Forst, J; Brown, TA				Forst, Jannine; Brown, Terence A.			Inability of 'Whole Genome Amplification' to Improve Success Rates for the Biomolecular Detection of Tuberculosis in Archaeological Samples	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DNA; COMPLEX; IDENTIFICATION; HUMANS; BOVIS; GENOTYPE; SEQUENCE; MICROTI; ELEMENT	We assessed the ability of whole genome amplification (WGA) to improve the efficiency of downstream polymerase chain reactions (PCRs) directed at ancient DNA (aDNA) of members of the Mycobacterium tuberculosis complex (MTBC). Using extracts from a variety of bones and a tooth from human skeletons with or without lesions indicative of tuberculosis, from multiple time periods, we obtained inconsistent results. We conclude that WGA does not provide any advantage in studies of MTBC aDNA. The sporadic nature of our results are probably due to the fact that WGA is itself a PCR-based procedure which, although designed to deal with fragmented DNA, might be inefficient with the low concentration of templates in an aDNA extract. As such, WGA is subject to similar, if not the same, restrictions as PCR when applied to aDNA.	[Forst, Jannine; Brown, Terence A.] Univ Manchester, Manchester Inst Biotechnol, Sch Earth & Environm Sci, Manchester, Lancs, England	University of Manchester	Brown, TA (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Earth & Environm Sci, Manchester, Lancs, England.	terry.brown@manchester.ac.uk		Forst, Jannine/0000-0002-3309-3165	University of Manchester	University of Manchester	This work was funded by the postgraduate tuition fees paid by the first author, and by a postgraduate bursary from University of Manchester.; We thank Darlene Weston (University of British Columbia) for collection of samples and the following people and institutions for allowing access to their material: Gloucester County Archaeology Service (Ashchurch Bridge); Division of Archaeological and Environmental Sciences, University of Bradford (St Peter's Collegiate Church, Wolverhampton); Cambridgeshire Archaeology and Norfolk Museums and Archaeology Service (Whitefriars, Norwich), Department of Anthropology, University of Coimbra (Pinhel), and Jaime Jennings who sampled the Auldhame skeleton that was excavated by AOC Archaeology on behalf of Historic Scotland. We also thank Romy Muller (University of Manchester) and Charlotte Roberts (University of Durham) for helpful discussions, and Anne Stone (Arizona State University) and Alicia Wilbur (Signal Bay Research Inc.) for design of the IS6110 and IS1081 qPCRs. This work was funded by the first author and in part by the University of Manchester.	Adams J, 2007, SUBSERIES BIRMINGHAM, V3; Adams J, 2007, BAR BRIT ARCHAEOLOGI; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Bouwman AS, 2012, P NATL ACAD SCI USA, V109, P18511, DOI 10.1073/pnas.1209444109; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; Brown T, 2011, P 2011 PART ACC C; Caffell A, 2007, 0806 YORK OST LTD; Clarkson L., 1975, DEATH DIS FAMINE PRE; COLLINS DM, 1991, FEMS MICROBIOL LETT, V83, P11; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dubos R, 1952, WHITE PLAGUE TUBERCU; EVANS CC, 1998, CLIN TUBERCULOSIS, P1; FRACASTORO G, 1930, HIERONYMI FRACASTORI; Frota CC, 2004, MICROBIOL-SGM, V150, P1519, DOI 10.1099/mic.0.26660-0; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Giles RJ, 2008, J ARCHAEOL SCI, V35, P2585, DOI 10.1016/j.jas.2008.04.011; Gutierrez M, 1997, J CLIN MICROBIOL, V35, P3328; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kiers A, 2008, INT J TUBERC LUNG D, V12, P1469; Lamb AL, 2012, J ANAL ATOM SPECTROM, V27, P765, DOI 10.1039/c2ja10363j; Muller R, 2014, AM J PHYS ANTHROPOL, V153, P178, DOI 10.1002/ajpa.22417; MULLER Romy, 2015, SCI TECHNOL ARCHAEOL, V1, P1; Nichols PW, 2008, ARCHAEOLOGICAL EXCAV; Roberts C., 2003, HLTH DIS BRITAIN PRE; Smith T, 1898, J Exp Med, V3, P451, DOI 10.1084/jem.3.4-5.451; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088356; Suzuki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012422; Taylor GM, 1996, J ARCHAEOL SCI, V23, P789; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188; Uda A, 2007, JPN J INFECT DIS, V60, P355; van Soolingen D, 1998, J CLIN MICROBIOL, V36, P1840, DOI 10.1128/JCM.36.7.1840-1845.1998; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; Veyrier FJ, 2011, TRENDS MICROBIOL, V19, P156, DOI 10.1016/j.tim.2010.12.008; Wilbur AK, 2009, J ARCHAEOL SCI, V36, P1990, DOI 10.1016/j.jas.2009.05.020; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	39	2	2	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163031	10.1371/journal.pone.0163031	http://dx.doi.org/10.1371/journal.pone.0163031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654468	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700033
J	Chen, YY; Hu, HY; Chu, DC; Chen, HH; Chang, CK; Chou, P				Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chang, Chin-Kuo; Chou, Pesus			Patients with Primary Open-Angle Glaucoma May Develop Ischemic Heart Disease More Often than Those without Glaucoma: An 11-Year Population-Based Cohort Study	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; SILENT-MYOCARDIAL-ISCHEMIA; RISK-FACTORS; PRESSURE; PREVALENCE; EYE; METAANALYSIS; NUTRITION; ALCOHOL; SMOKING	Objectives To investigate whether patients with primary open angle glaucoma (POAG) have a higher proportion of ischemic heart disease (IHD) development. Design A population-based retrospective cohort study, using the National Health Insurance Database (NHID) from 1st January, 2001, to 31st December, 2011, in Taiwan. Methods 3510 subjects with POAG were enrolled into the POAG group and 14040 subjects without glaucoma into the comparison group. The comparison group consisted of randomly selected individuals, matched with the POAG group based on age, gender, and index date (date of enrollment) at a ratio of 1:4. The participants of both groups should have no IHD before the index date, and they were followed until the end of 2011 to see whether they had new-onset IHD or not. Kaplan-Meier curves were used to compare the cumulative incidence of IHD between the two groups. Frailty model, a specialized form of Cox regression analysis, was used to estimate the crude and adjusted hazard ratio (HR) of IHD. Analyses were adjusted by age, gender, and systemic comorbidities (i.e. diabetes, hypertension, hyperlipidemia, atrial fibrillation and congestive heart failure). Results The mean age of the cohort was 57.6 +/- 11.0 years. There were slightly more males than females (51.6% vs. 48.4%). A log-rank test comparing Kaplan-Meier curves of the two groups revealed a significantly higher cumulative incidence of IHD in the POAG group (p-value<0.001). In the univariate analysis by Frailty model, POAG patients had a significantly higher hazard of IHD (unadjusted HR = 2.32; 95% confidence interval 1.93 to 2.79). After adjustment, results remained significant (adjusted HR = 1.41; 95% confidence interval 1.16 to 1.72). Conclusion People with POAG may suffer from IHD more often than those without glaucoma.	[Chen, Yu-Yen; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yu-Yen] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Taipei, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chang, Chin-Kuo] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England	National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; University of London; King's College London	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chang, CK (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.	chin-kuo.chang@kcl.ac.uk; pschou@ym.edu.tw	Chang, Chin-Kuo/E-4991-2010	Chang, Chin-Kuo/0000-0002-8338-7196				American Academy of Ophthalmology Glaucoma Panel, 2010, PREF PRACT PATT GUID; Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Balaratnasingam C, 2011, BRAIN RES, V1417, P67, DOI 10.1016/j.brainres.2011.08.022; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bonow RO, 2012, BRAUNWALDS HEART DIS; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cioffi GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1517, DOI 10.1001/archopht.122.10.1517; Cioffi George A, 2005, Trans Am Ophthalmol Soc, V103, P592; Emre M, 2005, BRIT J OPHTHALMOL, V89, P60, DOI 10.1136/bjo.2004.046755; Emre M, 2004, BRIT J OPHTHALMOL, V88, P662, DOI 10.1136/bjo.2003.032110; Flammer J, 2001, PROG RETIN EYE RES, V20, P319, DOI 10.1016/S1350-9462(00)00028-8; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Flammer J, 2013, EUR HEART J, V34, P1270, DOI 10.1093/eurheartj/eht023; French DD, 2011, J GLAUCOMA, V20, P452, DOI 10.1097/IJG.0b013e3181f7b134; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Galassi F, 1998, INT OPHTHALMOL, V22, P299, DOI 10.1023/A:1006347509491; Gasser P, 1999, J GLAUCOMA, V8, P8; Gherghel D, 2004, INVEST OPHTH VIS SCI, V45, P3546, DOI 10.1167/iovs.04-0290; Gherghel D, 2004, SURV OPHTHALMOL, V49, P491, DOI 10.1016/j.survophthal.2004.06.003; Gherghel D, 2007, OPHTHAL PHYSL OPT, V27, P336, DOI 10.1111/j.1475-1313.2007.00485.x; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Hougaard P, 1995, Lifetime Data Anal, V1, P255; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; Kang JH, 2003, ARCH OPHTHALMOL-CHIC, V121, P1762, DOI 10.1001/archopht.121.12.1762; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; KLEIN BEK, 1993, OPHTHALMOLOGY, V100, P1609; Kleinblaum D, 1982, EPIDEMIOLOGIC RES; Kolettis TM, 2013, CARDIOL REV, V21, P249, DOI 10.1097/CRD.0b013e318283f65a; Konieczka K, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-11; Lagrange F, 1922, GLAUCOME LHYPOTONIE; Lanza G A, 1999, Cardiologia, V44, P913; Lanza GA, 1996, J AM COLL CARDIOL, V28, P1249, DOI 10.1016/S0735-1097(96)00309-9; Leske M C, 1996, Ophthalmic Epidemiol, V3, P85, DOI 10.3109/09286589609080113; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Lin HC, 2010, OPHTHALMOLOGY, V117, P2088, DOI 10.1016/j.ophtha.2010.03.003; Liu Xu-yang, 2010, Zhonghua Yan Ke Za Zhi, V46, P1062; Longo DL, 2012, HARRISONS PRINCIPLES; McMonnies CW, 2016, J OPTOM IN PRESS; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Pache M, 2006, SURV OPHTHALMOL, V51, P179, DOI 10.1016/j.survophthal.2006.02.008; Pasquale LR, 2009, J GLAUCOMA, V18, P423, DOI 10.1097/IJG.0b013e31818d3899; PERASALO R, 1992, GRAEF ARCH CLIN EXP, V230, P213, DOI 10.1007/BF00176290; PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8; Qiu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133189; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Ronkko S, 2007, MOL VIS, V13, P408; Sihota R, 2006, OPTOMETRY VISION SCI, V83, P520, DOI 10.1097/01.opx.0000225910.51370.02; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; The Taiwan National Health Research Institutes, NAT HLTH INS RES DAT; Waldmann E, 1996, GRAEF ARCH CLIN EXP, V234, P595, DOI 10.1007/BF00185290; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P3399, DOI 10.1167/iovs.09-4867; Zhou MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102972	62	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163210	10.1371/journal.pone.0163210	http://dx.doi.org/10.1371/journal.pone.0163210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649414	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100066
J	Chutiwitoonchai, N; Siarot, L; Takeda, E; Shioda, T; Ueda, M; Aida, Y				Chutiwitoonchai, Nopporn; Siarot, Lowela; Takeda, Eri; Shioda, Tatsuo; Ueda, Motoki; Aida, Yoko			HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; PROTEIN-DEGRADATION; ESCRT MACHINERY; TYPE-1 VPR; ARREST; DOMAIN; TRAFFICKING; INTERACTS; COMPLEX; P6	HIV-1 budding requires interaction between Gag and cellular TSG101 to initiate viral particle assembly and release via the endosomal sorting complexes required for transport (ESCRT) pathway. However, some reports show that overexpression of TSG101 inhibits virus release by disruption of Gag targeting process. Since a HIV-1 accessory protein, Vpr binds to Gag p6 domain at the position close to the binding site for TSG101, whether Vpr implicates TSG101 overexpression effect has not been investigated. Here, we found that Vpr abrogates TSG101 overexpression effect to rescue viral production. Co-transfection of TSG101 and Gag with Vpr prevented TSG101-induced Gag accumulation in endosomes and lysosomes. In addition, Vpr rescued virus-like particle (VLP) production in a similar manner as a lysosomal inhibitor, Bafilomycin A1 indicating that Vpr inhibits TSG101-induced Gag downregulation via lysosomal pathway. Vpr and Gag interaction is required to counteract TSG101 overexpression effect since Vpr A30F mutant which is unable to interact with Gag and incorporate into virions, reduced ability to prevent Gag accumulation and to rescue VLP production. In addition, GST pull-down assays and Biacore analysis revealed that Vpr competed with TSG101 for Gag binding. These results indicate that Vpr overcomes the effects of TSG101 overexpression to support viral production by competing with TSG101 to bind Gag.	[Chutiwitoonchai, Nopporn; Siarot, Lowela; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Chutiwitoonchai, Nopporn] Japan Fdn AIDS Prevent, Chiyoda Ku, Tokyo, Japan; [Siarot, Lowela] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Takeda, Eri; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka, Japan; [Ueda, Motoki] RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan	RIKEN; University of Tokyo; Osaka University; RIKEN	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp	ueda, motoki/I-3686-2019; Ueda, Motoki/Y-8976-2018	ueda, motoki/0000-0002-1675-809X; Ueda, Motoki/0000-0002-1675-809X	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) [10103951, 13801920, 15fk0410010h0002]; Grants-in-Aid for Scientific Research [15F15416, 16H05194] Funding Source: KAKEN	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS), http://www.mhlw.go.jp/index.shtml. Grant numbers: 10103951, 13801920, 15fk0410010h0002. Recipient: YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kenzo Tokunaga for providing pNL43 Luc E-R<SUP>+</SUP> (Vpr<SUP>+</SUP>) and pNL43 Luc E-R (Vpr<SUP>-</SUP>), Dr. Akio Adashi for providing pNF462, Dr. Atsushi Miyawaki for providing pCS2/Venus and pCS2/eCFP, Dr. Hirotaka Sato for constructing pCAGGS/Venus and pCAGGS/eCFP, and Dr. Ken Kono for constructing pcDNA/YFP-Vpr. We are grateful to the RIKEN BSI Research Resources Center for help with DNA sequencing analysis. This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS).	Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Bouamr F, 2007, J VIROL, V81, P2909, DOI 10.1128/JVI.01413-06; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; Chutiwitoonchai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105081; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Im YJ, 2010, STRUCTURE, V18, P1536, DOI 10.1016/j.str.2010.08.010; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Kono K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072531; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Qian J, 2014, EXP THER MED, V8, P1375, DOI 10.3892/etm.2014.1928; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Salgado GF, 2009, BIOCHEMISTRY-US, V48, P2355, DOI 10.1021/bi801794v; Sawaya BE, 1999, GENE THER, V6, P947, DOI 10.1038/sj.gt.3300907; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Valiathan RR, 2004, J VIROL, V78, P12386, DOI 10.1128/JVI.78.22.12386-12394.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhu Henghu, 2004, Retrovirology, V1, P26, DOI 10.1186/1742-4690-1-26	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163100	10.1371/journal.pone.0163100	http://dx.doi.org/10.1371/journal.pone.0163100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648839	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100053
J	Conlisk, E; Swab, R; Martinez-Berdeja, A; Daugherty, MP				Conlisk, Erin; Swab, Rebecca; Martinez-Berdeja, Alejandra; Daugherty, Matthew P.			Post-Fire Recovery in Coastal Sage Scrub: Seed Rain and Community Trajectory	PLOS ONE			English	Article							EXOTIC ANNUAL BROMUS; SOUTHERN CALIFORNIA; FIRE; INVASION; RESTORATION; DISTURBANCE; ECOREGIONS; ABUNDANCE	Disturbance is a primary mechanism structuring ecological communities. However, human activity has the potential to alter the frequency and intensity of natural disturbance regimes, with subsequent effects on ecosystem processes. In Southern California, human development has led to increased fire frequency close to urban areas that can forma positive feedback with invasive plant spread. Understanding how abiotic and biotic factors structure post-fire plant communities is a critical component of post-fire management and restoration. In this study we considered a variety of mechanisms affecting post-fire vegetation recovery in Riversidean sage scrub. Comparing recently burned plots to unburned plots, we found that burning significantly reduced species richness and percent cover of exotic vegetation the first two years following a 100-hectare wildfire. Seed rain was higher in burned plots, with more native forb seeds, while unburned plots had more exotic grass seeds. Moreover, there were significant correlations between seed rain composition and plant cover composition the year prior and the year after. Collectively, this case study suggests that fire can alter community composition, but there was not compelling evidence of a vegetation-type conversion. Instead, the changes in the community composition were temporary and convergence in community composition was apparent within two years post-fire.	[Conlisk, Erin] San Diego State Univ, 5500 Campanile Dr, San Diego, CA 92182 USA; [Swab, Rebecca] The Wilds, 14000 Int Dr, Cumberland, OH 43732 USA; [Martinez-Berdeja, Alejandra] Univ Calif Davis, Dept Ecol & Evolut, One Shields Ave, Davis, CA 95616 USA; [Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, 900 Univ Ave, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Davis; University of California System; University of California Riverside	Conlisk, E (corresponding author), San Diego State Univ, 5500 Campanile Dr, San Diego, CA 92182 USA.	erin.conlisk@gmail.com			Riverside County Habitat Conservation Agency [005973002]	Riverside County Habitat Conservation Agency	This work was supported by Riverside County Habitat Conservation Agency (grant # 005973002).; The authors would like to acknowledge the Riverside County Habitat Conservation Agency for funding (grant 005973002). Tremendous thanks to A. Sanders at the UCR Herbarium and L. Lippit for plant and seed identification. Thanks also to D. Lee. Finally, thanks to K. Halama for logistical support at the Motte Rimrock Reserve; H. Regan, D. Jenerrette, and K. Anderson for the use of their labs, and A. Ayyaz, J. Gotoc, V. Duong, E. Roman, N. Freeman, N. Warounthorn, and J. Chen for help in the field and in the lab.	Allen EB., 2000, 2 INTERFACE ECOLOGY, P253; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auld TD, 2001, BIOL CONSERV, V97, P377, DOI 10.1016/S0006-3207(00)00136-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brooks ML, 2016, SPRINGER SER ENV MAN, P11, DOI 10.1007/978-3-319-24930-8_2; Brooks ML, 2011, RANGELAND ECOL MANAG, V64, P431, DOI 10.2111/REM-D-09-00165.1; Cox RD, 2008, J APPL ECOL, V45, P495, DOI 10.1111/j.1365-2664.2007.01437.x; De Mendiburu F, 2009, THESIS; DeSimone SA, 1999, ECOLOGY, V80, P2018, DOI 10.1890/0012-9658(1999)080[2018:SSRIUC]2.0.CO;2; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Egerton-Warburton LM, 1998, J EXP BOT, V49, P1317, DOI 10.1093/jexbot/49.325.1317; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Fleming GM, 2009, ECOL APPL, V19, P2210, DOI 10.1890/07-1959.1; Fox J., 2018, R COMPANION APPL REG, VThird; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Keeley JE, 2006, ECOL MONOGR, V76, P235, DOI 10.1890/0012-9615(2006)076[0235:DPOPRI]2.0.CO;2; Keeley JE, 2003, DIVERS DISTRIB, V9, P253, DOI 10.1046/j.1472-4642.2003.00017.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2012, OECOLOGIA, V169, P1043, DOI 10.1007/s00442-012-2253-8; Keeley JE, 2011, ECOL STUD-ANAL SYNTH, V213, P193, DOI 10.1007/978-94-007-0301-8_8; Krawchuck MA, 2012, CALIFORNIA ENERGY CO, VCEC-500-2012-026; Lambert AM., 2010, FREMONTIA, V38, P29; Link SO, 2006, INT J WILDLAND FIRE, V15, P113, DOI 10.1071/WF05001; MORGAN KR, 1992, ECOLOGY, V73, P2260, DOI 10.2307/1941473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; O'FARRELL M J, 1987, Wasmann Journal of Biology, V45, P34; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pinheiro J, 2020, R PACKAGE VERSION 31; Price MV, 1995, BRUSHFIRES CALIFORNI, P51; Pyke DA, 2016, SPRINGER SER ENV MAN, P307, DOI 10.1007/978-3-319-24930-8_11; R Core Team, 2021, R LANGUAGE ENV STAT; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Sandel B, 2012, GLOBAL CHANGE BIOL, V18, P277, DOI 10.1111/j.1365-2486.2011.02480.x; Schwede DB, 2014, ATMOS ENVIRON, V92, P207, DOI 10.1016/j.atmosenv.2014.04.008; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; Wainwright CE, 2012, J APPL ECOL, V49, P234, DOI 10.1111/j.1365-2664.2011.02088.x; Yelenik SG, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2009.00598.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	44	4	4	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162777	10.1371/journal.pone.0162777	http://dx.doi.org/10.1371/journal.pone.0162777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649564	Green Published, gold			2022-12-27	WOS:000383892100033
J	Kim, D; Kupfer, JA				Kim, Daehyun; Kupfer, John A.			Tri-Variate Relationships among Vegetation, Soil, and Topography along Gradients of Fluvial Biogeomorphic Succession	PLOS ONE			English	Article							MOUNT ST-HELENS; SPECIES DISTRIBUTION; RIPARIAN VEGETATION; POPULUS-NIGRA; RIVER; EVOLUTION; CHANNEL; DISTURBANCE; TEMPERATE; PATHWAYS	This research investigated how the strength of vegetation-soil-topography couplings varied along a gradient of biogeomorphic succession in two distinct fluvial systems: a forested river floodplain and a coastal salt marsh creek. The strength of couplings was quantified as tri-variance, which was calculated by correlating three singular axes, one each extracted using three-block partial least squares from vegetation, soil, and topography data blocks. Within each system, tri-variance was examined at low-, mid-, and high-elevation sites, which represented early-, intermediate-, and late-successional phases, respectively, and corresponded to differences in ongoing disturbance frequency and intensity. Both systems exhibited clearly increasing tri-variance from the early- to late-successional stages. The lowest-lying sites underwent frequent and intense hydrogeomorphic forcings that dynamically reworked soil substrates, restructured surface landforms, and controlled the colonization of plant species. Such conditions led vegetation, soil, and topography to show discrete, stochastic, and individualistic behaviors over space and time, resulting in a loose coupling among the three ecosystem components. In the highest-elevation sites, in contrast, disturbances that might disrupt the existing biotic-abiotic relationships were less common. Hence, ecological succession, soil-forming processes, and landform evolution occurred in tight conjunction with one another over a prolonged period, thereby strengthening couplings among them; namely, the three behaved in unity over space and time. We propose that the recurrence interval of physical disturbance is important to-and potentially serves as an indicator of-the intensity and mechanisms of vegetation-soil-topography feedbacks in fluvial biogeomorphic systems.	[Kim, Daehyun] Univ Kentucky, Dept Geog, Biogeomorphol Res & Anal Grp, Lexington, KY 40506 USA; [Kupfer, John A.] Univ South Carolina, Dept Geog, Columbia, SC 29208 USA	University of Kentucky; University of South Carolina System; University of South Carolina Columbia	Kim, D (corresponding author), Univ Kentucky, Dept Geog, Biogeomorphol Res & Anal Grp, Lexington, KY 40506 USA.	biogeokim@uky.edu			National Science Foundation [BCS-0825753]; U.S. Department of the Interior National Park Service	National Science Foundation(National Science Foundation (NSF)); U.S. Department of the Interior National Park Service	This research was supported by the National Science Foundation (BCS-0825753) and the U.S. Department of the Interior National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, PARTIAL LEAST SQUARE; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Batz N, 2015, CATENA, V126, P86, DOI 10.1016/j.catena.2014.10.013; BAKER WL, 1995, ANN ASSOC AM GEOGR, V85, P320, DOI 10.1111/j.1467-8306.1995.tb01797.x; Balke T, 2014, J ECOL, V102, P700, DOI 10.1111/1365-2745.12241; Baptist M.J, 2005, MODELLING FLOODPLAIN; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Bartholdy AT, 2010, MAR GEOL, V278, P31, DOI 10.1016/j.margeo.2010.09.001; Bartholdy J, 2004, MAR GEOL, V203, P1, DOI 10.1016/S0025-3227(03)00337-2; Bartholdy J., 1997, GEOGR TIDSSKR-DEN, V97, P11, DOI 10.1080/00167223.1997.10649389; Bartholdy J, 2007, SEDIMENT GEOL, V202, P436, DOI 10.1016/j.sedgeo.2007.03.008; Bendix J, 2000, HYDROL PROCESS, V14, P2977, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2977::AID-HYP130&gt;3.0.CO;2-4; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Brookes CJ, 2000, CATENA, V40, P93, DOI 10.1016/S0341-8162(99)00065-X; Brooks AP, 2003, GEOMORPHOLOGY, V51, P7, DOI 10.1016/S0169-555X(02)00323-9; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Cooper DJ, 2003, J ECOL, V91, P182, DOI 10.1046/j.1365-2745.2003.00766.x; Corenblit D, 2007, EARTH-SCI REV, V84, P56, DOI 10.1016/j.earscirev.2007.05.004; Corenblit D, 2015, GLOBAL ECOL BIOGEOGR, V24, P1363, DOI 10.1111/geb.12373; Corenblit D, 2010, ECOGRAPHY, V33, P1136, DOI 10.1111/j.1600-0587.2010.05894.x; Corenblit D, 2009, EARTH SURF PROC LAND, V34, P1790, DOI 10.1002/esp.1876; Crain CM, 2006, BIOSCIENCE, V56, P211; Davies NS, 2013, EARTH-SCI REV, V120, P40, DOI 10.1016/j.earscirev.2013.02.004; DELMORAL R, 1995, J VEG SCI, V6, P107, DOI 10.2307/3236262; Eichel J, 2013, GEOMORPHOLOGY, V201, P98, DOI 10.1016/j.geomorph.2013.06.012; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Francis RA, 2009, AQUAT SCI, V71, P290, DOI 10.1007/s00027-009-9182-6; Franklin J, 2009, MAPPING SPECIES DIST; Geerling GW, 2006, HYDROBIOLOGIA, V565, P71, DOI 10.1007/s10750-005-1906-6; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurnell AM, 2016, AQUAT SCI, V78, P135, DOI 10.1007/s00027-015-0436-1; Gurnell AM, 2002, FRESHWATER BIOL, V47, P581, DOI 10.1046/j.1365-2427.2002.00923.x; Gurnell A, 2014, EARTH SURF PROC LAND, V39, P4, DOI 10.1002/esp.3397; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; HALPERN CB, 1990, J VEG SCI, V1, P181, DOI 10.2307/3235657; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jones CG, 2012, GEOMORPHOLOGY, V157, P75, DOI 10.1016/j.geomorph.2011.04.039; Kim D, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-0074.1; Kim D, 2014, ECOL RES, V29, P661, DOI 10.1007/s11284-014-1157-y; Kim D, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00028.1; Kim D, 2012, ANN ASSOC AM GEOGR, V102, P276, DOI 10.1080/00045608.2011.620520; Kim D, 2010, PHYS GEOGR, V31, P58, DOI 10.2747/0272-3646.31.1.58; Kupfer JA, 1996, J VEG SCI, V7, P247, DOI 10.2307/3236325; Kupfer JA, 2010, FOREST ECOL MANAG, V259, P1880, DOI 10.1016/j.foreco.2010.01.050; Larsen LG, 2010, AM NAT, V176, pE66, DOI 10.1086/655215; Malanson G.P., 1993, RIPARIAN LANDSCAPES; Marani M, 2013, P NATL ACAD SCI USA, V110, P3259, DOI 10.1073/pnas.1218327110; Matthews B, 2014, ECOL MONOGR, V84, P245, DOI 10.1890/13-0953.1; McCune B, 1997, ECOLOGY, V78, P2617; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; Naylor LA, 2012, GEOMORPHOLOGY, V157, P17, DOI 10.1016/j.geomorph.2011.07.015; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Phillips JD, 2016, EARTH SURF PROC LAND, V41, P16, DOI 10.1002/esp.3764; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIELOU E. C., 1984, INTERPRETATION ECOLO; Pollock MM, 1998, ECOLOGY, V79, P94; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rood SB, 2000, TREES-STRUCT FUNCT, V14, P248, DOI 10.1007/s004680050010; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Shipley B., 2000, CAUSE CORRELATIONS B; SRIVASTAVA DS, 1995, J ECOL, V83, P421, DOI 10.2307/2261595; Stallins JA, 2006, GEOMORPHOLOGY, V77, P207, DOI 10.1016/j.geomorph.2006.01.005; Steiger J, 2005, RIVER RES APPL, V21, P719, DOI 10.1002/rra.879; Tabacchi E, 2005, RIVER RES APPL, V21, P299, DOI 10.1002/rra.848; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; *USDA NRCS, 2008, WEB SOIL SURV; Van Dyke C, 2015, PROG PHYS GEOG, V39, P594, DOI 10.1177/0309133315581700; Viles HA, 2008, EARTH SURF PROC LAND, V33, P1419, DOI 10.1002/esp.1717; Wang, 2010, HDB PARTIAL LEAST SQ, P47, DOI [10.1007/978-3-540-32827-8_3, DOI 10.1007/978-3-540-32827-8]; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Wolner CWV, 2013, GEOMORPHOLOGY, V199, P115, DOI 10.1016/j.geomorph.2013.03.035; Wright JT, 2012, ECOLOGY, V93, P1262, DOI 10.1890/11-1740.1	83	8	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163223	10.1371/journal.pone.0163223	http://dx.doi.org/10.1371/journal.pone.0163223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649497	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100067
J	Wang, MJ; Tang, WB; Xin, H; Zhu, YZ				Wang, Minjun; Tang, Wenbo; Xin, Hong; Zhu, Yi Zhun			S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; MORTALITY; STAT3; ERYTHROPOIESIS; ACTIVATION; MANAGEMENT; CAPACITY; MEDIATOR; HYPOXIA; DISEASE	Anemia of inflammation (AI) is clinically prevalent and greatly threatens public health. Traditional remedies have raised controversy during clinical practice, calling for alternative therapies. We have recently found that hydrogen sulfide (H2S) inhibits inflammatory hepcidin, the critical mediator of AI. However, due to the chemical property of H2S, there remains an urgent need for a stable H2S donor in AI treatment. Here we reported that S-propargyl-cysteine (SPRC), a novel water-soluble H2S donor, suppressed hepatic hepcidin and corrected hypoferremia induced by lipopolysaccharide. The effects of SPRC were reversed by inhibition of cystathionine gamma-lyase, one of the major endogenous H2S synthases. Moreover, SPRC reduced serum hepcidin, improved transferrin saturation, and maintained erythrocyte membrane integrity in a chronic mouse AI model. Consistently, splenomegaly was ameliorated and splenic iron accumulation relieved. Mechanism study indicated that serum IL-6 content and hepatic Il-6 mRNA were decreased by SPRC, in parallel with reduced hepatic JAK2/STAT3 activation. On the whole, our data reveal the inhibition of inflammatory hepcidin by SPRC, and suggest SPRC as a potential remedy against AI.	[Wang, Minjun; Xin, Hong; Zhu, Yi Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, Shanghai 201203, Peoples R China; [Tang, Wenbo] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Wang, Minjun; Zhu, Yi Zhun] Macau Univ Sci & Technol, Dept Pharmacol, Sch Pharm, Macau, Peoples R China	Fudan University; Fudan University; Macau University of Science & Technology	Zhu, YZ (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, Shanghai 201203, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Dept Pharmacol, Sch Pharm, Macau, Peoples R China.	zhuyz@fudan.edu.cn	Xin, Hong/AAF-5786-2020; Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China [81330080, 81573421]; Shanghai Committee of Science and Technology of China [14JC1401100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China	This work was supported by grants from National Natural Science Foundation of China (No. 81330080; 81573421) and Shanghai Committee of Science and Technology of China (No. 14JC1401100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gasche C, 2007, INFLAMM BOWEL DIS, V13, P1545, DOI 10.1002/ibd.20285; Gong QH, 2011, BRAIN BEHAV IMMUN, V25, P110, DOI 10.1016/j.bbi.2010.09.001; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Kan JT, 2014, ANTIOXID REDOX SIGN, V20, P2303, DOI 10.1089/ars.2013.5449; Langdon JM, 2014, AM J HEMATOL, V89, P470, DOI 10.1002/ajh.23670; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Miao L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22363; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Painter P, 2002, AM J KIDNEY DIS, V39, P257, DOI 10.1053/ajkd.2002.30544; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Roviezzo F, 2015, PHARMACOL RES, V100, P85, DOI 10.1016/j.phrs.2015.07.032; Sakamori R, 2010, J GASTROENTEROL, V45, P244, DOI 10.1007/s00535-009-0159-y; Shen YQ, 2015, ANTIOXID REDOX SIGN, V22, P224, DOI 10.1089/ars.2014.5909; Sidhapuriwala JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032574; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Teehan GS, 2004, CLIN INFECT DIS, V38, P1090, DOI 10.1086/382878; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Tonelli Marcello, 2009, CMAJ, V180, pE62, DOI 10.1503/cmaj.090470; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Xin H, 2016, ANTIOXID REDOX SIGN, V24, P70, DOI 10.1089/ars.2015.6315; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang Q, 2014, PHARMACOL RES, V84, P32, DOI 10.1016/j.phrs.2014.04.009; Zheng YT, 2012, XENOBIOTICA, V42, P304, DOI 10.3109/00498254.2011.617848; Zheng YT, 2011, J PHARMACEUT BIOMED, V54, P1187, DOI 10.1016/j.jpba.2010.11.027	46	22	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163289	10.1371/journal.pone.0163289	http://dx.doi.org/10.1371/journal.pone.0163289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649298	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100074
J	Duann, JR; Chiou, JC				Duann, Jeng-Ren; Chiou, Jin-Chern			A Comparison of Independent Event-Related Desynchronization Responses in Motor-Related Brain Areas to Movement Execution, Movement Imagery, and Movement Observation	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; COMPONENT ANALYSIS; MENTAL PRACTICE; MIRROR NEURONS; HUMANS; DYNAMICS; STROKE; REHABILITATION; RHYTHMS; SYSTEM	Electroencephalographic (EEG) event-related desynchronization (ERD) induced by movement imagery or by observing biological movements performed by someone else has recently been used extensively for brain-computer interface-based applications, such as applications used in stroke rehabilitation training and motor skill learning. However, the ERD responses induced by the movement imagery and observation might not be as reliable as the ERD responses induced by movement execution. Given that studies on the reliability of the EEG ERD responses induced by these activities are still lacking, here we conducted an EEG experiment with movement imagery, movement observation, and movement execution, performed multiple times each in a pseudorandomized order in the same experimental runs. Then, independent component analysis (ICA) was applied to the EEG data to find the common motor-related EEG source activity shared by the three motor tasks. Finally, conditional EEG ERD responses associated with the three movement conditions were computed and compared. Among the three motor conditions, the EEG ERD responses induced by motor execution revealed the alpha power suppression with highest strengths and longest durations. The ERD responses of the movement imagery and movement observation only partially resembled the ERD pattern of the movement execution condition, with slightly better detectability for the ERD responses associated with the movement imagery and faster ERD responses for movement observation. This may indicate different levels of involvement in the same motor-related brain circuits during different movement conditions. In addition, because the resulting conditional EEG ERD responses from the ICA preprocessing came with minimal contamination from the non-related and/or artifactual noisy components, this result can play a role of the reference for devising a brain-computer interface using the EEG ERD features of movement imagery or observation.	[Duann, Jeng-Ren] Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taoyuan Distric, Taiwan; [Duann, Jeng-Ren] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Chiou, Jin-Chern] Natl Chiao Tung Univ, Dept Elect Engn, Hsinchu, Taiwan	National Central University; University of California System; University of California San Diego; National Yang Ming Chiao Tung University	Duann, JR (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taoyuan Distric, Taiwan.; Duann, JR (corresponding author), Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA.	duann@sccn.ucsd.edu			National Chiao Tung University; Ministry of Education, Taiwan [MOE-100W960]; Ministry of Science and Technology, Taiwan [MOST-103-2221-E-039-007-MY3, MOST-104-2220-E-039-001]; National Chiao Tung University and the Ministry of Education, Taiwan [MOE-100W960]	National Chiao Tung University; Ministry of Education, Taiwan(Ministry of Education, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Chiao Tung University and the Ministry of Education, Taiwan	This work was supported in part by the "Aim for the Top University Plan" sponsored by National Chiao Tung University and the Ministry of Education, Taiwan (grant number MOE-100W960) and the Ministry of Science and Technology, Taiwan (grant numbers MOST-103-2221-E-039-007-MY3 and MOST-104-2220-E-039-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the "Aim for the Top University Plan" sponsored by National Chiao Tung University and the Ministry of Education, Taiwan (grant number MOE-100W960) and the Ministry of Science and Technology, Taiwan (grant numbers MOST-103-2221-E-039-007-MY3 and MOST-104-2220-E-039-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Babiloni C, 2016, CLIN NEUROPHYSIOL, V127, P641, DOI 10.1016/j.clinph.2015.04.068; Boe S, 2014, NEUROIMAGE, V101, P159, DOI 10.1016/j.neuroimage.2014.06.066; Braun SM, 2006, ARCH PHYS MED REHAB, V87, P842, DOI 10.1016/j.apmr.2006.02.034; Chou WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129019; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jeannerod M, 2001, NEUROIMAGE, V82, P1533; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keysers C, 2010, CURR BIOL, V20, pR353, DOI 10.1016/j.cub.2010.03.013; Keysers C, 2009, CURR BIOL, V19, pR971, DOI 10.1016/j.cub.2009.08.026; Kubler A, 2013, RECENT PROGR FUTURE; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1996, ADV NEUR IN, V8, P145; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Pfsutscheller G, 2007, PRESENCE-TELEOP VIRT, V16, P111; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Rodriguez-Bermudez G, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500159; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Wang YQ, 2010, MAGN RESON IMAGING, V28, P653, DOI 10.1016/j.mri.2010.02.008; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028; Zich C, 2015, NEUROIMAGE, V114, P438, DOI 10.1016/j.neuroimage.2015.04.020	40	26	27	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162546	10.1371/journal.pone.0162546	http://dx.doi.org/10.1371/journal.pone.0162546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636359	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700008
J	Siddiqi, MH; Alam, MGR; Hong, CS; Khan, AM; Choo, H				Siddiqi, Muhammad Hameed; Alam, Md. Golam Rabiul; Hong, Choong Seon; Khan, Adil Mehmood; Choo, Hyunseung			A Novel Maximum Entropy Markov Model for Human Facial Expression Recognition	PLOS ONE			English	Article							EMOTION RECOGNITION	Research in video based FER systems has exploded in the past decade. However, most of the previous methods work well when they are trained and tested on the same dataset. Illumination settings, image resolution, camera angle, and physical characteristics of the people differ from one dataset to another. Considering a single dataset keeps the variance, which results from differences, to a minimum. Having a robust FER system, which can work across several datasets, is thus highly desirable. The aim of this work is to design, implement, and validate such a system using different datasets. In this regard, the major contribution is made at the recognition module which uses the maximum entropy Markov model (MEMM) for expression recognition. In this model, the states of the human expressions are modeled as the states of an MEMM, by considering the video-sensor observations as the observations of MEMM. A modified Viterbi is utilized to generate the most probable expression state sequence based on such observations. Lastly, an algorithm is designed which predicts the expression state from the generated state sequence. Performance is compared against several existing state-of-the-art FER systems on six publicly available datasets. A weighted average accuracy of 97% is achieved across all datasets.	[Siddiqi, Muhammad Hameed; Choo, Hyunseung] Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon, Gyeonggi Do, South Korea; [Alam, Md. Golam Rabiul; Hong, Choong Seon] Kyung Hee Univ, Dept Comp Engn, Suwon, South Korea; [Khan, Adil Mehmood] Innopolis Univ, Dept Comp Sci, Kazan, Russia	Sungkyunkwan University (SKKU); Kyung Hee University; Innopolis University	Choo, H (corresponding author), Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon, Gyeonggi Do, South Korea.	choo@skku.edu	Siddiqi, Muhammad Hameed/ADU-4375-2022; Khan, Adil/L-2210-2017; Hong, Choong Seon/ABF-5527-2020; ALAM, MD GOLAM RABIUL/L-4373-2013	Siddiqi, Muhammad Hameed/0000-0002-4370-8012; ALAM, MD GOLAM RABIUL/0000-0002-9054-7557; Hong, Choong Seon/0000-0003-3484-7333	MSIP, Korea [IITP-2015-R6812-15-0001]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2010-0020210]	MSIP, Korea; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the MSIP, Korea, under the G-ITRC support program (IITP-2015-R6812-15-0001) supervised by the IITP, and by the Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2010-0020210).	Abdat F, 2011, UKSIM EURO SYMP COMP, P196, DOI 10.1109/EMS.2011.20; Abdulrahman M, 2015, SIG PROCESS COMMUN, P276, DOI 10.1109/SIU.2015.7129813; Ahsan T, 2013, IETE TECH REV, V30, P47, DOI 10.4103/0256-4602.107339; Aifanti N, 2010, 11 INT WORKSH IM AN, P1; [Anonymous], 2005, LEARNING BAYESIAN NE; [Anonymous], 2012, REV DECISION TREE DI; [Anonymous], 2001, CONDITIONAL RANDOM F; Bettadapura V., 2012, FACE EXPRESSION RECO, P1; Cohen I, 2003, PROC CVPR IEEE, P595; Dhall A, 2012, COLLECTING LARGE RIC; Dornaika F, 2009, FACIAL EXPRESSION RE; Dubuisson S, 2002, SIGNAL PROCESS-IMAGE, V17, P657, DOI 10.1016/S0923-5965(02)00076-0; Fragopanagos N, 2005, NEURAL NETWORKS, V18, P389, DOI 10.1016/j.neunet.2005.03.006; Gargesha M., 2002, ARTIF NEURAL COMPUT, P1; Gunawardana A., 2005, INTERSPEECH, P1117; Jurafsky D., SPEECH LANGUAGE PROC; Kumar P, 2015, INT J RES, V2, P271; Lucey P., 2010, 2010 IEEE COMPUTER S, P94, DOI [10.1109/cvprw.2010.5543262, DOI 10.1109/CVPRW.2010.5543262, 10.1109/CVPRW.2010.5543262]; Lyons M, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P200, DOI 10.1109/AFGR.1998.670949; Metallinou A, 2008, IEEE INT SYM MULTIM, P250, DOI 10.1109/ISM.2008.40; Mitra S, 2012, GAUSSIAN MIXTURE MOD; Mohseni Sina, 2013, Proceedings of the 2013 55th International Symposium. ELMAR-2013, P361; Quattoni A, 2007, IEEE T PATTERN ANAL, V29, P1848, DOI 10.1109/TPAMI.2007.1124; Rivera AR, 2013, IEEE T IMAGE PROCESS, V22, P1740, DOI 10.1109/TIP.2012.2235848; Rouxin Sang, 2015, 2015 IEEE International Conferences on Computer and Information Technology; Ubiquitous Computing and Communications; Dependable, Autonomic and Secure Computing; and Pervasive Intelligence and Computing (CIT/IUCC/DASC/PICOM). Proceedings, P989, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.149; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Samarawickrame K, 2013, INT CONF ADV ICT, P51, DOI 10.1109/ICTer.2013.6761154; Setty S, 2013, NAT CONF COMPUT VIS; Shan C, 2006, BMVC, VI, P297; Siddiqi M.H., 2013, AMBIENT ASSISTED LIV, P112, DOI [10.1007/978-3-319-03092-0_17, DOI 10.1007/978-3-319-03092-0_17, DOI 10.1007/978-3-319-03092-0]; Siddiqi MH, 2016, MULTIMED TOOLS APPL, V75, P935, DOI 10.1007/s11042-014-2333-3; Siddiqi MH, 2015, MULTIMEDIA SYST, V21, P541, DOI 10.1007/s00530-014-0400-2; Siddiqi MH, 2015, IEEE T IMAGE PROCESS, V24, P1386, DOI 10.1109/TIP.2015.2405346; Siddiqi MH, 2014, IETE TECH REV, V31, P277, DOI 10.1080/02564602.2014.944588; Siddiqi MH, 2013, SENSORS-BASEL, V13, P16682, DOI 10.3390/s131216682; Sy BW, 2006, IEEE C COMP VIS PATT, P1521, DOI DOI 10.1109/CVPR.2006.132; Tariq U, 2013, FG, P1; Tian YL, 2005, HANDBOOK OF FACE RECOGNITION, P247, DOI 10.1007/0-387-27257-7_12; Uddin MZ, 2013, INT J INNOV COMPUT I, V9, P1409; Wang SF, 2010, IEEE T MULTIMEDIA, V12, P682, DOI 10.1109/TMM.2010.2060716; Widanagamaachchi WN, 2009, FACIAL EMOTION RECOG; Yoon H, 2009, WORLD ACAD SCI ENG T, V2009, P50	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162702	10.1371/journal.pone.0162702	http://dx.doi.org/10.1371/journal.pone.0162702			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635654	Green Submitted, gold, Green Published			2022-12-27	WOS:000383723700014
J	de Wit, NJW; Hulst, M; Govers, C; van der Meulen, J; van Hoef, A; Stoopen, G; Hamers, A; Hoekman, A; de Vos, R; Bovee, TFH; Smits, M; Mes, JJ; Hendriksen, PJM				de Wit, Nicole J. W.; Hulst, Marcel; Govers, Coen; van der Meulen, Jan; van Hoef, Angeline; Stoopen, Geert; Hamers, Astrid; Hoekman, Arjan; de Vos, Ric; Bovee, Toine F. H.; Smits, Mari; Mes, Jurriaan J.; Hendriksen, Peter J. M.			Effects of Digested Onion Extracts on Intestinal Gene Expression: An Interspecies Comparison Using Different Intestine Models	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; CELL-LINE; DIGESTIBILITY; HUMANS; NRF2; INFLAMMATION; RESISTANCE; ENZYMES; PROTEIN; ILEAL	Human intestinal tissue samples are barely accessible to study potential health benefits of nutritional compounds. Numbers of animals used in animal trials, however, need to be minimalized. Therefore, we explored the applicability of in vitro (human Caco-2 cells) and ex vivo intestine models (rat precision cut intestine slices and the pig in-situ small intestinal segment perfusion (SISP) technique) to study the effect of food compounds. In vitro digested yellow (YOd) and white onion extracts (WOd) were used as model food compounds and transcriptomics was applied to obtain more insight into which extent mode of actions depend on the model. The three intestine models shared 9,140 genes which were used to compare the responses to digested onions between the models. Unsupervised clustering analysis showed that genes up-or down-regulated by WOd in human Caco-2 cells and rat intestine slices were similarly regulated by YOd, indicating comparable modes of action for the two onion species. Highly variable responses to onion were found in the pig SISP model. By focussing only on genes with significant differential expression, in combination with a fold change > 1.5, 15 genes showed similar onion-induced expression in human Caco-2 cells and rat intestine slices and 2 overlapping genes were found between the human Caco-2 and pig SISP model. Pathway analyses revealed that mainly processes related to oxidative stress, and especially the Keap1-Nrf2 pathway, were affected by onions in all three models. Our data fit with previous in vivo studies showing that the beneficial effects of onions are mostly linked to their antioxidant properties. Taken together, our data indicate that each of the in vitro and ex vivo intestine models used in this study, taking into account their limitations, can be used to determine modes of action of nutritional compounds and can thereby reduce the number of animals used in conventional nutritional intervention studies.	[de Wit, Nicole J. W.; Govers, Coen; Mes, Jurriaan J.] Univ Wageningen & Res Ctr, Food & Biobased Res, Wageningen, Netherlands; [Hulst, Marcel; van der Meulen, Jan; Hoekman, Arjan; Smits, Mari] Univ Wageningen & Res Ctr, Wageningen Livestock Res, Wageningen, Netherlands; [van Hoef, Angeline; Stoopen, Geert; Hamers, Astrid; Bovee, Toine F. H.; Hendriksen, Peter J. M.] Univ Wageningen & Res Ctr, RIKILT Inst Food Safety, Wageningen, Netherlands; [de Vos, Ric] Univ Wageningen & Res Ctr, Plant Res Int, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Hendriksen, PJM (corresponding author), Univ Wageningen & Res Ctr, RIKILT Inst Food Safety, Wageningen, Netherlands.	peter.hendriksen@wur.nl		van der Meulen, Jan/0000-0002-9451-2335	Dutch Ministry of Economic Affairs, Agriculture and Innovation	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This work was supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; Deglaire A, 2012, BRIT J NUTR, V108, pS273, DOI 10.1017/S0007114512002346; Deglaire A, 2009, BRIT J NUTR, V102, P1752, DOI 10.1017/S0007114509991267; El-Demerdash FM, 2005, FOOD CHEM TOXICOL, V43, P57, DOI 10.1016/j.fct.2004.08.012; Eldin IMT, 2010, ENVIRON HEALTH INSIG, V4, P71, DOI 10.4137/EHI.S5540; Galeone C, 2006, AM J CLIN NUTR, V84, P1027, DOI 10.1093/ajcn/84.5.1027; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths G, 2002, PHYTOTHER RES, V16, P603, DOI 10.1002/ptr.1222; Helen A, 2000, TOXICOL LETT, V116, P61, DOI 10.1016/S0378-4274(00)00208-3; Hendriks WH, 2012, BRIT J NUTR, V108, pS247, DOI 10.1017/S0007114512002395; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulst M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-18; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansman AJM, 2012, J ANIM SCI, V90, P161, DOI 10.2527/jas.53848; Jung JY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-18; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Li M, 2016, DRUG METAB DISPOS, V44, P683, DOI 10.1124/dmd.115.068684; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Lippmann D, 2014, FOOD FUNCT, V5, P1073, DOI 10.1039/c3fo60676g; Lisanti A, 2016, PHARM BIOL, V54, P799, DOI 10.3109/13880209.2015.1080733; Loos M, 2013, VET IMMUNOL IMMUNOP, V152, P82, DOI 10.1016/j.vetimm.2012.09.014; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Park J, 2007, J NUTR SCI VITAMINOL, V53, P21, DOI 10.3177/jnsv.53.21; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schokker D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100040; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; van der Meulen J, 2010, BENEF MICROBES, V1, P439, DOI 10.3920/BM2010.0025; van Kol SWM, 2011, TOXICOL APPL PHARM, V250, P299, DOI 10.1016/j.taap.2010.11.001; Vreeburg RAM, 2011, FOOD FUNCT, V2, P124, DOI 10.1039/c0fo00068j; Wan Hasan WN, 2014, BMC COMPLEM ALTERN M, V14, P1; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Yang J, 2004, J AGR FOOD CHEM, V52, P6787, DOI 10.1021/jf0307144	40	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160719	10.1371/journal.pone.0160719	http://dx.doi.org/10.1371/journal.pone.0160719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631494	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900011
J	Kim, B; Rhee, K				Kim, Byunghyuk; Rhee, Kunsoo			BOULE, a Deleted in Azoospermia Homolog, Is Recruited to Stress Granules in the Mouse Male Germ Cells	PLOS ONE			English	Article							HUMAN Y-CHROMOSOME; HEAT-STRESS; GENE FAMILY; IN-VIVO; DAZ; PROTEIN; EXPRESSION; RNA; SPERMATOGENESIS; TRANSLATION	High temperature adversely affects normal development of male germcells in mammals. Acute heat stress induces the formation of stress granules (SGs) in a set of male germ cells, and the SGs have been proposed to protect those cells from heat-induced apoptosis. DAZL, one of DAZ (Deleted in Azoospermia) family proteins, was shown to be an essential component of SGs, which is required for SG formation in the mouse testis. In the present study, we asked whether BOULE, the founding member of DAZ family proteins, is a component of the SGs. We show that BOULE is recruited to the SGs upon heat stress, and that these SGs are developmental stage-specific. These results suggest that DAZ family proteins may have conserved roles in the SGs of male germcells.	[Kim, Byunghyuk; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kim, Byunghyuk] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr			Marine Biotechnology Program [PJT200620]	Marine Biotechnology Program	This study was supported by grants from the Marine Biotechnology Program (PJT200620). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Haag ES, 2001, P NATL ACAD SCI USA, V98, P6983, DOI 10.1073/pnas.141237898; Harlow E, 1999, USING ANTIBODIES A L; Houston DW, 2000, DEVELOPMENT, V127, P447; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim B, 2014, REPROD FERT DEVELOP, V26, P307, DOI 10.1071/RD12290; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Kim B, 2009, HUM REPROD, V24, P1507, DOI 10.1093/humrep/dep032; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Maines JZ, 1999, NAT CELL BIOL, V1, P171, DOI 10.1038/11091; Menke DB, 1997, AM J HUM GENET, V60, P237; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Sekine K, 2015, DEV BIOL, V399, P154, DOI 10.1016/j.ydbio.2014.12.027; Setchell B. P., 2006, Animal Reproduction, V3, P81; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Tanaka SS, 2000, GENE DEV, V14, P841; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Vogt PH, 2003, APMIS, V111, P115, DOI 10.1034/j.1600-0463.2003.11101161.x; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163015	10.1371/journal.pone.0163015	http://dx.doi.org/10.1371/journal.pone.0163015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632217	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900116
J	van der Zwaard, S; Jaspers, RT; Blokland, IJ; Achterberg, C; Visser, JM; den Uil, AR; Hofmijster, MJ; Levels, K; Noordhof, DA; de Haan, A; de Koning, JJ; van der Laarse, WJ; de Ruiter, CJ				van der Zwaard, Stephan; Jaspers, Richard T.; Blokland, Ilse J.; Achterberg, Chantal; Visser, Jurrian M.; den Uil, Anne R.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Haan, Arnold; de Koning, Jos J.; van der Laarse, Willem J.; de Ruiter, Cornelis J.			Oxygenation Threshold Derived from Near-Infrared Spectroscopy: Reliability and Its Relationship with the First Ventilatory Threshold	PLOS ONE			English	Article							RAMP INCREMENTAL EXERCISE; ALVEOLAR GAS-EXCHANGE; MUSCLE BLOOD-FLOW; SKELETAL-MUSCLE; DYNAMIC HETEROGENEITY; VASTUS-LATERALIS; CYCLE EXERCISE; HEALTHY-ADULTS; DEOXYGENATION; NIRS	Background Near-infrared spectroscopy (NIRS) measurements of oxygenation reflect O-2 delivery and utilization in exercising muscle and may improve detection of a critical exercise threshold. Purpose First, to detect an oxygenation breakpoint (Delta[O(2)HbMb-HHbMb]-BP) and compare this breakpoint to ventilatory thresholds during a maximal incremental test across sexes and training status. Second, to assess reproducibility of NIRS signals and exercise thresholds and investigate confounding effects of adipose tissue thickness on NIRS measurements. Methods Forty subjects (10 trained male cyclists, 10 trained female cyclists, 11 endurance trained males and 9 recreationally trained males) performed maximal incremental cycling exercise to determine Delta[O(2)HbMb-HHbMb]-BP and ventilatory thresholds (VT1 and VT2). Muscle haemoglobin and myoglobin O-2 oxygenation ([HHbMb], [O(2)HbMb], SmO2) was determined in m. vastus lateralis. Delta[O(2)HbMb-HHbMb]-BP was determined by double linear regression. Trained cyclists performed the maximal incremental test twice to assess reproducibility. Adipose tissue thickness (ATT) was determined by skinfold measurements. Results Delta[O(2)HbMb-HHbMb]-BP was not different from VT1, but only moderately related (r = 0.58-0.63, p<0.001). VT1 was different across sexes and training status, whereas Delta[O(2)HbMb-HHbMb]-BP differed only across sexes. Reproducibility was high for SmO2 (ICC = 0.69-0.97), Delta[O(2)HbMb-HHbMb]-BP (ICC = 0.80-0.88) and ventilatory thresholds (ICC = 0.96-0.99). SmO2 at peak exercise and at occlusion were strongly related to adipose tissue thickness (r(2) = 0.81, p<0.001; r(2) = 0.79, p<0.001).Moreover, ATT was related to asymmetric changes in Delta[HHbMb] and Delta[O(2)HbMb] during incremental exercise (r = -0.64, p<0.001) and during occlusion (r = -0.50, p<0.05). Conclusion Although the oxygenation threshold is reproducible and potentially a suitable exercise threshold, VT1 discriminates better across sexes and training status during maximal step-wise incremental exercise. Continuous-wave NIRS measurements are reproducible, but strongly affected by adipose tissue thickness.	[van der Zwaard, Stephan; Jaspers, Richard T.; Blokland, Ilse J.; Achterberg, Chantal; Visser, Jurrian M.; den Uil, Anne R.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Haan, Arnold; de Koning, Jos J.; de Ruiter, Cornelis J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [van der Laarse, Willem J.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Hofmijster, Mathijs J.] Amsterdam Univ Appl Sci, Fac Sports & Nutr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Zwaard, S (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	s.vander.zwaard@vu.nl	Noordhof, Dionne/AFR-6657-2022; van der Zwaard, Stephan/J-9622-2019	van der Zwaard, Stephan/0000-0002-8296-828X; van der Laarse, Willem J/0000-0002-8391-0354; Jaspers, Richard/0000-0002-6951-0952; de Koning, Jos J/0000-0002-5596-0282	Technologiestichting STW (NL) [12891]; Technologiestichting STW, the Netherlands	Technologiestichting STW (NL); Technologiestichting STW, the Netherlands	This work was supported by Technologiestichting STW (NL). Award number: 12891. Recipient: JJdK. URL: http://stw.nl/nl/projecten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' work was supported by a research grant from Technologiestichting STW, the Netherlands.	Amann M, 2004, MED SCI SPORT EXER, V36, P1716, DOI 10.1249/01.MSS.0000142305.18543.34; Austin KG, 2005, RES Q EXERCISE SPORT, V76, P440; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bellotti C, 2013, MED SCI SPORT EXER, V45, P1208, DOI 10.1249/MSS.0b013e3182828ab2; Bhambhani YN, 2004, CAN J APPL PHYSIOL, V29, P504, DOI 10.1139/h04-033; Boone J, 2015, APPL PHYSIOL NUTR ME, DOI [10.1139/apnm-2015-02610b013e3182828ab2, DOI 10.1139/APNM-2015-02610B013E3182828AB2]; Boone J, 2015, EUR J APPL PHYSIOL, V115, P57, DOI 10.1007/s00421-014-2991-x; Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; De Ruiter CJ, 2007, MED SCI SPORT EXER, V39, P443, DOI 10.1249/mss.0b013e31802dd3cc; de Ruiter CJ, 2005, J APPL PHYSIOL, V99, P579, DOI 10.1152/japplphysiol.01420.2004; de Ruiter CJ, 2012, MED SCI SPORT EXER, V44, P1366, DOI 10.1249/MSS.0b013e318249d701; Evans JD., 1996, STRAIGHTFORWARD STAT; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Ferreira LF, 2007, J APPL PHYSIOL, V102, P358, DOI 10.1152/japplphysiol.00920.2005; Fontana FY, 2015, J SCI MED SPORT, V18, P590, DOI 10.1016/j.jsams.2014.07.016; Goodwin ML, 2012, J APPL PHYSIOL, V112, P9, DOI 10.1152/japplphysiol.01480.2010; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Hopker JG, 2007, APPL PHYSIOL NUTR ME, V32, P1036, DOI 10.1139/H07-070; Keir DA, 2015, MED SCI SPORT EXER, V47, P1932, DOI 10.1249/MSS.0000000000000613; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; McArdle WD, 2010, EXERCISE PHYSL NUTR, V7th; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; MITCHELL JH, 1992, MED SCI SPORT EXER, V24, pS258; Miura T, 1998, JPN CIRC J, V62, P649, DOI 10.1253/jcj.62.649; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Murias JM, 2013, RESP PHYSIOL NEUROBI, V189, P530, DOI 10.1016/j.resp.2013.08.011; Murias JM, 2013, AM J PHYSIOL-REG I, V304, pR720, DOI 10.1152/ajpregu.00016.2013; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Osawa T, 2011, MED SCI SPORT EXER, V43, P1406, DOI 10.1249/MSS.0b013e3182100261; Peltonen JE, 2013, RESP PHYSIOL NEUROBI, V188, P102, DOI 10.1016/j.resp.2013.05.014; Racinais S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00142; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rissanen APE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00265; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Southern WM, 2014, APPL PHYSIOL NUTR ME, V39, P521, DOI 10.1139/apnm-2013-0347; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; STRINGER W, 1994, J APPL PHYSIOL, V76, P1462, DOI 10.1152/jappl.1994.76.4.1462; Tew GA, 2010, EUR J APPL PHYSIOL, V110, P1083, DOI 10.1007/s00421-010-1596-2; Thiel C, 2011, INT J SPORTS MED, V32, P277, DOI 10.1055/s-0030-1269922; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; Wang BD, 2012, J SPORT SCI MED, V11, P606; Wang BD, 2012, EUR J APPL PHYSIOL, V112, P567, DOI 10.1007/s00421-011-2007-z; Wang LX, 2006, APPL PHYSIOL NUTR ME, V31, P612, DOI 10.1139/H06-069; WASSERMAN K, 1994, AM J PHYSIOL, V266, pE519, DOI 10.1152/ajpendo.1994.266.4.E519; WASSERMAN K, 1987, CIRCULATION, V76, P29	52	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162914	10.1371/journal.pone.0162914	http://dx.doi.org/10.1371/journal.pone.0162914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631607	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900092
J	Kim, YK; Yadava, RS; Mandal, M; Mahadevan, K; Yu, Q; Leitges, M; Mahadevan, MS				Kim, Yun K.; Yadava, Ramesh S.; Mandal, Mahua; Mahadevan, Karunasai; Yu, Qing; Leitges, Michael; Mahadevan, Mani S.			Disease Phenotypes in a Mouse Model of RNA Toxicity Are Independent of Protein Kinase Ca and Protein Kinase C beta	PLOS ONE			English	Article							EXPANDED-REPEAT TRANSCRIPTS; MYOTONIC MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; NUCLEAR FOCI; IN-VIVO; CARDIAC CONTRACTILITY; BINDING PROTEIN; TRIPLET REPEAT; HEART-FAILURE; PKC-ALPHA	Myotonic dystrophy type 1(DM1) is the prototype for diseases caused by RNA toxicity. RNAs from the mutant allele contain an expanded (CUG)(n) tract within the 3' untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. The toxic RNAs affect the function of RNA binding proteins leading to sequestration of muscleblind-like (MBNL) proteins and increased levels of CELF1 (CUGBP, Elav-like family member 1). The mechanism for increased CELF1 is not very clear. One favored proposition is hyper-phosphorylation of CELF1 by Protein Kinase C alpha (PKC alpha) leading to increased CELF1 stability. However, most of the evidence supporting a role for PKC-alpha relies on pharmacological inhibition of PKC. To further investigate the role of PKCs in the pathogenesis of RNA toxicity, we generated transgenic mice with RNA toxicity that lacked both the PKC alpha and PKC beta isoforms. We find that these mice show similar disease progression as mice wildtype for the PKC isoforms. Additionally, the expression of CELF1 is also not affected by deficiency of PKC alpha and PKC beta in these RNA toxicity mice. These data suggest that disease phenotypes of these RNA toxicity mice are independent of PKC alpha and PKC beta.	[Kim, Yun K.; Yadava, Ramesh S.; Mandal, Mahua; Mahadevan, Karunasai; Yu, Qing; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	University of Virginia; University of Oslo	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021; Leitges, Michael/AAN-1953-2021	Yadava, Ramesh S/0000-0002-0092-5033; Leitges, Michael/0000-0003-4203-6995	NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01AR045992, R01AR062189, R01AR052771]; Stone Circle of Friends; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052771, R01AR062189, R01AR045992] Funding Source: NIH RePORTER	NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases); Stone Circle of Friends; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support was provided by: NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Grant# R01AR045992; Grant# R01AR062189; Grant# R01AR052771; and the Stone Circle of Friends. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; BROOK, 1992, CELL, V69, P385; Camerino GM, 2014, PFLUG ARCH EUR J PHY, V466, P2215, DOI 10.1007/s00424-014-1495-1; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Furling D, 2001, HUM MOL GENET, V10, P2079, DOI 10.1093/hmg/10.19.2079; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Hers I, 1999, FEBS LETT, V460, P433, DOI 10.1016/S0014-5793(99)01389-7; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Jensen TE, 2009, AM J PHYSIOL-ENDOC M, V297, pE340, DOI 10.1152/ajpendo.90610.2008; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Ketley A, 2014, HUM MOL GENET, V23, P1551, DOI 10.1093/hmg/ddt542; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili LE, 2011, DIS MODEL MECH, V4, P381, DOI 10.1242/dmm.004150; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Madaro L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031515; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marino JS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-39; Marrocco V, 2014, BIOCHEM SOC T, V42, P1550, DOI 10.1042/BST20140207; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Poulos MG, 2013, HUM MOL GENET, V22, P3547, DOI 10.1093/hmg/ddt209; Rehman S, 2014, PLOS ONE, V9, DOI [0. 1371/ journal. pone. 0095957, DOI 10.1371/J0URNAL.P0NE.0095957]; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163325	10.1371/journal.pone.0163325	http://dx.doi.org/10.1371/journal.pone.0163325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657532	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200100
J	Nguyen, TH; Maltby, S; Eyers, F; Foster, PS; Yang, M				Thi Hiep Nguyen; Maltby, Steven; Eyers, Fiona; Foster, Paul S.; Yang, Ming			Bromodomain and Extra Terminal (BET) Inhibitor Suppresses Macrophage-Driven Steroid-Resistant Exacerbations of Airway Hyper-Responsiveness and Inflammation	PLOS ONE			English	Article							VIRUS-INDUCED EXACERBATIONS; SELECTIVE-INHIBITION; ASTHMA EXACERBATIONS; IFN-GAMMA; PULMONARY MACROPHAGES; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; SMOOTH-MUSCLE; LUNG-FUNCTION; MOUSE MODEL	Background Exacerbations of asthma are linked to significant decline in lung function and are often poorly controlled by corticosteroid treatment. Clinical investigations indicate that viral and bacterial infections play crucial roles in the onset of steroid-resistant inflammation and airways hyperresponsiveness (AHR) that are hallmark features of exacerbations. We have previously shown that interferon. (IFN gamma) and lipopolysaccharide (LPS) cooperatively activate pulmonary macrophages and induce steroid-resistant airway inflammation and AHR in mouse models. Furthermore, we have established a mouse model of respiratory syncytial virus (RSV)-induced exacerbation of asthma, which exhibits macrophage-dependent, steroid- resistant lung disease. Emerging evidence has demonstrated a key role for bromo-and extra-terminal (BET) proteins in the regulation of inflammatory gene expression in macrophages. We hypothesised that BET proteins may be involved in the regulation of AHR and airway inflammation in our steroid-resistant exacerbation models. Methodology/Principal Findings We investigated the effects of a BET inhibitor (I-BET-762) on the development of steroid-resistant AHR and airway inflammation in two mouse models. I-BET-762 administration decreased macrophage and neutrophil infiltration into the airways, and suppressed key inflammatory cytokines in both models. I-BET treatment also suppressed key inflammatory cytokines linked to the development of steroid-resistant inflammation such as monocyte chemoattractant protein 1 (MCP-1), keratinocyte-derived protein chemokine (KC), IFN gamma, and interleukin 27 (IL-27). Attenuation of inflammation was associated with suppression of AHR. Conclusions/Significance Our results suggest that BET proteins play an important role in the regulation of steroid-resistant exacerbations of airway inflammation and AHR. BET proteins may be potential targets for the development of future therapies to treat steroid-resistant inflammatory components of asthma.	[Foster, Paul S.; Yang, Ming] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Hlth Lungs, Callaghan, NSW 2300, Australia; Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2300, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Foster, PS; Yang, M (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Hlth Lungs, Callaghan, NSW 2300, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Foster, Paul/G-5057-2013	Maltby, Steven/0000-0003-1240-5964; , Paul/0000-0002-0827-8299	Canadian Institutes of Health Research (CIHR); University of Newcastle; Hunter Medical Research Institute (HMRI); NHMRC project grants (National Health and Medical Research Council, Australia)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Newcastle; Hunter Medical Research Institute (HMRI); NHMRC project grants (National Health and Medical Research Council, Australia)	SM is supported by the Canadian Institutes of Health Research (CIHR), the University of Newcastle and the Hunter Medical Research Institute (HMRI). PSF and MY are supported by the NHMRC project grants (National Health and Medical Research Council, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Baines KJ, 2015, EUR RESPIR J, V45, P557, DOI 10.1183/09031936.00187514; Bandukwala HS, 2012, P NATL ACAD SCI USA, V109, P14532, DOI 10.1073/pnas.1212264109; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Chen JJ, 2016, J IMMUNOL, V196, P4132, DOI 10.4049/jimmunol.1502261; Clifford RL, 2015, AM J PHYSIOL-LUNG C, V308, pL962, DOI 10.1152/ajplung.00021.2015; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Giuffrida MJ, 2014, INFLUENZA OTHER RESP, V8, P116, DOI 10.1111/irv.12155; Graham LM, 2015, CURR MED RES OPIN, V31, P825, DOI 10.1185/03007995.2014.1001062; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Iikura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123584; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kaiko GE, 2010, J IMMUNOL, V185, P4681, DOI 10.4049/jimmunol.1001758; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Li JJ, 2015, J ALLERGY CLIN IMMUN, V136, P462, DOI 10.1016/j.jaci.2014.11.044; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Manthei DM, 2014, CLIN EXP ALLERGY, V44, P1484, DOI 10.1111/cea.12387; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Perry MM, 2015, J BIOL CHEM, V290, P9111, DOI 10.1074/jbc.M114.612671; Raundhal M, 2015, J CLIN INVEST, V125, P3037, DOI 10.1172/JCI80911; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Schwantes EA, 2014, CLIN EXP ALLERGY, V44, P813, DOI 10.1111/cea.12269; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sullivan JM, 2015, J EXP MED, V212, P1771, DOI 10.1084/jem.20151271; Nguyen TH, 2016, J IMMUNOL, V196, P3547, DOI 10.4049/jimmunol.1502339; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Yang M, 2010, CLIN EXP ALLERGY, V40, P163, DOI 10.1111/j.1365-2222.2009.03393.x; Yang M, 2012, J LEUKOCYTE BIOL, V91, P557, DOI 10.1189/jlb.0711357; Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468	40	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163392	10.1371/journal.pone.0163392	http://dx.doi.org/10.1371/journal.pone.0163392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657907	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200110
J	Zhang, ZQ; Cao, Z; Liu, C; Li, R; Wang, WD; Wang, XY				Zhang, Zhi-Qiang; Cao, Zhi; Liu, Cong; Li, Rong; Wang, Wei-Dong; Wang, Xing-Yong			MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LEGUMAIN EXPRESSION; GENE-THERAPY; IN-VIVO; COLORECTAL-CANCER; METASTASIS; XENOGRAFTS; PROMOTERS; SCAFFOLDS; SEQUENCES	Legumain (LGMN) is highly expressed in breast cancer (BC) and other solid tumors and is a potential anticancer target. Here we investigate the anti-tumor effects of short hairpin RNAs (shRNAs) targeting LGMN embedded in a microRNA-155 (miR-155) architecture, which is driven by a radiation-inducible chimeric RNA polymerase II (Pol II) promoter. Lentiviral vectors were generated with the chimeric promoter which controlled the expression of downstream shRNA-miR-155 cassette. Fluorescence was observed by using confocal microscopy. Real-time quantitative PCR and Western blotting were used to determine the expression level of LGMN, MMP2, and MMP9. Furthermore, the proliferation and invasive ability of BC cells was analyzed via plate colony formation and invasion assays. Here we demonstrated that the chimeric promoter could be effectively induced by radiation treatment. Furthermore, the shRNA-miR-155 cassette targeting LGMN could be effectively activated by the chimeric promoter. Radiation plus knockdown of LGMN impairs colony formation and dampens cell migration and invasion in BC cells. Inhibition of LGMN downregulates MMP2 and MMP9 expression in BC cells. Pol II-driven shRNA-miR-155 could effectively suppress the growth and invasiveness of BC cells, and that the interference effects could be regulated by radiation doses. Moreover, knockdown of LGMN alleviates the aggressive phenotype of BC cells through modulating MMPs expression.	[Zhang, Zhi-Qiang; Wang, Xing-Yong] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China; [Zhang, Zhi-Qiang; Wang, Xing-Yong] Key Lab Pediat Chongqing, Chongqing 400014, Peoples R China; [Zhang, Zhi-Qiang; Wang, Xing-Yong] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing 400014, Peoples R China; [Zhang, Zhi-Qiang; Wang, Xing-Yong] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing 400014, Peoples R China; [Liu, Cong; Li, Rong] Third Mil Med Univ, Coll Prevent Med, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Chongqing 400038, Peoples R China; [Cao, Zhi; Wang, Wei-Dong] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu 610041, Peoples R China	Chongqing Medical University; Army Medical University	Wang, XY (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China.; Wang, XY (corresponding author), Key Lab Pediat Chongqing, Chongqing 400014, Peoples R China.; Wang, XY (corresponding author), Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing 400014, Peoples R China.; Wang, XY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing 400014, Peoples R China.; Wang, WD (corresponding author), Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu 610041, Peoples R China.	wwdwyl@sina.com; golden678@foxmail.com			National Natural Science Foundation of China [11375124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China http://www.nsfc.gov.cn/ (NO: 11375124). WW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Bofill-De Ros X, 2016, METHODS SAN DIEGO CA, DOI [10.1016/j.ymeth.2016.04.003, DOI 10.1016/J.YMETH.2016.04.003]; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Ding M, 2015, CANCER SCI, V106, P1163, DOI 10.1111/cas.12739; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fowler DK, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1246; Galka-Marciniak P, 2016, BBA-GENE REGUL MECH, V1859, P639, DOI 10.1016/j.bbagrm.2016.02.014; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Guo PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073090; Haugen MH, 2015, EUR J CANCER, V51, P9, DOI 10.1016/j.ejca.2014.10.020; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Li N, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0621-9; Lin YY, 2013, CANCER SCI, V104, P1217, DOI 10.1111/cas.12202; Liu C, 2003, CANCER RES, V63, P2957; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Maczuga P, 2013, MOL THER, V21, P217, DOI 10.1038/mt.2012.160; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Ohno Y, 2013, WORLD J UROL, V31, P359, DOI 10.1007/s00345-012-0977-z; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Scott SD, 2002, GENE THER, V9, P1396, DOI 10.1038/sj.gt.3301822; Shi Qiwen, 2015, Genes Cancer, V6, P220; Wang HB, 2012, INT J CANCER, V130, P443, DOI 10.1002/ijc.26013; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143; Wang WD, 2005, CANCER SCI, V96, P918, DOI 10.1111/j.1349-7006.2005.00129.x; Wu M, 2014, ASIAN PAC J CANCER P, V15, P10773, DOI 10.7314/APJCP.2014.15.24.10773; Xiong J, 2012, CANCER-AM CANCER SOC, V118, P536, DOI 10.1002/cncr.26289; Ye Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep16599; Zhang ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144376	33	7	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163446	10.1371/journal.pone.0163446	http://dx.doi.org/10.1371/journal.pone.0163446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656894	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200123
J	Freitas, AP; Santos, CR; Sarcinelli, PN; Silva, MV; Hauser-Davis, RA; Lopes, RM				Freitas, A. P.; Santos, C. R.; Sarcinelli, P. N.; Silva Filho, M. V.; Hauser-Davis, R. A.; Lopes, R. M.			Evaluation of a Brain Acetylcholinesterase Extraction Method and Kinetic Constants after Methyl-Paraoxon Inhibition in Three Brazilian Fish Species	PLOS ONE			English	Article							CHOLINESTERASE; BUTYRYLCHOLINESTERASE; SENSITIVITY; PARAMETERS; ACID	Acetylcholinesterase (AChE) is an important enzyme in the control of the neuronal action potential and sensitive to organophosphate inhibition. Brain fish AChE is less sensitive to organophosphate inhibition than AChE from terrestrial animals, although this sensitivity is variable among species and has not yet been fully evaluated in fish species. In this setting, inhibition kinetic constants for progressive irreversible inhibition of brain acetylcholinesterase due to methyl-paraoxon exposure were determined in three fish species (Mugil liza, Genidens genidens and Lagocephalus laevigatus) and hen (Gallus domesticus). Enzyme extraction using a detergent was shown to be adequate, and samples presented activity inhibition in high substrate concentrations and suppression of inhibition by methyl-paraoxon in the presence of the substrate, similar to kinetic patterns from purified enzyme preparations. Catfish (G. genidens) AChE presented the highest sensitivity among the evaluated fish species (IC50 = 1031.20 nM +/- 63.17) in comparison to M. liza and L. laevigatus (IC50: 2878.83 +/- 421.94 and 2842.5 +/- 144.63 nM respectively). The lower dissociation constant (K-d = 20.3 +/- 2.95 mu M) of catfish AChE showed greater enzyme affinity for methyl-paraoxon, explaining this species higher sensitivity to organophosphates. Hen AChE presented higher k(i) (900.57 +/- 65.3 mM(-1) min(-1)) and, consequently, greater sensitivity to methyl-paraoxon, explained by a lower K-d (0.6 +/- 0.13 mu M). Furthermore, hen AChE did not differentiate between the propionylthiocholine and acetylthiocholine substrates, indicating easier access of methyl-paraoxon to the hen enzyme activity site. The results obtained herein indicate a suitable extraction of AChE and, despite different inhibition kinetic constants, demonstrate that fish AChE is less sensitive to methyl-paraoxon, probably due to reduced access to the catalytic center which provides greater enzyme substrate selectivity.	[Freitas, A. P.; Santos, C. R.; Sarcinelli, P. N.; Silva Filho, M. V.; Hauser-Davis, R. A.] CESTEH, ENSP, FIOCRUZ, Rua Leopoldo Bulhoes,1480, BR-21041210 Rio De Janeiro, RJ, Brazil; [Santos, C. R.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Ave Carlos Chagas Filho,373,Bl D,S 05,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil; [Lopes, R. M.] Inst Oswaldo Cruz, FIOCRUZ, Lab Comunicacao Celular, Ave Brasil,4365 Manguinhos, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Santos, CR (corresponding author), CESTEH, ENSP, FIOCRUZ, Rua Leopoldo Bulhoes,1480, BR-21041210 Rio De Janeiro, RJ, Brazil.; Santos, CR (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Ave Carlos Chagas Filho,373,Bl D,S 05,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	carluciorsantos@gmail.com	Hauser-Davis, Rachel Ann/C-7970-2013	Hauser-Davis, Rachel Ann/0000-0002-9451-471X; Matos Lopes, Renato/0000-0002-0175-6673				ALDRIDGE WN, 1950, BIOCHEM J, V46, P451, DOI 10.1042/bj0460451; Barbieri E, 2011, PESTIC BIOCHEM PHYS, V99, P209, DOI 10.1016/j.pestbp.2010.09.002; Carr RL, 1996, TOXICOL APPL PHARM, V139, P365, DOI 10.1006/taap.1996.0177; de Aguiar LH, 2004, ENVIRON RES, V95, P224, DOI 10.1016/S0013-9351(03)00119-1; de Salles JB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/197196; Dos Santos CR, 2016, ECOTOX ENVIRON SAFE, V129, P250, DOI 10.1016/j.ecoenv.2016.03.028; DuPont, 2016, DUPONT TECHN B, P1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; JOHNSON JA, 1987, TOXICOL APPL PHARM, V88, P234, DOI 10.1016/0041-008X(87)90009-3; Kardos SA, 2000, TOXICOL SCI, V58, P118, DOI 10.1093/toxsci/58.1.118; KEMP JR, 1990, TOXICOL APPL PHARM, V104, P246, DOI 10.1016/0041-008X(90)90299-A; KITZ R, 1962, J BIOL CHEM, V237, P3245; Lockridge O, 1997, BIOCHEMISTRY-US, V36, P786, DOI 10.1021/bi961412g; Lopes RM, 2014, ENVIRON TOXICOL CHEM, V33, P1331, DOI 10.1002/etc.2556; MAIN AR, 1964, SCIENCE, V144, P992, DOI 10.1126/science.144.3621.992; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Oliveira MM, 2007, MAR ENVIRON RES, V63, P303, DOI 10.1016/j.marenvres.2006.10.002; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Rigotto RM, 2014, CAD SAUDE PUBLICA, V30, P1360, DOI 10.1590/0102-311XPE020714; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Silva MV, 2004, TOXICOL LETT, V153, P247, DOI 10.1016/j.toxlet.2004.04.026; Tortelli V, 2006, CHEMOSPHERE, V65, P560, DOI 10.1016/j.chemosphere.2006.02.047; Tougu V, 1996, BBA-PROTEIN STRUCT M, V1298, P12, DOI 10.1016/S0167-4838(96)00128-8; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; WANG C, 1982, TOXICOL APPL PHARM, V66, P409, DOI 10.1016/0041-008X(82)90307-6	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163317	10.1371/journal.pone.0163317	http://dx.doi.org/10.1371/journal.pone.0163317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655611	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700050
J	Huo, S; Scialli, AR; McGarvey, S; Hill, E; Tugertimur, B; Hogenmiller, A; Hirsch, AI; Fugh-Berman, A				Huo, Samantha; Scialli, Anthony R.; McGarvey, Sean; Hill, Elizabeth; Tugertimur, Bugra; Hogenmiller, Alycia; Hirsch, Alessandra I.; Fugh-Berman, Adriane			Treatment of Men for "Low Testosterone": A Systematic Review	PLOS ONE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; CONTROLLED-CLINICAL-TRIAL; CORONARY-ARTERY-DISEASE; QUALITY-OF-LIFE; CHRONIC HEART-FAILURE; HEALTHY OLDER MEN; NORMAL GONADAL STATUS; SERUM INFLAMMATORY MARKERS; MILD COGNITIVE IMPAIRMENT	Testosterone products are recommended by some prescribers in response to a diagnosis or presumption of "low testosterone" (low-T) for cardiovascular health, sexual function, muscle weakness or wasting, mood and behavior, and cognition. We performed a systematic review of 156 eligible randomized controlled trials in which testosterone was compared to placebo for one or more of these conditions. We included studies in bibliographic databases between January 1, 1950 and April 9, 2016, and excluded studies involving body-building, contraceptive effectiveness, or treatment of any condition in women or children. Studies with multiple relevant endpoints were included in all relevant tables. Testosterone supplementation did not show consistent benefit for cardiovascular risk, sexual function, mood and behavior, or cognition. Studies that examined clinical cardiovascular endpoints have not favored testosterone therapy over placebo. Testosterone is ineffective in treating erectile dysfunction and controlled trials did not show a consistent effect on libido. Testosterone supplementation consistently increased muscle strength but did not have beneficial effects on physical function. Most studies on mood-related endpoints found no beneficial effect of testosterone treatment on personality, psychological well-being, or mood. The prescription of testosterone supplementation for low-T for cardiovascular health, sexual function, physical function, mood, or cognitive function is without support from randomized clinical trials.	[Huo, Samantha] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Scialli, Anthony R.; McGarvey, Sean; Hill, Elizabeth; Hogenmiller, Alycia; Fugh-Berman, Adriane] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Scialli, Anthony R.] Scialli Consulting LLC, Washington, DC USA; [Tugertimur, Bugra] Univ S Florida, Tampa, FL USA; [Hirsch, Alessandra I.] Univ Illinois, Chicago, IL USA	Tulane University; Georgetown University; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fugh-Berman, A (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	ajf29@georgetown.edu		Fugh-Berman, Adriane/0000-0002-1717-7617				Agledahl I, 2008, SCAND J CLIN LAB INV, V68, P641, DOI 10.1080/00365510801999068; Allan CA, 2008, INT J IMPOT RES, V20, P396, DOI 10.1038/ijir.2008.22; Amiaz R, 2011, J SEX MARITAL THER, V37, P243, DOI 10.1080/0092623X.2011.582425; Amory JK, 2002, J AM GERIATR SOC, V50, P1698, DOI 10.1046/j.1532-5415.2002.50462.x; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anderson JL, 2016, AM J CARDIOL, V117, P794, DOI 10.1016/j.amjcard.2015.11.063; ANDERSON RA, 1992, J CLIN ENDOCR METAB, V75, P1503, DOI 10.1210/jc.75.6.1503; Asih PR, 2015, CNS NEUROL DISORD-DR, V14, P576, DOI 10.2174/1871527314666150429112112; Aversa A, 2003, CLIN ENDOCRINOL, V58, P632, DOI 10.1046/j.1365-2265.2003.01764.x; Aydin S, 1996, BRIT J UROL, V77, P256, DOI 10.1046/j.1464-410X.1996.86316.x; Baillargeon J, 2014, ANN PHARMACOTHER, V48, P1138, DOI 10.1177/1060028014539918; Bakhshi V, 2000, J AM GERIATR SOC, V48, P550, DOI 10.1111/j.1532-5415.2000.tb05002.x; Basaria S, 2015, JAMA-J AM MED ASSOC, V314, P570, DOI 10.1001/jama.2015.8881; Basaria S, 2015, PAIN, V156, P280, DOI 10.1097/01.j.pain.0000460308.86819.aa; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; BENKERT O, 1979, ARCH SEX BEHAV, V8, P471, DOI 10.1007/BF01541414; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3155, DOI 10.1210/jc.83.9.3155; Bhasin S, 2000, JAMA-J AM MED ASSOC, V283, P763, DOI 10.1001/jama.283.6.763; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1049, DOI 10.1210/jc.2006-2060; Borst SE, 2014, CLIN INTERV AGING, V9, P1327, DOI 10.2147/CIA.S61760; Borst SE, 2014, AM J PHYSIOL-ENDOC M, V306, pE433, DOI 10.1152/ajpendo.00592.2013; Brill KT, 2002, J CLIN ENDOCR METAB, V87, P5649, DOI 10.1210/jc.2002-020098; Brockenbrough AT, 2006, AM J KIDNEY DIS, V47, P251, DOI 10.1053/j.ajkd.2005.10.022; Buvat J, 2011, J SEX MED, V8, P284, DOI 10.1111/j.1743-6109.2010.01956.x; Caminiti G, 2009, J AM COLL CARDIOL, V54, P919, DOI 10.1016/j.jacc.2009.04.078; Casaburi R, 2004, AM J RESP CRIT CARE, V170, P870, DOI 10.1164/rccm.200305-617OC; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; Cherrier MM, 2007, PSYCHONEUROENDOCRINO, V32, P72, DOI 10.1016/j.psyneuen.2006.10.008; Cherrier MM, 2015, AM J ALZHEIMERS DIS, V30, P421, DOI 10.1177/1533317514556874; Cherrier MM, 2005, NEUROLOGY, V64, P290, DOI 10.1212/01.WNL.0000149639.25136.CA; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; Cherrier MM, 2004, PSYCHONEUROENDOCRINO, V29, P65, DOI 10.1016/S0306-4530(02)00136-1; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Chiang HS, 2007, INT J IMPOT RES, V19, P411, DOI 10.1038/sj.ijir.3901562; Chung T, 2007, CLIN ENDOCRINOL, V66, P235, DOI 10.1111/j.1365-2265.2006.02715.x; Clague JE, 1999, INT J ANDROL, V22, P261, DOI 10.1046/j.1365-2605.1999.00177.x; Coodley GO, 1997, AIDS, V11, P1347, DOI 10.1097/00002030-199711000-00008; Cornoldi A, 2010, INT J CARDIOL, V142, P50, DOI 10.1016/j.ijcard.2008.12.107; Crawford BAL, 2003, J CLIN ENDOCR METAB, V88, P3167, DOI 10.1210/jc.2002-021827; Dabbs JM, 2002, SOC BEHAV PERSONAL, V30, P795, DOI 10.2224/sbp.2002.30.8.795; Daly RC, 2001, ARCH GEN PSYCHIAT, V58, P172, DOI 10.1001/archpsyc.58.2.172; DAVIDSON JM, 1979, J CLIN ENDOCR METAB, V48, P955, DOI 10.1210/jcem-48-6-955; Del Fabbro E, 2013, SUPPORT CARE CANCER, V21, P2599, DOI 10.1007/s00520-013-1832-5; Dobs AS, 1999, AM J MED, V107, P126, DOI 10.1016/S0002-9343(99)00193-X; Dobs AS, 1998, J CLIN ENDOCR METAB, V83, P33, DOI 10.1210/jc.83.1.33; DOHN K, 1968, ANGIOLOGY, V19, P342, DOI 10.1177/000331976801900604; Emmelot-Vonk MH, 2009, INT J IMPOT RES, V21, P129, DOI 10.1038/ijir.2009.5; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906; Fairfield WP, 2001, J APPL PHYSIOL, V90, P2166, DOI 10.1152/jappl.2001.90.6.2166; Ferrando AA, 2001, CRIT CARE MED, V29, P1936, DOI 10.1097/00003246-200110000-00015; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Frederiksen L, 2013, HORM METAB RES, V45, P308, DOI 10.1055/s-0032-1323647; Gianatti EJ, 2014, J CLIN ENDOCR METAB, V99, P3821, DOI 10.1210/jc.2014-1872; Gianatti EJ, 2014, DIABETES CARE, V37, P2098, DOI 10.2337/dc13-2845; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Giltay EJ, 2010, J SEX MED, V7, P2572, DOI 10.1111/j.1743-6109.2010.01859.x; GLUUD C, 1988, GASTROENTEROLOGY, V95, P1582, DOI 10.1016/S0016-5085(88)80081-7; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRIGGS RC, 1989, NEUROLOGY, V39, P219, DOI 10.1212/WNL.39.2.219; Grinspoon S, 2000, ANN INTERN MED, V133, P348, DOI 10.7326/0003-4819-133-5-200009050-00010; Grinspoon S, 1998, ANN INTERN MED, V129, P18, DOI 10.7326/0003-4819-129-1-199807010-00005; Grinspoon S, 2000, J CLIN ENDOCR METAB, V85, P60, DOI 10.1210/jc.85.1.60; Guler N, 2006, INT J CARDIOL, V109, P339, DOI 10.1016/j.ijcard.2005.06.027; Hackett G, 2014, INT J CLIN PRACT, V68, P203, DOI 10.1111/ijcp.12235; Hackett G, 2014, J SEX MED, V11, P840, DOI 10.1111/jsm.12404; Hackett G, 2013, J SEX MED, V10, P1612, DOI 10.1111/jsm.12146; Haren M, 2005, AGE AGEING, V34, P125, DOI 10.1093/ageing/afi003; Haren MT, 2005, MATURITAS, V50, P124, DOI 10.1016/j.maturitas.2004.05.002; HENTZER E, 1967, SCAND J CLIN LAB INV, VS 19, P198; Hildreth KL, 2013, J CLIN ENDOCR METAB, V98, P1891, DOI 10.1210/jc.2012-3695; Ho CCK, 2012, BJU INT, V110, P260, DOI 10.1111/j.1464-410X.2011.10755.x; HOLMANG S, 1993, PROSTATE, V23, P99, DOI 10.1002/pros.2990230203; Howell SJ, 2001, CLIN ENDOCRINOL, V55, P315, DOI 10.1046/j.1365-2265.2001.01297.x; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JAFFE MD, 1977, BRIT HEART J, V39, P1217; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; Jockenhovel F, 1999, METABOLISM, V48, P590, DOI 10.1016/S0026-0495(99)90056-2; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x; Kang SM, 2002, AM J CARDIOL, V89, P862, DOI 10.1016/S0002-9149(02)02202-6; Kapoor D, 2007, EUR J ENDOCRINOL, V156, P595, DOI 10.1530/EJE-06-0737; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Kenny AM, 2001, J GERONTOL A-BIOL, V56, pM266, DOI 10.1093/gerona/56.5.M266; Kenny AM, 2004, J GERONTOL A-BIOL, V59, P75; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM460, DOI 10.1093/gerona/57.7.M460; Kenny AM, 2010, J AM GERIATR SOC, V58, P1134, DOI 10.1111/j.1532-5415.2010.02865.x; Knapp PE, 2008, AM J PHYSIOL-ENDOC M, V294, pE1135, DOI 10.1152/ajpendo.90213.2008; Ko YH, 2008, J CLIN PSYCHOPHARM, V28, P375, DOI 10.1097/JCP.0b013e31817d5912; KOURI EM, 1995, DRUG ALCOHOL DEPEN, V40, P73, DOI 10.1016/0376-8716(95)01192-7; Kouri EM, 1996, CLIN J SPORT MED, V6, P152, DOI 10.1097/00042752-199607000-00003; Kunelius P, 2002, J CLIN ENDOCR METAB, V87, P1467, DOI 10.1210/jc.87.4.1467; Legros JJ, 2009, EUR J ENDOCRINOL, V160, P821, DOI 10.1530/EJE-08-0634; Lu PH, 2006, ARCH NEUROL-CHICAGO, V63, P177, DOI 10.1001/archneur.63.2.nct50002; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210/jc.86.9.4078; Maki PM, 2007, J CLIN ENDOCR METAB, V92, P4107, DOI 10.1210/jc.2006-1805; Malkin CJ, 2006, EUR HEART J, V27, P57, DOI 10.1093/eurheartj/ehi443; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Malkin CJ, 2004, HEART, V90, P871, DOI 10.1136/hrt.2003.021121; Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092; Merza Z, 2006, INT J ANDROL, V29, P381, DOI 10.1111/j.1365-2605.2005.00612.x; Miner M, 2014, CAN J UROL, V21, P39; Mirdamadi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/392432; Morales A, 2009, AGING MALE, V12, P104, DOI 10.3109/13685530903294388; Muraleedharan V, 2013, EUR J ENDOCRINOL, V169, P725, DOI 10.1530/EJE-13-0321; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Nakhai-Pour HR, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.09.001; NANKIN HR, 1986, FERTIL STERIL, V46, P300; Ng MKC, 2002, ARTERIOSCL THROM VAS, V22, P1136, DOI 10.1161/01.ATV.0000022167.80130.A6; O'Connor DB, 2001, NEUROPSYCHOLOGIA, V39, P1385, DOI 10.1016/S0028-3932(01)00067-7; O'Connor DB, 2002, PHYSIOL BEHAV, V75, P557, DOI 10.1016/S0031-9384(02)00647-9; O'Connor DB, 2004, J CLIN ENDOCR METAB, V89, P2837, DOI 10.1210/jc.2003-031354; Okun MS, 2006, ARCH NEUROL-CHICAGO, V63, P729, DOI 10.1001/archneur.63.5.729; Ong PJL, 2000, AM J CARDIOL, V85, P269, DOI 10.1016/S0002-9149(99)00630-X; Orengo CA, 2005, J GERIATR PSYCH NEUR, V18, P20, DOI 10.1177/0891988704271767; Paduch DA, 2015, J CLIN ENDOCR METAB, V100, P2956, DOI 10.1210/jc.2014-4434; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Park N C, 2003, Aging Male, V6, P86, DOI 10.1080/713604766; Pope HG, 2010, J CLIN PSYCHOPHARM, V30, P126, DOI 10.1097/JCP.0b013e3181d207ca; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Pope HG, 2003, AM J PSYCHIAT, V160, P105, DOI 10.1176/appi.ajp.160.1.105; Pugh PJ, 2005, ENDOCR RES, V31, P271, DOI 10.1080/07435800500406205; Pugh PJ, 2004, HEART, V90, P446, DOI 10.1136/hrt.2003.014639; Pugh PJ, 2003, EUR HEART J, V24, P909, DOI 10.1016/S0195-668X(03)00083-6; Rabkin JG, 2004, J CLIN PSYCHOPHARM, V24, P379, DOI 10.1097/01.jcp.0000132442.35478.3c; Rabkin JG, 2000, ARCH GEN PSYCHIAT, V57, P141, DOI 10.1001/archpsyc.57.2.141; Reddy P, 2000, J CLIN PHARM THER, V25, P421, DOI 10.1046/j.1365-2710.2000.00309.x; Rosano GMC, 1999, CIRCULATION, V99, P1666, DOI 10.1161/01.CIR.99.13.1666; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P231; Sardar P, 2010, HIV CLIN TRIALS, V11, P220, DOI 10.1310/hct1104-220; Schiavi RC, 1997, ARCH SEX BEHAV, V26, P231, DOI 10.1023/A:1024518730222; Schwartz JB, 2011, INT J ANDROL, V34, pE415, DOI 10.1111/j.1365-2605.2011.01163.x; Seidman SN, 2006, J SEX MARITAL THER, V32, P267, DOI 10.1080/00926230600575355; Seidman SN, 2005, J CLIN PSYCHOPHARM, V25, P584, DOI 10.1097/01.jcp.0000185424.23515.e5; Seidman SN, 2001, J CLIN PSYCHIAT, V62, P406, DOI 10.4088/JCP.v62n0602; Seidman SN, 2009, J CLIN PSYCHOPHARM, V29, P216, DOI 10.1097/JCP.0b013e3181a39137; Shabsigh R, 2008, J UROLOGY, V179, pS97, DOI 10.1016/j.juro.2008.03.145; Sharma R, 2015, EUR HEART J, V36, P2706, DOI 10.1093/eurheartj/ehv346; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Shores MM, 2009, J CLIN PSYCHIAT, V70, P1009, DOI 10.4088/JCP.08m04478; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Singer N., 2013, NY TIMES; SKAKKEBAEK NE, 1981, CLIN ENDOCRINOL, V14, P49, DOI 10.1111/j.1365-2265.1981.tb00364.x; Smith AM, 2005, EUR J ENDOCRINOL, V152, P285, DOI 10.1530/eje.1.01848; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P1966, DOI 10.1210/jc.84.6.1966; Snyder PJ, 2001, AM J MED, V111, P255, DOI 10.1016/S0002-9343(01)00813-0; Spitzer M, 2012, ANN INTERN MED, V157, P681, DOI 10.7326/0003-4819-157-10-201211200-00004; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Sullivan DH, 2005, MED SCI SPORT EXER, V37, P1664, DOI 10.1249/01.mss.0000181840.54860.8b; Svartberg J, 2004, RESP MED, V98, P906, DOI 10.1016/j.rmed.2004.02.015; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; Thompson PD, 2002, AM HEART J, V143, P249, DOI 10.1067/mhj.2002.120144; Travison TG, 2011, J GERONTOL A-BIOL, V66, P1090, DOI 10.1093/gerona/glr100; Tricker R, 1996, J CLIN ENDOCR METAB, V81, P3754, DOI 10.1210/jc.81.10.3754; Uyanik BS, 1997, JPN HEART J, V38, P73; Vaughan C, 2007, J ANDROL, V28, P875, DOI 10.2164/jandrol.107.002931; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Webb CM, 2008, AM J CARDIOL, V101, P618, DOI 10.1016/j.amjcard.2007.09.114; Webb CM, 1999, AM J CARDIOL, V83, P437, DOI 10.1016/S0002-9149(98)00880-7; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618; Wolf OT, 2000, BIOL PSYCHIAT, V47, P650, DOI 10.1016/S0006-3223(99)00145-6; WU SZ, 1993, CHINESE MED J-PEKING, V106, P415; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330	170	66	66	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162480	10.1371/journal.pone.0162480	http://dx.doi.org/10.1371/journal.pone.0162480			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655114	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700024
J	Sanchez-Pinero, F; Urbano-Tenorio, F				Sanchez-Pinero, Francisco; Urbano-Tenorio, Fernando			Watch Out for Your Neighbor: Climbing onto Shrubs Is Related to Risk of Cannibalism in the Scorpion Buthus cf. occitanus	PLOS ONE			English	Article							GECKO TARENTOLA-MAURITANICA; PREY-LOCALIZING BEHAVIOR; PARUROCTONUS-MESAENSIS; DESERT SCORPION; PREDATION RISK; SAND SCORPION; ARID ZONE; POPULATION; DYNAMICS; PATTERNS	The distribution and behavior of foraging animals usually imply a balance between resource availability and predation risk. In some predators such as scorpions, cannibalism constitutes an important mortality factor determining their ecology and behavior. Climbing on vegetation by scorpions has been related both to prey availability and to predation (cannibalism) risk. We tested different hypotheses proposed to explain climbing on vegetation by scorpions. We analyzed shrub climbing in Buthus cf. occitanus with regard to the following: a) better suitability of prey size for scorpions foraging on shrubs than on the ground, b) selection of shrub species with higher prey load, c) seasonal variations in prey availability on shrubs, and d) whether or not cannibalism risk on the ground increases the frequency of shrub climbing. Prey availability on shrubs was compared by estimating prey abundance in sticky traps placed in shrubs. A prey sample from shrubs was measured to compare prey size. Scorpions were sampled in six plots (50 m x 10 m) to estimate the proportion of individuals climbing on shrubs. Size difference and distance between individuals and their closest scorpion neighbor were measured to assess cannibalism risk. The results showed that mean prey size was two-fold larger on the ground. Selection of particular shrub species was not related to prey availability. Seasonal variations in the number of scorpions on shrubs were related to the number of active scorpions, but not with fluctuations in prey availability. Size differences between a scorpion and its nearest neighbor were positively related with a higher probability for a scorpion to climb onto a shrub when at a disadvantage, but distance was not significantly related. These results do not support hypotheses explaining shrub climbing based on resource availability. By contrast, our results provide evidence that shrub climbing is related to cannibalism risk.	[Sanchez-Pinero, Francisco; Urbano-Tenorio, Fernando] Univ Granada, Fac Ciencias, Dept Zool, E-18071 Granada, Spain	University of Granada	Sanchez-Pinero, F (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, E-18071 Granada, Spain.	fspinero@ugr.es	Piñero, Francisco Sanchez/L-2629-2014	Piñero, Francisco Sanchez/0000-0002-9852-8318; Urbano Tenorio, Fernando/0000-0002-4292-7651				Atienza Juan Carlos, 1994, Ardeola, V41, P173; BRADLEY RA, 1988, J ANIM ECOL, V57, P533, DOI 10.2307/4923; Brown CA, 2000, AM MIDL NAT, V144, P406, DOI 10.1674/0003-0031(2000)144[0406:PCBITS]2.0.CO;2; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brownell P, 2001, SCORPION BIOLOGY AND RESEARCH, P159; BROWNELL P, 1979, ANIM BEHAV, V27, P185, DOI 10.1016/0003-3472(79)90138-6; BROWNELL PH, 1977, SCIENCE, V197, P479, DOI 10.1126/science.197.4302.479; Brownell PH, 2001, AM ZOOL, V41, P1229, DOI 10.1668/0003-1569(2001)041[1229:VSAACT]2.0.CO;2; Castilla AM, 2007, B SOC HIST NAT BALEA, V50, P267; Castilla AM, 2010, RECERCA, V19, P221; Corcobado G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-236; Cresswell W, 2013, BEHAV ECOL, V24, P871, DOI 10.1093/beheco/art023; Cribbie RA, 2007, J MOD APPL STAT METH, V6, P117, DOI 10.22237/jmasm/1177992660; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Doblas-Miranda E, 2009, SOIL BIOL BIOCHEM, V41, P2543, DOI 10.1016/j.soilbio.2009.09.014; Doblas-Miranda E, 2009, APPL SOIL ECOL, V41, P329, DOI 10.1016/j.apsoil.2008.12.008; Elgar M. A., 1992, CANNIBALISM ECOLOGY, P1; Fet V, 2010, ACTA ZOOL BULGAR, V62, P3; Gaffin D, 2001, SCORPION BIOLOGY AND RESEARCH, P184; GAFFIN DD, 1992, ETHOLOGY, V91, P59; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hodar JA, 1999, HERPETOL J, V9, P29; Hodar JA, 2006, J ARID ENVIRON, V65, P83, DOI 10.1016/j.jaridenv.2005.08.006; Hodar JA, 2002, J ZOOL, V257, P101, DOI 10.1017/S0952836902000699; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; HOLM S, 1979, SCAND J STAT, V6, P65; Hutto R.L., 1990, Studies in Avian Biology, P20; Knutson EM, 2010, SOUTHWEST ENTOMOL, V35, P289, DOI 10.3958/059.035.0307; Krebbs C. J., 1999, ECOLOGICAL METHODOLO; Lehmann LM, 2004, ETHOLOGY, V110, P323, DOI 10.1111/j.1439-0310.2004.00972.x; LEONARDSSON K, 1991, ECOLOGY, V72, P1273, DOI 10.2307/1941101; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOURENCO W. R., 2005, EUSCORPIUS, V19, P1; Lourenco Wilson R., 2004, Revista Iberica de Aracnologia, V9, P81; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; Moya-Larano J, 2002, EVOLUTION, V56, P420, DOI 10.1111/j.0014-3820.2002.tb01351.x; Petersen A, 2010, BEHAV ECOL, V21, P1112, DOI 10.1093/beheco/arq119; Pinero FS, 2011, J ARID ENVIRON, V75, P1321, DOI 10.1016/j.jaridenv.2011.06.014; Pizzatto L, 2008, BEHAV ECOL, V19, P990, DOI 10.1093/beheco/arn060; Polis G.A., 1990, P247; POLIS GA, 1986, J ANIM ECOL, V55, P59, DOI 10.2307/4692; POLIS GA, 1979, J ZOOL, V188, P333, DOI 10.1111/j.1469-7998.1979.tb03419.x; POLIS GA, 1985, OECOLOGIA, V67, P273, DOI 10.1007/BF00384298; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; POLIS GA, 1981, J ARID ENVIRON, V4, P309, DOI 10.1016/S0140-1963(18)31477-0; POLIS GA, 1980, BEHAV ECOL SOCIOBIOL, V7, P25, DOI 10.1007/BF00302515; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; POLIS GA, 1980, J ANIM ECOL, V49, P1, DOI 10.2307/4275; Quan Dong, 1992, P13; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rossi Andrea, 2012, Bulletin of the British Arachnological Society, V15, P273; Rudolf VHW, 2006, ECOLOGY, V87, P362, DOI 10.1890/05-0961; Pinero FS, 2013, J ARACHNOL, V41, P88, DOI 10.1636/Hi11-90.1; SHACHAK M, 1983, OECOLOGIA, V60, P371, DOI 10.1007/BF00376854; Skutelsky O, 1996, ANIM BEHAV, V52, P49, DOI 10.1006/anbe.1996.0151; SKUTELSKY O, 1995, J ARACHNOL, V23, P46; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; Steinmetz Steffany B., 2004, Euscorpius, V12-17, P1; Taylor MS, 2012, J ARACHNOL, V40, P240, DOI 10.1636/Hi11-75.1; Warburg M.R., 1990, P224; Wolda H., 1990, Studies in Avian Biology, P38; YAMASHITA T, 2004, EUSCORPIUS, V17, P25; Zollner PA, 2005, OIKOS, V108, P219, DOI 10.1111/j.0030-1299.2005.13711.x	64	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161747	10.1371/journal.pone.0161747	http://dx.doi.org/10.1371/journal.pone.0161747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655347	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700008
J	Ahmadi, Z; Sundh, J; Bornefalk-Hermansson, A; Ekstrom, M				Ahmadi, Zainab; Sundh, Josefin; Bornefalk-Hermansson, Anna; Ekstrom, Magnus			Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; SURVIVAL; EXPERIENCE; REGISTER; DYSPNEA; PEOPLE; RELIEF; TRIAL; HOME; AIR	Long-term oxygen therapy (LTOT) >= 15 h/day improves survival in hypoxemic chronic obstructive pulmonary disease ( COPD). LTOT 24 h/day is often recommended but may pose an unnecessary burden with no clear survival benefit compared with LTOT 15 h/day. The aim was to test the hypothesis that LTOT 24 h/day decreases all-cause, respiratory, and cardiovascular mortality compared to LTOT 15 h/day in hypoxemic COPD. This was a prospective, observational, population-based study of COPD patients starting LTOT between October 1, 2005 and June 30, 2009 in Sweden. Overall and cause-specific mortality was analyzed using Cox and Fine-Gray regression, controlling for age, sex, prescribed oxygen dose, PaO2 (air), PaCO2 (air), Forced Expiratory Volume in one second (FEV1), WHO performance status, body mass index, comorbidity, and oral glucocorticoids. A total of 2,249 included patients were included with a median follow-up of 1.1 years (interquartile range, 0.6-2.1). 1,129 (50%) patients died and no patient was lost to follow-up. Higher LTOT duration analyzed as a continuous variable was not associated with any change in mortality rate (hazard ratio [HR] 1.00; (95% confidence interval [CI], 0.98 to 1.02) per 1 h/day increase above 15 h/day. LTOT exactly 24 h/day was prescribed in 539 (24%) patients and LTOT 15-16 h/day in 1,231 (55%) patients. Mortality was similar between the groups for all-cause, respiratory and cardiovascular mortality. In hypoxemic COPD, LTOT 24 h/day was not associated with a survival benefit compared with treatment 15-16 h/day. A design for a registry-based randomized trial (R-RCT) is proposed.	[Ahmadi, Zainab; Ekstrom, Magnus] Lund Univ, Div Resp Med & Allergol, Dept Clin Sci, Lund, Sweden; [Sundh, Josefin] Univ Orebro, Sch Med Sci, Dept Resp Med, Orebro, Sweden; [Bornefalk-Hermansson, Anna] Uppsala Univ, Dept Stat, Uppsala, Sweden	Lund University; Orebro University; Uppsala University	Ahmadi, Z (corresponding author), Lund Univ, Div Resp Med & Allergol, Dept Clin Sci, Lund, Sweden.	zai.ahmd@gmail.com		Bornefalk-Hermansson, Anna/0000-0001-9934-8485	Swedish Society of Medicine; Swedish Respiratory Society; Swedish Heart Lung Foundation; Wera and Emil Cornell Foundation; Scientific Committee of Blekinge County Council; Scientific Committee of the Region of Orebro	Swedish Society of Medicine; Swedish Respiratory Society; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Wera and Emil Cornell Foundation; Scientific Committee of Blekinge County Council; Scientific Committee of the Region of Orebro	This work was supported by unrestricted grants from The Swedish Society of Medicine, the Swedish Respiratory Society, the Swedish Heart Lung Foundation, and the Wera and Emil Cornell Foundation to ME; and ME and ZA were supported by unrestricted grants from the Scientific Committee of Blekinge County Council. JS was supported by unrestricted grants from the Scientific Committee of the Region of Orebro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Ahmadi Z, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-30; Alton M, 1985, LAKARTIDNINGEN, V82, P4399; Ameer F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000238.pub2; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 1992, MAN INT STAT CLASS D; ANTHONISEN NR, 1989, AM REV RESPIR DIS, V140, pS95, DOI 10.1164/ajrccm/140.3_Pt_2.S95; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; Carpagnano GE, 2004, THORAX, V59, P1016, DOI 10.1136/thx.2003.020768; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Cranston JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001744.pub2; Cranston JM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004769.pub2; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; Croxton TL, 2006, AM J RESP CRIT CARE, V174, P373, DOI 10.1164/rccm.200507-1161WS; Dellborg M, 1993, Lakartidningen, V90, P3077; Disler RT, 2014, J PAIN SYMPTOM MANAG, V48, P1182, DOI 10.1016/j.jpainsymman.2014.03.009; Ekstrom MP, 2011, AM J RESP CRIT CARE, V183, P1032, DOI 10.1164/rccm.201010-1704OC; Ekstrom MP, 2013, AM J RESP CRIT CARE; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, pg445, DOI DOI 10.1136/BMJ.G445; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FLENLEY DC, 1981, LANCET, V1, P681; Franklin KA, 2007, RESP MED, V101, P1506, DOI 10.1016/j.rmed.2007.01.009; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Goldbart J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-124; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Gulbas G, 2012, INT J CLIN PRACT, V66, P152, DOI 10.1111/j.1742-1241.2011.02833.x; Hardinge M, 2015, THORAX, V70, P1, DOI 10.1136/thoraxjnl-2015-206865; Holguin Fernando, 2013, Ann Am Thorac Soc, V10 Suppl, pS150, DOI 10.1513/AnnalsATS.201305-116AW; James S, 2015, NAT REV CARDIOL, V12, P312, DOI 10.1038/nrcardio.2015.33; Kampelmacher MJ, 1998, RESP MED, V92, P70, DOI 10.1016/S0954-6111(98)90035-X; Katsenos S, 2011, PULM MED, V2011, DOI 10.1155/2011/325362; Lakemedelsverket (Swedish Medical Products Agency), 2015, LAK KRON OBSTR LUNGS; Lofdahl Kerstin, 2007, Lakartidningen, V104, P1902; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Ring L, 1997, J ADV NURS, V26, P337, DOI 10.1046/j.1365-2648.1997.1997026337.x; STARK RD, 1972, BRIT MED J, V3, P724, DOI 10.1136/bmj.3.5829.724; Stoller JK, 2010, CHEST, V138, P179, DOI 10.1378/chest.09-2555; STROM K, 1988, EUR RESPIR J, V1, P952; Swedish National Register for Respiratory Failure (Swedevox), 2015, GUID LONG TERM OXYG; Swedish National Register for Respiratory Failure (Swedevox), 2014, ANN REPORT; Uronis HE, 2015, THORAX, V70, P492, DOI 10.1136/thoraxjnl-2014-205720; Utens CMA, 2013, INT J NURS STUD, V50, P1537, DOI 10.1016/j.ijnurstu.2013.03.006; Welfare. SNBoHa, 2008, WELF SNBOHA QUAL CON; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; World Health Organization (WHO), 1978, MAN INT CLASS DIS IN; Zielinski J, 1998, CHEST, V113, P65, DOI 10.1378/chest.113.1.65	46	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163293	10.1371/journal.pone.0163293	http://dx.doi.org/10.1371/journal.pone.0163293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649490	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100076
J	Maroun, R; Maunoury, F; Benjamin, L; Nachbaur, G; Durand-Zaleski, I				Maroun, Rana; Maunoury, Franck; Benjamin, Laure; Nachbaur, Gaelle; Durand-Zaleski, Isabelle			In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013	PLOS ONE			English	Article							CANCER	Background & Objectives The aim of this study was to assess the economic burden of hospitalisations for metastatic renal cell carcinoma (mRCC), to describe the patterns of prescribing expensive drugs and to explore the impact of geographic and socio-demographic factors on the use of these drugs. Methods We performed a retrospective analysis from the French national hospitals database. Hospital stays for mRCC between 2008 and 2013 were identified by combining the 10th revision of the International Classification of Diseases (ICD-10) codes for renal cell carcinoma (C64) and codes for metastases (C77 to C79). Incident cases were identified out of all hospital stays and followed till December 2013. Descriptive analyses were performed with a focus on hospital stays and patient characteristics. Costs were assessed from the perspective of the French National Health Insurance and were obtained from official diagnosis-related group tariffs for public and private hospitals. Results A total of 15,752 adult patients were hospitalised for mRCC, corresponding to 102,613 hospital stays. Of those patients, 68% were men and the median age at first hospitalisation was 69 years [Min-Max: 18-102]. Over the study period, the hospital mortality rate reached 37%. The annual cost of managing mRCC at hospital varied between 28M(sic) in 2008 and 42M(sic) in 2012 and was mainly driven by inpatient costs. The mean annual per capita cost of hospital management of mRCC varied across the study period from 8,993(sic) (SD: (sic)8,906) in 2008 to 10,216(sic) (SD: (sic)10,527) in 2012. Analysis of the determinants of prescribing expensive drugs at hospital did not show social or territorial differences in the use of these drugs. Conclusion This study is the first to investigate the in-hospital economic burden of mRCC in France. Results showed that in-hospital costs of managing mRCC are mainly driven by expensive drugs and inpatient costs.	[Maroun, Rana; Benjamin, Laure; Nachbaur, Gaelle] GlaxoSmithKline, Marly Le Roi, France; [Maunoury, Franck] Statesia, Le Mans, France; [Durand-Zaleski, Isabelle] AP HP, URC Eco Ile de France, Paris, France; [Maroun, Rana; Durand-Zaleski, Isabelle] INSERM, ECEVE, Paris, France	GlaxoSmithKline; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Maroun, R (corresponding author), GlaxoSmithKline, Marly Le Roi, France.; Maroun, R (corresponding author), INSERM, ECEVE, Paris, France.	rana.r.maroun@gsk.com	; Maroun, Rana/D-5897-2017	Nachbaur, Gaelle/0000-0001-5116-0723; DUPONT-BENJAMIN, Laure/0000-0001-7748-0768; Maroun, Rana/0000-0002-6592-5739	GlaxoSmithKline; Association Nationale de la Recherche et de la Technologie (ANRT)	GlaxoSmithKline(GlaxoSmithKline); Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR))	This work is a part of a PhD program (CIFRE, Convention Industrielle de Formation par la REcherche) funded by GlaxoSmithKline and the Association Nationale de la Recherche et de la Technologie (ANRT).	A.R. Tu. R, 2016, TUMEURS REIN GEN EPI; Assurance Maladie, 2016, DONN MENS ANN MED RE; Benjamin L, 2015, CURR MED RES OPIN, V31, P323, DOI 10.1185/03007995.2014.986324; Casez P, 2015, MED MALADIES INFECT, V45, P446, DOI 10.1016/j.medmal.2015.10.004; Charles T, 2010, EMC UROLOGIE, V4, P1, DOI [10.1016/S1762-0953(10)52713-4, DOI 10.1016/S1762-0953(10)52713-4]; Geynisman Daniel M, 2015, Clin Genitourin Cancer, V13, pe93, DOI 10.1016/j.clgc.2014.08.013; Hansen RN, 2015, J MANAG CARE SPEC PH, V21, P37, DOI 10.18553/jmcp.2015.21.1.37; InCa, 2014, CANC FRANC; Institut National Du Cancer, 2015, INC NAT CANC; Larkin J, 2013, EXPERT OPIN PHARMACO, V14, P27, DOI 10.1517/14656566.2013.758713; Pal SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063341; Rey G, 2009, BMC PUBLIC HEALTH, V9, P33, DOI DOI 10.1186/1471-2458-9-33; Scherpereel A, 2015, VALUE HEALTH, V18, pA341, DOI 10.1016/j.jval.2015.09.145; Soerensen AV, 2015, EUR UROL, V68, P516, DOI 10.1016/j.eururo.2014.12.017; Windenberger F, 2012, EUR J PUBLIC HEALTH, V22, P347, DOI 10.1093/eurpub/ckr029	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162864	10.1371/journal.pone.0162864	http://dx.doi.org/10.1371/journal.pone.0162864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649305	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100038
J	White, D; Coombe, D; Rezania, V; Tuszynski, J				White, Diana; Coombe, Dennis; Rezania, Vahid; Tuszynski, Jack			Building a 3D Virtual Liver: Methods for Simulating Blood Flow and Hepatic Clearance on 3D Structures	PLOS ONE			English	Article							CONSTRAINED CONSTRUCTIVE OPTIMIZATION; ARTERIAL TREE MODELS; PACLITAXEL METABOLISM; VASCULAR TREES; NETWORK MODEL; HEMODYNAMICS	In this paper, we develop a spatio-temporal modeling approach to describe blood and drug flow, as well as drug uptake and elimination, on an approximation of the liver. Extending on previously developed computational approaches, we generate an approximation of a liver, which consists of a portal and hepatic vein vasculature structure, embedded in the surrounding liver tissue. The vasculature is generated via constrained constructive optimization, and then converted to a spatial grid of a selected grid size. Estimates for surrounding upscaled lobule tissue properties are then presented appropriate to the same grid size. Simulation of fluid flow and drug metabolism (hepatic clearance) are completed using discretized forms of the relevant convective-diffusive-reactive partial differential equations for these processes. This results in a single stage, uniformly consistent method to simulate equations for blood and drug flow, as well as drug metabolism, on a 3D structure representative of a liver.	[White, Diana] Clarkson Univ, Dept Math, Potsdam, NY USA; [Coombe, Dennis] Comp Modelling Grp Ltd, Calgary, AB, Canada; [Rezania, Vahid] MacEwan Univ, Dept Phys Sci, Edmonton, AB, Canada; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Tuszynski, Jack] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Clarkson University; University of Alberta; University of Alberta	Tuszynski, J (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.; Tuszynski, J (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	jackt@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429	Modelling Group Ltd.	Modelling Group Ltd.	The computer Modelling Group Ltd. only provided financial support in the form of author salary (DC) and access to research material (STARS software package). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arias M., 2009, LIVER BIOL PATHOLOGY, V5; ARTS T, 1979, AM J PHYSIOL, V237, pH469, DOI 10.1152/ajpheart.1979.237.4.H469; Bartholomew-Biggs M, 2008, SPRINGER SER OPTIM A, V19, P1, DOI 10.1007/978-0-387-78723-7_1; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; CMG Limited, 2013, STARS US GUID ADV PR; D'Alessandro LA, 2015, PROG BIOPHYS MOL BIO, V117, P78, DOI 10.1016/j.pbiomolbio.2014.11.005; Debbaut C, 2011, IEEE T BIO-MED ENG, V58, P25, DOI 10.1109/TBME.2010.2065229; Dullien F., 1992, POROUS MEDIA FLUID T, Vv2; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Goulet G., 2009, B APPL MECH, V5, P6; Goulet GC, 2009, ANN BIOMED ENG, V37, P1390, DOI 10.1007/s10439-009-9706-1; Hahn HK, 2005, MATH BIOSCI INTERAC, P55, DOI 10.1007/3-7643-7412-8_5; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Ierapetritou MG, 2009, CTS-CLIN TRANSL SCI, V2, P228, DOI 10.1111/j.1752-8062.2009.00092.x; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Johnson TN, 2010, CLIN PHARMACOKINET, V49, P189, DOI 10.2165/11318160-000000000-00000; KAMIYA A, 1972, B MATH BIOPHYS, V34, P431, DOI 10.1007/BF02476705; Karch R, 1999, COMPUT BIOL MED, V29, P19, DOI 10.1016/S0010-4825(98)00045-6; Kretowski M, 2003, COMPUT METH PROG BIO, V70, P129, DOI 10.1016/S0169-2607(01)00200-0; Louman-Gardiner KM, 2011, COMPUT METHOD BIOMEC, V14, P1071, DOI 10.1080/10255842.2010.508037; Monsarrat B, 1998, DRUG METAB DISPOS, V26, P229; Rezania V, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0034-5; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-53; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-52; Risoe C., 1991, BLOOD VOLUME CHANGES, V261, P1763; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schreiner W, 1997, J THEOR BIOL, V187, P147, DOI 10.1006/jtbi.1997.0413; SCHREINER W, 1993, J BIOMED ENG, V15, P148, DOI 10.1016/0141-5425(93)90046-2; SCHREINER W, 1995, J GEN PHYSIOL, V106, P583, DOI 10.1085/jgp.106.4.583; SCHREINER W, 1994, J GEN PHYSIOL, V103, P975, DOI 10.1085/jgp.103.6.975; SCHREINER W, 1993, IEEE T BIO-MED ENG, V40, P482, DOI 10.1109/10.243413; Schreiner W, 2006, MED ENG PHYS, V28, P416, DOI 10.1016/j.medengphy.2005.07.019; Schwen LO, 2016, COMPUT BIOL MED, V73, P108, DOI 10.1016/j.compbiomed.2016.04.004; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Selle D, 2002, IEEE T MED IMAGING, V21, P1344, DOI 10.1109/TMI.2002.801166; SHOEMAKER CP, 1964, CIRC RES, V15, P216, DOI 10.1161/01.RES.15.3.216; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666; Van Der Plaats A, 2004, INT J ARTIF ORGANS, V27, P222, DOI 10.1177/039139880402700309; Willmann Stefan, 2005, Expert Opin Drug Metab Toxicol, V1, P159, DOI 10.1517/17425255.1.1.159; ZAMIR M, 1988, J GEN PHYSIOL, V91, P725, DOI 10.1085/jgp.91.5.725; Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892	43	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162215	10.1371/journal.pone.0162215	http://dx.doi.org/10.1371/journal.pone.0162215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649537	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100014
J	Boko, PM; Ibikounle, M; Onzo-Aboki, A; Tougoue, JJ; Sissinto, Y; Batcho, W; Kinde-Gazard, D; Kabore, A				Boko, Pelagie M.; Ibikounle, Moudachirou; Onzo-Aboki, Ablawa; Tougoue, Jean-Jacques; Sissinto, Yollande; Batcho, Wilfrid; Kinde-Gazard, Dorothe; Kabore, Achille			Schistosomiasis and Soil Transmitted Helminths Distribution in Benin: A Baseline Prevalence Survey in 30 Districts	PLOS ONE			English	Article							INFECTION; EPIDEMIOLOGY	In 2013, Benin developed strategies to control neglected tropical diseases and one of the first step was the disease mapping of the entire country in order to identify endemic districts of schistosomiasis and soil transmitted helminths (STH). This study was carried out in 30 of the 77 districts of Benin. Of these 30 districts 22 were previously treated for Lymphatic Filariasis (LF) using the Ivermectin and Albendazole combination. In each district, five schools were selected and 50 children aged 8 to 14 years were sampled in each school, making a total of 250 children sampled in the district. The schools were selected mainly according to their proximity to lakes or any bodies of water that were likely to have been used by the children. Samples of faeces and urine were collected from each pupil. Urinary schistosomiasis was identified using the urine filtration technique while STH and intestinal schistosomiasis were identified through the Kato Katz method. Overall a total of 7500 pupils were surveyed across 150 schools with a gender ratio of 1:1. Hookworm was identified in all 30 districts with a prevalence ranging from 1.2% (95% CI: 0.0-2.5) to 60% (95% CI: 53.9-66.1). Ascaris lumbricoides was detected in 19 districts with a prevalence rate between 1% (95% CI: 0.0-2.2) and 39% (95% CI: 32.9-45.0). In addition to these common STH, Trichuris trichiura, Enterobius vermicularis and Strongyloides stercoralis were found at low prevalence. Only 16 districts were endemic to Schistosoma mansoni, while 29 districts were endemic to S. haematobium. The S. haematobium prevalence ranged from 0.8% (95% CI: 0.0-1.9) to 56% (95% CI: 50.2-62.5) while the prevalence of S. mansoni varied from 0.4% (95% CI: 0.0-1.2) to 46% (95% CI: 39.8-52.2). The 22 districts, where LF was successfully eliminated, still require mass drug administration (MDA) of albendazole indicating that school-based MDA would be needed even after LF elimination in districts co-endemic to LF and STH in Benin.	[Boko, Pelagie M.; Batcho, Wilfrid] Minist Hlth Benin, Natl Control Program Communicable Dis, 01BP882, Cotonou, Benin; [Ibikounle, Moudachirou; Onzo-Aboki, Ablawa] Univ Abomey Calavi, Fac Sci & Tech, 01BP526, Cotonou, Benin; [Tougoue, Jean-Jacques; Kabore, Achille] Res Triangle Inst, Washington, DC USA; [Tougoue, Jean-Jacques; Kabore, Achille] 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Sissinto, Yollande; Kinde-Gazard, Dorothe] Univ Abomey Calavi, Fac Hlth Sci, 01BP 526, Cotonou, Benin	University of Abomey Calavi; Research Triangle Institute; University of Abomey Calavi	Boko, PM (corresponding author), Minist Hlth Benin, Natl Control Program Communicable Dis, 01BP882, Cotonou, Benin.	pelagieboko@gmail.com		IBIKOUNLE, Moudachirou/0000-0002-3640-0175; Moudachirou, IBIKOUNLE/0000-0002-3517-1729	United States Agency for International Development (USAID); USAID through the ENVISION project [AID-OAA-A-11-00048]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID through the ENVISION project	This study was made possible with funding from the United States Agency for International Development (USAID). USAID support for NTD control in Benin led by RTI International under Cooperative Agreement No AID-OAA-A-11-00048 through the ENVISION project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelign Tilahun, 2015, J Parasitol Res, V2015, P641602, DOI 10.1155/2015/641602; Awasthi S, 2003, BMJ-BRIT MED J, V327, P431, DOI 10.1136/bmj.327.7412.431; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; CHIPPAUX JP, 1990, B SOC PATHOL EXOT, V83, P498; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Garba A, 1999, SANTE MONTROUGE FR, V10, P323; Hotez P.J., 2006, HELMINTH INFECT SOIL; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Ibikounle M, 2014, Bull Soc Pathol Exot, V107, P171, DOI 10.1007/s13149-014-0344-y; INSAE & ICF, 2013, ENQ DEM SANT BEN 201; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Katz N, 1972, SIMPLE DEVICE QUANTI; Kheir MM, 1999, AM J TROP MED HYG, V60, P307, DOI 10.4269/ajtmh.1999.60.307; Mone H, 2012, SCI WORLD J, DOI 10.1100/2012/793420; Mone H, 2010, ADV PARASIT, V71, P33, DOI 10.1016/S0065-308X(10)71001-0; NOKES C, 1991, T ROY SOC TROP MED H, V85, P272, DOI 10.1016/0035-9203(91)90052-Z; NOKES C, 1994, PARASITOL TODAY, V10, P14, DOI 10.1016/0169-4758(94)90348-4; Panesar A, 2015, SANITATION ACTIVITIE; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Sady H, 2015, PARASITE VECTOR, V8, P1, DOI DOI 10.1186/s13071-014-0608-1; Salawu A. S., 2014, Journal of Public Health and Epidemiology, V6, P417; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Tomas J, 2012, EPITOOLS EPIDEMIOLOG; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2015, SCHIST; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2001, SCHIST SOIL TRANSM H; World Health Organization, 2002, WHO TECHN REP SER; World Health Organization, 2015, PREV CHEM HUM HELM C	33	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162798	10.1371/journal.pone.0162798	http://dx.doi.org/10.1371/journal.pone.0162798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643795	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900018
J	Eschbaumer, M; Stenfeldt, C; Smoliga, GR; Pacheco, JM; Rodriguez, LL; Li, RW; Zhu, J; Arzt, J				Eschbaumer, Michael; Stenfeldt, Carolina; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.; Li, Robert W.; Zhu, James; Arzt, Jonathan			Transcriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the Nasopharynx	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC VIRAL-INFECTION; ESOPHAGEAL-PHARYNGEAL FLUID; CDNA MICROARRAY DATA; NF-KAPPA-B; CARRIER STATE; SECRETORY IGA; TR1 CELLS; IN-VITRO; PATHOGENESIS	In order to investigate the mechanisms of persistent foot-and-mouth disease virus (FMDV) infection in cattle, transcriptome alterations associated with the FMDV carrier state were characterized using a bovine whole-transcriptome microarray. Eighteen cattle (8 vaccinated with a recombinantFMDV A vaccine, 10 non-vaccinated) were challenged with FMDV A(24) Cruzeiro, and the gene expression profiles of nasopharyngeal tissues collected between 21 and 35 days after challenge were compared between 11 persistently infected carriers and 7 non-carriers. Carriers and non-carrierswere further compared to 2 naive animals that had been neither vaccinated nor challenged. At a controlled false-discovery rate of 10% and a minimum difference in expression of 50%, 648 genes were differentially expressed between FMDV carriers and non-carriers, and most (467) had higher expression in carriers. Among these, genes associated with cellular proliferation and the immune response-such as chemokines, cytokines and genes regulating T and B cells-were significantly overrepresented. Differential gene expression was significantly correlated between non-vaccinated and vaccinated animals (biological correlation +0.97), indicating a similar transcriptome profile across these groups. Genes related to prostaglandin E-2 production and the induction of regulatory T cells were over-expressed in carriers. In contrast, tissues from non-carrier animals expressed higher levels of complement regulators and pro-apoptotic genes that could promote virus clearance. Based on these findings, we propose a working hypothesis for FMDV persistence in nasopharyngeal tissues of cattle, in which the virus may be maintained by an impairment of apoptosis and the local suppression of cell-mediated antiviral immunity by inducible regulatory T cells.	[Eschbaumer, Michael; Stenfeldt, Carolina; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.; Zhu, James; Arzt, Jonathan] ARS, PIADC, FADRU, USDA, Greenport, NY 11944 USA; [Eschbaumer, Michael; Stenfeldt, Carolina] PIADC Res Participat Program, Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Li, Robert W.] ARS, AGIL, USDA, Beltsville, MD USA; [Eschbaumer, Michael] Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Agriculture (USDA); Friedrich Loeffler Institute	Zhu, J; Arzt, J (corresponding author), ARS, PIADC, FADRU, USDA, Greenport, NY 11944 USA.	james.zhu@ars.usda.gov; jonathan.arzt@ars.usda.gov	Ibrahim, Essam Hassan/G-1960-2018; Stenfeldt, Carolina/AAG-7940-2021	Ibrahim, Essam Hassan/0000-0003-0130-2257; Pacheco, Juan/0000-0001-5477-0201; Eschbaumer, Michael/0000-0002-1104-0695; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886	CRIS project (USDA, Agricultural Research Service) [1940-32000-057-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQPM-13-X-00131]; PIADC Research Participation Program fellowships	CRIS project (USDA, Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); PIADC Research Participation Program fellowships	This work was funded in part by CRIS project 1940-32000-057-00D (USDA, Agricultural Research Service), as well as through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQPM-13-X-00131. ME and CS were recipients of PIADC Research Participation Program fellowships, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement with the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki Y, 2004, J IMMUNOL, V173, P4352, DOI 10.4049/jimmunol.173.7.4352; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bell MP, 2007, J IMMUNOL, V179, P1893, DOI 10.4049/jimmunol.179.3.1893; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETZ M, 1991, J IMMUNOL, V146, P108; Brake DA, 2012, DEV BIOLOGICALS, V134, P123; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cecere TE, 2012, VIRUSES-BASEL, V4, P833, DOI 10.3390/v4050833; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Grubman MJ, 2010, FUTURE VIROL, V5, P51, DOI 10.2217/FVL.09.68; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P59; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff ND, 2012, VET IMMUNOL IMMUNOP, V148, P145, DOI 10.1016/j.vetimm.2011.05.013; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; McGuire HM, 2015, J IMMUNOL, V195, P5123, DOI 10.4049/jimmunol.1501463; Gonzalez SM, 2016, VIRAL IMMUNOL, V29, P2, DOI 10.1089/vim.2015.0066; Mohan MS, 2008, VET IMMUNOL IMMUNOP, V125, P337, DOI 10.1016/j.vetimm.2008.05.031; Moonen P, 2004, VET MICROBIOL, V103, P151, DOI 10.1016/j.vetmic.2004.07.005; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; OIE, 2012, MANUAL DIAGNOSTIC TE, P163; Olson BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00315; Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111; Otani K, 2014, J PATHOL, V234, P302, DOI 10.1002/path.4391; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pandya M, 2015, IMMUNOGENETICS, V67, P691, DOI 10.1007/s00251-015-0877-7; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Pellerin L, 2014, IMMUNOL RES, V58, P358, DOI 10.1007/s12026-014-8512-5; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; R Core Team, 2013, R LANG ENV STAT COMP; Rabizadeh E, 2015, THROMB RES, V136, P118, DOI 10.1016/j.thromres.2014.11.023; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Rieder E, 2005, J VIROL, V79, P12989, DOI 10.1128/JVI.79.20.12989-12998.2005; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2014, CURR TOP MICROBIOL, V380, P39, DOI 10.1007/978-3-662-43492-5_3; Rossi D, 2003, HAEMATOLOGICA, V88, P212; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Schutta C, 2016, VACCINE, V34, P3214, DOI 10.1016/j.vaccine.2015.12.018; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Shen L, 2015, CLIN SCI, V128, P665, DOI 10.1042/CS20140586; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; Smyth G, 2015, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Stack G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004641; Stenfeldt C, 2016, TRANSBOUND EMERG DIS, V63, P152, DOI 10.1111/tbed.12235; Stenfeldt C, 2012, J COMP PATHOL, V146, P243, DOI 10.1016/j.jcpa.2011.06.005; Stenfeldt C, 2016, J VIROL IN PRESS; Stenfeldt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143666; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; Svitek N, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-50; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Theron AJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/608930; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang YH, 2003, INST MATH S, V40, P403; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zeng HY, 2015, CELL MOL IMMUNOL, V12, P566, DOI 10.1038/cmi.2015.44; Zeng LL, 2012, J BIOL CHEM, V287, P29125, DOI 10.1074/jbc.M112.362038; Zhang Z, 2006, J COMP PATHOL, V134, P56, DOI 10.1016/j.jcpa.2005.06.011; Zhang ZD, 2004, J GEN VIROL, V85, P415, DOI 10.1099/vir.0.19538-0; Zhang ZD, 2003, J VIROL METHODS, V111, P95, DOI 10.1016/S0166-0934(03)00165-4; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431; Zhang ZD, 2015, VET RES, V46, DOI 10.1186/s13567-015-0276-y; Zhu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064119	121	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162750	10.1371/journal.pone.0162750	http://dx.doi.org/10.1371/journal.pone.0162750			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643611	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900016
J	Yu, SJ; Ding, LL; Luo, R; Li, XJ; Yang, J; Liu, HQ; Cong, L; Ran, C				Yu, Shijiang; Ding, Lili; Luo, Ren; Li, Xiaojiao; Yang, Juan; Liu, Haoqiang; Cong, Lin; Ran, Chun			Identification of Immunity-Related Genes in Dialeurodes citri against Entomopathogenic Fungus Lecanicillium attenuatum by RNA-Seq Analysis	PLOS ONE			English	Article							COTTON APHID; BOMBYX-MORI; TRIALEURODES-VAPORARIORUM; VERTICILLIUM-LECANII; MOLECULAR-CLONING; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; EXPRESSION; RESISTANCE; DROSOPHILA	Dialeurodes citri is a major pest in citrus producing areas, and large-scale outbreaks have occurred increasingly often in recent years. Lecanicillium attenuatum is an important ento-mopathogenic fungus that can parasitize and kill D. citri. We separated the fungus from corpses of D. citri larvae. However, the sound immune defense system of pests makes infection by an entomopathogenic fungus difficult. Here we used RNA sequencing technology (RNA-Seq) to build a transcriptome database for D. citri and performed digital gene expression profiling to screen genes that act in the immune defense of D. citri larvae infected with a pathogenic fungus. De novo assembly generated 84,733 unigenes with mean length of 772 nt. All unigenes were searched against GO, Nr, Swiss-Prot, COG, and KEGG databases and a total of 28,190 (33.3%) unigenes were annotated. We identified 129 immunity-related unigenes in transcriptome database that were related to pattern recognition receptors, information transduction factors and response factors. From the digital gene expression profile, we identified 441 unigenes that were differentially expressed in D. citri infected with L. attenuatum. Through calculated Log(2)Ratio values, we identified genes for which fold changes in expression were obvious, including cuticle protein, vitellogenin, cathepsin, prophenoloxidase, clip-domain serine protease, lysozyme, and others. Subsequent quantitative real-time polymerase chain reaction analysis verified the results. The identified genes may serve as target genes for microbial control of D. citri.	[Yu, Shijiang; Ding, Lili; Luo, Ren; Li, Xiaojiao; Yang, Juan; Liu, Haoqiang; Cong, Lin; Ran, Chun] Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Natl Engn Res Ctr Citrus, Chongqing 400712, Peoples R China	Chinese Academy of Agricultural Sciences; Southwest University - China	Ran, C (corresponding author), Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Natl Engn Res Ctr Citrus, Chongqing 400712, Peoples R China.	ranchun@cric.cn			National Science and Technology Support Program [2012BAD19B06]; National Sparking Plan Project [2012GA811001]; Technological Projects of Chongqing [cstc2014yykfB80007, cstc2014fazktjcsf80033]	National Science and Technology Support Program; National Sparking Plan Project; Technological Projects of Chongqing	This work was supported by the National Science and Technology Support Program (2012BAD19B06), the National Sparking Plan Project (2012GA811001), and Technological Projects of Chongqing (cstc2014yykfB80007, cstc2014fazktjcsf80033).	Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Asano T, 2013, INSECT BIOCHEM MOLEC, V43, P344, DOI 10.1016/j.ibmb.2013.01.001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Chen EH, 2014, INSECT MOL BIOL, V23, P52, DOI 10.1111/imb.12060; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fasulo TR, 1999, CITRUS WHITEFLY DIAL, V128, P1; Ford L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000377; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Gao YH, 2015, BIORESOURCES, V10, P10; GILL G, 2001, NZ BIOSECURITY, V26, P19; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Guo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043567; HALL RA, 1982, ANN APPL BIOL, V101, P1, DOI 10.1111/j.1744-7348.1982.tb00794.x; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Karatolos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031077; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Kim JJ, 2007, BIOCONTROL, V52, P789, DOI 10.1007/s10526-006-9050-4; Kim JJ, 2007, BIOL CONTROL, V40, P327, DOI 10.1016/j.biocontrol.2006.12.002; Kim Jeong Jun, 2008, Journal of Asia-Pacific Entomology, V11, P1, DOI 10.1016/j.aspen.2008.02.001; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Korolev N, 1999, MYCOL RES, V103, P833, DOI 10.1017/S0953756298007953; Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mound LA, 1978, WHITEFLY WORLD SYSTE; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; NGUYEN R, 1993, CATALOG ALEYRODIDAE; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purac J, 2008, J INSECT PHYSIOL, V54, P1356, DOI 10.1016/j.jinsphys.2008.07.012; Pyle K, 2009, CURRENT STATUS EC IM, P27; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderhall K., 1997, Developmental and Comparative Immunology, V21, P137, DOI 10.1016/S0145-305X(97)88601-6; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sultana K., 2000, Pakistan Journal of Phytopathology, V12, P42; Taft AS, 2001, INSECT MOL BIOL, V10, P97, DOI 10.1046/j.1365-2583.2001.00242.x; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Teets NM, 2014, J EXP BIOL, V217, P84, DOI 10.1242/jeb.089490; Wang RJ, 2015, FISH SHELLFISH IMMUN, V47, P582, DOI 10.1016/j.fsi.2015.09.047; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhang K, 2015, MOL IMMUNOL, V66, P409, DOI 10.1016/j.molimm.2015.04.008	49	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162659	10.1371/journal.pone.0162659	http://dx.doi.org/10.1371/journal.pone.0162659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644092	gold, Green Published, Green Submitted			2022-12-27	WOS:000383891900013
J	Akimoto, H; Oshima, S; Negishi, A; Ohara, K; Ohshima, S; Inoue, N; Kobayashi, D				Akimoto, Hayato; Oshima, Shinji; Negishi, Akio; Ohara, Kousuke; Ohshima, Shigeru; Inoue, Naoko; Kobayashi, Daisuke			Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline	PLOS ONE			English	Article							DEPRESSION	Smoking Cessation Treatment (SCT) is a policy that has to be promoted for health economics, and expectations for the success of treatments with varenicline (VAR) are large. However, the Food and Drug Administration (FDA) have issued a warning on VAR-induced depression and suicide. In the present study, utilizing the FDA Adverse Event Reporting System (FAERS), we searched for antidepressants (ADs) used during SCT that cause fewer suicide-related events (SRE) (Study 1). We also investigated whether VAR concomitantly administered with ADs increases the risk of SRE (Study 2). In addition, we investigated whether the use of VAR alone is a latent risk factor of SRE. The backgrounds of cases with and without SRE were matched using the Propensity Score. In Study 1, the highest integrated Reporting Odds Ratio (iROR) was noted in concomitantly administered mirtazapine (iROR 6.98; 95% Confidence Interval (CI) 1.57-30.99), while the lowest ratio was noted in concomitantly administered amitriptyline (iROR 0.59; iROR95% CI 0.23-1.50). Study 2 clarified that SCT increases the risk of SRE in AD-treated cases (iROR 8.02; iROR95% CI 5.47-11.76; not significance). Of ADs concomitantly used during SCT with VAR, amitriptyline and mirtazapine showed the lowest and highest risks, respectively (Study 1). It was clarified that concomitant use of VAR in the treatment of depression with ADs increased the risk of SRE (Study 2). The results of Studies 1 and 2 suggested that the use of VAR alone is a latent risk factor inducing suicide.	[Akimoto, Hayato; Oshima, Shinji; Negishi, Akio; Ohshima, Shigeru; Inoue, Naoko; Kobayashi, Daisuke] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama, Japan; [Ohara, Kousuke] Josai Int Univ, Fac Pharmaceut Sci, Togane, Chiba, Japan	Josai University	Kobayashi, D (corresponding author), Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama, Japan.	dkoba@josai.ac.jp		Oshima, Shinji/0000-0003-2638-0550; Akimoto, Hayato/0000-0002-5397-0137; Negishi, Akio/0000-0002-5887-9340				Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31; Brett Silverstein, 2011, PSYCHIAT RES, V187, P121, DOI [10.1016/j.psychres.2010.12.026, DOI 10.1016/J.PSYCHRES.2010.12.026]; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Fiore Michael C., TREATING TOBACCO USE; Food U. S. and Drug Administration, FDA REQ NEW BOX WARN; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Health and Social Care Information Centre, PRESCR COST AN ENGL; Institute for Economics and Policy, STUD ROL NONSM POL; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Nakagawa A, 2007, J CLIN PSYCHIAT, V68, P908, DOI 10.4088/JCP.v68n0613; Pompili M, 2003, BRIT J PSYCHIAT, V183, P173, DOI 10.1192/S0007125000162774; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; SURGEON GENERAL. GOV, 2014, HLTH CONS SMOK 50YEA; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; Wang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081045; World Health Organization, TOBACCO; Xu X, 2015, AM J PREV MED, V48, P326, DOI 10.1016/j.amepre.2014.10.012; Yang D., SAS GLOBAL FORUM 201; Zvolensky MJ, 2015, PSYCHIAT RES, V226, P73, DOI 10.1016/j.psychres.2014.11.064	23	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163583	10.1371/journal.pone.0163583	http://dx.doi.org/10.1371/journal.pone.0163583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657721	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200149
J	Cai, FC; Xiao, XY; Niu, X; Shi, H; Zhong, Y				Cai, Fucheng; Xiao, Xiyue; Niu, Xun; Shi, Hao; Zhong, Yi			Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE GENE; SQUAMOUS-CELL CARCINOMAS; TUMOR-ASSOCIATED GENES; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC VALUE; HEAD; HYPERMETHYLATION; P16; SURVIVAL; ASSOCIATION	Background O6-methylguanine-DNA methyl-transferase (MGMT) gene, a DNA repair gene, plays a critical role in the repair of alkylated DNA adducts that form following exposure to genotoxic agents. MGMT is generally expressed in various tumors, and its function is frequently lost because of hypermethylation in the promoter. The promoter methylation of MGMT has been extensively investigated in head and neck squamous cell carcinoma (HNSCC). However, the association between the promoter methylation of MGMT and HNSCC risk remains inconclusive and inconsistent. Therefore, we performed a meta-analysis to better clarify the association between the promoter methylation of MGMT and HNSCC risk. Methods A systematical search was conducted in PubMed, Web of Science, EMBASE, and Ovid for studies on the association between MGMT promoter methylation and HNSCC. Odds ratio (ORs) and 95% confidence intervals (CI) were calculated to estimate association between MGMT promoter methylation and risk of HNSCC. The meta-regression and subgroup analysis were undertaken to explore the potential sources of heterogeneity. Results Twenty studies with 1,030 cases and 775 controls were finally included in this study. The frequency of MGMT promoter methylation was 46.70% in HNSCC group and 23.23% in the control group. The frequency of MGMT promoter methylation in HNSCC group was significantly higher than the control group (OR = 2.83, 95% CI = 2.25-3.56). Conclusion This meta-analysis indicates that aberrant methylation of MGMT promoter was significantly associated with the risk of HNSCC, and it may be a potential molecular marker for monitoring the disease and may provide new insights to the treatment of HNSCC.	[Cai, Fucheng] Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat, Tongji Med Coll, Wuhan, Peoples R China; [Xiao, Xiyue] Huazhong Univ Sci & Technol, Union Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Peoples R China; [Niu, Xun; Zhong, Yi] Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Peoples R China; [Shi, Hao] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Epidemiol & Biostat, Tongji Med Coll, Wuhan, Peoples R China; [Shi, Hao] Huazhong Univ Sci & Technol, Sch Publ Hlth, Minist Educ, Key Lab Environm & Hlth,Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhong, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Peoples R China.	zyzy0411@163.com		Zhong, Yi/0000-0002-7138-5302	National Nature Science Foundation of China [81200745, 81501297]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 81200745 and No. 81501297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan GS, 2014, J CLIN DIAGN RES, V8, pZC09, DOI DOI 10.7860/JCDR/2014/9251.4949; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhatia V, 2014, PROMOTER REGION HYPE, V2014, DOI [10.1155/2014/248419, DOI 10.1155/2014/248419]; BURGER PC, 1987, CANCER, V59, P1617, DOI 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X; Celebi OO, 2013, VIRCHOWS ARCH, V463, P318; Celebi OO, 2016, PATHOL RES PRACT, V212, P456, DOI 10.1016/j.prp.2016.02.022; De Schutter H, 2009, ONCOL REP, V21, P507, DOI 10.3892/or_00000251; Demokan S, 2011, CLIN EPIGENETICS, V2, P123, DOI 10.1007/s13148-011-0045-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fackler MJ, 2006, CLIN CANCER RES, V12, P3306, DOI 10.1158/1078-0432.CCR-05-2733; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu ZY, 2015, TUMOR BIOL, V36, P1487, DOI 10.1007/s13277-014-2632-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato K, 2006, J CANCER RES CLIN, V132, P735, DOI 10.1007/s00432-006-0122-8; Kordi-Tamandani DM, 2010, ARCH ORAL BIOL, V55, P809, DOI 10.1016/j.archoralbio.2010.06.017; Koutsimpelas D, 2012, ONCOL REP, V27, P1135, DOI 10.3892/or.2012.1624; Krakowczyk L, 2008, MED SCI MONITOR, V14, pBR219; Kulkarni V, 2004, ORAL ONCOL, V40, P145, DOI 10.1016/S1368-8375(03)00143-X; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Martone T, 2007, CLIN CANCER RES, V13, P5089, DOI 10.1158/1078-0432.CCR-07-0119; Maruya SI, 2004, CLIN CANCER RES, V10, P3825, DOI 10.1158/1078-0432.CCR-03-0370; Misawa K, 2016, ONCOTARGET, V7, P26087, DOI 10.18632/oncotarget.8317; Paluszczak J, 2011, ORAL ONCOL, V47, P104, DOI 10.1016/j.oraloncology.2010.11.006; Park TJ, 2001, CANCER, V92, P2760, DOI 10.1002/1097-0142(20011201)92:11<2760::AID-CNCR10123>3.0.CO;2-8; PEGG AE, 1990, CANCER RES, V50, P6119; Rettori MM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-316; Righini CA, 2007, CLIN CANCER RES, V13, P1179, DOI 10.1158/1078-0432.CCR-06-2027; Rosas SLB, 2001, CANCER RES, V61, P939; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Shi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122302; Soejima H, 2005, BIOCHEM CELL BIOL, V83, P429, DOI 10.1139/O05-140; Steinmann K, 2009, ONCOL REP, V22, P1519, DOI 10.3892/or_00000596; Su PF, 2010, ORAL ONCOL, V46, P734, DOI 10.1016/j.oraloncology.2010.07.002; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058858; Viswanathan M, 2003, INT J CANCER, V105, P41, DOI 10.1002/ijc.11028; Weiss D, 2011, MOL CARCINOGEN, V50, P680, DOI 10.1002/mc.20798; Wong YK, 2011, J DENT SCI, V6, P158, DOI 10.1016/j.jds.2011.05.006; Worsham MJ, 2014, CANCER LETT, V342, P178, DOI 10.1016/j.canlet.2012.02.018; Wu PF, 2010, LUNG CANCER, V68, P484, DOI 10.1016/j.lungcan.2009.08.010; Yang J, 2015, ONCOL LETT, V9, P35, DOI 10.3892/ol.2014.2662; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209; Zuo CL, 2004, CANCER EPIDEM BIOMAR, V13, P967	45	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163534	10.1371/journal.pone.0163534	http://dx.doi.org/10.1371/journal.pone.0163534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657735	gold, Green Submitted, Green Published			2022-12-27	WOS:000383893200141
J	Huang, SH; Chi, F; Peng, L; Bo, T; Zhang, B; Liu, LQ; Wu, XD; Mor-Vaknin, N; Markovitz, DM; Cao, H; Zhou, YH				Huang, Sheng-He; Chi, Feng; Peng, Liang; Bo, Tao; Zhang, Bao; Liu, Li-Qun; Wu, Xuedong; Mor-Vaknin, Nirit; Markovitz, David M.; Cao, Hong; Zhou, Yan-Hong			Vimentin, a Novel NF-kappa B Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain Barrier	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NICOTINIC ACETYLCHOLINE-RECEPTOR; K1 INVASION; STREPTOCOCCUS-PNEUMONIAE; LIPID RAFTS; GENE LOCUS; IN-VITRO; IBEA; VIRULENCE; PROTEIN	Background NF-kappa B activation, pathogen invasion, polymorphonuclear leukocytes (PMN) transmigration (PMNT) across the blood-brain barrier (BBB) are the pathogenic triad hallmark features of bacterial meningitis, but the mechanisms underlying these events remain largely unknown. Vimentin, which is a novel NF-kappa B regulator, is the primary receptor for the major Escherichia coli K1 virulence factor IbeA that contributes to the pathogenesis of neonatal bacterial sepsis and meningitis (NSM). We have previously shown that IbeA-induced NF-kappa B signaling through its primary receptor vimentin as well as its co-receptor PTB-associated splicing factor (PSF) is required for pathogen penetration and leukocyte transmigration across the BBB. This is the first in vivo study to demonstrate how vimentin and related factors contributed to the pathogenic triad of bacterial meningitis. Methodology/Principal Findings The role of vimentin in IbeA(+) E. coli K1-induced NF-kappa B activation, pathogen invasion, leukocyte transmigration across the BBB has now been demonstrated by using vimentin knockout (KO) mice. In the in vivo studies presented here, IbeA-induced NF-kappa B activation, E. coli K1 invasion and polymorphonuclear neutrophil (PMN) transmigration across the BBB were significantly reduced in Vim-/- mice. Decreased neuronal injury in the hippocampal dentate gyrus was observed in Vim-/- mice with meningitis. The major inflammatory regulator alpha 7 nAChR and several signaling molecules contributing to NF-kappa B activation (p65 and p-Cam-KII) were significantly reduced in the brain tissues of the Vim-/- mice with E. coli meningitis. Furthermore, Vim KO resulted in significant reduction in neuronal injury and in a7 nAChR-mediated calcium signaling. Conclusion/Significance Vimentin, a novel NF-kappa B regulator, plays a detrimental role in the host defense against meningitic infection by modulating the NF-kappa B signaling pathway to increase pathogen invasion, PMN recruitment, BBB permeability and neuronal inflammation. Our findings provide the first evidence for Vim-dependent mechanisms underlying the pathogenic triad of bacterial meningitis.	[Huang, Sheng-He; Zhou, Yan-Hong] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan, Peoples R China; [Huang, Sheng-He; Chi, Feng; Peng, Liang; Bo, Tao; Zhang, Bao; Liu, Li-Qun] Univ Southern Calif, Dept Pediat, Saban Res Inst, Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA; [Huang, Sheng-He; Zhang, Bao] Southern Med Univ, Dept Microbiol, Sch Publ Hlth & Tropocal Med, Guangzhou 510515, Guangdong, Peoples R China; [Chi, Feng] Univ Southern Calif, Keck Sch Med, Dept Pathol, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90033 USA; [Peng, Liang] Guangzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Guangzhou 510260, Guangdong, Peoples R China; [Bo, Tao; Liu, Li-Qun] Cent S Univ, Xiangya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China; [Wu, Xuedong] Southern Med Univ, Nanfang Hosp, Dept Pediat, Guangzhou 510515, Guangdong, Peoples R China; [Mor-Vaknin, Nirit; Markovitz, David M.] Univ Michigan, Div Infect Dis, Dept Internal Med, 5220 MSRB III,1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA	Huazhong University of Science & Technology; Children's Hospital Los Angeles; University of Southern California; Southern Medical University - China; University of Southern California; Guangzhou Medical University; Central South University; Southern Medical University - China; University of Michigan System; University of Michigan	Huang, SH; Zhou, YH (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan, Peoples R China.; Huang, SH (corresponding author), Univ Southern Calif, Dept Pediat, Saban Res Inst, Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA.; Huang, SH (corresponding author), Southern Med Univ, Dept Microbiol, Sch Publ Hlth & Tropocal Med, Guangzhou 510515, Guangdong, Peoples R China.	shhuang@usc.edu; yhzhou@hust.edu.cn			National Institute of Health (NIH) [R21NS083967]; National Natural Science Foundation of China [81370740, 30971642]; Natural Science Foundation of Hubei Province of China [2009CDA161]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This project was financially supported by grants from National Institute of Health (NIH) (R21NS083967 to SHH), National Natural Science Foundation of China (81370740 to SHH; 30971642 to YHZ), and Natural Science Foundation of Hubei Province of China (2009CDA161 to YHZ). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035862; Chi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025016; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Chi F, 2010, BIOCHEM J, V427, P79, DOI 10.1042/BJ20091097; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Du J, 2009, MOL PHARMACEUT, V6, P905, DOI 10.1021/mp800218q; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Giebelen IAJ, 2008, J INFECT DIS, V198, P750, DOI 10.1086/590432; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Hawkes DJ, 2006, CURR DRUG TARGETS, V7, P1615, DOI 10.2174/138945006779025455; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang SH, 2016, J TRAUMA TREAT, V5, P2; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; Ichiyama T, 2002, NEUROL RES, V24, P709, DOI 10.1179/016164102101200627; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; JACKSON CJ, 1990, J CELL SCI, V96, P257; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson TJ, 2012, FOODBORNE PATHOG DIS, V9, P37, DOI 10.1089/fpd.2011.0961; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Kim BY, 2005, INT J MED MICROBIOL, V295, P463, DOI 10.1016/j.ijmm.2005.07.004; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim YV, 2008, CELL TISSUE RES, V332, P427, DOI 10.1007/s00441-008-0598-4; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Long M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-19; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045; Moreland JG, 2004, J IMMUNOL, V172, P426, DOI 10.4049/jimmunol.172.1.426; MULDER CJJ, 1984, J INFECT DIS, V150, P935, DOI 10.1093/infdis/150.6.935; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Russo BC, 2016, NAT MICROBI IN PRESS; Schmidt H, 2001, J NEUROIMMUNOL, V113, P30, DOI 10.1016/S0165-5728(00)00402-1; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shime H, 2002, INFECT IMMUN, V70, P6460, DOI 10.1128/IAI.70.11.6460-6463.2002; Soto SM, 2008, J CLIN MICROBIOL, V46, P1123, DOI 10.1128/JCM.01682-07; Sprenger RR, 2006, BIOCHEM J, V400, P401, DOI 10.1042/BJ20060355; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Strijbos MH, 2008, BRIT J CANCER, V98, P1731, DOI 10.1038/sj.bjc.6604383; Sukumaran SK, 2003, J BIOL CHEM, V278, P45753, DOI 10.1074/jbc.M307374200; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Wang SF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00148; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yong T, 1997, J NEUROIMMUNOL, V80, P158, DOI 10.1016/S0165-5728(97)00151-3; Zhang B, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1075-9; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	64	28	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162641	10.1371/journal.pone.0162641	http://dx.doi.org/10.1371/journal.pone.0162641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657497	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200028
J	Lim, H; Abidin, MZ; Pulungan, CP; de Bruyn, M; Nor, SAM				Lim, HongChiun; Abidin, Muchlisin Zainal; Pulungan, Chaidir Parlindungan; de Bruyn, Mark; Nor, Siti Azizah Mohd			DNA Barcoding Reveals High Cryptic Diversity of the Freshwater Halfbeak Genus Hemirhamphodon from Sundaland	PLOS ONE			English	Article							FISHES; UNIVERSAL; TELEOSTEI	DNA barcoding of the cytochrome oxidase subunit I (COI) gene was utilized to assess the species diversity of the freshwater halfbeak genus Hemirhamphodon. A total of 201 individuals from 46 locations in Peninsular Malaysia, north Borneo (Sarawak) and Sumatra were successfully amplified for 616 base pairs of the COI gene revealing 231 variable and 213 parsimony informative sites. COI gene trees showed that most recognized species form monophyletic clades with high bootstrap support. Pairwise within species comparisons exhibited a wide range of intraspecific diversity from 0.0% to 14.8%, suggesting presence of cryptic diversity. This finding was further supported by barcode gap analysis, ABGD and the constructed COI gene trees. In particular, H. pogonognathus from Kelantan (northeast Peninsular Malaysia) diverged from the other H. pogonognathus groups with distances ranging from 7.8 to 11.8%, exceeding the nearest neighbor taxon. High intraspecific diversity was also observed in H. byssus and H. kuekanthali, but of a lower magnitude. This study also provides insights into endemism and phylogeographic structuring, and limited support for the Paleodrainage divergence hypothesis as a driver of speciation in the genus Hemirhamphodon.	[Lim, HongChiun; Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Lim, HongChiun] Quest Int Univ Perak, Fac Integrat Sci & Technol, Sch Biol Sci, Ipoh, Perak, Malaysia; [Abidin, Muchlisin Zainal] Syiah Kuala Univ, Fac Marine & Fisheries, Dept Aquaculture, Banda Aceh, Indonesia; [Pulungan, Chaidir Parlindungan] Riau Univ, Fac Fisheries & Marine Sci, Dept Aquat Resources Management, Pekanbaru, Indonesia; [de Bruyn, Mark] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [de Bruyn, Mark] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Ctr Marine & Coastal Studies, George Town, Malaysia	Universiti Sains Malaysia; Quest International University Perak; Universitas Syiah Kuala; Universitas Riau; Bangor University; University of New South Wales Sydney; Universiti Sains Malaysia	Lim, H (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.; Lim, H (corresponding author), Quest Int Univ Perak, Fac Integrat Sci & Technol, Sch Biol Sci, Ipoh, Perak, Malaysia.	hongchiun_01@yahoo.com	Lim, Hong-Chiun/AAE-3047-2020; de Bruyn, Mark/C-5568-2008; Nor, Siti Azizah Mohd/A-8275-2011	Lim, Hong-Chiun/0000-0002-3417-6894; de Bruyn, Mark/0000-0003-1528-9604; 	Universiti Sains Malaysia, iRec project [1002/PBIOLOGI/910403]	Universiti Sains Malaysia, iRec project(Universiti Sains Malaysia)	This work was funded by Universiti Sains Malaysia, iRec project (1002/PBIOLOGI/910403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Anderson W.D. III, 1991, Ichthyological Exploration of Freshwaters, V2, P151; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bleeker P, 1852, NATUURKUNDIG TIJDSCH, V3, P87; Bleeker P, 1866, ATLAS ICHTHYOLOGIQUE, P170; Bleeker P., 1853, NATUURKUNDIG TIJDSCH, V5, P175; Bork D, 1998, SELTENE SCHONHEITEN, P38; Brembach M., 1978, Aquarium (Bornheim), V12, P340; Chen WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07995; Collette BB, 2004, CALIF ACAD SCI ANNOT, V22, P35; Coyne J.A., 2004, SPECIATION; de Bruyn M, 2013, SYST BIOL, V62, P398, DOI 10.1093/sysbio/syt007; De Bruyn Mark, 2012, Systematics Association Special Volume Series, V82, P316; Dorn Alexander, 2008, Bulletin of Fish Biology, V9, P99; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Grell W, 1998, AQUARISTIK AKTUELL, V6, P24; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hartl A., 1983, Aquarien- und Terrarien-Zeitschrift, V36, P368; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N., 2015, DNA BARCODES, V3, P44, DOI 10.1515/dna-2015-0006; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Kadarusman, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040627; Kim S, 2010, MOL CELLS, V30, P507, DOI 10.1007/s10059-010-0148-2; Leon-Romero Y, 2012, MOL ECOL RESOUR, V12, P1021, DOI 10.1111/1755-0998.12018; Lovejoy NR, 2000, EVOLUTION, V54, P1349; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ribeiro AD, 2012, MOL ECOL RESOUR, V12, P1012, DOI 10.1111/1755-0998.12007; Roberts TR, 1989, FRESHWATER FISHES W, P210; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Ruocco NL, 2012, ZOOL STUD, V51, P862; Sriwattanarothai N, 2010, J FISH BIOL, V77, P414, DOI 10.1111/j.1095-8649.2010.02715.x; Steindachner F., 1901, FISCHE ABHANDLUNGEN, V25, P409; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan HH, 2013, RAFFLES B ZOOL, V61, P735; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wickman A, 1981, AQUAR PONDKEEPER, V46, P40; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017	51	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163596	10.1371/journal.pone.0163596	http://dx.doi.org/10.1371/journal.pone.0163596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657915	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200150
J	Liu, HC; Yang, SY; Liao, YT; Chen, CC; Kuo, CJ				Liu, Hsing-Cheng; Yang, Shu-Yu; Liao, Ya-Tang; Chen, Chiao-Chicy; Kuo, Chian-Jue			Antipsychotic Medications and Risk of Acute Coronary Syndrome in Schizophrenia: A Nested Case-Control Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PSYCHOTROPIC-DRUGS; METABOLIC SYNDROME; BIPOLAR DISORDER; MORTALITY; HALOPERIDOL; ASSOCIATION; PNEUMONIA; DISEASE; EVENTS	Background This study assessed the risk of developing acute coronary syndrome requiring hospitalization in association with the use of certain antipsychotic medications in schizophrenia patients. Methods A nationwide cohort of 31,177 inpatients with schizophrenia between the ages of 18 and 65 years whose records were enrolled in the National Health Insurance Research Database in Taiwan from 2000 to 2008 and were studied after encrypting the identifications. Cases (n = 147) were patients with subsequent acute coronary syndrome requiring hospitalization after their first psychiatric admission. Based on a nested case-control design, each case was matched with 20 controls for age, sex and the year of first psychiatric admission using risk-set sampling. The effects of antipsychotic agents on the development of acute coronary syndrome were assessed using multiple conditional logistic regression and sensitivity analyses to confirm any association. Results We found that current use of aripiprazole (adjusted risk ratio [RR] = 3.68, 95% CI: 1.27-10.64, p< 0.05) and chlorpromazine (adjusted RR = 2.96, 95% CI: 1.40-6.24, p< 0.001) were associated with a dose-dependent increase in the risk of developing acute coronary syndrome. Although haloperidol was associated with an increased risk (adjusted RR = 2.03, 95% CI: 1.20-3.44, p< 0.01), there was no clear dose-dependent relationship. These three antipsychotic agents were also associated with an increased risk in the first 30 days of use, and the risk decreased as the duration of therapy increased. Sensitivity analyses using propensity score-adjusted modeling showed that the results were similar to those of multiple regression analysis. Conclusions Patients with schizophrenia who received aripiprazole, chlorpromazine, or haloperidol could have a potentially elevated risk of developing acute coronary syndrome, particularly at the start of therapy.	[Liu, Hsing-Cheng; Kuo, Chian-Jue] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Gen Psychiat, Taipei, Taiwan; [Liu, Hsing-Cheng; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Liu, Hsing-Cheng; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Yang, Shu-Yu] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Pharm, Taipei, Taiwan; [Yang, Shu-Yu] Kaohsiung Med Univ, Coll Pharm, Grad Inst Clin Pharm, Kaohsiung, Taiwan; [Liao, Ya-Tang] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Chen, Chiao-Chicy] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan	Taipei City Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei City Hospital; Kaohsiung Medical University; National Taiwan University; Mackay Memorial Hospital	Kuo, CJ (corresponding author), Taipei City Hosp, Taipei City Psychiat Ctr, Dept Gen Psychiat, Taipei, Taiwan.; Kuo, CJ (corresponding author), Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan.; Kuo, CJ (corresponding author), Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan.	tcpckuo@seed.net.tw			National Science Council of Taiwan [MOST 105-2314-B-532-006-MY3, NSC102-2628-B-532-001-MY3, NSC 101-2314-B-195-022]; Taipei City Hospital, Taipei, Taiwan [10201-62-008, 10301-01-027, 10401-62-013, 10401-62-059]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital, Taipei, Taiwan	This submission was supported by the National Science Council of Taiwan (MOST 105-2314-B-532-006-MY3; NSC102-2628-B-532-001-MY3; NSC 101-2314-B-195-022) and Taipei City Hospital (10201-62-008, 10301-01-027, 10401-62-013, 10401-62-059), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni AG, 2005, AM HEART J, V149, P1055, DOI 10.1016/j.ahj.2004.10.040; Bonafede Machaon, 2011, Hosp Pract (1995), V39, P16, DOI 10.3810/hp.2011.08.575; Brauer R, 2011, BRIT J CLIN PHARMACO, V72, P871, DOI 10.1111/j.1365-2125.2011.04043.x; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Cerimele JM, 2013, GEN HOSP PSYCHIAT, V35, P16, DOI 10.1016/j.genhosppsych.2012.08.001; Cerit C, 2010, PSYCHOPHARMACOL BULL, V43, P22; Correll CU, 2006, J CLIN PSYCHIAT, V67, P575, DOI 10.4088/JCP.v67n0408; Curkendall SM, 2004, J CLIN PSYCHIAT, V65, P715; Enger C, 2004, J NERV MENT DIS, V192, P19, DOI 10.1097/01.nmd.0000105996.62105.07; Etemad Lida R, 2005, J Manag Care Pharm, V11, P300; Etemad LR, 2005, CURR MED RES OPIN, V21, P1977, DOI 10.1185/030079905X74970; Gau SSF, 2008, J CLIN PSYCHOPHARM, V28, P271, DOI 10.1097/JCP.0b013e3181723713; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; Honkola J, 2012, EUR HEART J, V33, P745, DOI 10.1093/eurheartj/ehr368; Kleijer BC, 2012, HEART, V98, P1166, DOI 10.1136/heartjnl-2012-301801; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Lambert Timothy J R, 2003, Med J Aust, V178, pS67; Liao YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070142; McFalls EO, 2011, AM J MED, V124, P630, DOI 10.1016/j.amjmed.2011.02.024; Nakagawa S, 2006, J INTERN MED, V260, P451, DOI 10.1111/j.1365-2796.2006.01708.x; Olfson M, 2007, SCHIZOPHRENIA BULL, V33, P1379, DOI 10.1093/schbul/sbm033; Penttinen J, 1996, INT J EPIDEMIOL, V25, P760, DOI 10.1093/ije/25.4.760; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; THOROGOOD M, 1992, LANCET, V340, P1067, DOI 10.1016/0140-6736(92)93081-W; Vieweg W VictorR, 2003, Prim Care Companion J Clin Psychiatry, V5, P205; Wood M, 2007, EXPERT OPIN INV DRUG, V16, P771, DOI 10.1517/13543784.16.6.771; World Health Organization, 2013, WHO COLL CTR DRUG ST; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Yang SY, 2013, J CLIN PSYCHIAT, V74, pE79, DOI 10.4088/JCP.12m07938	33	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163533	10.1371/journal.pone.0163533	http://dx.doi.org/10.1371/journal.pone.0163533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657540	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200140
J	Xu, XJ; Chen, SJ				Xu, Xiaojun; Chen, Shi-Jie			VfoldCPX Server: Predicting RNA-RNA Complex Structure and Stability	PLOS ONE			English	Article							BASE-PAIRING PROBABILITIES; NUCLEIC-ACID STRANDS; SECONDARY STRUCTURE; PARTITION-FUNCTION; FOLDING THERMODYNAMICS; KISSING COMPLEX; ALGORITHM; HYBRIDIZATION; DIMERIZATION; PSEUDOKNOTS	RNA-RNA interactions are essential for genomic RNA dimerization, mRNA splicing, and many RNA-related gene expression and regulation processes. The prediction of the structure and folding stability of RNA-RNA complexes is a problem of significant biological importance and receives substantial interest in the biological community. The VfoldCPX server provides a new web interface to predict the two-dimensional (2D) structures of RNA-RNA complexes from the nucleotide sequences. The VfoldCPX server has several novel advantages including the ability to treat RNAs with tertiary contacts (crossing base pairs) such as loop-loop kissing interactions and the use of physical loop entropy parameters. Based on a partition function-based algorithm, the server enables prediction for structure with and without tertiary contacts. Furthermore, the server outputs a set of energetically stable structures, ranked by their stabilities. The results allow users to gain extensive physical insights into RNA-RNA interactions and their roles in RNA function. The web server is freely accessible at "http://rna.physics.missouri.edu/vfoldCPX".	[Xu, Xiaojun; Chen, Shi-Jie] Univ Missouri, Dept Phys, Columbia, MO 65211 USA; [Chen, Shi-Jie] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Chen, Shi-Jie] Univ Missouri, MU Informat Inst, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Chen, SJ (corresponding author), Univ Missouri, Dept Phys, Columbia, MO 65211 USA.; Chen, SJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Chen, SJ (corresponding author), Univ Missouri, MU Informat Inst, Columbia, MO 65211 USA.	chenshi@missouri.edu		Xu, Xiaojun/0000-0002-6380-698X; Chen, Shi-Jie/0000-0002-8093-7244	National Institutes of Health [R01-GM063732]; NIH [R01-GM063732]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant number R01-GM063732.; This research was supported by NIH grant R01-GM063732.	Afonin KA, 2016, NANO LETT, V16, P1746, DOI 10.1021/acs.nanolett.5b04676; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Bindewald E, 2016, NANO LETT, V16, P1726, DOI 10.1021/acs.nanolett.5b04651; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Cao S, 2006, J MOL BIOL, V357, P292, DOI 10.1016/j.jmb.2005.12.014; Cao S, 2005, RNA, V11, P1884, DOI 10.1261/rna.2109105; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2014, RNA, V20, P835, DOI 10.1261/rna.043976.113; Cao S, 2012, NUCLEIC ACIDS RES, V40, P4681, DOI 10.1093/nar/gks052; Cao S, 2011, RNA, V17, P2130, DOI 10.1261/rna.026658.111; Cao S, 2009, RNA, V15, P696, DOI 10.1261/rna.1429009; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chitsaz H, 2009, BIOINFORMATICS, V25, pI365, DOI 10.1093/bioinformatics/btp212; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; Dirks RM, 2004, J COMPUT CHEM, V25, P1295, DOI 10.1002/jcc.20057; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Huang FWD, 2010, BIOINFORMATICS, V26, P175, DOI 10.1093/bioinformatics/btp635; Huang FWD, 2009, BIOINFORMATICS, V25, P2646, DOI 10.1093/bioinformatics/btp481; Kato Y, 2010, BIOINFORMATICS, V26, pi460, DOI 10.1093/bioinformatics/btq372; Li AX, 2011, BIOINFORMATICS, V27, P456, DOI 10.1093/bioinformatics/btq659; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Poolsap U, 2011, J BIOINF COMPUT BIOL, V9, P697, DOI 10.1142/S0219720011005628; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Seemann SE, 2011, BIOINFORMATICS, V27, P211, DOI 10.1093/bioinformatics/btq634; Sperschneider J, 2011, RNA, V17, P27, DOI 10.1261/rna.2394511; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Xu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107504; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163454	10.1371/journal.pone.0163454	http://dx.doi.org/10.1371/journal.pone.0163454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657918	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200126
J	Christensen, MW; Ingerslev, HJ; Degn, B; Kesmodel, US				Christensen, Mette Wulf; Ingerslev, Hans Jakob; Degn, Birte; Kesmodel, Ulrik Schioler			Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTION; ADVERSELY AFFECT; OBESITY; IMPACT; RISK; INFERTILITY; MISCARRIAGE; OVERWEIGHT; OUTCOMES	Introduction Overweight and obese women may require higher doses of gonadotrophin when undergoing In Vitro Fertilization Treatment (IVF). Consequently, one may expect a sub-optimal oocyte retrieval in the first treatment cycle and thus a larger compensation in gonadotrophin-dose in the following treatment-cycles and a more favorable outcome. The main objective was to explore if treatment cycle number modifies the outcome when investigating the effect of female Body Mass Index (BMI) on oocyte quantity in IVF. Material and Methods A historical cohort study was conducted on 5,342 treatment-cycles during the period 1999-2009. Exclusion criteria were missing information on BMI or treatment type. Further, women were excluded if they had ovulated before oocyte retrieval. According to baseline BMI, women were divided into four categories following the World Health Organization standards. Multiple linear regressions analyses were performed accounting for the non-independence of >= 2 cycles in a woman. Results Stratification according to cycle number revealed a more suboptimal outcome in the first treatment-cycles than in the following cycles, suggesting a possible interaction or effect modification from cycle number or a factor related to cycle number. The median dose of total follicular stimulating hormone given to the four BMI groups could not straight forwardly explain the less optimal oocyte outcome observed in first treatment cycles. No statistically significant differences were observed in oocyte yield for underweight, overweight and obesity compared to normal weight women when analyzing all treatment-cycles. Overweight women had significantly fewer mature (MII) oocytes (p = 0.009) than normal weight women, whereas no differences was observed for underweight and obese women. Conclusion Our study suggests a possible interaction or effect modification related to treatment cycle number. Investigating the effects of BMI on IVF-results in first treatment-cycles alone should be carried out cautiously.	[Christensen, Mette Wulf; Ingerslev, Hans Jakob; Degn, Birte; Kesmodel, Ulrik Schioler] Aarhus Univ Hosp, Aarhus, Denmark; [Christensen, Mette Wulf; Ingerslev, Hans Jakob; Kesmodel, Ulrik Schioler] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Ingerslev, Hans Jakob] Aalborg Univ Hosp, Fertil Clin, Dronninglund, Denmark; [Degn, Birte] Aalborg Univ Hosp, Dept Clin Biochem, Sect Mol Diagnost, Aalborg, Denmark; [Kesmodel, Ulrik Schioler] Herlev & Gentofte Hosp, Fertil Clin, Herlev, Denmark	Aarhus University; Aarhus University; Aalborg University; Aalborg University; Aalborg University Hospital	Christensen, MW (corresponding author), Aarhus Univ Hosp, Aarhus, Denmark.; Christensen, MW (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	mwch@clin.au.dk		Christensen, Mette Wulf/0000-0001-9366-2166; Ingerslev, Hans Jakob/0000-0002-8099-5970				Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; Chavarro JE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.012; Dechaud H, 2006, EUR J OBSTET GYN R B, V127, P88, DOI 10.1016/j.ejogrb.2005.12.009; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Erel CT, 2009, CURR OPIN OBSTET GYN, V21, P228, DOI 10.1097/GCO.0b013e32832aee96; Esinler I, 2008, REPROD BIOMED ONLINE, V17, P583, DOI 10.1016/S1472-6483(10)60249-0; Farquhar C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001122.pub4; Fedorcsak P, 2004, HUM REPROD, V19, P2523, DOI 10.1093/humrep/deh485; Fedorcsak P, 2000, ACTA OBSTET GYN SCAN, V79, P43, DOI 10.1034/j.1600-0412.2000.079001043.x; Frattarelli JL, 2004, J ASSIST REPROD GEN, V21, P211, DOI 10.1023/B:JARG.0000040236.68523.6f; Imani B, 2002, FERTIL STERIL, V77, P83, DOI 10.1016/S0015-0282(01)02928-4; Jensen TK, 1999, EPIDEMIOLOGY, V10, P422, DOI 10.1097/00001648-199907000-00014; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Lashen H, 1999, HUM REPROD, V14, P712, DOI 10.1093/humrep/14.3.712; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Matalliotakis I, 2008, REPROD BIOMED ONLINE, V16, P778, DOI 10.1016/S1472-6483(10)60142-3; Ozgun MT, 2011, J OBSTET GYNAECOL, V31, P245, DOI 10.3109/01443615.2010.546906; Pinborg A, 2011, REPROD BIOMED ONLINE, V23, P490, DOI 10.1016/j.rbmo.2011.06.010; Purcell SH, 2011, J ASSIST REPROD GEN, V28, P517, DOI 10.1007/s10815-011-9592-y; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Rittenberg V, 2011, REPROD BIOMED ONLINE, V23, P421, DOI 10.1016/j.rbmo.2011.06.018; Rittenberg V, 2011, HUM REPROD, V26, P2642, DOI 10.1093/humrep/der254; Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004; Sneed ML, 2008, HUM REPROD, V23, P1835, DOI 10.1093/humrep/den188; Steward RG, 2014, FERTIL STERIL, V101, P967, DOI 10.1016/j.fertnstert.2013.12.026; Thum MY, 2007, J OBSTET GYNAECOL, V27, P699, DOI 10.1080/01443610701612334; Vilarino FL, 2011, GYNECOL ENDOCRINOL, V27, P232, DOI 10.3109/09513590.2010.490613; Waylen AL, 2009, HUM REPROD UPDATE, V15, P31, DOI 10.1093/humupd/dmn046; Wittemer C, 2000, J ASSIST REPROD GEN, V17, P547, DOI 10.1023/A:1026477628723; World Health Organization, 2016, OB OV	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163393	10.1371/journal.pone.0163393	http://dx.doi.org/10.1371/journal.pone.0163393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654907	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700055
J	Di Maggio, S; Gatti, E; Liu, JR; Bertolotti, M; Fritz, G; Bianchi, ME; Raucci, A				Di Maggio, Stefania; Gatti, Elena; Liu, Jaron; Bertolotti, Matteo; Fritz, Guenter; Bianchi, Marco E.; Raucci, Angela			The Mouse-Specific Splice Variant mRAGE_v4 Encodes a Membrane-Bound RAGE That Is Resistant to Shedding and Does Not Contribute to the Production of Soluble RAGE	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; N-CADHERIN; RECEPTOR; CLEAVAGE; ADAM10; IDENTIFICATION; DISEASE; ATHEROSCLEROSIS; ENDPRODUCTS; PROTEOLYSIS	The receptor for advanced glycation end-products (RAGE) is involved in the onset and progression of several inflammatory diseases. The RAGE primary transcript undergoes numerous alternative splicing (AS) events, some of which are species-specific. Here, we characterize the mouse-specific mRAGE_v4 splice variant, which is conserved in rodents and absent in primates. mRAGE_v4 derives from exon 9 skipping and encodes a receptor (M-RAGE) that lacks 9 amino acids between the transmembrane and the immunoglobulin (Ig) domains. RNA-Seq data confirm that in mouse lung mRAGE_v4 is the most abundant RAGE mRNA isoform after mRAGE, which codes for full-length RAGE (FL-RAGE), while in heart all RAGE variants are almost undetectable. The proteins M-RAGE and FL-RAGE are roughly equally abundant in mouse lung. Contrary to FL-RAGE, M-RAGE is extremely resistant to shedding because it lacks the peptide motif recognized by both ADAM10 and MMP9, and does not contribute significantly to soluble cRAGE formation. Thus, a cassette exon in RAGE corresponds to a specific function of the RAGE protein-the ability to be shed. Given the differences in RAGE AS variants between rodents and humans, caution is due in the interpretation of results obtained in mouse models of RAGE-dependent human pathologies.	[Di Maggio, Stefania; Bertolotti, Matteo; Raucci, Angela] Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Milan, Italy; [Gatti, Elena; Liu, Jaron; Bianchi, Marco E.] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Fritz, Guenter] Univ Freiburg, Inst Neuropathol, Freiburg, Germany; [Bianchi, Marco E.] Univ Vita Salute San Raffaele, Milan, Italy; [Liu, Jaron] A STAR Inst Med Biol, 8A Biomed Grove,Immunos 06-18A, Singapore 138648, Singapore	IRCCS Centro Cardiologico Monzino; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Freiburg; Vita-Salute San Raffaele University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Raucci, A (corresponding author), Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Milan, Italy.	araucci@ccfm.it	Bianchi, Marco Emilio/K-3417-2018; Raucci, Angela/K-3722-2018; Fritz, Guenter/E-2933-2013	Bianchi, Marco Emilio/0000-0002-5329-6445; Raucci, Angela/0000-0003-1333-9671; Fritz, Guenter/0000-0002-4571-8812	Italian Ministry of Health for Young Researchers [GR-2010-2312693]; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS (Ricerca Corrente); Deutsche Forschungsgemeinschaft; Heisenberg fellowship [FR1488/5-2, FR1488/3-2]; Italian Ministry of Health [GR-2010-2312693]	Italian Ministry of Health for Young Researchers; Fondazione Monzino and Centro Cardiologico Monzino-IRCCS (Ricerca Corrente); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg fellowship(German Research Foundation (DFG)); Italian Ministry of Health(Ministry of Health, Italy)	AR is supported by funding from Italian Ministry of Health for Young Researchers (GR-2010-2312693) and by Fondazione Monzino and Centro Cardiologico Monzino-IRCCS (Ricerca Corrente 2015-2017). GF acknowledges the financial support by a grant of the Deutsche Forschungsgemeinschaft and a Heisenberg fellowship (FR1488/5-2 and FR1488/3-2). MEB is supported by grant GR-2010-2312693 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; Mahajan N, 2013, INT J CARDIOL, V168, P1788, DOI 10.1016/j.ijcard.2013.05.013; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Marinakis E, 2014, CLIN CHEM LAB MED, V52, P189, DOI 10.1515/cclm-2013-0578; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Peng Y., 2016, PLOS ONE; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Sourris KC, 2010, DIABETOLOGIA, V53, P2442, DOI 10.1007/s00125-010-1837-2; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Yamakawa N, 2011, AM J PHYSIOL-LUNG C, V300, pL516, DOI 10.1152/ajplung.00118.2010; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	44	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0153832	10.1371/journal.pone.0153832	http://dx.doi.org/10.1371/journal.pone.0153832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655137	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700003
J	de Ruiter, CJ; van Oeveren, B; Francke, A; Zijlstra, P; van Dieen, JH				de Ruiter, Cornelis J.; van Oeveren, Ben; Francke, Agnieta; Zijlstra, Patrick; van Dieen, Jaap H.			Running Speed Can Be Predicted from Foot Contact Time during Outdoor over Ground Running	PLOS ONE			English	Article							REACTION FORCES; VALIDITY; RUNNERS; ECONOMY; WALKING; POWER; COST	The number of validation studies of commercially available foot pods that provide estimates of running speed is limited and these studies have been conducted under laboratory conditions. Moreover, internal data handling and algorithms used to derive speed from these pods are proprietary and thereby unclear. The present study investigates the use of foot contact time (CT) for running speed estimations, which potentially can be used in addition to the global positioning system (GPS) in situations where GPS performance is limited. CT was measured with tri axial inertial sensors attached to the feet of 14 runners, during natural over ground outdoor running, under optimized conditions for GPS. The individual relationships between running speed and CT were established during short runs at different speeds on two days. These relations were subsequently used to predict instantaneous speed during a straight line 4 km run with a single turning point halfway. Stopwatch derived speed, measured for each of 32 consecutive 125m intervals during the 4 km runs, was used as reference. Individual speed-CT relations were strong (r(2) > 0.96 for all trials) and consistent between days. During the 4km runs, median error (ranges) in predicted speed from CT 2.5% (5.2) was higher (P<0.05) than for GPS 1.6% (0.8). However, around the turning point and during the first and last 125m interval, error for GPS-speed increased to 5.0% (4.5) and became greater (P<0.05) than the error predicted from CT: 2.7% (4.4). Small speed fluctuations during 4km runs were adequately monitored with both methods: CT and GPS respectively explained 85% and 73% of the total speed variance during 4km runs. In conclusion, running speed estimates bases on speed-CT relations, have acceptable accuracy and could serve to backup or substitute for GPS during tarmac running on flat terrain whenever GPS performance is limited.	[de Ruiter, Cornelis J.; van Oeveren, Ben; Francke, Agnieta; Zijlstra, Patrick; van Dieen, Jaap H.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Behav & Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruiter, CJ (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Behav & Movement Sci, Amsterdam, Netherlands.	c.j.de.ruiter@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; van Oeveren, Benjamin/0000-0001-5090-7637; de Ruiter, Jo/0000-0003-0278-4235				CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Chapman RF, 2012, MED SCI SPORT EXER, V44, P917, DOI 10.1249/MSS.0b013e3182400520; Dalleau G, 1998, EUR J APPL PHYSIOL O, V77, P257, DOI 10.1007/s004210050330; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hausswirth C, 2009, INT J SPORTS MED, V30, P354, DOI 10.1055/s-0028-1105936; Hoyt DF, 2000, J EXP BIOL, V203, P221; Kane NA, 2010, INT J SPORTS MED, V31, P101, DOI 10.1055/s-0029-1242810; Neville J, 2011, PROCEDIA ENGINEER, V13, P487, DOI 10.1016/j.proeng.2011.05.119; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nummela A, 2007, INT J SPORTS MED, V28, P655, DOI 10.1055/s-2007-964896; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Rawstorn JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093693; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Weyand PG, 2001, J APPL PHYSIOL, V91, P451, DOI 10.1152/jappl.2001.91.1.451; Yang SZ, 2011, GAIT POSTURE, V34, P462, DOI 10.1016/j.gaitpost.2011.06.019	16	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163023	10.1371/journal.pone.0163023	http://dx.doi.org/10.1371/journal.pone.0163023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648946	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100045
J	Zhou, JY; Zhao, J; Zheng, J; Kong, M; Sun, K; Wang, B; Chen, X; Ding, W; Zhou, JY				Zhou, Jianya; Zhao, Jing; Zheng, Jing; Kong, Mei; Sun, Ke; Wang, Bo; Chen, Xi; Ding, Wei; Zhou, Jianying			A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features	PLOS ONE			English	Article							CANCER; MUTATIONS	Aims To identify the clinical and histological characteristics of ROS1-rearranged non-small-cell lung carcinomas (NSCLCs) and build a prediction model to prescreen suitable patients for molecular testing. Methods and Results We identified 27 cases of ROS1-rearranged lung adenocarcinomas in 1165 patients with NSCLCs confirmed by real-time PCR and FISH and performed univariate and multivariate analyses to identify predictive factors associated with ROS1 rearrangement and finally developed prediction model. Detected with ROS1 immunochemistry, 59 cases of 1165 patients had a certain degree of ROS1 expression. Among these cases, 19 cases (68%, 19/28) with 3+ and 8 cases (47%, 8/17) with 2+ staining were ROS1 rearrangement verified by real-time PCR and FISH. In the resected group, the acinar-predominant growth pattern was the most commonly observed (57%, 8/14), while in the biopsy group, solid patterns were the most frequently observed (78%, 7/13). Based on multiple logistic regression analysis, we determined that female sex, cribriform structure and the presence of psammoma body were the three most powerful indicators of ROS1 rearrangement, and we have developed a predictive model for the presence of ROS1 rearrangements in lung adenocarcinomas. Conclusions Female, cribriform structure and presence of psammoma body were the three most powerful indicator of ROS1 rearrangement status, and predictive formula was helpful in screening ROS1-rearranged NSCLC, especially for ROS1 immunochemistry equivocal cases.	[Zhou, Jianya; Zheng, Jing; Chen, Xi; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou, Zhejiang, Peoples R China; [Zhao, Jing; Kong, Mei; Sun, Ke; Wang, Bo; Ding, Wei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			Medicine and Health Project of Zhejiang Province, China [2015104004]; National Natural Science Foundation of China [81101768]	Medicine and Health Project of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Medicine and Health Project of Zhejiang Province, China (Grant No. 2015104004), (www.zjmed.org.cn), Jing Zhao and the National Natural Science Foundation of China (Grant No. 81101768), (http://www.nsfc.gov.cn/), Jianya Zhou. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; This work was supported by grants from the Medicine and Health Project of Zhejiang Province, China (Grant No. 2015104004) and the National Natural Science Foundation of China (Grant No. 81101768). The authors thank Ms. Shicui Liu for editing assistance.	Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Chen YF, 2014, J THORAC ONCOL, V9, P1171, DOI 10.1097/JTO.0000000000000232; Egashira Y, 2004, MODERN PATHOL, V17, P503, DOI 10.1038/modpathol.3800030; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Go H, 2013, J THORAC ONCOL, V8, P1445, DOI 10.1097/JTO.0b013e3182a4dd6e; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadota K, 2013, MODERN PATHOLOGY, P1; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee SE, 2015, MODERN PATHOL, V28, P468, DOI 10.1038/modpathol.2014.107; Lee YS, 2014, WORLD J SURG, V38, P1738, DOI 10.1007/s00268-014-2460-z; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7; Stumpfova M, 2012, CLIN CANCER RES, V18, P4222, DOI 10.1158/1078-0432.CCR-12-1812; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wen YS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000296; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]	20	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161861	10.1371/journal.pone.0161861	http://dx.doi.org/10.1371/journal.pone.0161861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648828	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100008
J	Piccolo, LR; Merz, EC; He, XF; Sowell, ER; Noble, KG				Piccolo, Luciane R.; Merz, Emily C.; He, Xiaofu; Sowell, Elizabeth R.; Noble, Kimberly G.		Pediat Imaging Neurocognition	Age-Related Differences in Cortical Thickness Vary by Socioeconomic Status	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; GENETIC INFLUENCES; PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; SEX-DIFFERENCES; SURFACE-AREA; TRAJECTORIES; CHILDREN; ADOLESCENCE; PLASTICITY	Recent findings indicate robust associations between socioeconomic status (SES) and brain structure in children, raising questions about the ways in which SES may modify structural brain development. In general, cortical thickness and surface area develop in nonlinear patterns across childhood and adolescence, with developmental patterns varying to some degree by cortical region. Here, we examined whether age-related nonlinear changes in cortical thickness and surface area varied by SES, as indexed by family income and parental education. We hypothesized that SES disparities in age-related change may be particularly evident for language-and literacy-supportingcortical regions. Participants were 1148 typically-developing individuals between 3 and 20 years of age. Results indicated that SES factors moderate patterns of age-associated change in cortical thickness but not surface area. Specifically, at lower levels of SES, associations between age and cortical thickness were curvilinear, with relatively steep age-related decreases in cortical thickness earlier in childhood, and subsequent leveling off during adolescence. In contrast, at high levels of SES, associations between age and cortical thickness were linear, with consistent reductions across the age range studied. Notably, this interaction was prominent in the left fusi-form gyrus, a region that is critical for reading development. In a similar pattern, SES factors significantly moderated linear age-related change in left superior temporal gyrus, such that higher SES was linked with steeper age-related decreases in cortical thickness in this region. These findings suggest that SES may moderate patterns of age-related cortical thinning, especially in language-and literacy-supportingcortical regions.	[Piccolo, Luciane R.; Noble, Kimberly G.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Merz, Emily C.] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [He, Xiaofu] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA	Columbia University; Columbia University Teachers College; Columbia University; Columbia University; New York State Psychiatry Institute; Children's Hospital Los Angeles	Noble, KG (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	kgn2106@tc.columbia.edu		Noble, Kimberly/0000-0003-1496-5113	Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant) [RC2DA029475]; National Institute on Drug Abuse; Annie E. Casey Foundation; Teachers College, Columbia University; National Institute of Mental Health (NIMH) [T32MH13043]; Brazilian National Council for the Improvement of Higher Education (CAPES); Eunice Kennedy Shriver National Institute of Child Health & Human Development; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER	Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Annie E. Casey Foundation; Teachers College, Columbia University; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brazilian National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data collection and sharing for this project was funded by the Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant RC2DA029475). PING is funded by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development. PING data are disseminated by the PING Coordinating Center at the Center Human Development, University of California, San Diego. This work was also made possible by funding from the Annie E. Casey Foundation; Teachers College, Columbia University; a National Institute of Mental Health (NIMH) training grant (T32MH13043); and the Brazilian National Council for the Improvement of Higher Education (CAPES).	Aiken L. S., 1991, MULTIPLE REGRESSION; Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Avants BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138217; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; Balsamo LM, 2006, NEUROIMAGE, V31, P1306, DOI 10.1016/j.neuroimage.2006.01.027; Bartsch H, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00025; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brito Natalie H, 2014, Front Neurosci, V8, P276, DOI 10.3389/fnins.2014.00276; Brooks-Gunn J, 2005, FUTURE CHILD, V15, P139, DOI 10.1353/foc.2005.0001; Brown TT, 2012, NEUROPSYCHOL REV, V22, P313, DOI 10.1007/s11065-012-9214-1; Brown TT, 2012, CURR BIOL, V22, P1693, DOI 10.1016/j.cub.2012.07.002; Burgaleta M, 2014, NEUROIMAGE, V84, P810, DOI 10.1016/j.neuroimage.2013.09.038; Callaghan BL, 2016, CURR OPIN BEHAV SCI, V7, P76, DOI 10.1016/j.cobeha.2015.11.018; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen J.E., 1988, STAT POWER ANAL BEHA; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dong WK, 2004, MENT RETARD DEV D R, V10, P85, DOI 10.1002/mrdd.20016; Duncan GJ, 2012, WIRES COGN SCI, V3, P377, DOI 10.1002/wcs.1176; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Fjell AM, 2012, P NATL ACAD SCI USA, V109, P19620, DOI 10.1073/pnas.1208243109; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hart B., 1995, MEANINGFUL DIFFERENC; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jernigan TL, 2016, NEUROIMAGE, V124, P1149, DOI 10.1016/j.neuroimage.2015.04.057; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Lawson GM, 2013, DEVELOPMENTAL SCI, V16, P641, DOI 10.1111/desc.12096; Lebel C, 2012, J NEUROSCI, V32, P15243, DOI 10.1523/JNEUROSCI.1161-12.2012; Mackey AP, 2015, PSYCHOL SCI, V26, P925, DOI 10.1177/0956797615572233; Mangina CA, 2006, INT J PSYCHOPHYSIOL, V60, P203, DOI 10.1016/j.ijpsycho.2005.11.004; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2005, FUTURE CHILD, V15, P71, DOI 10.1353/foc.2005.0006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Raizada RDS, 2008, NEUROIMAGE, V40, P1392, DOI 10.1016/j.neuroimage.2008.01.021; Raizada Rajeev D S, 2010, Front Hum Neurosci, V4, P3, DOI 10.3389/neuro.09.003.2010; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shaw P, 2013, BIOL PSYCHIAT, V74, P599, DOI 10.1016/j.biopsych.2013.04.007; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Tamnes CK, 2013, J COGNITIVE NEUROSCI, V25, P1611, DOI 10.1162/jocn_a_00434; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tottenham N, 2015, SOC NEUROSCI-UK, V10, P489, DOI 10.1080/17470919.2015.1087424; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; Vijayakumar N, 2014, SOC COGN AFFECT NEUR, V9, P1845, DOI 10.1093/scan/nst183; Wang JJ, 2015, HUM BRAIN MAPP, V36, P1908, DOI 10.1002/hbm.22745; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yang JY, 2016, COGN AFFECT BEHAV NE, V16, P51, DOI 10.3758/s13415-015-0371-6; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhou DM, 2015, NEUROIMAGE, V104, P138, DOI 10.1016/j.neuroimage.2014.10.005	79	87	88	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162511	10.1371/journal.pone.0162511	http://dx.doi.org/10.1371/journal.pone.0162511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27644039	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900012
J	Park, HS; Rinehart, M; Walzer, KA; Chi, JTA; Wax, A				Park, Han Sang; Rinehart, MatthewT.; Walzer, Katelyn A.; Chi, Jen-Tsan Ashley; Wax, Adam			Automated Detection of P. falciparum Using Machine Learning Algorithms with Quantitative Phase Images of Unstained Cells	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-FALCIPARUM; MALARIA; SENSITIVITY; MICROSCOPY	Malaria detection through microscopic examination of stained blood smears is a diagnostic challenge that heavily relies on the expertise of trained microscopists. This paper presents an automated analysis method for detection and staging of red blood cells infected by the malaria parasite Plasmodium falciparum at trophozoite or schizont stage. Unlike previous efforts in this area, this study uses quantitative phase images of unstained cells. Erythrocytes are automatically segmented using thresholds of optical phase and refocused to enable quantitative comparison of phase images. Refocused images are analyzed to extract 23 morphological descriptors based on the phase information. While all individual descriptors are highly statistically different between infected and uninfected cells, each descriptor does not enable separation of populations at a level satisfactory for clinical utility. To improve the diagnostic capacity, we applied various machine learning techniques, including linear discriminant classification (LDC), logistic regression (LR), and k-nearest neighbor classification (NNC), to formulate algorithms that combine all of the calculated physical parameters to distinguish cells more effectively. Results show that LDC provides the highest accuracy of up to 99.7% in detecting schizont stage infected cells compared to uninfected RBCs. NNC showed slightly better accuracy (99.5%) than either LDC (99.0%) or LR (99.1%) for discriminating late trophozoites from uninfected RBCs. However, for early trophozoites, LDC produced the best accuracy of 98%. Discrimination of infection stage was less accurate, producing high specificity (99.8%) but only 45.0%-66.8% sensitivity with early trophozoites most often mistaken for late trophozoite or schizont stage and late trophozoite and schizont stage most often confused for each other. Overall, this methodology points to a significant clinical potential of using quantitative phase imaging to detect and stage malaria infection without staining or expert analysis.	[Park, Han Sang; Rinehart, MatthewT.; Wax, Adam] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Walzer, Katelyn A.; Chi, Jen-Tsan Ashley] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Walzer, Katelyn A.; Chi, Jen-Tsan Ashley] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA	Duke University; Duke University; Duke University	Park, HS (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	hp36@duke.edu		Chi, Jen-Tsan/0000-0003-3433-903X	National Science Foundation, Division of Industrial Innovation and Partnership [NSF IIP-1346349]; National Institutes of Health (NIH) [R01-CA167421]; World Anti-Doping Agent; Burroughs Wellcome Fund; NSF GRFP; NATIONAL CANCER INSTITUTE [R01CA167421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER	National Science Foundation, Division of Industrial Innovation and Partnership; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Anti-Doping Agent; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Science Foundation, Division of Industrial Innovation and Partnership (NSF IIP-1346349, http://www.nsf.gov/, AW) and National Institutes of Health (NIH R01-CA167421, www.nih.gov/, AW) grants. JAC acknowledges financial support from the World Anti-Doping Agent (https://www.wada-ama.org/) and Burroughs Wellcome Fund (www.bwfund.org/). KAW is supported by the NSF GRFP (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, IEEE PHOTONICS J, V4, P1456, DOI 10.1109/JPHOT.2012.2210199; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Das DK, 2013, MICRON, V45, P97, DOI 10.1016/j.micron.2012.11.002; Di Ruberto C, 2002, IMAGE VISION COMPUT, V20, P133, DOI 10.1016/S0262-8856(01)00092-0; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Eldridge WJ, 2016, OPT LETT, V41, P352, DOI 10.1364/OL.41.000352; GEARY TG, 1989, AM J TROP MED HYG, V40, P240, DOI 10.4269/ajtmh.1989.40.240; Grobusch MP, 2003, CYTOM PART B-CLIN CY, V55B, P46, DOI 10.1002/cyto.b.10039; Hanscheid T, 2000, PARASITOL TODAY, V16, P549, DOI 10.1016/S0169-4758(00)01742-7; Iqbal J, 2003, MED PRIN PRACT, V12, P156, DOI 10.1159/000070751; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Kilian AHD, 2000, TROP MED INT HEALTH, V5, P3, DOI 10.1046/j.1365-3156.2000.00509.x; Liebling M, 2004, J OPT SOC AM A, V21, P367, DOI 10.1364/JOSAA.21.000367; Manser M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-428; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Organization WH, 2006, GUID TREATM MAL; Rinehart M, 2012, BIOMED OPT EXPRESS, V3, P958, DOI 10.1364/BOE.3.000958; Rinehart MT, 2015, BIOMED OPT EXPRESS, V6, P2067, DOI 10.1364/BOE.6.002067; Saliba K, 2013, MALARIA, P17, DOI DOI 10.1007/978-1-62703-026-7; Sangokoya C, 2010, METHODS MOL BIOL, V667, P193, DOI 10.1007/978-1-60761-811-9_13; Shaked NT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556717; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290242; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Yoo M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128005	29	74	76	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163045	10.1371/journal.pone.0163045	http://dx.doi.org/10.1371/journal.pone.0163045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636719	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700028
J	Plaisance, V; Brajkovic, S; Tenenbaum, M; Favre, D; Ezanno, H; Bonnefond, A; Bonner, C; Gmyr, V; Kerr-Conte, J; Gauthier, BR; Widmann, C; Waeber, G; Pattou, F; Froguel, P; Abderrahmani, A				Plaisance, Valerie; Brajkovic, Saska; Tenenbaum, Mathie; Favre, Dimitri; Ezanno, Helene; Bonnefond, Amelie; Bonner, Caroline; Gmyr, Valery; Kerr-Conte, Julie; Gauthier, Benoit R.; Widmann, Christian; Waeber, Gerard; Pattou, Francois; Froguel, Philippe; Abderrahmani, Amar			Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; DIABETES-MELLITUS; DENSITY-LIPOPROTEINS; ER STRESS; MACROPHAGES; APOPTOSIS; ANTIOXIDANTS; METABOLISM; ACTIVATION; EXPRESSION	Elevated plasma concentration of the pro-atherogenic oxidized low density lipoprotein cholesterol (LDL) triggers adverse effects in pancreatic beta-cells and is associated with type 2 diabetes. Here, we investigated whether the endoplasmic reticulum (ER) stress is a key player coupling oxidative stress to beta-cell dysfunction and death elicited by human oxidized LDL. We found that human oxidized LDL activates ER stress as evidenced by the activation of the inositol requiring 1a, and the elevated expression of both DDIT3 (also called CHOP) and DNAJC3 (also called P58IPK) ER stress markers in isolated human islets and the mouse insulin secreting MIN6 cells. Silencing of Chop and inhibition of ER stress markers by the chemical chaperone phenyl butyric acid (PBA) prevented cell death caused by oxidized LDL. Finally, we found that oxidative stress accounts for activation of ER stress markers induced by oxidized LDL. Induction of Chop/ CHOP and p58IPK/P58IPK by oxidized LDL was mimicked by hydrogen peroxide and was blocked by co-treatment with the N-acetylcystein antioxidant. As a conclusion, the harmful effects of oxidized LDL in beta-cells requires ER stress activation in a manner that involves oxidative stress. This mechanism may account for impaired beta-cell function in diabetes and can be reversed by antioxidant treatment.	[Plaisance, Valerie; Brajkovic, Saska; Tenenbaum, Mathie; Favre, Dimitri; Ezanno, Helene; Bonnefond, Amelie; Froguel, Philippe; Abderrahmani, Amar] Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199 EGID, Lille, France; [Brajkovic, Saska; Favre, Dimitri; Waeber, Gerard] Univ Lausanne, Ctr Hosp Univ Vaudois, Serv Internal Med, Lausanne, Switzerland; [Bonner, Caroline; Gmyr, Valery; Kerr-Conte, Julie; Pattou, Francois] Univ Lille, INSERM, CHU Lille, U1190 EGID, Lille, France; [Gauthier, Benoit R.] Andalusian Ctr Mol Biol & Regenerat Med, Dept Stem Cells, Seville, Spain; [Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Bonnefond, Amelie; Froguel, Philippe; Abderrahmani, Amar] Imperial Coll London, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Lausanne; Imperial College London	Abderrahmani, A (corresponding author), Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199 EGID, Lille, France.; Abderrahmani, A (corresponding author), Imperial Coll London, Dept Genom Common Dis, London, England.	amar.abderrahmani@univ-lille2.fr	Bonnefond, Amélie/O-2784-2017; Gauthier, Benoit R/C-3138-2017; Abderrahmani, Amar/O-3124-2017; Pattou, Francois/O-6151-2017; FROGUEL, Philippe/O-6799-2017; Bonner, Caroline/A-9819-2015; Widmann, Christian/N-9851-2013	Bonnefond, Amélie/0000-0001-9976-3005; Gauthier, Benoit R/0000-0001-8146-7486; Abderrahmani, Amar/0000-0003-0752-0343; Pattou, Francois/0000-0001-8388-3766; FROGUEL, Philippe/0000-0003-2972-0784; Bonner, Caroline/0000-0002-4430-8280; Waeber, Gerard/0000-0003-4193-788X; Widmann, Christian/0000-0002-6881-0363	"European Genomic Institute for Diabetes" (E.G.I.D.) [ANR-10-LABX-46]; European Commission; Regional Council Nord Pas de Calais; European Regional Development Fund	"European Genomic Institute for Diabetes" (E.G.I.D.); European Commission(European CommissionEuropean Commission Joint Research Centre); Regional Council Nord Pas de Calais(Region Hauts-de-France); European Regional Development Fund(European Commission)	This work was supported by the "European Genomic Institute for Diabetes" (E.G.I.D., ANR-10-LABX-46), European Commission, the Regional Council Nord Pas de Calais and the European Regional Development Fund.; This work was supported by the "European Genomic Institute for Diabetes" (E.G.I.D., ANR-10-LABX-46), European Commission, the Regional Council Nord Pas de Calais and the European Regional Development Fund. We are grateful to Denis Fahmi, Mr. Gilles Dubuis, Mr Guy Niederhauser, Mr Raphael Boutry and Ms Laure Rolland for technical assistance.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; BELLOMO G, 1995, DIABETES, V44, P60, DOI 10.2337/diabetes.44.1.60; Brajkovic S, 2012, ADIPOCYTE, V1, P157, DOI 10.4161/adip.20000; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc214; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Jessup W, 2000, CURR OPIN LIPIDOL, V11, P473, DOI 10.1097/00041433-200010000-00005; Li E, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0077-2; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maedler K, 2004, HORM RES, V62, P67, DOI 10.1159/000080503; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okajima F, 2005, BBA-MOL CELL BIOL L, V1687, P173, DOI 10.1016/j.bbalip.2004.11.018; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Petremand J, 2008, CURR OPIN LIPIDOL, V19, P95, DOI 10.1097/MOL.0b013e3282f41982; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Rohrer L, 2004, CURR OPIN LIPIDOL, V15, P269, DOI 10.1097/00041433-200406000-00006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799	39	59	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163046	10.1371/journal.pone.0163046	http://dx.doi.org/10.1371/journal.pone.0163046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636901	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700029
J	Cuppen, BVJ; Fu, JZ; van Wietmarschen, HA; Harms, AC; Koval, S; Marijnissen, ACA; Peeters, JJW; Bijlsma, JJ; Tekstra, J; van Laar, JM; Hankemeier, T; Lafeber, FPJG; van der Greef, J				Cuppen, Bart V. J.; Fu, Junzeng; van Wietmarschen, Herman A.; Harms, Amy C.; Koval, Slavik; Marijnissen, Anne C. A.; Peeters, Judith J. W.; Bijlsma, JohannesW. J.; Tekstra, Janneke; van Laar, Jacob M.; Hankemeier, Thomas; Lafeber, Floris P. J. G.; van der Greef, Jan		Soc Rheumatology Res Utrecht Inves	Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-alpha Inhibitors in Rheumatoid Arthritis	PLOS ONE			English	Article							VALIDATION; DISEASES; CYTOKINES; THERAPY; PROTEIN; MODELS	In clinical practice, approximately one-third of patients with rheumatoid arthritis(RA) respond insufficiently to TNF-alpha inhibitors (TNFis). The aim of the study was to explore the use of a metabolomics to identify predictors for the outcome of TNFi therapy, and study the metabolomic fingerprint in active RA irrespective of patients' response. In the metabolomic profiling, lipids, oxylipins, and amines were measured in serum samples of RA patients from the observational BiOCURA cohort, before start of biological treatment. Multivariable logistic regression models were established to identify predictors for good-and non-response in patients receiving TNFi (n = 124). The added value of metabolites over prediction using clinical parameters only was determined by comparing the area under receiver operating characteristic curve (AUC-ROC), sensitivity, specificity, positive-and negative predictive value and by the net reclassification index (NRI). The models were further validated by 10-fold cross validation and tested on the complete TNFi treatment cohort including moderate responders. Additionally, metabolites were identified that cross-sectionally associated with the RA disease activity score based on a 28-joint count (DAS28), erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP). Out of 139 metabolites, the best-performing predictors were sn1-LPC(18:3-omega 3/omega 6), sn1-LPC(15: 0), ethanolamine, and lysine. The model that combined the selected metabolites with clinical parameters showed a significant larger AUC-ROC than that of the model containing only clinical parameters (p = 0.01). The combined model was able to discriminate good-and non-responders with good accuracy and to reclassify non-responders with an improvement of 30% (total NRI = 0.23) and showed a prediction error of 0.27. For the complete TNFi cohort, the NRI was 0.22. In addition, 88 metaboliteswere associated with DAS28, ESR or CRP (p<0.05). Our study established an accurate prediction model for response to TNFi therapy, containing metabolites and clinical parameters. Associations between metabolites and disease activity may help elucidate additional pathologic mechanisms behind RA.	[Cuppen, Bart V. J.; Marijnissen, Anne C. A.; Bijlsma, JohannesW. J.; Tekstra, Janneke; van Laar, Jacob M.; Lafeber, Floris P. J. G.] Univ Med Ctr Utrecht, Rheumatol & Clin Immunol, Utrecht, Netherlands; [Fu, Junzeng; Harms, Amy C.; Koval, Slavik; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Fu, Junzeng; van Wietmarschen, Herman A.; van der Greef, Jan] Sinodutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [van Wietmarschen, Herman A.; van der Greef, Jan] TNO, Netherlands Org Appl Sci Res Microbiol & Syst Bio, Zeist, Netherlands; [Harms, Amy C.; Koval, Slavik; Hankemeier, Thomas; van der Greef, Jan] Netherlands Metabol Ctr, Leiden, Netherlands; [Peeters, Judith J. W.] St Jansdal Hosp, Harderwijk, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Fu, JZ (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands.; Fu, JZ (corresponding author), Sinodutch Ctr Prevent & Personalized Med, Zeist, Netherlands.	j.fu@lacdr.leidenuniv.nl	Hankemeier, Thomas/V-5407-2019	Hankemeier, Thomas/0000-0001-7871-2073	ZonMw: The Netherlands Association for Health Research and Development [152001008]; Pfizer; BMS; UCB; Roche; Schering-Plough; ReumaFonds [LLP-9] Funding Source: researchfish	ZonMw: The Netherlands Association for Health Research and Development; Pfizer(Pfizer); BMS(Bristol-Myers Squibb); UCB(UCB Pharma SA); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); ReumaFonds	This research was supported by ZonMw: The Netherlands Association for Health Research and Development (project no. 152001008), the Foundation Friends of the UMC Utrecht based on a private gift, and unrestricted grants from Pfizer, BMS, UCB, Roche, and Schering-Plough. None of the funders were involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; AUSTGEN TR, 1992, J TRAUMA, V32, P600, DOI 10.1097/00005373-199205000-00011; Behrens F, 2013, ARTHRIT CARE RES, V65, P1608, DOI 10.1002/acr.22037; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Cuppen BVJ, 2016, RHEUMATOLOGY, V55, P826, DOI 10.1093/rheumatology/kev421; Draisma HHM, 2010, ANAL CHEM, V82, P1039, DOI 10.1021/ac902346a; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FISCHER JE, 1991, AM J SURG, V161, P266, DOI 10.1016/0002-9610(91)91143-7; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; GINSBURG I, 1989, INFLAMMATION, V13, P163, DOI 10.1007/BF00924787; Guma M, 2016, NAT REV RHEUMATOL, V12, P269, DOI 10.1038/nrrheum.2016.1; Heemskerk MM, 2014, J LIPID RES, V55, P2532, DOI 10.1194/jlr.M051938; Heimerl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111348; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Madsen OR, 2016, CLIN RHEUMATOL, V35, P2403, DOI 10.1007/s10067-016-3322-x; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Martins FM, 2015, RHEUMATOLOGY, V54, P286, DOI 10.1093/rheumatology/keu313; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Nicastro H, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/136937; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Ouyang X, 2011, LUPUS, V20, P1411, DOI 10.1177/0961203311418707; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Priori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138537; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Sugiura T, 2016, ATHEROSCLEROSIS, V246, P157, DOI 10.1016/j.atherosclerosis.2016.01.015; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; WOLFE A M, 1968, Bulletin on the Rheumatic Diseases, V19, P524; Ye XQ, 2008, HUM REPROD UPDATE, V14, P519, DOI 10.1093/humupd/dmn023; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zabek A, 2016, J PHARMACEUT BIOMED, V117, P544, DOI 10.1016/j.jpba.2015.10.007	49	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163087	10.1371/journal.pone.0163087	http://dx.doi.org/10.1371/journal.pone.0163087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631111	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900129
J	Salomon, F; Keay, S; Carayon, N; Goiran, JP				Salomon, Ferreol; Keay, Simon; Carayon, Nicolas; Goiran, Jean-Philippe			The Development and Characteristics of Ancient Harbours-Applying the PADM Chart to the Case Studies of Ostia and Portus	PLOS ONE			English	Article							GEOARCHAEOLOGICAL EVIDENCE; ENVIRONMENTAL-CHANGES; TIBER DELTA; ROME; EVOLUTION; LAGOON; FRANCE; BASIN	Over the last 20 years, the geoarchaeology of ancient harbours has been a very active area of research around the Mediterranean basin, generatingmuch palaeoenvironmental data from many sites, including estimations of sedimentation rates, the height of the ancient sealevel at different dates and palaeo-geographical reconstructions. Combining this information has proved a major challenge. This article proposes a new chart called the Palaeoenvironmental Age-Depth Model (PADM chart), that allows the researchers to combine all relevant indicators in order to estimate harbour potential of a given ancient port, and to generate comparable data between harbours in termsof degree of closure and water depth available against a synchronised chronology. This new approach, developed in the context of the ERC-funded RoMP Portuslimen project, takes into account estimations of water depths relating to differing Roman ship draughts at different periods. It is tested against the palaeoenvironmental evidence published over 10 years from two Roman harbours located at the mouth of the river Tiber: Ostia and Portus. This reveals that: (1) there has been an underestimate of the real sedimentation rates due to the margins of error of the radiocarbon dates; (2) there was effective control of the water column by dredging; (3) there were different periods of control of the sedimentation. We suggest that the navigability of the Ostia harbour by ships with shallower draughts was maintained until sometime between the 2nd c. BC and 1st c. AD, while at Portus it was retained until the 6th-7th c. AD.	[Salomon, Ferreol; Keay, Simon; Carayon, Nicolas] Univ Southampton, Fac Humanities, Dept Archaeol, Ave Campus, Southampton SO17 1BF, Hants, England; [Goiran, Jean-Philippe] CNRS, UMR Archeorient 5133, MOM, 7 Rue Raulin, F-69007 Lyon, France	University of Southampton; Centre National de la Recherche Scientifique (CNRS)	Salomon, F (corresponding author), Univ Southampton, Fac Humanities, Dept Archaeol, Ave Campus, Southampton SO17 1BF, Hants, England.	ferreol.salomon@gmail.com		Salomon, Ferreol/0000-0002-4705-5370	FP7-IDEAS-ERC [339123]; NERC [bosc01001] Funding Source: UKRI; Natural Environment Research Council [bosc01001] Funding Source: researchfish	FP7-IDEAS-ERC; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by FP7-IDEAS-ERC (https://erc.europa.eu/romes-mediterranean-ports), (Project reference: 339123).	[Anonymous], 2002, JRA, DOI DOI 10.1017/S1047759400013817; Arnaud Pascal, 2010, ARCH RIV MED 50 ANS, P107; Arnoldus-Huyzendveld A, 2005, ARCHAEOLOGICAL MONOG, V15, P14; Bellotti P, 2009, MEDITERRANEE, P51; Boetto, 2010, B ARCHAEOLOGIA LINE, P112; Bony G, 2011, CR GEOSCI, V343, P701, DOI 10.1016/j.crte.2011.08.003; Bukowiecki E., 2011, MELANGES ECOLE FRANC, V123, P351; Bukowiecki E, 2013, PORTUS, DOI [10.4000/cefr.935, DOI 10.4000/CEFR.935]; Buti G, 2010, RIVES MEDITERRANEENN, P7; Buti G, 2010, RIVES MEDITERRANEENN, P11, DOI [10.4000/rives.3842, DOI 10.4000/RIVES.3842]; Carayon N, 2008, THESIS; Cinque A., 2009, MEDITERRANEE, V112, P23, DOI [10.4000/mediterranee.3045, DOI 10.4000/MEDITERRANEE.3045, https://doi.org/10.4000/mediterranee.3045]; Delile H, 2014, QUATERNARY SCI REV, V87, P34, DOI 10.1016/j.quascirev.2014.01.002; Flaux C, 2012, J ARCHAEOL SCI, V39, P3493, DOI 10.1016/j.jas.2012.06.010; Gassend J., 1982, NAVIRE ANTIQUE LACYD; Giraudi C, 2009, GEOARCHAEOLOGY, V24, P371, DOI 10.1002/gea.20270; Goiran J.-P., 2001, THESIS; Goiran J.-P., 2008, MEDITERRANEE, V120, P217, DOI [10.4000/mediterranee.3177, DOI 10.4000/MEDITERRANEE.3177]; Goiran J-P, 2011, MEFRA ANTIQ, V123, P157; Goiran J-P, 2011, ARCHAEOLOGICAL MONOG, V18, P31; Goiran J-P, 2015, GEOARCHAEOLOGY ANCIE, P291; Goiran J-P, 2012, RESULTATS PRELIMINAI, P123; Goiran JP, 2014, J ARCHAEOL SCI, V41, P389, DOI 10.1016/j.jas.2013.08.019; Goiran JP, 2010, QUATERN INT, V216, P3, DOI 10.1016/j.quaint.2009.10.030; Hadler H, 2015, J ARCHAEOL SCI, V61, P78, DOI 10.1016/j.jas.2015.05.002; Keay S., 2011, ARCHAEOLOGICAL MONOG, V18; Keay S.J., 2005, ARCHAEOLOGICAL MONOG, V15; Leonard H. Jones, 1923, GEOGRAPHY, V2, P50, DOI [10.4159/DLCL.strabo-geography.1917, DOI 10.4159/DLCL.STRABO-GEOGRAPHY.1917]; Marriner N, 2006, SEDIMENT GEOL, V186, P13, DOI 10.1016/j.sedgeo.2005.12.001; Marriner N, 2006, QUATERNARY RES, V65, P164, DOI 10.1016/j.yqres.2005.07.004; Marriner N, 2005, J ARCHAEOL SCI, V32, P1302, DOI 10.1016/j.jas.2005.03.019; Marriner N., 2010, GEOL TODAY, V26, P21; Marriner N, 2007, EARTH-SCI REV, V80, P137, DOI 10.1016/j.earscirev.2006.10.003; Marriner N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05554; Mazzini I, 2011, J PALEOLIMNOL, V46, P243, DOI 10.1007/s10933-011-9536-7; Meiggs R., 1973, ROMAN OSTIA; Moore F.G., 1949, AB URBE CONDITA, V8, P381, DOI [10.4159/DLCL.livy-history_rome_30.1949, DOI 10.4159/DLCL.LIVY-HISTORY_ROME_30.1949]; Morhange C, 2003, HOLOCENE, V13, P593, DOI 10.1191/0959683603hl619rr; Morhange C, 2015, GEOARCHAEOLOGY ANCIE, P281; Morhange C., 2003, TOPOI, V11, P645; Morhange C., 2015, QUATERNAIRE, V26, P117, DOI [10.4000/quaternaire.7215, DOI 10.4000/QUATERNAIRE.7215]; Paroli L., 2005, PORTUS ARCHAEOLOGICA, P43; Pavolini C., 2006, OSTIA GUIDE ARCHEOLO; Pepe C, 2013, QUATERN INT, V303, P73, DOI 10.1016/j.quaint.2012.11.008; Pomey P, 2005, LARCHEOLOGIE NAVALE; Pomey P, 1978, ARCHEONAUTICA, P233; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reinhardt EG, 1999, GEOLOGY, V27, P811, DOI 10.1130/0091-7613(1999)027<0811:DOHTGS>2.3.CO;2; Sadori L, 2016, HOLOCENE, V26, P1502, DOI 10.1177/0959683616640054; Sadori L, 2010, J ARCHAEOL SCI, V37, P3294, DOI 10.1016/j.jas.2010.07.032; Salomon F, 2014, OSTIE EMBOUCHURE TIB, DOI [10.4000/cefr.1062, DOI 10.4000/CEFR.1062]; Salomon F, 2017, GEOARCHAEOLOGY, V32, P215, DOI 10.1002/gea.21589; Salomon F, 2012, GEOMORPHOLOGIE, P75; Vittori C, 2015, J ARCHAEOL SCI, V54, P374, DOI 10.1016/j.jas.2014.06.017; [No title captured]	55	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162587	10.1371/journal.pone.0162587	http://dx.doi.org/10.1371/journal.pone.0162587			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631985	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000383706900054
J	Xie, YP; Meng, Y; Sun, H; Nie, ZL				Xie, Yan-Ping; Meng, Ying; Sun, Hang; Nie, Ze-Long			Molecular Phylogeny of Gueldenstaedtia and Tibetia (Fabaceae) and Their Biogeographic Differentiation within Eastern Asia	PLOS ONE			English	Article							HENGDUAN MOUNTAINS; TRIBE HEDYSAREAE; LEGUMINOSAE; DIVERSIFICATION; PAPILIONOIDEAE; RATES; EVOLUTIONARY; INFERENCE; EMPHASIS; REVISION	Tibetia and Gueldenstaedtia are two morphologically similar and small genera in Fabaceae, with distributions largely corresponding to the Sino-Himalayan and Sino-Japanese subkingdoms in eastern Asia, respectively. These two genera have confusing relationships based on morphology; therefore, we aimed to provide a clear understanding of their phylogenetic and biogeographic evolution within eastern Asia. In our investigations we included 88 samples representing five Gueldenstaedtia species, five Tibetia species, and outgroup species were sequenced using five markers (nuclear: ITS; chloroplast: matK, trnL-F, psbA-trnH and rbcL). Our phylogenetic results support (1) the monophyly of Tibetia and of Gueldenstaedtia, respectively; and (2) that Tibetia and Gueldenstaedtia are sister genera. Additionally, our data identified that Tibetia species hadmuch higher sequence variation than Gueldenstaedtia species. Our results suggest that the two genera were separated from each other about 17.23 million years ago, which is congruent with the Himalayan orogeny and the uplift of the Tibetan Plateau in the mid Miocene. The divergence of Tibetia and Gueldenstaedtia is strongly supported by the separation of the Sino-Himalayan and Sino-Japanese region within eastern Asia. In addition, the habitat heterogeneitymay accelerate the molecular divergence of Tibetia in the Sino-Himalayan region.	[Xie, Yan-Ping; Sun, Hang] Chinese Acad Sci, Key Lab Biodivers & Biogeog East Asia, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Xie, Yan-Ping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Meng, Ying; Nie, Ze-Long] Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Coll Biol & Environm Sci, Jishou, Hunan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University	Nie, ZL (corresponding author), Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Coll Biol & Environm Sci, Jishou, Hunan, Peoples R China.	zelongnie@163.com			Natural Sciences Foundation of China [NSFC 31570211]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Sciences Foundation of China (NSFC 31570211) to Ze-Long Nie.	Ahangarian S., 2007, Iranian Journal of Botany, V13, P64; ALI S. I., 1962, Candollea, V18, P137; Bao BJ, 2010, FLORA CHINA, V10, P506; Bruneau A, 2008, BOTANY, V86, P697, DOI 10.1139/B08-058; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Cui HP, 1998, FL REIP POP SIN, V42, P146; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duan L, 2015, TAXON, V64, P49, DOI 10.12705/641.26; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher FE, 1823, MEM SOC NAT MOSCON, V6, P170; GRIERSON AJC, 1987, FLORA BHUTAN; Gu Zhi-Jian, 1993, Acta Botanica Yunnanica, V15, P377; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HERENDEEN PS, 1990, SYST BOT, V15, P526, DOI 10.2307/2419152; Herendeen PS, 1992, FOSSIL RECORD; Herendeen PS, 2001, P BOT, P12; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karamian, 2003, THAISZIA J BOT, V13, P67; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li J., 1995, UPLIFT QINGHAI XIZAN; LI P, 1989, Acta Botanica Yunnanica, V11, P285; Li PC, 1985, FLORA OF XIZANGICA, V2, P793; Li XW, 1993, ACTA BOT YUNNANICA, V3, P217; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu JQ, 2002, MOL PHYLOGENET EVOL, V23, P307, DOI 10.1016/S1055-7903(02)00039-8; Liu YS, 2000, EVOLUTION LATE CRETA; Mabberley DJ, 1997, PLANT BOOK; Mao Kang-Shan, 2005, Acta Botanica Yunnanica, V27, P620; MATTEN LC, 1977, REV PALAEOBOT PALYNO, V24, P195, DOI 10.1016/0034-6667(77)90047-1; Nie ZL, 2006, MOL PHYLOGENET EVOL, V40, P155, DOI 10.1016/j.ympev.2006.03.012; Nie ZL, 2002, J PLANT RES, V115, P17, DOI 10.1007/s102650200003; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PAGE VM, 1993, IAWA J, V14, P299, DOI 10.1163/22941932-90001333; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, TRACER VERSION 1 5; Sanderson MJ, 1996, AM J BOT, V83, P1488, DOI 10.2307/2446103; Scherson RA, 2008, AM J BOT, V95, P1030, DOI 10.3732/ajb.0800017; Shi Y., 1999, ACTA GEOGR SIN CHIN, V54, P20; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Swofford DL, 2003, PAUP 4 OB 10 PHYLOGE; Thompson J.D., 2002, CURRENT PROTOCOLS BI; TSUI HP, 1979, B BOT LAB N E FOREST, V5, P31; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; Wheeler E.A., 2001, P DENVER MUS SCI IND, V4, P197; WHEELER EA, 1992, REV PALAEOBOT PALYNO, V74, P267, DOI 10.1016/0034-6667(92)90011-5; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wu, 1988, J JPN BOT, V63, P297; WU C-Y, 1979, Acta Botanica Yunnanica, V1, P1; Wu ZY., 1998, P 1 INT S FLOR CHAR, P3; Xie Yan-Ping, 2012, Plant Diversity and Resources, V34, P326, DOI 10.3724/SP.J.1143.2012.12006; YAKOVLEV G P, 1980, Botanicheskii Zhurnal (St. Petersburg), V65, P104; [杨德奎 Yang Dekui], 2002, [广西植物, Guihaia], V22, P349; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhou Z, 2013, MOL PHYLOGENET EVOL, V68, P482, DOI 10.1016/j.ympev.2013.04.027; Zhu XiangYun, 2005, Nordic Journal of Botany, V23, P373; Zhu XY, 2005, BOT J LINN SOC, V148, P475, DOI 10.1111/j.1095-8339.2005.00414.x; Zhu XY, 2004, ANN BOT FENN, V41, P283	70	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162982	10.1371/journal.pone.0162982	http://dx.doi.org/10.1371/journal.pone.0162982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632535	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900107
J	Wever, KE; Bruintjes, MHD; Warle, MC; Hooijmans, CR				Wever, Kimberley E.; Bruintjes, Moira H. D.; Warle, Michiel C.; Hooijmans, Carlijn R.			Renal Perfusion and Function during Pneumoperitoneum: A Systematic Review and Meta-Analysis of Animal Studies	PLOS ONE			English	Review							CARBON-DIOXIDE PNEUMOPERITONEUM; INCREASED INTRAABDOMINAL PRESSURE; BLOOD-FLOW; PORCINE MODEL; NITRIC-OXIDE; CO2 PNEUMOPERITONEUM; LAPAROSCOPIC CHOLECYSTECTOMY; HELIUM PNEUMOPERITONEUM; COMPARTMENT SYNDROME; GASLESS LAPAROSCOPY	Both preclinical and clinical studies indicate that raised intra-abdominal pressure (IAP) associated with pneumoperitoneum during laparoscopic surgical procedures can cause renal damage, the severity of which may be influenced by variables such as pressure level and duration. Several of these variables have been investigated in animal studies, but synthesis of all preclinical data has not been performed. This systematic review summarizes all available pre-clinical evidence on this topic, including an assessment of its quality and risk of bias. We performed meta-analysis to assess which aspects of the pneumoperitoneum determine the severity of its adverse effects. A systematic search in two databases identified 55 studies on the effect of pneumoperitoneum on renal function which met our inclusion criteria. There was high heterogeneity between the studies regarding study design, species, sex, pressure and duration of pneumoperitoneum, and type of gas used. Measures to reduce bias were poorly reported, leading to an unclear risk of bias in the majority of studies. Details on randomisation, blinding and a sample size calculation were not reported in >= 80% of the studies. Meta-analysis showed an overall increase in serum creatinine during pneumoperitoneum, and a decrease in urine output and renal blood flow. Subgroup analysis indicated that for serum creatinine, this effect differed between species. Subgroup analysis of pressure level indicated that urine output decreased as IAP level increased. No differences between types of gas were observed. Data were insufficient to reliably assess whether sex or IAP duration modulate the effect of pneumoperitoneum. Four studies assessing long-term effects indicated that serum creatinine normalized >= 24 hours after desufflation of pneumoperitoneum at 15mmHg. We conclude that harmful effects on renal function and perfusion during pneumoperitoneum appear to be robust, but evidence on long-term effects is very limited. The reliability and clinical relevance of these findings for healthy patients and patients at high risk of renal impairment remain uncertain. We emphasize the need for rigorous reporting of preclinical research methodology, which is of vital importance for clinical translation of preclinical data.	[Wever, Kimberley E.; Hooijmans, Carlijn R.] Radboud Univ Nijmegen, Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands; [Bruintjes, Moira H. D.; Warle, Michiel C.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Wever, KE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands.	kim.wever@radboudumc.nl	Hooijmans, C.R./L-4390-2015; Bruintjes, Moira H.D./G-8301-2016; Warle, M.C./L-4743-2015; Wever, Kimberley E./D-9705-2016	Hooijmans, C.R./0000-0001-6435-5714; Wever, Kimberley E./0000-0003-3635-3660	Netherlands Organization for Health Research and Development (ZonMW) [104024065]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMW, project #104024065, http://www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi Z, 2008, AM J PHYSIOL-REG I, V294, pR842, DOI 10.1152/ajpregu.00691.2007; Ali NA, 2005, ANN SURG, V241, P256, DOI 10.1097/01.sla.0000153034.54128.5e; Almeida Armando Vieira de, 2004, Rev Bras Anestesiol, V54, P343; Avraamidou A, 2012, LANGENBECK ARCH SURG, V397, P1333, DOI 10.1007/s00423-012-0977-x; Bayar MS, 2006, CHIR GASTROENTEROL, V22, P79, DOI 10.1159/000092731; Beduschi R, 1999, UROLOGY, V53, P451, DOI 10.1016/S0090-4295(98)00498-1; Benninger E, 2012, SHOCK, V38, P420, DOI 10.1097/SHK.0b013e31825ef7e7; Bergman S, 2006, SURG ENDOSC, V20, P794, DOI 10.1007/s00464-005-0086-9; Bishara B, 2012, EUR J HEART FAIL, V14, P1104, DOI 10.1093/eurjhf/hfs102; Bishara B, 2010, SURG ENDOSC, V24, P826, DOI 10.1007/s00464-009-0672-3; Bishara B, 2009, SURG ENDOSC, V23, P568, DOI 10.1007/s00464-008-9881-4; Bishara S, 2011, SURGICAL ENDOSCOPY A, V25, pS4; Borba MR, 2005, J ENDOUROL, V19, P1026, DOI 10.1089/end.2005.19.1026; Brundell SM, 2002, BRIT J SURG, V89, P617, DOI 10.1046/j.1365-2168.2002.02071.x; Carmona M, 2008, J ENDOUROL, V22, P1077, DOI 10.1089/end.2007.0369; Cheng Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009569.pub2; Chiu AW, 1996, UROL RES, V24, P361, DOI 10.1007/BF00389794; CHIU AW, 1995, J AM COLL SURGEONS, V181, P397; CHIU AW, 1994, J ENDOUROL, V8, P99, DOI 10.1089/end.1994.8.99; de Barros RF, 2012, SURG ENDOSC, V26, P3195, DOI 10.1007/s00464-012-2322-4; de Vries RBM., 2015, EVID BASED PRECLIN M, V2, DOI [10.1002/ebm2.7, DOI 10.1002/EBM2.7]; de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056; Demyttenaere SV, 2007, SURGERY, V142, P350, DOI 10.1016/j.surg.2007.02.018; Demyttenaere SV, 2006, SURG ENDOSC, V20, P274, DOI 10.1007/s00464-005-0244-0; FRENCH DM, 1951, AM J PHYSIOL, V167, P241, DOI 10.1152/ajplegacy.1951.167.1.241; Ge Liang, 2009, Zhonghua Shao Shang Za Zhi, V25, P137; Gong GW, 2011, J TRAUMA, V70, P775, DOI 10.1097/TA.0b013e318210fa1c; Guler C, 1998, J ENDOUROL, V12, P367, DOI 10.1089/end.1998.12.367; HASHIKURA Y, 1994, SURG ENDOSC-ULTRAS, V8, P759, DOI 10.1007/BF00593435; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Jonker SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150863; Junghans T, 1997, SURGERY, V121, P206, DOI 10.1016/S0039-6060(97)90291-9; Kacmaz A, 2003, PEPTIDES, V24, P1381, DOI 10.1016/j.peptides.2003.09.004; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Khoury W, 2008, J UROLOGY, V180, P1554, DOI 10.1016/j.juro.2008.06.008; KIRSCH AJ, 1994, UROLOGY, V43, P453, DOI 10.1016/0090-4295(94)90230-5; Lee BR, 1999, J ENDOUROL, V13, P279, DOI 10.1089/end.1999.13.279; Li W, 2015, UROL INT, V94, P225, DOI 10.1159/000362845; Lind MY, 2005, TRANSPLANTATION, V80, P700, DOI 10.1097/01.tp.0000172219.10178.0d; Lindberg F, 2003, SURG ENDOSC, V17, P480, DOI 10.1007/s00464-002-9044-y; Lindstrom P, 2003, NEPHROL DIAL TRANSPL, V18, P2269, DOI 10.1093/ndt/gfg362; Lindstrom P, 2003, ACTA PHYSIOL SCAND, V177, P149, DOI 10.1046/j.1365-201X.2003.01056.x; London ET, 2000, ANN SURG, V231, P195, DOI 10.1097/00000658-200002000-00007; McDougall EM, 1996, J AM COLL SURGEONS, V182, P317; Miki Y, 1997, SURG ENDOSC, V11, P838, DOI 10.1007/s004649900466; Moller M, 2012, ANNALS OF INTENSIVE; Naffaa M, 2013, SURG ENDOSC, V27, P2517, DOI 10.1007/s00464-012-2773-7; Neudecker J, 2002, SURG ENDOSC, V16, P1121, DOI 10.1007/s00464-001-9166-7; Ozdemir-van Brunschot DM, 2015, SURG ENDOSC; Perez J, 2002, SURG ENDOSC, V16, P1297, DOI 10.1007/s00464-001-9201-8; Rosin D, 2002, J LAPAROENDOSC ADV A, V12, P15, DOI 10.1089/109264202753486876; Saracoglu KT, 2013, J INVEST SURG; Schachtrupp A, 2005, SHOCK, V24, P153, DOI 10.1097/01.shk.0000172094.73918.c2; Schachtrupp A, 2002, J SURG RES, V106, P37, DOI 10.1006/jsre.2002.6421; Schafer M, 2001, SURG ENDOSC-ULTRAS, V15, P1197, DOI 10.1007/s004640080159; Sener G, 2003, J PINEAL RES, V35, P163, DOI 10.1034/j.1600-079X.2003.00070.x; Shimazutsu K, 2009, CTS-CLIN TRANSL SCI, V2, P405, DOI 10.1111/j.1752-8062.2009.00154.x; SHUTO K, 1995, SURG ENDOSC-ULTRAS, V9, P1173; de Freitas PFS, 2013, ACTA CIR BRAS, V28, P494, DOI 10.1590/S0102-86502013000700003; Tanaka K, 2002, WORLD J SURG, V26, P1412, DOI 10.1007/s00268-002-6447-9; Tsugawa K, 1999, SURG LAPARO ENDO PER, V9, P338, DOI 10.1097/00019509-199910000-00005; VARSHAVSKII B.Ya, 1967, BYUL EKSP BIOL MED, V63, P38; Warle MC, 2013, CLIN TRANSPLANT, V27, pE478, DOI 10.1111/ctr.12143; Wiesenthal JD, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.02.022; Xu Zhanping, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P119; Yasir M, 2012, SURG-J R COLL SURG E, V10, P71, DOI 10.1016/j.surge.2011.02.003; Yavuz Y, 2001, SURG ENDOSC-ULTRAS, V15, P149, DOI 10.1007/s004640000336	70	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163419	10.1371/journal.pone.0163419	http://dx.doi.org/10.1371/journal.pone.0163419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657740	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200117
J	Yang, MZ; Ma, MD; Yuan, MQ; Huang, ZY; Yang, WX; Zhang, HB; Huang, LH; Ren, AY; Shan, H				Yang, Ming-Zhi; Ma, Mian-Di; Yuan, Ming-Quan; Huang, Zhi-Yu; Yang, Wei-Xi; Zhang, Han-Bo; Huang, Li-Hua; Ren, An-Yun; Shan, Hui			Fungal Endophytes as a Metabolic Fine-Tuning Regulator for Wine Grape	PLOS ONE			English	Article							VITIS-VINIFERA; FUSARIUM-VERTICILLIOIDES; BIOACTIVE METABOLITES; CABERNET-SAUVIGNON; USTILAGO-MAYDIS; BERRIES; GROWTH; HOST; TEMPERATURE; RESPONSES	Endophytes proved to exert multiple effects on host plants, including growth promotion, stress resistance. However, whether endophytes have a role in metabolites shaping of grape has not been fully understood. Eight endophytic fungal strains which originally isolated from grapevines were re-inoculated to field-grown grapevines in this study, and their effects on both leaves and berries of grapevines at maturity stage were assessed, with special focused on secondary metabolites and antioxidant activities. High-density inoculation of all these endophytic fungal strains modified the physio-chemical status of grapevine to different degrees. Fungal inoculations promoted the content of reducing sugar (RS), total flavonoids (TF), total phenols (TPh), trans-resveratrol (Res) and activities of phenylalanine ammonia-lyase (PAL), in both leaves and berries of grapevine. Inoculation of endophytic fungal strains, CXB-11 (Nigrospora sp.) and CXC-13 (Fusarium sp.) conferred greater promotion effects in grape metabolic re-shaping, compared to other used fungal strains. Additionally, inoculation of different strains of fungal endophytes led to establish different metabolites patterns of wine grape. The work implies the possibility of using endophytic fungi as fine-tuning regulator to shape the quality and character of wine grape.	[Yang, Ming-Zhi; Ma, Mian-Di; Huang, Zhi-Yu; Zhang, Han-Bo; Huang, Li-Hua; Ren, An-Yun; Shan, Hui] Yunnan Univ, Sch Life Sci, Kunming, Peoples R China; [Yuan, Ming-Quan] Yunnan Univ, Sch Chem Sci & Technol, Kunming, Peoples R China; [Yang, Wei-Xi] China Agr Univ, Coll Food & Nutr Engn, Beijing, Peoples R China; [Ma, Mian-Di] Inst Zhaotong Apple Ind, Zhaotong, Yunnan, Peoples R China; [Huang, Zhi-Yu] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming, Peoples R China	Yunnan University; Yunnan University; China Agricultural University; Yunnan Minzu University	Yang, MZ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Peoples R China.	mzh-yang@163.com			National Natural Science Foundation of China [NSFC 31160070, 31560538]; Yunnan provincial Projects of Science and Technology [2010zc006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan provincial Projects of Science and Technology	This work was financially supported by the National Natural Science Foundation of China (NSFC 31160070 and 31560538), Yunnan provincial Projects of Science and Technology (2010zc006).	Agusta A, 2014, PROCEDIA CHEM, V13, P38, DOI 10.1016/j.proche.2014.12.004; Aly AH, 2013, PHARMAZIE, V68, P499, DOI 10.1691/ph.2013.6517; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Balik J, 2008, CZECH J FOOD SCI, V26, pS25, DOI 10.17221/246/2008-CJFS; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Bennett J, 2012, 18 FUNGAL BACTERIAL, P373; Bergmeyer H.-U., 2012, METHODS ENZYMATIC AN; Bergqvist J, 2001, AM J ENOL VITICULT, V52, P1; Blanco-Ulate B, 2015, PLANT PHYSIOL; Borges KB, 2009, TETRAHEDRON-ASYMMETR, V20, P385, DOI 10.1016/j.tetasy.2009.02.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carolyn E. L., 1996, J SCI FOOD AGR, V71, P313; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Considine MJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00060; de Oliveira AF, 2015, MOLECULES, V20, P2061, DOI 10.3390/molecules20022061; de Orduna RM, 2010, FOOD RES INT, V43, P1844, DOI 10.1016/j.foodres.2010.05.001; De Souza C, 2015, VITIS J GRAPEVINE RE, V44, P103; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Doty SL, 2015, PLANT ANIMAL GENOME; Downey MO, 2003, AUST J GRAPE WINE R, V9, P15, DOI 10.1111/j.1755-0238.2003.tb00228.x; DYGERT S, 1965, ANAL BIOCHEM, V13, P367, DOI 10.1016/0003-2697(65)90327-1; Estrada AER, 2012, FUNGAL GENET BIOL, V49, P578, DOI 10.1016/j.fgb.2012.05.001; Estrada AER, 2011, FUNGAL GENET BIOL, V48, P874, DOI 10.1016/j.fgb.2011.06.006; Faeth SH, 2002, INTEGR COMP BIOL, V42, P360, DOI 10.1093/icb/42.2.360; Ferreira V, 2000, J SCI FOOD AGR, V80, P1659, DOI 10.1002/1097-0010(20000901)80:11&lt;1659::AID-JSFA693&gt;3.0.CO;2-6; Flamini R, 2013, INT J MOL SCI, V14, P19651, DOI 10.3390/ijms141019651; Gaiero JR, 2013, AM J BOT, V100, P1738, DOI 10.3732/ajb.1200572; Hong YS, 2012, J EXP BOT, V63, P5773, DOI 10.1093/jxb/ers228; Jorgenesen ME, 2015, TRENDS PLANT SCI; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Khan AL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-3; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; Kuhn N, 2014, J EXP BOT, V65, P4543, DOI 10.1093/jxb/ert395; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Kusari S, 2012, METABOLOMICS ENDOPHY, P241; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lu H, 2000, PLANT SCI, V151, P67, DOI 10.1016/S0168-9452(99)00199-5; Ludwig-Muller J, 2015, BIOTECHNOL LETT, V37, P1325, DOI 10.1007/s10529-015-1814-4; Ma MD, 2014, S CHINA FRUITS, V43, P29; Ma MD, 2014, MICROBIOLOGY CHINA, V12; [马勉娣 Ma Miandi], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P118; Ma Y, 2011, BIOTECHNOL ADV, V29, P248, DOI 10.1016/j.biotechadv.2010.12.001; Marks S, 1996, NEW PHYTOL, V133, P727, DOI 10.1111/j.1469-8137.1996.tb01941.x; Martinez-Luscher J, 2014, PHYTOCHEMISTRY, V102, P106, DOI 10.1016/j.phytochem.2014.03.014; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ozden M., 2014, Journal of Food, Agriculture & Environment, V12, P338; Pascual-Marti MC, 2001, TALANTA, V54, P735, DOI 10.1016/S0039-9140(01)00319-8; Persoh D, 2013, FUNGAL DIVERS, V60, P55, DOI 10.1007/s13225-013-0225-x; Prado S, 2013, TETRAHEDRON LETT, V54, P1189, DOI 10.1016/j.tetlet.2012.12.038; Qian CD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0297-0; Reininger V, 2011, MICROB ECOL, V61, P676, DOI 10.1007/s00248-010-9798-z; Reynolds AG, 2001, HORTTECHNOLOGY, V11, P419, DOI 10.21273/HORTTECH.11.3.419; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Roldan A, 2003, J AGR FOOD CHEM, V51, P1464, DOI 10.1021/jf020774u; Saucedo-Garcia A, 2014, DIVERSITY COMMUNITIE; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Soubeyrand E, 2014, PHYTOCHEMISTRY, V103, P38, DOI 10.1016/j.phytochem.2014.03.024; Stone JK, 2000, BOOK SOIL P, P3; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; Tarr PT, 2013, METABOLOMICS, V9, pS170, DOI 10.1007/s11306-013-0497-x; Tian Y, 2014, PHYTOCHEMISTRY, V108, P95, DOI 10.1016/j.phytochem.2014.09.021; Wang XH, 2011, PLANT SCI, V180, P292, DOI 10.1016/j.plantsci.2010.09.007; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Xi ZM, 2013, FOOD CHEM, V141, P3056, DOI 10.1016/j.foodchem.2013.05.137; Xie Z, 2015, J SCI FOOD AGR; Yang Yong, 2015, African Journal of Agricultural Research, V10, P4543; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhao J, 2010, CURRENT RES TECHNOLO, P567, DOI DOI 10.1016/J.PHYTOCHEM.2012.07.021; Zhu L, 2012, INT J MOL SCI, V13, P3492, DOI 10.3390/ijms13033492	74	47	49	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163186	10.1371/journal.pone.0163186	http://dx.doi.org/10.1371/journal.pone.0163186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656886	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200083
J	Zhang, X; Ye, YL; Zhu, H; Sun, SN; Zheng, J; Fan, HH; Wu, HM; Chen, SF; Cheng, WH; Zhu, JH				Zhang, Xiong; Ye, Yang-Lie; Zhu, Hui; Sun, Sheng-Nan; Zheng, Jing; Fan, Hui-Hui; Wu, Hong-Mei; Chen, Song-Fang; Cheng, Wen-Hsing; Zhu, Jian-Hong			Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; SUBSTANTIA-NIGRA; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; OXIDATIVE DAMAGE; RAT MODEL; SELENIUM; MICE; DEFICIENT; NEUROTOXICITY	Genes of selenoproteome have been increasingly implicated in various aspects of neurobiology and neurological disorders, but remain largely elusive in Parkinson's disease (PD). In this study, we investigated the selenotranscriptome (24 selenoproteins in total) in five brain regions (cerebellum, substantia nigra, cortex, pons and hippocampus) by real time qPCR in a two-phase manner using a mouse model of chronic PD. A wide range of changes in selenotranscriptome was observed in a manner depending on selenoproteins and brain regions. While Selv mRNA was not detectable and Dio1& 3 mRNA levels were not affected, 1, 11 and 9 selenoproteins displayed patterns of increase only, decrease only, and mixed response, respectively, in these brain regions of PD mice. In particular, the mRNA expression of Gpx1-4 showed only a decreased trend in the PD mouse brains. In substantia nigra, levels of 17 selenoprotein mRNAs were significantly decreased whereas no selenoprotein was up-regulated in the PD mice. In contrast, the majority of selenotranscriptome did not change and a few selenoprotein mRNAs that respond displayed a mixed pattern of up-and down-regulation in cerebellum, cortex, hippocampus, and/or pons of the PD mice. Gpx4, Sep15, Selm, Sepw1, and Sepp1 mRNAs were most abundant across all these five brain regions. Our results showed differential responses of selenoproteins in various brain regions of the PD mouse model, providing critical selenotranscriptomic profiling for future functional investigation of individual selenoprotein in PD etiology.	[Zhang, Xiong; Ye, Yang-Lie; Zhu, Hui; Chen, Song-Fang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiong; Sun, Sheng-Nan; Zheng, Jing; Fan, Hui-Hui; Wu, Hong-Mei; Zhu, Jian-Hong] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Zhu, Jian-Hong] Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Zhejiang, Peoples R China; [Fan, Hui-Hui; Wu, Hong-Mei; Zhu, Jian-Hong] Wenzhou Med Univ, Inst Nutr & Dis, Wenzhou, Zhejiang, Peoples R China; [Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Mississippi State University	Zhu, JH (corresponding author), Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China.; Zhu, JH (corresponding author), Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Zhejiang, Peoples R China.; Zhu, JH (corresponding author), Wenzhou Med Univ, Inst Nutr & Dis, Wenzhou, Zhejiang, Peoples R China.	jhzhu@wmu.edu.cn	Zhu, Jian-Hong/E-3927-2010	Zhu, Jian-Hong/0000-0001-9412-8264	Zhejiang Provincial Natural Science Foundation [LR13H020002, LY15H090021, LY16H250003]; National Natural Science Foundation of China [81571087]; Health Bureau of Zhejiang Province [2016ZB078]; Wenzhou Bureau of Science and Technology [Y20150005]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Bureau of Zhejiang Province; Wenzhou Bureau of Science and Technology	This work was supported by funding from Zhejiang Provincial Natural Science Foundation (LR13H020002, LY15H090021 and LY16H250003), National Natural Science Foundation of China (81571087), Health Bureau of Zhejiang Province (2016ZB078) and Wenzhou Bureau of Science and Technology (Y20150005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet A, 2010, NEUROCHEM RES, V35, P1530, DOI 10.1007/s11064-010-0212-5; Bellinger FP, 2012, J PARKINSON DIS, V2, P115, DOI 10.3233/JPD-2012-11052; Bensadoun JC, 1998, EUR J NEUROSCI, V10, P3231, DOI 10.1046/j.1460-9568.1998.00345.x; Ellwanger JH, 2015, NUTRITION, V31, P359, DOI 10.1016/j.nut.2014.07.004; Grumolato L, 2008, FASEB J, V22, P1756, DOI 10.1096/fj.06-075820; Hare DJ, 2013, METALLOMICS, V5, P91, DOI 10.1039/c2mt20164j; Hauser DN, 2013, FREE RADICAL BIO MED, V65, P419, DOI 10.1016/j.freeradbiomed.2013.06.030; Hawkes WC, 2012, J BIOL CHEM, V287, P27371, DOI 10.1074/jbc.M112.346593; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Khan HA, 2010, NEUROCHEM INT, V57, P489, DOI 10.1016/j.neuint.2010.06.020; Kim YJ, 2005, BIOCHEM BIOPH RES CO, V330, P1095, DOI 10.1016/j.bbrc.2005.03.080; Klivenyi P, 2000, J NEUROSCI, V20, P1; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kuhbacher M, 2009, J NEUROCHEM, V110, P133, DOI 10.1111/j.1471-4159.2009.06109.x; Labunskyy VM, 2007, IUBMB LIFE, V59, P1, DOI 10.1080/15216540601126694; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu ZH, 2013, NEURAL REGEN RES, V8, P3275, DOI 10.3969/j.issn.1673-5374.2013.35.002; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Nikam S, 2009, INDIAN J CLIN BIOCHE, V24, P98, DOI 10.1007/s12291-009-0017-y; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Pitts MW, 2013, J BIOL CHEM, V288, P26121, DOI 10.1074/jbc.M113.471235; Ridet JL, 2006, NEUROBIOL DIS, V21, P29, DOI 10.1016/j.nbd.2005.06.003; Schintu N, 2009, NEUROTOX RES, V16, P127, DOI 10.1007/s12640-009-9061-x; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Stamper C, 2008, MOVEMENT DISORD, V23, P1588, DOI 10.1002/mds.22184; Sun Y, 2001, J NUTR BIOCHEM, V12, P88, DOI 10.1016/S0955-2863(00)00130-3; Tandeter H, 2001, ARCH GERONTOL GERIAT, V33, P295, DOI 10.1016/S0167-4943(01)00196-0; Umehara T, 2015, J NEUROL, V262, P1762, DOI 10.1007/s00415-015-7780-x; Venkateshappa C, 2012, NEUROCHEM RES, V37, P358, DOI 10.1007/s11064-011-0619-7; VIZUETE ML, 1994, EUR J PHARM-ENVIRON, V270, P183, DOI 10.1016/0926-6917(94)90061-2; Wu RTY, 2014, J BIOL CHEM, V289, P34378, DOI 10.1074/jbc.M114.611970; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yeh JY, 1997, J NUTR, V127, P394, DOI 10.1093/jn/127.3.394; Yim SY, 2009, INT J MOL MED, V24, P91, DOI 10.3892/ijmm_00000211; Zafar KS, 2003, J NEUROCHEM, V84, P438, DOI 10.1046/j.1471-4159.2003.01531.x; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083060	44	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163372	10.1371/journal.pone.0163372	http://dx.doi.org/10.1371/journal.pone.0163372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656880	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200107
J	Yao, X; Pham, T; Temple, B; Gray, S; Cannon, C; Chen, RW; Abdel-Mageed, AB; Biliran, H				Yao, Xin; Tri Pham; Temple, Brandi; Gray, Selena; Cannon, Cornita; Chen, Renwei; Abdel-Mageed, Asim B.; Biliran, Hector			The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COREPRESSOR CTBP; PROTEIN; INTEGRINS; BINDING; TLE1; TRANSFORMATION; TRANSCRIPTION; SUPPRESSION; METASTASIS	The mitochondrial Bcl-2 inhibitor of transcription 1 (Bit1) protein is part of an anoikis-regulating pathway that is selectively dependent on integrins. We previously demonstrated that the caspase-independent apoptotic effector Bit1 exerts tumor suppressive function in lung cancer in part by inhibiting anoikis resistance and anchorage-independent growth in vitro and tumorigenicity in vivo. Herein we show a novel function of Bit1 as an inhibitor cell migration and epithelial - mesenchymal transition (EMT) in the human lung adenocarcinoma A549 cell line. Suppression of endogenous Bit1 expression via siRNA and shRNA strategies promoted mesenchymal phenotypes, including enhanced fibroblastoid morphology and cell migratory potential with concomitant downregulation of the epithelial marker E-cadherin expression. Conversely, ectopic Bit1 expression in A549 cells promoted epithelial transition characterized by cuboidal-like epithelial cell phenotype, reduced cell motility, and upregulated E-cadherin expression. Specific downregulation of E-cadherin in Bit1-transfected cells was sufficient to block Bit1-mediated inhibition of cell motility while forced expression of E-cadherin alone attenuated the enhanced migration of Bit1 knockdown cells, indicating that E-cadherin is a downstream target of Bit1 in regulating cell motility. Furthermore, quantitative real-time PCR and reporter analyses revealed that Bit1 upregulates E-cadherin expression at the transcriptional level through the transcriptional regulator Amino-terminal Enhancer of Split (AES) protein. Importantly, the Bit1/AES pathway induction of E-cadherin expression involves inhibition of the TLE1-mediated repression of E-cadherin, by decreasing TLE1 corepressor occupancy at the E-cadherin promoter as revealed by chromatin immunoprecipitation assays. Consistent with its EMT inhibitory function, exogenous Bit1 expression significantly suppressed the formation of lung metastases of A549 cells in an in vivo experimental metastasis model. Taken together, our studies indicate Bit1 is an inhibitor of EMT and metastasis in lung cancer and hence can serve as a molecular target in curbing lung cancer aggressiveness.	[Yao, Xin; Tri Pham; Temple, Brandi; Gray, Selena; Cannon, Cornita; Biliran, Hector] Xavier Univ Louisiana, Dept Biol & Publ Hlth Sci, New Orleans, LA 70125 USA; [Chen, Renwei] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA; [Abdel-Mageed, Asim B.] Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA	Xavier University of Louisiana; University of California System; University of California Santa Barbara; Tulane University	Biliran, H (corresponding author), Xavier Univ Louisiana, Dept Biol & Publ Hlth Sci, New Orleans, LA 70125 USA.	hbiliran@xula.edu		Abdel-Mageed, Asim/0000-0001-8590-783X; Glover, Brandi/0000-0002-5760-8143	National Cancer Institute [NIH 2R15 CA158677-02]; National Institute of General Medical Sciences of the National Institutes of Health [R25GM060926]; NIH [2R15CA158677-02]; NATIONAL CANCER INSTITUTE [R15CA158677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060926] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Cancer Institute (NIH 2R15 CA158677-02). This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R25GM060926 to Xavier University of Louisiana and NIH 2R15CA158677-02 Grant to Hector Biliran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Griffiths GS, 2011, J BIOL CHEM, V286, P14713, DOI 10.1074/jbc.M111.228387; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Karmali PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023840; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Yao X, 2014, BIOCHEM BIOPH RES CO, V455, P277, DOI 10.1016/j.bbrc.2014.11.007; Yao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101564; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	25	9	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163228	10.1371/journal.pone.0163228	http://dx.doi.org/10.1371/journal.pone.0163228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655370	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700045
J	Akhmedov, D; Rajendran, K; Mendoza-Rodriguez, MG; Berdeaux, R				Akhmedov, Dmitry; Rajendran, Kavitha; Mendoza-Rodriguez, Maria G.; Berdeaux, Rebecca			Knock-in Luciferase Reporter Mice for In Vivo Monitoring of CREB Activity (vol 11, e0158274, 2016)	PLOS ONE			English	Correction																		Akhmedov D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158274	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163576	10.1371/journal.pone.0163576	http://dx.doi.org/10.1371/journal.pone.0163576			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648558	Green Published, gold			2022-12-27	WOS:000383892100088
J	Bruder-Nascimento, T; Callera, G; Montezano, AC; Antunes, TT; He, Y; Cat, AND; Ferreira, NS; Barreto, PA; Olivon, VC; Tostes, RC; Touyz, RM				Bruder-Nascimento, Thiago; Callera, Glaucia; Montezano, Augusto Cesar; Antunes, Tayze T.; He, Ying; Cat, Aurelie Nguyen Dinh; Ferreira, Nathanne S.; Barreto, Pedro A.; Olivon, Vania C.; Tostes, Rita C.; Touyz, Rhian M.			Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3	PLOS ONE			English	Article							KINASE INHIBITOR; AKT ACTIVATION; KIDNEY; NEPHROPATHY; ALDOSTERONE; DISEASE; PROLIFERATION; ROSUVASTATIN; HYPERTENSION; PITAVASTATIN	Potential benefits of statins in the treatment of chronic kidney disease beyond lipid-lowering effects have been described. However, molecular mechanisms involved in renoprotective actions of statins have not been fully elucidated. We questioned whether statins influence development of diabetic nephropathy through reactive oxygen species, RhoA and Akt/GSK3 pathway, known to be important in renal pathology. Diabetic mice (db/db) and their control counterparts(db/+) were treated with atorvastatin (10 mg/Kg/day, p.o., for 2 weeks). Diabetes-associated renal injurywas characterized by albuminuria (albumin: creatinine ratio, db/+: 3.2 +/- 0.6 vs. db/db: 12.5 +/- 3.1*; * P<0.05), increased glomerular/mesangial surface area, and kidney hypertrophy. Renal injurywas attenuated in atorvastatin-treated db/db mice. Increased ROS generation in the renal cortex of db/db mice was also inhibited by atorvastatin. ERK1/2 phosphorylation was increased in the renal cortex of db/db mice. Increased renal expression of Nox4 and proliferating cell nuclear antigen, observed in db/db mice, were abrogated by statin treatment. Atorvastatin also upregulated Akt/GSK3 beta phosphorylation in the renal cortex of db/db mice. Our findings suggest that atorvastatin attenuates diabetes-associated renal injury by reducing ROS generation, RhoA activity and normalizing Akt/GSK3 beta signaling pathways. The present study provides some new insights into molecular mechanisms whereby statins may protect against renal injury in diabetes.	[Bruder-Nascimento, Thiago; Ferreira, Nathanne S.; Barreto, Pedro A.; Olivon, Vania C.; Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, Brazil; [Bruder-Nascimento, Thiago; Callera, Glaucia; Antunes, Tayze T.; He, Ying; Touyz, Rhian M.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [Montezano, Augusto Cesar; Cat, Aurelie Nguyen Dinh; Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Universidade de Sao Paulo; University of Ottawa; Ottawa Hospital Research Institute; University of Glasgow	Touyz, RM (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada.; Touyz, RM (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Rhian.Touyz@glasgow.ac.uk	CAT, Aurelie NGUYEN DINH/H-8182-2013; Olivon, Vania Claudia/GNH-1889-2022; Bruder-Nascimento, Thiago/M-7051-2013; Tostes, Rita C/C-1025-2012; deng, qiongxia/A-3206-2017; Touyz, Rhian/AAM-3564-2020	Olivon, Vania Claudia/0000-0001-6689-0972; Tostes, Rita C/0000-0002-9446-0707; Touyz, Rhian/0000-0003-0670-0887	Sao Paulo Research Foundation (FAPESP) [2010/522146, 2011/01785-6, 2011/22035-5]; Coordination for the Improvement of Higher Education Personnel (CAPES) [88887.092495/2015-00]; Agence Universitaire de la Francophonie (AUF); Canadian Institutes of Health Research; British Heart Foundation (BHF) [29762, 30099]; British Heart Foundation [RG/13/7/30099] Funding Source: researchfish	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agence Universitaire de la Francophonie (AUF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by grants from Sao Paulo Research Foundation (FAPESP) [2010/522146 (RCT); 2011/01785-6; 2011/22035-5 (TBN)], Coordination for the Improvement of Higher Education Personnel (CAPES) [88887.092495/2015-00 (TBN)], Agence Universitaire de la Francophonie (AUF), Canadian Institutes of Health Research and the British Heart Foundation (BHF) [#29762, 30099 (RMT)].	Antunes TT, 2016, HYPERTENSION, V67, P763, DOI 10.1161/HYPERTENSIONAHA.115.07021; Athyros VG, 2007, NEPHROL DIAL TRANSPL, V22, P118, DOI 10.1093/ndt/gfl538; Brennan E, 2013, GENES-BASEL, V4, P596, DOI 10.3390/genes4040596; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Bruder-Nascimento T, 2015, CLIN SCI, V128, P411, DOI 10.1042/CS20140456; Chen C, 2009, NEPHRON EXP NEPHROL, V113, pE26, DOI 10.1159/000228080; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Davignon J, 2004, CORONARY ARTERY DIS, V15, P251, DOI 10.1097/01.mca.0000131573.31966.34; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Fellstrom B, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-9; Fujii M, 2007, KIDNEY INT, V72, P473, DOI 10.1038/sj.ki.5002366; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Gotto A M Jr, 1999, Circulation, V99, pE1; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Jin LM, 2006, J PHARMACOL EXP THER, V318, P288, DOI 10.1124/jpet.105.100735; KASISKE BL, 1988, CIRC RES, V62, P367, DOI 10.1161/01.RES.62.2.367; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Nagaoka T, 2006, J APPL PHYSIOL, V100, P996, DOI 10.1152/japplphysiol.01028.2005; Peng HB, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-321; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20304; Pinho-Gomes AC, 2014, ANTIOXID REDOX SIGN, V20, P1268, DOI 10.1089/ars.2013.5542; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takazakura A, 2015, J DIABETES INVEST, V6, P346, DOI 10.1111/jdi.12296; Tamura Y, 2011, INT J MOL MED, V28, P683, DOI 10.3892/ijmm.2011.769; Toba H, 2010, CLIN EXP PHARMACOL P, V37, P1064, DOI 10.1111/j.1440-1681.2010.05436.x; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Xiao HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059233; Xu F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/289327; Yin HP, 2013, INT J MOL SCI, V14, P20282, DOI 10.3390/ijms141020282; Yogi A, 2011, J HYPERTENS, V29, P1400, DOI 10.1097/HJH.0b013e32834786d6; Yokota T, 1999, KIDNEY INT, V56, pS178, DOI 10.1046/j.1523-1755.1999.07146.x; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhou SX, 2014, EUR J PHARMACOL, V740, P9, DOI 10.1016/j.ejphar.2014.06.055	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162731	10.1371/journal.pone.0162731	http://dx.doi.org/10.1371/journal.pone.0162731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649495	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000383892100031
J	Ciritsis, A; Truhn, D; Hansen, NL; Otto, J; Kuhl, CK; Kraemer, NA				Ciritsis, Alexander; Truhn, Daniel; Hansen, Nienke L.; Otto, Jens; Kuhl, Christiane K.; Kraemer, Nils A.			Positive Contrast MRI Techniques for Visualization of Iron-Loaded Hernia Mesh Implants in Patients (vol 11, e0155717, 2016)	PLOS ONE			English	Correction													Truhn, Daniel/AAL-1950-2021; Truhn, Daniel/AAG-9359-2021; Kraemer, Nils/ABD-9509-2020	Truhn, Daniel/0000-0002-9605-0728; 				Ciritsis A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155717	1	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163630	10.1371/journal.pone.0163630	http://dx.doi.org/10.1371/journal.pone.0163630			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648953	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100090
J	Monecke, S; Jatzwauk, L; Muller, E; Nitschke, H; Pfohl, K; Slickers, P; Reissig, A; Ruppelt-Lorz, A; Ehricht, R				Monecke, Stefan; Jatzwauk, Lutz; Mueller, Elke; Nitschke, Hedda; Pfohl, Katharina; Slickers, Peter; Reissig, Annett; Ruppelt-Lorz, Antje; Ehricht, Ralf			Diversity of SCCmec Elements in Staphylococcus aureus as Observed in South-Eastern Germany	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME RECOMBINASE; FUSIDIC ACID; MEC; EVOLUTION; STRAIN; EPIDEMIOLOGY; RESISTANCE; EMERGENCE	SCCmec elements are very important mobile genetic elements in Staphylococci that carry beta-lactam resistance genes mecA/mecC, recombinase genes and a variety of accessory genes. Twelve main types and a couple of variants have yet been described. In addition, there are also other SCC elements harbouring other markers. In order to subtype strains of methicillin-resistant S. aureus (MRSA) based on variations within their SCCmec elements, 86 markers were selected from published SCC sequences for an assay based on multiplexed primer extension reactions followed by hybridisation to the specific probes. These included mecA/mecC, fusC, regulatory genes, recombinase genes, genes from ACME and heavy metal resistance loci as well as several genes of unknown function. Hybridisation patterns for published genome or SCC sequences were theoretically predicted. For validation of the microarray based assay and for stringent hybridisation protocol optimization, real hybridization experiments with fully sequenced reference strains were performed modifying protocols until yielded the results were in concordance to the theoretical predictions. Subsequently, 226 clinical isolates from two hospitals in the city of Dresden, Germany, were characterised in detail. Beside previously described types and subtypes, a wide variety of additional SCC types or subtypes and pseudoSCC elements were observed as well as numerous composite elements. Within the study collection, 61 different such elements have been identified. Since hybridisation cannot recognise the localisation of target genes, gene duplications or inversions, this is a rather conservative estimate. Interestingly, some widespread epidemic strains engulf distinct variants with different SCCmec subtypes. Notable examples are ST239-MRSA-III, CC5-, CC22-, CC30-, and CC45-MRSA-IV or CC398MRSA- V. Conversely, identical SCC elements were observed in different strains with SCCmec IVa being spread among the highest number of Clonal Complexes. The proposed microarray can help to distinguish isolates that appear similar or identical by other typing methods and it can be used as high-throughput screening tool for the detection of putative new SCC types or variants that warrant further investigation and sequencing. The high degree of diversity of SCC elements even within so-called strains could be helpful for epidemiological typing. It also raises the question on scale and speed of the evolution of SCC elements.	[Monecke, Stefan; Pfohl, Katharina; Ruppelt-Lorz, Antje] Tech Univ Dresden, IMMH, Dresden, Germany; [Jatzwauk, Lutz] Dresden Univ Hosp, Dept Hosp Infect Control, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Slickers, Peter; Reissig, Annett; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Nitschke, Hedda] Hosp Dresden Neustadt, Dept Lab Med, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Slickers, Peter; Reissig, Annett; Ehricht, Ralf] InfectoGnost Res Campus, Jena, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere; Technische Universitat Dresden; Municipal Hospital Dresden	Monecke, S (corresponding author), Tech Univ Dresden, IMMH, Dresden, Germany.; Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.; Monecke, S (corresponding author), InfectoGnost Res Campus, Jena, Germany.	monecke@rocketmail.com			Alere Technologies	Alere Technologies	There was no external funding for this work. Each of the participating institutions covered the costs of experiments performed in the respective institutions, as well as granted the time needed to perform this study. Alere Technologies provided support in the form of salaries for authors EM, AR, PS, RE, and SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Baines SL, 2016, ANTIMICROB AGENTS CH, V60, P2359, DOI 10.1128/AAC.03020-15; Coombs GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043037; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Dijkshoorn L, 2000, J MED MICROBIOL, V49, P397, DOI 10.1099/0022-1317-49-5-397; Ellington MJ, 2015, INT J ANTIMICROB AG, V45, P477, DOI 10.1016/j.ijantimicag.2015.01.009; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Laham NA, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0120008; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke Stefan, 2013, BMC Res Notes, V6, P548, DOI 10.1186/1756-0500-6-548; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Williamson DA, 2014, CLIN INFECT DIS, V59, P1451, DOI 10.1093/cid/ciu658; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15	35	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162654	10.1371/journal.pone.0162654	http://dx.doi.org/10.1371/journal.pone.0162654			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648947	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100027
J	Salazar-Vidal, MN; Acosta-Segovia, E; Sanchez-Leon, N; Ahern, KR; Brutnell, TP; Sawers, RJH				Salazar-Vidal, M. Nancy; Acosta-Segovia, Edith; Sanchez-Leon, Nidia; Ahern, Kevin R.; Brutnell, Thomas P.; Sawers, Ruairidh J. H.			Characterization and Transposon Mutagenesis of the Maize (Zea mays) Pho1 Gene Family	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; PHOSPHATE HOMEOSTASIS; DISSOCIATION ELEMENTS; ACTIVATOR AC; KEY ROLE; ARABIDOPSIS; EVOLUTION; SHOOT	Phosphorus is an essential nutrient for all plants, but also one of the least mobile, and consequently least available, in the soil. Plants have evolved a series of molecular, metabolic and developmental adaptations to increase the acquisition of phosphorus and to maximize the efficiency of use within the plant. In Arabidopsis (Arabidopsis thaliana), the AtPHO1 protein regulates and facilitates the distribution of phosphorus. To investigate the role of PHO1 proteins in maize (Zea mays), the B73 reference genome was searched for homologous sequences, and four genes identified that were designated ZmPho1; 1, ZmPho1; 2a, ZmPho1; 2b and ZmPho1; 3. ZmPho1; 2a and ZmPho1; 2b are the most similar to AtPHO1, and represent candidate co-orthologs that we hypothesize to have been retained following whole genome duplication. Evidence was obtained for the production of natural anti-sense transcripts associated with both ZmPho1; 2a and ZmPho1; 2b, suggesting the possibility of regulatory crosstalk between paralogs. To characterize functional divergence between ZmPho1; 2a and ZmPho1; 2b, a program of transposon mutagenesis was initiated using the Ac/Ds system, and, here, we report the generation of novel alleles of ZmPho1; 2a and ZmPho1; 2b.	[Salazar-Vidal, M. Nancy; Acosta-Segovia, Edith; Sanchez-Leon, Nidia; Sawers, Ruairidh J. H.] CINVESTAV IPN, LANGEBIO, Unidad Genom Avanzada, Guanajuato 36821, Mexico; [Ahern, Kevin R.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Brutnell, Thomas P.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Cornell University; Boyce Thompson Institute for Plant Research; Donald Danforth Plant Science Center	Sawers, RJH (corresponding author), CINVESTAV IPN, LANGEBIO, Unidad Genom Avanzada, Guanajuato 36821, Mexico.	rusawers@cinvestav.mx	Brutnell, Thomas/M-2840-2013	Brutnell, Thomas/0000-0002-3581-8211; Salazar Vidal, Miriam Nancy/0000-0003-4894-9795; Sawers, Ruairidh James Hay/0000-0002-8945-3078	National Science Foundation [IOS-0922701]; Consejo Nacional de Ciencia y Technologia (Mexico) [CB2012-151947]; Mexican National Council of Science and Technology (CONACYT) [CB2012-151947]	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Technologia (Mexico); Mexican National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Science Foundation (www.nsf.gov) award IOS-0922701 to TB and Consejo Nacional de Ciencia y Technologia (Mexico; www.conacyt.mx) award CB2012-151947 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Juan M. Estevez-Palmas for valuable comments on the manuscript. This work was supported by the National Science Foundation grant IOS-0922701 to TB and the Mexican National Council of Science and Technology (CONACYT) grant CB2012-151947 to RS.	Ahern KR, 2009, METHODS, V49, P248, DOI 10.1016/j.ymeth.2009.04.009; ALLEMAN M, 1993, GENETICS, V135, P189; Bai L, 2007, GENETICS, V175, P981, DOI 10.1534/genetics.106.066837; Brutnell TP, 2003, METH MOL B, V236, P157; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Conrad LJ, 2005, GENETICS, V171, P1999, DOI 10.1534/genetics.105.046623; DOONER HK, 1989, GENETICS, V122, P447; Gonzalez-Munoz E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00341; Hoagland DR, 1936, PLANT PHYSIOL, V11, P471, DOI 10.1104/pp.11.3.471; Hughes TE, 2014, GENOME RES, V24, P1348, DOI 10.1101/gr.172684.114; Jabnoune M, 2013, PLANT CELL, V25, P4166, DOI 10.1105/tpc.113.116251; Kolkman JM, 2005, GENETICS, V169, P981, DOI 10.1534/genetics.104.033738; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Secco D, 2010, PLANT PHYSIOL, V152, P1693, DOI 10.1104/pp.109.149872; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Vance CP, 2014, UPDATE STATE NITROGE; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Vollbrecht E, 2010, PLANT CELL, V22, P1667, DOI 10.1105/tpc.109.073452; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; Wege S, 2015, PLANT PHYSL; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	27	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161882	10.1371/journal.pone.0161882	http://dx.doi.org/10.1371/journal.pone.0161882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648940	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100009
J	Adachi, K; Takahashi, S; Yamauchi, K; Mounai, N; Tanabu, R; Nakazawa, M				Adachi, Kobu; Takahashi, Shizuka; Yamauchi, Kodai; Mounai, Natsuki; Tanabu, Reiko; Nakazawa, Mitsuru			Optical Coherence Tomography of Retinal Degeneration in Royal College of Surgeons Rats and Its Correlation with Morphology and Electroretinography	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; RCS RAT; SD-OCT; GENE-TRANSFER; MOUSE MODELS; DYSTROPHY; MUTATIONS; THICKNESS; RECEPTOR; MERTK	Purpose To evaluate the correlation between optical coherence tomography (OCT) and the histological, ultrastructural and electroretinography (ERG) findings of retinal degeneration in Royal College of Surgeons (RCS-/-) rats. Materials and Methods Using OCT, we qualitatively and quantitatively observed the continual retinal degeneration in RCS-/- rats, from postnatal (PN) day 17 until PN day 111. These findings were compared with the corresponding histological, electron microscopic, and ERG findings. We also compared them to OCT findings in wild type RCS+/+ rats, which were used as controls. Results After PN day 17, the hyperreflective band at the apical side of the photoreceptor layer became blurred. The inner segment (IS) ellipsoid zone then became obscured, and the photoreceptor IS and outer segment (OS) layers became diffusely hyperreflective after PN day 21. These changes correlated with histological and electron microscopic findings showing extracellular lamellar material that accumulated in the photoreceptor OS layer. After PN day 26, the outer nuclear layer became significantly thinner (P < 0.01) and hyperreflective compared with that in the controls; conversely, the photoreceptor IS and OS layers, as well as the inner retinal layers, became significantly thicker (P < 0.001 and P = 0.05, respectively). The apical hyperreflective band, as well as the IS ellipsoid zone, gradually disappeared between PN day 20 and PN day 30; concurrently, the ERG a- and b-wave amplitudes deteriorated. In contrast, the thicknesses of the combined retinal pigment epithelium and choroid did not differ significantly between RCS-/- and RCS+/+ rats. Conclusion Our results suggest that OCT demonstrates histologically validated photoreceptor degeneration in RCS rats, and that OCT findings partly correlate with ERG findings. We propose that OCT is a less invasive and useful method for evaluating photoreceptor degeneration in animal models of retinitis pigmentosa.	[Adachi, Kobu; Takahashi, Shizuka; Yamauchi, Kodai; Mounai, Natsuki; Tanabu, Reiko; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan	Hirosaki University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712; Takahashi, Shizuka/0000-0001-7225-979X	Japan Society for the Promotion of Science [15K20246, 16K11313]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by the Grant-in Aid for Scientific Research (15K20246 and 16K11313) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported, in part, by the Grant-in-Aids for Scientific Research (15K20246 and 16K11313) from the Japan Society for the Promotion for Science.	Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Ghazi NG, 2016, HUM GENET, V135, P327, DOI 10.1007/s00439-016-1637-y; Grover S, 2006, AM J OPHTHALMOL, V141, P850, DOI 10.1016/j.ajo.2005.12.030; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Hasegawa T, 2016, JPN J OPHTHALMOL, V60, P111, DOI 10.1007/s10384-015-0422-0; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Levine ES, 2014, VISION RES, V102, P71, DOI 10.1016/j.visres.2014.07.011; LI ZY, 1995, J NEUROSCI, V15, P5429; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Oishi M, 2014, INVEST OPHTH VIS SCI, V55, P7369, DOI 10.1167/iovs.14-15458; Orhan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127319; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P4568, DOI 10.1167/iovs.08-1992; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Smith AJ, 2003, MOL THER, V8, P188, DOI 10.1016/S1525-0016(03)00144-8; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162835	10.1371/journal.pone.0162835	http://dx.doi.org/10.1371/journal.pone.0162835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644042	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900021
J	Donners, MMPC; Bai, LL; Lutgens, SPM; Wijnands, E; Johnson, J; Schurgers, LJ; Liu, CL; Daemen, MJAP; Cleutjens, KBJM; Shi, GP; Biessen, EAL; Heeneman, S				Donners, Marjo M. P. C.; Bai, Lili; Lutgens, Suzanne P. M.; Wijnands, Erwin; Johnson, Jason; Schurgers, Leon J.; Liu, Cong-Lin; Daemen, Mat J. A. P.; Cleutjens, Kitty B. J. M.; Shi, Guo-Ping; Biessen, Erik A. L.; Heeneman, Sylvia			Cathepsin K Deficiency Prevents the Aggravated Vascular Remodeling Response to Flow Cessation in ApoE(-/-) Mice	PLOS ONE			English	Article							ALTERNATIVE MACROPHAGE ACTIVATION; CAROTID-ARTERY; NEOINTIMA; GROWTH; ATHEROGENESIS; INFLAMMATION; EXPRESSION; INJURY	Cathepsin K (catK) is a potent lysosomal cysteine protease involved in extracellular matrix (ECM) degradation and inflammatory remodeling responses. Here we have investigated the contribution of catK deficiency on carotid arterial remodeling in response to flow cessation in apoE(-/-) and wild type (wt) background. Ligation-induced hyperplasia is considerably aggravated in apoE(-/-) versus wt mice. CatK protein expression was significantly increased in neointimal lesions of apoE(-/-) compared with wt mice, suggesting a role for catK in intimal hyperplasia under hyperlipidemic conditions. Surprisingly, CatK deficiency completely blunted the augmented hyperplastic response to flow cessation in apoE(-/-), whereas vascular remodeling in wt mice was unaffected. As catK deficiency did neither alter lesion collagen content and elastic laminae fragmentation in vivo, we focused on effects of catK on (systemic) inflammatory responses. CatK deficiency significantly reduced circulating CD3 T-cell numbers, but increased the regulatory T cell subset in apoE(-/-) but not wt mice. Moreover, catK deficiency changed CD11b+Ly6G-Ly6C (high) monocyte distribution in apoE(-/-) but not wt mice and tended to favour macrophage M2a polarization. In conclusion, catK deficiency almost completely blunted the increased vascular remodeling response of apoE(-)/(-) mice to flow cessation, possibly by correcting hyperlipidemia-associated pro-inflammatory effects on the peripheral immune response.	[Donners, Marjo M. P. C.; Bai, Lili; Lutgens, Suzanne P. M.; Wijnands, Erwin; Daemen, Mat J. A. P.; Cleutjens, Kitty B. J. M.; Biessen, Erik A. L.; Heeneman, Sylvia] Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Schurgers, Leon J.] Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Johnson, Jason] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Marlbrough St, Bristol BS2 8HW, Avon, England; [Liu, Cong-Lin; Shi, Guo-Ping] Brigham & Womens Hosp, Cardiovasc Med, NRB 742,77 Ave Louis Pasteur, Boston, MA 02115 USA	Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Bristol Royal Infirmary; University of Bristol; Harvard University; Brigham & Women's Hospital	Heeneman, S (corresponding author), Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	S.heeneman@maastrichtuniversity.nl	Johnson, Jason/AAC-3124-2019; Schurgers, Leon/AAT-7100-2021	Johnson, Jason/0000-0003-0630-9183; Daemen, Mat/0000-0003-1076-199X; Schurgers, Leon/0000-0001-7867-6957; Biessen, Erik/0000-0002-6454-8548	Netherlands Heart Foundation [2012T079, 2003T201]	Netherlands Heart Foundation(Netherlands Heart Foundation)	M.M.P.C. Donners and E.A.L. Biessen are supported by the Netherlands Heart Foundation (grant nrs. 2012T079 and 2003T201, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Cheng XW, 2004, AM J PATHOL, V164, P243, DOI 10.1016/S0002-9440(10)63114-8; CLOWES AW, 1983, LAB INVEST, V49, P327; Eschert H, 2009, ATHEROSCLEROSIS, V204, P96, DOI 10.1016/j.atherosclerosis.2008.08.025; FERNS GAA, 1992, P NATL ACAD SCI USA, V89, P11312, DOI 10.1073/pnas.89.23.11312; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kukhtina N B, 2009, Neurosci Behav Physiol, V39, P153, DOI 10.1007/s11055-009-9112-z; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lessner SM, 2004, ARTERIOSCL THROM VAS, V24, P2123, DOI 10.1161/01.ATV.0000141840.27300.fd; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Lutgens E, 2001, ARTERIOSCL THROM VAS, V21, P1359, DOI 10.1161/hq0801.093669; Lutgens SPM, 2006, J PATHOL, V210, P334, DOI 10.1002/path.2054; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MEHRA M, 1995, THE JOURNAL OF HEART, V14, pS207; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ostriker A, 2014, ARTERIOSCL THROM VAS, V34, P877, DOI 10.1161/ATVBAHA.114.303214; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162595	10.1371/journal.pone.0162595	http://dx.doi.org/10.1371/journal.pone.0162595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636705	gold, Green Published, Green Submitted			2022-12-27	WOS:000383723700010
J	Granic, A; Davies, K; Jagger, C; Kirkwood, TBL; Syddall, HE; Sayer, AA				Granic, Antoneta; Davies, Karen; Jagger, Carol; Kirkwood, Thomas B. L.; Syddall, Holly E.; Sayer, Avan A.			Grip Strength Decline and Its Determinants in the Very Old: Longitudinal Findings from the Newcastle 85+Study	PLOS ONE			English	Article							HANDGRIP STRENGTH; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; MUSCLE MASS; HEALTH; MEN; ASSOCIATION; PERFORMANCE; MORTALITY; AGE	Background Weak grip strength (GS) is a key component of sarcopenia and frailty and a powerful predictor of mortality, morbidity and disability. Despite increasing interest in understanding GS across the lifespan, little is known about GS decline in the very old (aged >= 85). We examined trajectories of GS in very old adults and identified the determinants. Methods GS (kg) was measured four times over 5 years in 319 men and 526 women participating in the Newcastle 85+ Study. A weak GS sub-cohort was identified as having strength of <= 27 kg (men), and <= 16 kg (women) at baseline and follow-up. Mixed models were used to establish trajectories of GS and associated factors in all participants, men and women, and in those with weak GS. Results Men's mean grip strength was 24.42 (SD = 6.77) kg, and women's 13.23 (4.42) kg (p<0.001) at baseline, with mean absolute change of -5.27 (4.90) kg and -3.14 (3.41), respectively (p<0.001) by 5-year follow-up. In the time-only mixed model, men experienced linear annual decline in GS of -1.13 (0.8) kg (beta (SE), p<0.001), whilst women's decline although slower, accelerated by -0.06 (0.02) kg (p = 0.01) over time. In the saturated model, higher baseline physical activity, height, fat-free mass, better self-rated health, and not having arthritis in hand(s) were associated with stronger GS initially in both sexes. Annual GS decline in men and participants with weak GS who were highly physically active was slower by 0.95 and 0.52 kg, respectively compared with inactive counterparts. Conclusion Grip strength decline in the very old followed linear (men) and curvilinear (women) trends. High levels of physical activity were protective of GS loss in men (but not in women) and in those with weak GS. Thus maintaining muscle strength in later life is important to reduce the morbidity and mortality in the very old.	[Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Univ, Ctr Ageing & Chron Dis, NIHR Newcastle Biomed Res, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Jagger, Carol; Kirkwood, Thomas B. L.; Sayer, Avan A.] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Jagger, Carol] Newcastle Univ Baddiley Clark, Inst Hlth & Soc, Richardson Rd, Newcastle Upon Tyne, Tyne & Wear, England; [Kirkwood, Thomas B. L.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Syddall, Holly E.; Sayer, Avan A.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Sayer, Avan A.] Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res & Care, Southampton, Hants, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Southampton; University of Southampton	Sayer, AA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Univ, Ctr Ageing & Chron Dis, NIHR Newcastle Biomed Res, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.; Sayer, AA (corresponding author), Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res & Care, Southampton, Hants, England.	avan.sayer@newcastle.ac.uk		Jagger, Carol/0000-0002-6377-9926; Aihie Sayer, Avan/0000-0003-1283-6457; Granic, Antoneta/0000-0001-9247-899X	National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust; Newcastle University; Medical Research Council; Biotechnology and Biological Sciences Research Council; Dunhill Medical Trust; British Heart Foundation; Unilever Corporate Research; North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC [G0500997, MC_UU_12011/2, MC_UP_A620_1015, MR/J50001X/1] Funding Source: UKRI; Medical Research Council [G0500997, U1475000002, MC_UP_A620_1015, MR/J50001X/1, MC_UU_12011/2] Funding Source: researchfish	National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust; Newcastle University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dunhill Medical Trust(Dunhill Medical Trust); British Heart Foundation(British Heart Foundation); Unilever Corporate Research(Unilever); North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been funded by the National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust and Newcastle University (AG). The Newcastle 85+ Study has been funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council and the Dunhill Medical Trust. Parts of the work have also been funded by the British Heart Foundation, Unilever Corporate Research, Newcastle University and the North of England Commissioning Support Unit (formerly NHS North of Tyne). The research was also supported by the National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the authors and not necessarily those of the National Health Service, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000192; Botoseneanu A, 2015, J AGING HEALTH, V27, P1123, DOI 10.1177/0898264315577587; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Cevenini E, 2014, AGE, V36, P949, DOI 10.1007/s11357-013-9604-1; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Cheung CL, 2013, AGE, V35, P929, DOI 10.1007/s11357-012-9385-y; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; COOPER R, 2011, PLOS ONE, V0006; Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013; Davies K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108370; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gomez-Cabello A, 2014, MATURITAS, V78, P106, DOI 10.1016/j.maturitas.2014.03.007; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Hicks GE, 2012, J GERONTOL A-BIOL, V67, P66, DOI 10.1093/gerona/glr055; Innerd P, 2015, AGE AGEING, V44, P691, DOI 10.1093/ageing/afv062; Ishizaki T, 2011, J EPIDEMIOL, V21, P176, DOI 10.2188/jea.JE20100138; Keevil VL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-93; Kerr A, 2006, AGE AGEING, V35, P82, DOI 10.1093/ageing/afj010; Kingston A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088016; Legrand D, 2013, ARCH GERONTOL GERIAT, V57, P345, DOI 10.1016/j.archger.2013.06.003; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Nahhas RW, 2010, AM J HUM BIOL, V22, P648, DOI 10.1002/ajhb.21057; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Oksuzyan A, 2010, J AGING HEALTH, V22, P589, DOI 10.1177/0898264310366752; Proctor DN, 2006, AGING CLIN EXP RES, V18, P517; Quinones AR, 2011, J GERONTOL B-PSYCHOL, V66, P739, DOI 10.1093/geronb/gbr106; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Roberts HC, 2014, AGE AGEING, V43, P241, DOI 10.1093/ageing/aft118; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sayer AA, 2006, AGE AGEING, V35, P409, DOI 10.1093/ageing/afl024; Sayer AA, 2015, LANCET, V386, P226, DOI 10.1016/S0140-6736(14)62349-7; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Siervo M, 2015, ARCH GERONTOL GERIAT, V60, P227, DOI 10.1016/j.archger.2014.09.004; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Stenholm S, 2012, J GERONTOL A-BIOL, V67, P1068, DOI 10.1093/gerona/gls064; Sternang O, 2015, AGE AGEING, V44, P269, DOI 10.1093/ageing/afu170; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Xue QL, 2011, ARCH INTERN MED, V171, P1119, DOI 10.1001/archinternmed.2011.252	49	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163183	10.1371/journal.pone.0163183	http://dx.doi.org/10.1371/journal.pone.0163183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637107	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700040
J	Jimenez-Fernandez, A; Lopez-Sanchez, A; Jimenez-Diaz, L; Navarrete, B; Calero, P; Platero, AI; Govantes, F				Jimenez-Fernandez, Alicia; Lopez-Sanchez, Aroa; Jimenez-Diaz, Lorena; Navarrete, Blanca; Calero, Patricia; Isabel Platero, Ana; Govantes, Fernando			Complex Interplay between FleQ, Cyclic Diguanylate and Multiple sigma Factors Coordinately Regulates Flagellar Motility and Biofilm Development in Pseudomonas putida	PLOS ONE			English	Article							C-DI-GMP; STARVATION-INDUCED DISPERSION; BINDING PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATOR; CELLULOSE SYNTHESIS; ESCHERICHIA-COLI; AERUGINOSA; DNA; ADHESION	Most bacteria alternate between a free living planktonic lifestyle and the formation of structured surface-associated communities named biofilms. The transition between these two lifestyles requires a precise and timely regulation of the factors involved in each of the stages that has been likened to a developmental process. Here we characterize the involvement of the transcriptional regulator FleQ and the second messenger cyclic diguanylate in the coordinate regulation of multiple functions related to motility and surface colonization in Pseudomonas putida. Disruption of fleQ caused strong defects in flagellar motility, biofilm formation and surface attachment, and the ability of this mutation to suppress multiple biofilm-related phenotypes associated to cyclic diguanylate overproduction suggests that FleQ mediates cyclic diguanylate signaling critical to biofilm growth. We have constructed a library containing 94 promoters potentially involved in motility and biofilm development fused to gfp and lacZ, screened this library for FleQ and cyclic diguanylate regulation, and assessed the involvement of alternative sigma factors sigma(N) and FliA in the transcription of FleQ-regulated promoters. Our results suggest a dual mode of action for FleQ. Low cyclic diguanylate levels favor FleQ interaction with sigma(N)-dependent promoters to activate the flagellar cascade, encompassing the flagellar cluster and additional genes involved in cyclic diguanylate metabolism, signal transduction and gene regulation. On the other hand, characterization of the FleQ-regulated sigma(N)- and FliA-independent PlapA and PbcsD promoters revealed two disparate regulatory mechanisms leading to a similar outcome: the synthesis of biofilm matrix components in response to increased cyclic diguanylate levels.	[Govantes, Fernando] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol & Desarrollo, Junta Andalucia, Seville, Spain; Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Carretera Utrera,Km 1, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad Pablo de Olavide	Govantes, F (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol & Desarrollo, Junta Andalucia, Seville, Spain.	fgovrom@upo.es	Govantes, Fernando/E-4790-2017; Sánchez, Aroa López/F-3465-2016; Jiménez-Fernández, Alicia/AAD-7751-2021; Platero, Ana Isabel/P-8266-2018	Govantes, Fernando/0000-0002-4866-6798; Sánchez, Aroa López/0000-0001-9022-3811; Jimenez-Fernandez, Alicia/0000-0002-5696-7865; Platero, Ana Isabel/0000-0002-4461-910X; Navarrete, Blanca/0000-0002-5122-1562	Ministerio de Ciencia e Innovacion, Spain; European Regional Development fund [BIO2010-17853, BIO2013-420173-P]; Ministerio de Economia y Competitividad, Spain; Consejo Superior de Investigaciones Cientificas, Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development fund(European Commission); Ministerio de Economia y Competitividad, Spain(Spanish Government); Consejo Superior de Investigaciones Cientificas, Spain	This work was supported by Ministerio de Ciencia e Innovacion, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_policy/en/funding/erdf/), Grant BIO2010-17853, awarded to FG; Ministerio de Economia y Competitividad, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_policy/en/funding/erdf/), Grant BIO2013-420173-P, awarded to FG; and Consejo Superior de Investigaciones Cientificas, Spain (http://www.csic.es/), JAE-Predoc 2010 scholarship, awarded to AJ-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Reyes-Darias JA, 2015, MOL MICROBIOL, V97, P488, DOI 10.1111/mmi.13045; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; Casaz P, 2001, MICROBIOL-UK, V147, P355, DOI 10.1099/00221287-147-2-355; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chang WS, 2003, J BACTERIOL, V185, P6199, DOI 10.1128/JB.185.20.6199-6204.2003; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Garcia-Gonzalez V, 2005, J BACTERIOL, V187, P155, DOI 10.1128/JB.187.1.155-167.2005; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Govantes F, 1996, J BACTERIOL, V178, P6817, DOI 10.1128/jb.178.23.6817-6823.1996; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jimenez-Fernandez A, 2015, ENV MICROBIOL REP, V7, P78, DOI 10.1111/1758-2229.12153; Joly N, 2012, BBA-MOL CELL RES, V1823, P108, DOI 10.1016/j.bbamcr.2011.08.012; Rodriguez-Herva JJ, 2010, ENV MICROBIOL REP, V2, P373, DOI 10.1111/j.1758-2229.2009.00084.x; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; KOHLER T, 1989, J BACTERIOL, V171, P4326; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lopez-Sanchez A, 2013, ENV MICROBIOL REP, V5, P679, DOI 10.1111/1758-2229.12067; LOPEZSANCHEZ A, 2016, FEMS MICROBIOL LETT, V363, DOI DOI 10.1093/IEM&LEDNW127; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; Porrua O, 2009, MOL MICROBIOL, V73, P419, DOI 10.1111/j.1365-2958.2009.06779.x; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Romling U, 2012, ENVIRON MICROBIOL, V14, P1817, DOI 10.1111/j.1462-2920.2011.02617.x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Turnbull GA, 2001, FEMS MICROBIOL ECOL, V35, P57, DOI 10.1111/j.1574-6941.2001.tb00788.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419; YANG CH, 1994, APPL ENVIRON MICROB, V60, P473, DOI 10.1128/AEM.60.2.473-481.1994; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	85	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163142	10.1371/journal.pone.0163142	http://dx.doi.org/10.1371/journal.pone.0163142			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636892	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700038
J	Kuprian, E; Tuong, TD; Pfaller, K; Wagner, J; Livingston, DP; Neuner, G				Kuprian, Edith; Tuong, Tan D.; Pfaller, Kristian; Wagner, Johanna; Livingston, David P., III; Neuner, Gilbert			Persistent Supercooling of Reproductive Shoots Is Enabled by Structural Ice Barriers Being Active Despite an Intact Xylem Connection	PLOS ONE			English	Article							FROST-RESISTANCE; FLOWER BUDS; CELL-WALL; COLD-ACCLIMATION; THERMAL-ANALYSIS; FREEZING AVOIDANCE; PLANTS; WINTER; PROPAGATION; NUCLEATION	Extracellular ice nucleation usually occurs at mild subzero temperatures in most plants. For persistent supercooling of certain plant parts ice barriers are necessary to prevent the entry of ice from already frozen tissues. The reproductive shoot of Calluna vulgaris is able to supercool down to below -22 degrees C throughout all developmental stages (shoot elongation, flowering, fruiting) despite an established xylem conductivity. After localization of the persistent ice barrier between the reproductive and vegetative shoot at the base of the pedicel by infrared differential thermal analysis, the currently unknown structural features of the ice barrier tissue were anatomically analyzed on cross and longitudinal sections. The ice barrier tissue was recognized as a 250 mu m long constriction zone at the base of the pedicel that lacked pith tissue and intercellular spaces. Most cell walls in this region were thickened and contained hydrophobic substances (lignin, suberin, and cutin). A few cell walls had what appeared to be thicker cellulose inclusions. In the ice barrier tissue, the area of the xylem was as much as 5.7 times smaller than in vegetative shoots and consisted of tracheids only. The mean number of conducting units in the xylem per cross section was reduced to 3.5% of that in vegetative shoots. Diameter of conducting units and tracheid length were 70% and 60% (respectively) of that in vegetative shoots. From vegetative shoots water transport into the ice barrier must pass pit membranes that are likely impermeable to ice. Pit apertures were about 1.9 mu m x 0.7 mu m, which was significantly smaller than in the vegetative shoot. The peculiar anatomical features of the xylem at the base of the pedicel suggest that the diameter of pores in pit membranes could be the critical constriction for ice propagation into the persistently supercooled reproductive shoots of C. vulgaris.	[Kuprian, Edith; Wagner, Johanna; Neuner, Gilbert] Univ Innsbruck, Inst Bot, Innsbruck, Austria; [Tuong, Tan D.; Livingston, David P., III] USDA ARS, Raleigh, NC 27695 USA; [Tuong, Tan D.; Livingston, David P., III] North Carolina State Univ, Raleigh, NC 27695 USA; [Pfaller, Kristian] Med Univ Innsbruck, Div Histol & Embryol, Innsbruck, Austria	University of Innsbruck; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Medical University of Innsbruck	Kuprian, E (corresponding author), Univ Innsbruck, Inst Bot, Innsbruck, Austria.	Edith.Kuprian@uibk.ac.at	Neuner, Gilbert/J-9909-2017	Neuner, Gilbert/0000-0003-2415-6125	Austrian Science Fund [23681 - B16]; Austrian Science Fund (FWF) [P 23681] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant number: 23681 - B16 from the Austrian Science Fund: https://www.fwf.ac.at/.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; ASHWORTH EN, 1992, PLANT CELL ENVIRON, V15, P607, DOI 10.1111/j.1365-3040.1992.tb01495.x; ASHWORTH EN, 1984, PLANT PHYSIOL, V76, P201, DOI 10.1104/pp.76.1.201; ASHWORTH EN, 1984, PLANT PHYSIOL, V74, P862, DOI 10.1104/pp.74.4.862; ASHWORTH EN, 1985, PLANT PHYSIOL, V79, P1033, DOI 10.1104/pp.79.4.1033; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; Carlquist S, 2002, AM J BOT, V89, P185, DOI 10.3732/ajb.89.2.185; Carter J, 2001, HORTSCIENCE, V36, P1027, DOI 10.21273/HORTSCI.36.6.1027; CHALKERSCOTT L, 1992, ANN BOT-LONDON, V70, P409, DOI 10.1093/oxfordjournals.aob.a088496; Fuller M, 2003, ANN APPL BIOL, V143, P93, DOI 10.1111/j.1744-7348.2003.tb00273.x; GEORGE MF, 1977, PLANT PHYSIOL, V59, P326, DOI 10.1104/pp.59.2.326; GEORGE MF, 1982, CRYOBIOLOGY, V19, P628, DOI 10.1016/0011-2240(82)90192-4; GIMINGHAM CH, 1960, J ECOL, V48, P455, DOI 10.2307/2257528; Greguss P., 1959, HOLZANATOMIE EUROPAI; Hacker J, 2007, TREE PHYSIOL, V27, P1661, DOI 10.1093/treephys/27.12.1661; Hacker J, 2011, PLANT SCI, V180, P149, DOI 10.1016/j.plantsci.2010.07.013; Hacker J, 2008, ARCT ANTARCT ALP RES, V40, P660, DOI 10.1657/1523-0430(07-077)[HACKER]2.0.CO;2; ISHIKAWA M, 1981, PLANT CELL PHYSIOL, V22, P953; ISHIKAWA M, 1985, PLANT CELL ENVIRON, V8, P333, DOI 10.1111/j.1365-3040.1985.tb01407.x; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Jones KS, 2000, CAN J BOT, V78, P3, DOI 10.1139/cjb-78-1-3; Julian C, 2007, J APPL BOT FOOD QUAL, V81, P21; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Kubacka-Zebalska M, 1999, PLANT SCI, V148, P59, DOI 10.1016/S0168-9452(99)00122-3; Kuprian E, 2014, ENVIRON EXP BOT, V106, P4, DOI 10.1016/j.envexpbot.2014.01.011; Ladinig U, 2013, OECOLOGIA, V171, P743, DOI 10.1007/s00442-012-2581-8; Landolt E, 1992, UNSERE ALPENFLORA; Livingston DP, 2009, CROP SCI, V49, P1837, DOI 10.2135/cropsci2009.02.0077; Neuner G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00654; Neuner G, 2014, METHODS MOL BIOL, V1166, P91, DOI 10.1007/978-1-4939-0844-8_9; Neuner G, 2013, PHYSIOL PLANTARUM, V147, P88, DOI 10.1111/j.1399-3054.2012.01616.x; Neuner G, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P163, DOI 10.1007/978-3-7091-0136-0_12; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Pramsohler M, 2013, TREE PHYSIOL, V33, P807, DOI 10.1093/treephys/tpt057; QUAMME HA, 1978, J AM SOC HORTIC SCI, V103, P57; QUAMME HA, 1995, J AM SOC HORTIC SCI, V120, P814, DOI 10.21273/JASHS.120.5.814; Rajashekar CB, 1996, PLANT PHYSIOL, V111, P605, DOI 10.1104/pp.111.2.605; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Schulte PJ, 2003, J EXP BOT, V54, P1597, DOI 10.1093/jxb/erg169; Schweingruber FH, 2013, ATLAS STEM ANATOMY H, VII, DOI [10.1007/978-3-642-20435-7, DOI 10.1007/978-3-642-20435-7]; Sitte P, 2002, STRASBURGER LEHRBUCH; Solecka D, 2008, ANN BOT-LONDON, V101, P521, DOI 10.1093/aob/mcm329; Stefanowska M, 1999, ANN BOT-LONDON, V84, P313, DOI 10.1006/anbo.1999.0924; STONE W, 1993, ANN BOT-LONDON, V72, P613, DOI 10.1006/anbo.1993.1152; Taschler D, 2004, PLANT CELL ENVIRON, V27, P737, DOI 10.1111/j.1365-3040.2004.01176.x; Tyree M. T., 2002, SPR S WOOD; Vandvik V, 2005, J APPL ECOL, V42, P139, DOI 10.1111/j.1365-2664.2005.00982.x; WEISER RL, 1990, PLANT PHYSIOL, V93, P1021, DOI 10.1104/pp.93.3.1021; WISNIEWSKI M, 1995, TREES-STRUCT FUNCT, V9, P253, DOI 10.1007/BF00202015; Wisniewski M, 1997, PLANT PHYSIOL, V113, P327, DOI 10.1104/pp.113.2.327; Wisniewski ME, 2009, PLANT COLD HARDINESS: FROM THE LABORATORY TO THE FIELD, P1, DOI 10.1079/9781845935139.0001; Wisniewski M, 2015, JOVE-J VIS EXP, DOI 10.3791/52703; Wisniewski M, 2014, ENVIRON EXP BOT, V99, P133, DOI 10.1016/j.envexpbot.2013.11.011; Workmaster BAA, 1999, J AM SOC HORTIC SCI, V124, P619, DOI 10.21273/JASHS.124.6.619	54	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163160	10.1371/journal.pone.0163160	http://dx.doi.org/10.1371/journal.pone.0163160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632365	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900137
J	Lin, CT; Lin, TH; Wu, CC; Wan, L; Huang, CF; Peng, HL				Lin, Ching-Ting; Lin, Tien-Huang; Wu, Chien-Chen; Wan, Lei; Huang, Chun-Fa; Peng, Hwei-Ling			CRP-Cyclic AMP Regulates the Expression of Type 3 Fimbriae via Cyclic di-GMP in Klebsiella pneumoniae	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; RECEPTOR PROTEIN; CATABOLITE REPRESSION; GENE-EXPRESSION; ANTIBIOTIC-RESISTANCE; SERRATIA-MARCESCENS; CPDA GENE; TRANSCRIPTION; BINDING	Klebsiella pneumoniae is the predominant pathogen isolated from liver abscesses of diabetic patients in Asian countries. However, the effects of elevated blood glucose levels on the virulence of this pathogen remain largely unknown. Type 3 fimbriae, encoded by the mrkABCDF genes, are important virulence factors in K. pneumoniae pathogenesis. In this study, the effects of exogenous glucose and the intracellular cyclic AMP (cAMP) signaling pathway on type 3 fimbriae expression regulation were investigated. The production of MrkA, the major subunit of type 3 fimbriae, was increased in glucose-rich medium, whereas cAMP supplementation reversed the effect. MrkA production was markedly increased by cyaA or crp deletion, but slightly decreased by cpdA deletion. In addition, the mRNA levels of mrkABCDF genes and the activity of P-mrkA were increased in Delta crp strain, as well as the mRNA levels of mrkHIJ genes that encode cyclic di-GMP (c-di-GMP)-related regulatory proteins that influence type 3 fimbriae expression. Moreover, the activities of P-mrkHI and P-mrkJ were decreased in Delta lacZ Delta crp strain. These results indicate that CRP-cAMP down-regulates mrkABCDF and mrkHIJ at the transcriptional level. Further deletion of mrkH or mrkI in Delta crp strain diminished the production of MrkA, indicating that MrkH and MrkI are required for the CRP regulation of type 3 fimbriae expression. Furthermore, the high activity of P-mrkHI in the Delta lacZ Delta crp strain was diminished in Delta lacZ Delta crp Delta mrkHI, but increased in the Delta lacZ Delta crp Delta mrkJ strain. Deletion of crp increased the intracellular c-di-GMP concentration and reduced the phosphodiesterase activity. Moreover, we found that the mRNA levels of multiple genes related to c-di-GMP metabolism were altered in Delta crp strain. These indicate that CRP regulates type 3 fimbriae expression indirectly via the c-di-GMP signaling pathway. In conclusion, we found evidence of a coordinated regulation of type 3 fimbriae expression by the CRP-cAMP and c-di-GMP signaling pathways in K. pneumoniae.	[Lin, Ching-Ting; Wan, Lei; Huang, Chun-Fa] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lin, Tien-Huang] Taichung Tzu Chi Hosp, Div Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Lin, Tien-Huang] Tzu Chi Univ, Sch Post Baccalaureate Chinese Med, Hualien, Taiwan; [Wu, Chien-Chen; Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University	Lin, CT (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Peng, HL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	gingting@mail.cmu.edu.tw; hlpeng@cc.nctu.edu.tw			Ministry of Science and Technology [MOST 104-2320-B-039-037-]; Taichung Tzuchi Hospital; Buddhist Tzu Chi Medical Foundation [TTCRD103-10]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taichung Tzuchi Hospital; Buddhist Tzu Chi Medical Foundation	The work is supported by the grant from Ministry of Science and Technology (MOST 104-2320-B-039-037-) and Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation (TTCRD103-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; EISENSTEIN BI, 1981, J BACTERIOL, V145, P620, DOI 10.1128/JB.145.1.620-623.1981; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Goncalves MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099995; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066740; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; ISHIZUKA H, 1993, MOL MICROBIOL, V10, P341, DOI 10.1111/j.1365-2958.1993.tb01960.x; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267; Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lavender H, 2005, INT J MED MICROBIOL, V295, P153, DOI 10.1016/j.ijmm.2005.04.001; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054430; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lin TH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/621701; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; SAIER MH, 1978, J BACTERIOL, V134, P356, DOI 10.1128/JB.134.1.356-358.1978; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Sebghati TA, 1999, INFECT IMMUN, V67, P1672; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Spurbeck RR, 2013, J BACTERIOL, V195, P3156, DOI 10.1128/JB.02254-12; Stella NA, 2014, ARCH MICROBIOL, V196, P323, DOI 10.1007/s00203-014-0970-6; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tan JWH, 2015, J BACTERIOL, V197, P1659, DOI 10.1128/JB.02615-14; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Vuotto C, 2014, PATHOGENS, V3, P743, DOI 10.3390/pathogens3030743; Wang Q, 2016, CANCER BIOMARK, V16, P1, DOI 10.3233/CBM-150535; Wang ZC, 2013, MICROBIOL-SGM, V159, P1402, DOI 10.1099/mic.0.067793-0; Weyand NJ, 2001, MOL MICROBIOL, V39, P1504, DOI 10.1046/j.1365-2958.2001.02338.x; White-Ziegler CA, 2000, J BACTERIOL, V182, P6391, DOI 10.1128/JB.182.22.6391-6400.2000; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Wu JH, 2005, EXP BIOL MED, V230, P757, DOI 10.1177/153537020523001009; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079038; Yang YS, 2009, J CLIN MICROBIOL, V47, P3336, DOI 10.1128/JCM.00918-09; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	73	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162884	10.1371/journal.pone.0162884	http://dx.doi.org/10.1371/journal.pone.0162884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631471	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900091
J	Pacella, E; Mipatrini, D; Pacella, F; Amorelli, G; Bottone, A; Smaldone, G; Turchetti, P; La Torre, G				Pacella, Elena; Mipatrini, Daniele; Pacella, Fernanda; Amorelli, Giulia; Bottone, Andrea; Smaldone, Gianpaolo; Turchetti, Paolo; La Torre, Giuseppe			Suspensory Materials for Surgery of Blepharoptosis: A Systematic Review of Observational Studies	PLOS ONE			English	Review							AUTOGENOUS FASCIA-LATA; SILICONE FRONTALIS SUSPENSION; DIFFERENT SURGICAL DESIGNS; RANDOMIZED CLINICAL-TRIAL; SEVERE CONGENITAL PTOSIS; MESH BROW SUSPENSION; UPPER EYELID PTOSIS; MERSILENE MESH; LEVATOR FUNCTION; SUTURE MATERIAL	Background Frontalis suspension surgery is considered the procedure of choice in cases of blepharoptosis. Among all the materials used in this type of surgery, ophthalmic and plastic surgeons prefer to use autologous Fascia Lata. However, during years, other autogenous and exogenous materials have been introduced. Objectives The aim of this study was therefore that of systematically reviewing the functional results and the rate of complications of different synthetic materials, as compared to autogenous Fascia Lata. The primary objective was to determine the rates of Successful Surgeries (SSs) of these materials. The secondary objective was to assess the onset of complications. The following materials were investigated: Fascia Lata, Mersilene, polytetrafluoroethylene (PTFE) and Silicon. Data Source and Methods Following the Prisma procedure, on January 30th, 2016 we used the following electronic databases to select the studies: MEDLINE and Scopus. Results The search strategy retrieved 48 publications that met the eligibility criteria of the systematic review. All studies were non-comparative. PTFE (n = 5) showed the best rate of SSs among the materials compared (statistically significant). Surgeries performed with autogenous Fascia Lata (n = 19) had a 87% rate of success those performed with Mersilene (n = 12) had 92% and those performed with Silicon (n = 17) 88%. PTFE had the best outcome, with 99% success rate. As for complications, surgeries performed with PTFE had a higher rate of suture infections (1.9%) as compared to Fascia Lata, but lower incidence for all other complications. Conclusions Although most studies were good quality cohort studies, the overall quality of this evidence should be regarded as low due to their non-comparative design. Our data suggest that PTFE seems to be the most valid alternative material for frontalis suspension surgery, with low recurrence rates and good cosmetic and functional results.	[Pacella, Elena; Pacella, Fernanda; Amorelli, Giulia; Bottone, Andrea; Smaldone, Gianpaolo] Sapienza Univ Rome, Fac Med & Dent, Dept Sense Organs, Rome, Italy; [Mipatrini, Daniele; La Torre, Giuseppe] Sapienza Univ Rome, Fac Pharm & Med, Dept Publ Hlth & Infect Dis, Rome, Italy; [Turchetti, Paolo] Natl Inst Hlth Migrat & Poverty INMP NIHMP, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Pacella, F (corresponding author), Sapienza Univ Rome, Fac Med & Dent, Dept Sense Organs, Rome, Italy.	fernanda.pacella@gmail.com	La Torre, Giuseppe/AAI-6866-2020	La Torre, Giuseppe/0000-0002-1233-2040; mipatrini, daniele/0000-0003-2682-4756; PACELLA, ELENA/0000-0002-5431-6399				Abou-Setta AM, 2011, NEWCASTLE OTTAWA SCA; Ali Zulfiquar, 2011, J Ayub Med Coll Abbottabad, V23, P30; Allen RC, 2012, BRIT J OPHTHALMOL, V96, P841, DOI 10.1136/bjophthalmol-2011-300667; Arajy ZY, 2012, J CRANIO MAXILL SURG, V40, P129, DOI 10.1016/j.jcms.2011.03.002; Bagheri A, 2007, OPHTHAL PLAST RECONS, V23, P217, DOI 10.1097/IOP.0b013e3180557479; Bansal RK, 2015, J PEDIAT OPHTH STRAB, V52, P93, DOI 10.3928/01913913-20150313-11; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Ben Simon GJ, 2005, AM J OPHTHALMOL, V140, P877, DOI 10.1016/j.ajo.2005.05.031; Bernardini Francesco P, 2002, Orbit, V21, P195, DOI 10.1076/orbi.21.3.195.7171; Bernardini FP, 2013, CURR OPIN OPHTHALMOL, V24, P484, DOI 10.1097/ICU.0b013e328363861a; Bilgin Lale Kozer, 2010, Plast Surg Int, V2010, P609462, DOI 10.1155/2010/609462; Buttanri IB, 2013, OPHTHAL PLAST RECONS, V29, P98, DOI 10.1097/IOP.0b013e31827a0068; Can I, 1996, Eur J Ophthalmol, V6, P150; Carter SR, 1996, OPHTHALMOLOGY, V103, P623, DOI 10.1016/S0161-6420(96)30643-X; Cates CA, 2008, ORBIT, V27, P83, DOI 10.1080/01676830701376072; Chong KKL, 2010, EYE, V24, P44, DOI 10.1038/eye.2009.48; CRAWFORD J S, 1956, Trans Am Acad Ophthalmol Otolaryngol, V60, P672; Davies BW, 2013, OPHTHAL PLAST RECONS, V29, pE111, DOI 10.1097/IOP.0b013e318281eb1f; Deenstra W, 1996, ANN PLAS SURG, V36, P348, DOI 10.1097/00000637-199604000-00004; DeMartelaere SL, 2007, OPHTHAL PLAST RECONS, V23, P279, DOI 10.1097/IOP.0b013e31806b16a9; DOWNES RN, 1989, BRIT J OPHTHALMOL, V73, P498, DOI 10.1136/bjo.73.7.498; DOWNES RN, 1990, EYE, V4, P456, DOI 10.1038/eye.1990.58; El-Toukhy E, 2001, EYE, V15, P178, DOI 10.1038/eye.2001.56; Evereklioglu C, 2012, BRIT J OPHTHALMOL, V96, P570, DOI 10.1136/bjophthalmol-2011-300400; Finsterer J, 2003, AESTHET PLAST SURG, V27, P193, DOI 10.1007/s00266-003-0127-5; Fogagnolo P, 2008, EUR J OPHTHALMOL, V18, P723, DOI 10.1177/112067210801800510; Friedhofer H, 2012, PLAST RECONSTR SURG, V129, p453E, DOI 10.1097/PRS.0b013e3182402deb; Gabrieli CB, 1996, OPHTHALMIC SURG LAS, V27, P924; Hafez A, 2008, MIDDLE EAST AFR J OP, V15, P117, DOI 10.4103/0974-9233.51986; Hayashi K, 2013, AM J OPHTHALMOL, V155, P654, DOI 10.1016/j.ajo.2012.10.022; HINTSCHICH CR, 1995, BRIT J OPHTHALMOL, V79, P358, DOI 10.1136/bjo.79.4.358; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; KEMP EG, 1986, T OPHTHAL SOC UK, V105, P84; Kemp EG, 2001, OPHTHALMIC PLAST REC, V17, P419, DOI 10.1097/00002341-200111000-00006; Khwarg SI, 1999, OPHTHALMOLOGY, V106, P1191, DOI 10.1016/S0161-6420(99)90258-0; Kim CY, 2015, BRIT J OPHTHALMOL, V99, P346, DOI 10.1136/bjophthalmol-2014-305101; Lam DSC, 1997, EYE, V11, P806, DOI 10.1038/eye.1997.210; Lamont M, 2010, ORBIT, V29, P102, DOI 10.3109/01676830903452957; Lee MJ, 2009, OPHTHALMOLOGY, V116, P123, DOI 10.1016/j.ophtha.2008.08.049; Leibovitch I, 2003, AM J OPHTHALMOL, V136, P866, DOI 10.1016/S0002-9394(03)00466-5; Lelli GJ, 2009, OPHTHAL PLAST RECONS, V25, P361, DOI 10.1097/IOP.0b013e3181b3b183; LEONE CR, 1981, OPHTHALMIC SURG LAS, V12, P881; Mehta P, 2004, BRIT J OPHTHALMOL, V88, P361, DOI 10.1136/bjo.2002.009951; Morris CL, 2008, J PEDIAT OPHTH STRAB, V45, P280, DOI 10.3928/01913913-20080901-11; Mutlu FM, 1999, OPHTHALMIC SURG LAS, V30, P47; Nakauchi K, 2013, CLIN OPHTHALMOL, V7, P131, DOI 10.2147/OPTH.S39057; Naugle TC, 1997, OPHTHALMOLOGY, V104, P1480, DOI 10.1016/S0161-6420(97)30107-9; Nucci P, 2015, SEMIN OPHTHALMOL, V21, P1; OLDER JJ, 1984, OPHTHALMIC SURG LAS, V15, P379; Payr E, 1909, DTSCH MED WOCHENSCHR, V35; Philandrianos C, 2010, J PLAST RECONSTR AES, V63, P782, DOI 10.1016/j.bjps.2009.01.083; Razavi ME, 2014, ORBIT, V33, P91, DOI 10.3109/01676830.2013.841714; Rizvi SAR, 2014, OPHTHAL PLAST RECONS, V30, P11, DOI 10.1097/IOP.0b013e3182a74f44; Rong G, 2013, SCI WORLD J, DOI [10.1155/2013/716342, 10.1155/2013/589215]; Salour H, 2008, EUR J OPHTHALMOL, V18, P853, DOI 10.1177/112067210801800601; Sharma TK, 2003, EYE, V17, P759, DOI 10.1038/sj.eye.6700498; Shimizu Y, 2015, J PLAST RECONSTR AES, V68, P49, DOI 10.1016/j.bjps.2014.08.068; Sokol JA, 2011, OPHTHAL PLAST RECONS, V27, P211, DOI 10.1097/IOP.0b013e3181ef72cd; STEINKOGLER FJ, 1993, PLAST RECONSTR SURG, V92, P1057, DOI 10.1097/00006534-199311000-00009; Suh Ji Young, 2013, Korean J Ophthalmol, V27, P311, DOI 10.3341/kjo.2013.27.5.311; TILLETT CW, 1966, AM J OPHTHALMOL, V62, P521, DOI 10.1016/0002-9394(66)91334-1; van Sorge AJ, 2012, ACTA OPHTHALMOL, V90, P188, DOI 10.1111/j.1755-3768.2010.01876.x; WAGNER RS, 1984, OPHTHALMOLOGY, V91, P245; Wasserman BN, 2001, ARCH OPHTHALMOL-CHIC, V119, P687, DOI 10.1001/archopht.119.5.687; Wei YH, 2009, J FORMOS MED ASSOC, V108, P943, DOI 10.1016/S0929-6646(10)60007-1; Wheatcroft SM, 1997, BRIT J OPHTHALMOL, V81, P581, DOI 10.1136/bjo.81.7.581; Woo KI, 2014, AM J OPHTHALMOL, V157, P1221, DOI 10.1016/j.ajo.2014.02.041; Wright WW, 1922, ARCH OPHTHALMOL-CHIC, V51, P99; Yoon JS, 2009, OPHTHALMOLOGY, V116, P1405, DOI 10.1016/j.ophtha.2009.01.040	69	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160827	10.1371/journal.pone.0160827	http://dx.doi.org/10.1371/journal.pone.0160827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631781	gold, Green Submitted, Green Published			2022-12-27	WOS:000383706900013
J	Popova, TG; Teunis, A; Espina, V; Liotta, LA; Popov, SG				Popova, Taissia G.; Teunis, Allison; Espina, Virginia; Liotta, Lance A.; Popov, Serguei G.			Chemokine-Releasing Microparticles Improve Bacterial Clearance and Survival of Anthrax Spore-Challenged Mice	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; BACILLUS-ANTHRACIS; LISTERIA-MONOCYTOGENES; LEUKOCYTE RECRUITMENT; MURINE MODEL; RESISTANCE; NANOPARTICLES; INTERLEUKIN-8; RESPONSES; CHEMOTAXIS	In this study the hydrogel microparticles (MPs) were used to enhance migration of neutrophils in order to improve outcome of anthrax infection in a mouse model. Two MP formulations were tested. In the first one the polyacrylamide gel MPs were chemically coupled with Cibacron Blue (CB) affinity bait. In the second one the bait molecules within the MPs were additionally loaded with neutrophil-attracting chemokines (CKs), human CXCL8 and mouse CCL3. A non-covalent interaction of the bait with the CKs provided their gradual release after administration of the MPs to the host. Mice were challenged into footpads with Bacillus anthracis Sterne spores and given a dose of MPs a few hours before and/or after the spores. Pre-treatment with a single dose of CK-releasing MPs without any additional intervention was able to induce influx of neutrophils to the site of spore inoculation and regional lymph nodes correlating with reduced bacterial burden and decreased inflammatory response in footpads. On average, in two independent experiments, up to 53% of mice survived over 13 days. All control spore-challenged but MP-untreated mice died. The CB-coupled particles were also found to improve survival likely due to the capacity to stimulate release of endogenous CKs, but were less potent at decreasing the inflammatory host response than the CK-releasing MPs. The CK post-treatment did not improve survival compared to the untreated mice which died within 4 to 6 days with a strong inflammation of footpads, indicating quick dissemination of spores though the lymphatics after challenge. This is the first report on the enhanced innate host resistance to anthrax in response to CKs delivered and/or endogenously induced by the MPs.	[Popova, Taissia G.; Espina, Virginia; Liotta, Lance A.] George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA; [Teunis, Allison; Popov, Serguei G.] George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA	George Mason University; George Mason University	Popov, SG (corresponding author), George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.	spopov@gmu.edu		Espina, Virginia/0000-0001-5080-5972	National Institutes of Health, USA [1R21AI117425-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117425] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grant 1R21AI117425-01 from the National Institutes of Health, USA (SP VE and LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Bonecchi R, 1999, J IMMUNOL, V162, P474; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Nguyen C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-2; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cote CK, 2008, MICROBES INFECT, V10, P613, DOI 10.1016/j.micinf.2008.02.006; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Gao D, 2008, NANO LETT, V8, P3320, DOI 10.1021/nl8017274; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Garvy BA, 1996, INFLAMMATION, V20, P499, DOI 10.1007/BF01487042; Goncalves DM, 2011, THESCIENTIFICWORLDJO, V11, P1877, DOI 10.1100/2011/768350; GRAHAM GJ, 1994, J BIOL CHEM, V269, P4974; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Klemola K., 2007, AUTEX RES J, V7, P224; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kress H, 2009, NAT METHODS, V6, P905, DOI 10.1038/nmeth.1400; Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64; Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1; Lisanby MW, 2008, J IMMUNOL, V181, P4989, DOI 10.4049/jimmunol.181.7.4989; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Marshall AJ, 1998, INFECT IMMUN, V66, P1325, DOI 10.1128/IAI.66.4.1325-1333.1998; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mejia JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013546; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Popova TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129860; Popova TG, 2015, NANOMATERIALS-BASEL, V5, P298, DOI 10.3390/nano5010298; Popova TG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110873; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Romani L, 1997, J IMMUNOL, V158, P5349; Romani L, 1997, J IMMUNOL, V158, P2356; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; Wenger Y, 2011, TOXICOL APPL PHARM, V251, P181, DOI 10.1016/j.taap.2010.11.017; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009; Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003	58	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163163	10.1371/journal.pone.0163163	http://dx.doi.org/10.1371/journal.pone.0163163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632537	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900138
J	Prost, S; Kishen, REB; Kluth, DC; Bellamy, COC				Prost, Sandrine; Kishen, Ria E. B.; Kluth, David C.; Bellamy, Christopher O. C.			Choice of Illumination System & Fluorophore for Multiplex Immunofluorescenceon FFPE Tissue Sections	PLOS ONE			English	Article							QUANTUM DOTS; CELLS; IMMUNOHISTOCHEMISTRY; AUTOFLUORESCENCE	The recent availability of novel dyes and alternative light sources to facilitate complex tissue immunofluorescence studies such as multiplex labelling has not been matched by reports critically evaluating the considerations and relative benefits of these new tools, particularly in combination. Product information is often limited to wavelengths used for older fluorophores (FITC, TRITC & corresponding Alexa dyes family). Consequently, novel agents such as Quantum dots are not widely appreciated or used, despite highly favourable properties including extremely bright emission, stability and potentially reduced tissue autofluorescence at the excitation wavelength. Using spectral analysis, we report here a detailed critical appraisal and comparative evaluation of different light sources and fluorophores in multiplex immunofluorescence of clinical biopsy sections. The comparison includes mercury light, metal halide and 3 different LED-based systems, using 7 Qdots (525, 565, 585, 605, 625, 705), Cy3 and Cy5. We discuss the considerations relevant to achieving the best combination of light source and fluorophore for accurate multiplex fluorescence quantitation. We highlight practical limitations and confounders to quantitation with filter-based approaches.	[Prost, Sandrine; Kishen, Ria E. B.] Univ Edinburgh, Dept Pathol, Deanery Mol Genet & Publ Hlth Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Kluth, David C.] Univ Edinburgh, Edinburgh Med Sch, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Univ Edinburgh, Royal Infirm Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Prost, S (corresponding author), Univ Edinburgh, Dept Pathol, Deanery Mol Genet & Publ Hlth Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	s.prost@ed.ac.uk		prost, sandrine/0000-0002-0140-7115	CSO (Chief Scientist Office Scotland) [ETM/189]; University of Edinburgh Development Trust [GR01858]; Chief Scientist Office [ETM/189] Funding Source: researchfish	CSO (Chief Scientist Office Scotland); University of Edinburgh Development Trust; Chief Scientist Office	The work was supported by a project grant from the CSO (Chief Scientist Office Scotland) ETM/189 to David Kluth, Christopher Bellamy & Sandrine Prost; a Moray Endowment Fund award to Sandrine Prost (University of Edinburgh), and an Innovation grant (GR01858) from the University of Edinburgh Development Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, US MAN NUANC 3 0 2; [Anonymous], 2010, MOL PROB HDB; Aswani KJ T., 2012, MICROSCOPY TODAY, V20, P18; Beacher J., 2008, BIOPHOTONICS INT, V15, P34; Biolegend, FLUOR SPECTR AN 2016; Brown CM, 2007, J CELL SCI, V120, P3488, DOI 10.1242/jcs.022079; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Diebele I, 2012, BIOMED OPT EXPRESS, V3, P467, DOI 10.1364/BOE.3.000467; Evans EW, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0037; Goldman ER, 2005, METH MOL B, V303, P19; Hoffman G., 2008, SHORT COURSE; Hoffman GE, 2008, CURRENT PROTOCOLS NE, DOI [10.1364/BOE.3.000467, DOI 10.1364/BOE.3.000467]; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Levenson RM, 2006, CYTOM PART A, V69A, P592, DOI 10.1002/cyto.a.20292; Lumencor, SOL LIGHT ENG SOL ST; Ma B, 2006, ACTA HISTOCHEM, V108, P243, DOI 10.1016/j.acthis.2006.02.002; Mansfield JR, 2001, CURRENT PROTOCOLS MO; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Osman TA, 2013, EUR J HISTOCHEM, V57, P143, DOI 10.4081/ejh.2013.e22; Pautke C, 2007, J ANAT, V210, P117, DOI 10.1111/j.1469-7580.2006.00660.x; Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; ThermoFisher, 2016, FLURO SPETRAVIEWER 2; Tholouli E, 2008, J PATHOL, V216, P275, DOI 10.1002/path.2421; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Zeiss, FILT ASS 2016; Zeiss, 2016, FUND LIGHT EM DIOD	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162419	10.1371/journal.pone.0162419	http://dx.doi.org/10.1371/journal.pone.0162419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632367	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900046
J	Salmiheimo, A; Mustonen, H; Stenman, UH; Puolakkainen, P; Kemppainen, E; Seppanen, H; Haglund, C				Salmiheimo, Aino; Mustonen, Harri; Stenman, Ulf-Hakan; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj			Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL-LYMPHOCYTE RATIO; PROGNOSTIC SCORE; CANCER; MECHANISMS; RESECTION; COLON	Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) currently relies on tumour-related factors such as resection margins and on lymph-node ratio (LNR) both inconveniently available only postoperatively. Our aim was to assess the accuracy of preoperative laboratory data in predicting PDAC prognosis. Methods Collection of laboratory and clinical data was retrospective from 265 consecutive patients undergoing surgery for PDAC at Helsinki University Hospital. Cancer-specific survival assessment utilized Kaplan-Meier analysis, and independent associations between factors were by the Cox regression model. Results During follow-up, 76% of the patients died of PDAC, with a median survival time of 19.6 months. In univariate analysis, CRP, albumin, CEA, and CA19-9 were significantly associated with postoperative cancer-specific survival. In multivariate analysis, taking into account age, gender, LNR, resection margins, tumour status, and adjuvant chemotherapy, the preoperative biomarkers independently associated with adverse prognosis were hypoalbuminemia (< 36 g/L, hazard ratio (HR) 1.56, 95% confidence interval (CI) 1.10-2.19, p = 0.011), elevated CRP (> 5 mg/L, HR 1.44, 95% CI 1.03-2.02, p = 0.036), CEA (> 5 mu g/L, HR 1.60, 95% CI 1.07-2.53, p = 0.047), and CA19-9 (>= 555 kU/L, HR 1.91, 95% CI 1.18-3.08, p = 0.008). Conclusion For patients with resectable PDAC, preoperative CRP, along with albumin and tumour markers, is useful for predicting prognosis.	[Salmiheimo, Aino; Mustonen, Harri; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Salmiheimo, Aino; Mustonen, Harri; Stenman, Ulf-Hakan; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Stenman, Ulf-Hakan] Univ Helsinki, Dept Clin Chem, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol Program, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Salmiheimo, A (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.	aino.koski@helsinki.fi	Haglund, Caj/N-1240-2019; Seppänen, Hanna/AER-1337-2022	Stenman, Ulf-Hakan/0000-0002-2695-3454; Mustonen, Harri Kalevi/0000-0001-5632-6796	Finnish Cancer Society; Medicinska understodsforeningen Liv och Halsa; Mary and Georg C Ehrnrooth -foundation	Finnish Cancer Society; Medicinska understodsforeningen Liv och Halsa; Mary and Georg C Ehrnrooth -foundation	This work was supported by the Finnish Cancer Society (www.cancersociety.fi) to CH, Medicinska understodsforeningen Liv och Halsa (http://www.livochhalsa.fi/) to CH and Mary and Georg C Ehrnrooth -foundation (http://www.marygeorg.fi/) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Benassai G, 2015, INT J SURG, V21, pS1, DOI 10.1016/j.ijsu.2015.06.050; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Bower JE, 2013, BRAIN BEHAV IMMUN, V30, pS48, DOI 10.1016/j.bbi.2012.06.011; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Doumatey AP, 2014, CLIN BIOCHEM, V47, P315, DOI 10.1016/j.clinbiochem.2013.12.014; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Garcea G, 2008, J PANCREAS, V9, P99; Gebhardt C, 2000, LANGENBECK ARCH SURG, V385, P14, DOI 10.1007/s004230050004; Haas M, 2013, J CANCER RES CLIN, V139, P681, DOI 10.1007/s00432-012-1371-3; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Kersten C, 2013, ACTA ONCOL, V52, P1691, DOI 10.3109/0284186X.2013.835494; La Torre M, 2012, ANN SURG ONCOL, V19, P2917, DOI 10.1245/s10434-012-2348-9; Laird BJ, 2013, ONCOLOGIST, V18, P1050, DOI 10.1634/theoncologist.2013-0120; Liu L, 2015, INT J CANCER, V136, P2216, DOI 10.1002/ijc.29242; LUNDIN J, 1994, BRIT J CANCER, V69, P515, DOI 10.1038/bjc.1994.93; MAGNANI JL, 1983, CANCER RES, V43, P5489; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Riediger H, 2009, J GASTROINTEST SURG, V13, P1337, DOI 10.1007/s11605-009-0919-2; Ruiz-Tovar J, 2010, REV ESP ENFERM DIG, V102, P631; Saito K, 2013, INT J UROL, V20, P161, DOI 10.1111/j.1442-2042.2012.03121.x; Sanjay P, 2012, J PANCREAS, V13, P199; Seppanen H, 2017, SCAND J SURG, V106, P54, DOI 10.1177/1457496916645963; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stevens L, 2015, HPB, V17, P285, DOI 10.1111/hpb.12355; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163064	10.1371/journal.pone.0163064	http://dx.doi.org/10.1371/journal.pone.0163064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632196	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900126
J	Van Lent, S; De Vos, WH; Creasy, HH; Marques, PX; Ravel, J; Vanrompay, D; Bavoil, P; Hsia, RC				Van Lent, Sarah; De Vos, Winnok H.; Creasy, Heather Huot; Marques, Patricia X.; Ravel, Jacques; Vanrompay, Daisy; Bavoil, Patrik; Hsia, Ru-ching			Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to Infection	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; DEVELOPMENTAL CYCLE; ANTIGENIC VARIATION; GENOME SEQUENCES; TRACHOMATIS; FAMILY; PNEUMONIAE; SURFACE; ABORTION; STRAINS	The polymorphic membrane protein (Pmp) paralogous families of Chlamydia trachomatis, Chlamydia pneumoniae and Chlamydia abortus are putative targets for Chlamydia vaccine development. To determine whether this is also the case for Pmp family members of C. psittaci, we analyzed transcription levels, protein production and localization of several Pmps of C. psittaci. Pmp expression profiles were characterized using quantitative real-time PCR (RT-qPCR), immunofluorescence (IF) and immuno-electron microscopy (IEM) under normal and stress conditions. We found that PmpA was highly produced in all inclusions as early as 12 hpi in all biological replicates. In addition, PmpA and PmpH appeared to be unusually accessible to antibody as determined by both immunofluorescence and immuno-electron microscopy. Our results suggest an important role for these Pmps in the pathogenesis of C. psittaci, and make them promising candidates in vaccine development.	[Van Lent, Sarah; Vanrompay, Daisy] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Ghent, Belgium; [De Vos, Winnok H.] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Sci, Antwerp, Belgium; [De Vos, Winnok H.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Ghent, Belgium; [Creasy, Heather Huot; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Creasy, Heather Huot; Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Marques, Patricia X.; Bavoil, Patrik] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Hsia, Ru-ching] Univ Maryland, Electron Microscopy Core Imaging Facil, Baltimore, MD 21201 USA	Ghent University; University of Antwerp; Ghent University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Van Lent, S (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Ghent, Belgium.	sarah.vanlent@ugent.be	de vos, winnok/A-6445-2012; Ravel, Jacques/D-2530-2009	de vos, winnok/0000-0003-0960-6781; Ravel, Jacques/0000-0002-0851-2233	BOF UGhent [B/11210/02]; NIH NIAID [U19 AI 084044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	BOF UGhent; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by BOF UGhent B/11210/02 (to DV) and NIH NIAID U19 AI 084044 (to PB, PXM and JR). Sarah Van Lent is a research fellow of the Research Foundation-Flanders (FWO-Vlaanderen, 11E8213N). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CALDWELL HD, 1987, INFECT IMMUN, V55, P93, DOI 10.1128/IAI.55.1.93-98.1987; CAMPBELL LA, 1990, J CLIN MICROBIOL, V28, P1261, DOI 10.1128/JCM.28.6.1261-1264.1990; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Carrasco JA, 2011, CELL MICROBIOL, V13, P1014, DOI 10.1111/j.1462-5822.2011.01598.x; CEVENINI R, 1991, FEMS MICROBIOL LETT, V81, P111, DOI 10.1111/j.1574-6968.1991.tb04722.x; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Forsbach-Birk V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080310; Giannikopoulou P, 1997, ELECTROPHORESIS, V18, P2104, DOI 10.1002/elps.1150181137; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Grinblat-Huse V, 2011, J BACTERIOL, V193, P4039, DOI 10.1128/JB.05277-11; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Heckema ER, 2006, EMERG INFECT DIS, V12, P1989; Heddema ER, 2006, EMERG INFECT DIS, V12, P1989; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Hovis KM, 2013, PATHOG DIS, V69, P213, DOI 10.1111/2049-632X.12070; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; Hu YQ, 2015, J MICROBIOL BIOTECHN, V25, P1246, DOI 10.4014/jmb.1502.02031; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Jasper DK, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv003; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Knudsen K, 1999, INFECT IMMUN, V67, P375, DOI 10.1128/IAI.67.1.375-383.1999; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Longbottom D, 1998, FEMS MICROBIOL LETT, V164, P111, DOI 10.1111/j.1574-6968.1998.tb13075.x; Longbottom D, 1998, INFECT IMMUN, V66, P1317, DOI 10.1128/IAI.66.4.1317-1324.1998; Marques PX, 2010, CLIN VACCINE IMMUNOL, V17, P1274, DOI 10.1128/CVI.00163-10; Matsumoto A:, 1982, INFECT IMMUN, V150, P358; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIBLEY LD, 1986, J CELL BIOL, V103, P867, DOI 10.1083/jcb.103.3.867; SOURIAU A, 1994, AM J VET RES, V55, P510; SPEER CA, 1989, INFECT IMMUN, V57, P999, DOI 10.1128/IAI.57.3.999-1001.1989; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2010, CELL MICROBIOL, V12, P174, DOI 10.1111/j.1462-5822.2009.01389.x; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Taraska T, 1996, INFECT IMMUN, V64, P3713, DOI 10.1128/IAI.64.9.3713-3727.1996; Vandahl BB, 2001, PROTEOME ANAL CHLAMY, P1204; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; VANROMPAY D, 1994, AVIAN PATHOL, V23, P247, DOI 10.1080/03079459408418993; Vanrompay D, 1996, INFECT IMMUN, V64, P1265, DOI 10.1128/IAI.64.4.1265-1271.1996; Vanrompay D, 1997, VET MICROBIOL, V54, P85, DOI 10.1016/S0378-1135(96)01224-2; Vasilevsky S, 2016, VIRULENCE, V7, P11, DOI 10.1080/21505594.2015.1111509; Verdoodt F, 2012, CELL BIOL INT, V36, P1251, DOI 10.1042/CBI20120187; Verminnen K, 2006, VET RES, V37, P623, DOI 10.1051/vetres:2006023; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wheelhouse N, 2009, VET RES, V40, DOI 10.1051/vetres/2009030; Wheelhouse N, 2012, VET MICROBIOL, V160, P525, DOI 10.1016/j.vetmic.2012.06.017; Wheelhouse NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049190	66	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162392	10.1371/journal.pone.0162392	http://dx.doi.org/10.1371/journal.pone.0162392			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631978	Green Published, gold			2022-12-27	WOS:000383706900044
J	Wang, Q; Liu, L; Li, H; Tao, P; Qi, YN; Li, JY				Wang, Qiong; Liu, Li; Li, Hui; Tao, Ping; Qi, Yana; Li, Jiayuan			Effects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility	PLOS ONE			English	Article							GROWTH-FACTOR-I; IGF BINDING PROTEIN-3; CIRCULATING LEVELS; SERUM-LEVELS; POSTMENOPAUSAL WOMEN; OVARIAN-CANCER; FACTOR (IGF)-I; CHINESE WOMEN; RISK; ASSOCIATION	Background Polymorphisms of IGF-1 and IGFBP-3 and environmental factors may work together to influence insulin-like growth factor (IGF) levels and thus breast cancer (BC) risk. However, very few studies have investigated high-order interactions among these variables. Methods A total of 277 newly diagnosed BC cases and 277 controls were recruited between October 2010 and July 2012. We collected each participant's demographic characteristics, dietary intake, and blood sample. IGF-1 rs1520220 and IGFBP-3 rs2854744 were then genotyped. A multi-analytic strategy combining unconditional logistic regression (ULR), generalized multifactor dimensionality reduction (GMDR), and classification and regression tree (CART) approaches was applied to systematically identify the interactions of the two single nucleotide polymorphisms (SNPs), body mass index (BMI), and daily intake of soy isoflavone (DISI) on BC susceptibility. Results In GMDR analyses, high-order interactions among BMI, DISI, and SNP rs2854744 were identified among overall and postmenopausal women. We also found significant dosage effects on BC risk with an increasing number of exposure factors, namely carrying the rs2854744 AA genotype, DISI < 9.85 mg/day, and BMI >= 24 kg/m(2) (P (trend)<0.05). Similarly, in CART analyses, compared with individuals having BMI<24kg/m(2), DISI<9.85 mg/day, and the rs2854744 CC+CA genotype, BC risk increased significantly for those carrying the rs2854744 AA genotype, with BMI<24 kg/m(2) and DISI<9.85 mg/day (OR = 1.95, 95% CI: 1.03-3.69), and also for those with BMI >= 24kg/m(2) and DISI<9.85 mg/day (OR = 2.13, 95% CI: 1.00-4.51). Similar interaction effects were observed among postmenopausal women. Conclusions This study suggests high-order interactions of the IGFBP-3 rs2854744 AA genotype, BMI >= 24kg/m(2), and DISI<9.85 mg/day on increased BC risk, particularly among postmenopausal women.	[Wang, Qiong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Guangzhou, Guangdong, Peoples R China; [Wang, Qiong; Li, Hui; Li, Jiayuan] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Liu, Li] Chengdu Womens & Childrens Cent Hosp, Comprehens Guidance Ctr Womens Hlth, Chengdu, Sichuan, Peoples R China; [Tao, Ping] Second Peoples Hosp Sichuan Prov, Dept Breast Surg, Chengdu, Sichuan, Peoples R China; [Qi, Yana] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China	Sun Yat Sen University; Sichuan University; Sichuan University	Li, JY (corresponding author), Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.	lijiayuan@scu.edu.cn	li, jia/GVT-7587-2022		Medical Scientific Research Foundation of Guangdong Province [A2015443]; National Natural Science Foundation of China [81602819, 81302500]; Medical Scientific Research Foundation of Sichuan Province [120520]	Medical Scientific Research Foundation of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Sichuan Province	Interpretation of data and manuscript writing was supported by: (1) Medical Scientific Research Foundation of Guangdong Province (funding number: A2015443). The first author QW received this funding. The URLs of funder's website is http://www.gdwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (2) National Natural Science Foundation of China (funding number: 81602819). The first author QW received this funding. The URLs of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (3) National Natural Science Foundation of China (funding number: 81302500). The corresponding author JL received this funding. The URLs of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (4) Medical Scientific Research Foundation of Sichuan Province (funding number: 120520). The co-first author LL received this funding. The URLs of funder's website is http://www.scwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Andrew AS, 2008, HUM HERED, V65, P105, DOI 10.1159/000108942; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Ferlay J., 2008, GLOBOCAN 2008 V1 2 C; Ferlay J, 2002, GLOBOCAN 2002 V2 0 C; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; Gann PH, 2005, INT J CANCER, V116, P297, DOI 10.1002/ijc.21042; Garcia-Magarinos M, 2009, ANN HUM GENET, V73, P360, DOI 10.1111/j.1469-1809.2009.00511.x; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hakkak R, 2011, ONCOL LETT, V2, P29, DOI 10.3892/ol.2010.202; Hu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067275; Jernstrom H, 2001, MOL GENET METAB, V72, P144, DOI 10.1006/mgme.2000.3130; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Lagiou P, 2009, BRIT J CANCER, V100, P1794, DOI 10.1038/sj.bjc.6605074; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu XO, 2014, ASIAN PAC J CANCER P, V15, P1291, DOI 10.7314/APJCP.2014.15.3.1291; Lu LG, 2013, CARCINOGENESIS, V34, P2024, DOI 10.1093/carcin/bgt168; Lu LG, 2012, CARCINOGENESIS, V33, P2119, DOI 10.1093/carcin/bgs243; NCBI, 2015, DAT SINGL NUCL POL S; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sarkissyan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103534; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Tao Ping, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P164; Wang J, 2016, CANCER EPIDEMIOL, V42, P1, DOI 10.1016/j.canep.2016.02.010; Wang Q, 2014, NANOTOXICOLOGY, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0108934; Wang Q, 2011, DNA CELL BIOL, V30, P585, DOI 10.1089/dna.2010.1195; Wang Qiong, 2010, Chin J Cancer, V29, P683; Wangen KE, 2000, J CLIN ENDOCR METAB, V85, P3043, DOI 10.1210/jc.85.9.3043; Wu YP, 2003, CANCER RES, V63, P4384; Yu H, 2002, CANCER EPIDEM BIOMAR, V11, P705; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790	48	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162970	10.1371/journal.pone.0162970	http://dx.doi.org/10.1371/journal.pone.0162970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631779	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900103
J	Benz, RA; Boyce, MS; Thurfjell, H; Paton, DG; Musiani, M; Dormann, CF; Ciuti, S				Benz, Robin A.; Boyce, Mark S.; Thurfjell, Henrik; Paton, Dale G.; Musiani, Marco; Dormann, Carsten F.; Ciuti, Simone			Dispersal Ecology Informs Design of Large-Scale Wildlife Corridors	PLOS ONE			English	Article							HABITAT SELECTION; RESOURCE SELECTION; MOVEMENT; NDVI; ELK; RESPONSES; MODELS; ROADS; BIODIVERSITY; LANDSCAPE	Landscape connectivity describes how the movement of animals relates to landscape structure. The way in which movement among populations is affected by environmental conditions is important for predicting the effects of habitat fragmentation, and for defining conservation corridors. One approach has been to map resistance surfaces to characterize how environmental variables affect animal movement, and to use these surfaces to model connectivity. However, current connectivity modelling typically uses information on species location or habitat preference rather than movement, which unfortunately may not capture dispersal limitations. Here we emphasize the importance of implementing dispersal ecology into landscape connectivity, i.e., observing patterns of habitat selection by dispersers during different phases of new areas' colonization to infer habitat connectivity. Disperser animals undertake a complex sequence of movements concatenated over time and strictly dependent on species ecology. Using satellite telemetry, we investigated the movement ecology of 54 young male elk Cervus elaphus, which commonly disperse, to design a corridor network across the Northern Rocky Mountains. Winter residency period is often followed by a spring-summer movement phase, when young elk migrate with mothers' groups to summering areas, and by a further dispersal bout performed alone to a novel summer area. After another summer residency phase, dispersers usually undertake a final autumnal movement to reach novel wintering areas. We used resource selection functions to identify winter and summer habitats selected by elk during residency phases. We then extracted movements undertaken during spring to move from winter to summer areas, and during autumn to move from summer to winter areas, and modelled them using step selection functions. We built friction surfaces, merged the different movement phases, and eventually mapped least-cost corridors. We showed an application of this tool by creating a scenario with movement predicted as there were no roads, and mapping highways' segments impeding elk connectivity.	[Benz, Robin A.; Dormann, Carsten F.; Ciuti, Simone] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Boyce, Mark S.; Thurfjell, Henrik] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Paton, Dale G.; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada	University of Freiburg; University of Alberta; University of Calgary	Ciuti, S (corresponding author), Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany.	simone.ciuti@biom.uni-freiburg.de	Boyce, Mark S/A-2620-2014; Ciuti, Simone/D-7283-2013; Musiani, Marco/ABB-9387-2021	Boyce, Mark S/0000-0001-5811-325X; Ciuti, Simone/0000-0003-1052-9509; Musiani, Marco/0000-0002-6097-5841; Dormann, Carsten/0000-0002-9835-1794; Thurfjell, Henrik/0000-0001-9261-7654	Natural Sciences and Engineering Research Council of Canada (NSERC) [364323-07]; Alberta Conservation Association [RES0008502]; Shell Canada Limited [364323]; Carl Tryggers Foundation for Scientific Research [CTS 12:499, CTS 13:477]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association; Shell Canada Limited; Carl Tryggers Foundation for Scientific Research	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, Grant number 364323-07) http://www.nserc-crsng.gc.ca/Index_eng.asp received by MSB; Alberta Conservation Association (Grant number RES0008502) http://www.ab-conservation.com/go/default/ received by MSB; Shell Canada Limited (Grant number 364323) http://www.shell.ca./ received by MSB, and the Carl Tryggers Foundation for Scientific Research (Grant numbers CTS 12:499, CTS 13:477) http://www.carltryggersstiftelse.se/ received by HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2014, R LANG ENV STAT COMP; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BEGG MD, 1990, ENVIRON HEALTH PERSP, V87, P69, DOI 10.2307/3431008; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Beyer, 2018, GEOSPATIAL MODELING; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Bolger DT, 2008, ECOL LETT, V11, P63; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Bruhl CA, 2003, BIODIVERS CONSERV, V12, P1371, DOI 10.1023/A:1023621609102; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P349, DOI 10.1007/978-4-431-87771-4_19; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Duffy JP, 2012, AFR J ECOL, V50, P455, DOI 10.1111/j.1365-2028.2012.01340.x; Elff M, 2013, MCLOGIT MIXED CONDIT; ESRI, 2012, ARCGIS 10 1 DESKT AD; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Killeen J, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0015-4; Kooijman S., 2012, ENCY THEORETICAL ECO; Laurance WF, 2008, CONSERV BIOL, V22, P1154, DOI 10.1111/j.1523-1739.2008.00981.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Long ES, 2008, BEHAV ECOL, V19, P1235, DOI 10.1093/beheco/arn082; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Manly B.F.J., 2002, RESOURCE SELECTION A; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Muggeo V., 2021, R PACKAGE; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Paton DG, 2012, CONNECTIVITY ELK MIG; Petersburg ML, 2000, WILDLIFE SOC B, V28, P708; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Photopoulou T, 2015, METHODS ECOL EVOL, V6, P278, DOI 10.1111/2041-210X.12328; PRESSEY RL, 1997, CONSERVATION OUTSIDE, P407; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Seidler RG, 2015, CONSERV BIOL, V29, P99, DOI 10.1111/cobi.12376; Shafer ABA, 2012, ECOLOGY, V93, P1317; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Squires JR, 2013, BIOL CONSERV, V157, P187, DOI 10.1016/j.biocon.2012.07.018; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van Oort H, 2011, ANIM CONSERV, V14, P215, DOI 10.1111/j.1469-1795.2010.00423.x; Vasudev D, 2015, ECOGRAPHY; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Zuur Alain F., 2009, P1	69	12	12	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162989	10.1371/journal.pone.0162989	http://dx.doi.org/10.1371/journal.pone.0162989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657496	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200052
J	Faulkner, S; Bee, P				Faulkner, Sophie; Bee, Penny			Perspectives on Sleep, Sleep Problems, and Their Treatment, in People with Serious Mental Illnesses: A Systematic Review	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; CIRCADIAN-RHYTHM DISRUPTION; QUALITY-OF-LIFE; BIPOLAR DISORDER; INSOMNIA; SCHIZOPHRENIA; PRESCRIPTION; EXPERIENCE; KNOWLEDGE; CONSENSUS	Sleep problems are common in people with serious mental illness, and impact negatively on functioning and wellbeing. To understand the development of sleep problems, their maintenance, and their treatment, an in depth understanding of patient perspectives is crucial. A systematic literature review was conducted using Medline, AMED, PsychInfo, Embase and CINAHL. Qualitative and quantitative studies were included if they explored or measured patient perspectives on sleep, sleep problems or sleep treatments in people with serious mental illness. Of the 2,067 hits, only 22 met review inclusion criteria, and high quality evidence was sparse. The limited findings suggested sleep was seen as highly interlinked with mental health. Evaluations of treatments varied, however perceived efficacy and personalisation of treatments were valued. Some evidence suggested patient priorities and conceptualisations regarding sleep may diverge from those of validated screening tools developed in general population and sleep medicine samples. More rigorous research is needed to support adaptation and development of interventions and outcome measures for use in specialist mental health settings. Qualitative studies exploring the experience of sleep disturbance in particular diagnostic groups and contexts are urgently required, as are patient perspectives on sleep interventions.	[Faulkner, Sophie; Bee, Penny] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Faulkner, Sophie] Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England	University of Manchester; Open University - UK	Faulkner, S (corresponding author), Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England.; Faulkner, S (corresponding author), Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England.	1sophiefaulkner@gmail.com	Bee, Penny/O-8822-2014	Bee, Penny/0000-0002-5600-0400; Faulkner, Sophie/0000-0003-1549-0922				Acaster S, 2012, DEV METHODOLOGICAL S; American Psychiatric Association, 2013, SLEEP WAK DIS FACT S; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], READ PAPER BASICS EV; Auslander LA, 2002, COMMUNITY MENT HLT J, V38, P391, DOI 10.1023/A:1019808412017; Baandrup L, 2013, ACTA PSYCHIAT SCAND, V127, P81, DOI 10.1111/acps.12016; Bee P, 2014, HLTH TECHNOL ASSESS, V18; Berk M, 2009, AUST FAM PHYSICIAN, V38, P302; Bootzin R, 2013, CLIN INVESTIGATION, V3, P1005, DOI DOI 10.4155/CLI.13.95; Bovaird T, 2007, PUBLIC ADMIN REV, V67, P846, DOI 10.1111/j.1540-6210.2007.00773.x; Carey Thomas J, 2005, Behav Sleep Med, V3, P73, DOI 10.1207/s15402010bsm0302_2; Cheung JMY, 2016, BEHAV SLEEP MED, V14, P235, DOI 10.1080/15402002.2014.981818; Cheung JMY, 2013, BEHAV SLEEP MED, V11, P369, DOI 10.1080/15402002.2012.694382; Chiu VW, 2015, J NERV MENT DIS, V203, P798, DOI 10.1097/NMD.0000000000000370; Collier E, 2003, J Psychiatr Ment Health Nurs, V10, P697, DOI 10.1046/j.1365-2850.2003.00654.x; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Davis KE, 2005, PSYCHIAT SERV, V56, P1288, DOI 10.1176/appi.ps.56.10.1288; de Niet GJ, 2008, J PSYCHIATR MENT HLT, V15, P465, DOI 10.1111/j.1365-2850.2008.01250.x; Denzin N.K., 2005, J CHEM INF MODEL, V53, P160; Department of Health, 2014, CLOS GAP PRIOR ESS C; Engqvist I, 2013, ISSUES MENT HEALTH N, V34, P82, DOI 10.3109/01612840.2012.723301; Engqvist I, 2011, ARCH PSYCHIAT NURS, V25, P376, DOI 10.1016/j.apnu.2010.12.003; Freeman D, 2015, LANCET PSYCHIAT, V2, P975, DOI 10.1016/S2215-0366(15)00314-4; Fulford KWM, 2011, J EVAL CLIN PRACT, V17, P341, DOI 10.1111/j.1365-2753.2010.01578.x; Green A., 2008, BRIT J OCCUP THER, V71, P196, DOI [https://doi.org/10.1177/030802260807100506, DOI 10.1177/030802260807100506]; Harvey AG, 2005, AM J PSYCHIAT, V162, P50; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOLMES EP, 1995, PSYCHIATR REHABIL J, V19, P9, DOI 10.1037/h0095445; Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008; Kallestad H, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-186; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kohn L, 2005, SLEEP, V28, P104, DOI 10.1093/sleep/28.1.104; Krystal AD, 2008, ANN CLIN PSYCHIATRY, V20, P39, DOI 10.1080/10401230701844661; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Kyle SD, 2010, BEHAV SLEEP MED, V8, P123, DOI 10.1080/15402002.2010.487450; Li Weihui, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P9, DOI 10.3969/j.issn.1672-7347.2011.01.002; Lien PC, 2003, SINGAPORE NURSING J, V30, P32; MacDonald J, 2015, INT CLIN PSYCHOPHARM, V30, P193, DOI 10.1097/YIC.0000000000000073; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; MUESER KT, 1992, BRIT J PSYCHIAT, V160, P674, DOI 10.1192/bjp.160.5.674; National Institute for Health Clinical Excellence (NICE), 2011, PSYCH COEX SUBST MIS; *NICE, 2014, BIP DIS ASS MAN CLIN; NICE, 2014, NICE CLINICAL GUIDEL; NICE, 2015, CLIN KNOWL SUMM INS; Noar SM, 2005, HEALTH EDUC RES, V20, P275, DOI 10.1093/her/cyg113; Pandina GJ, 2010, INT CLIN PSYCHOPHARM, V25, P51, DOI 10.1097/YIC.0b013e3283320667; Peacey J, 2012, J NERV MENT DIS, V200, P83, DOI 10.1097/NMD.0b013e31823e6552; Plante DT, 2013, PSYCHIAT RES, V210, P975, DOI 10.1016/j.psychres.2013.08.004; Poulin J, 2010, PSYCHIAT RES, V179, P274, DOI 10.1016/j.psychres.2009.08.009; Robotham D., 2011, SLEEP MATTERS IMPACT; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Samalin L, 2014, J NERV MENT DIS, V202, P550, DOI 10.1097/NMD.0000000000000157; Singleton N, 2000, PSYCHIAT MORBIDITY A, DOI [10.1080/0954026021000045967, DOI 10.1080/0954026021000045967]; Sobieraj A, 2013, PSYCHIAT DANUB, V25, pS203; Tait L., 2005, ADV PSYCHIAT TREATME, V11, P168, DOI DOI 10.1192/APT.11.3.168; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Taylor DJ, 2010, J CLIN PSYCHOL, V66, P1137, DOI 10.1002/jclp.20733; The Royal College of Ophthalmologists,, 2017, CATARACT ADULTS MANA; Waite F, 2016, PSYCHOL PSYCHOTHER-T, V89, P181, DOI 10.1111/papt.12073; Waters F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00990; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321; Zimmermann TM, 2013, J AFFECT DISORDERS, V148, P210, DOI 10.1016/j.jad.2012.11.062	69	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163486	10.1371/journal.pone.0163486	http://dx.doi.org/10.1371/journal.pone.0163486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657927	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200134
J	Kong, FY; Zhu, JW; Kong, XY; Sun, T; Deng, X; Du, YQ; Li, ZS				Kong, Fanyang; Zhu, Jianwei; Kong, Xiangyu; Sun, Tao; Deng, Xuan; Du, Yiqi; Li, Zhaoshen			Rapid On-Site Evaluation Does Not Improve Endoscopic Ultrasound-Guided Fine Needle Aspiration Adequacy in Pancreatic Masses: A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							DIAGNOSTIC-ACCURACY; CYTOPATHOLOGY EVALUATION; CLINICAL IMPACT; BIOPSY; CYTOLOGY; FNA; EXPERIENCE; INCREASES; TUMORS	Background and Objectives Rapid on-site evaluation (ROSE) during endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) of pancreatic masses has been reported to be associated with improved adequacy and diagnostic yield. However, recent observational data on the impact of ROSE have reported conflicting results. A meta-analysis and systematic review was therefore conducted to evaluate the contribution of ROSE during EUS-FNA of pancreatic masses. Method A systematic search was conducted in MEDLINE/Pubmed and EMBASE databases for studies comparing the efficacy of ROSE between patients in two cohorts. Outcomes considered included diagnostic adequate rate, diagnostic yield, number of needle passes, pooled sensitivity and specificity. Findings from a random-effects model were expressed as pooled risk difference (RD) with 95% confidence intervals (CIs). Results A total of 7 studies (1299 patients) was finally included and further analyzed in the current meta-analysis. EUS-FNA with ROSE could not improve diagnostic adequacy (RD = 0.05, 95% CI: -0.01-0.11) and diagnostic yield (RD = 0.04 95% CI: -0.05, 0.13). The number of needle passes showed no statistically significant difference with and without ROSE (RD = -0.68 95% CI: -2.35, 0.98). The pooled sensitivity and specificity of ROSE group were 0.91 (95% CI: 0.87, 0.94) and 1 (95% CI: 0.94, 1.00). The pooled sensitivity and specificity of non-ROSE group were 0.85 (95% CI: 0.80, 0.89) and 1 (95% CI: 0.95, 1.00). ROSE group and non-ROSE group showed comparable sensitivity and specificity. Conclusion Compared to historical reports of its clinical efficacy in patients with pancreatic lesions, ROSE may be not associated with an improvement of diagnostic yield, adequate rate, pooled sensitivity and specificity.	[Kong, Fanyang; Zhu, Jianwei; Kong, Xiangyu; Sun, Tao; Du, Yiqi; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Deng, Xuan] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China	Naval Medical University; Fudan University	Du, YQ; Li, ZS (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	yiqidu0304@sina.com; zhaoshenli5610@hotmail.com						Alsohaibani F, 2009, CAN J GASTROENTEROL, V23, P26, DOI 10.1155/2009/194351; Cermak TS, 2012, CANCER CYTOPATHOL, V120, P319, DOI 10.1002/cncy.21201; Cleveland P, 2010, GASTROINTEST ENDOSC, V71, P1194, DOI 10.1016/j.gie.2010.01.029; Collins BT, 2013, CANCER CYTOPATHOL, V121, P518, DOI 10.1002/cncy.21340; ElGabry EA, 2015, CYTOJOURNAL, V12, DOI 10.4103/1742-6413.151677; Erickson RA, 2004, GASTROINTEST ENDOSC, V60, P267, DOI 10.1016/S0016-5107(04)01529-9; Ganc RL, 2015, ACTA CIR BRAS, V30, P503, DOI 10.1590/S0102-865020150070000009; Gilani SM, 2014, PATHOLOGICA, V106, P45; HALL TL, 1989, CANCER, V63, P718, DOI 10.1002/1097-0142(19890215)63:4<718::AID-CNCR2820630420>3.0.CO;2-N; Harewood GC, 2002, GASTROENTEROLOGY, V123, P24, DOI 10.1053/gast.2002.34163; Hebert-Magee S, 2013, CYTOPATHOLOGY, V24, P159, DOI 10.1111/cyt.12071; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Iglesias-Garcia J, 2011, AM J GASTROENTEROL, V106, P1705, DOI 10.1038/ajg.2011.119; Jahan A, 2015, ACTA CYTOL, V59, P163, DOI 10.1159/000381173; Kim EY, 2014, CLIN ENDOSC, V47, P425, DOI 10.5946/ce.2014.47.5.425; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; LeBlanc JK, 2004, GASTROINTEST ENDOSC, V59, P475, DOI 10.1016/S0016-5107(03)02863-3; Lin M, 2014, ENDOSC INT OPEN, V2, pE220, DOI 10.1055/s-0034-1377611; Matynia AP, 2014, J GASTROEN HEPATOL, V29, P697, DOI 10.1111/jgh.12431; Nayar MK, 2013, J PANCREAS, V14, P44, DOI 10.6092/1590-8577/1277; O'Connor K, 2015, ACTA CYTOL, V59, P305, DOI 10.1159/000439398; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schmidt RL, 2013, DIGEST DIS SCI, V58, P872, DOI 10.1007/s10620-012-2411-1; Tadic M, 2014, WORLD J GASTROENTERO, V20, P14292, DOI 10.3748/wjg.v20.i39.14292; Tharian B, 2015, GASTROINTEST ENDOSC, V81, P1049, DOI 10.1016/j.gie.2014.10.016; van der Heijden EHFM, 2014, RESPIRATION, V88, P500, DOI 10.1159/000368857; Vazquez-Sequeiros E, 2003, GASTROENTEROLOGY, V125, P1626, DOI 10.1053/j.gastro.2003.08.036; Vazquez-Sequeiros E, 2001, GASTROINTEST ENDOSC, V53, P751, DOI 10.1067/mge.2001.112741; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wani S, 2015, AM J GASTROENTEROL, V110, P1429, DOI 10.1038/ajg.2015.262; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wiersema MJ, 1997, GASTROENTEROLOGY, V112, P1087, DOI 10.1016/S0016-5085(97)70164-1	33	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163056	10.1371/journal.pone.0163056	http://dx.doi.org/10.1371/journal.pone.0163056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657529	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200060
J	Lin, C; Chen, HC; Fang, WH; Wang, CC; Peng, YJ; Lee, HS; Chang, H; Chu, CM; Huang, GS; Chen, WT; Tsai, YJ; Lin, HL; Lin, FH; Su, SL				Lin, Chin; Chen, Hsiang-Cheng; Fang, Wen-Hui; Wang, Chih-Chien; Peng, Yi-Jen; Lee, Herng-Sheng; Chang, Hung; Chu, Chi-Ming; Huang, Guo-Shu; Chen, Wei-Teing; Tsai, Yu-Jui; Lin, Hong-Ling; Lin, Fu-Huang; Su, Sui-Lung			Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; HUMAN ARTICULAR CHONDROCYTES; B-2 RECEPTOR ANTAGONISM; DELETION POLYMORPHISM; RHEUMATOID-ARTHRITIS; HEART-FAILURE; GENETIC ASSOCIATION; ACE; BRADYKININ; DISEASE	Background Studies of angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and the risks of knee osteoarthritis (OA) have yielded conflicting results. Objective To determine the association between ACE I/D and knee OA, we conducted a combined case-control study and meta-analysis. Methods For the case-control study, 447 knee OA cases and 423 healthy controls were recruited between March 2010 and July 2011. Knee OA cases were defined using the Kellgren-Lawrence grading system, and the ACE I/D genotype was determined using a standard polymerase chain reaction. The association between ACE I/D and knee OA was detected using allele, genotype, dominant, and recessive models. For the meta-analysis, PubMed and Embase databases were systematically searched for prospective observational studies published up until August 2015. Studies of ACE I/D and knee OA with sufficient data were selected. Pooled results were expressed as odds ratios (ORs) with corresponding 95% confidence intervals (CI) for the D versus I allele with regard to knee OA risk. Results We found no significant association between the D allele and knee OA [OR: 1.09 (95% CI: 0.76-1.89)] in the present case-control study, and the results of other genetic models were also nonsignificant. Five current studies were included, and there were a total of six study populations after including our case-control study (1165 cases and 1029 controls). In the meta-analysis, the allele model also yielded nonsignificant results [OR: 1.37 (95% CI: 0.95-1.99)] and a high heterogeneity (I-2 : 87.2%). Conclusions The association between ACE I/D and knee OA tended to yield negative results. High heterogeneity suggests a complex, multifactorial mechanism, and an epistasis analysis of ACE I/D and knee OA should therefore be conducted.	[Lin, Chin; Chu, Chi-Ming; Tsai, Yu-Jui; Lin, Hong-Ling; Lin, Fu-Huang; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Hsiang-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Rheumatol Immunol Allergy, Taipei, Taiwan; [Fang, Wen-Hui] Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Taipei, Taiwan; [Wang, Chih-Chien] Triserv Gen Hosp, Natl Def Med Ctr, Dept Orthoped, Taipei, Taiwan; [Peng, Yi-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Chang, Hung] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Chang, Hung] Triserv Gen Hosp, Natl Def Med Ctr, Div Thorac Surg, Taipei, Taiwan; [Huang, Guo-Shu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Chen, Wei-Teing] Cheng Hsin Gen Hosp, Dept Med, Taipei, Taiwan; [Chen, Wei-Teing] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Cheng Hsin General Hospital; National Defense Medical Center; Tri-Service General Hospital	Lin, FH; Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	noldling@ms10.hinet.net; a131419@gmail.com	Peng, Yi-Jen/X-9124-2019; Chen, Hsiang-Cheng/AGQ-6364-2022; Chen, Hsiang-Cheng/O-1312-2016; Chen, Hsiang-Cheng/CAG-3864-2022; Lin, Chin/M-2832-2015	Peng, Yi-Jen/0000-0003-4630-2103; Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Su, Sui-Lung/0000-0003-3122-1116; Lin, Chin/0000-0003-2337-2096				1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abel K, 2006, AUTOIMMUN REV, V5, P258, DOI 10.1016/j.autrev.2005.07.005; Abramson SB, 2004, J RHEUMATOL, V31, P70, DOI 10.1097/BOR.0b013e328349c2b1; ALTMAN RD, 1991, SEMIN ARTHRITIS RHEU, V20, P40, DOI 10.1016/0049-0172(91)90026-V; Barbe F, 1996, AM J PHYSIOL-HEART C, V270, pH1985, DOI 10.1152/ajpheart.1996.270.6.H1985; Bayram B, 2011, MOL BIOL REP, V38, P1713, DOI 10.1007/s11033-010-0284-y; Bellucci E, 2013, OSTEOARTHR CARTILAGE, V21, P1774, DOI 10.1016/j.joca.2013.08.014; Bellucci F, 2009, BRIT J PHARMACOL, V158, P1996, DOI 10.1111/j.1476-5381.2009.00511.x; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; BLANN AD, 1991, SCAND J RHEUMATOL, V20, P213, DOI 10.3109/03009749109103024; Buchanan W. Watson, 2003, Inflammopharmacology, V11, P301, DOI 10.1163/156856003322699483; Chen SQ, 2012, ECOL INFORM, V10, P10, DOI 10.1016/j.ecoinf.2011.05.005; Chung CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056119; Ciombor DM, 2003, OSTEOARTHR CARTILAGE, V11, P455, DOI 10.1016/S1063-4584(03)00083-9; Cobankara V, 2005, RHEUMATOL INT, V25, P285, DOI 10.1007/s00296-004-0564-8; Dalbeth N, 2005, RHEUMATOLOGY, V44, P24, DOI 10.1093/rheumatology/keh398; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Fang WH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008542; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Fleiss JL, 2013, STATISTICAL METHODS; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Ghosh P, 2001, BEST PRACT RES CL RH, V15, P693, DOI 10.1053/berh.2001.0188; Gonzalez JR, 2008, GENET EPIDEMIOL, V32, P246, DOI 10.1002/gepi.20299; Gunel T, 2014, MOL MED REP, V9, P1422, DOI 10.3892/mmr.2014.1974; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong SJ, 2003, EXP MOL MED, V35, P189, DOI 10.1038/emm.2003.26; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Inanir A, 2013, DIS MARKERS, V34, P17, DOI [10.1155/2013/658654, 10.3233/DMA-2012-00939]; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P485, DOI 10.1136/ard.16.4.485; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Lin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152891; Lin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124967; LIN CY, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PONE.0087604; MacGregor AJ, 1999, RHEUMATOLOGY, V38, P583, DOI 10.1093/rheumatology/38.7.583; Meini S, 2011, BRIT J PHARMACOL, V162, P611, DOI 10.1111/j.1476-5381.2010.01062.x; Michael JWP, 2010, DTSCH ARZTEBL INT, V107, P152, DOI 10.3238/arztebl.2010.0152; Min BH, 2001, EXP MOL MED, V33, P299, DOI 10.1038/emm.2001.48; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nishimura M, 2002, ORAL SURG ORAL MED O, V94, P328, DOI 10.1067/moe.2002.124106; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; Poornima S, 2015, J RENIN-ANGIO-ALDO S, V16, P1281, DOI 10.1177/1470320314547403; Reginato AM, 2002, ARTHRITIS RES, V4, P337, DOI 10.1186/ar595; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Riordan JF, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-225; Ruiz-Ortega M, 2002, KIDNEY INT, V62, pS12, DOI 10.1046/j.1523-1755.62.s82.4.x; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Schwarzer G, 2012, META META ANALYSIS W; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; Shehab DK, 2008, CLIN EXP RHEUMATOL, V26, P305; Shinjo SK, 2015, J RENIN-ANGIO-ALDO S, V16, P666, DOI 10.1177/1470320314524995; Snelling S, 2007, RHEUMATOLOGY, V46, P250, DOI 10.1093/rheumatology/kel265; Su JB, 1999, J CARDIOVASC PHARM, V34, P700, DOI 10.1097/00005344-199911000-00012; Su SL, 2014, SCI WORLD J, DOI 10.1155/2014/169798; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; TIRET L, 1992, AM J HUM GENET, V51, P197; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Waarsing JH, 2011, ARTHRITIS RHEUM-US, V63, P1349, DOI 10.1002/art.30288; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walsh DA, 2000, ANN RHEUM DIS, V59, P125, DOI 10.1136/ard.59.2.125; Warde Nick, 2011, Nat Rev Rheumatol, V7, P375, DOI 10.1038/nrrheum.2011.82; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Witherow FN, 2001, CIRCULATION, V104, P2177, DOI 10.1161/hc4301.098252; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yang HY, 2015, J RENIN-ANGIO-ALDO S, V16, P203, DOI 10.1177/1470320313481837; Yang HY, 2013, J ORTHOP RES, V31, P680, DOI 10.1002/jor.22291; Zang Y, 2010, J STAT SOFTWARE, V33; Zheng G, 2008, BIOSTATISTICS, V9, P391, DOI 10.1093/biostatistics/kxm039; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	78	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161754	10.1371/journal.pone.0161754	http://dx.doi.org/10.1371/journal.pone.0161754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657933	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200014
J	Jiang, P; Chiba, R; Takakusaki, K; Ota, J				Jiang, Ping; Chiba, Ryosuke; Takakusaki, Kaoru; Ota, Jun			Generation of the Human Biped Stance by a Neural Controller Able to Compensate Neurological Time Delay	PLOS ONE			English	Article							HUMAN POSTURAL CONTROL; QUIET UPRIGHT STANCE; INVERTED PENDULUM MODEL; BALANCE CONTROL MODEL; FEEDBACK-CONTROL; BODY SWAY; SENSORIMOTOR INTEGRATION; INTERMITTENT CONTROL; MUSCLE CONTRIBUTIONS; ANKLE STIFFNESS	The development of a physiologically plausible computational model of a neural controller that can realize a human-like biped stance is important for a large number of potential applications, such as assisting device development and designing robotic control systems. In this paper, we develop a computational model of a neural controller that can maintain a musculoskeletal model in a standing position, while incorporating a 120-ms neurological time delay. Unlike previous studies that have used an inverted pendulum model, a musculoskeletal model with seven joints and 70 muscular-tendon actuators is adopted to represent the human anatomy. Our proposed neural controller is composed of both feed-forward and feedback controls. The feed-forward control corresponds to the constant activation input necessary for the musculoskeletal model to maintain a standing posture. This compensates for gravity and regulates stiffness. The developed neural controller model can replicate two salient features of the human biped stance: (1) physiologically plausible muscle activations for quiet standing; and (2) selection of a low active stiffness for low energy consumption.	[Jiang, Ping] Univ Tokyo, Sch Engn, Dept Precis Engn, Tokyo, Japan; [Chiba, Ryosuke; Takakusaki, Kaoru] Asahikawa Med Univ, Res Ctr Brain Funct & Med Engn, Asahikawa, Hokkaido, Japan; [Ota, Jun] Univ Tokyo, RACE, Kashiwa, Chiba, Japan	University of Tokyo; Asahikawa Medical College; University of Tokyo	Jiang, P (corresponding author), Univ Tokyo, Sch Engn, Dept Precis Engn, Tokyo, Japan.	jiang@race.u-tokyo.ac.jp	Jun, Ota/CAG-2441-2022	Jun, Ota/0000-0002-4738-2275	JSPS KAKENHI [26120006, 26120004]; Grants-in-Aid for Scientific Research [26120006] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research on Innovative Areas "Understanding brain plasticity on body representations to promote their adaptive functions" (Grant Number 26120006) and "Adaptive embodied-brain function due to alteration of the postural-locomotor synergies"(Grant Number 26120004). Website:http://embodied-brain.org/eng/about.	Ackermann M, 2012, J BIOMECH, V45, P1293, DOI 10.1016/j.jbiomech.2012.01.029; Allender L, 2013, DESIGNING SOLDIER SY; [Anonymous], 2015, CMA EVOLUTION STRATE; Au C., 2013, GAIT 2392 2354 MODEL; Boonstra TA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-23; BORAH J, 1988, ANN NY ACAD SCI, V545, P51; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Chiba R, 2016, NEUROSCI RES, V104, P96, DOI 10.1016/j.neures.2015.12.002; Clark A. E., 2012, THESIS U TENNESSEE; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dorn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121407; Elias LA, 2011, 3 NAT M BIOM ENG ENE, P153; Elias LA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003944; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gawthrop P, 2009, BIOL CYBERN, V101, P131, DOI 10.1007/s00422-009-0325-6; Gopalakrishnan A, 2014, FRONT COMPUT NEUROSC, V8, P1, DOI 10.3389/fncom.2014.00153; Gunther M, 2009, J BIOMECH, V42, P2739, DOI 10.1016/j.jbiomech.2009.08.014; Hamner SR, 2013, J BIOMECH, V46, P780, DOI 10.1016/j.jbiomech.2012.11.024; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Heitmann S, 2011, FRONT NEUROROBOTICS, V5, DOI [10.3389/fnbot.2011.00005, DOI 10.3389/FNBOT.2011.000005]; Hettich G, 2011, MULT DYN C; Hettich G, 2014, HUM MOVEMENT SCI, V37, P123, DOI 10.1016/j.humov.2014.07.004; Hicks J., 2014, SIMULATION BASED DES; Hidenori K, 2006, IEEE CONTR SYST MAG, V26, P18, DOI 10.1109/MCS.2006.252809; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horlings CGC, 2008, NAT CLIN PRACT NEURO, V4, P504, DOI 10.1038/ncpneuro0886; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; HUNT KH, 1975, J APPL MECH-T ASME, V42, P440, DOI 10.1115/1.3423596; Jacobs, 2018, FLOOD MOD ONL MAN; Jo S, 2004, BIOL CYBERN, V91, P188, DOI 10.1007/s00422-004-0497-z; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Loram ID, 2004, J PHYSIOL-LONDON, V556, P683, DOI 10.1113/jphysiol.2004.062398; Masani K, 2006, GAIT POSTURE, V23, P164, DOI 10.1016/j.gaitpost.2005.01.006; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Masani K, 2008, J NEUROPHYSIOL, V100, P1465, DOI 10.1152/jn.00801.2007; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; MCCLEARN D, 1985, J MORPHOL, V183, P87, DOI 10.1002/jmor.1051830106; Mergner T, 2010, ANNU REV CONTROL, V34, P177, DOI 10.1016/j.arcontrol.2010.08.001; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; Morasso PG, 2002, J NEUROPHYSIOL, V88, P2157, DOI 10.1152/jn.2002.88.4.2157; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2000, BIOL CYBERN, V82, P335, DOI 10.1007/s004220050587; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Qu XD, 2007, J BIOMECH, V40, P3590, DOI 10.1016/j.jbiomech.2007.06.003; Qu XD, 2009, J BIOMECH, V42, P1850, DOI 10.1016/j.jbiomech.2009.05.036; Sasagawa S, 2014, J NEUROPHYSIOL, V111, P313, DOI 10.1152/jn.01082.2012; Sherman MA, 2011, PROC IUTAM, V2, P241, DOI 10.1016/j.piutam.2011.04.023; Skalshoi O, 2015, GAIT POSTURE, V42, P529, DOI 10.1016/j.gaitpost.2015.08.008; Sousa ASP, 2012, SOMATOSENS MOT RES, V29, P131, DOI 10.3109/08990220.2012.725680; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Suzuki Y, 2011, IEEE ENG MED BIO, P7450, DOI 10.1109/IEMBS.2011.6091747; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Van der Kooij H, 2001, BIOL CYBERN, V84, P103, DOI 10.1007/s004220000196; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; Warnica MJ, 2014, GAIT POSTURE, V39, P1115, DOI 10.1016/j.gaitpost.2014.01.019; Welch TDJ, 2008, J NEUROPHYSIOL, V99, P1032, DOI 10.1152/jn.01110.2007; Welch TDJ, 2009, J NEUROPHYSIOL, V101, P3294, DOI 10.1152/jn.90775.2008; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; WINTERS JM, 1995, ANN BIOMED ENG, V23, P359, DOI 10.1007/BF02584437; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zebenay M, 2015, ICIMCO 2015 PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL. 2, P304; Zhang HB, 2016, MED ENG PHYS, V38, P204, DOI 10.1016/j.medengphy.2015.11.019; Zhang HB, 2015, J ELECTROMYOGR KINES, V25, P937, DOI 10.1016/j.jelekin.2015.10.011	75	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163212	10.1371/journal.pone.0163212	http://dx.doi.org/10.1371/journal.pone.0163212			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655271	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700042
J	Nakajima, H; Terazawa, S; Niwano, T; Yamamoto, Y; Imokawa, G				Nakajima, Hiroaki; Terazawa, Shuko; Niwano, Takao; Yamamoto, Yorihiro; Imokawa, Genji			The Inhibitory Effects of Anti-Oxidants on Ultraviolet-Induced Up-Regulation of the Wrinkling-Inducing Enzyme Neutral Endopeptidase in Human Fibroblasts	PLOS ONE			English	Article							KAPPA-B P65; RADIATION-INDUCED FORMATION; AGE-RELATED-CHANGES; SELECTIVE-INHIBITION; HUMAN KERATINOCYTES; ELASTASE ACTIVITY; IN-VIVO; SKIN; ASTAXANTHIN; IRRADIATION	We recently reported that the over-expression of skin fibroblast-derived neutral endopeptidase (NEP) plays a pivotal role in impairing the three-dimensional architecture of dermal elastic fibers during the biological mechanism of ultraviolet (UV)-induced skin wrinkling. In that process, a UVB-associated epithelial-mesenchymal cytokine interaction as well as a direct UVA-induced cellular stimulation are associated with the up-regulation of NEP in human fibroblasts. In this study, we characterized the mode of action of ubiquinol(10) which may abrogate the up-regulation of NEP by dermal fibroblasts, resulting in a reported in vivo anti-wrinkling action, and compared that with 3 other anti-oxidants, astaxanthin (AX), riboflavin (RF) and flavin mononucleotide (FMN). Post-irradiation treatment with all 4 of those anti-oxidants elicited an interrupting effect on the UVB-associated epithelial-mesenchymal cytokine interaction leading to the up-regulation of NEP in human fibroblasts but with different modes of action. While AX mainly served as an inhibitor of the secretion of wrinkle-inducing cytokines, such as interleukin-1 alpha (IL-1 alpha) and granulocyte macrophage colony stimulatory factor (GM-CSF) in UVB-exposed epidermal keratinocytes, ubiquinol(10), RF and FMN predominantly interrupted the IL-1 alpha and GM-CSF-stimulated expression of NEP in dermal fibroblasts. On the other hand, as for the UVA-associated mechanism, similar to the abrogating effects reported for AX and FMN, ubiquinol(10) but not RF had the potential to abrogate the increased expression of NEP and matrix-metalloproteinase-1 in UVAexposed human fibroblasts. Our findings strongly support the in vivo anti-wrinkling effects of ubiquinol(10) and AX on human and animal skin and provide convincing proof of the UV-induced wrinkling mechanism that essentially focuses on the over-expression of NEP by dermal fibroblasts as an intrinsic causative factor.	[Nakajima, Hiroaki] Toyo Beauty Co Ltd, R&D Div, Osaka, Japan; [Nakajima, Hiroaki; Niwano, Takao; Yamamoto, Yorihiro] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan; [Terazawa, Shuko; Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Aichi, Japan	Tokyo University of Technology; Chubu University	Imokawa, G (corresponding author), Chubu Univ, Res Inst Biol Funct, Aichi, Japan.	imokawag@dream.ocn.ne.jp						Akazaki S, 2002, BRIT J DERMATOL, V147, P689, DOI 10.1046/j.1365-2133.2002.04874.x; [Anonymous], [No title captured]; Hayashi N, 2003, EXP DERMATOL, V12, P13, DOI 10.1034/j.1600-0625.12.s2.2.x; Hoppe U, 1999, BIOFACTORS, V9, P371, DOI 10.1002/biof.5520090238; Imayama Shuhei, 1994, Journal of Dermatological Science, V7, P32, DOI 10.1016/0923-1811(94)90019-1; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P254, DOI 10.1111/1523-1747.ep12317607; Imokawa G, 2015, INT J MOL SCI, V16, P7776, DOI 10.3390/ijms16047776; Imokawa G, 2015, INT J MOL SCI, V16, P7753, DOI 10.3390/ijms16047753; Inui M, 2008, BIOFACTORS, V32, P237, DOI 10.1002/biof.5520320128; Mizutani Y, 2005, JAP J COS CHEM, V29, P9; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Nakajima H, 2012, ARCH DERMATOL RES, V304, P803, DOI 10.1007/s00403-012-1248-y; Nakajima H, 2012, BIOCHEM J, V443, P297, DOI 10.1042/BJ20111876; Nakajima H, 2011, ARCH DERMATOL RES, V303, P263, DOI 10.1007/s00403-011-1143-y; Niwano T, 2015, CYTOKINE, V73, P184, DOI 10.1016/j.cyto.2015.02.006; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Suganuma K, 2012, JICHI MED U J, V35, P25; Suganuma K, 2010, J DERMATOL SCI, V58, P136, DOI 10.1016/j.jdermsci.2010.02.009; Tagashira H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128678; Takema Y, 1995, J SOC COSMET CHEM, V46, P163; Takema Y, 1998, DERMATOLOGY, V196, P397, DOI 10.1159/000017931; Tanino Y, 2005, J DERMATOL SCI, pS21, DOI 10.1016/j.descs.2005.06.003; Terazawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136311; Terazawa S, 2012, EXP DERMATOL, V21, P11, DOI 10.1111/j.1600-0625.2012.01496.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; Tsukahara K, 2004, BRIT J DERMATOL, V151, P984, DOI 10.1111/j.1365-2133.2004.06203.x; Tsukahara K, 2001, J INVEST DERMATOL, V117, P671, DOI 10.1046/j.0022-202x.2001.01450.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0161580	10.1371/journal.pone.0161580	http://dx.doi.org/10.1371/journal.pone.0161580			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648570	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100007
J	Reimondo, G; Chiodini, I; Puglisi, S; Pia, A; Morelli, V; Kastelan, D; Cannavo, S; Berchialla, P; Giachino, D; Perotti, P; Cuccurullo, A; Paccotti, P; Beck-Peccoz, P; De Marchi, M; Terzolo, M				Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; De Marchi, Mario; Terzolo, Massimo			Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas	PLOS ONE			English	Article							METABOLIC PARAMETERS; WEIGHT-GAIN; IN-VIVO; SENSITIVITY; ASSOCIATION; MASS; CHOLESTEROL; MANAGEMENT; DIAGNOSIS; CORTISOL	Context Patients with adrenal incidentalomas (AI) may experience detrimental consequences due to a minimal cortisol excess sustained by adrenal adenoma. SNPs of the glucocorticoid receptor gene (NR3C1) modulate individual sensitivity to glucocorticoids and may interfere with the clinical presentation. Objective To compare the frequency of N363S, ER22/23EK and BclI SNPs in patients with AI with the general population and to evaluate whether these SNPs are linked to consequences of cortisol excess. Setting Multicentric, retrospective analysis of patients referred from 2010 to 2014 to 4 centers (Orbassano, Milano, Messina [Italy] and Zagreb [Croatia]). Patients 411 patients with AI; 153 males and 258 females and 186 from blood donors. Main outcomes measures All patients and controls were genotyped for BclI, N363S and ER22/23EK and SNPs frequency was associated with clinical and hormonal features. Results SNP frequency was: SNP frequency was: N363S 5.4% (MAF 0.027), BclI 54.7% (MAF 0.328), ER22/23EK 4.4% (MAF 0.022), without any significant difference between patients and controls. N363S was more frequent in hypertensive patients (p = 0.03) and was associated with hypertension (p = 0.015) in patients with suppressed cortisol after the 1-mg DST. Conclusions Our results demonstrate that SNPs of the glucocorticoid receptor gene do not play a pathogenetic role for AI. The impact of any single SNP on the phenotypic expression of minimal cortisol excess is limited and their analysis does not provide additional data that may be exploited for patient management.	[Reimondo, Giuseppe; Pia, Anna; Perotti, Paola; Paccotti, Piero; Terzolo, Massimo] Univ Turin, San Luigi Gonzaga Hosp, Internal Med 1, Dept Clin & Biol Sci, Orbassano, Italy; [Chiodini, Iacopo; Morelli, Valentina; Beck-Peccoz, Paolo] Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Endocrinol & Metab Dis, Milan, Italy; [Puglisi, Soraya; Cannavo, Salvatore] Univ Messina, Policlin G Martino Hosp, Dept Clin & Expt Med, Endocrine Unit, Messina, Italy; [Kastelan, Darko] Univ Hosp Zagreb, Dept Endocrinol, Zagreb, Croatia; [Berchialla, Paola] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Stat Unit, Orbassano, Italy; [Giachino, Daniela; Cuccurullo, Alessandra; De Marchi, Mario] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Med Genet, Orbassano, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Messina; University of Zagreb; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin	Reimondo, G (corresponding author), Univ Turin, San Luigi Gonzaga Hosp, Internal Med 1, Dept Clin & Biol Sci, Orbassano, Italy.	giuseppe.reimondo@unito.it	Iacopo, Chiodini/W-9911-2019; Kastelan, Darko/AAJ-4740-2020; Giachino, Daniela Francesca/L-9098-2019; De Marchi, Mario E./G-7558-2011; Perotti, Paola/AAC-4714-2022; Berchialla, Paola/A-3208-2009; Reimondo, Giuseppe/I-9156-2018; Puglisi, Soraya/AAQ-3894-2021; Puglisi, Soraya/AAB-9961-2019; MORELLI, Valentina/AAB-8866-2019; Cannavo, Salvatore/D-7608-2013	Iacopo, Chiodini/0000-0001-7594-3300; Giachino, Daniela Francesca/0000-0002-3186-6726; De Marchi, Mario E./0000-0002-6425-3205; Berchialla, Paola/0000-0001-5835-5638; Puglisi, Soraya/0000-0002-2883-6139; MORELLI, Valentina/0000-0002-6716-3045; REIMONDO, Giuseppe Matteo/0000-0001-9489-2094; Cannavo, Salvatore/0000-0001-8779-7283	University of Turin (Ricerca Locale)	University of Turin (Ricerca Locale)	The study was supported by grants from the University of Turin (Ricerca Locale 2013 and 2014) to GR and MT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2008, DIABETES CARE, P31; Bertalan R, 2009, GYNECOL ENDOCRINOL, V25, P379, DOI 10.1080/09513590902730762; Damjanovic SS, 2012, MOL MED, V18, P1456, DOI 10.2119/molmed.2012.00261; Di Blasio AM, 2003, CLIN ENDOCRINOL, V59, P68, DOI 10.1046/j.1365-2265.2003.01798.x; Echwald SM, 2001, INT J OBESITY, V25, P1563, DOI 10.1038/sj.ijo.0801744; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giordano R, 2012, CLIN ENDOCRINOL, V77, P863, DOI 10.1111/j.1365-2265.2012.04439.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamrahian AH, 2005, J CLIN ENDOCR METAB, V90, P871, DOI 10.1210/jc.2004-1627; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Koeijvoets KCMC, 2006, J CLIN ENDOCR METAB, V91, P4131, DOI 10.1210/jc.2006-0578; Koetz KR, 2013, CLIN ENDOCRINOL, V78, P831, DOI 10.1111/cen.12096; Koper JW, 2014, STEROIDS, V92, P62, DOI 10.1016/j.steroids.2014.07.015; Majnik J, 2006, J CLIN ENDOCR METAB, V91, P2796, DOI 10.1210/jc.2006-0066; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Manenschijn L, 2009, ANN NY ACAD SCI, V1179, P179, DOI 10.1111/j.1749-6632.2009.05013.x; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Marti A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-50; Morelli V, 2010, EUR J CLIN INVEST, V40, P803, DOI 10.1111/j.1365-2362.2010.02330.x; Nicolaides NC, 2016, EUR J CLIN INVEST, V46, P42, DOI 10.1111/eci.12563; R Core Team, 2021, R LANGUAGE ENV STAT; Ross IL, 2013, EUR J ENDOCRINOL, V168, P403, DOI 10.1530/EJE-12-0808; Ross IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086350; Syed AA, 2004, J CLIN ENDOCR METAB, V89, P232, DOI 10.1210/jc.2003-030995; Szappanos A, 2009, CLIN ENDOCRINOL, V71, P636, DOI 10.1111/j.1365-2265.2009.03528.x; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Trementino L, 2012, EUR J ENDOCRINOL, V166, P35, DOI 10.1530/EJE-11-0722; Tzanela M, 2012, J ENDOCRINOL INVEST, V35, P395, DOI 10.3275/7840; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; van Schoor NM, 2007, CLIN ENDOCRINOL, V67, P871, DOI 10.1111/j.1365-2265.2007.02978.x; WHO, 1997, PREV MAN GLOB EP OB; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zhukouskaya VV, 2015, J CLIN ENDOCR METAB, V100, P1417, DOI 10.1210/jc.2014-4177	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162437	10.1371/journal.pone.0162437	http://dx.doi.org/10.1371/journal.pone.0162437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649075	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000383892100019
J	Rodriguez-Cardenas, A; Rojas, AL; Conde-Gimenez, M; Velazquez-Campoy, A; Hurtado-Guerrero, R; Sancho, J				Rodriguez-Cardenas, Angela; Rojas, Adriana L.; Conde-Gimenez, Maria; Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier			Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target	PLOS ONE			English	Article							HELICOBACTER-PYLORI; FOLDING INTERMEDIATE; OXIDIZED FLAVODOXIN; VIRULENCE FACTORS; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; COFACTOR BINDING; ESSENTIAL GENES; STABILIZATION; APOFLAVODOXIN	Streptococcus pneumoniae (Sp) strain TIGR4 is a virulent, encapsulated serotype that causes bacteremia, otitis media, meningitis and pneumonia. Increased bacterial resistance and limited efficacy of the available vaccine to some serotypes complicate the treatment of diseases associated to this microorganism. Flavodoxins are bacterial proteins involved in several important metabolic pathways. The Sp flavodoxin (Spfld) gene was recently reported to be essential for the establishment of meningitis in a rat model, which makes SpFld a potential drug target. To facilitate future pharmacological studies, we have cloned and expressed SpFld in E. coli and we have performed an extensive structural and biochemical characterization of both the apo form and its active complex with the FMN cofactor. SpFld is a short-chain flavodoxin containing 146 residues. Unlike the well-characterized long-chain apoflavodoxins, the Sp apoprotein displays a simple two-state thermal unfolding equilibrium and binds FMN with moderate affinity. The X-ray structures of the apo and holo forms of SpFld differ at the FMN binding site, where substantial rearrangement of residues at the 91 - 100 loop occurs to permit cofactor binding. This work will set up the basis for future studies aiming at discovering new potential drugs to treat S. pneumoniae diseases through the inhibition of SpFld.	[Rodriguez-Cardenas, Angela; Conde-Gimenez, Maria; Sancho, Javier] Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza, Spain; [Rodriguez-Cardenas, Angela; Conde-Gimenez, Maria; Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Joint Unit EEAD CSIC BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain; [Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier] Univ Zaragoza, Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain; [Rojas, Adriana L.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio, Spain; [Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon] Govt Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; CIC bioGUNE	Sancho, J (corresponding author), Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza, Spain.; Hurtado-Guerrero, R; Sancho, J (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Joint Unit EEAD CSIC BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain.; Hurtado-Guerrero, R; Sancho, J (corresponding author), Univ Zaragoza, Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain.; Hurtado-Guerrero, R (corresponding author), Govt Aragon, Fdn ARAID, Zaragoza, Spain.	rhurtado@bifi.es; jsancho@unizar.es	Rojas, Adriana/G-2403-2011; Sancho, javier/AAA-1225-2019; Velazquez-Campoy, Adrian/E-7946-2012	Rojas, Adriana/0000-0002-7358-3505; Sancho, javier/0000-0002-2879-9200; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; CONDE GIMENEZ, MARIA/0000-0003-4358-9110	Ministerio de Ciencia e Innovacion Spain [BFU2010-16297, BFU2010-19504]; Ministerio de Economia y Competitividad, Spain [BFU2013-47064-P, BIO2014-57314-REDT, CTQ2013-44367-C2-2-P]; DGA [B89]; FP7 [BIOSTRUCTX-7687]; Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship; Government of Aragon	Ministerio de Ciencia e Innovacion Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad, Spain(Spanish Government); DGA; FP7; Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship; Government of Aragon(Gobierno de Aragon)	We acknowledge financial support from BFU2010-16297 and BFU2010-19504 [Ministerio de Ciencia e Innovacion Spain], BFU2013-47064-P, BIO2014-57314-REDT and CTQ2013-44367-C2-2-P [Ministerio de Economia y Competitividad, Spain], and DGA (Protein Targets B89). We also thank synchrotron radiation sources DLS (Oxford), and in particular beamline I04-1 (experiment number MX8035-3 and MX8035-11). The research leading to these results has also received funding from the FP7 (2007-2013) under BIOSTRUCTX-7687. A.R.C. was funded by a Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship. M. C-G was recipient of a predoctoral fellowship from the Government of Aragon. We thank Dr. Ana Sanchez for help with the dithionite titration.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Ayuso-Tejedor S, 2011, BIOCHEMISTRY-US, V50, P8703, DOI 10.1021/bi201025y; Ayuso-Tejedor S, 2011, J MOL BIOL, V406, P604, DOI 10.1016/j.jmb.2010.12.027; Ayuso-Tejedor S, 2010, J MOL BIOL, V400, P922, DOI 10.1016/j.jmb.2010.05.050; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BURKHART BM, 1995, ACTA CRYSTALLOGR D, V51, P318, DOI 10.1107/S0907444994011716; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Campos LA, 2004, J MOL BIOL, V344, P223, DOI 10.1016/j.jmb.2004.09.047; Cooper A, 2000, PROTEIN LIGAND INTER, P287; Cremades N, 2008, BIOPHYS J, V95, P1913, DOI 10.1529/biophysj.108.130153; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; Cremades N, 2008, BIOCHEMISTRY, V47; Cremades N, 2008, J BIOL CHEM, V283, P2883, DOI 10.1074/jbc.M705677200; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; DANNA JA, 1972, BIOCHEMISTRY-US, V11, P1073, DOI 10.1021/bi00756a020; Di Guilmi AM, 2002, EMBO REP, V3, P728, DOI 10.1093/embo-reports/kvf152; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; FUJII K, 1974, J BIOL CHEM, V249, P6745; Galano JJ, 2013, J MED CHEM, V56, P6248, DOI 10.1021/jm400786q; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HILL S, 1980, J BACTERIOL, V141, P470, DOI 10.1128/JB.141.2.470-475.1980; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu YF, 2006, J BIOL CHEM, V281, P35454, DOI 10.1074/jbc.M607336200; IFUKU O, 1994, EUR J BIOCHEM, V224, P173, DOI 10.1111/j.1432-1033.1994.tb20009.x; Irun MP, 2001, PROTEIN ENG, V14, P173, DOI 10.1093/protein/14.3.173; Kahn P C, 1979, Methods Enzymol, V61, P339; Lamazares E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09129; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Martin M, 2003, NEW ENGLAND J MED, V348; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Murray TA, 2003, BIOCHEMISTRY-US, V42, P2307, DOI 10.1021/bi026967s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Perez-Dorado I, 2013, INT J MOL SCI, V14, P1152, DOI 10.3390/ijms14011152; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Reynolds CA, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-16; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sancho J, 2013, ARCH BIOCHEM BIOPHYS, V531, P4, DOI 10.1016/j.abb.2012.10.014; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; WONG KK, 1993, BIOCHEMISTRY-US, V32, P14102, DOI 10.1021/bi00214a005; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	63	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161020	10.1371/journal.pone.0161020	http://dx.doi.org/10.1371/journal.pone.0161020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649488	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100004
J	Wang, S; Zheng, H; Liu, SH; Miao, YC; Li, J				Wang, Shu; Zheng, Hui; Liu, Shuhua; Miao, Yucong; Li, Jing			Numerical Study on the Stomatal Responses to Dry-Hot Wind Episodes and Its Effects on Land-Atmosphere Interactions	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; MAIZE PRODUCTION; CLIMATE-CHANGE; MODEL; TEMPERATURE; HEAT; CHINA; EVAPOTRANSPIRATION; PARAMETERIZATION; PHOTOSYNTHESIS	The wheat production in midland China is under serious threat by frequent Dry-Hot Wind (DHW) episodes with high temperature, low moisture and specific wind as well as intensive heat transfer and evapotranspiration. The numerical simulations of these episodes are important for monitoring grain yield and estimating agricultural water demand. However, uncertainties still remain despite that enormous experiments and modeling studies have been conducted concerning this issue, due to either inaccurate synoptic situation derived from mesoscale weather models or unrealistic parameterizations of stomatal physiology in land surface models. Hereby, we investigated the synoptic characteristics of DHW with widely-used mesoscale model Weather Research and Forecasting (WRF) and the effects of leaf physiology on surface evapotranspiration by comparing two land surface models: The Noah land surface model, and Peking University Land Model (PKULM) with stomata processes included. Results show that the WRF model could well replicate the synoptic situations of DHW. Two types of DHW were identified: (1) prevailing heated dry wind stream forces the formation of DHW along with intense sensible heating and (2) dry adiabatic processes overflowing mountains. Under both situations, the PKULM can reasonably model the stomatal closure phenomena, which significantly decreases both evapotranspiration and net ecosystem exchange of canopy, while these phenomena cannot be resolved in the Noah simulations. Therefore, our findings suggest that the WRF-PKULM coupled method may be a more reliable tool to investigate and forecast DHW as well as be instructive to crop models.	[Wang, Shu; Liu, Shuhua; Miao, Yucong; Li, Jing] Peking Univ, Dept Atmospher & Ocean Sci, Beijing, Peoples R China; [Zheng, Hui] Chinese Acad Sci, Key Lab Reg Climate Environm Res Temperate East A, Inst Atmospher Phys, Beijing, Peoples R China; [Zheng, Hui] Univ Texas Austin, Dept Geol Sci, John A & Katherine G Jackson Sch Geosci, Austin, TX USA	Peking University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; University of Texas System; University of Texas Austin	Wang, S; Liu, SH (corresponding author), Peking Univ, Dept Atmospher & Ocean Sci, Beijing, Peoples R China.	wangshu2011@pku.edu.cn; lshuhua@pku.edu.cn	Li, Jing/K-6290-2019; Miao, Yucong/AAJ-2361-2020	Wang, Shu/0000-0001-9239-9933	Chinese National Key Research and Development Projects - Ministry of Science and Technology of the People's Republic of China [2012BAH29B03]	Chinese National Key Research and Development Projects - Ministry of Science and Technology of the People's Republic of China	This research has been supported by Chinese National Key Research and Development Projects (grant NO. 2012BAH29B03), funded by Ministry of Science and Technology of the People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, STATE FOOD INWORLD; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; Betts AK, 2009, J ADV MODEL EARTH SY, V1, DOI 10.3894/JAMES.2009.1.4; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chung U, 2014, WEATHER CLIM EXTREME, V5-6, P67, DOI 10.1016/j.wace.2014.07.002; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Dai YJ, 2004, J CLIMATE, V17, P2281, DOI 10.1175/1520-0442(2004)017&lt;2281:ATMFCT&gt;2.0.CO;2; Decker M, 2009, J ADV MODEL EARTH SY, V1, DOI 10.3894/JAMES.2009.1.5; Dickinson R.E., 1984, CLIM PROCESS CLIM SE, V29, P58, DOI DOI 10.1029/GM029P0058; Dickinson RE, 2013, MODELING EVAPOTRANSP, P58; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Gadgil S., 2006, ASIAN MONSOON, P651; Heilig GK, 2000, INT J SUST DEV WORLD, V7, P153, DOI 10.1080/13504500009470038; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Hong SY, 2004, MON WEATHER REV, V132, P103, DOI 10.1175/1520-0493(2004)132<0103:ARATIM>2.0.CO;2; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Ingwersen J, 2011, AGR FOREST METEOROL, V151, P345, DOI 10.1016/j.agrformet.2010.11.010; Jagermeyr J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/025002; Keys PW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151993; Lawrence DM, 2007, J HYDROMETEOROL, V8, P862, DOI 10.1175/JHM596.1; Liu B, 2016, AGR FOREST METEOROL, V222, P45, DOI 10.1016/j.agrformet.2016.03.006; Liu SH, 2004, ADV ATMOS SCI, V21, P717, DOI 10.1007/BF02916369; Liu SH, 1996, ACTA SCI NATURALIUM, P69; [刘树华 Liu Shuhua], 2013, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V43, P1332; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; MANABE S, 1969, J ATMOS SCI, V26, P786, DOI 10.1175/1520-0469(1969)026<0786:CCWACO>2.0.CO;2; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Nicholson SE, 1998, B AM METEOROL SOC, V79, P815, DOI 10.1175/1520-0477(1998)079<0815:DDASVA>2.0.CO;2; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P3102, DOI 10.1111/j.1365-2486.2011.02459.x; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Ricchiazzi P, 1998, B AM METEOROL SOC, V79, P2101, DOI 10.1175/1520-0477(1998)079<2101:SARATS>2.0.CO;2; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2; Sheng L, 2010, ENVIRON RES LETT, V5, P123; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Yang Z., 1978, METEROL SHAANXI, V3, P6; Ying S, 2012, J GEOPHYS RES-ATMOS, V117, P103; Zeng XB, 1998, J CLIMATE, V11, P2628, DOI 10.1175/1520-0442(1998)011<2628:IOBAAF>2.0.CO;2; Zhang Y, 2007, HYDROL PROCESS, V21, P2016, DOI 10.1002/hyp.6711; Zheng H, 2016, CHINESE J GEOPHYS-CH, V59, P79, DOI 10.6038/cjg20160107; Zheng H, 2012, CHINESE J GEOPHYS-CH, V55, P2514, DOI 10.6038/j.issn.0001-5733.2012.08.004; Zhu L, 2014, IEEE J-STARS, V7, P458, DOI 10.1109/JSTARS.2013.2280466	50	8	10	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162852	10.1371/journal.pone.0162852	http://dx.doi.org/10.1371/journal.pone.0162852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648943	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100036
J	Xiao, XY; Cai, FC; Niu, X; Shi, H; Zhong, Y				Xiao, Xiyue; Cai, Fucheng; Niu, Xun; Shi, Hao; Zhong, Yi			Association between P16(INK4a) Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies	PLOS ONE			English	Article							DNA METHYLATION; GRAPHICAL TEST; P16 GENE; HYPERMETHYLATION; EXPRESSION; CARCINOMA; BIAS; POPULATION; MUTATIONS; PROFILE	Background Ovarian cancer is the primary cause of death in women diagnosed with gynecological malignancies worldwide. Absence of early symptoms prevents prompt diagnosis or successful therapeutic intervention. P16(INK4a) is a well-known tumor suppressor gene (TSG). Aberrant methylation of TSG promoter is an important epigenetic silencing mechanism leading to ovarian cancer progression. Studies have reported differences in methylation frequencies of the p16(INK4a) promoter between ovarian cancer and the corresponding control group. However, the association between p16(INK4a) promoter methylation and ovarian cancer remains unclear and controversial. Therefore, a meta-analysis was conducted to clarify the relationship between p16(INK4a) promoter methylation and ovarian cancer. Methods PubMed, Web of Science, EMBASE and CNKI were searched to identify eligible studies for the evaluation of the association between p16(INK4a) promoter methylation and ovarian cancer. Odds ratio (ORs) and 95% confidence intervals (95% CI) were calculated to determine the strength of association between p16(INK4a) promoter methylation and ovarian cancer. Results A total of 612 ovarian cancer patients and 289 controls from 12 eligible studies were included in the meta-analysis. Overall, a significant association was observed between p16(INK4a) methylation status and ovarian cancer risk using a fixed-effects model (OR = 2.02, 95% CI = 1.39-2.94). Conclusion The results of our meta-analysis show that aberrant methylation of p16(INK4a) promoter was significantly associated with ovarian cancer. It may represent a promising molecular marker to monitor the disease and provides new insights into the treatment of human ovarian cancer.	[Xiao, Xiyue] Huazhong Univ Sci & Technol, Union Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan, Peoples R China; [Cai, Fucheng] Huazhong Univ Sci & Technol, Union Hosp, Dept Pediat, Tongji Med Coll, Wuhan, Peoples R China; [Niu, Xun; Zhong, Yi] Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Peoples R China; [Shi, Hao] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Shi, Hao] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhong, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Otorhinolaryngol, Tongji Med Coll, Wuhan, Peoples R China.	zyzy0411@163.com		Zhong, Yi/0000-0002-7138-5302	National Nature Science Foundation of China [81200745, 81501297]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No.81200745 and No.81501297). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari M, 2013, MOL BIOL REP, V40, P4921, DOI 10.1007/s11033-013-2592-5; Bammidi LS, 2012, INT J GYNECOL CANCER, V22, P553, DOI 10.1097/IGC.0b013e31823fa90c; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Bhagat R, 2014, TUMOR BIOL, V35, P9069, DOI 10.1007/s13277-014-2136-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong R, 2012, J INT MED RES, V40, P681, DOI 10.1177/147323001204000231; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Ghazizadeh M, 2005, RESPIRATION, V72, P68, DOI 10.1159/000083403; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu LS, 2006, ONCOL REP, V15, P507; Hu ZY, 2015, TUMOR BIOL, V36, P1487, DOI 10.1007/s13277-014-2632-3; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim BN, 2005, INT J ONCOL, V26, P1217; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li Min, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P408; Liu ZS, 2005, CLIN CANCER RES, V11, P4968, DOI 10.1158/1078-0432.CCR-04-2293; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Mino A, 2006, ONCOL REP, V15, P615; de Assis LVM, 2014, BBA-REV CANCER, V1845, P232, DOI 10.1016/j.bbcan.2014.01.008; Niederacher D, 1999, BRIT J CANCER, V80, P1920, DOI 10.1038/sj.bjc.6690621; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Shen WJ, 2007, CHIN J CANC PREV TRE, V15, P530; Shi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122302; Shih YC, 1997, INT J CANCER, V70, P508, DOI 10.1002/(SICI)1097-0215(19970304)70:5<508::AID-IJC3>3.3.CO;2-6; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Tam KF, 2007, J CANCER RES CLIN, V133, P331, DOI 10.1007/s00432-006-0178-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang Q, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0231-1; Wei SH, 2006, CLIN CANCER RES, V12, P2788, DOI 10.1158/1078-0432.CCR-05-1551; Wei W, 1999, CURRENT ADV OBSTET G, V8, P109; Wong YF, 1999, CANCER LETT, V136, P231, DOI 10.1016/S0304-3835(98)00327-9; Xu B, 2003, MEDJQILU, V18, P227	37	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163257	10.1371/journal.pone.0163257	http://dx.doi.org/10.1371/journal.pone.0163257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648827	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100071
J	Yang, S; Park, J; Lee, H; Kim, S; Lee, BU; Chung, KY; Oh, B				Yang, Sejung; Park, Junhee; Lee, Hanuel; Kim, Soohyun; Lee, Byung-Uk; Chung, Kee-Yang; Oh, Byungho			Sequential Change of Wound Calculated by Image Analysis Using a Color Patch Method during a Secondary Intention Healing	PLOS ONE			English	Article							ACRAL LENTIGINOUS MELANOMA; GROWTH-FACTOR; EXCISION; RELIABILITY; FOOT	Background Photographs of skin wounds have the most important information during the secondary intention healing (SIH). However, there is no standard method for handling those images and analyzing them efficiently and conveniently. Objective To investigate the sequential changes of SIH depending on the body sites using a color patch method Methods We performed retrospective reviews of 30 patients (11 facial and 19 non-facial areas) who underwent SIH for the restoration of skin defects and captured sequential photographs with a color patch which is specially designed for automatically calculating defect and scar sizes. Results Using a novel image analysis method with a color patch, skin defects were calculated more accurately (range of error rate: -3.39% similar to+ 3.05%). All patients had smaller scar size than the original defect size after SIH treatment (rates of decrease: 18.8% similar to 86.1%), and facial area showed significantly higher decrease rate compared with the non-facial area such as scalp and extremities (67.05 +/- 12.48 vs. 53.29 +/- 18.11, P < 0.05). From the result of estimating the date corresponding to the half of the final decrement, all of the facial area showed improvements within two weeks (8.45 +/- 3.91), and non- facial area needed 14.33 +/- 9.78 days. Conclusion From the results of sequential changes of skin defects, SIH can be recommended as an alternative treatment method for restoration with more careful dressing for initial two weeks.	[Yang, Sejung] Ewha Womans Univ, Inst Art & Sci Convergence, Seoul, South Korea; [Park, Junhee; Lee, Hanuel; Lee, Byung-Uk] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Kim, Soohyun; Oh, Byungho] Keimyung Univ, Dept Dermatol, Coll Med, Daegu, South Korea; [Yang, Sejung] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA	Ewha Womans University; Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Keimyung University; Stanford University	Oh, B (corresponding author), Keimyung Univ, Dept Dermatol, Coll Med, Daegu, South Korea.	obh505@gmail.com		Oh, Byung Ho/0000-0001-9575-5665; Chung, Kee Yang/0000-0003-3257-0297	Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9B6055379]; Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3C8A7074199]	Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported in part by the Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B6055379), and by Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015M3C8A7074199) (http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2012, EUR J DERMATOL, V22, P46, DOI 10.1684/ejd.2011.1582; Ahn Chulhyun, 2008, Adv Skin Wound Care, V21, P85, DOI 10.1097/01.ASW.0000305411.58350.7d; BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6; Bieniek A, 2013, J EUR ACAD DERMATOL, V27, P1015, DOI 10.1111/j.1468-3083.2012.04646.x; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Haghpanah S, 2006, ARCH PHYS MED REHAB, V87, P1396, DOI 10.1016/j.apmr.2006.06.014; Hoigne D, 2014, J HAND SURG-EUR VOL, V39, P505, DOI 10.1177/1753193413489639; Jung JY, 2011, DERMATOL SURG, V37, P1245, DOI 10.1111/j.1524-4725.2011.02043.x; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Leung A, 2012, CURR OPIN PEDIATR, V24, P371, DOI 10.1097/MOP.0b013e3283535790; Liu TW, 2008, PATTERN RECOGN LETT, V29, P90, DOI 10.1016/j.patrec.2007.08.015; MAJESKE C, 1992, PHYS THER, V72, P138, DOI 10.1093/ptj/72.2.138; Monaco JL, 2003, CLIN PLAST SURG, V30, P1, DOI 10.1016/S0094-1298(02)00070-6; Oh BH, 2013, BRIT J DERMATOL, V168, P333, DOI 10.1111/bjd.12099; Rogers Lee C, 2010, J Diabetes Sci Technol, V4, P799; Thorne C, 2007, GRABB SMITHS PLASTIC, pxix; van der Eerden PA, 2008, PLAST RECONSTR SURG, V122, P1747, DOI 10.1097/PRS.0b013e31818a9aaa; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; ZITELLI JA, 1983, J AM ACAD DERMATOL, V9, P407, DOI 10.1016/S0190-9622(83)70150-7	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163092	10.1371/journal.pone.0163092	http://dx.doi.org/10.1371/journal.pone.0163092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648569	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100052
J	Yang, TH; Li, W; Duan, X; Zhu, L; Fan, L; Qiao, YB; Wu, H				Yang, Tiehong; Li, Wei; Duan, Xiao; Zhu, Lin; Fan, Li; Qiao, Youbei; Wu, Hong			Preparation of Two Types of Polymeric Micelles Based on Poly(beta-L-Malic Acid) for Antitumor Drug Delivery	PLOS ONE			English	Article							TUMOR-SPECIFIC UPTAKE; CELLULAR DELIVERY; NANOPARTICLES; ANTIBODIES; SYSTEMS; GROWTH	Polymeric micelles represent an effective delivery system for poorlywater-soluble anticancer drugs. In this work, two types of CPT-conjugated polymers were synthesized based on poly(beta-L-malic acid) (PMLA) derivatives. Folic acid (FA) was introduced into the polymers as tumor targeting group. The micellization behaviors of these polymers and antitumor activity of different self-assembled micelles were investigated. Results indicate that poly (ethylene glycol)-poly(beta-L-malic acid)-campotothecin-I (PEG-PMLA-CPT-I, P1) is a grafted copolymer, and could formstar micelles in aqueous solution with a diameter of about 97 nm, also that PEG-PMLA-CPT-II (P2) is an amphiphilic block copolymer, and could form crew cut micelles with a diameter of about 76 nm. Both P1 and P2 micelles could improve the cellular uptake of CPT, especially the FA-modified micelles, while P2 micelles showed higher stability, higher drug loading efficiency, smaller size, and slower drug release rate than that of P1 micelles. These results suggested that the P2 (crew cut) micelles possess better stability than that of the P1 (star) micelles and might be a potential drug delivery system for cancer therapy.	[Yang, Tiehong; Li, Wei; Duan, Xiao; Fan, Li; Qiao, Youbei; Wu, Hong] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Anal, Xian, Peoples R China; [Zhu, Lin] Texas A&M Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Irma Lerma Rangel Coll Pharm, Kingsville, TX 78363 USA	Air Force Military Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University Kingsville	Wu, H (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Anal, Xian, Peoples R China.	wuhong@fmmu.edu.cn	Zhu, Lin/O-3440-2018	Zhu, Lin/0000-0002-4047-1726	National Nature Science Foundation of China [81271687, 81571786, 81373948]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/); the grant number are 81271687 (HW), 81571786 (HW) and 81373948 (TY).; This work was supported by the National Natural Science Foundation of China (grants number 81271687, 81571786 and 81373948).	ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X; Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005; Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2; Chen KJ, 2012, BIOMATERIALS, V33, P1162, DOI 10.1016/j.biomaterials.2011.10.044; Chourpa I, 1998, BBA-GEN SUBJECTS, V1379, P353, DOI 10.1016/S0304-4165(97)00115-3; Dai M, 2011, CANCER LETT, V312, P189, DOI 10.1016/j.canlet.2011.08.007; Fujita M, 2007, J CONTROL RELEASE, V122, P356, DOI 10.1016/j.jconrel.2007.05.032; Garcia-Gonzalez CA, 2011, CARBOHYD POLYM, V86, P1425, DOI 10.1016/j.carbpol.2011.06.066; GIOVANELLA BC, 1991, CANCER RES, V51, P3052; Gong J, 2012, J CONTROL RELEASE, V159, P312, DOI 10.1016/j.jconrel.2011.12.012; Huang ZW, 2012, INT J PHARMACEUT, V423, P84, DOI 10.1016/j.ijpharm.2011.04.035; Jeanbat-Mimaud V, 2000, J BIOMAT SCI-POLYM E, V11, P979, DOI 10.1163/156856200744147; Jin YG, 2010, INT J PHARMACEUT, V386, P268, DOI 10.1016/j.ijpharm.2009.11.018; Kajiyama T, 2003, POLYM DEGRAD STABIL, V81, P525, DOI 10.1016/S0141-3910(03)00153-8; Kedar U, 2010, NANOMED-NANOTECHNOL, V6, P714, DOI 10.1016/j.nano.2010.05.005; Lee BS, 2000, FEMS MICROBIOL LETT, V193, P69, DOI 10.1111/j.1574-6968.2000.tb09404.x; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Lenz M. Vert R. W., 1979, ACS POLYM PREPT, V20, P608; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Ljubimova JY, 2008, NANOMEDICINE-UK, V3, P247, DOI 10.2217/17435889.3.2.247; Ljubimova JY, 2008, CHEM-BIOL INTERACT, V171, P195, DOI 10.1016/j.cbi.2007.01.015; Malmsten M, 2010, CURR OPIN COLLOID IN, V15, P435, DOI 10.1016/j.cocis.2010.05.016; Petrov PD, 2009, J PHYS CHEM B, V113, P4218, DOI 10.1021/jp809598v; Portilla-Arias J, 2010, J NANOMATER, V2010, DOI 10.1155/2010/825363; Qiao YB, 2014, J POLYM RES, V21, DOI 10.1007/s10965-014-0397-4; Yang TH, 2015, POLYM CHEM-UK, V6, P1373, DOI 10.1039/c4py01403k; YOKOYAMA M, 2011, J EXP CLIN MED, V3, P151; Zhou Q, 2015, INT J NANOMED, V10, P1941, DOI 10.2147/IJN.S78547	28	13	15	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162607	10.1371/journal.pone.0162607	http://dx.doi.org/10.1371/journal.pone.0162607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649562	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100024
J	Kim, KM; Moon, YJ; Park, SH; Park, HJ; Il Wang, S; Park, HS; Lee, H; Kwon, KS; Moon, WS; Lee, DG; Kim, JR; Jang, KY				Kim, Kyoung Min; Moon, Young Jae; Park, See-Hyoung; Park, Hye Jeong; Il Wang, Sung; Park, Ho Sung; Lee, Ho; Kwon, Keun Sang; Moon, Woo Sung; Lee, Dong Geun; Kim, Jung Ryul; Jang, Kyu Yun			Individual and Combined Expression of DNA Damage Response Molecules PARP1, gamma H2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients	PLOS ONE			English	Article							RIBOSE POLYMERASE INHIBITION; BREAST-CANCER; OVARIAN-CARCINOMA; GENE-EXPRESSION; POOR-PROGNOSIS; CELLS; RESISTANCE; H2AX	DNA damage response (DDR) molecules are protective against genotoxic stresses. DDR molecules are also involved in the survival of cancer cells in patients undergoing anti-cancer therapies. Therefore, DDR molecules are potential markers of cancer progression in addition to being potential therapeutic targets. In this study, we evaluated the immunohistochemical expression of PARP1, gamma H2AX, BRCA1, and BRCA2 and their prognostic significance in 112 cases of soft tissue sarcoma (STS). The expression of PARP1, gamma H2AX, BRCA1, and BRCA2 were significantly associated with each other and were associated with higher tumor stage and presence of distant metastasis. The expression of PARP1,gamma H2AX, and BRCA2 were significantly associated with shorter disease-specific survival (DSS) and event-free survival (EFS) by univariate analysis. BRCA1 expression was associated with shorter DSS. Multivariate analysis revealed the expression of PARP1 and gamma H2AX to be independent indicators of poor prognosis of DSS and EFS. BRCA2 expression was an independent indicator of poor prognosis of DSS. In addition, the combined expressional patterns of PARP1, gamma H2AX, BRCA1, and BRCA2 (CSddrm) were independent prognostic predictors of DSS (P < 0.001) and EFS (P = 0.016). The ten-year DSS rate of the CSddrm-low, CSddrm-intermediate, and CSddrm-high subgroups were 81%, 26%, and 0%, respectively. In conclusion, this study demonstrates that the individual and combined expression patterns of the DDR molecules PARP1, gamma H2AX, BRCA1, and BRCA2 could be predictive of the prognosis of STS patients and suggests that controlling the activity of these DDR molecules could be employed in new therapeutic stratagems for the treatment of STS.	[Kim, Kyoung Min; Park, Hye Jeong; Park, Ho Sung; Moon, Woo Sung; Lee, Dong Geun; Jang, Kyu Yun] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Pathol,Sch Med,Biomed Res Inst, Jeonju, South Korea; [Kim, Kyoung Min; Moon, Young Jae; Park, Hye Jeong; Il Wang, Sung; Park, Ho Sung; Moon, Woo Sung; Lee, Dong Geun; Kim, Jung Ryul; Jang, Kyu Yun] Res Inst Endocrine Sci, Jeonju, South Korea; [Moon, Young Jae; Il Wang, Sung; Kim, Jung Ryul] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Orthoped Surg,Sch Med,Biomed Res Inst, Jeonju, South Korea; [Park, See-Hyoung] Hongik Univ, Dept Bio & Chem Engn, Sejong, South Korea; [Lee, Ho] Chonbuk Natl Univ, Sch Med, Dept Forens Med, Jeonju, South Korea; [Kwon, Keun Sang] Chonbuk Natl Univ, Sch Med, Dept Prevent Med, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Hongik University; Jeonbuk National University; Jeonbuk National University	Jang, KY (corresponding author), Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Pathol,Sch Med,Biomed Res Inst, Jeonju, South Korea.; Kim, JR (corresponding author), Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Orthoped Surg,Sch Med,Biomed Res Inst, Jeonju, South Korea.	jrkeem@jbnu.ac.kr; kyjang@chonbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea government [NRF-2014R1A2A1A11052707]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2014R1A2A1A11052707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brunner AH, 2011, GYNECOL ONCOL, V121, P206, DOI 10.1016/j.ygyno.2010.11.037; Carey LA, 2011, NEW ENGL J MED, V364, P277, DOI 10.1056/NEJMe1012546; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Cho DH, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0129-3; Choy E, 2013, CANCER RES, V73, pLB; Coindre JM, 1998, VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 82. TAGUNG, P59; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Edge SB, 2010, AJCC CANC STAGING HD, P1073, DOI [10.1634/theoncologist.2013-0163, DOI 10.1634/THEONCOLOGIST.2013-0163]; Engert F, 2015, MOL CANCER THER, V14, P2818, DOI 10.1158/1535-7163.MCT-15-0587; Fam HK, 2013, MOL CANCER RES, V11, P1179, DOI 10.1158/1541-7786.MCR-12-0575; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Galia A, 2012, EUR J HISTOCHEM, V56, P45, DOI 10.4081/ejh.2012.e9; Gan A, 2013, HUM PATHOL, V44, P1638, DOI 10.1016/j.humpath.2013.01.015; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Parra J, 2014, EUR J CANCER, V50, P2725, DOI 10.1016/j.ejca.2014.07.004; Garg K, 2013, AM J SURG PATHOL, V37, P138, DOI 10.1097/PAS.0b013e31826cabbd; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Gill SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140988; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Kim JE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074458, 10.1371/journal.pone.0069961, 10.1371/journal.pone.0051986, 10.1371/journal.pone.0060505]; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Kivlin CM, 2016, CANCER BIOL THER, V17, P129, DOI 10.1080/15384047.2015.1108486; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Li ZH, 2016, CANCER BIOMARK, V16, P633, DOI 10.3233/CBM-160605; Matthaios D, 2012, ONCOTARGETS THER, V5, P309, DOI 10.2147/OTT.S36995; Mylona E, 2014, PATHOL RES PRACT, V210, P533, DOI 10.1016/j.prp.2014.05.009; Nagelkerke A, 2011, RADIOTHER ONCOL, V101, P39, DOI 10.1016/j.radonc.2011.07.009; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Park SH, 2015, ONCOTARGET, V6, P44819, DOI 10.18632/oncotarget.6264; Park SH, 2015, TRANSL ONCOL, V8, P239, DOI 10.1016/j.tranon.2015.04.004; PRASAD SC, 1990, CANCER RES, V50, P38; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Staibano S, 2005, HUM PATHOL, V36, P724, DOI 10.1016/j.humpath.2005.04.017; Stewart BW, 2014, WORLD CANC REPORT 20, P211, DOI [10.1016/j.ygyno.2010.11.037, DOI 10.1016/J.YGYNO.2010.11.037]; Stewart E, 2014, CELL REP, V9, P829, DOI 10.1016/j.celrep.2014.09.028; Tutt A, 2009, J CLIN ONCOL, V27; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vormoor B, 2014, CURR OPIN ONCOL, V26, P428, DOI 10.1097/CCO.0000000000000091; Wiedemeyer WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00034; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Yan J, 2014, EXP CELL RES, V328, P132, DOI 10.1016/j.yexcr.2014.08.016; Zhou F, 2011, J HUAZHONG U SCI-MED, V31, P154, DOI 10.1007/s11596-011-0242-5	54	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163193	10.1371/journal.pone.0163193	http://dx.doi.org/10.1371/journal.pone.0163193			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643881	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900037
J	Musa, HI; Hassan, L; Shamsuddin, ZH; Panchadcharam, C; Zakaria, Z; Aziz, SA				Musa, Hassan Ismail; Hassan, Latiffah; Shamsuddin, Zulkifli Hj.; Panchadcharam, Chandrawathani; Zakaria, Zunita; Aziz, Saleha Abdul			Physicochemical Properties Influencing Presence of Burkholderia pseudomallei in Soil from Small Ruminant Farms in Peninsular Malaysia	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; ENVIRONMENTAL-FACTORS; ORGANIC-MATTER; MELIOIDOSIS; SURVIVAL; WATER; IRON; GROWTH; MICROBIOLOGY; ACQUISITION	Soil is considered to be a major reservoir of Burkholderia pseudomallei in the environment. This paper investigates soil physicochemical properties that may influence presence of B. pseudomallei in soil samples from small ruminant farms in Peninsular Malaysia. Soil samples were collected from the farms and cultured for B. pseudomallei. The texture, organic matter and water contents, pH, elemental contents, cation exchange capacities, carbon, sulfur and nitrogen contents were determined. Analysis of soil samples that were positive and negative for B. pseudomallei using multivariable logistic regression found that the odds of bacterial isolation from soil was significantly higher for samples with higher contents of iron (OR = 1.01, 95% CI = 1.00-1.02, p = 0.03), water (OR = 1.28, 95% CI = 1.05-1.55, p = 0.01) and clay (OR = 1.54, 95% CI = 1.15-2.06, p = 0.004) compared to the odds of isolation in samples with lower contents of the above variables. These three factors may have favored the survival of B. pseudomallei because iron regulates expression of respiratory enzymes, while water is essential for soil ecology and agent's biological processes and clay retains water and nutrients.	[Musa, Hassan Ismail; Hassan, Latiffah; Zakaria, Zunita; Aziz, Saleha Abdul] Univ Putra Malaysia, Fac Vet Med, Serdang, Selangor, Malaysia; [Shamsuddin, Zulkifli Hj.] Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang, Selangor, Malaysia; [Panchadcharam, Chandrawathani] Vet Res Inst, Ipoh, Perak, Malaysia; [Musa, Hassan Ismail] Univ Maiduguri, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Maiduguri, Borno State, Nigeria	Universiti Putra Malaysia; Universiti Putra Malaysia; Institute Penyelidikan Haiwan	Hassan, L (corresponding author), Univ Putra Malaysia, Fac Vet Med, Serdang, Selangor, Malaysia.	latiffah@upm.edu.my	Zakaria, Zunita/AAF-5110-2020		Universiti Putra Malaysia research grant [GP-IBT/2013/9419100]	Universiti Putra Malaysia research grant	This study was supported by Universiti Putra Malaysia research grant GP-IBT/2013/9419100. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAM D, 1961, CAN J MICROBIOL, V7, P741, DOI 10.1139/m61-088; Alef K, 1995, METHODS APPL SOIL MI; Amornrit W, 2012, ASIAN BIOMED, V6, P465, DOI 10.5372/1905-7415.0603.078; Baker AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138953; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965; Cho MH, 2012, J MICROBIOL, V50, P1029, DOI 10.1007/s12275-012-2267-2; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; Deni SM, 2008, THEOR APPL CLIMATOL, V94, P163, DOI 10.1007/s00704-007-0355-8; Draper ADK, 2010, APPL ENVIRON MICROB, V76, P5305, DOI 10.1128/AEM.00287-10; ENGLAND LS, 1993, SOIL BIOL BIOCHEM, V25, P525, DOI 10.1016/0038-0717(93)90189-I; Hicks CL, 2000, AUST VET J, V78, P193, DOI 10.1111/j.1751-0813.2000.tb10593.x; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Inglis TJJ, 2001, REV MED MICROBIOL, V12, P13; JUMA NG, 1993, GEODERMA, V57, P3, DOI 10.1016/0016-7061(93)90145-B; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Kaestli M, 2007, APPL ENVIRON MICROB, V73, P6891, DOI 10.1128/AEM.01038-07; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kanai K, 1994, MELIOIDOSIS PREVAILI, P26; Lehtola MJ, 2004, WATER RES, V38, P3769, DOI 10.1016/j.watres.2004.06.024; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072; Limmathurotsakul D, 2012, APPL ENVIRON MICROB, V78, P876, DOI 10.1128/AEM.07039-11; Lunsdorf H, 2000, ENVIRON MICROBIOL, V2, P161; MARSHALL KC, 1975, ANNU REV PHYTOPATHOL, V13, P357, DOI 10.1146/annurev.py.13.090175.002041; MILLER WP, 1987, COMMUN SOIL SCI PLAN, V18, P1, DOI 10.1080/00103628709367799; Musa HI, 2015, J APPL MICROBIOL, V119, P331, DOI 10.1111/jam.12830; Musa HI, 2012, MALAYS J VET RES, V3, P41; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; Paul EA, 2006, SOIL MICROBIOLOGY EC, P30; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Perkin-Elmer, 1964, AN METH AT ABS SPECT; Praveen S., 2009, ANAL MICRONUTRIENTS; Pumpuang A, 2011, T ROY SOC TROP MED H, V105, P598, DOI 10.1016/j.trstmh.2011.06.004; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; Robert M., 1992, SOIL BIOCH, P307; Salehi MH, 2011, PEDOSPHERE, V21, P473, DOI 10.1016/S1002-0160(11)60149-5; Schulte EE, 1999, SOIL AND APPLIED COP; Schulte EE, 2004, SOIL AND APPLIED IRO, P2; Schwertmann U, 1993, SOIL SCI SOC AM J, V31, P51, DOI DOI 10.2136/SSSASPECPUB31.C4; SMITH MD, 1995, T ROY SOC TROP MED H, V89, P488, DOI 10.1016/0035-9203(95)90078-0; STRAUSS JM, 1969, AM J TROP MED HYG, V18, P698, DOI 10.4269/ajtmh.1969.18.698; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; THOMAS AD, 1981, AUST VET J, V57, P535, DOI 10.1111/j.1751-0813.1981.tb05804.x; THOMAS AD, 1979, AM J EPIDEMIOL, V110, P515, DOI 10.1093/oxfordjournals.aje.a112832; Tong SD, 1996, MICROBIOL IMMUNOL, V40, P451, DOI 10.1111/j.1348-0421.1996.tb01092.x; Tuanyok A, 2005, FEMS MICROBIOL LETT, V252, P327, DOI 10.1016/j.femsle.2005.09.043; van der Kooij D, 2005, WATER RES, V39, P2789, DOI 10.1016/j.watres.2005.04.075; Vidyalakshmi K, 2012, INT J INFECT DIS, V16, pE491, DOI 10.1016/j.ijid.2012.02.012; Wang-Ngarm S, 2014, AM J TROP MED HYG, V90, P480, DOI 10.4269/ajtmh.13-0446; Weightman B. B. A, 2011, DRAGONS TIGERS GEOGR; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7; Yip TW, 2015, EMERG INFECT DIS, V21, P1038, DOI 10.3201/eid2106.141908	62	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162348	10.1371/journal.pone.0162348	http://dx.doi.org/10.1371/journal.pone.0162348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635652	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700005
J	Boon, PJ; Belopolsky, AV; Theeuwes, J				Boon, Paul J.; Belopolsky, Artem V.; Theeuwes, Jan			The Role of the Oculomotor System in Updating Visual-Spatial Working Memory across Saccades	PLOS ONE			English	Article							FRONTAL EYE FIELD; MONKEY SUPERIOR COLLICULUS; TRANSSACCADIC INTEGRATION; COROLLARY DISCHARGE; SPACE CONSTANCY; PARIETAL CORTEX; MOVEMENTS; PERCEPTION; ATTENTION; DISPLACEMENT	Visual-spatial working memory (VSWM) helps us to maintain and manipulate visual information in the absence of sensory input. It has been proposed that VSWM is an emergent property of the oculomotor system. In the present study we investigated the role of the oculomotor system in updating of spatial working memory representations across saccades. Participants had to maintain a location in memory while making a saccade to a different location. During the saccade the target was displaced, which went unnoticed by the participants. After executing the saccade, participants had to indicate the memorized location. If memory updating fully relies on cancellation driven by extraretinal oculomotor signals, the displacement should have no effect on the perceived location of the memorized stimulus. However, if postsaccadic retinal information about the location of the saccade target is used, the perceived location will be shifted according to the target displacement. As it has been suggested that maintenance of accurate spatial representations across saccades is especially important for action control, we used different ways of reporting the location held in memory; a match-to-sample task, a mouse click or by making another saccade. The results showed a small systematic target displacement bias in all response modalities. Parametric manipulation of the distance between the to-be-memorized stimulus and saccade target revealed that target displacement bias increased over time and changed its spatial profile from being initially centered on locations around the saccade target to becoming spatially global. Taken together results suggest that we neither rely exclusively on extraretinal nor on retinal information in updating working memory representations across saccades. The relative contribution of retinal signals is not fixed but depends on both the time available to integrate these signals as well as the distance between the saccade target and the remembered location.	[Boon, Paul J.; Belopolsky, Artem V.; Theeuwes, Jan] Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Boon, PJ (corresponding author), Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands.	p.j.boon@vu.nl	Theeuwes, Jan/ABF-3771-2020	Belopolsky, Artem/0000-0003-3606-2134; Theeuwes, Jan/0000-0002-5849-7721	Open Area Research Grant from the Netherlands Organization for Scientific Research [ORA 464-15-193]; ERC [ERC-2012-AdG - 323413]	Open Area Research Grant from the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission)	This research was supported by an Open Area Research Grant from the Netherlands Organization for Scientific Research to Artem Belopolsky [ORA 464-15-193] and an ERC advanced grant [ERC-2012-AdG - 323413 Jan Theeuwes]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 2013, COGNITION, V129, P439, DOI 10.1016/j.cognition.2013.08.006; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; Belopolsky AV, 2015, PERCEPTION, V44, P920, DOI 10.1177/0301006615596866; Belopolsky AV, 2013, J NEUROPHYSIOL, V110, P2370, DOI 10.1152/jn.00293.2013; Belopolsky AV, 2011, NEUROPSYCHOLOGIA, V49, P1605, DOI 10.1016/j.neuropsychologia.2010.12.045; Boon PJ, 2014, VISION RES, V94, P51, DOI 10.1016/j.visres.2013.11.002; Bray LCJ, 2016, J NEUROPHYSIOL, V115, P1132, DOI 10.1152/jn.00657.2015; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; CARLSONRADVANSKY LA, 1995, J EXP PSYCHOL LEARN, V21, P1441, DOI 10.1037/0278-7393.21.6.1441; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Deubel H, 2002, PROGR BRAIN RES, P140; Deubel H, 2010, VISION RES, V50, P249, DOI 10.1016/j.visres.2009.09.020; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dunn CA, 2010, J NEUROPHYSIOL, V104, P1267, DOI 10.1152/jn.00675.2009; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Germeys F, 2004, VIS COGN, V11, P203, DOI 10.1080/13506280344000301; Hamker FH, 2004, VISION RES, V44, P501, DOI 10.1016/j.visres.2003.09.033; Hollingworth A, 2008, J EXP PSYCHOL GEN, V137, P163, DOI 10.1037/0096-3445.137.1.163; Irwin DE, 1998, VIS COGN, V5, P127, DOI 10.1080/713756783; Irwin DE, 2002, PERCEPT PSYCHOPHYS, V64, P882, DOI 10.3758/BF03196793; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Jonikaitis D, 2014, J NEUROSCI, V34, P6687, DOI 10.1523/JNEUROSCI.4453-13.2014; Jonikaitis D, 2013, J NEUROPHYSIOL, V109, P1425, DOI 10.1152/jn.00656.2012; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; LI WX, 1990, PERCEPT PSYCHOPHYS, V48, P453, DOI 10.3758/BF03211589; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Ostendorf F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116810; Parks NA, 2008, PSYCHOPHYSIOLOGY, V45, P776, DOI 10.1111/j.1469-8986.2008.00669.x; Pearson DG, 2014, COGNITION, V132, P416, DOI 10.1016/j.cognition.2014.05.006; Poletti M, 2013, J NEUROSCI, V33, P14259, DOI 10.1523/JNEUROSCI.0523-13.2013; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sprague TC, 2014, CURR BIOL, V24, P2174, DOI 10.1016/j.cub.2014.07.066; Szinte M, 2015, J NEUROPHYSIOL, V113, P2220, DOI 10.1152/jn.00966.2014; Theeuwes J, 2005, PSYCHOL SCI, V16, P196, DOI 10.1111/j.0956-7976.2005.00803.x; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Ziesche A, 2011, J NEUROSCI, V31, P17392, DOI 10.1523/JNEUROSCI.3407-11.2011	54	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161829	10.1371/journal.pone.0161829	http://dx.doi.org/10.1371/journal.pone.0161829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631767	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900023
J	Budzinska, MA; Tu, T; d'Avigdor, WMH; McCaughan, GW; Luciani, F; Shackel, NA				Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Luciani, Fabio; Shackel, Nicholas A.			Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SOMATIC MUTATIONS; CANCER; P53; AFLATOXINS; PATHWAYS	In hepatocellular carcinoma (HCC), somatic genome-wide DNA mutations are numerous, universal and heterogeneous. Some of these somatic mutations are drivers of the malignant process but the vast majority are passenger mutations. These passenger mutations can be deleterious to individual protein function but are tolerated by the cell or are offset by a survival advantage conferred by driver mutations. It is unknown if these somatic deleterious passenger mutations (DPMs) develop in the precancerous state of cirrhosis or if it is confined to HCC. Therefore, we studied four whole-exome sequencing datasets, including patients with non-cirrhotic liver (n = 12), cirrhosis without HCC (n = 6) and paired HCC with surrounding non-HCC liver (n = 74 paired samples), to identify DPMs. After filtering out putative germline mutations, we identified 187+/-22 DPMs per non-diseased tissue. DPMs number was associated with liver disease progressing to HCC, independent of the number of exonic mutations. Tumours contained significantly more DPMs compared to paired non-tumour tissue (258-293 per HCC exome). Cirrhosis-and HCC-associated DPMs do not occur predominantly in specific genes, chromosomes or biological pathways and the effect on tumour biology is presently unknown. Importantly, for the first time we have shown a significant increase in DPMs with HCC.	[Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Univ Sydney, Centenary Inst, Sydney, NSW, Australia; [Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Budzinska, Magdalena A.; Luciani, Fabio] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [McCaughan, Geoffrey W.; Shackel, Nicholas A.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of New South Wales Sydney; University of Sydney	Shackel, NA (corresponding author), Univ Sydney, Centenary Inst, Sydney, NSW, Australia.; Shackel, NA (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.; Shackel, NA (corresponding author), Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia.	n.shackel@centenary.usyd.edu.au	Tu, Thomas/H-2894-2019; Budzinska, Magdalena/X-5364-2019	Tu, Thomas/0000-0002-0482-4387; Budzinska, Magdalena/0000-0002-3624-431X; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636	Sydney Foundation for Medical Research [53030]	Sydney Foundation for Medical Research	This project, T.T. and M.A.B. were funded by Sydney Foundation for Medical Research (Grant number 53030) NAS, http://nfmri.org.au/about-us/.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Dan LUO, 1998, WORLD J GASTROENTERO, V4, P97; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Ito T, 2004, J GASTROENTEROL, V39, P355, DOI 10.1007/s00535-003-1302-9; Iwamoto KS, 1998, J NATL CANCER I, V90, P1167, DOI 10.1093/jnci/90.15.1167; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; Jiang SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040363; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar R, 2008, QJM-INT J MED, V101, P479, DOI 10.1093/qjmed/hcn033; Lim KC, 2012, BRIT J SURG, V99, P1622, DOI 10.1002/bjs.8915; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Morris-Stiff G, 2009, SURG ONCOL, V18, P298, DOI 10.1016/j.suronc.2008.08.003; Nault JC, 2014, HEPATOLOGY; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Omer RE, 2004, NUTR CANCER, V48, P15, DOI 10.1207/s15327914nc4801_3; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Peng L, 2015, HEPATOLOGY, V61, P1251, DOI 10.1002/hep.27608; Schoniger-Hekele M, 2000, EUR J GASTROEN HEPAT, V12, P941, DOI 10.1097/00042737-200012080-00015; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su H, 2008, MUTAT RES-FUND MOL M, V641, P27, DOI 10.1016/j.mrfmmm.2008.02.005; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tu T, 2015, J VIRAL HEPATITIS, V22, P737, DOI 10.1111/jvh.12380; Tu T, 2015, LIVER INT, V35, P1786, DOI 10.1111/liv.12773; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wong PY, 2011, J IMMIGR MINOR HEALT, V13, P842, DOI 10.1007/s10903-010-9395-8; Woo HG, 2011, MOL CARCINOGEN, V50, P235, DOI 10.1002/mc.20691; YEH FS, 1989, CANCER RES, V49, P2506	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162586	10.1371/journal.pone.0162586	http://dx.doi.org/10.1371/journal.pone.0162586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631787	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900053
J	Harter, M; Dirmaier, J; Dwinger, S; Kriston, L; Herbarth, L; Siegmund-Schultze, E; Bermejo, I; Matschinger, H; Heider, D; Konig, HH				Haerter, Martin; Dirmaier, Joerg; Dwinger, Sarah; Kriston, Levente; Herbarth, Lutz; Siegmund-Schultze, Elisabeth; Bermejo, Isaac; Matschinger, Herbert; Heider, Dirk; Koenig, Hans-Helmut			Effectiveness of Telephone-Based Health Coaching for Patients with Chronic Conditions: A Randomised Controlled Trial	PLOS ONE			English	Article							CARE; DISEASE; DISABILITY; SERVICES; PEOPLE; COSTS	Background Chronic diseases, like diabetes mellitus, heart disease and cancer are leading causes of death and disability. These conditions are at least partially preventable or modifiable, e.g. by enhancing patients' self-management. We aimed to examine the effectiveness of telephone-based health coaching (TBHC) in chronically ill patients. Methods and Findings This prospective, pragmatic randomized controlled trial compares an intervention group (IG) of participants in TBHC to a control group (CG) without TBHC. Endpoints were assessed two years after enrolment. Three different groups of insurees with 1) multiple conditions (chronic campaign), 2) heart failure (heart failure campaign), or 3) chronic mental illness conditions (mental health campaign) were targeted. The telephone coaching included evidence-based information and was based on the concepts of motivational interviewing, shared decision-making, and collaborative goal setting. Patients received an average of 12.9 calls. Primary outcome was time from enrolment until hospital readmission within a two-year follow-up period. Secondary outcomes comprised the probability of hospital readmission, number of daily defined medication doses (DDD), frequency and duration of inability to work, and mortality within two years. All outcomes were collected from routine data provided by the statutory health insurance. As informed consent was obtained after randomization, propensity score matching (PSM) was used to minimize selection bias introduced by decliners. For the analysis of hospital readmission and mortality, we calculated Kaplan-Meier curves and estimated hazard ratios (HR). Probability of hospital readmission and probability of death were analysed by calculating odds ratios (OR). Quantity of health service use and inability to work were analysed by linear random effects regression models. PSM resulted in patient samples of 5,309 (IG: 2,713; CG: 2,596) in the chronic campaign, of 660 (IG: 338; CG: 322) in the heart failure campaign, and of 239 (IG: 101; KG: 138) in the mental health campaign. In none of the three campaigns, there were significant differences between IG and CG in time until hospital readmission. In the chronic campaign, the probability of hospital readmission was higher in the IG than in the CG (OR = 1.13; p = 0.045); no significant differences could be found for the other two campaigns. In the heart failure campaign, the IG showed a significantly reduced number of hospital admissions (-0.41; p = 0.012), although the corresponding reduction in the number of hospital days was not significant. In the chronic campaign, the IG showed significantly increased number of DDDs. Most striking, there were significant differences in mortality between IG and CG in the chronic campaign (OR = 0.64; p = 0.005) as well as in the heart failure campaign (OR = 0.44; p = 0.001). Conclusions While TBHC seems to reduce hospitalization only in specific patient groups, it may reduce mortality in patients with chronic somatic conditions. Further research should examine intervention effects in various subgroups of patients, for example for different diagnostic groups within the chronic campaign, or duration of coaching.	[Haerter, Martin; Dirmaier, Joerg; Dwinger, Sarah; Kriston, Levente] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Herbarth, Lutz; Siegmund-Schultze, Elisabeth] Kaufmann Krankenkasse KKH, Hannover, Germany; [Bermejo, Isaac] Univ Med Ctr Freiburg, Freiburg, Germany; [Matschinger, Herbert; Heider, Dirk; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Harter, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	m.haerter@uke.de	König, Hans-Helmut/P-1211-2018; Kriston, Levente/D-1713-2013	König, Hans-Helmut/0000-0001-5711-6862; Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890; Dwinger, Sarah/0000-0003-4868-5662; Matschinger, Herbert/0000-0001-7146-6770; Dirmaier, Joerg/0000-0002-5729-7357	Kaufmannische Krankenkasse Hannover (KKH)	Kaufmannische Krankenkasse Hannover (KKH)	The study is funded by Kaufmannische Krankenkasse Hannover (KKH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema GE, 2007, HEALTH SERV RES, V42, P1632, DOI 10.1111/j.1475-6773.2006.00668.x; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bloom DE, 2011, GLOBAL EC BURDEN NON; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Dennis SM, 2013, AUST HEALTH REV, V37, P381, DOI 10.1071/AH13005; DeVol R, 2007, UNHEALTHY AM EC BURD; Dwinger S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-337; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Harter M, 2013, HEALTH EDUC J, V72, P622, DOI 10.1177/0017896912453990; Hoffmann F, 2007, BUNDESGESUNDHEITSBLA, V50, P1418, DOI 10.1007/s00103-007-0369-5; Hutchison AJ, 2011, J TELEMED TELECARE, V17, P451, DOI 10.1258/jtt.2011.110513; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; Jia HM, 2013, VALUE HEALTH, V16, P140, DOI 10.1016/j.jval.2012.08.2208; Jonk Y, 2015, MED CARE, V53, P133, DOI 10.1097/MLR.0000000000000287; Kim SE, 2013, HEALTH SERV RES, V48, P1730, DOI 10.1111/1475-6773.12060; Lin WC, 2012, MED CARE, V50, P91, DOI 10.1097/MLR.0b013e31822dcedf; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Richards T., 2012, BMJ, V344; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Schubert I, 2010, GESUNDHEITSWESEN, V72, P316, DOI 10.1055/s-0030-1249688; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Steventon A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4585; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	31	31	32	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161269	10.1371/journal.pone.0161269	http://dx.doi.org/10.1371/journal.pone.0161269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632360	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900017
J	Raudales, JLM; Yoshimura, A; Ziauddin, SM; Kaneko, T; Ozaki, Y; Ukai, T; Miyazaki, T; Latz, E; Hara, Y				Raudales, Jorge Luis Montenegro; Yoshimura, Atsutoshi; Ziauddin, S. M.; Kaneko, Takashi; Ozaki, Yukio; Ukai, Takashi; Miyazaki, Toshihiro; Latz, Eicke; Hara, Yoshitaka			Dental Calculus Stimulates Interleukin-1 beta Secretion by Activating NLRP3 Inflammasome in Human and Mouse Phagocytes	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; BONE-RESORPTION INVITRO; NALP3 INFLAMMASOME; PERIODONTAL-DISEASES; SUBGINGIVAL CALCULUS; ELECTRON-MICROSCOPY; CELLS; EXPRESSION; IL-1-BETA; CRYSTALS	Dental calculus is a mineralized deposit associated with periodontitis. The bacterial components contained in dental calculus can be recognized by host immune sensors, such as Toll-like receptors (TLRs), and induce transcription of proinflammatory cytokines, such as IL-1 beta. Studies have shown that cellular uptake of crystalline particles may trigger NLRP3 inflammasome activation, leading to the cleavage of the IL-1 beta precursor to its mature form. Phagocytosis of dental calculus in the periodontal pocket may therefore lead to the secretion of IL-1 beta, promoting inflammatory responses in periodontal tissues. However, the capacity of dental calculus to induce IL-1 beta secretion in human phagocytes has not been explored. To study this, we stimulated human polymorphonuclear leukocytes (PMNs) and peripheral blood mononuclear cells (PBMCs) with dental calculus collected from periodontitis patients, and measured IL-1 beta secretion by ELISA. We found that calculus induced IL-1 beta secretion in both human PMNs and PBMCs. Calculus also induced IL-1 beta in macrophages from wildtype mice, but not in macrophages from NLRP3- and ASC-deficient mice, indicating the involvement of NLRP3 and ASC. IL-1 beta induction was inhibited by polymyxin B, suggesting that LPS is one of the components of calculus that induces pro-IL-1 beta transcription. To analyze the effect of the inorganic structure, we baked calculus at 250 degrees C for 1 h. This baked calculus failed to induce pro-IL-1 beta transcription. However, it did induce IL-1 beta secretion in lipid A-primed cells, indicating that the crystalline structure of calculus induces inflammasome activation. Furthermore, hydroxyapatite crystals, a component of dental calculus, induced IL-1 beta in mouse macrophages, and baked calculus induced IL-1 beta in lipid A-primed human PMNs and PBMCs. These results indicate that dental calculus stimulates IL-1 beta secretion via NLRP3 inflammasome in human and mouse phagocytes, and that the crystalline structure has a partial role in the activation of NLRP3 inflammasome.	[Raudales, Jorge Luis Montenegro; Yoshimura, Atsutoshi; Ziauddin, S. M.; Ozaki, Yukio; Ukai, Takashi; Hara, Yoshitaka] Nagasaki Univ, Grad Sch Biomed Sci, Dept Periodontol, Nagasaki, Japan; [Kaneko, Takashi] Fukuoka Dent Coll, Ctr Oral Dis, Fukuoka, Japan; [Miyazaki, Toshihiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki, Japan; [Latz, Eicke] Univ Bonn, Univ Hosp, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Latz, Eicke] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway	Nagasaki University; Fukuoka Dental College (FDC); Nagasaki University; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Norwegian University of Science & Technology (NTNU)	Yoshimura, A (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Periodontol, Nagasaki, Japan.	ayoshi@nagasaki-u.ac.jp	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; MONTENEGRO CAMACHO, LUIS ARTURO/0000-0002-5224-4854; Kaneko, Takashi/0000-0001-9276-5550	Japan Society for the Promotion of Science, Tokyo, Japan [24593126]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (C) 24593126 from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2005, J BIOMED MATER RES A, V75A, P623, DOI 10.1002/jbm.a.30484; Assuma R, 1998, J IMMUNOL, V160, P403; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x; Delben JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155427; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; FUJIKAWA K, 1988, J PERIODONTOL, V59, P170, DOI 10.1902/jop.1988.59.3.170; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; GOWEN M, 1986, J IMMUNOL, V136, P2478; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x; Huang X, 2015, J PERIODONTOL, V86, P327, DOI 10.1902/jop.2014.140403; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Kakei M, 2009, J ELECTRON MICROSC, V58, P393, DOI 10.1093/jmicro/dfp034; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; LUSTMANN J, 1976, CALC TISS RES, V21, P47, DOI 10.1007/BF02547382; Madouri F, 2015, J MOL CELL BIOL, V7, P351, DOI 10.1093/jmcb/mjv012; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; MANDEL ID, 1986, J CLIN PERIODONTOL, V13, P249, DOI 10.1111/j.1600-051X.1986.tb02219.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nair P N, 1999, Aust Endod J, V25, P19; Oh H, 2015, J ORAL SCI, V57, P67, DOI 10.2334/josnusd.57.67; Ono M, 2011, IN VIVO, V25, P763; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Roberts-Harry EA, 2000, J DENT, V28, P93, DOI 10.1016/S0300-5712(99)00056-1; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; Ryu OH, 2007, J PERIODONTOL, V78, P1627, DOI 10.1902/jop.2007.070066; Song M, 2011, J ENDODONT, V37, P1516, DOI 10.1016/j.joen.2011.06.032; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; WELCH H, 1945, J AM PHARM ASSOC SCI, V34, P114, DOI 10.1002/jps.3030340404; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhang K, 2010, J ENDODONT, V36, P105, DOI 10.1016/j.joen.2009.10.020; Zhang K, 2010, DENT MATER, V26, P514, DOI 10.1016/j.dental.2010.01.009; Zhu HH, 2015, INT J CLIN EXP PATHO, V8, P2214	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162865	10.1371/journal.pone.0162865	http://dx.doi.org/10.1371/journal.pone.0162865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632566	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900088
J	Tan, WC; Isa, NAM				Tan, Weng Chun; Isa, Nor Ashidi Mat			Automated Sperm Head Detection Using Intersecting Cortical Model Optimised by Particle Swarm Optimization	PLOS ONE			English	Article							SEGMENTATION; ALGORITHM; MOTILITY	In human spermmotility analysis, sperm segmentation plays an important role to determine the location of multiple sperms. To ensure an improved segmentation result, the Laplacian of Gaussian filter is implemented as a kernel in a pre-processing step before applying the image segmentation process to automatically segment and detect human spermatozoa. This study proposes an intersecting cortical model (ICM), which was derived from several visual cortex models, to segment the spermhead region. However, the proposed method suffered from parameter selection; thus, the ICM network is optimised using particle swarm optimization where feature mutual information is introduced as the new fitness function. The final results showed that the proposed method is more accurate and robust than four state-of-the-artsegmentation methods. The proposed method resulted in rates of 98.14%, 98.82%, 86.46% and 99.81% in accuracy, sensitivity, specificity and precision, respectively, after testing with 1200 sperms. The proposed algorithm is expected to be implemented in analysing spermmotility because of the robustness and capability of this algorithm.	[Tan, Weng Chun; Isa, Nor Ashidi Mat] Univ Sains Malaysia, Imaging & Intelligent Syst Res Team ISRT, Sch Elect & Elect Engn, Nibong Tebal, Penang, Malaysia	Universiti Sains Malaysia	Isa, NAM (corresponding author), Univ Sains Malaysia, Imaging & Intelligent Syst Res Team ISRT, Sch Elect & Elect Engn, Nibong Tebal, Penang, Malaysia.	ashidi@usm.my	Tan, Jason/AAS-6418-2021; Isa, Nor Ashidi Mat/I-7826-2017	Isa, Nor Ashidi Mat/0000-0002-2675-4914	Ministry of Higher Education (MOHE), Malaysia; Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Ministry of Higher Education (MOHE)	Ministry of Higher Education (MOHE), Malaysia; Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	This study is supported by the Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns". The fund is received by Nor Ashidi Mat Isa. The study was also partially supported by the Ministry of Higher Education (MOHE), Malaysia under MyPhD Scholarship [https://biasiswa.mohe.gov.my/MyBrain15/v2/index_myphd.php]. The fund is received by Tan Weng Chun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns," and by the Ministry of Higher Education (MOHE) under the MyPhD Scholarship. Credits are given to Associate Professor Dr Mahaneem Mohamed and Nur Syuhada Mohd Nafis for their assistance on taking the sperm videos.	Abbiramy V.S, 2010, INT J COMPUT APPL, V3; Balafar MA, 2008, 4 INT C INT COMP ICI, P177; Bijar A., 2012, J BIOMED SCI ENG, V5, P384, DOI [10.4236/jbise.2012.57049, DOI 10.4236/JBISE.2012.57049]; Bogovic JA, 2013, COMPUT VIS IMAGE UND, V117, P145, DOI 10.1016/j.cviu.2012.10.006; Carrillo H, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P1152; Chang V, 2014, COMPUT METH PROG BIO, V117, P225, DOI 10.1016/j.cmpb.2014.06.018; Chen Y, 2011, IEEE T NEURAL NETWOR, V22, P880, DOI 10.1109/TNN.2011.2128880; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Deng X, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/9/090601; Djerou L, 2012, J APPL COMPUT SCI MA, V13, P24; Ekblad U, 2004, NUCL INSTRUM METH A, V525, P392, DOI 10.1016/j.nima.2004.03.102; Ekblad U, 2004, SIGNAL PROCESS, V84, P1131, DOI 10.1016/j.sigpro.2004.03.012; Ellis AL, 2014, COMPUT VIS IMAGE UND, V122, P47, DOI 10.1016/j.cviu.2014.01.009; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; Gao C, 2013, NEUROCOMPUTING, V119, P332, DOI 10.1016/j.neucom.2013.03.025; Ghamisi P, 2012, EXPERT SYST APPL, V39, P12407, DOI 10.1016/j.eswa.2012.04.078; Hage I, 2013, COMPUT MED IMAGING G; Hage IS, 2013, COMPUT MED IMAG GRAP, V37, P466, DOI 10.1016/j.compmedimag.2013.08.003; Hammouche K, 2008, COMPUT VIS IMAGE UND, V109, P163, DOI 10.1016/j.cviu.2007.09.001; Ma YD, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P743; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; Murugavel M, 2009, NEUROIMAGE, V45, P845, DOI 10.1016/j.neuroimage.2008.12.021; Niu JQ, 2009, 2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, P185; Park KS, 1997, ANN BIOMED ENG, V25, P294, DOI 10.1007/BF02648044; PAVLIDIS T, 1990, IEEE T PATTERN ANAL, V12, P225, DOI 10.1109/34.49050; Ranamuka NG, 2013, IET IMAGE PROCESS, V7, P121, DOI 10.1049/iet-ipr.2012.0134; Wang H, 2014, ALGORITHMS, V7, P405, DOI 10.3390/a7030405; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wong WK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124720; Xu GZ, 2008, INT J COGN INFORM NA, V2, P43, DOI 10.4018/jcini.2008070104; Xu Xinzheng, 2011, Journal of Computers, V6, P1546, DOI 10.4304/jcp.6.8.1546-1553; Xuan Z, 2010, 2010 INT C 11 14 JUL, Vl5, p[2448, 11]; Yan PK, 2013, COMPUT VIS IMAGE UND, V117, P1017, DOI 10.1016/j.cviu.2013.03.006; Yonekawa M, 2009, LECT NOTES COMPUT SC, V5768, P834, DOI 10.1007/978-3-642-04274-4_86; Zheng Li Xuan, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P2444, DOI 10.1109/ICMLC.2010.5580766; Zheng RL, 1997, FREE RADICAL BIO MED, V22, P581, DOI 10.1016/S0891-5849(96)00272-9; Zhou DG, 2016, PATTERN ANAL APPL, V19, P939, DOI 10.1007/s10044-015-0462-6	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162985	10.1371/journal.pone.0162985	http://dx.doi.org/10.1371/journal.pone.0162985			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632581	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900108
J	Vitali, F; Cohen, LD; Demartini, A; Amato, A; Eterno, V; Zambelli, A; Bellazzi, R				Vitali, Francesca; Cohen, Laurie D.; Demartini, Andrea; Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Bellazzi, Riccardo			A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer	PLOS ONE			English	Article							IMATINIB MESYLATE; PHARMACOLOGY; IDENTIFICATION; DISCOVERY; PARADIGM; EFFICACY; DISEASE; SAFETY; HUBS	The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promising multi-target drugs. Given a certain tumor type/ subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization. Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies. We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our "in-silico" findings have been confirmed by a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.	[Vitali, Francesca; Cohen, Laurie D.; Demartini, Andrea; Bellazzi, Riccardo] Univ Pavia, Dipartimento Ingn Ind & Informaz, Pavia, Italy; [Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Bellazzi, Riccardo] IRCCS Fdn S Maugeri, Pavia, Italy; [Zambelli, Alberto] ASST Papa Giovanni XXIII, Oncol Med, Bergamo, Italy	University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; ASST Papa Giovanni XXIII	Vitali, F (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Pavia, Italy.	francesca.vitali03@universitadipavia.it	Bellazzi, Riccardo/J-6432-2018; Amato, Angela/T-1221-2019; Zambelli, Alberto/HGB-1572-2022	Bellazzi, Riccardo/0000-0002-6974-9808; Zambelli, Alberto/0000-0002-1374-1831; Vitali, Francesca/0000-0003-2916-6402; Amato, Angela/0000-0002-1932-1299	Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)" [A1.2010.0103195]; Associazione Italiana per la Ricerca sul Cancro AIRC [10016]	Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)"; Associazione Italiana per la Ricerca sul Cancro AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)"- A1.2010.0103195-http://www.regione.lombardia.it/. The in vitro experiments were conducted through the support of Associazione Italiana per la Ricerca sul Cancro AIRC 5x1000 Program (2010-2015) Grant (10016-http://www.airc.it/aiutare-la-ricerca/5-per-mille.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Billur Engin H, NETWORK BASED STRATE; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/130620; Cogle CR, 2015, ONCOLOGIST, V20, P1404, DOI 10.1634/theoncologist.2015-0165; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Emig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060618; Fearnley LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041977; Fumia HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069008; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Huang L, 2014, BIOINFORMATICS, V30, P228, DOI 10.1093/bioinformatics/btu278; Jimeno-Yepes AJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-171; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kibble M, 2015, NAT PROD REP, V32, P1249, DOI 10.1039/c5np00005j; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.10; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lin DD, 2013, BMC BIOINFORMATICS, V14, DOI [10.1186/1471-2105-14-245, 10.1186/1471-2105-14-S16-S3]; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Maass N, 2014, ONCOLOGY-BASEL, V87, P300, DOI 10.1159/000365553; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; McArthur GA, 2006, CURR OPIN ONCOL, V18, P341, DOI 10.1097/01.cco.0000228739.62756.df; McGarry K, 2015, IDENTIFYING CANDIDAT; Merijn van Erp LS., VARIANTS BORDA COUNT; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Raju R, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0490-y; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Schriml LM, 2015, MAMM GENOME, V26, P584, DOI 10.1007/s00335-015-9576-9; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Steggles LJ, 2006, LECT NOTES COMPUT SC, V4210, P127; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang J, 2014, CURR PHARM DESIGN, V20, P23, DOI 10.2174/13816128113199990470; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; TYAGI AK, 1983, TRENDS PHARMACOL SCI, V4, P299, DOI 10.1016/0165-6147(83)90412-1; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Vitali F, 2013, J BIOMED INFORM, V46, P876, DOI 10.1016/j.jbi.2013.06.015; Wang F., 2008, P SIAM INT C DAT MIN, P1, DOI DOI 10.1137/1.9781611972788.1; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Woochang Hwang YCAZMR, BRIDGING CENTRALITY; Wright CJM, 2013, DRUGS, V73, P1245, DOI 10.1007/s40265-013-0096-1; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zitnik M, 2015, IEEE T PATTERN ANAL, V37, P41, DOI 10.1109/TPAMI.2014.2343973; Zou D, 2015, GENOM PROTEOM BIOINF, V13, P55, DOI 10.1016/j.gpb.2015.01.006	58	31	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162407	10.1371/journal.pone.0162407	http://dx.doi.org/10.1371/journal.pone.0162407			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632168	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900045
J	Xu, DW; Zhao, W; Zhu, XH; Fan, JB; Cui, SY; Sun, YY; Chen, X; Liu, W; Cui, ZM				Xu, Dawei; Zhao, Wei; Zhu, Xinhui; Fan, Jianbo; Cui, Shengyu; Sun, Yuyu; Chen, Xiang; Liu, Wei; Cui, Zhi-ming			OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED-APOPTOSIS; PROTEIN-KINASE; CULTURED OSTEOBLASTS; IN-VITRO; STRESS; ENERGY; OSTEONECROSIS; HOMEOSTASIS; METABOLISM; MECHANISMS	Excessive dexamethasone (Dex) application causes osteoblast cell death, which could lead to osteoporosis or osteonecrosis. AMP-activated protein kinase (AMPK) activation is shown to protect osteoblasts/osteoblastic cells from Dex. In this report, we tested the potential effect of OSU53, a novel AMPK activator, in Dex-treated osteoblastic cells. We show that OSU53 activated AMPK signaling in human OB-6 osteoblastic cells. Further, Dex-induced osteoblastic OB-6 cell death and apoptosis were largely attenuated with pre-treatment with OSU53. OSU53 was more efficient than other known AMPK activators (A769662 and Compound 13) in protecting OB-6 cells against Dex. AMPK activation is required for OSU53-induced actions in OB-6 cells. AMPK alpha shRNA knockdown or dominant- negative mutation (dn-AMPK alpha T172A) almost completely blocked OSU53-induced AMPK activation and OB-6 cell protection against Dex. Further studies showed that OSU53 increased NADPH (nicotinamide adenine dinucleotide phosphate) activity and alleviated Dex-induced oxidative stress in OB-6 cells. Such effects by OSU53 were again almost abolished with AMPK alpha shRNA or dn-AMPK alpha in OB-6 cells. Together, these results demonstrate that OSU53 protects osteoblastic cells from Dex possibly via activating AMPK-dependent signaling.	[Xu, Dawei; Zhao, Wei; Zhu, Xinhui; Fan, Jianbo; Cui, Shengyu; Sun, Yuyu; Chen, Xiang; Liu, Wei; Cui, Zhi-ming] Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China	Nantong University	Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China.	zhimingcuiorth@163.com			National Natural Scientific Foundation of China [81300955]; Projects of Nantong [MS22015047]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Nantong	This work was supported by the National Natural Scientific Foundation of China (No. 81300955, to ZC) and Projects of Nantong (MS22015047, to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Balteau M., 2014, AM J PHYSL HEART CIR; den Uyl D, 2011, CURR RHEUMATOL REP, V13, P233, DOI 10.1007/s11926-011-0173-y; Ding HY, 2015, BIOCHEM BIOPH RES CO, V460, P157, DOI 10.1016/j.bbrc.2015.02.161; Fan JB, 2015, MOL CELL BIOCHEM, V398, P105, DOI 10.1007/s11010-014-2210-4; Fan JB, 2014, BIOCHEM BIOPH RES CO, V447, P425, DOI 10.1016/j.bbrc.2014.04.002; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Guh JH, 2010, J MED CHEM, V53, P2552, DOI 10.1021/jm901773d; Guo SG, 2016, BIOCHEM BIOPH RES CO, V469, P281, DOI 10.1016/j.bbrc.2015.11.104; Guo SH, 2015, CHIN AUTOM CONGR, P1, DOI 10.1109/CAC.2015.7382459; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hu X, 2015, TUMOUR BIOL; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Lu PH, 2016, ONCOTARGET; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; She C, 2014, CELL SIGNAL, V26, P1, DOI 10.1016/j.cellsig.2013.08.046; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Yun SI, 2009, J BONE MINER METAB, V27, P140, DOI 10.1007/s00774-008-0019-5; Zhang K, 2016, BIOCHEM BIOPH RES CO, V469, P753, DOI [10.1016/j.bbrc.2015.12.014, DOI 10.1016/J.BBRC.2015.12.014]; Zhen YF, 2014, J CELL PHYSIOL, V229, P1475, DOI 10.1002/jcp.24589; Zheng KL, 2016, BIOCHEM BIOPH RES CO, V469, P753, DOI 10.1016/j.bbrc.2015.12.014; Zhu YL, 2014, INT J MOL SCI, V15, P11190, DOI 10.3390/ijms150611190	33	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162694	10.1371/journal.pone.0162694	http://dx.doi.org/10.1371/journal.pone.0162694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632213	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900066
J	Altmann, F; Kosma, P; O'Callaghan, A; Leahy, S; Bottacini, F; Molloy, E; Plattner, S; Schiavi, E; Gleinser, M; Groeger, D; Grant, R; Perez, NR; Healy, S; Svehla, E; Windwarder, M; Hofinger, A; Motherway, MO; Akdis, CA; Xu, J; Roper, J; van Sinderen, D; O'Mahony, L				Altmann, Friedrich; Kosma, Paul; O'Callaghan, Amy; Leahy, Sinead; Bottacini, Francesca; Molloy, Evelyn; Plattner, Stephan; Schiavi, Elisa; Gleinser, Marita; Groeger, David; Grant, Ray; Perez, Noelia Rodriguez; Healy, Selena; Svehla, Elisabeth; Windwarder, Markus; Hofinger, Andreas; Motherway, Mary O'Connell; Akdis, Cezmi A.; Xu, Jun; Roper, Jennifer; van Sinderen, Douwe; O'Mahony, Liam			Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp longum 35624 (TM)	PLOS ONE			English	Article							O-SPECIFIC POLYSACCHARIDE; PERFORMANCE LIQUID-CHROMATOGRAPHY; ASSISTED STRUCTURAL-ANALYSIS; PROBIOTIC STRAINS; GUT MICROBIOTA; CELL-WALL; HOST; LIPOPOLYSACCHARIDE; SEPARATION; MONOSACCHARIDES	The Bifibobacterium longum subsp. longum 35624 (TM) strain (formerly named Bifidobacterium longum subsp. infantis) is a well described probiotic with clinical efficacy in Irritable Bowel Syndrome clinical trials and induces immunoregulatory effects in mice and in humans. This paper presents (a) the genome sequence of the organism allowing the assignment to its correct subspeciation longum; (b) a comparative genome assessment with other B. longum strains and (c) the molecular structure of the 35624 exopolysaccharide (EPS624). Comparative genome analysis of the 35624 strain with other B. longum strains determined that the sub-speciation of the strain is longum and revealed the presence of a 35624-specific gene cluster, predicted to encode the biosynthetic machinery for EPS624. Following isolation and acid treatment of the EPS, its chemical structure was determined using gas and liquid chromatography for sugar constituent and linkage analysis, electrospray and matrix assisted laser desorption ionization mass spectrometry for sequencing and NMR. The EPS consists of a branched hexasaccharide repeating unit containing two galactose and two glucose moieties, galacturonic acid and the unusual sugar 6-deoxy- L-talose. These data demonstrate that the B. longum 35624 strain has specific genetic features, one of which leads to the generation of a characteristic exopolysaccharide.	[Altmann, Friedrich; Kosma, Paul; Svehla, Elisabeth; Windwarder, Markus; Hofinger, Andreas] Univ Nat Resources & Life Sci, Vienna, Austria; [O'Callaghan, Amy; Leahy, Sinead; Bottacini, Francesca; Molloy, Evelyn; Gleinser, Marita; Motherway, Mary O'Connell; van Sinderen, Douwe] Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [O'Callaghan, Amy; Leahy, Sinead; Bottacini, Francesca; Molloy, Evelyn; Gleinser, Marita; Motherway, Mary O'Connell; van Sinderen, Douwe] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Plattner, Stephan; Healy, Selena; Roper, Jennifer] Alimentary Hlth, Cork, Ireland; [Schiavi, Elisa; Perez, Noelia Rodriguez; Akdis, Cezmi A.; O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Schiavi, Elisa; Groeger, David; Grant, Ray] Alimentary Hlth Pharma Davos, Davos, Switzerland; [Xu, Jun] Procter & Gamble, Cincinnati, OH USA	University of Natural Resources & Life Sciences, Vienna; University College Cork; University College Cork; Swiss Institute of Allergy & Asthma Research; University of Zurich; Procter & Gamble	O'Mahony, L (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	liam.omahony@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020; Bottacini, Francesca/AAO-2431-2021; Van Sinderen, Douwe/A-6778-2015; O'Mahony, Liam/AAG-5838-2019; Kosma, Paul/Y-7443-2019	Akdis, Cezmi/0000-0001-8020-019X; Bottacini, Francesca/0000-0002-0142-2956; Van Sinderen, Douwe/0000-0003-1823-7957; O'Mahony, Liam/0000-0003-4705-3583; Kosma, Paul/0000-0001-5342-7161; O'Connell Motherway, Mary/0000-0001-9164-9320; Altmann, Friedrich/0000-0002-0112-7877; Molloy, Evelyn/0000-0001-8822-7207	European Union; Swiss National Foundation [CRSII3_154488, 310030_144219]; Christine Kuhne Center for Allergy Research and Education; Science Foundation Ireland (SFI) [SFI/12/RC/2273]; Irish Research Council; HRB postdoctoral fellowship [PDTM/20011/9]	European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Christine Kuhne Center for Allergy Research and Education; Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Research Council(Irish Research Council for Science, Engineering and Technology); HRB postdoctoral fellowship	These studies were directly supported by a European Union Marie Curie training network, entitled "TEAM-EPIC". In addition, the authors are supported by Swiss National Foundation grants (project numbers CRSII3_154488 and 310030_144219), Christine Kuhne Center for Allergy Research and Education, and by Science Foundation Ireland (SFI) (Grant No. SFI/12/RC/2273). AO was supported by an enterprise partnership scheme of the Irish Research Council, while MOM is a recipient of an HRB postdoctoral fellowship (Grant No. PDTM/20011/9). The funder provided support in the form of salaries for authors [DG, E. Schiavi, RG - Alimentary Health Pharma Davos; SP, SH, JR - Alimentary Health; JX - Procter & Gamble], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alp G, 2010, ANAEROBE, V16, P101, DOI 10.1016/j.anaerobe.2009.06.006; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Arbatsky NP, 1999, EUR J BIOCHEM, V261, P392, DOI 10.1046/j.1432-1327.1999.00250.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bitzer J, 2006, EUR J ORG CHEM, V2006, P3661, DOI 10.1002/ejoc.200600221; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Chu DB, 2015, ANAL BIOANAL CHEM, V407, P2865, DOI 10.1007/s00216-015-8521-9; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; De Castro C, 2007, BIOMACROMOLECULES, V8, P1047, DOI 10.1021/bm061081f; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Frei R, 2015, CURR OPIN GASTROEN, V31, P153, DOI 10.1097/MOG.0000000000000151; Fujiwara N, 2007, J BACTERIOL, V189, P1099, DOI 10.1128/JB.01471-06; GAUGLER RW, 1973, J BIOL CHEM, V248, P6041; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Groeger D, 2013, GUT MICROBES, V4, P325, DOI 10.4161/gmic.25487; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HABU Y, 1987, J BIOCHEM-TOKYO, V102, P1423, DOI 10.1093/oxfordjournals.jbchem.a122188; HARA S, 1987, CHEM PHARM BULL, V35, P501; Hidalgo-Cantabrana C, 2015, APPL ENVIRON MICROB, V81, P7960, DOI 10.1128/AEM.02095-15; Hidalgo-Cantabrana C, 2014, APPL ENVIRON MICROB, V80, P9, DOI 10.1128/AEM.02977-13; Hidalgo-Cantabrana C, 2012, PROBIOTICS ANTIMICRO, V4, P227, DOI 10.1007/s12602-012-9110-2; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Isshiki Y, 2001, FEMS MICROBIOL LETT, V199, P21, DOI 10.1111/j.1574-6968.2001.tb10645.x; JANSSON PE, 1989, CARBOHYD RES, V188, P169, DOI 10.1016/0008-6215(89)84069-8; Katzenellenbogen E, 1999, J CARBOHYD CHEM, V18, P545, DOI 10.1080/07328309908544018; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Konieczna P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062617; Konieczna P, 2012, GUT MICROBES, V3, P261, DOI 10.4161/gmic.20358; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Lopez P, 2012, FOOD RES INT, V46, P99, DOI 10.1016/j.foodres.2011.11.020; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; MARUMO K, 1992, EUR J BIOCHEM, V204, P539, DOI 10.1111/j.1432-1033.1992.tb16665.x; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Miyamoto Y, 2006, J BACTERIOL, V188, P86, DOI 10.1128/JB.188.1.86-95.2006; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Muldoon J, 2003, CARBOHYD RES, V338, P459, DOI 10.1016/S0008-6215(02)00483-4; NAGAOKA M, 1988, J BIOCHEM-TOKYO, V103, P618, DOI 10.1093/oxfordjournals.jbchem.a122316; Nakano Y, 2000, J BIOL CHEM, V275, P6806, DOI 10.1074/jbc.275.10.6806; O'Callaghan A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1968-4; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; O'Riordan K, 1998, J APPL MICROBIOL, V85, P103, DOI 10.1046/j.1365-2672.1998.00474.x; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Perepelov AV, 2002, CARBOHYD RES, V337, P2463, DOI 10.1016/S0008-6215(02)00226-4; Perry MB, 1996, EUR J BIOCHEM, V242, P682, DOI 10.1111/j.1432-1033.1996.0682r.x; Prasanna PHP, 2012, CARBOHYD POLYM, V90, P533, DOI 10.1016/j.carbpol.2012.05.075; Ruas-Madiedo P, 2006, J FOOD PROTECT, V69, P2011, DOI 10.4315/0362-028X-69.8.2011; RUSSA R, 1995, ARCH MICROBIOL, V163, P345, DOI 10.1007/BF00404207; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAAMANEN AM, 1988, GLYCOCONJUGATE J, V5, P235, DOI 10.1007/BF01049084; Salazar N, 2015, CRIT REV FOOD SCI NU, V12; Salazar N, 2009, INT J FOOD MICROBIOL, V135, P260, DOI 10.1016/j.ijfoodmicro.2009.08.017; Schmid J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00496; Scully P, 2013, CELL IMMUNOL, V281, P134, DOI 10.1016/j.cellimm.2013.03.008; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Staden R, 2000, Methods Mol Biol, V132, P115; Symonds EL, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.9; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tomkovich S, 2016, IMMUNOLOGY, V147, P1, DOI 10.1111/imm.12538; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Vanhaverbeke C, 2001, CARBOHYD RES, V334, P127, DOI 10.1016/S0008-6215(01)00176-8; Walker SG, 1999, ORAL MICROBIOL IMMUN, V14, P304, DOI 10.1034/j.1399-302X.1999.140506.x; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Windwarder M, ANAL BIOCH IN PRESS; Wu MH, 2010, INT J FOOD MICROBIOL, V144, P104, DOI 10.1016/j.ijfoodmicro.2010.09.003; Xu CL, 2009, BIORESOURCE TECHNOL, V100, P2095, DOI 10.1016/j.biortech.2008.10.037; Yoshida Y, 1999, J BIOL CHEM, V274, P16933, DOI 10.1074/jbc.274.24.16933	76	56	58	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162983	10.1371/journal.pone.0162983	http://dx.doi.org/10.1371/journal.pone.0162983			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656878	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000383893200051
J	Majid, SA; Graw, MF; Chatziefthimiou, AD; Nguyen, H; Richer, R; Louge, M; Sultan, AA; Schloss, P; Hay, AG				Majid, Sara Abdul; Graw, Michael F.; Chatziefthimiou, Aspassia D.; Hanh Nguyen; Richer, Renee; Louge, Michel; Sultan, Ali A.; Schloss, Patrick; Hay, Anthony G.			Microbial Characterization of Qatari Barchan Sand Dunes	PLOS ONE			English	Article							BACTERIAL DIVERSITY; GENE-TRANSFER; DESERT DUST; SEQUENCE; COMMUNITIES; ENVIRONMENT; PROFILES; EXPOSURE	This study represents the first characterization of sand microbiota in migrating barchan sand dunes. Bacterial communities were studied through direct counts and cultivation, as well as 16S rRNA gene and metagenomic sequence analysis to gain an understanding of microbial abundance, diversity, and potential metabolic capabilities. Direct on-grain cell counts gave an average of 5.3 x 0.4 x 10(5) cells g(-1) of sand. Cultured isolates N = 64) selected for 16S rRNA gene sequencing belonged to the phyla Actinobacteria 58%), Firmicutes 27%) and Proteobacteria 15%). Deep-sequencing of 16S rRNA gene amplicons from 18 dunes demonstrated a high relative abundance of Proteobacteria, particularly enteric bacteria, and a dune-specific-pattern of bacterial community composition that correlated with dune size. Shotgun metagenome sequences of two representative dunes were analyzed and found to have similar relative bacterial abundance, though the relative abundances of eukaryotic, viral and enterobacterial sequences were greater in sand from the dune closer to a camel-pen. Functional analysis revealed patterns similar to those observed in desert soils; however, the increased relative abundance of genes encoding sporulation and dormancy are consistent with the dune microbiome being well-adapted to the exceptionally hyper-arid Qatari desert.	[Majid, Sara Abdul; Chatziefthimiou, Aspassia D.; Richer, Renee; Sultan, Ali A.] Qatar Fdn, Dept Res, Weill Cornell Med Qatar, Doha, Qatar; [Graw, Michael F.; Hanh Nguyen; Hay, Anthony G.] Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA; [Louge, Michel] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Schloss, Patrick] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Graw, Michael F.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Richer, Renee] Univ Wisconsin Marinette, Dept Biol Sci, Marinette, WI USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Cornell University; University of Michigan System; University of Michigan; Oregon State University	Hay, AG (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA.	agh5@cornell.edu	Louge, Michel Y./A-4380-2018	Louge, Michel Y./0000-0002-1155-9163; Hay, Anthony/0000-0002-9427-148X; Abdul Majid, Sara/0000-0002-0438-6209; Schloss, Patrick/0000-0002-6935-4275; Chatziefthimiou, Aspassia D./0000-0002-6557-2427	Qatar National Research Fund as part of the National Priorities Research Program [09-546-2-206, 06-059-2-023]	Qatar National Research Fund as part of the National Priorities Research Program(Qatar National Research Fund (QNRF))	This work was supported by The Qatar National Research Fund as part of the National Priorities Research Program [09-546-2-206] AND [06-059-2-023]. Dr. Michel Louge received the funding. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2013, MICROB ECOL, V66, P850, DOI 10.1007/s00248-013-0276-2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Ashelford KE, 1997, FEMS MICROBIOL ECOL, V23, P81, DOI 10.1016/S0168-6496(97)00015-9; Bagnold R., 1941, PHYS BLOWN SAND DESE; Bhatnagar A, 2005, CURR SCI INDIA, V89, P91; BOKHARY HA, 1998, J KING SAUD U, V10, P15; Chan CC, 2008, ENVIRON RES, V106, P393, DOI 10.1016/j.envres.2007.09.006; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Charru F, 2013, ANNU REV FLUID MECH, V45, P469, DOI 10.1146/annurev-fluid-011212-140806; Cheng MF, 2008, J TOXICOL ENV HEAL A, V71, P1295, DOI 10.1080/15287390802114808; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Cox PA, 2009, AMYOTROPH LATERAL SC, V10, P109, DOI 10.3109/17482960903286066; Direito SOL, 2011, INT J ASTROBIOL, V10, P191, DOI 10.1017/S1473550411000012; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EMBABI NS, 1993, J ARID ENVIRON, V25, P49, DOI 10.1006/jare.1993.1042; Fang HY, 2007, SOIL TILL RES, V93, P222, DOI 10.1016/j.still.2006.04.006; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Gay SP, 1999, GEOMORPHOLOGY, V27, P279; Gommeaux M, 2010, GEOMICROBIOL J, V27, P76, DOI 10.1080/01490450903393066; Gonzalez-Martin C, 2013, RES MICROBIOL, V164, P17, DOI 10.1016/j.resmic.2012.08.009; Gupta RS, 2013, ANTON LEEUW INT J G, V103, P99, DOI 10.1007/s10482-012-9790-3; Herrmann HJ, 2005, PHYSICA A, V358, P30, DOI 10.1016/j.physa.2005.06.004; Hill KE, 1998, FEMS MICROBIOL ECOL, V25, P319, DOI 10.1111/j.1574-6941.1998.tb00483.x; IBM Corp, 2016, IBM SPSS STAT WIND V; Jones D.L, 2017, FATHOM TOOLBOX MATLA; Jousime-Somers H, 2002, WADSWORTH KTL ANAERO; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Li K, 2015, EXTREMOPHILES, V19, P171, DOI 10.1007/s00792-014-0696-z; Liu RY, 2014, J MICROBIOL, V52, P898, DOI 10.1007/s12275-014-4075-3; Louge MY, 2013, J GEOPHYS RES-EARTH, V118, P2392, DOI 10.1002/2013JF002839; Makhalanyane TP, 2015, FEMS MICROBIOL REV, V39, P203, DOI 10.1093/femsre/fuu011; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McKee ED., 1979, 1052 NASA US DEP INT; Melton FA, 1940, J GEOL, V48, P113, DOI 10.1086/624871; Metcalf JS, 2012, SCI TOTAL ENVIRON, V421, P118, DOI 10.1016/j.scitotenv.2012.01.053; Metcalf JS, 2015, J ARID ENV B, V112, P140; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Neveu J, 2011, APPL MICROBIOL BIOT, V91, P635, DOI 10.1007/s00253-011-3256-9; Orlando J, 2010, SOIL BIOL BIOCHEM, V42, P1183, DOI 10.1016/j.soilbio.2010.03.025; Pandit AS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00439-14; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Patel R, 2015, GENOM DATA, V3, P137, DOI 10.1016/j.gdata.2015.01.003; Prestel E, 2013, ANTON LEEUW INT J G, V103, P1329, DOI 10.1007/s10482-013-9914-4; Puspitasari F, 2015, AIR QUAL ATMOS HLTH, V26, P1; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Ronca S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00845; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Stan-Lotter H, 2012, ADAPTION MICROIAL LI; Stieglmeier M., 2014, PROKARYOTES, DOI [10.1007/978-3-642-38954-2_338, DOI 10.1007/978-3-642-38954-2_338]; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tiwari K, 2013, CRIT REV MICROBIOL, V39, P256, DOI 10.3109/1040841X.2012.709819; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Walsh DA, 2005, ENVIRON MICROBIOL, V7, P1655, DOI 10.1111/j.1462-2920.2005.00864.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Yadav AN, 2015, J BIOSCI BIOENG, V119, P683, DOI 10.1016/j.jbiosc.2014.11.006; Yu J, 2012, SOIL BIOL BIOCHEM, V45, P71, DOI 10.1016/j.soilbio.2011.10.005; Zhang W, 2012, J ENVIRON SCI, V24, P2004, DOI 10.1016/S1001-0742(11)61037-1	68	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161836	10.1371/journal.pone.0161836	http://dx.doi.org/10.1371/journal.pone.0161836			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655399	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700010
J	Medina, LS; Souza, BA; Queiroz, A; Guimaraes, LH; Machado, PRL; Carvalho, EM; Wilson, ME; Schriefer, A				Medina, Lilian S.; Souza, Bruno Araujo; Queiroz, Adriano; Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Wilson, Mary Edythe; Schriefer, Albert			The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; DNA-SEQUENCE POLYMORPHISM; POLYMERASE-CHAIN-REACTION; CUTANEOUS LEISHMANIASIS; NORTHEASTERN BRAZIL; PROTEASE MSP; BALB/C MICE; VISCERAL LEISHMANIASIS; MEXICANA AMASTIGOTES; DONOVANI COMPLEX	GP63 or leishmanolysin is the major surface protease of Leishmania spp. involved in parasite virulence and host cell interaction. As such, GP63 is a potential target of eventual vaccines against these protozoa. In the current study we evaluate the polymorphism of gp63 in Leishmania (Viannia) braziliensis isolated from two sets of American tegumentary leishmaniasis (ATL) cases from Corte de Pedra, Brazil, including 35 cases diagnosed between 1994 and 2001 and 6 cases diagnosed between 2008 and 2011. Parasites were obtained from lesions by needle aspiration and cultivation. Genomic DNA was extracted, and 405 bp fragments, including sequences encoding the putative macrophage interacting sites, were amplified from gp63 genes of all isolates. DNA amplicons were cloned into plasmid vectors and ten clones per L. (V.) braziliensis isolate were sequenced. Alignment of cloned sequences showed extensive polymorphism among gp63 genes within, and between parasite isolates. Overall, 45 different polymorphic alleles were detected in all samples, which could be segregated into two clusters. Cluster one included 25, and cluster two included 20 such genotypes. The predicted peptides showed overall conservation below 50%. In marked contrast, the conservation at segments with putative functional domains approached 90% (Fisher's exact test p<0.0001). These findings show that gp63 is very polymorphic even among parasites from a same endemic focus, but the functional domains interacting with the mammalian host environment are conserved.	[Medina, Lilian S.; Souza, Bruno Araujo; Queiroz, Adriano; Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Schriefer, Albert] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Schriefer, Albert] INCT DT, Brasilia, DF, Brazil; [Carvalho, Edgar M.] Ctr Pesquisa Goncalo Moniz Fiocruz, Salvador, BA, Brazil; [Wilson, Mary Edythe] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary Edythe] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary Edythe] VA Med Ctr, Iowa City, IA USA; [Schriefer, Albert] Univ Fed Bahia, Inst Ciencias Saude, Dept Ciencias Biointeracao, Salvador, BA, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Universidade Federal da Bahia	Schriefer, A (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Schriefer, A (corresponding author), INCT DT, Brasilia, DF, Brazil.; Schriefer, A (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Dept Ciencias Biointeracao, Salvador, BA, Brazil.	aschriefer@ufba.br	Queiroz, Adriano/AAQ-1164-2020; Schriefer, Albert/AAP-2765-2020; Henrique, Luiz/ABA-2621-2020; MACHADO, PAULO ROBERTO LIMA/AAP-2642-2020	Queiroz, Adriano/0000-0003-0080-6509; Schriefer, Albert/0000-0002-5496-6789; MACHADO, PAULO ROBERTO LIMA/0000-0003-1894-6171; Wilson, Mary/0000-0001-8680-7275	National Institutes of Health (NIH), USA [NIH P50-AI30639, NIH R03 A167663]; NIH [R03 A167663, P50-AI30639]; CAPES MS scholarship; CAPES PhD scholarship; CNPq Scientific Initiation Fellowship scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES MS scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES PhD scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Scientific Initiation Fellowship scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH), USA, through grants NIH P50-AI30639 and NIH R03 A167663. AS and MW were recipients of NIH R03 A167663 and EMC, AS and MW were recipients of NIH P50-AI30639. LSM, AQ and LHG were recipients of CAPES MS and PhD scholarships. BAS was the recipient of a CNPq Scientific Initiation Fellowship scholarship.	Alexander J, 1998, J IMMUNOL, V161, P6794; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; AZULAY RD, 1995, INT J DERMATOL, V34, P303, DOI 10.1111/j.1365-4362.1995.tb03608.x; Bhowmick S, 2008, EXPERT OPIN DRUG DEL, V5, P789, DOI [10.1517/17425247.5.7.789, 10.1517/17425247.5.7.789 ]; Bianchini G, 2006, PROTEINS, V64, P385, DOI 10.1002/prot.21009; Brito G, 2014, AM J TROP MED HYG, V90, P617, DOI 10.4269/ajtmh.12-0729; CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; COOMBS GH, 1982, PARASITOLOGY, V84, P149, DOI 10.1017/S003118200005174X; COSTA JML, 1986, J TROP MED HYG, V89, P319; Cuervo P, 2008, ACTA TROP, V106, P143, DOI 10.1016/j.actatropica.2008.03.005; Dumonteil E, 2003, VACCINE, V21, P2161, DOI 10.1016/S0264-410X(02)00769-7; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; Guimaraes LH, 2009, T ROY SOC TROP MED H, V103, P712, DOI 10.1016/j.trstmh.2009.04.019; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Jaafari MR, 2006, VACCINE, V24, P5708, DOI 10.1016/j.vaccine.2006.04.062; Kaur T, 2011, PARASITE IMMUNOL, V33, P95, DOI 10.1111/j.1365-3024.2010.01253.x; Kaur Tejinder, 2013, J Parasit Dis, V37, P231, DOI 10.1007/s12639-012-0171-7; Lieke T, 2008, CLIN EXP IMMUNOL, V153, P221, DOI 10.1111/j.1365-2249.2008.03687.x; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Llanes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08550; Machado PR, 2011, T ROY SOC TROP MED H, V105, P438, DOI 10.1016/j.trstmh.2011.05.002; Machado PRL, 2015, CLIN INFECT DIS, V61, P945, DOI 10.1093/cid/civ416; Mauricio IL, 2007, INT J PARASITOL, V37, P565, DOI 10.1016/j.ijpara.2006.11.020; Mazumder S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001429; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Ministerio da Saude SdVe Saude, 2007, MAN VIG LEISHM TEG A; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Newlove T, 2011, AM J TROP MED HYG, V84, P551, DOI 10.4269/ajtmh.2011.10-0423; NORTH MJ, 1981, MOL BIOCHEM PARASIT, V3, P293, DOI 10.1016/0166-6851(81)90003-7; Pandey S, 2004, J BIOSCIENCES, V29, P15, DOI 10.1007/BF02702557; Papadopoulou G, 1998, VACCINE, V16, P885, DOI 10.1016/S0264-410X(97)00308-3; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Puentes F, 1999, EXP PARASITOL, V93, P7, DOI 10.1006/expr.1999.4427; PUPKIS MF, 1984, J GEN MICROBIOL, V130, P2375; Queiroz A, 2012, J CLIN MICROBIOL, V50, P4028, DOI 10.1128/JCM.02064-12; ROBERTS SC, 1993, MOL BIOCHEM PARASIT, V62, P157, DOI 10.1016/0166-6851(93)90106-8; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Romero GAS, 2001, ACTA TROP, V79, P225, DOI 10.1016/S0001-706X(01)00140-1; Rosenthal PJ, 1999, ADV PARASIT, V43, P105, DOI 10.1016/S0065-308X(08)60242-0; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; RUSSELL DG, 1986, J IMMUNOL, V136, P2613; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Sadlova J, 2006, FOLIA PARASIT, V53, P81, DOI 10.14411/fp.2006.011; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos JB, 2004, J INFECT DIS, V190, P1793, DOI 10.1086/424848; Schriefer A, 2004, INFECT IMMUN, V72, P508, DOI 10.1128/IAI.72.1.508-514.2004; Schriefer A, 2009, EMERG INFECT DIS, V15, P871, DOI 10.3201/eid1506.080406; SOTERIADOU KP, 1992, J BIOL CHEM, V267, P13980; STEINKRAUS HB, 1992, MOL BIOCHEM PARASIT, V52, P141, DOI 10.1016/0166-6851(92)90045-L; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772; Unger A, 2009, AM J TROP MED HYG, V80, P574, DOI 10.4269/ajtmh.2009.80.574; Victoir K, 2005, PARASITOLOGY, V131, P207, DOI 10.1017/S0031182005007535; VICTOIR K, 1995, PARASITOLOGY, V111, P265, DOI 10.1017/S0031182000081828; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Voth BR, 1998, MOL BIOCHEM PARASIT, V93, P31, DOI 10.1016/S0166-6851(98)00013-9; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; (WHO) WHO, 2011, LEISHMANIASIS; XU D, 1995, IMMUNOLOGY, V84, P173; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	67	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163284	10.1371/journal.pone.0163284	http://dx.doi.org/10.1371/journal.pone.0163284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648939	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100072
J	Nakajima, R; Okano, H; Noce, T				Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki			JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; HISTONE DEMETHYLASE; LYSINE METHYLATION; SELF-RENEWAL; IDENTIFICATION; TRANSCRIPTION; DIFFERENTIATION; PLURIPOTENCY	Jmjd1C is one of the Jmjd1 family genes that encode putative demethylases against histone H3K9 and non-histone proteins and has been proven to play an indispensable role in mouse spermatogenesis. Here, we analyzed a newly-bred transgenic mouse strain carrying a Jmjd1C loss-of-function allele in which a beta-geo cassette was integrated into the intron of the Jmjd1C locus. Jmjd1C gene-trap homozygous testes exhibited malformations in postmeiotic processes and a deficiency in the long-term maintenance of undifferentiated spermatogonia. Some groups of spermatids in the homozygous testis showed abnormal organization and incomplete elongation from the first wave of spermatogenesis onwards. Moreover, histone H4K16 acetylation, which is required for the onset of chromatin remodeling, appeared to be remarkably decreased. These effects may not have been a result of the drastic decrease in gene expression related to the events but instead may have been due to the lack of interaction between JMJD1C and its partner proteins, such as MDC1 and HSP90. Additionally, significant decreases in Oct4 expression and NANOG- and OCT4-expressing spermatogonia were found in the Jmjd1C homozygous mature testis, suggesting that JMJD1C may participate in the maintenance of spermatogonial stem cell self-renewal by up-regulating Oct4 expression. These results indicate that JMJD1C has multiple functions during spermatogenesis through interactions with different partners during the spermatogenic stages.	[Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo 1608582, Japan; [Noce, Toshiaki] Mitsubishi Kagaku Inst Life Sci, 11 Minami Ooya, Machida, Tokyo, Japan	Keio University; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Nakajima, R (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo 1608582, Japan.	rnakajima@a3.keio.jp	Okano, Hideyuki/X-9131-2019; Okano, Hideyuki/I-7584-2019	Okano, Hideyuki/0000-0001-7482-5935; Nakajima, Ryusuke/0000-0002-0908-0292	Japan Society for the Promotion of Science Research Fellowship Program	Japan Society for the Promotion of Science Research Fellowship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science Research Fellowship Program.; We thank Mr. Michio Satoh, Ms. Ako Tokumasu and Ms. Natsue Yoshida (former Mitsubishi-Kagaku Institute of Life Science), and Ms. Tomoko Suzuki (Keio University, School of Medicine) for their technical help. This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science Research Fellowship Program (to R.N.).	Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Dowdle JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003945; Ichijima Y, 2015, GENE DEV, V25, P959; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Kajiwara C, 2012, BIOL OPEN, V1, P977, DOI 10.1242/bio.2012646; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kasioulis I, 2014, MOL BIOL CELL, V25, P1216, DOI 10.1091/mbc.E13-08-0471; Katoh M, 2007, INT J ONCOL, V31, P219; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Li WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4812; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Saez M A, 2015, GENET MED, V18, P1; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shakya A, 2015, MOL CELL BIOL, V35, P1014, DOI 10.1128/MCB.01105-14; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Tsunekawa N, 1999, J VET MED SCI, V61, P381, DOI 10.1292/jvms.61.381; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang JL, 2014, J BIOL CHEM, V289, P2384, DOI 10.1074/jbc.M113.535799; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978; Zhuang TG, 2014, MECH DEVELOP, V131, P35, DOI 10.1016/j.mod.2013.10.005	43	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163466	10.1371/journal.pone.0163466	http://dx.doi.org/10.1371/journal.pone.0163466			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649575	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100087
J	Ricotti, V; Evans, MRB; Sinclair, CDJ; Butler, JW; Ridout, DA; Hogrel, JY; Emira, A; Morrow, JM; Reilly, MM; Hanna, MG; Janiczek, RL; Matthews, PM; Yousry, TA; Muntoni, F; Thornton, JS				Ricotti, Valeria; Evans, Matthew R. B.; Sinclair, Christopher D. J.; Butler, Jordan W.; Ridout, Deborah A.; Hogrel, Jean-Yves; Emira, Ahmed; Morrow, Jasper M.; Reilly, Mary M.; Hanna, Michael G.; Janiczek, Robert L.; Matthews, Paul M.; Yousry, Tarek A.; Muntoni, Francesco; Thornton, John S.			Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials	PLOS ONE			English	Article							3-POINT DIXON TECHNIQUE; DISEASE PROGRESSION; THIGH MUSCLES; BOYS; STRENGTH; INFILTRATION; RELIABILITY; ASSESSMENTS; PERFORMANCE; PHASE-2	Objective A number of promising experimental therapies for Duchenne muscular dystrophy (DMD) are emerging. Clinical trials currently rely on invasive biopsies or motivation-dependent functional tests to assess outcome. Quantitative muscle magnetic resonance imaging (MRI) could offer a valuable alternative and permit inclusion of non-ambulant DMD subjects. The aims of our study were to explore the responsiveness of upper-limb MRI muscle- fat measurement as a non-invasive objective endpoint for clinical trials in nonambulant DMD, and to investigate the relationship of these MRI measures to those of muscle force and function. Methods 15 non-ambulant DMD boys (mean age 13.3 y) and 10 age-gender matched healthy controls (mean age 14.6 y) were recruited. 3-Tesla MRI fat-water quantification was used to measure forearm muscle fat transformation in non-ambulant DMD boys compared with healthy controls. DMD boys were assessed at 4 time-points over 12 months, using 3-point Dixon MRI to measure muscle fat-fraction (f. f.). Images from ten forearm muscles were segmented and mean f. f. and cross-sectional area recorded. DMD subjects also underwent comprehensive upper limb function and force evaluation. Results Overall mean baseline forearm f. f. was higher in DMD than in healthy controls (p<0.001). A progressive f. f. increase was observed in DMD over 12 months, reaching significance from 6 months (p<0.001, n = 7), accompanied by a significant loss in pinch strength at 6 months (p<0.001, n = 9) and a loss of upper limb function and grip force observed over 12 months (p<0.001, n = 8). Conclusions These results support the use of MRI muscle f. f. as a biomarker to monitor disease progression in the upper limb in non-ambulant DMD, with sensitivity adequate to detect group-level change over time intervals practical for use in clinical trials. Clinical validity is supported by the association of the progressive fat transformation of muscle with loss of muscle force and function.	[Ricotti, Valeria; Butler, Jordan W.; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Ricotti, Valeria; Butler, Jordan W.; Ridout, Deborah A.; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Evans, Matthew R. B.; Sinclair, Christopher D. J.; Emira, Ahmed; Morrow, Jasper M.; Reilly, Mary M.; Hanna, Michael G.; Matthews, Paul M.; Yousry, Tarek A.; Muntoni, Francesco; Thornton, John S.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [Evans, Matthew R. B.; Sinclair, Christopher D. J.; Emira, Ahmed; Yousry, Tarek A.; Thornton, John S.] UCL Inst Neurol, Neuroradiol Acad Unit, London, England; [Ridout, Deborah A.] UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Hogrel, Jean-Yves] GH Pitie Salpetriere, Inst Myol, Paris, France; [Janiczek, Robert L.] GlaxoSmithKline, London, England; [Matthews, Paul M.] Imperial Coll London, Div Brain Sci & Ctr Neurotechnol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline; Imperial College London	Ricotti, V (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.; Ricotti, V (corresponding author), Great Ormond St Hosp Sick Children, London, England.	v.ricotti@ucl.ac.uk	Ridout, Deborah/C-1578-2008	Hanna, Michael/0000-0003-0825-4075; Hogrel, Jean-Yves/0000-0003-0045-7505; Reilly, Mary/0000-0003-0686-905X; Ridout, Deborah/0000-0003-1336-6450; Thornton, John/0000-0003-3248-8437	GlaxoSmithKline foundation; GlaxoSmithKline; EU grant SKIP-NMD [HEALTH-F4-2012-30537]; L'Association Francaise contre les Myopathies; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC; Muscular Dystrophy Campaign; Imperial College Healthcare Trust NIHR BRC; Edmond J Safra Foundation; Medical Research Council [MR/M009106/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10022] Funding Source: researchfish; MRC [MR/M009106/1] Funding Source: UKRI	GlaxoSmithKline foundation(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); EU grant SKIP-NMD; L'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Imperial College Healthcare Trust NIHR BRC; Edmond J Safra Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GlaxoSmithKline foundation: Francesco Muntoni. GlaxoSmithKline funded this study. The funder provided financial support for the overall conduct of this study and contributed to study design and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section during the duration of this study VR was supported by the EU grant SKIP-NMD (No. HEALTH-F4-2012-30537) and L'Association Francaise contre les Myopathies (AFM). This study was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (FM), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (JST, TAY). The MRC support to the Centre for Neuromuscular Diseases at UCL, and the support of the Muscular Dystrophy Campaign to the Neuromuscular Centres at GOSH and UCLH is also gratefully acknowledged. PMM gratefully acknowledges personal support from the Imperial College Healthcare Trust NIHR BRC and from the Edmond J Safra Foundation and Lily Safra.	Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; Alfano LN, 2014, NEUROMUSCULAR DISORD, V24, P860, DOI 10.1016/j.nmd.2014.06.224; Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Bishop C, 2015, NEUROLOGY S, V84; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Ellis JA, 2013, NEUROMUSCULAR DISORD, V23, P682, DOI 10.1016/j.nmd.2013.05.008; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hollingsworth KG, 2014, MAGN RESON MED, V72, P1610, DOI 10.1002/mrm.25072; Hollingsworth KG, 2013, MUSCLE NERVE, V48, P586, DOI 10.1002/mus.23879; Hollingsworth Kieren G, 2012, Neuromuscul Disord, V22 Suppl 2, pS54, DOI 10.1016/j.nmd.2012.06.005; Kim HK, 2013, PEDIATR RADIOL, V43, P1327, DOI 10.1007/s00247-013-2696-z; Kovanlikaya A, 2005, ACAD RADIOL, V12, P636, DOI 10.1016/j.acra.2005.01.019; Li WZ, 2015, NEUROMUSCULAR DISORD, V25, P375, DOI 10.1016/j.nmd.2015.01.003; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221; Straub Volker, 2012, Neuromuscul Disord, V22 Suppl 2, pS42, DOI 10.1016/j.nmd.2012.08.002; Vohra RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128915; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Wokke BH, 2014, NEUROMUSCULAR DISORD, V24, P409, DOI 10.1016/j.nmd.2014.01.015; Wokke BH, 2016, MUSCLE NERVE, V53, P38, DOI 10.1002/mus.24679; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	40	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162542	10.1371/journal.pone.0162542	http://dx.doi.org/10.1371/journal.pone.0162542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649492	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100022
J	Arroyo-Lopez, FN; Medina, E; Ruiz-Bellido, MA; Romero-Gil, V; Montes-Borrego, M; Landa, BB				Noe Arroyo-Lopez, Francisco; Medina, Eduardo; Angel Ruiz-Bellido, Miguel; Romero-Gil, Veronica; Montes-Borrego, Miguel; Landa, Blanca B.			Enhancement of the Knowledge on Fungal Communities in Directly Brined Alorena de Malaga Green Olive Fermentations by Metabarcoding Analysis	PLOS ONE			English	Article							TABLE OLIVES; MICROBIAL COMMUNITIES; DIVERSITY; IDENTIFICATION; DYNAMICS; YEASTS; BACTERIAL; SPOILAGE; STORAGE	Nowadays, our knowledge of the fungal biodiversity in fermented vegetables is limited although these microorganisms could have a great influence on the quality and safety of this kind of food. This work uses a metagenetic approach to obtain basic knowledge of the fungal community ecology during the course of fermentation of natural Alorena de Malaga table olives, from reception of raw material to edible fruits. For this purpose, samples of brines and fruits were collected from two industries in Guadalhorce Valley (Malaga, Spain) at different moments of fermentation (0, 7, 30 and 120 days). The physicochemical and microbial counts performed during fermentation showed the typical evolution of this type of processes, mainly dominated by yeasts in apparent absence of Enterobacteriaceae and Lactobacillaceae. High-throughput barcoded pyrosequencing analysis of ITS1-5.8S-ITS2 region showed a low biodiversity of the fungal community, with the presence at 97% identity of 29 different fungal genera included in 105 operational taxonomic units (OTUs). The most important genera in the raw material at the moment of reception in the industry were Penicillium, Cladosporium, Malassezia, and Candida, whilst after 4 months of fermentation in brines Zygotorulaspora and Pichia were predominant, whereas in fruits were Candida, Penicillium, Debaryomyces and Saccharomyces. The fungal genera Penicillium, Pichia, and Zygotorulaspora were shared among the three types of substrates during all the course of fermentation, representing the core fungal population for this table olive specialty. A phylogenetic analysis of the ITS sequences allowed a more accurate assignment of diverse OTUs to Pichia manshurica, Candida parapsilosis/C. tropicalis, Candida diddensiae, and Citeromyces nyonensis clades. This study highlights the existence of a complex fungal consortium in olive fermentations including phytopathogenic, saprofitic, spoilage and fermentative genera. Insights into the ecology, identification and quantification of fungi species in olive fermentation will facilitate the design of new strategies to improve the quality and safety of this fermented vegetable.	[Noe Arroyo-Lopez, Francisco; Medina, Eduardo; Romero-Gil, Veronica] Univ Campus Pablo Olavide, IG CSIC, Dept Food Biotechnol, Bldg 46,Ctra,Utrera,Km 1, Seville 41013, Spain; [Angel Ruiz-Bellido, Miguel; Romero-Gil, Veronica] Regulatory Council PDO Alorena Malaga Table Olive, C Dehesa 80, Malaga 29560, Spain; [Montes-Borrego, Miguel; Landa, Blanca B.] Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Ave Menendez Pidal S-N Campus Alameda Obispo, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Landa, BB (corresponding author), Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Ave Menendez Pidal S-N Campus Alameda Obispo, Cordoba 14004, Spain.	blanca.landa@csic.es	Gil, Verónica Romero/AAA-1604-2020; Landa, Blanca B/K-9629-2014; Arroyo-Lopez, Francisco Noe/I-8266-2012; Eduardo, Medina/D-3296-2014	Gil, Verónica Romero/0000-0002-9644-1745; Landa, Blanca B/0000-0002-9511-3731; Arroyo-Lopez, Francisco Noe/0000-0001-6308-7746; Eduardo, Medina/0000-0002-9978-4524	Junta de Andalucia Government through the PrediAlo project [AGR-7755]; FEDER European funds	Junta de Andalucia Government through the PrediAlo project(Junta de Andalucia); FEDER European funds(European Commission)	The research leading to these results has received funding from Junta de Andalucia Government through the PrediAlo project (AGR-7755: www.predialo.science.com.es) and FEDER European funds. FNAL wishes to express thanks to the Spanish government for his Ramon y Cajal postdoctoral research contract, while VRG would like to thank ceiA3, Spanish Government, Bank of Santander, IG-CSIC and 'Alorena de Malaga' Olive Manufacturing Association for her pre-doctoral fellowship.; The research leading to these results has received funding from Junta de Andalucia Government through the PrediAlo project (AGR-7755: www.predialo.science.com.es) and FEDER European funds. FNAL wishes to express thanks to the Spanish government for his RyC postdoctoral research contract while VRG would like to thank ceiA3, Spanish Government, Bank of Santander, IG-CSIC and 'Alorena de Malaga' Olive Manufacturing Association for her predoctoral fellowship.	Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Abriouel H, 2011, INT J FOOD MICROBIOL, V144, P487, DOI 10.1016/j.ijfoodmicro.2010.11.006; Arroyo-Lopez FN, 2006, FOOD MICROBIOL, V23, P791, DOI 10.1016/j.fm.2006.02.008; Arroyo-Lopez FN, 2012, INT J FOOD MICROBIOL, V160, P42, DOI 10.1016/j.ijfoodmicro.2012.08.003; Baffi MA, 2012, NEW BIOTECHNOL, V29, P451, DOI 10.1016/j.nbt.2011.05.004; Bautista-Gallego J, 2011, INT J FOOD MICROBIOL, V147, P89, DOI 10.1016/j.ijfoodmicro.2011.03.013; Bevilacqua A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00194; Bokulich NA, 2014, APPL ENVIRON MICROB, V80, P5522, DOI 10.1128/AEM.00663-14; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen P, 2016, GENOM DATA, V7, P134, DOI 10.1016/j.gdata.2015.12.028; Cocolin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069074; De Angelis M, 2015, FOOD MICROBIOL, V52, P18, DOI 10.1016/j.fm.2015.06.002; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garrido-Fernandez A., 1997, TABLE OLIVES PRODUCT; Gholami M, 2012, PLANT BIOTECHNOL J, V10, P635, DOI 10.1111/j.1467-7652.2012.00696.x; Gonzalez Cancho F., 1995, GRASAS ACEITES, V16, P230; Heperkan D, 2006, ADV EXP MED BIOL, V571, P203, DOI 10.1007/0-387-28391-9_13; Hurtado A, 2012, FOOD MICROBIOL, V31, P1, DOI 10.1016/j.fm.2012.01.006; Illeghems K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038040; IOC, 2015, WORLD TABL OL FIG; Jeong SH, 2013, INT J FOOD MICROBIOL, V160, P252, DOI 10.1016/j.ijfoodmicro.2012.10.015; Kergourlay G, 2015, INT J FOOD MICROBIOL, V213, P31, DOI 10.1016/j.ijfoodmicro.2015.09.010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Liu WJ, 2015, ANN MICROBIOL, V65, P1741, DOI 10.1007/s13213-014-1013-x; Lopez-Lopez A., 2006, PRODUCCION ELABORACI; Lucena-Padros H, 2014, FOOD MICROBIOL, V42, P154, DOI 10.1016/j.fm.2014.03.020; Marsh AJ, 2014, FOOD MICROBIOL, V38, P171, DOI 10.1016/j.fm.2013.09.003; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Mateus T, 2016, INT J FOOD MICROBIOL, V218, P57, DOI 10.1016/j.ijfoodmicro.2015.11.008; Medina E, 2016, J FOOD SCI, V81, pM121, DOI 10.1111/1750-3841.13158; MRAK EM, 1956, FOOD TECHNOL-CHICAGO, V10, P416; Nisiotou AA, 2010, J APPL MICROBIOL, V108, P396, DOI 10.1111/j.1365-2672.2009.04424.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pereira EL, 2015, FOOD MICROBIOL, V46, P582, DOI 10.1016/j.fm.2014.10.003; Prigigallo MI, 2016, PHYTOPATHOLOGY, V106, P305, DOI 10.1094/PHYTO-07-15-0167-R; Rodriguez-Gomez F, 2015, LWT-FOOD SCI TECHNOL, V63, P367, DOI 10.1016/j.lwt.2015.03.095; Romero-Gil V, 2016, LWT-FOOD SCI TECHNOL, V70, P252, DOI 10.1016/j.lwt.2016.02.058; Roussos S, 2006, MOL NUTR FOOD RES, V50, P500, DOI 10.1002/mnfr.200600005; RUIZBARBA JL, 1993, J APPL BACTERIOL, V74, P15, DOI 10.1111/j.1365-2672.1993.tb02990.x; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Silva T, 2011, LWT-FOOD SCI TECHNOL, V44, P1349, DOI 10.1016/j.lwt.2011.01.029; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tofalo R, 2013, INT J FOOD MICROBIOL, V161, P203, DOI 10.1016/j.ijfoodmicro.2012.12.011; del Arbol JT, 2016, INT J FOOD MICROBIOL, V216, P1, DOI 10.1016/j.ijfoodmicro.2015.09.001; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041	47	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163135	10.1371/journal.pone.0163135	http://dx.doi.org/10.1371/journal.pone.0163135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636546	Green Published, gold			2022-12-27	WOS:000383723700036
J	Bevilacqua, A; Costabile, A; Bergillos-Meca, T; Gonzalez, I; Landriscina, L; Ciuffreda, E; D'Agnello, P; Corbo, MR; Sinigaglia, M; Lamacchia, C				Bevilacqua, Antonio; Costabile, Adele; Bergillos-Meca, Triana; Gonzalez, Isidro; Landriscina, Loretta; Ciuffreda, Emanuela; D'Agnello, Paola; Corbo, Maria Rosaria; Sinigaglia, Milena; Lamacchia, Carmela			Impact of Gluten-Friendly Bread on the Metabolism and Function of In Vitro Gut Microbiota in Healthy Human and Coeliac Subjects	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; DUODENAL MICROBIOTA; OLIGONUCLEOTIDE PROBES; SITU HYBRIDIZATION; DISEASE PATIENTS; CHILDREN; BIFIDOBACTERIUM; FERMENTATION; VIABILITY; MODEL	The main aim of this paper was to assess the in vitro response of healthy and coeliac human faecal microbiota to gluten-friendly bread (GFB). Thus, GFB and control bread (CB) were fermented with faecal microbiota in pH-controlled batch cultures. The effects on the major groups of microbiota were monitored over 48 h incubations by fluorescence in situ hybridisation. Short-chain fatty acids (SCFAs) were measured by high-performance liquid chromatography (HPLC). Furthermore, the death kinetics of Lactobacillus acidophilus, Bifidobacterium animalis subsp. lactis, Staphylococcus aureus, and Salmonella Typhimurium in a saline solution supplemented with GFB or CB were also assessed. The experiments in saline solution pinpointed that GFB prolonged the survival of L. acidophilus and exerted an antibacterial effect towards S. aureus and S. Typhimurium. Moreover, GFB modulated the intestinal microbiota in vitro, promoting changes in lactobacilli and bifidobacteria members in coeliac subjects. A final multivariate approach combining both viable counts and metabolites suggested that GFB could beneficially modulate the coeliac gut microbiome; however, human studies are needed to prove its efficacy.	[Bevilacqua, Antonio; Landriscina, Loretta; Ciuffreda, Emanuela; D'Agnello, Paola; Corbo, Maria Rosaria; Sinigaglia, Milena; Lamacchia, Carmela] Univ Foggia, Dept Sci Agr Food & Environm, Via Foggia, Foggia, Italy; [Costabile, Adele; Bergillos-Meca, Triana; Gonzalez, Isidro] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Costabile, Adele] Univ Roehampton, Hlth Sci Res Ctr, Dept Life Sci, Whitelands Coll, London, England	University of Foggia; University of Reading; Roehampton University	Lamacchia, C (corresponding author), Univ Foggia, Dept Sci Agr Food & Environm, Via Foggia, Foggia, Italy.	carmela.lamacchia@unifg.it		Costabile, Adele/0000-0003-3185-030X; Bevilacqua, Antonio/0000-0002-2118-9186	Casillo Group	Casillo Group	Casillo Group supported the research, but the funder had no role in any aspect of the research (design, data collection and analysis, decision to publish, preparation of the manuscript).	Altieri C, 2008, FOOD MICROBIOL, V25, P729, DOI 10.1016/j.fm.2008.03.005; Altieri C, 2013, ANAEROBE, V23, P23, DOI 10.1016/j.anaerobe.2013.07.008; Altieri C, 2011, J FOOD SCI, V76, pM336, DOI 10.1111/j.1750-3841.2011.02269.x; Bevilacqua A, 2008, J FOOD PROTECT, V71, P1366, DOI 10.4315/0362-028X-71.7.1366; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; Collado Maria Carmen, 2007, Curr Issues Intest Microbiol, V8, P9; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Costabile A, 2014, PLOS ONE, V30, P9; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Galipeau HJ, 2014, GUT MICROBES, V5, P594, DOI 10.4161/19490976.2014.969635; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Kang Jo-Eun, 2015, Prev Nutr Food Sci, V20, P78, DOI 10.3746/pnf.2015.20.1.78; Krishnan S, 2015, CURR OPIN BIOTECH, V36, P137, DOI 10.1016/j.copbio.2015.08.015; Lamacchia C, 2015, BIOVARIACONGRESS EUR; Lamacchia C., 2015, Italian Patent, Patent No. 0001414717; Lamacchia C, 2015, Patent Cooperation Treaty, Patent No. [PCT/IB 2013/000797, 2013000797]; Lamacchia C, 2016, FOOD CHEM, V197, P634, DOI 10.1016/j.foodchem.2015.11.016; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Maccaferri S, 2012, MOL NUTR FOOD RES, V56, P1342, DOI 10.1002/mnfr.201200046; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Malanovic N, 2016, BBA-BIOMEMBRANES, V1858, P936, DOI 10.1016/j.bbamem.2015.11.004; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; New Gluten World, Italian priority patent, Patent No. 102015000084813; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oda H, 2013, APPL ENVIRON MICROB, V79, P1843, DOI 10.1128/AEM.03343-12; Rizzello CG, 2007, APPL ENVIRON MICROB, V73, P4499, DOI 10.1128/AEM.00260-07; Rosero JA, 2016, INT J SYST EVOL MICR, V66, P768, DOI 10.1099/ijsem.0.000788; Rossi M, 2010, J LEUKOCYTE BIOL, V87, P749, DOI 10.1189/jlb.1209784; Sanchez E, 2013, APPL ENVIRON MICROB, V79, P5472, DOI 10.1128/AEM.00869-13; Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x; Schippa S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-175; Sugahara H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13548; Tejero-Sarinena S, 2012, ANAEROBE, V18, P530, DOI 10.1016/j.anaerobe.2012.08.004; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wacklin P, 2014, AM J GASTROENTEROL, V109, P1933, DOI 10.1038/ajg.2014.355; Wacklin P, 2013, INFLAMM BOWEL DIS, V19, P934, DOI 10.1097/MIB.0b013e31828029a9; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	49	16	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162770	10.1371/journal.pone.0162770	http://dx.doi.org/10.1371/journal.pone.0162770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632361	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000383706900077
J	Gieraltowski, L; Higa, J; Peralta, V; Green, A; Schwensohn, C; Rosen, H; Libby, T; Kissler, B; Marsden-Haug, N; Booth, H; Kimura, A; Grass, J; Bicknese, A; Tolar, B; Defibaugh-Chavez, S; Williams, I; Wise, M				Gieraltowski, Laura; Higa, Jeffrey; Peralta, Vi; Green, Alice; Schwensohn, Colin; Rosen, Hilary; Libby, Tanya; Kissler, Bonnie; Marsden-Haug, Nicola; Booth, Hillary; Kimura, Akiko; Grass, Julian; Bicknese, Amelia; Tolar, Beth; Defibaugh-Chavez, Stephanie; Williams, Ian; Wise, Matthew		Salmonella Heidelberg Invest Team	National Outbreak of Multidrug Resistant Salmonella Heidelberg Infections Linked to a Single Poultry Company	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; UNITED-STATES; FOOD ANIMALS; SEROTYPE	Importance This large outbreak of foodborne salmonellosis demonstrated the complexity of investigating outbreaks linked to poultry products. The outbreak also highlighted the importance of efforts to strengthen food safety policies related to Salmonella in chicken parts and has implications for future changes within the poultry industry. Objective To investigate a large multistate outbreak of multidrug resistant Salmonella Heidelberg infections. Design Epidemiologic and laboratory investigations of patients infected with the outbreak strains of Salmonella Heidelberg and traceback of possible food exposures. Setting United States. Outbreak period was March 1, 2013 through July 11, 2014 Patients A case was defined as illness in a person infected with a laboratory-confirmed Salmonella Heidelberg with 1 of 7 outbreak pulsed-field gel electrophoresis (PFGE) XbaI patterns with illness onset from March 1, 2013 through July 11, 2014. A total of 634 case-patients were identified through passive surveillance; 200/528 (38%) were hospitalized, none died. Results Interviews were conducted with 435 case-patients: 371 (85%) reported eating any chicken in the 7 days before becoming ill. Of 273 case-patients interviewed with a focused questionnaire, 201 (74%) reported eating chicken prepared at home. Among case-patients with available brand information, 152 (87%) of 175 patients reported consuming Company A brand chicken. Antimicrobial susceptibility testing was completed on 69 clinical isolates collected from case-patients; 67% were drug resistant, including 24 isolates (35%) that were multidrug resistant. The source of Company A brand chicken consumed by case-patients was traced back to 3 California production establishments from which 6 of 7 outbreak strains were isolated. Conclusions Epidemiologic, laboratory, traceback, and environmental investigations conducted by local, state, and federal public health and regulatory officials indicated that consumption of Company A chicken was the cause of this outbreak. The outbreak involved multiple PFGE patterns, a variety of chicken products, and 3 production establishments, suggesting a reservoir for contamination upstream from the production establishments. Sources of bacteria and genes responsible for resistance, such as farms providing birds for slaughter or environmental reservoir on farms that raise chickens, might explain how multiple PFGE patterns were linked to chicken from 3 separate production establishments and many different poultry products.	[Gieraltowski, Laura; Schwensohn, Colin; Grass, Julian; Bicknese, Amelia; Tolar, Beth; Williams, Ian; Wise, Matthew] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Gardena, CA USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Richmond, CA USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Sacramento, CA USA; [Libby, Tanya] Calif Emerging Infect Program, Oakland, CA USA; [Marsden-Haug, Nicola] Washington State Dept Hlth, Olympia, WA USA; [Booth, Hillary] Oregon Publ Hlth Div, Portland, OR USA; [Green, Alice; Kissler, Bonnie; Defibaugh-Chavez, Stephanie] US Food Safety & Inspect Serv, Off Publ Hlth Sci, USDA, Washington, DC 20250 USA	Centers for Disease Control & Prevention - USA; California Department of Public Health; California Department of Public Health; California Department of Public Health; California Emerging Infections Program; United States Department of Agriculture (USDA)	Gieraltowski, L (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA.	LGieraltowski@cdc.gov	Brown, Allison Cory/ABB-3230-2021	Brown, Allison Cory/0000-0003-0011-0309; Libby, Tanya/0000-0002-8569-9206; Bhatnagar, Amelia/0000-0003-3859-0328; /0000-0003-2270-5573				BARNHART HM, 1993, AVIAN DIS, V37, P977, DOI 10.2307/1591902; CDC, MULT OUTBR HUM SALM; CDC, 2013, NAT ANT RES MON SYST; CDC, 2014, FOODB DIS ACT SURV N; Folster JP, 2012, FOODBORNE PATHOG DIS, V9, P638, DOI 10.1089/fpd.2012.1130; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 2013, NAT ANT ERS MON SYST; Naugle AL, 2005, J FOOD PROTECT, V68, P462, DOI 10.4315/0362-028X-68.3.462; Routh JA, 2015, EPIDEMIOL INFECT, V143, P3227, DOI 10.1017/S0950268815000497; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; U.S. Centers for Disease Control and Prevention, 2007, FOODB DIS ACT SURV N; United States Department of Agriculture, 2012, NAT MICR BAS DAT COL; US Food and Drug Administration, 2015, NAT ANT RES MON SYST; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08	17	64	64	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162369	10.1371/journal.pone.0162369	http://dx.doi.org/10.1371/journal.pone.0162369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631492	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900041
J	Kuo, SM				Kuo, Shiu-Ming			Gender Difference in Bacteria Endotoxin-Induced Inflammatory and Anorexic Responses	PLOS ONE			English	Article							INDUCED SICKNESS BEHAVIOR; TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSE; FOOD-INTAKE; LIPOPOLYSACCHARIDE; MICE; BRAIN; INTERLEUKIN-10; DISEASE; LIVER	Inflammation-related anorexic response has been observed in systemic diseases as well as in localized infection and is an important issue in patient care. We tested the hypothesis that upon the same endotoxin exposure, males have more severe inflammatory responses and thus suffer from more negative effect on appetite. Ten-week old male and female mice were compared in their plasma levels of pro-inflammatory cytokines after a body weight-based i.p. injection of bacterial endotoxin lipopolysaccharide. Male mice consistently showed significantly higher levels of IL6 and TNF alpha than female mice. The difference was observed starting at 3 hours after the systemic endotoxin exposure. It was independent of the level of endotoxin dosage and of the genotype of the anti-inflammatory cytokine, IL10. Interestingly, endotoxin-injected male mice also had significantly higher plasma IL10 levels compared to the female mice. Pre-puberty young mice showed no gender differences in the plasma levels of IL6, TNFa and IL10. Their cytokine levels were mostly between that of the adult males and females. Consistent with the higher inflammatory response in malemice, the endotoxin exposure also led to significantly more appetite loss in male mice at a range of doses in two strains of mice. Saline injection in the absence of endotoxin affected neither the cytokine levels nor the appetite. Although a direct mechanistic link between inflammation parameters and appetite was not addressed here, the results support that male gender could be a risk factor for higher pro-inflammatory cytokines and anorexic response after the endotoxin exposure.	[Kuo, Shiu-Ming] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kuo, SM (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			University at Buffalo Gender Institute	University at Buffalo Gender Institute	This study was supported partly by a University at Buffalo Gender Institute Research Award. Beside University at Buffalo Gender Institute, there was no additional external funding received for this study.	Biesmans S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/716920; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Chaskiel L, 2016, NEUROPHARMACOLOGY, V107, P146, DOI 10.1016/j.neuropharm.2016.03.030; Coyle SM, 2006, SHOCK, V26, P538, DOI 10.1097/01.shk.0000232589.39001.4d; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; DISANTO E, 1995, NEUROIMMUNOMODULAT, V2, P149, DOI 10.1159/000096885; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Geary N, 2004, PHYSIOL BEHAV, V82, P251, DOI 10.1016/j.physbeh.2004.03.034; Hill NE, 2015, CRIT CARE MED, V43, pE84, DOI 10.1097/CCM.0000000000000854; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Konsman JP, 2001, NUTRITION, V17, P664, DOI 10.1016/S0899-9007(01)00602-5; Kuo SM, 2005, J NUTR, V135, P2411, DOI 10.1093/jn/135.10.2411; Kuo SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060270; Kuo SM, 2004, J NUTR, V134, P2216; Lasselin J, 2016, CURR OPIN PHARMACOL, V29, P34, DOI 10.1016/j.coph.2016.05.003; Leon LR, 1999, AM J PHYSIOL-REG I, V276, pR81, DOI 10.1152/ajpregu.1999.276.1.R81; Masso-Welch PA, 2012, IMMUNOL INVEST, V41, P521, DOI 10.3109/08820139.2012.684193; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Moxley G, 2004, J RHEUMATOL, V31, P686; Nasir N, 2015, PAK J MED SCI, V31, P1201, DOI 10.12669/pjms.315.6925; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Peluso I, 2016, HUM IMMUNOL, V77, P47, DOI 10.1016/j.humimm.2015.10.008; Razmara A, 2005, AM J PHYSIOL-HEART C, V289, pH1843, DOI 10.1152/ajpheart.00465.2005; Roberts BJ, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-25; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Speyer CL, 2005, AM J PHYSIOL-CELL PH, V288, pC881, DOI 10.1152/ajpcell.00467.2004; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Trentzsch H, 2003, CRIT CARE MED, V31, P232, DOI 10.1097/00003246-200301000-00036; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wegner A, 2015, PAIN, V156, P1954, DOI 10.1097/j.pain.0000000000000256	37	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162971	10.1371/journal.pone.0162971	http://dx.doi.org/10.1371/journal.pone.0162971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631979	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900104
J	Stanger, FV; Harms, A; Dehio, C; Schirmer, T				Stanger, Frederic V.; Harms, Alexander; Dehio, Christoph; Schirmer, Tilman			Crystal Structure of the Escherichia coli Fic Toxin-Like Protein in Complex with Its Cognate Antitoxin	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; CYCLIC-AMP; DOMAIN; DOC; AMPYLATION; FILAMENTATION; ADENYLYLATION	FIC domain proteins mediate post-translational modifications of target proteins, which typically results in their inactivation. Depending on the conservation of crucial active site residues, the FIC fold serves as structural scaffold for various enzymatic activities, mostly target adenylylation. The founding member of the vast Fic protein family, EcFicT, was identified in Escherichia coli some time ago. The G55R point mutant of EcFicT displays the "filamentation induced by cAMP" (Fic) phenotype at high 3', 5'-cyclic adenosine monophosphate (cAMP) concentrations and elevated temperature, but the underlying molecular mechanism and any putative biochemical activity of EcFicT have remained unknown. EcFicT belongs to class vertical bar Fic toxin proteins that are encoded together with a small inhibitory protein (antitoxin), named EcFicA in E. coli. Here, we report the crystal structures of two mutant EcFicT/EcFicA complexes (EcFicT(G55RA) and EcFicTA(E28G)) both showing close resemblance with the structure of the AMP-transferase VbhT from Bartonella schoenbuchensis in complex with its cognate antitoxin VbhA. However, crucial differences in the active site of EcFicT compared to VbhT and other AMP-transferases rationalize the lack of evidence for adenylylation activity. Comprehensive bioinformatic analysis suggests that EcFicT has evolved from canonical AMP-transferases and has acquired a conserved binding site for a yet to be discovered novel substrate. The G55R mutation has no effect on structure or thermal stability of EcFicT, such that the molecular basis for its associated Fic phenotype remains elusive. We anticipate that this structure will inspire further bioinformatic and experimental analyses in order to characterize the enzymatic activity of EcFicT and help revealing its physiological role.	[Stanger, Frederic V.; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland; [Stanger, Frederic V.; Harms, Alexander; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland; [Stanger, Frederic V.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Harms, Alexander] Univ Copenhagen, Dept Biol, Ctr Excellence Bacterial Stress Response & Persis, Copenhagen, Denmark	University of Basel; University of Basel; Johns Hopkins University; University of Copenhagen	Schirmer, T (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland.; Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.	christoph.dehio@unibas.ch; tilman.schirmer@unibas.ch	Dehio, Christoph/R-8277-2016; Harms, Alexander/J-5710-2019; Dehio, Christoph/AAD-5572-2019	Dehio, Christoph/0000-0001-7288-1052; Harms, Alexander/0000-0003-2106-1286; Dehio, Christoph/0000-0001-7288-1052; Stanger, Frederic/0000-0002-9847-5084	European Research Council (ERC) [FICModFun 340330]; Swiss National Science Foundation (SNSF) [310030B-149886, 31003A_138414]; ERC [FICModFun 340330]; SNF [310030B-149886, 31003A_138414]	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); SNF	This work was supported by the European Research Council (ERC) Advanced Grant FICModFun 340330 (to CD) and Swiss National Science Foundation (SNSF) grants 310030B-149886 (to CD) and 31003A_138414 (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Arnaud Goepfert and Nikolaus Schmitz for critical reading of the manuscript. We thank the staff of beam-lines X06DA and X06SA of the Swiss Light Source (Villigen, Switzerland) for their excellent support. This work was supported by the ERC Advanced Grant FICModFun 340330 (to CD) and SNF grants 310030B-149886 (to CD) and 31003A_138414 (to TS).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castello Paiva Daniel, 2013, Natural and Artificial Models in Computation and Biology. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings, Part I: LNCS 7930, P1, DOI 10.1007/978-3-642-38637-4_1; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Gieter S, 2014, J BIOL CHEM, V289, P34013, DOI 10.1074/jbc.M114.572396; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goepfert A, 2012, TYPE II TOXIN ANTITO, P177; Goepfert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064901; Harms A, 2016, ANN REV MICROBIOL, V70; Harms A, 2015, CELL REP, V12, P1497, DOI 10.1016/j.celrep.2015.07.056; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988; KAWAMUKAI M, 1989, J BACTERIOL, V171, P4525, DOI 10.1128/JB.171.8.4525-4529.1989; Khater S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10804; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KOMANO T, 1991, RES MICROBIOL, V142, P269, DOI 10.1016/0923-2508(91)90040-H; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee CC, 2004, STRUCTURE, V12, P487, DOI 10.1016/j.str.2004.02.013; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lu CH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0446; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Roy CR, 2015, NAT REV MICROBIOL, V13, P631, DOI 10.1038/nrmicro3520; Stanger FV, 2016, P NATL ACAD SCI USA, V113, pE529, DOI 10.1073/pnas.1516930113; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982; UTSUMI R, 1981, J BACTERIOL, V147, P1105, DOI 10.1128/JB.147.3.1105-1109.1981; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	46	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							0163654	10.1371/journal.pone.0163654	http://dx.doi.org/10.1371/journal.pone.0163654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657533	Green Accepted, gold, Green Published			2022-12-27	WOS:000383893200156
J	Aarts, JMMJG; Alink, GM; Scherjon, F; MacDonald, K; Smith, AC; Nijveen, H; Roebroeks, W				Aarts, Jac M. M. J. G.; Alink, Gerrit M.; Scherjon, Fulco; MacDonald, Katharine; Smith, Alison C.; Nijveen, Harm; Roebroeks, Wil			Fire Usage and Ancient Hominin Detoxification Genes: Protective Ancestral Variants Dominate While Additional Derived Risk Variants Appear in Modern Humans	PLOS ONE			English	Article							HETEROCYCLIC AROMATIC-AMINES; ARYL-HYDROCARBON RECEPTOR; EPOXIDE-DNA ADDUCTS; GENOME SEQUENCE; TRYPTOPHAN PHOTOPRODUCTS; MATERNAL SMOKING; TOBACCO-SMOKE; AH RECEPTOR; CYP1A1; POLYMORPHISMS	Studies of the defence capacity of ancient hominins against toxic substances may contribute importantly to the reconstruction of their niche, including their diets and use of fire. Fire usage implies frequent exposure to hazardous compounds from smoke and heated food, known to affect general health and fertility, probably resulting in genetic selection for improved detoxification. To investigate whether such genetic selection occurred, we investigated the alleles in Neanderthals, Denisovans and modern humans at gene polymorphisms well-known to be relevant from modern human epidemiological studies of habitual tobacco smoke exposure and mechanistic evidence. We compared these with the alleles in chimpanzees and gorillas. Neanderthal and Denisovan hominins predominantly possess gene variants conferring increased resistance to these toxic compounds. Surprisingly, we observed the same in chimpanzees and gorillas, implying that less efficient variants are derived and mainly evolved inmodern humans. Less efficient variants are observable from the first early Upper Palaeolithic hunter-gatherers onwards. While not clarifying the deep history of fire use, our results highlight the long-term stability of the genes under consideration despite major changes in the hominin dietary niche. Specifically for detoxification gene variants characterised as deleterious by epidemiological studies, our results confirm the predominantly recent appearance reported for deleterious human gene variants, suggesting substantial impact of recent human population history, including pre-Holocene expansions.	[Aarts, Jac M. M. J. G.; Alink, Gerrit M.; Scherjon, Fulco; MacDonald, Katharine; Smith, Alison C.; Roebroeks, Wil] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Aarts, Jac M. M. J. G.] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, Wageningen, Netherlands; [Alink, Gerrit M.] Wageningen Univ, Div Toxicol, Dept Agrotechnol & Food Sci, Wageningen, Netherlands; [Nijveen, Harm] Wageningen Univ, Dept Plant Sci, Bioinformat Grp, Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Aarts, JMMJG (corresponding author), Leiden Univ, Fac Archaeol, Leiden, Netherlands.; Aarts, JMMJG (corresponding author), Wageningen Univ, Dept Plant Sci, Mol Biol Lab, Wageningen, Netherlands.	jac.aarts@wur.nl	; Nijveen, Harm/L-2272-2014	Roebroeks, Wil/0000-0002-5075-6899; MacDonald, Katharine/0000-0003-0411-9589; Scherjon, Fulco/0000-0002-5859-8813; Nijveen, Harm/0000-0002-9167-4945	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [28-548]; Koninklijke Nederlandse Akademie van Wetenschappen (KNAW)	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Koninklijke Nederlandse Akademie van Wetenschappen (KNAW)	This research was financially supported by the following grants to WR: 1. Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO; http://www.nwo.nl/en): Spinoza Grant 28-548; 2. Koninklijke Nederlandse Akademie van Wetenschappen (KNAW; https://www.knaw.nl/en): Academy Professor Prize program 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh I, 2010, B ENVIRON CONTAM TOX, V84, P23, DOI 10.1007/s00128-009-9889-z; ALINK GM, 1989, FOOD CHEM TOXICOL, V27, P427, DOI 10.1016/0278-6915(89)90028-8; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ande A, 2013, MINI-REV ORG CHEM, V10, P384, DOI 10.2174/1570193X113106660023; Ardayfio-Schandorf E, 1993, Health Care Women Int, V14, P375; Arlt VM, 2012, TOXICOL LETT, V213, P160, DOI 10.1016/j.toxlet.2012.06.016; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; BRITTEBO EB, 1994, FOOD CHEM TOXICOL, V32, P717, DOI 10.1016/S0278-6915(09)80004-5; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Ding KY, 2008, PHARMACOGENET GENOM, V18, P169, DOI 10.1097/FPC.0b013e3282f44d99; Eichholzer M, 2012, INT J MOL EPIDEMIOL, V3, P96; EMA M, 1994, J BIOL CHEM, V269, P27337; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Flaveny CA, 2010, TOXICOL SCI, V114, P217, DOI 10.1093/toxsci/kfp308; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; FREEMAN DJ, 1990, ENVIRON SCI TECHNOL, V24, P1581, DOI 10.1021/es00080a019; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Gowlett JAJ, 2006, CR PALEVOL, V5, P299, DOI 10.1016/j.crpv.2005.10.008; Gowlett JAJ, 2013, AZANIA, V48, P5, DOI 10.1080/0067270X.2012.756754; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gu AH, 2010, FERTIL STERIL, V94, P2620, DOI 10.1016/j.fertnstert.2010.04.059; Hanna IH, 2000, CANCER RES, V60, P3440; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Henn BM, 2016, P NATL ACAD SCI USA, V113, pE440, DOI 10.1073/pnas.1510805112; Henn BM, 2015, NAT REV GENET, V16, P333, DOI 10.1038/nrg3931; Henry AG, 2014, J HUM EVOL, V69, P44, DOI 10.1016/j.jhevol.2013.12.014; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hublin JJ, 2014, SCIENCE, V344, P1338, DOI 10.1126/science.1255554; Ikeda Y, 1999, TOXICOL PATHOL, V27, P628, DOI 10.1177/019262339902700603; Ji GX, 2008, REPROD BIOMED ONLINE, V17, P36, DOI 10.1016/S1472-6483(10)60290-8; Ji GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013145; Jonsson ME, 2009, CHEM-BIOL INTERACT, V181, P447, DOI 10.1016/j.cbi.2009.07.003; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Korkina LG, 2008, CURR DRUG METAB, V9, P710, DOI 10.2174/138920008786049267; Lammer EJ, 2004, EPIDEMIOLOGY, V15, P150, DOI 10.1097/01.ede.0000112214.33432.cc; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lee-Hilz YY, 2006, CHEM RES TOXICOL, V19, P1499, DOI 10.1021/tx060157q; Lodovici M, 2004, CANCER EPIDEM BIOMAR, V13, P1342; Martinez-Cadenas C, 2013, MOL BIOL EVOL, V30, P2654, DOI 10.1093/molbev/mst158; MCCORMICK JP, 1978, J AM CHEM SOC, V100, P312, DOI 10.1021/ja00469a068; Metry KJ, 2009, DRUG METAB DISPOS, V37, P2123, DOI 10.1124/dmd.109.029512; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mishra V, 2005, INT J ENVIRON HEAL R, V15, P397, DOI 10.1080/09603120500288913; Moonen HJJ, 2004, MOL CARCINOGEN, V40, P180, DOI 10.1002/mc.20032; Moorjani P, 2016, P NATL ACAD SCI USA, V113, P5652, DOI 10.1073/pnas.1514696113; Mukai M, 2007, TOXICOL SCI, V95, P172, DOI 10.1093/toxsci/kfl126; Mukhopadhyay D, 2010, FERTIL STERIL, V94, P595, DOI 10.1016/j.fertnstert.2009.02.031; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Nebert DW, 1999, DRUG METAB REV, V31, P467, DOI 10.1081/DMR-100101931; Park JYK, 1996, P NATL ACAD SCI USA, V93, P2322, DOI 10.1073/pnas.93.6.2322; Perrin J, 2011, FERTIL STERIL, V95, P2013, DOI 10.1016/j.fertnstert.2011.02.021; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin YF, 2012, GENE, V510, P171, DOI 10.1016/j.gene.2012.09.016; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sanchez-Quinto F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0374; Sandel AA, 2013, AM J PHYS ANTHROPOL, V152, P145, DOI 10.1002/ajpa.22333; Sandgathe DM, 2011, P NATL ACAD SCI USA, V108, pE298, DOI 10.1073/pnas.1106759108; SAVELA K, 1991, CARCINOGENESIS, V12, P503, DOI 10.1093/carcin/12.3.503; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Shi Min, 2008, Birth Defects Research, V84, P16, DOI 10.1002/bdrc.20117; Shimelmitz R, 2014, J HUM EVOL, V77, P196, DOI 10.1016/j.jhevol.2014.07.005; Skog KI, 1998, FOOD CHEM TOXICOL, V36, P879, DOI 10.1016/S0278-6915(98)00061-1; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; Suryanarayana V, 2004, HUM REPROD, V19, P2648, DOI 10.1093/humrep/deh463; Tiemersma EW, 2004, INT J CANCER, V108, P97, DOI 10.1002/ijc.11533; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Turesky RJ, 2007, TOXICOL LETT, V168, P219, DOI 10.1016/j.toxlet.2006.10.018; Vrba J, 2012, PHYTOTHER RES, V26, P1746, DOI 10.1002/ptr.4637; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wrangham RW, 2009, CATCHING FIRE COOKIN; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159	99	7	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161102	10.1371/journal.pone.0161102	http://dx.doi.org/10.1371/journal.pone.0161102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DW8GK	27655273	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700006
J	Lam, J; Sutton, P; Kalkbrenner, A; Windham, G; Halladay, A; Koustas, E; Lawler, C; Davidson, L; Daniels, N; Newschaffer, C; Woodruff, T				Lam, Juleen; Sutton, Patrice; Kalkbrenner, Amy; Windham, Gayle; Halladay, Alycia; Koustas, Erica; Lawler, Cindy; Davidson, Lisette; Daniels, Natalyn; Newschaffer, Craig; Woodruff, Tracey			A Systematic Review and Meta-Analysis of Multiple Airborne Pollutants and Autism Spectrum Disorder	PLOS ONE			English	Review							HAZARDOUS AIR-POLLUTANTS; EVIDENCE-BASED MEDICINE; ENVIRONMENTAL-HEALTH SCIENCE; PARTICULATE MATTER; NEURODEVELOPMENTAL DISORDERS; OCCUPATIONAL EXPOSURES; RESIDENTIAL PROXIMITY; AMBIENT AIR; POLLUTION; RISK	Background Exposure to ambient air pollution is widespread and may be detrimental to human brain development and a potential risk factor for Autism Spectrum Disorder (ASD). We conducted a systematic review of the human evidence on the relationship between ASD and exposure to all airborne pollutants, including particulate matter air pollutants and others (e.g. pesticides and metals). Objective To answer the question: "is developmental exposure to air pollution associated with ASD?" Methods We conducted a comprehensive search of the literature, identified relevant studies using inclusion/exclusion criteria pre-specified in our protocol (registered in PROSPERO, CRD #42015017890), evaluated the potential risk of bias for each included study and identified an appropriate subset of studies to combine in a meta-analysis. We then rated the overall quality and strength of the evidence collectively across all air pollutants. Results Of 1,158 total references identified, 23 human studies met our inclusion criteria (17 case-control, 4 ecological, 2 cohort). Risk of bias was generally low across studies for most domains; study limitations were related to potential confounding and accuracy of exposure assessment methods. We rated the quality of the body of evidence across all air pollutants as "moderate." From our meta-analysis, we found statistically significant summary odds ratios (ORs) of 1.07 (95% CI: 1.06, 1.08) per 10-mu g/m(3) increase in PM10 exposure (n = 6 studies) and 2.32 (95% CI: 2.15, 2.51) per 10-mu g/m(3) increase in PM2.5 exposure (n = 3 studies). For pollutants not included in a meta-analysis, we collectively evaluated evidence from each study in rating the strength and quality of overall evidence considering factors such as inconsistency, imprecision, and evidence of dose-response. All included studies generally showed increased risk of ASD with increasing exposure to air pollution, although not consistently across all chemical components. Conclusion After considering strengths and limitations of the body of research, we concluded that there is "limited evidence of toxicity" for the association between early life exposure to air pollution as a whole and diagnosis of ASD. The strongest evidence was between prenatal exposure to particulate matter and ASD. However, the small number of studies in the meta-analysis and unexplained statistical heterogeneity across the individual study estimates means that the effect could be larger or smaller (including not significant) than these studies estimate. Our research supports the need for health protective public policy to reduce exposures to harmful airborne contaminants among pregnant women and children and suggests opportunities for optimizing future research.	[Lam, Juleen; Sutton, Patrice; Daniels, Natalyn; Woodruff, Tracey] Univ Calif San Francisco, Program Reprod Hlth & Environm, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Kalkbrenner, Amy] Univ Wisconsin Milwaukee, Joseph J Zilber Sch Publ Hlth, Milkwaukee, WI USA; [Windham, Gayle] Calif Dept Publ Hlth, Div Environm & Occupat Dis Control, Richmond, CA USA; [Halladay, Alycia] Autism Sci Fdn, New York, NY USA; [Halladay, Alycia] Rutgers State Univ, Dept Pharmacol & Toxicol, New Brunswick, NJ USA; [Koustas, Erica] Univ Calif San Francisco, Sci Consultant, San Francisco, CA 94143 USA; [Lawler, Cindy] NIEHS, Div Extramural Res & Training, POB 12233, Res Triangle Pk, NC 27709 USA; [Davidson, Lisette] Kaiser Permanente, Dept Obstet & Gynecol, Oakland, CA USA; [Newschaffer, Craig] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Milwaukee; California Department of Public Health; Rutgers State University New Brunswick; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kaiser Permanente; Drexel University	Lam, J (corresponding author), Univ Calif San Francisco, Program Reprod Hlth & Environm, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	Juleen.Lam@ucsf.edu	Kalkbrenner, Amy/AAC-3297-2019	Woodruff, Tracey/0000-0003-3622-1297	Autism Speaks; P01 grant from the US Environmental Protection Agency and National Institute of Environmental Health Sciences; NIEHS [P01ES022841]; USEPA [83543301]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022841] Funding Source: NIH RePORTER	Autism Speaks; P01 grant from the US Environmental Protection Agency and National Institute of Environmental Health Sciences; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); USEPA(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work of JL, PS, ND, TW was supported in part by a grant from Autism Speaks (https://www.autismspeaks.org/) and by a P01 grant from the US Environmental Protection Agency and National Institute of Environmental Health Sciences (https://www3.epa.gov/; http://www.niehs.nih.gov/). NIEHS grant number: P01ES022841; USEPA grant number: 83543301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, IARC MON EV CARC RIS; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Blanchard K. Stephen, 2011, Reviews on Environmental Health, V26, P111, DOI 10.1515/REVEH.2011.015; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2009, TOXICOL PATHOL, V37, P644, DOI 10.1177/0192623309340277; Calderon-Garciduerias L, 2011, BRAIN COGNITION, V77, P345, DOI 10.101661.bandc.2011.09.006; Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07; Chen H, 2008, REV ENV HLTH, V23; Costa LG, 2015, NEUROTOXICO IN PRESS; Costa LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736385; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; de Kok TMCM, 2006, MUTAT RES-REV MUTAT, V613, P103, DOI 10.1016/j.mrrev.2006.07.001; Dickerson AS, 2015, SCI TOTAL ENVIRON, V536, P245, DOI 10.1016/j.scitotenv.2015.07.024; Dickerson AS, 2016, PEDIATR PERINA UNPUB; ELLIOTT JH, 2015, NATURE, V527, P31; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Environmental Protection Agency U.S. (US EPA), LIM 1996 NAT SCAL AI; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Gong T, 2014, TWIN RES HUM GENET, V17, P553, DOI 10.1017/thg.2014.58; Grahame TJ, 2014, J AIR WASTE MANAGE, V64, P620, DOI 10.1080/10962247.2014.912692; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Guxens M, 2016, ENVIRON HEALTH PERSP, V124, P133, DOI 10.1289/ehp.1408483; Guxens M, 2012, ENVIRON HEALTH PERSP, V120, P144, DOI 10.1289/ehp.1103469; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hertz-Picciotto I, 2011, AUTISM SPECTRUM DISO, P827; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huffling K, 2016, ENVIRON HEALTH PERSP, V124, pA118, DOI 10.1289/EHP358; Johnson PI, 2014, ENVIRON HEALTH PERSP, V122, P1028, DOI 10.1289/ehp.1307893; Johnson PI, 2016, ENV INT; Jung CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075510; Kalkbrenner AE, 2015, EPIDEMIOLOGY, V26, P30, DOI 10.1097/EDE.0000000000000173; Kalkbrenner AE, 2014, CURR PROB PEDIATR AD, V44, P277, DOI 10.1016/j.cppeds.2014.06.001; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kim YS, 2015, BIOL PSYCHIAT, V77, P66, DOI 10.1016/j.biopsych.2014.11.001; Koustas E, 2014, ENVIRON HEALTH PERSP, V122, P1015, DOI 10.1289/ehp.1307177; Lam J, 2014, SYSTEMATIC REV HUMAN; Lam J, 2014, ENVIRON HEALTH PERSP, V122, P1040, DOI 10.1289/ehp.1307923; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Lawler CP, 2008, ENVIRON HEALTH PERSP, V116, pA416, DOI 10.1289/ehp.12107; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Lewandowski TA, 2009, J TOXICOL ENV HEAL A, V72, P1592, DOI 10.1080/15287390903232483; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; Lyall K, 2014, INT J EPIDEMIOL, V43, P443, DOI 10.1093/ije/dyt282; Mandy W, 2016, J CHILD PSYCHOL PSYC, V57, P271, DOI 10.1111/jcpp.12501; McCanlies EC, 2012, J AUTISM DEV DISORD, V42, P2323, DOI 10.1007/s10803-012-1468-1; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; National Research Council, 2000, SCI FRONT DEV TOX RI, Vxviii; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Pino-Lopez M, 2013, REV ESP SALUD PUBLIC, V87, P73, DOI 10.4321/S1135-57272013000100008; Raz R, 2015, ENVIRON HEALTH PERSP, V123, P264, DOI 10.1289/ehp.1408133; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Rooney AA, 2014, ENVIRON HEALTH PERSP, V122, P711, DOI 10.1289/ehp.1307972; Rosenbaum AS, 1999, J AIR WASTE MANAGE, V49, P1138, DOI 10.1080/10473289.1999.10463919; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sawaya GF, 2007, UPDATE METHODS ESTIM; Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suades-Gonzalez E, 2015, ENDOCRINOLOGY, V156, P3473, DOI 10.1210/en.2015-1403; Talbott EO, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0064-1; Talbott EO, 2015, ENVIRON RES, V140, P414, DOI 10.1016/j.envres.2015.04.021; Tilson HA, 2013, ENVIRON HEALTH PERSP, V121, pA320, DOI 10.1289/ehp.1307676; Trousdale K, 2010, AUTISM SPECTRUM DISO; U. S. EPA, 1996, GUID REPR TOX RISK A; U. S. EPA (U. S. Environmental Protection Agency), 1991, GUID DEV TOX RISK AS; US Environmental Protection Agency, 2002, LIM 1996 NAT SCAL AI; van Berlo D, 2010, ARCH TOXICOL, V84, P553, DOI 10.1007/s00204-010-0551-7; Vesterinen HM, 2013, ENVIRON HEALTH PERSP, V121, pA325, DOI 10.1289/ehp.1307775; Vesterinen HM, 2014, J MATERN-FETAL NEO M, P1; Viswanathan M AM, 2012, METHODS GUIDE EFFECT; Volk HE, 2014, LIM 1996 NAT SCAL AI; Volk HE, 2014, EPIDEMIOLOGY, V2014; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; von Ehrenstein OS, 2014, EPIDEMIOLOGY, V25, P851, DOI 10.1097/EDE.0000000000000150; Wang SQ, 2009, ENVIRON HEALTH PERSP, V117, P1612, DOI 10.1289/ehp.0800023; Windham G, 2007, EPIDEMIOLOGY, V18, pS174; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Windham GC, 2013, AUTISM RES, V6, P57, DOI 10.1002/aur.1275; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Woodruff TJ, 2014, ENVIRON HEALTH PERSP, V122, P1007, DOI 10.1289/ehp.1307175; Woodruff TJ, 2011, HEALTH AFFAIR, V30, P931, DOI 10.1377/hlthaff.2010.1219; World Health Organisation, BURD DIS AMB AIR POL	90	124	126	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161851	10.1371/journal.pone.0161851	http://dx.doi.org/10.1371/journal.pone.0161851			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27653281	Green Published, gold			2022-12-27	WOS:000383892700012
J	Turesson, HK; Ribeiro, S; Pereira, DR; Papa, JP; de Albuquerque, VHC				Turesson, Hjalmar K.; Ribeiro, Sidarta; Pereira, Danillo R.; Papa, Joao P.; de Albuquerque, Victor Hugo C.			Machine Learning Algorithms for Automatic Classification of Marmoset Vocalizations	PLOS ONE			English	Article							COMMON MARMOSET; NEUROSCIENCE RESEARCH; CALL; RECOGNITION; SOUNDS	Automatic classification of vocalization type could potentially become a useful tool for acoustic the monitoring of captive colonies of highly vocal primates. However, for classification to be useful in practice, a reliable algorithm that can be successfully trained on small datasets is necessary. In this work, we consider seven different classification algorithms with the goal of finding a robust classifier that can be successfully trained on small datasets. We found good classification performance (accuracy > 0.83 and F-1-score > 0.84) using the Optimum Path Forest classifier. Dataset and algorithms are made publicly available.	[Turesson, Hjalmar K.; Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Inst Cerebro, Natal, RN, Brazil; [Pereira, Danillo R.; Papa, Joao P.] Univ Estadual Paulista, Dept Comp, Bauru, SP, Brazil; [de Albuquerque, Victor Hugo C.] Univ Fortaleza, Lab Bioinformat, Programa Posgrad Informat Aplicada, Fortaleza, Ceara, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Estadual Paulista; Universidade Fortaleza	Turesson, HK (corresponding author), Univ Fed Rio Grande do Norte, Inst Cerebro, Natal, RN, Brazil.	turesson@neuro.ufrn.br	Papa, Joao Paulo/ABC-6283-2020; de Albuquerque, Victor Hugo C./C-3677-2016; Ribeiro, Sidarta/C-5794-2016	Papa, Joao Paulo/0000-0002-6494-7514; de Albuquerque, Victor Hugo C./0000-0003-3886-4309; Ribeiro, Sidarta/0000-0001-9325-9545	National Council for Scientific and Technological Development [402422/2012-0, 470501/2013-8, 301928/2014-2, 470571/2013-6, 306166/2014-3]; Sao Paulo Research Foundation [2013/07699-0, 2014/16250-9, 2015/50319-9]; CNPq/BJT grant [402422/2012-0]; CNPq [470501/2013-8, 301928/2014-2, 470571/2013-6, 306166/2014-3]; FAPESP Research, Innovation and Dissemination Center for Neuromathematics (S. Paulo Research Foundation) [2013/07699-0]; FAPESP [2014/16250-9, 2015/50319-9]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/BJT grant; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP Research, Innovation and Dissemination Center for Neuromathematics (S. Paulo Research Foundation); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by National Council for Scientific and Technological Development 402422/2012-0 (http://cnpq.br/) HKT and SR; National Council for Scientific and Technological Development 470501/2013-8 and 301928/2014-2 (http://cnpq.br/) VHCA; Sao Paulo Research Foundation 2013/07699-0 (http://www.fapesp.br) SR; Sao Paulo Research Foundation 2014/16250-9 and 2015/50319-9 (http://www.fapesp.br) JPP; and National Council for Scientific and Technological Development 470571/2013-6 and 306166/2014-3 (http://cnpq.br/) JPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Daniel Y Takahashi for comments on the manuscript, and Thamiris Botelho, William Wood, Josy Pontes, Janaina Figueiredo, Bruno Soares, Maria Bernardete de Souza and the Primatology Center of UFRN for help with various aspects of housing & specialized marmoset care. Research equipment and HKT's stipend were funded by CNPq/BJT grant # 402422/2012-0 to SR and HKT. The last author thanks CNPq for providing financial support through a grants # 470501/2013-8 and # 301928/2014-2. The second author thanks the FAPESP Research, Innovation and Dissemination Center for Neuromathematics (grant # 2013/07699-0, S. Paulo Research Foundation). The fourth author thanks FAPESP grants # 2014/16250-9 and # 2015/50319-9, as well as CNPq grants # 470571/2013-6 and # 306166/2014-3.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Allene C, 2010, IMAGE VISION COMPUT, V28, P1460, DOI 10.1016/j.imavis.2009.06.017; Bezerra BM, 2006, THESIS; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Bezerra BM, 2009, PRIMATES, V50, P231, DOI 10.1007/s10329-009-0132-7; Briggs F, 2012, J ACOUST SOC AM, V131, P4640, DOI 10.1121/1.4707424; BUTYNSKI TM, 1992, AM J PRIMATOL, V28, P183, DOI 10.1002/ajp.1350280303; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Ceugniet M, 2004, CR BIOL, V327, P149, DOI 10.1016/j.crvi.2003.11.008; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COOMANS D, 1982, ANAL CHIM ACTA, V136, P15, DOI 10.1016/S0003-2670(01)95359-0; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Damoulas T., 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P424, DOI 10.1109/ICMLA.2010.69; Dayou J, 2011, INT PR CHEM BIO ENV, V3, P184; Deng Li., 2003, SPEECH PROCESSING DY; Duda R.O., 2000, PATTERN CLASSIFICATI; EPPLE G, 1968, FOLIA PRIMATOL, V8, P1, DOI 10.1159/000155129; Falcao AX, 2004, IEEE T PATTERN ANAL, V26, P19, DOI 10.1109/TPAMI.2004.1261076; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Hall P, 2008, ANN STAT, V36, P2135, DOI 10.1214/07-AOS537; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Horvat B, 2014, CURR OPIN VIROL, V9, P97, DOI 10.1016/j.coviro.2014.09.012; Huang CJ, 2009, EXPERT SYST APPL, V36, P3737, DOI 10.1016/j.eswa.2008.02.059; Jackson LB, 1996, DIGITAL FILTERS SIGN; Jarvis S., 2008, CAN ACOUST, V36, P34; Jaynes E., 2003, PROBABILITY THEORY L, DOI [10.1017/CBO9780511790423, DOI 10.1017/CBO9780511790423]; JONES BS, 1993, AM J PRIMATOL, V31, P67, DOI 10.1002/ajp.1350310107; Jones CB, 1997, MARMOSETS TAMARINS B, P145; Kanamori T, 2004, MOST ROBUST LOSS FUN, P496; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Lakshminarayanan B, 2009, EIGHTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P53, DOI 10.1109/ICMLA.2009.79; MACEDONIA JM, 1986, AM J PRIMATOL, V11, P163, DOI 10.1002/ajp.1350110208; McIlraith AL, 1997, IEEE T SIGNAL PROCES, V45, P2740, DOI 10.1109/78.650100; Mielke A, 2013, ANIM BEHAV, V86, P475, DOI 10.1016/j.anbehav.2013.04.017; Miller CT, 2010, AM J PRIMATOL, V72, P974, DOI 10.1002/ajp.20854; Molnar C, 2008, ANIM COGN, V11, P389, DOI 10.1007/s10071-007-0129-9; Okano H, 2015, PHILOS T R SOC B, V370, P33, DOI 10.1098/rstb.2014.0310; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Papa JP, 2009, INT J IMAG SYST TECH, V19, P120, DOI 10.1002/ima.20188; Papa JP, 2012, PATTERN RECOGN, V45, P512, DOI 10.1016/j.patcog.2011.07.013; Papa JP, 2008, LECT NOTES COMPUT SC, V5358, P935, DOI 10.1007/978-3-540-89639-5_89; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pozzi Luca, 2013, P305; Pozzi L, 2010, AM J PRIMATOL, V72, P337, DOI 10.1002/ajp.20786; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Scholkopf B., 2002, LEARNING KERNELS; Snowdon CT, 2004, VIENNA SER THEOR BIO, P131; SNOWDON CT, 1983, ANIM BEHAV, V31, P92, DOI 10.1016/S0003-3472(83)80177-8; Solomon SG, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00096; Stevenson M.F., 1988, P131; Stowell D, 2014, PEERJ, V2, DOI 10.7717/peerj.488; 't Hart BA, 2015, ANN CLIN TRANSL NEUR, V2, P581, DOI 10.1002/acn3.194; Turesson HK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01519; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Weninger F, 2011, INT CONF ACOUST SPEE, P337; Winter M., 1978, HEARN BIOL BEHAV MAR, P127; Witten I.H., 2005, DATA MINING PRACTICA; Zhu J, 2009, STAT INTERFACE, V2, P349	62	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163041	10.1371/journal.pone.0163041	http://dx.doi.org/10.1371/journal.pone.0163041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654941	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700036
J	Yang, G; Li, YZ; Cui, L; Jiang, HY; Li, X; Jin, CZ; Jin, DH; Zhao, GX; Jin, JY; Sun, R; Piao, LM; Xu, WH; Fang, CH; Lei, YN; Yuan, KC; Xuan, CH; Ding, DZ; Cheng, XW				Yang, Guang; Li, Yuzi; Cui, Lan; Jiang, Haiying; Li, Xiang; Jin, Chunzi; Jin, Dehao; Zhao, Guangxian; Jin, Jiyong; Sun, Rui; Piao, Limei; Xu, Wenhu; Fang, Chenghu; Lei, Yanna; Yuan, Kuichang; Xuan, Chunhua; Ding, Dazi; Cheng, Xianwu			Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR OUTCOMES; DPP4 ACTIVITIES; CATHEPSIN K; TASK-FORCE; IV; ATHEROSCLEROSIS; SITAGLIPTIN; INHIBITOR; OBESITY	Dipeptidyl peptidase-4 (DPP4) is one of the most potent mammalian serine proteases participated in the pathogenesis of subclinical atherosclerosis. Here we investigated whether the plasma soluble form of DPP4 is associated with the prevalence of coronary artery disease (CAD) with and without diabetes mellitus (DM). A cross-sectional study was conducted of 496 aged 26-81 years with (n = 362) and without (n = 134) CAD. Plasma DPP4 activity, high sensitive C-reactive protein (hs-CRP), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein levels were measured. The coronary atherosclerotic plaques were evaluated by coronary angiography. The CAD patients with (n = 84) and without (n = 278) DM had significantly higher DPP4 levels (11.8 +/- 3.1 vs. 6.9 +/- 3.5 ng/mL, P < 0.01) than the nonCAD subjects. The acute coronary syndrome patients (n = 299) had elevated DPP4 levels than those with stable angina patients (n = 83). CAD patients even without DM had increased plasma DPP4 activities as compared with nonCAD subjects (10.9 +/- 4.9 vs. 6.4 +/- 3.1, ng/L, P < 0.01). A linear regression analysis revealed that overall, the DPP4 levels were positively associated with LCL-C and hs-CRP levels as well as syntax scores. A multiple logistic regression analysis demonstrated that plasma DPP4 activity was independent predictor of CAD (odds ratio, 1.56; 95% CI, 1.19 +/- 1.73; P < 0.01). Our study shows that increased DPP4 activity levels are associated with the presence of CAD and that the plasma DPP4 level serves as a novel biomarker for CAD even without DM.	[Yang, Guang; Li, Yuzi; Cui, Lan; Li, Xiang; Zhao, Guangxian; Jin, Jiyong; Sun, Rui; Piao, Limei; Xu, Wenhu; Fang, Chenghu; Lei, Yanna; Yuan, Kuichang; Xuan, Chunhua; Ding, Dazi; Cheng, Xianwu] Yanbian Univ Hosp, Dept Cardiol, Yanji, Jilin, Peoples R China; [Jiang, Haiying] Yanbian Univ, Coll Med, Dept Physiol, Yanji, Peoples R China; [Jin, Chunzi] Yanbian Univ Hosp, Dept Cent Lab, Yanji, Peoples R China; [Jin, Dehao] Yanbian Univ Hosp, Dept Angiog Ctr, Yanji, Peoples R China; [Cheng, Xianwu] Kyung Hee Univ, Dept Internal Med, Seoul, South Korea	Yanbian University; Yanbian University; Yanbian University; Yanbian University; Kyung Hee University	Cui, L; Cheng, XW (corresponding author), Yanbian Univ Hosp, Dept Cardiol, Yanji, Jilin, Peoples R China.; Cheng, XW (corresponding author), Kyung Hee Univ, Dept Internal Med, Seoul, South Korea.	lancui@ybu.edu.cn; chengxw0908@163.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Scientific Research Fund of the Chinese Ministry of Education [81260068, 81560240]; Scientific Research Fund of the Jilin Province Department of Education [JJKHZ-2015-05]	Scientific Research Fund of the Chinese Ministry of Education; Scientific Research Fund of the Jilin Province Department of Education	Our study was supported from the Scientific Research Fund of the Chinese Ministry of Education (nos. 81260068, 81560240) and Scientific Research Fund of the Jilin Province Department of Education (no. JJKHZ-2015-05 to G.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001469; Aoyama M, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002081; Barbieri M, 2013, ATHEROSCLEROSIS, V227, P349, DOI 10.1016/j.atherosclerosis.2012.12.018; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; Cheng XW, 2013, ATHEROSCLEROSIS, V228, P211, DOI 10.1016/j.atherosclerosis.2013.01.004; Cheng XW, 2011, HYPERTENSION, V58, P978, DOI 10.1161/HYPERTENSIONAHA.111.180935; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Cordero OJ, 1997, IMMUNOBIOLOGY, V197, P522, DOI 10.1016/S0171-2985(97)80084-8; Drakopoulou M, 2009, ATHEROSCLEROSIS, V206, P335, DOI 10.1016/j.atherosclerosis.2009.01.041; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Fox CS, 2015, DIABETES CARE, V38, P1777, DOI 10.2337/dci15-0012; Geluk CA, 2008, ATHEROSCLEROSIS, V196, P372, DOI 10.1016/j.atherosclerosis.2006.11.013; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Hermus L, 2010, ATHEROSCLEROSIS, V213, P21, DOI 10.1016/j.atherosclerosis.2010.05.013; Ikushima H, 2002, CELL IMMUNOL, V215, P106, DOI 10.1016/S0008-8749(02)00010-2; Javidroozi M, 2012, DIS MARKERS, V32, P309, DOI [10.3233/DMA-2011-0889, 10.1155/2012/706745]; Keaney JF, 2014, NEW ENGL J MED, V370, P1957, DOI 10.1056/NEJMc1403438; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Li X, 2014, YONSEI MED J, V55, P912, DOI 10.3349/ymj.2014.55.4.912; LOJDA Z, 1979, HISTOCHEMISTRY, V59, P153, DOI 10.1007/BF00495663; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Moon JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150745; Nazarian A, 2014, MOL CELL PROTEOMICS, V13, P3082, DOI 10.1074/mcp.M114.038836; Nistala R, 2014, ENDOCRINOLOGY, V155, P2266, DOI 10.1210/en.2013-1920; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Ta NN, 2011, J CARDIOVASC PHARM, V58, P157, DOI 10.1097/FJC.0b013e31821e5626; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tremblay AJ, 2011, DIABETES OBES METAB, V13, P366, DOI 10.1111/j.1463-1326.2011.01362.x; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yakovleva AA, 2015, NEUROPEPTIDES, V52, P113, DOI 10.1016/j.npep.2015.05.001; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhao GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136093; Zheng TP, 2015, ATHEROSCLEROSIS, V242, P580, DOI 10.1016/j.atherosclerosis.2015.07.042; Zheng TP, 2014, ATHEROSCLEROSIS, V235, P619, DOI 10.1016/j.atherosclerosis.2014.05.956; Zheng TP, 2015, J CLIN ENDOCR METAB, V100, P3862, DOI 10.1210/jc.2015-2233; Zhong JX, 2015, CIRC RES, V116, P1491, DOI 10.1161/CIRCRESAHA.116.305665; Zhong JX, 2013, ATHEROSCLEROSIS, V226, P305, DOI 10.1016/j.atherosclerosis.2012.09.012	46	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163027	10.1371/journal.pone.0163027	http://dx.doi.org/10.1371/journal.pone.0163027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654253	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700032
J	Vigeland, CL; Collins, SL; Chan-Li, Y; Hughes, AH; Oh, MH; Powell, JD; Horton, MR				Vigeland, Christine L.; Collins, Samuel L.; Chan-Li, Yee; Hughes, Andrew H.; Oh, Min-Hee; Powell, Jonathan D.; Horton, Maureen R.			Deletion of mTORC1 Activity in CD4+T Cells Is Associated with Lung Fibrosis and Increased gamma delta T Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BLEOMYCIN; INFLAMMATION; PROMOTES; DIFFERENTIATION; PNEUMONIA; MICE	Pulmonary fibrosis is a devastating, incurable disease in which chronic inflammation and dysregulated, excessive wound healing lead to progressive fibrosis, lung dysfunction, and ultimately death. Prior studies have implicated the cytokine IL-17A and Th17 cells in promoting the development of fibrosis. We hypothesized that loss of Th17 cells via CD4-specific deletion of mTORC1 activity would abrogate the development of bleomycin-induced pulmonary fibrosis. However, in actuality loss of Th17 cells led to increased mortalityand fibrosis in response to bleomycin. We found that in the absence of Th17 cells, there was continued production of IL-17A by gamma delta T cells. These IL-17A+ gamma delta T cells were associated with increased lung neutrophils and M2 macrophages, accelerated development of fibrosis, and increased mortality. These data elucidate the critical role of IL-17A+ gamma delta T cells in promoting chronic inflammation and fibrosis, and reveal a novel therapeutic target for treatment of pulmonary fibrosis.	[Vigeland, Christine L.; Collins, Samuel L.; Chan-Li, Yee; Hughes, Andrew H.; Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Oh, Min-Hee; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Horton, MR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	mhorton2@jhmi.edu		Oh, Min-Hee/0000-0003-1581-4288; Vigeland, Christine/0000-0003-4468-374X	National Institutes of Health [F32 HL124887, PO1 HL010342, R21 HL111783]; Flight Attendant Medical Research Institute; Osborne Family Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342, R21HL111783, F32HL124887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Osborne Family Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by: National Institutes of Health (https://www.nih.gov/) F32 HL124887 (CLV); National Institutes of Health (https://www.nih.gov/) PO1 HL010342 (MRH); National Institutes of Health (https://www.nih.gov/) R21 HL111783 (MRH); Flight Attendant Medical Research Institute (http://www.famri.org/intro/) (MRH); and the Osborne Family Research Fund (MRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Collins SL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.83116; Collins SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031299; Conte E, 2014, IMMUNOBIOLOGY, V219, P425, DOI 10.1016/j.imbio.2014.02.001; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kuhn C, 1993, MONOGR PATH, V78, P1; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Martinet Y, 1996, ARCH TOX S, V18, P127; Mathews JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131236; Mathews JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097707; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Parkinson RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087265; Pociask DA, 2011, AM J PATHOL, V178, P1167, DOI 10.1016/j.ajpath.2010.11.055; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Segawa S, 2016, CLIN EXP IMMUNOL, V185, P348, DOI 10.1111/cei.12802; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI [10.4049/jimmunol.1002907, DOI 10.4049/JIMMUN01.1002907]	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163288	10.1371/journal.pone.0163288	http://dx.doi.org/10.1371/journal.pone.0163288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649073	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100073
J	Yoon, MS; Jeong, JU; Nam, TK; Ahn, SJ; Chung, WK; Song, JY				Yoon, Mee Sun; Jeong, Jae-Uk; Nam, Taek-Keun; Ahn, Sung-Ja; Chung, Woong-Ki; Song, Ju-Young			Evaluation of Dose Distribution in Intensity Modulated Radiosurgery for Lung Cancer under Condition of Respiratory Motion	PLOS ONE			English	Article							STEREOTACTIC ABLATIVE RADIOTHERAPY; ARC THERAPY; ACCURACY	The dose of a real tumor target volume and surrounding organs at risk (OARs) under the effect of respiratory motion was calculated for a lung tumor plan, based on the target volume covering the whole tumor motion range for intensity modulated radiosurgery (IMRS). Two types of IMRS plans based on simulated respiratory motion were designed using humanoid and dynamic phantoms. Delivery quality assurance (DQA) was performed using Arc-CHECK and MapCHECK2 for several moving conditions of the tumor and the real dose inside the humanoid phantom was evaluated using the 3DVH program. This evaluated dose in the tumor target and OAR using the 3DVH program was higher than the calculated dose in the plan, and a greater difference was seen for the RapidArc treatment than for the standard intensity modulated radiation therapy (IMRT) with fixed gantry angle beams. The results of this study show that for IMRS plans based on target volume, including the whole tumor motion range, tighter constraints of the OAR should be considered in the optimization process. The method devised in this study can be applied effectively to analyze the dose distribution in the real volume of tumor target and OARs in IMRT plans targeting the whole tumor motion range.	[Yoon, Mee Sun; Jeong, Jae-Uk; Nam, Taek-Keun; Ahn, Sung-Ja; Chung, Woong-Ki; Song, Ju-Young] Chonnam Natl Univ, Dept Radiat Oncol, Sch Med, Gwangju, South Korea	Chonnam National University	Song, JY (corresponding author), Chonnam Natl Univ, Dept Radiat Oncol, Sch Med, Gwangju, South Korea.	jysong@jnu.ac.kr						Carrasco P, 2012, MED PHYS, V39, P5040, DOI 10.1118/1.4736949; Coleman L, 2013, MED PHYS, V40, DOI 10.1118/1.4824433; Godart J, 2011, PHYS MED BIOL, V56, P5029, DOI 10.1088/0031-9155/56/15/023; Guerrero E, 2016, LUNG CANCER, V92, P22, DOI 10.1016/j.lungcan.2015.11.015; Hauri P1, 2014, J APPL CLIN MED PHYS, V15, P4647, DOI DOI 10.1120/JACMP.V15I2.4647; Hrbacek J, 2014, MED PHYS, V41, DOI 10.1118/1.4866231; Infusino E, 2014, MED DOSIM, V39, P276, DOI 10.1016/j.meddos.2014.04.004; Kadoya N, 2015, J APPL CLIN MED PHYS, V16, P179, DOI 10.1120/jacmp.v16i3.5251; Kang H, 2010, J APPL CLIN MED PHYS, V11, P78, DOI 10.1120/jacmp.v11i3.3182; Murray L, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150628; Nakaguchi Y, 2015, J APPL CLIN MED PHYS, V16, P264, DOI 10.1120/jacmp.v16i1.5199; Nakaguchi Y, 2015, RADIOL PHYS TECHNOL, V8, P73, DOI 10.1007/s12194-014-0294-x; Nicolini G, 2010, PHYS MED BIOL, V55, pN347, DOI 10.1088/0031-9155/55/12/N01; Olch AJ, 2012, MED PHYS, V39, P81, DOI 10.1118/1.3666771; Quan K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00213; Riley C, 2014, MED PHYS, V41, DOI 10.1118/1.4855956; Seco J, 2008, MED PHYS, V35, P356, DOI 10.1118/1.2821704; Solberg TD, 2014, J APPL CLIN MED PHYS, V15, P4685, DOI DOI 10.1120/JACMP.V15I2.4685; Song JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119937; Subramanian SV, 2015, J APPL CLIN MED PHYS, V16, P112, DOI 10.1120/jacmp.v16i4.5415; Tjima Y, 2015, BRIT J RADIOL, V88, P1052; Watanabe Y, 2013, MED PHYS, V40, DOI 10.1118/1.4813301; Zou W, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0225-3	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163112	10.1371/journal.pone.0163112	http://dx.doi.org/10.1371/journal.pone.0163112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648949	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100054
J	Bourrelle-Langlois, M; Morrow, G; Finet, S; Tanguay, RM				Bourrelle-Langlois, Maxime; Morrow, Genevieve; Finet, Stephanie; Tanguay, Robert M.			In Vitro Structural and Functional Characterization of the Small Heat Shock Proteins (sHSP) of the Cyanophage S-ShM2 and Its Host, Synechococcus sp. WH7803	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; ESCHERICHIA-COLI GROES; CHAPERONE ACTIVITY; PCC 6803; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; PHOTOSYNTHESIS GENES; SUBUNIT EXCHANGE; MARINE VIRUSES; STABILITY	We previously reported the in silico characterization of Synechococcus sp. phage 18 kDa small heat shock protein (HspSP-ShM2). This small heat shock protein (sHSP) contains a highly conserved core alpha crystalline domain of 92 amino acids and relatively short Nand C-terminal arms, the later containing the classical C-terminal anchoring module motif (L-X-I/L/V). Here we establish the oligomeric profile of HspSP-ShM2 and its structural dynamics under in vitro experimental conditions using size exclusion chromatography (SEC/FPLC), gradient native gels electrophoresis and dynamic light scattering (DLS). Under native conditions, HspSP-ShM2 displays the ability to form large oligomers and shows a polydisperse profile. At higher temperatures, it shows extensive structural dynamics and undergoes conformational changes through an increased of subunit rearrangement and formation of sub-oligomeric species. We also demonstrate its capacity to prevent the aggregation of citrate synthase, malate dehydrogenase and luciferase under heat shock conditions through the formation of stable and soluble hetero-oligomeric complexes (sHSP: substrate). In contrast, the host cyanobacteria Synechococcus sp. WH7803 15 kDa sHSP (HspS-WH7803) aggregates when in the same conditions as HspSP-ShM2. However, its solubility can be maintained in the presence of non-ionic detergent Triton (TM) X-100 and forms an oligomeric structure estimated to be between dimer and tetramer but exhibits no apparent inducible structural dynamics neither chaperon-like activity in all the assays and molar ratios tested. SEC/FPLC and thermal aggregation prevention assays results indicate no formation of hetero-oligomeric complex or functional interactions between both sHSPs. Taken together these in vitro results portray the phage HspSP-ShM2 as a classical sHSP and suggest that it may be functional at the in vivo level while behaving differently than its host amphitropic sHSP.	[Bourrelle-Langlois, Maxime; Morrow, Genevieve; Tanguay, Robert M.] Fac Med, IBIS, Lab Biol Cellulaire & Mol, Quebec City, PQ, Canada; [Bourrelle-Langlois, Maxime; Morrow, Genevieve; Tanguay, Robert M.] Fac Med, PROTEO, Dept Biol Mol Biochim Med, Quebec City, PQ, Canada; [Finet, Stephanie] Univ Paris 06, Sorbonne Univ, CNRS, IRD MNHN,IMPMC UMR7590, Paris, France	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Tanguay, RM (corresponding author), Fac Med, IBIS, Lab Biol Cellulaire & Mol, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Fac Med, PROTEO, Dept Biol Mol Biochim Med, Quebec City, PQ, Canada.	Robert.tanguay@fmed.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [3526-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada to RMT (grant number: 3526-2011 and URL: http://www.nserc-crsng.gc.ca/index_eng.asp) and studentships from PROTEO (URL: http://www.proteo.ca/index.html) and Universite Laval Medicine Faculty (URL: http://www.fmed.ulaval.ca/accueil/) to MBL.	Ang D, 2001, J BIOL CHEM, V276, P8720, DOI 10.1074/jbc.M008477200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2013, J MOL BIOL, V425, P1683, DOI 10.1016/j.jmb.2013.02.011; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Fu XM, 2013, J BIOL CHEM, V288, P31646, DOI 10.1074/jbc.M113.501817; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kurochkina LP, 2012, J VIROL, V86, P10103, DOI 10.1128/JVI.00940-12; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Michiel M, 2009, BIOCHEMISTRY-US, V48, P442, DOI 10.1021/bi8014967; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nitta K, 2005, FEBS LETT, V579, P1235, DOI 10.1016/j.febslet.2004.12.095; Semenyuk PI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P172, DOI 10.1134/S0006297915020042; Semenyuk PI, 2016, BIOCHEM J, V473, P2383, DOI 10.1042/BCJ20160367; Skouri-Panet F, 2012, BIOCHIMIE, V94, P975, DOI 10.1016/j.biochi.2011.12.018; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zhang H, 2005, BIOCHEM BIOPH RES CO, V330, P1055, DOI 10.1016/j.bbrc.2005.03.092	71	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162233	10.1371/journal.pone.0162233	http://dx.doi.org/10.1371/journal.pone.0162233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643500	gold, Green Published, Green Submitted			2022-12-27	WOS:000383891900006
J	Gavazzi, F; Braglia, L; Mastromauro, F; Giani, S; Morello, L; Breviario, D				Gavazzi, Floriana; Braglia, Luca; Mastromauro, Francesco; Giani, Silvia; Morello, Laura; Breviario, Diego			The Tubulin-Based-Polymorphism Method Provides a Simple and Effective Alternative to the Genomic Profiling of Grape	PLOS ONE			English	Article							GENETIC DIVERSITY; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; AUTHENTICITY MARKERS; MOLECULAR MARKERS; VITIS VITACEAE; SSR MARKERS; IDENTIFICATION; CULTIVARS; L.	The TBP (Tubulin-Based-Polymorphism) method, based on a nuclear ILP (Intron-Length-Polymorphism) molecular marker, has been used for genotyping 37 accessions of the genus Vitis inclusive of different species, rootstocks, wild and cultivated subspecies. A distinct DNA barcode made up by a different number of amplicons, was attributed to each of the different accessions. TBP data were compared with those obtained, with the use of an internationally validated set of six SSR markers. Genetic relationships among the different accessions, dendrogram distributions, correlation values and polymorphic index values (PICs) were definitively comparable when not in favor of TBP. Such an experimental consistency is based upon a genomic organization of the multiple members of the beta-tubulin gene family, the targets of TBP-mediated amplification, that is conserved in Vitis as in any other plant species. The TBP amplicons can actually be used as a useful source of sequence polymorphisms for generating primer pairs capable of identifying specific cultivars in a simple assay. An example for the identification of the 'Sangiovese' cv. is reported. More generally, these data are discussed in terms of the actual advantages that the introduction of the TBP method in the field of grape characterization and genotyping can provide.	[Gavazzi, Floriana; Braglia, Luca; Mastromauro, Francesco; Giani, Silvia; Morello, Laura; Breviario, Diego] CNR, Inst Agr Biol & Biotechnol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR)	Breviario, D (corresponding author), CNR, Inst Agr Biol & Biotechnol, Milan, Italy.	breviario@ibba.cnr.it	Gavazzi, Floriana/AAC-4544-2022; Braglia, Luca/G-4122-2018; Breviario, Diego/AAX-6378-2020; MORELLO, LAURAEMMAMARIA/AAX-4620-2020; Gianì, Silvia/AAV-3716-2020; Braglia, Luca/AAA-4803-2019; Morello, Laura/ABF-9139-2022	Braglia, Luca/0000-0001-6772-5362; Breviario, Diego/0000-0002-3062-7598; Braglia, Luca/0000-0001-6772-5362; Morello, Laura/0000-0002-8854-1770; GIANI, SILVIA/0000-0001-8740-1787	project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare"; Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583; intramural funds (IBBA-CNR)	project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare"; Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583; intramural funds (IBBA-CNR)	This work was supported by both project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare", Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583 and intramural funds (IBBA-CNR) available from residuals.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Alba V, 2015, MOL BIOTECHNOL, V57, P709, DOI 10.1007/s12033-015-9862-5; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], 2009, VITIS; Bardini M, 2004, GENOME, V47, P281, DOI [10.1139/g03-132, 10.1139/G03-132]; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; Braglia L., 2010, Diversity, V2, P572; Braglia L, 2014, MOL BREEDING, V33, P209, DOI 10.1007/s11032-013-9945-6; Bureau SM, 2000, J AGR FOOD CHEM, V48, P1290, DOI 10.1021/jf990507x; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Casazza AP, 2012, J CEREAL SCI, V56, P733, DOI 10.1016/j.jcs.2012.08.015; Chabreyrie D, 2008, J AGR FOOD CHEM, V56, P6785, DOI 10.1021/jf800117k; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Cipriani G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-127; Costa JH, 2009, PHYSIOL PLANTARUM, V137, P553, DOI 10.1111/j.1399-3054.2009.01267.x; Cunha J, 2009, GENET RESOUR CROP EV, V56, P975, DOI 10.1007/s10722-009-9416-4; Dhanorkar VM, 2005, VITIS, V44, P127; Di Vecchi Staraz M, 2007, J AM SOC HORTIC SCI, V132, P514; Losada ED, 2010, VITIS, V49, P55; Dodig D, 2010, CROP PASTURE SCI, V61, P812, DOI 10.1071/CP10001; Fan L, 2013, PLANT MOL BIOL REP, V31, P1271, DOI 10.1007/s11105-013-0586-z; Gavazzi F, 2012, ELECTROPHORESIS, V33, P2840, DOI 10.1002/elps.201200144; Ghan R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2115-y; HANSEN JM, 1978, BER DEUT BOT GES, V91, P39; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang Ke, 2011, BMC Res Notes, V4, P52, DOI 10.1186/1756-0500-4-52; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Liu XQ, 2016, MOL PHYLOGENET EVOL, V95, P217, DOI 10.1016/j.ympev.2015.10.013; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Lopez M, 2009, AM J ENOL VITICULT, V60, P215; MANTEL N, 1967, CANCER RES, V27, P209; McGovern PE, 2003, ANCIENT WINE SEARCH; Merdinoglu D, 2005, MOL BREEDING, V15, P349, DOI 10.1007/s11032-004-7651-0; Mwamahonje A, 2015, AM J RES COMMUN, V3, P10; Nasi A, 2008, FOOD CHEM, V110, P762, DOI 10.1016/j.foodchem.2008.03.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Peros JP, 2011, J BIOGEOGR, V38, P471, DOI 10.1111/j.1365-2699.2010.02410.x; Ponzoni E, 2013, ANAL BIOANAL CHEM, V405, P9849, DOI 10.1007/s00216-013-7434-8; Popluechai S, 2009, NATURE PRECEEDING; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Riviere C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Tamborra P, 2010, ANAL CHIM ACTA, V660, P221, DOI 10.1016/j.aca.2009.11.014; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Trondle D, 2010, AM J BOT, V97, P1168, DOI 10.3732/ajb.0900218; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; VERSINI G, 1991, VITIS, V30, P143; Versini G, 2003, ENOLOGIE 2003, P166; Villano C, 2014, MOL BIOTECHNOL, V56, P1011, DOI 10.1007/s12033-014-9780-y; von Baer D, 2008, ANAL CHIM ACTA, V621, P52, DOI 10.1016/j.aca.2007.11.034; Wang XS, 2005, DNA RES, V12, P417, DOI 10.1093/dnares/dsi019; Wen J., 2007, FAMILIES GENERA VASC, P466, DOI [10.1007/978-3-540-32219-1_54, DOI 10.1007/978-3-540-32219-1_54]; Zecca G, 2010, PLANT BIOLOGY, V12, P558, DOI 10.1111/j.1438-8677.2009.00226.x; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144701	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163335	10.1371/journal.pone.0163335	http://dx.doi.org/10.1371/journal.pone.0163335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643687	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900044
J	Menard, L; Trudeau-Fisette, P; Cote, D; Turgeon, C				Menard, Lucie; Trudeau-Fisette, Pamela; Cote, Dominique; Turgeon, Christine			Speaking Clearly for the Blind: Acoustic and Articulatory Correlates of Speaking Conditions in Sighted and Congenitally Blind Speakers	PLOS ONE			English	Article							HARD-OF-HEARING; CONVERSATIONAL SPEECH; FRENCH VOWELS; PERCEPTION; INTELLIGIBILITY; ADULTS; LISTENERS; DISCRIMINATION; IDENTIFICATION; CONTRAST	Compared to conversational speech, clear speech is produced with longer vowel duration, greater intensity, increased contrasts between vowel categories, and decreased dispersion within vowel categories. Those acoustic correlates are produced by larger movements of the orofacial articulators, including visible (lips) and invisible (tongue) articulators. Thus, clear speech provides the listener with audible and visual cues that are used to increase the overall intelligibility of speech produced by the speaker. It is unclear how those cues are produced by visually impaired speakers who never had access to vision. In this paper, we investigate the acoustic and articulatory correlates of vowels in clear versus conversational speech, and in sighted and congenitally blind speakers. Participants were recorded using electroarticulography while producing multiple repetitions of the ten Quebec French oral vowels in carrier sentences in both speaking conditions. Articulatory variables (lip, jaw, and tongue positions) as well as acoustic variables (contrasts between vowels, within-vowel dispersion, pitch, duration, and intensity) were measured. Lip movements were larger when going from conversational to clear speech in sighted speakers only. On the other hand, tongue movements were affected to a larger extent in blind speakers compared to their sighted peers. These findings confirm that vision plays an important role in the maintenance of speech intelligibility.	[Menard, Lucie; Trudeau-Fisette, Pamela; Cote, Dominique; Turgeon, Christine] Univ Quebec Montreal, Ctr Res Brain Language & Mus, Lab Phonet, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal	Menard, L (corresponding author), Univ Quebec Montreal, Ctr Res Brain Language & Mus, Lab Phonet, Montreal, PQ, Canada.	menard.lucie@uqam.ca			Social Sciences and Humanities Research Council of Canada [411779]; Natural Sciences and Engineering Research Council of Canada [279863]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Social Sciences and Humanities Research Council of Canada (grant number 411779) and the Natural Sciences and Engineering Research Council of Canada (grant number 279863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Social Sciences and Humanities Research Council of Canada (Insight Grant) and a grant from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant). Thanks to Marlene Busko for copyediting the paper and to Joseph Perkell for insightful comments and suggestions.	Barbier G., 2015, INTERSPEECH 2015; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Carstens Medizinelektronik, 2006, AG500 MAN; Chen Francine Robina, 1980, THESIS; Dietrich S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-74; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Ferland-Longpre V., 2013, LORS JOURN SCI CTR R; Gagne JP, 2002, SPEECH COMMUN, V37, P213, DOI 10.1016/S0167-6393(01)00012-7; Goldreich D, 2003, J NEUROSCI, V23, P3439; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hay JF, 2006, J ACOUST SOC AM, V119, P3022, DOI 10.1121/1.2184226; Helfer KS, 1997, J AM ACAD AUDIOL, V9, P234; Hugdahl K, 2004, COGNITIVE BRAIN RES, V19, P28, DOI 10.1016/j.cogbrainres.2003.10.015; Krause J. C., 1995, J ACOUST SOC AM, V98, P2982; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; LUCAS SA, 1984, INT J REHABIL RES, V7, P74, DOI 10.1097/00004356-198403000-00016; Menard L, 2007, J ACOUST SOC AM, V121, P3790, DOI 10.1121/1.2710963; Menard L, 2014, J SPEECH LANG HEAR R, V57, P793, DOI 10.1044/2014_JSLHR-S-12-0395; Menard L, 2013, J ACOUST SOC AM, V134, P2975, DOI 10.1121/1.4818740; Menard L, 2009, J ACOUST SOC AM, V126, P1406, DOI 10.1121/1.3158930; Moon S-J, 1991, ACOUSTIC PERCEPTUAL, P153; MOON SJ, 1994, J ACOUST SOC AM, V96, P40, DOI 10.1121/1.410492; Ozdemir RA, 2013, GAIT POSTURE, V38, P603, DOI 10.1016/j.gaitpost.2013.02.003; PAYTON KL, 1994, J ACOUST SOC AM, V95, P1581, DOI 10.1121/1.408545; Perkell JS, 2000, J PHONETICS, V28, P233, DOI 10.1006/jpho.2000.0116; Perkell JS, 2002, J ACOUST SOC AM, V112, P1627, DOI 10.1121/1.1506369; PICHENY MA, 1985, J SPEECH HEAR RES, V28, P96, DOI 10.1044/jshr.2801.96; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; PICKETT JM, 1956, J ACOUST SOC AM, V28, P902, DOI 10.1121/1.1908510; Schum D J, 1996, J Am Acad Audiol, V7, P212; SCHWARTZ JL, 1993, J PHONETICS, V21, P411, DOI 10.1016/S0095-4470(19)30228-1; Smiljanic R, 2005, J ACOUST SOC AM, V118, P1677, DOI 10.1121/1.2000788; Tasko SM, 2004, J SPEECH HEAR RES, V53, P84; Torre P, 2009, J COMMUN DISORD, V42, P324, DOI 10.1016/j.jcomdis.2009.03.001; Uchanski RM, 1996, J SPEECH HEAR RES, V39, P494, DOI 10.1044/jshr.3903.494; Uchanski RM, 2005, BLACKW HBK LINGUIST, P207, DOI 10.1002/9780470757024.ch9; Vick JC, 2001, J SPEECH LANG HEAR R, V44, P1257, DOI 10.1044/1092-4388(2001/098); Westbury J. R., 1994, XRAY MICROBEAM SPEEC	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0160088	10.1371/journal.pone.0160088	http://dx.doi.org/10.1371/journal.pone.0160088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643997	gold, Green Submitted, Green Published			2022-12-27	WOS:000383891900002
J	Goel, P; Bhuria, M; Kaushal, M; Singh, AK				Goel, Parul; Bhuria, Monika; Kaushal, Mamta; Singh, Anil Kumar			Carbon: Nitrogen Interaction Regulates Expression of Genes Involved in N-Uptake and Assimilation in Brassica juncea L.	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; LATERAL ROOT INITIATION; ARABIDOPSIS-THALIANA; GLUTAMINE-SYNTHETASE; MICROARRAY ANALYSIS; NUTRIENT RESPONSE; ION TRANSPORTERS; GENOMIC ANALYSIS; ELEVATED CO2; C-STATUS	In plants, several cellular and metabolic pathways interact with each other to regulate processes that are vital for their growth and development. Carbon (C) and Nitrogen (N) are two main nutrients for plants and coordination of C and N pathways is an important factor for maintaining plant growth and development. In the present work, influence of nitrogen and sucrose (C source) on growth parameters and expression of genes involved in nitrogen transport and assimilatory pathways was studied in B. juncea seedlings. For this, B. juncea seedlings were treated with four combinations of C and N source viz., N source alone (-Suc +N), C source alone (+Suc-N), with N and C source (+Suc+N) or without N and C source (-Suc-N). Cotyledon size and shoot length were found to be increased in seedlings, when nitrogen alone was present in the medium. Distinct expression pattern of genes in both, root and shoot tissues was observed in response to exogenously supplied N and C. The presence or depletion of nitrogen alone in the medium leads to severe up-or down-regulation of key genes involved in N-uptake and transport (BjNRT1.1, BjNRT1.8) in root tissue and genes involved in nitrate reduction (BjNR1 and BjNR2) in shoot tissue. Moreover, expression of several genes, like BjAMT1.2, BjAMT2 and BjPK in root and two genes BjAMT2 and BjGS1.1 in shoot were found to be regulated only when C source was present in the medium. Majority of genes were found to respond in root and shoot tissues, when both C and N source were present in the medium, thus reflecting their importance as a signal in regulating expression of genes involved in N-uptake and assimilation. The present work provides insight into the regulation of genes of N-uptake and assimilatory pathway in B. juncea by interaction of both carbon and nitrogen.	[Goel, Parul; Bhuria, Monika; Kaushal, Mamta; Singh, Anil Kumar] Inst Himalayan Bioresource Technol, CSIR, Palampur 176061, Himachal Prades, India; [Goel, Parul; Bhuria, Monika; Singh, Anil Kumar] Acad Sci & Innovat Res, New Delhi, India; [Singh, Anil Kumar] ICAR Indian Inst Agr Biotechnol, IINRG, PDU Campus, Namkum 834010, Ranchi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology; ICAR - Indian Institute of Natural Resins & Gums	Singh, AK (corresponding author), Inst Himalayan Bioresource Technol, CSIR, Palampur 176061, Himachal Prades, India.; Singh, AK (corresponding author), Acad Sci & Innovat Res, New Delhi, India.; Singh, AK (corresponding author), ICAR Indian Inst Agr Biotechnol, IINRG, PDU Campus, Namkum 834010, Ranchi, India.	anils13@gmail.com		Bhuria, Monika/0000-0003-4254-6805; Singh, Anil/0000-0002-3569-5207	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Authors thank Director CSIR-Institute of Himalayan Bioresource Technology, Palampur for constant support and encouragement. Authors thank Prof. Deepak Pental, Department of Genetics, Delhi University South Campus, New Delhi, India for providing seeds of B. juncea cv. Varuna. PG and MB acknowledge Council of Scientific and Industrial Research, New Delhi for providing Junior and Senior Research Fellowship. This manuscript represents CSIR-IHBT communication number 4055A.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Ahmad T, 2007, PAK J BOT, V39, P1269; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; Bloom AJ, 2002, J PLANT GROWTH REGUL, V21, P416, DOI 10.1007/s00344-003-0009-8; Camanes G, 2007, J EXP BOT, V58, P2811, DOI 10.1093/jxb/erm135; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; de Jong F, 2014, PLANT PHYSIOL, V164, P308, DOI 10.1104/pp.113.230599; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Foyer CH, 2011, J EXP BOT, V62, P1467, DOI 10.1093/jxb/erq453; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Gao P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001387; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Girin T, 2007, PLANT CELL ENVIRON, V30, P1366, DOI 10.1111/j.1365-3040.2007.01712.x; Goel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143645; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Jorgensen I, 1916, NEW PHYTOL, V15, P176; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Krapp A, 2011, PLANT PHYSIOL, V157, P1255, DOI 10.1104/pp.111.179838; Kusano M, 2011, J EXP BOT, V62, P1439, DOI 10.1093/jxb/erq417; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lejay L, 1999, PLANT J, V18, P509, DOI 10.1046/j.1365-313X.1999.00480.x; Lejay L, 2003, PLANT CELL, V15, P2218, DOI 10.1105/tpc.013516; Lejay L, 2008, PLANT PHYSIOL, V146, P2036, DOI 10.1104/pp.107.114710; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloret F, 1999, FUNCT ECOL, V13, P210, DOI 10.1046/j.1365-2435.1999.00309.x; Lopes MS, 2008, PHYSIOL PLANTARUM, V134, P134, DOI 10.1111/j.1399-3054.2008.01114.x; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; MANCINELLI AL, 1988, PLANT PHYSIOL, V86, P652, DOI 10.1104/pp.86.3.652; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matt P, 2002, PLANT J, V30, P663, DOI 10.1046/j.1365-313X.2002.01323.x; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Mokhele B, 2012, CAN J PLANT SCI, V92, P399, DOI [10.4141/CJPS2011-135, 10.4141/cjps2011-135]; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Ourry A, 2001, PLANT NITROGEN, P255; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Patterson K, 2010, PLANT CELL ENVIRON, V33, P1486, DOI 10.1111/j.1365-3040.2010.02158.x; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; RAAB TK, 1994, PLANT PHYSIOL, V105, P1159, DOI 10.1104/pp.105.4.1159; Rabha BK, 1998, PHOTOSYNTHETICA, V35, P597, DOI 10.1023/A:1006991210089; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Roycewicz P, 2012, PHILOS T R SOC B, V367, P1489, DOI 10.1098/rstb.2011.0230; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sehtiya HL, 2000, PLANT SOIL, V227, P185, DOI 10.1023/A:1026503700825; Seth CS, 2014, J PLANT RES, V127, P793, DOI 10.1007/s10265-014-0664-9; Shangguan ZP, 2004, BOT BULL ACAD SINICA, V45, P49; Signora L, 2001, PLANT J, V28, P655, DOI 10.1046/j.1365-313x.2001.01185.x; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sun WF, 2013, J PLANT GROWTH REGUL, V32, P575, DOI 10.1007/s00344-013-9324-x; Thompson MR., 1987, CELL TISSUE CULTURE, P89, DOI [DOI 10.1007/978-94-017-0994-1_6, 10.1007/978-94-017-0994-1_6]; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Uprety DC, 2000, J AGRON CROP SCI, V184, P271, DOI 10.1046/j.1439-037x.2000.00392.x; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zhou SY, 2009, Z NATURFORSCH C, V64, P697; Zhu GH, 2006, J INTEGR PLANT BIOL, V48, P1177, DOI 10.1111/j.1744-7909.2006.00332.x	77	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163061	10.1371/journal.pone.0163061	http://dx.doi.org/10.1371/journal.pone.0163061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637072	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700030
J	Inic-Kanada, A; Stojanovic, M; Marinkovic, E; Becker, E; Stein, E; Lukic, I; Djokic, R; Schuerer, N; Hegemann, JH; Barisani-Asenbauer, T				Inic-Kanada, Aleksandra; Stojanovic, Marijana; Marinkovic, Emilija; Becker, Elisabeth; Stein, Elisabeth; Lukic, Ivana; Djokic, Radmila; Schuerer, Nadine; Hegemann, Johannes H.; Barisani-Asenbauer, Talin			A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C	PLOS ONE			English	Article							REGULATORY T-CELLS; TRACHOMATIS INFECTION; PROTECTIVE IMMUNITY; GENITAL-TRACT; VACCINE; ADHESION; DELIVERY; FAMILY; IGG	Recent advances in the development of chlamydia vaccines, using live-attenuated or ultraviolet light-inactivated chlamydia, are paving the way for new possibilities to oppose the societal challenges posed by chlamydia-related diseases, such as blinding trachoma. An effective subunit vaccine would mitigate the risks associated with the use of a whole-cell vaccine. Our rationale for the design of an efficient subunit vaccine against Chlamydia trachomatis (Ct) is based on the membrane proteins involved in the initial Ct-host cell contact and on the route of immunization that mimics the natural infection process (i.e., via the ocular mucosa). The first aim of our study was to characterize the specific conjunctival and vaginal immune responses following eye drop immunization in BALB/c mice, using the N-terminal portion of the Ct serovar E polymorphic membrane protein C (N-PmpC) as the subunit vaccine antigen. Second, we aimed to examine the adjuvant properties of the probiotic Lactobacillus rhamnosus (LB) when formulated with N-PmpC. N-PmpC applied alone stimulated the production of N-PmpC-and Ct serovar B-specific antibodies in serum, tears and vaginal washes, whereas the combination with LB significantly enhanced these responses. The N-PmpC/LB combination initiated a T cell response characterized by an elevated percentage of CD25+ T cells and CD8+ effector T cells, enhanced CD4+ T-helper 1 skewing, and increased regulatory T cell responses. Together, these results show that eye drop vaccination with combined use of N-PmpC and a live probiotic LB stimulates specific cellular and humoral immune responses, not only locally in the conjunctiva but also in the vaginal mucosa, which could be a promising approach in Ct vaccine development.	[Inic-Kanada, Aleksandra; Stein, Elisabeth; Schuerer, Nadine; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Stojanovic, Marijana; Marinkovic, Emilija; Lukic, Ivana; Djokic, Radmila] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Becker, Elisabeth; Hegemann, Johannes H.] Heinrich Heine Univ Dusseldorf, Inst Funkt Genomforsch Mikroorganismen, Univ Str 1,Gebaude 25-02-U1, D-40225 Dusseldorf, Germany	Medical University of Vienna; Heinrich Heine University Dusseldorf	Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	talin.barisani@meduniwien.ac.at		Stojanovic, Marijana/0000-0002-8204-4183; Stein, Elisabeth/0000-0002-1240-506X; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Lukic, Ivana/0000-0002-6330-471X; Schuerer, Nadine/0000-0002-5894-2784; Inic-Kanada, Aleksandra/0000-0001-7854-3812	"Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]	"Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project); Ministry of Education, Science, and Technological Development of the Republic of Serbia	This research was funded by the "Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project number 822768) (https://www.ffg.at/en), and by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant number 172049) (http://www.mpn.gov.rs/).	BAILEY RL, 1993, EPIDEMIOL INFECT, V111, P315, DOI 10.1017/S0950268800057022; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Boje S, 2015, IMMUNOL CELL BIOL; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Cochrane M, 2010, FUTURE MICROBIOL, V5, P1833, DOI [10.2217/fmb.10.148, 10.2217/FMB.10.148]; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dasgupta G, 2011, INVEST OPHTH VIS SCI, V52, P3321, DOI 10.1167/iovs.10-6522; GILL HS, 2001, THE BRITISH JOURNAL, V86, P285; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Inic-Kanada A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144380; Iovieno A, 2008, GRAEF ARCH CLIN EXP, V246, P435, DOI 10.1007/s00417-007-0682-6; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Licciardi PV, 2011, DISCOV MED, V12, P525; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Nesburn AB, 2005, VACCINE, V23, P873, DOI 10.1016/j.vaccine.2004.08.019; Norman J, 2002, BEST PRACT RES CL OB, V16, P775, DOI 10.1053/beog.2002.0325; Perry LL, 1999, J IMMUNOL, V162, P3541; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Rosenthal K L, 1997, Semin Immunol, V9, P303; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; SCHACHTER J, 1980, ANNU REV MICROBIOL, V34, P285, DOI 10.1146/annurev.mi.34.100180.001441; SCHACHTER J, 1985, REV INFECT DIS, V7, P713; Schautteet Katelijn, 2011, Infect Dis Obstet Gynecol, V2011, P963513, DOI 10.1155/2011/963513; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wizel B, 2008, MICROBES INFECT, V10, P1420, DOI 10.1016/j.micinf.2008.08.006	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0157875	10.1371/journal.pone.0157875	http://dx.doi.org/10.1371/journal.pone.0157875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636704	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700001
J	Morel, M; Vanderstraete, M; Cailliau, K; Hahnel, S; Grevelding, CG; Dissous, C				Morel, Marion; Vanderstraete, Mathieu; Cailliau, Katia; Hahnel, Steffen; Grevelding, Christoph G.; Dissous, Colette			SmShb, the SH2-Containing Adaptor Protein B of Schistosoma mansoni Regulates Venus Kinase Receptor Signaling Pathways	PLOS ONE			English	Article							TYROSINE KINASE; GROWTH-FACTOR; SHB; DOMAIN; PRAZIQUANTEL; DIFFERENTIATION; REPRODUCTION; REQUIRES; INSULIN; FAMILY	Venus kinase receptors (VKRs) are invertebrate receptor tyrosine kinases (RTKs) formed by an extracellular Venus Fly Trap (VFT) ligand binding domain associated via a transmembrane domain with an intracellular tyrosine kinase (TK) domain. Schistosoma mansoni VKRs, SmVKR1 and SmVKR2, are both implicated in reproductive activities of the parasite. In this work, we show that the SH2 domain-containing protein SmShb is a partner of the phosphorylated formof SmVKR1. Expression of these proteins in Xenopus oocytes allowed us to demonstrate that the SH2 domain of SmShb interacts with the phosphotyrosine residue (pY979) located in the juxtamembrane region of SmVKR1. This interaction leads to phosphorylation of SmShb on tyrosines and promotes SmVKR1 signaling towards the JNK pathway. SmShb transcripts are expressed in all parasite stages and they were found in ovary and testes of adult worms, suggesting a possible colocalization of SmShb and SmVKR1 proteins. Silencing of SmShb in adult S. mansoni resulted in an accumulation of mature spermin testes, indicating a possible role of SmShb in gametogenesis.	[Morel, Marion; Vanderstraete, Mathieu; Dissous, Colette] Univ Lille, CHU Lille, INSERM,U1019,UMR 8204,CIIL, CNRS,Inst Pasteur Lille,Ctr Infect & Immun Lille, Lille, France; [Cailliau, Katia] Univ Lille, CNRS, UMR 8576, UGSF, Lille, France; [Hahnel, Steffen; Grevelding, Christoph G.] Justus Liebig Univ, Inst Parasitol, BFS, Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Justus Liebig University Giessen	Dissous, C (corresponding author), Univ Lille, CHU Lille, INSERM,U1019,UMR 8204,CIIL, CNRS,Inst Pasteur Lille,Ctr Infect & Immun Lille, Lille, France.	colette.dissous@pasteur-lille.fr	Morel, Marion/X-4104-2019	Cailliau, Katia/0000-0001-7993-8437; Morel, Marion/0000-0002-1439-5360; cailliau, katia/0000-0003-1772-1034	CNRS; INSERM; Universita Lille Nord de France; Ministere de l'Education Nationale et de la Recherche; Fondation pour La Recherche Medicale, France (FRM) [FDT20150532257]; Deutsche Forschungsgemeinschaft [GR1549/7-2]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universita Lille Nord de France; Ministere de l'Education Nationale et de la Recherche; Fondation pour La Recherche Medicale, France (FRM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by CNRS, INSERM and Universita Lille Nord de France. M.M. fellowships were from the Ministere de l'Education Nationale et de la Recherche and from the Fondation pour La Recherche Medicale, France (FRM No FDT20150532257). This work was supported by the Deutsche Forschungsgemeinschaft, grant GR1549/7-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Akerblom B, 2009, J ENDOCRINOL, V203, P271, DOI 10.1677/JOE-09-0198; Anneren C, 2003, CURR MOL MED, V3, P313, DOI 10.2174/1566524033479744; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Calounova G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011155; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dissous C, 2007, BIOESSAYS, V29, P1281, DOI 10.1002/bies.20662; Dissous C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00118; Dissous C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00072; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Funa NS, 2008, DIFFERENTIATION, V76, P443, DOI 10.1111/j.1432-0436.2007.00249.x; Gelmedin V, 2015, FUTURE MED CHEM, V7, P737, DOI [10.4155/FMC.15.31, 10.4155/fmc.15.31]; Gouignard N, 2012, EXP PARASITOL, V132, P32, DOI 10.1016/j.exppara.2011.05.007; Gustafsson K, 2014, IMMUNOLOGY, V143, P33, DOI 10.1111/imm.12286; Gustafsson K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-3; Hagerkvist R, 2007, EXP CELL RES, V313, P284, DOI 10.1016/j.yexcr.2006.10.011; Hahnel S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00170; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; KARLSSON T, 1995, ONCOGENE, V10, P1475; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Lindholm CK, 2000, BIOCHEM BIOPH RES CO, V278, P537, DOI 10.1006/bbrc.2000.3847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LG, 2000, EXP CELL RES, V259, P370, DOI 10.1006/excr.2000.4984; Machado-Silva JR, 1998, MEM I OSWALDO CRUZ, V93, P303, DOI 10.1590/S0074-02761998000700060; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Morel M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00238; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Oda T, 1997, ONCOGENE, V15, P1255, DOI 10.1038/sj.onc.1201299; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pica-Mattoccia L, 2009, ACTA TROP, V111, P82, DOI 10.1016/j.actatropica.2009.01.012; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanderstraete M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004138; Vanderstraete M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-361; Vanderstraete M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002226; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Vogel KJ, 2015, P NATL ACAD SCI USA, V112, P5057, DOI 10.1073/pnas.1501814112; WELSH M, 1994, ONCOGENE, V9, P19; Welsh M, 1998, ONCOGENE, V16, P891, DOI 10.1038/sj.onc.1201607; Welsh M, 2016, J MOL ENDOCRINOL, V56, pR21, DOI 10.1530/JME-15-0228	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163283	10.1371/journal.pone.0163283	http://dx.doi.org/10.1371/journal.pone.0163283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636711	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700046
J	Tang, SF; Wei, LL; Sun, YF; Zhou, F; Zhu, SB; Yang, RQ; Huang, YY; Zhang, HY; Xu, H; Yang, JQ				Tang, Shifu; Wei, Lili; Sun, Yifan; Zhou, Fang; Zhu, Shengbo; Yang, Renqi; Huang, Yiyong; Zhang, Hongyu; Xu, Hong; Yang, Jianqing			CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; SCREENING MAMMOGRAPHY; NIPPLE DISCHARGE; RISK; MANAGEMENT; PATTERNS; CURVE; FLUID; CEA	Purpose Many studies have reported that carbohydrate antigen 153 (CA153) in breast secretions (BS) can discriminate breast cancer (BC) patients from healthy individuals, indicating CA153 in BS as a potential index for BC. This meta-analysis aimed to evaluate the actual diagnostic value of CA153 in BS. Methods Related papers were obtained from Pubmed, Embase, Scopus, Ovid, Sciverse, the Cochrane library, Chinese Biomedical literature Database (CBM), Technology of Chongqing (VIP), Wan Fang Data, and Chinese National Knowledge Infrastructure (CNKI). Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) of CA153 in BS for BC diagnosis were analyzed with the random effect model. SROC and the area under the curve (AUC) were applied to assess overall diagnostic efficiency. Results This meta-analysis included five studies with a total of 329 BC patients and 381 healthy subjects. For CA153 in BS, the summary sensitivity, specificity, and DOR to diagnose BC were 0.63 (95% confidence interval (CI): 0.57 similar to 0.68), 0.82 (95% CI: 0.78 similar to 0.86), and 9.18 (95% CI: 4.22 similar to 19.95), respectively. Furthermore, the AUC of BS CA153 in the diagnosis of BC was 0.8614. Conclusions CA153 in BS is a valuable molecular marker in diagnosing BC and should be applied in standard clinical practices of BC screening upon confirmation of our findings in a larger prospective study.	[Tang, Shifu; Sun, Yifan; Zhu, Shengbo; Yang, Renqi; Huang, Yiyong; Zhang, Hongyu] Guangxi Univ Chinese Med, Affiliated Hosp 3, Dept Lab Med, Guangxi, Peoples R China; [Wei, Lili; Xu, Hong] Guangxi Univ Chinese Med, Affiliated Hosp 3, Dept Internal Med, Guangxi, Peoples R China; [Zhou, Fang] Guangxi Med Univ, Affiliated Hosp 4, Dept Rheumatol, Guangxi, Peoples R China; [Yang, Jianqing] Guangxi Univ Chinese Med, Affiliated Hosp 4, Dept Gen Surg, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi University of Chinese Medicine	Yang, JQ (corresponding author), Guangxi Univ Chinese Med, Affiliated Hosp 4, Dept Gen Surg, Guangxi, Peoples R China.	524908210@qq.com; yangjianqing2004@163.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022					Ali RM, 2015, RADIOGRAPHY, V21, P298, DOI 10.1016/j.radi.2015.07.008; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brooks Mai, 2009, V472, P307, DOI 10.1007/978-1-60327-492-0_13; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Dinkel HP, 2000, BRIT J RADIOL, V73, P706, DOI 10.1259/bjr.73.871.11089460; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gewefel H, 2014, CLIN BREAST CANCER, V14, P390, DOI 10.1016/j.clbc.2014.06.002; GION M, 1991, BRIT J CANCER, V63, P809, DOI 10.1038/bjc.1991.179; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Ichihara S, 2011, VIRCHOWS ARCH, V458, P547, DOI 10.1007/s00428-011-1065-2; Jardines L, 1996, AM SURGEON, V62, P119; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Kurebayashi Junichi, 2004, Gan To Kagaku Ryoho, V31, P1021; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Macacu A, 2015, BREAST CANCER RES TR, V154, P213, DOI 10.1007/s10549-015-3628-4; Mannello Ferdinando, 2008, Expert Opin Med Diagn, V2, P1221, DOI 10.1517/17530059.2.11.1221; Mantas D, 2016, ATHEROSCLEROSIS, V248, P1, DOI 10.1016/j.atherosclerosis.2016.02.019; Morrow M, 2011, LANCET, V378, P1804, DOI 10.1016/S0140-6736(11)61350-0; Pinto MM, 1996, ACTA CYTOL, V40, P437; Sauter ER, 1999, BRIT J CANCER, V81, P1222, DOI 10.1038/sj.bjc.6690832; Schennink A, 2015, REPROD TOXICOL, V54, P93, DOI 10.1016/j.reprotox.2014.10.020; Shield KD, 2016, ALCOHOL CLIN EXP RES, V40, P1166, DOI 10.1111/acer.13071; Tang S, 2016, BREAST CANC; Vargas Hernan I, 2002, Curr Treat Options Oncol, V3, P157, DOI 10.1007/s11864-002-0061-9; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wang GP, 2014, INT J MOL SCI, V15, P9546, DOI 10.3390/ijms15069546; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wong AW, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-75; Yip CH, 2011, BREAST, V20, pS12, DOI 10.1016/j.breast.2011.02.015; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhao S, 2015, INT J CLIN EXP MED, V8, P20837; Zhao S, 2015, CHINESE J PHYSIOL, V58, P385, DOI 10.4077/CJP.2015.BAD336; [庄志刚 Zhuang Zhigang], 2005, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V32, P690	38	19	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163030	10.1371/journal.pone.0163030	http://dx.doi.org/10.1371/journal.pone.0163030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636552	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700027
J	Aoki, H; Ogino, H; Tomita, H; Hara, A; Kunisada, T				Aoki, Hitomi; Ogino, Hajime; Tomita, Hiroyuki; Hara, Akira; Kunisada, Takahiro			Disruption of Rest Leads to the Early Onset of Cataracts with the Aberrant Terminal Differentiation of Lens Fiber Cells	PLOS ONE			English	Article							MELANOCYTE STEM-CELLS; CONGENITAL CATARACTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET GENES; MOLECULAR-GENETICS; DOWN-SYNDROME; IN-VIVO; REPRESSOR; NEUROGENESIS	REST (RE1-silencing transcription factor, also called Nrsf) is involved in the maintenance of the undifferentiated state of neuronal stem/progenitor cells in vitro by preventing precocious expression of neuronal genes. REST expression was then decreased in developing neurons to down-regulate neuronal genes which allow their maturation. However, the function of REST during neurogenesis in vivo remains to be elucidated because of the early embryonic lethal phenotype of conventional Rest knockout mice. In order to investigate the role of REST in ocular tissues, we generated and examined the mice evoking genetic ablation to Rest specifically to neural tissues including ocular tissue. We used a Sox1-Cre allele to excise the floxed Rest gene in the early neural tissues including the lens and retinal primordia. The resulting Rest conditional knockout (CKO) and co cntrol mice were used in comparative morphological, histological, and gene expression analyses. Rest CKO mice had an abnormal lens morphology after birth. The proliferation of lens epithelial cells was likely to be slightly reduced, and vacuoles formed without a visible increase in apoptotic cells. Although the aberrant expression of late onset cataract marker proteins was not detected, the expression of Notch signaling-related genes including a previously identified REST-target gene was up-regulated around birth, and this was followed by the down-regulated expression of lens fiber regulators such as c-Maf and Prox1. Rest CKO induces a unique cataract phenotype just after birth. Augmented Notch signaling and the down-regulated expression of lens fiber regulator genes may be responsible for this phenotype. Our results highlight the significance of REST function in lens fiber formation, which is necessary for maintaining an intact lens structure.	[Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Dept Tissue & Organ Dev, Grad Sch Med, Gifu, Japan; [Ogino, Hajime] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Japan; [Tomita, Hiroyuki; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University	Kunisada, T (corresponding author), Gifu Univ, Dept Tissue & Organ Dev, Grad Sch Med, Gifu, Japan.	tkunisad@gifu-u.ac.jp	Ogino, Hajime/G-5279-2019; Tomita, Hiroyuki/L-5571-2019	Ogino, Hajime/0000-0003-2707-2330; Tomita, Hiroyuki/0000-0002-3291-0274	Japan Science and Technology Agency; JSPS	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by a grant from the Japan Science and Technology Agency and by Grants-in-Aid for Scientific Research by the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2005, FEBS LETT, V579, P6199, DOI 10.1016/j.febslet.2005.09.093; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Aoki H, 2014, GENES CELLS, V19, P723, DOI 10.1111/gtc.12172; Aoki H, 2013, J INVEST DERMATOL, V133, P2143, DOI 10.1038/jid.2013.155; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Aoki H, 2011, J INVEST DERMATOL, V131, P1906, DOI 10.1038/jid.2011.148; Audette DS, 2016, DEVELOPMENT, V143, P318, DOI 10.1242/dev.127860; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Berry V, 2011, MOL VIS, V17, P1249; Bitel CL, 2010, MOL VIS, V16, P2301; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Frederikse PH, 2012, DEV BIOL, V368, P255, DOI 10.1016/j.ydbio.2012.05.022; Gillespie RL, 2015, INVEST OPHTH VIS SCI, V56, P883, DOI 10.1167/iovs.14-15861; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; Korsakova N V, 2008, Neurosci Behav Physiol, V38, P887, DOI 10.1007/s11055-008-9066-6; Le TT, 2012, DEV DYNAM, V241, P493, DOI 10.1002/dvdy.23739; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Merath K, 2013, INVEST OPHTH VIS SCI, V54, P6646, DOI 10.1167/iovs.13-12283; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Ogino H, 2000, DEV GROWTH DIFFER, V42, P437; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Ogino H, 2008, DEVELOPMENT, V135, P249, DOI 10.1242/dev.009548; Ogino H, 2012, DEV BIOL, V363, P333, DOI 10.1016/j.ydbio.2012.01.006; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Takeuchi T, 2009, GENES CELLS, V14, P941, DOI 10.1111/j.1365-2443.2009.01321.x; Uusitalo M, 1997, GRAEF ARCH CLIN EXP, V235, P506, DOI 10.1007/BF00947008; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	52	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163042	10.1371/journal.pone.0163042	http://dx.doi.org/10.1371/journal.pone.0163042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631609	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900122
J	de Munck, E; Palomo, V; Munoz-Saez, E; Perez, DI; Gomez-Miguel, B; Solas, MT; Gil, C; Martinez, A; Arahuetes, RM				de Munck, Estefania; Palomo, Valle; Munoz-Saez, Emma; Perez, Daniel I.; Gomez-Miguel, Begona; Teresa Solas, M.; Gil, Carmen; Martinez, Ana; Arahuetes, Rosa M.			Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SYNTHASE KINASE 3; METHYLAMINO-L-ALANINE; ALZHEIMERS-DISEASE; SPINAL-CORD; NEURODEGENERATIVE DISEASES; BMAA NEUROTOXICITY; TRANSGENIC MICE; PROTEIN-KINASE; MOUSE MODEL	Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron degenerative disease that has no effective treatment up to date. Drug discovery tasks have been hampered due to the lack of knowledge in its molecular etiology together with the limited animal models for research. Recently, a motor neuron disease animal model has been developed using beta-N-methylamino-L-alanine (L-BMAA), a neurotoxic amino acid related to the appearing of ALS. In the present work, the neuroprotective role of VP2.51, a small heterocyclic GSK-3 inhibitor, is analysed in this novel murine model together with the analysis of autophagy. VP2.51 daily administration for two weeks, starting the first day after L-BMAA treatment, leads to total recovery of neurological symptoms and prevents the activation of autophagic processes in rats. These results show that the L-BMAAmurine model can be used to test the efficacy of new drugs. In addition, the results confirm the therapeutic potential of GSK-3 inhibitors, and specially VP2.51, for the disease-modifying future treatment of motor neuron disorders like ALS.	[de Munck, Estefania; Arahuetes, Rosa M.] Univ Complutense Madrid, Dept Biol Anim 2, Ciudad Univ, Madrid, Spain; [Palomo, Valle; Perez, Daniel I.; Gil, Carmen; Martinez, Ana] CSIC, Ctr Invest Biol, Ramiro de Maetzu 9, Madrid, Spain; [Munoz-Saez, Emma; Gomez-Miguel, Begona] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Ciudad Univ, Madrid, Spain; [Teresa Solas, M.] Univ Complutense Madrid, Dept Biol Celular, Ciudad Univ, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Complutense University of Madrid	Arahuetes, RM (corresponding author), Univ Complutense Madrid, Dept Biol Anim 2, Ciudad Univ, Madrid, Spain.; Martinez, A (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maetzu 9, Madrid, Spain.	ana.martinez@csic.es; rportero@bio.ucm.es	Martinez, Ana/L-6414-2014; Gil, Carmen/J-8932-2014; Muñoz-Sáez, Emma EMS/F-4937-2016; del Valle Palomo Ruiz, María/N-2932-2016; de Munck Garcia, Estefania/C-8910-2015; Perez, Daniel I./L-6245-2014	Martinez, Ana/0000-0002-2707-8110; Gil, Carmen/0000-0002-3882-6081; Muñoz-Sáez, Emma EMS/0000-0003-3654-0343; del Valle Palomo Ruiz, María/0000-0002-1473-4086; de Munck Garcia, Estefania/0000-0001-6073-5242; Perez, Daniel I./0000-0003-1774-4471	MINECO [SAF2012-37979-C03-01]; FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation); Association Francaise contre les Myopathies [AFM-16169]	MINECO(Spanish Government); FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors wish to express their gratitude for the expert technical assistance provided by the Animal Facilities of the Biological Science School of Complutense University of Madrid. This work was supported by MINECO (grant no. SAF2012-37979-C03-01), FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation) and Association Francaise contre les Myopathies (AFM-16169).	Agostini M, 2011, BIOCHEM BIOPH RES CO, V414, P451, DOI 10.1016/j.bbrc.2011.09.081; Ahn SW, 2014, J NEUROL SCI, V340, P112, DOI 10.1016/j.jns.2014.03.008; Ahn SW, 2012, J NEUROL SCI, V320, P1, DOI 10.1016/j.jns.2012.05.038; ALLEY MC, 1988, CANCER RES, V48, P589; [Anonymous], 2013, ADV BIOSCI BIOTECHNO, DOI DOI 10.4236/ABB.2013.45083; Baki A, 2007, ASSAY DRUG DEV TECHN, V5, P75, DOI 10.1089/adt.2006.029; Banack SA, 2010, TOXINS, V2, P2837, DOI 10.3390/toxins2122837; Beurel E, 2013, J IMMUNOL, V190, P5000, DOI 10.4049/jimmunol.1203057; Bucchia M, 2015, CLIN THER, V37, P668, DOI 10.1016/j.clinthera.2014.12.020; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Crippa V, 2010, AUTOPHAGY, V6, P958, DOI 10.4161/auto.6.7.13042; de Munck E, 2015, ENVIRON TOXICOL PHAR, V39, P1232, DOI 10.1016/j.etap.2015.04.022; de Munck E, 2013, ENVIRON TOXICOL PHAR, V36, P243, DOI 10.1016/j.etap.2013.04.007; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Emde A, 2015, EMBO J, V34, P2633, DOI 10.15252/embj.201490493; Ferrucci M, 2011, ARCH ITAL BIOL, V149, P121, DOI 10.4449/aib.v149i1.1258; Gladman M, 2014, AMYOTROPH LAT SCL FR, V15, P426, DOI 10.3109/21678421.2014.932382; Hellwig C T, 2011, Curr Mol Med, V11, P31; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Jennum P, 2013, J NEUROL, V260, P785, DOI 10.1007/s00415-012-6706-0; Karamyan VT, 2008, LIFE SCI, V82, P233, DOI 10.1016/j.lfs.2007.11.020; King MK, 2014, PHARMACOL THERAPEUT, V141, P1, DOI 10.1016/j.pharmthera.2013.07.010; Kiriyama Y, 2015, INT J MOL SCI, V16, P26797, DOI 10.3390/ijms161125990; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Martinez A, 2013, CURR TOP MED CHEM, V13, P1808, DOI 10.2174/15680266113139990138; Morales-Garcia JA, 2012, ACS CHEM NEUROSCI, V3, P963, DOI 10.1021/cn300110c; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Moujalled D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067433; Munoz-Saez E, 2015, NEUROTOXICOLOGY, V48, P192, DOI 10.1016/j.neuro.2015.04.001; Nassif M, 2011, AUTOPHAGY, V7, P450, DOI 10.4161/auto.7.4.14700; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Paez-Colasante X, 2015, NAT REV NEUROL, V11, P266, DOI 10.1038/nrneurol.2015.57; Palomo V, 2011, CURR MED CHEM, V18, P3028, DOI 10.2174/092986711796391697; Palomo V, 2012, J MED CHEM, V55, P1645, DOI 10.1021/jm201463v; Palomo V, 2011, J MED CHEM, V54, P8461, DOI 10.1021/jm200996g; Perez DI, 2011, J MED CHEM, V54, P4042, DOI 10.1021/jm1016279; Rosenfeld J, 2015, NEUROTHERAPEUTICS, V12, P317, DOI 10.1007/s13311-014-0332-8; Salado IG, 2014, J MED CHEM, V57, P2755, DOI 10.1021/jm500065f; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P352, DOI 10.1007/s13311-015-0338-x; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Tasker RA, 2010, EPMA J, V1, P217, DOI 10.1007/s13167-010-0019-0; Yang WC, 2008, BRAIN RES, V1196, P131, DOI 10.1016/j.brainres.2007.12.031; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143	52	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162723	10.1371/journal.pone.0162723	http://dx.doi.org/10.1371/journal.pone.0162723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631495	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000383706900071
J	Eastwood, SV; Mathur, R; Atkinson, M; Brophy, S; Sudlow, C; Flaig, R; de Lusignan, S; Allen, N; Chaturvedi, N				Eastwood, Sophie V.; Mathur, Rohini; Atkinson, Mark; Brophy, Sinead; Sudlow, Cathie; Flaig, Robin; de Lusignan, Simon; Allen, Naomi; Chaturvedi, Nishi			Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank	PLOS ONE			English	Article							PRIMARY-CARE; SELF-REPORTS; MISCLASSIFICATION; MISDIAGNOSIS; VALIDITY	Objectives UK Biobank is a UK-wide cohort of 502,655 people aged 40-69, recruited from National Health Service registrants between 2006-10, with healthcare data linkage. Type 2 diabetes is a key exposure and outcome. We developed algorithms to define prevalent and incident diabetes for UK Biobank. The algorithms will be implemented by UK Biobank and their results made available to researchers on request. Methods We used UK Biobank self-reported medical history and medication to assign prevalent diabetes and type, and tested this against linked primary and secondary care data in Welsh UK Biobank participants. Additionally, we derived and tested algorithms for incident diabetes using linked primary and secondary care data in the English Clinical Practice Research Datalink, and ran these on secondary care data in UK Biobank. Results and Significance For prevalent diabetes, 0.001% and 0.002% of people classified as "diabetes unlikely" in UK Biobank had evidence of diabetes in their primary or secondary care record respectively. Of those classified as "probable" type 2 diabetes, 75% and 96% had specific type 2 diabetes codes in their primary and secondary care records. For incidence, 95% of people with the type 2 diabetes-specific C10F Read code in primary care had corroborative evidence of diabetes from medications, blood testing or diabetes specific process of care codes. Only 41% of people identified with type 2 diabetes in primary care had secondary care evidence of type 2 diabetes. In contrast, of incident cases using ICD-10 type 2 diabetes specific codes in secondary care, 77% had corroborative evidence of diabetes in primary care. We suggest our definition of prevalent diabetes from UK Biobank baseline data has external validity, and recommend that specific primary care Read codes should be used for incident diabetes to ensure precision. Secondary care data should be used for incident diabetes with caution, as around half of all cases are missed, and a quarter have no corroborative evidence of diabetes in primary care.	[Eastwood, Sophie V.; Chaturvedi, Nishi] UCL, Inst Cardiovasc Sci, London, England; [Mathur, Rohini] London Sch Hyg & Trop Med, Dept Noncommunicable Dis, London, England; [Atkinson, Mark; Brophy, Sinead] Swansea Univ, CIPHER Ctr Improvement Populat Hlth E Records Res, Coll Med, Swansea, W Glam, Wales; [Sudlow, Cathie; Flaig, Robin] Univ Edinburgh, CCBS, Edinburgh, Midlothian, Scotland; [de Lusignan, Simon] Univ Surrey, Dept Clin & Expt Med, Guildford, England; [Allen, Naomi] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Sudlow, Cathie; Flaig, Robin; Allen, Naomi] United Kingdom Biobank, Stockport, Lancs, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Swansea University; University of Edinburgh; University of Surrey; University of Oxford	Eastwood, SV (corresponding author), UCL, Inst Cardiovasc Sci, London, England.	sophie.eastwood@ucl.ac.uk	de Lusignan, Smion/S-7838-2019; Atkinson, Mark D/K-1813-2013	de Lusignan, Smion/0000-0002-8553-2641; Atkinson, Mark D/0000-0003-4237-3588; Chaturvedi, Nishi/0000-0002-6211-2775; Brophy, Sinead/0000-0001-7417-2858; Eastwood, Sophie/0000-0002-1883-8771; Sudlow, Cathie/0000-0002-7725-7520	UK Biobank; MRC [MC_U137686860, MR/K006525/1, MR/K023233/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1, MC_U137686860, MC_qA137853, MR/K023233/1] Funding Source: researchfish	UK Biobank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from UK Biobank. Funders inputted into discussion around the design of the work, and contributed to manuscript writing. They did not however have any role in data analysis.	Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; de Lusignan S, 2012, DIABETIC MED, V29, P181, DOI 10.1111/j.1464-5491.2011.03419.x; de Lusignan S, 2010, DIABETIC MED, V27, P203, DOI 10.1111/j.1464-5491.2009.02917.x; Goto A, 2013, J EPIDEMIOL, V23, P295, DOI 10.2188/jea.JE20120221; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Sluijs I, 2010, NETH J MED, V68, P333; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779	11	102	102	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162388	10.1371/journal.pone.0162388	http://dx.doi.org/10.1371/journal.pone.0162388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631769	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000383706900043
J	Koo, M; Chen, JC; Hwang, JH				Koo, Malcolm; Chen, Jin-Cherng; Hwang, Juen-Haur			Risk of Peripheral Artery Occlusive Disease in Patients with Vertigo, Tinnitus, or Sudden Deafness: A Secondary Case-Control Analysis of a Nationwide, Population-Based Health Claims Database	PLOS ONE			English	Article							DYSFUNCTION	Background Cochleovestibular symptoms, such as vertigo, tinnitus, and sudden deafness, are common manifestations of microvascular diseases. However, it is unclear whether these symptoms occurred preceding the diagnosis of peripheral arteryocclusive disease (PAOD). Therefore, the aim of this case-control study was to investigate the risk of PAOD among patients with vertigo, tinnitus, and sudden deafness using a nationwide, population-based health claim database in Taiwan. Methods We identified 5,340 adult patients with PAOD diagnosed between January 1, 2006 and December 31, 2010 and 16,020 controls, frequency matched on age interval, sex, and year of index date, from the Taiwan National Health Insurance Research Database. Risks of PAOD in patients with vertigo, tinnitus, or sudden deafness were separately evaluated with multivariate logistic regression analyses. Results Of the 5,340 patients with PAOD, 12.7%, 6.7%, and 0.3% were diagnosed with vertigo, tinnitus, and sudden deafness, respectively. In the controls, 10.6%, 6.1%, and 0.3% were diagnosed with vertigo (P < 0.001), tinnitus (P = 0.161), and sudden deafness (P = 0.774), respectively. Results from the multivariate logistic regression analyses showed that the risk of PAOD was significantly increased in patients with vertigo (adjusted odds ratio = 1.12, P = 0.027) but not in those with tinnitus or sudden deafness. Conclusions A modest increase in the risk of PAOD was observed among Taiwanese patients with vertigo, after adjustment for comorbidities.	[Koo, Malcolm] Dalin Tzu Chi Hosp, Dept Med Res, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chen, Jin-Cherng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Chiayi, Taiwan; [Chen, Jin-Cherng; Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Sleep Ctr, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Sleep Ctr, Chiayi, Taiwan.	g120796@tzuchi.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Berard AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0037882; Criqui MH, 2005, CIRCULATION, V112, P2703, DOI 10.1161/CIRCULATIONAHA.105.546507; GRAD A, 1989, ARCH NEUROL-CHICAGO, V46, P281, DOI 10.1001/archneur.1989.00520390047014; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; Kim JS, 2009, SEMIN NEUROL, V29, P534, DOI 10.1055/s-0029-1241037; Kuwabara M, 2015, PULSE, V3, P242, DOI 10.1159/000443769; Lai YT, 2011, OTOLARYNG HEAD NECK, V145, P110, DOI 10.1177/0194599811400007; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; MacLean A, 2010, SOC SCI MED, V70, P597, DOI 10.1016/j.socscimed.2009.10.042; Moubayed SP, 2009, LARYNGOSCOPE, V119, P2071, DOI 10.1002/lary.20597; National Health Insurance Administration Ministry of Health and Welfare Taiwan, 2013, NATIONAL HEALTH INSU; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Sen S, 2009, STROKE, V40, P3472, DOI 10.1161/STROKEAHA.109.559278; Welsh LW, 2000, ANN OTO RHINOL LARYN, V109, P239, DOI 10.1177/000348940010900301; Wong TY, 2008, AM J EPIDEMIOL, V167, P51, DOI 10.1093/aje/kwm256	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162629	10.1371/journal.pone.0162629	http://dx.doi.org/10.1371/journal.pone.0162629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631630	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900062
J	Gleibs, IH; Wilson, N; Reddy, G; Catmur, C				Gleibs, Ilka H.; Wilson, Neil; Reddy, Geetha; Catmur, Caroline			Group Dynamics in Automatic Imitation	PLOS ONE			English	Article							BEHAVIORAL MIMICRY; CONSEQUENCES; MODULATION; SYNCHRONY; IMPACT	Imitation-matching the configural body movements of another individual-plays a crucial part in social interaction. We investigated whether automatic imitation is not only influenced by who we imitate (ingroup vs. outgroup member) but also by the nature of an expected interaction situation (competitive vs. cooperative). In line with assumptions from Social Identity Theory), we predicted that both social group membership and the expected situation impact on the level of automatic imitation. We adopted a 2 (group membership target: ingroup, outgroup) x 2 (situation: cooperative, competitive) design. The dependent variable was the degree to which participants imitated the target in a reaction time automatic imitation task. 99 female students from two British Universities participated. We found a significant two-way interaction on the imitation effect. When interacting in expectation of cooperation, imitation was stronger for an ingroup target compared to an outgroup target. However, this was not the case in the competitive condition where imitation did not differ between ingroup and outgroup target. This demonstrates that the goal structure of an expected interaction will determine the extent to which intergroup relations influence imitation, supporting a social identity approach.	[Gleibs, Ilka H.; Reddy, Geetha] London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England; [Wilson, Neil] Univ Cent Lancashire, Coll Hlth & Wellbeing, Preston, Lancs, England; [Catmur, Caroline] Kings Coll London, Dept Psychol, London, England	University of London; London School Economics & Political Science; University of Central Lancashire; University of London; King's College London	Gleibs, IH (corresponding author), London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England.	i.h.gleibs@lse.ac.uk	Gleibs, Ilka/T-4655-2019	Reddy, Geetha/0000-0003-1656-8576; Gleibs, Ilka/0000-0002-9913-250X; Catmur, Caroline/0000-0001-6996-4295	Engineering and Physical Science Research Council [EP/J005053/1]; Economic and Social Research Council [ES/K00140X/1]; Engineering and Physical Sciences Research Council [EP/J005053/1] Funding Source: researchfish; EPSRC [EP/J005053/1] Funding Source: UKRI; ESRC [ES/K00140X/1] Funding Source: UKRI	Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by a grant from the Engineering and Physical Science Research Council (EP/J005053/1). CC was supported by the Economic and Social Research Council (ES/K00140X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelas J. B., 1987, EMPATHY ITS DEV, P317; BAVELAS JB, 1986, J PERS SOC PSYCHOL, V50, P322, DOI 10.1037/0022-3514.50.2.322; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; BROWN R, 1986, J EXP SOC PSYCHOL, V22, P78, DOI 10.1016/0022-1031(86)90041-7; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Catmur C, J EXPT PSYC IN PRESS; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Deutsch M, 1949, HUM RELAT, V2, P199, DOI 10.1177/001872674900200301; Duffy KA, 2015, CURR OPIN BEHAV SCI, V3, P112, DOI 10.1016/j.cobeha.2015.03.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Haslam S.A., 2004, PSYCHOL ORG; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; Lakens D, 2014, PERSPECT PSYCHOL SCI, V9, P278, DOI 10.1177/1745691614528520; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Rauchbauer B, 2015, CORTEX, V70, P49, DOI 10.1016/j.cortex.2015.03.007; Semin GR, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P119; Stel M, 2010, EUR J SOC PSYCHOL, V40, P867, DOI 10.1002/ejsp.655; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Turner J.C., 1987, REDISCOVERING SOCIAL; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6	35	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162880	10.1371/journal.pone.0162880	http://dx.doi.org/10.1371/journal.pone.0162880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657926	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200038
J	Jeronymo, DC; Coelho, AAR				Jeronymo, Daniel Cavalcanti; Rodrigues Coelho, Antonio Augusto			Model Based Predictive Control of Multivariable Hammerstein Processes with Fuzzy Logic Hypercube Interpolated Models	PLOS ONE			English	Article							NONLINEAR-SYSTEMS; IDENTIFICATION; DISTILLATION	This paper introduces the Fuzzy Logic Hypercube Interpolator (FLHI) and demonstrates applications in control of multiple-input single-output (MISO) and multiple-input multiple-output (MIMO) processes with Hammerstein nonlinearities. FLHI consists of a Takagi-Sugeno fuzzy inference system where membership functions act as kernel functions of an interpolator. Conjunction of membership functions in an unitary hypercube space enables multivariable interpolation of N-dimensions. Membership functions act as interpolation kernels, such that choice of membership functions determines interpolation characteristics, allowing FLHI to behave as a nearest-neighbor, linear, cubic, spline or Lanczos interpolator, to name a few. The proposed interpolator is presented as a solution to the modeling problem of static nonlinearities since it is capable of modeling both a function and its inverse function. Three study cases from literature are presented, a single-input single-output (SISO) system, a MISO and a MIMO system. Good results are obtained regarding performance metrics such as set-point tracking, control variation and robustness. Results demonstrate applicability of the proposed method in modeling Hammerstein nonlinearities and their inverse functions for implementation of an output compensator with Model Based Predictive Control (MBPC), in particular Dynamic Matrix Control (DMC).	[Jeronymo, Daniel Cavalcanti] Fed Univ Technol, Dept Comp Engn, Toledo, Parana, Brazil; [Jeronymo, Daniel Cavalcanti; Rodrigues Coelho, Antonio Augusto] Univ Fed Santa Catarina, Automat & Syst Engn Grad Program PPGEAS, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Jeronymo, DC (corresponding author), Fed Univ Technol, Dept Comp Engn, Toledo, Parana, Brazil.; Jeronymo, DC (corresponding author), Univ Fed Santa Catarina, Automat & Syst Engn Grad Program PPGEAS, Florianopolis, SC, Brazil.	danielc@utfpr.edu.br	dos Santos Coelho, Leandro/G-8213-2014; Jeronymo, Daniel/L-4527-2013	dos Santos Coelho, Leandro/0000-0001-5728-943X; Jeronymo, Daniel/0000-0003-3492-4466	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [140592/2012-1]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author received a PhD scholarship by Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), process: 140592/2012-1, http://cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonyi J, 2000, IND ENG CHEM RES, V39, P4302, DOI 10.1021/ie990629e; [Anonymous], 1979, DYNAMICMATRIXCONTROL; BRISTOL EH, 1966, IEEE T AUTOMAT CONTR, VAC11, P133, DOI 10.1109/TAC.1966.1098266; Camacho E.F., 2007, ADV TXB CONTROL SIGN; Cao Y, 1997, COMPUT CHEM ENG, V21, P563, DOI 10.1016/S0098-1354(96)00296-7; Chen JH, 2003, J CHEM ENG JPN, V36, P198, DOI 10.1252/jcej.36.198; Clarke D., 1994, ADV MODEL BASED PRED; Cutler C.R., 1980, P 17 JOINT AUT CONTR, V17, P72; Dutta P, 1999, ISA T, V38, P251, DOI 10.1016/S0019-0578(99)00025-7; ESKINAT E, 1991, AICHE J, V37, P255, DOI 10.1002/aic.690370211; FARSI M, 1994, PROCEEDINGS OF THE 1994 AMERICAN CONTROL CONFERENCE, VOLS 1-3, P3499; Guo F., 2003, EUR CONTR C 2003, P2144, DOI [10.23919/ECC. 2003.7085284., DOI 10.23919/ECC.2003.7085284]; Hughes T.J. R., 2000, FINITE ELEMENT METHO; Ibarrola JJ, 2002, CONTROL ENG PRACT, V10, P713, DOI 10.1016/S0967-0661(02)00029-1; Isidori A., 2013, NONLINEAR CONTROL SY; Jana AK, 2005, J PROCESS CONTR, V15, P169, DOI 10.1016/j.jprocont.2004.06.002; Jeng JC, 2007, 8 INT IFAC S DYN CON, V2, P409; Jeng JC, 2008, IND ENG CHEM RES, V47, P6640, DOI 10.1021/ie071512q; Jin XZ, 2012, P INT C MACH LEARN C, V2, P440; Jurado F, 2006, J POWER SOURCES, V158, P245, DOI 10.1016/j.jpowsour.2005.08.041; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Lee JH, 2011, INT J CONTROL AUTOM, V9, P415, DOI 10.1007/s12555-011-0300-6; Li H, 2008, 2008 CHINESE CONTROL AND DECISION CONFERENCE, VOLS 1-11, P5075, DOI 10.1109/CCDC.2008.4598296; Lim SP, 2014, ARTIF INTELL REV, V42, P59, DOI 10.1007/s10462-012-9329-z; Marusak PM, 2010, ADV INTEL SOFT COMPU, V75, P11; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Ozkan L, 1998, COMPUT CHEM ENG, V22, pS883, DOI 10.1016/S0098-1354(98)00172-0; Pearson RK, 1999, DISCRE TIME DYNAMIC; Qin SJ, 2003, CONTROL ENG PRACT, V11, P733, DOI 10.1016/S0967-0661(02)00186-7; RICHALET J, 1978, AUTOMATICA, V14, P413, DOI 10.1016/0005-1098(78)90001-8; Seborg D.E., 2011, PROCESS DYNAMICS CON; Talas Stanislav, 2014, 28th European Conference on Modelling and Simulation ECMS 2014. Proceedings, P267; Ugray Z, 2007, INFORMS J COMPUT, V19, P328, DOI 10.1287/ijoc.1060.0175; Zou ZY, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P1981	34	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163116	10.1371/journal.pone.0163116	http://dx.doi.org/10.1371/journal.pone.0163116			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657723	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200069
J	Jouret, F; Leenders, J; Poma, L; Defraigne, JO; Krzesinski, JM; de Tullio, P				Jouret, Francois; Leenders, Justine; Poma, Laurence; Defraigne, Jean-Olivier; Krzesinski, Jean-Marie; de Tullio, Pascal			Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							CLINICAL-PRACTICE; BIOMARKERS; TAURINE; RAT; TRANSPLANTATION; NEPHROTOXICITY; NORMALIZATION; NEPHROLOGY; CREATININE; MODEL	Background Ischemia/reperfusion (I/R) is the most common cause of acute kidney injury (AKI). Its pathophysiology remains unclear. Metabolomics is dedicated to identify metabolites involved in (patho) physiological changes of integrated living systems. Here, we performed H-1-Nuclear Magnetic Resonance metabolomics using urine, serum and kidney samples from a mouse model of renal I/R. Methods Renal 30-min ischemia was induced in 12-week-old C57BL/6J male mice by bilaterally clamping vascular pedicles, and was followed by 6, 24 or 48-hour reperfusion (n = 12/group). Sham-operated mice were used as controls. Statistical discriminant analyses, i.e. principal component analysis and orthogonal projections to latent structures (OPLS-DA), were performed on urine, serum and kidney lysates at each time-point. Multivariate receiver operating characteristic (ROC) curves were drawn, and sensitivity and specificity were calculated from ROC confusion matrix (with averaged class probabilities across 100 cross-validations). Results Urine OPLS-DA analysis showed a net separation between I/R and sham groups, with significant variations in levels of taurine, di-and tri-methylamine, creatine and lactate. Such changes were observed as early as 6 hours post reperfusion. Major metabolome modifications occurred at 24h post reperfusion. At this time-point, correlation coefficients between urine spectra and conventional AKI biomarkers, i.e. serum creatinine and urea levels, reached 0.94 and 0.95, respectively. The area under ROC curve at 6h, 24h and 48h post surgery were 0.73, 0.98 and 0.97, respectively. Similar discriminations were found in kidney samples, with changes in levels of lactate, fatty acids, choline and taurine. By contrast, serum OPLS-DA analysis could not discriminate sham-operated from I/R-exposed animals. Conclusions Our study demonstrates that renal I/R in mouse causes early and sustained metabolomic changes in urine and kidney composition. The most implicated pathways at 6h and 24h post reperfusion include gluconeogenesis, taurine and hypotaurine metabolism, whereas protein biosynthesis, glycolysis, and galactose and arginine metabolism are key at 48h post reperfusion.	[Jouret, Francois; Poma, Laurence; Krzesinski, Jean-Marie] Univ Liege Hosp ULg CHU, Div Nephrol, Liege, Belgium; [Jouret, Francois; Poma, Laurence; Defraigne, Jean-Olivier; Krzesinski, Jean-Marie] Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium; [Leenders, Justine; de Tullio, Pascal] Univ Liege, CIRM, Liege, Belgium	University of Liege; University of Liege; University of Liege	Jouret, F (corresponding author), Univ Liege Hosp ULg CHU, Div Nephrol, Liege, Belgium.; Jouret, F (corresponding author), Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium.	francois.jouret@chu.ulg.ac.be	De Tullio, Pascal/ABE-5585-2021; Leenders, Justine/AAA-4470-2020	Leenders, Justine/0000-0003-1488-5287	FNRS [3309]; University of Liege (Fonds Speciaux a la Recherche; Fonds Leon Fredericq); Belgian Royal Academy of Medicine (Fondation O. Dupont)	FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege (Fonds Speciaux a la Recherche; Fonds Leon Fredericq); Belgian Royal Academy of Medicine (Fondation O. Dupont)	PT is Senior Research Associate of the Fonds de la Recherche Scientifique (FNRS) and FJ is a MD Postdoctoral Fellow of the Fonds de la Recherche Scientifique (FNRS), and received support from FNRS (Research Credit #3309), University of Liege (Fonds Speciaux a la Recherche; Fonds Leon Fredericq) and from the Belgian Royal Academy of Medicine (Fondation O. Dupont).; The authors cordially thank Eric Brevers (Pr. E. Cavalier's lab) for measuring serum creatinine and urea levels. PT is Senior Research Associate of the Fonds de la Recherche Scientifique (FNRS) and FJ is a MD Postdoctoral Fellow of the FNRS, and received support from FNRS (Research Credit #3309), University of Liege (Fonds Speciaux a la Recherche; Fonds Leon Fredericq) and from the Belgian Royal Academy of Medicine (Fondation O. Dupont).	Atzler D, 2014, NEPHROL DIAL TRANSPL, V29, P1467, DOI 10.1093/ndt/gft492; Bain MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chesney RW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S4; Cowin GJ, 1999, AM J PHYSIOL-RENAL, V277, pF338, DOI 10.1152/ajprenal.1999.277.3.F338; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Erpicum P, 2014, NEPHROL DIAL TRANSPL; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Hauet T, 2000, CLIN CHEM LAB MED, V38, P1093, DOI 10.1515/CCLM.2000.162; Huen SC, 2015, PEDIATR NEPHROL, V30, P199, DOI 10.1007/s00467-013-2726-y; Kempson SA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00159; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Lagny MG, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0066-9; Liu Y, 2012, KIDNEY BLOOD PRESS R, V35, P373, DOI 10.1159/000336171; Michalk DV, 2003, ADV EXP MED BIOL, V526, P49; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Nkuipou-Kenfack E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096955; Ogino T, 2009, ADV EXP MED BIOL, V643, P451, DOI 10.1007/978-0-387-75681-3_47; Rao S, 2016, AM J PHYSL RENAL PHY; Rasmiena AA, 2013, CLIN SCI, V124, P289, DOI 10.1042/CS20120268; Rowart P., 2015, J IMMUNOL RES, V2015, P8; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Subramaniam S, 2011, CHEM REV, V111, P6452, DOI 10.1021/cr200295k; Sun JC, 2012, J CHROMATOGR B, V893, P107, DOI 10.1016/j.jchromb.2012.02.042; Tang KWA, 2015, SINGAP MED J, V56, P7, DOI 10.11622/smedj.2015003; Thakar CV, 2013, ADV CHRONIC KIDNEY D, V20, P67, DOI 10.1053/j.ackd.2012.10.003; Uehara T, 2014, J APPL TOXICOL, V34, P1087, DOI 10.1002/jat.2933; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wang HF, 2013, J ETHNOPHARMACOL, V146, P572, DOI 10.1016/j.jep.2013.01.026; Weekers L, 2015, AM J TRANSL RES, V7, P128; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; WEINER MW, 1987, ANN NY ACAD SCI, V508, P287, DOI 10.1111/j.1749-6632.1987.tb32911.x; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; WINGENFELD P, 1995, IN VITRO CELL DEV-AN, V31, P483; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhang AH, 2014, INT UROL NEPHROL, V46, P1025, DOI 10.1007/s11255-013-0600-2	42	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163021	10.1371/journal.pone.0163021	http://dx.doi.org/10.1371/journal.pone.0163021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657885	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200054
J	Juneau, AD; Frankel, LK; Bricker, TM; Roose, JL				Juneau, Andrea D.; Frankel, Laurie K.; Bricker, Terry M.; Roose, Johnna L.			N- Terminal Lipid Modification Is Required for the Stable Accumulation of CyanoQ in Synechocystis sp PCC 6803	PLOS ONE			English	Article							CYANOBACTERIAL PHOTOSYSTEM-II; X-114 PHASE-FRACTIONATION; PSBQ PROTEIN; EXTRINSIC PROTEINS; THYLAKOID MEMBRANES; CRYSTAL-STRUCTURE; SIGNAL PEPTIDES; LIPOPROTEINS; COMPLEXES; BACTERIA	The CyanoQ protein has been demonstrated to be a component of cyanobacterial Photosystem II (PS II), but there exist a number of outstanding questions concerning its physical association with the complex. CyanoQ is a lipoprotein; upon cleavage of its transit peptide by Signal Peptidase II, which targets delivery of the mature protein to the thylakoid lumenal space, the N-terminal cysteinyl residue is lipid-modified. This modification appears to tether this otherwise soluble component to the thylakoid membrane. To probe the functional significance of the lipid anchor, mutants of the CyanoQ protein have been generated in Synechocystis sp. PCC 6803 to eliminate the N-terminal cysteinyl residue, preventing lipid modification. Substitution of the N-terminal cysteinyl residue with serine (Q-C22S) resulted in a decrease in the amount of detectable CyanoQ protein to 17% that of the wild-type protein. Moreover, the physical properties of the accumulated Q-C22S protein were consistent with altered processing of the CyanoQ precursor. The Q-C22S protein was shifted to a higher apparent molecular mass and partitioned in the hydrophobic phase in TX-114 phase-partitioning experiments. These results suggest that the hydrophobic N-terminal 22 amino acids were not properly cleaved by a signal peptidase. Substitution of the entire CyanoQ transit peptide with the transit peptide of the soluble lumenal protein PsbO yielded the Q-SS mutant and resulted in no detectable accumulation of the modified CyanoQ protein. Finally, the CyanoQ protein was present at normal amounts in the PS II mutant strains Delta psbB and Delta psbO, indicating that an association with PS II was not a prerequisite for stable CyanoQ accumulation. Together these results indicate that CyanoQ accumulation in Synechocystis sp. PCC 6803 depends on the presence of the N-terminal lipid anchor, but not on the association of CyanoQ with the PS II complex.	[Juneau, Andrea D.; Frankel, Laurie K.; Bricker, Terry M.; Roose, Johnna L.] Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Roose, JL (corresponding author), Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jroose@lsu.edu			United States Department of Energy, Office of Basic Energy Sciences [DE-FG02-09ER20310]	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Basic Energy Sciences grant DE-FG02-09ER20310 to TMB and LKF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; BRICKER TM, 1982, FEBS LETT, V149, P197, DOI 10.1016/0014-5793(82)81100-9; BRICKER TM, 1984, ARCH BIOCHEM BIOPHYS, V235, P204, DOI 10.1016/0003-9861(84)90269-8; Chandler LE, 2003, BIOCHEMISTRY-US, V42, P5508, DOI 10.1021/bi027113a; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; ETTINGER WF, 1991, J CELL BIOL, V115, P321, DOI 10.1083/jcb.115.2.321; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Ifuku K, 2014, PLANT PHYSIOL BIOCH, V81, P108, DOI 10.1016/j.plaphy.2014.01.001; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kashino Y, 2006, J BIOL CHEM, V281, P20834, DOI 10.1074/jbc.M603188200; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu HJ, 2015, PHOTOSYNTH RES, V126, P375, DOI 10.1007/s11120-015-0123-z; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Michoux F, 2014, PHOTOSYNTH RES, V122, P57, DOI 10.1007/s11120-014-0010-z; Mori J, 2001, BIOCHIM BIOPHYS ACTA, V1541, P80; NILSSON F, 1990, PLANT MOL BIOL, V14, P1051, DOI 10.1007/BF00019402; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PUTNAMEVANS C, 1992, BIOCHEMISTRY-US, V31, P11482, DOI 10.1021/bi00161a029; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Roose JL, 2016, PLANTA, V243, P889, DOI 10.1007/s00425-015-2462-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Summerfield TC, 2005, BIOCHEMISTRY-US, V44, P805, DOI 10.1021/bi048394k; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P7762, DOI 10.1093/nar/16.15.7762; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Ujihara T, 2008, ANAL BIOCHEM, V374, P429, DOI 10.1016/j.ab.2007.11.014; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zhang SL, 2010, J BIOL CHEM, V285, P32047, DOI 10.1074/jbc.M110.166983	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							0163646	10.1371/journal.pone.0163646	http://dx.doi.org/10.1371/journal.pone.0163646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656895	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200155
J	Norlin, AC; Hansen, S; Wahren-Borgstro, E; Granert, C; Bjorkhem-Bergman, L; Bergman, P				Norlin, Anna-Carin; Hansen, Susanne; Wahren-Borgstrom, Emilie; Granert, Carl; Bjorkhem-Bergman, Linda; Bergman, Peter			Vitamin D-3 Supplementation and Antibiotic Consumption - Results from a Prospective, Observational Study at an Immune-Deficiency Unit in Sweden	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; SERUM 25-HYDROXYVITAMIN D; RANDOMIZED-TRIAL; RISK; CALCITRIOL; PNEUMONIA; CHILDREN; KABUL	Background Vitamin D supplementation has been proposed to improve clinical symptoms during respiratory tract infections (RTIs), but results from randomized, placebo-controlled trials (RCT) are inconclusive. Previously, we performed an RCT in patients with various immune-disorders and observed that supplementation with 4000 IU vitamin D/day during 12 months significantly reduced antibiotic consumption and RTIs. This formed the basis for new guidelines at our unit; i.e. patients with insufficient levels of 25-hydroxyvitamin D (<= 75 nmol/L) are now offered vitamin D supplementation. The aim of this prospective follow-up study was to evaluate the outcome of these new recommendations with regard to antibiotic consumption in our unit. Method 277 patients with insufficiency were supplemented with vitamin D-3, 1500-1600 IU/day for 12 months. Each patient was its own control and data on antibiotic consumption was monitored 12 months before and 12 months after initiation of vitamin D-3 supplementation. Results Vitamin D-3 supplementation resulted in a significantly reduced antibiotic consumption, from 20 to 15 days/patient (p<0.05). The number of antibiotic-free patients increased from 52 to 81 after vitamin D-3 supplementation; OR 1.79; 95% CI 1.20-2.66 (p<0.01). The number of antibiotic-prescriptions decreased significantly, a finding that mainly was attributed to a reduction of respiratory tract antibiotics (p<0.05). Subgroup analysis showed that only patients without immunoglobulin substitution (n = 135) had a significant effect of vitamin D supplementation. Conclusion Vitamin D-3 supplementation of 1600 IE/day is safe to use in immunodeficient patients with 25-OHD levels less than 75 nmol/L and significantly reduced the antibiotic consumption in patients without immunoglobulin substitution.	[Norlin, Anna-Carin; Hansen, Susanne; Wahren-Borgstrom, Emilie; Granert, Carl] Karolinska Univ Hosp, Infect Dis Clin, SE-14186 Stockholm, Sweden; [Norlin, Anna-Carin] Karolinska Inst, Dept Lab Med, Div Clin Immunol, S-14186 Stockholm, Sweden; [Bjorkhem-Bergman, Linda; Bergman, Peter] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Bergman, P (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, S-14186 Stockholm, Sweden.	peter.bergman@ki.se		Bergman, Peter/0000-0003-3306-3713	Karolinska Institutet; Stockholm County Council; Swedish Foundation for Cancer Research; Magnus Bergwall Foundation; Swedish Research Council	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Swedish Foundation for Cancer Research; Magnus Bergwall Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was provided through the regional agreement on training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council (PB and LBB), Swedish Foundation for Cancer Research (LBB), Magnus Bergwall Foundation (PB and LBB), Karolinska Institutet (PB and LBB) and the Swedish Research Council (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided through the regional agreement on training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council (PB and LBB), Swedish Foundation for Cancer Research (LBB), Magnus Bergwall Foundation (PB and LBB), Karolinska Institutet (PB and LBB) and the Swedish Research Council (PB).	Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095, DOI 10.1017/S0950268807008308; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Bergman Peter, 2015, BMC Res Notes, V8, P498, DOI 10.1186/s13104-015-1504-2; Bergman Peter, 2015, BMC Res Notes, V8, P391, DOI 10.1186/s13104-015-1378-3; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Bergman P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001663; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Jorde R, 2012, SCAND J INFECT DIS, V44, P126, DOI 10.3109/00365548.2011.621446; Katikaneni R, 2009, CLIN PEDIATR, V48, P750, DOI 10.1177/0009922809332588; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Leaf DE, 2014, AM J RESP CRIT CARE, V190, P533, DOI 10.1164/rccm.201405-0988OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Michaelsson K, 2014, LANCET DIABETES ENDO, V2, P269, DOI 10.1016/S2213-8587(14)70008-7; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Nagaoka I, 2005, INFLAMM RES, V54, P66, DOI 10.1007/s00011-004-1323-8; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Xue Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-724	36	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163451	10.1371/journal.pone.0163451	http://dx.doi.org/10.1371/journal.pone.0163451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657724	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200125
J	Schmitz, S; Tacke, S; Guth, B; Henke, J				Schmitz, Sabrina; Tacke, Sabine; Guth, Brian; Henke, Julia			Comparison of Physiological Parameters and Anaesthesia Specific Observations during Isoflurane, Ketamine-Xylazine or Medetomidine-Midazolam-Fentanyl Anaesthesia in Male Guinea Pigs	PLOS ONE			English	Article								Guinea pigs (GPs) are difficult to anaesthetize successfully, the choices for anaesthesia are limited and physiological parameters are likely to be influenced substantially under anaesthesia. We implanted blood pressure radio-telemetry devices into 16 male GPs and subjected them to anaesthesia with ketamine-xylazine (KX), medetomidine-midazolam-fentanyl (MMF) or isoflurane (Iso, plus atropine premedication) in a randomized order with a 7 day interval between an aesthesias. Each anaesthesia lasted 40min, after which Iso was discontinued, MMF was fully antagonized with atipamezole-flumazenil-naloxone and KX was partially antagonized with atipamezole. Hemodynamics were recorded continuously for at least 240min after induction and the GPs were monitored for respiratory rate, reflex responses and specific observations until regaining of their righting reflex (RR). Blood for glucose testing was taken from the ear at 7.5, 20 and 40min during anaesthesia. Recovery time was short with MMF and Iso but long for KX. MMF induced only a transient blood pressure drop after antagonization, whereas Iso caused a marked hypotension during maintenance and KX led to moderate hypotension after antagonization. MMF and Iso produced tolerable heart rate changes, but KX led to long termpost-anaesthetic bradycardia. Hypothermia occurred with all anaesthesias, but the GPs returned to normothermia the fastest under MMF, followed shortly by Iso. KX, however, caused a profound and prolonged hypothermia. The respiration was depressed with all anaesthesias, substantially with MMF(-41%) and KX (-52%) and severe during Iso maintenance (-71%). Blood glucose with MMF and KX increased throughout the anaesthesia, but the values remained within reference values with all anaesthetics. The reflex responses character and strength varied between the anaesthetics. In conclusion, MMF is the anaesthetic of choice and Iso may be used for short, non-painful procedures. We advise against the use of KX in GPs.	[Schmitz, Sabrina; Henke, Julia] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biol Lab Serv, Biberach, Germany; [Tacke, Sabine] Univ Giessen, Dept Vet Clin Sci, Clin Small Anim Surg, Giessen, Germany; [Guth, Brian] Boehringer Ingelheim PharmaGmbH & Co KG, Dept Drug Discovery Support, Gen Pharmacol, Biberach, Germany; [Guth, Brian] North West Univ, DST NWU Preclin Drug Dev Platform, Fac Hlth Sci, Potchefstroom, South Africa	Boehringer Ingelheim; Justus Liebig University Giessen; Boehringer Ingelheim; North West University - South Africa	Schmitz, S (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept Nonclin Drug Safety, Biol Lab Serv, Biberach, Germany.	Sabrina.schmitz@boehringer-ingelheim.com	Tacke, Sabine/A-3213-2019		Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors SS, BG and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2014, BMC VET RES, V2014; [Anonymous], 2004, PHARM RAHM AN PER SC, P31; Baker NJ, 2011, J AM ASSOC LAB ANIM, V50, P916; ERHARDT W, 2004, ANASTHESIE ANALGESIE; Erhardt W, 2004, ANAESTHESIE ANALGESI, P31; Flecknell P, 2015, LAB ANIMAL ANAESTHES, P95; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Heide CC, 2003, INHALATIONSNARKOSE U; Hein J., 2001, LABORDIAGNOSTISCHE R; Henke J, 2005, VET ANAESTH ANALG, V32, P261, DOI 10.1111/j.1467-2995.2005.00242.x; Henke J., 1998, KLEINT KONKR, V1, P36; Henke J, 2007, BLUTDRUCK PUNKT GEBR, P95; Henke J, 2010, PRAKT TIERARZT, V91, P294; Ikeda T, 1999, ANESTH ANALG, V88, P921, DOI 10.1097/00000539-199904000-00044; Jacobson C, 2001, LAB ANIM-UK, V35, P271, DOI 10.1258/0023677011911598; Kanda T, 2008, CAN J VET RES, V72, P278; Kierschke G, 2012, ANASTHESIOLOGIE ALLG, P745; Lee JS, 2002, ANESTHESIOLOGY, V96, P1214, DOI 10.1097/00000542-200205000-00026; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Qian TL, 2009, WORLD J GASTROENTERO, V15, P4163, DOI 10.3748/wjg.15.4163; Radde GR, 1996, LAB ANIM-UK, V30, P220, DOI 10.1258/002367796780684935; Roberts U, 1993, THESIS; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Schmitz S, 2016, J PHARMACOL TOX MET, V80, P9, DOI 10.1016/j.vascn.2016.03.003; Schwenke DO, 2004, COMPARATIVE MED, V54, P77; Seidensticker Y, 2004, THESIS; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44; Zhou HH, 1997, ANESTHESIOLOGY, V86, P302, DOI 10.1097/00000542-199702000-00005	29	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161258	10.1371/journal.pone.0161258	http://dx.doi.org/10.1371/journal.pone.0161258			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658033	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200007
J	Ursini, F; D'Angelo, S; Russo, E; Nicolosi, K; Gallucci, A; Chiaravalloti, A; Bruno, C; Naty, S; De Sarro, G; Olivieri, I; Grembiale, RD				Ursini, Francesco; D'Angelo, Salvatore; Russo, Emilio; Nicolosi, Kassandra; Gallucci, Antonio; Chiaravalloti, Agostino; Bruno, Caterina; Naty, Saverio; De Sarro, Giovambattista; Olivieri, Ignazio; Grembiale, Rosa Daniela			Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; DIABETES-MELLITUS; RESISTANCE; GLUCOSE; RISK; PREVALENCE; SECRETION; OBESITY	Objectives To evaluate the correlation between inflammatory measures and whole-body insulin sensitivity in psoriatic arthritis (PsA) patients. Methods For the present study, 40 nondiabetic PsA patients were recruited. A standard oral glucose tolerance test (OGTT) was performed. The insulin sensitivity index (ISI), insulinogenic index (IGI) and oral disposition index (ODI) were calculated from dynamic values of glucose and insulin obtained during OGTT. Results In our study population, mean ISI was 3.5 +/- 2.5, median IGI was 1.2 (0.7-1.8), mean ODI 4.5 +/- 4.5. In univariate correlation analysis, ISI correlated inversely with systolic blood pressure (sBP) (R = -0.52, p = 0.001), diastolic blood pressure (dBP) (R = -0.45, p = 0.004) and complement C3 (R = -0.43, p = 0.006) and ODI correlated inversely with sBP (R = -0.38, p = 0.02), dBP (R = -0.35, p = 0.03) and complement C3 (R = -0.37, p = 0.02). No significant correlations were found between analyzed variables and IGI. In a stepwise multiple regression, only complement C3 entered in the regression equation and accounted for approximately 50% of the variance of ISI. Using a receiver operating characteristic (ROC) curve we identified the best cut-off for complement C3 of 1.32 g/L that yielded a sensitivity of 56% and a specificity of 96% for classification of insulin resistant patients. Conclusions In conclusion, our data suggest that serum complement C3 could represent a useful marker of whole-body insulin sensitivity in PsA patients.	[Ursini, Francesco; Russo, Emilio; Nicolosi, Kassandra; Bruno, Caterina; Naty, Saverio; De Sarro, Giovambattista; Grembiale, Rosa Daniela] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Ursini, Francesco; D'Angelo, Salvatore; Olivieri, Ignazio] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy; [Ursini, Francesco; D'Angelo, Salvatore; Olivieri, Ignazio] Madonna Grazie Hosp Matera, Potenza, Italy; [Gallucci, Antonio] Pugliese Ciaccio Hosp, Catanzaro, Italy; [Chiaravalloti, Agostino] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Magna Graecia University of Catanzaro; University of Rome Tor Vergata	Ursini, F (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.; Ursini, F (corresponding author), San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy.; Ursini, F (corresponding author), Madonna Grazie Hosp Matera, Potenza, Italy.	francesco.ursini@yahoo.it	D'Angelo, Salvatore/H-9010-2012; Ursini, Francesco/AAC-5725-2022; Chiaravalloti, Agostino/K-5153-2018; Chiaravalloti, Agostino/AAA-3342-2021; Russo, Emilio/G-5241-2010; Ursini, Francesco/K-5632-2016; Bruno, Caterina/K-5772-2016	Chiaravalloti, Agostino/0000-0002-8017-8858; Chiaravalloti, Agostino/0000-0002-8017-8858; Russo, Emilio/0000-0002-1279-8123; Ursini, Francesco/0000-0001-8194-8642; Bruno, Caterina/0000-0002-5995-4592; D'Angelo, Salvatore/0000-0002-7442-1110; GREMBIALE, Rosa Daniela/0000-0002-0338-6784				Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; BASSETSEGUIN N, 1993, J INVEST DERMATOL, V101, P827, DOI 10.1111/1523-1747.ep12371702; Bostoen J, 2014, J EUR ACAD DERMATOL, V28, P507, DOI 10.1111/jdv.12071; Costa L, 2015, IMMUNOL RES, V61, P147, DOI 10.1007/s12026-014-8595-z; Costa L, 2014, CLIN RHEUMATOL, V33, P833, DOI 10.1007/s10067-013-2369-1; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dehdashtihaghighat Setareh, 2013, J Reprod Infertil, V14, P197; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DOVEZENSKI N, 1992, J CLIN INVEST, V90, P2000, DOI 10.1172/JCI116080; Dubreuil M, 2014, RHEUMATOLOGY, V53, P346, DOI 10.1093/rheumatology/ket343; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Fiorentino TV, 2015, NUTR METAB CARDIOVAS, V25, P510, DOI 10.1016/j.numecd.2015.02.007; GERMINARIO R, 1993, METABOLISM, V42, P574, DOI 10.1016/0026-0495(93)90215-A; Haroon M, 2014, J RHEUMATOL, V41, P1357, DOI 10.3899/jrheum.140021; Helliwell PS, 2007, ANN RHEUM DIS, V66, P113, DOI 10.1136/ard.2006.054288; Hernandez-Mijares A, 2007, INT J OBESITY, V31, P927, DOI 10.1038/sj.ijo.0803543; Hertle E, 2012, DIABETOLOGIA, V55, P881, DOI 10.1007/s00125-012-2462-z; Hertle E, 2014, THROMB HAEMOSTASIS, V111, P1102, DOI 10.1160/TH13-10-0831; Jiang P, 2015, CLIN EXP RHEUMATOL, V33, P115; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Labitigan M, 2014, ARTHRIT CARE RES, V66, P600, DOI 10.1002/acr.22185; Lalia AZ, 2016, J CLIN ENDOCR METAB, V101, P626, DOI 10.1210/jc.2015-2892; Lorenzo C, 2015, J CLIN ENDOCR METAB, V100, P544, DOI 10.1210/jc.2014-2299; Lorenzo C, 2012, J CLIN ENDOCR METAB, V97, P793, DOI 10.1210/jc.2011-2272; Maslowska M, 1999, EUR J CLIN INVEST, V29, P679, DOI 10.1046/j.1365-2362.1999.00514.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mulnier HE, 2008, DIABETOLOGIA, V51, P1639, DOI 10.1007/s00125-008-1076-y; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Naughton MA, 1996, J IMMUNOL, V156, P3051; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Perdan-Pirkmajer K, 2016, SCAND J RHEUMATOL, P1; da Silva BSP, 2010, BIOLOGICALS, V38, P567, DOI 10.1016/j.biologicals.2010.05.003; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Torres T, 2014, ARCH DERMATOL RES, V306, P653, DOI 10.1007/s00403-014-1467-5; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; Ursini F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000888; Ursini F, 2014, CLIN RHEUMATOL, V33, P1759, DOI 10.1007/s10067-013-2366-4; Ursini F, 2012, CLIN RHEUMATOL, V31, P1401, DOI 10.1007/s10067-012-2034-0; Ursini F, 2010, AUTOIMMUN REV, V9, P536, DOI 10.1016/j.autrev.2009.12.014; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; van Greevenbroek MMJ, 2012, INT J CARDIOL, V154, P158, DOI 10.1016/j.ijcard.2010.09.017; Vlaicu SI, 2016, IMMUNOL RES, V64, P653, DOI 10.1007/s12026-015-8783-5; VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P277, DOI 10.1146/annurev.immunol.13.1.277; Wlazlo N, 2014, DIABETES CARE, V37, P1900, DOI 10.2337/dc13-2804	51	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163464	10.1371/journal.pone.0163464	http://dx.doi.org/10.1371/journal.pone.0163464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656896	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200131
J	Auld, E; Lin, J; Chang, E; Byanyima, P; Ayakaka, I; Musisi, E; Worodria, W; Davis, JL; Segal, M; Blackburn, E; Huang, L				Auld, Elizabeth; Lin, Jue; Chang, Emily; Byanyima, Patrick; Ayakaka, Irene; Musisi, Emmanuel; Worodria, William; Davis, J. Lucian; Segal, Mark; Blackburn, Elizabeth; Huang, Laurence			HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; CORONARY-HEART-DISEASE; PULMONARY TUBERCULOSIS; CIRCULATING LEUKOCYTES; OXIDATIVE STRESS; RISK; CANCER; PREVALENCE; MORTALITY; AFRICA	Introduction HIV infection is a risk factor for opportunistic pneumonias such as tuberculosis (TB) and for age-associated health complications. Short telomeres, markers of biological aging, are also associated with an increased risk of age-associated diseases and mortality. Our goals were to use a single cohort of HIV-infected and HIV-uninfected individuals hospitalized with pneumonia to assess whether shortened telomere length was associated with HIV infection, TB diagnosis, and 2-month mortality. Methods This was a sub-study of the IHOP Study, a prospective observational study. Participants consisted of 184 adults admitted to Mulago Hospital in Kampala, Uganda who underwent evaluation for suspected TB and were followed for 2 months. Standardized questionnaires were administered to collect demographic and clinical data. PBMCs were isolated and analyzed using quantitative PCR to determine telomere length. The association between HIV infection, demographic and clinical characteristics, and telomere length was assessed, as were the associations between telomere length, TB diagnosis and 2-month mortality. Variables with a P <= 0.2 in bivariate analysis were included in multivariate models. Results No significant demographic or clinical differences were observed between the HIV-infected and HIV-uninfected subjects. Older age (P < 0.0001), male gender (P = 0.04), total pack- years smoked (P < 0.001), alcohol consumption in the past year (P = 0.12), and asthma (P = 0.08) were all associated (P <= 0.2) with shorter telomere length in bivariate analysis. In multivariate analysis adjusting for these five variables, HIV-positive participants had significantly shorter telomeres than HIV-negative participants (beta = -0.0621, 95% CI -0.113 to -0.011, P = 0.02). Shortened telomeres were not associated with TB or short-term mortality. Conclusions The association between HIV infection and shorter telomeres suggests that HIV may play a role in cellular senescence and biological aging and that shorter telomeres may be involved in age-associated health complications seen in this population. The findings indicate a need to further research the impact of HIV on aging.	[Auld, Elizabeth; Chang, Emily; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Lin, Jue; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA USA; [Chang, Emily; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Byanyima, Patrick; Ayakaka, Irene; Musisi, Emmanuel; Worodria, William; Huang, Laurence] Makerere Univ Univ Calif San Francisco MU UCSF Re, Kampala, Uganda; [Worodria, William] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Davis, J. Lucian] Yale Univ, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA; [Segal, Mark] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Makerere University; Mulago National Referral Hospital; Yale University; University of California System; University of California San Francisco	Auld, E (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	lizzy.auld@gmail.com	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; 	National Institutes of Health [K24 087713, R01 128156, R01 090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL128156, R01HL090335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the National Institutes of Health (K24 087713, L.H., R01 128156, L.H. and R01 090335, L.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bates M, 2013, HUMAN CYTOMEGALOVIRU; Blanco JR, 2010, AIDS REV, V12, P218; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Cattamanchi Adithya, 2012, PLoS One, V7, pe39838, DOI 10.1371/journal.pone.0039838; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cote HCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039266; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dowd JB, 2013, EXP GERONTOL, V48, P385, DOI 10.1016/j.exger.2013.01.016; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Giesbrecht CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089556; Goyns MH, 2000, MECH AGEING DEV, V114, P69, DOI 10.1016/S0047-6374(00)00095-6; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Kisembo HN, 2012, BRIT J RADIOL, V85, pE130, DOI 10.1259/bjr/70704099; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Leeansyah E, 2013, J INFECT DIS, V207, P1157, DOI 10.1093/infdis/jit006; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Liu JY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005584; Liu XH, 2007, NUCLEOS NUCLEOT NUCL, V26, P1067, DOI 10.1080/15257770701515468; Lung FW, 2008, J HUM HYPERTENS, V22, P230, DOI 10.1038/sj.jhh.1002314; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Murakami J, 1999, EUR J CANCER, V35, P1027, DOI 10.1016/S0959-8049(99)00037-4; Nakwagala F N, 2002, East Afr Med J, V79, P68; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Oeseburg Hisko, 2010, Pflugers Arch, V459, P259, DOI 10.1007/s00424-009-0728-1; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Puterman E, 2012, SOC PERSONAL PSYCHOL, V6, P807, DOI 10.1111/j.1751-9004.2012.00465.x; Regidor E, 2009, SOC SCI MED, V68, P419, DOI 10.1016/j.socscimed.2008.10.039; Robertson T, 2012, EPIDEMIOL REV; Sanders JL, 2013, EPIDEMIOL REV; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Solomon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109718; Strahl C, 1996, MOL CELL BIOL, V16, P53; Tokman S, 2014, RESPIROLOGY, V19, P382, DOI 10.1111/resp.12237; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Vignoli M, 1998, AIDS, V12, P999, DOI 10.1097/00002030-199809000-00005; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Weischer M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004191; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Yoo SD, 2011, RESPIROLOGY, V16, P836, DOI 10.1111/j.1440-1843.2011.01981.x; Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051; Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744	61	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163153	10.1371/journal.pone.0163153	http://dx.doi.org/10.1371/journal.pone.0163153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655116	Green Published, gold			2022-12-27	WOS:000383892700039
J	Hammond, MA; Laine, TJ; Berman, AG; Wallace, JM				Hammond, Max A.; Laine, Tyler J.; Berman, Alycia G.; Wallace, Joseph M.			Treadmill Exercise Improves Fracture Toughness and Indentation Modulus without Altering the Nanoscale Morphology of Collagen in Mice	PLOS ONE			English	Article							BONE MECHANICAL-PROPERTIES; BRTL MOUSE MODEL; I COLLAGEN; LYSYL OXIDASE; CORTICAL BONE; OSTEOGENESIS IMPERFECTA; BETA-AMINOPROPIONITRILE; ESTROGEN DEPLETION; CROSS-LINKING; C57B1/6 MICE	The specifics of how the nanoscale properties of collagen (e.g., the crosslinking profile) affect the mechanical integrity of bone at larger length scales is poorly understood despite growing evidence that collagen's nanoscale properties are altered with disease. Additionally, mass independent increases in postyield displacement due to exercise suggest loadinginduced improvements in bone quality associated with collagen. To test whether diseaseinduced reductions in bone quality driven by alterations in collagen can be rescued or prevented via exercise-mediated changes to collagen's nanoscale morphology and mechanical properties, the effects of treadmill exercise and beta-aminopropionitrile treatment were investigated. Eight week old female C57BL/6 mice were given a daily subcutaneous injection of either 164 mg/kg beta-aminopropionitrile or phosphate buffered saline while experiencing either normal cage activity or 30 min of treadmill exercise for 21 consecutive days. Despite differences in D-spacing distribution (P = 0.003) and increased cortical area (tibial: P = 0.005 and femoral: P = 0.015) due to beta-aminopropionitrile treatment, an overt mechanical disease state was not achieved as there were no differences in fracture toughness or 4 point bending due to beta-aminopropionitrile treatment. While exercise did not alter (P = 0.058) the D-spacing distribution of collagen or prevent (P < 0.001) the beta-aminopropionitrile-induced changes present in the unexercised animals, there were differential effects in the distribution of the reduced elastic modulus due to exercise between control and beta-aminopropionitrile-treated animals (P < 0.001). Fracture toughness was increased (P = 0.043) as a main effect of exercise, but no significant differences due to exercise were observed using 4 point bending. Future studies should examine the potential for sex specific differences in the dose of beta-aminopropionitrile required to induce mechanical effects in mice and the contributions of other nanoscale aspects of bone (e.g., the mineral - collagen interface) to elucidate the mechanism for the exercise-based improvements in fracture toughness observed here and the increased postyield deformation observed in other studies.	[Hammond, Max A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Laine, Tyler J.; Berman, Alycia G.; Wallace, Joseph M.] Indiana Univ Purdue Univ Indianapolis, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Wallace, JM (corresponding author), Indiana Univ Purdue Univ Indianapolis, Dept Biomed Engn, Indianapolis, IN 46202 USA.; Wallace, JM (corresponding author), Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA.	jmwalla@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058	Indiana University-Purdue University Indianapolis departmental startup funds; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K25AR067221]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR067221] Funding Source: NIH RePORTER	Indiana University-Purdue University Indianapolis departmental startup funds; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Indiana University-Purdue University Indianapolis (www. iupui.edu) departmental startup funds and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (www.niams.nih.gov) under award number K25AR067221 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart ZR, 2014, CONNECT TISSUE RES, V55, P4, DOI 10.3109/03008207.2014.923860; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; El Rouby DH, 2008, ARCH ORAL BIOL, V53, P916, DOI 10.1016/j.archoralbio.2008.04.008; Erickson B, 2013, BIOTECHNOL J, V8, P117, DOI 10.1002/biot.201200174; Fang M, 2012, ACS NANO, V6, P9503, DOI 10.1021/nn302483x; Fang M, 2012, J INVEST DERMATOL, V132, P1791, DOI 10.1038/jid.2012.47; Gonzalez AD, 2014, J BIOMECH, V47, P681, DOI 10.1016/j.jbiomech.2013.11.045; Hammond MA, 2016, BONE, V88, P85, DOI 10.1016/j.bone.2016.04.021; Hammond MA, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.12; Hammond MA, 2014, BONE, V60, P26, DOI 10.1016/j.bone.2013.11.015; Haque Anisul, 1997, Natural Toxins, V5, P43, DOI 10.1002/(SICI)(1997)5:1<43::AID-NT7>3.0.CO;2-M; HENNEMAN DH, 1972, CLIN ORTHOP RELAT R, P245; Jepsen KJ, 2009, WIRES SYST BIOL MED, V1, P73, DOI 10.1002/wsbm.15; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kemp AD, 2012, J STRUCT BIOL, V180, P428, DOI 10.1016/j.jsb.2012.09.012; Kondo H, 2015, J ORAL BIOSCI, V57, P9, DOI 10.1016/j.job.2014.09.003; LEES S, 1994, J BONE MINER RES, V9, P1377; Machon C, 2014, BIOMED CHROMATOGR, V28, P1017, DOI 10.1002/bmc.3110; McNerny EMB, 2015, BONE, V81, P327, DOI 10.1016/j.bone.2015.07.030; McNerny EMB, 2015, J BONE MINER RES, V30, P446, DOI 10.1002/jbmr.2356; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; Nagan N, 1998, FRONT BIOSCI, V3, P23, DOI [10.2741/A247, DOI 10.2741/A247]; Newman CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099262; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Paschalis EP, 2011, BONE, V49, P1232, DOI 10.1016/j.bone.2011.08.027; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; ROSMUS J, 1966, BIOCHEM PHARMACOL, V15, P1405, DOI 10.1016/0006-2952(66)90184-5; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004; SIMMONS DJ, 1965, AM J ANAT, V116, P387, DOI 10.1002/aja.1001160205; SNEDDON IN, 1948, P CAMB PHILOS SOC, V44, P492, DOI 10.1017/S0305004100024518; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; SPENGLER DM, 1977, J BONE JOINT SURG AM, V59, P670, DOI 10.2106/00004623-197759050-00014; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003; Wallace JM, 2010, BONE, V46, P1349, DOI 10.1016/j.bone.2009.11.020; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8; Wang LY, 2005, P NATL ACAD SCI USA, V102, P11911, DOI 10.1073/pnas.0505193102; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y	47	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163273	10.1371/journal.pone.0163273	http://dx.doi.org/10.1371/journal.pone.0163273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655444	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892700048
J	Pashaei, E; Guzel, E; Ozgurses, ME; Demirel, G; Aydin, N; Ozen, M				Pashaei, Elnaz; Guzel, Esra; Ozgurses, Mete Emir; Demirel, Goksun; Aydin, Nizamettin; Ozen, Mustafa			A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; URACIL-DNA GLYCOSYLASE; PROSTATE-CANCER; MICRORNA EXPRESSION; BREAST-CANCER; SUPPRESSIVE MICRORNAS; COLORECTAL-CANCER; LUNG-CANCER; TUMORIGENESIS; PREDICTION	Background MicroRNAs, which are small regulatory RNAs, post-transcriptionally regulate gene expression by binding 3'-UTR of their mRNA targets. Their deregulation has been shown to cause increased proliferation, migration, invasion, and apoptosis. miR-145, an important tumor supressor microRNA, has shown to be downregulated in many cancer types and has crucial roles in tumor initiation, progression, metastasis, invasion, recurrence, and chemo-radioresistance. Our aim is to investigate potential common target genes of miR-145, and to help understanding the underlying molecular pathways of tumor pathogenesis in association with those common target genes. Methods Eight published microarray datasets, where targets of mir-145 were investigated in cell lines upon mir-145 over expression, were included into this study for meta-analysis. Inter group variabilities were assessed by box-plot analysis. Microarray datasets were analyzed using GEOquery package in Bioconducter 3.2 with R version 3.2.2 and two-way Hierarchical Clustering was used for gene expression data analysis. Results Meta-analysis of different GEO datasets showed that UNG, FUCA2, DERA, GMFB, TF, and SNX2 were commonly downregulated genes, whereas MYL9 and TAGLN were found to be commonly upregulated upon mir-145 over expression in prostate, breast, esophageal, bladder cancer, and head and neck squamous cell carcinoma. Biological process, molecular function, and pathway analysis of these potential targets of mir-145 through functional enrichments in PPI network demonstrated that those genes are significantly involved in telomere maintenance, DNA binding and repair mechanisms. Conclusion As a conclusion, our results indicated that mir-145, through targeting its common potential targets, may significantly contribute to tumor pathogenesis in distinct cancer types and might serve as an important target for cancer therapy.	[Pashaei, Elnaz; Aydin, Nizamettin] Yildiz Tech Univ, Dept Comp Engn, Istanbul, Turkey; [Guzel, Esra; Ozgurses, Mete Emir; Demirel, Goksun; Ozen, Mustafa] Biruni Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Guzel, Esra; Ozen, Mustafa] Istanbul Univ, Dept Med Genet, Cerrahpasa Med Sch, Istanbul, Turkey; [Ozen, Mustafa] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Yildiz Technical University; Biruni University; Istanbul University; Istanbul University - Cerrahpasa; Baylor College of Medicine	Ozen, M (corresponding author), Biruni Univ, Dept Mol Biol & Genet, Istanbul, Turkey.; Ozen, M (corresponding author), Istanbul Univ, Dept Med Genet, Cerrahpasa Med Sch, Istanbul, Turkey.; Ozen, M (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mozen@bcm.edu	AYDIN, Nizamettin/AAZ-6030-2020; Ozgurses, Mete Emir/AHE-0203-2022; PASHAEI, ELNAZ/AAI-7928-2021; Demirel, GÃksun/AAC-5688-2020; Guzel, Esra/AAB-8509-2019	AYDIN, Nizamettin/0000-0003-0022-2247; Ozgurses, Mete Emir/0000-0002-8472-3948; PASHAEI, ELNAZ/0000-0001-9391-9785; Ozen, Mustafa/0000-0002-6142-5294; Guzel Tanoglu, Esra/0000-0002-0909-8935	Scientific and Technological Research Council of Turkey (TUBITAK) [210T009]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The research carried out in this manuscript is supported by grant number 210T009 supported by The Scientific and Technological Research Council of Turkey (TUBITAK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Das AV, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0247-4; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; ElHefnawi Mahmoud, 2013, Genomics Proteomics & Bioinformatics, V11, P354, DOI 10.1016/j.gpb.2013.05.007; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hegre SA, 2013, DNA REPAIR, V12, P80, DOI 10.1016/j.dnarep.2012.10.007; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Karatas OF, 2015, TUMOUR BIOL; Karatas OF, 2016, HEAD NECK-J SCI SPEC, V38, P260, DOI 10.1002/hed.23890; Kinoshita T, 2012, ONCOTARGET, V3, P1386, DOI 10.18632/oncotarget.709; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MH, 2015, ACTA PHARMACOL SIN, V36, P1200, DOI 10.1038/aps.2015.67; Li YL, 2010, EUR J CANCER, V46, P2104, DOI 10.1016/j.ejca.2010.04.015; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Moriya Y, 2012, J HUM GENET, V57, P38, DOI 10.1038/jhg.2011.126; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Nohata N, 2011, BRIT J CANCER, V105, P833, DOI 10.1038/bjc.2011.311; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Ozen M, 2015, CANCER INVEST, V33, P251, DOI 10.3109/07357907.2015.1025407; Sachdeva M, 2012, NUCLEIC ACIDS RES, V40, P6683, DOI 10.1093/nar/gks324; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Seven M, 2014, FUTURE ONCOL, V10, P1027, DOI 10.2217/fon.13.259; Shao Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-51; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Su JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114420; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weeks LD, 2013, MOL CANCER THER, V12, P2248, DOI 10.1158/1535-7163.MCT-13-0172; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742	44	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161491	10.1371/journal.pone.0161491	http://dx.doi.org/10.1371/journal.pone.0161491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655328	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700007
J	Walker, FM; Williamson, CHD; Sanchez, DE; Sobek, CJ; Chambers, CL				Walker, Faith M.; Williamson, Charles H. D.; Sanchez, Daniel E.; Sobek, Colin J.; Chambers, Carol L.			Species From Feces: Order-Wide Identification of Chiroptera From Guano and Other Non-Invasive Genetic Samples	PLOS ONE			English	Article							DNA BARCODE; PCR AMPLIFICATION; BATS; MITOCHONDRIAL; BACTERIAL; QUALITY; PRESERVATION; COMMUNITIES; GENERATION; COVERAGE	Bat guano is a relatively untapped reservoir of information, having great utility as a DNA source because it is often available at roosts even when bats are not and is an easy type of sample to collect from a difficult-to-study mammalian order. Recent advances from microbial community studies in primer design, sequencing, and analysis enable fast, accurate, and cost-effective species identification. Here, we borrow from this discipline to develop an order-wide DNA mini-barcode assay (Species from Feces) based on a segment of the mitochondrial gene cytochrome c oxidase I (COI). The assay works effectively with fecal DNA and is conveniently transferable to low-cost, high-throughput Illumina MiSeq technology that also allows simultaneous pairing with other markers. Our PCR primers target a region of COI that is highly discriminatory among Chiroptera (92% species-level identification of barcoded species), and are sufficiently degenerate to allow hybridization across diverse bat taxa. We successfully validated our system with 54 bat species across both suborders. Despite abundant arthropod prey DNA in guano, our primers were highly specific to bats; no arthropod DNA was detected in thousands of feces run on Sanger and Illumina platforms. The assay is extendable to fecal pellets of unknown age as well as individual and pooled guano, to allow for individual (using singular fecal pellets) and community (using combined pellets collected from across long-term roost sites) analyses. We developed a searchable database (http://nau.edu/CEFNS/Forestry/Research/Bats/Search-Tool/) that allows users to determine the discriminatory capability of our markers for bat species of interest. Our assay has applications worldwide for examining disease impacts on vulnerable species, determining species assemblages within roosts, and assessing the presence of bat species that are vulnerable or facing extinction. The development and analytical pathways are rapid, reliable, and inexpensive, and can be applied to ecology and conservation studies of other taxa.	[Walker, Faith M.; Sanchez, Daniel E.; Sobek, Colin J.; Chambers, Carol L.] No Arizona Univ, Sch Forestry, Bat Ecol & Genet Lab, Flagstaff, AZ 86011 USA; [Walker, Faith M.; Williamson, Charles H. D.; Sanchez, Daniel E.; Sobek, Colin J.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University	Walker, FM (corresponding author), No Arizona Univ, Sch Forestry, Bat Ecol & Genet Lab, Flagstaff, AZ 86011 USA.; Walker, FM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Faith.Walker@nau.edu	Chambers, Carol L/GXV-9460-2022	Sobek, Colin/0000-0002-0885-0435; Walker, Faith/0000-0001-8435-4452	Northern Arizona University through the Arizona Technology & Research Initiative Fund; Bat Conservation International [1002263]; U.S. Bureau of Land Management [1002263]; National Park Service (U.S.) [1002506]; Arizona's Technology and Research Initiative Fund	Northern Arizona University through the Arizona Technology & Research Initiative Fund; Bat Conservation International; U.S. Bureau of Land Management; National Park Service (U.S.); Arizona's Technology and Research Initiative Fund	This work was supported by Northern Arizona University through the Arizona Technology & Research Initiative Fund. We also received funding from Bat Conservation International (1002263; www.batcon.org), the U.S. Bureau of Land Management (1002263), and the National Park Service (U.S.) (1002506). Computational analyses were run on Northern Arizona University's Monsoon computing cluster, funded by Arizona's Technology and Research Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Bokulich NA, 2015, PEERJ PREPRINTS, V3, pe1502, DOI DOI 10.7287/PEERJ.PREPRINTS.934V2; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chambers CL, 2011, CAN J ZOOL, V89, P1256, DOI 10.1139/Z11-106; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colman RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126626; Drakulovski P, 2013, EXP PARASITOL, V135, P257, DOI 10.1016/j.exppara.2013.07.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fenton MB, 2014, BATS WORLD SCI MYSTE; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; FRANCIS CM, 2008, FIELD GUIDE MAMMALS; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hayman DTS, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500831; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Davila A, 2012, MOL ECOL RESOUR, V12, P590, DOI 10.1111/j.1755-0998.2012.03125.x; Hutson A, 2001, MICROCHIROPTERAN BAT; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Jordal BH, 2014, MOL ECOL RESOUR, V14, P7, DOI 10.1111/1755-0998.12150; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Korstian JM, 2016, CONSERV GENET RESOUR, V8, P27, DOI 10.1007/s12686-015-0509-4; Korstian JM, 2015, CONSERV GENET RESOUR, V7, P803, DOI 10.1007/s12686-015-0488-5; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kruskop SV, 2012, ACTA CHIROPTEROL, V14, P1, DOI 10.3161/150811012X654222; Kunz T.H., 1988, P1; Kunz TH, 2003, BAT ECOLOGY, P3; Kunz TH, 1998, BAT BIOL CONSERVATIO; Kunz TH, 2009, ECOLOGICAL BEHAV MET; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Kwong S, 2012, CLADISTICS, V28, P639, DOI 10.1111/j.1096-0031.2012.00408.x; Lacki Michael J., 2007, P83; Larsen AM, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu031; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Medina-Fitoria Arnulfo, 2015, Mastozool. neotrop., V22, P43; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; O'Shea TJ, 2016, MAMMAL REV, V46, P175, DOI 10.1111/mam.12064; O'Shea TJ, 2003, USGSBRDITR20030003; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Porter TM, 2014, MOL ECOL RESOUR, V14, P929, DOI 10.1111/1755-0998.12240; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Puechmaille SJ, 2014, MAMMALIA, V78, P251, DOI 10.1515/mammalia-2013-0040; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tobin A, 2016, MS THESIS; Vlckova K, 2012, J MICROBIOL METH, V91, P45, DOI 10.1016/j.mimet.2012.07.015; Walker FM, 2009, MOL ECOL RESOUR, V9, P720, DOI 10.1111/j.1755-0998.2009.02582.x; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weller TJ, 2012, J WILDLIFE MANAGE, V76, P619, DOI 10.1002/jwmg.260; Wilson JJ, 2014, GENET MOL RES, V13, P920, DOI 10.4238/2014.February.19.2; Zinck JM, 2004, MOL ECOL NOTES, V4, P239, DOI 10.1111/j.1471-8286.2004.00629.x; Zukal J, 2015, MAMM BIOL, V80, P220, DOI 10.1016/j.mambio.2015.01.001	81	43	44	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162342	10.1371/journal.pone.0162342	http://dx.doi.org/10.1371/journal.pone.0162342			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654850	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700020
J	Qiao, N; Wang, XY; Liu, L				Qiao, Niu; Wang, Xuan-Yi; Liu, Lei			Temporal Evolutionary Dynamics of Norovirus GII. 4 Variants in China between 2004 and 2015	PLOS ONE			English	Article							GASTROENTERITIS; OUTBREAKS; CLASSIFICATION; EMERGENCE; VIRUSES	Background Noroviruses are one of the major causes of acute human nonbacterial gastroenteritis, and genotype II. 4 (GII. 4) has accounted for the majority of adult outbreaks. In addition, novel epidemic strain emerges every 2 to 3 years and spreads globally in months. There are little data reporting the evolutionary dynamics of GII. 4 variants along a specific period in China. Methods All norovirus GII. 4 sequences in China were downloaded from GenBank Database. Phylogenetic tree was constructed by MEGA and Bayesian evolutionary inference techniques were applied by BEAST software to study the genetic relationships, evolution rate, evolutionary time scale and the demographic history of GII. 4 variants. Homology models were predicted by SWISS-MODEL to analyze the spatial structure changes. Results During the 12-year period, 624 GII. 4 sequences were subtyped into six GII. 4 variants (clusters). A rate of 4.74x10(-3), 6.99x10(-3) and 7.68x10(-3) nucleotide substitutions/site/year for the strict, uncorrelated log-normal and uncorrelated exponential derivation clocks were estimated, respectively. Three amino acid mutations (G255S, S393G and H414P) in both Den Haag_2006b sub-clusters and six mutations (I244T, N309S, A377T, T244I, T377A and S393G) in three Sydney_2012 sub-clusters were observed. Conclusions The temporal distribution pattern of noroviruses GII. 4 lineages in China was similar to the worldwide observation. The evolutionary rate of GII. 4 was consistent with the global studies. Amino acid changes in the vicinity of norovirus epitope may have profound influences on carbohydrate binding affinity between different sub-clusters of norovirus variants. Hence understanding the evolutionary dynamics of norovirus is of great value for developing effective prevention and control strategies.	[Qiao, Niu; Liu, Lei] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Qiao, Niu; Wang, Xuan-Yi; Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Qiao, Niu; Wang, Xuan-Yi; Liu, Lei] Fudan Univ, Key Lab Med Mol Virol, MoE MoH, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, L (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Liu, L (corresponding author), Fudan Univ, Key Lab Med Mol Virol, MoE MoH, Shanghai 200032, Peoples R China.	liulei_fdu@163.com			 [2015AA020104];  [2106YFC0901900]	; 	This work was supported by 2015AA020104 (http://loca.fudan.edu.cn/list.php?pid=34&ty=125), and 2106YFC0901900 (http://service.most.gov.cn/2015tztg_all/20160625/1127.html).	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kroneman A, 2011, CLIN INFECT DIS, V51, P121, DOI [10.1016/j, 10. 1086/525259, DOI 10.1086/525259]; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seto Y, 2005, MICROBIOL IMMUNOL, V49, P275, DOI 10.1111/j.1348-0421.2005.tb03718.x; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163166	10.1371/journal.pone.0163166	http://dx.doi.org/10.1371/journal.pone.0163166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649572	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100060
J	Ueda, Y; Frindte, K; Knief, C; Ashrafuzzaman, M; Frei, M				Ueda, Yoshiaki; Frindte, Katharina; Knief, Claudia; Ashrafuzzaman, Md; Frei, Michael			Effects of Elevated Tropospheric Ozone Concentration on the Bacterial Community in the Phyllosphere and Rhizoplane of Rice	PLOS ONE			English	Article							GROUND-LEVEL OZONE; MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; ARABIDOPSIS-THALIANA; ATMOSPHERIC CO2; AIR-QUALITY; CELL-DEATH; PLANTS; CARBON; SOIL	Microbes constitute a vital part of the plant holobiont. They establish plant-microbe or microbe-microbe associations, forming a unique microbiota with each plant species and under different environmental conditions. These microbial communities have to adapt to diverse environmental conditions, such as geographical location, climate conditions and soil types, and are subjected to changes in their surrounding environment. Elevated ozone concentration is one of the most important aspects of global change, but its effect on microbial communities living on plant surfaces has barely been investigated. In the current study, we aimed at elucidating the potential effect of elevated ozone concentrations on the phyllosphere (aerial part of the plant) and rhizoplane (surface of the root) microbiota by adopting next-generation 16S rRNA amplicon sequencing. A standard japonica rice cultivar Nipponbare and an ozone-tolerant breeding line L81 (Nipponbare background) were pre-grown in a greenhouse for 10 weeks and then exposed to ozone at 85 ppb for 7 h daily for 30 days in open top chambers. Microbial cells were collected from the phyllosphere and rhizoplane separately. The treatment or different genotypes did not affect various diversity indices. On the other hand, the relative abundance of some bacterial taxa were significantly affected in the rhizoplane community of ozone-treated plants. A significant effect of ozone was detected by homogeneity of molecular variance analysis in the phyllosphere, meaning that the community from ozone-treated phyllosphere samples was more variable than those from control plants. In addition, a weak treatment effect was observed by clustering samples based on the Yue and Clayton and weighted UniFrac distance matrices among samples. We therefore conclude that the elevated ozone concentrations affected the bacterial community structure of the phyllosphere and the rhizosplane as a whole, even though this effect was rather weak and did not lead to changes of the function of the communities.	[Ueda, Yoshiaki; Ashrafuzzaman, Md; Frei, Michael] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany; [Frindte, Katharina; Knief, Claudia] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Mol Biol, Bonn, Germany; [Ueda, Yoshiaki] Univ Tokyo, Biotechnol Res Ctr, Plant Biotechnol Lab, Tokyo, Japan	University of Bonn; University of Bonn; University of Tokyo	Frei, M (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany.	mfrei@uni-bonn.de	, Ashrafuzzaman/P-6485-2016; Ashrafuzzaman/O-7750-2014; Frei, Michael/K-5511-2013; Knief, Claudia/H-1221-2013	, Ashrafuzzaman/0000-0001-8564-7943; Ashrafuzzaman/0000-0001-8454-3173; Frei, Michael/0000-0002-2474-6558; Knief, Claudia/0000-0001-9939-6241; Frindte, Katharina/0000-0002-6801-5853; Ueda, Yoshiaki/0000-0002-4304-368X	Deutsche Forschungsgemeinschaft [FR2952-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financially supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/; Project ID FR2952-1/1).	Ai C, 2015, SOIL BIOL BIOCHEM, V80, P70, DOI 10.1016/j.soilbio.2014.09.028; Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; Andersen CP, 1995, NEW PHYTOL, V131, P471, DOI 10.1111/j.1469-8137.1995.tb03084.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLASCHKE H, 1990, ENVIRON POLLUT, V68, P409, DOI 10.1016/0269-7491(90)90041-A; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Brandt BW, 2012, NUCLEIC ACIDS RES, V40, pW82, DOI 10.1093/nar/gks418; Bringel F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00486; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen CP, 2011, PLANT CELL ENVIRON, V34, P1141, DOI 10.1111/j.1365-3040.2011.02312.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; DYAS A, 1983, J CLIN PATHOL, V36, P1102, DOI 10.1136/jcp.36.10.1102; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Elford WJ, 1942, J HYG-CAMBRIDGE, V42, P240, DOI 10.1017/S0022172400035464; ERNST D, 1992, PLANT MOL BIOL, V20, P673, DOI 10.1007/BF00046452; Fares S, 2008, PLANT BIOLOGY, V10, P44, DOI 10.1055/s-2007-965257; Feng YZ, 2015, ENVIRON POLLUT, V197, P195, DOI 10.1016/j.envpol.2014.11.032; Feng YZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03193; Feng ZZ, 2014, ENVIRON POLLUT, V193, P296, DOI 10.1016/j.envpol.2014.06.004; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Frei M, 2008, J EXP BOT, V59, P3741, DOI 10.1093/jxb/ern222; Frei M, 2015, ENVIRON POLLUT, V197, P144, DOI 10.1016/j.envpol.2014.12.011; Frei M, 2010, J EXP BOT, V61, P1405, DOI 10.1093/jxb/erq007; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Holler S, 2014, PLANTA, V239, P367, DOI 10.1007/s00425-013-1978-x; Im WT, 2010, INT J SYST EVOL MICR, V60, P1565, DOI 10.1099/ijs.0.014514-0; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Jing LQ, 2016, ENVIRON POLLUT, V210, P397, DOI 10.1016/j.envpol.2016.01.023; Junker RR, 2013, J CHEM ECOL, V39, P810, DOI 10.1007/s10886-013-0325-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Katanic M, 2014, EUR J FOREST RES, V133, P735, DOI 10.1007/s10342-013-0751-9; Kerner R, 2014, J PROTEOMICS, V109, P417, DOI 10.1016/j.jprot.2014.05.021; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LAISK A, 1989, PLANT PHYSIOL, V90, P1163, DOI 10.1104/pp.90.3.1163; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lei H, 2013, ATMOS ENVIRON, V68, P315, DOI 10.1016/j.atmosenv.2012.12.002; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Maignien L, 2014, MBIO, V5, DOI 10.1128/mBio.00682-13; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mills G, 2007, ATMOS ENVIRON, V41, P2630, DOI 10.1016/j.atmosenv.2006.11.016; Niswati A, 2005, SOIL SCI PLANT NUTR, V51, P565, DOI 10.1111/j.1747-0765.2005.tb00065.x; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Quain MD, 2015, PHYTOCHEMISTRY, V112, P179, DOI 10.1016/j.phytochem.2014.12.027; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rai R, 2015, ECOTOX ENVIRON SAFE, V112, P29, DOI 10.1016/j.ecoenv.2014.10.031; Ren GD, 2014, APPL MICROBIOL BIOT, V98, P9459, DOI 10.1007/s00253-014-5915-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sugano S, 2010, PLANT MOL BIOL, V74, P549, DOI 10.1007/s11103-010-9695-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; TURNER NC, 1974, NATURE, V250, P486, DOI 10.1038/250486a0; Ueda Y, 2015, PLANT PHYSIOL, V169, P873, DOI 10.1104/pp.15.00956; Vainonen JP, 2015, PLANT CELL ENVIRON, V38, P240, DOI 10.1111/pce.12273; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang SG, 2011, J ENVIRON SCI-CHINA, V23, P968, DOI 10.1016/S1001-0742(10)60503-7; Wang XK, 2007, ENVIRON POLLUT, V147, P394, DOI 10.1016/j.envpol.2006.05.006; Wang XN, 2015, ENVIRON POLLUT, V197, P116, DOI 10.1016/j.envpol.2014.11.031; Wang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01748; Wang YX, 2014, ENVIRON EXP BOT, V104, P26, DOI 10.1016/j.envexpbot.2014.03.005; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663; Yoshida S, 2009, PHYSIOL PLANTARUM, V136, P284, DOI 10.1111/j.1399-3054.2009.01220.x; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhang JW, 2016, ENVIRON POLLUT, V213, P127, DOI 10.1016/j.envpol.2016.01.062	90	21	21	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163178	10.1371/journal.pone.0163178	http://dx.doi.org/10.1371/journal.pone.0163178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643794	gold, Green Submitted, Green Published			2022-12-27	WOS:000383891900036
J	Bazelet, CS; Thompson, AC; Naskrecki, P				Bazelet, Corinna S.; Thompson, Aileen C.; Naskrecki, Piotr			Testing the Efficacy of Global Biodiversity Hotspots for Insect Conservation: The Case of South African Katydids	PLOS ONE			English	Article							CAPE FLORISTIC REGION; SPECIES RICHNESS; LEAFHOPPERS HOMOPTERA; DIVERSITY; ENDEMISM; RESTIONACEAE; DRAGONFLIES; PATTERNS	The use of endemism and vascular plants only for biodiversity hotspot delineation has long been contested. Few studies have focused on the efficacy of global biodiversity hotspots for the conservation of insects, an important, abundant, and often ignored component of biodiversity. We aimed to test five alternative diversity measures for hotspot delineation and examine the efficacy of biodiversity hotspots for conserving a non-typical target organism, South African katydids. Using a 1 degrees fishnet grid, we delineated katydid hotspots in two ways: (1) count-based: grid cells in the top 10% of total, endemic, threatened and/or sensitive species richness; vs. (2) score-based: grid cells with a mean value in the top 10% on a scoring system which scored each species on the basis of its IUCN Red List threat status, distribution, mobility and trophic level. We then compared katydid hotspots with each other and with recognized biodiversity hotspots. Grid cells within biodiversity hotspots had significantly higher count-based and score-based diversity than non-hotspot grid cells. There was a significant association between the three types of hotspots. Of the count-based measures, endemic species richness was the best surrogate for the others. However, the score-based measure out-performedall count-based diversity measures. Species richness was the least successful surrogate of all. The strong performance of the score-based method for hotspot prediction emphasizes the importance of including species' natural history information for conservation decision-making, and is easily adaptable to other organisms. Furthermore, these results add empirical support for the efficacy of biodiversity hotspots in conserving non-target organisms.	[Bazelet, Corinna S.; Thompson, Aileen C.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa; [Naskrecki, Piotr] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Stellenbosch University; Harvard University	Bazelet, CS (corresponding author), Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa.	cbazelet@sun.ac.za	van der Mescht, Aileen/AAY-3475-2021		South Africa's National Research Foundation (NRF)	South Africa's National Research Foundation (NRF)(National Research Foundation - South Africa)	CSB was funded through South Africa's National Research Foundation (NRF) Innovation Postdoctoral Fellowship. The authors received no specific funding for this work.	[Anonymous], 2015, ARCGIS 9 2; BJORNSTAD ON, 2013, NCF SPATIAL NONPARAM; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Burnham K. P., 2002, MODEL SELECTION AND; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; COLWELL R. K., 2013, ESTIMATES STATISTICA; Cottrell C.B., 1985, Transvaal Museum Monograph, P115; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P31; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P65; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Eades DC, 2015, ORTHOPTERASPECIES FI; Giliomee JH, 2003, AFR J ECOL, V41, P237, DOI 10.1046/j.1365-2028.2003.00442.x; Grant PBC, 2007, BIODIVERS CONSERV, V16, P787, DOI 10.1007/s10531-005-6201-3; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; International Union for Conservation of Nature, 2012, IUCN RED LIST CATEGO; International Union for Conservation of Nature, 2014, THE IUCN RED LIST OF; Jennings MD, 2008, BIODIVERS CONSERV, V17, P833, DOI 10.1007/s10531-008-9322-7; Kaltenbach A.P., 1990, P280; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Kleynhans E, 2009, BIOL LETTERS, V5, P93, DOI 10.1098/rsbl.2008.0545; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Magoba RN, 2010, J INSECT CONSERV, V14, P627, DOI 10.1007/s10841-010-9291-5; Mucina L, 2006, THE VEGETATION OF SO; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naskrecki P., 2008, MANTIS A MANAGER OF; Naskrecki PA, 1993, J AFRICAN ZOOLOGY, V108, P279; Naskrecki P, 2012, ZOOTAXA, P47, DOI 10.11646/zootaxa.3218.1.5; Naskrecki P, 2009, ZOOTAXA, P46, DOI 10.11646/zootaxa.2056.1.2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pohlert T., 2015, PMCMR CALCULATE PAIR; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Price BW, 2007, MOL ECOL, V16, P2574, DOI 10.1111/j.1365-294X.2007.03328.x; Proches S, 2007, S AFR J SCI, V103, P258; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Proches S, 2009, MOL PHYLOGENET EVOL, V51, P94, DOI 10.1016/j.ympev.2008.05.040; Quantum GIS Development Team, 2015, QUANTUM GIS GEOGRAPH; R Development Core Team, 2015, R A LANGUAGE AND ENV; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Simaika JP, 2009, BIOL CONSERV, V142, P638, DOI 10.1016/j.biocon.2008.11.012; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537	47	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160630	10.1371/journal.pone.0160630	http://dx.doi.org/10.1371/journal.pone.0160630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631131	Green Published, gold			2022-12-27	WOS:000383706900009
J	El Atat, O; Antonios, D; Hilal, G; Hokayem, N; Abou-Ghoch, J; Hashim, H; Serhal, R; Hebbo, C; Moussa, M; Alaaeddine, N				El Atat, Oula; Antonios, Diane; Hilal, George; Hokayem, Nabil; Abou-Ghoch, Joelle; Hashim, Hussein; Serhal, Rim; Hebbo, Clara; Moussa, Mayssam; Alaaeddine, Nada			An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells	PLOS ONE			English	Article							THERAPY POSITION STATEMENT; MESENCHYMAL STROMAL CELLS; GROWTH-PROMOTING ACTIVITY; TISSUE INHIBITOR; BONE-MARROW; TELOMERASE ACTIVITY; REGENERATIVE MEDICINE; INTERNATIONAL-SOCIETY; SIGNALING PATHWAY; LIFE-SPAN	The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long-term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic propertiesand aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.	[El Atat, Oula; Serhal, Rim; Hebbo, Clara; Moussa, Mayssam; Alaaeddine, Nada] St Joseph Univ, Regenerat Med & Inflammat Lab, Fac Med, Beirut, Lebanon; [Antonios, Diane] St Joseph Univ, Toxicol Lab, Fac Pharm, Beirut, Lebanon; [Hilal, George] St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon; [Hokayem, Nabil] Hotel Dieu France, Dept Plast & Reconstruct Surg, Beirut, Lebanon; [Hokayem, Nabil] St Joseph Univ, Fac Med, Beirut, Lebanon; [Abou-Ghoch, Joelle] St Joseph Univ, Med Genet Unit, Fac Med, Beirut, Lebanon; [Hashim, Hussein] Fuad Khoury Hosp, Dept Plast & Reconstruct Surg, Beirut, Lebanon		Alaaeddine, N (corresponding author), St Joseph Univ, Regenerat Med & Inflammat Lab, Fac Med, Beirut, Lebanon.	nada.aladdin@usj.edu.lb	atat, oula el/AAH-7689-2019; Antonios, Diane/ABG-5120-2020	atat, oula el/0000-0003-1341-0204; antonios, diane/0000-0003-2740-1640	Research Council of Saint-Joseph University	Research Council of Saint-Joseph University	This work was supported in whole by the Research Council of Saint-Joseph University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTAUX B, 1991, J INVEST DERMATOL, V97, P679, DOI 10.1111/1523-1747.ep12483956; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caterson Edward J., 2008, Birth Defects Research, V84, P322, DOI 10.1002/bdrc.20139; Chatterjee D, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0063-9; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dennis J E, 1992, Cell Transplant, V1, P23; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elenitoba-Johnson KSJ, 2001, AM J PATHOL, V159, P405, DOI 10.1016/S0002-9440(10)61710-5; Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ihn H, 2002, J IMMUNOL, V168, P1895, DOI 10.4049/jimmunol.168.4.1895; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x; Jeon BG, 2011, CELL TISSUE RES, V345, P149, DOI 10.1007/s00441-011-1191-9; Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li H, 2010, TOHOKU J EXP MED, V222, P131, DOI 10.1620/tjem.222.131; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Melief SM, 2013, HAEMATOLOGICA, V98, pE121, DOI 10.3324/haematol.2013.093864; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Nava MB, 2015, PLAST RECONSTR SURG, V135, p114E, DOI 10.1097/PRS.0000000000001008; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Oh JY, 2014, STEM CELLS, V32, P1553, DOI 10.1002/stem.1608; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Parsch D, 2004, J MOL MED-JMM, V82, P49, DOI 10.1007/s00109-003-0506-z; Paula ACC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0030-4; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodriguez R, 2013, STEM CELLS, V31, P2061, DOI 10.1002/stem.1472; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Rubio R, 2013, ONCOGENE, V32, P4970, DOI 10.1038/onc.2012.507; Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647; Schneider-Stock R, 2003, PATHOL RES PRACT, V199, P445, DOI 10.1078/0344-0338-00444; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Sterodimas A, 2009, ANN PLAS SURG, V62, P97, DOI 10.1097/SAP.0b013e3181788ec9; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; Tang LN, 2012, CELL REPROGRAM, V14, P342, DOI 10.1089/cell.2011.0098; Ueda M, 1997, CANCER RES, V57, P370; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Zaman WSWK, 2014, J TISSUE ENG REGEN M, V8, P67, DOI 10.1002/term.1501; Zeng X, 2007, NEUROSCIENCE, V145, P1348, DOI 10.1016/j.neuroscience.2006.09.017; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	76	12	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162332	10.1371/journal.pone.0162332	http://dx.doi.org/10.1371/journal.pone.0162332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632538	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900038
J	de Diego-Balaguer, R; Schramm, C; Rebeix, I; Dupoux, E; Durr, A; Brice, A; Charles, P; de Langavant, LC; Youssov, K; Verny, C; Damotte, V; Azulay, JP; Goizet, C; Simonin, C; Tranchant, C; Maison, P; Rialland, A; Schmitz, D; Jacquemot, C; Fontaine, B; Bachoud-Levi, AC				de Diego-Balaguer, Ruth; Schramm, Catherine; Rebeix, Isabelle; Dupoux, Emmanuel; Durr, Alexandra; Brice, Alexis; Charles, Perrine; de langavant, Laurent Cleret; Youssov, Katia; Verny, Christophe; Damotte, Vincent; Azulay, Jean-Philippe; Goizet, Cyril; Simonin, Clemence; Tranchant, Christine; Maison, Patrick; Rialland, Amandine; Schmitz, David; Jacquemot, Charlotte; Fontaine, Bertrand; Bachoud-Levi, Anne-Catherine		French Speaking Huntington Grp	COMT Val(158)Met Polymorphism Modulates Huntington's Disease Progression	PLOS ONE			English	Article							TRINUCLEOTIDE REPEAT LENGTH; PARKINSONS-DISEASE; COGNITIVE DECLINE; CLINICAL PROGRESSION; GENETIC MODIFIERS; DOPAMINE; ONSET; AGE; NEURODEGENERATION; SYMPTOMS	Little is known about the genetic factors modulating the progression of Huntington's disease (HD). Dopamine levels are affected in HD and modulate executive functions, the main cognitive disorder of HD. We investigated whether the Val (158)Met polymorphism of the catechol-O-methyltransferase (COMT) gene, which influences dopamine (DA) degradation, affects clinical progression in HD. We carried out a prospective longitudinal multicenter study from 1994 to 2011, on 438 HD gene carriers at different stages of the disease (34 pre-manifest; 172 stage 1; 130 stage 2; 80 stage 3; 17 stage 4; and 5 stage 5), according to Total Functional Capacity (TFC) score. We used the Unified Huntington's Disease Rating Scale to evaluate motor, cognitive, behavioral and functional decline. We genotyped participants for COMT polymorphism (107 Met-homozygous, 114 Val-homozygous and 217 heterozygous). 367 controls of similar ancestry were also genotyped. We compared clinical progression, on each domain, between groups of COMT polymorphisms, using latent-class mixed models accounting for disease duration and number of CAG (cytosine adenine guanine) repeats. We show that HD gene carriers with fewer CAG repeats and with the Val allele in COMT polymorphism displayed slower cognitive decline. The rate of cognitive decline was greater for Met/Met homozygotes, which displayed a better maintenance of cognitive capacity in earlier stages of the disease, but had a worse performance than Val allele carriers later on. COMT polymorphism did not significantly impact functional and behavioral performance. Since COMT polymorphism influences progression in HD, it could be used for stratification in future clinical trials. Moreover, DA treatments based on the specific COMT polymorphism and adapted according to disease duration could potentially slow HD progression.	[de Diego-Balaguer, Ruth; Schramm, Catherine; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] INSERM, U955, Equipe Neuropsychol Intervent 01, F-94000 Creteil, France; [de Diego-Balaguer, Ruth; Schramm, Catherine; Dupoux, Emmanuel; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, F-75005 Paris, France; [de Diego-Balaguer, Ruth; Schramm, Catherine; de langavant, Laurent Cleret; Youssov, Katia; Maison, Patrick; Jacquemot, Charlotte; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, F-94000 Creteil, France; [de Diego-Balaguer, Ruth] ICREA, Barcelona 08010, Spain; [de Diego-Balaguer, Ruth] Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona 08035, Spain; [de Diego-Balaguer, Ruth] IDIBELL, Unitat Cognicio & Plasticitat Cerebral, Lhospitalet De Llobregat 08907, Spain; [de Diego-Balaguer, Ruth] Univ Barcelona, Inst Neurociencia, Barcelona, Spain; [Rebeix, Isabelle; Durr, Alexandra; Brice, Alexis; Damotte, Vincent] INSERM UPMC CNRS, UMR 7225 1127, Inst Cerveau Moelle, Hop Pitie Salpetriere, F-74013 Paris, France; [Rebeix, Isabelle; Damotte, Vincent; Fontaine, Bertrand] Hop La Pitie Salpetriere, AP HP, Dept Malad Syst Nerveux, F-74013 Paris, France; [Dupoux, Emmanuel] ENS EHESS CNRS, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France; [Durr, Alexandra; Brice, Alexis; Charles, Perrine; Fontaine, Bertrand] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-74013 Paris, France; [de langavant, Laurent Cleret; Youssov, Katia; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor Albert Chenevier, AP HP, Ctr Reference Malad Huntington, Serv Neurol, F-94000 Creteil, France; [Verny, Christophe] CHU Angers, Ctr Reference Malad Neurogenerat, Serv Neurol, F-49933 Angers, France; [Azulay, Jean-Philippe] CHU Marseille, Hop Timone, Serv Neurol & Pathol Mouvement, F-13385 Marseille, France; [Goizet, Cyril] CHU Bordeaux, GH Sud, Hop Haut Leveque, Serv Neurol, F-33604 Pessac, France; [Simonin, Clemence] CHRU Lille, Serv Neurol & Pathol Mouvement, F-59000 Lille, France; [Simonin, Clemence] Univ Lille, INSERM UMR S 1172, JPArc, Ctr Rech Jean Pierre Aubert Neurosci & Canc, F-59000 Lille, France; [Tranchant, Christine] CHU Strasbourg, Serv Neurol, Hop Hautepierre, F-67098 Strasbourg, France; [Maison, Patrick; Rialland, Amandine; Schmitz, David] Hop Henri Mondor, AP HP, Unite Rech Clin, F-94000 Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); ICREA; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Bachoud-Levi, AC (corresponding author), INSERM, U955, Equipe Neuropsychol Intervent 01, F-94000 Creteil, France.; Bachoud-Levi, AC (corresponding author), PSL Res Univ, Dept Etud Cognit, Ecole Normale Super, F-75005 Paris, France.; Bachoud-Levi, AC (corresponding author), Univ Paris Est, Fac Med, F-94000 Creteil, France.; Bachoud-Levi, AC (corresponding author), Hop Henri Mondor Albert Chenevier, AP HP, Ctr Reference Malad Huntington, Serv Neurol, F-94000 Creteil, France.	bachoud@gmail.com	GOIZET, Cyril/M-4576-2014; Schramm, Catherine/AAB-5104-2021; brice, alexis/AAE-8275-2019; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; Brice, Alexis/A-2170-2009; Damotte, Vincent/ABH-4760-2020; de Diego-Balaguer, Ruth/V-2131-2017	GOIZET, Cyril/0000-0002-1913-889X; Schramm, Catherine/0000-0002-1185-8809; brice, alexis/0000-0002-0941-3990; Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Damotte, Vincent/0000-0002-7321-8575; tranchant, christine/0000-0002-2895-1292; Jacquemot, Charlotte/0000-0002-6611-0742; Simonin, Clemence/0000-0002-2282-4372; Cleret de Langavant, Laurent/0000-0001-6551-4641; de Diego-Balaguer, Ruth/0000-0002-2357-5195; Dupoux, Emmanuel/0000-0002-7814-2952	Gis [A02216JS/A04159JS]; Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM; French Ministry of Health; Ministerio de Economia y Competitividad (MINECO) [PSI2011-23624]; NeuroStemcell Consortium (European Community Seventh Framework Program) [222943]; investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences [ANR-11-INBS-0011]; IHU grant [ANR-10-IAIHU-06]; AP-HP/CEA interface contract;  [ANR-10-LBX-0087 IEC];  [ANR-10-IDEX-0001-02 PSL*]; ICREA Funding Source: Custom	Gis; Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Health; Ministerio de Economia y Competitividad (MINECO); NeuroStemcell Consortium (European Community Seventh Framework Program); investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences; IHU grant; AP-HP/CEA interface contract; ; ; ICREA(ICREA)	A-C Bachoud-Levi is the PI of the biomarker program initially funded by Gis A02216JS/A04159JS and then by Assistance Publique-Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); she had full access to all of the data for this study and takes responsibility for the integrity of the data and the accuracy of data analysis. She is supported by an interface contract from INSERM and is the Head of the French National Center for Huntington's Disease (funded by the French Ministry of Health). R de Diego-Balaguer was supported by grant PSI2011-23624 from the Ministerio de Economia y Competitividad (MINECO). C Schramm was supported by the NeuroStemcell Consortium (European Community Seventh Framework Program grant agreement no. 222943) and by investment for the future NeurATRIS: Infrastructure de recherche translationnelle pour les biotherapies en Neurosciences (ANR-11-INBS-0011). Additional support was provided by ANR-10-LBX-0087 IEC and ANR-10-IDEX-0001-02 PSL* grants. A Durr, A Brice, V Damotte, I Rebeix and B Fontaine were supported by IHU grant ANR-10-IAIHU-06. L Cleret de Langavant was supported by an AP-HP/CEA interface contract. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Arning L, 2013, NEUROGENETICS, V14, P171, DOI 10.1007/s10048-013-0365-x; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Becanovic K, 2015, NAT NEUROSCI, V18, P807, DOI 10.1038/nn.4014; Biglan KM, 2016, JAMA NEUROL, V73, P102, DOI 10.1001/jamaneurol.2015.2736; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brandt J, 1996, NEUROLOGY, V46, P527, DOI 10.1212/WNL.46.2.527; Cardebat D, ACTA MED BELGICA, V90, P207; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Charvin D, 2008, NEUROBIOL DIS, V29, P22, DOI 10.1016/j.nbd.2007.07.028; Chen JY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00114; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Choi ML, 2014, NEUROBIOL DIS, V66, P19, DOI 10.1016/j.nbd.2014.02.004; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Corvol JC, 2011, ANN NEUROL, V69, P111, DOI 10.1002/ana.22155; Epping EA, 2016, AM J PSYCHIAT, V173, P184, DOI 10.1176/appi.ajp.2015.14121551; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Gennatas ED, 2012, NEUROLOGY, V78, P1663, DOI 10.1212/WNL.0b013e3182574fa1; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Gusella JF, 2014, MOVEMENT DISORD, V29, P1359, DOI 10.1002/mds.26001; Harbo HF, 2009, EUR J NEUROL, V16, P777, DOI 10.1111/j.1468-1331.2009.02646.x; KIEBURTZ K, 1994, J MED GENET, V31, P872, DOI 10.1136/jmg.31.11.872; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Mura T, 2014, J NEUROL NEUROSUR PS, V85, P363, DOI 10.1136/jnnp-2013-305078; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Pavese N, 2010, NEUROBIOL DIS, V37, P356, DOI 10.1016/j.nbd.2009.10.015; Proust-Lima C, 2013, BRIT J MATH STAT PSY, V66, P470, DOI 10.1111/bmsp.12000; Ramos EM, 2013, NEUROGENETICS, V14, P173, DOI 10.1007/s10048-013-0364-y; Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Schacht JP, 2016, PHARMACOGENOMICS J, V16, P430, DOI 10.1038/tpj.2016.43; Schwab LC, 2015, EXPERT REV NEUROTHER, V15, P445, DOI 10.1586/14737175.2015.1025383; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; TURJANSKI N, 1995, BRAIN, V118, P689, DOI 10.1093/brain/118.3.689; Vinther-Jensen T, 2016, CLIN GENET, V89, P320, DOI 10.1111/cge.12628; Vivot A, 2015, MOL PSYCHIATR, V20, P1173, DOI 10.1038/mp.2015.62; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Vuono R, 2015, BRAIN, V138, P1907, DOI 10.1093/brain/awv107; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Williams-Gray CH, 2008, BRAIN, V131, P397, DOI 10.1093/brain/awm313; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wolf RC, 2013, EXP NEUROL, V247, P39, DOI 10.1016/j.expneurol.2013.03.022; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012	56	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161106	10.1371/journal.pone.0161106	http://dx.doi.org/10.1371/journal.pone.0161106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657697	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200005
J	Finnegan, T; Steenkamp, PA; Piater, LA; Dubery, IA				Finnegan, Tarryn; Steenkamp, Paul A.; Piater, Lizelle A.; Dubery, Ian A.			The Lipopolysaccharide-Induced Metabolome Signature in Arabidopsis thaliana Reveals Dynamic Reprogramming of Phytoalexin and Phytoanticipin Pathways	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA CONTRIBUTE; SYSTEMIC ACQUIRED-RESISTANCE; PLANT DEFENSE RESPONSES; GLUCOSINOLATE METABOLISM; INNATE IMMUNITY; INDOLE-3-CARBOXYLIC ACID; INDUCTION; CAMALEXIN; IDENTIFICATION; BIOSYNTHESIS	Lipopolysaccharides (LPSs), as MAMP molecules, trigger the activation of signal transduction pathways involved in defence. Currently, plant metabolomics is providing new dimensions into understanding the intracellular adaptive responses to external stimuli. The effect of LPS on the metabolomes of Arabidopsis thaliana cells and leaf tissue was investigated over a 24 h period. Cellular metabolites and those secreted into the medium were extracted with methanol and liquid chromatography coupled to mass spectrometry was used for quantitative and qualitative analyses. Multivariate statistical data analyses were used to extract interpretable information from the generated multidimensional LC-MS data. The results show that LPS perception triggered differential changes in the metabolomes of cells and leaves, leading to variation in the biosynthesis of specialised secondary metabolites. Time-dependent changes in metabolite profiles were observed and biomarkers associated with the LPS-induced response were tentatively identified. These include the phytohormones salicylic acid and jasmonic acid, and also the associated methyl esters and sugar conjugates. The induced defensive state resulted in increases in indole D and other glucosinolates, indole derivatives, camalexin as well as cinnamic acid derivatives and other phenylpropanoids. These annotated metabolites indicate dynamic reprogramming of metabolic pathways that are functionally related towards creating an enhanced defensive capacity. The results reveal new insights into the mode of action of LPS as an activator of plant innate immunity, broadens knowledge about the defence metabolite pathways involved in Arabidopsis responses to LPS, and identifies specialised metabolites of functional importance that can be employed to enhance immunity against pathogen infection.	[Finnegan, Tarryn; Steenkamp, Paul A.; Piater, Lizelle A.; Dubery, Ian A.] Univ Johannesburg, Dept Biochem, ZA-2006 Auckland Pk, South Africa; [Steenkamp, Paul A.] CSIR, Biosci Nat Prod & Agroproc Grp, ZA-0001 Pretoria, South Africa	University of Johannesburg; Council for Scientific & Industrial Research (CSIR) - South Africa	Dubery, IA (corresponding author), Univ Johannesburg, Dept Biochem, ZA-2006 Auckland Pk, South Africa.	idubery@uj.ac.za	Dubery, Ian/A-6346-2013	Dubery, Ian/0000-0002-9079-4769; Piater, Lizelle/0000-0002-9526-0109	South African National Research Foundation (NRF) [95818]; Council for Scientific and Industrial Research (CSIR); University of Johannesburg (UJ)	South African National Research Foundation (NRF)(National Research Foundation - South Africa); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University of Johannesburg (UJ)	The South African National Research Foundation (NRF: www.nrf.ac.za) is thanked for grant support (number 95818) to IAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Council for Scientific and Industrial Research (CSIR) and the University of Johannesburg (UJ) are thanked for fellowship support to TF. Fidele Tugizimana is thanked for assisting with data deposition.	Arany AM, 2008, CHEMOECOLOGY, V18, P65, DOI 10.1007/s00049-007-0394-8; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2011, NEW PHYTOL, V192, P713, DOI 10.1111/j.1469-8137.2011.03824.x; Beets CA, 2012, PLANTA, V236, P261, DOI 10.1007/s00425-012-1606-1; Bottcher C, 2014, PLANT PHYSIOL, V165, P841, DOI 10.1104/pp.114.235630; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chen S, 2001, PLANT PHYSIOL BIOCH, V39, P743, DOI 10.1016/S0981-9428(01)01301-8; Choudhary Devendra K., 2007, Indian Journal of Microbiology, V47, P289, DOI 10.1007/s12088-007-0054-2; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Coventry HS, 2001, PHYSIOL MOL PLANT P, V58, P149, DOI 10.1006/pmpp.2001.0323; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Frerigmann H, 2014, PLANT PHYSIOL, V166, P349, DOI 10.1104/pp.114.240887; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gamir J, 2012, PLANT PHYSIOL BIOCH, V61, P169, DOI 10.1016/j.plaphy.2012.10.004; Gamir J, 2014, PLANT J, V78, P227, DOI 10.1111/tpj.12465; Gerber IB, 2004, PLANTA, V218, P647, DOI 10.1007/s00425-003-1142-0; Gerber IB, 2008, BBA-PROTEINS PROTEOM, V1784, P1750, DOI 10.1016/j.bbapap.2008.06.012; Gigolashvili T, 2009, PHYTOCHEM REV, V8, P3, DOI 10.1007/s11101-008-9112-6; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hagemeier J, 2001, P NATL ACAD SCI USA, V98, P753, DOI 10.1073/pnas.021551098; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hardy NW, 2012, METHOD MOL BIOL, V860, P1; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Hiruma K, 2013, P NATL ACAD SCI USA, V110, P9589, DOI 10.1073/pnas.1305745110; Huang JC, 2012, PHYSIOL MOL PLANT P, V80, P19, DOI 10.1016/j.pmpp.2012.07.002; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kiddle G, 2001, PHYTOCHEM ANALYSIS, V12, P226, DOI 10.1002/pca.589; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Madala Ntakadzeni E., 2012, Innate Immunity, V18, P140, DOI 10.1177/1753425910392609; Madala NE, 2014, PLANT PHYSIOL BIOCH, V84, P87, DOI 10.1016/j.plaphy.2014.08.023; Mavel S, 2013, TALANTA, V114, P95, DOI 10.1016/j.talanta.2013.03.064; Mhlongo MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151350; Mhlongo MI, 2014, PHYSIOL MOL PLANT P, V88, P61, DOI 10.1016/j.pmpp.2014.09.002; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Newman MA, 2007, J ENDOTOXIN RES, V13, P69, DOI 10.1177/0968051907079399; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nyamundanda G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-571; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Pedras MSC, 2008, J AGR FOOD CHEM, V56, P9949, DOI 10.1021/jf802192f; Pencik A, 2013, PLANT CELL, V25, P3858, DOI 10.1105/tpc.113.114421; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Piasecka A, 2015, NEW PHYTOL, V206, P948, DOI 10.1111/nph.13325; Piater LA, 2004, MOL PLANT PATHOL, V5, P331, DOI 10.1111/j.1364-3703.2004.00234.x; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Rajniak J, 2015, NATURE, V525, P376, DOI 10.1038/nature14907; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Ryffel F, 2016, ISME J, V10, P632, DOI 10.1038/ismej.2015.141; Sanabria Natasha M, 2010, Self Nonself, V1, P40; Sanabria NM, 2012, GENE, V501, P39, DOI 10.1016/j.gene.2012.03.073; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; Trivedi DK, 2012, J CHROMATOGR SEP TEC, V3, P2, DOI DOI 10.4172/2157-7064.10; Tugizimana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087846; Tugizimana F, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120005; van de Mortel JE, 2012, PLANT PHYSIOL, V160, P2173, DOI 10.1104/pp.112.207324; Ward JL, 2010, PLANT J, V63, P443, DOI 10.1111/j.1365-313X.2010.04254.x; Wittstock U., 2010, Arabidopsis Book, V8, pe0134, DOI 10.1199/tab.0134; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yu K, 2008, Application note 720002572EN LB-KP, Patent No. 720002572; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zeidler D, 2010, MOL PLANT PATHOL, V11, P747, DOI 10.1111/j.1364-3703.2010.00638.x; Zhu F, 2014, MOL PLANT MICROBE IN, V27, P567, DOI 10.1094/MPMI-11-13-0349-R	76	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163572	10.1371/journal.pone.0163572	http://dx.doi.org/10.1371/journal.pone.0163572			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656890	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200147
J	Burke, HM; Moret, W; Field, S; Chen, M; Zeng, YW; Seka, FM				Burke, Holly M.; Moret, Whitney; Field, Samuel; Chen, Mario; Zeng, Yanwu; Seka, Firmin M.			Assessing Household Economic Vulnerability in HIV-Affected Communities in Five Regions of Cote d'Ivoire	PLOS ONE			English	Article								The objective of this study was to identify and describe levels of household economic vulnerability in HIV-affected communities in Cote d'Ivoire, defined as those with a high prevalence of HIV and large numbers of orphans and vulnerable children. We conducted a cross-sectional survey of 3,749 households in five health regions of Cote d'Ivoire. Using principal component analysis, we attempted to identify sets of correlated vulnerabilities and derive a small number of composite scores to create an index for targeting interventions to vulnerable populations. The 65 vulnerability measures examined did not cluster in ways that would allow for the creation of a small number of composite measures. Instead, we found that households face numerous unique pathways to vulnerability.	[Burke, Holly M.; Field, Samuel; Chen, Mario; Zeng, Yanwu] Global Hlth Populat & Nutr Dept, Durham, NC USA; [Moret, Whitney] Social & Econ Dev Dept, Washington, DC USA; [Seka, Firmin M.] Synergie Expertise, Abidjan, Cote Ivoire		Burke, HM (corresponding author), Global Hlth Populat & Nutr Dept, Durham, NC USA.	hburke@fhi360.org			American people through the United States Department of State; United States Agency for International Development (USAID)	American people through the United States Department of State; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was made possible by the generous support of the American people through the United States Department of State and the United States Agency for International Development (USAID). This study was produced under United States Agency for International Development (USAID) Cooperative Agreement No. AID-OAA-LA-13-00001. The contents are the responsibility of FHI 360 and do not necessarily reflect the views of USAID or the United States Government. Author FMS is employed by Synergie Expertise. Synergie Expertiseis the data collection firm hired to collect the data for this study, and it provided support in the form of salary for author FMS, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alwang J, SOCIAL PROTECTION DI; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Chen MA, 1996, HOUSEHOLD EC PORTFOL; Donahue J, 2005, GENERATION AT RISK G, P37; FANRPAN, 2011, HOUS VULN IND; Farrington J, NATURAL RESOURCE PER; Frankenberger T.R., 2002, HOUSEHOLD LIVELIHOOD; Gebrehiwot T, 2013, J EAST AFR STUD, V7, P607, DOI 10.1080/17531055.2013.817162; Ghimire YN, 2010, INT J SUST DEV WORLD, V17, P225, DOI 10.1080/13504501003737500; Institut National de la Statistique (INS), 2008, ENQ NIV VIE MEN; Institut National de la Statistique (INS) and ICF International, 2012, ENQ DEM SANT IND MUL; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Krantz L., 2001, IEEE T ULTRASON FERR, DOI DOI 10.1021/es702992q; Kureya T, 2013, HOUSEHOLD VULNERABIL; Lindenberg M, 2002, WORLD DEV, V30, P301, DOI 10.1016/S0305-750X(01)00105-X; Maxwell D., 2008, COPING STRATEGIES IN; Mazzeo J, 2009, ZIMBABWE HOUSEHOLD L; Moret W., 2014, VULNERABILITY ASSESS, P360; Murray C, LIVELIHOODS RES SOME; Oluoko-Odingo AA, 2011, ANN ASSOC AM GEOGR, V101, P1, DOI 10.1080/00045608.2010.532739; Schreiner M., 2013, SIMPLE POVERTY SCORE; Scoones I, 721998 IDS; Sibanda LM, 2008, HOUSEHOLD VULNERABIL; Simanowitz A, 1998, PARTICIPATORY WEALTH; The U.S. President's Emergency Plan for AIDS Relief, 2012, US PRES EM PLAN AIDS; UNAIDS, 2013, HIV AIDS EST; Wolfe J., 2009, HOUSEHOLD EC STRENGT; World Food Programme Vulnerability Analysis and Mapping Branch (ODAV), 2008, FOOD CONS AN CALC US	28	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163285	10.1371/journal.pone.0163285	http://dx.doi.org/10.1371/journal.pone.0163285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655530	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700049
J	Ursing, J; Rombo, L; Rodrigues, A; Kofoed, PE				Ursing, Johan; Rombo, Lars; Rodrigues, Amabelia; Kofoed, Poul-Erik			Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial	PLOS ONE			English	Article							CHLOROQUINE	Background Artemether-lumefantrine (AL) was introduced for treatment of uncomplicated malaria in Guinea-Bissau in 2008. Malaria then resurged and recurrent malaria after treatment with AL and stock-outs of AL were common. This study therefore aimed to assess the efficacy of AL and identify an alternative second line antimalarial. Dihydroartemisinin-piperaquine (DP) was chosen as it has been shown to be safe and efficacious and to reduce the incidence of recurrent malaria. Methods and Findings In a multicentre randomised open-label non-inferiority clinical trial, AL or DP were given over 3 days to children aged 6 months-15 years with uncomplicated P. falciparummonoinfection. Intake was observed and AL was given with milk. Children were seen on days 0, 1, 2 and 3 and then weekly days 7-42. Recurring P. falciparumwere classified as recrudescence or new infections by genotyping. Between November 2012 and July 2015, 312 children were randomised to AL (n = 155) or DP (n = 157). The day 42 PCR adjusted per protocol adequate clinical and parasitological responses were 95% and 100% in the AL and DP groups respectively, Mantel-Haenszel weighted odds ratio (OR) 0.22 (95% CI 0-0.68), p = 0.022. In a modified intention to treat analysis in which treatment failures day 0 and reinfections were also considered as treatment failures adequate clinical and parasitological responses were 94% and 97% (OR 0.42 [95% CI, 0.13-1.38], p = 0.15). Parasite clearance and symptom resolution were similar with both treatments. Conclusions Both treatments achieved the WHO recommended efficacy for antimalarials about to be adopted as policy. DP was not inferior to AL for treatment of uncomplicated P. falciparum malaria in Guinea-Bissau.	[Ursing, Johan; Rodrigues, Amabelia; Kofoed, Poul-Erik] Indepth Network, Projecto Saude Bandim, Bissau, Guinea Bissau; [Ursing, Johan; Rombo, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16, S-17165 Stockholm, Sweden; [Ursing, Johan] Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden; [Rombo, Lars] Sormland Cty Council, Clin Res Ctr, Eskilstuna, Sweden; [Rombo, Lars] Uppsala Univ, Uppsala, Sweden; [Kofoed, Poul-Erik] Kolding Cty Hosp, Dept Paediat, Kolding, Denmark	Karolinska Institutet; Danderyds Hospital; Uppsala University; Kolding Hospital	Ursing, J; Kofoed, PE (corresponding author), Indepth Network, Projecto Saude Bandim, Bissau, Guinea Bissau.; Ursing, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16, S-17165 Stockholm, Sweden.; Ursing, J (corresponding author), Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden.; Kofoed, PE (corresponding author), Kolding Cty Hosp, Dept Paediat, Kolding, Denmark.	johan.ursing@ds.se; poul.erik.kofoed@rsyd.dk		Ursing, Johan/0000-0002-5508-9327	Anthony Cerami and Ann Dunne Foundation for world health; Svenska Lakaresallskapet	Anthony Cerami and Ann Dunne Foundation for world health; Svenska Lakaresallskapet	The study was funded by an Award from the Anthony Cerami and Ann Dunne Foundation for world health (http://acadforworldhealth.org/) and a grant from Svenska Lakaresallskapet (www.sls.se). Dihydroartemisnin-piperaquine (eurartesim) was provided free of charge by Sigma-Tau (www.sigmatau.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also confirm that this does not alter our adherence to PLOS ONE policies on sharing data and materials.; The study was funded by an Award from the Anthony Cerami and Ann Dunne Foundation for world health and a grant from Svenska Lakaresallskapet. The authors thank the patients and their parents who took part and the staff at Projecto Saude Bandim.	Atwine D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001119; Bassat Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007871; Boni MF, 2008, P NATL ACAD SCI USA, V105, P14216, DOI 10.1073/pnas.0804628105; Creek D, 2010, AM J TROP MED HYG, V83, P873, DOI 10.4269/ajtmh.2010.10-0158; Jovel IT, 2015, ANTIMICROB AGENTS CH, V59, P872, DOI 10.1128/AAC.03554-14; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Kofoed PE, 1997, T ROY SOC TROP MED H, V91, P462, DOI 10.1016/S0035-9203(97)90286-8; Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Ogutu BR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-33; Sylla K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-598; Ursing J, 2007, AM J TROP MED HYG, V76, P844, DOI 10.4269/ajtmh.2007.76.844; Ursing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101167; Ursing J, 2011, J INFECT DIS, V203, P109, DOI 10.1093/infdis/jiq001; Wanzira H, 2014, CLIN INFECT DIS, V59, P509, DOI 10.1093/cid/ciu353; WHO, 2007, METH TECHN CLIN TRIA; World Health Organization, METH SURV ANT DRUG E; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yeka A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002390	19	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161495	10.1371/journal.pone.0161495	http://dx.doi.org/10.1371/journal.pone.0161495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649561	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100006
J	Feijen, EAM; Font-Gonzalez, A; van Dalen, EC; van der Pal, HJH; Reulen, RC; Winter, DL; Kuehni, CE; Haupt, R; Alessi, D; Byrne, J; Bardi, E; Jakab, Z; Grabow, D; Garwicz, S; Jankovic, M; Levitt, GA; Skinner, R; Zaletel, LZ; Hjorth, L; Tissing, WJE; de Vathaire, F; Hawkins, MM; Kremer, LCM				Feijen, Elizabeth A. M.; Font-Gonzalez, Anna; van Dalen, Elvira C.; van der Pal, Helena J. H.; Reulen, Raoul C.; Winter, David L.; Kuehni, Claudia E.; Haupt, Riccardo; Alessi, Daniela; Byrne, Julianne; Bardi, Edit; Jakab, Zsuzsanna; Grabow, Desiree; Garwicz, Stanislaw; Jankovic, Momcilo; Levitt, Gill A.; Skinner, Roderick; Zaletel, Lorna Zadravec; Hjorth, Lars; Tissing, Wim J. E.; de Vathaire, Florent; Hawkins, Mike M.; Kremer, Leontien C. M.		PanCareSurFup Consortium	Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; LONG-TERM; ADULT SURVIVORS; RISK-FACTORS; DOXORUBICIN THERAPY; HEALTH OUTCOMES; CARDIOTOXICITY; MORTALITY	Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cancer and its treatment, including cardiac events. The pan-European PanCareSurFup study determined the incidence and risk factors for cardiac events among childhood cancer survivors. The aim of this article is to describe the methodology of the cardiac cohort and nested case-control study within PanCareSurFup. Methods Eight data providers in Europe participating in PanCareSurFup identified and validated symptomatic cardiac events in their cohorts of childhood cancer survivors. Data on symptomatic heart failure, ischemia, pericarditis, valvular disease and arrhythmia were collected and graded according to the Criteria for Adverse Events. Detailed treatment data, data on potential confounders, lifestyle related risk factors and general health problems were collected. Results The PanCareSurFup cardiac cohort consisted of 59,915 5-year childhood cancer survivors with malignancies diagnosed between 1940 and 2009 and classified according to the International Classification of Childhood Cancer 3. Different strategies were used to identify cardiac events such as record linkage to population/hospital or regional based databases, and patient-and general practitioner-based questionnaires. Conclusion The cardiac study of the European collaborative research project PanCareSurFup will provide the largest cohort of 5-year childhood cancer survivors with systematically ascertained and validated data on symptomatic cardiac events. The result of this study can provide information to minimize the burden of cardiac events in childhood cancer survivors by tailoring the follow-up of childhood cancer survivors at high risk of cardiac adverse events, transferring this knowledge into evidence-based clinical practice guidelines and providing a platform for future research studies in childhood cancer patients.	[Feijen, Elizabeth A. M.; Font-Gonzalez, Anna; van Dalen, Elvira C.; van der Pal, Helena J. H.; Kremer, Leontien C. M.] Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Pediat Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van der Pal, Helena J. H.; Reulen, Raoul C.; Winter, David L.] Acad Med Ctr Amsterdam, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hawkins, Mike M.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England; [Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Finkenhubelweg 11, CH-3012 Bern, Switzerland; [Haupt, Riccardo] Gaslini Children Hosp, Epidemiol & Biostat Sect, Via Gerolamo Gaslini,5, I-16148 Genoa, Italy; [Alessi, Daniela] Univ Turin, Citta Salute & Sci Hosp, Canc Epidemiol Unit, Childhood Canc Registry Piedmont, Via Santena 7, I-10126 Turin, Italy; [Alessi, Daniela] Ctr Canc Prevent CPO, Via Santena 7, I-10126 Turin, Italy; [Byrne, Julianne] Boyne Res Inst, Tiernan House, Fair Green, Drogheda, Ireland; [Bardi, Edit] Semmelweis Univ, Dept Pediat 2, Ulloi Ut 26, H-1085 Budapest, Hungary; [Jakab, Zsuzsanna] Markusovszky Hosp, Dept Pediat Oncol, Markusovszky Lajos U 5, H-9700 Szombathely, Hungary; [Grabow, Desiree] Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, GCCR, Mainz, Germany; [Garwicz, Stanislaw; Hjorth, Lars] Skane Univ Lund, Dept Pediat, Getingevagen 4, S-22241 Lund, Sweden; [Jankovic, Momcilo] San Gerardo Hosp, Pediat Hematol Unit, Via Primo Maggio,22, I-38089 Monza, Italy; [Levitt, Gill A.] Great North Childrens Hosp, Dept Paediat & Adolescent Haematol & Oncol, Newcastle, England; [Levitt, Gill A.; Skinner, Roderick] Great North Childrens Hosp, Childrens BMT Unit, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Dept Paediat & Adolescent Haematol & Oncol, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Great North Childrens Hosp, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Northern Inst Canc Res, Newcastle, England; [Zaletel, Lorna Zadravec] Inst Oncol, Div Radiotherapy, Zaloska Cesta 2, SL-1000 Ljubljana, Slovenia; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Oncol, Groningen, Netherlands; [de Vathaire, Florent] INSERM, Gustave Roussy, Radiat Epidemiol Grp, UMR1018, Villejuif, France	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Bern; University of Genoa; IRCCS Istituto Giannina Gaslini; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Semmelweis University; Johannes Gutenberg University of Mainz; San Gerardo Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Institute of Oncology - Slovenia; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Feijen, EAM (corresponding author), Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Pediat Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.a.feijen@amc.uva.nl	Haupt, Riccardo/AAA-7437-2020; de Vathaire, Florent/L-2983-2016; Reulen, Raoul/AAO-1033-2020	Haupt, Riccardo/0000-0003-0571-8460; Reulen, Raoul/0000-0002-7328-0467; Kremer, Leontien/0000-0001-7422-3248; kremer, leontien/0000-0002-7619-7845; Zadravec Zaletel, Lorna/0000-0002-4423-0276; de Vathaire, Florent/0000-0002-8374-9281	PanCareSurFup, EU [257505]; Swiss Cancer League [KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011, KLS-3412-02-2014]	PanCareSurFup, EU; Swiss Cancer League	This study was supported by PanCareSurFup, EU-Grant agreement number 257505, https://ec.europa.eu/research/fp7/, no role. The Swiss Childhood Cancer Survivor Study was funded by the Swiss Cancer League (KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011, KLS-3412-02-2014), http://www.uicc.org/, no role.	Armenian SH, 2015, LANCET ONCOL, V16, pE123, DOI 10.1016/S1470-2045(14)70409-7; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Badouna ANI, 2012, PHYS MED BIOL, V57, P473, DOI 10.1088/0031-9155/57/2/473; Behar C, 1996, MED PEDIATR ONCOL, V26, P173, DOI 10.1002/(SICI)1096-911X(199603)26:3<173::AID-MPO5>3.0.CO;2-H; Blanco JG, 2008, CANCER-AM CANCER SOC, V112, P2789, DOI 10.1002/cncr.23534; Feijen EAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100432; Garwicz S, 2012, INT J CANCER, V131, P1659, DOI 10.1002/ijc.27393; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; GOLDBERG MA, 1986, BLOOD, V68, P1114; GOTTDIENER JS, 1981, ARCH INTERN MED, V141, P758, DOI 10.1001/archinte.141.6.758; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Gudmundsdottir T, 2015, INT J CANCER, V137, P1176, DOI 10.1002/ijc.29468; Hoff DD, 1977, AM J MED, V62, P200; Hudson MM, 2007, J CLIN ONCOL, V25, P3635, DOI 10.1200/JCO.2006.09.7451; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hummel YM, 2015, ACTA ONCOL, V54, P515, DOI 10.3109/0284186X.2014.969845; Kero AE, 2014, INT J CANCER, V134, P664, DOI 10.1002/ijc.28385; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; Landy DC, 2013, PEDIATR CARDIOL, V34, P826, DOI 10.1007/s00246-012-0539-6; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Mulrooney DA, 2014, CANCER-AM CANCER SOC, V120, P3536, DOI 10.1002/cncr.28925; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; NCI, 2010, COMMONTERMINOLOGY CR; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Tassinari D, 1997, ANN ONCOL, V8, P1263, DOI 10.1023/A:1008231521553; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; van Dalen EC, 2004, EUR J CANCER, V40, P643, DOI 10.1016/j.ejca.2003.12.006; van der Pal HJ, 2015, INT J RADIAT ONCOL, V91, P213, DOI 10.1016/j.ijrobp.2014.09.010; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Winther JF, 2015, ACTA ONCOL, V54, P655, DOI 10.3109/0284186X.2015.1008648	40	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162778	10.1371/journal.pone.0162778	http://dx.doi.org/10.1371/journal.pone.0162778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643694	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900017
J	Kreysa, H; Kessler, L; Schweinberger, SR				Kreysa, Helene; Kessler, Luise; Schweinberger, Stefan R.			Direct Speaker Gaze Promotes Trust in Truth-Ambiguous Statements	PLOS ONE			English	Article							EYE CONTACT; FACIAL EXPRESSION; SOCIAL JUDGMENTS; PERCEPTION; FACE; CUES; ATTRACTIVENESS; PERSONALITY; DOMINANCE; LOOKING	A speaker's gaze behaviour can provide perceivers with a multitude of cues which are relevant for communication, thus constituting an important non-verbal interaction channel. The present study investigated whether direct eye gaze of a speaker affects the likelihood of listeners believing truth-ambiguous statements. Participants were presented with videos in which a speaker produced such statements with either direct or averted gaze. The statements were selected through a rating study to ensure that participants were unlikely to know a-priori whether they were true or not (e.g., "sniffer dogs cannot smell the difference between identical twins"). Participants indicated in a forced-choice task whether or not they believed each statement. We found that participants were more likely to believe statements by a speaker looking at them directly, compared to a speaker with averted gaze. Moreover, when participants disagreed with a statement, they were slower to do so when the statement was uttered with direct (compared to averted) gaze, suggesting that the process of rejecting a statement as untrue may be inhibited when that statement is accompanied by direct gaze.	[Kreysa, Helene; Kessler, Luise; Schweinberger, Stefan R.] Univ Jena, Dept Psychol Gen Psychol & Cognit Neurosci, Jena, Germany; [Schweinberger, Stefan R.] Univ Jena, DFG Res Unit Person Percept, Jena, Germany; [Kreysa, Helene; Kessler, Luise; Schweinberger, Stefan R.] Inst Psychol, Steiger 3 Haus 1, D-07743 Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kreysa, H (corresponding author), Univ Jena, Dept Psychol Gen Psychol & Cognit Neurosci, Jena, Germany.; Kreysa, H (corresponding author), Inst Psychol, Steiger 3 Haus 1, D-07743 Jena, Germany.	helene.kreysa@uni-jena.de	Schweinberger, Stefan/A-1860-2009; Kreysa, Helene/R-7534-2019	Schweinberger, Stefan/0000-0001-5762-0188; Kreysa, Helene/0000-0001-7163-7023	Deutsche Forschungsgemeinschaft [FOR1097]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	SRS has been supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/), grant FOR1097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2006, J CROSS CULT PSYCHOL, V37, P60, DOI 10.1177/0022022105282295; Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2010, J EXP SOC PSYCHOL, V46, P478, DOI 10.1016/j.jesp.2009.12.016; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Alwall N, 2010, PERS INDIV DIFFER, V49, P729, DOI 10.1016/j.paid.2010.06.016; Argyle M., 1976, GAZE MUTUAL GAZE; Batten JP, 2013, J EYE MOVEMENT RES, P391; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Bindemann M, 2008, VIS COGN, V16, P708, DOI 10.1080/13506280701269318; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; BOND CF, 1990, J NONVERBAL BEHAV, V14, P189, DOI 10.1007/BF00996226; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Chen FS, 2013, PSYCHOL SCI, V24, P2254, DOI 10.1177/0956797613491968; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Ewing L, 2010, VIS COGN, V18, P321, DOI 10.1080/13506280902965599; Falck-Ytter T, 2015, CHILD DEV, V86, P37, DOI 10.1111/cdev.12273; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; GRONWALL DM, 1971, BRIT J PSYCHOL, V62, P175, DOI 10.1111/j.2044-8295.1971.tb02028.x; Helminen TM, 2011, BIOL PSYCHOL, V88, P124, DOI 10.1016/j.biopsycho.2011.07.002; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jones BC, 2006, PSYCHOL SCI, V17, P588, DOI 10.1111/j.1467-9280.2006.01749.x; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kloth N, 2011, Q J EXP PSYCHOL, V64, P1906, DOI 10.1080/17470218.2011.587254; Kuhlen AK, 2015, SOC COGN AFFECT NEUR, V10, P729, DOI 10.1093/scan/nsu111; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Larsen RJ, 1996, PERS INDIV DIFFER, V21, P907, DOI 10.1016/S0191-8869(96)00148-1; Main JC, 2009, PERCEPTION, V38, P1275, DOI 10.1068/p6347; Mann S, 2012, J NONVERBAL BEHAV, V36, P205, DOI 10.1007/s10919-012-0132-y; Mason MF, 2005, PSYCHOL SCI, V16, P236, DOI 10.1111/j.0956-7976.2005.00809.x; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; MAZUR A, 1985, SOC FORCES, V64, P377; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; NICHOLS KA, 1971, J EXP SOC PSYCHOL, V7, P623, DOI 10.1016/0022-1031(71)90024-2; Olivola CY, 2014, TRENDS COGN SCI, V18, P566, DOI 10.1016/j.tics.2014.09.007; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Pfeiffer UJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00537; Pinc L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020704; Schaller GB, 1963, MOUNTAIN GORILLA ECO, Vxvii; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Swerts M, 2005, J MEM LANG, V53, P81, DOI 10.1016/j.jml.2005.02.003; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vrij Aldert, 2010, Psychol Sci Public Interest, V11, P89, DOI 10.1177/1529100610390861; Willis ML, 2011, SOC COGNITION, V29, P415, DOI 10.1521/soco.2011.29.4.415; Wyland CL, 2010, SOC COGNITION, V28, P133, DOI 10.1521/soco.2010.28.1.133	48	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162291	10.1371/journal.pone.0162291	http://dx.doi.org/10.1371/journal.pone.0162291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643789	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900009
J	Liu, XX; Zheng, W; Sivasankar, MP				Liu, Xinxin; Zheng, Wei; Sivasankar, M. Preeti			Acute Acrolein Exposure Induces Impairment of Vocal Fold Epithelial Barrier Function	PLOS ONE			English	Article							CIGARETTE-SMOKE; ION-TRANSPORT; EXPRESSION; DECREASES; MEMBRANE; CLAUDINS; OCCLUDIN; DEFENSE; PROTEIN; MUCOSA	Acrolein is a ubiquitous pollutant abundant in cigarette smoke, mobile exhaust, and industrial waste. There is limited literature on the effects of acrolein on vocal fold tissue, although there are clinical reports of voice changes after pollutant exposures. Vocal folds are responsible for voice production. The overall objective of this study was to investigate the effects of acrolein exposure on viable, excised vocal fold epithelial tissue and to characterize the mechanism underlying acrolein toxicity. Vocal fold epithelia were studied because they form the outermost layer of the vocal folds and are a primary recipient of inhaled pollutants. Porcine vocal fold epithelia were exposed to 0, 50, 100, 500, 900 or 1300 mu M of acrolein for 3 hours; the metabolic activity, epithelial resistance, epithelial permeability, tight junction protein (occludin and claudin 3) expression, cell membrane integrity and lipid peroxidation were investigated. The data demonstrated that acrolein exposure at 500 mu M significantly reduced vocal fold epithelial metabolic activity by 27.2% (p <= 0.001). Incubation with 100 mu M acrolein caused a marked increase in epithelial permeability by 130.5% (p<0.05) and a reduction in transepithelial electrical resistance (TEER) by 180.0% (p<0.001). While the expression of tight junctional protein did not change in acrolein-treated samples, the cell membrane integrity was significantly damaged with a 45.6% increase of lipid peroxidation as compared to controls (p<0.05). Taken together, these data provide evidence that acute acrolein exposure impairs vocal fold epithelial barrier integrity. Lipid peroxidation-induced cell membrane damage may play an important role in reducing the barrier function of the epithelium.	[Liu, Xinxin; Zheng, Wei] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Sivasankar, M. Preeti] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sivasankar, M. Preeti] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sivasankar, MP (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Sivasankar, MP (corresponding author), Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.	msivasan@purdue.edu			National Institutes of Health/National Institute on Deafness and other Communication Disorders [R01DC011759]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011759] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC011759 (National Institutes of Health/National Institute on Deafness and other Communication Disorders), https://www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P187, DOI 10.1016/0891-5849(93)90058-3; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; AYER HE, 1982, AM J PUBLIC HEALTH, V72, P1283, DOI 10.2105/AJPH.72.11.1283; Baum M, 2010, TOXICOL LETT, V196, pS44, DOI 10.1016/j.toxlet.2010.03.182; Branski RC, 2011, LARYNGOSCOPE, V121, P601, DOI 10.1002/lary.21388; BURNS AR, 1989, J APPL PHYSIOL, V66, P2109, DOI 10.1152/jappl.1989.66.5.2109; CDC, 1992, OCC SAF HLTH GUID AC; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Dorman DC, 2008, INHAL TOXICOL, V20, P205, DOI 10.1080/08958370701864151 ; Durkes A, 2014, ANN OTO RHINOL LARYN, V123, P71, DOI 10.1177/0003489414521143; ELMOFTY SK, 1975, AM J PATHOL, V79, P579; Erickson E, 2010, LARYNGOSCOPE, V120, P1569, DOI 10.1002/lary.20983; Erickson-DiRenzo E, 2015, LARYNGOSCOPE, V125, pE180, DOI 10.1002/lary.25100; Erickson-Levendoski E, 2012, OTOLARYNG HEAD NECK, V146, P272, DOI 10.1177/0194599811428273; Faroon O, 2008, TOXICOL IND HEALTH, V24, P543, DOI 10.1177/0748233708098124; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; GAAFAR HA, 1981, J LARYNGOL OTOL, V95, P721, DOI 10.1017/S0022215100091349; Gonzalez J, 2004, MED SCI MONITOR, V10, pCR649; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Higo R, 2003, J NEUROL NEUROSUR PS, V74, P982, DOI 10.1136/jnnp.74.7.982; Horton ND, 1999, J BIOL CHEM, V274, P9200, DOI 10.1074/jbc.274.14.9200; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Isik ACU, 2004, J OTOLARYNGOL, V33, P382; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kasahara DI, 2008, J IMMUNOL, V181, P736, DOI 10.4049/jimmunol.181.1.736; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; LEONARD R, 1995, J VOICE, V9, P443, DOI 10.1016/S0892-1997(05)80208-5; Levendoski EE, 2014, J SPEECH LANG HEAR R, V57, P1679, DOI 10.1044/2014_JSLHR-S-13-0283; Levendoski EE, 2014, J MEMBRANE BIOL, V247, P441, DOI 10.1007/s00232-014-9651-2; Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Li Hongyu, 2004, J Cyst Fibros, V3 Suppl 2, P123, DOI 10.1016/j.jcf.2004.05.026; Liu XY, 2010, TOXICOL MECH METHOD, V20, P36, DOI 10.3109/15376510903530845; Mizuta M, 2012, ANN OTO RHINOL LARYN, V121, P804, DOI 10.1177/000348941212101206; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; NISHIKAWA H, 1987, ANALYST, V112, P859, DOI 10.1039/an9871200859; Pang XB, 2011, SCI TOTAL ENVIRON, V409, P5000, DOI 10.1016/j.scitotenv.2011.07.065; Phillips JE, 1999, BIOPHYS J, V76, P869, DOI 10.1016/S0006-3495(99)77250-4; Piade JJ, 2013, FOOD CHEM TOXICOL, V55, P329, DOI 10.1016/j.fct.2013.01.016; ROMETHADDAD S, 1993, TOXICOL IN VITRO, V7, P373, DOI 10.1016/0887-2333(93)90030-9; Sivasankar M, 2007, J SPEECH LANG HEAR R, V50, P886, DOI 10.1044/1092-4388(2007/063); Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; STAHLMANN R, 1985, ARCH TOXICOL, V57, P163, DOI 10.1007/BF00290881; Sun Y, 2014, TOXICOL LETT, V229, P384, DOI 10.1016/j.toxlet.2014.06.021; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Xu XB, 2014, AURIS NASUS LARYNX, V41, P539, DOI 10.1016/j.anl.2014.05.011; Zhang QR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034017	51	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163237	10.1371/journal.pone.0163237	http://dx.doi.org/10.1371/journal.pone.0163237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643990	gold, Green Submitted, Green Published			2022-12-27	WOS:000383891900038
J	Bonmati-Carrion, MA; Hild, K; Isherwood, C; Sweeney, SJ; Revell, VL; Skene, DJ; Rol, MA; Madrid, JA				Angeles Bonmati-Carrion, Maria; Hild, Konstanze; Isherwood, Cheryl; Sweeney, Stephen J.; Revell, Victoria L.; Skene, Debra J.; Angeles Rol, Maria; Antonio Madrid, Juan			Relationship between Human Pupillary Light Reflex and Circadian System Status	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MELATONIN SUPPRESSION; ACTION SPECTRUM; MOTOR-ACTIVITY; SLEEP-APNEA; MELANOPSIN; SENSITIVITY; WAVELENGTH; RESPONSES; RHYTHM	Intrinsically photosensitive retinal ganglion cells (ipRGCs), whose photopigment melanopsin has a peak of sensitivity in the short wavelength range of the spectrum, constitute a common light input pathway to the olivary pretectal nucleus (OPN), the pupillary light reflex (PLR) regulatory centre, and to the suprachiasmatic nuclei (SCN), the major pacemaker of the circadian system. Thus, evaluating PLR under short wavelength light (lambda(max) <= 500 nm) and creating an integrated PLR parameter, as a possible tool to indirectly assess the status of the circadian system, becomes of interest. Nine monochromatic, photon-matched light stimuli (300 s), in 10 nm increments from lambda(max) 420 to 500 nm were administered to 15 healthy young participants (8 females), analyzing: i) the PLR; ii) wrist temperature (WT) and motor activity rhythms (WA), iii) light exposure (L) pattern and iv) diurnal preference (Horne (TM) stberg), sleep quality (Pittsburgh) and daytime sleepiness (Epworth). Linear correlations between the different PLR parameters and circadian status index obtained from WT, WA and L recordings and scores from questionnaires were calculated. In summary, we found markers of robust circadian rhythms, namely high stability, reduced fragmentation, high amplitude, phase advance and low internal desynchronization, were correlated with a reduced PLR to 460-490 nm wavelengths. Integrated circadian (CSI) and PLR (cp-PLR) parameters are proposed, that also showed an inverse correlation. These results demonstrate, for the first time, the existence of a close relationship between the circadian system robustness and the pupillary reflex response, two non-visual functions primarily under mela-nopsin- ipRGC input.	[Angeles Bonmati-Carrion, Maria; Angeles Rol, Maria; Antonio Madrid, Juan] Univ Murcia, Chronobiol Lab, Dept Physiol, Fac Biol,IMIB Arrixaca, E-30100 Murcia, Spain; [Hild, Konstanze; Sweeney, Stephen J.] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England; [Hild, Konstanze; Sweeney, Stephen J.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Isherwood, Cheryl; Revell, Victoria L.; Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Chronobiol, Guildford GU2 7XH, Surrey, England	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Surrey; University of Surrey; University of Surrey	Rol, MA (corresponding author), Univ Murcia, Chronobiol Lab, Dept Physiol, Fac Biol,IMIB Arrixaca, E-30100 Murcia, Spain.	angerol@um.es	ROL, ANGELES/ABH-6431-2020; Sweeney, Stephen/P-9879-2019; ROL, ANGELES/C-6718-2009	ROL, ANGELES/0000-0002-9343-3918; Sweeney, Stephen/0000-0001-8561-6071; ROL, ANGELES/0000-0002-9343-3918; Bonmati-Carrion, Maria-Angeles/0000-0002-9050-6448; Skene, Debra/0000-0001-8202-6180; Madrid, Juan Antonio/0000-0002-9286-1371	Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation; Ministry of Economy and Competitiveness through the Spanish Network for Light Pollution Studies [AYA2015-71542-REDT]; EPSRC MILES grant [EP/1000992/1]; EPSRC Leadership Fellowship [EP/H005587/1]; FEDER; Seneca Foundation [19410/PI/14, AP2009-1051]; Engineering and Physical Sciences Research Council [EP/I000992/1] Funding Source: researchfish; EPSRC [EP/I000992/1] Funding Source: UKRI	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness through the Spanish Network for Light Pollution Studies; EPSRC MILES grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Leadership Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FEDER(European Commission); Seneca Foundation(Fundacion Seneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors wish to thank the Instituto de Salud Carlos III, the Spanish Ministry of Science and Innovation and the Ministry of Economy and Competitiveness for their financial support through the Spanish Network for Light Pollution Studies (AYA2015-71542-REDT), the Ageing and Frailty Cooperative Research Network, RD12/0043/0011, SAF2013-49132-C2-1-R, the latter including FEDER cofunding granted to Juan Antonio Madrid, and Seneca Foundation 19410/PI/14 to Maria Angeles Rol. Research fellowship granted to MA Bonmati (AP2009-1051). The work was parted funded by an EPSRC MILES grant [EP/1000992/1]. S. J. Sweeney gratefully acknowledges EPSRC Leadership Fellowship funding under project EP/H005587/1. D. J. Skene is a Royal Society Wolfson Research Merit Award holder.; The authors wish to thank the Instituto de Salud Carlos III, the Ministry of Science and Innovation and the Ministry of Economy and Competitiveness for their financial support through the Spanish Network for Light Pollution Studies (AYA2015-71542-REDT), the Ageing and Frailty Cooperative Research Network, RD12/0043/0011, SAF2013-49132-C2-1-R, the latter including FEDER cofounding, granted to Juan Antonio Madrid, and Seneca Foundation 19410/PI/14 to Maria Angeles Rol. Research fellowship granted to MA Bonmati-Carrion (AP2009-1051). The work was partly funded by an EPSRC MILES grant [EP/1000992/1]. S. J. Sweeney gratefully acknowledges EPSRC Leadership Fellowship funding under project EP/H005587/1. D. J. Skene is a Royal Society Wolfson Research Merit Award holder. We also want to thank Benita Middleton for her assistance with administration of the pupil dilator.	Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Bonmati-Carrion MA, 2014, INT J MOL SCI, V15, P23448, DOI 10.3390/ijms151223448; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bonmati-Carrion MA, 2015, CHRONOBIOL INT, V32, P701, DOI 10.3109/07420528.2015.1016613; Bonmati-Carrion MA, 2014, CHRONOBIOL INT, V31, P37, DOI 10.3109/07420528.2013.820740; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Feigl B, 2014, OPTOMETRY VISION SCI, V91, P894, DOI 10.1097/OPX.0000000000000284; Figueiro Mariana G, 2005, J Circadian Rhythms, V3, P14, DOI 10.1186/1740-3391-3-14; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; Kawasaki A, 2007, J NEURO-OPHTHALMOL, V27, P195, DOI 10.1097/WNO.0b013e31814b1df9; Koenig D, 2011, J VISION, V11, DOI 10.1167/11.1.21; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741, DOI 10.1152/ajpregu.2000.278.3.R741; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Martinez-Nicolas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061142; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; MICIELI G, 1995, ACTA NEUROL SCAND, V91, P382, DOI 10.1111/j.1600-0404.1995.tb07025.x; Monaco A, 2014, CRANIO, V32, P139, DOI 10.1179/0886963413Z.00000000022; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Ortiz-Tudela E, 2014, PHYSIOL BEHAV, V126, P30, DOI 10.1016/j.physbeh.2013.12.009; Ortiz-Tudela E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000996; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Revell VL, 2010, CHRONOBIOL INT, V27, P1762, DOI 10.3109/07420528.2010.516048; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; STOCKMAN A, 1999, COLOR VISION GENES P, P53; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Van Cauter E, 2005, MEDSCAPE NEUROL, V7; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Vartanian GV, 2015, J BIOL RHYTHM, V30, P351, DOI 10.1177/0748730415585413; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895	53	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162476	10.1371/journal.pone.0162476	http://dx.doi.org/10.1371/journal.pone.0162476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636197	Green Published, gold			2022-12-27	WOS:000383723700007
J	Bamberger, S; Vinson, CM; Mohamed, D; Viala, J; Carel, JC; Hugot, JP; Simon, D				Bamberger, Sarah; Vinson, Christine Martinez; Mohamed, Damir; Viala, Jerome; Carel, Jean-Claude; Hugot, Jean-Pierre; Simon, Dominique			Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor a Antibodies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LINEAR GROWTH; INFLIXIMAB THERAPY; FACTOR-ALPHA; CHILDREN; HORMONE; ADALIMUMAB; FAILURE; COLITIS	Inflammation contributes to growth failure associated with inflammatory bowel diseases. Anti-TNF alpha therapy induces sustained remission and short-term improvements in height velocity and/or height standard deviation score (H-SDS) patients with Crohn's disease. The purpose of this study was to evaluate growth and adult height in patients with Crohn's disease taking maintenance infliximab or adalimumab therapy. This university-hospital based retrospective study included 61 patients, with a median follow-up of 2.6 years (2.0; 3.3). 38 patients (62%) reached their adult height. H-SDS was collected at diagnosis and together with disease activity markers (Harvey-Bradshaw Index, albumin, and C-reactive protein) at treatment initiation (baseline), and follow-up completion. Wilcoxon's signed-rank test was chosen for comparisons. Median H-SDS decreased from diagnosis to baseline (-0.08 [-0.73; +0.77] to -0.94 [-1.44; +0.11], p<0.0001) and then increased to follow-up completion (-0.63 [-1.08; 0.49], p = 0.003 versus baseline), concomitantly with an improvement in disease activity. Median adult H-SDS was within the normal range (-0.72 [-1.25; +0.42]) but did not differ from baseline H-SDS and was significantly lower than the target H-SDS (-0.09 [-0.67; +0.42], p = 0.01). Only 2 (6%) males had adult heights significantly below their target heights (10.5 and -13.5 cm [-1.75 and -2.25 SD]). In conclusion, anti-tumor necrosis factor a (TNF) therapy prevented loss of height without fully restoring the genetic growth potential in this group of patients with CD. Earlier treatment initiation might improve growth outcomes in these patients.	[Bamberger, Sarah; Vinson, Christine Martinez; Viala, Jerome; Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol Pediat, Paris, France; [Mohamed, Damir] Hop Robert Debre, AP HP, Unite Epidemiol Clin, Paris, France; [Mohamed, Damir] INSERM, Ctr Invest Clin, Epidemiol Clin Unite 1426, Paris, France; [Carel, Jean-Claude; Simon, Dominique] Hop Robert Debre, AP HP, Serv Endocrinol Diabetol Pediat, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France; [Carel, Jean-Claude] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Carel, Jean-Claude; Simon, Dominique] DHU Protect, INSERM, Unite 1141, Paris, France; [Hugot, Jean-Pierre] INSERM, Ctr Rech Inflammat, Unite 1149, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Simon, D (corresponding author), Hop Robert Debre, AP HP, Serv Endocrinol Diabetol Pediat, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France.; Simon, D (corresponding author), DHU Protect, INSERM, Unite 1141, Paris, France.	dominique.simon@aphp.fr	Carel, Jean-Claude/AAZ-7691-2020	Carel, Jean-Claude/0000-0002-0424-6767; Hugot, Jean-Pierre/0000-0002-8446-6056				Alemzadeh N, 2002, GUT, V51, P26, DOI 10.1136/gut.51.1.26; Assa A, 2013, J CROHNS COLITIS, V7, P369, DOI 10.1016/j.crohns.2012.03.006; Ballinger AB, 2000, GUT, V46, P694, DOI 10.1136/gut.46.5.695; Borrelli O, 2004, DIGEST LIVER DIS, V36, P342, DOI 10.1016/j.dld.2003.12.014; Calenda KA, 2005, INFLAMM BOWEL DIS, V11, P435, DOI 10.1097/01.MIB.0000159321.58773.a6; Church PC, 2014, INFLAMM BOWEL DIS, V20, P1177, DOI 10.1097/MIB.0000000000000083; Crombe V, 2011, INFLAMM BOWEL DIS, V17, P2144, DOI 10.1002/ibd.21615; DeBoer MD, 2010, J GASTROENTEROL, V45, P277, DOI 10.1007/s00535-009-0192-x; DeBoer M, 2012, J GASTROENTEROL, V47, P647, DOI 10.1007/s00535-012-0542-y; Fuentes D, 2003, ALIMENT PHARM THER, V17, P913, DOI 10.1046/j.1365-2036.2003.01540.x; Gentilucci UV, 2005, ALIMENT PHARM THER, V21, P1063, DOI 10.1111/j.1365-2036.2005.02449.x; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; HARVEY RF, 1980, LANCET, V1, P514; Hyams J, 2011, CURR MED RES OPIN, V27, P651, DOI 10.1185/03007995.2010.547575; Hyams JS, 2012, GASTROENTEROLOGY, V143, P365, DOI 10.1053/j.gastro.2012.04.046; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; LIPSON AB, 1990, EUR J PEDIATR, V149, P687, DOI 10.1007/BF01959522; Lonnkvist MH, 2011, SCAND J GASTROENTERO, V46, P420, DOI 10.3109/00365521.2010.539253; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; MacRae VE, 2006, INT J MOL MED, V18, P1011; Malik S, 2012, J CROHNS COLITIS, V6, P337, DOI 10.1016/j.crohns.2011.09.004; MARKOWITZ J, 1993, J PEDIATR GASTR NUTR, V16, P373, DOI 10.1097/00005176-199305000-00005; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Mason A, 2011, HORM RES PAEDIAT, V75, P8, DOI 10.1159/000315902; Mauras N, 2002, METABOLISM, V51, P127, DOI 10.1053/meta.2002.28972; Rolland-Cachera MF, 1991, AM J CLIN NUTR, V45, P13; Ruemmele FM, 2014, J CROHNS COLITIS, V8, P1179, DOI 10.1016/j.crohns.2014.04.005; SANDERSON IR, 1987, ARCH DIS CHILD, V62, P123, DOI 10.1136/adc.62.2.123; Sawczenko A, 2006, PEDIATRICS, V118, P124, DOI 10.1542/peds.2005-2931; Sempe M, 1979, AUXOLOGIE METHODE ET; Thayu M, 2010, GASTROENTEROLOGY, V139, P430, DOI 10.1053/j.gastro.2010.04.044; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Walters TD, 2007, INFLAMM BOWEL DIS, V13, P424, DOI 10.1002/ibd.20069; Walters TD, 2014, GASTROENTEROLOGY, V146, P383, DOI 10.1053/j.gastro.2013.10.027; Wong SC, 2010, CLIN ENDOCRINOL, V73, P220, DOI 10.1111/j.1365-2265.2010.03799.x	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163126	10.1371/journal.pone.0163126	http://dx.doi.org/10.1371/journal.pone.0163126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636201	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700034
J	Gupta, A; Herman, Y; Ayers, C; Beg, MS; Lakoski, SG; Abdullah, SM; Johnson, DH; Neeland, IJ				Gupta, Arjun; Herman, Yehuda; Ayers, Colby; Beg, Muhammad S.; Lakoski, Susan G.; Abdullah, Shuaib M.; Johnson, David H.; Neeland, Ian J.			Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; PROSTATE-CANCER; COLORECTAL-CANCER; BREAST-CANCER; LUNG-CANCER; ADIPONECTIN; METAANALYSIS; ADIPOKINES; RECEPTOR	Purpose Leptin dysregulation has been postulated to affect cancer risk through its effects on obesity and inflammation. Epidemiological data evaluating this relationship are conflicting and studies in non-white cohorts is lacking. Therefore, we examined the association of leptin with the risk of incident cancer in the multiethnic Dallas Heart Study (DHS). Methods Participants enrolled in the DHS without prevalent cancer and with baseline leptin measurements were included. Incident cancer cases were identified through a systematic linkage of the DHS and the Texas Cancer Registry. Leptin was evaluated both as a continuous variable and in sex-specific quartiles. Multivariable Cox proportional hazards modeling was performed to examine the association between leptin levels with incident cancer after adjusting for age, sex, race, smoking status, alcohol use, family history of malignancy, body mass index (BMI), diabetes mellitus and C-reactive protein. Results Among 2,919 participants (median age 44 years; 54% women; 70% nonwhite; median BMI 29.4 kg/m(2)), 190 (6.5%) developed cancer after median follow-up of 12 years. Median leptin levels were 12.9 (interquartile range [IQR] 5.8-29.5) ng/ml in the incident cancer group vs. 12.3 (IQR 5.4-26.4) ng/ml those without an incident cancer (p = 0.34). Leptin was not associated with cancer incidence in multivariable analysis (unit standard deviation increase in log-transformed leptin, hazard ratio 0.95; 95% confidence interval, 0.77-1.16; p = 0.60). No association was observed in analyses stratified by sex, race/ethnicity, diabetes, or obesity status. Conclusions In this study of a predominantly minority population, no association between premorbid leptin levels and cancer incidence was demonstrated. Despite preclinical rationale and positive findings in other studies, this association may not replicate across all racial/ethnic populations.	[Gupta, Arjun; Johnson, David H.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Herman, Yehuda] Collin Coll, Preston Rd, Frisco, TX USA; [Ayers, Colby] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Beg, Muhammad S.] Univ Texas Southwestern Med Ctr Dallas, Div Oncol, Dallas, TX 75390 USA; [Lakoski, Susan G.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent & Cardiol, Houston, TX 77030 USA; [Abdullah, Shuaib M.; Neeland, Ian J.] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Neeland, IJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA.	ian.neeland@utsouthwestern.edu	Johnson, David/AHI-8369-2022	Gilchrist, Susan C./0000-0001-9624-0292; Gupta, Arjun/0000-0003-0875-4731	National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK106520]; National Institutes of Health [UL1DE019584, PL1DK081182]; National Center for Advancing Translational Sciences [UL1TR001105]; Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grant 1K23DK106520 from the National Institute of Diabetes and Digestive and Kidney Diseases to Dr. Neeland, by grants UL1DE019584 and PL1DK081182 from the National Institutes of Health, and by grant number UL1TR001105 from the National Center for Advancing Translational Sciences. Dr. Neeland is supported as a Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center.	Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Aleksandrova K, 2012, CANCER RES, V72, P5328, DOI 10.1158/0008-5472.CAN-12-0465; Aparicio T, 2005, GUT, V54, P1136, DOI 10.1136/gut.2004.060533; Baillargeon J, 2006, CANCER EPIDEM BIOMAR, V15, P1331, DOI 10.1158/1055-9965.EPI-06-0082; Beg MS, 2015, J NATL COMPR CANC NE, V13, P873, DOI 10.6004/jnccn.2015.0104; Bologna M, 2013, ONCOLOGY HEMATOLOGY, V9, P10; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; Chen CL, 2014, CANCER EPIDEM BIOMAR, V23, P1659, DOI 10.1158/1055-9965.EPI-14-0161; Engineer Diana R, 2012, Int J Pept, V2012, P287457, DOI 10.1155/2012/287457; Frederich R, 2002, J LAB CLIN MED, V139, P72, DOI 10.1067/mlc.2002.121014; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gong TT, 2015, INT J CANCER, V137, P1967, DOI 10.1002/ijc.29561; Harris HR, 2011, CANCER PREV RES, V4, P1449, DOI 10.1158/1940-6207.CAPR-11-0125; Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783; Joshi RK, 2014, ASIAN PAC J CANCER P, V15, P397, DOI 10.7314/APJCP.2014.15.1.397; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Lai GY, 2014, CANCER CAUSE CONTROL, V25, P625, DOI 10.1007/s10552-014-0369-3; Li HJ, 2010, CLIN CHEM, V56, P34, DOI 10.1373/clinchem.2009.133272; Liu PC, 2014, J BUON, V19, P855; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067349; Ollberding NJ, 2013, CANCER PREV RES, V6, P188, DOI 10.1158/1940-6207.CAPR-12-0374; Petridou E, 2002, ANN NUTR METAB, V46, P147, DOI 10.1159/000063081; Petridou E, 2000, CANCER CAUSE CONTROL, V11, P383, DOI 10.1023/A:1008903727238; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Snoussi K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-38; Song CH, 2014, CLIN BIOCHEM, V47, P230, DOI 10.1016/j.clinbiochem.2013.12.003; Song MY, 2013, CANCER PREV RES, V6, P875, DOI 10.1158/1940-6207.CAPR-13-0169; Unsal M, 2014, TUMOR BIOL, V35, P10231, DOI 10.1007/s13277-014-2293-2; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Wu MH, 2009, BRIT J CANCER, V100, P578, DOI 10.1038/sj.bjc.6604913; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104630; Wulaningsih W, 2016, CANCER MED-US, V5, P120, DOI 10.1002/cam4.570; Yeung CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078594	35	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162845	10.1371/journal.pone.0162845	http://dx.doi.org/10.1371/journal.pone.0162845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636369	Green Submitted, Green Published, gold			2022-12-27	WOS:000383723700017
J	Pan, FD; Shi, L; Zhang, L; Lu, QY; Xue, S				Pan, Fada; Shi, Liang; Zhang, Li; Lu, Qingyun; Xue, Song			Different Stages, Different Signals: The Modulating Effect of Cognitive Conflict on Subsequent Processing	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX	The present study used event-related potentials (ERPs) to investigate the function of signals induced by cognitive conflict during the detection stage and the resolution stage of perceptual processing. The study used a combination of the Stroop task and an affective priming task to examine the conflict priming effect when the stimulus onset asynchrony (SOA) was 200 ms or 800 ms. Behavioral results showed that the RTs were shorter for positive targets following congruent primes relative to incongruent primes, and for negative targets following incongruent primes relative to congruent primes when the SOA was 200 ms. ERP results showed that the N2 amplitudes (200-300 ms) for incongruent stimuli were significantly larger than for congruent stimuli in the Stroop task, which indicated a significant conflict effect. Moreover, the N400 amplitudes (500-700 ms) for positive targets after congruent primes were significantly lower than those after incongruent primes when the SOA was 200 ms, which showed a significant negative priming effect. While the SOA was 800 ms, behavioral results showed that the RTs were shorter for positive targets following incongruent primes relative to congruent primes. ERP results showed that the N2 amplitudes (200-300 ms) for incongruent stimuli were significantly larger than for congruent stimuli in the Stroop task, which indicated a significant conflict effect. The N400 amplitudes (11001300 ms) for the negative targets after congruent primes were significantly lower than those after incongruent primes when the SOA was 800 ms, which showed a significant positive priming effect. The results demonstrated that the functions of signals induced by cognitive conflict were reversed in two different cognitive processing stages.	[Pan, Fada; Shi, Liang; Zhang, Li] Nantong Univ, Sch Educ Sci, Nantong, Peoples R China; [Lu, Qingyun] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China; [Xue, Song] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Xue, Song] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China	Nantong University; Nantong University; Beijing Normal University; Beijing Normal University	Pan, FD (corresponding author), Nantong Univ, Sch Educ Sci, Nantong, Peoples R China.; Xue, S (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Xue, S (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.	psyc_lee2015@126.com; xues@mail.bnu.edu.cn			Humanities and Social Sciences Foundation of the Chinese Ministry of Education [12YJC190026]; Social Sciences Foundation of Jiangsu Province, China [14SHC006]; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China [C-a/2013/01/003]; National Natural Science Foundation of China [81502827]	Humanities and Social Sciences Foundation of the Chinese Ministry of Education; Social Sciences Foundation of Jiangsu Province, China; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Humanities and Social Sciences Foundation of the Chinese Ministry of Education, grant number: 12YJC190026, http://www.sinoss.net/#, to FDP; this funder had roles in study design and decision to publish. The Social Sciences Foundation of Jiangsu Province, China, also supported this work: grant number: 14SHC006, http://jspopss.jschina.com.cn, to FDP; this funder had roles in data collection, analysis and decision to publish. This work was also supported by the Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China, grant number: C-a/2013/01/003, http://www.jssghb.cn/, to FDP; this funder had a role in decision to publish; and the National Natural Science Foundation of China, grant number: 81502827, http://www.nsfc.gov.cn/, to QYL; this funder had a role in preparation of the manuscript.	Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braem S, 2012, COGNITION, V125, P324, DOI 10.1016/j.cognition.2012.07.015; Brouillet T, 2011, EMOTION, V11, P1202, DOI 10.1037/a0024742; Brown CM, 2000, BRAIN LANG, V72, P158, DOI 10.1006/brln.1999.2284; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fritz J, 2015, EXP PSYCHOL, V62, P30, DOI 10.1027/1618-3169/a000271; Fritz J, 2013, COGN AFFECT BEHAV NE, V13, P311, DOI 10.3758/s13415-012-0147-1; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Guo TM, 2003, PSYCHOL SCI SHANGHAI, V26, P750; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Molapour T., 2011, LANG ACQUIS, P1; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schouppe N, 2015, COGN AFFECT BEHAV NE, V15, P251, DOI 10.3758/s13415-014-0318-3; Schouppe N, 2014, ACTA PSYCHOL, V146, P63, DOI 10.1016/j.actpsy.2013.11.010; Schouppe N, 2012, Q J EXP PSYCHOL, V65, P1052, DOI 10.1080/17470218.2012.685080; Silvetti M, 2010, FRONT HUM NEUROSCI, V5, P75; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; van Bochove ME, 2013, COGN AFFECT BEHAV NE, V13, P346, DOI 10.3758/s13415-012-0138-2; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; van Steenbergen H, 2012, BIOL PSYCHOL, V90, P234, DOI 10.1016/j.biopsycho.2012.03.018; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; [王一牛 WANG Yi-Niu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P608; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023	30	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163263	10.1371/journal.pone.0163263	http://dx.doi.org/10.1371/journal.pone.0163263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5YN	27636368	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700044
J	Gysin, DV; Dao, D; Gysin, CM; Lytvyn, L; Loeb, M				Gysin, Danielle Vuichard; Dao, Dyda; Gysin, Christian Michael; Lytvyn, Lyubov; Loeb, Mark			Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							25-HYDROXYVITAMIN D LEVEL; INFLUENZA; PREVENTION; RISK; EFFICACY; ILLNESS	Objective Vitamin D supplementation may be a simple preventive measure against respiratory tract infections (RTIs) but evidence from randomized controlled trials is inconclusive. We aimed to systematically summarize results from interventions studying the protective effect of vitamin D supplementation on clinical and laboratory confirmed RTIs in healthy adults and children. Methods Medline, EMBASE, CENTRAL, and CINAHL were screened from inception until present (last updated in January 2016) completed by a search of the grey literature, clinical trial registers and conference abstracts. We included randomized trials comparing vitamin D versus placebo or no treatment. Two independent reviewers were responsible for study selection and data extraction. Cochrane's risk of bias tool and the GRADE approach were used for quality assessment. Estimates were pooled with random-effects models. Heterogeneity was explored by sub-group and meta-regression analyses. Results Of 2627 original hits, 15 trials including 7053 individuals were ultimately eligible. All used oral cholecalciferol. We found a 6% risk reduction with vitamin D3 supplementation on clinical RTIs, but the result was not statistically significant (RR 0.94; 95% CI 0.88 to 1.00). Heterogeneity was large (I-square 57%) and overall study quality was low. There were too few studies to reliably assess a potential risk reduction of laboratory confirmed RTI. Evidence was insufficient to demonstrate an association between vitamin D supplementation and risk of clinical RTI in sub-groups with vitamin D deficiency. Conclusions In previously healthy individuals vitamin D supplementation does not reduce the risk of clinical RTIs. However, this conclusion is based on a meta-analysis where the included studies differed with respect to population, baseline vitamin D levels and study length. This needs to be considered when interpreting the results. Future trials should focus on vitamin D deficient individuals and apply more objective and standardized outcome measurements.	[Gysin, Danielle Vuichard; Dao, Dyda; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Gysin, Christian Michael] McMaster Univ, St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Lytvyn, Lyubov] Hosp Sick Children, Dept Child Hlth & Evaluat Sci, Toronto, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Loeb, Mark] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada.	loebm@mcmaster.ca	Vuichard, Danielle/ABI-4258-2020	Dao, Dyda/0000-0002-8261-5361; Dao, Dyda/0000-0003-2941-8374	Medical Division of the Lichtenstein Foundation of the University of Basel, Switzerland	Medical Division of the Lichtenstein Foundation of the University of Basel, Switzerland	DVG was a recipient of a scholarship from the Medical Division of the Lichtenstein Foundation of the University of Basel, Switzerland. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095, DOI 10.1017/S0950268807008308; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; D'Mello T, 2015, MMWR-MORBID MORTAL W, V64, P206; de Gruijl Frank R, 2012, Photochem Photobiol Sci, V11, P1848, DOI 10.1039/c2pp25179e; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dubnov-Raz G, 2015, PEDIATR EXERC SCI, V27, P113, DOI 10.1123/pes.2014-0030; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Goodall EC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-273; Grant CC, 2015, ACTA PAEDIATR, V104, P396, DOI 10.1111/apa.12819; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hirani V, 2013, J AM GERIATR SOC, V61, P969, DOI 10.1111/jgs.12254; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jolliffe DA, 2013, J STEROID BIOCHEM, V136, P321, DOI 10.1016/j.jsbmb.2012.11.017; Karve S, 2013, HUM VACC IMMUNOTHER, V9, P841, DOI 10.4161/hv.23413; Laaksi I, 2012, J INFECT DIS, V202, P809; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Little P, 2015, LANCET, V386, P1631, DOI 10.1016/S0140-6736(15)60127-1; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Manaseki-Holland S, 2012, LANCET, V378, P1419; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293; Martineau Adrian R, 2015, Thorax, V70, P953, DOI 10.1136/thoraxjnl-2015-206996; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Murdoch DR, 2012, JAMA J AM MED ASS, V308, P1333; Neale R, 2013, AM J EPIDEMIOLOGY, V177; Neale R, 2013, AM J EPIDEMIOL, V177, pS131; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Rees JR, 2013, CLIN INFECT DIS, V57, P1384, DOI 10.1093/cid/cit549; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Science M, 2013, CLIN INFECT DIS, V57, P392, DOI 10.1093/cid/cit289; Simpson S., 2015, BMC NUTR, V1, P7, DOI [10.1186/2055-0928-1-7, DOI 10.1186/2055-0928-1-7]; Sundaram ME, 2012, ADV NUTR, V3, P517, DOI 10.3945/an.112.002162; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Urashima M, 2014, FOOD FUNCT, V5, P2365, DOI [10.1039/C4FO00371C, 10.1039/c4fo00371c]; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR	56	55	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162996	10.1371/journal.pone.0162996	http://dx.doi.org/10.1371/journal.pone.0162996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631625	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900112
J	Komiyama, EY; Lepesqueur, LSS; Yassuda, CG; Samaranayake, LP; Parahitiyawa, NB; Balducci, I; Koga-Ito, CY				Komiyama, Edson Yukio; Souto Lepesqueur, Laura Soares; Yassuda, Cinthia Gomes; Samaranayake, Lakshman P.; Parahitiyawa, Nipuna B.; Balducci, Ivan; Koga-Ito, Cristiane Yumi			Enterococcus Species in the Oral Cavity: Prevalence, Virulence Factors and Antimicrobial Susceptibility	PLOS ONE			English	Article							ENDODONTIC ENTEROCOCCUS; ANTIBIOTIC-RESISTANCE; IN-VITRO; FAECALIS; IDENTIFICATION; CULTURE; ENDOCARDITIS; PHENOTYPE; INFECTION; BACTERIAL	Enterococci are considered as transient constituent components of the oral microbiome that may cause a variety of oral and systemic infections. As there is sparse data on the oral enterococcal prevalence, we evaluated the Enterococcus spp. and their virulence attributes including antimicrobial resistance in a healthy Brazilian cohort. A total of 240 individuals in different age groups were studied (children 4-11 yrs, adolescents 12-17 yrs, young adults 18-29 yrs, adults 30-59 yrs, elderly over 60 yrs). Oral rinses were collected and isolates were identified by API 20 Strep and confirmed by 16S rDNA sequencing. E. faecalis isolates, in particular, were evaluated for virulence attributes such as their biofilm formation potential, and susceptibility to antimicrobials and an antiseptic, chlorhexidine gluconate. A total of 40 individuals (16.6%) and 10% children, 4% adolescents, 14% young adults, 30% adults, and 25% elderly carried oral enterococci. The oral enterococcal burden in adolescents was significantly lower than in the adults (p = 0.000) and elderly (p = 0.004). The proportion of carriers was higher among females (p = 0.001). E. faecalis was the most frequent isolate in all the age groups (p = 0.000), followed by E. durans and E. faecium. Whilst all the clinical isolates were able to form biofilms, only a proportion of them were able to produce lipase (92%), hemolysin (38%), and gelatinase (39%). Of all the isolates 53.8% were resistant to tetracycline, 12.3% to amoxicillin, 16.0% to ampicillin, 20.8% to chloramphenicol and 43.4% to erythromycin. None of the isolates were resistant to vancomycin. Our data suggest that in this Brazilian cohort the oral cavity may act as a significant reservoir of rather virulent and antibiotic resistant enterococci, with an increasing degree of carriage in the adults and elderly. Hence clinicians should be cognizant of this silent reservoir of virulent enterococci that may pose a particular threat of nosocomial infection.	[Komiyama, Edson Yukio; Souto Lepesqueur, Laura Soares; Yassuda, Cinthia Gomes; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista UNESP, Dept Oral Biosci & Diag, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Paulo, Brazil; [Samaranayake, Lakshman P.] Univ Queensland, UQ Oral Hlth Ctr, Sch Dent, Brisbane, Qld, Australia; [Parahitiyawa, Nipuna B.] Univ Hong Kong, Dept Oral Biosci, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Balducci, Ivan] Univ Estadual Paulista UNESP, Dept Social Dent, Inst Sci & Technol, Sao Paulo, Brazil; [Koga-Ito, Cristiane Yumi] Univ Estadual Paulista UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Paulo, Brazil	Universidade Estadual Paulista; University of Queensland; University of Hong Kong; Universidade Estadual Paulista; Universidade Estadual Paulista	Koga-Ito, CY (corresponding author), Univ Estadual Paulista UNESP, Dept Oral Biosci & Diag, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Paulo, Brazil.; Koga-Ito, CY (corresponding author), Univ Estadual Paulista UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Paulo, Brazil.	cristiane@ict.unesp.br	Koga-Ito, Cristiane/ABC-6537-2020; Koga-Ito, Cristiane Y/D-7999-2012	Koga-Ito, Cristiane Y/0000-0002-2416-2173; Soares Souto Lepesqueur, Laura/0000-0001-8584-885X	Sao Paulo Research Foundation [06/50503-5, 07/54438-6, 09/50497-3, 07/ 5443-0, 09/50498-0]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (www.fapesp.br/en), 06/50503-5 (CYKI), 07/54438-6, 09/50497-3 (LSSL), and 07/ 5443-0, 09/50498-0 (CGY); and Coordination for the Improvement of Higher Education Personnel (CAPES), http://www.iie.org/Programs/CAPES#.V1vVBLsrLIU, EYK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Ahmad A, 2009, J ENDODONT, V35, P986, DOI 10.1016/j.joen.2009.04.013; Anderson AC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01534; Andre P, 2005, FEMS MICROBIOL LETT, V245, P123, DOI 10.1016/j.femsle.2005.02.036; Appelbe OK, 2007, ORAL MICROBIOL IMMUN, V22, P169, DOI 10.1111/j.1399-302X.2007.00340.x; Araya M, 2005, ARCH LATINOAM NUTR, V55, P161; Butler Karina M, 2006, Semin Pediatr Infect Dis, V17, P128, DOI 10.1053/j.spid.2006.06.006; Chai Wen L, 2007, J Oral Sci, V49, P161, DOI 10.2334/josnusd.49.161; Chirouze C, 2013, CLIN MICROBIOL INFEC, V19, P1140, DOI 10.1111/1469-0691.12166; Chomicz Lidia, 2004, Wiad Parazytol, V50, P177; Chowdhury SA, 2014, J CLIN MICROBIOL, V52, P549, DOI 10.1128/JCM.02763-13; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Colodner R, 2006, EUR J CLIN MICROBIOL, V25, P238, DOI 10.1007/s10096-006-0132-0; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Dahlen G, 1993, Adv Dent Res, V7, P163; Duggan JM, 2007, J ENDODONT, V33, P815, DOI 10.1016/j.joen.2007.02.016; Elsner HA, 2000, EUR J CLIN MICROBIOL, V19, P39, DOI 10.1007/s100960050007; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foschi F, 2005, ORAL MICROBIOL IMMUN, V20, P289, DOI 10.1111/j.1399-302X.2005.00227.x; Franzetti L, 2004, CURR MICROBIOL, V49, P255, DOI 10.1007/s00284-004-4242-6; Garcia-Garrote F, 2000, J CLIN MICROBIOL, V38, P2108; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001; Kouidhi B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-155; Lavigne JP, 2005, PATHOL BIOL, V53, P539, DOI 10.1016/j.patbio.2005.06.005; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P1; Mihaila-Amrouche L, 2004, INDIAN J MED RES, V119, P80; Miranda JM, 2005, LETT APPL MICROBIOL, V41, P153, DOI 10.1111/j.1472-765X.2005.01728.x; Mittal S, 2016, J PATHOG, V2016, DOI 10.1155/2016/8262561; Rams TE, 2013, J PERIODONTOL, V84, P1026, DOI 10.1902/jop.2012.120050; Ran S, 2015, INT ENDOD J, V48, P362, DOI 10.1111/iej.12322; Razavi A, 2007, ORAL MICROBIOL IMMUN, V22, P248, DOI 10.1111/j.1399-302X.2006.00349.x; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17; Samaranayake LP, 1998, J ORAL PATHOL, V15, P286; Sedgley C, 2006, J ENDODONT, V32, P104, DOI 10.1016/j.joen.2005.10.022; Sedgley CM, 2005, ARCH ORAL BIOL, V50, P575, DOI 10.1016/j.archoralbio.2004.10.017; Sedgley CM, 2005, ORAL MICROBIOL IMMUN, V20, P10, DOI 10.1111/j.1399-302X.2004.00180.x; Sedgley CM, 2004, ORAL MICROBIOL IMMUN, V19, P95, DOI 10.1111/j.0902-0055.2004.00122.x; Sena NT, 2006, INT ENDOD J, V39, P878, DOI 10.1111/j.1365-2591.2006.01161.x; Silva J, 2005, REV MED CHILE, V133, P1201; Sun J, 2012, EUR J CLIN MICROBIOL, V31, P267, DOI 10.1007/s10096-011-1305-z; Vidana R, 2016, INT ENDOD J, V49, P343, DOI 10.1111/iej.12464; Winston LG, 2004, DIAGN MICR INFEC DIS, V48, P287, DOI 10.1016/j.diagmicrobio.2003.10.008; Zehnder M, 2009, INT ENDOD J, V42, P277, DOI 10.1111/j.1365-2591.2008.01537.x; Zoletti GO, 2006, J ENDODONT, V32, P722, DOI 10.1016/j.joen.2006.02.001	46	75	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163001	10.1371/journal.pone.0163001	http://dx.doi.org/10.1371/journal.pone.0163001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631785	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900113
J	Krishnan, P; Ghosh, S; Wang, B; Heyns, M; Graham, K; Mackey, JR; Kovalchuk, O; Damaraju, S				Krishnan, Preethi; Ghosh, Sunita; Wang, Bo; Heyns, Mieke; Graham, Kathryn; Mackey, John R.; Kovalchuk, Olga; Damaraju, Sambasivarao			Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis	PLOS ONE			English	Article							SMALL NONCODING RNA; LUNG-CANCER; MICRORNA SIGNATURE; MICROARRAY DATA; GASTRIC-CANCER; MESSENGER-RNA; C-ELEGANS; SNORNA; EXPRESSION; GENE	One of the most abundant, yet least explored, classes of RNA is the small nucleolar RNAs (snoRNAs), which are well known for their involvement in post-transcriptional modifications of other RNAs. Although snoRNAs were only considered to perform housekeeping functions for a long time, recent studies have highlighted their importance as regulators of gene expression and as diagnostic/prognostic markers. However, the prognostic potential of these RNAs has not been interrogated for breast cancer (BC). The objective of the current study was to identify snoRNAs as prognostic markers for BC. Small RNA sequencing (Illumina Genome Analyzer IIx) was performed for 104 BC cases and 11 normal breast tissues. Partek Genomics Suite was used for analyzing the sequencing files. Two independent and proven approaches were used to identify prognostic markers: case-control (CC) and case-only (CO). For both approaches, snoRNAs significant in the permutation test, following univariate Cox proportional hazards regression model were used for constructing risk scores. Risk scores were subsequently adjusted for potential confounders in a multivariate Cox model. For both approaches, thirteen snoRNAs were associated with overall survival and/or recurrence free survival. Patients belonging to the high-risk group were associated with poor outcomes, and the risk score was significant after adjusting for confounders. Validation of representative snoRNAs (SNORD46 and SNORD89) using qRT-PCR confirmedthe observations from sequencing experiments. We also observed 64 snoRNAs harboring piwi-interacting RNAs and/or microRNAs that were predicted to target genes (mRNAs) involved in tumorigenesis. Our results demonstrate the potential of snoRNAs to serve (i) as novel prognostic markers for BC and (ii) as indirect regulators of gene expression.	[Krishnan, Preethi; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Ghosh, Sunita; Graham, Kathryn; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Ghosh, Sunita; Graham, Kathryn; Mackey, John R.; Damaraju, Sambasivarao] Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada; [Wang, Bo; Heyns, Mieke; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Lethbridge	Damaraju, S (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.; Damaraju, S (corresponding author), Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada.	sdamaraj@ualberta.ca	Heyns, Mieke/ABB-6676-2021; Krishnan, Preethi/AAY-2604-2020		Canadian Breast Cancer Foundation-Prairies/NWT Chapter	Canadian Breast Cancer Foundation-Prairies/NWT Chapter	This work was supported by the Canadian Breast Cancer Foundation-Prairies/NWT Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0463-6; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Dobbin KK, 2007, BIOSTATISTICS, V8, P101, DOI 10.1093/biostatistics/kxj036; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gao L, 2015, INT J CANCER, V136, pE623, DOI 10.1002/ijc.29169; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hashim A, 2014, ONCOTARGET, V5, P9901, DOI 10.18632/oncotarget.2476; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Krishnan P, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9272; Krishnan P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1899-0; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Liu N, 2014, INT J CANCER, V134, P1359, DOI 10.1002/ijc.28468; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens-Uzunova ES, 2015, ONCOTARGET, V6, P17430, DOI 10.18632/oncotarget.4172; Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okugawa Y, 2015, GUT; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Ravo M, 2015, ONCOTARGET, V6, P4677, DOI 10.18632/oncotarget.2911; Ribelles N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3559; Ronchetti D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-27; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Su H, 2014, ONCOGENE, V33, P1348, DOI 10.1038/onc.2013.89; Su YY, 2012, INT IMMUNOPHARMACOL, V13, P468, DOI 10.1016/j.intimp.2012.05.016; Venkataraman S, 2013, J BIOL CHEM, V288, P1918, DOI 10.1074/jbc.M112.396762; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-216; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhong FD, 2015, NUCLEIC ACIDS RES, V43, P10474, DOI 10.1093/nar/gkv954	52	40	42	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162622	10.1371/journal.pone.0162622	http://dx.doi.org/10.1371/journal.pone.0162622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631501	Green Published, gold			2022-12-27	WOS:000383706900061
J	Markus, B; Grote, K; Worsch, M; Parviz, B; Boening, A; Schieffer, B; Parahuleva, MS				Markus, Birgit; Grote, Karsten; Worsch, Michael; Parviz, Behnoush; Boening, Andreas; Schieffer, Bernhard; Parahuleva, Mariana S.			Differential Expression of MicroRNAs in Endarterectomy Specimens Taken from Patients with Asymptomatic and Symptomatic Carotid Plaques	PLOS ONE			English	Article							ACTIVATING PROTEASE FSAP; ATHEROSCLEROTIC PLAQUES; ISCHEMIC-STROKE; SIGNATURE; HUMANS; INSTABILITY; DISEASE; LESIONS; CELLS	Objective Stroke and transient ischemic attacks are considered as clinical manifestations of atherosclerotic disease due to on-going vascular inflammation and finally atherothrombosis of the carotid arteries. MicroRNAs (miRNA/miR) are known to be involved in vascular inflammation and plaque destabilization. The aim of this study was to analyze the expression profile of selected miRNAs in endarterectomy specimen from carotid arteries that were taken from patients with asymptomatic and symptomatic atherosclerotic plaques. Methods and Results 11 miRNAs were selected and their expression was analyzed using real-time RT-PCR. Therefore, samples were divided into three different groups. On the one hand we investigated the expression patterns from patients in asymptomatic (n = 14) and symptomatic (n = 10) plaques; on the other hand we took samples from normal configurated internalmammary arteries (n = 15). Out of these 11 targets we identified some miRNAs, which were up- or down-regulated in either one of the two groups. Interestingly, the expression of two miRNAs was significantly different between asymptomatic and symptomatic samples, namely miR-21 (P<0.01) and miR-143 (P<0.05). Conclusion In the present study, we identified miRNA subtypes which showed different expression in endarterectomy specimen from patients with asymptomatic and symptomatic plaques, suggesting that these miRNAs correlated with advanced vascular inflammation and plaque stability. They may represent new therapeutic targets for vascular proliferative diseases such as atherosclerosis.	[Markus, Birgit; Grote, Karsten; Schieffer, Bernhard; Parahuleva, Mariana S.] Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol, Marburg, Germany; [Worsch, Michael; Parviz, Behnoush; Parahuleva, Mariana S.] Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol 1, Giessen, Germany; [Boening, Andreas] Univ Hosp Giessen & Marburg, Dept Cardiovasc Surg, Giessen, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Parahuleva, MS (corresponding author), Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol, Marburg, Germany.; Parahuleva, MS (corresponding author), Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol 1, Giessen, Germany.	parahule@med.uni-marburg.de	Parahuleva, Mariana/AAN-8686-2021	Grote, Karsten/0000-0001-7914-3159				Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Fan XS, 2014, EXP MOL PATHOL, V96, P242, DOI 10.1016/j.yexmp.2014.02.009; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hartmann P, 2015, CELL MOL LIFE SCI, V72, P3253, DOI 10.1007/s00018-015-1925-z; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jansen F, 2015, J CELL MOL MED, V19, P2202, DOI 10.1111/jcmm.12607; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Li SH, 2015, CURR NEUROVASC RES, V12, P214, DOI 10.2174/1567202612666150605121709; Maitrias P, 2015, J VASC SURG, V62, P1245, DOI 10.1016/j.jvs.2015.06.136; Nazari-Jahantigh M, 2015, J MOL CELL CARDIOL, V89, P35, DOI 10.1016/j.yjmcc.2014.10.021; Parahuleva MS, 2008, ATHEROSCLEROSIS, V196, P164, DOI 10.1016/j.atherosclerosis.2007.03.042; Parahuleva MS, 2012, CIRC J, V76, P2653, DOI 10.1253/circj.CJ-11-1502; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Soeki T, 2015, CIRC J, V79, P413, DOI 10.1253/circj.CJ-14-0958; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Swirski FK, 2012, CELL METAB, V15, P135, DOI 10.1016/j.cmet.2012.01.012; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Thim T, 2008, J INTERN MED, V263, P506, DOI 10.1111/j.1365-2796.2008.01947.x; Togliatto G, 2011, DIABETOLOGIA, V54, P1930, DOI 10.1007/s00125-011-2125-5	28	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161632	10.1371/journal.pone.0161632	http://dx.doi.org/10.1371/journal.pone.0161632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631489	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900021
J	Hoang, TN; Van, TN; Gammeltoft, T; Meyrowitsch, DW; Thuy, HNT; Rasch, V				Thanh Nguyen Hoang; Toan Ngo Van; Gammeltoft, Tine; Meyrowitsch, Dan W.; Hanh Nguyen Thi Thuy; Rasch, Vibeke			Association between Intimate Partner Violence during Pregnancy and Adverse Pregnancy Outcomes in Vietnam: A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; LAST MENSTRUAL PERIOD; DOMESTIC VIOLENCE; PRETERM BIRTH; NEONATAL OUTCOMES; MATERNAL EXPOSURE; HEALTH; WOMEN; RISK; PREVALENCE	Background Violence against pregnant women is an increasing public health concern particularly in low- and middle-income countries. The purpose of this study was to measure the association between intimate partner violence (IPV) during pregnancy and the risk of adverse birth outcomes. Methods Prospective cohort study of 1276 pregnant women in Dong Anh district, Vietnam. Women with gestational age less than 24 weeks were enrolled and interviewed. Repeated interviews were performed at 30-34 weeks gestation to assess experience of IPV during pregnancy and again 48 hours post-delivery to assess the birth outcome including birth weight and gestational age at delivery. Results There was a statistically significant association between exposure to physical violence during pregnancy and preterm birth (PTB) or low birth weight (LBW). After adjustment for age, education, occupation, body mass index (BMI), haemoglobin level, previous adverse pregnancy outcomes, the pregnant women who were exposed to physical violence during pregnancy were five times more likely to have PTB (AOR = 5.5; 95% CI: 2.1-14.1) and were nearly six times more likely to give birth to a child of LBW (AOR = 5.7; 95% CI: 2.2-14.9) as compared to those who were not exposed to physical violence. Conclusion Exposure to IPV during pregnancy increases the risk of PTB and LBW. Case-finding for violence in relation to antenatal care may help protect pregnant women and improve pregnancy outcomes.	[Thanh Nguyen Hoang; Toan Ngo Van; Hanh Nguyen Thi Thuy] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Hanoi Medical University; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Hoang, TN (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	nguyenhoangthanh@hmu.edu.vn	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Gammeltoft, Tine Mette/0000-0002-6723-2370	Danish International Development Agency; larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE)	Danish International Development Agency; larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE)	This work was supported by the Danish International Development Agency. The funder had no role in study design, data collection and analysis, manuscript preparation.; This research was conducted under the auspices of the larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE). We are extremely grateful to the pregnant women who took part in this study, the research assistants, the hospital staff at Dong Anh Hospital and Bac Thang Long Hospital and, the population centre and community health centre in Dong Anh district.	Abadi MNL, 2013, J NERV MENT DIS, V201, P602, DOI 10.1097/NMD.0b013e3182982b1d; Abdollahi F, 2015, J FAM COMMUNITY MED, V22, P13, DOI 10.4103/2230-8229.149577; Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872; Alhusen JL, 2013, J PEDIATR-US, V163, P471, DOI 10.1016/j.jpeds.2013.01.036; Nunes MAA, 2011, EUR J PUBLIC HEALTH, V21, P92, DOI 10.1093/eurpub/ckp241; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Chai J, 2016, B WORLD HEALTH ORGAN, V94, P331, DOI 10.2471/BLT.15.152462; Chan KL, 2011, J INTERPERS VIOLENCE, V26, P1478, DOI 10.1177/0886260510369134; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Audi CAF, 2008, J PEDIAT-BRAZIL, V84, P60, DOI 10.2223/JPED.1744; Garcia-Moreno C, 2005, MULTICOUNTRY STUDY W, V1ra; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Han A, 2014, INT J GYNECOL OBSTET, V124, P6, DOI 10.1016/j.ijgo.2013.06.037; Henrica AFMJ, 2010, RESULTS NATL STUDY D; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Ibrahim Zm Fau-Sayed Ahmed WA, 2015, INTIMATE PARTNER VIO; James L, 2013, VIOLENCE VICTIMS, V28, P359, DOI 10.1891/0886-6708.VV-D-12-00034; Kaye DK, 2006, TROP MED INT HEALTH, V11, P1576, DOI 10.1111/j.1365-3156.2006.01711.x; Leone JM, 2010, J WOMENS HEALTH, V19, P1501, DOI 10.1089/jwh.2009.1716; Ministry of Health General Statistics Office, 2011, MULT IND CLUST SURV; Niemi M, 2013, TROP MED INT HEALTH, V18, P687, DOI 10.1111/tmi.12101; Saito A, 2013, HEALTH CARE WOMEN IN, V34, P757, DOI 10.1080/07399332.2013.794459; Sanchez SE, 2013, MATERN CHILD HLTH J, V17, P485, DOI 10.1007/s10995-012-1012-0; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Shah PS, 2010, J WOMENS HEALTH, V19, P2017, DOI 10.1089/jwh.2010.2051; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Tessa W, 2004, LOW BIRTHW COUNTR RE; Waller DK, 2000, PAEDIATR PERINAT EP, V14, P263, DOI 10.1046/j.1365-3016.2000.00275.x; Zhang Y, 2013, ASIA-PAC PSYCHIAT, V5, P2, DOI 10.1111/appy.12021	33	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162844	10.1371/journal.pone.0162844	http://dx.doi.org/10.1371/journal.pone.0162844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631968	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900084
J	Miller, SE; Bell, CS; McClain, MS; Cover, TL; Giorgio, TD				Miller, Sinead E.; Bell, Charleson S.; McClain, Mark S.; Cover, Timothy L.; Giorgio, Todd D.			Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; KLEBSIELLA-PNEUMONIAE; SEVERE SEPSIS; MOUSE MODEL; COLISTIN; INFECTION; CLEARANCE; MORTALITY; LIVER; EPIDEMIOLOGY	The rise of multi-drug resistance has decreased the effectiveness of antibiotics, which has led to increased mortality rates associated with symptomatic bacteremia, or bacterial sepsis. To combat decreasing antibiotic effectiveness, extracorporeal bacterial separation approaches have been proposed to capture and separate bacteria from blood. However, bacteremia is dynamic and involves host-pathogen interactions across various anatomical sites. We developed a mathematical model that quantitatively describes the kinetics of pathogenesis and progression of symptomatic bacteremia under various conditions, including bacterial separation therapy, to better understand disease mechanisms and quantitatively assess the biological impact of bacterial separation therapy. Model validity was tested against experimental data from published studies. This is the first multi-compartment model of symptomatic bacteremia in mammals that includes extracorporeal bacterial separation and antibiotic treatment, separately and in combination. The addition of an extracorporeal bacterial separation circuit reduced the predicted time of total bacteria clearance from the blood of an immunocompromised rodent by 49%, compared to antibiotic treatment alone. Implementation of bacterial separation therapy resulted in predicted multi-drug resistant bacterial clearance from the blood of a human in 97% less time than antibiotic treatment alone. The model also proposes a quantitative correlation between time-dependent bacterial load among tissues and bacteremia severity, analogous to the well-known 'area under the curve' for characterization of drug efficacy. The engineering-based mathematical model developed may be useful for informing the design of extracorporeal bacterial separation devices. This work enables the quantitative identification of the characteristics required of an extracorporeal bacteria separation device to provide biological benefit. These devices will potentially decrease the bacterial load in blood. Additionally, the devices may achieve bacterial separation rates that allow consequent acceleration of bacterial clearance in other tissues, inhibiting the progression of symptomatic bacteremia, including multi-drug resistant variations.	[Miller, Sinead E.; Bell, Charleson S.; Giorgio, Todd D.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [McClain, Mark S.; Cover, Timothy L.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Cover, Timothy L.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Giorgio, TD (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	todd.d.giorgio@vanderbilt.edu	McClain, Mark S/A-6942-2009; Cover, Timothy/I-3814-2015	McClain, Mark S/0000-0002-9857-4883; Cover, Timothy/0000-0001-8503-002X; Bell, Charleson/0000-0002-1821-8484	US Department of Defense [W81XWH-13-1-0397, W81XWH-13-1-0399]; NATIONAL CANCER INSTITUTE [P01CA116087] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US Department of Defense grants W81XWH-13-1-0397 (TDG) and W81XWH-13-1-0399 (TLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anazi KA, 2014, FRONT ONCOL, V4, P1, DOI DOI 10.3389/F0NC.2014.00311; Altamura M, 2001, IMMUNOPHARM IMMUNOT, V23, P153, DOI 10.1081/IPH-100103856; Bansal S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-456; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Bruhn KW, 2015, J INFECT DIS, V211, P1296, DOI 10.1093/infdis/jiu593; CHEEWATRAKOOLPONG B, 1983, J IMMUNOL METHODS, V58, P375, DOI 10.1016/0022-1759(83)90365-4; Chiang S-R, 2009, CRIT CARE MED, V2851, P2851; Choi JY, 2005, INTERN MED J, V35, P599, DOI 10.1111/j.1445-5994.2005.00925.x; Chung HM, 2008, SHOCK, V30, P518, DOI 10.1097/SHK.0b013e31816a0b77; CROSS AS, 1993, INFECT IMMUN, V61, P2741, DOI 10.1128/IAI.61.7.2741-2747.1993; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; DEBIASI J, 1991, J BIOMED ENG, V13, P439, DOI 10.1016/0141-5425(91)90028-6; Decolin D, 1997, J CHROMATOGR SCI, V35, P557, DOI 10.1093/chromsci/35.12.557; Docobo-Perez F, 2012, INT J ANTIMICROB AG, V39, P251, DOI 10.1016/j.ijantimicag.2011.10.012; Erbay A, 2009, INT J ANTIMICROB AG, V34, P575, DOI 10.1016/j.ijantimicag.2009.07.006; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gandhi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095707; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; GROSS K, 1985, J PEDIATR SURG, V20, P320, DOI 10.1016/S0022-3468(85)80211-6; Guo BN, 2011, ANTIMICROB AGENTS CH, V55, P4601, DOI 10.1128/AAC.00508-11; Hoshino K, 2012, ANAL CHEM, V84, P4292, DOI 10.1021/ac2032386; Iguder R, 2016, AM J INFECT CONTROL; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Kang JH, 2015, SMALL, V11, P5657, DOI 10.1002/smll.201501820; Kang JH, 2014, NAT MED, V20, P1211, DOI 10.1038/nm.3640; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis ND, 2013, J IMMUNOL, V190, P3533, DOI 10.4049/jimmunol.1201810; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Lin JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015005; Lin YT, 2014, INFECT IMMUN, V82, P1335, DOI 10.1128/IAI.01347-13; Miller SE, 2016, J BIOMED NANOTECHNOL, V12; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; Montero A, 2002, ANTIMICROB AGENTS CH, V46, P1946, DOI 10.1128/AAC.46.6.1946-1952.2002; Moore TA, 2003, SHOCK, V20, P309, DOI 10.1097/01.shk.0000087203.34916.45; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Pan CY, 2015, MAR DRUGS, V13, P2287, DOI 10.3390/md13042287; Pantopoulou A, 2007, INT J ANTIMICROB AG, V29, P51, DOI 10.1016/j.ijantimicag.2006.09.009; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Plowchalk DR, 2002, TOXICOL SCI, V69, P60, DOI 10.1093/toxsci/69.1.60; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Russo TA, 2008, INFECT IMMUN, V76, P3577, DOI 10.1128/IAI.00269-08; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Singh R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00158; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wendt C, 2001, CLIN INFECT DIS, V33, P460, DOI 10.1086/322591	55	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163167	10.1371/journal.pone.0163167	http://dx.doi.org/10.1371/journal.pone.0163167			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657881	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200078
J	Kakimoto, Y; Tanaka, M; Kamiguchi, H; Ochiai, E; Osawa, M				Kakimoto, Yu; Tanaka, Masayuki; Kamiguchi, Hiroshi; Ochiai, Eriko; Osawa, Motoki			MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content	PLOS ONE			English	Article							RNA SEQUENCING REVEALS; MESSENGER-RNA; NONCODING RNAS; HUMAN HEART; QUALITY; CANCER	MicroRNAs (miRNAs) are small non-coding RNAs responsible for fine-tuning of gene expression at post-transcriptional level. The alterations in miRNA expression levels profoundly affect human health and often lead to the development of severe diseases. Currently, high throughput analyses, such as microarray and deep sequencing, are performed in order to identify miRNA biomarkers, using archival patient tissue samples. MiRNAs are more robust than longer RNAs, and resistant to extreme temperatures, pH, and formalinfixed paraffin-embedding (FFPE) process. Here, we have compared the stability of miRNAs in FFPE cardiac tissues using next-generation sequencing. The mode read length in FFPE samples was 11 nucleotides (nt), while that in the matched frozen samples was 22 nt. Although the read counts were increased 1.7-fold in FFPE samples, compared with those in the frozen samples, the average miRNA mapping rate decreased from 32.0% to 9.4%. These results indicate that, in addition to the fragmentation of longer RNAs, miRNAs are to some extent degraded in FFPE tissues as well. The expression profiles of total miRNAs in two groups were highly correlated (0.88 < r < 0.92). However, the relative read count of each miRNA was different depending on the GC content (p<0.0001). The unequal degradation of each miRNA affected the abundance ranking in the library, and miR-133a was shown to be the most abundant in FFPE cardiac tissues instead of miR-1, which was predominant before fixation. Subsequent quantitative PCR (qPCR) analyses revealed that miRNAs with GC content of less than 40% are more degraded than GC-rich miRNAs (p<0.0001). We showed that deep sequencing data obtained using FFPE samples cannot be directly compared with that of fresh frozen samples. The combination of miRNA deep sequencing and other quantitative analyses, such as qPCR, may improve the utility of archival FFPE tissue samples.	[Kakimoto, Yu; Ochiai, Eriko; Osawa, Motoki] Tokai Univ, Dept Forens Med, Sch Med, Isehara, Kanagawa, Japan; [Tanaka, Masayuki; Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Osawa, M (corresponding author), Tokai Univ, Dept Forens Med, Sch Med, Isehara, Kanagawa, Japan.	osawa@is.icc.u-tokai.ac.jp		Tanaka, Masayuki/0000-0002-8682-8719	Japan Society for the Promotion of Science KAKENHI Grant [16K19300]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) KAKENHI Grant 16K19300. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen MY, 2014, MAR GENOM, V13, P39, DOI 10.1016/j.margen.2014.01.002; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Greytak SR, 2015, CANCER RES, V75, P1541, DOI 10.1158/0008-5472.CAN-14-2378; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Kakimoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129338; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Li P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0778-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0109-x; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Stik G, 2014, J BIOTECHNOL, V181, P35, DOI 10.1016/j.jbiotec.2014.04.005; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zuo J, 2015, PLOS ONE, V10, DOI [10.1371/Journal.pcme.0124873, DOI 10.1371/JOURNAL.PCME.0124873]	37	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163125	10.1371/journal.pone.0163125	http://dx.doi.org/10.1371/journal.pone.0163125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649415	gold, Green Submitted, Green Published			2022-12-27	WOS:000383892100057
J	Qi, HS; Liu, MQ; Wang, DH; Chen, MW				Qi, Hongsheng; Liu, Meiqi; Wang, Dianhai; Chen, Mengwei			Spatial-Temporal Congestion Identification Based on Time Series Similarity Considering Missing Data	PLOS ONE			English	Article							TRAFFIC FLOW; MACRO MODEL; NETWORK	Traffic congestion varies spatially and temporally. The observation of the formation, propagation and dispersion of network traffic congestion can lead to insights about the network performance, the bottleneck dynamics etc. While many researchers use the traffic flow data to reconstruct the congestion profile, the data missing problem is bypassed. Current methods either omit the missing data or supplement the missing part by average etc. Great error may be introduced during these processes. Rather than simply discarding the missing data, this research regards the data missing event as a result of either the severe congestion which prevent the floating vehicle from entering the congested area, or a type of feature of the resulting traffic flow time series. Hence a new traffic flow operational index time series similarity measurement is expected to be established as a basis of identifying the dynamic network bottleneck. The method first measures the traffic flow operational similarity between pairs of neighboring links, and then the similarity results are used to cluster the spatial-temporal congestion. In order to get the similarity under missing data condition, the measurement is implemented in a two-stage manner: firstly the so called first order similarity is calculated given that the traffic flow variables are bounded both upside and downside; then the first order similarity is aggregated to generate the second order similarity as the output. We implement the method on part of the real-world road network; the results generated are not only consistent with empirical observation, but also provide useful insights.	[Qi, Hongsheng; Liu, Meiqi; Wang, Dianhai; Chen, Mengwei] Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Chen, MW (corresponding author), Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	vivianmao001@hotmail.com			National Natural Science Foundation of China [51408538, 51338008, 51278454]; Key Science and Technology Innovation Team of Zhejiang Province [2013TD09]; Fundamental Research Funds for the Central Universities [2015QNA4025]; State Key Development Program for Basic Research of China [2012CB725402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Innovation Team of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	National Natural Science Foundation of China (Grant No. 51408538, 51338008, 51278454); Key Science and Technology Innovation Team of Zhejiang Province (2013TD09); Fundamental Research Funds for the Central Universities: (2015QNA4025) and State Key Development Program for Basic Research of China (Grant No. 2012CB725402).; Project supported by the National Natural Science Foundation of China (Grant No. 51408538, 51338008, 51278454); Key Science and Technology Innovation Team of Zhejiang Province (2013TD09); Fundamental Research Funds for the Central Universities: (2015QNA4025) and State Key Development Program for Basic Research of China (Grant No. 2012CB725402);	Anbaroglu B, 2014, TRANSPORT RES C-EMER, V48, P47, DOI 10.1016/j.trc.2014.08.002; Bauza R, 2013, J NETW COMPUT APPL, V36, P1295, DOI 10.1016/j.jnca.2012.02.007; Damaiyanti TI, 2014, 2014 IEEE FOURTH INTERNATIONAL CONFERENCE ON BIG DATA AND CLOUD COMPUTING (BDCLOUD), P209, DOI 10.1109/BDCloud.2014.97; Jianming H, 2012, IET INTELL TRANSP SY, V6, P153, DOI 10.1049/iet-its.2011.0124; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li DQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05381; Li QQ, 2011, J TRANSP GEOGR, V19, P379, DOI 10.1016/j.jtrangeo.2010.07.003; SCHRANK DL, 2013, TRANSP RES BOARD 92; Song Y, 2012, TRANSPORTATION, V39, P215, DOI 10.1007/s11116-011-9343-z; Tang TQ, 2013, PHYSICA A, V392, P3537, DOI 10.1016/j.physa.2013.03.056; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P300, DOI 10.1088/0253-6102/58/2/23; Wang SH, 2015, IEEE SIGNAL PROC LET, V22, DOI 10.1109/LSP.2015.2464791; Wang ZC, 2013, IEEE T VIS COMPUT GR, V19, P2159, DOI 10.1109/TVCG.2013.228; Xu L, 2013, PROCD SOC BEHV, V96, P2084, DOI 10.1016/j.sbspro.2013.08.235	14	4	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162043	10.1371/journal.pone.0162043	http://dx.doi.org/10.1371/journal.pone.0162043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649412	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100012
J	Murakami, E; Shionoya, T; Komenoi, S; Suzuki, Y; Sakane, F				Murakami, Eri; Shionoya, Takao; Komenoi, Suguru; Suzuki, Yuji; Sakane, Fumio			Cloning and Characterization of Novel Testis-Specific Diacylglycerol Kinase eta Splice Variants 3 and 4	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BIPOLAR-DISORDER; MALE-INFERTILITY; ISOZYMES DELTA; LIFE-STYLE; SAM DOMAIN; LOCALIZATION; EXPRESSION; KAPPA; DGKH	Diacylglycerol kinase (DGK) phosphorylates DG to generate phosphatidic acid. Recently, we found that a new alternative splicing product of the DGK. gene, DGK eta 3, which lacks exon 26 encoding 31 amino acid residues, was expressed only in the secondary spermatocytes and round spermatids of the testis. In this study, we cloned the full length DGK eta 3 gene and confirmedthe endogenous expression of its protein product. During the cloning procedure, we found a new testis-specific alternative splicing product of the DGK eta gene, DGK eta 4, which lacks half of the catalytic domain. We examined the DGK activity and subcellular localization of DGK eta 3 and eta 4. DGK eta 3 had almost the same activity as DGK eta 1, whereas the activity of DGK eta 4 was not detectable. In resting NEC8 cells (human testicular germcell tumor cell line), DGK eta 1, eta 3 and eta 4 were broadly distributed in the cytoplasm. When osmotically shocked, DGK eta 1 and eta 4 were distributed in punctate vesicles in the cytoplasm. In contrast, DGK eta 3 was partly translocated to the plasma membrane and co-localized with the actin cytoskeleton. These results suggest that DGK eta 3 and eta 4 have properties different from those of DGK eta 1 and that they play roles in the testis in a different manner.	[Murakami, Eri; Shionoya, Takao; Komenoi, Suguru; Suzuki, Yuji; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan	Chiba University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.	sakane@faculty.chiba-u.jp	Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377	MEXT/JSPS KAKENHI Grant [22370047, 23116505, 25116704, 26291017, 15K14470]; Japan Science and Technology Agency [AS221Z00794F, AS231Z00139G, AS251Z01788Q, AS2621643Q]; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Venture Business Laboratory of Chiba University; Grants-in-Aid for Scientific Research [26291017, 16J06865] Funding Source: KAKEN	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Venture Business Laboratory of Chiba University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant Numbers 22370047 (Grant-in-Aid for Scientific Research (B)), 23116505 (Grant-in-Aid for Scientific Research on Innovative Areas), 25116704 (Grant-in-Aid for Scientific Research on Innovative Areas), 26291017 (Grant-in-Aid for Scientific Research (B)) and 15K14470 (Grant-in-Aid for Challenging Exploratory Research), the Japan Science and Technology Agency (AS221Z00794F, AS231Z00139G, AS251Z01788Q and AS2621643Q), the Naito Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, the Daiichi-Sankyo Foundation of Life Science, the Terumo Life Science Foundation, the Futaba Electronic Memorial Foundation, the Daiwa Securities Health Foundation, the Ono Medical Research Foundation, the Japan Foundation for Applied Enzymology, the Food Science Institute Foundation, the Skylark Food Science Institute and the Venture Business Laboratory of Chiba University (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, BIOMED PHARMACOTHER, V62, P550, DOI 10.1016/j.biopha.2008.07.052; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Isozaki T, 2016, J NEUROCHEM, V138, P448, DOI 10.1111/jnc.13661; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Knight MJ, 2010, BIOCHEMISTRY-US, V49, P9667, DOI 10.1021/bi101261x; Komenoi S, 2015, FEBS LETT, V589, P1272, DOI 10.1016/j.febslet.2015.03.032; Kume A, 2016, J BIOL CHEM, V291, P8150, DOI 10.1074/jbc.M115.648717; Matsutomo D, 2013, J BIOCHEM, V153, P179, DOI 10.1093/jb/mvs130; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Nakano T, 2014, CLIN TRANSL ONCOL, V16, P29, DOI 10.1007/s12094-013-1036-y; Rittiner JE, 2014, MOL PHARMACOL, V85, P800, DOI 10.1124/mol.113.091280; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sharpe RM, 2000, BRIT MED BULL, V56, P630, DOI 10.1258/0007142001903436; Shionoya T, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0055-z; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zeng Z, 2011, MOL PSYCHIATR, V16, P473, DOI 10.1038/mp.2010.86	31	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162997	10.1371/journal.pone.0162997	http://dx.doi.org/10.1371/journal.pone.0162997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643686	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900026
J	Erlendsson, AM; Thaysen-Petersen, D; Bay, C; Hald, A; Skak, K; Zibert, JR; Paasch, U; Wulf, HC; Haedersdal, M				Erlendsson, Andres Mar; Thaysen-Petersen, Daniel; Bay, Christiane; Hald, Andreas; Skak, Kresten; Zibert, John Robert; Paasch, Uwe; Wulf, Hans Christian; Haedersdal, Merete			Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; SQUAMOUS-CELL CARCINOMAS; PEP005; NEUTROPHILS; PATTERNS; EXPOSURE; ANGELATE; THERAPY; REPAIR; DAMAGE	Background and Aim Ingenol mebutate (IngMeb) is an effective treatment for actinic keratosis. In this study, we hypothesized that repeated treatments with IngMeb may prevent progression of UV-induced photodamage, and that concurrent application of a corticosteroid may reduce IngMeb-induced local skin responses (LSR). Methods Hairless mice (n = 60; 3 groups of 20 mice) were irradiated with solar simulated ultraviolet radiation (UVR) throughout the study. Five single treatments with IngMeb were given at 4week intervals (Days 21, 49, 77, 105, and 133). Clobetasol propionate (CP) was applied once daily for 5 days prior to each IngMeb application, as well as 6 h and 1 day post treatment. One week after IngMeb treatment No. 1, 3, and 5 (Days 28, 84, and 140), biopsies from four mice in each group were collected for histological evaluation of UV-damage on a standardized UV-damage scale (0-12). LSR (0-24) were assessed once daily (Days 1-7) after each IngMeb treatment. Results IngMeb prevented progression of photodamage in terms of keratosis grade, epidermal hypertrophy, dysplasia, and dermal actinic damage with a lower composite UV-damage score on day 140 (UVR 10.25 vs. UVR+ IngMeb 6.00, p = 0.002) compared to UVR alone. IngMeb induced LSR, including erythema, flaking, crusting, bleeding, vesiculation, and ulceration. Concurrent CP increased LSR (max LSR Tx 1-5: UVR+IngMeb+CP 3.6-5.5 vs. UVR+IngMeb 2.6-4.3) and provided better prevention of photodamage compared to IngMeb alone (Day 140: UVR+IngMeb 6.00 vs. UVR+IngMeb+CP 3.00 p < 0.001). Conclusion Repeated field-directed treatments with IngMeb prevent progression of cutaneous photodamage in hairless mice, while CP cannot be used to alleviate IngMeb-induced LSR. The findings suggest that IngMeb may potentially serve as a prophylactic treatment for UV-induced tumors.	[Erlendsson, Andres Mar; Thaysen-Petersen, Daniel; Bay, Christiane; Wulf, Hans Christian; Haedersdal, Merete] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark; [Hald, Andreas; Skak, Kresten; Zibert, John Robert] Leo Pharma AS, Ballerup, Denmark; [Paasch, Uwe] Univ Leipzig, Dept Dermatol, Div Aesthet & Laserdermatol, Leipzig, Germany	University of Copenhagen; Bispebjerg Hospital; LEO Pharma; Leipzig University	Erlendsson, AM (corresponding author), Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark.	andres.erlendsson@gmail.com	Thaysen-Petersen, Daniel/M-8423-2019; Zibert, John Robert/GRY-3584-2022; Bay, Christiane/H-2451-2013	Bay, Christiane/0000-0002-5176-8322	Leo Pharma A/S	Leo Pharma A/S	Leo Pharma A/S provided ingenol mebutate gel for the study and support in the form of salaries for authors AH, KS, and JRZ, but the funder had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BechThomsen N, 1997, DAN MED BULL, V44, P242; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Erlendsson AM, 2016, J PHOTOCH PHOTOBIO B, V163, P144, DOI 10.1016/j.jphotobiol.2016.08.022; Erlendsson AM, 2016, J AM ACAD DERMATOL, V74, P709, DOI 10.1016/j.jaad.2015.11.034; Faurschou A, 2007, SKIN RES TECHNOL, V13, P202, DOI 10.1111/j.1600-0846.2007.00222.x; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KAARSEN LL, 1995, PHOTODERMATOL PHOTO, V11, P1, DOI 10.1111/j.1600-0781.1995.tb00128.x; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; KLIGMAN LH, 1981, JNCI-J NATL CANCER I, V67, P1289; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Lerche CM, 2015, PHOTODERMATOL PHOTO, V31, P261, DOI 10.1111/phpp.12181; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; MONTAGNA W, 1954, J INVEST DERMATOL, V23, P259, DOI 10.1038/jid.1954.106; Mukhtar H, 1999, PHOTODERMATOL PHOTO, V15, P91, DOI 10.1111/j.1600-0781.1999.tb00065.x; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; Rosen R, 2014, DERMATOLOGY THER, V4, P207, DOI 10.1007/s13555-014-0059-9; Rosso S, 1996, BRIT J CANCER, V73, P1447, DOI 10.1038/bjc.1996.275; Schafer-Korting M, 2005, SKIN PHARMACOL PHYS, V18, P103, DOI 10.1159/000084907; Serova M, 2008, MOL CANCER THER, V7, P915, DOI 10.1158/1535-7163.MCT-07-2060; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; WULF HC, 1982, J AM ACAD DERMATOL, V7, P194, DOI 10.1016/S0190-9622(82)70108-2; Yadav V, 2010, AM J PATHOL, V176, P1091, DOI 10.2353/ajpath.2010.090816	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162597	10.1371/journal.pone.0162597	http://dx.doi.org/10.1371/journal.pone.0162597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636884	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700011
J	Caporarello, N; Salmeri, M; Scalia, M; Motta, C; Parrino, C; Frittitta, L; Olivieri, M; Cristaldi, M; Avola, R; Bramanti, V; Toscano, MA; Anfuso, CD; Lupo, G				Caporarello, Nunzia; Salmeri, Mario; Scalia, Marina; Motta, Carla; Parrino, Cristina; Frittitta, Lucia; Olivieri, Melania; Cristaldi, Martina; Avola, Roberto; Bramanti, Vincenzo; Toscano, Maria Antonietta; Anfuso, Carmelina Daniela; Lupo, Gabriella			Cytosolic and Calcium-Independent Phospholipases A(2) Activation and Prostaglandins E-2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells	PLOS ONE			English	Article							INDUCED ACUTE-PANCREATITIS; HEMOLYTIC-UREMIC SYNDROME; BETA-CELL; PKC-ALPHA; DIABETES-MELLITUS; ARACHIDONIC-ACID; FATTY-ACID; GLUCOSE; ISLETS; INFECTION	It is suspected that microbial infections take part in the pathogenesis of diabetes mellitus type 1 (T1DM). Glucose-induced insulin secretion is accompanied by the release of free arachidonic acid (AA) mainly by cytosolic-and calcium independent phospholipases A(2) (cPLA(2) and iPLA(2)). Insulinoma cell line (INS-1E) was infected with E. coli isolated from the blood culture of a patient with sepsis. Invasion assay, Scanning Electron Microscopy and Transmission Electron Microscopy demonstrated the capacity of E. coli to enter cells, which was reduced by PLA(2) inhibitors. Glucose-induced insulin secretion was significantly increased after acute infection (8h) but significantly decreased after chronic infection (72h). PLA(2) activities, cPLA(2), iPLA(2), phospho-cPLA(2), and COX-2 expressions were increased after acute and, even more, after chronic E. coli infection. The silencing of the two isoforms of PLA(2)s, with specific cPLA(2)- or iPLA(2)-siRNAs, reduced insulin secretion after acute infection and determined a rise in insulin release after chronic infection. Prostaglandins E-2 (PGE(2)) production was significantly elevated in INS-1E after long-termE. coli infection and the restored insulin secretion in presence of L798106, a specific EP3 antagonist, and NS398, a COX-2 inhibitor, and the reduction of insulin secretion in presence of sulprostone, a specific EP3 agonist, revealed their involvement in the effects triggered by bacterial infection. The results obtained demonstrated that cPLA(2) and iPLA(2) play a key role in insulin secretion process after E. coli infection. The high concentration of AA released is transformed into PGE(2), which could be responsible for the reduced insulin secretion.	[Caporarello, Nunzia; Salmeri, Mario; Scalia, Marina; Motta, Carla; Olivieri, Melania; Cristaldi, Martina; Avola, Roberto; Bramanti, Vincenzo; Toscano, Maria Antonietta; Anfuso, Carmelina Daniela; Lupo, Gabriella] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy; [Parrino, Cristina; Frittitta, Lucia] Univ Catania, Sch Med, Dept Clin & Expt Med, Catania, Italy	University of Catania; University of Catania	Lupo, G (corresponding author), Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy.	lupogab@unict.it	Parrino, Cristina/H-4009-2018; Parrino, Cristina/ABA-7496-2020; frittitta, lucia/AAA-4733-2019; Bramanti, Vincenzo/L-8828-2019; frittitta, Lucia/J-2334-2012	Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208; frittitta, lucia/0000-0002-7941-5828; Bramanti, Vincenzo/0000-0002-9380-8062; Caporarello, Nunzia/0000-0002-3183-2868; ANFUSO, Carmelina Daniela/0000-0001-7951-1812	 [PON01-00110]		This work was supported by National Grant PON01-00110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina M, 2010, MICROVASC RES, V80, P280, DOI 10.1016/j.mvr.2010.03.013; Ali T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071748; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Anfuso CD, 2014, BIOCHIMIE, V99, P77, DOI 10.1016/j.biochi.2013.11.013; ARENDT T, 1993, DIGEST DIS SCI, V38, P39, DOI 10.1007/BF01296771; Arendt T, 1998, INT J PANCREATOL, V24, P111; Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-549; Baker S, 2004, Crit Care Resusc, V6, P17; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Caporarello N, 2015, FEBS LETT, V589, P3969, DOI 10.1016/j.febslet.2015.11.035; Crouzet J, 2011, INT J INFECT DIS, V15, pE601, DOI 10.1016/j.ijid.2011.05.003; Culetto A, 2015, DIGEST LIVER DIS, V47, P584, DOI 10.1016/j.dld.2015.03.009; D'Hertog W, 2011, PROTEOMICS, V11, P1365, DOI 10.1002/pmic.201000006; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; DelGiorno KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092807; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Du SC, 2012, CELL MOL BIOL, V58, P1654, DOI 10.1170/192; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Frommel U, 2013, APPL ENVIRON MICROB, V79, P5814, DOI 10.1128/AEM.01384-13; GIANANTONIO CA, 1973, NEPHRON, V11, P174; Giurdanella G, 2011, MICROVASC RES, V81, P1, DOI 10.1016/j.mvr.2010.11.005; Hsieh PS, 2008, LIVER INT, V28, P1167, DOI 10.1111/j.1478-3231.2008.01714.x; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Ismaili A, 1998, INFECT IMMUN, V66, P1688, DOI 10.1128/IAI.66.4.1688-1696.1998; Juhl K, 2003, AM J PHYSIOL-ENDOC M, V285, pE73, DOI 10.1152/ajpendo.00086.2003; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Lammi N, 2005, MED SCI MONITOR, V11, pRA63; Milne HM, 2005, DIABETES, V54, P116, DOI 10.2337/diabetes.54.1.116; Myers MA, 2001, DIABETOLOGIA, V44, P1199; Nikolic DM, 2011, BRIT J BIOMED SCI, V68, P181, DOI 10.1080/09674845.2011.11730347; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Osto M, 2011, ENDOCRINOLOGY, V152, P804, DOI 10.1210/en.2010-0999; Patane G, 2013, ACTA DIABETOL, V50, P851, DOI 10.1007/s00592-013-0458-x; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Persaud SJ, 2002, DIABETES, V51, P98, DOI 10.2337/diabetes.51.1.98; Pezzilli Raffaele, 2003, JOP, V4, P200; Ramanadham S, 1998, BBA-LIPID LIPID MET, V1390, P301, DOI 10.1016/S0005-2760(97)00189-6; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Safi M, 2016, J INFECT CHEMOTHER, V22, P221, DOI 10.1016/j.jiac.2015.12.017; Salmeri M, 2013, CELL MICROBIOL, V15, P1367, DOI 10.1111/cmi.12121; Salmeri M, 2012, NEUROSCI LETT, V511, P33, DOI 10.1016/j.neulet.2012.01.031; Sanchez-Villamil J, 2015, FUTURE MICROBIOL, V10, P1009, DOI [10.2217/FMB.15.17, 10.2217/fmb.15.17]; Sansonetti P, 2002, GUT, V50, P2; Sass DA, 2003, DIGEST DIS SCI, V48, P415, DOI 10.1023/A:1021912518129; Sharma R, 2006, AM J PHYSIOL-GASTR L, V290, pG685, DOI 10.1152/ajpgi.00404.2005; Shen-Tu G, 2014, INFECT IMMUN, V82, P1648, DOI 10.1128/IAI.00534-13; Shunzhong B, 2008, AM J PHYSIOL-ENDOC M, V294, pE217; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Slavov E, 2010, VET RES COMMUN, V34, P205, DOI 10.1007/s11259-010-9345-x; Smith EJ, 2013, FUTURE MICROBIOL, V8, P1289, DOI 10.2217/fmb.13.94; Song HW, 2012, J BIOL CHEM, V287, P5528, DOI 10.1074/jbc.M111.285114; Suri RS, 2009, KIDNEY INT, V75, pS44, DOI 10.1038/ki.2008.619; Taser N, 2014, EUR J GASTROEN HEPAT, V26, P937, DOI 10.1097/MEG.0000000000000129; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; van Waardenburg DA, 2006, J CLIN ENDOCR METAB, V91, P3916, DOI 10.1210/jc.2006-0525; von Herrath MG, 2000, J NEUROIMMUNOL, V107, P154, DOI 10.1016/S0165-5728(00)00227-7; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711	67	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159874	10.1371/journal.pone.0159874	http://dx.doi.org/10.1371/journal.pone.0159874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631977	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900004
J	Ebrahimi, L; Fotuhifar, KB; Nikkhah, MJ; Naghavi, MR; Baisakh, N				Ebrahimi, Leila; Fotuhifar, Khalil-Berdi; Nikkhah, Mohammad Javan; Naghavi, Mohammad-Reza; Baisakh, Niranjan			Population Genetic Structure of Apple Scab (Venturia inaequalis (Cooke) G. Winter) in Iran	PLOS ONE			English	Article							RESISTANCE; RACES; SOFTWARE; MALUS; ASIA	The population genetic structure of 278 Venturia inaequalis isolates, collected from different apple cultivars of eighteen different provinces in Iran, was investigated using 22 polymorphic microsatellite markers. Analysis of molecular variation, Bayesian clustering and Nei's genetic distance analyses based on 88 microsatellite alleles indicated substantial levels of gene flow among the collection sites. Ninety three percent of the variation was observed among the individuals within the populations and only 7% variation was observed among the populations. Structure analysis grouped the isolates into two populations. Maximum number of pathogen genotypes (44) was observed in the North of Iran that grows various different apple cultivars. Investigation on the variation of the pathogen on different cultivars in the North of Iran suggested a significant differentiation of the pathogen populations between wild apple and commercial cultivars. During sampling, varying ranges of scab infection were observed on various apple cultivars in forests, monoculture and mix orchards. Wild type apple (Malus orientalis) along the Caspian Sea Coast had the most infection in comparison with the Iranian endemic and commercial cultivars. Based on the genetic analysis and host tracking scenario of the pathogen, it was presumed that Iran could potentially be the center of origin of V. inaequalis, which requires further detailed studies with isolates collected from different parts of central Asia and world for confirmation.	[Ebrahimi, Leila; Fotuhifar, Khalil-Berdi; Nikkhah, Mohammad Javan] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Pathol, Karaj, Iran; [Naghavi, Mohammad-Reza] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Biotechnol, Karaj, Iran; [Ebrahimi, Leila; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	University of Tehran; University of Tehran; Louisiana State University System; Louisiana State University	Baisakh, N (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu	Naghavi, Mohammad Reza/L-8722-2017; Salehi, Maryam/AAD-3641-2019; Ebrahimi, Leila/S-4092-2018	Naghavi, Mohammad Reza/0000-0002-2427-3332; Salehi, Maryam/0000-0002-2427-3332; Ebrahimi, Leila/0000-0001-8021-9106				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Boehm EWA, 2003, PHYTOPARASITICA, V31, P236, DOI 10.1007/BF02980833; BROWN AHD, 1980, GENETICS, V96, P523; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Clark Meredith, 2014, THESIS; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ershad D., 2009, FUNGI IRAN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Gao LQ, 2009, PEST MANAG SCI, V65, P1241, DOI 10.1002/ps.1816; Gharghani A, 2009, GENET RESOUR CROP EV, V56, P829, DOI 10.1007/s10722-008-9404-0; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Guerin F, 2004, MOL ECOL NOTES, V4, P268, DOI 10.1111/j.1471-8286.2004.00637.x; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Leroy T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-64; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; Martinez-Bilbao A, 2005, PLANT DIS, V89, P908, DOI 10.1094/PD-89-0908A; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Melounova M, 2004, PLANT SOIL ENVIRON, V50, P416, DOI 10.17221/4053-PSE; Nei M., 1987, MOL EVOLUTIONARY GEN; Padder B. A., 2011, Asian Journal of Plant Pathology, V5, P75, DOI 10.3923/ajppaj.2011.75.83; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Sandskar B, 2005, ACTA AGR SCAND B-S P, V55, P143, DOI [10.1080/090647105100029042, 10.1080/09064710510029042]; Schenato PG, 2008, TROP PLANT PATHOL, V33, P281, DOI 10.1590/S1982-56762008000400004; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Tenzer I, 1999, PHYTOPATHOLOGY, V89, P748, DOI 10.1094/PHYTO.1999.89.9.748; Tenzer I, 1997, EUR J PLANT PATHOL, V103, P565, DOI 10.1023/A:1008636913211; Xu XM, 2008, PLANT DIS, V92, P247, DOI 10.1094/PDIS-92-2-0247; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zhang L., 2010, THESIS	36	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160737	10.1371/journal.pone.0160737	http://dx.doi.org/10.1371/journal.pone.0160737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631622	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900012
J	Lapadula, G; Bernasconi, DP; Casari, S; Maggiolo, F; Cauda, R; Di Pietro, M; Ladisa, N; Sighinolfi, L; Dal Zoppo, S; Sabbatini, F; Soria, A; Pezzoli, C; Mondi, A; Costarelli, S; Valsecchi, MG; Torti, C; Gori, A				Lapadula, Giuseppe; Bernasconi, Davide Paolo; Casari, Salvatore; Maggiolo, Franco; Cauda, Roberto; Di Pietro, Massimo; Ladisa, Nicoletta; Sighinolfi, Laura; Dal Zoppo, Sarah; Sabbatini, Francesca; Soria, Alessandro; Pezzoli, Chiara; Mondi, Annalisa; Costarelli, Silvia; Valsecchi, Maria Grazia; Torti, Carlo; Gori, Andrea		Italian MASTER Cohort	Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; DISOPROXIL FUMARATE; INCOMPLETE REVERSIBILITY; POSITIVE PATIENTS; NAIVE PATIENTS; LARGE COHORT; EXPOSURE; SAFETY; ASSOCIATION	Background Tenofovir (TDF) can cause kidney injury through tubular dysfunction, with or without drop of estimated glomerular filtration rate (eGFR). Whether mild eGFR reductions during treatment should be considered a reason for prompt TDF discontinuation, however, remains unclear. Methods Patients with normal pre-TDF eGFR levels, who had developed mild renal impairment (i.e., two consecutive eGFR results between 89-60 ml/min) on TDF, were observed until onset of chronic kidney disease (CKD), defined as two eGFR< 60 ml/min 3 to 6 months apart. Multivariable Poisson regression analysis was used to investigate whether outcome was associated with current and cumulative use of TDF (modeled as time-varying covariates). Results 2023 (29%) out of 6984 patients developed mild renal impairment on TDF. Among them, 191 progressed to CKD. The incidence of CKD did not significantly differ during TDF treatment (2.6 per 100 PYFU; 95% CI 2.2-3.2) or after its discontinuation (2.2 per 100 PYFU; 95% CI 1.8-2.6). However, the rate of CKD was significantly higher among patients continuing with TDF treatment compared to those who had discontinued it within 6 months of occurrence of mild renal impairment (aIRR 4, 95% CI 2.4-6.8). In contrast, among patients who had maintained TDF > 6 months despite mild renal impairment, current TDF use was not associated with a significantly higher rate of CKD. Other significant predictors of CKD were older age, intravenous drug use, diabetes, hypertension, lower pre- TDF eGFR, higher eGFR drop since TDF introduction and longer exposure to TDF. Conclusions Prompt discontinuation of TDF among patients developing mild renal impairmentmay prevent further progression of renal damage.	[Lapadula, Giuseppe; Sabbatini, Francesca; Soria, Alessandro; Costarelli, Silvia; Gori, Andrea] San Gerardo Hosp, Monza, Italy; [Bernasconi, Davide Paolo; Valsecchi, Maria Grazia; Gori, Andrea] Univ Milano Bicocca, Milan, Italy; [Casari, Salvatore; Pezzoli, Chiara] Univ Brescia, Brescia, Italy; [Maggiolo, Franco] Papa Giovanni XXIII Hosp, Bergamo, Italy; [Cauda, Roberto; Mondi, Annalisa] Univ Cattolica Sacro Cuore, Rome, Italy; [Di Pietro, Massimo] Osped S Maria Annunziata, Florence, Italy; [Ladisa, Nicoletta] Osped Policlin, Bari, Italy; [Sighinolfi, Laura] Osped St Anna, Ferrara, Italy; [Dal Zoppo, Sarah] Ist Ospitalieri, Cremona, Italy; [Torti, Carlo] Magna Graecia Univ Catanzaro, Catanzaro, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Brescia; ASST Papa Giovanni XXIII; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Ferrara; Arcispedale Sant'Anna; Magna Graecia University of Catanzaro	Lapadula, G (corresponding author), San Gerardo Hosp, Monza, Italy.	giuseppe.lapadula@gmail.com	Casari, Salvatore/AAC-5790-2022; Valsecchi, Maria Grazia/K-8891-2016; Sighinolfi, Laura/AAH-1426-2020; Lapadula, Giuseppe/J-5163-2012; mondi, annalisa/AAA-8283-2019; Gori, Andrea/AAC-6078-2022; mondi, annalisa/HGC-9562-2022	Casari, Salvatore/0000-0001-5422-8754; Valsecchi, Maria Grazia/0000-0001-5574-3504; MONNO, Laura/0000-0002-2713-4258	Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy	Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy	The Italian MASTER cohort is sponsored by the Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy (www.fondazionemisi.it). No specific funding was received for the present article.	Baxi SM, 2016, AIDS, V30, P609, DOI 10.1097/QAD.0000000000000958; Baxi SM, 2014, AIDS, V28, P59, DOI 10.1097/QAD.0000000000000033; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Cote HCF, 2006, ANTIVIR THER, V11, P79; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gupta SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092717; Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Izzedine H, 2004, AIDS, V18, P1074, DOI 10.1097/00002030-200404300-00019; Jose S, 2014, J INFECT DIS, V210, P363, DOI 10.1093/infdis/jiu107; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kearney BP, 2006, CLIN PHARMACOKINET, V45, P1115, DOI 10.2165/00003088-200645110-00005; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Rodriguez-Novoa S, 2010, AIDS, V24, P1064, DOI 10.1097/QAD.0b013e32833202e2; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Ryom L, 2014, AIDS, V28, P187, DOI 10.1097/QAD.0000000000000042; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Squires K, 2003, ANN INTERN MED, V139, P313, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00006; Torti C, 2015, INT J EPIDEMIOL; Vrouenraets SME, 2011, AIDS, V25, P2149, DOI 10.1097/QAD.0b013e32834bba87; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Yoshino M, 2012, J INFECT CHEMOTHER, V18, P169, DOI 10.1007/s10156-011-0310-6; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162320	10.1371/journal.pone.0162320	http://dx.doi.org/10.1371/journal.pone.0162320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632369	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900037
J	Carvalho, RCT; Vasconcellos, SEG; Issa, MD; Soares, PM; Mota, PMPC; de Araujo, FR; Carvalho, ACD; Gomes, HM; Suffys, PN; Figueiredo, EED; Paschoalin, VMF				Tavares Carvalho, Ricardo Cesar; Goncalves Vasconcellos, Sidra Ezidio; Issa, Marina de Azevedo; Soares Filho, Paulo Martins; Pinto Coelho Mota, Pedro Moacyr; de Araujo, Flabio Ribeiro; da Silva Carvalho, Ana Carolina; Gomes, Harrison Magdinier; Suffys, Philip Noel; de Souza Figueiredo, Eduardo Eustaquio; Flosi Paschoalin, Vania Margaret			Molecular Typing of Mycobacterium bovis from Cattle Reared in Midwest Brazil	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX BACTERIA; LENGTH-POLYMORPHISM ANALYSIS; MATO-GROSSO; DISCRIMINATORY ABILITY; SPOLIGOTYPE DIVERSITY; GENETIC DIVERSITY; REPETITIVE UNITS; HIGH-RESOLUTION; TANDEM REPEATS; STRAINS	Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB), the pathogen responsible for serious economic impact on the livestock sector. In order to obtain data on isolated M. bovis strains and assist in the control and eradication program for BTB, a cross sectional descriptive molecular epidemiology study in the Brazilian Midwest was conducted. Through spoligotyping and 24-loci MIRU-VNTR methods, 37 clinical isolates of M. bovis circulating in the region were analyzed, 10 isolated from the state of Mato Grosso, 12 from the state of Mato Grosso do Sul and 15 from the state of Goias. The spoligotyping analysis identified 10 distinct M. bovis profiles (SB0121 n = 14, SB0295 n = 6, SB0140 n = 6, SB0881 n = 3, SB1144 n = 2, SB1145 n = 2, SB0134 n = 1, SB1050 n = 1, SB1055 n = 1, SB1136 n = 1) grouped in six clusters and four orphan patterns. The MIRU-VNTR 24-loci grouped the same isolates in six clusters and 22 unique orphan patterns, showing higher discriminatory power than spoligotyping. When associating the results of both techniques, the isolates were grouped in five clusters and 24 unique M. bovis profiles. Among the 24-loci MIRUVNTR evaluated, two, ETR-A and QUB 11b loci, showed high discriminatory ability (h = >= 0.50), while MIRU 16, MIRU 27, ETR-B, ETR-C, Mtub21 and QUB 26 loci showed moderate ability (h = 0.33 or h = 0.49) and were the most effective in evaluating the genotypic similarities among the clinical M. bovis isolate samples. Herein, the 29 patterns found amongst the 37 isolates of M. bovis circulating in the Brazilian Midwest can be due to the animal movement between regions, municipalities and farms, thus causing the spread of various M. bovis strains in herds from Midwest Brazil.	[Tavares Carvalho, Ricardo Cesar; da Silva Carvalho, Ana Carolina; Flosi Paschoalin, Vania Margaret] Univ Fed Rio de Janeiro, Inst Quim, Rio de Janeiro, RJ, Brazil; [Goncalves Vasconcellos, Sidra Ezidio; Gomes, Harrison Magdinier; Suffys, Philip Noel] Fundacao Oswaldo Cruz FIOCRUZ, IOC, Lab Biol Mol Aplicado & Micobacterias, Rio De Janeiro, RJ, Brazil; [Suffys, Philip Noel] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Issa, Marina de Azevedo; Soares Filho, Paulo Martins; Pinto Coelho Mota, Pedro Moacyr] MAPA, Lab Nacl Agr LANAGRO, Pedro Leopoldo, MG, Brazil; [de Araujo, Flabio Ribeiro] Empresa Brasileira Pesquisa Agr EMBRAPA Gado Cort, Campo Grande, MS, Brazil; [da Silva Carvalho, Ana Carolina] Univ Fed Rio de Janeiro UFRJ Campus Macae, Macae, RJ, Brazil; [de Souza Figueiredo, Eduardo Eustaquio] Univ Fed Mato Grosso UFMT, Fac Nutr, Cuiaba, MT, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Institute of Tropical Medicine (ITM); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso do Sul	Figueiredo, EED (corresponding author), Univ Fed Mato Grosso UFMT, Fac Nutr, Cuiaba, MT, Brazil.	figueiredoeduardo@ufmt.br	Paschoalin, Vania/Q-4997-2019; suffys, philip/E-3009-2013; FIGUEIREDO, EDUARDO E S/I-2803-2013; vasconcellos, Sidra E G Ezidio gonçalves/H-9651-2014; Paschoalin, Vania M F/J-1746-2014; Carvalho, Ana Carolina/W-5365-2018; de Souza Figueiredo, Eduardo Eustaquio/J-4085-2014	vasconcellos, Sidra E G Ezidio gonçalves/0000-0001-6983-1310; Paschoalin, Vania M F/0000-0001-6093-134X; Carvalho, Ana Carolina/0000-0002-1163-3407; de Souza Figueiredo, Eduardo Eustaquio/0000-0002-2608-4324; Tavares Carvalho, Ricardo Cesar/0000-0002-0666-7135	PRONEM/FAPEMAT [472914/2011]; CNPq/Universal [14/2014 (443235/2014-7), 443235/2014-7]; EMBRAPA [02.13.16.002.00.00]; FUNDECT [085/2015]; CAPES/AUX-PE/PROCAD [2493/2008]; CAPES/PNPD [23038.007901/2010-81]; CNPq [140492/2013-5]; FAPEMAT/PRONEM [472914/2011]; FAPERJ; CAPES [AUX-PE PROCAD 2493/2008]; Brazilian Agricultural Research Corporation EMBRAPA [02.13.16.002.00.00]	PRONEM/FAPEMAT; CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CAPES/AUX-PE/PROCAD; CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMAT/PRONEM(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Agricultural Research Corporation EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	The authors thank the Brazilian funding agencies for support: PRONEM/FAPEMAT (472914/2011) Dr. Eduardo Eustaquio de Souza Figueiredo; CNPq/Universal 14/2014 (443235/2014-7) Dr. Flabio Ribeiro de Araujo; EMBRAPA (02.13.16.002.00.00) Dr. Flabio Ribeiro de Araujo; FUNDECT (085/2015) Dr. Flabio Ribeiro de Araujo; CAPES/AUX-PE/PROCAD (2493/2008) Dra. Vania Margaret Flosi Paschoalin; CAPES/PNPD (23038.007901/2010-81) Dra. Ana Carolina da Silva Carvalho; and CNPq PhD grant (140492/2013-5) Dr. Ricardo Cesar Tavares Carvalho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Brazilian funding agencies FAPEMAT/PRONEM (472914/2011), FAPERJ, FUNDECT (085/2015), CNPq/Universal (443235/2014-7), CAPES (AUX-PE PROCAD 2493/2008), CAPES/PNPD (23038.007901/2010-81), the Brazilian Agricultural Research Corporation EMBRAPA (project 02.13.16.002.00.00), and CNPq PhD grant (140492/2013-5) for financial support, and to National Agricultural Laboratory (LANAGRO/MAPA) and sequencing platform group (PDTIS-FIOCRUZ/RJ) for their assistance in research.	Acha PN, 2001, BACTERIOSES MYCOSES, P395; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Alzamora F, 2014, PESQUI VET BRASIL, V34, P103, DOI 10.1590/S0100-736X2014000200001; Araujo CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091023; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Brazil, 2014, PROD PEC; Brazil, 2015, PROD PEC; Brazil, 2006, PROGR NAC CONTR ERR; Campos SR, 2013, J CLIN MICROBIOL, V51, P3658, DOI [10.1128/JCM.01271-13, DOI 10.1128/JCM.01271-13]; Carvalho RCT, 2015, TUBERCULOSIS EXPANDI, P191; Cazola DD, 2015, PESQUI VET BRASIL, V35, P141, DOI 10.1590/S0100-736X2015000200008; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Cobos-Marin L, 2005, CAN J MICROBIOL, V51, P996, DOI [10.1139/w05-083, 10.1139/W05-083]; Costa A.C.F., 2010, Arq. Inst. Biol., V77, P233, DOI 10.1590/1808-1657v77p2332010; Costello E, 1999, J CLIN MICROBIOL, V37, P3217, DOI 10.1128/JCM.37.10.3217-3222.1999; Cousins D, 1998, J CLIN MICROBIOL, V36, P168, DOI 10.1128/JCM.36.1.168-178.1998; da Silva C F, 2001, Rev Inst Med Trop Sao Paulo, V43, P25, DOI 10.1590/S0036-46652001000100005; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; Figueiredo EED, 2012, UNDERSTANDING TUBERCULOSIS - GLOBAL EXPERIENCES AND INNOVATIVE APPROACHES TO THE DIAGNOSIS, P411; Figueiredo EED, 2012, VET J, V193, P296, DOI 10.1016/j.tvjl.2011.11.006; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027; Rocha VCF, 2013, VECTOR-BORNE ZOONOT, V13, P17, DOI 10.1089/vbz.2012.1035; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Furlanetto LV, 2012, ARQ BRAS MED VET ZOO, V64, P274, DOI 10.1590/S0102-09352012000200004; Gibson AL, 2004, J CLIN MICROBIOL, V42, P431, DOI 10.1128/JCM.42.1.431-434.2004; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Reyes JAG, 2012, PREV VET MED, V106, P1, DOI 10.1016/j.prevetmed.2012.05.008; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Leite CQF, 2003, MEM I OSWALDO CRUZ, V98, P319, DOI 10.1590/S0074-02762003000300005; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Medeiros LD, 2010, BRAZ J MICROBIOL, V41, P531, DOI 10.1590/S1517-83822010005000002; Michel AL, 2008, VET MICROBIOL, V126, P151, DOI 10.1016/j.vetmic.2007.07.015; Mignard S, 2006, EMERG INFECT DIS, V12, P1431, DOI 10.3201/eid1209.060209; Murakami P. S., 2009, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V12, P67; *OIE, 2007, WAHID INT; OIE-World Organisation for Animal Health, 2009, BOVINE TUBERCULOSIS; Parreiras PM, 2012, MEM I OSWALDO CRUZ, V107, P64, DOI 10.1590/S0074-02762012000100009; Ramos DF, 2014, BRAZ J MICROBIOL, V45, P657, DOI 10.1590/S1517-83822014000200039; Rodriguez C. A. R., 2004, Arquivos do Instituto Biologico (Sao Paulo), V71, P277; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2011, J CLIN MICROBIOL, V49, P3361, DOI 10.1128/JCM.00301-11; Roring S, 2004, VET MICROBIOL, V101, P65, DOI 10.1016/j.vetmic.2004.02.013; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Roxo E, 2004, SITUACAO ATUAL TUBER; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Serraino A, 1999, J CLIN MICROBIOL, V37, P2766, DOI 10.1128/JCM.37.9.2766-2771.1999; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Carvalho RCT, 2015, MEAT SCI, V106, P11, DOI 10.1016/j.meatsci.2015.03.017; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Viana-Niero C, 2006, J MED MICROBIOL, V55, P451, DOI 10.1099/jmm.0.46364-0; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; *WHO, 1996, WHOEMCZOO964; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zumarraga MJ, 2013, RES VET SCI, V94, P9, DOI 10.1016/j.rvsc.2012.07.012; Zumarraga MJ, 1999, J CLIN MICROBIOL, V37, P296	72	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162459	10.1371/journal.pone.0162459	http://dx.doi.org/10.1371/journal.pone.0162459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631383	Green Published, gold			2022-12-27	WOS:000383706900050
J	Wong, A; Lau, AYL; Yang, J; Wang, ZL; Liu, WY; Lam, BYK; Au, L; Shi, L; Wang, DF; Chu, WCW; Xiong, YY; Lo, ESK; Law, LSN; Leung, TWH; Lam, LCW; Chan, AYY; Soo, YOY; Leung, EYL; Wong, LKS; Mok, VCT				Wong, Adrian; Lau, Alexander Y. L.; Yang, Jie; Wang, Zhaolu; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Shi, Lin; Wang, Defeng; Chu, Winnie C. W.; Xiong, Yun-yun; Lo, Eugene S. K.; Law, Lorraine S. N.; Leung, Thomas W. H.; Lam, Linda C. W.; Chan, Anne Y. Y.; Soo, Yannie O. Y.; Leung, Eric Y. L.; Wong, Lawrence K. S.; Mok, Vincent C. T.			Neuropsychiatric Symptom Clusters in Stroke and Transient Ischemic Attack by Cognitive Status and Stroke Subtype: Frequency and Relationships with Vascular Lesions, Brain Atrophy and Amyloid	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; ALZHEIMERS-DISEASE; MRI SCANS; DEMENTIA; IMPAIRMENT; PREVALENCE; DEFINITIONS; RELIABILITY; INVENTORY; DIAGNOSIS	Background The objectives of this study are 1) to examine the frequencies of neuropsychiatric symptom clusters in patients with stroke or transient ischemic attack (TIA) by cognitive level and stroke subtype; and 2) to evaluate effect of demographic, clinical, and neuroimaging measures of chronic brain changes and amyloid upon neuropsychiatric symptom clusters. Methods Hospital-based, cross-sectional study. 518 patients were administered the Neuropsychiatric Inventory (NPI) 3-6 months post index admission. NPI symptoms were classified into four symptom clusters (Behavioral Problems, Psychosis, Mood Disturbance & Euphoria) derived from a confirmatoryfactor analysis of the 12 NPI items. Multivariable logistic regression was used to determine independent associations between demographic, clinical and neuroimaging measures of chronic brain changes (white matter changes, old infarcts, whole brain atrophy, medial temporal lobe atrophy [MTLA] and frontal lobe atrophy [FLA]) with the presence of NPI symptoms and all symptom clusters except euphoria. C-11-Pittsburg Compound B Positron Emission Tomography (C-11-PiB PET) was performed in 24 patients to measure amyloid retention for Alzheimer's Disease (AD) pathology. Results 50.6% of the whole sample, including 28.7% cognitively normal and 66.7% of patients with mild cognitive symptoms, had >= 1 NPI symptoms. Frequencies of symptom clusters were largely similar between stroke subtypes. Compared to patients with cardioembolic stroke and intracranial haemorrhage, those with TIA had less frequent mood disturbance. Stroke severity at admission and MTLA were the most robust correlates of symptoms. FLA was associated with behavioral problems cluster only. Frequency of symptom clusters did not differ between patients with and without significant amyloid retention. Conclusion Frequency of neuropsychiatric symptoms increased with level of cognitive impairment but was largely similar between stroke subtypes. Stroke severity and MTLA were associated with neuropsychiatric symptoms. AD pathology appeared to be unrelated to neuropsychiatric manifestations but further studies with larger sample size are required to substantiate this finding.	[Wong, Adrian; Lau, Alexander Y. L.; Wang, Zhaolu; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Shi, Lin; Lo, Eugene S. K.; Law, Lorraine S. N.; Leung, Thomas W. H.; Chan, Anne Y. Y.; Soo, Yannie O. Y.; Wong, Lawrence K. S.; Mok, Vincent C. T.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Linda C. W.] Chinese Univ Hong Kong, Dept Psychiat, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian; Lau, Alexander Y. L.; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Mok, Vincent C. T.] Chinese Univ Hong Kong, Therese Pei Fong Chow Res Ctr Prevent Dementia, Hong Kong, Hong Kong, Peoples R China; [Yang, Jie] Guangzhou Med Univ, Inst Neurosci, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Minist Educ China, Guangzhou 510260, Guangdong, Peoples R China; [Xiong, Yun-yun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Leung, Eric Y. L.] Hong Kong Sanat & Hosp, Dept Nucl Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Nanjing University	Mok, VCT (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.; Mok, VCT (corresponding author), Chinese Univ Hong Kong, Therese Pei Fong Chow Res Ctr Prevent Dementia, Hong Kong, Hong Kong, Peoples R China.	vctmok@cuhk.edu.hk	Lam, Bonnie Yin Ka/J-7578-2016; Chan, Yin Yan Anne/B-5093-2016; Lau, Alexander Y/N-2485-2015; Leung, Thomas W. H./O-8567-2015; Shi, Lin/K-5241-2014; liu, wen/HGE-3071-2022; Mok, Vincent/N-6421-2015; Leung, Thomas W/AAU-6475-2021; Wong, Vincent WS/K-3864-2014; Au, Chi Lisa/B-4218-2017; Wong, Ka Sing Lawrence/N-3434-2015; Wong, Adrian/K-4859-2014; Chu, Winnie CW/F-8449-2014	Lam, Bonnie Yin Ka/0000-0002-1656-2433; Lau, Alexander Y/0000-0002-5933-9290; Shi, Lin/0000-0003-2318-4669; Mok, Vincent/0000-0002-8102-8835; Leung, Thomas W/0000-0001-8193-0709; Wong, Vincent WS/0000-0003-2215-9410; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Wong, Adrian/0000-0002-7859-3956; Chu, Winnie CW/0000-0003-4962-4132	Health and Health Services Research Fund of the Food and Health Bureau [HHSRF 0708041]; Hong Kong Special Administrative Region; Therese Pei Fong Chow Research Centre for Prevention of Dementia; Neurology Research Fund of the Chinese University of Hong Kong	Health and Health Services Research Fund of the Food and Health Bureau; Hong Kong Special Administrative Region; Therese Pei Fong Chow Research Centre for Prevention of Dementia; Neurology Research Fund of the Chinese University of Hong Kong	This work was supported by Health and Health Services Research Fund (HHSRF 0708041) of the Food and Health Bureau, Hong Kong Special Administrative Region, The Therese Pei Fong Chow Research Centre for Prevention of Dementia and the Neurology Research Fund of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; Brazzelli M, 2014, ANN NEUROL, V75, P67, DOI 10.1002/ana.24026; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; CASTILLO CS, 1993, J NERV MENT DIS, V181, P100, DOI 10.1097/00005053-199302000-00005; Chemerinski E, 2000, PSYCHOSOMATICS, V41, P5, DOI 10.1016/S0033-3182(00)71168-6; Cheng ST, 2012, INT PSYCHOGERIATR, V24, P1465, DOI 10.1017/S1041610212000609; Chiu H., 1994, HONG KONG J PSYCH S2, V4, P25; Chiu Pai-Yi, 2007, Acta Neurol Taiwan, V16, P86; de Groot JC, 2000, ANN NEUROL, V47, P145; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Geda YE, 2008, ARCH GEN PSYCHIAT, V65, P1193, DOI 10.1001/archpsyc.65.10.1193; Gupta M, 2013, ANN INDIAN ACAD NEUR, V16, P599, DOI 10.4103/0972-2327.120488; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/s1474-4422(14)70016-X, 10.1016/S1474-4422(14)70016-X]; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kim HJ, 2013, NEUROBIOL AGING, V34, P1913, DOI 10.1016/j.neurobiolaging.2013.01.002; Leung VPY, 2001, INT J GERIATR PSYCH, V16, P789, DOI 10.1002/gps.427.abs; Liu WY, 2015, STROKE, V46, P3074, DOI 10.1161/STROKEAHA.115.010449; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mayer LS, 2006, INT J GERIATR PSYCH, V21, P930, DOI 10.1002/gps.1583; Mok V, 2010, J NEUROL SCI, V290, P135, DOI 10.1016/j.jns.2009.12.014; Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031; O'Brien JT, 2006, AM J GERIAT PSYCHIAT, V14, P834, DOI 10.1097/01.JGP.0000214558.63358.94; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Peters ME, 2012, AM J GERIAT PSYCHIAT, V20, P416, DOI 10.1097/JGP.0b013e318211057d; Prabhakaran S, 2011, ARCH NEUROL-CHICAGO, V68, P85, DOI 10.1001/archneurol.2010.320; ROBINSON RG, 1988, STROKE, V19, P125, DOI 10.1161/01.STR.19.1.125; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Samus QM, 2006, J GERONTOL B-PSYCHOL, V61, pP311, DOI 10.1093/geronb/61.5.P311; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tang WK, 2009, J NEUROL; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Xiong Y, 2011, EUR J NEUROL, V18, P744, DOI 10.1111/j.1468-1331.2010.03272.x; Yang J, 2015, ALZHEIMERS DEMENT, V11, P16, DOI 10.1016/j.jalz.2014.01.003	41	19	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162846	10.1371/journal.pone.0162846	http://dx.doi.org/10.1371/journal.pone.0162846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632159	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900085
J	Wong, RG; Wu, JR; Gloor, GB				Wong, Ruth G.; Wu, Jia R.; Gloor, Gregory B.			Expanding the UniFrac Toolbox	PLOS ONE			English	Article							RNA GENE DATABASE; DIVERSITY	The UniFrac distance metric is often used to separate groups in microbiome analysis, but requires a constant sequencing depth to work properly. Here we demonstrate that unweighted UniFrac is highly sensitive to rarefaction instance and to sequencing depth in uniform data sets with no clear structure or separation between groups. We show that this arises because of subcompositional effects. We introduce information UniFrac and ratio UniFrac, two new weightings that are not as sensitive to rarefaction and allow greater separation of outliers than classic unweighted and weighted UniFrac. With this expansion of the UniFrac toolbox, we hope to empower researchers to extract more varied information from their data.	[Wong, Ruth G.; Wu, Jia R.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario)	Gloor, GB (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380	National Research Council of Canada [RGPIN-2015-03878]; Canadian Institutes of Health Research [MOP123459]	National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Discovery Grant from the National Research Council of Canada RGPIN-2015-03878 and Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca, MOP123459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; BEALS EW, 1984, ADV ECOL RES, V14, P1, DOI 10.1016/S0065-2504(08)60168-3; Callahan BJ, 2015, BIORXIV; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P8795, DOI 10.1128/AEM.05491-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egozcue J. J., 2011, P 4 INT WORKSH COMP, P1; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Oksanen J., 2007, COMMUN ECOL PACK, P631; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simberloff D., 1978, BIOLOGICAL DATA WATE, P150; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y; Wong RG, 2016, UNIFRAC WORKSH; Wong RG, 2016, SCRIPTS GENERATING P; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	42	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161196	10.1371/journal.pone.0161196	http://dx.doi.org/10.1371/journal.pone.0161196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632205	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900016
J	Murakami, W; Kobayashi, S; Susa, T; Nanno, T; Ishiguchi, H; Myoren, T; Nishimura, S; Kato, T; Hino, A; Oda, T; Okuda, S; Yamamoto, T; Yano, M				Murakami, Wakako; Kobayashi, Shigeki; Susa, Takehisa; Nanno, Takuma; Ishiguchi, Hironori; Myoren, Takeki; Nishimura, Shigehiko; Kato, Takayoshi; Hino, Akihiro; Oda, Tetsuro; Okuda, Shinichi; Yamamoto, Takeshi; Yano, Masafumi			Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes	PLOS ONE			English	Article							GUANYLYL CYCLASE-A; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; OXIDATIVE STRESS; INTERDOMAIN INTERACTIONS; THERAPEUTIC STRATEGY; CARDIAC-HYPERTROPHY; PROTEIN-KINASE; DNA-DAMAGE; CONTRIBUTES	Catecholamines induce intracellular reactive oxygen species (ROS), thus enhancing diastolic Ca2+ leakage through the ryanodine receptor during heart failure (HF). However, little is known regarding the effect of atrial natriuretic peptide (ANP) on ROS generation and Ca2+ handling in failing cardiomyocytes. The aim of the present study was to clarify the mechanism by which an exogenous ANP exerts cardioprotective effects during HF. Cardiomyocytes were isolated from the left ventricles of a canine tachycardia-induced HF model and sham-operated vehicle controls. The degree of mitochondrial oxidized DNA was evaluated by double immunohistochemical (IHC) staining using an anti-VDAC antibody for the mitochondria and an anti-8-hydroxy-20-deoxyguanosine antibody for oxidized DNA. The effect of ANP on ROS was investigated using 2,7-dichlorofluorescin diacetate, diastolic Ca2+ sparks assessed by confocal microscopy using Fluo 4-AM, and the survival rate of myocytes after 48 h. The double IHC study revealed that isoproterenol (ISO) markedly increased oxidized DNA in the mitochondria in HF and that the ISO-induced DNA damage was markedly inhibited by the co-presence of ANP. ROS production and Ca2+ spark frequency (CaSF) were increased in HF compared to normal controls, and were further increased in the presence of ISO. Notably, ANP significantly suppressed both ISO-induced ROS and CaSF without changing sarcoplasmic reticulum Ca2+ content in HF (p<0.01, respectively). The survival rate after 48 h in HF was significantly decreased in the presence of ISO compared with baseline (p<0.01), whereas it was significantly improved by the copresence of ANP (p<0.01). Together, our results suggest that ANP strongly suppresses ISO-induced mitochondrial ROS generation, which might correct aberrant diastolic Ca2+ sparks, eventually contributing to the improvement of cardiomyocyte survival in HF.	[Murakami, Wakako; Kobayashi, Shigeki; Susa, Takehisa; Nanno, Takuma; Ishiguchi, Hironori; Myoren, Takeki; Nishimura, Shigehiko; Kato, Takayoshi; Hino, Akihiro; Oda, Tetsuro; Okuda, Shinichi; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Div Cardiol, Dept Med & Clin Sci, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan	Yamaguchi University	Kobayashi, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Div Cardiol, Dept Med & Clin Sci, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	skoba@yamaguchi-u.ac.jp	ishiguchi, hironori/AAK-9793-2020; Okuda, Shinichi/AAG-8968-2020	Okuda, Shinichi/0000-0003-2639-5373; Kato, Takayoshi/0000-0001-9723-242X	Ministry of Education in Japan [23592256, 23390215]; Takeda Science Foundation in Japan; Daiichi-Sankyo; Grants-in-Aid for Scientific Research [16K15443] Funding Source: KAKEN	Ministry of Education in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation in Japan(Takeda Science Foundation (TSF)); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by grants-in-aid for scientific research from the Ministry of Education in Japan (Grant No. 23592256 to S.K. and Grant No. 23390215 to M.Y.) and grant from Takeda Science Foundation in Japan to S.K. Funding for this study was also provided by Daiichi-Sankyo who did not have any additional role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovo E, 2015, BIOPHYS J, V109, P1583, DOI 10.1016/j.bpj.2015.09.002; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Dobrev D, 2014, CIRC RES, V114, P1311, DOI 10.1161/CIRCRESAHA.114.300568; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Goto K, 2009, MED MOL MORPHOL, V42, P92, DOI 10.1007/s00795-009-0439-x; Hayashi M, 2001, J AM COLL CARDIOL, V37, P1820, DOI 10.1016/S0735-1097(01)01233-5; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Javadov S, 2006, AM J PHYSIOL-HEART C, V291, pH1722, DOI 10.1152/ajpheart.00159.2006; Javadov S, 2006, J PHARMACOL EXP THER, V317, P1036, DOI 10.1124/jpet.105.100107; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Klaiber M, 2011, P NATL ACAD SCI USA, V108, P18500, DOI 10.1073/pnas.1103300108; Kobayashi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114314; Kobayashi S, 2011, EUR J HEART FAIL, V13, P29, DOI 10.1093/eurjhf/hfq178; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Li YH, 2002, CIRCULATION, V106, P1722, DOI 10.1161/01.CIR.0000029923.57048.61; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Maruyama R, 2001, AM J PATHOL, V159, P683, DOI 10.1016/S0002-9440(10)61739-7; Mattana J, 2003, AM J PHYSIOL, V265, pC92; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Perera RK, 2015, CIRC RES, V116, P1304, DOI 10.1161/CIRCRESAHA.116.306082; SAITO Y, 1987, CIRCULATION, V76, P115, DOI 10.1161/01.CIR.76.1.115; Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Susa T, 2012, CIRC J, V76, P117, DOI 10.1253/circj.CJ-11-0537; Suwa M, 2005, CIRC J, V69, P283, DOI 10.1253/circj.69.283; Tokudome T, 2005, CIRCULATION, V111, P3095, DOI 10.1161/CIRCULATIONAHA.104.510594; TSUTAMOTO T, 1989, AM HEART J, V117, P599, DOI 10.1016/0002-8703(89)90734-5; Tsutsui H, 2001, CIRCULATION, V104, P2883, DOI 10.1161/hc4901.101347; Vollmar AM, 2005, PEPTIDES, V26, P1086, DOI 10.1016/j.peptides.2004.08.034; Yamamoto T, 2008, CIRCULATION, V117, P762, DOI 10.1161/CIRCULATIONAHA.107.718957; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195	42	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163250	10.1371/journal.pone.0163250	http://dx.doi.org/10.1371/journal.pone.0163250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657534	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200092
J	Peng, YQ; Horwitz, N; Lakatta, EG; Lin, L				Peng, Yunqian; Horwitz, Naftali; Lakatta, Edward G.; Lin, Li			Mouse RAGE Variant 4 Is a Dominant Membrane Receptor that Does Not Shed to Generate Soluble RAGE	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ATHEROSCLEROSIS RISK; ENDPRODUCTS RAGE; INFLAMMATION; EXPRESSION; ACTIVATION; ROLES; CELLS; SRAGE	The receptor for advanced glycation end products (RAGE) is a multi-ligand, immunoglobulin-like receptor that has been implicated in aging-associated diseases. Recent studies have demonstrated that both human and murine Ager genes undergo extensive alternative splicing that generatesmultiple putative transcripts encoding different receptor isoforms. Except for the soluble isoform(esRAGE), the majority of putative RAGE isoforms remain unstudied. Profiling of murine Ager transcripts showed that variant transcript 4 (mRAGE_v4), the second most abundant transcript in lungs and multiple other tissues, encodes a receptor that lacks nine residues located within the C2 extracellular section close to the trans-membrane domain. We therefore characterizedmRAGEV4 isoreceptor in comparison with the full-length mRAGE (mRAGEFL). Although differing in only nine residues, mRAGEFL and mRAGEV4 display very different cellular behaviors. While mRAGEFL undergoes constitutive, extensive shedding in the cell to generate sRAGE, mRAGEV4 hardly sheds. In addition, we found that while mRAGEFL can localize to both the plasma membrane and the endosome, mRAGEV4 is exclusively localized to the plasma membrane. These very different cellular localization patterns suggest that, in addition to their roles in sRAGE production, mRAGEFL and mRAGEV4 may play distinct, spatiotemporal roles in signaling and innate immune responses. Compared to mice, humans do not have the v4 transcript. Although hRAGE, like mRAGEFL, also localizes to the plasma membrane and the endosome, its rate of constitutive shedding is significantly lower. These observations provide valuable information regarding RAGE biology, and serve as a reference by which to create mouse models relating to human diseases.	[Peng, Yunqian; Horwitz, Naftali; Lakatta, Edward G.; Lin, Li] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lin, L (corresponding author), NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.	linli@mail.nih.gov	Lakatta, Edward G/AAL-1447-2020	Lakatta, Edward/0000-0002-4772-0035	intramural research program of the National Institute on Aging, NIH	intramural research program of the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the intramural research program of the National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Al Rifai M, 2015, J DIABETES COMPLICAT, V29, P180, DOI 10.1016/j.jdiacomp.2014.11.008; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Buckley ST, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/917108; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Di Fiore PP, 2014, COLD SPRING HARB PER, P6; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Giron MD, 1998, BIOCHEM BIOPH RES CO, V251, P230, DOI 10.1006/bbrc.1998.9446; Gopal P, 2015, BBA-MOL BASIS DIS, V1852, P992, DOI 10.1016/j.bbadis.2015.02.003; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2015, ATHEROSCLEROSIS, V240, P17, DOI 10.1016/j.atherosclerosis.2015.02.015; Hudson BI, 2014, METABOLISM, V63, P1125, DOI 10.1016/j.metabol.2014.05.011; Hudson BI, 2011, ATHEROSCLEROSIS, V216, P192, DOI 10.1016/j.atherosclerosis.2011.01.024; Jules J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078267; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lazo M, 2015, AM HEART J, V170, P961, DOI 10.1016/j.ahj.2015.08.008; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Maruthur NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128452; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Pang J, 2009, PROTEIN SCI, V18, P1261, DOI 10.1002/pro.136; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Schmidt AM, 2015, VASCUL PHARM; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Tae HJ, 2013, J MOL MED, V91, P1369, DOI 10.1007/s00109-013-1091-4; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050736; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0153657	10.1371/journal.pone.0153657	http://dx.doi.org/10.1371/journal.pone.0153657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655067	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700002
J	Contreras-Cubas, C; Sanchez-Hernandez, BE; Garcia-Ortiz, H; Martinez-Hernandez, A; Barajas-Olmos, F; Cid, M; Mendoza-Caamal, EC; Centeno-Cruz, F; Ortiz-Cruz, G; Jimenez-Lopez, JC; Cordova, EJ; Salas-Bautista, EG; Saldana-Alvarez, Y; Fernandez-Lopez, JC; Mutchinick, OM; Orozco, L				Contreras-Cubas, Cecilia; Sanchez-Hernandez, Beatriz E.; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Barajas-Olmos, Francisco; Cid, Miguel; Mendoza-Caamal, Elvia C.; Centeno-Cruz, Federico; Ortiz-Cruz, Gabriela; Concepcion Jimenez-Lopez, Jose; Cordova, Emilio J.; Gabriela Salas-Bautista, Eva; Saldana-Alvarez, Yolanda; Carlos Fernandez-Lopez, Juan; Mutchinick, Osvaldo M.; Orozco, Lorena			Heterogenous Distribution of MTHFR Gene Variants among Mestizos and Diverse Amerindian Groups from Mexico	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE GENE; METHYLENETETRAHYDROFOLATE-REDUCTASE; RISK-FACTOR; ETHNIC VARIATION; C677T; POPULATIONS; MUTATION; POLYMORPHISMS; ASSOCIATION	Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in folate metabolism. Folate deficiency has been related to several conditions, including neural tube defects (NTDs) and cardiovascular diseases. Hence, MTHFR genetic variants have been studied worldwide, particularly the C677T and A1298C. We genotyped the C677T and A1298C MTHFR polymorphisms in Mexican Amerindians (MAs), from the largest sample included in a genetic study (n = 2026, from 62 ethnic groups), and in a geographically-matched Mexican Mestizo population (MEZ, n = 638). The 677T allele was most frequent in Mexican individuals, particularly in MAs. The frequency of this allele in both MAs and MEZs was clearly enriched in the South region of the country, followed by the Central East and South East regions. In contrast, the frequency of the 1298C risk allele in Mexicans was one of the lowest in the world. Both in MAs and MEZs the variants 677T and 1298C displayed opposite allele frequency gradients from southern to northern Mexico. Our findings suggest that in Mestizos the 677T allele was derived from Amerindians while the 1298C allele was a European contribution. Some subgroups showed an allele frequency distribution that highlighted their genetic diversity. Notably, the distribution of the frequency of the 677T allele was consistent with that of the high incidence of NTDs reported in MEZ.	[Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Barajas-Olmos, Francisco; Cid, Miguel; Mendoza-Caamal, Elvia C.; Centeno-Cruz, Federico; Cordova, Emilio J.; Saldana-Alvarez, Yolanda; Orozco, Lorena] Inst Nacl Med Genom SS, Inmunogen & Metab Dis Lab, Mexico City, DF, Mexico; [Sanchez-Hernandez, Beatriz E.; Ortiz-Cruz, Gabriela; Mutchinick, Osvaldo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran SS, Dept Genet, Mexico City, DF, Mexico; [Concepcion Jimenez-Lopez, Jose; Gabriela Salas-Bautista, Eva] Museo Nacl Antropol, Inst Nacl Antropol & Hist, Phys Anthropol Direct, Mexico City, DF, Mexico; [Carlos Fernandez-Lopez, Juan] Inst Nacl Med Genom, Computat Genom, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Orozco, L (corresponding author), Inst Nacl Med Genom SS, Inmunogen & Metab Dis Lab, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	HERNÁNDEZ, BEATRIZ E. SÁNCHEZ/AAZ-3922-2020	HERNÁNDEZ, BEATRIZ E. SÁNCHEZ/0000-0003-1255-0117	Consejo Nacional de Ciencia y Tecnologia [S008-2014-1, 233970, CB-2014-01-243587]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.mx/) grants S008-2014-1 No. 233970 (LO) and CB-2014-01-243587 (EJC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Olaf Ivan Corro Labra and Jose Luis de Jesus Garcia Ruiz from the "Comision Nacional para el Desarrollo de los Pueblos Indigenas" for their support in this work. We would like to acknowledge to IBQ Julio Cesar Canseco M, and Biol. Alfredo Mendoza-Vargas from the USec INMEGEN for technical support. This study was supported by Consejo Nacional de Ciencia y Tecnologia grants S008-2014-1 No. 233970 and CB-2014-01-243587.	Alluri RV, 2005, EUR J NEUROL, V12, P40, DOI 10.1111/j.1468-1331.2004.00938.x; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonio-Vejar V, 2014, GENET MOL RES, V13, P7950, DOI 10.4238/2014.September.29.8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Binia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0421-7; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2007, SER, P56; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2003, PUEBL IND MEX CONT, P31; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2004, PAM, P31; Davalos IP, 2000, ANN GENET-PARIS, V43, P89, DOI 10.1016/S0003-3995(00)90012-1; de Franchis R, 1998, J MED GENET, V35, P1009, DOI 10.1136/jmg.35.12.1009; Fodil-Cornu N, 2009, GENES IMMUN, V10, P662, DOI 10.1038/gene.2009.50; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonzalez-Herrera L, 2002, CLIN GENET, V62, P394, DOI 10.1034/j.1399-0004.2002.620507.x; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; Gueant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701; INEGI, 2010, CENS POBL VIV 2010; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Juarez-Velazquez R, 2010, DIS MARKERS, V28, P323, DOI [10.1155/2010/716542, 10.3233/DMA-2010-0712]; Kim YI., 1999, J NUTR BIOCH, V10, P66; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Melnick M, 1998, J CRAN GENET DEV BIO, V18, P233; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Mutchinick OM, 1999, MOL GENET METAB, V68, P461, DOI 10.1006/mgme.1999.2939; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Ordonez G, 2015, CLIN NEUROL NEUROSUR, V130, P55, DOI 10.1016/j.clineuro.2014.11.026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangel-Villalobos H, 2008, AM J PHYS ANTHROPOL, V135, P448, DOI 10.1002/ajpa.20765; Reddy MVPL, 2007, HUM GENET, V121, P721, DOI 10.1007/s00439-007-0367-6; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Valdes-Hernandez J, 2010, SALUD PUBLICA MEXICO, V52, P341; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; van der Put NMJ, 2000, EUR J OBSTET GYN R B, V92, P57, DOI 10.1016/S0301-2115(00)00426-7; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Varga EA, 2005, CIRCULATION, V111, pE289, DOI 10.1161/01.CIR.0000165142.37711.E7; Waes JG, 2005, BIRTH DEFECTS RES A, V73, P487, DOI 10.1002/bdra.20148; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	44	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163248	10.1371/journal.pone.0163248	http://dx.doi.org/10.1371/journal.pone.0163248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649570	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100069
J	Mangussi, F; Zanette, DH				Mangussi, Franco; Zanette, Damian H.			Internal Resonance in a Vibrating Beam: A Zoo of Nonlinear Resonance Peaks	PLOS ONE			English	Article								In oscillating mechanical systems, nonlinearity is responsible for the departure from proportionality between the forces that sustain their motion and the resulting vibration amplitude. Such effect may have both beneficial and harmful effects in a broad class of technological applications, ranging from microelectromechanical devices to edifice structures. The dependence of the oscillation frequency on the amplitude, in particular, jeopardizes the use of nonlinear oscillators in the design of time-keeping electronic components. Nonlinearity, however, can itself counteract this adverse response by triggering a resonant interaction between different oscillation modes, which transfers the excess of energy in the main oscillation to higher harmonics, and thus stabilizes its frequency. In this paper, we examine a model for internal resonance in a vibrating elastic beam clamped at its two ends. In this case, nonlinearity occurs in the form of a restoring force proportional to the cube of the oscillation amplitude, which induces resonance between modes whose frequencies are in a ratio close to 1:3. The model is based on a representation of the resonant modes as two Duffing oscillators, coupled through cubic interactions. Our focus is put on illustrating the diversity of behavior that internal resonance brings about in the dynamical response of the system, depending on the detailed form of the coupling forces. The mathematical treatment of the model is developed at several approximation levels. A qualitative comparison of our results with previous experiments and numerical calculations on elastic beams is outlined.	[Zanette, Damian H.] Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zanette, DH (corresponding author), Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	zanette@cab.cnea.gov.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-1611]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (URL: www.agencia.mincyt.gob.ar), grant number PICT 2014-1611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834707; Agarwal M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2785018; Ando B., 2000, STOCHASTIC RESONANCE; Antonio D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.034103; Antonio D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1813; Arroyo SI, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2015-60517-3; Chen LQ, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4029606; Drazin P.G., 1992, NONLINEAR SYSTEMS; Duffing G., 1918, ZAMM Z ANGEW MATH ME; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Gaffurius F, THEORICA MUSICAE; Habib G, 2015, MECH SYST SIGNAL PR, V52-53, P17, DOI 10.1016/j.ymssp.2014.08.009; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Kirkendall CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22897; Kovacic I., 2011, DUFFING EQUATION NON; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lee CL., 1992, NONLINEAR DYNAM, V3, P465, DOI [10.1007/BF00045648, DOI 10.1007/BF00045648]; Lulla KJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113040; Mangussi F, 2015, THESIS; Molteno TC, 2004, AM J PHYS, V72, P1157, DOI 10.1119/1.1764557; NARASIMHA R, 1968, J SOUND VIB, V8, P134, DOI 10.1016/0022-460X(68)90200-9; Nayfeh A H, 1995, NONLINEAR OSCILLATIO; Nayfeh AH., 1989, APPL MECH REV, V42, pS175; Nguyen CTC, 2007, IEEE T ULTRASON FERR, V54, P251, DOI 10.1109/TUFFC.2007.240; Postma HWC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1929098; Press W. H., 1992, NUMERICAL RECIPES FO, P372; RAO GV, 1991, J SOUND VIB, V149, P25, DOI 10.1016/0022-460X(91)90909-4; Ribeiro P, 1999, J SOUND VIB, V224, P591, DOI 10.1006/jvsi.1999.2193; Sancho J, 1989, NOISE NONLINEAR DYNA; Timoshenko S, 1953, HIST STRENGTH MAT; van Beek JTM, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/013001; Westra HJR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117205; Yang YS, 2015, PROC IEEE MICR ELECT, P1008, DOI 10.1109/MEMSYS.2015.7051132; YURKE B, 1995, PHYS REV A, V51, P4211, DOI 10.1103/PhysRevA.51.4211; Zanette DH, 2014, EUR PHYS J-SPEC TOP, V223, P2807, DOI 10.1140/epjst/e2014-02294-7	35	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162365	10.1371/journal.pone.0162365	http://dx.doi.org/10.1371/journal.pone.0162365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648829	Green Published, gold			2022-12-27	WOS:000383892100017
J	Zanello, G; Srinivasan, CS; Shankar, B				Zanello, Giacomo; Srinivasan, C. S.; Shankar, Bhavani			What Explains Cambodia's Success in Reducing Child Stunting-2000-2014?	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; UNDERNUTRITION; CONSEQUENCES; MALNUTRITION; NUTRITION; TRENDS; CARE; INTERVENTIONS; REDUCTION	In many developing countries, high levels of child undernutrition persist alongside rapid economic growth. There is considerable interest in the study of countries that have made rapid progress in child nutrition to uncover the driving forces behind these improvements. Cambodia is often cited as a success case having reduced the incidence of child stunting from 51% to 34% over the period 2000 to 2014. To what extent is this success driven by improvements in the underlying determinants of nutrition, such as wealth and education, ("covariate effects") and to what extent by changes in the strengths of association between these determinants and nutrition outcomes ("coefficient effects")? Using determinants derived from the widely-applied UNICEF framework for the analysis of child nutrition and data from four Demographic and Health Surveys datasets, we apply quantile regression based decomposition methods to quantify the covariate and coefficient effect contributions to this improvement in child nutrition. The method used in the study allows the covariate and coefficient effects to vary across the entire distribution of child nutrition outcomes. There are important differences in the drivers of improvements in child nutrition between severely stunted and moderately stunted children and between rural and urban areas. The translation of improvements in household endowments, characteristics and practices into improvements in child nutrition (the coefficient effects) may be influenced by macroeconomic shocks or other events such as natural calamities or civil disturbance and may vary substantially over different time periods. Our analysis also highlights the need to explicitly examine the contribution of targeted child health and nutrition interventions to improvements in child nutrition in developing countries.	[Zanello, Giacomo; Srinivasan, C. S.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Shankar, Bhavani] Univ London, Sch Oriental & African Studies, Ctr Dev Environm & Policy, London, England	University of Reading; University of London; University of London School Oriental & African Studies (SOAS)	Srinivasan, CS (corresponding author), Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England.	c.s.srinivasan@reading.ac.uk	Srinivasan, Chittur S/C-8509-2017	Srinivasan, Chittur S/0000-0003-2537-7675; Shankar, Bhavani/0000-0001-8102-321X; Zanello, Giacomo/0000-0002-0477-1385				ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Bagriansky J, 2014, ASIA PAC J CLIN NUTR, V23, P524, DOI 10.6133/apjcn.2014.23.4.08; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Block SA, 2004, ECON HUM BIOL, V2, P21, DOI 10.1016/j.ehb.2003.12.007; Brinkman HJ, 2010, J NUTR, V140, p153S, DOI 10.3945/jn.109.110767; Chandararot K, 2009, RAPID ASSESSMENT IMP; Conkle J, 2007, EXCLUSIVE BREASTFEED; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; DiNardo J, 1996, ECONOMETRICA, V64, P1001, DOI 10.2307/2171954; Engle PL, 1999, WORLD DEV, V27, P1309, DOI 10.1016/S0305-750X(99)00059-5; Firpo S, 2009, ECONOMETRICA, V77, P953, DOI 10.3982/ECTA6822; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; IFPRI, 2015, GLOBAL NUTR REPORT 2; Ikeda N, 2013, B WORLD HEALTH ORGAN, V91, P341, DOI 10.2471/BLT.12.113381; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kov P., 2013, GROWING TALLER TOILE; Laillou A, 2015, NUTRIENTS, V7, P4189, DOI 10.3390/nu7064189; Leroy J.L., 2011, ZSCORE06 STATA COMMA; Makoka D., 2013, IMPACT MATERNAL ED C; Marriott BP, 2010, MATERN CHILD NUTR, V6, P358, DOI 10.1111/j.1740-8709.2009.00217.x; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; NATIONAL INSTITUTE OF STATISTICS, 2001, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health and ICF International, 2015, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health and IM, 2010, CAMB DEM HLTH SURV 2; NCDM & UNDP, 2014, CAMB DIS LOSS DAM IN; NCDM WFP, 2012, 2012 CAMB POSTFL REL; NMCHC, 2014, NUTR STAT NUTR INT C; O'Donnell O, 2009, J DEV ECON, V88, P45, DOI 10.1016/j.jdeveco.2008.01.004; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Prak S, 2014, NUTRIENTS, V6, P2920, DOI 10.3390/nu6072920; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; RESULTS UK, 2014, UND LAND RIC WHY 3 S; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein S. O., 2004, DHS WEALTH INDEX; Sastry N, 1997, SOC SCI MED, V44, P989, DOI 10.1016/S0277-9536(96)00224-9; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Smith LC, 2001, AGR ECON-BLACKWELL, V26, P191, DOI 10.1111/j.1574-0862.2001.tb00063.x; SOTHATH Ngo, 2010, MORE VULNERABLE IMPA; Spears D, 2013, NUTR VALUE TOILETS M; Srinivasan CS, 2013, BMC PUBLIC HEALTH, P13; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Sunil TS, 2013, MATERNAL CHILD NUTR; UN in Cambodia, 2009, GLOB EC DOWNT OPP CR; UNICEF, 1990, STRAT IMPR NUTR WOM STRAT IMPR NUTR WOM; UNICEF, 2009, CAMB ANTHR SURV; UNICEF, 2012, PROGR DRINK WAT SAN; UNSCN, 2014, PRIOR NUTR IND POST; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2014, MAT INF YOUNG CHILD; WHO, 2006, WHO CHILD GROWTH STA; World Bank, 2012, WORLD DEV IND 2012; World Health Organization, 2008, IND ASS INF YOUNG CH; World Health Organization, 2015, WHO REC ROUT IMM SUM	63	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162668	10.1371/journal.pone.0162668	http://dx.doi.org/10.1371/journal.pone.0162668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649080	Green Accepted, Green Published, gold			2022-12-27	WOS:000383892100028
J	Velazquez-Villoria, A; Recalde, S; Anter, J; Bezunartea, J; Hernandez-Sanchez, M; Garcia-Garcia, L; Alonso, E; Ruiz-Moreno, JM; Araiz-Iribarren, J; Fernandez-Robredo, P; Garcia-Layana, A				Velazquez-Villoria, Alvaro; Recalde, Sergio; Anter, Jaouad; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Garcia-Garcia, Laura; Alonso, Elena; Marina Ruiz-Moreno, Jose; Araiz-Iribarren, Javier; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo			Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes	PLOS ONE			English	Article							COMPLEMENT FACTOR-I; MACULAR DEGENERATION; CANDIDATE GENE; RISK-FACTORS; COL1A1 GENE; SUSCEPTIBILITY GENE; PATHOLOGICAL MYOPIA; MOLECULAR-GENETICS; REFRACTIVE ERRORS; PREVALENCE	Choroidal neovascularization (CNV) commonly occurs in age related macular degeneration and pathological myopia patients. In this study we conducted a case-control prospective study including 431 participants. The aim of this study was to determine the potential association between 10 single nucleotide polymorphisms (SNPs) located in 4 different genetic regions (CFI, COL8A1, LIPC, and APOE), and choroidal neovascularization in age-related macular degeneration and the development of choroidal neovascularization in highly myopic eyes of a Caucasian population. Univariate and multivariate logistic regression analysis adjusted for age, sex and hypertension was performed for each allele, genotype and haplotype frequency analysis. We found that in the univariate analysis that both single-nucleotide polymorphisms in COL8A1 gene (rs13095226 and rs669676) together with age, sex and hypertension were significantly associated with myopic CNV development in Spanish patients (p<0.05). After correcting for multiple testing none of the polymorphisms studied remained significantly associated with myopic CNV (p>0.05); however, analysis of the axial length between genotypes of rs13095226 revealed an important influence of COL8A1 in the development of CNV in high myopia. Furthermore we conducted a meta-analysis of COL8A1, CFI and LIPC genes SNPs (rs669676, rs10033900 and rs10468017) and found that only rs669676 of these SNPs were associated with high myopia neovascularization.	[Velazquez-Villoria, Alvaro; Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Garcia-Garcia, Laura; Alonso, Elena; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain; [Velazquez-Villoria, Alvaro; Alonso, Elena; Garcia-Layana, Alfredo] Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain; [Anter, Jaouad] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Celular & Mol Med, Madrid, Spain; [Marina Ruiz-Moreno, Jose] Castilla La Mancha Univ, Albacete & Baviera European Inst Retina, Dept Ophthalmol, Alicante, Spain; [Araiz-Iribarren, Javier] Univ Basque Country, Surg Clin Inst Ophthalmol, Bilbao, Spain; [Araiz-Iribarren, Javier] San Eloy Hosp, Bilbao, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Basque Country	Recalde, S (corresponding author), Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain.	srecalde@unav.es	Recalde, Sergio/D-1815-2017	Recalde, Sergio/0000-0002-9328-9725; Ruiz-Moreno, Jose M/0000-0001-9636-0788	PN I + D + I; ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; European Program FEDER	PN I + D + I; ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; European Program FEDER	This work has been developed by members of the Spanish Vitreoretinal society (SERV), the RETICs: RD07-0062: "Age Related Ocular Diseases, Quality of Life, and Vision", and RETICS OFTARED (RD12/0034) "Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology" from the Instituto de Salud Carlos III from the Ministerio de Economia y Competitividad, Spain. This work has been partly funded by the PN I + D + I 20082011; the ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; and the European Program FEDER.; We greatly thank all the patients who participated in this study. This work has been developed by members of the Spanish Vitreoretinal society (SERV), the RETICs: RD07-0062: "Age Related Ocular Diseases, Quality of Life, and Vision", and RETICS OFTARED (RD12/0034) "Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology" from the Instituto de Salud Carlos III from the Ministerio de Economia y Competitividad, Spain. This work has been partly funded by the PN I + D + I 2008-2011; the ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; and the European Program FEDER.	Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Chan NS, 2015, EYE CONTACT LENS; Chen SJ, 2012, INVEST OPHTH VIS SCI, V53, P4868, DOI 10.1167/iovs.12-9919; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241, DOI 10.1016/S0161-6420(96)30515-0; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P534, DOI 10.1167/iovs.07-1123; Ennis S, 2010, EUR J HUM GENET, V18, P15, DOI 10.1038/ejhg.2009.113; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Fernandez-Robredo P, 2008, OPHTHALMOLOGY, V115, P1632, DOI 10.1016/j.ophtha.2008.03.004; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gorin MB, 2007, ARCH OPHTHALMOL-CHIC, V125, P21, DOI 10.1001/archopht.125.1.21; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Haghighi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112747; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Han W, 2006, INVEST OPHTH VIS SCI, V47, P2291, DOI 10.1167/iovs.05-1344; Hayashi T, 2007, JPN J OPHTHALMOL, V51, P96, DOI 10.1007/s10384-006-0417-y; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hrynchak PK, 2013, OPTOMETRY VISION SCI, V90, P1331, DOI 10.1097/OPX.0000000000000069; Hufnagel SB, 2014, AM J MED GENET A, V164, P2607, DOI 10.1002/ajmg.a.36688; Ikuno Y, 2008, RETINA-J RET VIT DIS, V28, P1124, DOI 10.1097/IAE.0b013e318174417a; Inamori Y, 2007, HUM GENET, V122, P151, DOI 10.1007/s00439-007-0388-1; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Lechanteur YTE, 2012, INVEST OPHTH VIS SCI, V53, P5846, DOI 10.1167/iovs.11-7731; Leveziel N, 2012, INVEST OPHTH VIS SCI, V53, P5004, DOI 10.1167/iovs.12-9538; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Lin HJ, 2010, EYE, V24, P1093, DOI 10.1038/eye.2009.254; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Lu BY, 2011, INVEST OPHTH VIS SCI, V52, P8258, DOI 10.1167/iovs.11-7914; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Miyake M, 2013, INVEST OPHTH VIS SCI, V54, P4208, DOI 10.1167/iovs.13-12280; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Mutti DO, 2007, MOL VIS, V13, P1012; Nakanishi H, 2010, EYE, V24, P1078, DOI 10.1038/eye.2009.215; Nakanishi H, 2009, INVEST OPHTH VIS SCI, V50, P544, DOI 10.1167/iovs.08-2425; NOBLE KG, 1982, OPHTHALMOLOGY, V89, P1099; Pacella R, 1999, OPTOMETRY VISION SCI, V76, P381, DOI 10.1097/00006324-199906000-00017; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Percival S P, 1987, Dev Ophthalmol, V14, P42; Pertile KK, 2008, INVEST OPHTH VIS SCI, V49, P49, DOI 10.1167/iovs.07-0896; Saw Seang-Mei, 2003, Clin Exp Optom, V86, P289; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Scavello GS, 2004, INVEST OPHTH VIS SCI, V45, P2091, DOI 10.1167/iovs.03-0933; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Seddon JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087047; Sergouniotis PI, 2015, EYE, V29, P475, DOI 10.1038/eye.2014.334; Shih YF, 2006, BRIT J OPHTHALMOL, V90, P546, DOI 10.1136/bjo.2005.081992; Shuttleworth CA, 1997, INT J BIOCHEM CELL B, V29, P1145, DOI 10.1016/S1357-2725(97)00033-2; Snead MP, 1999, J MED GENET, V36, P353; Soubrane G, 2008, SURV OPHTHALMOL, V53, P121, DOI 10.1016/j.survophthal.2007.12.004; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; TAMURA Y, 1991, INVEST OPHTH VIS SCI, V32, P2636; Tang WC, 2007, MOL VIS, V13, P534; TEIKARI JM, 1991, HUM HERED, V41, P151, DOI 10.1159/000153994; Terhal PA, 2015, AM J MED GENET A, V167, P461, DOI 10.1002/ajmg.a.36922; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wang PF, 2009, INVEST OPHTH VIS SCI, V50, P1546, DOI 10.1167/iovs.08-2537; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Woo W W, 2004, Singapore Med J, V45, P470; Yu Y, 2015, INT J CLIN EXP PATHO, V8, P11635; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; Zayats T, 2009, MOL VIS, V15, P213; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623; Zhang DD, 2011, MOL VIS, V17, P3379; Zhang X, 2015, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-015-0050-0	73	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162296	10.1371/journal.pone.0162296	http://dx.doi.org/10.1371/journal.pone.0162296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643879	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900010
J	Zhang, JL; Wu, SZ; Liu, YL; Qiao, L; Gao, WH; Zhang, WG; Liu, Z				Zhang, Jinlong; Wu, Shengzheng; Liu, Yongliang; Qiao, Lu; Gao, Wenhong; Zhang, Weiguo; Liu, Zheng			Disruption of Prostate Microvasculature by Combining Microbubble-Enhanced Ultrasound and Prothrombin	PLOS ONE			English	Article							MINIMALLY INVASIVE THERAPIES; INERTIAL CAVITATION; IN-VIVO; CONTRAST AGENTS; DRUG-DELIVERY; HYPERPLASIA; ANGIOGENESIS; ACTIVATION; BRAIN	Previous studies have shown a unique method to disrupt tumor vasculature using pulsed, high-pressure amplitude therapeutic ultrasound combined with microbubbles. In this study, we attempted to destroy the prostate vasculature of canine prostates using microbubble-enhanced ultrasound (MEUS) and prothrombin. The prostates of 43 male mongrel canines were surgically exposed. Twenty-two prostates were treated using MEUS (n = 11) or MEUS and prothrombin (PMEUS, n = 11). The other 21 prostates, which were treated using microbubbles (n = 7), ultrasound (n = 7) or prothrombin (n = 7) only, served as the controls. Prothrombin was intravenously infused at 20 IU/kg. MEUS was induced using a therapeutic ultrasound device at a peak negative pressure of 4.47 MPa and a microbubble injection. Contrast-enhanced ultrasound was performed to assess the blood perfusion of the prostates. Then, the prostate tissue was harvested immediately after treatment and at 48 hours later for pathological examination. The contrast-enhanced ultrasound peak value of the prostate decreased significantly from 36.2 +/- 5.6 to 27.1 +/- 6.3 after treatment in the PMEUS group, but it remained unchanged in the other groups. Histological examination found severe microvascular rupture, hemorrhage and thrombosis in both MEUS- and PMEUS-treated prostates immediately after treatment, while disruption in the PMEUS group was more severe than in the MEUS group. Forty-eight hours after treatment, massive necrosis and infiltration of white blood cells occurred in the PMEUS group. This study demonstrated that PMEUS disrupted the normal microvasculature of canine prostates and induced massive necrosis. PMEUS could potentially become a new noninvasive method used for the treatment of benign prostatic hyperplasia.	[Zhang, Jinlong; Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Wu, Shengzheng; Qiao, Lu; Gao, Wenhong; Liu, Zheng] Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Liu, Yongliang] Third Mil Med Univ, Xinqiao Hosp, Dept Urol, Chongqing, Peoples R China; [Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China.; Liu, Z (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China.; Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wgzhang01@163.com; liuzhengs@hotmail.com	zhang, jin/GXV-9154-2022		Natural Science Foundation of China [81227004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was received from the Natural Science Foundation of China (Grant No. 81227004) (http://www.nsfc.gov.cn/). ZL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brujan EA, 2009, MED ENG PHYS, V31, P742, DOI 10.1016/j.medengphy.2009.03.007; Burgess A, 2016, ADV EXP MED BIOL, V880, P293, DOI 10.1007/978-3-319-22536-4_16; Cabelin M A, 2000, Curr Opin Urol, V10, P301, DOI 10.1097/00042307-200007000-00003; DEERING RE, 1995, PROSTATE, V26, P111, DOI 10.1002/pros.2990260302; Djavan B, 2012, CURR OPIN UROL, V22, P16, DOI 10.1097/MOU.0b013e32834d5469; Downs ME, 2015, SCI REP-UK, V5, DOI 10.1038/srep15076; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Hall TL, 2009, UROLOGY, V74, P932, DOI 10.1016/j.urology.2009.03.049; Hempel CR, 2011, J UROLOGY, V185, P1484, DOI 10.1016/j.juro.2010.11.044; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Hwang JH, 2006, ULTRASOUND MED BIOL, V32, P1611, DOI 10.1016/j.ultrasmedbio.2006.07.016; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kutty S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000689; Lake AM, 2008, UROLOGY, V72, P682, DOI 10.1016/j.urology.2008.01.037; Liu P, 2011, ULTRASONICS, V51, P210, DOI 10.1016/j.ultras.2010.07.008; Liu Z, 2012, ULTRASOUND MED BIOL, V38, P253, DOI 10.1016/j.ultrasmedbio.2011.11.007; Majeed A, 2012, THROMB RES, V129, P146, DOI 10.1016/j.thromres.2011.07.024; MCNEAL JE, 1978, INVEST UROL, V15, P340; MILLER DL, 1995, ULTRASOUND MED BIOL, V21, P1059, DOI 10.1016/0301-5629(95)93252-U; Miller DL, 2000, ULTRASOUND MED BIOL, V26, P307, DOI 10.1016/S0301-5629(99)00138-6; Miller DL, 2000, P NATL ACAD SCI USA, V97, P10179, DOI 10.1073/pnas.180294397; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Ohigashi T, 2007, INT J UROL, V14, P326, DOI 10.1111/j.1442-2042.2007.01692.x; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123619; Sun N, 2014, INT UROL NEPHROL, V46, P1277, DOI 10.1007/s11255-014-0646-9; Tang Jie, 2007, Zhonghua Nan Ke Xue, V13, P584; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tunuguntla HSGR, 2002, WORLD J UROL, V20, P197, DOI 10.1007/s00345-002-0283-2; Wheat JC, 2010, UROLOGY, V75, P207, DOI 10.1016/j.urology.2009.09.021; Wu SZ, 2014, INT J NANOMED, V9, P5639, DOI 10.2147/IJN.S73950; Xie F, 2009, CIRCULATION, V119, P1378, DOI 10.1161/CIRCULATIONAHA.108.825067; Yu XH, 2008, J UROLOGY, V180, P241, DOI 10.1016/j.juro.2008.03.039	34	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162398	10.1371/journal.pone.0162398	http://dx.doi.org/10.1371/journal.pone.0162398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643992	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900011
J	Azadeh-Fard, N; Ghaffarzadegan, N; Camelio, JA				Azadeh-Fard, Nasibeh; Ghaffarzadegan, Navid; Camelio, Jaime A.			Can a Patient's In-Hospital Length of Stay and Mortality Be Explained by Early-Risk Assessments?	PLOS ONE			English	Article							EARLY WARNING SCORE; MEDICAL ADMISSIONS; NEWS	Objective To assess whether a patient's in-hospital length of stay (LOS) and mortality can be explained by early objective and/or physicians' subjective-risk assessments. Data Sources/Study Setting Analysis of a detailed dataset of 1,021 patients admitted to a large U.S. hospital between January and September 2014. Study Design We empirically test the explanatory power of objective and subjective early-risk assessments using various linear and logistic regression models. Principal Findings The objective measures of early warning can only weakly explain LOS and mortality. When controlled for various vital signs and demographics, objective signs lose their explanatory power. LOS and death are more associated with physicians' early subjective risk assessments than the objective measures. Conclusions Explaining LOS and mortality require variables beyond patients' initial medical risk measures. LOS and in-hospital mortality are more associated with the way in which the human element of healthcare service (e.g., physicians) perceives and reacts to the risks.	[Azadeh-Fard, Nasibeh] Rochester Inst Technol, Dept Ind & Syst Engn, Rochester, NY 14623 USA; [Ghaffarzadegan, Navid; Camelio, Jaime A.] Virginia Tech, Grado Dept Ind & Syst Engn, Blacksburg, VA USA	Rochester Institute of Technology; Virginia Polytechnic Institute & State University	Azadeh-Fard, N (corresponding author), Rochester Inst Technol, Dept Ind & Syst Engn, Rochester, NY 14623 USA.	nafeie@rit.edu	Zixuan, Huang/ABI-3557-2020	Ghaffarzadegan, Navid/0000-0003-3632-8588				Badriyah T, 2014, RESUSCITATION, V85, P418, DOI 10.1016/j.resuscitation.2013.12.011; Barlow G, 2007, THORAX, V62, P253, DOI 10.1136/thx.2006.067371; Brabrand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101739; BROWNELL MD, 1995, CAN MED ASSOC J, V152, P675; Burch VC, 2008, EMERG MED J, V25, P674, DOI 10.1136/emj.2007.057661; Cei M, 2009, INT J CLIN PRACT, V63, P591, DOI 10.1111/j.1742-1241.2008.01986.x; Cuthbertson BH, 2007, BRIT J ANAESTH, V98, P704, DOI 10.1093/bja/aem121; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Hill K, 2012, NURSING CRITICAL CAR, V17, P318, DOI DOI 10.1111/J.1478-5153.2012.00540_3.X; Hosseinichimeh N, 2016, WORLD MED HEALTH POL, V8, P58, DOI 10.1002/wmh3.175; Hosseinichimeh N, 2014, WORLD MED HEALTH POL, V6, P9, DOI 10.1002/wmh3.77; Institute for Healthcare Improvement, 2014, EARL WARN SYST SCOR; Kim WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130523; Kyriacos U, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087073, 10.1371/journal.pone.0087320]; McGinley A, 2012, BMJ, V345; Paterson R, 2006, CLIN MED, V6, P281, DOI 10.7861/clinmedicine.6-3-281; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Subbe CP, 2003, ANAESTHESIA, V58, P797, DOI 10.1046/j.1365-2044.2003.03258.x; Wheeler I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059830	21	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162976	10.1371/journal.pone.0162976	http://dx.doi.org/10.1371/journal.pone.0162976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632368	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900106
J	Berg, E; Sivertsen, A; Ariansen, AMS; Filip, C; Vindenes, HA; Feragen, KB; Moster, D; Lie, RT; Haaland, OA				Berg, Erik; Sivertsen, Ase; Ariansen, Anja Maria Steinsland; Filip, Charles; Vindenes, Halvard A.; Feragen, Kristin B.; Moster, Dag; Lie, Rolv Terje; Haaland, Oystein A.			Socio-Economic Status and Reproduction among Adults Born with an Oral Cleft: A Population-Based Cohort Study in Norway	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACADEMIC-ACHIEVEMENT; BIRTH-DEFECTS; BABIES BORN; LIP; PALATE; CHILDREN; RISK; RECURRENCE; SURVIVAL	Background It has been reported that people born with orofacial clefts do worse in life than their peers regarding a range of social markers, such as academic achievement and reproduction. We have compared otherwise healthy individuals with and without clefts, to investigate if these differences are due to the cleft or other background factors. Materials and Methods In a retrospective national cohort study, based on compulsory registers with data collected prospectively, we included everybody born in Norway between 1967 and 1992 (1490279 individuals, 2584 with clefts). This cohort was followed until the year 2010, when the youngest individuals were 18 years old. In order to ensure that the individuals were not affected by unknown syndromes or diseases, we excluded all individuals with any chronic medical condition, or who had other birth defects than clefts, hydroceles and dislocated hips. Individuals with oral clefts who were included in the study are said to have isolated clefts. Results Isolated cleft patients are similar to the general population regarding education, income and social class. Isolated cleft patients have lower fertility than the background population, but considering only married couples this difference in fertility disappeared. Conclusions An oral cleft did not appear to affect future socioeconomic status or chances of becoming a parent for children born in Norway. An exception was males with cleft lip and palate, but differences were small.	[Berg, Erik; Ariansen, Anja Maria Steinsland; Moster, Dag; Lie, Rolv Terje; Haaland, Oystein A.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Sivertsen, Ase; Vindenes, Halvard A.] Haukeland Hosp, Dept Plast Surg, Bergen, Norway; [Sivertsen, Ase; Filip, Charles; Vindenes, Halvard A.] Norwegian Qual Registry Cleft Lip & Palate, Bergen, Norway; [Filip, Charles] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Rikshosp, Oslo, Norway; [Feragen, Kristin B.] Oslo Univ Hosp, Ctr Rare Disorders, Oslo, Norway; [Moster, Dag; Lie, Rolv Terje] Norwegian Inst Publ Hlth, Bergen, Norway; [Haaland, Oystein A.] Haukeland Hosp, Dept Pediat, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; National Hospital Norway; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital	Berg, E (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	erik.berg@uib.no						Administration TT, NAT REG; Breen R, 2005, APPROACHES CLASS ANA, P31; Collett BR, 2014, J PEDIATR PSYCHOL, V39, P743, DOI 10.1093/jpepsy/jsu049; Herkrath APCD, 2015, CLEFT PALATE-CRAN J, V52, P157, DOI 10.1597/13-104; Erikson R, 2010, BRIT J SOCIOL, V61, P185, DOI 10.1111/j.1468-4446.2009.01246.x; Flemmen M, 2009, IMPLEMENTERING EGP K; Flynn T, 2014, CLEFT PALATE-CRAN J, V51, pE94, DOI 10.1597/12-288; Health NIoP, 2012, MED BIRTH REG NORW; Hunt O, 2005, EUR J ORTHODONT, V27, P274, DOI 10.1093/ejo/cji004; Koenker R., 2015, QUANTILE REGRESSION; Kubon C, 2007, ACTA OBSTET GYN SCAN, V86, P1453, DOI 10.1080/08037050701645090; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; Lindberg N, 2014, SCAND J CARING SCI, V28, P66, DOI 10.1111/scs.12048; Mani M, 2010, CLEFT PALATE-CRAN J, V47, P491, DOI 10.1597/08-281; Marcusson A, 2001, CLEFT PALATE-CRAN J, V38, P379, DOI 10.1597/1545-1569(2001)038<0379:QOLIAW>2.0.CO;2; Milerad J, 1997, PEDIATRICS, V100, P180, DOI 10.1542/peds.100.2.180; Morris JK, 2014, AM J MED GENET A, V164, P2979, DOI 10.1002/ajmg.a.36780; Mossey P A, 2011, Adv Dent Res, V23, P247, DOI 10.1177/0022034511402083; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Norway S., NASJONAL UTDANNINGSD; Persson M, 2008, SCAND J PLAST RECONS, V42, P14, DOI 10.1080/02844310701694472; Persson M, 2012, CLEFT PALATE-CRAN J, V49, P153, DOI 10.1597/09-047; PETER JP, 1975, CLEFT PALATE J, V12, P193; RAMSTAD T, 1995, SCAND J PLAST RECONS, V29, P251, DOI 10.3109/02844319509050135; Richman LC, 2012, CLEFT PALATE-CRAN J, V49, P387, DOI 10.1597/10-237; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; Roberts RM, 2012, J PEDIATR PSYCHOL, V37, P786, DOI 10.1093/jpepsy/jss052; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; StataCorp, CART STAT STAT SOFTW; Team RC, 2015, R LANG ENV STAT COMP; Wehby GL, 2014, PEDIATRICS, V133, P785, DOI 10.1542/peds.2013-3072; World Health Organization, INT CLASS DIS ICD; Yttri JE, 2011, CLEFT PALATE-CRAN J, V48, P601, DOI 10.1597/09-245; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162196	10.1371/journal.pone.0162196	http://dx.doi.org/10.1371/journal.pone.0162196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631472	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900031
J	Jiang, FZ; Jin, K; Huang, SY; Bao, Q; Shao, ZR; Hu, XQ; Ye, J				Jiang, Fangzhen; Jin, Kai; Huang, Shenyu; Bao, Qi; Shao, Zheren; Hu, Xueqing; Ye, Juan			Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER CELLS; IN-VITRO; GROWTH-INHIBITION; DEPHOSPHORYLATION; OSTEOSARCOMA; NANOLIPOSOME; C6-CERAMIDE; DEPENDENCE; PATHWAY	Melanoma is one common skin cancer. In the present study, the potential anti-melanoma activity by a liposomal C6 ceramide was tested in vitro. We showed that the liposomal C6 (ceramide) was cytotoxic and anti-proliferative against a panel of human melanoma cell lines (SK-Mel2, WM-266.4 and A-375 and WM-115). In addition, liposomal C6 induced caspase-dependent apoptotic death in the melanoma cells. Reversely, its cytotoxicity was attenuated by several caspase inhibitors. Intriguingly, liposomal C6 was non-cytotoxic to B10BR mouse melanocytes and primary human melanocytes. Molecularly, liposomal C6 activated protein phosphatase 1 (PP1) to inactivate Akt-mammalian target of rapamycin (mTOR) signaling in melanoma cells. On the other hand, PP1 shRNA knockdown or exogenous expression of constitutively activate Akt1 (CA-Akt1) restored Akt-mTOR activation and significantly attenuated liposomal C6-mediated cytotoxicity and apoptosis in melanoma cells. Our results suggest that liposomal C6 activates PP1 to inhibit melanoma cells.	[Jiang, Fangzhen; Bao, Qi; Shao, Zheren; Hu, Xueqing] Zhejiang Univ, Affiliated Hosp 2, Dept Plast & Reconstruct Surg, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China; [Jin, Kai; Huang, Shenyu; Ye, Juan] Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Jin, K (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China.	drkaijinvip@sina.com			Zhejiang Key Laboratory fund of China [2011E10006]; Zhejiang Provincial Public Welfare Technical Program for Applied Research [2015C33180]	Zhejiang Key Laboratory fund of China; Zhejiang Provincial Public Welfare Technical Program for Applied Research	This work was generously supported by grants from Zhejiang Key Laboratory fund of China (2011E10006, to KJ) and Zhejiang Provincial Public Welfare Technical Program for Applied Research (2015C33180, to KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Banerjee Hirendra Nath, 2012, J Cancer Sci Ther, V4, P12; Braeuer RR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12172; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Dimanche-Boitrel MT, 2011, RECENT PAT ANTI-CANC, V6, P284, DOI 10.2174/157489211796957838; Eggermont AMM, 2014, NAT REV CLIN ONCOL, V11, P181, DOI 10.1038/nrclinonc.2014.36; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; Henry B., 2011, CANC LETT; Hu X, 2015, TUMOUR BIOL; Huo HZ, 2013, MOL CELL BIOCHEM, V378, P171, DOI 10.1007/s11010-013-1608-8; Hutchinson Lisa, 2015, Nat Rev Clin Oncol, V12, P1, DOI 10.1038/nrclinonc.2014.219; Hutchinson L, 2014, NAT REV CLIN ONCOL, V11, P299, DOI [10.1038/nrclinonc.2014.87, 10.1038/nrclinonc.2014.132]; Ilinykh PA, 2014, J BIOL CHEM, V289, P22723, DOI 10.1074/jbc.M114.575050; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Kingwell K, 2014, NAT REV DRUG DISCOV, V13, P334, DOI 10.1038/nrd4314; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen T. D., 2011, ANTICANCER AGENTS ME; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Ryland LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084648; Schadendorf D, 2014, NAT REV CLIN ONCOL, V11, P75, DOI 10.1038/nrclinonc.2013.246; Shen J, 2015, TUMOUR BIOL; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Ullal AJ, 2014, CLIN IMMUNOL, V154, P178, DOI 10.1016/j.clim.2014.05.007; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Webster RM, 2014, NAT REV DRUG DISCOV, V13, P491, DOI 10.1038/nrd4326; Wu L, 2015, BIOCHEM BIOPH RES CO, V466, P547, DOI 10.1016/j.bbrc.2015.09.068; Yang L, 2015, EXP CELL RES, V332, P47, DOI 10.1016/j.yexcr.2014.12.017; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Yu T, 2010, CANCER CHEMOTH PHARM, V66, P999, DOI 10.1007/s00280-010-1374-1; Zhai L, 2015, BIOCHEM BIOPH RES CO, V468, P274, DOI 10.1016/j.bbrc.2015.10.113; Zhang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09275; Zolnik BS, 2008, DRUG METAB DISPOS, V36, P1709, DOI 10.1124/dmd.107.019679	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159849	10.1371/journal.pone.0159849	http://dx.doi.org/10.1371/journal.pone.0159849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631768	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900003
J	Marks, D; Bisset, L; Comans, T; Thomas, M; Ng, SK; O'Leary, S; Conaghan, PG; Scuffham, PA				Marks, Darryn; Bisset, Leanne; Comans, Tracy; Thomas, Michael; Ng, Shu Kay; O'Leary, Shaun; Conaghan, Philip G.; Scuffham, Paul A.			Increasing Capacity for the Treatment of Common Musculoskeletal Problems: A Non-Inferiority RCT and Economic Analysis of Corticosteroid Injection for Shoulder Pain Comparing a Physiotherapist and Orthopaedic Surgeon	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADVERSE DRUG-REACTIONS; PRIMARY-HEALTH-CARE; ROTATOR CUFF TEARS; SUBACROMIAL IMPINGEMENT; EXERCISE THERAPY; GLOBAL BURDEN; DIAGNOSIS; QUESTIONNAIRE; RELIABILITY	Background Role substitution is a strategy employed to assist health services manage the growing demand for musculoskeletal care. Corticosteroid injection is a common treatment in this population but the efficacy of its prescription and delivery by physiotherapists has not been established against orthopaedic standards. This paper investigates whether corticosteroid injection given by a physiotherapist for shoulder pain is as clinically and cost effective as that from an orthopaedic surgeon. Methods A double blind non-inferiority randomized controlled trial was conducted in an Australian public hospital orthopaedic outpatient service, from January 2013 to June 2014. Adults with a General Practitioner referral to Orthopaedics for shoulder pain received subacromial corticosteroid and local anaesthetic injection prescribed and delivered independently by a physiotherapist or a consultant orthopaedic surgeon. The main outcome measure was total Shoulder Pain and Disability Index (SPADI) score at baseline, six and 12 weeks, applying a non-inferiority margin of 15 points. Secondary outcomes tested for superiority included pain, shoulder movement, perceived improvement, adverse events, satisfaction, quality of life and costs. Results 278 participants were independently assessed by the physiotherapist and the orthopaedic surgeon, with 64 randomised (physiotherapist 33, orthopaedic surgeon 31). There were no significant differences in baseline characteristics between groups. Non-inferiority of injection by the physiotherapist was declared from total SPADI scores at 6 and 12 weeks (upper limit of the 95% one-sided confidence interval 13.34 and 7.17 at 6 and 12 weeks, respectively). There were no statistically significant differences between groups on any outcome measures at 6 or 12 weeks. From the perspective of the health funder, the physiotherapist was less expensive. Conclusions Corticosteroid injection for shoulder pain, provided by a suitably qualified physiotherapist is at least as clinically effective, and less expensive, compared with similar care delivered by an orthopaedic surgeon. Policy makers and service providers should consider implementing this model of care.	[Marks, Darryn; Thomas, Michael] Gold Coast Univ Hosp, Gold Cost Hosp & Hlth Serv, 1 Hosp Blvd, Gold Coast, Qld 4215, Australia; [Marks, Darryn; Bisset, Leanne; Comans, Tracy; Ng, Shu Kay; Scuffham, Paul A.] Griffith Univ, Menzies Hlth Inst Queensland, Parklands Dr, Gold Coast, Qld 4222, Australia; [Comans, Tracy] Metro North Hosp & Hlth Serv, 112 Alfred St, Brisbane, Qld 4006, Australia; [O'Leary, Shaun] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; [O'Leary, Shaun] Royal Brisbane & Womens Hosp, Physiotherapy Dept, Butterfield St, Herston, Qld 4006, Australia; [Conaghan, Philip G.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England; [Conaghan, Philip G.] Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England	Gold Coast University Hospital; Griffith University; Menzies Health Institute Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Leeds; Chapel Allerton Hospital; Leeds Biomedical Research Centre	Marks, D (corresponding author), Gold Coast Univ Hosp, Gold Cost Hosp & Hlth Serv, 1 Hosp Blvd, Gold Coast, Qld 4215, Australia.; Marks, D (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Parklands Dr, Gold Coast, Qld 4222, Australia.	darryn.marks@health.qld.gov.au	Comans, Tracy/D-9308-2018; Scuffham, Paul/B-3066-2014; Scuffham, Paul/AAS-8084-2021; Bisset, Leanne/AAS-8947-2021; Marks, Darryn/AAQ-8598-2021	Comans, Tracy/0000-0003-2840-3496; Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Bisset, Leanne/0000-0001-8807-7093; Marks, Darryn/0000-0002-8884-8596; Ng, Shu Kay/0000-0002-6865-9384; Conaghan, Philip/0000-0002-3478-5665	Queensland Health through the Allied Health Professions Office; Gold Coast Hospital and Health Service	Queensland Health through the Allied Health Professions Office; Gold Coast Hospital and Health Service	We received support from within Queensland Health through the Allied Health Professions Office and the Gold Coast Hospital and Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; [Anonymous], 2013, MILLIONS PATIENTS BE; Australian Government Department of Health, 2015, MBS ONL MED BEN SCHE, DOI 10.1016/j.jse.2009.04.006; Australian Government Productivity Commission, 2011, 53 AUSTR GOV PROD CO; Brittain E, 2005, STAT MED, V24, P1, DOI 10.1002/sim.1934; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Buchbinder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061243; Cadogan A, 2012, J REHABIL MED, V44, P877, DOI 10.2340/16501977-1049; Carter T, 2012, PHYSIOTHERAPY, V98, P40, DOI 10.1016/j.physio.2010.12.003; Curtis AJ, 2010, MED J AUSTRALIA, V192, P217, DOI 10.5694/j.1326-5377.2010.tb03482.x; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Daker-White G, 1999, J EPIDEMIOL COMMUN H, V53, P643, DOI 10.1136/jech.53.10.643; Department of Health, 2006, JOINT DOCTRINE INTER; Department of Health, 2009, ALL HLTH PROF PRESCR; Desmeules F, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-107; Diercks R, 2014, ACTA ORTHOP, V85, P314, DOI 10.3109/17453674.2014.920991; Dorrestijn O, 2011, RHEUMATOLOGY, V50, P389, DOI 10.1093/rheumatology/keq333; Duckett Stephen J, 2005, Aust Health Rev, V29, P201; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Government Queensland, QUEENSL HLTH WAG RAT; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Hambly N, 2007, AM J ROENTGENOL, V189, P1179, DOI 10.2214/AJR.07.2421; Hattam P, 1999, Clin Perform Qual Health Care, V7, P121, DOI 10.1108/14664109910306749; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Health Q, 2014, ATT 3 TOT REM FRAM C; Helliwell PS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3037; Hill JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124557; Hockin J, 1994, PHYSIOTHERAPY, V80, P281, DOI DOI 10.1016/S0031-9406(10)61050-4; James M, 2005, RHEUMATOLOGY, V44, P1447, DOI 10.1093/rheumatology/kei043; Johansson K, 2011, FAM PRACT, V28, P355, DOI 10.1093/fampra/cmq119; Joseph C, 2014, PHYSIOTHERAPY, V100, P277, DOI 10.1016/j.physio.2014.03.007; Jowett S, 2013, RHEUMATOLOGY, V52, P1485, DOI 10.1093/rheumatology/ket149; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kolber MJ, 2012, INT J SPORTS PHYS TH, V7, P306; Kuijpers T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-83; Laurant M, 2004, COCHRANE DATABASE SY; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lee HJ, 2015, KNEE SURG SPORT TR A, V23, P555, DOI 10.1007/s00167-013-2395-1; Lewis J, 2001, PHYSIOTHERAPY, V87, P458, DOI DOI 10.1016/S0031-9406(05)60693-1; Lewis JS, 2009, BRIT J SPORT MED, V43, P259, DOI 10.1136/bjsm.2008.052183; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Linsell L, 2006, RHEUMATOLOGY, V45, P215, DOI 10.1093/rheumatology/kei139; Maman E, 2016, AM J SPORT MED, V44, P177, DOI 10.1177/0363546515591266; Marks D, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-503; Mascha EJ, 2011, ANESTH ANALG, V112, P678, DOI 10.1213/ANE.0b013e318206f872; May S, 2010, PHYSIOTHERAPY, V96, P179, DOI 10.1016/j.physio.2009.12.002; Michener LA, 2009, ARCH PHYS MED REHAB, V90, P1898, DOI 10.1016/j.apmr.2009.05.015; Mitchell C, 2005, BMJ-BRIT MED J, V331, P1124, DOI 10.1136/bmj.331.7525.1124; Moosmayer S, 2010, ACTA ORTHOP, V81, P361, DOI 10.3109/17453674.2010.483993; Mullaney Michael J., 2010, Physiotherapy Theory and Practice, V26, P327, DOI 10.3109/09593980903094230; Murphy RJ, 2010, SHOULDER PAIN, V2010; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NHS, 2015, REF TREATM RTT WAIT; Norman R, 2013, APPL HEALTH ECON HEA, V11, P287, DOI 10.1007/s40258-013-0035-z; Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110; OVERMAN SS, 1988, PHYS THER, V68, P199, DOI 10.1093/ptj/68.2.199; Parsons S, 2007, FAM PRACT, V24, P308, DOI 10.1093/fampra/cmm027; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2010, JAMA-J AM MED ASSOC, V2012, P2594, DOI DOI 10.1001/JAMA.2012.87802; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Piitulainen K, 2012, DISABIL REHABIL, V34, P2071, DOI 10.3109/09638288.2012.670363; Queensland Government QH, 2015, HOSP PERF; Ramirez J, 2014, MOD RHEUMATOL, V24, P667, DOI 10.3109/14397595.2013.857798; Resteghini P, 2003, J ORTHOP MED, V25, P58; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Robb G, 2009, J PRIM HEALTH CARE, V1, P42, DOI 10.1071/HC09042; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Samsson K, 2014, MANUAL THER, V19, P386, DOI 10.1016/j.math.2013.10.004; Scott A, 2013, BRIT J SPORT MED, V47, P536, DOI 10.1136/bjsports-2013-092329; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Smith KL, 2000, J SHOULDER ELB SURG, V9, P395, DOI 10.1067/mse.2000.108962; Stanhope J, 2012, J MULTIDISCIP HEALTH, V5, P37, DOI 10.2147/JMDH.S28891; Tashjian RZ, 2009, J SHOULDER ELB SURG, V18, P927, DOI 10.1016/j.jse.2009.03.021; Taylor William, 2005, N Z Med J, V118, pU1629; The Kings Fund, 2015, MUCH MON DOES NHS NE; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weale A E, 1995, Ann R Coll Surg Engl, V77, P71; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006	83	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162679	10.1371/journal.pone.0162679	http://dx.doi.org/10.1371/journal.pone.0162679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631987	Green Published, gold			2022-12-27	WOS:000383706900064
J	Sohn, SI; Oh, YJ; Lee, KR; Ko, HC; Cho, HS; Lee, YH; Chang, A				Sohn, Soo-In; Oh, Young-Ju; Lee, Kyeong-Ryeol; Ko, Ho-Cheol; Cho, Hyun-Suk; Lee, Yeon-Hee; Chang, Ancheol			Characteristics Analysis of F-1 Hybrids between Genetically Modified Brassica napus and B. rapa	PLOS ONE			English	Article							OILSEED RAPE; PLOIDY LEVEL; GENE FLOW; SEED OIL; FITNESS; INTROGRESSION; TRANSGENE; BACKCROSS; PLANTS; HYBRIDIZATION	A number of studies have been conducted on hybridization between transgenic Brassica napus and B. rapa or backcross of F-1 hybrid to their parents. However, trait changes must be analyzed to evaluate hybrid sustainability in nature. In the present study, B. rapa and transgenic (BrAGL20) B. napus were hybridized to verify the early flowering phenomenon of F-1 hybrids, and F-1 hybrid traits were analyzed to predict their impact on sustainability. Flowering of F-1 hybrid has been induced slightly later than that of the transgenic B. napus, but flowering was available in the greenhouse without low temperature treatment to young plant, similar to the transgenic B. napus. It is because the BrAGL20 gene has been transferred from transgenic B. napus to F-1 hybrid. The size of F-1 hybrid seeds was intermediate between those of B. rapa and transgenic B. napus, and similar to 40% of F-1 pollen exhibited abnormal size and morphology. The form of the F-1 stomata was also intermediate between that of B. rapa and transgenic B. napus, and the number of stomata was close to the parental mean. Among various fatty acids, the content of erucic acid exhibited the greatest change, owing to the polymorphism of parental FATTY ACID ELONGASE 1 alleles. Furthermore, F-2 hybrids could not be obtained. However, BC1 progeny were obtained by hand pollination of B. rapa with F-1 hybrid pollen, with an outcrossing rate of 50%.	[Sohn, Soo-In; Lee, Kyeong-Ryeol; Cho, Hyun-Suk; Lee, Yeon-Hee; Chang, Ancheol] Natl Inst Agr Sci, Dept Agr Biotechnol, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea; [Oh, Young-Ju] Inst Future Environm Ecol Co Ltd, 5,Palbok 1 Gil, Jeonju 54883, North Jeolla Pr, South Korea; [Ko, Ho-Cheol] Natl Inst Agr Sci, Natl Agrobiodivers Ctr, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea	National Institute of Agricultural Sciences; National Institute of Agricultural Sciences	Sohn, SI (corresponding author), Natl Inst Agr Sci, Dept Agr Biotechnol, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea.	sisohn@korea.kr	Lee, Kyeong-Ryeol/I-7389-2019		Research Program for Agricultural Science & Technology Development [PJ01186703]; National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	Research Program for Agricultural Science & Technology Development; National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	This study was conducted with the support of the Research Program for Agricultural Science & Technology Development (Project No. PJ01186703), National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea.	Allainguillaume J, 2006, MOL ECOL, V15, P1175, DOI 10.1111/j.1365-294X.2006.02856.x; Barthet VJ, 2008, PHYTOCHEMISTRY, V69, P411, DOI 10.1016/j.phytochem.2007.08.016; Beck SL, 2003, BOT J LINN SOC, V141, P177, DOI 10.1046/j.1095-8339.2003.00132.x; Bozcali E, 2009, INT J CLIN EXP MED, V2, P337; Broun P, 1999, ANNU REV NUTR, V19, P197, DOI 10.1146/annurev.nutr.19.1.197; CALDER R. A., 1937, New Zealand Journal of Agriculture, V55, P299; Cao D, 2014, PLANT SCI, V227, P45, DOI 10.1016/j.plantsci.2014.06.018; Chevre AM, 2003, ACTA AGR SCAND B-S P, V53, P22, DOI 10.1080/16519140310015102; DOWNEY RK, 1964, J AM OIL CHEM SOC, V41, P475, DOI 10.1007/BF02670026; ECKE W, 1995, THEOR APPL GENET, V91, P972, DOI 10.1007/BF00223908; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; Gueritaine G, 2002, MOL ECOL, V11, P1419, DOI 10.1046/j.1365-294X.2002.01540.x; Halfhill Matthew D., 2002, Environmental Biosafety Research, V1, P19, DOI 10.1051/ebr:2002002; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; Halfhill MD, 2003, THEOR APPL GENET, V107, P1533, DOI 10.1007/s00122-003-1397-7; Hauser TP, 1998, HEREDITY, V81, P429, DOI 10.1046/j.1365-2540.1998.00424.x; Hauser TP, 1998, HEREDITY, V81, P436, DOI 10.1046/j.1365-2540.1998.00425.x; Hauser TP, 1999, HEREDITAS, V130, P89, DOI 10.1111/j.1601-5223.1999.00089.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hilbeck Angelika, 2011, Environmental Sciences Europe, V23, P13, DOI 10.1186/2190-4715-23-13; Hong JK, 2013, PLANT BIOTECHNOL REP, V7, P231, DOI 10.1007/s11816-012-0254-z; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Jorgensen RB, 1998, ACTA HORTIC, P211, DOI 10.17660/ActaHortic.1998.459.23; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Legere A, 2005, PEST MANAG SCI, V61, P292, DOI 10.1002/ps.975; Liu YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039705; Lu CM, 2001, BREEDING SCI, V51, P73, DOI 10.1270/jsbbs.51.73; Mandal S, 2002, GENET RESOUR CROP EV, V49, P551, DOI 10.1023/A:1021210800414; Meng J. L., 1990, Acta Agronomica Sinica, V16, P19; Mikkelsen TR, 1996, THEOR APPL GENET, V92, P492, DOI 10.1007/BF00223698; Mikkelsen TR, 1996, NATURE, V380, P31, DOI 10.1038/380031a0; Mishra MK, 1999, ANN BOT, V80, P689; Naidu MM, 2012, DRY TECHNOL, V30, P808, DOI 10.1080/07373937.2012.666607; Padoan D, 2013, THEOR EXP PLANT PHYS, V25, P283, DOI 10.1590/S2197-00252013000400006; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Phillips J, 1997, EMBO J, V16, P4489, DOI 10.1093/emboj/16.15.4489; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; ROGERS SO, 1994, PLANT MOL BIOL MANUA, P1, DOI DOI 10.1007/978-94-011-0511-8_12; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; STEFANSSON B. R., 1961, CANADIAN JOUR PLANT SCI, V41, P218; Tomiuk J, 2000, THEOR APPL GENET, V100, P750, DOI 10.1007/s001220051348; Tsuda M, 2014, BREEDING SCI, V64, P74, DOI 10.1270/jsbbs.64.74; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Wilkinson Mike, 2009, Environmental Biosafety Research, V8, P1, DOI 10.1051/ebr/2009003; Wilkinson MJ, 2003, TRENDS PLANT SCI, V8, P208, DOI 10.1016/S1360-1385(03)00057-8; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Xiao L, 2009, TRANSGENIC RES, V18, P733, DOI 10.1007/s11248-009-9261-4; Yao K, 2005, PLANT PHYSIOL BIOCH, V43, P83, DOI 10.1016/j.plaphy.2004.12.006; Ye YM, 2010, SCI HORTIC-AMSTERDAM, V124, P95, DOI 10.1016/j.scienta.2009.12.016; Yuan SX, 2009, AGR SCI CHINA, V8, P939, DOI 10.1016/S1671-2927(08)60298-9	57	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162103	10.1371/journal.pone.0162103	http://dx.doi.org/10.1371/journal.pone.0162103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632286	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900027
J	Fukai, T				Fukai, Tohru			Mouse Specific Cleavage-Resistant RAGE Splice Variant	PLOS ONE			English	Editorial Material							GLYCATION END-PRODUCTS; SOLUBLE RECEPTOR; ATHEROSCLEROSIS; SUPPRESSION; RESPONSES; BLOCKADE; ROLES		[Fukai, Tohru] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60612 USA; [Fukai, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fukai, T (corresponding author), Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60612 USA.; Fukai, T (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA.	tfukai@uic.edu			NHLBI NIH HHS [R01 HL116976, R01 HL070187] Funding Source: Medline; BLRD VA [I01 BX001232] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BLRD VA		Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Braley A, 2016, J BIOL CHEM; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Di Maggio S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153832; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Lazo M, 2015, AM HEART J, V170, P961, DOI 10.1016/j.ahj.2015.08.008; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Peng Y, 2016, PLOS ONE; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Yamakawa N, 2011, AM J PHYSIOL-LUNG C, V300, pL516, DOI 10.1152/ajplung.00118.2010; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162120	10.1371/journal.pone.0162120	http://dx.doi.org/10.1371/journal.pone.0162120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27653772	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700015
J	Stanley, WT; Kihaule, PM				Stanley, William T.; Kihaule, Philip M.			Elevational Distribution and Ecology of Small Mammals on Tanzania's Second Highest Mountain	PLOS ONE			English	Article							WEST USAMBARA MOUNTAINS; SPECIES RICHNESS; EAST; INVENTORIES; ABUNDANCE; KILIMANJARO; DIVERSITY; GRADIENTS; TRANSECT; RODENTIA	Mt. Meru is Tanzania's second highest mountain and the ninth highest in Africa. The distribution and abundance of small mammals on this massif are poorly known. Here we document the distribution of shrews and rodents along an elevational gradient on the southeastern versant of Mt. Meru. Five sites were sampled with elevational center points of 1950, 2300, 2650, 3000, and 3600 m, using a systematic methodology of standard traps and pitfall lines, to inventory the shrews and rodents of the slope. Ten species of mammal were recorded, comprising 2 shrew and 8 rodent species with the greatest diversity for each group at 2300 m. No species previously unrecorded on Mt. Meru was observed. Two rodent genera that occur in nearby Eastern Arc Mountains (Hylomyscus and Beamys) were not recorded. The rodent Lophuromys verhageni and a recently described species of shrew, Crocidura newmarki, are the only endemic mammals on Mt. Meru, and were widespread across the elevational gradient. As in similar small mammal surveys on other mountains of Tanzania, rainfall positively influenced trap success rates for shrews, but not for rodents. This study provides new information on the local small mammal fauna of the massif, but numerous other questions remain to be explored. Comparisons are made to similar surveys of other mountains in Tanzania.	[Stanley, William T.] Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA; [Kihaule, Philip M.] Univ Dar Es Salaam, Dept Zool, Dar Es Salaam, Tanzania	Field Museum of Natural History (Chicago); University of Dar es Salaam	Stanley, WT (corresponding author), Field Museum Nat Hist, Dept Sci & Educ, Chicago, IL 60605 USA.	mrogers@fieldmuseum.org			Field Museum of Natural History; The Field Museum/IDP Foundation, Inc.; Barbara Brown Fund of the Field Museum; African Training Fund	Field Museum of Natural History; The Field Museum/IDP Foundation, Inc.; Barbara Brown Fund of the Field Museum; African Training Fund	Funding for this study came from the Field Museum of Natural History, including awards from The Field Museum/IDP Foundation, Inc. African Training Fund, and the Barbara Brown Fund of the Field Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP IR, 1979, MAMMALIA, V43, P519, DOI 10.1515/mamm.1979.43.4.519; Carleton MD, 2005, P BIOL SOC WASH, V118, P619, DOI 10.2988/0006-324X(2005)118[619:ROTHDC]2.0.CO;2; Carleton MD, 2012, ZOOL J LINN SOC-LOND, V165, P420, DOI 10.1111/j.1096-3642.2012.00817.x; DeBlase AF, 1974, MANUAL MAMMALOGY KEY; DEMETER A, 1986, Cimbebasia Series A, V8, P199; Dieterlen F, 1979, STUTTGARTER BEITR A, V330, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goodman S.M., 2003, P1159; Goodman Steven M., 1995, Oryx, V29, P212; Grimshaw J.M., 1997, Journal of East African Natural History, V84, P105, DOI 10.2982/0012-8317(1995)84[105:TMOK]2.0.CO;2; Guest NJ, 1953, RECORDS GEOLOGICAL S, V3, P40; HAPPOLD DCD, 1989, J BIOGEOGR, V16, P353, DOI 10.2307/2845227; Holden ME, 2005, MAMMAL SPECIES WORLD, V2, P819; Hutterer R, 2005, MAMMAL SPECIES WORLD, P220; Kerbis Peterhans JC., 1998, RUWENZORI MOUNTAINS, P149; Lundgren B., 1972, Geografiska Annaler, V54A, P227; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mulungu LS, 2008, MAMMALIA, V72, P178, DOI 10.1515/MAMM.2008.021; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; PATTERSON BD, 1989, J MAMMAL, V70, P67, DOI 10.2307/1381670; RICKART EA, 1991, J MAMMAL, V72, P458, DOI 10.2307/1382128; SHORE RF, 1991, MAMMALIA, V55, P601, DOI 10.1515/mamm.1991.55.4.601; Stanley W.T., 2000, Journal of East African Natural History, V87, P91, DOI 10.2982/0012-8317(1998)87[91:SMOTEA]2.0.CO;2; Stanley WT, 2007, ACTA THERIOL, V52, P261, DOI 10.1007/BF03194222; Stanley WT, 2015, ZOOL J LINN SOC-LOND, V174, P185, DOI 10.1111/zoj.12230; Stanley WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109904; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P18; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P53; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P1; Stanley William T., 2007, Journal of East African Natural History, V96, P215, DOI 10.2982/0012-8317(2007)96[215:SMOTFR]2.0.CO;2; Thompson LG, 2009, P NATL ACAD SCI USA, V106, P19770, DOI 10.1073/pnas.0906029106; Verheyen Walter, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V72, P141; YALDEN DW, 1988, AFR J ECOL, V26, P281, DOI 10.1111/j.1365-2028.1988.tb00980.x; YU HT, 1994, J ZOOL, V234, P577, DOI 10.1111/j.1469-7998.1994.tb04866.x	37	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162009	10.1371/journal.pone.0162009	http://dx.doi.org/10.1371/journal.pone.0162009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27653635	Green Published, gold			2022-12-27	WOS:000383892700014
J	Chisholm, JM; Pang, DSJ				Chisholm, Jessica M.; Pang, Daniel S. J.			Assessment of Carbon Dioxide, Carbon Dioxide/Oxygen, Isoflurane and Pentobarbital Killing Methods in Adult Female Sprague-Dawley Rats	PLOS ONE			English	Article							NOXIOUS CHEMICAL-STIMULATION; INTRAPERITONEAL INJECTIONS; NASAL STIMULATION; FLOW-RATE; EUTHANASIA; CO2; BRAIN; ANESTHESIA; RESPONSES; AVERSION	Background Exposure to carbon dioxide (CO2) gas as a killing method is aversive and exposure to high concentrations is likely to be painful. Bradycardia during exposure to CO2 is associated with nociception and pain. However, it is unclear if bradycardia occurs before loss of consciousness as definitions of loss of consciousness vary in the literature. The objectives of this study were to explore the relationship between recumbency, loss of righting reflex (LORR) and a quiescent electromyograph as measures of loss of consciousness, and identify the onset of bradycardia in relation to these measures. Our primary hypothesis was that CO2 exposure would result in bradycardia, which would precede LORR. Methods Thirty-two adult, female Sprague-Dawley rats were instrumented with a telemetry device and randomly assigned to one of four killing methods (concentrations of 100% CO2, CO2 (70%)/O-2 (30%), isoflurane (5%) and intraperitoneal pentobarbital (200 mg/kg). Time to achieve recumbency, LORR, quiescent electromyograph, isoelectric electrocorticograph, heart rate and apnea were recorded. Results The general order of progression was recumbency, LORR, quiescent electromyograph, isoelectric electrocorticograph and apnea. Recumbency preceded LORR in the majority of animals (CO2; 7/8, CO2/O-2; 8/8, isoflurane; 5/8, pentobarbital; 4/8). Bradycardia occurred before recumbency in the CO2 (p = 0.0002) and CO2/O2 (p = 0.005) groups, with a 50% reduction in heart rate compared to baseline. The slowest (time to apnea) and least consistent killing methods were CO2/O-2 (1180 +/- 658.1s) and pentobarbital (875 [239 to 4680] s). Conclusion Bradycardia, and consequently nociception and pain, occurs before loss of consciousness during CO2 exposure. Pentobarbital displayed an unexpected lack of consistency, questioning its classification as an acceptable euthanasia method in rats.	[Chisholm, Jessica M.; Pang, Daniel S. J.] Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB T2N 1N4, Canada; [Pang, Daniel S. J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Chisholm, Jessica M.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE, Canada; [Pang, Daniel S. J.] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ, Canada	University of Calgary; University of Calgary; University of Prince Edward Island; Universite de Montreal	Pang, DSJ (corresponding author), Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB T2N 1N4, Canada.; Pang, DSJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada.; Pang, DSJ (corresponding author), Univ Montreal, Fac Med Vet, St Hyacinthe, PQ, Canada.	daniel.pang@umontreal.ca		Chisholm, Jessica/0000-0002-4410-4843; Pang, Daniel/0000-0002-6420-477X	Natural Sciences and Engineering Research Council of Canada Discovery Grant [424022-2013]; Margaret Gunn Endowment for Animal Research (University of Calgary)	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Margaret Gunn Endowment for Animal Research (University of Calgary)	Natural Sciences and Engineering Research Council of Canada Discovery Grant (424022-2013), awarded to DP. Margaret Gunn Endowment for Animal Research (University of Calgary), awarded to DP.	ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Antognini JF, 2005, COMPARATIVE MED, V55, P413; Antognini JF, 2002, ANESTHESIOLOGY, V96, P980, DOI 10.1097/00000542-200204000-00028; ANTON F, 1992, PAIN, V49, P53, DOI 10.1016/0304-3959(92)90187-G; ANTON F, 1991, NEUROSCI LETT, V123, P208, DOI 10.1016/0304-3940(91)90932-J; Association AVM, 2013, AVMA GUIDELINES EUTH; Azabou E, 2016, CLIN EEG NEUROSCI, V47, P75, DOI 10.1177/1550059415612375; Ballard T., 2009, Animal Technology and Welfare, V8, P17; Boivin GP, 2016, J AM ASSOC LAB ANIM, V55, P451; Charbonneau R., 2010, CCAC GUIDELINES EUTH; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Citerio G, 2014, NEUROCRIT CARE, V21, P376, DOI 10.1007/s12028-014-9983-x; COENEN AML, 1995, LAB ANIM, V29, P262, DOI 10.1258/002367795781088289; Coria-Avila GA, 2007, LAB ANIMAL, V36, P25, DOI 10.1038/laban0707-25; Correia R, 2015, IEEE 4PORT BIOENGINE; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; DRIPPS RD, 1947, AM J PHYSIOL, V149, P43, DOI 10.1152/ajplegacy.1947.149.1.43; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Feng YW, 2003, INVEST OPHTH VIS SCI, V44, P529, DOI 10.1167/iovs.02-0003; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; GREGORY GA, 1974, ANESTHESIOLOGY, V40, P301, DOI 10.1097/00000542-197403000-00022; Hawkins P., 2006, NEWCASTLE CONSENSUS; HEWETT TA, 1993, LAB ANIM SCI, V43, P579; Iwarsson K., 1993, Scandinavian Journal of Laboratory Animal Science, V20, P191; KIMURA J, 1968, ARCH INTERN MED, V121, P511, DOI 10.1001/archinte.121.6.511; Kirkden RD, 2008, ANIM WELFARE, V17, P79; Kobayashi M, 2004, BRAIN RES, V1009, P137, DOI 10.1016/j.brainres.2004.02.056; Kobayashi M, 1999, AM J PHYSIOL-HEART C, V276, pH176, DOI 10.1152/ajpheart.1999.276.1.H176; Leach MC, 2002, COMPARATIVE MED, V52, P249; LEWIS RE, 1966, LAB ANIM CARE, V16, P505; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Makowska IJ, 2009, APPL ANIM BEHAV SCI, V119, P229, DOI 10.1016/j.applanim.2009.04.003; MCARDLE L, 1959, BRIT J ANAESTH, V31, P142, DOI 10.1093/bja/31.4.142; Moody CM, 2015, APPL ANIM BEHAV SCI, V163, P183, DOI 10.1016/j.applanim.2014.11.010; Niel L, 2008, APPL ANIM BEHAV SCI, V109, P77, DOI 10.1016/j.applanim.2007.02.004; Niel L, 2007, APPL ANIM BEHAV SCI, V107, P100, DOI 10.1016/j.applanim.2006.08.002; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; PEPPEL P, 1993, J NEUROPHYSIOL, V70, P2260, DOI 10.1152/jn.1993.70.6.2260; POWNER DJ, 1976, JAMA-J AM MED ASSOC, V236, P1123, DOI 10.1001/jama.236.10.1123; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Shusterman D, 2003, CHEM SENSES, V28, P595, DOI 10.1093/chemse/bjg050; Smith W, 1997, LAB ANIM-UK, V31, P337, DOI 10.1258/002367797780596130; STOELTING RK, 1970, ANESTHESIOLOGY, V33, P5, DOI 10.1097/00000542-197007000-00004; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Thurauf N, 2002, BRAIN RES, V942, P79, DOI 10.1016/S0006-8993(02)02697-5; Valentine H, 2012, J AM ASSOC LAB ANIM, V51, P50; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; Yavari P, 1996, J AUTONOM NERV SYST, V61, P195, DOI 10.1016/S0165-1838(96)00072-0	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162639	10.1371/journal.pone.0162639	http://dx.doi.org/10.1371/journal.pone.0162639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648836	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100026
J	Mohr, A; Ripoli, FL; Hammer, SC; Willenbrock, S; Hewicker-Trautwein, M; Kielbowicz, Z; Escobar, HM; Nolte, I				Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Willenbrock, Saskia; Hewicker-Trautwein, Marion; Kielbowicz, Zdzislaw; Escobar, Hugo Murua; Nolte, Ingo			Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; TUMOR CHARACTERISTICS; CARCINOMAS; PROLACTIN; DOGS; IMMUNOHISTOCHEMISTRY; SERUM	Immunohistochemistry (IHC) is currently considered the method of choice for steroid hormone receptor status evaluation in human breast cancer and, therefore, it is commonly utilized for assessing canine mammary tumors. In case of low hormone receptor expression, IHC is limited and thus is complemented by molecular analyses. In the present study, a multiplex bDNA assay was evaluated as a method for hormone receptor gene expression detection in canine mammary tissues. Estrogen receptor (ESR1), progesterone receptor (PGR), prolactin receptor (PRLR) and growth hormone receptor (GHR) gene expressions were evaluated in neoplastic and non-neoplastic canine mammary tissues. A set of 119 fresh frozen and 180 formalin-fixed, paraffin-embedded (FFPE) was comparatively analyzed and used for assay evaluation. Furthermore, a possible association between the hormone receptor expression in different histological subtypes of canine malignant mammary tumors and the castration status, breed and invasive growth of the tumor were analyzed. Themultiplex bDNA assay proved to be more sensitive for fresh frozen specimens. Hormone receptor expression found was significantly decreased in malignant mammary tumors in comparison to non-neoplastic tissue and benign mammary tumors. Among the histological subtypes the lowest gene expression levels of ESR1, PGR and PRLR were found in solid, anaplastic and ductal carcinomas. In summary, the evaluation showed that the measurement of hormone receptors with the multiplex bDNA assay represents a practicable method for obtaining detailed quantitative information about gene expression in canine mammary tissue for future studies. Still, comparison with IHC or quantitative real-time PCR is needed for further validation of the present method.	[Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Willenbrock, Saskia; Escobar, Hugo Murua; Nolte, Ingo] Univ Vet Med Hannover, Fdn, Small Anim Clin, Hannover, Germany; [Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Escobar, Hugo Murua] Univ Rostock, Div Med Clin Hematol Oncol & Palliat Med 3, Rostock, Germany; [Hewicker-Trautwein, Marion] Univ Vet Med Hannover, Inst Pathol, Fdn, Hannover, Germany; [Kielbowicz, Zdzislaw] Wroclaw Univ Environm & Life Sci, Dept & Clin Vet Surg, Fac Vet Med, Wroclaw, Poland	University of Veterinary Medicine Hannover, Foundation; University of Rostock; University of Veterinary Medicine Hannover, Foundation; Wroclaw University of Environmental & Life Sciences	Nolte, I (corresponding author), Univ Vet Med Hannover, Fdn, Small Anim Clin, Hannover, Germany.	ingo.nolte@tiho-hannover.de	Kiełbowicz, Zdzisław/D-1056-2017	Kiełbowicz, Zdzisław/0000-0003-4946-0449				Azizun-Nisa, 2008, ASIAN PAC J CANCER P, V9, P553; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Beck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075485; BOSTOCK DE, 1986, BRIT VET J, V142, P506, DOI 10.1016/0007-1935(86)90107-7; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Faupel-Badger JM, 2014, HORM CANCER-US, V5, P42, DOI 10.1007/s12672-013-0165-7; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; Gebre-Medhin M, 2001, AM J PATHOL, V158, P1217, DOI 10.1016/S0002-9440(10)64071-0; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Guil-Luna S, 2011, J VET INTERN MED, V25, P518, DOI 10.1111/j.1939-1676.2011.0723.x; Hachim IY, 2015, PROLACTIN RECEPTOR E; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hennecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131280; Kim MS, 2010, METHODMOL BIOL CLI, V949, P349; Kim NH, 2014, J COMP PATHOL, V151, P42, DOI 10.1016/j.jcpa.2014.04.001; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Kraus JA, 2012, MODERN PATHOL, V25, P869, DOI 10.1038/modpathol.2011.219; Mainenti M, 2014, VET J, V202, P62, DOI 10.1016/j.tvjl.2014.06.003; Millanta F, 2005, RES VET SCI, V79, P225, DOI 10.1016/j.rvsc.2005.02.002; Nieto A, 2000, VET PATHOL, V37, P239, DOI 10.1354/vp.37-3-239; Pena L, 2014, VET PATHOL, V51, P127, DOI 10.1177/0300985813509388; Queiroga FL, 2014, VET REC, V175, P403, DOI 10.1136/vr.102263; Rasotto R, 2012, VET PATHOL, V49, P330, DOI 10.1177/0300985811409253; Ressel L, 2013, RES VET SCI, V94, P299, DOI 10.1016/j.rvsc.2012.09.016; Rivera P, 2009, CANCER RES, V69, P8770, DOI 10.1158/0008-5472.CAN-09-1725; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; Sorenmo KU, 2000, J VET INTERN MED, V14, P266, DOI 10.1892/0891-6640(2000)014&lt;0266:EOSATO&gt;2.3.CO;2; Spoerri M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0546-y; URDEA MS, 1994, BIO-TECHNOL, V12, P926, DOI 10.1038/nbt0994-926; Yang W, 2006, BIOTECHNIQUES, V40, P481, DOI 10.2144/000112133; Yim HW, 2010, J BREAST CANCER, V13, P267, DOI 10.4048/jbc.2010.13.3.267	34	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163311	10.1371/journal.pone.0163311	http://dx.doi.org/10.1371/journal.pone.0163311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649560	gold, Green Submitted, Green Published			2022-12-27	WOS:000383892100078
J	Rincon, B; Kenchington, EL				Rincon, Beatriz; Kenchington, Ellen L.			Influence of Benthic Macrofauna as a Spatial Structuring Agent for Juvenile Haddock (Melanogrammus aeglefinus) on the Eastern Scotian Shelf, Atlantic Canada	PLOS ONE			English	Article							DEMERSAL FISH ASSEMBLAGES; NORTHWEST ATLANTIC; WESTERN BANK; ST-LAWRENCE; HABITAT; COD; COMMUNITIES; DYNAMICS; GULF; DISTRIBUTIONS	We examined the habitat of juvenile haddock on the eastern Scotian Shelf (off Nova Scotia, Canada) in relation to grab-sampled benthic macrofaunal invertebrate species assemblages in order to determine whether there were significant differences in benthic macrofauna between areas of historically persistent high and low juvenile haddock abundance. Our analyses were conducted over two spatial scales in each of two years: among banks (Emerald, Western and Sable Island), approximately 60 km distant from each other, and between areas of high and low juvenile haddock abundance at distances of 10 to 30 km-all in an area that had not experienced groundfishing in the decade prior to sampling. We also examined fine-scale (10s of metres) within-site variability in the macrofauna and used surficial sediment characteristics, along with hydrographic variables, to identify environmental correlates. PERMANOVA identified statistically significant differences in biomass, density and composition of the benthos associated with juvenile haddock abundance; however it was difficult to determine whether the results had biological relevance. Post hoc tests showed that these differences occurred only on Sable Island Bank where both fish and benthos may have been independently responding to sediment type which was most different there (100% sand in the area of low haddock abundance vs. 22% gravel in the area of high haddock abundance). In total, 383 benthic taxa representing 13 phyla were identified. Annelida was the most specious phylum (36.29% of taxa, representing 33 families), followed by Arthropoda (with Crustaceans, mostly Amphipoda, accounting for 25.07% of the total number of taxa). The strongest pattern in the macrofauna was expressed at the largest scale, between banks, accounting for approximately 25% of the variation in the data. Emerald Bank, deeper, warmer and saltier than the Western and Sable Island Banks, had a distinctive fauna.	[Rincon, Beatriz; Kenchington, Ellen L.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Kenchington, EL (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca			Science Branch of Fisheries and Oceans Canada	Science Branch of Fisheries and Oceans Canada	This project was funded by the Science Branch of Fisheries and Oceans Canada.	Anderson JT, 2005, AM FISH S S, V41, P251; Anderson JT, 2007, 2770 CAN TECH REP FI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Auster P.J., 2005, DIVING SCI 2005 P AM, P89; Auster PJ, 1997, ENVIRON BIOL FISH, V50, P195, DOI 10.1023/A:1007305628035; Auster PJ, 2003, ENVIRON BIOL FISH, V68, P381, DOI 10.1023/B:EBFI.0000005751.30906.d5; Auster PJ, 2001, ENVIRON BIOL FISH, V60, P331, DOI 10.1023/A:1011022320818; Auster PJ, 1998, AM FISH S S, V22, P150; Bowman RE, 1984, NMFSFNEC28 NOAA US D; Bowman RE, 1979, 7943 US DEP COMM NAT; Breeze H, 2002, CAN TECH REP FISH AQ; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cargnelli L., 1999, NMFSNE128 NOAA; Cargnelli LM, 1999, NMESNF148 NOAA; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Courtney R. C., 2005, P INT C UND AC MEAS; Cuff A, 2015, CONT SHELF RES, V110, P149, DOI 10.1016/j.csr.2015.10.004; Dalley E. L., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P18; Davis SD, 1973, 10 NOV SCOT MUS; Davis SD, 1973, BENTHIC ANIMALS CRUI; Davis SD, 1974, BENTHIC ANIMALS CRUI; Desrosiers G, 2000, DEEP-SEA RES PT II, V47, P663, DOI 10.1016/S0967-0645(99)00122-8; Diaz RJ, 2003, ESTUARIES, V26, P12, DOI 10.1007/BF02691689; FADER GBJ, 2007, CAN TECH REP FISH AQ, V2770, P29; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frojan CRSB, 2012, ICES J MAR SCI, V69, P213, DOI 10.1093/icesjms/fss004; Gilkinson K., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P46; Gilkinson KD, 2005, ICES J MAR SCI, V62, P925, DOI 10.1016/j.icesjms.2005.03.009; Gilkinson KD, 2012, DFO CAN SCI ADVIS SE; Gordon D. C. Jr., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P1; Gordon Jr DC, 2000, ICES 2000 ANN C 2000; Gorley C.K., 2006, GETTING STARTED PRIM; GOTCEITAS V, 1993, OECOLOGIA, V93, P31, DOI 10.1007/BF00321187; Gregory R., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P10; Hargrave BT, 2004, MAR ECOL PROG SER, V270, P55, DOI 10.3354/meps270055; Henry LA, 2006, MAR ECOL PROG SER, V306, P63, DOI 10.3354/meps306063; Homans RES, 1944, P NOVA SCOTIA I SCI, V21, P1; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Murillo FJ, 2016, DEEP-SEA RES PT I, V109, P99, DOI 10.1016/j.dsr.2015.08.006; Kaiser MJ, 2004, ESTUAR COAST SHELF S, V60, P445, DOI 10.1016/j.ecss.2004.02.005; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E., 2004, AM FISHERIES SOC S, V41, P391; Kenchington EL, 2005, AM FISH S S, V41, P391; Kenchington ELR, 2006, J SEA RES, V56, P249, DOI 10.1016/j.seares.2006.03.010; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Kilada RW, 2009, MAR BIOL, V156, P1029, DOI 10.1007/s00227-009-1146-9; KOELLER PA, 1986, J CONSEIL, V43, P59; KOHLER AC, 1969, J FISH RES BOARD CAN, V26, P1273, DOI 10.1139/f69-113; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Kutti T, 2015, MAR ECOL PROG SER, V520, P175, DOI 10.3354/meps11047; Langton Richard W., 1995, Reviews in Fisheries Science, V3, P201; Langton RW, 1980, SSRF740 NOAA NMFS US; Legendre P., 2012, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lindholm JB, 1999, MAR ECOL PROG SER, V180, P247, DOI 10.3354/meps180247; Linehan J, 2004, 2526 CAN TECH REP FI; LOUGH RG, 1989, MAR ECOL PROG SER, V56, P1, DOI 10.3354/meps056001; Maciolek-Blake N, 1984, 141200129192 US MIN; MAHON R, 1989, CAN J FISH AQUAT SCI, V46, P134, DOI 10.1139/f89-285; MAHON R, 1987, MAR ECOL PROG SER, V37, P123, DOI 10.3354/meps037123; MATTSON S, 1992, SARSIA, V77, P33, DOI 10.1080/00364827.1992.10413490; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; McKeown DL, 1997, 2159 CAN TECH REP FI; Methven DA, 1999, 2267 CAN TECH REP FI; MILLER DAVID, 1963, JOUR CONS, V28, P37; MILLS EL, 1979, MAR BIOL, V54, P101, DOI 10.1007/BF00386589; Nesis KNN, 1970, FISHERIES RES BOARD, V1375; O'Boyle R, 2001, 2948 CAN TECH REP FI; Ollerhead L. M. N., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P49; Rowell TW, 1997, 2190 CAN TECH REP FI; Scharf FS, 2006, J EXP MAR BIOL ECOL, V335, P167, DOI 10.1016/j.jembe.2006.03.018; SCHNEIDER DC, 1987, MAR ECOL PROG SER, V39, P1, DOI 10.3354/meps039001; Schuckel S, 2010, J FISH BIOL, V77, P98, DOI 10.1111/j.1095-8649.2010.02657.x; Sell AF, 2013, J SEA RES, V80, P12, DOI 10.1016/j.seares.2013.01.007; Shaw J, 2014, GEOL SOC MEM, V41, P7, DOI 10.1144/M41.2; Sissenwine M.P., 1984, Life Sciences Research Report, P59; Stanley DJ, 1971, SMITHSONIAN CONTRIBU, V6; Theroux Roger B, 1988, 140 NOAA NMES US DEP; Thorson G., 1957, TREATISE MARINE ECOL, V67, P461, DOI DOI 10.1130/MEM67V1-P461; Uiblein F, 2003, MAR ECOL PROG SER, V257, P223, DOI 10.3354/meps257223; Young EF, 2015, EVOL APPL, V8, P486, DOI 10.1111/eva.12259	84	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163374	10.1371/journal.pone.0163374	http://dx.doi.org/10.1371/journal.pone.0163374			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649419	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100084
J	Schenk-Jager, KM; Egli, S; Hanimann, D; Senn-Irlet, B; Kupferschmidt, H; Buntgen, U				Schenk-Jaeger, Katharina M.; Egli, Simon; Hanimann, David; Senn-Irlet, Beatrice; Kupferschmidt, Hugo; Buntgen, Ulf			Introducing Mushroom Fruiting Patterns from the Swiss National Poisons Information Centre	PLOS ONE			English	Article							CITIZEN SCIENCE; CLIMATE-CHANGE; LONG-TERM; GROWTH; BIODIVERSITY; RESPONSES; FUTURE; FUNGI; CO2	Changes in the ecology of macrofungi are poorly understood, not only because much of their life cycle is hidden belowground, but also because experiments often miss real-world complexity and most fruitbody inventories are limited in space and time. The National Poisons Information Centre 'Tox Info Suisse' provides countrywide 24hours/7days medical advice in case of poisonings since 1966. Here, we introduce a total of 12,126-mushroom-related phone calls that were received by Tox Info Suisse between 1966 and 2014. This indirect source of mycological information is dominated by the families of Boletaceae (11%), Agaricaceae (10%) and Amanitaceae (8%), which account for similar to 30% of all cases. Mushroom fruiting patterns revealed by the Poisons Centre inventory statistically resemble changes in fungal phenology, productivity and diversity as reflected by the Swiss National Data Centre 'SwissFungi'. Although the newly developed Tox Info Suisse dataset provides an innovative basis for timely environmental research, caution is advised when interpreting some of the observed long-term changes and autumnal extremes. Uncertainty of the new record relates to possible data incompleteness, imprecise species description and/or identification, as well as the inclusion of cultivated and non-indigenous mushrooms. Nevertheless, we hope that the Tox Info Suisse inventory will stimulate and enable a variety of ecological-oriented follow-up studies.	[Schenk-Jaeger, Katharina M.; Kupferschmidt, Hugo] Univ Zurich, Associated Inst, Tox Info Suisse, Natl Poisons Informat Ctr, Zurich, Switzerland; [Egli, Simon; Hanimann, David; Buntgen, Ulf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buntgen, Ulf] Oeschger Ctr Climate Change Res, Bern, Switzerland; [Buntgen, Ulf] Global Change Res Ctr AS CR, Brno, Czech Republic	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Buntgen, U (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.; Buntgen, U (corresponding author), Oeschger Ctr Climate Change Res, Bern, Switzerland.; Buntgen, U (corresponding author), Global Change Res Ctr AS CR, Brno, Czech Republic.	buentgen@wsl.ch	buentgen, ulf/J-6952-2013; Senn-Irlet, Beatrice/AFQ-5299-2022		WSL-internal DITREC project; Ernst Gohner Foundation; Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0248]	WSL-internal DITREC project; Ernst Gohner Foundation; Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic	Funding was received from the WSL-internal DITREC project, the Ernst Gohner Foundation, as well as the Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic (No. CZ.1.07/2.3.00/20.0248).	Andrew C, 2014, MYCORRHIZA, V24, P581, DOI 10.1007/s00572-014-0577-4; Andrew C, 2009, ECOL LETT, V12, P813, DOI 10.1111/j.1461-0248.2009.01334.x; [Anonymous], CLIN TOXICOL; Bedry R, 2001, NEW ENG J MED, V345; Boddy L, 2014, FUNGAL ECOL, V10, P20, DOI 10.1016/j.funeco.2013.10.006; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Buntgen U, 2015, AGR ECOSYST ENVIRON, V202, P148, DOI 10.1016/j.agee.2014.12.016; Buntgen U, 2014, TRENDS PLANT SCI, V19, P613, DOI 10.1016/j.tplants.2014.07.001; Buntgen U, 2014, ECOL LETT, V17, P303, DOI 10.1111/ele.12231; Buntgen U, 2013, GLOBAL PLANET CHANGE, V107, P177, DOI 10.1016/j.gloplacha.2013.05.013; Buntgen U, 2013, GLOBAL CHANGE BIOL, V19, P2785, DOI 10.1111/gcb.12263; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Buntgen U, 2012, FRONT ECOL ENVIRON, V10, P14, DOI 10.1890/110064; Davies S, 2008, CLIN TOXICOL, V46, P596; Diez JM, 2013, GLOBAL CHANGE BIOL, V19, P3145, DOI 10.1111/gcb.12278; Eggenberg S, 2013, HOTSPOT, V28, P10; Egli S, 2006, BIOL CONSERV, V129, P271, DOI 10.1016/j.biocon.2005.10.042; Flammer R, 2002, SWISS MED FORUM, V132, P5; Gange AC, 2007, SCIENCE, V316, P71, DOI 10.1126/science.1137489; Gange AC, 2013, P NATL ACAD SCI USA, V110, pE333, DOI 10.1073/pnas.1219640110; Gange AC, 2011, FUNGAL ECOL, V4, P184, DOI 10.1016/j.funeco.2010.09.004; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Halme P, 2012, FUNGAL ECOL, V5, P750, DOI 10.1016/j.funeco.2012.05.005; Heilmann-Clausen J, 2015, CONSERV BIOL, V29, P61, DOI 10.1111/cobi.12388; Henderson S, 2012, FRONT ECOL ENVIRON, V10, P283, DOI 10.1890/1540-9295-10.6.283; Henneken R, 2012, ENVIRON ENTOMOL, V41, P1462, DOI 10.1603/EN12139; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Kauserud H, 2008, P NATL ACAD SCI USA, V105, P3811, DOI 10.1073/pnas.0709037105; Kauserud H, 2012, P NATL ACAD SCI USA, V109, P14488, DOI 10.1073/pnas.1200789109; Kauserud H, 2011, BIOL LETTERS, V7, P273, DOI 10.1098/rsbl.2010.0820; Kauserud H, 2010, P ROY SOC B-BIOL SCI, V277, P1169, DOI 10.1098/rspb.2009.1537; Kirk PM., 2008, DICT FUNGI, V10th ed; Kupferschmidt H., 2003, Journal of Toxicology Clinical Toxicology, V41, P665; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Mills JA, 2015, TRENDS ECOL EVOL, V30, P581, DOI 10.1016/j.tree.2015.07.006; Moore D, 2008, BR MYCOL SY, V28, P79; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049777; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Senn-Irlet B, 2010, MYCOL BALCANICA, V7, P59; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Straatsma G, 2001, MYCOL RES, V105, P515, DOI 10.1017/S0953756201004154; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yang XF, 2012, FUNGAL DIVERS, V56, P189, DOI 10.1007/s13225-012-0163-z; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076	48	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162314	10.1371/journal.pone.0162314	http://dx.doi.org/10.1371/journal.pone.0162314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648562	gold, Green Published			2022-12-27	WOS:000383892100016
J	Teraguchi, M; Samartzis, D; Hashizume, H; Yamada, H; Muraki, S; Oka, H; Cheung, JPY; Kagotani, R; Iwahashi, H; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Cheung, KMC; Yoshimura, N; Yoshida, M				Teraguchi, Masatoshi; Samartzis, Dino; Hashizume, Hiroshi; Yamada, Hiroshi; Muraki, Shigeyuki; Oka, Hiroyuki; Cheung, Jason Pui Yin; Kagotani, Ryohei; Iwahashi, Hiroki; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Cheung, Kenneth Man-Chee; Yoshimura, Noriko; Yoshida, Munehito			Classification of High Intensity Zones of the Lumbar Spine and Their Association with Other Spinal MRI Phenotypes: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; POPULATION-BASED COHORT; INTERVERTEBRAL DISC DEGENERATION; ISSLS PRIZE WINNER; MODIC CHANGES; PHYSICAL PERFORMANCE; ANNULAR TEARS; RISK-FACTORS; PREVALENCE; DISCOGRAPHY	Introduction High intensity zones (HIZ) of the lumbar spine are a phenotype of the intervertebral disc noted on MRI whose clinical relevance has been debated. Traditionally, T2-weighted (T2W) magnetic resonance imaging (MRI) has been utilized to identify HIZ of lumbar discs. However, controversy exists with regards to HIZ morphology, topography, and association with other MRI spinal phenotypes. Moreover, classification of HIZ has not been thoroughly defined in the past and the use of additional imaging parameters (e.g. T1W MRI) to assist in defining this phenotype has not been addressed. Materials and Methods A cross-sectional study of 814 (69.8% females) subjects with mean age of 63.6 years from a homogenous Japanese population was performed. T2W and T1W sagittal 1.5T MRI was obtained on all subjects to assess HIZ from L1-S1. We created a morphological and topographical HIZ classification based on disc level, shape type (round, fissure, vertical, rim, and enlarged), location within the disc (posterior, anterior), and signal type on T1W MRI (low, high and iso intensity) in comparison to the typical high intensity on T2W MRI. Results HIZ was noted in 38.0% of subjects. Of these, the prevalence of posterior, anterior, and both posterior/anterior HIZ in the overall lumbar spine were 47.3%, 42.4%, and 10.4%, respectively. Posterior HIZ was most common, occurring at L4/5 (32.5%) and L5/S1 (47.0%), whereas anterior HIZ was most common at L3/4 (41.8%). T1W iso-intensity type of HIZ was most prevalent (71.8%), followed by T1W high-intensity (21.4%) and T1W low-intensity (6.8%). Of all discs, round types were most prevalent (anterior: 3.6%, posterior: 3.7%) followed by vertical type (posterior: 1.6%). At all affected levels, there was a significant association between HIZ and disc degeneration, disc bulge/protrusion and Modic type II (p<0.01). Posterior HIZ and T1W high-intensity type of HIZ were significantly associated with disc bulge/protrusion and disc degeneration (p< 0.01). In addition, posterior HIZ was significantly associated with Modic type II and III. T1W low-intensity type of HIZ was significantly associated with Modic type II. Conclusions This is the first large-scale study reporting a novel classification scheme of HIZ of the lumbar spine. This study is the first that has utilized T2W and T1W MRIs in differentiating HIZ sub-phenotypes. Specific HIZ sub-phenotypes were found to be more associated with specific MRI degenerative changes. With a more detailed description of the HIZ phenotype, this scheme can be standardized for future clinical and research initiatives.	[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yamada, Hiroshi; Kagotani, Ryohei; Iwahashi, Hiroki; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan; [Samartzis, Dino; Cheung, Jason Pui Yin; Cheung, Kenneth Man-Chee] Univ Hong Kong, Dept Orthopaed & Traumatol, Professorial Block,5th Floor,102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China; [Muraki, Shigeyuki] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Oka, Hiroyuki] Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Healthcare Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, 5-1 Tsukudo Chome, Tokyo 1628543, Japan; [Nakamura, Kozo; Akune, Toru] Rehabil Serv Bur, Natl Rehabil Ctr Persons Disabil, 1 Namiki 4 Chome, Tokorozawa, Saitama 3598555, Japan	Wakayama Medical University; University of Hong Kong; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.; Samartzis, D (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Professorial Block,5th Floor,102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.	dsamartzis@msn.com; hashizum@wakayama-med.ac.jp	Cheung, Jason Pui Yin/AAJ-2016-2020; Hashizume, Hiroshi/V-6888-2019; Tanaka, Sakae/Y-3061-2019; Cheung, Jason Pui Yin/J-2214-2012	Cheung, Jason Pui Yin/0000-0002-7052-0875; Hashizume, Hiroshi/0000-0002-9064-0284; Tanaka, Sakae/0000-0001-9210-9414; Cheung, Kenneth/0000-0001-8304-0419; Samartzis, Dino/0000-0002-7473-1311	Grants-in-Aid for Scientific Research [26462249] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Bogduk N, 2008, SPINE, V33, P1298, DOI 10.1097/BRS.0b013e3181732a0d; Carragee EJ, 2000, SPINE, V25, P2987, DOI 10.1097/00007632-200012010-00005; Carragee EJ, 2004, SPINE, V29, P1112, DOI 10.1097/00007632-200405150-00012; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Chen JY, 2011, CLIN J PAIN, V27, P125, DOI 10.1097/AJP.0b013e3181fb2203; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Dudli S, 2016, EUR SPINE J IN PRESS; Hayashi T, 2015, J NEUROSURG-SPINE, V22, P511, DOI 10.3171/2014.10.SPINE14496; HIRSCH C., 1953, ACTA ORTHOPAED SCAND, V22, P184; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Lam KS, 2000, EUR SPINE J, V9, P36, DOI 10.1007/s005860050006; Li Y, SPINE J IN PRESS; Luk KDK, 2015, SPINE J, V15, P1915, DOI 10.1016/j.spinee.2014.07.020; Maatta JH, MEDICINE IN PRESS; Maatta JH, 2015, SPINE J, V15, P1933, DOI 10.1016/j.spinee.2015.06.056; Maatta JH, 2015, SPINE, V40, P1187, DOI 10.1097/BRS.0000000000000937; Maatta JH, 2014, EUR SPINE J, V23, P1856, DOI 10.1007/s00586-014-3333-8; Martinez-Quinones JV, 2014, J SPINAL DI IN PRESS; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Mok FPS, 2010, SPINE, V35, P1944, DOI 10.1097/BRS.0b013e3181d534f3; Muraki S, 2012, OSTEOARTHR CARTILAGE, V20, P712, DOI 10.1016/j.joca.2012.03.009; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; OSTI OL, 1992, J BONE JOINT SURG BR, V74, P678, DOI 10.1302/0301-620X.74B5.1388173; Park KW, 2007, ASIAN SPINE J, V1, P38, DOI 10.4184/asj.2007.1.1.38; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rankine JJ, 1999, SPINE, V24, P1913, DOI 10.1097/00007632-199909150-00009; Ricketson R, 1996, SPINE, V21, P2758, DOI 10.1097/00007632-199612010-00010; Samartzis D, OSTEOARTHRI IN PRESS; Samartzis D, 2015, SPINE J, V15, P1919, DOI 10.1016/j.spinee.2014.09.010; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; Schellhas KP, 1996, SPINE, V21, P79, DOI 10.1097/00007632-199601010-00018; Schmidt TA, 1998, SPINE, V23, P2167, DOI 10.1097/00007632-199810150-00005; Sharma A, 2009, AM J NEURORADIOL, V30, P500, DOI 10.3174/ajnr.A1411; Takatalo J, 2012, SPINE, V37, P1231, DOI 10.1097/BRS.0b013e3182443855; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Teraguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147565; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Vangeneugden T, 2005, BIOMETRICS, V61, P295, DOI 10.1111/j.0006-341X.2005.031040.x; Vavken P, 2015, GLOB SPINE J, V5, P156, DOI 10.1055/s-0035-1547525; Wang HQ, 2014, INT J CLIN EXP PATHO, V7, P1293; Wang Y, 2012, SPINE J, V12, P411, DOI 10.1016/j.spinee.2012.03.026; Williams R, 2016, GLOB SPINE J, V6, P35, DOI 10.1055/s-0035-1555655; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; YU SW, 1989, AM J NEURORADIOL, V10, P1077	50	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0160111	10.1371/journal.pone.0160111	http://dx.doi.org/10.1371/journal.pone.0160111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649071	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100001
J	Arras, SDM; Fraser, JA				Arras, Samantha D. M.; Fraser, James A.			Chemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-PK; HOMOLOGOUS RECOMBINATION; ASPERGILLUS-FUMIGATUS; INFECTIOUS-DISEASES; PNEUMOCOCCAL TYPES; REPLICATION FORKS; HYBRID PLASMID; GENE DELETION	The development of a biolistic transformation protocol for Cryptococcus neoformans over 25 years ago ushered in a new era of molecular characterization of virulence in this previously intractable fungal pathogen. However, due to the low rate of homologous recombination in this species, the process of creating targeted gene deletions using biolistic transformation remains inefficient. To overcome the corresponding difficulty achieving molecular genetic modifications, members of the Cryptococcus community have investigated the use of specific genetic backgrounds or construct design strategies aimed at reducing ectopic construct integration via non-homologous end joining (NHEJ). One such approach involves deletion of components of the NHEJ-associated Ku heterodimer. While this strategy increases homologous recombination to nearly 100%, it also restricts strain generation to a ku80 Delta genetic background and requires subsequent complex mating procedures to reestablish wild-type DNA repair. In this study, we have investigated the ability of known inhibitors of mammalian NHEJ to transiently phenocopy the C. neoformans Ku deletion strains. Testing of eight candidate inhibitors revealed a range of efficacies in C. neoformans, with the most promising compound (W7) routinely increasing the rate of gene deletion to over 50%. We have successfully employed multiple inhibitors to reproducibly enhance the deletion rate at multiple loci, demonstrating a new, easily applied methodology to expedite acquisition of precise genetic alterations in C. neoformans. Based on this success, we anticipate that the use of these inhibitors will not only become widespread in the Cryptococcus community, but may also find use in other fungal species as well.	[Arras, Samantha D. M.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012	Fraser, James A/0000-0001-5724-5285	National Health and Medical Research Council [455980]; ARC Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Australian Postgraduate Award(Australian Research Council)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) grant# 455980 to JAF and ARC Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards) to SDMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; CASE ME, 1979, P NATL ACAD SCI USA, V76, P5259, DOI 10.1073/pnas.76.10.5259; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; Chow EWL, 2012, MOL BIOL EVOL, V29, P1987, DOI 10.1093/molbev/mss066; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; De Soto JA, 2006, INT J BIOL SCI, V2, P179; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Institute. CaLS, 2005, M27A2 CLSI; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lin XR, 2015, MED MYCOL, V53, P225, DOI 10.1093/mmy/myu083; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; SLEIGH MJ, 1976, NUCLEIC ACIDS RES, V3, P891, DOI 10.1093/nar/3.4.891; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Thompson EG, 2012, ENVIRON MOL MUTAGEN, V53, P32, DOI 10.1002/em.21674; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417	52	20	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163049	10.1371/journal.pone.0163049	http://dx.doi.org/10.1371/journal.pone.0163049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643854	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900028
J	Ishikawa, Y; Fujii, T; Ishikawa, SK; Yukawa, N; Hashimoto, M; Furu, M; Ito, H; Ohmura, K; Mimori, T				Ishikawa, Yuki; Fujii, Takao; Ishikawa, Seiko Kondo; Yukawa, Naoichiro; Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Ohmura, Koichiro; Mimori, Tsuneyo			Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; CLINICAL-RESPONSE; DISEASE-ACTIVITY; THROMBOEMBOLIC EVENTS; ANTINUCLEAR ANTIBODY; ANTIDRUG ANTIBODIES; TNF; ADALIMUMAB; ERYTHEMATOSUS	Besides anti-drug antibodies, anti-nuclear antibodies and anti-DNA antibodies are often induced in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. We examined the association between immunogenicity, autoantibody production, and serum cytokine profiles in patients with rheumatoid arthritis treated with infliximab. Japanese patients with rheumatoid arthritis (n = 57) were retrospectively examined. Serum trough levels of infliximab, anti-drug antibody, anti-nuclear antibody, and anti-DNA (Farr), anti-single-stranded DNA and anti-double-stranded DNA antibodies were measured. Interleukin-6, interferon-., interferon-a, and B-cell activating factor levels were also measured in the same sera. Then, we validated the association between anti-drug antibody and these serum markers along with clinical response to infliximab. Anti-drug antibodies developed in twenty-one patients (36.8%), whose serum trough levels of infliximab were significantly lower than those in anti-drug antibody-negative patients (0.09 +/- 0.03 vs. 2.48 +/- 0.326 mu g/mL, p < 0.0001). There were no significant differences in clinical backgrounds between the two groups. The anti-drug antibody-positive patients were more likely to develop antinuclear antibody titers of >= x160 compared to the negative patients (14 to 57% vs. 17 to 33%). In addition, anti-DNA antibodies (Farr) (from 1.5 +/- 0.4 to 35 +/- 17 IU/mL, p = 0.0001), especially IgM-anti-double stranded DNA antibody (from 5.1 +/- 0.7 to 41 +/- 8.9 IU/mL, p < 0.0001), and IgG-anti-single stranded DNA antibody (from 13 +/- 1.1 to 35 +/- 13, p = 0.0145) were significantly increased in anti-drug antibody-positive but not in negative patients. Moreover, the anti-drug antibody-positive, but not the negative patients, showed significant increased levels of interferon-a (from 248.7 +/- 102.3 to 466.8 +/- 135.1 pg/mL, p = 0.0353) and B-cell activating factor (from 1073 +/- 75.1 to 1387 +/- 136.5 pg/mL, p = 0.0208) following infliximab treatment. The development of anti-drug antibody against infliximab and lupus-like autoantibody production in patients with rheumatoid arthritis treated with infliximab can be linked each other along with increased lupus-associated cytokine levels including type I interferons.	[Ishikawa, Yuki; Fujii, Takao; Ishikawa, Seiko Kondo; Yukawa, Naoichiro; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Fujii, Takao] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan	Kyoto University; Kyoto University; Kyoto University; Wakayama Medical University	Fujii, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.; Fujii, T (corresponding author), Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan.	takfujii@wakayama-med.ac.jp	Ishikawa, Yuki/AAI-6721-2020	Ishikawa, Yuki/0000-0002-6514-8239	Grants-in-Aid for Scientific Research [16K09901] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Andrade D, 2011, ARTHRITIS RHEUM-US, V63, P2764, DOI 10.1002/art.30424; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Becker-Merok A, 2013, LUPUS, V22, P155, DOI 10.1177/0961203312468964; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Bootsma H, 1997, ANN RHEUM DIS, V56, P661, DOI 10.1136/ard.56.11.661; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Choy EHS, 2002, RHEUMATOLOGY, V41, P1133, DOI 10.1093/rheumatology/41.10.1133; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; De Rycke L, 2005, LUPUS, V14, P931, DOI 10.1191/0961203305lu2240rr; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; Ferraro-Peyret C, 2004, ARTHRITIS RES THER, V6, pR535, DOI 10.1186/ar1440; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Hall JC, 2015, ARTHRITIS RHEUMATOL, V67, P2437, DOI 10.1002/art.39204; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jamnitski A, 2012, ANN RHEUM DIS, V71, P88, DOI 10.1136/annrheumdis-2011-200184; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Jullien D, 2012, ANN DERMATOL VENER, V139, pS58, DOI 10.1016/S0151-9638(12)70112-6; Kay J, 2015, ANN RHEUM DIS, V74, P538, DOI 10.1136/annrheumdis-2013-204195; Kneepkens EL, 2014, ANN RHEUM DIS, V73, P2217, DOI 10.1136/annrheumdis-2014-205983; Korswagen LA, 2011, ARTHRITIS RHEUM-US, V63, P877, DOI 10.1002/art.30209; Makol Ashima, 2010, J Med Case Rep, V4, P12, DOI 10.1186/1752-1947-4-12; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Moulis G, 2014, RHEUMATOLOGY, V53, P1864, DOI 10.1093/rheumatology/keu214; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Petitpain N, 2009, BIO-MED MATER ENG, V19, P355, DOI 10.3233/BME-2009-0600; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Svenson M, 2007, RHEUMATOLOGY, V46, P1828, DOI 10.1093/rheumatology/kem261; Takase K, 2014, ANN RHEUM DIS, V73, P1695, DOI 10.1136/annrheumdis-2014-205318; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671; Xu Y, 2015, ARTHRITIS RHEUMATOL, V67, P225, DOI 10.1002/art.38882; Yukawa N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3546; Zhou HH, 2007, J CLIN PHARMACOL, V47, P383, DOI 10.1177/0091270006298188	45	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162896	10.1371/journal.pone.0162896	http://dx.doi.org/10.1371/journal.pone.0162896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643491	Green Submitted, gold, Green Published			2022-12-27	WOS:000383891900024
J	Shen, Y; Kim, AL; Du, R; Liu, L				Shen, Yao; Kim, Arianna L.; Du, Rong; Liu, Liang			Transcriptome Analysis Identifies the Dysregulation of Ultraviolet Target Genes in Human Skin Cancers	PLOS ONE			English	Article							HUMAN KERATINOCYTE; DAMAGE RESPONSE; SUN PROTECTION; BREAST-CANCER; RADIATION; EXPRESSION; EXPOSURE; IRRADIATION; GENOME; RISK	Exposure to ultraviolet radiation (UVR) is a major risk factor for both melanoma and non-melanoma skin cancers. In addition to its mutagenic effect, UVR can also induce substantial transcriptional instability in skin cells affecting thousands of genes, including many cancer genes, suggesting that transcriptional instability may be another important etiological factor in skin photocarcinogenesis. In this study, we performed detailed transcriptomic profiling studies to characterize the kinetic changes in global gene expression in human keratinocytes exposed to different UVR conditions. We identified a subset of UV-responsive genes as UV signature genes (UVSGs) based on 1) conserved UV-responsiveness of this subset of genes among different keratinocyte lines; and 2) UV-induced persistent changes in their mRNA levels long after exposure. Interestingly, 11 of the UVSGs were shown to be critical to skin cancer cell proliferation and survival. Through computational Gene Set Enrichment Analysis, we demonstrated that a significant portion of the UVSGs were dysregulated in human skin squamous cell carcinomas, but not in other human malignancies. This highlights the potential and specificity of the UVSGs in clinical diagnosis of UV damage and stratification of skin cancer risk.	[Shen, Yao] Columbia Univ, Dept Syst Biol, New York, NY USA; [Kim, Arianna L.; Du, Rong; Liu, Liang] Columbia Univ, Dept Dermatol, New York, NY 10027 USA	Columbia University; Columbia University	Liu, L (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10027 USA.	LL2697@columbia.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K01AR064315]; Columbia University Skin Disease Research Center [P30AR44535]; Center for Environmental Health in Northern Manhattan [P30 ES009089]; American Skin Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, K01AR064315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Columbia University Skin Disease Research Center; Center for Environmental Health in Northern Manhattan; American Skin Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number K01AR064315, the Columbia University Skin Disease Research Center grant P30AR44535, the Center for Environmental Health in Northern Manhattan P30 ES009089, and the American Skin Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, REPORTS SURG GEN; Batagelj V, 2004, MATH VIS, P77; Bens Guido, 2014, Adv Exp Med Biol, V810, P429; Boice JD, 2005, JNCI-J NATL CANCER I, V97, P703, DOI 10.1093/jnci/dji151; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dawes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093338; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; de la Fuente H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006735; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fartasch M, 2012, DTSCH ARZTEBL INT, V109, P715, DOI 10.3238/arztebl.2012.0715; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guy GP, 2015, AM J PREV MED, V48, P183, DOI 10.1016/j.amepre.2014.08.036; Gyorffy B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0514-2; Hacker E, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12157; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heckman CJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Lautenschlager S, 2007, LANCET, V370, P528, DOI 10.1016/S0140-6736(07)60638-2; Lin SW, 2012, INT J CANCER, V131, pE1015, DOI 10.1002/ijc.27619; Osterwalder U, 2009, BRIT J DERMATOL, V161, P13, DOI 10.1111/j.1365-2133.2009.09506.x; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Robinson JK, 2005, JAMA-J AM MED ASSOC, V294, P1541, DOI 10.1001/jama.294.12.1541; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Seite S, 2010, BRIT J DERMATOL, V163, P903, DOI 10.1111/j.1365-2133.2010.10018.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XY, 2016, EXP DERMATOL, V25, P708, DOI 10.1111/exd.13057; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takao J, 2002, PHOTODERMATOL PHOTO, V18, P5, DOI 10.1034/j.1600-0781.2002.180102.x; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421; Wu SW, 2014, CANCER EPIDEM BIOMAR, V23, P1080, DOI 10.1158/1055-9965.EPI-13-0821; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; You YN, 2015, SURG ONCOL, V24, P61, DOI 10.1016/j.suronc.2015.02.001; Zanotti L, 2014, TUMOR BIOL, V35, P8461, DOI 10.1007/s13277-014-2366-2	39	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163054	10.1371/journal.pone.0163054	http://dx.doi.org/10.1371/journal.pone.0163054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643989	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900029
J	Smabrekke, B; Rinde, LB; Hindberg, K; Hald, EM; Vik, A; Wilsgaard, T; Lochen, ML; Njolstad, I; Mathiesen, EB; Hansen, JB; Braekkan, S				Smabrekke, Birgit; Rinde, Ludvig Balteskard; Hindberg, Kristian; Hald, Erin Mathiesen; Vik, Anders; Wilsgaard, Tom; Lochen, Maja-Lisa; Njolstad, Inger; Mathiesen, Ellisiv B.; Hansen, John-Bjarne; Braekkan, Sigrid			Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromso Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; REGRESSION DILUTION; CONFIDENCE-INTERVALS; DIABETES-MELLITUS; MEASUREMENT ERROR; SEX-DIFFERENCES; BLOOD-PRESSURE; FOLLOW-UP; STATINS; IMPACT	Background Single measurements of modifiable risk factors may underestimate associations with outcomes in cohorts. We aimed to compare risk estimates of myocardial infarction (MI) and venous thromboembolism (VTE) by atherosclerotic risk factors during long follow-up using time-fixed analyses without and with correction for regression dilution and time-varying analyses. Methods The study included 5970 subjects enrolled in the fourth survey of the Tromso Study (1994/95). Blood pressure, lipid levels, body mass index (BMI), diabetes and smoking status were measured at baseline, and subjects still alive at the fifth (2001/02, n = 5179) and sixth (2007/08, n = 4391) survey were re-measured. Incident events of MI (n = 714) and VTE (n = 214) were recorded until December 2010. Time-fixed and time-varyingCox regression models were used to estimate hazard ratios (HR) for MI and VTE adjusted for age and sex. Results Variations in BMI, blood pressure and lipid levels were small, and did not alter the risk estimates when time-varying analyses were compared to time-fixed analyses. For MI, variables that changed considerably over time yielded the greatest changes in risk estimates (HR for smoking changed from 1.80 (95% CI 1.55-2.10) to 2.08 (95% CI 1.78-2.42)). For VTE, only BMI was associated with increased risk in both time-fixed and time-varying analysis, but the risk estimates weakened in the time-varying analysis. Correction of time-fixed HRs with Rosner's method tended to overestimate risk estimates compared to time-varying analysis. Comment For MI and VTE, risk estimates based on baseline and repeated measures corresponded well, whereas correction for regression dilution tended to overestimate risks.	[Smabrekke, Birgit; Rinde, Ludvig Balteskard; Hindberg, Kristian; Hald, Erin Mathiesen; Vik, Anders; Njolstad, Inger; Mathiesen, Ellisiv B.; Hansen, John-Bjarne; Braekkan, Sigrid] UiT Arctic Univ Norway, Dept Clin Med, KG Jebsen Thrombosis Res & Expertise Ctr TREC, Tromso, Norway; [Hald, Erin Mathiesen; Vik, Anders; Hansen, John-Bjarne; Braekkan, Sigrid] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Wilsgaard, Tom; Lochen, Maja-Lisa; Njolstad, Inger] UiT Arctic Univ Norway, Dept Community Med, Epidemiol Chron Dis Res Grp, Tromso, Norway; [Mathiesen, Ellisiv B.] UiT Arctic Univ Norway, Dept Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp North Norway, Dept Neurol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Smabrekke, B (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, KG Jebsen Thrombosis Res & Expertise Ctr TREC, Tromso, Norway.	birgit.smabrekke@uit.no	Njolstad, Inger/X-3784-2019	Rinde, Ludvig/0000-0002-1621-1756; Braekkan, Sigrid/0000-0002-9678-9696; Lochen, Maja-Lisa/0000-0002-8532-6573	K. G. Jebsen Foundation	K. G. Jebsen Foundation	This research is supported by an independent grant from the K. G. Jebsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Borch KH, 2010, ARTERIOSCL THROM VAS, V30, P121, DOI 10.1161/ATVBAHA.109.188920; Braekkan SK, 2008, J THROMB HAEMOST, V6, P1851, DOI 10.1111/j.1538-7836.2008.03102.x; Braekkan SK, 2012, ARTERIOSCL THROM VAS, V32, P487, DOI 10.1161/ATVBAHA.111.237545; Braekkan SK, 2010, AM J EPIDEMIOL, V171, P1109, DOI 10.1093/aje/kwq066; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Deguchi H, 2005, CIRCULATION, V112, P893, DOI 10.1161/CIRCULATIONAHA.104.521344; Doggen CJM, 2004, ARTERIOSCL THROM VAS, V24, P1970, DOI 10.1161/01.ATV.0000143134.87051.46; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Frost C, 2005, INT J EPIDEMIOL, V34, P1359, DOI 10.1093/ije/dyi148; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Heit JA, 2009, ARTERIOSCL THROM VAS, V29, P1399, DOI 10.1161/ATVBAHA.109.189290; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Lerstad G, 2014, J THROMB HAEMOST, V12, P313, DOI 10.1111/jth.12498; Lind C, 2014, CIRC-CARDIOVASC GENE, V7, P684, DOI 10.1161/CIRCGENETICS.114.000621; Lind C, 2014, CIRCULATION, V129, P855, DOI 10.1161/CIRCULATIONAHA.113.004168; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mannsverk J, 2016, CIRCULATION, V133, P74, DOI 10.1161/CIRCULATIONAHA.115.016960; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; Njolstad I, 1996, CIRCULATION, V93, P450; Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Quist-Paulsen P, 2010, HAEMATOL-HEMATOL J, V95, P119, DOI 10.3324/haematol.2009.011866; Reich LM, 2006, J THROMB HAEMOST, V4, P1909, DOI 10.1111/j.1538-7836.2006.02121.x; Rinde LB, 2016, J THROMB HAEMOST, V14, P1183, DOI 10.1111/jth.13329; ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Squizzato A, 2010, EUR HEART J, V31, P1248, DOI 10.1093/eurheartj/ehp556; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Undas A, 2005, ARTERIOSCL THROM VAS, V25, P287, DOI 10.1161/01.ATV.0000151647.14923.ec; Vaughan CJ, 1996, LANCET, V348, P1079, DOI 10.1016/S0140-6736(96)05190-2; Wattanakit K, 2012, THROMB HAEMOSTASIS, V108, P508, DOI 10.1160/TH11-10-0726; WHOMONICA Project, 2015, MONICA MANUAL; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	44	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163242	10.1371/journal.pone.0163242	http://dx.doi.org/10.1371/journal.pone.0163242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635655	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700041
J	Chen, Y; Marino, J; Chen, Y; Tao, Q; Sullivan, CD; Shi, K; Macdonald, DW				Chen, Ying; Marino, Jorgelina; Chen, Yong; Tao, Qing; Sullivan, Casey D.; Shi, Kun; Macdonald, David W.			Predicting Hotspots of Human-Elephant Conflict to Inform Mitigation Strategies in Xishuangbanna, Southwest China	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; COVER CHANGE; LAND-USE; CONSERVATION; BIODIVERSITY; PATTERNS; YUNNAN	Research on the spatial patterns of human-wildlife conflict is fundamental to understanding the mechanisms underlying it and to identifying opportunities for mitigation. In the state of Xishuangbanna, containing China's largest tropical forest, an imbalance between nature conservation and economic development has led to increasing conflicts between humans and Asian elephants (Elephas maximus), as both elephant numbers and conversion of habitable land to rubber plantations have increased over the last several decades. We analyzed government data on the compensation costs of elephant-caused damage in Xishuangbanna between 2008 and 2012 to understand the spatial and temporal patterns of conflict, in terms of their occurrence, frequency and distribution. More than 18,261 incidents were reported, including episodes involving damage to rubber trees (n = 10,999), damage to crops such as paddy, upland rice, corn, bananas and sugarcane (n = 11,020), property loss (n = 689) and attacks on humans (n = 19). The conflict data reconfirmed the presence of elephants in areas which have lacked records since the late 1990s. Zero Altered Negative Binomial models revealed that the risk of damage to crops and plantations increased with proximity to protected areas, increasing distance from roads, and lower settlement density. The patterns were constant across seasons and types of crop damaged. Damage to rubber trees was essentially incidental as elephants searched for crops to eat. A predictive map of risks revealed hotspots of conflict within and around protected areas, the last refuges for elephants in the region, and along habitat corridors connecting them. Additionally, we analyzed how mitigation efforts can best diminish the risk of conflict while minimizing financial costs and adverse biological impacts. Our analytical approach can be adopted, adjusted and expanded to other areas with historical records of human-wildlife conflict.	[Chen, Ying; Sullivan, Casey D.; Shi, Kun] Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing 100083, Peoples R China; [Chen, Ying; Marino, Jorgelina; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Oxford OX13 5QL, England; [Chen, Yong] Xishuangbanna Forestry Adm, Jinghong 666100, Yunnan, Peoples R China; [Tao, Qing] Xishuangbanna Natl Nat Reserve, Jinghong 666100, Yunnan, Peoples R China	Beijing Forestry University; University of Oxford	Shi, K (corresponding author), Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing 100083, Peoples R China.	kunshi@bjfu.edu.cn		Sullivan, Casey/0000-0001-7230-9574	Cambridge University; Recanati-Kaplan Foundation; Wildlife Conservation Network; State Forestry Administration; Yunnan Forest Administration	Cambridge University(University of Cambridge); Recanati-Kaplan Foundation; Wildlife Conservation Network; State Forestry Administration; Yunnan Forest Administration	The work was supported by the following: Cambridge University grant, http://www.cam.ac.uk; Recanati-Kaplan Foundation; Wildlife Conservation Network, http://wildnet.org; State Forestry Administration, http://www.forestry.gov.cn, China under the Program of Wildlife Survey, Monitoring and Management, with effective support by the Yunnan Forest Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cai J, 2008, EUR J WILDLIFE RES, V54, P723, DOI 10.1007/s10344-008-0203-x; Carpenter J, 2000, BOOTSTRAP CONDENCE I; Chartier L, 2011, ORYX, V45, P528, DOI 10.1017/S0030605311000044; Chen Jin, 2006, Acta Ecologica Sinica, V26, P309, DOI 10.1016/S1872-2032(06)60006-1; Chen S, 2013, BIOL CONSERV, V168, P31, DOI 10.1016/j.biocon.2013.09.017; China Ministry of Agriculture State Forestry Administration, 2003, STAT COUNC B PEOPL R, V23; Das Jyoti P., 2012, Gajah, V37, P34; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Goswami VR, 2015, CONSERV BIOL, V29, P1100, DOI 10.1111/cobi.12475; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Gubbi S, 2012, BIOL CONSERV, V148, P88, DOI 10.1016/j.biocon.2012.01.046; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; He QC, 2011, CHINESE GEOGR SCI, V21, P629, DOI 10.1007/s11769-011-0499-4; Hoare R, 2000, ORYX, V34, P34, DOI 10.1017/S0030605300030878; Hollander M., 1973, NONPARAMETRIC STAT M, P185; IUCN, IUCN RED LIST THREAT; Joshi R., 2008, J AM SCI, V4, P34; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Lacoeuilhe A, 2016, ACTA OECOL, V71, P61, DOI 10.1016/j.actao.2016.01.009; Lahkar B.P., 2007, STUDY HABITAT UTILIZ; Li C., 1999, CHINESE WILDLIFE, V20, P8; Li Zeng-Jia, 2008, Zhiwu Shengtai Xuebao, V32, P1091, DOI 10.3773/j.issn.1005-264x.2008.05.014; Lin Liu, 2011, Acta Theriologica Sinica, V31, P226; Liu J, 2010, J ENVIRON MANAGE, V91, P2254, DOI 10.1016/j.jenvman.2010.06.007; MacKinnon, 1987, ECOLOGIVAL GUIDELINE; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nyhus P, 2004, AGR ECOSYST ENVIRON, V104, P87, DOI 10.1016/j.agee.2004.01.009; Okabe A, 2009, INT J GEOGR INF SCI, V23, P7, DOI 10.1080/13658810802475491; Quantum GIS Development Team, 2013, QUANT GIS GEOGR INF; R Development Core Team R, 2014, R LANG ENV STAT COMP; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Songhurst A, 2014, ECOL EVOL, V4, P582, DOI 10.1002/ece3.837; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sun G, 1997, J NE FORESTRY U, V26, P47; Tsinghua U., FINER RESOLUTION OBS; USGS NGA NASA, 2013, SHUTTL RAD TOP MISS; Webber CE, 2011, ORYX, V45, P243, DOI 10.1017/S0030605310000335; Wilson R., FREE GIS DATA 2014; Wilson S, 2013, ORYX, P1; XSBN-NNR N, 2010, MAST PLAN XISH NAT N; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; [杨文忠 YANG Wenzhong], 2009, [山地学报, Journal of Mountain Science], V27, P306; Yang Z, 2006, FOREST INVENTORY PLA, V31; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Yuan Zhiqiang, 2006, Acta Theriologica Sinica, V26, P359; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhang L., 2006, BIOL BULL, V42, P1; Zhang L., 2007, GAJAH, V35; Zhang L, 2006, INTEGR ZOOL, V1, P179, DOI 10.1111/j.1749-4877.2006.00031.x; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028; Zong J, 2014, FOREST INVENORY PLAN, V39, P89; Zuur Alain F., 2009, P1	61	49	49	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162035	10.1371/journal.pone.0162035	http://dx.doi.org/10.1371/journal.pone.0162035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631976	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900024
J	Hueper, K; Gutberlet, M; Brasen, JH; Jang, MS; Thorenz, A; Chen, RJ; Hertel, B; Barrmeyer, A; Schmidbauer, M; Meier, M; von Vietinghoff, S; Khalifa, A; Hartung, D; Haller, H; Wacker, F; Rong, S; Gueler, F				Hueper, Katja; Gutberlet, Marcel; Braesen, Jan Hinrich; Jang, Mi-Sun; Thorenz, Anja; Chen, Rongjun; Hertel, Barbara; Barrmeyer, Amelie; Schmidbauer, Martina; Meier, Martin; von Vietinghoff, Sibylle; Khalifa, Abedalrazag; Hartung, Dagmar; Haller, Hermann; Wacker, Frank; Rong, Song; Gueler, Faikah			Multiparametric Functional MRI: Non-Invasive Imaging of Inflammation and Edema Formation after Kidney Transplantation in Mice	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; MAGNETIC-RESONANCE; RENAL-ALLOGRAFTS; RELAXATION-TIME; WATER-CONTENT; INJURY; INHIBITION; FIBROSIS; RECEPTOR	Background Kidney transplantation (ktx) in mice is used to learn about rejection and to develop new treatment strategies. Past studies have mainly been based on histological or molecular biological methods. Imaging techniques to monitor allograft pathology have rarely been used. Methods Here we investigated mice after isogenic and allogenic ktx over time with functional MRI with diffusion-weighted imaging (DWI) and mapping of T2-relaxation time (T2-mapping) to assess graft inflammation and edema formation. To characterize graft pathology, we used PAS-staining, counted CD3-positive T-lymphocytes, analyzed leukocytes by means flow cytometry. Results DWI revealed progressive restriction of diffusion of water molecules in allogenic kidney grafts. This was paralleled by enhanced infiltration of the kidney by inflammatory cells. Changes in tissue diffusion were not seen following isogenic ktx. T2-times in renal cortex were increased after both isogenic and allogenic transplantation, consistent with tissue edema due to ischemic injury following prolonged cold ischemia time of 60 minutes. Lack of T2 increase in the inner stripe of the inner medulla in allogenic kidney grafts matched loss of tubular autofluorescence and may result from rejection-driven reductions in tubular water content due to tubular dysfunction and renal functional impairment. Conclusions Functional MRI is a valuable non-invasive technique for monitoring inflammation, tissue edema and tubular function. It permits on to differentiate between acute rejection and ischemic renal injury in a mouse model of ktx.	[Hueper, Katja; Gutberlet, Marcel; Barrmeyer, Amelie; Schmidbauer, Martina; Hartung, Dagmar; Wacker, Frank] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Braesen, Jan Hinrich; Khalifa, Abedalrazag] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Jang, Mi-Sun; Thorenz, Anja; Chen, Rongjun; Hertel, Barbara; von Vietinghoff, Sibylle; Haller, Hermann; Rong, Song; Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Meier, Martin] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Rong, Song] Zunyi Med Coll, Transplantat Ctr, Affiliated Hosp, Zunyi, Peoples R China; [Chen, Rongjun] Zhejiang Univ, Kidney Dis Ctr, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Zunyi Medical University; Zhejiang University	Hueper, K (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	hueper.katja@mh-hannover.de		Meier, Martin/0000-0001-8642-0409; /0000-0001-9985-1515	German Research Foundation [HU2232/1-1, GU613/1-1]; "Junge Akademie" program of Hannover Medical School	German Research Foundation(German Research Foundation (DFG)); "Junge Akademie" program of Hannover Medical School	This work was supported by the German Research Foundation HU2232/1-1 (Hueper) and GU613/1-1 (Gueler) "Junge Akademie" program of Hannover Medical School (Hueper).	Blondin D, 2009, ROFO-FORTSCHR RONTG, V181, P1162, DOI 10.1055/s-0028-1109511; Eisenberger U, 2014, RADIOLOGY, V270, P800, DOI 10.1148/radiol.13122588; Eisenberger U, 2010, EUR RADIOL, V20, P1374, DOI 10.1007/s00330-009-1679-9; Fan WJ, 2016, EUR RADIOL, V26, P567, DOI 10.1007/s00330-015-3841-x; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; Gueler F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115709; Gueler F, 2008, J AM SOC NEPHROL, V19, P2302, DOI 10.1681/ASN.2007111267; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hueper K, 2016, J MAGN RESON IMAGING, V44, P112, DOI 10.1002/jmri.25158; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2015, AM J PHYSIOL-RENAL, V308, pF1444, DOI 10.1152/ajprenal.00064.2015; Hueper K, 2014, EUR RADIOL, V24, P2252, DOI 10.1007/s00330-014-3250-6; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; KIRICUTA IC, 1975, CANCER RES, V35, P1164; KUNDEL HL, 1986, INVEST RADIOL, V21, P12, DOI 10.1097/00004424-198601000-00002; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pohlmann A, 2014, INVEST RADIOL, V49, P547, DOI 10.1097/RLI.0000000000000054; Qayyum A, 2009, RADIOGRAPHICS, V29, P1797, DOI 10.1148/rg.296095521; Ren T, 2016, MAGN RESON IMAGING, V34, P908, DOI 10.1016/j.mri.2016.04.022; Rong S, 2014, AM J PHYSIOL-RENAL, V307, pF718, DOI 10.1152/ajprenal.00372.2013; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Thoeny HC, 2006, RADIOLOGY, V241, P812, DOI 10.1148/radiol.2413060103; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Yang DW, 2004, RADIOLOGY, V231, P702, DOI 10.1148/radiol.2313021587	28	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162705	10.1371/journal.pone.0162705	http://dx.doi.org/10.1371/journal.pone.0162705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632553	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900068
J	Jee, YH; Lee, SJ; Jung, KJ; Jee, SH				Jee, Yon Ho; Lee, Sun Ju; Jung, Keum Ji; Jee, Sun Ha			Alcohol Intake and Serum Glucose Levels from the Perspective of a Mendelian Randomization Design: The KCPS-II Biobank	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; GENETIC EPIDEMIOLOGY; DRINKING BEHAVIOR; CONSUMPTION; MEN	Background Previous studies have suggested that alcohol intake is associated with increased fasting serumglucose (FSG), but the nature of the relationship remains unknown. We used Mendelian randomization analysis to assess the causal effect of alcohol intake on FSG in a middle-aged Korean population. Methods Clinical data including FSG and alcohol intake were collected from 156,386 Koreans aged 20 years or older who took part in the Korean Cancer Prevention Study-II (KCPS-II) Biobank Cohort. The single nucleotide polymorphism rs671 in ALDH2 was genotyped among 2,993 men and 1,374 women in 2016. This was a randomly selected subcohort of KCPS-II Biobank participants. Results Alcohol consumption was positively associated with FSG level in men, but not in women. The rs671 major G allele was associated with increased alcohol intake (F-statistic = 302.62) and an increase in FSG in men. Using Mendelian randomization analysis, alcohol intake increased FSG by 1.78 mg/dL per alcohol unit (10 g ethanol) per day (95% CI: 0.97-2.59) in men. The associations became stronger when we excluded heavy drinkers and the elderly. However, in women, no significant association between rs671 and alcohol or serumglucose was found. Conclusion Using Mendelian randomization analysis, we suggest a causal relationship between alcohol intake and FSG among Korean men. Moreover, we found that the ALDH2 variant rs671 was not associated with FSG among Korean women.	[Jee, Yon Ho; Lee, Sun Ju; Jung, Keum Ji; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul, South Korea; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, KJ (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul, South Korea.	kjjung@yuhs.ac		Jee, Sun Ha/0000-0001-9519-3068; Jung, Keum Ji/0000-0003-4993-0666	grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2686]	grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslow RA, 2003, J STUD ALCOHOL, V64, P884, DOI 10.15288/jsa.2003.64.884; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; GOEDDE HW, 1992, HUM GENET, V88, P344; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602; Kiage J. N., 2014, Current Nutrition Reports, V3, P213; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149321; Korean Statistics Information Service, STAT DAT; Li XH, 2016, AM J CLIN NUTR, V103, P818, DOI 10.3945/ajcn.115.114389; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; NAKAJIMA T, 1994, AM J CLIN NUTR, V60, P87, DOI 10.1093/ajcn/60.1.87; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20691; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137790; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162930	10.1371/journal.pone.0162930	http://dx.doi.org/10.1371/journal.pone.0162930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632197	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900096
J	Nicklen, P; Rivers, G; Ooi, C; Ilic, D; Reeves, S; Walsh, K; Maloney, S				Nicklen, Peter; Rivers, George; Ooi, Caryn; Ilic, Dragan; Reeves, Scott; Walsh, Kieran; Maloney, Stephen			An Approach for Calculating Student-Centered Value in Education - A Link between Quality, Efficiency, and the Learning Experience in the Health Professions	PLOS ONE			English	Article							DEVELOPING-WORLD	Health professional education is experiencing a cultural shift towards student-centered education. Although we are now challenging our traditional training methods, our methods for evaluating the impact of the training on the learner remains largely unchanged. What is not typically measured is student-centered value; whether it was 'worth' what the learner paid. The primary aim of this study was to apply a method of calculating student-centered value, applied to the context of a change in teaching methods within a health professional program. This study took place over the first semester of the third year of the Bachelor of Physiotherapy at Monash University, Victoria, Australia, in 2014. The entire third year cohort (n = 78) was invited to participate. Survey based design was used to collect the appropriate data. A blended learning model was implemented; subsequently students were only required to attend campus three days per week, with the remaining two days comprising online learning. This was compared to the previous year's format, a campus-based face-to-face approach where students attended campus five days per week, with the primary outcome-Value to student. Value to student incorporates, user costs associated with transportation and equipment, the amount of time saved, the price paid and perceived gross benefit. Of the 78 students invited to participate, 76 completed the post-unit survey (non-participation rate 2.6%). Based on Value to student the blended learning approach provided a $1,314.93 net benefit to students. Another significant finding was that the perceived gross benefit for the blended learning approach was $4014.84 compared to the campus-based face-to-face approach of $3651.72, indicating that students would pay more for the blended learning approach. This paper successfully applied a novel method of calculating student-centered value. This is the first step in validating the value to student outcome. Measuring economic value to the student may be used as a way of evaluating effective change in a modern health professional curriculum. This could extend to calculate total value, which would incorporate the economic implications for the educational providers. Further research is required for validation of this outcome.	[Nicklen, Peter; Ooi, Caryn; Maloney, Stephen] Monash Univ, Dept Physiotherapy, Frankston, Vic, Australia; [Rivers, George] Monash Univ, Dept Econ, Caulfield, Vic, Australia; [Ilic, Dragan] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Reeves, Scott] St Georges Univ London, Cranmer Terrace, London, England; [Walsh, Kieran] British Med Journal, Tavistock Sq, London, England	Monash University; Monash University; Monash University; St Georges University London	Nicklen, P (corresponding author), Monash Univ, Dept Physiotherapy, Frankston, Vic, Australia.	peter.nicklen@monash.edu		Maloney, Stephen/0000-0003-2612-5162	office of the Vice Provost Learning and Teaching of Monash University	office of the Vice Provost Learning and Teaching of Monash University	The authors would like to acknowledge the internal funding to support the research team from the office of the Vice Provost Learning and Teaching of Monash University - SM, DI, GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age CS, 1985, VALUE IS COMPLEX EQU, P18; Bates P, 2005, EVALUATING STUDENT C; Blackie MAL, 2010, TEACH HIGH EDUC, V15, P637, DOI 10.1080/13562517.2010.491910; Brown CA, 2002, BMJ-BRIT MED J, V16, P652; Choules AP, 2007, POSTGRAD MED J, V83, P212, DOI 10.1136/pgmj.2006.054189; Commission P, 2005, AUSTR HLTH WORKFORCE; CRAVENS DW, 1988, IND MARKET MANAG, V17, P285, DOI 10.1016/0019-8501(88)90032-6; Curtis LJ, 2014, EC HLTH EC EVALUATIO; Hartnett M., 1998, DISCOUNT STORE NEWS, V37, P21; Kremer M, 2013, SCIENCE, V340, P297, DOI 10.1126/science.1235350; Kremer M, 2009, ANNU REV ECON, V1, P513, DOI 10.1146/annurev.economics.050708.143323; McDonald B., 2012, SELF ASSESSMENT STUD; Monroe K. B., 1990, PRICING MAKING PROFI; Oblinger D., 2012, GAME CHANGERS ED INF; Sweeney JC, 2001, J RETAILING, V77, P203, DOI 10.1016/S0022-4359(01)00041-0; Walsh K, 2013, AM J PHARM ED, V77; Walsh K, 2013, EDUC PRIM CARE, V24, P391, DOI 10.1080/14739879.2013.11494206; Walsh K, 2010, EDUC PRIM CARE, V21, P396; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446; Zurn Pascal, 2004, Hum Resour Health, V2, P13, DOI 10.1186/1478-4491-2-13	20	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162941	10.1371/journal.pone.0162941	http://dx.doi.org/10.1371/journal.pone.0162941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632427	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900098
J	Plawecki, M; Lheritier, E; Clavarino, G; Jourde-Chiche, N; Ouili, S; Paul, S; Gout, E; Sarrot-Reynauld, F; Bardin, N; Boelle, PY; Chiche, L; Bouillet, L; Thielens, NM; Cesbron, JY; Dumestre-Perard, C				Plawecki, Maelle; Lheritier, Elise; Clavarino, Giovanna; Jourde-Chiche, Noemie; Ouili, Saber; Paul, Stephane; Gout, Evelyne; Sarrot-Reynauld, Francoise; Bardin, Nathalie; Boelle, Pierre-Yves; Chiche, Laurent; Bouillet, Laurence; Thielens, Nicole M.; Cesbron, Jean-Yves; Dumestre-Perard, Chantal			Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; ANTI-C1Q ANTIBODIES; HAKATA ANTIGEN; DISEASE-ACTIVITY; APOPTOTIC CELLS; H-FICOLIN; COMPLEMENT ACTIVATION; COLLAGEN-LIKE; PATHWAY; C1Q	Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of multiple autoantibodies. Antibodies against Ficolin-3 were previously identified in the sera of some SLE patients, but their prevalence and significance have not been yet investigated. The aims of this study were to determine the prevalence of anti-ficolin-3 antibodies among SLE patients and to investigate their potential as diagnostic and/or prognostic biomarkers in SLE. In this retrospective study, sera from SLE patients (n = 165) were selected from a preexisting declared biological collection. Samples from healthy controls (n = 48) were matched with SLE sera. Disease activity was determined according to the SLEDAI score. Anti-ficolin-3, anti-dsDNA and anti-C1q antibodies levels were measured in sera by ELISA. First, a highly significant difference was found in the anti-ficolin-3 levels between SLE patients and healthy subjects. Anti-ficolin-3 antibodies were detected as positive in 56 of 165 (34%) SLE patients. The titer of anti-ficolin-3 antibodies was correlated with the SLEDAI score (r = 0.38, p<0.0001). The presence of anti-ficolin-3 antibodies was associated with anti-C1q and anti-dsDNA antibodies. Regarding associations with clinical manifestations, the presence of active lupus nephritis was significantly associated with the presence of anti-ficolin-3 antibodies (p <= 0.001). This association with renal involvement was higher with anti-ficolin-3 or anti-C1q antibodies than with other auto-antibodies. Interestingly, the combination of anti-ficolin-3 and anti-C1q antibodies demonstrated higher specificity than any other serological biomarker. These results suggest that anti-ficolin-3 antibodies could be useful for the diagnosis of active nephritis in SLE patients.	[Plawecki, Maelle; Lheritier, Elise; Clavarino, Giovanna; Ouili, Saber; Cesbron, Jean-Yves; Dumestre-Perard, Chantal] CHU Grenoble Alpes, Lab Immunol Pole Biol, Grenoble, France; [Clavarino, Giovanna; Cesbron, Jean-Yves; Dumestre-Perard, Chantal] Univ Grenoble Alpes, TIMC IMAG UMR5525, BNI Team, Grenoble, France; [Jourde-Chiche, Noemie; Bardin, Nathalie] Aix Marseille Univ, Fac Med, Vasc Res Ctr Marseille, UMR S 1076, Marseille, France; [Jourde-Chiche, Noemie] Aix Marseille Univ, CHU Concept, Ctr Nephrol & Transplantat Renale, Marseille, France; [Paul, Stephane] CHU St Etienne, INSERM, Immunol Lab, GIMAPEA3064,CIC Vaccinol 1488, St Etienne, France; [Gout, Evelyne; Thielens, Nicole M.] Univ Grenoble Alpes, IBS, Grenoble, France; [Gout, Evelyne; Thielens, Nicole M.] CNRS, IBS, Grenoble, France; [Gout, Evelyne; Thielens, Nicole M.] CEA, IBS, Grenoble, France; [Sarrot-Reynauld, Francoise; Bouillet, Laurence] CHU Grenoble Alpes, Clin Univ Med Interne Pole Pluridisciplinaire Med, Grenoble, France; [Bardin, Nathalie] Aix Marseille Univ, Hop Concept, Immunol Lab, Marseille, France; [Boelle, Pierre-Yves] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S 1136, Paris, France; [Chiche, Laurent] Hop Europeen, Serv Med Interne, Marseille, France	CHU Grenoble Alpes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Dumestre-Perard, C (corresponding author), CHU Grenoble Alpes, Lab Immunol Pole Biol, Grenoble, France.; Dumestre-Perard, C (corresponding author), Univ Grenoble Alpes, TIMC IMAG UMR5525, BNI Team, Grenoble, France.	cdumestre-perard@chu-grenoble.fr	Bardin, Nathalie/AAL-3663-2020; Thielens, Nicole M/F-2512-2013	Bardin, Nathalie/0000-0003-3680-082X; Thielens, Nicole M/0000-0002-7354-0302; Clavarino, Giovanna/0000-0003-1778-1352; PLAWECKI, Maelle/0000-0001-6930-9426; paul, stephane/0000-0002-8830-4273; Jourde-Chiche, Noemie/0000-0001-9315-1577; Boelle, Pierre-Yves/0000-0002-5367-8232				Akaiwa M, 1999, J HISTOCHEM CYTOCHEM, V47, P777, DOI 10.1177/002215549904700607; Andersen T, 2009, J RHEUMATOL, V36, P757, DOI 10.3899/jrheum.080361; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fraser DA, 2008, CURR DRUG TARGETS, V9, P113, DOI 10.2174/138945008783502476; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Gullstrand B, 2012, J RHEUMATOL, V39, P1619, DOI 10.3899/jrheum.111511; Haque SF, 2012, NOVEL SCIENCE INTERN, P1; Hein E, 2015, MOL IMMUNOL, V63, P209, DOI 10.1016/j.molimm.2014.07.003; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Julkunen H, 2012, RHEUMATOL INT, V32, P2445, DOI 10.1007/s00296-011-1962-3; Jung JY, 2015, INT J RHEUM DIS, V18, P294, DOI 10.1111/1756-185X.12568; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Kravitz MS, 2005, J CLIN IMMUNOL, V25, P582, DOI 10.1007/s10875-005-7828-2; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Launay D, 2010, CLIN CHIM ACTA, V411, P959, DOI 10.1016/j.cca.2010.03.016; Liphaus BL, 2010, CLINICS, V65, P327, DOI 10.1590/S1807-59322010000300014; Meyer OC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2725; Michalski M, 2012, IMMUNOBIOLOGY, V217, P730, DOI 10.1016/j.imbio.2011.12.004; Moura CG, 2009, J CLIN LAB ANAL, V23, P19, DOI 10.1002/jcla.20280; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nisihara RM, 2013, HUM IMMUNOL, V74, P907, DOI 10.1016/j.humimm.2013.04.030; Orbai AM, 2015, LUPUS, V24, P42, DOI 10.1177/0961203314547791; Panda AK, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4057; Pang Y, 2014, IMMUNOBIOLOGY, V219, P980, DOI 10.1016/j.imbio.2014.07.004; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SASAKI T, 1983, BIOCHIM BIOPHYS ACTA, V742, P122, DOI 10.1016/0167-4838(83)90367-9; Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561; Seelen MA, 2003, CLIN EXP IMMUNOL, V134, P335, DOI 10.1046/j.1365-2249.2003.02274.x; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Takahashi R, 2004, CLIN EXP IMMUNOL, V136, P585, DOI 10.1111/j.1365-2249.2004.02477.x; Trad B, 2013, PATHOL BIOL, V61, P113, DOI 10.1016/j.patbio.2013.01.007; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Tsutsumi A, 2005, AUTOIMMUN REV, V4, P364, DOI 10.1016/j.autrev.2005.02.004; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; YAE Y, 1991, BIOCHIM BIOPHYS ACTA, V1078, P369, DOI 10.1016/0167-4838(91)90158-V; Yang XW, 2012, NEPHROL DIAL TRANSPL, V27, P3552, DOI 10.1093/ndt/gfs179; Yoshizawa S, 1997, CLIN CHIM ACTA, V264, P219, DOI 10.1016/S0009-8981(97)00078-8	47	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160879	10.1371/journal.pone.0160879	http://dx.doi.org/10.1371/journal.pone.0160879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631981	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900014
J	Ipponjima, S; Hibi, T; Nemoto, T				Ipponjima, Sari; Hibi, Terumasa; Nemoto, Tomomi			Three-Dimensional Analysis of Cell Division Orientation in Epidermal Basal Layer Using Intravital Two-Photon Microscopy	PLOS ONE			English	Article							STEM-CELLS; SPINDLE ORIENTATION; IMMUNE-RESPONSES; MAMMALIAN SKIN; MOUSE; HOMEOSTASIS; HYPERPROLIFERATION; DIFFERENTIATION; FATE; LGN	Epidermal structures are different among body sites, and proliferative keratinocytes in the epidermis play an important role in the maintenance of the epidermal structures. In recent years, intravital skin imaging has been used in mammalian skin research for the investigation of cell behaviors, but most of these experiments were performed with rodent ears. Here, we established a non-invasive intravital imaging approach for dorsal, ear, hind paw, or tail skin using R26H2BEGFP hairless mice. Using four-dimensional (x, y, z, and time) imaging, we successfully visualized mitotic cell division in epidermal basal cells. A comparison of cell division orientation relative to the basement membrane in each body site revealed that most divisions in dorsal and ear epidermis occurred in parallel, whereas the cell divisions in hind paw and tail epidermis occurred both in parallel and oblique orientations. Based on the quantitative analysis of the four-dimensional images, we showed that the epidermal thickness correlated with the basal cell density and the rate of the oblique divisions.	[Ipponjima, Sari; Hibi, Terumasa; Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Ipponjima, Sari; Nemoto, Tomomi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Nemoto, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.; Nemoto, T (corresponding author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan.	tn@es.hokudai.ac.jp	Nemoto, Tomomi/B-4412-2012; Hibi, Terumasa/I-3407-2013	Nemoto, Tomomi/0000-0001-6102-1495; Hibi, Terumasa/0000-0001-9373-9602	MEXT/JSPS KAKENHI Grant [JP15H05953, JP26242082, JP25-1699, JP25560411]; NIBB Priority Collaborative Research Project [15-406]; Grants-in-Aid for Scientific Research [15H05953] Funding Source: KAKEN	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIBB Priority Collaborative Research Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT/JSPS KAKENHI Grant Number JP15H05953 "Resonance Bio" and JP26242082 (TN), JP25-1699 (SI) and JP25560411 (TH) and by the NIBB Priority Collaborative Research Project (#15-406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Aoki K, 2013, DEV GROWTH DIFFER, V55, P515, DOI 10.1111/dgd.12039; Benavides F, 2009, J DERMATOL SCI, V53, P10, DOI 10.1016/j.jdermsci.2008.08.012; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Dainichi T, 2016, CELL REP, V15, P1615, DOI 10.1016/j.celrep.2016.04.051; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Egawa G, 2013, J DERMATOL SCI, V70, P143, DOI 10.1016/j.jdermsci.2013.01.005; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Kabashima K, 2014, J INVEST DERMATOL, V134, P2680, DOI 10.1038/jid.2014.225; Kilarski WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057135; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kulukian A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0016; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Page ME, 2013, CELL STEM CELL, V13, P471, DOI 10.1016/j.stem.2013.07.010; Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; Ra H, 2011, J INVEST DERMATOL, V131, P1061, DOI 10.1038/jid.2010.401; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stringari C, 2015, CELL REP, V10, P1, DOI 10.1016/j.celrep.2014.12.007; Watt FM, 2014, SCIENCE, V346, P937, DOI 10.1126/science.1253734; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Wu MF, 2010, DEV CELL, V19, P114, DOI 10.1016/j.devcel.2010.06.011; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	32	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163199	10.1371/journal.pone.0163199	http://dx.doi.org/10.1371/journal.pone.0163199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657513	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200084
J	Wu, YH; Taggart, J; Song, PX; MacDiarmid, C; Eide, DJ				Wu, Yi-Hsuan; Taggart, Janet; Song, Pamela Xiyao; MacDiarmid, Colin; Eide, David J.			An MSC2 Promoter-lacZ Fusion Gene Reveals Zinc-Responsive Changes in Sites of Transcription Initiation That Occur across the Yeast Genome	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; HISTONE DEACETYLASES; TFIIB; PROTEIN; ROLES; CONSTRUCTION; TRANSLATION; DEGRADATION	The Msc2 and Zrg17 proteins of Saccharomyces cerevisiae form a complex to transport zinc into the endoplasmic reticulum. ZRG17 is transcriptionally induced in zinc-limited cells by the Zap1 transcription factor. In this report, we show that MSC2 mRNA also increases (similar to 1.5 fold) in zinc-limited cells. The MSC2 gene has two in-frame ATG codons at its 5' end, ATG1 and ATG2; ATG2 is the predicted initiation codon. When the MSC2 promoter was fused at ATG2 to the lacZ gene, we found that unlike the chromosomal gene this reporter showed a 4-fold decrease in lacZ mRNA in zinc-limited cells. Surprisingly, beta-galactosidase activity generated by this fusion gene increased similar to 7 fold during zinc deficiency suggesting the influence of post-transcriptional factors. Transcription of MSC2(ATG2)-lacZ was found to start upstream of ATG1 in zinc-replete cells. In zinc-limited cells, transcription initiation shifted to sites just upstream of ATG2. From the results of mutational and polysome profile analyses, we propose the following explanation for these effects. In zinc-replete cells, MSC2(ATG2)-lacZ mRNA with long 5' UTRs fold into secondary structures that inhibit translation. In zinc-limited cells, transcripts with shorter unstructured 5' UTRs are generated that are more efficiently translated. Surprisingly, chromosomal MSC2 did not show start site shifts in response to zinc status and only shorter 5' UTRs were observed. However, the shifts that occur in the MSC2(ATG2)-lacZ construct led us to identify significant transcription start site changes affecting the expression of similar to 3% of all genes. Therefore, zinc status can profoundly alter transcription initiation across the yeast genome.	[Wu, Yi-Hsuan; Taggart, Janet; Song, Pamela Xiyao; MacDiarmid, Colin; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eide@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021	MacDiarmid, Colin/0000-0001-8578-5756	National Institutes of Health [RO1 GM56285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant RO1 GM56285 to D.E. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belancio VP, 2011, ANAL BIOCHEM, V417, P159, DOI 10.1016/j.ab.2011.05.035; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; BERROTERAN RW, 1994, MOL CELL BIOL, V14, P226, DOI 10.1128/MCB.14.1.226; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; HINNEBUSCH AG, 1985, P NATL ACAD SCI USA, V82, P498, DOI 10.1073/pnas.82.2.498; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Lawless C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-7; Lefimil C, 2012, ANAL BIOCHEM, V421, P333, DOI 10.1016/j.ab.2011.10.019; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2016, J BIOL CHEM, V291, P18880, DOI 10.1074/jbc.M116.743120; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; OLIVEIRA CC, 1995, J BIOL CHEM, V270, P8936, DOI 10.1074/jbc.270.15.8936; Park D, 2014, NUCLEIC ACIDS RES, V42, P3736, DOI 10.1093/nar/gkt1366; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; SAGLIOCCO FA, 1993, J BIOL CHEM, V268, P26522; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; Vermulst M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9065; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Wu YH, 2011, BIOCHEM J, V435, P259, DOI 10.1042/BJ20102003; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163256	10.1371/journal.pone.0163256	http://dx.doi.org/10.1371/journal.pone.0163256			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657924	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200094
J	Wysocki, WP; Burke, SV; Swingley, WD; Duvall, MR				Wysocki, William P.; Burke, Sean V.; Swingley, Wesley D.; Duvall, Melvin R.			The First Complete Plastid Genome from Joinvilleaceae (J-ascendens; Poales) Shows Unique and Unpredicted Rearrangements	PLOS ONE			English	Article							CHLOROPLAST GENOME; COMPLETE SEQUENCE; ACCD GENE; EVOLUTION; POACEAE; INVERSIONS; WORLD; DNA; RECOMBINATION; PHYLOGENOMICS	Joinvilleaceae is a family of tropical grass-like monocots that comprises only the genus Joinvillea. Previous studies have placed Joinvilleaceae in close phylogenetic proximity to the well-studied grass family. A full plastome sequence was determined and characterized for J. ascendens. The plastome was sequenced with next generation methods, fully assembled de novo and annotated. The assembly revealed two novel inversions specific to the Joinvilleaceae lineage and at least one novel plastid inversion in the Joinvilleaceae-Poaceae lineage. Two previously documented inversions in the Joinvilleaceae-Poaceae lineage and one previously documented inversion in the Poaceae lineage were also verified. Inversion events were identified visually and verified computationally by simulation mutations. Additionally, the loss and subsequent degradation of the accD gene in order Poales was explored extensively in Poaceae and J. ascendens. The two novel inversions along with changes in gene composition between families better delimited lineages in the Poales. The presence of large inversions and subsequent reversals in this small family suggested a high potential for large-scale rearrangements to occur in plastid genomes.	[Wysocki, William P.] Univ Chicago, Ctr Data Intens Sci, 5454 South Shore Dr, Chicago, IL 60615 USA; [Wysocki, William P.; Burke, Sean V.; Swingley, Wesley D.; Duvall, Melvin R.] Northern Illinois Univ, 1425 W Lincoln Hwy, De Kalb, IL 60115 USA	University of Chicago; Northern Illinois University	Wysocki, WP (corresponding author), Univ Chicago, Ctr Data Intens Sci, 5454 South Shore Dr, Chicago, IL 60615 USA.; Wysocki, WP (corresponding author), Northern Illinois Univ, 1425 W Lincoln Hwy, De Kalb, IL 60115 USA.	wwysoc2@gmail.com	Burke, Sean/H-9535-2019	Burke, Sean/0000-0001-6500-5425	NSF [DEB-1120761, DEB-1342782]; Plant Molecular and Bioinformatics Center; Department of Biological Sciences at Northern Illinois University; National Science Foundation [DEB-1120761, DEB-1342782]; Direct For Biological Sciences [1120761] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Plant Molecular and Bioinformatics Center; Department of Biological Sciences at Northern Illinois University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by DEB-1120761 and DEB-1342782 to MRD from NSF (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank LG Clark for providing the leaf material for this study and JI Davis for helpful comments and conversations. This work was supported in part by the Plant Molecular and Bioinformatics Center and the Department of Biological Sciences at Northern Illinois University as well as by grants from the National Science Foundation to M. R. Duvall (DEB-1120761 and DEB-1342782). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2013, VERS 1 1; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Burke SV, 2014, AM J BOT, V101, P886, DOI 10.3732/ajb.1400063; Burke SV, 2012, AM J BOT, V99, P1951, DOI 10.3732/ajb.1200365; Cotton JL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0563-9; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Duvall MR, 2016, INT J PLANT SCI, V177, P235, DOI 10.1086/684526; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Harris ME, 2013, PLANT MOL BIOL REP, V31, P21, DOI 10.1007/s11105-012-0461-3; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Jones SS, 2014, PLANT SYST EVOL, V300, P1421, DOI 10.1007/s00606-013-0971-y; KATAYAMA H, 1993, CURR GENET, V23, P160, DOI 10.1007/BF00352016; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; Palmer JD, 1983, NATURE; Roskov Y., 2016, SPECIES 2000 ITIS CA; Rudall PJ, 2005, AM J BOT, V92, P1432, DOI 10.3732/ajb.92.9.1432; Saarela JM, 2015, AOB PLANTS, V7, DOI [10.1093/aobpla/plv046, 10.10]; STEIN DB, 1986, CURR GENET, V10, P835, DOI 10.1007/BF00418530; Stone B.C, 1982, GARD B SING, V34, P223; WATSON L, 1986, AUST J BOT, V34, P223, DOI 10.1071/BT9860223; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Wysocki WP, 2014, TAXON, V63, P899, DOI 10.12705/634.5; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163218	10.1371/journal.pone.0163218	http://dx.doi.org/10.1371/journal.pone.0163218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658044	Green Published, gold			2022-12-27	WOS:000383893200087
J	Hey, YY; O'Neill, HC				Hey, Ying-Ying; O'Neill, Helen C.			Antigen Presenting Properties of a Myeloid Dendritic-Like Cell in Murine Spleen	PLOS ONE			English	Article							CD8 T-CELLS; CROSS-PRESENTATION; STEADY-STATE; INHIBITORY RECEPTOR; MANNOSE RECEPTOR; BONE-MARROW; MOLECULAR-CLONING; SOLUBLE-ANTIGEN; CUTTING EDGE; FLT3 LIGAND	This paper distinguishes a rare subset of myeloid dendritic-like cells found in mouse spleen from conventional (c) dendritic cells (DC) in terms of phenotype, function and gene expression. These cells are tentatively named "L-DC" since they resemble dendritic-like cells produced in longterm cultures of spleen. L-DC can be distinguished on the basis of their unique phenotype as CD11b(hi)CD11c(lo)MHCII(-)CD43(+)Ly6C(-)Ly6G(-)Siglec-F- cells. They demonstrate similar ability as cDC to uptake and retain complex antigens like mannan via mannose receptors, but much lower ability to endocytose and retain soluble antigen. While LDC differ from cDC by their inability to activate CD4(+) T cells, they are capable of antigen cross-presentation for activation of CD8(+) T cells, although less effectively so than the cDC subsets. In terms of gene expression, CD8(-) cDC and CD8(+) cDC are quite distinct from LDC. CD8(+) cDC are distinguishable from the other two subsets by expression of CD24a, Clec9a, Xcr1 and Tlr11, while CD8(-) cDC are distinguished by expression of Ccnd1 and H-2Eb2. L-DC are distinct from the two cDC subsets through upregulated expression of Clec4a3, Emr4, Itgam, Csf1r and CD300ld. The L-DC gene profile is quite distinct from that of cDC, confirming a myeloid cell type with distinct antigen presenting properties.	[Hey, Ying-Ying] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Hey, Ying-Ying; O'Neill, Helen C.] Bond Univ, Clem Jones Res Ctr Regenerat Med, Gold Coast, Qld, Australia	Australian National University; Bond University	O'Neill, HC (corresponding author), Bond Univ, Clem Jones Res Ctr Regenerat Med, Gold Coast, Qld, Australia.	honeill@bond.edu.au	O'NEILL, Helen/AAW-8921-2021	O'NEILL, Helen/0000-0002-9506-284X	National Health and Medical Research Council of Australia [585443]; Australian National University Graduate School scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian National University Graduate School scholarship(Australian National University)	This work was supported by funding from the National Health and Medical Research Council of Australia to H.O (Project grant # 585443 (https://www.nhmrc.gov.au/). Y.H. was supported by an Australian National University Graduate School scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from the National Health and Medical Research Council of Australia to H.O (Project grant # 585443). Y.H. was supported by an Australian National University Graduate School scholarship. Mannan-FITC used in the endocytosis assays was kindly donated by Dr. Craig Freeman in John Curtin School of Medical Research, Australian National University, Canberra, Australia.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ARNAOUT MA, 1983, J CLIN INVEST, V72, P171, DOI 10.1172/JCI110955; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Burgdorf S, 2010, P NATL ACAD SCI USA, V107, pE48, DOI 10.1073/pnas.1000598107; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; Caminschi I, 2001, MOL IMMUNOL, V38, P365, DOI 10.1016/S0161-5890(01)00067-0; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Carreno BM, 2003, TRENDS IMMUNOL, V24, P524, DOI 10.1016/j.it.2003.08.005; Chen JT, 2008, IMMUNOL LETT, V120, P42, DOI 10.1016/j.imlet.2008.06.010; Comas-Casellas E, 2012, J BIOL CHEM, V287, P9682, DOI 10.1074/jbc.M111.279224; Corbett AJ, 2005, EUR J IMMUNOL, V35, P2815, DOI 10.1002/eji.200526100; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; Gays F, 2006, J IMMUNOL, V177, P5840, DOI 10.4049/jimmunol.177.9.5840; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Griffiths KL, 2013, J CELL MOL MED, V17, P1608, DOI 10.1111/jcmm.12174; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652; Hinton RA, 2012, SCAND J IMMUNOL, V75, P168, DOI 10.1111/j.1365-3083.2011.02643.x; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kroczek RA, 2012, FRONT IMMUNOL, V3; Kronin V, 2001, INT IMMUNOL, V13, P465, DOI 10.1093/intimm/13.4.465; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Mitchell A, 2008, EUR J IMMUNOL, V38, P3459, DOI 10.1002/eji.200838415; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; O'Neill HC, 1999, CANCER BIOTHER RADIO, V14, P263, DOI 10.1089/cbr.1999.14.263; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Periasamy P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00073; Periasamy P, 2013, EXP HEMATOL, V41, P281, DOI 10.1016/j.exphem.2012.11.003; Periasamy P, 2013, J LEUKOCYTE BIOL, V93, P63, DOI 10.1189/jlb.0512260; Periasamy P, 2009, EXP HEMATOL, V37, P1060, DOI 10.1016/j.exphem.2009.06.001; Petvises S, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00501; Petvises S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088311; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Qi S, 2012, PLOS ONE, V7; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schulz O, 2002, IMMUNOLOGY, V107, P183, DOI 10.1046/j.1365-2567.2002.01513.x; Segura E, 2010, P NATL ACAD SCI USA, V107, pE50, DOI 10.1073/pnas.1001014107; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tan JKH, 2011, J CELL MOL MED, V15, P1189, DOI 10.1111/j.1582-4934.2010.01089.x; Tan JKH, 2010, BLOOD, V115, P3678, DOI 10.1182/blood-2009-06-227108; Tang Wen-bin, 2010, Front Biosci (Elite Ed), V2, P857; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamada T., 2014, RECEPTORS CLIN INVES, V1, P1; Yu MJ, 2013, J IMMUNOL, V190; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	83	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162358	10.1371/journal.pone.0162358	http://dx.doi.org/10.1371/journal.pone.0162358			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654936	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700021
J	Groot-Kormelink, PJ; Ferrand, S; Kelley, N; Bill, A; Freuler, F; Imbert, PE; Marelli, A; Gerwin, N; Sivilotti, LG; Miraglia, L; Orth, AP; Oakeley, EJ; Schopfer, U; Siehler, S				Groot-Kormelink, Paul J.; Ferrand, Sandrine; Kelley, Nicholas; Bill, Anke; Freuler, Felix; Imbert, Pierre-Eloi; Marelli, Anthony; Gerwin, Nicole; Sivilotti, Lucia G.; Miraglia, Loren; Orth, Anthony P.; Oakeley, Edward J.; Schopfer, Ulrich; Siehler, Sandra			High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							ALPHA-SUBUNIT; BINDING-SITE; SELECTIVITY; DISEASE; IDENTIFICATION; PHARMACOLOGY; TRAFFICKING; RESOLUTION; MECHANISM; RESIDUES	High throughput random mutagenesis is a powerful tool to identify which residues are important for the function of a protein, and gain insight into its structure-function relation. The human muscle nicotinic acetylcholine receptor was used to test whether this technique previously used for monomeric receptors can be applied to a pentameric ligand-gated ion channel. A mutant library for the alpha 1 subunit of the channel was generated by error-prone PCR, and full length sequences of all 2816 mutants were retrieved using single molecule real time sequencing. Each a1 mutant was co-transfected with wildtype beta 1, delta, and epsilon subunits, and the channel function characterized by an ion flux assay. To test whether the strategy could map the structure-function relation of this receptor, we attempted to identify mutations that conferred resistance to competitive antagonists. Mutant hits were defined as receptors that responded to the nicotinic agonist epibatidine, but were not inhibited by either a-bungarotoxin or tubocurarine. Eight a1 subunit mutant hits were identified, six of which contained mutations at position Y233 or V275 in the transmembrane domain. Three single point mutations (Y233N, Y233H, and V275M) were studied further, and found to enhance the potencies of five channel agonists tested. This suggests that the mutations made the channel resistant to the antagonists, not by impairing antagonist binding, but rather by producing a gain-of-function phenotype, e.g. increased agonist sensitivity. Our data show that random high throughput mutagenesis is applicable to multimeric proteins to discover novel functional mutants, and outlines the benefits of using single molecule real time sequencing with regards to quality control of the mutant library as well as downstream mutant data interpretation.	[Groot-Kormelink, Paul J.; Gerwin, Nicole] Novartis Inst BioMed Res, Musculoskeletal Dis Area, Basel, Switzerland; [Ferrand, Sandrine; Freuler, Felix; Imbert, Pierre-Eloi; Schopfer, Ulrich; Siehler, Sandra] Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland; [Kelley, Nicholas; Oakeley, Edward J.] Novartis Inst BioMed Res, Analyt Sci & Imaging, Basel, Switzerland; [Bill, Anke] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Marelli, Anthony; Miraglia, Loren; Orth, Anthony P.] Novartis Res Fdn, Novartis Inst BioMed Res, Genom Inst, San Diego, CA USA; [Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Novartis; Novartis; Novartis; Novartis; Novartis; University of London; University College London	Siehler, S (corresponding author), Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland.	sandra.siehler@novartis.com		Bill, Anke/0000-0003-1244-7574; Sivilotti, Lucia/0000-0003-2510-8424	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	The work was funded by the Novartis Institutes for BioMedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BEESON D, 1990, EMBO J, V9, P2101, DOI 10.1002/j.1460-2075.1990.tb07378.x; Bill A, 2015, J BIOL CHEM, V290, P889, DOI 10.1074/jbc.M114.618140; Bill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097973; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Briggs CA, 1999, EUR J PHARMACOL, V366, P301, DOI 10.1016/S0014-2999(98)00909-1; Buschmann T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-264; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; Engel AG, 1999, ARCH NEUROL-CHICAGO, V56, P163, DOI 10.1001/archneur.56.2.163; Guo XG, 2015, G3-GENES GENOM GENET, V5, P2801, DOI 10.1534/g3.115.023317; KOPTA C, 1994, J NEUROSCI, V14, P3922; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; Michelmore S, 2002, N-S ARCH PHARMACOL, V366, P235, DOI 10.1007/s00210-002-0589-z; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Shen XM, 2016, HUM MUTAT, DOI [10.2002/humu.23043, DOI 10.2002/HUMU.23043]; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Wan HS, 2012, ANAL BIOCHEM, V420, P163, DOI 10.1016/j.ab.2011.09.019; Wang HL, 2003, J BIOL CHEM, V278, P32284, DOI 10.1074/jbc.M304366200; Wenningmann I, 2001, MOL PHARMACOL, V60, P790	32	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163129	10.1371/journal.pone.0163129	http://dx.doi.org/10.1371/journal.pone.0163129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649498	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100058
J	Ogasawara, S; Chiba, T; Motoyama, T; Kanogawa, N; Saito, T; Shinozaki, Y; Suzuki, E; Ooka, Y; Tawada, A; Kato, H; Okabe, S; Kanai, F; Yoshikawa, M; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Motoyama, Tenyu; Kanogawa, Naoya; Saito, Tomoko; Shinozaki, Yusuke; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Kato, Hideyuki; Okabe, Shinichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu			Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							ENHANCED MRI; ADENOMATOUS HYPERPLASIA; CT; HYPOINTENSE; DEVELOP	Background Hypovascular nodules often occur together with hypervascular hepatocellular carcinoma (HCC). However, it remains controversial whether hypovascular nodules associated with hypervascular HCC have any prognostic value. This study evaluated the prognostic impact of hypovascular nodules co-existing with hypervascular HCC as diagnosed by computed tomography during arterial portography (CTAP) and computed tomography during hepatic arteriography (CTHA), which can sensitively capture the dynamic changes in blood flow through the portal vein and hepatic artery in patients with early stage HCC. Methods A total of 152 patients with hypervascular HCC (<= 30 mm, <= 3 nodules), who underwent initial local ablation, were analyzed retrospectively. All patients received CTAP and CTHA prior to treatment. Overall survival (OS) was compared among group A (hypervascular HCC only, 107 patients) and group B (hypovascular nodules and hypervascular HCC, 45 patients). Results Among all hypovascular nodules, 81% (46 of 57) developed hypervascularization within the follow-up period. The 1-and 2-year hypervascularization rates were 17% and 51%, respectively. OS was significantly longer for group A than for group B (P < 0.001). A Cox proportional-hazards model identified the presence of hypovascular nodules concurrent with hypervascular HCC as an independent poor prognostic factor. Conclusion The prognosis of hypervascular HCC patients with hypovascular nodules detected during CTAP and CTHA is poor. Clinical HCC categories seem to be dissimilar between patients with and without hypovascular nodules.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Motoyama, Tenyu; Kanogawa, Naoya; Saito, Tomoko; Shinozaki, Yusuke; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Okabe, Shinichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Kato, Hideyuki] Chiba Univ Hosp, Dept Radiol, Chiba, Japan	Chiba University; Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064				Bruix J, 2011, HEPATOLOGY, V54, P2238, DOI 10.1002/hep.24670; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Inoue T, 2013, DIGEST DIS, V31, P472, DOI 10.1159/000355248; Kobayashi M, 2006, CANCER-AM CANCER SOC, V106, P636, DOI 10.1002/cncr.21607; Komatsu N, 2014, HEPATOL RES, V44, P1339, DOI 10.1111/hepr.12309; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kudo M, 2010, HEPATOL RES, V40, P686, DOI 10.1111/j.1872-034X.2010.00674.x; MATSUI O, 1991, RADIOLOGY, V178, P493, DOI 10.1148/radiology.178.2.1846240; Midorikawa Y, 2013, J HEPATOL, V58, P306, DOI 10.1016/j.jhep.2012.09.026; Ogasawara S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125244; Ooka Y, 2013, MAGN RESON IMAGING, V31, P748, DOI 10.1016/j.mri.2012.10.028; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; TAKAYASU K, 1995, RADIOLOGY, V194, P101, DOI 10.1148/radiology.194.1.7997534; Toyoda H, 2013, J HEPATOL, V58, P1174, DOI 10.1016/j.jhep.2013.01.030; UNOURA M, 1993, HEPATO-GASTROENTEROL, V40, P305; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163119	10.1371/journal.pone.0163119	http://dx.doi.org/10.1371/journal.pone.0163119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649084	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100055
J	Lambert, PM; Nakata, PA				Lambert, Peter M.; Nakata, Paul A.			Determining the Biochemical Properties of the Oxalate BiosyntheticComponent (Obc) 1 from Burkholderia mallei	PLOS ONE			English	Article							OXALIC-ACID BIOSYNTHESIS; SCLEROTINIA-SCLEROTIORUM; COA SYNTHETASE; GRAIN ROT; GLUMAE; PATHOGEN; RICE; RESISTANCE; GLANDERS; OXIDASE	Oxalic acid is produced by a variety of organisms ranging from simple microbes to complex animals. This acid has been proposed to fulfill various physiological and pathological functions which vary between organisms. In bacteria from the Burkholderia genus, oxalate secretion has been shown to be quorum sensing dependent and to support pathogenicity and cell viability. In light of the critical roles of oxalate in Burkholderia as well as other organisms, it is surprising that our understanding of how this simple dicarboxylate is biosynthesized remains incomplete. Here we report the expression, purification, and partial characterization of the first intact bacterial oxalate biosynthetic enzyme, Obc1, from B. mallei. An N-terminal His-tagged Bmobc1 was cloned into pDUET, expressed in E. coli BLR (DE3), and the recombinant enzyme purified by affinity chromatography. Oxalate biosynthetic enzyme assays coupled with HPLC analysis revealed that BmObc1 catalyzed the biosynthesis of oxalate, acetoacetate, and free CoA from oxaloacetate and a short chain acyl-CoA following Michaelis- Menten kinetics. Optimal enzyme activity was measured at pH 8.0 and a temperature around 44 degrees C. Kinetic analysis conducted under conditions of saturating acetyl-CoA and varying oxaloacetate concentrations resulted in a calculated Km value for oxaloacetate of 94.3 +/- 9.2 mu M (mean +/- SE). Under conditions of saturating oxaloacetate concentration and varying acyl-CoA (acetyl- or propionyl-CoA) concentrations kinetic analysis generated a calculated Km value of 26.8 +/- 2.3 mu M (mean +/- SE) for acetyl-CoA and 104.4 +/- 12.7 mu M for propionyl-CoA. The significantly lower K-m for acetyl-CoA suggests that it is strongly favored as a substrate over propionyl-CoA.	[Lambert, Peter M.; Nakata, Paul A.] USDA ARS, Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), USDA ARS, Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700; Lambert, Peter/0000-0001-9427-638X	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]; ARS [ARS-0426342] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service under Cooperative agreement number 58-3092-5-001 to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The contents of this publication do not necessarily reflect the views or policies of the U.S. Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the U.S. Department of Agriculture, Agricultural Research Service, under Cooperative Agreement number 58-3092-5-001.	APPANNA VD, 1999, RRD MICROBIOL 2, V3, P615; BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Chen C, 2010, J BIOL CHEM, V285, P26685, DOI 10.1074/jbc.M110.117804; DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Foster J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149850; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gharieb MM, 2000, MYCOL RES, V104, P550, DOI 10.1017/S0953756299001707; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Green F, 2003, INT BIODETER BIODEGR, V51, P145, DOI 10.1016/S0964-8305(02)00099-9; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hodgkinson A., 1977, OXALIC ACID BIOL MED; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jacob G, 2007, RECENT PAT ANTIINFEC, V2, P233; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Livingstone DM, 2005, PLANT PHYSIOL, V137, P1354, DOI 10.1104/pp.104.057232; Munir E, 2001, P NATL ACAD SCI USA, V98, P11126, DOI 10.1073/pnas.191389598; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oh J, 2014, J BIOL CHEM, V289, P11465, DOI 10.1074/jbc.M113.543462; SHIMADA M, 1994, FEMS MICROBIOL REV, V13, P285, DOI 10.1111/j.1574-6976.1994.tb00049.x; Tsushima Seiya, 1996, Annals of the Phytopathological Society of Japan, V62, P108, DOI 10.3186/jjphytopath.62.108; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163294	10.1371/journal.pone.0163294	http://dx.doi.org/10.1371/journal.pone.0163294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643499	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900042
J	Allwood, EG; Tyler, JJ; Urbanek, AN; Smaczynska-de Rooij, II; Ayscough, KR				Allwood, Ellen G.; Tyler, Joe J.; Urbanek, Agnieszka N.; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.			Elucidating Key Motifs Required for Arp2/3-Dependent and Independent Actin Nucleation by Las17/WASP	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP FAMILY PROTEINS; ARP2/3 COMPLEX; BINDING MOTIF; BUDDING YEAST; ENDOCYTOSIS; HOMOLOGY; DOMAINS; SPIRE	Actin nucleation is the key rate limiting step in the process of actin polymerization, and tight regulation of this process is critical to ensure actin filaments form only at specific times and at defined regions of the cell. Arp2/3 is a well-characterised protein complex that can promote nucleation of new filaments, though its activity requires additional nucleation promotion factors (NPFs). The best recognized of these factors are the WASP family of proteins that contain binding motifs for both monomeric actin and for Arp2/3. Previously we demonstrated that the yeast WASP homologue, Las17, in addition to activating Arp2/3 can also nucleate actin filaments de novo, independently of Arp2/3. This activity is dependent on its polyproline rich region. Through biochemical and in vivo analysis we have now identified key motifs within the polyproline region that are required for nucleation and elongation of actin filaments, and have addressed the role of the WH2 domain in the context of actin nucleation without Arp2/3. We have also demonstrated that full length Las17 is able to bind liposomes giving rise to the possibility of direct linkage of nascent actin filaments to specific membrane sites to which Las17 has been recruited. Overall, we propose that Las17 functions as the key initiator of de novo actin filament formation at endocytic sites by nucleating, elongating and tethering nascent filaments which then serve as a platformfor Arp2/3 recruitment and function.	[Allwood, Ellen G.; Tyler, Joe J.; Urbanek, Agnieszka N.; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.] Univ Sheffield, Dept Biomed Sci, Court 5, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Biomed Sci, Court 5, Sheffield S10 2TN, S Yorkshire, England.	k.ayscough@sheffield.ac.uk		Ayscough, Kathryn/0000-0003-3716-4490; Allwood, Ellen/0000-0003-3825-4789; Tyler, Joe/0000-0003-3940-876X	BBSRC [BB/J017094/1, BB/N007581/1, BB/J014443/1, BB/L013851/1]; Biotechnology and Biological Sciences Research Council [BB/L013851/1, BB/N007581/1, BB/J017094/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC project grant funding (BB/J017094/1 and BB/N007581/1) to KA. JT is a student funded by the BBSRC White Rose Doctoral training programme (BB/J014443/1). Thermophoresis was carried out in the Biomolecular Interaction suite at the University of Sheffield funded by support from BBSRC (BB/L013851/1). All funding bbsrc (http://www.bbsrc.ac.uk/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Burianek LE, 2013, SEMIN CELL DEV BIOL, V24, P258, DOI 10.1016/j.semcdb.2012.12.005; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Feliciano D, 2015, TRAFFIC, V16, P379, DOI 10.1111/tra.12259; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gaucher JF, 2012, J BIOL CHEM, V287, P34646, DOI 10.1074/jbc.M112.394361; Hagan IM, 2000, PRACT APPROACH SER, V218, P179; Kaiser C., 1994, METHODS YEAST GENETI; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lewellyn EB, 2015, DEV CELL, V35, P281, DOI 10.1016/j.devcel.2015.10.007; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Robertson AS, 2009, MOL BIOL CELL, V20, P1618, DOI 10.1091/mbc.E08-09-0982; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith BA, 2013, P NATL ACAD SCI USA, V110, P1285, DOI 10.1073/pnas.1211164110; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Urbanek AN, 2013, CURR BIOL, V23, P196, DOI 10.1016/j.cub.2012.12.024; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WINDER SJ, 1995, J CELL SCI, V108, P63; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895	34	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163177	10.1371/journal.pone.0163177	http://dx.doi.org/10.1371/journal.pone.0163177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637067	Green Accepted, Green Published, gold			2022-12-27	WOS:000383723700039
J	Oliver, JM; Almada, AL; Van Eck, LE; Shah, M; Mitchell, JB; Jones, MT; Jagim, AR; Rowlands, DS				Oliver, Jonathan M.; Almada, Anthony L.; Van Eck, Leighsa E.; Shah, Meena; Mitchell, Joel B.; Jones, Margaret T.; Jagim, Andrew R.; Rowlands, David S.			Ingestion of High Molecular Weight Carbohydrate Enhances Subsequent Repeated Maximal Power: A Randomized Controlled Trial	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; HIGH-INTENSITY EXERCISE; II MUSCLE-FIBERS; GLYCOGEN AVAILABILITY; METABOLIC-RESPONSE; GLUCOSE POLYMER; REPEATED BOUTS; VAGUS NERVE; PERFORMANCE; STRENGTH	Athletes in sports demanding repeat maximal work outputs frequently train concurrently utilizing sequential bouts of intense endurance and resistance training sessions. On a daily basis, maximal work within subsequent bouts may be limited by muscle glycogen availability. Recently, the ingestion of a unique high molecular weight (HMW) carbohydrate was found to increase glycogen re-synthesis rate and enhance work output during subsequent endurance exercise, relative to low molecular weight (LMW) carbohydrate ingestion. The effect of the HMW carbohydrate, however, on the performance of intense resistance exercise following prolonged-intense endurance training is unknown. Sixteen resistance trained men (23 +/- 3 years; 176.7 +/- 9.8 cm; 88.2 +/- 8.6 kg) participated in a double-blind, placebo-controlled, randomized 3-way crossover design comprising a muscle-glycogen depleting cycling exercise followed by ingestion of placebo (PLA), or 1.2 g. kg. bw(-1) of LMW or HMW carbohydrate solution (10%) with blood sampling for 2-h post-ingestion. Thereafter, participants performed 5 sets of 10 maximal explosive repetitions of back squat (75% of 1RM). Compared to PLA, ingestion of HMW (4.9%, 90% CI 3.8%, 5.9%) and LMW (1.9%, 90% CI 0.8%, 3.0%) carbohydrate solutions substantially increased power output during resistance exercise, with the 3.1%(90% CI 4.3, 2.0%) almost certain additional gain in power after HMW-LMW ingestion attributed to higher movement velocity after force kinematic analysis (HMW-LMW2.5%, 90% CI 1.4, 3.7%). Both carbohydrate solutions increased post-exercise plasma glucose, glucoregulatory and gut hormones compared to PLA, but differences between carbohydrates were unclear; thus, the underlying mechanism remains to be elucidated. Ingestion of a HMW carbohydrate following prolonged intense endurance exercise provides superior benefits to movement velocity and power output during subsequent repeated maximal explosive resistance exercise.	[Oliver, Jonathan M.; Van Eck, Leighsa E.; Shah, Meena; Mitchell, Joel B.] Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76129 USA; [Almada, Anthony L.] Vitargo Global Sci Inc, Dana Point, CA USA; [Jones, Margaret T.] George Mason Univ, Div Hlth & Human Performance, Fairfax, VA USA; [Jagim, Andrew R.] Univ Wisconsin La Crosse, Exercise & Sport Sci Dept, La Crosse, WI USA; [Rowlands, David S.] Massey Univ, Sch Sport & Exercise, Wellington, New Zealand	Texas Christian University; George Mason University; University of Wisconsin System; University of Wisconsin La Crosse; Massey University	Oliver, JM (corresponding author), Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu	Jagim, Andrew/Y-2447-2019	Jagim, Andrew/0000-0002-6651-5096; Almada, Anthony/0000-0001-9066-369X	Vitargo Global Sciences, INC; Texas Christian University Kinesiology Department	Vitargo Global Sciences, INC; Texas Christian University Kinesiology Department	This study was funded in part by Vitargo Global Sciences, INC, http://www.vitargo.com/. Vitargo Global Sciences was not involved in data collection or subsequent analysis. Vitargo did assist in design. The decision to publish was that of the researchers. Additional funding was provided by Texas Christian University Kinesiology Department. No additional funding was received.	Aulin KP, 2000, EUR J APPL PHYSIOL, V81, P346, DOI 10.1007/s004210050053; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Balsom PD, 1999, ACTA PHYSIOL SCAND, V165, P337, DOI 10.1046/j.1365-201x.1999.00517.x; BERTHOUD HR, 1982, PEPTIDES, V3, P907, DOI 10.1016/0196-9781(82)90059-6; BUCHAN AMJ, 1978, HISTOCHEMISTRY, V56, P37, DOI 10.1007/BF00492251; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burke LM, 2004, J SPORT SCI, V22, P15, DOI 10.1080/0264041031000140527; Casey A, 1996, EUR J APPL PHYSIOL O, V72, P249, DOI 10.1007/BF00838647; Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE38, DOI 10.1152/ajpendo.1996.271.1.E38; CASEY A, 1995, J PHYSIOL-LONDON, V483, P265, DOI 10.1113/jphysiol.1995.sp020583; Cormie P, 2007, J APPL BIOMECH, V23, P103, DOI 10.1123/jab.23.2.103; COSTILL DL, 1988, J APPL PHYSIOL, V64, P2245, DOI 10.1152/jappl.1988.64.5.2245; COSTILL DL, 1988, MED SCI SPORT EXER, V20, P249, DOI 10.1249/00005768-198806000-00006; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; GREENHAFF PL, 1994, J PHYSIOL-LONDON, V478, P149, DOI 10.1113/jphysiol.1994.sp020238; HARGREAVES M, 1995, J APPL PHYSIOL, V78, P288, DOI 10.1063/1.360672; HEPBURN D, 1982, J PHYSIOL-LONDON, V325, pP52; Hopkins W., 2006, SPORTSCIENCE, V10, P63; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACOBS I, 1981, EUR J APPL PHYSIOL O, V46, P47, DOI 10.1007/BF00422176; Leiper JB, 2000, SCAND J GASTROENTERO, V35, P1143, DOI 10.1080/003655200750056600; Leveritt M, 1999, J STRENGTH COND RES, V13, P52; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; MacDougall JD, 1999, CAN J APPL PHYSIOL, V24, P209, DOI 10.1139/h99-017; McGlory C, 2010, INT J SPORT NUTR EXE, V20, P361, DOI 10.1123/ijsnem.20.5.361; Mitchell JB, 2014, J STRENGTH COND RES, V28, P1906, DOI 10.1519/JSC.0000000000000319; OHNEDA A, 1985, TOHOKU J EXP MED, V147, P183, DOI 10.1620/tjem.147.183; Oliver JM, 2016, J STRENGTH COND RES, V30; Oliver JM, 2016, J STRENGTH COND RES, V30, P235, DOI 10.1519/JSC.0000000000001023; Oliver JM, 2015, EUR J APPL PHYSIOL, V115, P2383, DOI 10.1007/s00421-015-3216-7; Oliver JM, 2013, J STRENGTH COND RES, V27, P3116, DOI 10.1519/JSC.0b013e3182891672; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P111; Prats C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077774; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Rowlands DS, 2015, MED SCI SPORT EXER, V47, P547, DOI 10.1249/MSS.0000000000000447; SOMOGYI M, 1948, J BIOL CHEM, V174, P189; Stephens FB, 2008, J SPORT SCI, V26, P149, DOI 10.1080/02640410701361548; SYMONS JD, 1989, MED SCI SPORT EXER, V21, P550; Takii H, 2005, INT J SPORTS MED, V26, P314, DOI 10.1055/s-2004-820999; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Van Eck LE, 2015, J INT SOC SPORT NUTR, V12, P32; VIST GE, 1995, J PHYSIOL-LONDON, V486, P523, DOI 10.1113/jphysiol.1995.sp020831	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163009	10.1371/journal.pone.0163009	http://dx.doi.org/10.1371/journal.pone.0163009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636206	Green Submitted, Green Published, gold			2022-12-27	WOS:000383723700025
J	Colnaghi, L; Clemenza, K; Groleau, SE; Weiss, S; Snyder, AM; Lopez-Rosas, M; Levine, AA				Colnaghi, Luca; Clemenza, Kelly; Groleau, Sarah E.; Weiss, Shira; Snyder, Anna M.; Lopez-Rosas, Mariana; Levine, Amir A.			Social Involvement Modulates the Response to Novel and Adverse Life Events in Mice	PLOS ONE			English	Article							MENTAL-HEALTH; STRESS; RATS; PAIN; MECHANISMS; DOPAMINE; ALCOHOL; SUPPORT	Epidemiological findings suggest that social involvement plays a major role in establishing resilience to adversity, however, the neurobiology by which social involvement confers protection is not well understood. Hypothesizing that social involvement confers resilience by changing the way adverse life events are encoded, we designed a series of behavioral tests in mice that utilize the presence or absence of conspecific cage mates in measuring response to novel and adverse events. We found that the presence of cage mates increased movement after exposure to a novel environment, increased time spent in the open arms of the elevated plus maze, and decreased freezing time after a foot shock as well as expedited fear extinction, therefore significantly changing the response to adversity. This is a first description of a mouse model for the effects of social involvement on adverse life events. Understanding how social involvement provides resilience to adversity may contribute to the future treatment and prevention of mental and physical illness.	[Colnaghi, Luca; Clemenza, Kelly; Snyder, Anna M.; Lopez-Rosas, Mariana; Levine, Amir A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Groleau, Sarah E.] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON, Canada; [Weiss, Shira] McMaster Univ, Dept Neurosci, Toronto, ON, Canada; [Levine, Amir A.] New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA	Columbia University; University of Toronto; Centre for Addiction & Mental Health - Canada; McMaster University; New York State Psychiatry Institute	Levine, AA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.; Levine, AA (corresponding author), New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA.	ama146@cumc.columbia.edu	Colnaghi, Luca/W-4192-2019	Colnaghi, Luca/0000-0002-9699-5318				Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; HADFIELD MG, 1983, BEHAV BRAIN RES, V7, P269, DOI 10.1016/0166-4328(83)90019-0; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; KANEYUKI H, 1991, BRAIN RES, V557, P154, DOI 10.1016/0006-8993(91)90129-J; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kim EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015077; Kiyokawa Y, 2004, BEHAV NEUROSCI, V118, P798, DOI 10.1037/0735-7044.118.4.798; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moak ZB, 2010, J PUBLIC HEALTH-UK, V32, P191, DOI 10.1093/pubmed/fdp093; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Stockdale SE, 2007, SOC SCI MED, V65, P1867, DOI 10.1016/j.socscimed.2007.05.045	17	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163077	10.1371/journal.pone.0163077	http://dx.doi.org/10.1371/journal.pone.0163077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632422	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900128
J	Negahbani, E; Steyn-Ross, DA; Steyn-Ross, ML; Aguirre, LA				Negahbani, Ehsan; Steyn-Ross, D. Alistair; Steyn-Ross, Moira L.; Aguirre, Luis A.			Which System Variables Carry Robust Early Signs of Upcoming Phase Transition? An Ecological Example	PLOS ONE			English	Article							OBSERVABILITY	Growth of critical fluctuations prior to catastrophic state transition is generally regarded as a universal phenomenon, providing a valuable early warning signal in dynamical systems. Using an ecological fisheries model of three populations (juvenile prey J, adult prey A and predator P), a recent study has reported silent early warning signals obtained from P and A populations prior to saddle-node (SN) bifurcation, and thus concluded that early warning signals are not universal. By performing a full eigenvalue analysis of the same system we demonstrate that while J and P populations undergo SN bifurcation, A does not jump to a new state, so it is not expected to carry early warning signs. In contrast with the previous study, we capture a significant increase in the noise-induced fluctuations in the P population, but only on close approach to the bifurcation point; it is not clear why the P variance initially shows a decaying trend. Here we resolve this puzzle using observability measures from control theory. By computing the observability coefficient for the system from the recordings of each population considered one at a time, we are able to quantify their ability to describe changing internal dynamics. We demonstrate that precursor fluctuations are best observed using only the J variable, and also P variable if close to transition. Using observability analysis we are able to describe why a poorly observable variable (P) has poor forecasting capabilities although a full eigenvalue analysis shows that this variable undergoes a bifurcation. We conclude that observability analysis provides complementary information to identify the variables carrying early-warning signs about impending state transition.	[Negahbani, Ehsan; Steyn-Ross, D. Alistair; Steyn-Ross, Moira L.] Univ Waikato, Sch Engn, Hamilton, Waikato, New Zealand; [Aguirre, Luis A.] Univ Federeal Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil	University of Waikato	Negahbani, E (corresponding author), Univ Waikato, Sch Engn, Hamilton, Waikato, New Zealand.	enegahbani@gmail.com	Aguirre, Luis A./A-2737-2008	Aguirre, Luis A./0000-0002-2746-5102	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work of LAA is partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil: http://cnpq.br/. EN, DASR, and MLSR received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L. A. Aguirre's research is partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Aguirre LA, 2005, J PHYS A-MATH GEN, V38, P6311, DOI 10.1088/0305-4470/38/28/004; AGUIRRE LA, 1995, IEEE T EDUC, V38, P33, DOI 10.1109/13.350218; Aguirre LA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066209; Boerlijst MC, 2013, PLOS ONE, P1; Cairoli A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.264102; CHATURVEDI S, 1977, J STAT PHYS, V17, P469, DOI 10.1007/BF01014350; Gardiner C.W, 2004, HDB STOCHASTIC METHO, P80; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Laub AJ, 2005, MATRIX ANAL SCI ENG, P139; McQuarrie D. A., 2003, MATH METHODS SCI ENG; Negahbani E., 2014, THESIS; Negahbani E, 2015, J MATH NEUROSCI, V5, DOI 10.1186/s13408-015-0021-x; REICHL LE, 1980, MODERN COURSE STAT M; Steyn-Ross ML, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021902; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032	15	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163003	10.1371/journal.pone.0163003	http://dx.doi.org/10.1371/journal.pone.0163003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631984	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900114
J	Wingstrand, VL; Larsen, CG; Jensen, DH; Bork, K; Sebbesen, L; Balle, J; Fischer-Nielsen, A; von Buchwald, C				Wingstrand, Vibe Lindeblad; Larsen, Christian Gronhoj; Jensen, David H.; Bork, Kristian; Sebbesen, Lars; Balle, Jesper; Fischer-Nielsen, Anne; von Buchwald, Christian			Mesenchymal Stem Cell Therapy for the Treatment of Vocal Fold Scarring: A Systematic Review of Preclinical Studies	PLOS ONE			English	Review							STROMAL CELLS; CANINE MODEL; INJECTION; REGENERATION; BIOLOGY	Objectives Therapy with mesenchymal stem cells exhibits potential for the development of novel interventions for many diseases and injuries. The use of mesenchymal stem cells in regenerative therapy for vocal fold scarring exhibited promising results to reduce stiffness and enhance the biomechanical properties of injured vocal folds. This study evaluated the biomechanical effects of mesenchymal stem cell therapy for the treatment of vocal fold scarring. Data Sources PubMed, Embase, the Cochrane Library and Google Scholar were searched. Methods Controlled studies that assessed the biomechanical effects of mesenchymal stem cell therapy for the treatment of vocal fold scarring were included. Primary outcomes were viscoelastic properties and mucosal wave amplitude. Results Seven preclinical animal studies (n = 152 single vocal folds) were eligible for inclusion. Evaluation of viscoelastic parameters revealed a decreased dynamic viscosity (eta') and elastic modulus (G'), i.e., decreased resistance and stiffness, in scarred vocal folds treated with mesenchymal stem cells compared to non-treated scarred vocal folds. Mucosal wave amplitude was increased in scarred vocal folds treated with mesenchymal stem cells vs. non-treated scarred vocal folds. Conclusion The results from these studies suggest an increased regenerative effect of therapy with mesenchymal stem cells for scarred vocal folds and are encouraging for further clinical studies.	[Wingstrand, Vibe Lindeblad; Larsen, Christian Gronhoj; Jensen, David H.; Bork, Kristian; Sebbesen, Lars; Balle, Jesper; von Buchwald, Christian] Univ Copenhagen, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Rigshosp, Copenhagen, Denmark; [Fischer-Nielsen, Anne] Copenhagen Univ Hosp, Dept Clin Immunol, Rigshosp, Cell Therapy Facil,Blood Bank, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Larsen, CG (corresponding author), Univ Copenhagen, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Rigshosp, Copenhagen, Denmark.	christian.groenhoej.larsen@regionh.dk	von Buchwald, Christian/D-5336-2016; Gronhoj, Christian/C-2817-2016	von Buchwald, Christian/0000-0001-6753-8129; Gronhoj, Christian/0000-0002-4524-8291				Assistance-Publique-Hopitaux-De-Marseille, NCT02622464 ASS PUBL; Baer Patrick C, 2014, World J Stem Cells, V6, P256, DOI 10.4252/wjsc.v6.i3.256; Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Choi JW, 2014, BIOMATERIALS, V35, P4911, DOI 10.1016/j.biomaterials.2014.03.008; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Fishman JM, 2016, LARYNGOSCOPE; Gugatschka M, 2013, EUR SURG, V45, P136, DOI 10.1007/s10353-013-0214-z; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Hiwatashi N, 2014, LARYNGOSCOPE, V124, pE461, DOI 10.1002/lary.24816; Jiang J, 2000, OTOLARYNG CLIN N AM, V33, P699, DOI 10.1016/S0030-6665(05)70238-3; Karolinska-University-Hospital, NCT01981330 KAR U HO; Kim YM, 2014, LARYNGOSCOPE, V124, pE64, DOI 10.1002/lary.24405; Kim YM, 2013, ANN OTO RHINOL LARYN, V122, P121, DOI 10.1177/000348941312200208; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; Kumai Y, 2010, CURR STEM CELL RES T, V5, P175, DOI 10.2174/157488810791268591; Minteer DM, 2015, CLIN PLAST SURG, V42, P169, DOI 10.1016/j.cps.2014.12.007; Naderi N., 2016, INT WOUND J; Ohno S, 2011, ANN OTO RHINOL LARYN, V120, P401, DOI 10.1177/000348941112000610; Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Squillaro T, 2015, CELL TRANSPLANT; Svensson B, 2011, RESTORATION SCARRED; Svensson B, 2011, LARYNGOSCOPE, V121, P2185, DOI 10.1002/lary.22143; Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4	27	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162349	10.1371/journal.pone.0162349	http://dx.doi.org/10.1371/journal.pone.0162349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631373	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900040
J	Chen, CJ; Zhang, YF; Xu, ZQ; Luan, AP; Mao, Q; Feng, JT; Xie, T; Gong, X; Wang, XS; Chen, H; He, YH				Chen, Chengjie; Zhang, Yafeng; Xu, Zhiqiang; Luan, Aiping; Mao, Qi; Feng, Junting; Xie, Tao; Gong, Xue; Wang, Xiaoshuang; Chen, Hao; He, Yehua			Transcriptome Profiling of the Pineapple under Low Temperature to Facilitate Its Breeding for Cold Tolerance	PLOS ONE			English	Article							RNA-SEQ DATA; RESPONSE PATHWAY; ABIOTIC STRESS; CBF REGULON; ARABIDOPSIS; ACCLIMATION; GENERATION; RESISTANCE; GENOTYPES; NETWORKS	The pineapple (Ananas comosus) is cold sensitive. Most cultivars are injured during winter periods, especially in sub-tropical regions. There is a lack of molecular information on the pineapple's response to cold stress. In this study, high-throughput transcriptome sequencing and gene expression analysis were performed on plantlets of a cold-tolerant genotype of the pineapple cultivar 'Shenwan' before and after cold treatment. A total of 1,186 candidate cold responsive genes were identified, and their credibility was confirmed by RTq-PCR. Gene set functional enrichment analysis indicated that genes related to cell wall properties, stomatal closure and ABA and ROS signal transduction play important roles in pineapple cold tolerance. In addition, a protein association network of CORs (cold responsive genes) was predicted, which could serve as an entry point to dissect the complex cold response network. Our study found a series of candidate genes and their association network, which will be helpful to cold stress response studies and pineapple breeding for cold tolerance.	[Chen, Chengjie; Zhang, Yafeng; Xu, Zhiqiang; Luan, Aiping; Mao, Qi; Feng, Junting; Xie, Tao; Gong, Xue; Wang, Xiaoshuang; Chen, Hao; He, Yehua] South China Agr Univ, Coll Hort, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	He, YH (corresponding author), South China Agr Univ, Coll Hort, Guangzhou 510642, Guangdong, Peoples R China.	heyehua@hotmail.com	, CJ - 陈程杰/AFS-3021-2022; White, Zoiv/GQY-5055-2022		Special Fund for Agro-scientific Research in the Public Interest [201303021]; Technology Commission of Guangdong Province [2013B020304002]; National Natural Science Foundation of China [31572089, 30971984]	Special Fund for Agro-scientific Research in the Public Interest; Technology Commission of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303021), Technology Commission of Guangdong Province (2013B020304002) and the National Natural Science Foundation of China (31572089, 30971984).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bai B, 2015, INT J MOL SCI, V16, P11398, DOI 10.3390/ijms160511398; Banti V, 2010, PLANT PHYSL; Baxter A, 2014, J EXP BOT; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calzadilla PI, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00374; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Connors J., 2009, CIRCOS INFORM AESTHE, P1639; Dai X, 2013, PLANTTFCAT ONLINE PL; Dametto A, 2015, PLANT SCI, V238, P1, DOI 10.1016/j.plantsci.2015.05.009; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; DROZDOV SN, 1984, J EXP BOT, V35, P1603, DOI 10.1093/jxb/35.11.1603; Du C, 2016, MOL GENET GENOMICS; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gehan MA, 2015, PLANT J, V84, P682, DOI 10.1111/tpj.13027; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Imaizumi T, 2005, SCIENCE; Ji H, 2015, ARABIDOPSIS RCC1 FAM, P1, DOI [10.1371/journal.pgen.1005471, DOI 10.1371/JOURNAL.PGEN.1005471]; Johansson H., 2003, GENE REGULATION UDP; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, MOL MICROBIOLOGY, V66, P1136; Ma YY, 2014, SCI HORTIC-AMSTERDAM, V174, P65, DOI 10.1016/j.scienta.2014.05.009; Meissner M, 2013, PLANT CELL ENVIRON, V36, P1256, DOI 10.1111/pce.12054; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Ming R, 2015, NAT GENET, V47, P1435, DOI 10.1038/ng.3435; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2002, TRENDS PLANT SCI; Moliterni VMC, 2015, PLANTA, V242, P187, DOI 10.1007/s00425-015-2299-z; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakata M, 2013, PLANT CELL, V25, P1641, DOI 10.1105/tpc.113.111112; Ogawa D, J EXPT BOT, V58, P3373; Oono Youko, 2006, Functional & Integrative Genomics, V6, P212, DOI 10.1007/s10142-005-0014-z; Pandey G., 2011, PLANT SCI; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Peng J, GENES DEV, V11, P3194; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajashekar CB, 1996, PLANT PHYSIOL, V111, P605, DOI 10.1104/pp.111.2.605; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen CX, 2014, J PLANT BIOL, V57, P337, DOI 10.1007/s12374-014-0183-1; Shi H, 2014, NEW PHYTOL; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Sinha S, ELUCIDATION ABIOTIC, P143; Solanke Amolkumar U., 2008, Physiology and Molecular Biology of Plants, V14, P69, DOI 10.1007/s12298-008-0006-2; Song C, 2016, MOL CELLS; Sun ZF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005598; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Weiser R, 1990, PLANT PHYSL; Wilkinson S, 2001, PLANT PHYSL; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-461; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhang Z, P NATL ACAD SCI, V108, P2160; Zhao CZ, 2015, TRENDS PLANT SCI, V20, P466, DOI 10.1016/j.tplants.2015.06.001; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910	61	19	20	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163315	10.1371/journal.pone.0163315	http://dx.doi.org/10.1371/journal.pone.0163315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656892	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200099
J	Rodrigues, FB; Byrne, LM; McColgan, P; Robertson, N; Tabrizi, SJ; Zetterberg, H; Wild, EJ				Rodrigues, Filipe Brogueira; Byrne, Lauren M.; McColgan, Peter; Robertson, Nicola; Tabrizi, Sarah J.; Zetterberg, Henrik; Wild, Edward J.			Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease	PLOS ONE			English	Article							ACTIVATION; YKL-40; MARKER; BLOOD; NEUROINFLAMMATION; MICROGLIA; PATHOLOGY; PATHWAY; ONSET	Introduction Immune system activation is involved in Huntington's disease (HD) pathogenesis and biomarkers for this process could be relevant to study the disease and characterise the therapeutic response to specific interventions. We aimed to study inflammatory cytokines and microglial markers in the CSF of HD patients. Methods CSF TNF-alpha, IL-1 beta, IL-6, IL-8, YKL-40, chitotriosidase, total tau and neurofilament light chain (NFL) from 23 mutation carriers and 14 healthy controls were assayed. Results CSF TNF-alpha and IL-1 beta were below the limit of detection. Mutation carriers had higher YKL-40 (p = 0.003), chitotriosidase (p = 0.015) and IL-6 (p = 0.041) than controls. YKL-40 significantly correlated with disease stage (p = 0.007), UHDRS total functional capacity score (r = -0.46, p = 0.016), and UHDRS total motor score (r = 0.59, p = 4.5*10(-4)) after adjustment for age. Conclusion YKL-40 levels in CSF may, after further study, come to have a role as biomarkers for some aspects of HD. Further investigation is needed to support our exploratory findings.	[Rodrigues, Filipe Brogueira; Byrne, Lauren M.; McColgan, Peter; Robertson, Nicola; Tabrizi, Sarah J.; Wild, Edward J.] UCL, Huntingtons Dis Ctr, Inst Neurol, London, England; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, London, England	University of London; University College London; University of Gothenburg; University of London; University College London	Wild, EJ (corresponding author), UCL, Huntingtons Dis Ctr, Inst Neurol, London, England.	e.wild@ucl.ac.uk	Byrne, Lauren/C-4572-2017; Wild, Edward/G-1436-2016; Rodrigues, Filipe B./R-2679-2017; Robertson, Nicola/GWR-2021-2022	Byrne, Lauren/0000-0003-1650-4273; Wild, Edward/0000-0002-6921-7887; Rodrigues, Filipe B./0000-0002-5567-7938; Tabrizi, Sarah/0000-0003-2716-2045	CHDI Foundation; Medical Research Council; Swedish Research Council; European Research Council; Knut and Alice Wallenberg Foundation; Wolfson Foundation; GlaxoSmithKline foundation; National Institute for Health Research University College London Hospitals Biomedical Research Centre; UCL Leonard Wolfson Experimental Neurology Centre; Knut ooch Alice Wallenbergs Stiftelse; Medical Research Council [MR/P007015/1, MR/M008592/1] Funding Source: researchfish; Wellcome Trust [200181/Z/15/Z] Funding Source: researchfish; MRC [MR/M008592/1] Funding Source: UKRI	CHDI Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Wolfson Foundation; GlaxoSmithKline foundation(GlaxoSmithKline); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); UCL Leonard Wolfson Experimental Neurology Centre; Knut ooch Alice Wallenbergs Stiftelse; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by CHDI Foundation to EW and FBR, GlaxoSmithKline foundation to EW, Swedish Research Council to HZ, European Research Council to SJT and HZ, Medical Research Council to EW, SJT and LB, Knut ooch Alice Wallenbergs Stiftelse to HZ and Wolfson Foundation to SJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patient and control volunteers who contributed to this study. FBR and EJW are supported by CHDI Foundation. LMB, SJT and EJW are supported by the Medical Research Council. HZ is supported by the Swedish Research Council, European Research Council, and the Knut and Alice Wallenberg Foundation. SJT is supported by the Wolfson Foundation. EJW received funds from GlaxoSmithKline foundation. This work was supported in part by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and the UCL Leonard Wolfson Experimental Neurology Centre.	[Anonymous], 2014, CLIN STUD SUBJ HUNT; Aronson NN, 1997, J CHEM INF COMP SCI, V37, P999, DOI 10.1021/ci970236v; BANKS WA, 1995, NEUROIMMUNOMODULAT, V2, P161, DOI 10.1159/000096887; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2012, BRAIN PATHOL, V22, P530, DOI 10.1111/j.1750-3639.2011.00550.x; Byrne LM, 2016, J HUNTINGTONS DIS, V5, P1, DOI 10.3233/JHD-160196; Fiala M, 2010, EXP GERONTOL, V45, P57, DOI 10.1016/j.exger.2009.08.003; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kwan W, 2012, J NEUROSCI, V32, P133, DOI 10.1523/JNEUROSCI.4846-11.2012; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mattsson N, 2011, NEUROMOL MED, V13, P151, DOI 10.1007/s12017-011-8147-9; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Rodrigues FB, 2016, J NEUROCHEM, V139, P22, DOI 10.1111/jnc.13719; Samgard K, 2010, INT J GERIATR PSYCH, V25, P403, DOI 10.1002/gps.2353; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Vinther-Jensen T, 2014, PARKINSONISM RELAT D, V20, P1301, DOI 10.1016/j.parkreldis.2014.08.011; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Wild EJ, 2016, 11TH ANNUAL CHDI HD; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	33	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163479	10.1371/journal.pone.0163479	http://dx.doi.org/10.1371/journal.pone.0163479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657730	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200133
J	Chen, LS; Li, M; Talwar, D; Xu, L; Zhao, M				Chen, Lei-Shih; Li, Ming; Talwar, Divya; Xu, Lei; Zhao, Mei			Chinese Americans' Views and Use of Family Health History: A Qualitative Study	PLOS ONE			English	Article							PUBLIC-HEALTH; CARE; BARRIERS; ACCESS	Objective Family health history (FHH) plays a significant role in early disease detection and prevention. Although Asian Americans are the fastest growing U.S. immigrant group, no data exists regarding Chinese Americans' (the largest Asian subgroup) views and use of FHH. This study examines this important issue. Methods Forty-nine adults from southern U.S. Chinese American communities participated in this qualitative, semi-structured, in-depth interview study. Interviews were audio recorded, transcribed, and analyzed with a content analysis approach. Results Although the majority of participants perceived the importance of collecting FHH, most lacked FHH knowledge and failed to collect FHH information. Barriers affecting FHH collection and discussion among family members included long-distance separation from family members, self-defined "healthy family," and Chinese cultural beliefs. Lack of doctors' inquiries, never/rarely visiting physicians, self-defined " healthy family," perceived insignificance of discussing FHH with doctors, and Chinese cultural beliefs were the obstacles in communicating FHH with physicians. Conclusions Chinese Americans had limited usage of their FHH and faced cultural, distance, knowledge-,and healthcare system-related barriers that influenced their FHH use. Developing FHH education programs for Chinese Americans is highly recommended.	[Chen, Lei-Shih; Li, Ming; Talwar, Divya] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA; [Xu, Lei] East Carolina Univ, Dept Hlth Educ & Promot, Greenville, NC USA; [Zhao, Mei] Univ North Florida, Dept Publ Hlth, Jacksonville, FL USA	Texas A&M University System; Texas A&M University College Station; University of North Carolina; East Carolina University; State University System of Florida; University of North Florida	Chen, LS (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA.	lace@hlkn.tamu.edu						Al-Habsi H, 2008, GENET MED, V10, P751, DOI 10.1097/GIM.0b013e318185212a; Aroian KJ, 2005, RES NURS HEALTH, V28, P95, DOI 10.1002/nur.20069; Beene-Harris RY, 2007, COMMUNITY GENET, V10, P10, DOI 10.1159/000096275; Butty JAM, 2012, J COMMUN GENET, V3, P1, DOI 10.1007/s12687-011-0068-7; Centers for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W; Centers for Disease Control and Prevention, 2013, GATH SHAR YOUR FAM H; Centers for Disease Control and Prevention, 2014, PUBLIC HLTH GENOMICS; G Egon G., 1985, NATURALISTIC INQUIRY, P416; Goergen AF, 2016, PUBLIC HEALTH GENOM, V19, P93, DOI 10.1159/000443473; Goins RT, 2005, J RURAL HEALTH, V21, P206, DOI 10.1111/j.1748-0361.2005.tb00084.x; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kaphingst KA, 2011, PUBLIC HEALTH GENOM, V14, P211, DOI 10.1159/000272456; Laveist TA, 2002, J HEALTH SOC BEHAV, V43, P296, DOI 10.2307/3090205; Leong F T, 2001, Ment Health Serv Res, V3, P201, DOI 10.1023/A:1013177014788; LEONG FTL, 1986, J COUNS PSYCHOL, V33, P196, DOI 10.1037/0022-0167.33.2.196; Liang WC, 2008, HEALTH EDUC BEHAV, V35, P361, DOI 10.1177/1090198106294893; Lim JNW, 2011, J COMMUN GENET, V2, P19, DOI 10.1007/s12687-011-0034-4; Ma G X, 2000, J Allied Health, V29, P64; Ma GX, 1999, J COMMUN HEALTH, V24, P421, DOI 10.1023/A:1018742505785; Murthy VS, 2011, J GENET COUNS, V20, P639, DOI 10.1007/s10897-011-9389-2; Petruccio C, 2008, COMMUNITY GENET, V11, P343, DOI 10.1159/000133306; Pew Research Center, 2012, RIS AS AM; Saldana J, 2012, CODING MANUAL QUALIT, VKindle Edition; Secretary's Advisory Committee on Genetics Health and Society, 2011, GEN ED TRAIN; Tanenbaum Sandra J, 2007, Congenit Heart Dis, V2, P354, DOI 10.1111/j.1747-0803.2007.00126.x; Thompson T, 2015, J HEALTH COMMUN, V20, P416, DOI 10.1080/10810730.2014.977466; Thorpe R., 2008, SAGE DICT QUALITATIV; Trinh-Shevrin C., 2009, ASIAN AM COMMUNITIES; U.S. Census Bureau, 2012, ASIAN POPULATION 201; U.S. Department of Health & Human Services. U.S. Surgeon General's Office, 2005, MY FAM HLTH PORTR; Wang JH, 2008, HEALTH EDUC BEHAV, V35, P806, DOI 10.1177/1090198106296768; Welch BM, 2015, AM J MED GENET A, V167, P2026, DOI 10.1002/ajmg.a.37139; Xu Y., 2004, HOME HLTH CARE MAN P, V16, P433, DOI [10.1177/1084822304264659, DOI 10.1177/1084822304264659]; Yoon PW, 2003, AM J PREV MED, V24, P128, DOI 10.1016/S0749-3797(02)00585-8; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162706	10.1371/journal.pone.0162706	http://dx.doi.org/10.1371/journal.pone.0162706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649411	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100030
J	Yang, TG; Gu, CG; Yang, HJ				Yang, Tianguang; Gu, Changgui; Yang, Huijie			Long-Range Correlations in Sentence Series from A Story of the Stone	PLOS ONE			English	Article							TIME-SERIES; COMPLEX NETWORK; MOVING AVERAGE; DISTRIBUTIONS; DIFFUSION; ORIGIN	A sentence is the natural unit of language. Patterns embedded in series of sentences can be used to model the formation and evolution of languages, and to solve practical problems such as evaluating linguistic ability. In this paper, we apply de-trended fluctuation analysis to detect long-range correlations embedded in sentence series from A Story of the Stone, one of the greatest masterpieces of Chinese literature. We identified a weak long-range correlation, with a Hurst exponent of 0.575 +/- 0.002 up to a scale of 10(4). We used the structural stability to confirm the behavior of the long-range correlation, and found that different parts of the series had almost identical Hurst exponents. We found that noisy records can lead to false results and conclusions, even if the noise covers a limited proportion of the total records (e.g., less than 1%). Thus, the structural stability test is an essential procedure for confirming the existence of long-range correlations, which has been widely neglected in previous studies. Furthermore, a combination of de-trended fluctuation analysis and diffusion entropy analysis demonstrated that the sentence series was generated by a fractional Brownian motion.	[Yang, Tianguang] Nankai Univ, Sch Math Sci, Dept Stat, Tianjin 300071, Peoples R China; [Gu, Changgui; Yang, Huijie] Univ Shanghai Sci & Technol, Dept Syst Sci, Sch Business, Shanghai 200093, Peoples R China	Nankai University; University of Shanghai for Science & Technology	Yang, HJ (corresponding author), Univ Shanghai Sci & Technol, Dept Syst Sci, Sch Business, Shanghai 200093, Peoples R China.	hjyang@ustc.edu.cn			National Science Foundation of China [10975099]; National Natural Science Foundation of China [11505114]; Shanghai Municipal Education Commission [13YZ072, D-USST02, QD2015016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work is supported by the National Science Foundation of China under the Grant No. 10975099 to Professor Huijie Yang; National Natural Science Foundation of China 11505114 to Prof. Changgui Gu; the Shanghai Municipal Education Commission 13YZ072 to Professor Huijie Yang; the Shanghai Municipal Education Commission D-USST02 to Professor Huijie Yang; and the Shanghai Municipal Education Commission QD2015016 to Prof. Changgui Gu.	Alessio E, 2002, EUR PHYS J B, V27, P197, DOI 10.1140/epjb/e20020150; Altmann EG, 2012, P NATL ACAD SCI USA, V109, P11582, DOI 10.1073/pnas.1117723109; Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Ausloos M, 2012, CHAOS SOLITON FRACT, V45, P1349, DOI 10.1016/j.chaos.2012.06.016; Ausloos M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031108; Bickerton D., 2009, ADAMS TONGUE HUMANS; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; Drozdz S, 2016, INFORM SCIENCES, V331, P32, DOI 10.1016/j.ins.2015.10.023; Forster P, 2003, P NATL ACAD SCI USA, V100, P9079, DOI 10.1073/pnas.1331158100; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Grigolini P, 2001, FRACTALS, V9, P439, DOI 10.1142/S0218348X01000865; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Kulig A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032810; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Montemurro MA, 2002, FRACTALS, V10, P451, DOI 10.1142/S0218348X02001257; Mutua S, 2016, CHAOS, V26, DOI 10.1063/1.4951681; Pan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116128; Pan X, 2014, PHYS LETT A, V378, P2591, DOI 10.1016/j.physleta.2014.07.012; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pinker Steven, 1994, LANGUAGE INSTINCT; Qi JC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066114; Scafetta N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.138501; Scafetta N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.248701; Scafetta N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036130; Scafetta N, 2001, FRACTALS, V9, P193, DOI 10.1142/S0218348X0100052X; Scafetta N, 2010, DIFFUSION ENTROPY AN; Stanley H.E., 1971, INTRO PHASE TRANSITI; Stephen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143015; Xiao Q, 2015, PHYSICA A, V421, P161, DOI 10.1016/j.physa.2014.11.032; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Yang HJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066104; Zhang W, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061134; Zhou Ruchang, 2009, NOBLE HUMBLE CAO XQ; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	41	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162423	10.1371/journal.pone.0162423	http://dx.doi.org/10.1371/journal.pone.0162423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648941	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100018
J	Elands, RJJ; Simons, CCJM; van Dongen, M; Schouten, LJ; Verhage, BAJ; van den Brandt, PA; Weijenberg, MP				Elands, Rachel J. J.; Simons, Colinda C. J. M.; van Dongen, Martien; Schouten, Leo J.; Verhage, Bas A. J.; van den Brandt, Piet A.; Weijenberg, Matty P.			A Systematic Literature Review and Meta-Regression Analysis on Early-Life Energy Restriction and Cancer Risk in Humans	PLOS ONE			English	Review							WORLD-WAR-II; INTERMITTENT CALORIE RESTRICTION; INDUCED MAMMARY TUMORIGENESIS; CPG ISLAND METHYLATION; BREAST-CANCER; COLORECTAL-CANCER; TESTICULAR CANCER; PHYSICAL-ACTIVITY; DIETARY RESTRICTION; EUROPEAN COUNTRIES	Background In animal models, long-term moderate energy restriction (ER) is reported to decelerate carcinogenesis, whereas the effect of severe ER is inconsistent. The impact of early-life ER on cancer risk has never been reviewed systematically and quantitatively based on observational studies in humans. Objective We conducted a systematic review of observational studies and a meta-(regression) analysis on cohort studies to clarify the association between early-life ER and organ site-specific cancer risk. Methods PubMed and EMBASE (1982 - August 2015) were searched for observational studies. Summary relative risks (RRs) were estimated using a random effects model when available >= 3 studies. Results Twenty-four studies were included. Eleven publications, emanating from seven prospective cohort studies and some reporting on multiple cancer endpoints, met the inclusion criteria for quantitative analysis. Women exposed to early-life ER (ranging from 220-1660 kcal/day) had a higher breast cancer risk than those not exposed (RRRE all ages = 1.28, 95% CI: 1.05-1.56; RRRE for 10-20 years of age = 1.21, 95% CI: 1.09-1.34). Men exposed to early-life ER (ranging from 220-800kcal/day) had a higher prostate cancer risk than those not exposed (RRRE = 1.16, 95% CI: 1.03-1.30). Summary relative risks were not computed for colorectal cancer, because of heterogeneity, and for stomach-, pancreas-, ovarian-, and respiratory cancer because there were <3 available studies. Longer duration of exposure to ER, after adjustment for severity, was positively associated with overall cancer risk in women (p = 0.02). Ecological studies suggest that less severe ER is generally associated with a reduced risk of cancer. Conclusions Early-life transient severe ER seems to be associated with increased cancer risk in the breast (particularly ER exposure at adolescent age) and prostate. The duration, rather than severity of exposure to ER, seems to positively influence relative risk estimates. This result should be interpreted with caution due to the limited number of studies and difficulty in disentangling duration, severity, and geographical setting of exposure.	[Elands, Rachel J. J.; Simons, Colinda C. J. M.; van Dongen, Martien; Schouten, Leo J.; Verhage, Bas A. J.; van den Brandt, Piet A.; Weijenberg, Matty P.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands	Maastricht University	Elands, RJJ (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands.	rachel.elands@maastrichtuniversity.nl	Schouten, Leo J/AAB-2275-2019	Schouten, Leo J/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099	Wereld Kanker Onderzoek Fonds Nederland (WCRF-NL), as part of the World Cancer Research Fund International grant program [2012/618, 2013/973]	Wereld Kanker Onderzoek Fonds Nederland (WCRF-NL), as part of the World Cancer Research Fund International grant program	This work was supported by Wereld Kanker Onderzoek Fonds Nederland (WCRF-NL), as part of the World Cancer Research Fund International grant program (grant numbers 2012/618 and 2013/973 to MPW).	Angell-Andersen E, 2004, ANN HUM BIOL, V31, P342, DOI 10.1080/03014460410001685304; Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005; Becker N, 2001, J CANCER RES CLIN, V127, P293, DOI 10.1007/s004320000222; Bennett MK, 1949, J POLIT ECON, V57, P185, DOI 10.1086/256805; Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; Borsoi L, 2011, CANCER EPIDEMIOL, V35, P120, DOI 10.1016/j.canep.2010.06.018; Bown MJ, 2010, EUR J VASC ENDOVASC, V40, P669, DOI 10.1016/j.ejvs.2010.07.011; BRUNDTLAND GH, 1980, ANN HUM BIOL, V7, P307, DOI 10.1080/03014468000004381; Burger G, 1948, MALNUTRITION STARV 1; BurgerG SH, 1948, MALNUTRITION STARV 2; Chauvenet M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-282; CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420; Cleary MP, 2007, EXP BIOL MED, V232, P70; Cleary Margot P, 2011, J Carcinog, V10, P21, DOI 10.4103/1477-3163.85181; Da Li Q, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-315; De Assis S, 2006, ANN NY ACAD SCI, V1089, P14, DOI 10.1196/annals.1386.039; Dirx MJM, 2001, AM J EPIDEMIOL, V154, P530, DOI 10.1093/aje/154.6.530; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Dirx MJM, 2003, INT J CANCER, V106, P766, DOI 10.1002/ijc.11277; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; Dogan S, 2010, ONCOL LETT, V1, P167, DOI 10.3892/ol_00000031; Dols M vAA, 1946, VOEDING, P193; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2004, INT J CANCER, V108, P628, DOI 10.1002/ijc.11584; Elias SG, 2007, CANCER CAUSE CONTROL, V18, P1, DOI 10.1007/s10552-006-0080-0; ENGELMAN RW, 1994, CANCER RES, V54, P5724; Fair Alecia Malin, 2009, V472, P57, DOI 10.1007/978-1-60327-492-0_3; Fentiman IS, 2007, INT J CLIN PRACT, V61, P937, DOI 10.1111/j.1742-1241.2007.01288.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; HANSEN OG, 1947, P NUTR SOC, V5, P263; Heinen MM, 2011, AM J CLIN NUTR, V94, P1314, DOI 10.3945/ajcn.110.007542; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilakivi-Clarke L, 2007, CURR CANCER DRUG TAR, V7, P465; Hughes LAE, 2011, AM J EPIDEMIOL, V174, P1127, DOI 10.1093/aje/kwr247; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Jacobsen R, 2006, INT J ANDROL, V29, P199, DOI 10.1111/j.1365-2605.2005.00605.x; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Kim HC, 2005, J GASTROEN HEPATOL, V20, P1920, DOI 10.1111/j.1440-1746.2005.03943.x; Kim HC, 2005, J CANCER RES CLIN, V131, P733, DOI 10.1007/s00432-005-0017-0; Klebanov Simon, 2007, V35, P176; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; KLURFELD DM, 1989, INT J CANCER, V43, P922, DOI 10.1002/ijc.2910430532; Koupil I, 2009, INT J CANCER, V124, P1416, DOI 10.1002/ijc.24093; KRITCHEVSKY D, 1989, NUTR CANCER, V12, P259, DOI 10.1080/01635588909514025; KRITCHEVSKY D, 1987, AM J CLIN NUTR, V45, P236, DOI 10.1093/ajcn/45.1.236; KUMAR SP, 1990, CANCER RES, V50, P5761; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Mahabir S, 2013, J ADOLESCENT HEALTH, V52, pS30, DOI 10.1016/j.jadohealth.2012.08.008; Martin B, 2008, AGEING RES REV, V7, P209, DOI 10.1016/j.arr.2008.01.002; McCarty CA, 1997, MED HYPOTHESE; Mizuno NK, 2013, CANCER PREV RES, V6, P540, DOI 10.1158/1940-6207.CAPR-13-0033; Moher David, 2009, Open Med, V3, pe123; MOLLER H, 1989, J NATL CANCER I, V81, P1668, DOI 10.1093/jnci/81.21.1668-a; Moller H, 2001, HUM REPROD, V16, P1007, DOI 10.1093/humrep/16.5.1007; NOLEN GA, 1972, J NUTR, V102, P1477; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Papadopoulos FC, 2009, EUR J CANCER PREV, V18, P207, DOI 10.1097/CEJ.0b013e32831bc558; Richiardi L, 2004, CANCER EPIDEM BIOMAR, V13, P2157; Roberts SB, 2013, ADV NUTR, V4, P563, DOI 10.3945/an.113.004317; Robsahm TE, 2002, BRIT J CANCER, V86, P362, DOI 10.1038/sj.bjc.6600084; ROEBUCK BD, 1993, CANCER RES, V53, P46; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; ROSS MH, 1971, J NATL CANCER I, V47, P1095; Schouten LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027960; Sell C, 2003, HORM METAB RES, V35, P705, DOI 10.1055/s-2004-814156; Simons CCJM, 2014, CANCER EPIDEM BIOMAR, V23, P1852, DOI 10.1158/1055-9965.EPI-13-1285; Soeters MR, 2012, AM J PHYSIOL-ENDOC M, V303, pE1397, DOI 10.1152/ajpendo.00397.2012; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strom A, 1948, EXAMINATION DIET NOR; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; SYLVESTER PW, 1982, CANCER RES, V42, P4943; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorn M, 1998, CANCER CAUSE CONTROL, V9, P145, DOI 10.1023/A:1008826109697; Tretli S, 1996, CANCER CAUSE CONTROL, V7, P507, DOI 10.1007/BF00051882; van Noord PAH, 2004, J NUTR, V134, p3399S, DOI 10.1093/jn/134.12.3399S; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vin-Raviv N, 2012, INT J CLIN PRACT, V66, P948, DOI 10.1111/j.1742-1241.2012.02966.x; Vin-Raviv N, 2014, INT PSYCHOGERIATR, V26, P499, DOI 10.1017/S1041610213002081; WALFORD RL, 1992, P NATL ACAD SCI USA, V89, P11533, DOI 10.1073/pnas.89.23.11533; Walford RL, 1999, TOXICOL SCI, V52, P61, DOI 10.1093/toxsci/52.suppl_1.61; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; Wanderas EH, 1995, EUR J CANCER, V31A, P2044, DOI 10.1016/0959-8049(95)00321-5; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weijenberg Matty P, 2013, Curr Nutr Rep, V2, P19; Wells G.A., 2000, VIS COMMUN Q	95	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0158003	10.1371/journal.pone.0158003	http://dx.doi.org/10.1371/journal.pone.0158003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643873	gold, Green Published, Green Submitted			2022-12-27	WOS:000383891900001
J	Mburu, LW; Helbich, M				Mburu, Lucy Waruguru; Helbich, Marco			Environmental Risk Factors influencing Bicycle Theft: A Spatial Analysis in London, UK	PLOS ONE			English	Article							CRIME; TRANSPORT; DETERMINANTS; MULTILEVEL; POLICIES; WEATHER; IMPACT; MODEL	Urban authorities are continuously drawing up policies to promote cycling among commuters. However, these initiatives are counterproductive for the targeted objectives because they increase opportunities for bicycle theft. This paper explores Inner London as a case study to address place-specific risk factors for bicycle theft at the street-segment level while controlling for seasonal variation. The presence of certain public amenities (e.g., bicycle stands, railway stations, pawnshops) was evaluated against locations of bicycle theft between 2013 and 2016 and risk effects were estimated using negative binomial regression models. Results showed that a greater level of risk stemmed from land-use facilities than from area-based socioeconomic status. The presence of facilities such as train stations, vacant houses, pawnbrokers and payday lenders increased bicycle theft, but no evidence was found that linked police stations with crime levels. The findings have significant implications for urban crime prevention with respect to non-residential land use.	[Mburu, Lucy Waruguru] Heidelberg Univ, Inst Geog, Heidelberg, Germany; [Helbich, Marco] Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands; [Mburu, Lucy Waruguru] KCA Univ, Fac Comp & InformationManagement, Nairobi, Kenya	Ruprecht Karls University Heidelberg; Utrecht University	Mburu, LW (corresponding author), Heidelberg Univ, Inst Geog, Heidelberg, Germany.; Mburu, LW (corresponding author), KCA Univ, Fac Comp & InformationManagement, Nairobi, Kenya.	mburulou@gmail.com		Mburu, Lucy/0000-0002-6822-4954	National Commission for Science, Technology and Innovation (NACOSTI), Kenya; German Academic Exchange Service, Germany at Heidelberg University [A1291674]; Ruprecht-Karls-Universitat Heidelberg; Deutsche Forschungsgemeinschaft	National Commission for Science, Technology and Innovation (NACOSTI), Kenya; German Academic Exchange Service, Germany at Heidelberg University; Ruprecht-Karls-Universitat Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was jointly funded by the National Commission for Science, Technology and Innovation (NACOSTI), Kenya and the German Academic Exchange Service, Germany at Heidelberg University (A1291674). Publishing support was provided by the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Ackerman PL, 2000, J EXP PSYCHOL-APPL, V6, P259, DOI 10.1037//1076-898X.6.4.259; Andresen MA, 2013, APPL GEOGR, V43, P25, DOI 10.1016/j.apgeog.2013.06.007; Arsanjani JJ, 2015, INT J DIGIT EARTH, V8, P74, DOI 10.1080/17538947.2013.847125; Bai L, 2013, TRANSPORT RES D-TR E, V20, P48, DOI 10.1016/j.trd.2013.02.001; Belsley D.A., 2005, REGRESSION DIAGNOSTI, V571; Bernasco W, 2011, J RES CRIME DELINQ, V48, P33, DOI 10.1177/0022427810384135; Blau P. M., 1977, INEQUALITY HETEROGEN, V7; Blyton P., 2014, CHANGES WORKING TIME; Bowers K, 2014, J QUANT CRIMINOL, V30, P389, DOI 10.1007/s10940-013-9208-z; Braga AA, 2015, J RES CRIME DELINQ, V52, P567, DOI 10.1177/0022427815576576; Brantingham Patricia L, 1993, ROUTINE ACTIVITY RAT, V5, P259; Ceccato V, 2014, ANN ASSOC AM GEOGR, V104, P131, DOI 10.1080/00045608.2013.846150; CLARKE R.V., 2005, CRIME ANAL PROBLEM S; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Curman ASN, 2015, J QUANT CRIMINOL, V31, P127, DOI 10.1007/s10940-014-9228-3; de Melo SN, 2015, APPL GEOGR, V62, P314, DOI 10.1016/j.apgeog.2015.05.012; Eck J.E., 2007, CRIME PREVENTION STU, V21, P225; Felson M., 2015, CRIME SCI, V4, P31, DOI [10.1186/s40163-015-0039-0, DOI 10.1186/S40163-015-0039-0, DOI 10.1186/s40163-015-0039-0]; Gamman L., 2004, CRIME PREV COMMUNITY, V6, P19, DOI [10.1057/palgrave.cpcs.8140199, DOI 10.1057/PALGRAVE.CPCS.8140199]; Groff ER, 2014, J RES CRIME DELINQ, V51, P277, DOI 10.1177/0022427813512494; Haklay M, 2010, ENVIRON PLANN B, V37, P682, DOI 10.1068/b35097; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Helbich M, 2014, J TRANSP GEOGR, V38, P38, DOI 10.1016/j.jtrangeo.2014.05.009; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Iacono M, 2010, J TRANSP GEOGR, V18, P133, DOI 10.1016/j.jtrangeo.2009.02.002; Jean P., 2008, POCKETS CRIME BROKEN; Johnson S. D., 2008, BICYCLE THEFT; Kautt PaulaM., 2007, CRIMINAL JUSTICE REV, V32, P339, DOI DOI 10.1177/0734016807311559; Kennedy LW, 2011, J QUANT CRIMINOL, V27, P339, DOI 10.1007/s10940-010-9126-2; Koetse MJ, 2009, TRANSPORT RES D-TR E, V14, P205, DOI 10.1016/j.trd.2008.12.004; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Lathia N, 2012, TRANSPORT RES C-EMER, V22, P88, DOI 10.1016/j.trc.2011.12.004; Leitner M., 2011, CARTOGR GEOGR INF SC, V38, P213, DOI [10.1559/15230406382213, DOI 10.1559/15230406382213]; LEVINE N, 1986, TRANSPORT RES A-POL, V20, P273, DOI 10.1016/0191-2607(86)90086-5; LEVINE N, 1986, J ARCHIT PLAN RES, V3, P339; Levine N, 2009, J INVEST PSYCHOL OFF, V6, P237, DOI 10.1002/jip.110; Malleson N., 2015, CRIME SCI, V4, P10, DOI DOI 10.1186/S40163-015-0023-8; Mburu L., 2016, ANN ASSOC AM GEOGR, V106, P1; Mburu LW, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5040047; Mercat N, 2003, SUSTAINABLE TRANSPOR, P642; Miller J, 2016, CRIME DELINQUENCY, V62, P169, DOI 10.1177/0011128713478130; Montani JP, 2015, OBES REV, V16, P7, DOI 10.1111/obr.12251; Moreto WD, 2010, APPL RISK TERRAIN MO; Moreto WD, 2014, JUSTICE Q, V31, P1102, DOI 10.1080/07418825.2012.754921; Murphy E, 2015, INT J SUSTAIN TRANSP, V9, P116, DOI 10.1080/15568318.2012.748855; Nettle D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051738; Office for National Statistics, 2012, CRIM ENGL WAL Q 1 RE; Oliver LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-41; Openshaw S., 1984, MODIFIABLE AREAL UNI; PEARLSTEIN A, 1982, TRANSPORTATION, V11, P277; Posick C., 2012, JUSTICE RES POLICY, V14, P79, DOI 10.3818/JRP.14.2.2012.79; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rietveld P, 2004, TRANSPORT RES A-POL, V38, P531, DOI 10.1016/j.tra.2004.05.003; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 2010, ENCY CRIMINOLOGICAL, P802; Schepers P, 2014, INJ PREV; SHERMAN LW, 1989, CRIMINOLOGY, V27, P27, DOI 10.1111/j.1745-9125.1989.tb00862.x; Sidebottom A, 2009, EUR J CRIMINOL, V6, P267, DOI 10.1177/1477370809102168; SKOGAN WG, 1974, SOC SCI QUART, V55, P25; Stults BJ, 2015, J QUANT CRIMINOL, V31, P331, DOI 10.1007/s10940-015-9251-z; Transport for London, 2010, CYCL REV LOND END YE; Van Lierop D, 2015, INT J SUSTAIN TRANSP, V9, P490, DOI 10.1080/15568318.2013.811332; Vandenbulcke G, 2009, TRANSP POL, V16; Vandeviver C, 2015, APPL GEOGR, V64, P24, DOI 10.1016/j.apgeog.2015.08.004; Walsh C, 2008, TRANSPORT RES D-TR E, V13, P392, DOI 10.1016/j.trd.2008.07.002; Weisburd D., 2012, CRIMINOLOGY PLACE ST; Winters M, 2010, J URBAN HEALTH, V87, P969, DOI 10.1007/s11524-010-9509-6; Zhang L, 2007, J RES CRIME DELINQ, V44, P406	68	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163354	10.1371/journal.pone.0163354	http://dx.doi.org/10.1371/journal.pone.0163354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643788	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900045
J	Narendran, G; Kavitha, D; Karunaianantham, R; Gil-Santana, L; Almeida, JL; Reddy, SD; Kumar, MM; Hemalatha, H; Jayanthi, NN; Ravichandran, N; Krishnaraja, R; Prabhakar, A; Manoharan, T; Nithyananthan, L; Arjunan, G; Natrajan, M; Swaminathan, S; Andrade, BB				Narendran, Gopalan; Kavitha, Dhanasekaran; Karunaianantham, Ramesh; Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Reddy, Sirasanambatti Devarajulu; Kumar, Marimuthu Makesh; Hemalatha, Haribabu; Jayanthi, Nagesh Nalini; Ravichandran, Narayanan; Krishnaraja, Raja; Prabhakar, Angamuthu; Manoharan, Tamizhselvan; Nithyananthan, Lokeswaran; Arjunan, Gunasundari; Natrajan, Mohan; Swaminathan, Soumya; Andrade, Bruno B.			Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV	PLOS ONE			English	Article							PREDICTION	Background Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory phenomenon complicating HIV management in coincidental tuberculosis (TB) infection, upon immune reconstitution driven by antiretroviral therapy (ART). Leukotriene A4 hydroxylase (LTA4H), an enzyme which converts LTA(4) to LTB4, regulates the balance between the anti-inflammatory lipoxins and pro-inflammatory LTB4, with direct implications in TB-driven inflammation. In humans, a single nucleotide polymorphism (SNP) in the LTA4H promoter which regulates its transcriptional activity (rs17525495) has been identified and described to impact clinical severity of TB presentation and response to corticosteroid therapy. Notably, the role of LTA4H on TB-IRIS has not been previously evaluated. Here, we performed an exploratory investigation testing the association of LTA4H polymorphism with respect to frequency of TB-IRIS occurrence and severity of TB-IRIS presentation in HIV-TB co-infected individuals. Methods Genotypic evaluation of the LTA4H enzyme from available samples was retrospectively correlated with clinical data captured in case sheets including IRIS details. The cohort included patients recruited from a prospective cohort study nested within a randomized clinical trial (NCT0933790) of ART-naive HIV+ patients with newly diagnosed rifampicin sensitive pulmonary TB in South India. Frequency of the wild type genotype (CC), as well as of the mutant genotypes (CT or TT) in the IRIS and non-IRIS patients was estimated. Comparative analyses were performed between wild genotype (CC) and the mutant genotypes (CT or TT) and tested for association between the LTA4H polymorphisms and IRIS incidence and clinical severity. Results A total of 142 eligible ART-naive patients were included in the analyses. Eighty-six individuals exhibited the wild genotype (CC) while 56 had mutant genotypes (43-CT and only 13-TT). Variant allele frequency was 0.23 and 0.26 in non-IRIS group and in IRIS group, respectively. Upon ART initiation, 51 patients developed IRIS while 91 did not. IRIS incidence was 34% and 37% in the wild (CC) and mutant type (CT/TT), respectively (p = 0.858) with a higher frequency of severe IRIS presentation in the mutant genotype group compared to the wild type genotype (p = 0.0006). A logistic regression model confirmed the association between the presence of CT/TT genotypes and occurrence of severe IRIS. Corticosteroid therapy successfully resolved IRIS in all cases irrespective of the LTA4H genotype. Conclusion A higher incidence of severe IRIS among patients with mutant LTA4H genotypes (CT and TT) was observed compared to the wild type, despite similar IRIS incidence and immune restoration in both groups. Steroids were effective in alleviating IRIS in all the genotypes.	[Narendran, Gopalan; Kavitha, Dhanasekaran; Karunaianantham, Ramesh; Reddy, Sirasanambatti Devarajulu; Kumar, Marimuthu Makesh; Hemalatha, Haribabu; Manoharan, Tamizhselvan; Nithyananthan, Lokeswaran; Arjunan, Gunasundari; Natrajan, Mohan; Swaminathan, Soumya] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Integrado Microbiol & Imunorregulacao, Unidade Med Investigat, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Jose Silveira, MONSTER Initiat, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil; [Jayanthi, Nagesh Nalini; Ravichandran, Narayanan; Krishnaraja, Raja] Govt Hosp Thorac Med, Tambaram Sanat, Madras, Tamil Nadu, India; [Prabhakar, Angamuthu] Govt Vellore Med Coll & Hosp, Vellore, Tamil Nadu, India; [Swaminathan, Soumya] India Council Med Res Hlth Secretary, Dept Hlth Res, Minist Hlth & FamilyWelfare, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Fundacao Oswaldo Cruz	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Integrado Microbiol & Imunorregulacao, Unidade Med Investigat, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, MONSTER Initiat, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil.	bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020	Dhanasekaran, Kavitha/0000-0002-3756-3419	Intramural-to-India Program, NIAID, NIH, USA; Indian Council of Medical Research, India; Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil	Intramural-to-India Program, NIAID, NIH, USA; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil	The work was supported by the Intramural-to-India Program, NIAID, NIH, USA and by the Indian Council of Medical Research, India. LG-S and JLA-J were supported by a scientific initiation fellowship from the Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil.	Andrade BB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004433; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Departmentof Health & Human Services, 2015, MYC TUB DIS HIV COIN; Gopalan N, 2014, EXPERT REV CLIN IMMU, V10, P631, DOI 10.1586/1744666X.2014.892828; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Lai RPJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9451; Marais S, 2013, CLIN INFECT DIS, V56, P450, DOI 10.1093/cid/cis899; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2012, AM J RESP CRIT CARE, V186, P369, DOI 10.1164/rccm.201201-0094OC; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Narendran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063541; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Tan HY, 2016, J IMMUNOL, V196, P4052, DOI 10.4049/jimmunol.1502203; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013	19	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163298	10.1371/journal.pone.0163298	http://dx.doi.org/10.1371/journal.pone.0163298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643598	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000383891900043
J	Bryant, RA; Foord, R				Bryant, Richard A.; Foord, Rachael			Activating Attachments Reduces Memories of Traumatic Images	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ADULT ATTACHMENT; BASOLATERAL AMYGDALA; CORTISOL RESPONSES; STYLE; DEPRESSION; ANXIETY; SYSTEM; REPRESENTATIONS; CONSOLIDATION	Emotional memories, and especially intrusive memories, are a common feature of many psychological disorders, and are overconsolidated by stress. Attachment theory posits that activation of mental representations of attachment figures can reduce stress and boost coping. This study tested the proposition that attachment activation would reduce consolidation of emotional and intrusive memories. Sixty-seven undergraduate students viewed subliminal presentations of traumatic and neutral images, which were preceded by subliminal presentations of either attachment-related images or non-attachment-related images; free recall and intrusive memories were assessed two days later. Participants with low avoidant attachment tendencies who received the attachment primes recalled fewer memories and reported fewer intrusions than those who received the non-attachment primes. Unexpectedly, those with high anxious attachment tendencies reported fewer memories. These findings generally accord with attachment theory, and suggest that consolidation of emotional memories can be moderated by activation of attachment representations.	[Bryant, Richard A.; Foord, Rachael] Univ New South Wales, Sydney, NSW, Australia	University of New South Wales Sydney	Bryant, RA (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	r.bryant@.unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X; Foord, Rachael/0000-0001-7043-9252	National Health and Medical Research Council [1073041]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a National Health and Medical Research Council Program Grant (1073041). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bifulco A, 2002, SOC PSYCH PSYCH EPID, V37, P50, DOI 10.1007/s127-002-8215-0; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brennan KA, 1998, J PERS, V66, P835, DOI 10.1111/1467-6494.00034; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 2015, PSYCHONEUROENDOCRINO, V60, P39, DOI 10.1016/j.psyneuen.2015.06.004; Bryant RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062675; Bryant RA, 2011, J PSYCHIATR RES, V45, P842, DOI 10.1016/j.jpsychires.2010.11.012; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Dekel R, 2004, ANXIETY STRESS COPIN, V17, P141, DOI 10.1080/10615800410001721184; Ditzen B, 2008, J PSYCHOSOM RES, V64, P479, DOI 10.1016/j.jpsychores.2007.11.011; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Fraley RC, 2006, PERS SOC PSYCHOL B, V32, P538, DOI 10.1177/0146167205282741; George C., 1985, ADULT ATTACHMENT INT; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1057, DOI 10.1177/0146167208318141; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kidd T, 2011, PSYCHONEUROENDOCRINO, V36, P771, DOI 10.1016/j.psyneuen.2010.10.014; Kleim B, 2013, J ABNORM PSYCHOL, V122, P998, DOI 10.1037/a0034957; Lang P. J., 2005, INT AFFECTIVE PICTUR; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101491; Lonergan MH, 2013, J PSYCHIATR NEUROSCI, V38, P222, DOI 10.1503/jpn.120111; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mikulincer M, 2000, J PERS SOC PSYCHOL, V78, P509, DOI 10.1037/0022-3514.78.3.509; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P305, DOI 10.1037//0022-3514.81.2.305; Mikulincer M, 1998, J PERS SOC PSYCHOL, V75, P436, DOI 10.1037/0022-3514.75.2.436; Mikulincer M, 2006, EMOTION REGULATION F, P77, DOI [10.1037/11468-004, DOI 10.1037/11468-004]; Mikulincer M., 1998, ATTACHMENT THEORY CL, P143; Mikulincer M, 2012, WORLD PSYCHIATRY, V11, P11, DOI 10.1016/j.wpsyc.2012.01.003; Pierce T, 1998, J PERS SOC PSYCHOL, V75, P1441, DOI 10.1037/0022-3514.75.6.1441; Quirin M, 2008, PSYCHONEUROENDOCRINO, V33, P581, DOI 10.1016/j.psyneuen.2008.01.013; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Wei MF, 2007, J PERS ASSESS, V88, P187, DOI 10.1080/00223890701268041; Weiss D.S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; West GC, 2001, ADULT ATTACHMENT PRO, V3	42	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162550	10.1371/journal.pone.0162550	http://dx.doi.org/10.1371/journal.pone.0162550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631498	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900051
J	Poovorawan, K; Pan-ngum, W; White, LJ; Soonthornworasiri, N; Wilairatana, P; Wasitthankasem, R; Tangkijvanich, P; Poovorawan, Y				Poovorawan, Kittiyod; Pan-ngum, Wirichada; White, Lisa J.; Soonthornworasiri, Ngamphol; Wilairatana, Polrat; Wasitthankasem, Rujipat; Tangkijvanich, Pisit; Poovorawan, Yong			Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; DRUG-USERS; EPIDEMIOLOGY; GENOTYPES; SURVIVAL; RISK; POPULATION; INTERFERON	Hepatitis C virus (HCV) infection is an important worldwide public health problem, and most of the global HCV burden is in low-to middle-income countries. This study aimed to estimate the future burden of chronic hepatitis C (CHC) and the impact of public health policies using novel antiviral agents in Thailand. A mathematical model of CHC transmission dynamics was constructed to examine the disease burden over the next 20 years using different treatment strategies. We compared and evaluated the current treatment (PEGylated interferon and ribavirin) with new treatments using novel direct-acting antiviral agents among various treatment policies. Thailand's CHC prevalence was estimated to decrease 1.09%-0.19% in 2015-2035. Expanding treatment coverage (i.e., a five-fold increment in treatment accessibility) was estimated to decrease cumulative deaths (33,007 deaths avoided, 25.5% reduction) from CHC-related decompensated cirrhosis and hepatocellular carcinoma (HCC). The yearly incidence of HCC-associated HCV was estimated to decrease from 2,305 to 1,877 cases yearly with expanding treatment coverage. A generalized treatment scenario (i.e., an equal proportional distribution of available treatment to individuals at all disease stages according to the number of cases at each stage) was predicted to further reduce death from HCC (9,170 deaths avoided, 11.3% reduction) and the annual incidence of HCC (i.e., a further decrease from 1,877 to 1,168 cases yearly, 37.7% reduction), but cumulative deaths were predicted to increase (by 3,626 deaths, 3.7% increase). Based on the extensive coverage scenario and the generalized treatment scenario, we estimated near-zero death from decompensated cirrhosis in 2031. In conclusion, CHC-related morbidity and mortality in Thailand are estimated to decrease dramatically over the next 20 years. Treatment coverage and allocation strategies are important factors that affect the future burden of CHC in resource-limited countries like Thailand.	[Poovorawan, Kittiyod; Wilairatana, Polrat] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Pan-ngum, Wirichada; Soonthornworasiri, Ngamphol] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Pan-ngum, Wirichada; White, Lisa J.] Mahidol Univ, Fac Trop Med, Math & Econ Modelling Grp, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [White, Lisa J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Wasitthankasem, Rujipat; Poovorawan, Yong] Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Chulalongkorn University; Chulalongkorn University	Poovorawan, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	kittiyod.poo@mahidol.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	pan-ngum, wirichada/0000-0002-9839-5359; White, Lisa/0000-0002-6523-185X; Poovorawan, Kittiyod/0000-0001-7016-7605	ICTM Grant of the Faculty of Tropical Medicine; Talent Management Fund, Mahidol University; NSTDA; Wellcome Trust Major Overseas Programme in SE Asia [106698/Z/14/Z]	ICTM Grant of the Faculty of Tropical Medicine; Talent Management Fund, Mahidol University; NSTDA; Wellcome Trust Major Overseas Programme in SE Asia(Wellcome Trust)	This research project was supported by an ICTM Grant of the Faculty of Tropical Medicine, the Talent Management Fund, Mahidol University, a Research Chair Grant, NSTDA and the Wellcome Trust Major Overseas Programme in SE Asia (grant number: 106698/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2014, J MED VIROL, V86, P1482, DOI 10.1002/jmv.23957; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633; Avihingsanon A, 2014, J GASTROEN HEPATOL, V29, P1706, DOI 10.1111/jgh.12613; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Benvegnu L, 2001, GUT, V48, P110, DOI 10.1136/gut.48.1.110; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Cure S, 2015, J MED ECON, V18, P678, DOI 10.3111/13696998.2015.1040024; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gutierrez JA, 2015, J VIRAL HEPATITIS, V22, P861, DOI 10.1111/jvh.12422; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hansurabhanon T, 2002, ANN TROP MED PARASIT, V96, P615, DOI 10.1179/000349802125001465; Hedskog C, 2015, J VIRAL HEPATITIS, V22, P871, DOI 10.1111/jvh.12405; Imran M, 2014, THEOR BIOSCI, V133, P91, DOI 10.1007/s12064-013-0197-0; Jatapai A, 2010, AM J TROP MED HYG, V83, P433, DOI 10.4269/ajtmh.2010.09-0749; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; Pho MT, 2015, J VIRAL HEPATITIS, V22, P630, DOI 10.1111/jvh.12412; Quesada P, 2015, J CLIN VIROL, V68, P89, DOI 10.1016/j.jcv.2015.05.005; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; Solomon SS, 2015, LANCET INFECT DIS, V15, P36, DOI 10.1016/S1473-3099(14)71045-X; Somboon K, 2014, ASIAN PAC J CANCER P, V15, P3567, DOI 10.7314/APJCP.2014.15.8.3567; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Suthar AB, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001795; Thai Red Cross Organ Donation Center, 2015, ANN REPORT; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; 2012, J HEPATOL, V56, P908, DOI DOI 10.1016/J.JHEP.2011.12.001S0168-8278(11)00873-7	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163095	10.1371/journal.pone.0163095	http://dx.doi.org/10.1371/journal.pone.0163095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631382	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900130
J	Cheng, Y; Gao, L; Zhao, YA; Du, F				Cheng, Ying; Gao, Li; Zhao, Yanan; Du, Feng			Drivers' Visual Characteristics when Merging onto or Exiting an Urban Expressway	PLOS ONE			English	Article							OLDER; GAZE; ATTENTION; BEHAVIOR	The aim of this study is to examine drivers' visual and driving behavior while merging onto or exiting an urban expressway with low and high traffic densities. The analysis was conducted according to three periods (approaching, merging or exiting, and accelerating or decelerating). A total of 10 subjects (8 males and 2 females) with ages ranging from 25 to 52 years old (M = 30.0 years old) participated in the study. The research was conducted in a natural driving situation, and the drivers' eye movements were monitored and recorded using an eye tracking system. The results show that the influence of traffic density on the glance duration and scan duration is more significant when merging than when exiting. The results also demonstrate that the number of glances and the mean glance duration are mainly related to the driving task (e.g., the merging period). Therefore, drivers' visual search strategies mainly depend on the current driving task. With regard to driving behavior, the variation tendencies of the duration and the velocity of each period are similar. These results support building an automated driving assistant system that can automatically identify gaps and accelerate or decelerate the car accordingly or provide suggestions to the driver to do so.	[Cheng, Ying; Gao, Li; Zhao, Yanan] Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China; [Cheng, Ying; Du, Feng] Tianjin Univ Technol & Educ, Sch Automot & Transportat, Tianjin, Peoples R China	Beijing Institute of Technology; Tianjin University of Technology & Education	Zhao, YA (corresponding author), Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China.	zyn@bit.edu.cn			Tianjin National Science Foundation [16JCZDJC38200]	Tianjin National Science Foundation	This study was partially supported by grant 16JCZDJC38200 from Tianjin National Science Foundation (http://www.zhenghe.cn/xwzx/zxDetail.aspx?id=113648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BALL K, 1991, HUM FACTORS, V33, P583, DOI 10.1177/001872089103300509; Bao S, 2009, ACCIDENT ANAL PREV, V41, P146, DOI 10.1016/j.aap.2008.10.007; Chan CY, 2006, IEEE T INTELL TRANSP, V7, P322, DOI 10.1109/TITS.2006.880638; Green P., 2002, HUMAN FACTORS TRAFFI, P77; Itkonen T., 2015, PLOS ONE, V10, pe0135505, DOI [10.1371/journal.pone.0135505, DOI 10.1371/journal.pone.0135505]; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Laberge JC, 2006, TRANSPORT RES C-EMER, V14, P39, DOI 10.1016/j.trc.2006.03.001; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O, 2013, J EYE MOVEMENT RES, V6; Lappi O, 2013, J VISION, V13, DOI 10.1167/13.13.11; Lappi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068326; Lehtonen E, 2012, TRANSPORT RES F-TRAF, V15, P369, DOI 10.1016/j.trf.2011.08.007; Lemonnier S, 2015, TRANSPORT RES F-TRAF, V35, P60, DOI 10.1016/j.trf.2015.10.015; Lemonnier S, 2014, J EYE MOVEMENT RES, V7; Rasanen M, 1998, ACCIDENT ANAL PREV, V30, P657, DOI 10.1016/S0001-4575(98)00007-4; ROBINSON GH, 1972, HUM FACTORS, V14, P315, DOI 10.1177/001872087201400404; Romoser MRE, 2013, TRANSPORT RES F-TRAF, V16, P104, DOI 10.1016/j.trf.2012.08.004; Romoser MRE, 2009, HUM FACTORS, V51, P652, DOI 10.1177/0018720809352654; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Tomoki F, 2004, P JAPAN SOC CIVIL EN, V772, P153; Underwood G, 2011, TRANSPORT RES F-TRAF, V14, P435, DOI 10.1016/j.trf.2011.04.008; Werneke J, 2014, COGN TECHNOL WORK, V16, P157, DOI 10.1007/s10111-013-0254-y; Werneke J, 2012, ACCIDENT ANAL PREV, V45, P610, DOI 10.1016/j.aap.2011.09.048; Yuan Wei, 2011, Journal of Traffic and Transportation Engineering, V11, P119	24	3	3	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162298	10.1371/journal.pone.0162298	http://dx.doi.org/10.1371/journal.pone.0162298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657888	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200022
J	Gasparini, S; Ferlazzo, E; Leonardi, CG; Cianci, V; Mumoli, L; Sueri, C; Labate, A; Gambardella, A; Aguglia, U				Gasparini, Sara; Ferlazzo, Edoardo; Leonardi, Cinzia Grazia; Cianci, Vittoria; Mumoli, Laura; Sueri, Chiara; Labate, Angelo; Gambardella, Antonio; Aguglia, Umberto			The Natural History of Epilepsy in 163 Untreated Patients: Looking for "Oligoepilepsy"	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; ILAE COMMISSION; TASK-FORCE; SEIZURES; CLASSIFICATION; TERMINOLOGY; REMISSION; ONSET	The clinical evolution of untreated epilepsy has been rarely studied in developed countries, and the existence of a distinct syndrome characterized by rarely repeated seizures (oligoepilepsy) is debated. The aim of this study is to assess the natural history of 163 untreated patients with epilepsy in order to evaluate whether oligoepilepsy retains specific features. We retrospectively evaluated 7344 patients with >= 2 unprovoked seizures. Inclusion criteria: sufficient anamnestic/EEG data, disease duration >= 10 years, follow-up >= 3 years. Exclusion criteria: psychogenic seizures, natural history of disease < 5 years. The 163 included subjects were divided into 2 groups according to seizure frequency: oligoepilepsy (<= 1/year; 47 subjects) and controls (> 1/year; 116 subjects). We also evaluated seizure frequency during the natural history. There were no differences between groups regarding duration of natural history, family history of epilepsy/febrile seizures, interictal EEG. Subjects with oligoepilepsy differed from controls in terms of sex (females 38% vs. 58%, p = 0.03) and drug resistance (6% vs 28%; p = 0.003). Juvenile myoclonic epilepsy was more frequent in controls (9.5% vs 0%, p = 0.04). Patients with oligoepilepsy, differently from controls, had stable seizure frequency. Oligoepilepsy represents a favourable evolution of different epileptic syndromes and keeps a stable seizure frequency over time.	[Gasparini, Sara; Ferlazzo, Edoardo; Leonardi, Cinzia Grazia; Mumoli, Laura; Labate, Angelo; Gambardella, Antonio; Aguglia, Umberto] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, Catanzaro, Italy; [Gasparini, Sara; Ferlazzo, Edoardo; Leonardi, Cinzia Grazia; Cianci, Vittoria; Sueri, Chiara; Aguglia, Umberto] Bianchi Melacrino Morelli Hosp, Reg Epilepsy Ctr, Via Melacrino, Reggio Di Calabria, Italy	Magna Graecia University of Catanzaro	Aguglia, U (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Viale Europa, Catanzaro, Italy.; Aguglia, U (corresponding author), Bianchi Melacrino Morelli Hosp, Reg Epilepsy Ctr, Via Melacrino, Reggio Di Calabria, Italy.	u.aguglia@tin.it	Ferlazzo, Edoardo/F-9566-2018; Gambardella, Antonio/F-5295-2012; Aguglia, Umberto/AAB-9898-2019	Gambardella, Antonio/0000-0001-7384-3074; Aguglia, Umberto/0000-0002-4574-2951; Labate, Angelo/0000-0002-8827-7324				Aguglia U, 1998, CAN J NEUROL SCI, V25, P282, DOI 10.1017/S0317167100034284; Andermann F, 2001, EPILEPSIA, V42, P317, DOI 10.1046/j.1528-1157.2001.36400.x; Berg AT, 2011, ANN NEUROL, V70, P566, DOI 10.1002/ana.22461; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; Camfield P, 2005, NEUROLOGY, V64, P973, DOI 10.1212/01.WNL.0000154517.82748.A7; Devilat BM, 1985, REV CHIL PEDIAT, V56, P53; Doose H, 1971, EPILEPSIE, P9; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Firkin AL, 2015, EPILEPSIA, V56, P1534, DOI 10.1111/epi.13127; GANSHIRT H, 1983, NERVENARZT, V54, P628; Gasparini S, 2016, EPILEPSIA, V57, P164, DOI 10.1111/epi.13237; Gasparini S, 2013, EPILEPSY RES, V107, P101, DOI 10.1016/j.eplepsyres.2013.07.004; JANZ D, 1985, ACTA NEUROL SCAND, V72, P449; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Labate A, 2011, NAT REV NEUROL, V7, P237, DOI 10.1038/nrneurol.2010.212; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Nicoletti A, 2009, EPILEPSIA, V50, P2199, DOI 10.1111/j.1528-1167.2009.02174.x; Persad V, 2004, ANN NEUROL, V55, P353, DOI 10.1002/ana.10831; REYNOLDS EH, 1983, LANCET, V2, P952	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161722	10.1371/journal.pone.0161722	http://dx.doi.org/10.1371/journal.pone.0161722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657542	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200012
J	Wang, FF; Sun, X; Shi, XY; Zhai, H; Tian, CG; Kong, FJ; Liu, BH; Yuan, XH				Wang, Feifei; Sun, Xia; Shi, Xinyi; Zhai, Hong; Tian, Changen; Kong, Fanjiang; Liu, Baohui; Yuan, Xiaohui			A Global Analysis of the Polygalacturonase Gene Family in Soybean (Glycine max)	PLOS ONE			English	Article							CELL-SEPARATION; ARABIDOPSIS; EXPRESSION; EVOLUTION; SEQUENCE; PECTIN; TOMATO; DUPLICATION; DEHISCENCE; ABSCISSION	Polygalacturonase is one of the pectin hydrolytic enzymes involved in various developmental and physiological processes such as seed germination, organ abscission, pod and anther dehiscence, and xylem cell formation. To date, no systematic analysis of polygalacturonase incorporating genome organization, gene structure, and expression profiling has been conducted in soybean (Glycine max var. Williams 82). In this study, we identified 112 GmPG genes from the soybean Wm82.a2v1 genome. These genes were classified into three groups, group I (105 genes), group II (5 genes), and group III (2 genes). Fifty-four pairs of duplicate paralogous genes were preferentially identified from duplicated regions of the soybean genome, which implied that long segmental duplications significantly contributed to the expansion of the GmPG gene family. Moreover, GmPG transcripts were analyzed in various tissues using RNA-seq data. The results showed the differential expression of 64 GmPGs in the tissue and partially redundant expression of some duplicate genes, while others showed functional diversity. These findings suggested that the GmPGs were retained by substantial subfunctionalization during the soybean evolutionary processes. Finally, evolutionary analysis based on single nucleotide polymorphisms (SNPs) in wild and cultivated soybeans revealed that 107 GmPGs had selected site(s), which indicated that these genes may have undergone strong selection during soybean domestication. Among them, one non-synonymous SNP of GmPG031 affected floral development during selection, which was consistent with the results of RNA-seq and evolutionary analyses. Thus, our results contribute to the functional characterization of GmPG genes in soybean.	[Wang, Feifei; Sun, Xia; Zhai, Hong; Kong, Fanjiang; Liu, Baohui; Yuan, Xiaohui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin 150081, Peoples R China; [Wang, Feifei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shi, Xinyi] Heilongjiang Univ, Sch Comp Sci & Technol, Harbin 150080, Peoples R China; [Tian, Changen] Guangzhou Univ, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Heilongjiang University; Guangzhou University	Liu, BH; Yuan, XH (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin 150081, Peoples R China.	liubh@iga.ac.cn; yuanxh@iga.ac.cn	Kong, Fanjiang/AGQ-2334-2022		National Natural Science Foundation of China [31301337]; National Natural Science Foundation of Heilongjiang Province [QC2014C036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This study was supported by the National Natural Science Foundation of China (No. 31301337) and the National Natural Science Foundation of Heilongjiang Province (No. QC2014C036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Babu Y, 2013, PLANT PHYSIOL, V162, P1448, DOI 10.1104/pp.113.217166; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cheng Q, 2008, J GENET GENOMICS, V35, P631, DOI 10.1016/S1673-8527(08)60084-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; Daher FB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00523; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li XA, 2010, J GENET GENOMICS, V37, P749, DOI 10.1016/S1673-8527(09)60092-8; Liu T, 2016, PLANT J, V85, P96; Lyu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131173; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Orozco-Cardenas ML, 2003, PLANT PHYSIOL, V133, P693, DOI 10.1104/pp.103.023226; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00412; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Rodriguez-Gacio MD, 2004, J PLANT PHYSIOL, V161, P219, DOI 10.1078/0176-1617-01153; Rose JKC, 1999, TRENDS PLANT SCI, V4, P176, DOI 10.1016/S1360-1385(99)01405-3; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Sitrit Y, 1999, PLANT PHYSIOL, V121, P419, DOI 10.1104/pp.121.2.419; Sitrit Y, 1996, PLANT PHYSIOL, V111, P155; SONG H, 2016, FRONT PLANT SCI, V7, DOI DOI 10.3389/FPLS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torki M, 1999, MOL GEN GENET, V261, P948, DOI 10.1007/s004380051042; Wang FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138467; Wang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111406; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Xiao C, 2014, PLANT CELL, V26, P1018, DOI 10.1105/tpc.114.123968; Yang ZL, 2013, NEW PHYTOL, V197, P1353, DOI 10.1111/nph.12107; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	46	12	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163012	10.1371/journal.pone.0163012	http://dx.doi.org/10.1371/journal.pone.0163012			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657691	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200053
J	Vroomen, JM; Bosmans, JE; Eekhout, I; Joling, KJ; van Mierlo, LD; Meiland, FJM; van Hout, HPJ; de Rooij, SE				Vroomen, Janet MacNeil; Bosmans, Judith E.; Eekhout, Iris; Joling, Karlijn J.; van Mierlo, Lisa D.; Meiland, Franka J. M.; van Hout, Hein P. J.; de Rooij, Sophia E.			The Cost- Effectiveness of Two Forms of Case Management Compared to a Control Group for Persons with Dementia and Their Informal Caregivers from a Societal Perspective	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; QUALITY-OF-LIFE; ECONOMIC-EVALUATION; MISSING DATA; HEALTH-CARE; UTILITY; DESIGN; NEED	Objectives The objective of this article was to compare the costs and cost-effectiveness of the two most prominent types of case management in the Netherlands (intensive case management and linkage models) against no access to case management (control group) for people with already diagnosed dementia and their informal caregivers. Methods The economic evaluation was conducted from a societal perspective embedded within a two year prospective, observational, controlled, cohort study with 521 informal caregivers and community-dwelling persons with dementia. Case management provided within one care organization (intensive case management model, ICMM), case management where care was provided by different care organizations within one region (Linkage model, LM), and a group with no access to case management (control) were compared. The economic evaluation related incremental costs to incremental effects regarding neuropsychiatric symptoms (NPI), psychological health of the informal caregiver (GHQ-12), and quality adjusted life years (QALY) of the person with dementia and informal caregiver. Results Inverse-propensity-score-weighted models showed no significant differences in clinical or total cost outcomes between the three groups. Informal care costs were significantly lower in the ICMM group compared to both other groups. Day center costs were significantly lower in the ICMM group compared to the control group. For all outcomes, the probability that the ICMM was cost-effective in comparison with LM and the control group was larger than 0.97 at a threshold ratio of 0 (sic)/incremental unit of effect. Conclusion This study provides preliminary evidence that the ICMM is cost-effective compared to the control group and the LM. However, the findings should be interpreted with caution since this study was not a randomized controlled trial.	[Vroomen, Janet MacNeil; de Rooij, Sophia E.] Univ Amsterdam, Acad Med Ctr, Geriatr Med Sect, Dept Internal Med, Amsterdam, Netherlands; [Vroomen, Janet MacNeil] Yale Sch Med, Dept Biostat, New Haven, CT USA; [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Bosmans, Judith E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Eekhout, Iris] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Joling, Karlijn J.; van Mierlo, Lisa D.; Meiland, Franka J. M.; van Hout, Hein P. J.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Joling, Karlijn J.; van Mierlo, Lisa D.; Meiland, Franka J. M.; van Hout, Hein P. J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [de Rooij, Sophia E.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Dept Internal Med, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Yale University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen	Vroomen, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Geriatr Med Sect, Dept Internal Med, Amsterdam, Netherlands.; Vroomen, JM (corresponding author), Yale Sch Med, Dept Biostat, New Haven, CT USA.	janet.macneilvroomen@yale.edu	Vroomen, Janet MacNeil/M-5358-2017	Vroomen, Janet MacNeil/0000-0001-6400-7189; van Hout, Hein/0000-0002-2495-4808; Bosmans, Judith/0000-0002-1443-1026	Dutch National Programme for Improving Care for Older Persons (ZonMw) [313080201]; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]	Dutch National Programme for Improving Care for Older Persons (ZonMw); Yale Claude D. Pepper Older Americans Independence Center	Research funding was provided by a governmental grant by the Dutch National Programme for Improving Care for Older Persons (ZonMw no 313080201, www.zonmw.nl). The primary author was also funded by the Yale Claude D. Pepper Older Americans Independence Center (P30AG021342, http://medicine.yale.edu/intmed/geriatrics/peppercenter/) during the revision stage of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer Europe, 2006, WHO CAR STAT DEM CAR; [Anonymous], 2010, WORLD ALZHEIMER REPO; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, STAT STAT SOFTW REL; Banks P., 2004, INTEGRATING SERVICES, P101; Briggs A, 2000, BRIT MED J, V321, P1362, DOI 10.1136/bmj.321.7273.1362; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Case Management Society of America, 2021, WHAT IS CAS MAN; Centraal Bureau voor de Statistiek, 2010, PRIJS; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Faria R, 2014, PHARMACOECONOMICS, V32, P1157, DOI 10.1007/s40273-014-0193-3; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hakkart-van Roijen L, 2010, HANDLEIDING KOSTENON; index Z, 2009, IND Z G STAND; Jansen APD, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-133; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042145; Joling KJ, 2010, AM J GERIAT PSYCHIAT, V18, P146, DOI 10.1097/JGP.0b013e3181bf9f0f; Khanassov V, 2014, CLIN INTERV AGING, V9, P915, DOI 10.2147/CIA.S64723; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; McPhail S, 2008, MED CARE, V46, P1140, DOI 10.1097/MLR.0b013e31817d69a6; Ministry of Health Welfare and Sport, 2009, GUID INT DEM CAR EXC; Nixon RM, 2010, HEALTH ECON, V19, P316, DOI 10.1002/hec.1477; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Peeters JM, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-9; Pimouguet C, 2010, J NUTR HEALTH AGING, V14, P669, DOI 10.1007/s12603-010-0314-4; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schoenmakers B, 2010, MATURITAS, V66, P191, DOI 10.1016/j.maturitas.2010.02.009; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Van der Roest HG, 2008, ST HEAL T, V137, P210; Van Mierlo LD, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-84; Vroomen J.M., 2015, EUR J HLTH EC; Vroomen JM, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.011; Vroomen JM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-132; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Willan A, 2006, STAT ANAL COST EFFEC; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Zwaanswijk Marieke, 2013, Open Nurs J, V7, P6, DOI 10.2174/1874434601307010006	45	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0160908	10.1371/journal.pone.0160908	http://dx.doi.org/10.1371/journal.pone.0160908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655234	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700005
J	Conway, ML; Evans, BJW; Evans, JC; Suttle, CM				Conway, Miriam L.; Evans, Bruce J. W.; Evans, Josephine C.; Suttle, Catherine M.			Does Gender Influence Colour Choice in the Treatment of Visual Stress?	PLOS ONE			English	Article							CONTROLLED TRIAL; SEX-DIFFERENCES; PREFERENCES; OVERLAYS; CHILDREN; DYSLEXIA; FILTERS; DIFFICULTIES; MIGRAINE; LENSES	Purpose Visual Stress (VS) is a condition in which words appear blurred, in motion, or otherwise distorted when reading. Some people diagnosed with VS find that viewing black text on white paper through coloured overlays or precision tinted lenses (PTLs) reduces symptoms attributed to VS. The aim of the present study is to determine whether the choice of colour of overlays or PTLs is influenced by a patient's gender. Methods Records of all patients attending a VS assessment in two optometry practices between 2009 and 2014 were reviewed retrospectively. Patients who reported a significant and consistent reduction in symptoms with either overlay and or PTL were included in the analysis. Overlays and PTLs were categorized as stereotypical male, female or neutral colours based on gender preferences as described in the literature. Chi-square analysis was carried out to determine whether gender (across all ages or within age groups) was associated with overlay or PTL colour choice. Results 279 patients (133 males and 146 females, mean age 17 years) consistently showed a reduction in symptoms with an overlay and were included. Chi-square analysis revealed no significant association between the colour of overlay chosen and male or female gender (Chi-square 0.788, p = 0.674). 244 patients (120 males and 124 females, mean age 24.5 years) consistently showed a reduction in symptoms with PTLs and were included. Chi-square analysis revealed a significant association between stereotypical male/female/neutral colours of PTLs chosen and male/female gender (Chi-square 6.46, p = 0.040). More males preferred stereotypical male colour PTLs including blue and green while more females preferred stereotypical female colour PTLs including pink and purple. Conclusions For some VS patients, the choice of PTL colour is influenced not only by the alleviation of symptoms but also by other non-visual factors such as gender.	[Conway, Miriam L.; Evans, Bruce J. W.; Evans, Josephine C.; Suttle, Catherine M.] City Univ London, Div Optometry & Visual Sci, Sch Hlth Sci, London, England; [Evans, Bruce J. W.] Inst Optometry, Neville Chappell Res Clin, London, England	City University London; University of London; University College London	Suttle, CM (corresponding author), City Univ London, Div Optometry & Visual Sci, Sch Hlth Sci, London, England.	Catherine.suttle.1@city.ac.uk		Suttle, Catherine/0000-0001-8694-195X	Research Sustainability Fund, City University London [90000HS]	Research Sustainability Fund, City University London	Grant number 90000HS Funding received by MC from the Research Sustainability Fund, City University London. The funder had no role in any aspect of the study or preparation of the manuscript.	Akcay O, 2012, IJBSS, V3; Al-Rasheed AS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00030; Albon E., 2008, EFFECTIVENESS COST E; Allen PM, 2008, INVEST OPHTH VIS SCI, V49, P4210, DOI 10.1167/iovs.07-1587; Allen PM, 2010, INVEST OPHTH VIS SCI, V51, P6843, DOI 10.1167/iovs.09-5086; Allen PM, 2010, TEN ALPS CREATIVE; Auty S, 2004, PSYCHOL MARKET, V21, P697, DOI 10.1002/mar.20025; Bjerstedt A., 1960, PERCEPT MOTOR SKILL, V10, P31; Bouldoukian J, 2002, OPHTHAL PHYSL OPT, V22, P55, DOI 10.1046/j.1475-1313.2002.00002.x; Chiu SW, 2006, SEX ROLES, V55, P385, DOI 10.1007/s11199-006-9089-9; Chouinard BD, 2012, BRAIN TOPOGR, V25, P293, DOI 10.1007/s10548-011-0212-z; Coutts LV, 2012, CEPHALALGIA, V32, P621, DOI 10.1177/0333102412444474; Ellis L, 2001, PERS INDIV DIFFER, V31, P1375, DOI 10.1016/S0191-8869(00)00231-2; Evans BJ, 2016, J OPTOM IN PRESS; Funk D., 2006, MANAGE RES NEWS, V29, P41, DOI DOI 10.1108/01409170610645439; Griffiths PG, 2015, SCAND J OCCUP THER, V22, P328, DOI 10.3109/11038128.2015.1033456; Hollis J, 2006, OPHTHAL PHYSL OPT, V26, P566, DOI 10.1111/j.1475-1313.2006.00401.x; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Hurlbert AC, 2007, CURR BIOL, V17, pR623, DOI 10.1016/j.cub.2007.06.022; Jeanes R, 1997, BRIT J PSYCHOL, V88, P531; Kim Ji Hyun, 2015, Korean J Ophthalmol, V29, P121, DOI 10.3341/kjo.2015.29.2.121; Kriss I, 2005, J RES READ, V28, P350, DOI 10.1111/j.1467-9817.2005.00274.x; LIGHTSTONE A, 1995, OPHTHAL PHYSL OPT, V15, P507, DOI 10.1016/0275-5408(95)00060-Q; Lightstone A, 1999, OPHTHAL PHYSL OPT, V19, P279, DOI 10.1046/j.1475-1313.1999.00442.x; LoBue V, 2011, BRIT J DEV PSYCHOL, V29, P656, DOI 10.1111/j.2044-835X.2011.02027.x; MATHER J, 1971, GERONTOLOGIST, V11, P311, DOI 10.1093/geront/11.4_Part_1.311; Nandakumar K, 2008, CLIN EXP OPTOM, V91, P333, DOI 10.1111/j.1444-0938.2008.00277.x; Northway N, 2003, OPHTHAL PHYSL OPT, V23, P457, DOI 10.1046/j.1475-1313.2003.00144.x; Riddell PM, 2006, OPTOMETRY VISION SCI, V83, P299, DOI 10.1097/01.opx.0000216125.83236.af; Robinson GL, 1999, PERCEPT MOTOR SKILL, V89, P83, DOI 10.2466/PMS.89.5.83-113; Scott L, 2002, OPHTHAL PHYSL OPT, V22, P156, DOI 10.1046/j.1475-1313.2002.00009.x; SILVER NC, 1988, PERCEPT MOTOR SKILL, V66, P295, DOI 10.2466/pms.1988.66.1.295; Simmers AJ, 2001, INVEST OPHTH VIS SCI, V42, P879; Singleton C, 2007, DYSLEXIA, V13, P130, DOI 10.1002/dys.329; Sorokowski P, 2014, PSYCHON B REV, V21, P1195, DOI 10.3758/s13423-014-0591-8; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Taylor C, 2013, J EXP PSYCHOL GEN, V142, P1015, DOI 10.1037/a0030273; Tweedie W., 2001, J RES READ, V24, P41, DOI [10.1111/1467-9817.00132, DOI 10.1111/1467-9817.00132]; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wijk H, 1999, AGING CLIN EXP RES, V11, P176, DOI 10.1007/BF03399660; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins A, 1993, MANUAL INTUITIVE COL; WILKINS AJ, 1994, OPHTHAL PHYSL OPT, V14, P365, DOI 10.1111/j.1475-1313.1994.tb00126.x; Wilkins AJ, 1996, OPHTHAL PHYSL OPT, V16, P491, DOI 10.1016/0275-5408(96)00028-2; Wong WI, 2015, ARCH SEX BEHAV, V44, P1243, DOI 10.1007/s10508-015-0489-1	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163326	10.1371/journal.pone.0163326	http://dx.doi.org/10.1371/journal.pone.0163326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27648842	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000383892100080
J	Mehiriz, K; Gosselin, P				Mehiriz, Kaddour; Gosselin, Pierre			Municipalities' Preparedness for Weather Hazards and Response to Weather Warnings	PLOS ONE			English	Article							EMERGENCY MANAGEMENT; DISASTER MANAGEMENT; NATURAL DISASTERS; PERCEIVED RISK; CLIMATE-CHANGE; HEALTH; FRAMEWORK; CAPACITY; SERVICES; IMPACTS	The study of the management of weather-related disaster risks by municipalities has attracted little attention even though these organizations play a key role in protecting the population from extreme meteorological conditions. This article contributes to filling this gap with new evidence on the level and determinants of Quebec municipalities' preparedness for weather hazards and response to related weather warnings. Using survey data from municipal emergency management coordinators and secondary data on the financial and demographic characteristics of municipalities, the study shows that most Quebec municipalities are sufficiently prepared for weather hazards and undertake measures to protect the population when informed of imminent extreme weather events. Significant differences between municipalities were noted though. Specifically, the level of preparedness was positively correlated with the municipalities' capacity and population support for weather-related disaster management policies. In addition, the risk of weather-related disasters increases the preparedness level through its effect on population support. We also found that the response to weather warnings depended on the risk of weather-related disasters, the preparedness level and the quality of weather warnings. These results highlight areas for improvement in the context of increasing frequency and/or severity of such events with current climate change.	[Mehiriz, Kaddour] Inst Natl Rech Sci, Ctr Eau Terre & Environm, Quebec City, PQ, Canada; [Gosselin, Pierre] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Gosselin, Pierre] OURANOS, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Institut national de sante publique du Quebec (INSPQ); Ouranos Consortium	Mehiriz, K (corresponding author), Inst Natl Rech Sci, Ctr Eau Terre & Environm, Quebec City, PQ, Canada.	kaddour.mehiriz@inrs.ca			Natural Sciences and Engineering Research Council of Canada; Institut national de sante publique du Quebec; Environment Canada's Meteorological Service (Quebec Region); IRIACC-FACE program of the International Development Research Centre; Canadian Institutes for Health Research in Canada; Ministere de la Securite Publique du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Institut national de sante publique du Quebec; Environment Canada's Meteorological Service (Quebec Region); IRIACC-FACE program of the International Development Research Centre; Canadian Institutes for Health Research in Canada(Canadian Institutes of Health Research (CIHR)); Ministere de la Securite Publique du Quebec	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the reviewers of this article for their helpful comments and the Institut national de sante publique du Quebec, the Ministere de la Securite Publique du Quebec, Environment Canada's Meteorological Service (Quebec Region), the IRIACC-FACE program of the International Development Research Centre and the Canadian Institutes for Health Research in Canada for their support.	Abrahamson V, 2009, J PUBLIC HEALTH-UK, V31, P478, DOI 10.1093/pubmed/fdp059; [Anonymous], 2005, WORLD C DIS RED KOB; Basher R, 2006, PHILOS T R SOC A, V364, P2167, DOI 10.1098/rsta.2006.1819; Berkhout F, 2006, CLIMATIC CHANGE, V78, P135, DOI 10.1007/s10584-006-9089-3; BORCHERDING TE, 1972, AM ECON REV, V62, P891; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Daupras F, 2015, NAT HAZARDS, V75, P215, DOI 10.1007/s11069-014-1318-x; Donahue AK, 2014, AM REV PUBLIC ADM, V44, p89S, DOI 10.1177/0275074013506517; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Escaleras M, 2012, PUBLIC CHOICE, V151, P165, DOI 10.1007/s11127-010-9740-4; Fisher R.C., 2015, STATE LOCAL GOVT FIN, V4th ed., DOI https://doi.org/10.4324/9781315718729; Gall M., 2014, IRDR AIRDR PUBLICATI; Gasper JT, 2011, AM J POLIT SCI, V55, P340, DOI 10.1111/j.1540-5907.2010.00503.x; George D, 2003, SPSS WINDOWS STEP ST; Gerber BJ, 2005, POLICY STUD J, V33, P395, DOI 10.1111/j.1541-0072.2005.00122.x; Gouvernement du Quebec, APPR PRINC SEC CIV; Gouvernement du Quebec, 2016, FIN FISC ORG MUN QUE; Gouvernement du Quebec, 2008, PLAN REP SIN GUID IN; Gouvernement du Quebec, 2010, COMM ORG SEC CIV QUE; Government of Canada, 2011, EM MAN FRAM CAN; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hansjurgens B., 2014, MEGACITIES, P9, DOI [10.1007/978-90-481-3417-5_2, DOI 10.1007/978-90-481-3417-5_2]; Healy A, 2009, AM POLIT SCI REV, V103, P387, DOI 10.1017/S0003055409990104; Henstra D, 2005, CAN PUBLIC POL, V31, P303, DOI 10.2307/3552443; Henstra D, 2010, PUBLIC ADMIN REV, V70, P236, DOI 10.1111/j.1540-6210.2010.02130.x; Huang, 2011, AM J PREV MED, V40, P183, DOI [10.1016/j.amepre.2010.10.025, DOI 10.1016/J.AMEPRE.2010.10.025]; Hwacha V., 2005, MITIG ADAPT STRATEG, V10, P507, DOI DOI 10.1007/S11027-005-0058-3; Ivey, 2004, ENVIRON MANAGE, V33, P36; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kalkstein AJ, 2007, INT J BIOMETEOROL, V52, P43, DOI 10.1007/s00484-006-0073-4; Kapucu N., 2008, DISASTERS J DISASTER, V32, P239, DOI DOI 10.1111/J.1467-7717.2008.01037.X; Leskens JG, 2014, ENVIRON MODELL SOFTW, V53, P53, DOI 10.1016/j.envsoft.2013.11.003; Maibach, 2008, CLIMATE CHANGE PUBLI, V3, P1; McGuire M, 2010, PUBLIC ADMIN REV, V70, P279, DOI 10.1111/j.1540-6210.2010.02134.x; Mehiriz K, 2014, PUBLIC BUDG FINANC, V34, P85, DOI 10.1111/pbaf.12026; Mendes CC, 2006, APPL ECON, V38, P239, DOI 10.1080/00036840500215378; Neumayer E, 2014, GLOBAL ENVIRON CHANG, V24, P8, DOI 10.1016/j.gloenvcha.2013.03.011; Parker DJ, 2012, WATER RESOUR MANAG, V26, P2927, DOI 10.1007/s11269-012-0057-6; Paton D, 2003, J DISASTER PREV MANA, V12, P210, DOI DOI 10.1108/09653560310480686; Polivka BJ, 2012, ENVIRON HEALTH PERSP, V120, P321, DOI 10.1289/ehp.1104025; Prater C.S., 2000, NAT HAZARDS REV, V1, P73, DOI [10.1061/(ASCE)1527-6988(2000)1:2(73), DOI 10.1061/(ASCE)1527-6988(2000)1:2(73), DOI 10.1061/(ASCE)1527-6988(2000)1]; Rahm D, 2011, J CONTING CRISIS MAN, V19, P136, DOI 10.1111/j.1468-5973.2011.00647.x; Reeves A, 2011, J POLIT, V73, P1142, DOI 10.1017/S0022381611000843; Robledo C., 2005, ADAPTATION FOREST EC; Rumbach A, 2016, HABITAT INT, V52, P35, DOI 10.1016/j.habitatint.2015.08.026; Sattele M, 2015, RELIAB ENG SYST SAFE, V142, P192, DOI 10.1016/j.ress.2015.05.003; Scott Z., 2011, GLOB ASS REP DIS RIS; Skidmore M, 2013, LAND ECON, V89, P101, DOI 10.3368/le.89.1.101; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Somers S, 2009, PUBLIC ADMIN REV, V69, P181, DOI 10.1111/j.1540-6210.2008.01963.x; Ullman S., 2001, USING MULTIVARIATE S, P653; UNDRR, 2015, AUST J EMERG MANAG; United Nations, 1997, REP EARL WARN HYDR H; Wildasin DE, 2008, PUBLIC FINANC REV, V36, P497, DOI 10.1177/1091142107306286; Wolensky R. P., 1990, POLICY STUDIES REV, V9, P703, DOI [10.1080/03003939108433570, DOI 10.1080/03003939108433570]; Yzer M, 2012, THEOR PRACT, P21; Zhang Q, 2015, NAT HAZARDS, V77, P1915, DOI 10.1007/s11069-015-1683-0	58	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163390	10.1371/journal.pone.0163390	http://dx.doi.org/10.1371/journal.pone.0163390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649547	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100086
J	Gutierrez, MJ; Gomez, JL; Perez, GF; Pancham, K; Val, S; Pillai, DK; Giri, M; Ferrante, S; Freishtat, R; Rose, MC; Preciado, D; Nino, G				Gutierrez, Maria J.; Gomez, Jose L.; Perez, Geovanny F.; Pancham, Krishna; Val, Stephanie; Pillai, Dinesh K.; Giri, Mamta; Ferrante, Sarah; Freishtat, Robert; Rose, Mary C.; Preciado, Diego; Nino, Gustavo			Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; EXTRACELLULAR VESICLES; INFLAMMATORY RESPONSE; EXPRESSION PROFILES; DENDRITIC CELLS; MESSENGER-RNAS; IN-VITRO; EXOSOMES; MIR-155; IMMUNE	Background Innate immune responses are fine-tuned by small noncoding RNA molecules termed microRNAs (miRs) that modify gene expression in response to the environment. During acute infections, miRs can be secreted in extracellular vesicles (EV) to facilitate cell-to-cell genetic communication. The purpose of this study was to characterize the baseline population of miRs secreted in EVs in the airways of young children (airway secretory microRNAome) and examine the changes during rhinovirus (RV) infection, the most common cause of asthma exacerbations and the most important early risk factor for the development of asthma beyond childhood. Methods Nasal airway secretions were obtained from children (<= 3 yrs. old) during PCR-confirmed RV infections (n = 10) and age-matched controls (n = 10). Nasal EVs were isolated with polymer-based precipitation and global miR profiles generated using NanoString microarrays. We validated our in vivo airway secretory miR data in an in vitro airway epithelium model using apical secretions from primaryhuman bronchial epithelial cells (HBEC) differentiated at air-liquid interface (ALI). Bioinformatics tools were used to determine the unified (nasal and bronchial) signature airway secretory miRNAome and changes during RV infection in children. Results Multiscale analysis identified four signature miRs comprising the baseline airway secretory miRNAome: hsa-miR-630, hsa-miR-302d-3p, hsa-miR-320e, hsa-miR-612. We identified hsa-miR-155 as the main change in the baseline miRNAome during RV infection in young children. We investigated the potential biological relevance of the airway secretion of hsa-mir-155 using in silico models derived from gene datasets of experimental in vivo human RV infection. These analyses confirmed that hsa-miR-155 targetome is an overrepresented pathway in the upper airways of individuals infected with RV. Conclusions Comparative analysis of the airway secretory microRNAome in children indicates that RV infection is associated with airway secretion of EVs containing miR-155, which is predicted in silico to regulate antiviral immunity. Further characterization of the airway secretory microRNAome during health and disease may lead to completely new strategies to treat and monitor respiratory conditions in all ages.	[Gutierrez, Maria J.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Nino, Gustavo] Yale Univ, Sch Med, Div Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Rose, Mary C.; Nino, Gustavo] Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Med Genet Res Ctr, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Giri, Mamta; Ferrante, Sarah; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Gomez, Jose L.; Pancham, Krishna] Univ Kentucky, Div Pediat Pulmonol, Lexington, KY USA; [Val, Stephanie; Preciado, Diego] Childrens Natl Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Washington, DC 20010 USA; [Freishtat, Robert] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA	Johns Hopkins University; Yale University; Children's National Health System; George Washington University; George Washington University; George Washington University; Children's National Health System; University of Kentucky; Children's National Health System; Children's National Health System	Nino, G (corresponding author), Yale Univ, Sch Med, Div Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA.; Nino, G (corresponding author), Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA.; Nino, G (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Nino, G (corresponding author), George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20052 USA.; Nino, G (corresponding author), George Washington Univ, Med Genet Res Ctr, Washington, DC 20052 USA.; Nino, G (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	gnino@childrensnational.org	giri, mamta/ABC-2895-2020; Gutierrez, Maria/AAK-2528-2021	Freishtat, Robert/0000-0002-7411-2342; Gutierrez, Maria Jimena/0000-0001-5494-5841; Perez, Geovanny/0000-0003-2843-6837; Gomez, Jose/0000-0002-6521-6318	National Heart, Lung and Blood Institute [NHLBI/HL090020, NHLBI/1K01HL125474-01]; National Institute for Child Health and Human Development [NICHC/HD001399]; National Center for Advancing Translational Sciences [KL2TR000076, UL1TR000075]; FAMRI: Young Clinical Scientist Award [113393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125474] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FAMRI: Young Clinical Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants: GN-National Heart, Lung and Blood Institute, NHLBI/HL090020 (K12 Genomics of Lung), http://www.nhlbi.nih.gov; JLG-National Heart, Lung and Blood Institute, NHLBI/1K01HL125474-01, http://www.nhlbi.nih.gov; GN-National Institute for Child Health and Human Development, NICHC/HD001399 (K12 Child Health Research Career Development Award), https://www.nichd.nih.gov; GN-National Center for Advancing Translational Sciences, KL2TR000076, https://www.nichd.nih.gov; GN-National Center for Advancing Translational Sciences, UL1TR000075, https://www.nichd.nih.gov; JLG-FAMRI: Young Clinical Scientist Award, 113393, http://www.famri.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala SE, 2014, AM J RESP CELL MOL, V51, P363, DOI 10.1165/rcmb.2013-0396OC; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Biosciences S., EXOQUICK EXOSOME PRE; Bondanese Victor Paky, 2014, World J Biol Chem, V5, P437, DOI 10.4331/wjbc.v5.i4.437; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Cao JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.386; Ceppi Maurizio, 2009, Immunome Res, V5, P5, DOI 10.1186/1745-7580-5-5; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Cheng YQ, 2015, IMMUNOLOGY, V145, P485, DOI 10.1111/imm.12463; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fry RC, 2014, AM J PHYSIOL-LUNG C, V306, pL1129, DOI 10.1152/ajplung.00348.2013; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Graff JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044066; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Hsu S-D, 2010, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKQ1107; Inchley CS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0878-z; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kesimer M, 2015, METHODS, V87, P59, DOI 10.1016/j.ymeth.2015.03.013; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim YS, 2013, CLIN EXP ALLERGY, V43, P443, DOI 10.1111/cea.12085; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Lossner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022146; Lu TX, 2013, J ALLERGY CLIN IMMUN, V132, P3, DOI 10.1016/j.jaci.2013.04.039; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Malmstrom K, 2015, ANN ALLERG ASTHMA IM, V114, P90, DOI 10.1016/j.anai.2014.09.019; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; NanoStringTechnologies I, 2012, NCOUNTER EXPR DAT AN; Nino G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115398; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Okoye IS, 2014, P NATL ACAD SCI USA, V111, pE3081, DOI 10.1073/pnas.1406322111; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Pillai DK, 2014, AM J RESP CELL MOL, V50, P292, DOI 10.1165/rcmb.2013-0188OC; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sessa R, 2013, PULM CIRC, V3, P315, DOI 10.4103/2045-8932.114758; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Su CH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-354; Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu GP, 2015, ALLERGY ASTHMA IMMUN, V7, P449, DOI 10.4168/aair.2015.7.5.449; Wu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074190; Xi Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.27; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; Zech A, 2015, ALLERGY, V70, P1121, DOI 10.1111/all.12643; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	69	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162244	10.1371/journal.pone.0162244	http://dx.doi.org/10.1371/journal.pone.0162244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643599	gold, Green Submitted, Green Published			2022-12-27	WOS:000383891900007
J	Hwang, OH; Cho, SB; Han, DW; Lee, SR; Kwag, JH; Park, SK				Hwang, Ok Hwa; Cho, Sung Back; Han, Deug Woo; Lee, Sang Ryoung; Kwag, Jeong Hoon; Park, Sung Kwon			Effect of Storage Period on the Changes of Odorous Compound Concentrations and Bacterial Ecology for Identifying the Cause of Odor Production from Pig Slurry	PLOS ONE			English	Article							FIELD SAMPLING METHOD; SWINE MANURE SLURRY; SP-NOV.; MICROBIAL-POPULATIONS; HUMAN COLON; GEN. NOV.; 16S RDNA; WASTE; FECES; ACID	Odor from buildings where pigs are housed is generated by anaerobic fermentation of undigested materials in pig slurry stored for several weeks in pit. The objective of this study was to investigate the effect of storage period on the level of odorous compounds in pig slurry and on its bacterial community. A slurry sample (15 L) was taken from the pit of a finisher pig building and incubated in acryl chambers for six-weeks. Slurry for analysis was sampled every two-week. Levels of odorous compounds in the slurry sample were drastically changed after two weeks of storage period; levels of phenols and short chain fatty acids (SCFAs) were decreased (P< 0.05), whereas indoles and branched-chain fatty acids (BCFAs) were increased (P< 0.05). Among dominant bacteria, Bacteroides and Porphyro-monadacese_uc_g revealed a strong positive correlation with the levels of phenols and SCFAs. Populations of AC160630_g, Acholeplasmatales_uc_g, Mollicutes_uc_g and Cloacamonas_f_uc_g positively correlated with indole and BCFAs content. Taken together, levels of odorous compounds were increased after two weeks of storage, possibly because of changes in the predominant bacterial groups to those that use protein as a carbon source in the hypo-carbohydrate conditions.	[Hwang, Ok Hwa; Cho, Sung Back; Han, Deug Woo; Lee, Sang Ryoung; Kwag, Jeong Hoon] Rural Dev Adm, Natl Inst Anim Sci, Wanju Gun, Jeollabuk Do, South Korea; [Park, Sung Kwon] Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Sejong University	Park, SK (corresponding author), Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea.	sungkwonpark@sejong.ac.kr	Park, Sungkwon/AAJ-2209-2021; Lee, Sang-Ryong/C-2167-2017; Lee, Sang-Ryong/Q-7531-2019	Lee, Sang-Ryong/0000-0002-8672-301X; Lee, Sang-Ryong/0000-0002-8672-301X	National Institute of Animal Science, Rural Development Administration, Republic of Korea [PJ01026302]	National Institute of Animal Science, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was carried out with the support of "Practical use of odor reducing agent developed to symbiotic technology for pigpen (Project title: Practical research of odor reducing agent to add in pigpen slurry, Project No. PJ01026302)" by National Institute of Animal Science, Rural Development Administration, Republic of Korea.	Andrea IS, 2014, INT J SYST EVOL MICR, V64, P3936; [Anonymous], 1994, APPL ENV MICROB, V60, P1897; Boopathy R, 1995, BIORESOURCE TECHNOL, V54, P29, DOI 10.1016/0960-8524(95)00106-9; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; Cotta MA, 2003, ENVIRON MICROBIOL, V5, P737, DOI 10.1046/j.1467-2920.2003.00467.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELSDEN SR, 1978, ARCH MICROBIOL, V117, P165, DOI 10.1007/BF00402304; Gaskins HR, 2001, INTESTINAL BACTERIA; Goux X, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0309-9; GUNDERSEN DE, 1994, J BACTERIOL, V176, P5244, DOI 10.1128/JB.176.17.5244-5254.1994; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMOND EG, 1989, AGR ECOSYST ENVIRON, V25, P103, DOI 10.1016/0167-8809(89)90043-1; Hobbs PJ, 1999, J AGR ENG RES, V72, P291, DOI 10.1006/jaer.1998.0372; HOBSON PN, 1974, WATER RES, V8, P507, DOI 10.1016/0043-1354(74)90057-8; Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189; IANNOTTI EL, 1982, APPL ENVIRON MICROB, V43, P136, DOI 10.1128/AEM.43.1.136-143.1982; ISHAQUE M, 1985, AGR WASTES, V13, P229, DOI 10.1016/0141-4607(85)90037-X; JENSEN MT, 1995, APPL ENVIRON MICROB, V61, P3180, DOI 10.1128/AEM.61.8.3180-3184.1995; Ju F, 2014, MICROB ECOL, V68, P235, DOI 10.1007/s00248-014-0405-6; Kai P, 2004, AGR ENG INT GIGR J, pVI; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klose V, 2010, VET MICROBIOL, V144, P515, DOI 10.1016/j.vetmic.2010.02.025; Kube M, 2014, J MOL MICROB BIOTECH, V24, P19, DOI 10.1159/000354322; Lazarev VN, 2011, J BACTERIOL, V193, P4943, DOI 10.1128/JB.05059-11; Le PD, 2008, LIVEST SCI, V114, P48, DOI 10.1016/j.livsci.2007.04.009; Le PD, 2005, NUTR RES REV, V18, P3, DOI 10.1079/NRR200592; Leung K, 2001, FEMS MICROBIOL ECOL, V38, P169, DOI 10.1111/j.1574-6941.2001.tb00895.x; Limam RD, 2014, MICROBIOLOGYOPEN, V3, P157, DOI 10.1002/mbo3.144; Mackie R., 1994, P INT ROUND TABL SWI, P13; Mackie RI, 1998, J ANIM SCI, V76, P1331; MAFRA, 2010, MIN AGR FOOD RUR AFF; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; MEV, 2011, LAW LIV EXCR MAN US; MEV, 2012, LAW OFF OD CONTR; Miller DN, 2003, J ANIM SCI, V81, P2131; Modak, 1958, BALWADIS RURAL AREAS; NIAS, 2012, KOR FEED STAND SWIN; ONEILL DH, 1992, J AGR ENG RES, V53, P23, DOI 10.1016/0021-8634(92)80072-Z; Parker DB, 2013, ATMOS ENVIRON, V66, P91, DOI 10.1016/j.atmosenv.2012.01.001; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Peu P, 2006, APPL ENVIRON MICROB, V72, P3578, DOI 10.1128/AEM.72.5.3578-3585.2006; Qiu YL, 2014, ARCH MICROBIOL, V196, P149, DOI 10.1007/s00203-013-0951-1; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Rappert S, 2005, WASTE MANAGE, V25, P887, DOI 10.1016/j.wasman.2005.07.008; RIEPE SP, 1980, J CLIN INVEST, V66, P314, DOI 10.1172/JCI109859; Roustan J, 1980, TENTATIVE MEASUREMEN; Sakamoto M, 2009, INT J SYST EVOL MICR, V59, P1748, DOI 10.1099/ijs.0.007674-0; SALYERS AA, 1979, AM J CLIN NUTR, V32, P158, DOI 10.1093/ajcn/32.1.158; SAS, 2002, SAS STAT SOFTW VERS; Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith EA, 1998, FEMS MICROBIOL ECOL, V25, P355, DOI 10.1016/S0168-6496(98)00004-X; Smith M. B, 2007, MARCHS ADV ORGANIC C; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Solli L, 2014, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-014-0146-2; Song YL, 2005, J CLIN MICROBIOL, V43, P4522, DOI 10.1128/JCM.43.9.4522-4527.2005; SPOELSTRA SF, 1978, APPL ENVIRON MICROB, V35, P841, DOI 10.1128/AEM.35.5.841-846.1978; Spoelstra SF, 1978, MICROBIAL ASPECTS FO; Sutton AL, 1999, J ANIM SCI, V77, P430; Trabue S, 2008, ATMOS ENVIRON, V42, P3332, DOI 10.1016/j.atmosenv.2007.03.016; Trabue S, 2011, J ENVIRON QUAL, V40, P1510, DOI 10.2134/jeq2010.0522; Trabue S, 2011, ATMOS ENVIRON, V45, P4243, DOI 10.1016/j.atmosenv.2011.04.081; Trabue SL, 2008, ENVIRON SCI TECHNOL, V42, P3745, DOI 10.1021/es7031407; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Van der Meulen R, 2008, INT J FOOD MICROBIOL, V124, P27, DOI 10.1016/j.ijfoodmicro.2008.02.013; Whitehead TR, 2001, ANAEROBE, V7, P181, DOI 10.1006/anae.2001.0388; WILLIAMS AG, 1981, AGR WASTES, V3, P311, DOI 10.1016/0141-4607(81)90017-2; Willig S, 2005, J AGR FOOD CHEM, V53, P1173, DOI 10.1021/jf048658+; Wu JJ, 1999, J AGR ENG RES, V72, P317, DOI 10.1006/jaer.1998.0378; Zahn JA, 1997, J ENVIRON QUAL, V26, P1687, DOI 10.2134/jeq1997.00472425002600060032x; Zhang S, 2010, INT S AIR QUAL MAN M; Zhu J, 1996, J ENVIRON SCI HEAL A, V31, P2487, DOI 10.1080/10934529609376505; Zhu J, 2000, AGR ECOSYST ENVIRON, V78, P93, DOI 10.1016/S0167-8809(99)00116-4; Ziemer CJ, 2009, J ENVIRON QUAL, V38, P2138, DOI 10.2134/jeq2008.0039; Ziganshin AM, 2011, APPL MICROBIOL BIOT, V89, P2039, DOI 10.1007/s00253-010-2981-9	79	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162714	10.1371/journal.pone.0162714	http://dx.doi.org/10.1371/journal.pone.0162714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642752	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900014
J	Vicentini, GE; Fracaro, L; de Souza, SRG; Martins, HA; Guarnier, FA; Zanoni, JN				Vicentini, Geraldo E.; Fracaro, Luciane; de Souza, Sara R. G.; Martins, Heber A.; Guarnier, Flavia A.; Zanoni, Jacqueline N.			Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; COLONIC ENDOCRINE-CELLS; OXIDATIVE STRESS; MYENTERIC NEURONS; TUMOR-GROWTH; RATS; GLUTATHIONE; CARCINOMA; INNERVATION; ILEUM	Gastrointestinal dysmotility frequently occurs in cancer cachexia and may result from damage to enteric innervation caused by oxidative stress, especially due to glutathione depletion. We assessed the effect of dietary supplementation with 20 g/kg L-glutamine (a glutathione precursor) on the intrinsic innervation of the enteric nervous system in healthy and Walker 256 tumor-bearing Wistar rats during the development of experimental cachexia (14 days), in comparison with non-supplemented rats, by using immunohistochemical methods and Western blotting. The total neural population and cholinergic subpopulation densities in the myenteric plexus, as well as the total population and VIPergic subpopulation in the submucosal plexus of the jejunum and ileum, were reduced in cachectic rats, resulting in adaptive morphometric alterations and an increase in vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) expression, suggesting a neuroplastic response. L-glutamine supplementation prevented decrease in myenteric neuronal density in the ileum, morphometric alterations in the neurons and nerve fibers (in both the plexuses of the jejunum and ileum), and the overexpression of VIP and CGRP. Cancer cachexia severely affected the intrinsic innervation of the jejunum and ileum to various degrees and this injury seems to be associated with adaptive neural plasticity. L-glutamine supplementation presented partial protective effects on the enteric innervation against cancer cachexia, possibly by attenuating oxidative stress.	[Vicentini, Geraldo E.; Fracaro, Luciane; de Souza, Sara R. G.; Martins, Heber A.; Zanoni, Jacqueline N.] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [Guarnier, Flavia A.] Univ Estadual Londrina, Dept Gen Pathol, Londrina, Parana, Brazil; [Vicentini, Geraldo E.] Univ Estadual Oeste Parana, Hlth Sci Ctr, Francisco Beltrao, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Londrina; Universidade Estadual do Oeste do Parana	Zanoni, JN (corresponding author), Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil.	zanonijn@gmail.com	Guarnier, Flávia A/E-3800-2012; Cecchini, Rubens/D-9811-2013	Guarnier, Flávia A/0000-0001-9302-878X; Cecchini, Rubens/0000-0001-9941-2344	Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana) [266/14]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil	Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was funded by a grant from the Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana) - 266/14, and from the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil to JNZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara S, 2008, ANN PHARMACOTHER, V42, P1481, DOI 10.1345/aph.1L179; Amores-Sanchez MI, 1999, MOL GENET METAB, V67, P100, DOI 10.1006/mgme.1999.2857; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Arias-Rotunno LR, 2007, THESIS; Alves EPB, 2010, NUTR NEUROSCI, V13, P43, DOI 10.1179/147683010X12611460763841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033177; Chiocchetti R, 2006, CELL TISSUE RES, V323, P183, DOI 10.1007/s00441-005-0075-2; COSTA M, 1980, HISTOCHEMISTRY, V65, P157, DOI 10.1007/BF00493164; Cowen T, 2000, GUT, V47, P653, DOI 10.1136/gut.47.5.653; DiBaise JK, 1998, DIGEST DIS SCI, V43, P1369, DOI 10.1023/A:1018853106696; Ekblad E, 2004, NEUROGASTROENT MOTIL, V16, P123, DOI 10.1111/j.1743-3150.2004.00487.x; Ekblad E, 1998, GUT, V42, P836, DOI 10.1136/gut.42.6.836; Ekelund KM, 1999, GUT, V45, P236, DOI 10.1136/gut.45.2.236; El-Salhy M, 1998, EUR J GASTROEN HEPAT, V10, P517, DOI 10.1097/00042737-199806000-00015; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fenner FL, 2015, FOLIA NEUROPATHOL, V53, P139, DOI 10.5114/fn.2015.52410; Pereira RVF, 2011, DIGEST DIS SCI, V56, P3507, DOI 10.1007/s10620-011-1806-8; Fracaro L, 2015, NEUROGASTROENT MOTIL, DOI [10.1111/nmo.12702, DOI 10.1111/NMO.12702]; Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x; Furness JB, 2006, ENTERIC NERVOUS SYST, Vxiii; Gamage P P K M, 2013, Neurogastroenterol Motil, V25, pe495; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Godlewski J, 2012, ANN ANAT, V194, P368, DOI 10.1016/j.aanat.2011.11.009; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P475, DOI 10.2478/v10042-010-0079-y; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P208, DOI 10.2478/v10042-010-0052-9; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P157, DOI 10.2478/v10042-010-0029-8; GUAITANI A, 1982, ONCOLOGY, V39, P173, DOI 10.1159/000225631; Guarnier FA, 2010, MUSCLE NERVE, V42, P950, DOI 10.1002/mus.21798; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hay DL, 2011, ENDOCR-RELAT CANCER, V18, pC1, DOI 10.1677/ERC-10-0244; Hermes-Uliana C, 2014, DIGEST DIS SCI, V59, P937, DOI 10.1007/s10620-013-2993-2; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Iagher F, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-146; Johnson RJR, 1998, J ANAT, V192, P479, DOI 10.1046/j.1469-7580.1998.19240479.x; Kuhn KS, 2010, EUR J NUTR, V49, P197, DOI 10.1007/s00394-009-0082-2; Kurnik M, 2015, FOLIA HISTOCHEM CYTO, V53, P49, DOI 10.5603/FHC.a2015.0010; Levine B A, 1996, Surg Oncol Clin N Am, V5, P609; Lima MMR, 2002, CELL BIOCHEM FUNCT, V20, P107, DOI 10.1002/cbf.961; Machado AP, 2004, CELL TISSUE RES, V318, P503, DOI 10.1007/s00441-004-0987-2; Mann PT, 1999, CELL TISSUE RES, V297, P241, DOI 10.1007/s004410051352; Mantovani G, 2012, CURR PHARM DESIGN, V18, P4813, DOI 10.2174/138161212803216889; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; Michalak KP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964321; Paulino AS, 2011, DIGEST DIS SCI, V56, P2262, DOI 10.1007/s10620-011-1588-z; Pereira RVF, 2016, AN ACAD BRAS CIENC, V88, P609, DOI 10.1590/0001-3765201620150228; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Rasmussen TN, 2001, REGUL PEPTIDES, V98, P137, DOI 10.1016/S0167-0115(00)00242-1; Rebeca R, 2008, CELL BIOCHEM FUNCT, V26, P731, DOI 10.1002/cbf.1497; Rosa CV, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0143005, DOI 10.1371/JOURNAL.PONE.0143005]; Shin EJ, 2016, ARCH TOXICOL, V90, P937, DOI 10.1007/s00204-015-1516-7; Sitohy B, 2002, ACTA ONCOL, V41, P543; Sitohy B, 2001, HISTOL HISTOPATHOL, V16, P833, DOI 10.14670/HH-16.833; Soares A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0228-z; SOUBA WW, 1988, THE JOURNAL OF SURGI, V44, P720; Tashima CM, 2007, DIGEST DIS SCI, V52, P1233, DOI 10.1007/s10620-006-9564-8; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Tuncel N, 2012, J MOL NEUROSCI, V46, P51, DOI 10.1007/s12031-011-9618-z; Wang AL, 2015, INT J CLIN EXP PATHO, V8, P7896; Wu Y, 2015, NEUROSCI LETT, V598, P52, DOI 10.1016/j.neulet.2015.05.009; Zanoni Jacqueline Nelisis, 2011, Arq. Gastroenterol., V48, P66, DOI 10.1590/S0004-28032011000100014; Zhang F, 2008, INFLAMMATION, V31, P344, DOI 10.1007/s10753-008-9084-0	65	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162998	10.1371/journal.pone.0162998	http://dx.doi.org/10.1371/journal.pone.0162998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635657	gold, Green Published, Green Submitted			2022-12-27	WOS:000383723700023
J	Dumas, E; Neagoe, PE; McDonald, PP; White, M; Sirois, MG				Dumas, Elizabeth; Neagoe, Paul-Eduard; McDonald, Patrick P.; White, Michel; Sirois, Martin G.			New Insights into the Pro-Inflammatory Activities of Ang1 on Neutrophils: Induction of MIP-1 beta Synthesis and Release	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; PLATELET-ACTIVATING-FACTOR; VASCULAR-PERMEABILITY; CELL PROLIFERATION; IL-8 SYNTHESIS; TIE2 RECEPTOR; PAF SYNTHESIS; IN-VIVO; ANGIOPOIETIN-1	We reported the expression of angiopoietin Tie2 receptor on human neutrophils and the capacity of angiopoietins (Ang1 and Ang2) to induce pro-inflammatory activities, such as platelet-activating factor synthesis, beta(2)-integrin activation and neutrophil migration. Recently, we observed differential effects between both angiopoietins, namely, the capacity of Ang1, but not Ang2, to promote rapid interleukin-8 synthesis and release, as well as neutrophil viability. Herein, we addressed whether Ang1 and/or Ang2 could modulate the synthesis and release of macrophage inflammatory protein-1 beta (MIP-1 beta) by neutrophils. Neutrophils were isolated from blood of healthy volunteers; intracellular and extracellular MIP-1 beta protein concentrations were assessed by ELISA. After 24 hours, the basal intracellular and extracellular MIP-1 beta protein concentrations were approximate to 500 and 100 pg/10(6) neutrophils, respectively. Treatment with Ang1 (10 nM) increased neutrophil intracellular and extracellular MIP-1 beta concentrations by 310 and 388% respectively. Pretreatment with PI3K (LY294002), p38 MAPK (SB203580) and MEK (U0126) inhibitors completely inhibited Ang1-mediated increase of MIP-1 beta intracellular and extracellular protein levels. Pretreatment with NF-kappa B complex inhibitors, namely Bay11-7085 and IKK inhibitor VII or with a transcription inhibitor (actinomycin D) and protein synthesis inhibitor (cycloheximide), did also abrogate Ang1-mediated increase of MIP-1 beta intracellular and extracellular protein levels. We validated by RT-qPCR analyses the effect of Ang1 on the induction of MIP-1 beta mRNA levels. Our study is the first one to report Ang1 capacity to induce MIP-1 beta gene expression, protein synthesis and release from neutrophils, and that these effects are mediated by PI3K, p38 MAPK and MEK activation and downstream NF-kappa B activation.	[Dumas, Elizabeth; Neagoe, Paul-Eduard; White, Michel; Sirois, Martin G.] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Dumas, Elizabeth; Neagoe, Paul-Eduard; Sirois, Martin G.] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ, Canada; [McDonald, Patrick P.] Univ Sherbrooke, Fac Med, Pulm Div Res, Sherbrooke, PQ, Canada; [White, Michel] Univ Montreal, Dept Med, Fac Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Universite de Montreal	Sirois, MG (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada.; Sirois, MG (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ, Canada.	martin.sirois@icm-mhi.org			Canadian Institutes of Health Research (CIHR) [MOP-97943]; Heart and Stroke Foundation of Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP-97943) [http://www.cihr-irsc.gc.ca] and from the Heart and Stroke Foundation of Quebec [http://www.heartandstroke.qc.ca] to MGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Aplin AC, 2006, PHYSIOL GENOMICS, V27, P20, DOI 10.1152/physiolgenomics.00048.2006; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Brkovic A, 2007, J LEUKOCYTE BIOL, V81, P1093, DOI 10.1189/jlb.0906580; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CAVALIER.LF, 1968, BIOCHIM BIOPHYS ACTA, V166, P722, DOI 10.1016/0005-2787(68)90385-7; Chen HC, 2004, J BIOMED SCI, V11, P49, DOI 10.1159/000075288; Cloutier A, 2007, J LEUKOCYTE BIOL, V81, P567, DOI 10.1189/jlb.0806536; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feistritzer C, 2004, J ALLERGY CLIN IMMUN, V114, P1077, DOI 10.1016/j.jaci.2004.06.045; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Goodman ER, 1998, ARCH SURG-CHICAGO, V133, P1234, DOI 10.1001/archsurg.133.11.1234; Haddad LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088980; Hansen TM, 2010, CELL SIGNAL, V22, P527, DOI 10.1016/j.cellsig.2009.11.007; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Ismail H, 2012, ARTERIOSCL THROM VAS, V32, P1707, DOI 10.1161/ATVBAHA.112.251546; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jeon BH, 2003, CIRC RES, V92, P586, DOI 10.1161/01.RES.0000066881.04116.45; Khreiss T, 2004, CELL SIGNAL, V16, P801, DOI 10.1016/j.cellsig.2003.12.005; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maliba R, 2006, CELL SIGNAL, V18, P1947, DOI 10.1016/j.cellsig.2006.02.015; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Maziere C, 1996, BIOCHEM MOL BIOL INT, V39, P1201; Naegelen I, 2015, J LEUKOCYTE BIOL, V97, P557, DOI 10.1189/jlb.3A0514-254RR; Neagoe PE, 2012, J CELL PHYSIOL, V227, P3099, DOI 10.1002/jcp.23061; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; RE F, 1993, EUR J IMMUNOL, V23, P570, DOI 10.1002/eji.1830230242; Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Seok SH, 2013, MOL CELLS, V35, P550, DOI 10.1007/s10059-013-0088-8; Sinnathamby T, 2015, J CELL BIOCHEM, V116, P45, DOI 10.1002/jcb.24941; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; Sturn DH, 2005, MICROCIRCULATION, V12, P393, DOI 10.1080/10739680590960296; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; von Stebut E, 2003, BLOOD, V101, P210, DOI 10.1182/blood-2002-03-0921; Waelchli R, 2006, BIOORG MED CHEM LETT, V16, P108, DOI 10.1016/j.bmcl.2005.09.035; Xing LY, 2004, CELL IMMUNOL, V231, P126, DOI 10.1016/j.cellimm.2004.12.008; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	57	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163140	10.1371/journal.pone.0163140	http://dx.doi.org/10.1371/journal.pone.0163140			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632174	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900135
J	Henry, KA; Sulea, T; van Faassen, H; Hussack, G; Purisima, EO; MacKenzie, CR; Arbabi-Ghahroudi, M				Henry, Kevin A.; Sulea, Traian; van Faassen, Henk; Hussack, Greg; Purisima, Enrico O.; MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi			A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; THERAPEUTIC ANTIBODIES; STRUCTURAL BASIS; IMMUNOGLOBULIN-BINDING; NEXT-GENERATION; FORCE-FIELD; ANTIGEN; PURIFICATION; AFFINITIES; NANOBODIES	Staphylococcal protein A (SpA) and streptococcal protein G (SpG) affinity chromatography are the gold standards for purifying monoclonal antibodies (mAbs) in therapeutic applications. However, camelid VHH single-domain Abs (sdAbs or V(H)Hs) are not bound by SpG and only sporadically bound by SpA. Currently, V(H)Hs require affinity tag-based purification, which limits their therapeutic potential and adds considerable complexity and cost to their production. Here we describe a simple and rapid mutagenesis-based approach designed to confer SpA binding upon a priori non-SpA-binding V(H)Hs. We show that SpA binding of V(H)Hs is determined primarily by the same set of residues as in human mAbs, albeit with an unexpected degree of tolerance to substitutions at certain core and non-core positions and some limited dependence on at least one residue outside the SpA interface, and that SpA binding could be successfully introduced into five V(H)Hs against three different targets with no adverse effects on expression yield or antigen binding. Next-generation sequencing of llama, alpaca and dromedary VHH repertoires suggested that species differences in SpA binding may result from frequency variation in specific deleterious polymorphisms, especially Ile57. Thus, the SpA binding phenotype of camelid V(H)Hs can be easily modulated to take advantage of tag-less purification techniques, although the frequency with which this is required may depend on the source species.	[Henry, Kevin A.; van Faassen, Henk; Hussack, Greg; MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi] Natl Res Council Canada, Human Hlth Therapeut Portfolio, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Sulea, Traian; Purisima, Enrico O.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada; [MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi] Univ Guelph, Sch Environm Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Arbabi-Ghahroudi, Mehdi] Carleton Univ, Dept Biol, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada	National Research Council Canada; National Research Council Canada; University of Guelph; Carleton University	Arbabi-Ghahroudi, M (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Portfolio, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Arbabi-Ghahroudi, M (corresponding author), Univ Guelph, Sch Environm Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.; Arbabi-Ghahroudi, M (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	mehdi.arbabi@nrc-cnrc.gc.ca			National Research Council Canada	National Research Council Canada	This work was supported by funding from the National Research Council Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A., 2011, Patent No. [US 8623369 B2, 8623369]; Alturki NA, 2015, METHODS MOL BIOL, V1348, P167, DOI 10.1007/978-1-4939-2999-3_16; Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; Baral Toya Nath, 2013, Curr Protoc Immunol, V103, DOI 10.1002/0471142735.im0217s103; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bell A, 2010, CANCER LETT, V289, P81, DOI 10.1016/j.canlet.2009.08.003; BJORCK L, 1984, J IMMUNOL, V133, P969; Cary S, 1999, MOL IMMUNOL, V36, P769, DOI 10.1016/S0161-5890(99)00085-1; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Fridy PC, 2015, ANAL BIOCHEM, V477, P92, DOI 10.1016/j.ab.2015.02.013; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hamilton S, 2003, HYBRIDOMA HYBRIDOM, V22, P347, DOI 10.1089/153685903771797048; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Henry KA, 2015, PROTEIN ENG DES SEL, V28, P379, DOI 10.1093/protein/gzv039; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jain M, 2007, TRENDS BIOTECHNOL, V25, P307, DOI 10.1016/j.tibtech.2007.05.001; Khan F, 2012, BIOTECHNOL J, V7, P133, DOI 10.1002/biot.201100331; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumaran Jyothi, 2012, Methods Mol Biol, V911, P105, DOI 10.1007/978-1-61779-968-6_7; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; OConchuir S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0130433, DOI 10.1371/JOURNAL.PONE.0130433]; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Potter KN, 1996, J IMMUNOL, V157, P2982; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROMAGNANI S, 1982, J IMMUNOL, V129, P596; SASANO M, 1993, J IMMUNOL, V151, P5822; SASSO EH, 1989, J IMMUNOL, V142, P2778; SASSO EH, 1991, J IMMUNOL, V147, P1877; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SEPPALA I, 1990, J IMMUNOL, V145, P2989; Stanimirovic D, 2014, World Intellectual Property Organization patent application WO, Patent No. 2015131256; Sulea T, 2016, J CHEM INF MODEL, V56, P1292, DOI 10.1021/acs.jcim.6b00043; Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Zhang JB, 2004, J MOL BIOL, V341, P161, DOI 10.1016/j.jmb.2004.05.069; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17	61	18	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163113	10.1371/journal.pone.0163113	http://dx.doi.org/10.1371/journal.pone.0163113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631624	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900132
J	Orue, A; Rieber, M				Orue, Andrea; Rieber, Manuel			Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR	PLOS ONE			English	Article							REAL-TIME PCR; METASTATIC COLORECTAL-CANCER; ASSAY; GENERATION; THERAPY; CETUXIMAB; MUTANT; GENE; RAS	Establishing the KRAS mutational status of tumor samples is essential to manage patients with colorectal or lung cancer, since these mutations preclude treatment with monoclonal anti-epidermal growth factor receptor (EGFR) antibodies. We report an inexpensive, rapid multiplex allele-specific qPCR method detecting the 7 most clinically relevant KRAS somatic mutations with concomitant amplification of non-mutated KRAS in tumor cells and tissues from CRC patients. Positive samples evidenced in the multiplex assay were further subjected to individual allele-specific analysis, to define the specific mutation. Reference human cancer DNA harbouring either G12A, G12C, G12D, G12R, G12S, G12V and G13D confirmed assay specificity with <= 1% sensitivity of mutant alleles. KRAS multiplex mutation analysis usefulness was also demonstrated with formalin-fixed paraffin embedded (FFPE) from CRC biopsies. Conclusion. Co-amplification of non-mutated DNA avoided false negatives from degraded samples. Moreover, this cost effective assay is compatible with mutation detection by DNA sequencing in FFPE tissues, but with a greater sensitivity when mutant DNA concentrations are limiting.	[Orue, Andrea; Rieber, Manuel] IVIC, Tumor Cell Biol Lab, Apartado 21827, Caracas 1020A, Venezuela	Venezuelan Institute Science Research	Rieber, M (corresponding author), IVIC, Tumor Cell Biol Lab, Apartado 21827, Caracas 1020A, Venezuela.	manuel.rieber@gmail.com			Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant	Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant	This research was funded by Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant to Manuel Rieber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M; Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Borras E, 2016, CANCER PREV RES, V9, P417, DOI 10.1158/1940-6207.CAPR-16-0081; Chen CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055793; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; de Macedo MP, 2014, EXP MOL PATHOL, V96, P257, DOI 10.1016/j.yexmp.2014.02.014; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Domagala P, 2012, POL J PATHOL, V63, P145, DOI 10.5114/PJP.2012.31499; Fiala O, 2016, TUMOR BIOL, V37, P6823, DOI 10.1007/s13277-015-4523-7; Fiala O, 2013, CANCER GENET-NY, V206, P26, DOI 10.1016/j.cancergen.2012.12.003; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; Han JY, 2014, LUNG CANCER, V85, P161, DOI 10.1016/j.lungcan.2014.04.009; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Huang Q, 2010, MOL CELL PROBE, V24, P376, DOI 10.1016/j.mcp.2010.07.010; Lang AH, 2011, J MOL DIAGN, V13, P23, DOI 10.1016/j.jmoldx.2010.11.007; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; Morandi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036084; Naidoo J, 2016, ADV EXP MED BIOL, V893, P155, DOI 10.1007/978-3-319-24223-1_8; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ostrow SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21927; Plesec TP, 2009, ADV ANAT PATHOL, V16, P196, DOI 10.1097/PAP.0b013e3181a9d4ed; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Seekhuntod S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147672; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stintzing S, 2015, HEMATOL ONCOL CLIN N, V29, P43, DOI 10.1016/j.hoc.2014.09.009; Szankasi P, 2013, J MOL DIAGN, V15, P248, DOI 10.1016/j.jmoldx.2012.11.005; Tan C, 2012, WORLD J GASTROENTERO, V18, P5171, DOI 10.3748/wjg.v18.i37.5171; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Wang T, 2015, EXP MOL PATHOL, V98, P152, DOI 10.1016/j.yexmp.2015.03.004; Weichert W, 2010, J MOL DIAGN, V12, P35, DOI 10.2353/jmoldx.2010.090079; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057; Zhang HP, 2012, CELL BIOCHEM BIOPHYS, V62, P415, DOI 10.1007/s12013-011-9318-x	39	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163070	10.1371/journal.pone.0163070	http://dx.doi.org/10.1371/journal.pone.0163070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632281	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900127
J	Taubel, J; Ferber, G; Fernandes, S; Lorch, U; Santamaria, E; Izquierdo, I				Taeubel, Joerg; Ferber, Georg; Fernandes, Sara; Lorch, Ulrike; Santamaria, Eva; Izquierdo, Inaki			Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial	PLOS ONE			English	Article							CHRONIC IDIOPATHIC URTICARIA; SEASONAL ALLERGIC RHINITIS; DOUBLE-BLIND; ACTIVATING-FACTOR; OPEN-LABEL; VOLUNTEERS; LEVOCETIRIZINE; DESLORATADINE; DISORDERS; SYMPTOMS	Introduction Rupatadine is a marketed second generation antihistamine, with anti-PAF activity, indicated for symptomatic treatment of allergic rhinitis and urticaria. This study was conducted to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of rupatadine in healthy Japanese subjects after single and multiple oral doses. Methods In this randomised, double-blind, placebo-controlled study, 27 male and female healthy Japanese subjects were administered single and multiple escalating rupatadine dose of 10, 20 and 40 mg or placebo. Blood samples were collected at different time points for PK measurements and subjects were assessed for safety and tolerability. The effect of rupatadine on cognitive functioning was evaluated by means of computerized cognitive tests: rapid visual information processing (RVP), reaction time (RT), spatial working memory (SWM) and visual analogue scales (VAS). Results Exposure to rupatadine as measured by C-max and AUC was found to increase in a dose dependent manner over the dose range of 10-40 mg for both single and multiple dose administration. The safety assessments showed that all treatment related side effects were of mild intensity and there were no serious adverse events (SAEs) or withdrawals due to treatment-emergent adverse events (TEAEs) in this study. The therapeutic dose of rupatadine did not show any CNS impairmentin any of the cognitive tests. Conclusions This study demonstrated that rupatadine is safe and well tolerated by Japanese healthy subjects. The PK-PD profile confirmed previous experience with rupatadine.	[Taeubel, Joerg; Fernandes, Sara; Lorch, Ulrike] St Georges Univ London, Richmond Pharmacol Ltd, Cranmer Terrace, London, England; [Ferber, Georg] Stat Georg Ferber GmbH, Cagliostrostr, Riehen, Switzerland; [Santamaria, Eva; Izquierdo, Inaki] J Uriach & Co SA, Avda Cami Reial, Barcelona, Spain	St Georges University London	Taubel, J (corresponding author), St Georges Univ London, Richmond Pharmacol Ltd, Cranmer Terrace, London, England.	j.taubel@richmondpharmacology.com	Taubel, Jorg/I-1286-2019	Taubel, Jorg/0000-0002-0010-207X	J. Uriach y Compania, S.A. Uriach; Richmond Pharmacology	J. Uriach y Compania, S.A. Uriach; Richmond Pharmacology	Rupatadine was discovered and developed by J. Uriach y Compania, S.A. Uriach funded this clinical trial investigating Rupatadine and funded publication of this manuscript. The funder provided support in the form of salaries for authors II and ES and had an additional role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. Richmond Pharmacology funded data analysis. Richmond Pharmacology and Statistik Georg Ferber played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions section".	Abajian M, 2016, ACTA DERM-VENEREOL, V96, P56, DOI 10.2340/00015555-2150; Barbanoj MJ, 2004, NEUROPSYCHOBIOLOGY, V50, P311, DOI 10.1159/000080959; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Dakhale GN, 2014, INT J DERMATOL, V53, P643, DOI 10.1111/ijd.12250; Donado E, 2010, BRIT J CLIN PHARMACO, V69, P401, DOI 10.1111/j.1365-2125.2009.03599.x; Dubertret L, 2007, EUR J DERMATOL, V17, P223; Edwards LD, 2007, PRINCIPLES PRACTICE, P242; Fantin S, 2008, ALLERGY, V63, P924, DOI 10.1111/j.1398-9995.2008.01668.x; Frick GS, 2004, CLIN PHARMACOL THER, V75, pP9, DOI 10.1016/j.clpt.2003.11.033; Gimenez-Arnau A, 2007, ALLERGY, V62, P539, DOI 10.1111/j.1398-9995.2007.01330.x; Guadano EM, 2004, ALLERGY, V59, P766, DOI 10.1111/j.1398-9995.2004.00576.x; Izquierdo I., 1997, Methods and Findings in Experimental and Clinical Pharmacology, V19, P189; Keam SJ, 2007, DRUGS, V67, P457, DOI 10.2165/00003495-200767030-00008; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lehmann EL, 1973, NONPARAMETRICS STAT; Maiti R, 2011, J DRUGS DERMATOL, V10, P1444; Maiti R, 2010, ARCH OTOLARYNGOL, V136, P796, DOI 10.1001/archoto.2010.128; Metz M, 2011, EXPERT REV CLIN IMMU, V7, P15, DOI 10.1586/ECI.10.85; Mullol J, 2015, ALLERGY, V70, P1, DOI 10.1111/all.12531; Munoz-Cano R, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-43; Perez I, 2002, ALLERGY, V57, P245; Picado C, 2006, EXPERT OPIN PHARMACO, V7, P1989, DOI 10.1517/14656566.7.14.1989; Prenner B, 2006, EXPERT OPIN DRUG SAF, V5, P211, DOI 10.1517/14740338.5.2.211; Ramanathan R, 2007, XENOBIOTICA, V37, P770, DOI 10.1080/00498250701463325; Rao MS, 2009, INDIAN J OTOLARYNGOL, V61, P320, DOI 10.1007/s12070-009-0091-8; Shamizadeh S, 2014, ALLERGO J, V23, P27, DOI 10.1007/s15007-014-0555-3; Solans A, 2008, CLIN THER, V30, P1639, DOI 10.1016/j.clinthera.2008.09.002; Solans A, 2007, CLIN THER, V29, P900, DOI 10.1016/j.clinthera.2007.05.004; Tillement J.-P., 2005, Clinical and Experimental Allergy Reviews, V5, P7, DOI 10.1111/j.1365-2222.2005.0075.x; Valero A, 2006, 25 EAACI C 10 14 JUN; Xiong YQ, 2016, EUR J DRUG METAB PH, V41, P117, DOI 10.1007/s13318-014-0236-3	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163020	10.1371/journal.pone.0163020	http://dx.doi.org/10.1371/journal.pone.0163020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632557	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000383706900118
J	Chen, YQ; Zhang, YH; Zhao, GJ; Chen, C; Yang, PX; Ye, S; Tan, XR				Chen, Yequn; Zhang, Yanhong; Zhao, Guojun; Chen, Chang; Yang, Peixuan; Ye, Shu; Tan, Xuerui			Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LONG-TERM MORTALITY; ELEVATION MYOCARDIAL-INFARCTION; LYMPHOCYTE RATIO; CARDIOVASCULAR-DISEASE; CARDIAC REVASCULARIZATION; AUTOIMMUNE-DISEASE; CELL COUNT; NEUTROPHIL; RISK	There are sex differences in many inflammatory and immune diseases, and the differences tend to diminish after menopause. The underlying reasons are unclear, but sex hormone levels are likely to be an important factor. Blood leukocyte count and composition provide an indicator of the inflammatory and immune status of an individual. We performed a cross-sectional analysis of blood leukocyte data from 46,879 individuals (26,212 men and 20,667 women, aged 18 to 93 years) who underwent a routine health checkup. In women aged around 50 years, neutrophil percentage (NE%) dropped whilst lymphocyte percentage (LY%) rose. Accordingly, women before age 50 had significantly higher NE%, lower LY%, and higher neutrophil-to-lymphocyte ratio (NLR) than women of 51-70 years of age (p = 1.35x10(-82), p = 5.32x10(-100), and p = 1.25x10(-26), respectively). In age groups of <50 years, women had higher NE%, lower LY% and higher NLR than men (p = 1.82x10(-206), p = 1.46x10(-69), and p = 2.30x10(-118), respectively), whereas in age groups of >51 years, it was the reverse (p = 1.92x10(-15), p = 1.43x10(-84), and p = 1.51x10(-48), respectively). These results show that blood leukocyte composition differs between women before and after menopausal age, with distinct sexual dimorphism.	[Chen, Yequn; Chen, Chang; Yang, Peixuan; Ye, Shu; Tan, Xuerui] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Peoples R China; [Zhang, Yanhong; Zhao, Guojun; Ye, Shu] Shantou Univ, Coll Med, Shantou, Peoples R China; [Ye, Shu] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Ye, Shu] NIHR Biomed Res Ctr Cardiovasc Dis, Leicester, Leics, England	Shantou University; Shantou University; University of Leicester	Ye, S; Tan, XR (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Peoples R China.; Ye, S (corresponding author), Shantou Univ, Coll Med, Shantou, Peoples R China.; Ye, S (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.; Ye, S (corresponding author), NIHR Biomed Res Ctr Cardiovasc Dis, Leicester, Leics, England.	sy127@le.ac.uk; tanxuerui@vip.sina.com	Ye, Shu/R-6384-2017	Ye, Shu/0000-0002-4126-4278				Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Bhatia Aruna, 2014, ScientificWorldJournal, V2014, P159150, DOI 10.1155/2014/159150; Bloomer LDS, 2012, ATHEROSCLEROSIS, V225, P22, DOI 10.1016/j.atherosclerosis.2012.06.057; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Burleson MH, 1998, PSYCHOSOM MED, V60, P17, DOI 10.1097/00006842-199801000-00004; CHATTA GS, 1994, J AM GERIATR SOC, V42, P77, DOI 10.1111/j.1532-5415.1994.tb06077.x; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.067; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.034; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Hartaigh BO, 2013, EUR HEART J, V34, P932, DOI 10.1093/eurheartj/ehs396; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; MacIntyre K, 2001, J AM COLL CARDIOL, V38, P729, DOI 10.1016/S0735-1097(01)01465-6; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Medina KL, 2000, BLOOD, V95, P2059, DOI 10.1182/blood.V95.6.2059; MEDINA KL, 1993, J EXP MED, V178, P1507, DOI 10.1084/jem.178.5.1507; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; Nielsen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004598; Norman JE, 2011, REPROD SCI, V18, P435, DOI 10.1177/1933719110395404; Nowbar AN, 2014, INT J CARDIOL, V174, P293, DOI 10.1016/j.ijcard.2014.04.096; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Rosengren A, 2001, EUR HEART J, V22, P314, DOI 10.1053/euhj.2000.2368; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; SAXENA S, 1990, ARCH PATHOL LAB MED, V114, P715; Sen N, 2013, ATHEROSCLEROSIS, V228, P203, DOI 10.1016/j.atherosclerosis.2013.02.017; Shah N, 2014, INT J CARDIOL, V171, P390, DOI 10.1016/j.ijcard.2013.12.019; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	42	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162953	10.1371/journal.pone.0162953	http://dx.doi.org/10.1371/journal.pone.0162953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657912	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200046
J	Dawson, WK; Jono, R; Terada, T; Shimizu, K				Dawson, Wayne K.; Jono, Ryota; Terada, Tohru; Shimizu, Kentaro			Electron Transport in a Dioxygenase-Ferredoxin Complex: Long Range Charge Coupling between the Rieske and Non-Heme Iron Center	PLOS ONE			English	Article							SPIN-LATTICE-RELAXATION; GAUSSIAN-BASIS SETS; X-RAY DIFFRACTION; TERMINAL OXYGENASE COMPONENT; MAGNETIC CIRCULAR-DICHROISM; RESONANCE RAMAN; CARBAZOLE 1,9A-DIOXYGENASE; MOLECULAR-DYNAMICS; 2FE-2S FERREDOXIN; SULFUR PROTEIN	Dioxygenase (dOx) utilizes stereospecific oxidation on aromatic molecules; consequently, dOx has potential applications in bioremediation and stereospecific oxidation synthesis. The reactive components of dOx comprise a Rieske structure Cys(2)[2Fe-2S]His(2) and a nonheme reactive oxygen center (ROC). Between the Rieske structure and the ROC, a universally conserved Asp residue appears to bridge the two structures forming a Rieske-AspROC triad, where the Asp is known to be essential for electron transfer processes. The Rieske and ROC share hydrogen bonds with Asp through their His ligands; suggesting an ideal network for electron transfer via the carboxyl side chain of Asp. Associated with the dOx is an itinerant charge carrying protein Ferredoxin (Fdx). Depending on the specific cognate, Fdx may also possess either the Rieske structure or a related structure known as 4Cys-[2Fe-2S] (4-Cys). In this study, we extensively explore, at different levels of theory, the behavior of the individual components (Rieske and ROC) and their interaction together via the Asp using a variety of density function methods, basis sets, and a method known as Generalized Ionic Fragment Approach (GIFA) that permits setting up spin configurations manually. We also report results on the 4-Cys structure for comparison. The individual optimized structures are compared with observed spectroscopic data from the Rieske, 4-Cys and ROC structures (where information is available). The separate pieces are then combined together into a large Rieske-Asp-ROC (donor/bridge/acceptor) complex to estimate the overall coupling between individual components, based on changes to the partial charges. The results suggest that the partial charges are significantly altered when Asp bridges the Rieske and the ROC; hence, long range coupling through hydrogen bonding effects via the intercalated Asp bridge can drastically affect the partial charge distributions compared to the individual isolated structures. The results are consistent with a proton coupled electron transfer mechanism.	[Dawson, Wayne K.; Terada, Tohru; Shimizu, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1038657, Japan; [Dawson, Wayne K.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Ul Ks Trojdena 4, PL-02109 Warsaw, Poland; [Dawson, Wayne K.] Univ Warsaw, Ctr New Technol, Lab Funct & Struct Gen, Banacha 2C, PL-02089 Warsaw, Poland; [Jono, Ryota] Univ Tokyo Komaba, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1038657, Japan	University of Tokyo; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Warsaw; University of Tokyo	Dawson, WK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1038657, Japan.; Dawson, WK (corresponding author), Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Ul Ks Trojdena 4, PL-02109 Warsaw, Poland.; Dawson, WK (corresponding author), Univ Warsaw, Ctr New Technol, Lab Funct & Struct Gen, Banacha 2C, PL-02089 Warsaw, Poland.	wdawson@genesilico.pl	Terada, Tohru/W-2956-2019; JONO, Ryota/AAW-2676-2021; Jono, Ryota/H-4087-2014; Dawson, Wayne/AAY-5576-2020	Terada, Tohru/0000-0002-7091-0646; Dawson, Wayne/0000-0001-7751-7778	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; European Commission (E.C.) [316125]; Polish National Science Centre [2014/15/B/ST6/05082, 2013/09/B/NZ2/00121]	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; European Commission (E.C.)(European CommissionEuropean Commission Joint Research Centre); Polish National Science Centre	This work was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Additional support also came from the following : the European Commission (E.C.) [REGPOT grant FishMed, contract number 316125 to Jacek Kuznicki in International Institute of Molecular and Cellular Biology in Warsaw] and from the Polish National Science Centre [grant numbers 2014/15/B/ST6/05082, 2013/09/B/NZ2/00121 to Dariusz Plewczynski in Centre of New Technologies]	Albers A, 2014, J AM CHEM SOC, V136, P3946, DOI 10.1021/ja412449v; Albers A, 2013, CHEM-EUR J, V19, P10101, DOI 10.1002/chem.201301760; ANDERSSON KK, 1988, J BIOL CHEM, V263, P18621; Ashikawa Y, 2005, ACTA CRYSTALLOGR F, V61, P577, DOI 10.1107/S174430910504557; Ashikawa Y, 2006, STRUCTURE, V14, P1779, DOI 10.1016/j.str.2006.10.004; Balabanov NB, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1998907; Bassan A, 2004, J BIOL INORG CHEM, V9, P439, DOI 10.1007/s00775-004-0537-0; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERTRAND P, 1987, BIOCHIM BIOPHYS ACTA, V916, P24, DOI 10.1016/0167-4838(87)90206-8; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; Bixon M, 1997, J CHEM PHYS, V107, P5154, DOI 10.1063/1.474878; BOEKEMA C, 1981, HYPERFINE INTERACT, V8, P609, DOI 10.1007/BF01037534; BOEKEMA C, 1986, PHYS REV B, V33, P210, DOI 10.1103/PhysRevB.33.210; BOEKEMA C, 1980, HELV PHYS ACTA, V53, P228; BOEKEMA C, 1986, HYPERFINE INTERACT, V31, P487, DOI 10.1007/BF02401601; BOEKEMA C, 1986, J MAGN MAGN MATER, V54-7, P353, DOI 10.1016/0304-8853(86)90616-5; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Costentin C, 2013, J AM CHEM SOC, V135, P9023, DOI 10.1021/ja4030148; Costentin C, 2011, P NATL ACAD SCI USA, V108, P8559, DOI 10.1073/pnas.1104952108; DAVE BC, 1994, BIOCHEMISTRY-US, V33, P3572, DOI 10.1021/bi00178a013; Dawson W, 2011, CATALOG IRON CTR THE; Dawson WK, 2016, METHODS, V103, P138, DOI 10.1016/j.ymeth.2016.04.026; de Oliveira FT, 2004, J AM CHEM SOC, V126, P5338, DOI 10.1021/ja031746a; DENISON AB, 1984, J APPL PHYS, V55, P2278, DOI 10.1063/1.333635; Ellis LBM, 2006, NUCLEIC ACIDS RES, V34, pD517, DOI 10.1093/nar/gkj076; FEE JA, 1984, J BIOL CHEM, V259, P124; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Frisch M. J., 2009, US; Frisch M. J., 2004, GAUSSIAN 03 REVISION; FU WG, 1992, J BIOL CHEM, V267, P15502; GAYDA JP, 1981, BIOCHIMIE, V63, P847; GAYDA JP, 1979, BIOCHIM BIOPHYS ACTA, V581, P15, DOI 10.1016/0005-2795(79)90216-2; GAYDA JP, 1976, BIOCHIM BIOPHYS ACTA, V434, P154, DOI 10.1016/0005-2795(76)90045-3; Guell M, 2008, J PHYS CHEM A, V112, P6384, DOI 10.1021/jp803441m; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/s007750050013; Hammes-Schiffer S, 2006, ACCOUNTS CHEM RES, V39, P93, DOI 10.1021/ar040199a; Hammes-Schiffer S, 2010, CHEM REV, V110, P6939, DOI 10.1021/cr1001436; HAN S, 1989, J AM CHEM SOC, V111, P3496, DOI 10.1021/ja00192a002; HAN S, 1989, J AM CHEM SOC, V111, P3505, DOI 10.1021/ja00192a003; Handy NC, 2001, MOL PHYS, V99; HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.mi.46.100192.003025; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; HAY PJ, 1977, J CHEM PHYS, V66, P4377, DOI 10.1063/1.433731; Herebian D, 2003, J AM CHEM SOC, V125, P10997, DOI 10.1021/ja030124m; Hoe WM, 2001, CHEM PHYS LETT, V341, P319, DOI 10.1016/S0009-2614(01)00581-4; Hunenberger P, 2005, ADV POLYM SCI, V173, P105, DOI 10.1007/b99427; Hunsicker-Wang LM, 2003, BIOCHEMISTRY-US, V42, P7303, DOI 10.1021/bi0342719; Inoue H, 2008, THESIS; Inoue K, 2009, J MOL BIOL, V392, P436, DOI 10.1016/j.jmb.2009.07.029; Iwasaki T, 2006, PROTEIN SCI, V15, P2019, DOI 10.1110/ps.052035406; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jiang HY, 1996, J BACTERIOL, V178, P3133, DOI 10.1128/jb.178.11.3133-3139.1996; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jortner J, 1997, P INDIAN AS-CHEM SCI, V109, P365; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Kilbane JJ, 2002, BIOCHEM BIOPH RES CO, V297, P242, DOI 10.1016/S0006-291X(02)02183-6; Kornobis K, 2011, J PHYS CHEM A, V115, P1280, DOI 10.1021/jp110914y; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kweon Ohgew, 2008, BMC Biochemistry, V9, P11, DOI 10.1186/1471-2091-9-11; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Link TA, 1996, BBA-BIOENERGETICS, V1275, P54, DOI 10.1016/0005-2728(96)00050-3; Link TA, 1999, J INORG BIOCHEM, V74, P208; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; Maeda R, 2009, FEMS MICROBIOL LETT, V292, P203, DOI 10.1111/j.1574-6968.2009.01497.x; Maeda R, 2009, CURR MICROBIOL, V59, P154, DOI 10.1007/s00284-009-9414-y; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Morishita T, 2000, J CHEM PHYS, V113, P2976, DOI 10.1063/1.1287333; Moser CC, 2010, BBA-BIOENERGETICS, V1797, P1573, DOI 10.1016/j.bbabio.2010.04.441; Nam JW, 2005, PROTEINS, V58, P779, DOI 10.1002/prot.20374; Neese F, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829047; Nojiri H, 1999, J BACTERIOL, V181, P3105, DOI 10.1128/JB.181.10.3105-3113.1999; Nojiri H, 2005, J MOL BIOL, V351, P355, DOI 10.1016/j.jmb.2005.05.059; Nolan LC, 2008, BIOTECHNOL LETT, V30, P1879, DOI 10.1007/s10529-008-9791-5; NOODLEMAN L, 1995, COORDIN CHEM REV, V144, P199, DOI 10.1016/0010-8545(95)07011-L; Noodleman L, 1999, DENSITY FUNCTIONAL T; Ohrstrom L, 1996, J AM CHEM SOC, V118, P3283, DOI 10.1021/ja953409a; Ohta T, 2008, J AM CHEM SOC, V130, P1601, DOI 10.1021/ja074769o; OZAKI Y, 1983, FEBS LETT, V152, P236, DOI 10.1016/0014-5793(83)80387-1; Page CC, 2001, SIMPLE EFFECTIVE MOD; Papaioannou JC, 2005, J PHYS CHEM SOLIDS, V66, P839, DOI 10.1016/j.jpcs.2004.11.002; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Petrenko T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770706; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; RAGHAVACHARI K, 1989, J CHEM PHYS, V91, P1062, DOI 10.1063/1.457230; Ray K, 2007, CHEM-EUR J, V13, P2783, DOI 10.1002/chem.200601425; Rotsaert FAJ, 2003, J BIOL INORG CHEM, V8, P318, DOI 10.1007/s00775-002-0417-4; RUEGG K, 1980, J MAGN MAGN MATER, V15-8, P669, DOI 10.1016/0304-8853(80)90713-1; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarewicz M, 2015, PHYS CHEM CHEM PHYS, V17, P25297, DOI 10.1039/c5cp02815a; Sato S, 1997, J BACTERIOL, V179, P4841, DOI 10.1128/jb.179.15.4841-4849.1997; Sato SI, 1997, J BACTERIOL, V179, P4850, DOI 10.1128/jb.179.15.4850-4858.1997; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Sevrioukova IF, 2005, J MOL BIOL, V347, P607, DOI 10.1016/j.jmb.2005.01.047; Shakya SK, 2005, BIOPOLYMERS, V78, P9, DOI 10.1002/bip.20242; Silva PJ, 1999, J BIOL INORG CHEM, V4, P284, DOI 10.1007/s007750050314; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SOLOMON EI, 1995, COORDIN CHEM REV, V144, P369, DOI 10.1016/0010-8545(95)01150-N; Sousa SF, 2007, J PHYS CHEM A, V111, P10439, DOI 10.1021/jp0734474; Swart M, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3213193; Szilagyi RK, 2006, J COMPUT CHEM, V27, P1385, DOI 10.1002/jcc.20449; Tarasev M, 2006, BIOCHEMISTRY-US, V45, P10208, DOI 10.1021/bi060219b; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Trinh T, 2006, BIOCATALYSIS BIODEGR; TSANG HT, 1989, BIOCHEMISTRY-US, V28, P7233, DOI 10.1021/bi00444a015; Uchimura H, 2008, BIOSCI BIOTECH BIOCH, V72, P3237, DOI 10.1271/bbb.80512; Ullmann GM, 2002, J BIOL INORG CHEM, V7, P632, DOI 10.1007/s00775-002-0342-6; Umeda T, 2010, ACTA CRYSTALLOGR F, V66, P1480, DOI 10.1107/S1744309110034949; Umeda T, 2010, ACTA CRYSTALLOGR F, V66, P712, DOI 10.1107/S1744309110014491; Vidakovic MS, 1996, J BIOL CHEM, V271, P14734, DOI 10.1074/jbc.271.25.14734; Vittal KY, 1983, J AM CHEM SOC, V105, P6462; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xiao YM, 2008, BIOCHEMISTRY-US, V47, P6612, DOI 10.1021/bi701433m; Young ER, 2009, J AM CHEM SOC, V131, P7678, DOI 10.1021/ja809777j	128	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162031	10.1371/journal.pone.0162031	http://dx.doi.org/10.1371/journal.pone.0162031			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656882	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200019
J	Howard, BJ; Hurtig-Wennlof, A; Olsson, LA; Nilsson, TK; Dunstan, DW; Wennberg, P				Howard, Bethany J.; Hurtig-Wennlof, Anita; Olsson, Lovisa A.; Nilsson, Torbjorn K.; Dunstan, David W.; Wennberg, Patrik			Self-Reported Sitting Time, Physical Activity and Fibrinolytic and Other Novel Cardio-Metabolic Biomarkers in Active Swedish Seniors	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEDENTARY BEHAVIOR; MYOCARDIAL-INFARCTION; REDUCED RISK; VIEWING TIME; MARKERS; INFLAMMATION; STROKE; HEALTH; ASSOCIATIONS	Background Too much sitting is linked with an increased risk of cardiovascular disease and mortality. The mediating mechanisms for these associations are largely unknown, however dysregulated fibrinolysis have emerged as a possible contributor. Objective We examined the associations of self-reported overall sitting time and physical activity with fibrinolytic and other novel cardio-metabolic biomarkers in older adults. Materials and Methods Data was analysed for 364 participants (74 +/- 7 yrs) of the Active Seniors group (retired, living independently in their own homes). Linear regression analyses examined associations of categories of categories of sitting time (<= 3, 3-6, >6 hrs/day) and overall physical activity (Low, Moderate and High) with biomarkers in serum or plasma, adjusting for age, gender and smoking (with further adjustment for either overall physical activity or sitting time and BMI in secondary analyses). Results Compared to sitting <= 3 hrs/day, sitting > 6 hrs/day was associated with higher tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 complex (tPA-PAI-1 complex). These associations were not independent of overall physical activity or BMI. Compared to those in the high physical activity, low physical activity was associated with a higher BMI, high-sensitivity C-reactive protein (hs-CRP) and tPA-PAI-1 complex levels. Only the associations of BMI and hs-CRP were independent of sitting time. Conclusions These findings provide preliminary cross-sectional evidence for the relationships of sitting time with fibrinolytic markers in older adults. They also reinforce the importance of regular physical activity for cardio-metabolic health.	[Howard, Bethany J.; Dunstan, David W.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Howard, Bethany J.; Dunstan, David W.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Hurtig-Wennlof, Anita] Univ Orebro, Sch Hlth Sci, Fac Med & Hlth, Orebro, Sweden; [Olsson, Lovisa A.] Univ Orebro, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Nilsson, Torbjorn K.] Umea Univ, Dept Med Biosci Clin Chem, Umea, Sweden; [Dunstan, David W.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Dunstan, David W.] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA, Australia; [Dunstan, David W.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Wennberg, Patrik] Umea Univ, Family Med, Publ Hlth & Clin Med, Umea, Sweden	Baker Heart and Diabetes Institute; Monash University; Orebro University; Orebro University; Umea University; Australian Catholic University; Deakin University; University of Western Australia; University of Queensland; Umea University	Wennberg, P (corresponding author), Umea Univ, Family Med, Publ Hlth & Clin Med, Umea, Sweden.	patrik.wennberg@umu.se	Dunstan, David Wayne/E-8473-2010	Dunstan, David Wayne/0000-0003-2629-9568				Ansari MT, 2006, BLOOD COAGUL FIBRIN, V17, P335, DOI 10.1097/01.mbc.0000233362.80486.6c; Favaloro EJ, 2014, SEMIN THROMB HEMOST, V40, P621, DOI 10.1055/s-0034-1384631; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Gardiner PA, 2011, J AM GERIATR SOC, V59, P788, DOI 10.1111/j.1532-5415.2011.03390.x; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Howard BJ, 2015, BRIT J SPORT MED, V49, P255, DOI 10.1136/bjsports-2013-093014; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olsson LA, 2013, ARCH GERONTOL GERIAT, V56, P303, DOI 10.1016/j.archger.2012.07.009; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Penny J A, 1999, Blood Press Monit, V4, P91, DOI 10.1097/00126097-199900420-00006; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; RANBY M, 1989, THROMB HAEMOSTASIS, V62, P917; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; STRATTON JR, 1991, CIRCULATION, V83, P1692, DOI 10.1161/01.CIR.83.5.1692; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Van Cauwenberg J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-734; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Wennberg P, 2010, EUR J CARDIOV PREV R, V17, P56, DOI 10.1097/HJR.0b013e32832f3b11; Willeit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055175; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Yates T, 2012, AM J PREV MED, V42, P1, DOI 10.1016/j.amepre.2011.09.022; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163409	10.1371/journal.pone.0163409	http://dx.doi.org/10.1371/journal.pone.0163409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658041	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200111
J	Jokihaara, J; Porsti, IH; Sievanen, H; Koobi, P; Kannus, P; Niemela, O; Turner, RT; Iwaniec, UT; Jarvinen, TLN				Jokihaara, Jarkko; Porsti, Ilkka H.; Sievanen, Harri; Koobi, Peeter; Kannus, Pekka; Niemela, Onni; Turner, Russell T.; Iwaniec, Urszula T.; Jarvinen, Teppo L. N.			Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC METABOLIC-ACIDOSIS; CALCIUM-CARBONATE; RAT FEMUR; HEMODIALYSIS-PATIENTS; PARATHYROID-HORMONE; PROXIMAL FEMUR; FAILURE RATS; FEMALE RATS; OSTEODYSTROPHY	Introduction Phosphate binding with sevelamer can ameliorate detrimental histomorphometric changes of bone in chronic renal insufficiency (CRI). Here we explored the effects of sevelamer-HCl treatment on bone strength and structure in experimental CRI. Methods Forty-eight 8-week-old rats were assigned to surgical 5/6 nephrectomy (CRI) or renal decapsulation (Sham). After 14 weeks of disease progression, the rats were allocated to untreated and sevelamer-treated (3% in chow) groups for 9 weeks. Then the animals were sacrificed, plasma samples collected, and femora excised for structural analysis (biomechanical testing, quantitative computed tomography). Results Sevelamer-HCl significantly reduced blood pH, and final creatinine clearance in the CRI groups ranged 30%-50% of that in the Sham group. Final plasma phosphate increased 2.4- to 2.9-fold, and parathyroid hormone 13- to 21-fold in CRI rats, with no difference between sevelamer-treated and untreated animals. In the femoral midshaft, CRI reduced cortical bone mineral density (-3%) and breaking load (-15%) (p<0.05 for all versus Sham), while sevelamer increased bone mineral density (+2%) and prevented the deleterious changes in bone. In the femoral neck, CRI reduced bone mineral density (-11%) and breaking load(-10%), while sevelamer prevented the decrease in bone mineral density (+6%) so that breaking load did not differ from controls. Conclusions In this model of stage 3-4 CRI, sevelamer-HCl treatment ameliorated the decreases in femoral midshaft and neck mineral density, and restored bone strength despite prevailing acidosis. Therefore, treatment with sevelamer can efficiently preserve mechanical competence of bone in CRI.	[Jokihaara, Jarkko] Tampere Univ Hosp, Dept Hand & Microsurg, Tampere, Finland; [Jokihaara, Jarkko; Jarvinen, Teppo L. N.] Univ British Columbia, Dept Orthopaed, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Porsti, Ilkka H.; Koobi, Peeter; Niemela, Onni] Univ Tampere, Sch Med, Tampere, Finland; [Sievanen, Harri; Kannus, Pekka] UKK Inst, Bone Res Grp, Tampere, Finland; [Niemela, Onni] Seinajoki Cent Hosp Lab, Dept Lab Med, Seinajoki, Finland; [Turner, Russell T.; Iwaniec, Urszula T.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Skeletal Biol Lab, Corvallis, OR 97331 USA; [Jarvinen, Teppo L. N.] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland	Tampere University; Tampere University Hospital; University of British Columbia; Tampere University; UKK Institute; Seinajoki Central Hospital; Oregon State University; University of Helsinki	Jokihaara, J (corresponding author), Tampere Univ Hosp, Dept Hand & Microsurg, Tampere, Finland.; Jokihaara, J (corresponding author), Univ British Columbia, Dept Orthopaed, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.	Jarkko.Jokihaara@pshp.fi	Järvinen, Teppo/B-8189-2013; Jokihaara, Jarkko/C-5817-2017	Järvinen, Teppo/0000-0003-3713-956X; Jokihaara, Jarkko/0000-0001-6153-2180	Academy of Finland; Sigrid Juselius Foundation; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital [9T011]; Finnish Foundation for Cardiovascular Research	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Finnish Foundation for Cardiovascular Research	The study was supported by the Academy of Finland (www.aka.fi), Sigrid Juselius Foundation (www.sigridjuselius.fi), Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (Grant number 9T011, www.pshp.fi/valtiontutkimusrahoitus), and the Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi/).	Asmus HG, 2005, NEPHROL DIAL TRANSPL, V20, P1653, DOI 10.1093/ndt/gfh894; Bagi CM, 1997, BONE, V21, P261, DOI 10.1016/S8756-3282(97)00121-X; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Brezina B, 2004, KIDNEY INT, V66, pS39, DOI 10.1111/j.1523-1755.2004.09007.x; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Cozzolino M, 2003, KIDNEY INT, V64, P1653, DOI 10.1046/j.1523-1755.2003.00284.x; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Friedman EA, 2005, KIDNEY INT, V67, pS1, DOI 10.1111/j.1523-1755.2005.09500.x; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Guillemin F, 2013, OSTEOPOROSIS INT, V24, P3001, DOI 10.1007/s00198-013-2408-4; Jara A, 2000, KIDNEY INT, V58, P1023, DOI 10.1046/j.1523-1755.2000.00260.x; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; Jarvinen TLN, 2005, J BONE MINER RES, V20, P717, DOI 10.1359/JBMR.050211; Jarvinen TLN, 1998, J BONE MINER RES, V13, P1475, DOI 10.1359/jbmr.1998.13.9.1475; Jarvinen TLN, 1998, BONE, V22, P551, DOI 10.1016/S8756-3282(98)00025-8; Jarvinen TLN, 2003, J BONE MINER RES, V18, P1292, DOI 10.1359/jbmr.2003.18.7.1292; Jokihaara J, 2006, J BONE MINER RES, V21, P745, DOI 10.1359/JBMR.060114; Jokihaara J, 2006, BONE, V39, P353, DOI 10.1016/j.bone.2006.01.157; Katsumata K, 2003, KIDNEY INT, V64, P441, DOI 10.1046/j.1523-1755.2003.00126.x; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Ketteler M, 2015, KIDNEY INT, V87, P502, DOI 10.1038/ki.2014.425; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; KRAPF R, 1992, J CLIN INVEST, V90, P2456, DOI 10.1172/JCI116137; Krieger NS, 2012, AM J PHYSIOL-RENAL, V303, pF431, DOI 10.1152/ajprenal.00199.2012; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Lima F, 2014, CLIN NEPHROL, V82, P287, DOI 10.5414/CN108407; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Martin KJ, 2007, J AM SOC NEPHROL, V18, P875, DOI 10.1681/ASN.2006070771; Martin KJ, 2004, AM J KIDNEY DIS, V43, P558, DOI 10.1053/j.ajkd.2003.12.003; Mathew S, 2007, J AM SOC NEPHROL, V18, P122, DOI 10.1681/ASN.2006050490; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moorthi Ranjani N, 2011, Am J Kidney Dis, V58, P1022, DOI 10.1053/j.ajkd.2011.08.009; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Navaneethan SD, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006023.pub2; Neves KR, 2004, KIDNEY INT, V66, P2237, DOI 10.1111/j.1523-1755.2004.66013.x; Nickolas TL, 2008, KIDNEY INT, V74, P721, DOI 10.1038/ki.2008.264; Pajamaki I, 2003, J BONE MINER RES, V18, P544, DOI 10.1359/jbmr.2003.18.3.544; Parfitt AM, 1998, J BONE MINER RES, V13, P1213, DOI 10.1359/jbmr.1998.13.8.1213; PELKER R R, 1984, Journal of Orthopaedic Research, V1, P405; Pierce D, 2011, NEPHROL DIAL TRANSPL, V26, P1615, DOI 10.1093/ndt/gfq598; Porsti I, 2004, KIDNEY INT, V66, P2155, DOI 10.1111/j.1523-1755.2004.66006.x; RO HK, 1990, J BONE MINER RES, V5, P273, DOI 10.1002/jbmr.5650050311; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Salusky IB, 2005, J AM SOC NEPHROL, V16, P2501, DOI 10.1681/ASN.2004100885; Schober HC, 1998, J AM SOC NEPHROL, V9, P1225; SEDLIN ED, 1966, ACTA ORTHOP SCAND, V37, P29, DOI 10.3109/17453676608989401; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Slatopolsky E, 2001, AM J KIDNEY DIS, V37, pS54, DOI 10.1053/ajkd.2001.20740; SOGAARD CH, 1994, J BONE MINER RES, V9, P409; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Tormanen S, 2014, ADV NEPHROL; van der Meulen MCH, 2001, BONE, V29, P101, DOI 10.1016/S8756-3282(01)00491-4; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; Wrong OM, 2005, KIDNEY INT, V67, P776, DOI 10.1111/j.1523-1755.2005.67142_2.x	55	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163022	10.1371/journal.pone.0163022	http://dx.doi.org/10.1371/journal.pone.0163022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658028	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200055
J	Bernik, I; Prislan, K				Bernik, Igor; Prislan, Kaja			Measuring Information Security Performance with 10 by 10 Model for Holistic State Evaluation	PLOS ONE			English	Article							SYSTEMS; MANAGEMENT; BUSINESS; ADOPTION	Organizations should measure their information security performance if they wish to take the right decisions and develop it in line with their security needs. Since the measurement of information security is generally underdeveloped in practice and many organizations find the existing recommendations too complex, the paper presents a solution in the form of a 10 by 10 information security performance measurement model. The model-ISP 10x10M is composed of ten critical success factors, 100 key performance indicators and 6 performance levels. Its content was devised on the basis of findings presented in the current research studies and standards, while its structure results from an empirical research conducted among information security professionals from Slovenia. Results of the study show that a high level of information security performance is mostly dependent on measures aimed at managing information risks, employees and information sources, while formal and environmental factors have a lesser impact. Experts believe that information security should evolve systematically, where it's recommended that beginning steps include technical, logical and physical security controls, while advanced activities should relate predominantly strategic management activities. By applying the proposed model, organizations are able to determine the actual level of information security performance based on the weighted indexing technique. In this manner they identify the measures they ought to develop in order to improve the current situation. The ISP 10x10M is a useful tool for conducting internal system evaluations and decision-making. It may also be applied to a larger sample of organizations in order to determine the general state-of-play for research purposes.	[Bernik, Igor; Prislan, Kaja] Univ Maribor, Fac Criminal Justice & Secur, SI-1000 Ljubljana, Slovenia	University of Maribor	Bernik, I (corresponding author), Univ Maribor, Fac Criminal Justice & Secur, SI-1000 Ljubljana, Slovenia.	igor.bernik@fvv.uni-mb.si	Bernik, Igor/A-1742-2017	Bernik, Igor/0000-0003-1644-5672				[Anonymous], 2011, ISSUES INF SYST; Baskerville R, 2014, INFORM MANAGE-AMSTER, V51, P138, DOI 10.1016/j.im.2013.11.004; Bayuk JL, 2011, SYSTEMS ENG, V14, P294, DOI 10.1002/sys.20182; Bojanc R, 2008, INT J INFORM MANAGE, V28, P413, DOI 10.1016/j.ijinfomgt.2008.02.002; Carnegie Mellon University, 2010, CMMI DEV VERS 1 3; Cassar G, 2007, J SMALL BUS MANAGE, V45, P283, DOI 10.1111/j.1540-627X.2007.00213.x; Chang SE, 2006, IND MANAGE DATA SYST, V106, P345, DOI 10.1108/02635570610653498; Commission European, 2015, EUR AG SEC; D'Arcy J, 2009, J BUS ETHICS, V89, P59, DOI 10.1007/s10551-008-9909-7; Da Veiga A, 2010, COMPUT SECUR, V29, P196, DOI 10.1016/j.cose.2009.09.002; Deloitte, 2013, TMT GLOB SEC STUD BL; Ernst & Young, 2014, GLOB INF SEC SURV GE; European Union Agency for Network and Information Security, 2013, ENISA THREAT LANDSC; Feng N, 2014, INFORM SCIENCES, V256, P57, DOI 10.1016/j.ins.2013.02.036; Garson D, 2012, TESTING STAT ASSUMPT; Goel S, 2009, INFORM MANAGE-AMSTER, V46, P404, DOI 10.1016/j.im.2009.06.005; Gordon L. A., 2002, ACM Transactions on Information and Systems Security, V5, P438, DOI 10.1145/581271.581274; Hagen Janne Merete, 2008, Information Management & Computer Security, V16, P377, DOI 10.1108/09685220810908796; Herath HSB, 2014, DECIS SUPPORT SYST, V57, P54, DOI 10.1016/j.dss.2013.07.010; Herbane B, 2010, INT SMALL BUS J, V28, P43, DOI 10.1177/0266242609350804; Hewlett Packard Development Company [HP], 2015, STAT SEC OP REP CAP; Hogue Z., 2004, INT BUSINESS REV, V13, P485, DOI DOI 10.1016/J.IBUSREV.2004.04.003; Hu Q, 2012, DECISION SCI, V43, P615, DOI 10.1111/j.1540-5915.2012.00361.x; Hua J, 2013, J GLOB INF TECH MAN, V16, P47, DOI 10.1080/1097198X.2013.10845648; IBM Corp, 2013, IBM SPSS SOFTW WIND; Ifinedo P, 2014, INFORM MANAGE-AMSTER, V51, P69, DOI 10.1016/j.im.2013.10.001; Institute Ponemon, 2014, GLOB REP COST CYB CR; Institute Ponemon, 2010, SEC EFF FRAM STUD; Institute SANS, 2016, CRIT SEC CONTR VERS; Jackson S, 2011, INFORM ORGAN-UK, V21, P57, DOI 10.1016/j.infoandorg.2011.03.003; Jacobs MA, 2013, TECHNOVATION, V33, P111, DOI 10.1016/j.technovation.2013.01.001; Ji X, 2016, ADV ENG SOFTW, V99, P18, DOI 10.1016/j.advengsoft.2016.04.010; Kankanhalli A, 2003, INT J INFORM MANAGE, V23, P139, DOI 10.1016/S0268-4012(02)00105-6; KAPLAN RS, 1992, HARVARD BUS REV, V70, P71; Kim TH, 2014, INFORM MANAGE-AMSTER, V51, P398, DOI 10.1016/j.im.2014.03.001; Kong HK, 2012, J INTELL MANUF, V23, P941, DOI 10.1007/s10845-010-0402-7; Kotulic AG, 2004, INFORM MANAGE-AMSTER, V41, P597, DOI 10.1016/j.im.2003.08.001; Lee CM, 2014, J SUPERCOMPUT, V70, P211, DOI 10.1007/s11227-014-1194-x; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Mehmood A., 2014, NETW PROTOC ALGORITH, V6, P60, DOI DOI 10.5296/NPA.V6I4.6028; NATO 2020, 2010, NATO 2020 ASS SEC DY; Nguyen TH, 2015, J SMALL BUS MANAGE, V53, P207, DOI 10.1111/jsbm.12058; Patel SC, 2008, INT J INFORM MANAGE, V28, P483, DOI 10.1016/j.ijinfomgt.2008.01.009; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Pironti John P., 2007, INFORM SYSTEMS CONTR, V2, P1; Posey C, 2014, INFORM MANAGE-AMSTER, V51, P551, DOI 10.1016/j.im.2014.03.009; PWC PricewaterhouseCoopers, 2013, **NON-TRADITIONAL**; Rhee HS, 2012, COMPUT SECUR, V31, P221, DOI 10.1016/j.cose.2011.12.001; Saleh S, 2006, ISACA J, V6, P1; Sansage, 2012, STAT SEC INF EV MAN; Savola RM, 2013, COMPUT SECUR, V37, P78, DOI 10.1016/j.cose.2013.05.002; Scott W.R., 1995, I CONSTRUCTION ORG I; Solomon P. J., 2013, CROSSTALK, p[25, 25]; Son JY, 2011, INFORM MANAGE-AMSTER, V48, P296, DOI 10.1016/j.im.2011.07.002; Squire R, 2014, PROCESS SAF PROG, V33, P329, DOI 10.1002/prs.11676; Technologies Turning, 2014, TURN POINT POLL SOFT; Teo TSH, 2009, ADV MANAG INFORM SYS, V14, P68; The Department for Business Innovation & Skills [BIS], 2013, UK CYB SEC STAND RES; The Department for Business Innovation & Skills [BIS] PricewaterhouseCoopers [PWC], 2014, INF SEC BREACH SURV; Thompson M, 2012, INFORM ORGAN-UK, V22, P188, DOI 10.1016/j.infoandorg.2012.04.001; Thomson KL, 2006, COMPUT FRAUD SECUR, P11; Tornatzky LG, 1990, PROCESS TECHNOLOGY I; Verizon, 2014, DAT BREACH INV REP; von Solms B, 2004, COMPUT SECUR, V23, P371, DOI 10.1016/j.cose.2004.05.002; Whitman M. E., 2011, PRINCIPLES INFORM SE; Willison R., 2006, Information and Organization, V16, P304, DOI 10.1016/j.infoandorg.2006.08.001; World Economic Forum, 2015, GLOB RISKS 2015, V10th; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863	68	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163050	10.1371/journal.pone.0163050	http://dx.doi.org/10.1371/journal.pone.0163050			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27655001	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700037
J	Hohnen, R; Tuft, K; McGregor, HW; Legge, S; Radford, IJ; Johnson, CN				Hohnen, Rosemary; Tuft, Katherine; McGregor, Hughw W.; Legge, Sarah; Radford, Ian J.; Johnson, Christopher N.			Occupancy of the Invasive Feral Cat Varies with Habitat Complexity	PLOS ONE			English	Article							DOMESTIC CAT; AUSTRALIA; DECLINE; CONSERVATION; ISLAND; FAUNA; IMPACTS; MAMMALS; MODELS	The domestic cat (Felis catus) is an invasive exotic in many locations around the world and is thought to be a key factor driving recent mammal declines across northern Australia. Many mammal species native to this region now persist only in areas with high topographic complexity, provided by features such as gorges or escarpments. Do mammals persist in these habitats because cats occupy them less, or despite high cat occupancy? We show that occupancy of feral cats was lower in mammal- rich habitats of high topographic complexity. These results support the idea that predation pressure by feral cats is a factor contributing to the collapse of mammal communities across northern Australia. Managing impacts of feral cats is a global conservation challenge. Conservation actions such as choosing sites for small mammal reintroductions may be more successful if variation in cat occupancy with landscape features is taken into account.	[Hohnen, Rosemary; Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Hohnen, Rosemary; Tuft, Katherine; McGregor, Hughw W.; Legge, Sarah] Australian Wildlife Conservancy, Mornington Wildlife Sanctuary, PMB 925, Derby, WA 6728, Australia; [Legge, Sarah] Charles Darwin Univ, Threatened Species Recovery Hub, Natl Environm Sci Program, Darwin, NT 0900, Australia; [Radford, Ian J.] Western Australian Govt, Dept Pk & Wildlife, POB 942, Kununurra, WA 6743, Australia	University of Tasmania; Charles Darwin University	Hohnen, R (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.; Hohnen, R (corresponding author), Australian Wildlife Conservancy, Mornington Wildlife Sanctuary, PMB 925, Derby, WA 6728, Australia.	rhohnen@utas.edu.au	Legge, Sarah/AAB-7229-2019; Johnson, Christopher/J-7894-2014; Legge, Sarah/GYE-1554-2022; McGregor, Hugh W/T-2283-2017	Legge, Sarah/0000-0001-6968-2781; Johnson, Christopher/0000-0002-9719-3771; McGregor, Hugh W/0000-0003-3255-9282; Tuft, Katherine/0000-0002-3585-444X	Australian Research Council [100100033]; Department of Parks and Wildlife (Western Australia); Australian Wildlife Conservancy	Australian Research Council(Australian Research Council); Department of Parks and Wildlife (Western Australia); Australian Wildlife Conservancy	This study was funded by supporters of the Australian Wildlife Conservancy, an Australian Research Council Discovery Grant (100100033), and the Department of Parks and Wildlife (Western Australia).; This study was supported by the Australian Wildlife Conservancy and the study methods were approved by the University of Tasmania Animal Ethics Committee (Permit number A12516). A big thanks to Australian Wildlife Conservancy's Mornington Wildlife Sanctuary staff, in particular to Alex James, James Smith, Isabel Connell, Butch Maher and Greg Michat.	Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; Bureau of Meteorology, 2015, CLIM DAT ONL; Daniels MJ, 2001, J APPL ECOL, V38, P146, DOI 10.1046/j.1365-2664.2001.00580.x; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Duffy DC, 2012, PAC SCI, V66, P173, DOI 10.2984/66.2.7; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Frank ASK, 2014, J APPL ECOL, V51, P1486, DOI 10.1111/1365-2664.12323; Gibson F, 1993, AUST MAMMAL, V17, P103; KINNEAR JE, 1988, AUST WILDLIFE RES, V15, P435; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Marlow NJ, 2015, AUST J ZOOL, V63, P18, DOI 10.1071/ZO14024; McGregor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133915; McGregor HW, 2015, WILDLIFE RES, V42, P223, DOI 10.1071/WR14180; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Nishimura Y, 1999, J VIROL, V73, P7916, DOI 10.1128/JVI.73.9.7916-7921.1999; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Phillips RB, 2007, J MAMMAL, V88, P173, DOI 10.1644/06-MAMM-A-015R2.1; R Development Core Team, 2005, R VERS 3 03 R LANG E; Radford IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092341; Recio MR, 2015, BIOL CONSERV, V192, P48, DOI 10.1016/j.biocon.2015.09.004; Start A. N., 2007, AUST MAMMAL, V29, P1, DOI [10.1071/AM07001, DOI 10.1071/AM07001]; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Ziembicki Mark R., 2015, Therya, V6, P169, DOI 10.12933/therya-15-236	28	40	40	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0152520	10.1371/journal.pone.0152520	http://dx.doi.org/10.1371/journal.pone.0152520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655024	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700001
J	Khare, S; Drake, KL; Lawhon, SD; Nunes, JES; Figueiredo, JF; Rossetti, CA; Gull, T; Everts, RE; Lewin, HA; Adams, LG				Khare, Sangeeta; Drake, Kenneth L.; Lawhon, Sara D.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Everts, Robin E.; Lewin, Harris. A.; Adams, Leslie Garry			Systems Analysis of Early Host Gene Expression Provides Clues for Transient Mycobacterium avium ssp avium vs. Persistent Mycobacterium avium ssp paratuberculosis Intestinal Infections	PLOS ONE			English	Article							SUBSP-PARATUBERCULOSIS; BOVINE MONOCYTES; IMMUNE-RESPONSE; ECONOMIC-IMPACT; NK CELLS; KINASE; MACROPHAGES; ACTIVATION; MICROARRAY; RECEPTORS	It has long been a quest in ruminants to understand how two very similar mycobacterial species, Mycobacterium avium ssp. paratuberculosis (MAP) and Mycobacterium avium ssp. avium (MAA) lead to either a chronic persistent infection or a rapid-transient infection, respectively. Here, we hypothesized that when the host immune response is activated by MAP or MAA, the outcome of the infection depends on the early activation of signaling molecules and host temporal gene expression. To test our hypothesis, ligated jejuno-ileal loops including Peyer's patches in neonatal calves were inoculated with PBS, MAP, or MAA. A temporal analysis of the host transcriptome profile was conducted at several times post-infection (0.5, 1, 2, 4, 8 and 12 hours). When comparing the transcriptional responses of calves infected with the MAA versus MAP, discordant patterns of mucosal expression were clearly evident, and the numbers of unique transcripts altered were moderately less for MAA-infected tissue than were mucosal tissues infected with the MAP. To interpret these complex data, changes in the gene expression were further analyzed by dynamic Bayesian analysis. Bayesian network modeling identified mechanistic genes, gene-to-gene relationships, pathways and Gene Ontologies (GO) biological processes that are involved in specific cell activation during infection. MAP and MAA had significant different pathway perturbation at 0.5 and 12 hours post inoculation. Inverse processes were observed between MAP and MAA response for epithelial cell proliferation, negative regulation of chemotaxis, cell-cell adhesion mediated by integrin and regulation of cytokine-mediated signaling. MAP inoculated tissue had significantly lower expression of phagocytosis receptors such as mannose receptor and complement receptors. This study reveals that perturbation of genes and cellular pathways during MAP infection resulted in host evasion by mucosal membrane barrierweakening to access entry in the ileum, inhibition of Ca signaling associated with decreased phagosome-lysosome fusion as well as phagocytosis inhibition, bias toward Th2 cell immune response accompanied by cell recruitment, cell proliferation and cell differentiation; leading to persistent infection. Contrarily, MAA infection was related to cellular responses associated with activation of molecular pathways that release chemicals and cytokines involved with containment of infection and a strong bias toward Th1 immune response, resulting in a transient infection.	[Khare, Sangeeta; Lawhon, Sara D.; Nunes, Jairo E. S.; Figueiredo, Josely F.; Rossetti, Carlos A.; Gull, Tamara; Adams, Leslie Garry] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Khare, Sangeeta] US FDA, Natl Ctr Toxicol Res, Div Microbiol, Jefferson, AR 72079 USA; [Drake, Kenneth L.] Seralogix LLC, Austin, TX 78730 USA; [Everts, Robin E.; Lewin, Harris. A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	Texas A&M University System; Texas A&M University College Station; US Food & Drug Administration (FDA); University of Illinois System; University of Illinois Urbana-Champaign	Khare, S; Adams, LG (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.; Khare, S (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Microbiol, Jefferson, AR 72079 USA.	Sangeeta.khare@fda.hhs.gov; gadams@cvm.tamu.edu	LEWIN, HARRIS/HGC-6543-2022; Lawhon, Sara D./G-5147-2011; Khare, SangeetA/Q-5470-2019	LEWIN, HARRIS/0000-0002-1043-7287; Lawhon, Sara D./0000-0001-9154-8909; Khare, SangeetA/0000-0002-9496-6636	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program [2004-35605-14243, Q6286224133]; USDA [TEX08409]	U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program; USDA(United States Department of Agriculture (USDA))	This work was funded by a U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program (2004-35605-14243 sub-award Q6286224133) to SK and USDA Project TEX08409 to LGA. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.; The authors thank Alan Patranella for the assistance with animal care, Roberta Pugh and Doris Hunter for technical support. The study was supported by funds to Sangeeta Khare from the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Coordinated Agricultural Project-Johne's Disease Integrated Program (2004-35605-14243 sub-award Q6286224133) and funds awarded to L. Garry Adams through USDA Project TEX08409. "Funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials." The views presented in this article do not reflect those of the US Food and Drug Administration.	Allen AJ, 2009, CLIN VACCINE IMMUNOL, V16, P453, DOI 10.1128/CVI.00347-08; Arsenault RJ, 2013, INFECT IMMUN, V81, P226, DOI 10.1128/IAI.00785-12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bannantine JP, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-10; Bannantine JP, 2002, J CLIN MICROBIOL, V40, P1303, DOI 10.1128/JCM.40.4.1303-1310.2002; Carvalho NB, 2011, INFECT IMMUN, V79, P1638, DOI 10.1128/IAI.01030-10; Coussens PM, 2004, INFECT IMMUN, V72, P1409, DOI 10.1128/IAI.72.3.1409-1422.2004; Crawford GC, 2006, J WILDLIFE DIS, V42, P715, DOI 10.7589/0090-3558-42.4.715; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Everts RE, 2005, VET IMMUNOL IMMUNOP, V105, P235, DOI 10.1016/j.vetimm.2005.02.003; Fooksman DR, 2011, ANN REV IMMUNOLOGY; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Gulliver EL, 2015, J COMP PATHOL, V153, P67, DOI 10.1016/j.jcpa.2015.05.005; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khare S, 2004, J CLIN MICROBIOL, V42, P1075, DOI 10.1128/JCM.42.3.1075-1081.2004; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Koo HC, 2004, INFECT IMMUN, V72, P6870, DOI 10.1128/IAI.72.12.6870-6883.2004; KWIATKOWSKI AP, 1995, GASTROENTEROLOGY, V109, P1316, DOI 10.1016/0016-5085(95)90594-4; Laughlin RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147027; Li HJ, 2008, MUTAT RES-FUND MOL M, V644, P1, DOI 10.1016/j.mrfmmm.2008.06.013; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Losinger WC, 2005, J DAIRY RES, V72, P425, DOI 10.1017/S0022029905001007; Magombedze G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141539; Merga Y, 2014, DIGEST DIS, V32, P475, DOI 10.1159/000358156; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Mortier RAR, 2014, VET RES, V45, DOI 10.1186/s13567-014-0071-1; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Olsen I, 2005, INFECT IMMUN, V73, P5628, DOI 10.1128/IAI.73.9.5628-5635.2005; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Pokkali S, 2009, FEMS IMMUNOL MED MIC, V55, P352, DOI 10.1111/j.1574-695X.2008.00520.x; Rindi L, 2014, INFECT GENET EVOL, V21, P375, DOI 10.1016/j.meegid.2013.12.007; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Singh Udai P, 2008, BMC Immunol, V9, P25, DOI 10.1186/1471-2172-9-25; Smeed Jennifer A, 2007, BMC Vet Res, V3, P18, DOI 10.1186/1746-6148-3-18; Sommer S, 2009, VET IMMUNOL IMMUNOP, V128, P44, DOI 10.1016/j.vetimm.2008.10.294; Sousa S, 2005, NAT CELL BIOL, V7, P954, DOI 10.1038/ncb1308; Souza CD, 2007, MICROBES INFECT, V9, P1545, DOI 10.1016/j.micinf.2007.08.008; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; Tachibana M, 2008, ALLERGY, V63, P1136, DOI 10.1111/j.1398-9995.2008.01677.x; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Waitt CJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1274-4; Weiss DJ, 2004, VET PATHOL, V41, P326, DOI 10.1354/vp.41-4-326; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490	56	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161946	10.1371/journal.pone.0161946	http://dx.doi.org/10.1371/journal.pone.0161946			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27653506	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700013
J	Chand, S; Atkinson, D; Collins, C; Briggs, D; Ball, S; Sharif, A; Skordilis, K; Vydianath, B; Neil, D; Borrows, R				Chand, Sourabh; Atkinson, David; Collins, Clare; Briggs, David; Ball, Simon; Sharif, Adnan; Skordilis, Kassiani; Vydianath, Bindu; Neil, Desley; Borrows, Richard			The Spectrum of Renal Allograft Failure	PLOS ONE			English	Article							KIDNEY-TRANSPLANT FAILURE; ANTIBODY-MEDIATED REJECTION; SURVIVAL; DISEASE; INFLAMMATION; METAANALYSIS; FIBROSIS; THERAPY; LESIONS; INJURY	Background Causes of "true" late kidney allograft failure remain unclear as study selection bias and limited follow-up risk incomplete representation of the spectrum. Methods We evaluated all unselected graft failures from 2008-2014 (n = 171; 0-36 years post-transplantation) by contemporary classification of indication biopsies "proximate" to failure, DSA assessment, clinical and biochemical data. Results The spectrum of graft failure changed markedly depending on the timing of allograft failure. Failures within the first year were most commonly attributed to technical failure, acute rejection (with T-cell mediated rejection [TCMR] dominating antibody-mediated rejection [ABMR]). Failures beyond a year were increasingly dominated by ABMR and 'interstitial fibrosis with tubular atrophy' without rejection, infection or recurrent disease ("IFTA"). Cases of IFTA associated with inflammation in non-scarred areas (compared with no inflammation or inflammation solely within scarred regions) were more commonly associated with episodes of prior rejection, late rejection and nonadherence, pointing to an alloimmune aetiology. Nonadherence and late rejection were common in ABMR and TCMR, particularly Acute Active ABMR. Acute Active ABMR and nonadherence were associated with younger age, faster functional decline, and less hyalinosis on biopsy. Chronic and Chronic Active ABMR were more commonly associated with Class II DSA. C1q-binding DSA, detected in 33% of ABMR episodes, were associated with shorter time to graft failure. Most non-biopsied patients were DSA-negative (16/21; 76.1%). Finally, twelve losses to recurrent disease were seen (16%). Conclusion This data from an unselected population identifies IFTA alongside ABMR as a very important cause of true late graft failure, with nonadherence-associated TCMR as a phenomenon in some patients. It highlights clinical and immunological characteristics of ABMR subgroups, and should informclinical practice and individualised patient care.	[Chand, Sourabh; Ball, Simon; Sharif, Adnan; Borrows, Richard] Queen Elizabeth Hosp, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England; [Chand, Sourabh; Ball, Simon; Sharif, Adnan; Borrows, Richard] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England; [Chand, Sourabh] Royal Shrewsbury Hosp, Renal Dept, Shrewsbury, Shrops, England; [Atkinson, David; Collins, Clare; Briggs, David] NHSBT Birmingham Ctr, Histocompatibil & Immunogenet Lab, Vincent Dr, Birmingham, W Midlands, England; [Skordilis, Kassiani; Vydianath, Bindu; Neil, Desley] Queen Elizabeth Hosp, Dept Renal Histopathol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Chand, S (corresponding author), Queen Elizabeth Hosp, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England.; Chand, S (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England.; Chand, S (corresponding author), Royal Shrewsbury Hosp, Renal Dept, Shrewsbury, Shrops, England.	sourabh.chand@nhs.net		Ball, Simon/0000-0001-7410-5268; Sharif, Adnan/0000-0002-7586-9136; Chand, Sourabh/0000-0002-6126-3678				Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; Del Bello A, 2012, CLIN J AM SOC NEPHRO, V7, P1310, DOI 10.2215/CJN.00260112; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Halloran PF, 2013, AM J TRANSPLANT, V13, P1931, DOI 10.1111/ajt.12317; Halloran P.F., 2014, J AM SOC NEPHROL; HALLORAN PF, 1990, TRANSPLANTATION, V49, P85, DOI 10.1097/00007890-199001000-00019; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Kawakami T, 2014, KIDNEY INT SUPPL, V4, P107, DOI 10.1038/kisup.2014.20; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; McDonald S, 2011, 33 ANZDATA, V3. 2; McGettrick HM, 2012, J LEUKOCYTE BIOL, V91, P385, DOI 10.1189/jlb.0911458; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Naesens M, 2013, AM J TRANSPLANT, V13, P1933, DOI 10.1111/ajt.12316; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Prommool S, 2000, J AM SOC NEPHROL, V11, P565, DOI 10.1681/ASN.V113565; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; Sharif A, 2011, J AM SOC NEPHROL, V22, P2107, DOI 10.1681/ASN.2010111160; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Vitalone MJ, 2014, AM J TRANSPLANT, V14, P1912, DOI 10.1111/ajt.12746; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	26	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162278	10.1371/journal.pone.0162278	http://dx.doi.org/10.1371/journal.pone.0162278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649571	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100015
J	Huang, CH; Pei, C; Sun, TL				Huang, Chien-Hua; Pei, Chun; Sun, Tien-Lung			Influence of the Perspectives on the Movement of One-Leg Lifting in an Interactive-Visual Virtual Environment: A Pilot Study	PLOS ONE			English	Article							REALITY; PEOPLE	Background Numerous studies have confirmed the feasibility of active video games for clinical rehabilitation. To maximize training effectiveness, a personal program is necessary; however, little evidence is available to guide individualized game design for rehabilitation. This study assessed the perspectives and kinematic and temporal parameters of a participant's postural control in an interactive-visual virtual environment. Methods Twenty-four healthy participants performed one-leg standing by leg lifting when a posture frame appeared either in a first-or third-person perspective of a virtual environment. A foot force plate was used to detect the displacement of the center of pressure. A three-way mixed factor design was applied, where the perspective was the between-participant factor, and the leg-lifting times (0.7 and 2.7 seconds) and leg-lifting angles (30 degrees and 90 degrees) were the within-participant factors. The reaction time, accuracy of the movement, and ability to shift weight were the dependent variables. Results Regarding the reaction time and accuracy of the movement, there were no significant main effects of the perspective, leg-lifting time, or angle. For the ability to shift weight, however, both the perspective and time exerted significant main effects, F(1,22) = 6.429 and F(1,22) = 13.978, respectively. Conclusions Participants could shift their weight more effectively in the third-person perspective of the virtual environment. The results can serve as a reference for future designs of interactive-visual virtual environment as applied to rehabilitation.	[Huang, Chien-Hua; Sun, Tien-Lung] Yuan Ze Univ, Dept Ind Engn & Management, Chungli, Taiwan; [Huang, Chien-Hua] Feng Yuan Hosp, Minist Hlth & Welf, Taichung, Taiwan; [Pei, Chun] Nan Kai Univ Technol, Dept Geron Technol & Serv Management, Caotun 542, Nantou, Taiwan	Yuan Ze University; Nan Kai University Technology	Sun, TL (corresponding author), Yuan Ze Univ, Dept Ind Engn & Management, Chungli, Taiwan.	tsun@saturn.yzu.edu.tw			German Research Foundation (DFG) [BO 649/21-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by travel grant BO 649/21-1 from the German Research Foundation (DFG). We thank Thomas Kesnerus for programming the tablet version of the MET.	Barry G, 2014, J NEUROENG REHABIL, V11, DOI [10.1186/1743-0003-11-33, 10.1186/1743-0003-11-60]; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Cohen J.E., 1988, STAT POWER ANAL BEHA; Covaci A, 2014, 20 ACM S VIRT REAL S; Davies PM, 2012, STEPS FOLLOW COMPREH; Edwards W. H., 2010, MOTOR LEARNING CONTR; Glegg SMN, 2013, CYBERPSYCH BEH SOC N, V16, P385, DOI 10.1089/cyber.2013.1506; Guo R, 2013, 19 ACM S VIRT REAL S; Koritnik T, 2008, GAIT POSTURE, V27, P323, DOI 10.1016/j.gaitpost.2007.04.015; Lai CL, 2013, HUM FACTOR ERGON MAN, V23, P517, DOI 10.1002/hfm.20345; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Levin MF, 2009, STUD HEALTH TECHNOL, V145, P94, DOI 10.3233/978-1-60750-018-6-94; Lohse KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093318; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Novak, 2011, GAME DEV ESSENTIALS; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Prasad S, 2009, J EXP PSYCHOL HUMAN, V35, P39, DOI 10.1037/a0012728; Salamin P, 2010, IEEE T LEARN TECHNOL, V3, P272, DOI 10.1109/TLT.2010.13; Schmidt R.A, 1991, MOTOR LEARNING PERFO; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Sun TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069471; Ustinova KI, 2010, ACTA PSYCHOL, V133, P180, DOI 10.1016/j.actpsy.2009.11.006; VANDERMEULEN JHP, 1991, DEV MED CHILD NEUROL, V33, P40; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384	25	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163247	10.1371/journal.pone.0163247	http://dx.doi.org/10.1371/journal.pone.0163247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649536	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892100068
J	Mittal, A; Tandon, S; Singla, SK; Tandon, C				Mittal, Amisha; Tandon, Simran; Singla, Surender Kumar; Tandon, Chanderdeep			Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTAL; RENAL EPITHELIAL-CELLS; LLC-PK1 CELLS; IN-VITRO; MONOHYDRATE CRYSTALS; OXIDATIVE STRESS; APOPTOTIC CHANGES; LIGAND-BINDING; STONE DISEASE; TUBULAR CELLS	Kidney stone formation during hyperoxaluric condition is inherently dependent on the interaction between renal epithelial cells and calcium oxalate (CaOx) crystals. Although modern medicine has progressed in termsof removal of these stones, recurrence and persistent side effects restricts their use. Strategies involving plant based agents which could be used as adjunct therapy is an area which needs to be explored. Plant proteins having antilithiatic activity is a hitherto unexplored area and therefore, we conducted a detailed identification and characterization of antilithiatic proteins from Terminalia arjuna (T. arjuna). Proteins were isolated from the dried bark of T. arjuna and those having molecular weights > 3 kDa were subjected to anion exchange chromatography followed by gel filtration chromatography. Four proteins were identified exhibiting inhibitory activity against CaOx crystallization and crystal growth kinetics The cytoprotective and anti-apoptotic efficacy of these purified proteins was further investigated on oxalate injured renal epithelial cells (MDCK and NRK-52E) wherein, injury due to oxalate was significantly attenuated and led to a dose dependent increase in viability of these cells. These proteins also prevented the interaction of the CaOx crystals to the cell surface and reduced the number of apoptotic cells. Identification of these 4 anionic proteins from the bark of T. arjuna was carried out by Matrix-assisted laser desorption/ionization-time of flight Mass spectrometry (MALDI-TOF MS). This was followed by database search with the MASCOT server and sequence similaritywas found with Nuclear pore anchor, DEAD Box ATP-dependent RNA helicase 45, Lon protease homolog 1 and Heat shock protein 90-3. These novel proteins isolated from T. arjuna have the potential to inhibit CaOx crystallization and promote cell survival and therefore, offer novel avenues which need to be explored further for the medical management of urolithiasis.	[Mittal, Amisha] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Tandon, Simran] Amity Univ Uttar Pradesh, AIMMSCR, Noida, Uttar Pradesh, India; [Singla, Surender Kumar] Panjab Univ, Dept Biochem, Chandigarh, India; [Tandon, Chanderdeep] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Noida, Uttar Pradesh, India	Jaypee University of Information Technology; Amity University Noida; Panjab University; Amity University Noida	Tandon, C (corresponding author), Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Noida, Uttar Pradesh, India.	ctandon@amity.edu	TANDON, simran/AAF-1158-2020; Tandon, Chanderdeep/AAF-1124-2020	Tandon, Chanderdeep/0000-0003-3720-0455; Tandon, Simran/0000-0002-6937-0216	Department of Science and Technology, Govt. of India, New Delhi [SR/SO/HS/132/2010]	Department of Science and Technology, Govt. of India, New Delhi(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Govt. of India, New Delhi, Grant Number-SR/SO/HS/132/2010.	Aggarwal A, 2014, INDIAN J EXP BIOL, V52, P103; Aggarwal A, 2010, INT BRAZ J UROL, V36, P480, DOI 10.1590/S1677-55382010000400011; Aggarwal KP, 2013, CLIN CHIM ACTA, V415, P181, DOI 10.1016/j.cca.2012.10.040; Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ankur C., 2010, INT J DRUG DEV RES, V2, P431; Bijarnia RK, 2009, PROTEIN J, V28, P161, DOI 10.1007/s10930-009-9179-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhary A, 2010, INDIAN J PHARM SCI, V72, P340, DOI 10.4103/0250-474X.70480; Chitme HR, 2010, INT J PHARM SCI RES, V1, P24, DOI 10.13040/IJPSR.0975-8232.1(2).24-31; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; DEGANELLO S, 1991, CALCIFIED TISSUE INT, V48, P421, DOI 10.1007/BF02556456; Dublin CH, 2009, DRUG DELIV TECHNOL, V9, P29; Dwivedi S, 2007, J ETHNOPHARMACOL, V114, P114, DOI 10.1016/j.jep.2007.08.003; HACKETT RL, 1995, SCANNING MICROSCOPY, V9, P587; HAMMES MS, 1995, KIDNEY INT, V48, P501, DOI 10.1038/ki.1995.320; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; HESS B, 1995, UROL RES, V23, P231, DOI 10.1007/BF00393304; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; Johri N, 2010, NEPHRON CLIN PRACT, V116, pC159, DOI 10.1159/000317196; Jonassen JA, 1999, J AM SOC NEPHROL, V10, pS446; Jonassen JA, 2003, CRIT REV EUKAR GENE, V13, P55, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.50; Khan SR, 2004, NEPHRON EXP NEPHROL, V98, pE55, DOI 10.1159/000080257; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; Khan SR, 1999, J AM SOC NEPHROL, V10, pS457; Khaskhali MH, 2009, UROL RES, V37, P1, DOI 10.1007/s00240-008-0160-6; KNIGHT TF, 1979, KIDNEY INT, V16, P572, DOI 10.1038/ki.1979.167; Kohjimoto Y, 1999, KIDNEY INT, V56, P1432, DOI 10.1046/j.1523-1755.1999.00683.x; KOUL H, 1994, AM J PHYSIOL, V266, pF266, DOI 10.1152/ajprenal.1994.266.2.F266; Koul H, 1996, KIDNEY INT, V50, P1525, DOI 10.1038/ki.1996.467; KOUL H, 1994, BIOCHEM BIOPH RES CO, V205, P1632, DOI 10.1006/bbrc.1994.2854; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; LIESKE JC, 1995, AM J PHYSIOL-RENAL, V268, pF604, DOI 10.1152/ajprenal.1995.268.4.F604; LIESKE JC, 1993, AM J PHYSIOL, V264, pF800, DOI 10.1152/ajprenal.1993.264.5.F800; Maroni PD, 2004, ANN NY ACAD SCI, V1030, P144, DOI 10.1196/annals.1329.018; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; MENON M, 1992, J CLIN ENDOCR METAB, V74, P703, DOI 10.1210/jc.74.4.703; Mittal A, 2016, UROLITHIASIS, V44, P117, DOI 10.1007/s00240-015-0822-0; Mittal A, 2015, INT BRAZ J UROL, V41, P935, DOI 10.1590/S1677-5538.IBJU.2014.0547; Nagiah S, 2016, CHEM-BIOL INTERACT, V252, P82, DOI 10.1016/j.cbi.2016.03.021; NAKAGAWA Y, 1987, J CLIN INVEST, V79, P1782, DOI 10.1172/JCI113019; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Patnaik BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050900; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Prezioso D, 2014, ARCH ITAL UROL ANDRO, V86, P99, DOI 10.4081/aiua.2014.2.99; Rizvi SAH, 2002, BJU INT, V89, P62, DOI 10.1046/j.1465-5101.2001.134.x; Sarica K, 2001, UROL RES, V29, P34, DOI 10.1007/s002400000150; Scheid CR, 1995, SCANNING MICROSCOPY, V9, P1097; Scheid CR, 2004, FRONT BIOSCI-LANDMRK, V9, P797, DOI 10.2741/1265; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Selvam R, 2003, UROL RES, V31, P242, DOI 10.1007/s00240-003-0316-3; Semangoen T, 2008, J PROTEOME RES, V7, P2889, DOI 10.1021/pr800113k; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; STAPLETON AMF, 1994, MINER ELECTROL METAB, V20, P399; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tiwari A, 2012, ASIAN J PHARM CLIN R, V5, P7; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Umekawa T, 2005, NEPHROL DIAL TRANSPL, V20, P870, DOI 10.1093/ndt/gfh750; Vijaya R, 1999, BIOCHEM BIOPH RES CO, V266, P72, DOI 10.1006/bbrc.1999.1772; WORCESTER EM, 1994, J AM SOC NEPHROL, V5, pS46; WORCESTER EM, 1995, ANN NY ACAD SCI, V760, P375, DOI 10.1111/j.1749-6632.1995.tb44661.x; Xu J, 2015, GENE, V555, P318, DOI 10.1016/j.gene.2014.11.025; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Yamate T, 1999, UROL INT, V62, P81, DOI 10.1159/000030363; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang L, 2013, INT J MOL SCI, V14, P24742, DOI 10.3390/ijms141224742	71	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162600	10.1371/journal.pone.0162600	http://dx.doi.org/10.1371/journal.pone.0162600			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649531	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100023
J	Guo, HT; Huo, HW; Yu, Q				Guo, Haitao; Huo, Hongwei; Yu, Qiang			SMCis: An Effective Algorithm for Discovery of Cis-Regulatory Modules	PLOS ONE			English	Article							MOTIF DISCOVERY; BINDING SITES; IDENTIFICATION; PREDICTION; ALIGNMENTS; DROSOPHILA; CLUSTERS; REGIONS; MODELS	The discovery of cis-regulatory modules (CRMs) is a challenging problem in computational biology. Limited by the difficulty of using an HMM to model dependent features in transcriptional regulatory sequences (TRSs), the probabilistic modeling methods based on HMMs cannot accurately represent the distance between regulatory elements in TRSs and are cumbersome to model the prevailing dependencies between motifs within CRMs. We propose a probabilistic modeling algorithm called SMCis, which builds a more powerful CRM discovery model based on a hidden semi-Markov model. Our model characterizes the regulatory structure of CRMs and effectively models dependencies between motifs at a higher level of abstraction based on segments rather than nucleotides. Experimental results on three benchmark datasets indicate that our method performs better than the compared algorithms.	[Guo, Haitao; Huo, Hongwei; Yu, Qiang] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China	Xidian University	Huo, HW (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	hwhuo@mail.xidian.edu.cn	Huo, Hongwei/AAM-1200-2020		National Natural Science Foundation of China [61173025, 61373044, 61502366]; China Postdoctoral Science Foundation [2015M582621]; Fundamental Research Funds for the Central Universities [JB150306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China under Grant 61173025, 61373044, and 61502366, the China Postdoctoral Science Foundation under Grant 2015M582621, and the Fundamental Research Funds for the Central Universities under Grant JB150306. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2003, BIOINFORMATICS, V19, pII5, DOI 10.1093/bioinformatics/btg1052; Alkema WBL, 2004, NUCLEIC ACIDS RES, V32, pW195, DOI 10.1093/nar/gkh387; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Bilmes JA, 2006, IEICE T INF SYST, VE89D, P869, DOI 10.1093/ietisy/e89-d.3.869; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Davidson EH, 2006, REG GEN GEN REG; Fariselli P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S12; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gan YL, 2014, IEEE ACM T COMPUT BI, V11, P73, DOI 10.1109/TCBB.2013.131; Gonzalez S, 2012, BIOINFORMATICS, V28, P763, DOI 10.1093/bioinformatics/bts024; Guns T, 2010, 2010 IEEE INT C BIOI; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Klepper K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-123; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Kulakovskiy I. V., 2009, Biophysics, V54, P667, DOI 10.1134/S0006350909060013; Lin TH, 2008, LECT N BIOINFORMAT, V4955, P66; Liu X, 2001, Pac Symp Biocomput, P127; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mitchison, 1998, BIOLOGICAL SEQUENCE; Navarro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108065; Nikulova AA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks235; Ostendorf M, 1996, IEEE T SPEECH AUDI P, V4, P360, DOI 10.1109/89.536930; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rouault H, 2014, NUCLEIC ACIDS RES, V42, P6128, DOI 10.1093/nar/gku209; Shaw WM, 1997, INFORM PROCESS MANAG, V33, P1, DOI 10.1016/S0306-4573(96)00043-X; Sinha S, 2007, PLOS COMPUT BIOL, V3, P2175, DOI 10.1371/journal.pcbi.0030216; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Su J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001020; Suryamohan K, 2015, WIRES DEV BIOL, V4, P59, DOI 10.1002/wdev.168; Thompson JA, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1022, DOI 10.1109/CEC.2014.6900542; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Yu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048442; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011; Zambelli F, 2013, BRIEF BIOINFORM, V14, P225, DOI 10.1093/bib/bbs016; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	45	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162968	10.1371/journal.pone.0162968	http://dx.doi.org/10.1371/journal.pone.0162968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637070	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700021
J	Ayouni, S; Estienney, M; Hammami, S; Guediche, MN; Pothier, P; Aouni, M; Belliot, G; de Rougemont, A				Ayouni, Siwar; Estienney, Marie; Hammami, Sabeur; Guediche, Mohamed Neji; Pothier, Pierre; Aouni, Mahjoub; Belliot, Gael; de Rougemont, Alexis			Cosavirus, Salivirus and Bufavirus in Diarrheal Tunisian Infants	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION-PCR; HUMAN ASTROVIRUSES; ENTERIC VIRUSES; GASTROENTERITIS; ROTAVIRUS; CHILDREN; IDENTIFICATION; KLASSEVIRUS; PICORNAVIRIDAE; INFECTIONS	Three newly discovered viruses have been recently described in diarrheal patients: Cosavirus (CosV) and Salivirus (SalV), two picornaviruses, and Bufavirus (BuV), a parvovirus. The detection rate and the role of these viruses remain to be established in acute gastroenteritis (AGE) in diarrheal Tunisian infants. From October 2010 through March 2012, stool samples were collected from 203 children < 5 years-old suffering from AGE and attending the Children's Hospital in Monastir, Tunisia. All samples were screened for CosV, SalV and BuV as well as for norovirus (NoV) and group A rotavirus (RVA) by molecular biology. Positive samples for the three screened viruses were also tested for astrovirus, sapovirus, adenovirus, and Aichi virus, then genotyped when technically feasible. During the study period, 11 (5.4%) samples were positive for one of the three investigated viruses: 2 (1.0%) CosV-A10, 7 (3.5%) SalV-A1 and 2 (1.0%) BuV-1, whereas 71 (35.0%) children were infected with NoV and 50 (24.6%) with RVA. No mixed infections involving the three viruses were found, but multiple infections with up to 4 classic enteric viruses were found in all cases. Although these viruses are suspected to be responsible for AGE in children, our data showed that this association was uncertain since all infected children also presented infections with several enteric viruses, suggesting here potential water-borne transmission. Therefore, further studies with large cohorts of healthy and diarrheal children will be needed to evaluate their clinical role in AGE.	[Ayouni, Siwar; Estienney, Marie; Pothier, Pierre; Belliot, Gael; de Rougemont, Alexis] CHU Dijon, Ctr Natl Reference Virus Enter, Lab Virol Serol, Pole Tech Biol, Dijon, France; [Ayouni, Siwar; Aouni, Mahjoub] Univ Monastir, Fac Pharm, Monastir, Tunisia; [Hammami, Sabeur; Guediche, Mohamed Neji] Hop Univ Fattouma Bourguiba, Serv Pediat, Monastir, Tunisia; [Hammami, Sabeur; Guediche, Mohamed Neji] Univ Monastir, Fac Med, Monastir, Tunisia; [Pothier, Pierre; Belliot, Gael; de Rougemont, Alexis] Univ Bourgogne Franche Comte AgroSup Dijon, UMR PAM A Proc Alimentaires & Microbiol 02 102, Dijon, France	CHU Dijon Bourgogne; Universite de Monastir; Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Monastir; Institut Agro; AgroSup Dijon; Universite de Bourgogne	de Rougemont, A (corresponding author), CHU Dijon, Ctr Natl Reference Virus Enter, Lab Virol Serol, Pole Tech Biol, Dijon, France.; de Rougemont, A (corresponding author), Univ Bourgogne Franche Comte AgroSup Dijon, UMR PAM A Proc Alimentaires & Microbiol 02 102, Dijon, France.	alexis.de-rougemont@u-bourgogne.fr	de ROUGEMONT, Alexis/M-1090-2016; Belliot, Gaël/AAC-4649-2019	de ROUGEMONT, Alexis/0000-0002-3084-9414; BELLIOT, Gael/0000-0003-1161-9530	Campus France (PHC-UTIQUE program)	Campus France (PHC-UTIQUE program)	SA was awarded a fellowship from Campus France (PHC-UTIQUE program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Siwar Ayouni was awarded a fellowship from Campus France (PHC-UTIQUE program). We would like to thank Philip Bastable for editorial assistance.	Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Altay A, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.006; Ayouni S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.015; Ayouni S, 2015, EMERG INFECT DIS, V21, P2055, DOI 10.3201/eid2111.141901; Boros A, 2016, ARCH VIROL, V161, P1671, DOI 10.1007/s00705-016-2824-9; Chieochansin T, 2015, ARCH VIROL, V160, P1781, DOI 10.1007/s00705-015-2441-z; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Dai XQ, 2010, J CLIN VIROL, V48, P228, DOI 10.1016/j.jcv.2010.03.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EuroRotaNet, 2009, EUR ROT DET TYP METH; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Gutierrez-Aguirre I, 2008, J CLIN MICROBIOL, V46, P2547, DOI 10.1128/JCM.02428-07; Han TH, 2010, EMERG INFECT DIS, V16, P1623, DOI 10.3201/eid1610.100539; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Huang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13272; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; LeGuyader F, 1996, ARCH VIROL, V141, P2225, DOI 10.1007/BF01718228; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Noel JS, 1997, J MED VIROL, V52, P173, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;173::AID-JMV10&gt;3.0.CO;2-M; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Rezig D, 2015, J MED VIROL, V87, P940, DOI 10.1002/jmv.24076; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Smits SL, 2014, EMERG INFECT DIS, V20, P1218, DOI 10.3201/eid2007.140190; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yahiro T, 2014, EMERG INFECT DIS, V20, P1037, DOI 10.3201/eid2006.131430; Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000	36	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162255	10.1371/journal.pone.0162255	http://dx.doi.org/10.1371/journal.pone.0162255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631733	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900033
J	Lakiotaki, K; Kartsaki, E; Kanterakis, A; Katsila, T; Patrinos, GP; Potamias, G				Lakiotaki, Kleanthi; Kartsaki, Evgenia; Kanterakis, Alexandros; Katsila, Theodora; Patrinos, George P.; Potamias, George			ePGA: A Web-Based Information System for Translational Pharmacogenomics	PLOS ONE			English	Article							RESEARCH NETWORK; INDIVIDUALIZED MEDICINE; PERSONALIZED MEDICINE; ALLELE NOMENCLATURE; CLINICAL-PRACTICE; CHALLENGES; IMPLEMENTATION; ASSOCIATION; MICROATTRIBUTION; KNOWLEDGE	One of the challenges that arise from the advent of personal genomics services is to efficiently couple individual data with state of the art Pharmacogenomics (PGx) knowledge. Existing services are limited to either providing static views of PGx variants or applying a simplistic match between individual genotypes and existing PGx variants. Moreover, there is a considerable amount of haplotype variation associated with drug metabolism that is currently insufficiently addressed. Here, we present a web-based electronic Pharmacogenomics Assistant (ePGA; http://www.epga.gr/) that provides personalized genotype-to-phenotype translation, linked to state of the art clinical guidelines. ePGA's translation service matches individual genotype-profiles with PGx gene haplotypes and infers the corresponding diplotype and phenotype profiles, accompanied with summary statistics. Additional features include i) the ability to customize translation based on subsets of variants of clinical interest, and ii) to update the knowledge base with novel PGx findings. We demonstrate ePGA's functionality on genetic variation data from the 1000 Genomes Project.	[Lakiotaki, Kleanthi; Kartsaki, Evgenia; Kanterakis, Alexandros; Potamias, George] Fdn Res & Technol, Inst Comp Sci, Iraklion, Crete, Greece; [Katsila, Theodora; Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece	University of Patras	Potamias, G (corresponding author), Fdn Res & Technol, Inst Comp Sci, Iraklion, Crete, Greece.; Patrinos, GP (corresponding author), Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece.	gpatrinos@upatras.gr; potamias@ics.forth.gr	Kanterakis, Alexandros/ABC-1705-2021; Katsila, Theodora/O-3228-2015	Kanterakis, Alexandros/0000-0003-4276-0115; Katsila, Theodora/0000-0002-6263-4231	eMoDiA (electronic Molecular Diagnostics Assistant) project under the 'Competitiveness and Entrepreneurship' (OPCE II Greek-EU) operational program [11_SigmaYN10145]; European Commission [FP7-305444]	eMoDiA (electronic Molecular Diagnostics Assistant) project under the 'Competitiveness and Entrepreneurship' (OPCE II Greek-EU) operational program; European Commission(European CommissionEuropean Commission Joint Research Centre)	The reported work was funded by the eMoDiA (electronic Molecular Diagnostics Assistant) project (11_Sigma YN10145) under the 'Competitiveness and Entrepreneurship' (OPCE II Greek-EU) operational program and the RD-Connect project (FP7-305444; European Commission) to GPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RB, 2013, CLIN PHARMACOL THER, V94, P211, DOI 10.1038/clpt.2013.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brookes AJ, 2015, NAT REV GENET, V16, P702, DOI 10.1038/nrg3932; Cheng RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141105; Crews KR, 2012, CLIN PHARMACOL THER, V92, P467, DOI 10.1038/clpt.2012.120; Dalabira E, 2014, PUBLIC HEALTH GENOM, V17, P265, DOI 10.1159/000365895; Farmen Mark, 2009, PHARMASUG C PORTL OR; Giacomini KM, 2007, CLIN PHARMACOL THER, V81, P328, DOI 10.1038/sj.clpt.6100087; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Harper AR, 2012, NAT BIOTECHNOL, V30, P1117, DOI 10.1038/nbt.2424; Kampourakis K, 2014, EMBO REP, V15, P472, DOI 10.1002/embr.201438641; Karnes JH, 2014, WIRES SYST BIOL MED, V6, P125, DOI 10.1002/wsbm.1255; Katsila T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00061; Lakiotaki K, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P13, DOI 10.1109/BHI.2014.6864292; Lee JW, 2014, CLIN GENET, V86, P21, DOI 10.1111/cge.12392; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01099; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; Mette L, 2012, PHARMACOGENOMICS, V13, P803, DOI [10.2217/PGS.12.52, 10.2217/pgs.12.52]; Mitropoulou C, 2014, PUBLIC HEALTH GENOM, V17, P280, DOI 10.1159/000365896; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Motsinger-Reif AA, 2013, PHARMACOGENET GENOM, V23, P383, DOI 10.1097/FPC.0b013e32833d7b45; Papadopoulos P, 2014, NUCLEIC ACIDS RES, V42, pD1020, DOI 10.1093/nar/gkt1125; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Potamias G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140071; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Ritchie MD, 2012, HUM GENET, V131, P1615, DOI 10.1007/s00439-012-1221-z; Robarge J, 2007, CLIN PHARMACOL THER, V82, P244, DOI 10.1038/sj.clpt.6100284; Salleh MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071554; Sebelius K, 2009, HLTH US 2009 SPEC FE; Shuldiner AR, 2013, CLIN PHARMACOL THER, V94, P207, DOI 10.1038/clpt.2013.59; Sim SC, 2011, HUM MUTAT, V32, P526, DOI 10.1002/humu.21454; Sim Sarah C., 2010, Human Genomics, V4, P278; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI [10.2217/pgs.10.97, 10.2217/PGS.10.97]; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Xie L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003554; Younesi E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-23; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162801	10.1371/journal.pone.0162801	http://dx.doi.org/10.1371/journal.pone.0162801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631363	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900080
J	Li, LL; Wang, PC; Chao, KH; Zhou, YT; Xie, Y				Li, Lingling; Wang, Pengchong; Chao, Kuei-Hsiang; Zhou, Yatong; Xie, Yang			Remaining Useful Life Prediction for Lithium-Ion Batteries Based on Gaussian Processes Mixture	PLOS ONE			English	Article							TIME-SERIES; PROGNOSTICS; FILTER	The remaining useful life (RUL) prediction of Lithium-ion batteries is closely related to the capacity degeneration trajectories. Due to the self-charging and the capacity regeneration, the trajectories have the property of multimodality. Traditional prediction models such as the support vector machines (SVM) or the Gaussian Process regression (GPR) cannot accurately characterize this multimodality. This paper proposes a novel RUL prediction method based on the Gaussian Process Mixture (GPM). It can process multimodality by fitting different segments of trajectories with different GPR models separately, such that the tiny differences among these segments can be revealed. The method is demonstrated to be effective for prediction by the excellent predictive result of the experiments on the two commercial and chargeable Type 1850 Lithium-ion batteries, provided by NASA. The performance comparison among the models illustrates that the GPM is more accurate than the SVM and the GPR. In addition, GPM can yield the predictive confidence interval, which makes the prediction more reliable than that of traditional models.	[Li, Lingling; Wang, Pengchong; Xie, Yang] Hebei Univ Technol, Prov Minist Joint Key Lab Electromagnet Field & E, Tianjin 300130, Peoples R China; [Li, Lingling; Chao, Kuei-Hsiang] Natl Chin Yi Univ Technol, Coll Elect Engn & Comp Sci, Taichung 41170, Taiwan; [Zhou, Yatong] Hebei Univ Technol, Sch Elect & Informat Engn, Tianjin 300130, Peoples R China	Hebei University of Technology; National Chin-Yi University of Technology; Hebei University of Technology	Chao, KH (corresponding author), Natl Chin Yi Univ Technol, Coll Elect Engn & Comp Sci, Taichung 41170, Taiwan.	zhengwentongzhi@126.com			National Natural Science Foundation of China [51475136]; Natural Science Foundation of Hebei Province of China [E2014202230]; Hebei Province Science and Technology Support Program [15212117]; University Innovation Team Leader Program of Hebei Province [LJRC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Hebei Province Science and Technology Support Program; University Innovation Team Leader Program of Hebei Province	This work was supported by National Natural Science Foundation of China (Program No. 51475136), Lingling Li, http://www.nsfc.gov.cn/; Natural Science Foundation of Hebei Province of China (Program No. E2014202230), Lingling Li, http://www.hensf.gov.cn/; Hebei Province Science and Technology Support Program (Program No. 15212117), http://www.hebstd.gov.cn; and University Innovation Team Leader Program of Hebei Province (Program No. LJRC003), http://www.hee.gov.cn/.	Andre D, 2013, ENG APPL ARTIF INTEL, V26, P951, DOI 10.1016/j.engappai.2012.09.013; Bian MM, 2010, PROCEEDINGS OF 2010 INTERNATIONAL SYMPOSIUM ON IMAGE ANALYSIS AND SIGNAL PROCESSING, P1, DOI 10.1109/ICGPR.2010.5550226; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; [陈雄姿 Chen Xiongzi], 2013, [航空学报, Acta Aeronautica et Astronautica Sinica], V34, P2219; Chen Y, 2016, APPL SOFT COMPUT, V43, P357, DOI 10.1016/j.asoc.2016.02.045; Chen Y, 2013, ENERGIES, V6, P3082, DOI 10.3390/en6063082; Chen ZX, 2014, LECT NOTES COMP SCI, V98, P199, DOI 10.1007/978-3-319-05789-7_16; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; Goebel K, 2008, IEEE INSTRU MEAS MAG, V11, P33, DOI 10.1109/MIM.2008.4579269; He W, 2011, J POWER SOURCES, V196, P10314, DOI 10.1016/j.jpowsour.2011.08.040; Lazaro-Gredilla M, 2012, PATTERN RECOGN, V45, P1386, DOI 10.1016/j.patcog.2011.10.004; Liu Dan, 2012, Proceedings 2012 IEEE Symposium on Electrical & Electronics Engineering (EEESYM 2012), P1, DOI 10.1109/EEESym.2012.6258572; Liu Y, 2015, IEEE T RELIAB, V64, P1287, DOI 10.1109/TR.2015.2418294; Nguyen TV, 2014, PR MACH LEARN RES, V32; Nuhic A, 2013, J POWER SOURCES, V239, P680, DOI 10.1016/j.jpowsour.2012.11.146; Platanios EA, 2014, IEEE T PATTERN ANAL, V36, P888, DOI 10.1109/TPAMI.2013.183; Sun SL, 2013, INT CONF MACH LEARN, P1011, DOI 10.1109/ICMLC.2013.6890744; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tayal A., 2012, P 26 ASS ADV ART INT, P1126; Zhou J., 2013, THESIS; Zhou YT, 2007, CHINESE PHYS LETT, V24, P42, DOI 10.1088/0256-307X/24/1/012; Zhou YT, 2006, LECT NOTES COMPUT SC, V4232, P513; Zhou ZW, 2014, PROGNOST SYST HEALT, P297, DOI 10.1109/PHM.2014.6988182	26	33	36	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163004	10.1371/journal.pone.0163004	http://dx.doi.org/10.1371/journal.pone.0163004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632176	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900115
J	Mester, T; Raychaudhuri, N; Gillespie, EF; Chen, H; Smith, TJ; Douglas, RS				Mester, Tuende; Raychaudhuri, Nupur; Gillespie, Erin F.; Chen, Hong; Smith, Terry J.; Douglas, Raymond S.			CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; ORBITAL FIBROBLASTS; GRAVES-DISEASE; CIRCULATING FIBROCYTES; RECEPTOR; CELLS; SUSCEPTIBILITY; MECHANISMS; GENERATION; FIBROSIS	Context Fibrocytes appear to participate in inflammation and tissue remodeling in patients with thyroid-associated ophthalmopathy (TAO). These patients have increased frequencies of circulating TSH receptor (TSHR)- and CD40-positive fibrocytes, suggesting TSHR and CD40 may play roles in proinflammatory cytokine production, which ultimately leads to orbital inflammation and tissue remodeling. Objective To investigate the potential interactions between the TSHR and CD40 signaling pathways and their roles in IL-6 and TNF-alpha production. Design and Outcome Measures CD40 expression on fibrocytes was assessed using flow cytometry; IL-6 and TNF-alpha protein release using Luminex technology; increased IL-6 and TNF-alpha mRNA abundance, using real-time PCR; TSH- and CD40 ligand (CD40L)-stimulated Akt phosphorylation in fibrocytes, by western blot analysis; TSHR-CD40 protein-protein interaction, using co-immunoprecipitation, and CD40-TSHR co-localization, using immunocytochemistry. Results TSH enhances CD40 expression at a pre-translational level in fibrocytes. Production of IL-6 and TNF-alpha after costimulation with TSH and CD40L was greater than that after TSH or CD40L stimulation alone. TSH and CD40L costimulation also resulted in greater Akt phosphorylation. Akt and nuclear factor (NF)-kappa B inhibitors significantly reduced cytokine production after TSH and CD40L costimulation. TSHR and CD40L are colocalized on the cell surface and forma complex. Conclusions TSHR and CD40 in fibrocytes appear to be physically and functionally related. TSH stimulates CD40 production on the fibrocyte surface. Cytokine expression upon simultaneous stimulation of TSHR and CD40 is greater than levels achieved with TSH or CD40L alone. Increased expression of CD40 by TSH is a potential mechanism for this process.	[Mester, Tuende; Raychaudhuri, Nupur; Gillespie, Erin F.; Chen, Hong; Smith, Terry J.; Douglas, Raymond S.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Chen, Hong] Huazhong Univ Sci & Technol, Dept Ophthalmol, Union Hosp, Coll Med, Wuhan 430022, Hubei, Peoples R China; [Smith, Terry J.] Univ Michigan, Sch Med, Internal Med, Ann Arbor, MI 48105 USA; [Douglas, Raymond S.] Ann Arbor Vet Adm Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; Huazhong University of Science & Technology; University of Michigan System; University of Michigan	Douglas, RS (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA.; Douglas, RS (corresponding author), Ann Arbor Vet Adm Med Ctr, Ann Arbor, MI 48105 USA.	raydougl@med.umich.edu	Gillespie, Erin/AAZ-8543-2021; Smith, Terry/ABG-1360-2020	Gillespie, Erin/0000-0002-1386-1542; Douglas, Raymond S./0000-0002-3435-8161; Smith, Terry/0000-0002-6279-9685	National Institutes of Health [EY008976, EY011708, DK063121, EY021197, EY007003]; Eye Core Grant; Bell Charitable Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY008976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye Core Grant; Bell Charitable Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health grants EY008976, EY011708, DK063121, EY021197, and EY007003; an Eye Core Grant; the Bell Charitable Foundation; and the following grants from Research to Prevent Blindness: a Career Development Award, a Lew Wasserman Merit Award, and a Physician Scientist Award.	Bahn RS, 2002, THYROID, V12, P193, DOI 10.1089/105072502753600124; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Chen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130322; Chen H, 2014, J CLIN ENDOCR METAB, V99, pE1635, DOI 10.1210/jc.2014-1580; Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5; Dik WA, 2016, EXP EYE RES, V142, P83, DOI 10.1016/j.exer.2015.02.007; Douglas Raymond S, 2014, Trans Am Ophthalmol Soc, V112, P26; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; Foster N, 2012, J IMMUNOL, V189, P5632, DOI 10.4049/jimmunol.1202010; Galligan CL, 2010, RHEUMATOLOGY, V49, P640, DOI 10.1093/rheumatology/kep265; Gillespie EF, 2012, INVEST OPHTH VIS SCI, V53, P7746, DOI 10.1167/iovs.12-9861; Gillespie EF, 2012, J CLIN ENDOCR METAB, V97, pE740, DOI 10.1210/jc.2011-2514; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Kaufman J, 2004, J IMMUNOL, V172, P1862, DOI 10.4049/jimmunol.172.3.1862; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Li B, 2014, J CLIN ENDOCR METAB, V99, pE625, DOI 10.1210/jc.2013-3977; Liossis SNC, 2004, BIODRUGS, V18, P95, DOI 10.2165/00063030-200418020-00003; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Qi YC, 2014, CLIN ENDOCRINOL, V80, P128, DOI 10.1111/cen.12229; Raychaudhuri N, 2010, PLOS ONE, V5, DOI [10.1164/rccm.200810-1534OC, DOI 10.1164/RCCM.200810-1534OC]; Raychaudhuri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075100; SMITH BR, 1974, LANCET, V2, P427; Smith TJ, 2013, J CLIN ENDOCR METAB, V98, P515, DOI 10.1210/jc.2013-1004; Smith TJ, 2011, J CLIN ENDOCR METAB, V96, P3827, DOI 10.1210/jc.2011-1249; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Yamamoto K, 2012, THYROID, V22, P516, DOI 10.1089/thy.2011.0222; Yang DM, 1999, THYROID, V9, P305, DOI 10.1089/thy.1999.9.305	34	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162994	10.1371/journal.pone.0162994	http://dx.doi.org/10.1371/journal.pone.0162994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631497	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900111
J	Shitova, N; Roelofs, A; Schriefers, H; Bastiaansen, M; Schoffelen, JM				Shitova, Natalia; Roelofs, Ardi; Schriefers, Herbert; Bastiaansen, Marcel; Schoffelen, Jan-Mathijs			Using Brain Potentials to Functionally Localise Stroop-Like Effects in Colour and Picture Naming: Perceptual Encoding versus Word Planning	PLOS ONE			English	Article							TIME-COURSE ANALYSIS; SEMANTIC INTERFERENCE; COGNITIVE CONTROL; LEXICAL ACCESS; TEMPORAL COURSE; TASK; LANGUAGE; ERP; RESPONSES; CONFLICT	The colour-word Stroop task and the picture-word interference task (PWI) have been used extensively to study the functional processes underlying spoken word production. One of the consistent behavioural effects in both tasks is the Stroop-like effect: The reaction time (RT) is longer on incongruent trials than on congruent trials. The effect in the Stroop task is usually linked to word planning, whereas the effect in the PWI task is associated with either word planning or perceptual encoding. To adjudicate between the word planning and perceptual encoding accounts of the effect in PWI, we conducted an EEG experiment consisting of three tasks: a standard colour-word Stroop task (three colours), a standard PWI task (39 pictures), and a Stroop-like version of the PWI task (three pictures). Participants overtly named the colours and pictures while their EEG was recorded. A Stroop-like effect in RTs was observed in all three tasks. ERPs at centro-parietal sensors started to deflect negatively for incongruent relative to congruent stimuli around 350 ms after stimulus onset for the Stroop, Stroop-like PWI, and the Standard PWI tasks: an N400 effect. No early differences were found in the PWI tasks. The onset of the Stroop-like effect at about 350 ms in all three tasks links the effect to word planning rather than perceptual encoding, which has been estimated in the literature to be finished around 200-250 ms after stimulus onset. We conclude that the Stroop-like effect arises during word planning in both Stroop and PWI.	[Shitova, Natalia; Roelofs, Ardi; Schriefers, Herbert; Schoffelen, Jan-Mathijs] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Shitova, Natalia] Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Bastiaansen, Marcel] Acad Leisure, NHTV Breda Univ Appl Sci, Breda, Netherlands; [Schoffelen, Jan-Mathijs] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Breda University of Applied Sciences; Max Planck Society	Shitova, N (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Shitova, N (corresponding author), Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands.	n.shitova@donders.ru.nl	Schriefers, Herbert/D-8532-2012; Schoffelen, Jan-Mathijs/D-3716-2009; Roelofs, Ardi/A-5311-2010	Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Bastiaansen, Marcel/0000-0003-2865-7859	NWO [864.14.011]	NWO(Netherlands Organization for Scientific Research (NWO))	J-MS was funded by NWO (grant # 864.14.011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Ayora P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00057; Badzakova-Trajkov G, 2009, BRAIN RES, V1253, P139, DOI 10.1016/j.brainres.2008.11.069; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Boersma Paul, 2002, GLOT INT, V5, P341; Damian MF, 1999, J EXP PSYCHOL LEARN, V25, P345, DOI 10.1037/0278-7393.25.2.345; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; Dell GS, 2013, COGNITION, V128, P380, DOI 10.1016/j.cognition.2013.05.007; Dell'Acqua R, 2007, PSYCHON B REV, V14, P717, DOI 10.3758/BF03196827; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; FAGOT C, 1992, J EXP PSYCHOL HUMAN, V18, P1058, DOI 10.1037/0096-1523.18.4.1058; Finkbeiner M, 2006, CORTEX, V42, P790, DOI 10.1016/S0010-9452(08)70419-2; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Hashimoto N, 2010, APHASIOLOGY, V24, P580, DOI 10.1080/02687030902777567; HOLCOMB PJ, 1993, LANG COGNITIVE PROC, V8, P379, DOI 10.1080/01690969308407583; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2008, J EXP PSYCHOL LEARN, V34, P249, DOI 10.1037/0278-7393.34.1.249; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Piai V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088674; Piai V, 2014, J EXP PSYCHOL LEARN, V40, P147, DOI 10.1037/a0033745; Piai V, 2012, BRAIN RES, V1450, P87, DOI 10.1016/j.brainres.2012.02.050; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; RAYNER K, 1986, BRIT J PSYCHOL, V77, P207, DOI 10.1111/j.2044-8295.1986.tb01995.x; Ries S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058197; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; ROELOFS A, 1992, J EXPT PSYCHOL LEARN, V42, P107, DOI DOI 10.1016/0010-0277(92)90041-F; Roelofs A, 2014, J EXP PSYCHOL LEARN, V40, P1332, DOI 10.1037/a0036575; Roelofs A, 2013, LANG COGNITIVE PROC, V28, P655, DOI 10.1080/01690965.2011.615663; ROSINSKI RR, 1975, CHILD DEV, V46, P247, DOI 10.2307/1128859; Schnur TT, 2012, PSYCHON B REV, V19, P301, DOI 10.3758/s13423-011-0190-x; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Seiger-Gardner L, 2008, INT J LANG COMM DIS, V43, P528, DOI 10.1080/13682820701768581; Thompson CK, 2012, BRAIN LANG, V120, P237, DOI 10.1016/j.bandl.2011.11.003; Ueno T, 2011, NEURON, V72, P385, DOI 10.1016/j.neuron.2011.09.013; van Casteren M, 2006, BEHAV RES METHODS, V38, P584, DOI 10.3758/BF03193889; van Maanen L, 2012, COGNITIVE SCI, V36, P62, DOI 10.1111/j.1551-6709.2011.01213.x; van Maanen L, 2009, PSYCHON B REV, V16, P987, DOI 10.3758/PBR.16.6.987; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Xiao X, 2010, NEUROREPORT, V21, P104, DOI 10.1097/WNR.0b013e32833499ff	52	11	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161052	10.1371/journal.pone.0161052	http://dx.doi.org/10.1371/journal.pone.0161052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632171	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900015
J	Takesaki, N; Kikuchi, M; Yoshimura, Y; Hiraishi, H; Hasegawa, C; Kaneda, R; Nakatani, H; Takahashi, T; Mottron, L; Minabe, Y				Takesaki, Natsumi; Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Kaneda, Reizo; Nakatani, Hideo; Takahashi, Tetsuya; Mottron, Laurent; Minabe, Yoshio			The Contribution of Increased Gamma Band Connectivity to Visual Non-Verbal Reasoning in Autistic Children: A MEG Study	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; TOP-DOWN MODULATION; FUNCTIONAL CONNECTIVITY; SPATIAL VISUALIZATION; SPECTRUM DISORDER; BRAIN CONNECTIVITY; ALZHEIMERS-DISEASE; FLUID INTELLIGENCE; PHOTIC-STIMULATION; EEG COHERENCE	Some individuals with autism spectrum (AS) perform better on visual reasoning tasks than would be predicted by their general cognitive performance. In individuals with AS, mechanisms in the brain's visual area that underlie visual processing play a more prominent role in visual reasoning tasks than they do in normal individuals. In addition, increased connectivity with the visual area is thought to be one of the neural bases of autistic visual cognitive abilities. However, the contribution of such brain connectivity to visual cognitive abilities is not well understood, particularly in children. In this study, we investigated how functional connectivity between the visual areas and higher-order regions, which is reflected by alpha, beta and gamma band oscillations, contributes to the performance of visual reasoning tasks in typically developing (TD) (n = 18) children and AS children (n = 18). Brain activity was measured using a custom child-sized magneto-encephalograph. Imaginary coherence analysis was used as a proxy to estimate the functional connectivity between the occipital and other areas of the brain. Stronger connectivity from the occipital area, as evidenced by higher imaginary coherence in the gamma band, was associated with higher performance in the AS children only. We observed no significant correlation between the alpha or beta bands imaginary coherence and performance in the both groups. Alpha and beta bands reflect top-down pathways, while gamma band oscillations reflect a bottom-up influence. Therefore, our results suggest that visual reasoning in AS children is at least partially based on an enhanced reliance on visual perception and increased bottom-up connectivity from the visual areas.	[Takesaki, Natsumi; Kikuchi, Mitsuru; Kaneda, Reizo; Nakatani, Hideo; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa 9208640, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan; [Takahashi, Tetsuya] Univ Fukui, Hlth Adm Ctr, Matsuokashimoaizuki 9101193, Japan; [Mottron, Laurent] Univ Montreal, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada	Kanazawa University; Kanazawa University; University of Fukui; Universite de Montreal	Kikuchi, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa 9208640, Japan.; Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan.	mitsuruk@med.kanazawa-u.ac.jp	Hasegawa, Chiaki/HHS-2658-2022	Hasegawa, Chiaki/0000-0001-8730-8769; Mottron, Laurent/0000-0001-5668-5422	Centre of Innovation Programme from Japan Science and Technology Agency, JST;  [26293262]	Centre of Innovation Programme from Japan Science and Technology Agency, JST; 	Yoshio Minabe was supported by the Centre of Innovation Programme from the Japan Science and Technology Agency, JST. Mitsuru Kikuchi was supported by Grants-in-Aid for Scientific Research (B) (Research Number 26293262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb HM, 2004, PERCEPT MOTOR SKILL, V98, P865; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amso D, 2014, J AUTISM DEV DISORD, V44, P664, DOI 10.1007/s10803-013-1925-5; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Charman T, 2011, BRAIN RES, V1380, P10, DOI 10.1016/j.brainres.2010.10.075; Cook J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00175; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; Doesburg SM, 2016, NEUROIMAGE, V132, P512, DOI 10.1016/j.neuroimage.2016.02.076; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; GASSER T, 1985, ELECTROEN CLIN NEURO, V60, P312, DOI 10.1016/0013-4694(85)90005-7; Grandin T, 2009, PHILOS T R SOC B, V364, P1437, DOI 10.1098/rstb.2008.0297; Grandin T, 2009, BIOL PSYCHIAT, V65, P15, DOI 10.1016/j.biopsych.2008.11.005; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Hassan MM, 1999, PERCEPT MOTOR SKILL, V88, P387, DOI 10.2466/PMS.88.2.387-390; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; Karhson DS, 2016, AUTISM RES; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Keown CL, 2013, CELL REP, V5, P567, DOI 10.1016/j.celrep.2013.10.003; Khan S, 2015, BRAIN; Kikuchi M, 2002, CLIN NEUROPHYSIOL, V113, P1045, DOI 10.1016/S1388-2457(02)00129-3; Kikuchi M, 2015, SOC COGN AFFECT NEUR, V10, P248, DOI 10.1093/scan/nsu049; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; Kunda M, 2011, J AUTISM DEV DISORD, V41, P1157, DOI 10.1007/s10803-010-1137-1; Leveille C, 2010, AUTISM RES, V3, P280, DOI 10.1002/aur.155; Lopes da Silva F., 1991, ELECTROENCEPHALOGRAP, V79, P81, DOI DOI 10.1016/0013-4694(91)90044-5; Lord C., 1999, AUTISM DIAGNOSTIC OB; Maeda Y, 2013, EDUC PSYCHOL REV, V25, P69, DOI 10.1007/s10648-012-9215-x; Martin-Buro MC, 2016, HUM BRAIN MAPP, V37, P179, DOI 10.1002/hbm.23027; Michalareas G., 2016, NEURON; MOCKS J, 1984, ELECTROEN CLIN NEURO, V58, P89, DOI 10.1016/0013-4694(84)90205-0; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Nader A. M., 2014, J AUTISM DEV DISORD; Neumann D, 2006, SOC COGN AFFECT NEUR, V1, P194, DOI 10.1093/scan/nsl030; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Perreault A, 2015, NEUROPSYCHOLOGIA, V77, P380, DOI 10.1016/j.neuropsychologia.2015.09.022; Picci G, 2016, DEV SCI IN PRESS; Rudie JD, 2013, CELL REP, V5, P565, DOI 10.1016/j.celrep.2013.10.043; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Sekihara K, 2011, IEEE T BIO-MED ENG, V58, P3121, DOI 10.1109/TBME.2011.2162514; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Simard I, 2015, NEUROIMAGE-CLIN, V9, P467, DOI 10.1016/j.nicl.2015.09.007; Soulieres I, 2011, NEUROPSYCHOLOGIA, V49, P848, DOI 10.1016/j.neuropsychologia.2011.01.027; Soulieres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025372; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Spaak E, 2015, CEREB CORTEX, P14988, DOI [10.1523/JNEUROSCI.2785-11.2011, DOI 10.1523/JNEUROSCI.2785-11.2011]; Spreen O, 1998, COMPENDIUM NEUROPSYC; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Takarae Y, 2014, J INT NEUROPSYCH SOC, V20, P113, DOI 10.1017/S1355617713001203; Tavassoli T, 2015, AUTISM RES; Wada Y, 1998, EUR ARCH PSY CLIN N, V248, P203, DOI 10.1007/s004060050038; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Zheng CG, 2015, NEURON, V85, P236, DOI 10.1016/j.neuron.2014.12.067	65	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163133	10.1371/journal.pone.0163133	http://dx.doi.org/10.1371/journal.pone.0163133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631982	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900134
J	Ferris, LJ; Jetten, J; Molenberghs, P; Bastian, B; Karnadewi, F				Ferris, Laura J.; Jetten, Jolanda; Molenberghs, Pascal; Bastian, Brock; Karnadewi, Fika			Increased Pain Communication following Multiple Group Memberships Salience Leads to a Relative Reduction in Pain-Related Brain Activity	PLOS ONE			English	Article							SOCIAL SUPPORT; PHYSIOLOGICAL AROUSAL; ANTERIOR CINGULATE; RESPONSES; EMPATHY; CATEGORIZATION; SEPARATION; SIGNATURE; RECOVERY; INSULA	Pain is a fundamental human experience that triggers a range of social and psychological responses. In this study, we present behavioral and fMRI data to examine the effect of multiple group memberships salience on reported and neural indices of pain. We found that participants expressed higher levels of pain when more social group memberships were salient. This is consistent with the notion that pain itself motivates people to communicate their pain, and more so when multiple psychological resources are salient. In addition, fMRI results reveal an interesting twist: when participants increased their pain reporting as group memberships increased (from one group to four), there was a corresponding relative reduction in dorsal anterior cingulate cortex and anterior insula activation. These results provide evidence for an adaptive response to pain: the more people make use of the social resources at their disposal when experiencing pain, the less pain areas are activated.	[Ferris, Laura J.; Jetten, Jolanda; Karnadewi, Fika] Univ Queensland, Brisbane, Qld, Australia; [Molenberghs, Pascal] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Molenberghs, Pascal] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Bastian, Brock] Monash Univ, Melbourne, Vic, Australia	University of Queensland; Monash University; Monash University; Monash University	Ferris, LJ (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	l.ferris@uq.edu.au	Molenberghs, Pascal/C-8176-2009	Molenberghs, Pascal/0000-0003-0350-6659; Ferris, Laura/0000-0002-2127-1825; Bastian, Brock/0000-0003-4619-3322	Australian Research Council (ARC) [FT110100238]; ARC [DE130100120, DP130100559, DP140103716]; Heart Foundation Future Leader Fellowship [100458]	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); Heart Foundation Future Leader Fellowship	This research was supported by an Australian Research Council (ARC) Future Fellowship (FT110100238) awarded to Jolanda Jetten, an ARC Discovery Early Career Researcher Award (DE130100120) and Heart Foundation Future Leader Fellowship (100458) awarded to Pascal Molenberghs, an ARC Discovery Grant (DP130100559) awarded to Pascal Molenberghs, and an ARC Discovery Grant (DP140103716) awarded to Brock Bastian and Jolanda Jetten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2013, TRENDS COGN SCI, V17, P309, DOI 10.1016/j.tics.2013.05.001; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Cacioppo S, 2014, PSYCHOL BULL, V140, P1464, DOI 10.1037/a0037618; Cano A, 2009, PAIN, V147, P249, DOI 10.1016/j.pain.2009.09.023; COGAN R, 1988, J PSYCHOSOM OBST GYN, V8, P209, DOI 10.3109/01674828809016789; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Corns J, 2014, PHILOS STUD, V169, P355, DOI 10.1007/s11098-013-0186-7; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRAIG KD, 1968, J ABNORM PSYCHOL, V73, P513, DOI 10.1037/h0026531; Craig KD, 2004, PAIN, V107, P5, DOI 10.1016/S0304-3959(03)00264-1; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; Cruwys T, 2015, SOC PSYCHOL PERS SCI, V6, P65, DOI 10.1177/1948550614543309; Dingle GA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01795; Drury J., 2012, SOCIAL CURE IDENTITY; Durkheim E, 1912, LES FORMES ELEMENTAI; FERNANDEZ E, 1992, PSYCHOL BULL, V112, P205, DOI 10.1037/0033-2909.112.2.205; Greenaway KH, 2016, EUR J SOC PSYCHOL, V46, P294, DOI 10.1002/ejsp.2169; Greenaway KH, 2015, PERS SOC PSYCHOL B, V41, P171, DOI 10.1177/0146167214559709; Hadjistavropoulos T, 2011, PSYCHOL BULL, V137, P910, DOI 10.1037/a0023876; Haslam S.A., 2002, STEREOTYPES EXPLANAT, P157; HERMAN BH, 1978, PHARMACOL BIOCHEM BE, V9, P213, DOI 10.1016/0091-3057(78)90167-3; Hodnett E. D., 2015, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003766.PUB5; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jetten J., 2012, SOCIAL CURE IDENTITY, P3, DOI [10.4324/9780203813195, DOI 10.4324/9780203813195]; Jetten J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124609; Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003; Jones JM, 2011, SOC PSYCHOL PERS SCI, V2, P239, DOI 10.1177/1948550610386806; Kappesser J, 2006, PAIN, V124, P109, DOI 10.1016/j.pain.2006.04.003; KING KB, 1993, HEALTH PSYCHOL, V12, P56, DOI 10.1037/0278-6133.12.1.56; KULIK JA, 1989, HEALTH PSYCHOL, V8, P221, DOI 10.1037/0278-6133.8.2.221; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lopez-Martinez AE, 2008, J PAIN, V9, P373, DOI 10.1016/j.jpain.2007.12.002; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Mogil JS, 2015, PAIN, V156, pS35, DOI 10.1097/01.j.pain.0000460341.62094.77; Morris D. B., 1991, CULTURE PAIN; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Platow MJ, 2007, EUR J SOC PSYCHOL, V37, P649, DOI 10.1002/ejsp.381; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; POOLE GD, 1992, J PERS SOC PSYCHOL, V63, P797, DOI 10.1037/0022-3514.63.5.797; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Scarry Elaine, 1985, BODY PAIN MAKING UNM; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Stephens R, 2011, J PAIN, V12, P1274, DOI 10.1016/j.jpain.2011.09.004; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; Sullivan MJL, 2006, PAIN, V123, P37, DOI 10.1016/j.pain.2006.02.007; Sullivan MJL, 2012, CAN PSYCHOL, V53, P32, DOI 10.1037/a0026726; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Swee G, 2015, J PAIN, V16, P326, DOI 10.1016/j.jpain.2015.01.002; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tarrant M, 2009, BRIT J SOC PSYCHOL, V48, P427, DOI 10.1348/014466608X373589; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wager TD, 2013, PERSPECT PSYCHOL SCI, V8, P91, DOI 10.1177/1745691612469631; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Wong D, 1988, J PEDIAT, V4, P140; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Yamada M, 2009, PAIN, V143, P71, DOI 10.1016/j.pain.2009.01.028	65	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163117	10.1371/journal.pone.0163117	http://dx.doi.org/10.1371/journal.pone.0163117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657917	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200070
J	Gabster, A; Mohammed, DY; Arteaga, GB; Castillero, O; Mojica, N; Dyamond, J; Varela, M; Pascale, JM				Gabster, Amanda; Mohammed, Debbie Y.; Arteaga, Griselda B.; Castillero, Omar; Mojica, Nataly; Dyamond, Jose; Varela, Maria; Miguel Pascale, Juan			Correlates of Sexually Transmitted Infections among Adolescents Attending Public High Schools, Panama, 2015	PLOS ONE			English	Article							RISK BEHAVIORS; YOUNG-ADULTS; ABSTINENCE; PARTNERS; INTERCOURSE; PREVALENCE; INITIATION	Background Sexually transmitted infections (STIs) are common in adolescents worldwide. Vulnerability to STIs increases with risky sexual practices. This study described the sexual practices, estimated the prevalence of STIs, and identified correlates associated with STIs among participants, enrolled in public high schools, in the District of Panama, Panama. Methods A cross sectional study, using multistage cluster sampling, was conducted among participants, aged 14-18 years, enrolled in public high schools, in the District of Panama, Panama City, Panama, from August to November, 2015. Participants completed a self-administered questionnaire and provided biological samples. The samples of those reporting sexual activity (oral, vaginal, and/or anal intercourse) were tested for STIs. Odds ratios were used to identify correlates of STIs in this population. Results A total of 592 participants were included, of whom, 60.8% reported a history of sexual activity, and 24.4% tested positive for least one STI. STIs were more common in female participants, (33.5%). Compared to those without STIs, higher proportions of those with at least one STI reported >= 3 sexual partners in their lifetime (60.0%) and current sexual activity (76.3%). In the multivariable model, correlates of STI included female participants (Adjusted Odds Ratio (AOR) = 5.8, 95% Confidence Interval (CI) 2.3-14.6) and those who engaged in sexual intercourse with casual partners (AOR = 3.0, 95% CI: 1.2-7.5). Conclusions We report a high STI prevalence among adolescents attending public high schools, in the District of Panama. Reported risky sexual practices were common and correlated with STIs. Female participants and those reporting sexual intercourse with casual partners were more likely test positive for at least one STI. Our study identified a need for effective interventions to curb future infections in this population.	[Gabster, Amanda; Castillero, Omar; Dyamond, Jose; Miguel Pascale, Juan] Inst Conmemorativo Gorgas Estudios Salud, Dept Genom & Prote, Calle 35,Ave Justo Arosemena, Panama City, Panama; [Mohammed, Debbie Y.] William Paterson Univ, 300 Pompton Rd, Wayne, NJ 07470 USA; [Mohammed, Debbie Y.] St Michaels Hosp, 111 Cent Ave, Newark, NJ USA; [Arteaga, Griselda B.; Mojica, Nataly; Miguel Pascale, Juan] Univ Panama, Fac Med, Panama City, Panama; [Varela, Maria] Hosp Santo Tomas, Calle 37 Este, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Universidad de Panama	Gabster, A (corresponding author), Inst Conmemorativo Gorgas Estudios Salud, Dept Genom & Prote, Calle 35,Ave Justo Arosemena, Panama City, Panama.	agabster@gorgas.gob.pa	Gabster, Amanda/AAU-7587-2021	Gabster, Amanda/0000-0002-7712-0444	National Secretariat of Science, Technology and Innovation; Ministerio de Economia y Finanzas [009044.049]	National Secretariat of Science, Technology and Innovation; Ministerio de Economia y Finanzas	Ministerio de Economia y Finanzas, project number 009044.049, http://www.mef.gob.pa/es/Paginas/home.aspx. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We are grateful to all guardians, participants, school faculty and administrators who participated in the data and biological sample collection process. Additionally, we thank Ministry of Education personnel, especially Taydee Gordon from the Populations Department. We are grateful for the Ministry of Health's involvement, especially those health centers used for giving results, as well as Isolda Martinez, Yandra Avila, Gisselle Moran and Yenisey Mosley, who provided mental health support to the participants. We also extend our gratitude to the Medical Technology and Social Work students from the University of Panama for their help in sample collection, Jesus Mojica for his assistance with EpiInfo software, and Roxana Mendoza for her administrative assistance. Dr. Juan Miguel Pascale is a distinguished member of the National Research System that is supported by the National Secretariat of Science, Technology and Innovation.	[Anonymous], 2009, MULT NAT PLAN STI HI; Aramburu Maria G, 2012, Int J Adolesc Med Health, V24, P135, DOI 10.1515/ijamh.2012.020; Centers for Disease Control and Prevention, 2014, PELV INFL DIS PID CD; Centers for Disease Control and Prevention, 2009, SEX REPR HLTH PERS A; Centers for Disease Control and Prevention, 2014, STDS AD YOUNG AD; Centers for Disease Control and Prevention, SEX TRANSM DIS TREAT; Das A, 2013, SEX TRANSM INFECT, V89, P5, DOI 10.1136/sextrans-2012-050472; De Leon RG, 2011, ENCUESTA NACL SALUD; Decat P, 2015, EUR J CONTRACEP REPR, V20, P88, DOI 10.3109/13625187.2014.955846; DiClemente RJ, 2005, PUBLIC HEALTH, V119, P825, DOI 10.1016/j.puhe.2004.10.015; Epstein M, 2014, J SEX RES, V51, P721, DOI 10.1080/00224499.2013.849652; Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089692; Forhan SE, 2009, PEDIATRICS, V124, P1505, DOI 10.1542/peds.2009-0674; Gutierrez JP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-49; International Planned Parenthood Foundation, 2013, VOC UNIEND FUERZ REN; JOFFE GP, 1992, SEX TRANSM DIS, V19, P272, DOI 10.1097/00007435-199209000-00006; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; Kirby DB, SEX RES SOCIAL POLIC, V5; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Lo NC, 2016, HEALTH AFFAIR, V35, P856, DOI 10.1377/hlthaff.2015.0828; Maharaj Rohan G, 2009, Child Adolesc Psychiatry Ment Health, V3, P10, DOI 10.1186/1753-2000-3-10; Manlove J, 2006, PERSPECT SEX REPRO H, V38, P197, DOI 10.1363/3819706; Marrazzo JM, 1997, SEX TRANSM DIS, V24, P131, DOI 10.1097/00007435-199703000-00003; Ministry of Education, 2015, MATR MIDDL SCH HIGH; Ministry of Health, 2014, EP SURV TABL TOT GON; Ministry of Health, 2015, PERS EST INF AS VIR; Ministry of Health Caja de Seguro Social Instituto Conmemorativo Gorgas de Estudios de la Salud, 2015, NORM NAC AB INT INF; National STI/HIV/AIDS Program, 2013, GUIA AS AP SIC VIH S; Ryon S, 2008, PERSPECT SEX REPRO H, V40, P17, DOI 10.1363/4001708; Santelli JS, 1998, FAM PLANN PERSPECT, V30, P271, DOI 10.2307/2991502; Simms I, 2000, SEX TRANSM INFECT, V76, P80, DOI 10.1136/sti.76.2.80; Torrone E, PREVALENCE CHLAMYDIA; Tubman JG, 1996, J ADOLESCENT HEALTH, V18, P182, DOI 10.1016/1054-139X(95)00128-F; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; United Nations Kosovo Team, 2008, KNOWL ATT PRACT BEH; Valverde Z, 2012, B ESATADISTICO ANUAR; Valverde Z., 2013, SITUACION SALUD PANA; Westrom L, 1992, SEX TRANSM DIS, P185; *WHO, 2004, SEX TRANSM INF ISS A; World Health O, 2013, SEX TRANSM INF STIS; World Health Organization, 2015, SEX TRANSM INF FACT; World Health Organization, 2014, HLTH WORLDS AD; World Health Organization, 2014, CUEST ENC MUND SAL E; Yu Cheung A., 2015, AMBIENTE FAMILIAR RE	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163391	10.1371/journal.pone.0163391	http://dx.doi.org/10.1371/journal.pone.0163391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657700	gold, Green Published			2022-12-27	WOS:000383893200109
J	Jafarzadeh, J; Bonnett, D; Jannink, JL; Akdemir, D; Dreisigacker, S; Sorrells, ME				Jafarzadeh, Jafar; Bonnett, David; Jannink, Jean-Luc; Akdemir, Deniz; Dreisigacker, Susanne; Sorrells, Mark E.			Breeding Value of Primary Synthetic Wheat Genotypes for Grain Yield	PLOS ONE			English	Article							GENOMIC RELATIONSHIP MATRICES; BACKCROSS-DERIVED LINES; HEXAPLOID WHEAT; CHROMOSOMAL LOCATION; TRITICUM-TAUSCHII; BREAD WHEAT; RESISTANCE; DIVERSITY; TRAITS; POPULATION	To introduce new genetic diversity into the bread wheat gene pool from its progenitor, Aegi-lops tauschii (Coss.) Schmalh, 33 primary synthetic hexaploid wheat genotypes (SYN) were crossed to 20 spring bread wheat (BW) cultivars at the International Wheat and Maize Improvement Center. Modified single seed descent was used to develop 97 populations with 50 individuals per population using first back-cross, biparental, and three-way crosses. Individuals from each cross were selected for short stature, early heading, flowering and maturity, minimal lodging, and free threshing. Yield trials were conducted under irrigated, drought, and heat-stress conditions from 2011 to 2014 in Ciudad Obregon, Mexico. Genomic estimated breeding values (GEBVs) of parents and synthetic derived lines (SDLs) were estimated using a genomic best linear unbiased prediction (GBLUP) model with markers in each trial. In each environment, there were SDLs that had higher GEBVs than their recurrent BW parent for yield. The GEBVs of BW parents for yield ranged from -0.32 in heat to 1.40 in irrigated trials. The range of the SYN parent GEBVs for yield was from -2.69 in the irrigated to 0.26 in the heat trials and were mostly negative across environments. The contribution of the SYN parents to improved grain yield of the SDLs was highest under heat stress, with an average GEBV for the top 10% of the SDLs of 0.55 while the weighted average GEBV of their corresponding recurrent BW parents was 0.26. Using the pedigree-based model, the accuracy of genomic prediction for yield was 0.42, 0.43, and 0.49 in the drought, heat and irrigated trials, respectively, while for the marker-based model these values were 0.43, 0.44, and 0.55. The SYN parents introduced novel diversity into the wheat gene pool. Higher GEBVs of progenies were due to introgression and retention of some positive alleles from SYN parents.	[Jafarzadeh, Jafar; Akdemir, Deniz; Sorrells, Mark E.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA; [Bonnett, David; Dreisigacker, Susanne] CIMMYT, Int Maize & Wheat Improvement Ctr, El Batan 06600, Mexico; [Jannink, Jean-Luc] USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Bonnett, David] Bayer Crop Sci, Sabin, MN USA	Cornell University; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA); Bayer AG; Bayer CropScience	Jafarzadeh, J; Sorrells, ME (corresponding author), Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA.	jjafarzadeh52@gmail.com; mes12@cornell.edu	Akdemir, Deniz/ABC-2712-2020; Jafarzadeh, Jafar/O-3724-2017	Jannink, Jean-Luc/0000-0003-4849-628X; Jafarzadeh, Jafar/0000-0002-0144-6034	Monsanto's Beachell-Borlaug International Scholars Program; "Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA Mexico)" through the MasAgro Biodiversidad/Seeds of Discovery Project-CIMMYT; USDA-NIFA-AFRI grants [2009-65300-05661, 2011-68002-30029, 2005-05130]; Hatch project [149-449]; Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA, Mexico)	Monsanto's Beachell-Borlaug International Scholars Program; "Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA Mexico)" through the MasAgro Biodiversidad/Seeds of Discovery Project-CIMMYT; USDA-NIFA-AFRI grants; Hatch project(United States Department of Agriculture (USDA)); Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA, Mexico)	This work was a Ph.D. project entitled, "Determining the breeding value of primary synthetic wheats for increased grain yield" was funded by the Monsanto's Beachell-Borlaug International Scholars Program which supports Ph.D. students from developing countries who are working on breeding of wheat and rice. This award did not have grant number and the funder's URL is http://www.monsanto.com/improvingagriculture/Pages/beachell-borlaug-internationalscholars-propram.aspx. This project was conducted in the Global Wheat Program (GWP) of the International Maize and Wheat Improvement Center (CIMMYT), Mexico that developed the experimental populations and supported two years of field trials. Funding to conduct the first year of phenotypic experiments and to generate the sequencing data used in this project was provided by "Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA Mexico)" through the MasAgro Biodiversidad/Seeds of Discovery Project-CIMMYT. http://www.cimmyt.org, http://www.cimmyt.org/seeds-of-discovery/, http://www.cimmyt.org/project-profile/masagro-biodiversity/, http://seedsofdiscovery.org/. This research was supported in part by USDA-NIFA-AFRI grants, award numbers 2009-65300-05661, 2011-68002-30029, and 2005-05130, and by Hatch project 149-449.; We are grateful to the Monsanto's Beachell-Borlaug International Scholars Program which supports Ph.D. students from developing countries who are working on breeding of wheat and rice. We are grateful to the Global Wheat Program of the International Maize and Wheat Improvement Center (CIMMYT) for excellent collaboration with Cornell University and to "Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion (SAGARPA, Mexico)" for supporting the MasAgro Biodiversidad/Seeds of Discovery Project-CIMMYT to conduct this study.	Akdemir D, 2014, PACKAGE EMMREML, P1; Bassi FM, 2016, PLANT SCI, V242, P23, DOI 10.1016/j.plantsci.2015.08.021; Christiansen MJ, 2002, MOL BREEDING, V9, P1, DOI 10.1023/A:1019234323372; Cooper JK, 2012, CROP SCI, V52, P2014, DOI 10.2135/cropsci2011.07.0382; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; del Blanco IA, 2001, CROP SCI, V41, P670, DOI 10.2135/cropsci2001.413670x; Dreccer AF, 2007, FIELD CROP RES, V100, P218, DOI 10.1016/j.fcr.2006.07.005; Dreisigacker S, 2008, AUST J AGR RES, V59, P413, DOI 10.1071/AR07225; Dreisigacker S, 2013, ICAR CIMMYT MOL BREE, P36; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Gao HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-8; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gororo NN, 2002, EUPHYTICA, V123, P241, DOI 10.1023/A:1014910000128; Haile-Mariam M, 2003, ANIM SCI, V76, P35, DOI 10.1017/S1357729800053297; Heckenberger M, 2002, MOL BREEDING, V10, P181, DOI 10.1023/A:1020539330957; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; KEMA GHJ, 1995, PHYTOPATHOLOGY, V85, P425, DOI 10.1094/Phyto-85-425; Kosman E, 2003, PLANT PATHOL, V52, P533, DOI 10.1046/j.1365-3059.2003.00923.x; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Li J, 2014, J SYST EVOL, V52, P735, DOI 10.1111/jse.12110; Li Jun, 2011, Acta Agronomica Sinica, V37, P255; Loberg A, 2015, J ANIM BREED GENET, V132, P376, DOI 10.1111/jbg.12142; Lopes MS, 2011, CROP SCI, V51, P1617, DOI 10.2135/cropsci2010.07.0445; Cossani CM, 2015, CROP SCI, V55, P2719, DOI 10.2135/cropsci2015.02.0092; Mehmani A, 2015, STRUCT MULTIDISCIP O, V52, P353, DOI 10.1007/s00158-015-1234-z; Meuwissen THE, 2001, GENETICS, V157, P1819; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Mulki MA, 2013, MOL BREEDING, V31, P299, DOI 10.1007/s11032-012-9790-z; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Ogbonnaya FC, 2008, AUST J AGR RES, V59, P421, DOI 10.1071/AR07227; Ogbonnaya FC, 2007, EUPHYTICA, V157, P321, DOI 10.1007/s10681-007-9381-y; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Pradeep Sharma, 2014, Australian Journal of Crop Science, V8, P515; Reddy N., 1996, P 8 ASS WHEAT BREED, P24; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Reynolds M., 2012, PHYSL BREEDING 2; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Russell JR, 2000, MOL BREEDING, V6, P553, DOI 10.1023/A:1011372312962; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Simon MR, 2005, NJAS-WAGEN J LIFE SC, V53, P113, DOI 10.1016/S1573-5214(05)80001-6; Timm NH, 2002, APPLIED MULTIVARIATE; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Verhulst N, 2011, FIELD CROP RES, V124, P347, DOI 10.1016/j.fcr.2011.07.002; Villanueva B, 2005, J ANIM SCI, V83, P1747; VILLAREAL RL, 1994, PLANT BREEDING, V112, P63, DOI 10.1111/j.1439-0523.1994.tb01277.x; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Zapata-Valenzuela J, 2013, G3-GENES GENOM GENET, V3, P909, DOI 10.1534/g3.113.005975; Zhang PZ, 2005, MOL BREEDING, V15, P1, DOI 10.1007/s11032-004-1167-5	54	33	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e162860	10.1371/journal.pone.0162860	http://dx.doi.org/10.1371/journal.pone.0162860			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656893	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200035
J	Nlend, AEN; Nguwoh, PS; Ngounouh, CT; Tchidjou, HK; Pieme, CA; Otele, JM; Penlap, V; Colizzi, V; Moyou, RS; Fokam, J				Nlend, Anne Esther Njom; Nguwoh, Philippe Salomon; Ngounouh, Christian Taheu; Tchidjou, Hyppolite Kuekou; Pieme, Constant Anatole; Otele, Jean Mbede; Penlap, Vearonique; Colizzi, Vittorio; Moyou, Roger Somo; Fokam, Joseph			HIV-Infected or -Exposed Children Exhibit Lower Immunogenicityto Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?	PLOS ONE			English	Article							SURFACE-ANTIGEN; FOLLOW-UP; VIRUS; IMMUNIZATION; INFANTS; ANTIBODY; PROGRAM	Background Since 2005, anti-hepatitis B virus (anti-HBV) vaccine is part of the Expanded Program on Immunization (EPI) for infants born in Cameroon, with 99% anti-HBV coverage. In a context of generalized HIV epidemiology, we assessed paediatric anti-HBV vaccine response according to HIV status, feeding option and age in a tropical context. Methodology Prospective, observational and cross-sectional study conducted among 82 children (27 [IQR: 9-47] months, min-max: 6-59), after complete anti-HBV vaccination (Zilbrix Hepta: 10 mu g AgHBs) at the Essos Health Centre in Yaounde, Cameroon, classified as group-A: HIV unexposed (28), group-B: HIV-exposed/uninfected (29), group-C: HIV-infected (25). Quantitative anti-HBs ELISA was interpreted as "no", "low-" or "protective-response" with < 1, 1-10, or >= 10 IU/L respectively; with p-value< 0.05 considered significant. Results Children were all HBV-unexposed (AcHBc-negative) and uninfected (HBsAg-negative). Response to anti-HBV vaccine was 80.49% (66/82), with only 45.12% (37/82) developed a protective-response (>= 10IU/L). According to HIV status, 60.71% (17/28) developed a protective-response in group-A, vs. 51.72% (15/29) and 20% (5/25) in group-B and group-C respectively, Odds Ratio (OR): 2.627 [CI95% 0.933-7.500], p = 0.041. According to feeding option during first six months of life, 47.67% (21/45) developed a protective-response on exclusive breastfeeding vs. 43.24% (16/37) on mixed or formula feeding, OR: 1.148 [CI95% 0.437-3.026], p = 0.757. According to age, protective-response decreased significantly as children grow older: 58.33% (28/48) < 24 months vs. 26.47% (9/34) >= 24 months, OR: 3.889 [CI95% 1.362-11.356], p = 0.004; and specifically 67.65% (23/34) <= 6 months vs. 0%, (0/5) 33-41 months, p = 0.008. Conclusions Anti-HBV vaccine provides low rate of protection (< 50%) among children in general, and particularly if HIV-exposed, infected and/or older children. Implementing policies for early vaccination, specific immunization algorithm for HIV-exposed/infected children, and monitoring vaccine response would ensure effective protection in tropical settings, pending extensive/confirmatory investigations.	[Nlend, Anne Esther Njom] Natl Insurance Fund Welf Hosp, Serv Pediat, Yaounde, Cameroon; [Nlend, Anne Esther Njom; Pieme, Constant Anatole; Moyou, Roger Somo; Fokam, Joseph] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Nguwoh, Philippe Salomon; Pieme, Constant Anatole; Otele, Jean Mbede; Penlap, Vearonique] Higher Inst Hlth Profess, Yaounde, Cameroon; [Nguwoh, Philippe Salomon] Minist Publ Hlth, Yaounde, Cameroon; [Nguwoh, Philippe Salomon; Ngounouh, Christian Taheu] Inst Sci & Technol Appl Hlth, Yaounde, Cameroon; [Tchidjou, Hyppolite Kuekou] Bambino Gesu Paediat Hosp, Rome, Italy; [Penlap, Vearonique] Univ Yaounde I, Fac Sci, Dept Biochem & Microbiol, Yaounde, Cameroon; [Colizzi, Vittorio; Moyou, Roger Somo; Fokam, Joseph] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Colizzi, Vittorio; Fokam, Joseph] Univ Roma Tor Vergata, Rome, Italy; [Colizzi, Vittorio] UNESCO Interdisciplinary Board Biotechnol, Rome, Italy; [Moyou, Roger Somo] Inst Res Med & Med Plants, Yaounde, Cameroon	University of Yaounde I; IRCCS Bambino Gesu; University of Yaounde I; University of Rome Tor Vergata	Fokam, J (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Fokam, J (corresponding author), Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon.; Fokam, J (corresponding author), Univ Roma Tor Vergata, Rome, Italy.	josephfokam@gmail.com	Anatole, PIEME Constant/O-1765-2015; NLEND, ANNE ESTHER NJOM/AAZ-8748-2020	Anatole, PIEME Constant/0000-0003-1602-6494; tchidjou kuekou, hyppolite/0000-0001-9573-3845				Abramczuk BM, 2011, CLIN VACCINE IMMUNOL, V18, P1406, DOI 10.1128/CVI.05065-11; Beghin JC, 2017, J MED VIROL, V89, P182, DOI 10.1002/jmv.24598; Bekondi C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1000-2; Billong SC, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.79.4216; Bose D, 2016, INDIAN J PEDIAT; Bruce MG, 2016, J INFECT DIS, V214, P16, DOI 10.1093/infdis/jiv748; Garcia-Knight MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143043; Hesseling AC, 2016, VACCINE, V34, P3702, DOI 10.1016/j.vaccine.2016.03.081; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Hsu HY, 2015, HEPATOLOGY, V61, P1183, DOI 10.1002/hep.27650; Hsu HY, 2013, J INFECT DIS, V207, P1047, DOI 10.1093/infdis/jis943; Irungu E, 2013, J INFECT DIS, V207, P402, DOI 10.1093/infdis/jis695; Klushkina VV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157161; Kourtis AP, 2012, NEW ENGL J MED, V367, P2362; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Njoya O, 2014, FACTEURS ASS ENFANT; Ota MOC, 2004, VACCINE, V22, P511, DOI 10.1016/j.vaccine.2003.07.020; Rey-Cuille MA, 2013, PEDIATR INFECT DIS J, V32, P1110, DOI 10.1097/INF.0b013e31829be401; Rey-Cuille MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038153; RUTSTEIN RM, 1994, AIDS, V8, P1281, DOI 10.1097/00002030-199409000-00010; Salpini R, 2015, CURR HIV RES; Temgoua EMS, 2015, CURR HIV RES, V13, P286, DOI 10.2174/1570162X13666150407143525; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Tsiazoc HPT, 2014, EVALUATION REPONSE P; UNAIDS, GLOB REP UNAIDS REP; World Health Organisation, 2008, WKLY EPIDEMIOL REC, V83, P429; World Health Organisation, 2015, GLOB SUMM HIV AIDS E; Wu JF, 2008, PEDIATR RES, V64, P100, DOI 10.1203/PDR.0b013e3181732908	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161714	10.1371/journal.pone.0161714	http://dx.doi.org/10.1371/journal.pone.0161714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656883	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200011
J	Pegas, RV; Leal, MED; Kellner, AWA				Pegas, Rodrigo Vargas; de Castro Leal, Maria Eduarda; Armin Kellner, Alexander Wilhelm			A Basal Tapejarine (Pterosauria; Pterodactyloidea; Tapejaridae) from the Crato Formation, Early Cretaceous of Brazil	PLOS ONE			English	Article							AZHDARCHOID PTEROSAUR; JIUFOTANG FORMATION; ONTOGENY; TAXONOMY; CHINA	A three-dimensional and almost complete pterosaur mandible from the Crato Formation (Early Cretaceous of Northeastern Brazil), Araripe Basin, is described as a new species of a tapejarine tapejarid. Tapejarines are a particular group of toothless pterosaurs, characterized by well-developed cranial crests, downturned rostra, and have been proposed to represent frugivorous flying reptiles. Though comparatively well represented and distributed, the evolutionary history of the group is still poorly known, and the internal relationships of its members are not well understood. The new species here reported, named Aymberedactylus cearensis gen. et sp. nov., adds new data concerning the evolution of the group, concerning their morphology and geographical origin. It differs from known tapejarids due to its unusually elongate retroarticular process and a shallow fossa on the splenial exhibiting distinctive rugose texture. Furthermore, it exhibits a suite of basal and derived conditions within the Tapejaridae, demonstrating how their morphological traits probably evolved and that these forms were even more diverse than already acknowledged. The discovery of Aymberedactylus cearensis sheds new light on the evolutionary history of the Tapejarinae.	[Pegas, Rodrigo Vargas; Armin Kellner, Alexander Wilhelm] Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Systemat & Taphon Fossil Vertebrates, Rio De Janeiro, Brazil; [de Castro Leal, Maria Eduarda] Univ Fed Ceara, Dept Geol, Fortaleza, Ceara, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara	Pegas, RV (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Systemat & Taphon Fossil Vertebrates, Rio De Janeiro, Brazil.	pegas.rv@mn.ufrj.br	Kellner, Alexander/ABE-9591-2020; PEGAS, RODRIGO/P-3871-2019; Kellner, Alexander W/H-1023-2015	Kellner, Alexander/0000-0001-7174-9447; PEGAS, RODRIGO/0000-0003-2909-3346; Kellner, Alexander W/0000-0001-7174-9447	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [213265, E-26/102.737/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [CNPq 304780/2013-8]; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) [CNPq/FUNCAP-DCR/305426/2014-1]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) http://www.faperj.br/Grant numbers 213265 to RVP and E-26/102.737/2012 to AWAK. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) http://cnpq.br/ Grant number CNPq 304780/2013-8 to AWAK. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) & Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) http://www.funcap.ce.gov.br/ Grant number CNPq/FUNCAP-DCR/305426/2014-1 to MECL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires ASS, 2014, PALAEONTOLOGY, V57, P343, DOI 10.1111/pala.12069; Andres B, 2013, T ROY SOC EDIN-EARTH, P1, DOI [10. 1017/91755691013000303, DOI 10.1017/91755691013000303]; Andres B, 2014, CURR BIOL, V24, P1011, DOI 10.1016/j.cub.2014.03.030; Assine ML., 2007, B GEOCIENCIAS PETROB, V15, P371; Averianov A, 2008, PALEONTOL J+, V42, P634, DOI 10.1134/S0031030108060099; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P264; Averianov A, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.432.7913; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; Bennett SC, 2013, NEUES JAHRB GEOL P-A, V267, P23, DOI 10.1127/0077-7749/2012/0295; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BRIGGS DEG, 1981, LETHAIA, V14, P157, DOI 10.1111/j.1502-3931.1981.tb01918.x; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Campos Diogenes De A., 1997, Anais da Academia Brasileira de Ciencias, V69, P83; Dong Z., 2003, GLOBAL GEOLOGY, V22, P1; Fielding S, 2005, PALAEONTOLOGY, V48, P1301, DOI 10.1111/j.1475-4983.2005.00508.x; Frey Eberhard, 2003, Geological Society Special Publication, V217, P55, DOI 10.1144/GSL.SP.2003.217.01.05; Frey Eberhard, 2003, Geological Society Special Publication, V217, P65, DOI 10.1144/GSL.SP.2003.217.01.06; Goloboff P.A., 2003, TREE ANAL USING NEW; Headden JA, 2015, HIST BIOL, V27, P815, DOI 10.1080/08912963.2014.904302; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Kellner, 2006, PTEROSSAUROS SENHORE; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; Kellner A.W.A., 1991, P376; Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2013, AN ACAD BRAS CIENC, V85, P113, DOI 10.1590/S0001-37652013000100009; Kellner AWA, 2010, AN ACAD BRAS CIENC, V82, P1063, DOI 10.1590/S0001-37652010000400025; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 2013, EARTH ENV SCI T R SO, V103, P1, DOI DOI 10.1017/S1755691013000327; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2007, ACTA GEOL SINICA, V79, P453; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Maisey JG, 1991, SANTANA FOSSILS ILLU; Manzig PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100005; Martill DM, 2007, B GEOCIENCIAS PETROB; Martins Neto R.G., 1988, Anais da Academia Brasileira de Ciencias, V60, P61; Naish D., 2007, CRATO FOSSIL BEDS BR, P525; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Rodrigues T, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.308.5559; Sayao JM, 2011, AN ACAD BRAS CIENC, V83, P197, DOI 10.1590/S0001-37652011000100010; Sayao Juliana M., 1998, Journal of Vertebrate Paleontology, V18, p75A; Sayao Juliana M., 2000, Boletim do Museu Nacional Nova Serie Geologia, V54, P1; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; Valenca L. M. M., 2003, Geologica Acta, V1, P261; Veldmeijer Andre J., 2005, Deinsea (Rotterdam), P67; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wang Xiao-Lin, 2003, Vertebrata Palasiatica, V41, P34; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Webster M, 1999, J PALEONTOL, V73, P355, DOI 10.1017/S0022336000027827; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655; Witton MP, 2009, CRETACEOUS RES, V30, P1293, DOI 10.1016/j.cretres.2009.07.006; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x; Zhou CF, 2010, NEUES JAHRB GEOL P-A, V257, P341, DOI 10.1127/0077-7749/2010/0081	64	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162692	10.1371/journal.pone.0162692	http://dx.doi.org/10.1371/journal.pone.0162692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655346	Green Published, gold			2022-12-27	WOS:000383892700029
J	Azarpeykan, S; Dittmer, KE; Marshall, JC; Perera, KC; Gee, EK; Acke, E; Thompson, KG				Azarpeykan, Sara; Dittmer, Keren E.; Marshall, Jonathan C.; Perera, Kalyani C.; Gee, Erica K.; Acke, Els; Thompson, Keith G.			Evaluation and Comparison of Vitamin D Responsive Gene Expression in Ovine, Canine and Equine Kidney	PLOS ONE			English	Article							EPITHELIAL CA2+ CHANNEL; CALCIUM-TRANSPORT; TRPV5; PROTEINS; DUODENUM; SHEEP; ABSORPTION; MECHANISMS; PHOSPHATE; PMCA1B	The aim of this study was to determine the relative abundance and relationship of vitamin D responsive and calcium transporting transcripts (TRPV5, TRPV6, calD(9k), calD(28k), PMCA, NCX1, CYP27B1, CYP24A1, and VDR) in ovine, canine and, equine kidney using quantitative real-timePCR (RT-qPCR), and then performa comparison between the three species. Renal tissue samples were harvested post-mortemfrom 10 horses, 10 sheep, and five dogs. Primerswere designed for each gene. For each sample total RNA was extracted, cDNA synthesised, and RT-qPCR was performed. RT-qPCR data were normalised and statistical comparisonwas performed. Due to their consistent correlation with each other in each species, TRPV6, calD(9k)/calD(28k), and PMCA appeared to be the main pathways involved in active transepithelial calcium transport in the kidney of sheep, dogs and horses. The results indicate that all of the studied genes were expressed in the renal tissue of studied species, although the expression levels and correlation of transcripts with each other were different from species to species. All vitamin D responsive and calcium transporting transcripts were highly correlated with VDR in equine kidney, but not in sheep and dogs. The CYP27B1 and CYP24A1 mRNAs showed a different renal expression pattern and correlation in horses compared with sheep and dogs. Given the high urinary calcium concentration and low serum 1,25(OH)(2)D concentration in horses, it could be expected that CYP27B1 expression would be lower than CYP24A1 in the horse, and this did not appear to be the case. The findings suggest that despite low serum vitamin D concentrations, vitamin D still plays a significant role in calcium metabolism in horses, especially given the strong correlations between VDR and vitamin D responsive transcripts in these animals.	[Azarpeykan, Sara; Dittmer, Keren E.; Perera, Kalyani C.; Gee, Erica K.; Acke, Els; Thompson, Keith G.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Marshall, Jonathan C.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	Azarpeykan, S (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	S.Azarpeykan@massey.ac.nz	Dittmer, Keren/AAR-3148-2021; Gee, Erica/Y-1999-2018	Dittmer, Keren/0000-0002-1813-2197; Gee, Erica/0000-0001-5218-6589; Azarpeykan, Sara/0000-0003-4229-3115				Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Alexander RT, 2014, BIOCHEM CELL BIOL, V92, P467, DOI 10.1139/bcb-2014-0061; Azarpeykan S, 2016, J ANIM PHYSIOL AN N, V100, P1058, DOI 10.1111/jpn.12477; Azarpeykan S, 2016, DOMEST ANIM ENDOCRIN, V56, P75, DOI 10.1016/j.domaniend.2016.03.003; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bonny O, 2013, AM J PHYSIOL-RENAL, V304, pF585, DOI 10.1152/ajprenal.00493.2012; BORKE JL, 1989, AM J PHYSIOL, V257, pF842, DOI 10.1152/ajprenal.1989.257.5.F842; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Breidenbach A, 1998, VET RES, V29, P173; COSTANZO LS, 1978, AM J PHYSIOL, V235, pF492, DOI 10.1152/ajprenal.1978.235.5.F492; Dittmer KE, 2011, VET PATHOL, V48, P389, DOI 10.1177/0300985810375240; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herm G, 2015, J ANIM SCI, V93, P1608, DOI 10.2527/jas.2014-8450; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hwang I, 2011, J VET MED SCI, V73, P1437, DOI 10.1292/jvms.11-0141; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kayis SA, 2011, ANIM REPROD SCI, V125, P124, DOI 10.1016/j.anireprosci.2011.02.019; Kim JA, 2011, IN VIVO, V25, P773; Kumar R, 2012, ARCH BIOCHEM BIOPHYS, V523, P77, DOI 10.1016/j.abb.2012.03.003; Lefebvre HP, 2008, VET CLIN PATH, V37, P4, DOI 10.1111/j.1939-165X.2008.00010.x; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; MAENPAA PH, 1988, J ANIM SCI, V66, P1418; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; Mensenkamp A. R., 2007, V179, P207; PAK CYC, 1975, NEW ENGL J MED, V292, P497, DOI 10.1056/NEJM197503062921002; Palm C, 2010, ANAT REC, V293, P770, DOI 10.1002/ar.21104; Palviainen M, 2012, VET J, V193, P287, DOI 10.1016/j.tvjl.2011.10.004; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; R Core Team, 2021, R LANGUAGE ENV STAT; Radlovic N, 2012, SRP ARK CELOK LEK, V140, P110, DOI 10.2298/SARH1202110R; Rourke KM, 2010, GEN COMP ENDOCR, V167, P6, DOI 10.1016/j.ygcen.2010.02.022; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Sprekeler N, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-65; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2nd ed., P415; Strehler EE, 2015, BIOCHEM BIOPH RES CO, V460, P26, DOI 10.1016/j.bbrc.2015.01.121; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; Wilkens MR, 2014, ANIM PROD SCI, V54, P1507, DOI 10.1071/AN14349; Wilkens MR, 2012, COMP BIOCHEM PHYS A, V163, P396, DOI 10.1016/j.cbpa.2012.06.011; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162598	10.1371/journal.pone.0162598	http://dx.doi.org/10.1371/journal.pone.0162598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632366	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900057
J	Chen, YL; Cao, J; Zhang, XB				Chen, Yulei; Cao, Jiao; Zhang, Xiaobo			The Role of Cytokine PF4 in the Antiviral Immune Response of Shrimp	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; INNATE IMMUNITY; PENAEUS-JAPONICUS; ADAPTIVE IMMUNITY; VIRAL-INFECTION; IN-VIVO; PHAGOCYTOSIS; PLATELET-FACTOR-4; PROTEIN; CANCER	During viral infection in vertebrates, cytokines play important roles in the host defense against the virus. However, the function of cytokines in invertebrates has not been well characterized. In this study, shrimp cytokines involved in viral infection were screened using a cytokine antibody microarray. The results showed that three cytokines, the Fas receptor (Fas), platelet factor 4 (PF4) and interleukin-22 (IL-22), were significantly upregulated in the white spot syndrome virus (WSSV)-challenged shrimp, suggesting that these cytokines played positive regulatory roles in the immune response of shrimp against the virus. Further experiments revealed that PF4 had positive effects on the antiviral immunity of shrimp by enhancing the shrimp phagocytic activity and inhibiting the apoptotic activity of virus-infected hemocytes. Therefore, our study presented a novel mechanism of cytokines in the innate immunity of invertebrates.	[Chen, Yulei; Cao, Jiao; Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, XB (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	National Natural Science Foundation of China [41276152, 31430089]; National Program on the Key Basic Research Project [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on the Key Basic Research Project	This work was financially supported by National Natural Science Foundation of China (41276152, 31430089) and National Program on the Key Basic Research Project (2015CB755903).	Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; Fantuzzi G, 2011, THESCIENTIFICWORLDJO, V11, P2506, DOI 10.1100/2011/271206; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Han F, 2007, FISH SHELLFISH IMMUN, V23, P937, DOI 10.1016/j.fsi.2007.01.022; He YD, 2014, J VIROL, V88, P1104, DOI 10.1128/JVI.02455-13; Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Huang TZ, 2014, J VIROL, V88, P2544, DOI 10.1128/JVI.03575-13; Huang TZ, 2013, EUR J IMMUNOL, V43, P137, DOI 10.1002/eji.201242806; Huang TZ, 2012, J VIROL, V86, P12997, DOI 10.1128/JVI.01702-12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Liang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0275-7; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Matte I, 2012, AM J CANCER RES, V2, P566; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Peng XX, 2013, DEV COMP IMMUNOL, V39, P63, DOI 10.1016/j.dci.2012.03.017; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Rajeshkumar S, 2009, FISH SHELLFISH IMMUN, V26, P429, DOI 10.1016/j.fsi.2009.01.003; RUCINSKI B, 1990, THROMB HAEMOSTASIS, V63, P493; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Wang PH, 2014, ANTIVIR RES, V108, P129, DOI 10.1016/j.antiviral.2014.05.013; Wang ZW, 2016, DEV COMP IMMUNOL, V63, P111, DOI 10.1016/j.dci.2016.05.020; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Ye T, 2012, J PROTEOME RES, V11, P4834, DOI 10.1021/pr300274k; Ye T, 2012, FISH SHELLFISH IMMUN, V33, P350, DOI 10.1016/j.fsi.2012.05.017; Zhao Z, 2011, FISH SHELLFISH IMMUN, V31, P1013, DOI 10.1016/j.fsi.2011.08.022; Zhu F, 2015, FISH SHELLFISH IMMUN, V47, P777, DOI 10.1016/j.fsi.2015.10.015; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2	47	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162954	10.1371/journal.pone.0162954	http://dx.doi.org/10.1371/journal.pone.0162954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631372	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900100
J	Chin, T; Tsai, SB; Fang, K; Zhu, WZ; Yang, DJ; Liu, RH; Tsuei, RTC				Chin, Tachia; Tsai, Sang-Bing; Fang, Kai; Zhu, Wenzhong; Yang, Dongjin; Liu, Ren-huai; Tsuei, Richard Ting Chang			EO-Performance relationships in Reverse Internationalization by Chinese Global Startup OEMs: Social Networks and Strategic Flexibility	PLOS ONE			English	Article							ENTREPRENEURIAL ORIENTATION; BUSINESS PERFORMANCE; FIRM PERFORMANCE; INNOVATIVENESS; PROACTIVENESS; SUGGESTIONS; VENTURES; HARMONY	Due to the context-sensitive nature of entrepreneurial orientation (EO), it is imperative to in-depth explore the EO-performance mechanism in China at its critical, specific stage of economic reform. Under the context of "reverse internationalization" by Chinese global startup original equipment manufacturers (OEMs), this paper aims to manifest the unique links and complicated interrelationships between the individual EO dimensions and firm performance. Using structural equation modeling, we found that during reverse internationalization, proactiveness is positively related to performance; risk taking is not statistically associated with performance; innovativeness is negatively related to performance. The proactiveness-performance relationship is mediated by Strategic flexibility and moderated by social networking relationships. The dynamic and complex institutional setting, coupled with the issues of overcapacity and rising labor cost in China may explain why our distinctive results occur. This research advances the understanding of how contingent factors (social network relationships and strategic flexibility) facilitate entrepreneurial firms to break down institutional barriers and reap the most from EO. It brings new insights into how Chinese global startup OEMs draw on EO to undertake reverse internationalization, responding the calls for unraveling the heterogeneous characteristics of EO sub-dimensions and for more contextually-embedded treatment of EO-performance associations.	[Chin, Tachia] Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Tsai, Sang-Bing] Dongguan Univ Technol, Coll Business Adm, Dongguan, Guangdong, Peoples R China; [Tsai, Sang-Bing] Univ Elect Sci & Technol China, Zhongshan Inst, Huizhou, Guangdong, Peoples R China; [Tsai, Sang-Bing] Nankai Univ, Sch Law, Tianjin, Peoples R China; [Fang, Kai] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY USA; [Zhu, Wenzhong] Guangdong Univ Foreign Studies, Sch Business, Guangzhou, Guangdong, Peoples R China; [Yang, Dongjin] Jinan Univ, Sch Management, Guangzhou, Guangdong, Peoples R China; [Liu, Ren-huai] Jinan Univ, Res Ctr Strateg Management, Guangzhou, Guangdong, Peoples R China; [Liu, Ren-huai] Hangzhou Dianzi Univ, Inst Innovat & Dev, Hangzhou, Zhejiang, Peoples R China; [Tsuei, Richard Ting Chang] GuanxiWuzhou Zhongheng Grp Co Ltd, Wuzhou, Guangxi, Peoples R China	Hangzhou Dianzi University; Dongguan University of Technology; University of Electronic Science & Technology of China; Nankai University; Columbia University; Guangdong University of Foreign Studies; Jinan University; Jinan University; Hangzhou Dianzi University	Chin, T (corresponding author), Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.	tachia1231@yahoo.com.sg	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829	Innovative School Project in Higher Education of Guangdong Province, China [GWTP-LH-2014-01]; Guangdong University of Foreign Studies [Guangwaike [2016]2]	Innovative School Project in Higher Education of Guangdong Province, China; Guangdong University of Foreign Studies	This paper is supported by the 2014 Innovative School Project in Higher Education of Guangdong Province, China (GWTP-LH-2014-01) and the 2016 Research Innovation Team Project of Guangdong University of Foreign Studies (Guangwaike [2016]2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although one author is currently employed by a commercial company (i.e., Guanxi Wuzhou Zhongheng Group Co. Ltd), this affiliation is only an employer of this author and didn't play any role in this study.	Acquaah M, 2012, STRATEGIC MANAGE J, V33, P1215, DOI 10.1002/smj.1973; Anderson AR, 2010, SCAND J MANAG, V26, P121, DOI 10.1016/j.scaman.2010.01.005; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Baron RA, 2009, J MANAGE, V35, P282, DOI 10.1177/0149206307312513; Chen CC, 2013, MANAGE ORGAN REV, V9, P167, DOI 10.1111/more.12010; Child J., 2005, MANAGE ORGAN REV, V1, P381, DOI [10.1111/j.1740-8784.2005.0020a.x, DOI 10.1111/J.1740-8784.2005.0020A.X]; Chin T, 2015, ASIA PACIFIC BUSINES, V22, P201; Chin T., 2013, INT BUSINESS RES, V6, P199; Chin TC, 2015, INT J CONFL MANAGE, V26, P288, DOI 10.1108/IJCMA-09-2014-0074; Chin T, 2015, INT J HUM RESOUR MAN, V26, P1110, DOI 10.1080/09585192.2014.934882; Chin TC, 2014, CROSS CULT MANAG, V21, P326, DOI 10.1108/CCM-05-2012-0038; Cohen J., 2003, APPL MULTIPLE REGRES; Covin JG, 2012, ENTREP THEORY PRACT, V36, P677, DOI 10.1111/j.1540-6520.2010.00432.x; Dai L, 2014, J BUS VENTURING, V29, P511, DOI 10.1016/j.jbusvent.2013.07.004; Fuentes-Fuentes MD, 2015, INT ENTREP MANAG J, V11, P695, DOI 10.1007/s11365-014-0336-1; Huang KP, 2013, QUAL QUANT, V47, P1617, DOI 10.1007/s11135-011-9614-y; Hughes M, 2007, IND MARKET MANAG, V36, P651, DOI 10.1016/j.indmarman.2006.04.003; Jones DA, 2014, ACAD MANAGE J, V57, P383, DOI 10.5465/amj.2011.0848; Jones MV, 2011, J BUS VENTURING, V26, P632, DOI 10.1016/j.jbusvent.2011.04.001; Kiss Andreea N., 2008, European Management Journal, V26, P388, DOI 10.1016/j.emj.2008.09.001; Kiss AN, 2012, J BUS VENTURING, V27, P266, DOI 10.1016/j.jbusvent.2011.09.004; Kollmann T., 2012, ENTREP THEORY PRACT, V38, P1001, DOI DOI 10.1111/J.1540-6520.2012.00530.X; Kraus S, 2012, REV MANAG SCI, V6, P161, DOI 10.1007/s11846-011-0062-9; Kreiser PM, 2013, SMALL BUS ECON, V40, P273, DOI 10.1007/s11187-012-9460-x; Krug B, 2012, ASIA PAC J MANAG, V29, P525, DOI 10.1007/s10490-010-9225-5; Lian HW, 2014, ACAD MANAGE J, V57, P116, DOI 10.5465/amj.2011.0977; Lim K, 2012, ASIA PAC J MANAG, V29, P573, DOI 10.1007/s10490-010-9212-x; Little T. D., 2006, STRUCTURAL EQUATION, V13, P479, DOI DOI 10.1207/S15328007SEM1304_1; Lu Y, 2010, J INT BUS STUD, V41, P419, DOI 10.1057/jibs.2009.73; Lumpkin GT, 1996, ACAD MANAGE REV, V21, P135, DOI 10.2307/258632; Luo YD, 2012, MANAGE ORGAN REV, V8, P139, DOI 10.1111/j.1740-8784.2011.00273.x; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; McKeever E, 2014, ENTREP REGION DEV, V26, P453, DOI 10.1080/08985626.2014.939536; MILLER D, 1983, MANAGE SCI, V29, P770, DOI 10.1287/mnsc.29.7.770; Nadkarni S, 2010, ACAD MANAGE J, V53, P1050, DOI 10.5465/AMJ.2010.54533196; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rauch A, 2009, ENTREP THEORY PRACT, V33, P761, DOI 10.1111/j.1540-6520.2009.00308.x; Sciascia S, 2014, EUR MANAG J, V32, P761, DOI 10.1016/j.emj.2013.12.007; Semrau T, 2012, STRATEG ENTREP J, V6, P335, DOI 10.1002/sej.1146; Tang Z, 2012, ASIA PAC J MANAG, V29, P409, DOI 10.1007/s10490-010-9200-1; Wales WJ, 2013, INT SMALL BUS J, V31, P357, DOI 10.1177/0266242611418261; Wiklund J, 2005, J BUS VENTURING, V20, P71, DOI 10.1016/j.jbusvent.2004.01.001; Wiklund J, 2011, ENTREP THEORY PRACT, V35, P925, DOI 10.1111/j.1540-6520.2011.00454.x; Zahra SA, 2005, J INT BUS STUD, V36, P20, DOI 10.1057/palgrave.jibs.8400118; Zhang H, 2014, J ENTREPRENEURSHIP E, V6, P102, DOI DOI 10.1108/JEEE-03-2014-0004; Zheng P, 2014, INT ENTREP MANAG J, V10, P539, DOI 10.1007/s11365-012-0236-1; Zhou KZ, 2010, STRATEGIC MANAGE J, V31, P547, DOI 10.1002/smj.830; Zhu YM, 2012, ASIA PAC J MANAG, V29, P1131, DOI 10.1007/s10490-011-9263-7	48	32	32	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162175	10.1371/journal.pone.0162175	http://dx.doi.org/10.1371/journal.pone.0162175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631368	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900030
J	Dering, B; Donaldson, DI				Dering, Benjamin; Donaldson, David I.			Dissociating Attention Effects from Categorical Perception with ERP Functional Microstates	PLOS ONE			English	Article							FACE-SENSITIVE N170; EMOTIONAL EXPRESSION; DOMAIN SPECIFICITY; OBJECT; BRAIN; COMPONENT; POTENTIALS; EXPERTISE; INVERSION; DISCRIMINATION	When faces appear in our visual environment we naturally attend to them, possibly to the detriment of other visual information. Evidence from behavioural studies suggests that faces capture attention because they are more salient than other types of visual stimuli, reflecting a category-dependent modulation of attention. By contrast, neuroimaging data has led to a domain-specific account of face perception that rules out the direct contribution of attention, suggesting a dedicated neural network for face perception. Here we sought to dissociate effects of attention from categorical perception using Event Related Potentials. Participants viewed physically matched face and butterfly images, with each category acting as a target stimulus during different blocks in an oddball paradigm. Using a data-driven approach based on functional microstates, we show that the locus of endogenous attention effects with ERPs occurs in the N1 time range. Earlier categorical effects were also found around the level of the P1, reflecting either an exogenous increase in attention towards face stimuli, or a putative face-selective measure. Both category and attention effects were dissociable from one another hinting at the role that faces may play in early capturing of attention before top-down control of attention is observed. Our data support the conclusion that certain object categories, in this experiment, faces, may capture attention before topdown voluntary control of attention is initiated.	[Dering, Benjamin; Donaldson, David I.] Univ Stirling, Sch Nat Sci, Stirling, Scotland	University of Stirling	Dering, B (corresponding author), Univ Stirling, Sch Nat Sci, Stirling, Scotland.	brd1@stir.ac.uk	Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455; Dering, Benjamin/0000-0002-0705-5325	Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; University of Stirling Research Impact Fellowship	Center for Biomedical Imaging (CIBM) of Geneva; Center for Biomedical Imaging (CIBM) of Lausanne; University of Stirling Research Impact Fellowship	The research was supported by a University of Stirling Research Impact Fellowship awarded to B.D.r The authors wish to thank Keith Pollock for assistance with data collection, Alan Pegna, and Stephan Boehm for comments. The Cartool software (brainmapping.unige.ch/cartool) has been programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Bayer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036042; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bindemann M, 2005, PSYCHON B REV, V12, P1048, DOI 10.3758/BF03206442; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Boehm SG, 2011, NEUROPSYCHOLOGIA, V49, P2082, DOI 10.1016/j.neuropsychologia.2011.03.039; Boutonnet B, 2013, J COGNITIVE NEUROSCI, V25, P1702, DOI 10.1162/jocn_a_00415; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Cauquil AS, 2000, NEUROREPORT, V11, P2167, DOI 10.1097/00001756-200007140-00021; Crist RE, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.010.2007; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.4.2; Darque A, 2012, BRAIN TOPOGR, V25, P167, DOI 10.1007/s10548-011-0199-5; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; De Cesarei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065103; Dering B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00093; Dering B, 2009, NEUROREPORT, V20, P902, DOI 10.1097/WNR.0b013e328327201d; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2011, OXFORD HDB FACE PERC, P329, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0017; Eimer M, 2010, CEREB CORTEX, V20, P2442, DOI 10.1093/cercor/bhp312; Furey ML, 2006, P NATL ACAD SCI USA, V103, P1065, DOI 10.1073/pnas.0510124103; Ganis G, 2012, NEUROIMAGE, V62, P1563, DOI 10.1016/j.neuroimage.2012.05.043; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hansen BC, 2012, J NEUROPHYSIOL, V108, P2160, DOI 10.1152/jn.00288.2012; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES, V46, P3028, DOI 10.1016/j.visres.2006.03.023; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Huang LQ, 2005, VISION RES, V45, P1909, DOI 10.1016/j.visres.2005.01.013; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Kaldy Z, 2009, INFANCY, V14, P222, DOI 10.1080/15250000802707088; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kloth N, 2013, BRAIN COGNITION, V81, P321, DOI 10.1016/j.bandc.2013.01.002; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; LEHMANN D, 1984, PROG NEUROBIOL, V23, P227, DOI 10.1016/0301-0082(84)90003-0; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Mohamed TN, 2009, NEUROREPORT, V20, P782, DOI 10.1097/WNR.0b013e32832b7e24; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Pegna AJ, 1997, HUM BRAIN MAPP, V5, P410, DOI 10.1002/(SICI)1097-0193(1997)5:6<410::AID-HBM2>3.0.CO;2-6; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2007, J COGNITIVE NEUROSCI, V19, P543, DOI 10.1162/jocn.2007.19.3.543; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sadeh B, 2008, NEUROIMAGE, V42, P778, DOI 10.1016/j.neuroimage.2008.04.168; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Sreenivasan KK, 2009, ATTEN PERCEPT PSYCHO, V71, P837, DOI 10.3758/APP.71.4.837; Stefanics G, 2015, FRONTIERS HUMAN NEUR; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Taylor MJ, 2002, CLIN NEUROPHYSIOL, V113, P1903, DOI 10.1016/S1388-2457(02)00309-7; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Vizioli L, 2010, P NATL ACAD SCI USA, V107, P20081, DOI 10.1073/pnas.1005751107; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	67	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163336	10.1371/journal.pone.0163336	http://dx.doi.org/10.1371/journal.pone.0163336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657921	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200102
J	Si, M; Xu, Q; Jiang, L; Huang, H				Si, Meng; Xu, Qing; Jiang, Ling; Huang, He			SpyTag/SpyCatcher Cyclization Enhances the Thermostability of Firefly Luciferase	PLOS ONE			English	Article							BIOLUMINESCENCE COLOR; STRUCTURAL-ANALYSIS; DISULFIDE BRIDGE; LIPASE B; PROTEIN; MUTAGENESIS; SPYCATCHER; DESIGN; SPYTAG; ANTARCTICA	SpyTag can spontaneously form a covalent isopeptide bond with its protein partner SpyCatcher. Firefly luciferase from Photinus pyralis was cyclized in vivo by fusing SpyCatcher at the N terminus and SpyTag at the C terminus. Circular LUC was more thermostable and alkali-tolerant than the wild type, without compromising the specific activity. Structural analysis indicated that the cyclized LUC increased the thermodynamic stability of the structure and remained more properly folded at high temperatures when compared with the wild type. We also prepared an N-terminally and C-terminally shortened form of the SpyCatcher protein and cyclization using this truncated form led to even more thermostability than the original form. Our findings suggest that cyclization with SpyTag and SpyCatcher is a promising and effective strategy to enhance thermostability of enzymes.	[Si, Meng; Xu, Qing; Huang, He] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 211816, Jiangsu, Peoples R China; [Jiang, Ling] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 211816, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China; [Xu, Qing] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University; Tianjin University	Huang, H (corresponding author), Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 211816, Jiangsu, Peoples R China.; Jiang, L (corresponding author), Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 211816, Jiangsu, Peoples R China.; Huang, H (corresponding author), Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China.	jiangling@njtech.edu.cn; biotech@njtech.edu.cn			National Science Foundation for Distinguished Young Scholars of China [21225626]; State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS [SKLBNPC15429]; Six Talent Peaks Project in Jiangsu Province [2015-JY-009]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS(Chinese Academy of Sciences); Six Talent Peaks Project in Jiangsu Province	This work was supported by the National Science Foundation for Distinguished Young Scholars of China (21225626), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), the Six Talent Peaks Project in Jiangsu Province (2015-JY-009).; We thank Dr. Zhao Zhong and Yingfeng Li (Shanghai Tech University, China) for help in designing the experiments. This work was supported by the National Science Foundation for Distinguished Young Scholars of China (21225626), the State Key Laboratory of Bio-organic and Natural Products Chemistry, CAS (SKLBNPC15429), and the Six Talent Peaks Project in Jiangsu Province (2015-JY-009).	Alipour BS, 2009, PHOTOCH PHOTOBIO SCI, V8, P847, DOI 10.1039/b901938c; Ataei F, 2013, BIOSENS BIOELECTRON, V41, P642, DOI 10.1016/j.bios.2012.09.037; Camarero JA, 1999, J AM CHEM SOC, V121, P5597, DOI 10.1021/ja990929n; Fierer JO, 2014, P NATL ACAD SCI USA, V111, pE1176, DOI 10.1073/pnas.1315776111; Fraga H, 2008, PHOTOCH PHOTOBIO SCI, V7, P146, DOI 10.1039/b719181b; Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155; GOLDENBERG DP, 1983, J MOL BIOL, V165, P407, DOI 10.1016/S0022-2836(83)80265-4; Hagan RM, 2010, ANGEW CHEM INT EDIT, V49, P8421, DOI 10.1002/anie.201004340; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Jia R, 2013, ACS CATAL, V3, P1976, DOI 10.1021/cs400404f; Jia R, 2013, ORG BIOMOL CHEM, V11, P7192, DOI 10.1039/c3ob41076e; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Karimzadeh S, 2012, INT J BIOL MACROMOL, V51, P837, DOI 10.1016/j.ijbiomac.2012.06.028; Koksharov MI, 2011, PROTEIN ENG DES SEL, V24, P835, DOI 10.1093/protein/gzr044; Koksharov MI, 2011, PHOTOCH PHOTOBIO SCI, V10, P931, DOI 10.1039/c0pp00318b; Law GHE, 2006, BIOCHEM J, V397, P305, DOI 10.1042/BJ20051847; Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021; Liu DN, 2010, CHEMBIOCHEM, V11, P789, DOI 10.1002/cbic.200900776; Liu ZD, 2014, SCI REP-UK, V4, DOI 10.1038/srep07266; Madvar AR, 2009, PROTEIN ENG DESIGN S, V22, P655, DOI [10.1093/protein/gzp047, DOI 10.1093/PROTEIN/GZP047]; Maeda M, 2003, J PHARMACEUT BIOMED, V30, P1725, DOI 10.1016/S0731-7085(02)00514-9; Maghami P, 2010, PHOTOCH PHOTOBIO SCI, V9, P376, DOI 10.1039/b9pp00161a; Modestova Y, 2014, BBA-PROTEINS PROTEOM, V1844, P1463, DOI 10.1016/j.bbapap.2014.04.021; Mollania N, 2011, ENZYME MICROB TECH, V49, P446, DOI 10.1016/j.enzmictec.2011.08.001; Nazari M, 2011, PHOTOCH PHOTOBIO SCI, V10, P1203, DOI 10.1039/c1pp05012e; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Qi XH, 2012, BIOTECHNOL LETT, V34, P339, DOI 10.1007/s10529-011-0775-5; Reddington SC, 2015, CURR OPIN CHEM BIOL, V29, P94, DOI 10.1016/j.cbpa.2015.10.002; Schoene Christopher, 2014, Angew Chem Int Ed Engl, V53, P6101, DOI 10.1002/anie.201402519; Stains CI, 2010, ACS CHEM BIOL, V5, P943, DOI 10.1021/cb100143m; Sun F, 2014, P NATL ACAD SCI USA, V111, P11269, DOI 10.1073/pnas.1401291111; Tafreshi NK, 2008, BIOCHEM J, V412, P27, DOI 10.1042/BJ20070733; Tai C, 2014, ENERG FUEL, V28, P1956, DOI 10.1021/ef402163p; Wang JD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0490-5; White PJ, 1996, BIOCHEM J, V319, P343, DOI 10.1042/bj3190343; Xu MQ, 2001, METHODS, V24, P257, DOI 10.1006/meth.2001.1187; Yamakawa Y, 2002, J BIOSCI BIOENG, V93, P537, DOI 10.1263/jbb.93.537; Zakeri B, 2011, PNAS, V109, P690, DOI [10.1073/pnas.1115485109/-/DCSupplemental, DOI 10.1073/PNAS.1115485109/-/DCSUPPLEMENTAL]; Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452; Zhou C, 2015, APPL ENVIRON MICROB, V81, P5714, DOI 10.1128/AEM.01017-15	42	43	48	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162318	10.1371/journal.pone.0162318	http://dx.doi.org/10.1371/journal.pone.0162318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27658030	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200023
J	van Dyck, Z; Vogele, C; Blechert, J; Lutz, APC; Schulz, AA; Herbert, BM				van Dyck, Zoe; Vogele, Claus; Blechert, Jens; Lutz, Annika P. C.; Schulz, Andre A.; Herbert, Beate M.			The Water Load Test As a Measure of Gastric Interoception: Development of a Two-Stage Protocol and Application to a Healthy Female Population	PLOS ONE			English	Article							MEDIATES BODILY SENSIBILITY; EATING-DISORDER INVENTORY-2; IMPAIRED DRINKING CAPACITY; TEST-MEAL INTAKE; BULIMIA-NERVOSA; HEARTBEAT PERCEPTION; MYOELECTRICAL ACTIVITY; FUNCTIONAL DYSPEPSIA; CARDIAC AWARENESS; SOCIAL ANXIETY	The sensitivity for one's own internal body signals (i.e., interoception) has been demonstrated to play an important role in the pathogenesis of eating and weight disorders. Most previous measures assessing interoceptive processing have not, or only partly, captured perception of hunger and satiety cues, which is a core aspect of interoceptive deficits in eating disorders. In addition, methods used to measure sensitivity to gastric signals are heterogeneous and findings inconsistent. The primary aim of the present study was to establish a standardised test to measure gastric interoception, and to provide normative data using a non-clinical adult sample. The two-step Water Load Test (WLT-II) involves ingestion of non-caloric water until perceived satiation (step 1) and until maximum fullness (step 2). The WLT-II consists of several variables: Besides volumes of water ingested until satiation and maximum fullness expressed in ml, percentage of satiation to maximum fullness is calculated as an individual index of gastric interoception that is not confounded with stomach capacity. Ninety-nine healthy women participated in the study. Measures included the WLT-II, the heartbeat tracking test, a self-report questionnaire assessing subjective sensations, and the Eating Disorder Inventory-2. Twenty-eight participants underwent test-retest of the WLT-II. Results suggest that the WLT-II is a valid and reliable measure of gastric interoception. Importantly, satiation volume and percentage of satiation to maximum fullness were strongly positively related to self-reported bulimic symptoms, indicating that the WLT-II could emerge as a useful clinical tool to measure interoceptive processing in the field of eating disorders.	[van Dyck, Zoe; Vogele, Claus; Lutz, Annika P. C.; Schulz, Andre A.] Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Esch Sur Alzette, Luxembourg; [Blechert, Jens] Salzburg Univ, Ctr Cognit Neurosci, Salzburg, Austria; [Blechert, Jens] Salzburg Univ, Dept Psychol, Salzburg, Austria; [Herbert, Beate M.] Univ Tubingen, Dept Clin Psychol & Psychotherapy, Tubingen, Germany	University of Luxembourg; Salzburg University; Salzburg University; Eberhard Karls University of Tubingen	van Dyck, Z (corresponding author), Univ Luxembourg, Res Unit INSIDE, Inst Hlth & Behav, Esch Sur Alzette, Luxembourg.; Herbert, BM (corresponding author), Univ Tubingen, Dept Clin Psychol & Psychotherapy, Tubingen, Germany.	zoe.vandyck@uni.lu; b.herbert@uni-tuebingen.de	Vögele, Claus/I-5682-2013; Schulz, André/AAC-5576-2021; Herbert, Beate/L-5036-2015; Blechert, Jens/X-4040-2019	Schulz, André/0000-0002-9381-2651; Blechert, Jens/0000-0002-3820-109X; Vogele, Claus/0000-0001-8086-0788; Lutz, Annika/0000-0002-3247-3262; Herbert, Beate/0000-0002-3284-4529				Ainley V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055568; Andresen V, 2009, BEST PRACT RES CL GA, V23, P313, DOI 10.1016/j.bpg.2009.04.007; Benelam B, 2009, NUTR BULL, V34, P126, DOI 10.1111/j.1467-3010.2009.01753.x; Blinder BJ, 2006, PSYCHOSOM MED, V68, P454, DOI 10.1097/01.psy.0000221254.77675.f5; Blundell JE, 2004, PHYSIOL BEHAV, V82, P21, DOI 10.1016/j.physbeh.2004.04.021; Boeckxstaens GE, 2001, GASTROENTEROLOGY, V121, P1054, DOI 10.1053/gast.2001.28656; Boeckxstaens GE, 1999, GASTROENTEROLOGY, V116, pA960; BRENER J, 1988, PSYCHOPHYSIOLOGY, V25, P554, DOI 10.1111/j.1469-8986.1988.tb01891.x; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; Dunn BD, 2007, BEHAV RES THER, V45, P1921, DOI 10.1016/j.brat.2006.09.008; EBERENZ KP, 1994, INT J EAT DISORDER, V16, P371, DOI 10.1002/1098-108X(199412)16:4&lt;371::AID-EAT2260160406&gt;3.0.CO;2-W; EHLERS A, 1992, J ABNORM PSYCHOL, V101, P371, DOI 10.1037/0021-843X.101.3.371; Eshkevari E, 2014, EUR EAT DISORD REV, V22, P383, DOI 10.1002/erv.2305; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GARNER DM, 1991, EATING DISORDERS INV; Geliebter A, 1996, AM J CLIN NUTR, V63, P170, DOI 10.1093/ajcn/63.2.170; Geliebter A, 2001, PHYSIOL BEHAV, V74, P743, DOI 10.1016/S0031-9384(01)00619-9; GELIEBTER A, 1992, AM J CLIN NUTR, V56, P656, DOI 10.1093/ajcn/56.4.656; Goetze O, 2007, AM J PHYSIOL-GASTR L, V292, pG11, DOI 10.1152/ajpgi.00498.2005; Hausken T, 1998, SCAND J GASTROENTERO, V33, P484; Hellstrom PM, 2004, BRIT J NUTR, V92, pS47, DOI 10.1079/BJN20041142; Herbert BM, 2013, APPETITE, V70, P22, DOI 10.1016/j.appet.2013.06.082; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Jones MP, 2003, AM J PHYSIOL-GASTR L, V284, pG896, DOI 10.1152/ajpgi.00361.2002; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kissileff HR, 1996, PHYSIOL BEHAV, V60, P1077, DOI 10.1016/0031-9384(96)00086-8; Klabunde M, 2013, EAT BEHAV, V14, P488, DOI 10.1016/j.eatbeh.2013.08.002; KNOLL JF, 1992, PSYCHOPHYSIOLOGY, V29, P218, DOI 10.1111/j.1469-8986.1992.tb01689.x; Koch KL, 2000, J CLIN GASTROENTEROL, V31, P125, DOI 10.1097/00004836-200009000-00007; Koch KL, 1998, NEUROGASTROENT MOTIL, V10, P3, DOI 10.1046/j.1365-2982.1998.00080.x; Kong MF, 1998, NUCL MED COMMUN, V19, P77, DOI 10.1097/00006231-199801000-00011; LAWLEY DN, 1956, BIOMETRIKA, V43, P128; Li Qi-xiang, 2004, Zhonghua Nei Ke Za Zhi, V43, P436; Lutz APC, 2015, 45 ANN EABCT C JER I; Mejia-Rivas M, 2009, Rev Gastroenterol Mex, V74, P71; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Molinari C, 2006, BRAIN RES BULL, V69, P140, DOI 10.1016/j.brainresbull.2005.11.014; Montepare JM, 2006, J ADULT DEV, V13, P102, DOI 10.1007/s10804-007-9010-y; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; PAUL T, 2005, EDI 2 EATING DISORDE; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; ROLAND J, 1990, EUR J NUCL MED, V17, P130, DOI 10.1007/BF00811440; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Sengupta J. N., 1994, P483; Serra J, 1998, J PHYSIOL-LONDON, V506, P579, DOI 10.1111/j.1469-7793.1998.579bw.x; Stevens J, 1996, APPL MULTIVARIATE ST, V3rd ed.; Sysko R, 2007, INT J EAT DISORDER, V40, P554, DOI 10.1002/eat.20384; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Terhaar J, 2012, CLIN NEUROPHYSIOL, V123, P1950, DOI 10.1016/j.clinph.2012.02.086; Thiel A, 2006, J PSYCHOSOM RES, V61, P567, DOI 10.1016/j.jpsychores.2006.02.015; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Zimmerli EJ, 2006, PHYSIOL BEHAV, V87, P441, DOI 10.1016/j.physbeh.2005.11.010	68	54	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163574	10.1371/journal.pone.0163574	http://dx.doi.org/10.1371/journal.pone.0163574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657528	Green Published, gold			2022-12-27	WOS:000383893200148
J	Ye, ZH; Zhang, X; Luo, YH; Li, SK; Huang, LS; Li, ZY; Li, P; Chen, G				Ye, Zhihua; Zhang, Xin; Luo, Yihuan; Li, Shikang; Huang, Lanshan; Li, Zuyun; Li, Ping; Chen, Gang			Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POOR-PROGNOSIS; STATISTICAL-METHODS; TARGETED THERAPY; E-CADHERIN; EMT; HETEROGENEITY; SURVIVAL; CATENIN; MARKERS	Background Vimentin is a member of the intermediate filament proteins and a canonical marker of the epithelial-mesenchymal transition (EMT), which is pivotal in tumorigenesis, metastasis and invasion in non-small cell lung cancer (NSCLC). The current meta-analysis aimed to investigate the associations between vimentin and prognosis and progression in NSCLC. Methods Databases with literature published in English, including PubMed, Web of Science, Embase, Science Direct, Wiley Online Library, Ovid, Cochrane Central Register of Controlled Trials, LILACS and Google Scholar, and the CNKI, VIP, CBM and WanFang databases in Chinese were used for the literature search. The key terms included (1) 'vimentin' OR 'vim' OR 'vmt' OR 'vm' OR 'hel113' OR 'ctrct30' and (2) 'pulmon*' OR 'lung' OR 'alveolar' and (3) 'cancer' OR 'carcinoma' OR 'tumor' OR 'adenocarcinoma' OR 'squamous' OR 'neoplas*' OR 'malignan*'. The data were combined by random effect model and the H value and I 2 were used to assess the heterogeneity. All the meta-analysis was conducted using Stata 12.0. Results Thirty-two qualified studies (4118 cases) were included in the current meta-analysis. Twelve studies with 1750 patients were included to assess the significance of vimentin in the overall survival (OS) of NSCLC; the pooled hazard ratio (HR) was 1.831 (confidence interval (CI): 1.315-2.550, P<0.001) in the univariate analysis and 1.266 (CI: 0.906-1.768, P = 0.167) in the multivariate analysis. Four studies with 988 cases were applicable to determine the significance of vimentin in the disease-free survival (DFS) of NSCLC; the pooled HR of the DFS was 1.224 (CI: 0.921-1.628, P = 0.164) in the univariate analysis and 1.254 (CI: 0.985-1.956, P = 0.067) in the multivariate analysis. Regarding the relationships between vimentin and clinicopathological factors, the pooled odds ratio (OR) with 3406 NSCLCs indicated that up-regulated vimentin was associated with smoking (OR = 1.359, CI: 1.098-1.683, P = 0.004), poor differentiation (OR = 2.133, CI: 1.664-2.735, P<0.001), an advanced TNM stage (OR = 3.275, CI: 1.987-5.397, P<0.001), vascular invasion (OR = 3.492, CI: 1.063-11.472, P = 0.039), lymph node metastasis (OR = 2.628, CI: 1.857-3.718, P<0.001), recurrence (OR = 1.631, CI: 1.052-2.528, P = 0.029) and pleural invasion (OR = 2.346, CI: 1.397-3.941, P = 0.001). There was no significant correlation between vimentin and age, gender, diameter, T stage, distant metastasis, or marginal invasion (P>0.05). Conclusion An overexpression of vimentin may predict the progression and an unfavorable survival of NSCLC. Vimentin may represent a helpful biomarker and a potential target for the treatment strategies of NSCLC. Additional, prospective studies with large samples are necessary to confirm the significance of vimentin in NSCLC.	[Ye, Zhihua; Zhang, Xin; Luo, Yihuan; Huang, Lanshan; Li, Zuyun; Li, Ping; Chen, Gang] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China; [Li, Shikang] Guangxi Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiovasc Surg, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Chen, G (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China.	chen_gang_triones@163.com	Zhang, Daniel Xin/L-5143-2019	Zhang, Daniel Xin/0000-0001-8561-6928; Li, Shikang/0000-0002-8187-3676	Fund of Guangxi Provincial Health Bureau Scientific Research Project [Z2013201, Z2014055]; Natural Science Foundation of Guangxi, China [2015GXNSFCA139009]; National Natural Science Foundation of China [NSFC 81360327, NSFC 81560469]	Fund of Guangxi Provincial Health Bureau Scientific Research Project; Natural Science Foundation of Guangxi, China(National Natural Science Foundation of Guangxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Fund of Guangxi Provincial Health Bureau Scientific Research Project (Z2013201, Z2014055), Natural Science Foundation of Guangxi, China (2015GXNSFCA139009) and the Fund of National Natural Science Foundation of China (NSFC 81360327, NSFC 81560469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Fund of Guangxi Provincial Health Bureau Scientific Research Project (Z2013201, Z2014055), Natural Science Foundation of Guangxi, China (2015GXNSFCA139009) and the Fund of National Natural Science Foundation of China (NSFC 81360327, NSFC 81560469). American Journal Experts (AJE) provided professional scientific editing service on this manuscript.	Bai X, 2013, J INNER MONGOLIA MED, V35, P1; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Brothers JF, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-168; Che JJ, 2015, TUMOR BIOL, V36, P6559, DOI 10.1007/s13277-015-3350-1; Chen WQ, 2014, CHINESE J CANCER RES, V26, P48, DOI 10.3978/j.issn.1000-9604.2014.01.08; Chikaish Y, 2011, ANTICANCER RES, V31, P4451; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Deng QF, 2009, RESPIROLOGY, V14, P371, DOI 10.1111/j.1440-1843.2009.01496.x; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dou W, CLIN SIGNIFICANCE EP; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Guan X, 2014, J PRACTICAL ONCOLOGY, V28, P5; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; He WL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1124-1; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Hou Q, 2011, PRELIMINARY STUDY RE; Huang J, 2012, MED ONCOL, V29, P1606, DOI 10.1007/s12032-011-9998-5; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim H, 2013, KOREAN J PATHOL, V47, P44, DOI 10.4132/KoreanJPathol.2013.47.1.44; Kim SH, 2012, HISTOL HISTOPATHOL, V27, P581, DOI 10.14670/HH-27.581; Kong FF, 2014, ONCOL REP, V31, P2660, DOI 10.3892/or.2014.3129; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Kumarakulasinghe NB, 2015, RESPIROLOGY, V20, P370, DOI 10.1111/resp.12490; Li M, 2013, MED QILU, V28, P117; Liu FengJuan, 2012, Progress in Modern Biomedicine, V12, P1110; Long H, 2015, ONCOTARGET; Merikallio H, 2014, INT J CLIN EXP PATHO, V7, P5846; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Nakashima H, 2015, PATHOL INT, V65, P183, DOI 10.1111/pin.12257; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Parums DV, 2014, DRUG TODAY, V50, P503, DOI [10.1358/dot.2014.50.07.2185913, 10.1358/dot.2014.50.7.2185913]; Pelletier MP, 2001, CAN J SURG, V44, P180; Richardson F, 2012, ANTICANCER RES, V32, P537; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Shi Y, 2011, EXPRESSION PROGNOSTI; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Sowa T, 2015, CANCER MED-US, V4, P1853, DOI 10.1002/cam4.556; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sun J, 2014, CHIN J CANC PREV TRE, V21, P1258; Sung WJ, 2015, INT J CLIN EXP PATHO, V8, P8997; Tian M, 2011, CHIN J BIOL, V24; Wang Hai-Bing, 2011, Zhonghua Zhong Liu Za Zhi, V33, P590; Wang L, 2012, RELATIONSHIP EXPRESS; Xu MM, 2014, ASIAN PAC J CANCER P, V15, P4013, DOI 10.7314/APJCP.2014.15.9.4013; Ye T, 2009, PROGNOSTICSIGNIFICAN; Zhang H, 2013, J CLIN PATHOL, V66, P937, DOI 10.1136/jclinpath-2013-201467; Zhang M., 2012, INFLUENCE BMI 1 EPIT; Zhang X, 2014, CLIN TRANSL ONCOL, V16, P178, DOI 10.1007/s12094-013-1057-6; Zhang Y, 2014, JIANGSU MED J, V40, P1915; Zhao C, 2013, BIOSCI TRENDS, V7, P264, DOI 10.5582/bst.2013.v7.6.264; Zhao Y, 2013, TOXICOL SCI, V135, P265, DOI 10.1093/toxsci/kft150; Zhong ZP, 2014, MOL MED REP, V10, P2575, DOI 10.3892/mmr.2014.2494; Zhou H, 2012, CORRELATION HYPOXIA; Zhou L, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0657-8	60	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163162	10.1371/journal.pone.0163162	http://dx.doi.org/10.1371/journal.pone.0163162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657690	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200077
J	Darracq, AK; Conner, LM; Brown, JS; McCleery, RA				Darracq, Andrea K.; Conner, L. Mike; Brown, Joel S.; McCleery, Robert A.			Cotton Rats Alter Foraging in Response to an Invasive Ant	PLOS ONE			English	Article							IMPORTED FIRE ANTS; PREDATOR-PREY INTERACTIONS; PATCH USE; NATIVE ANTS; RISK; DEER; HYMENOPTERA; RECRUITMENT; WILDLIFE; FOOD	We assessed the effects of red imported fire ants (Solenopsis invicta; hereafter fire ant) on the foraging of hispid cotton rats (Sigmodon hispidus). We used a manipulative experiment, placing resource patches with a known amount of millet seed within areas with reduced (RIFA [-]) or ambient (RIFA [+]) numbers of fire ants. We measured giving up densities (the amount of food left within each patch) within the resource patches for 4 days to quantify the effects of fire ants on cotton rat foraging. We assessed the effects of fire ant treatment (RIFA), Day, and their interaction on cotton rat giving up densities. Giving up densities on RIFA [+] grids were nearly 2.2 times greater across all foraging days and ranged from 1.6 to 2.3 times greater from day 1 to day 4 than the RIFA [-] grids. From day 1 to day 4, mean giving up densities decreased significantly faster for the RIFA [-] than RIFA [+] treatments, 58% and 13%, respectively. Our results demonstrate that cotton rats perceive a risk of injury from fire ants, which is likely caused by interference competition, rather than direct predation. Envenomation from ants likely decrease the foraging efficiency of cotton rats resulting in more time spent foraging. Increased time spent foraging is likely stressful in terms of the opportunity for direct injury and encounters with other predators. These indirect effects may reduce an individual cotton rat's fitness and translate into lowered population abundances.	[Darracq, Andrea K.] Univ North Georgia, Dept Biol, 151 Sunset Blvd, Dahlonega, GA 30597 USA; [Conner, L. Mike] Joseph W Jones Ecol Res Ctr, 3988 Jones Ctr Dr, Newton, GA USA; [Brown, Joel S.] Univ Illinois, Dept Biol Sci, 845 West Taylor St, Chicago, IL USA; [McCleery, Robert A.] Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Ziegler Hall,POB 110430, Gainesville, FL USA	University of North Georgia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Darracq, AK (corresponding author), Univ North Georgia, Dept Biol, 151 Sunset Blvd, Dahlonega, GA 30597 USA.	akdarracq@ung.edu		McCleery, Robert/0000-0001-7018-005X	Joseph W.Jones Ecological Research Center; University of Florida	Joseph W.Jones Ecological Research Center; University of Florida(University of Florida)	Our research was supported by the Joseph W.Jones Ecological Research Center (www.jonesctr.org) and the University of Florida (www.ufl.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 1997, J HERPETOL, V31, P318, DOI 10.2307/1565408; Allen CR, 2004, AM MIDL NAT, V152, P88, DOI 10.1674/0003-0031(2004)152[0088:RIFAIO]2.0.CO;2; Allen CR, 2001, FLA ENTOMOL, V84, P250, DOI 10.2307/3496175; Allen CR, 1997, J WILDLIFE MANAGE, V61, P911, DOI 10.2307/3802200; [Anonymous], 2014, R LANG ENV STAT COMP; APPERSON CS, 1984, J GEORGIA ENTOMOL SO, V19, P508; Berger-Tal O, 2009, BEHAV ECOL SOCIOBIOL, V63, P1821, DOI 10.1007/s00265-009-0809-3; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; BROWN JS, 1992, ANN ZOOL FENN, V29, P301; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; Cameron G. N., 2001, MAMMALIAN SPECIES, V158, P1; Caro Tim, 2005, pXIII; COLLOPY MW, 1987, AUK, V104, P11, DOI 10.2307/4087227; Ferris KP, 1994, THESIS, P1; Garton Edward O., 2005, P43; Godbois IA, 2003, PROCEEDINGS OF THE FIFTY-SEVENTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P222; HAMILTON WJ, 1956, ECOLOGY, V37, P519, DOI 10.2307/1930174; Holldobler B., 1990, pi; Holtcamp WN, 1997, ECOLOGY, V78, P308; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Lach L, 2010, ANT ECOLOGY, P1; Langkilde T, 2010, WILDLIFE RES, V37, P566, DOI 10.1071/WR10098; Lechner KA, 1996, SOUTHWEST NAT, V41, P123; Lima S. L., 1998, ADV STUDY BEHAV; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Long AK, 2015, J MAMMAL, V96, P1135, DOI 10.1093/jmammal/gyv121; Lowe S., 2000, ENCY BIOL INVASIONS; LUBIN YD, 1984, BIOL J LINN SOC, V21, P229, DOI 10.1111/j.1095-8312.1984.tb02064.x; Macnab J., 1983, Wildlife Society Bulletin, V11, P397; Mueller JM, 2001, TEX J SCI, V53, P87; Norrdahl K, 1998, ECOLOGY, V79, P226; Orrock JL, 2004, OECOLOGIA, V140, P662, DOI 10.1007/s00442-004-1613-4; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schultz TR, 2000, P NATL ACAD SCI USA, V97, P14028, DOI 10.1073/pnas.011513798; Sieg CH, 1987, 8 GREAT PLAINS WILDL, P28; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith JE, 2007, EVOL ECOL RES, V9, P433; Tschinkel WR, 2006, FIRE ANTS; Vanderwoude C, 2000, AUSTRAL ECOL, V25, P253; Vinson S. Bradleigh, 1997, American Entomologist, V43, P23	48	7	7	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163220	10.1371/journal.pone.0163220	http://dx.doi.org/10.1371/journal.pone.0163220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655320	Green Submitted, gold, Green Published			2022-12-27	WOS:000383892700043
J	de Freitas, MM; Fontes, PR; Souza, PM; Fagg, CW; Guerra, ENS; Nobrega, YKD; Silveira, D; Fonseca-Bazzo, Y; Simeoni, LA; Homem-de-Mello, M; Magalhaes, PO				de Freitas, Marcela Medeiros; Fontes, Pedro Ribeiro; Souza, Paula Monteiro; Fagg, Christopher William; Silva Guerra, Eliete Neves; de Medeiros Nobrega, Yanna Karla; Silveira, Damaris; Fonseca-Bazzo, Yris; Simeoni, Luiz Alberto; Homem-de-Mello, Mauricio; Magalhaes, Perola Oliveira			Extracts of Morus nigra L. Leaves Standardized in Chlorogenic Acid, Rutin and Isoquercitrin: Tyrosinase Inhibition and Cytotoxicity	PLOS ONE			English	Article							B16 MELANOMA-CELLS; ANTIOXIDANT ACTIVITY; HYPOPIGMENTING AGENTS; SKIN PIGMENTATION; MULBERRY LEAVES; MELANOGENESIS; CONSTITUENTS; FRUITS; ALBA; BIOSYNTHESIS	Melanogenesis is a process responsible for melanin production, which is stored in melanocytes containing tyrosinase. Inhibition of this enzyme is a target in the cosmetics industry, since it controls undesirable skin conditions such as hyperpigmentation due to the overproduction of melanin. Species of the Morus genus are known for the beneficial uses offered in different parts of its plants, including tyrosinase inhibition. Thus, this project aimed to study the inhibitory activity of tyrosinase by extracts from Morus nigra leaves as well as the characterization of its chromatographic profile and cytotoxicity in order to become a new therapeutic option from a natural source. M. nigra leaves were collected, pulverized, equally divided into five batches and the standardized extract was obtained by passive maceration. There was no significant difference between batches for total solids content, yield and moisture content, which shows good reproducibility of the extraction process. Tyrosinase enzymatic activity was determined for each batch, providing the percentage of enzyme inhibition and IC50 values obtained by constructing dose-response curves and compared to kojic acid, a well-known tyrosinase inhibitor. High inhibition of tyrosinase activity was observed (above 90% at 15.625 mu g/mL). The obtained IC50 values ranged from 5.00 mu g/mL +/- 0.23 to 8.49 mu g/mL +/- 0.59 and were compared to kojic acid (3.37 mu g/mL +/- 0.65). High Performance Liquid Chromatography analysis revealed the presence of chlorogenic acid, rutin and, its major compound, isoquercitrin. The chromatographic method employed was validated according to ICH guidelines and the extract was standardized using these polyphenols as markers. Cytotoxicity, assessed by MTT assay, was not observed on murine melanomas, human keratinocytes and mouse fibroblasts in tyrosinase IC50 values. This study demonstrated the potential of M. nigra leaf extract as a promising whitening agent of natural source against skin hyperpigmentation.	[de Freitas, Marcela Medeiros; Fontes, Pedro Ribeiro; Souza, Paula Monteiro; Silveira, Damaris; Fonseca-Bazzo, Yris; Simeoni, Luiz Alberto; Homem-de-Mello, Mauricio; Magalhaes, Perola Oliveira] Univ Brasilia, Sch Hlth Sci, Dept Pharm, Brasilia, DF, Brazil; [Fagg, Christopher William] Univ Brasilia, Sch Pharm, Dept Bot, Inst Biol Sci, Ceilandia Campus, Brasilia, DF, Brazil; [Silva Guerra, Eliete Neves] Univ Brasilia, Sch Hlth Sci, Dept Odontol, Brasilia, DF, Brazil; [de Medeiros Nobrega, Yanna Karla] Univ Brasilia, Sch Med, Immunogenet & Chron Degenerat Dis Lab, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	de Freitas, MM (corresponding author), Univ Brasilia, Sch Hlth Sci, Dept Pharm, Brasilia, DF, Brazil.	marcelamdf1@gmail.com	Fagg, Christopher W/G-3599-2016; Fonseca, Yris M/A-9893-2016; MAGALHÃES, PÉROLA/P-3378-2018; Guerra, Eliete Neves Silva/E-1021-2016; Silveira, Damaris/A-1942-2008; Simeoni, Luiz Alberto/A-9088-2008; MAGALHÃES, PÉROLA O/P-2521-2017; Souza, Paula/AAE-5731-2021; Homem-de-Mello, Mauricio/G-9858-2012; Homem-de-Mello, Mauricio/ABE-3673-2020	Fagg, Christopher W/0000-0001-6072-7832; Fonseca, Yris M/0000-0002-1230-3207; MAGALHÃES, PÉROLA/0000-0001-8011-6940; Guerra, Eliete Neves Silva/0000-0002-7622-1550; Silveira, Damaris/0000-0003-1851-5224; Simeoni, Luiz Alberto/0000-0003-3401-290X; MAGALHÃES, PÉROLA O/0000-0001-8011-6940; Homem-de-Mello, Mauricio/0000-0002-4541-9177; Homem-de-Mello, Mauricio/0000-0002-4541-9177; Souza, Paula/0000-0003-1824-2211; Fontes, Pedro/0000-0002-5804-7632; de Freitas, Marcela/0000-0002-6112-9903	National Counsel of Technological and Scientific Development (CNPq); Support Research of the Federal District Foundation (FAPDF); Higher Education Personnel Improvement Coordination (CAPES); Scientific and Technological Enterprise Foundation (FINATEC); University of Brasilia (UnB)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Support Research of the Federal District Foundation (FAPDF); Higher Education Personnel Improvement Coordination (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Scientific and Technological Enterprise Foundation (FINATEC); University of Brasilia (UnB)	The authors are grateful to National Counsel of Technological and Scientific Development (CNPq), Support Research of the Federal District Foundation (FAPDF), Higher Education Personnel Improvement Coordination (CAPES), Scientific and Technological Enterprise Foundation (FINATEC), and University of Brasilia (UnB) for providing funds to perform the present research.	Adham AN, 2015, INT J PHARM PHARM SC, V7, P263; [Anonymous], 2014, TODAY CHROMATOG 1126; Arfan M, 2012, INT J MOL SCI, V13, P2472, DOI 10.3390/ijms13022472; Chang LW, 2011, FOOD CHEM TOXICOL, V49, P785, DOI 10.1016/j.fct.2010.11.045; Chang TS, 2012, MATERIALS, V5, P1661, DOI 10.3390/ma5091661; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153080; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; Curto EV, 1999, BIOCHEM PHARMACOL, V57, P663, DOI 10.1016/S0006-2952(98)00340-2; Dallwitz M.J., FAMILIES FLOWERING P; Drewa G, 1998, NEOPLASMA, V45, P266; Dutra DM, 2014, QUIM NOVA, V37, P1510, DOI 10.5935/0100-4042.20140237; Eleazu C., 2002, J BIOTECHNOL PHARM R, V3, P42; Eo HJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-200; Ercisli S, 2007, FOOD CHEM, V103, P1380, DOI 10.1016/j.foodchem.2006.10.054; Ercisli S, 2010, FOOD TECHNOL BIOTECH, V48, P102; Farheen Hanif, 2012, Journal of Biology and Earth Sciences, V2, pB54; Gandhi Vijay, 2012, Indian J Dermatol, V57, P394, DOI 10.4103/0019-5154.100498; Garcia-Gavin J, 2010, CONTACT DERMATITIS, V62, P63, DOI 10.1111/j.1600-0536.2009.01673.x; Garg Vandana, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1077, DOI 10.3736/jcim20121002; Gilchrest BA, 2011, J INVEST DERMATOL, V131, P6, DOI [10.1038/jid.2010.325, 10.1038/skinbio.2011.6]; Hu X, 2012, J ASIAN NAT PROD RES, V14, P1103, DOI 10.1080/10286020.2012.724400; Hu X, 2012, J NAT PROD, V75, P82, DOI 10.1021/np2007318; Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619; ICH, 1996, GUIDI ND Q2B VAL AN; Ikino JK, 2015, AN BRAS DERMATOL, V90, P196, DOI 10.1590/abd1806-4841.20152771; Jeong SH, 2009, J AGR FOOD CHEM, V57, P1195, DOI 10.1021/jf8033286; Jiang Y, 2015, FOOD CHEM, V174, P460, DOI 10.1016/j.foodchem.2014.11.083; Khatib S, 2005, BIOORGAN MED CHEM, V13, P433, DOI 10.1016/j.bmc.2004.10.010; Kim K, 2015, J GINSENG RES, V39, P1, DOI 10.1016/j.jgr.2014.10.006; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; Landim LP, 2013, REV BRAS FARMACOGN, V23, P58, DOI [10.1590/S0102-695X2012005000111, 10.1590/S0102-695X2013000100008]; Lee AY, 2013, ARCH PHARM RES, V36, P792, DOI 10.1007/s12272-013-0130-6; Lee SH, 2002, BIOL PHARM BULL, V25, P1045, DOI 10.1248/bpb.25.1045; LERCH K, 1986, J INORG BIOCHEM, V26, P213, DOI 10.1016/0162-0134(86)80043-5; LERNER AB, 1949, J BIOL CHEM, V178, P185; LERNER AB, 1951, J BIOL CHEM, V191, P799; Li HR, 2014, MOLECULES, V19, P12940, DOI 10.3390/molecules190912940; Mallhi TH, 2014, BANGL J PHARMACOL, V9, P60, DOI 10.3329/bjp.v9i1.17337; Masuda T, 2005, BIOSCI BIOTECH BIOCH, V69, P197, DOI 10.1271/bbb.69.197; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Mazimba O, 2011, AFR J PHARM PHARMACO, V5, P751, DOI 10.5897/AJPP11.260; Momtaz S, 2008, S AFR J BOT, V74, P577, DOI 10.1016/j.sajb.2008.02.005; Leite CFM, 2014, B LATINOAM CARIBE PL, V13, P135; Naderi GA, 2004, PHYTOTHER RES, V18, P365, DOI 10.1002/ptr.1400; Nole Gregory, 2004, Dermatol Ther, V17 Suppl 1, P57, DOI 10.1111/j.1396-0296.2004.04S1007.x; Oliveira A.C.B., 2013, Rev. bras. plantas med., V15, P244, DOI 10.1590/S1516-05722013000200012; Ozgen M, 2009, SCI HORTIC-AMSTERDAM, V119, P275, DOI 10.1016/j.scienta.2008.08.007; Palav Y. K., 2006, Indian Journal of Pharmaceutical Sciences, V68, P506; Pandya AG, 2000, DERMATOL CLIN, V18, P91, DOI 10.1016/S0733-8635(05)70150-9; Park KT, 2011, FOOD CHEM TOXICOL, V49, P3038, DOI 10.1016/j.fct.2011.09.008; Patel D. K., 2012, Asian Pacific Journal of Tropical Disease, pS56; PROTA G, 1988, MED RES REV, V8, P525, DOI 10.1002/med.2610080405; Qadir MI, 2014, BANGL J PHARMACOL, V9, P496, DOI 10.3329/bjp.v9i4.19783; Ravi A, 2011, J ETHNOPHARMACOL, V137, P1353, DOI 10.1016/j.jep.2011.07.067; Ribas J, 2010, AN BRAS DERMATOL, V85; Ryu YB, 2008, J ENZYM INHIB MED CH, V23, P922, DOI [10.1080/14756360701810207, 10.1080/14756360701810207 ]; Sanchez-Salcedo EM, 2015, J FUNCT FOODS, V18, P1039, DOI 10.1016/j.jff.2015.03.053; Sanchez-Salcedo EM, 2016, FOOD CHEM, V212, P250, DOI 10.1016/j.foodchem.2016.05.121; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sarer E, 2008, TURK J PHARM SCI, V5, P167; Si YX, 2012, J BIOMOL STRUCT DYN, V29, P999, DOI 10.1080/073911012010525028; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Son SM, 2000, J FOOD SCI, V65, P1288, DOI 10.1111/j.1365-2621.2000.tb10598.x; Souza PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048589; Tag HM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0744-y; Takahashi M, 2012, J OLEO SCI, V61, P585, DOI 10.5650/jos.61.585; Turan I, 2016, SAUDI PHA J IN PRESS; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109396; Zhang XD, 2009, BIOL PHARM BULL, V32, P86, DOI 10.1248/bpb.32.86; Zheng ZP, 2008, FOOD CHEM, V106, P529, DOI 10.1016/j.foodchem.2007.06.037; Zheng ZP, 2012, FITOTERAPIA, V83, P1008, DOI 10.1016/j.fitote.2012.06.001; Zheng ZP, 2010, J AGR FOOD CHEM, V58, P5368, DOI 10.1021/jf1003607; Zhu WY, 2008, J INVEST DERM SYMP P, V13, P20, DOI 10.1038/jidsymp.2008.8; Ziaullah, 2013, BIOORGAN MED CHEM, V21, P684, DOI 10.1016/j.bmc.2012.11.034	77	47	48	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163130	10.1371/journal.pone.0163130	http://dx.doi.org/10.1371/journal.pone.0163130			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655047	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700038
J	Khalid, R; Afzal, M; Khurshid, S; Paracha, RZ; Khan, IH; Akhtar, MW				Khalid, Ruqyya; Afzal, Madeeha; Khurshid, Sana; Paracha, Rehan Zafar; Khan, Imran H.; Akhtar, Muhammad Waheed			Fusion Molecules of Heat Shock Protein HSPX with Other Antigens of Mycobacterium tuberculosis Show High Potential in Serodiagnosis of Tuberculosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PULMONARY TUBERCULOSIS; 16-KILODALTON ANTIGEN; CRYSTAL-STRUCTURE; PSTS1 ANTIGEN; INFECTION; DIAGNOSIS; PURIFICATION; SENSITIVITY; EXPRESSION	Variable individual response against the antigens of Mycobacterium tuberculosis necessitates detection of multiple antibodies for enhancing reliability of serodiagnosis of tuberculosis. Fusion molecules consisting of two or more antigens showing high sensitivity would be helpful in achieving this objective. Antigens of M. tuberculosis HSPX and PE35 were expressed in a soluble form whereas tnPstS1 and FbpC1 were expressed as inclusion bodies at 37 degrees C. Heat shock protein HSPX when attached to the N-termini of the antigens PE35, tnPstS1 and FbpC1, all the fusion molecules were expressed at high levels in E. coli in a soluble form. ELISA analysis of the plasma samples of TB patients against HSPX-tnPstS1 showed 57.7% sensitivity which is nearly the same as the expected combined value obtained after deducting the number of plasma samples (32) containing the antibodies against both the individual antigens. Likewise, the 54.4% sensitivity of HSPX-PE35 was nearly the same as that expected from the combined values of the contributing antigens. Structural analysis of all the fusion molecules by CD spectroscopy showed that alpha-helical and beta-sheet contents were found close to those obtained through molecular modeling. Molecular modeling studies of HSPX-tnPstS1 and HSPX-PE35 support the analytical results as most of the epitopes of the contributing antigens were found to be available for binding to the corresponding antibodies. Using these fusion molecules in combination with other antigenic molecules should reduce the number of antigenic proteins required for a more reliable and economical serodiagnosis of tuberculosis. Also, HSPX seems to have potential application in soluble expression of heterologous proteins in E. coli.	[Khalid, Ruqyya; Afzal, Madeeha; Khurshid, Sana; Akhtar, Muhammad Waheed] Univ Punjab, Sch Biol Sci, Quaid E Azam Campus, Lahore, Pakistan; [Paracha, Rehan Zafar] Natl Univ Sci & Technol, Atta Ur Rehman Sch Appl Biosci, Islamabad, Pakistan; [Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA	University of Punjab; National University of Sciences & Technology - Pakistan; University of California System; University of California Davis	Akhtar, MW (corresponding author), Univ Punjab, Sch Biol Sci, Quaid E Azam Campus, Lahore, Pakistan.	mwa.sbs@pu.edu.pk	Nadeem, Muhammad Shahid/H-2372-2017; Khurshid, Sana/AHE-7142-2022; Khan, Imran Ali/GVT-0232-2022; Khan, imran/GQQ-2176-2022	Nadeem, Muhammad Shahid/0000-0003-4112-0925; Khurshid, Sana/0000-0002-0399-0754; Khan, Imran Ali/0000-0002-8774-2896; Khalid, Ruqyya/0000-0001-5658-3506; Afzal, Madeeha/0000-0001-8954-8934	Higher Education Commission of Pakistan (HEC) [106-1903-BM6-145, 106-1926-BM6-144, 106-1907-BM6-149]	Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan)	The work was supported by Higher Education Commission of Pakistan (HEC grant number: 106-1903-BM6-145, 106-1926-BM6-144, 106-1907-BM6-149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Afzal M, 2015, J MICROBIOL METH, V115, P104, DOI 10.1016/j.mimet.2015.06.003; Ahmad S, 2003, PROTEIN EXPRES PURIF, V29, P167, DOI 10.1016/S1046-5928(03)00052-4; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 2011, COMM SER TESTS DIAGN; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bethunaickan R, 2007, SCAND J INFECT DIS, V39, P867, DOI 10.1080/00365540701402954; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng Z, 2011, J CLIN LAB ANAL, V25, P344, DOI 10.1002/jcla.20483; Chiang IH, 1997, AM J RESP CRIT CARE, V156, P906, DOI 10.1164/ajrccm.156.3.9607122; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; CROWTHER JR, 2001, METHODS MOL BIOL; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; ESPITIA C, 1989, CLIN EXP IMMUNOL, V77, P373; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; HARBOE M, 1992, J INFECT DIS, V166, P874, DOI 10.1093/infdis/166.4.874; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hwang WH, 2014, PROTEIN EXPRES PURIF, V95, P77, DOI 10.1016/j.pep.2013.11.011; Imaz MS, 2001, INT J TUBERC LUNG D, V5, P1036; Kaushik A, 2012, INDIAN J MED RES, V135, P771; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Khurshid S, 2014, TUBERCULOSIS, V94, P519, DOI 10.1016/j.tube.2014.06.006; Khurshid S, 2013, TUBERCULOSIS, V93, P654, DOI 10.1016/j.tube.2013.07.005; Kyratsous CA, 2009, GENE, V440, P9, DOI 10.1016/j.gene.2009.03.011; MITCHISON DA, 1977, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.6073.1383; Mukherjee P, 2007, CLIN MICROBIOL INFEC, V13, P146, DOI 10.1111/j.1469-0691.2006.01660.x; Perkins MD, 2003, CHEST, V123, P107, DOI 10.1378/chest.123.1.107; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; Raja A, 2002, CLIN DIAGN LAB IMMUN, V9, P308, DOI 10.1128/CDLI.9.2.308-312.2002; Sadaf S, 2007, BIOTECHNOL APPL BIOC, V47, P21, DOI 10.1042/BA20060154; Sajjad M, 2012, J BIOTECHNOL, V161, P206, DOI 10.1016/j.jbiotec.2012.05.023; Samanich K, 2001, INFECT IMMUN, V69, P4600, DOI 10.1128/IAI.69.7.4600-4609.2001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Shandar A, 2004, BMC BIOINFORMATICS, V5, DOI DOI 10.1186/1471-2105-5-51; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VERBON A, 1992, CLIN EXP IMMUNOL, V89, P395; von Grotthuss M, 2004, SCIENCE, V304, P1596; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; WHO, 2014, GLOB TUB REP 2014; Wilson RA, 2004, J MOL BIOL, V335, P519, DOI 10.1016/j.jmb.2003.11.001; Zhang Guoqiang, 2009, Genomics Proteomics & Bioinformatics, V7, P107, DOI 10.1016/S1672-0229(08)60039-X; Zhang SL, 2009, TUBERCULOSIS, V89, P278, DOI 10.1016/j.tube.2009.05.005	53	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163349	10.1371/journal.pone.0163349	http://dx.doi.org/10.1371/journal.pone.0163349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654048	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700051
J	Lajoie, I; Tancredi, FB; Hoge, RD				Lajoie, Isabelle; Tancredi, Felipe B.; Hoge, Richard D.			Regional Reproducibility of BOLD Calibration Parameter M, OEF and Resting-State CMRO2 Measurements with QUO2 MRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SPIN-LABELING MRI; POSITRON-EMISSION-TOMOGRAPHY; OXYGEN EXTRACTION FRACTION; LEVEL-DEPENDENT RESPONSES; TEST-RETEST RELIABILITY; QUANTITATIVE MEASUREMENT; ALZHEIMERS-DISEASE; METABOLIC-RATE; NORMAL VALUES	The current generation of calibrated MRI methods goes beyond simple localization of task-related responses to allow the mapping of resting-state cerebral metabolic rate of oxygen (CMRO2) in micromolar units and estimation of oxygen extraction fraction (OEF). Prior to the adoption of such techniques in neuroscience research applications, knowledge about the precision and accuracy of absolute estimates of CMRO2 and OEF is crucial and remains unexplored to this day. In this study, we addressed the question of methodological precision by assessing the regional inter-subject variance and intra-subject reproducibility of the BOLD calibration parameter M, OEF, O-2 delivery and absolute CMRO2 estimates derived from a state-of-the-art calibrated BOLD technique, the QUantitative O-2 (QUO2) approach. We acquired simultaneous measurements of CBF and R2* at rest and during periods of hypercapnia (HC) and hyperoxia (HO) on two separate scan sessions within 24 hours using a clinical 3 T MRI scanner. Maps of M, OEF, oxygen delivery and CMRO2, were estimated from the measured end-tidal O-2, CBF0, CBFHC/HO and R2(HC/HO)*. Variability was assessed by computing the between-subject coefficients of variation (bwCV) and within-subject CV (wsCV) in seven ROIs. All tests GM-averaged values of CBF0, M, OEF, O-2 delivery and CMRO2 were: 49.5 +/- 6.4 mL/100 g/min, 4.69 +/- 0.91%, 0.37 +/- 0.06, 377 +/- 51 mu mol/100 g/min and 143 +/- 34 mu mol/100 g/min respectively. The variability of parameter estimates was found to be the lowest when averaged throughout all GM, with general trends toward higher CVs when averaged over smaller regions. Among the MRI measurements, the most reproducible across scans was R2(0)* (wsCV(GM) = 0.33%) along with CBF0 (wsCV(GM) = 3.88%) and R2(HC)* (wsCV(GM) = 6.7%). CBFHC and R2(HO)* were found to have a higher intra-subject variability (wsCV(GM) = 22.4% and wsCV(GM) = 16% respectively), which is likely due to propagation of random measurement errors, especially for CBFHC due to the low contrast-to-noise ratio intrinsic to ASL. Reproducibility of the QUO2 derived estimates were computed, yielding a GM intra-subject reproducibility of 3.87% for O-2 delivery, 16.8% for the M value, 13.6% for OEF and 15.2% for CMRO2. Although these results focus on the precision of the QUO2 method, rather than the accuracy, the information will be useful for calculation of statistical power in future validation studies and ultimately for research applications of the method. The higher test-retest variability for the more extensively modeled parameters (M, OEF, and CMRO2) highlights the need for further improvement of acquisition methods to reduce noise levels.	[Lajoie, Isabelle] Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada; [Lajoie, Isabelle; Hoge, Richard D.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Tancredi, Felipe B.] Hosp Israelita Albert Einstein, Ctr Pesquisa Imagem, Dept Radiol, Sao Paulo, SP, Brazil	Universite de Montreal; McGill University; Hospital Israelita Albert Einstein	Lajoie, I (corresponding author), Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada.; Lajoie, I (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	isabelle.lajoie@mail.mcgill.ca			Canadian Institutes of Health Research [MOP 123492]; Canada Foundation for Innovation [17380]; Natural Sciences and Engineering Research Council of Canada [R0018142]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM)	This study was supported by the Canadian Institutes of Health Research MOP 123492 to RDH, Canada Foundation for Innovation 17380 to RDH, Natural Sciences and Engineering Research Council of Canada R0018142 to RDH, Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM) to RDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Asllani I, 2008, J CEREBR BLOOD F MET, V28, P725, DOI 10.1038/sj.jcbfm.9600570; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bolar DS, 2011, MAGN RESON MED, V66, P1550, DOI 10.1002/mrm.22946; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte DP, 2009, MAGN RESON MED, V61, P391, DOI 10.1002/mrm.21862; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen JJ, 2010, NEUROIMAGE, V53, P383, DOI 10.1016/j.neuroimage.2010.07.003; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Donahue MJ, 2014, J CEREBR BLOOD F MET, V34, P1243, DOI 10.1038/jcbfm.2014.81; Du AT, 2006, NEUROLOGY, V67, P1215, DOI 10.1212/01.wnl.0000238163.71349.78; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Gallichan D, 2009, MAGN RESON MED, V61, P686, DOI 10.1002/mrm.21886; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Gauthier CJ, 2011, NEUROIMAGE, V54, P1001, DOI 10.1016/j.neuroimage.2010.09.059; Gauthier CJ, 2013, HUM BRAIN MAPP, V34, P1053, DOI 10.1002/hbm.21495; Ghariq E, 2014, NEUROIMAGE, V103, P316, DOI 10.1016/j.neuroimage.2014.09.051; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Gustard S, 2003, MAGN RESON IMAGING, V21, P599, DOI 10.1016/S0730-725X(03)00083-3; Hino JK, 2000, CRIT CARE MED, V28, P3505, DOI 10.1097/00003246-200010000-00026; HORVATH I, 1994, J CEREBR BLOOD F MET, V14, P503, DOI 10.1038/jcbfm.1994.62; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Jahanian H, 2011, NMR BIOMED, V24, P1202, DOI 10.1002/nbm.1675; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Krieger SN, 2014, NEUROIMAGE, V101, P8, DOI 10.1016/j.neuroimage.2014.06.072; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Lin AL, 2008, MAGN RESON MED, V60, P380, DOI 10.1002/mrm.21655; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; MCPHERSON RW, 1991, J NEUROSURG ANESTH, V3, P12, DOI 10.1097/00008506-199103000-00003; Merola A, 2016, NEUROIMAGE, V129, P159, DOI 10.1016/j.neuroimage.2016.01.021; Padhani AR, 2002, NMR BIOMED, V15, P143, DOI 10.1002/nbm.732; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Pilkinton DT, 2012, MAGN RESON MED, V67, P1556, DOI 10.1002/mrm.23137; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; SEVERINGHAUS JW, 1989, ANESTHESIOLOGY, V70, P996, DOI 10.1097/00000542-198906000-00019; Sherif T, 2014, FRONT NEUROINFORM, V8, DOI [10.3389/fninf.2014.00054, 10.3389/fninf.2014.00089]; Siero JCW, 2015, NMR BIOMED, V28, P1518, DOI 10.1002/nbm.3411; Tancredi FB, 2013, J CEREB BLOOD FLOW M, P1; Tancredi FB, 2015, J MAGN RESON IMAGING, V42, P1144, DOI 10.1002/jmri.24878; Tancredi Felipe B, 2014, BMC Res Notes, V7, P235, DOI 10.1186/1756-0500-7-235; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Tohgi H, 1998, NEURORADIOLOGY, V40, P131, DOI 10.1007/s002340050553; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Wu WC, 2009, IEEE T MED IMAGING, V28, P703, DOI 10.1109/TMI.2008.2012020; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zaharchuk G, 2008, AM J NEURORADIOL, V29, P663, DOI 10.3174/ajnr.A0896; Zappe AC, 2008, MAGN RESON IMAGING, V26, P961, DOI 10.1016/j.mri.2008.02.005; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310	87	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163071	10.1371/journal.pone.0163071	http://dx.doi.org/10.1371/journal.pone.0163071			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649493	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100049
J	Su, Y; Blazey, TM; Owen, CJ; Christensen, JJ; Friedrichsen, K; Joseph-Mathurin, N; Wang, Q; Hornbeck, RC; Ances, BM; Snyder, AZ; Cash, LA; Koeppe, RA; Klunk, WE; Galasko, D; Brickman, AM; McDade, E; Ringman, JM; Thompson, PM; Saykin, AJ; Ghetti, B; Sperling, RA; Johnson, KA; Salloway, SP; Schofield, PR; Masters, CL; Villemagne, VL; Fox, NC; Forster, S; Chen, KW; Reiman, EM; Xiong, CJ; Marcus, DS; Weiner, MW; Morris, JC; Bateman, RJ; Benzinger, TLS				Su, Yi; Blazey, Tyler M.; Owen, Christopher J.; Christensen, Jon J.; Friedrichsen, Karl; Joseph-Mathurin, Nelly; Wang, Qing; Hornbeck, Russ C.; Ances, Beau M.; Snyder, Abraham Z.; Cash, Lisa A.; Koeppe, Robert A.; Klunk, William E.; Galasko, Douglas; Brickman, Adam M.; McDade, Eric; Ringman, John M.; Thompson, Paul M.; Saykin, Andrew J.; Ghetti, Bernardino; Sperling, Reisa A.; Johnson, Keith A.; Salloway, Stephen P.; Schofield, Peter R.; Masters, Colin L.; Villemagne, Victor L.; Fox, Nick C.; Forster, Stefan; Chen, Kewei; Reiman, Eric M.; Xiong, Chengjie; Marcus, Daniel S.; Weiner, Michael W.; Morris, John C.; Bateman, Randall J.; Benzinger, Tammie L. S.		Dominantly Inherited Alzheimer	Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group (vol 11, e0152082, 2016)	PLOS ONE			English	Correction													Fox, Nick C/B-1319-2009; Villemagne, Victor/AAC-5406-2019; Benzinger, Tammie/L-6104-2013	Fox, Nick C/0000-0002-6660-657X; Villemagne, Victor/0000-0002-5832-9875; Benzinger, Tammie/0000-0002-8114-0552; Friedrichsen, Karl/0000-0002-9233-1418; Joseph-Mathurin, Nelly/0000-0002-9735-5152	NCATS NIH HHS [UL1 TR000448] Funding Source: Medline; NIA NIH HHS [P50 AG005142, U19 AG032438, UF1 AG032438, P30 AG053760] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG032438, P30AG053760, UF1AG032438, P50AG005142] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0513-10134] Funding Source: researchfish	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR))		Su Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152082	1	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163669	10.1371/journal.pone.0163669	http://dx.doi.org/10.1371/journal.pone.0163669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649320	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100092
J	Bak, M; Drukker, M; Hasmi, L; van Os, J				Bak, Maarten; Drukker, Marjan; Hasmi, Laila; van Os, Jim			An n=1 Clinical Network Analysis of Symptoms and Treatment in Psychosis	PLOS ONE			English	Article							EXPERIENCE SAMPLING METHOD; DAILY-LIFE; SCHIZOPHRENIA; PSYCHIATRY; DEPRESSION; DIAGNOSIS	Introduction Dynamic relationships between the symptoms of psychosis can be shown in individual networks of psychopathology. In a single patient, data collected with the Experience Sampling Method (ESM-a method to construct intensive time series of experience and context) can be used to study lagged associations between symptoms in relation to illness severity and pharmacological treatment. Method The patient completed, over the course of 1 year, for 4 days per week, 10 daily assessments scheduled randomly between 10 minutes and 3 hours apart. Five a priori selected symptoms were analysed: 'hearing voices', 'down', 'relaxed', 'paranoia' and 'loss of control'. Regression analysis was performed including current level of one symptom as the dependent variable and all symptoms at the previous assessment (lag) as the independent variables. Resulting regression coefficients were printed in graphs representing a network of symptoms. Network graphs were generated for different levels of severity: stable, impending relapse and full relapse. Results ESM data showed that symptoms varied intensely from moment to moment. Network representations showed meaningful relations between symptoms, e.g. 'down' and 'paranoia' fuelling each other, and 'paranoia' negatively impacting 'relaxed'. During relapse, symptom levels as well as the level of clustering between symptoms markedly increased, indicating qualitative changes in the network. While 'hearing voices' was the most prominent symptom subjectively, the data suggested that a strategic focus on 'paranoia', as the most central symptom, had the potential to bring about changes affecting the whole network. Conclusion Construction of intensive ESM time series in a single patient is feasible and informative, particularly if represented as a network, showing both quantitative and qualitative changes as a function of relapse.	[Bak, Maarten; Drukker, Marjan; Hasmi, Laila; van Os, Jim] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England; [Bak, Maarten] Maastricht Univ, FHML, Dept Psychiat & Psychol, POB 616 P Vijverdal, NL-6200 MD Maastricht, Netherlands	Maastricht University; University of London; King's College London; Maastricht University	Bak, M (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, Maastricht, Netherlands.; Bak, M (corresponding author), Maastricht Univ, FHML, Dept Psychiat & Psychol, POB 616 P Vijverdal, NL-6200 MD Maastricht, Netherlands.	m.bak@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Hasmi, Laila/AAK-8256-2021	van Os, Jim/0000-0002-7245-1586; Hasmi, Laila/0000-0001-7184-4989; Bak, Maarten/0000-0003-1822-5542				American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Bak M, 2005, COMPR PSYCHIAT, V46, P192, DOI 10.1016/j.comppsych.2004.08.003; Blum LH, 2015, PSYCHIAT RES, V227, P318, DOI 10.1016/j.psychres.2015.03.008; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Bos FM, 2015, EUR NEUROPSYCHOPHARM, V25, P1853, DOI 10.1016/j.euroneuro.2015.08.008; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Costantini M, J RES PERSO IN PRESS, DOI [10.1177/2045125311419552, DOI 10.1177/2045125311419552]; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Declerck CH, 2006, BRAIN COGNITION, V62, P143, DOI 10.1016/j.bandc.2006.04.004; Delespaul P, 2002, HANDLEIDING MAASTRIC; DELESPAUL PAEG, 1987, J NERV MENT DIS, V175, P537, DOI 10.1097/00005053-198709000-00005; Delespaul PAEG, 1995, THESIS, DOI DOI 10.1002/WPS.20090; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Goekoop R, 2016, Tijdschr Psychiatr, V58, P38; Goekoop R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112734; Groot PC, 2010, J MENT HEALTH, V19, P352, DOI 10.3109/09638237.2010.494188; Johnson EI, 2009, INT J METH PSYCH RES, V18, P48, DOI 10.1002/mpr.276; Kendler KS, 2011, PSYCHOL MED, V41, P1143, DOI 10.1017/S0033291710001844; Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665; Kramer I, 2014, SCHIZOPHRENIA BULL, V40, P278, DOI 10.1093/schbul/sbs194; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Lardinois M, 2007, ACTA PSYCHIAT SCAND, V116, P71, DOI 10.1111/j.1600-0447.2007.01022.x; Lataster J, 2011, THER ADV PSYCHOPHARM, V1, P145, DOI 10.1177/2045125311419552; Lataster J, 2011, J CLIN PSYCHIAT, V72, P1397, DOI 10.4088/JCP.09m05466yel; McManus RJ, 2014, JAMA-J AM MED ASSOC, V312, P799, DOI 10.1001/jama.2014.10057; Myin-Germeys I, 2009, PSYCHOL MED, P1; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; R Core Team, 2021, R LANGUAGE ENV STAT; RCore Team, 2020, R LANG ENV STAT COMP; Silvia PJ, 2013, SOC SCI COMPUT REV, V31, P471, DOI 10.1177/0894439313479902; Statacorp, 2009, STAT SOFTW REL 11; StataCorp, 2009, STAT STAT SOFTW REL; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115254; van Os J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086652; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; van Wijngaarden-Cremers P J M, 2014, Tijdschr Psychiatr, V56, P670; Verhagen SJW, 2016, EVID-BASED MENT HEAL, V19, P86, DOI 10.1136/ebmental-2016-102418; Wang LJ, 2015, PSYCHOL METHODS, V20, P63, DOI 10.1037/met0000030; Wichers M, 2014, PSYCHOL MED, V44, P1349, DOI 10.1017/S0033291713001979; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers M, 2016, PSYCHOTHER PSYCHOSOM, V85, P114, DOI 10.1159/000441458; Wigman J. T. W., 2015, PSYCHOL MED, P1; Wigman JTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054653	46	58	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162811	10.1371/journal.pone.0162811	http://dx.doi.org/10.1371/journal.pone.0162811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643994	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900020
J	Braunholz, D; Saki, M; Niehr, F; Ozturk, M; Puertolas, BB; Konschak, R; Budach, V; Tinhofer, I				Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Oeztuerk, Merve; Puertolas, Berta Borras; Konschak, Robert; Budach, Volker; Tinhofer, Ingeborg			Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; GROWTH-FACTOR RECEPTOR; PROGRESSION-FREE; LUNG-CANCER; RESISTANCE; BLOOD; METASTASIS; CARCINOMA; MET; EXPRESSION	In solid tumours millions of cells are shed into the blood circulation each day. Only a subset of these circulating tumour cells (CTCs) survive, many of them presumable because of their potential to formmulti-cellular clusters also named spheroids. Tumour cells within these spheroids are protected from anoikis, which allows them to metastasize to distant organs or re-seed at the primary site. We used spheroid cultures of head and neck squamous cell carcinoma (HNSCC) cell lines as a model for such CTC clusters for determining the role of the epidermal growth factor receptor (EGFR) in cluster formation ability and cell survival after detachment from the extra-cellular matrix. The HNSCC cell lines FaDu, SCC-9 and UT-SCC-9 (UT-SCC-9P) as well as its cetuximab (CTX)-resistant sub-clone (UT-SCC-9R) were forced to grow in an anchorage-independent manner by coating culture dishes with the anti-adhesive polymer poly-2-hydroxyethylmethacrylate (poly-HEMA). The extent of apoptosis, clonogenic survival and EGFR signalling under such culture conditions was evaluated. The potential of spheroid formation in suspension culture was found to be positively correlated with the proliferation rate of HNSCC cell lines as well as their basal EGFR expression levels. CTX and gefitinib blocked, whereas the addition of EGFR ligands promoted anchorage-independent cell survival and spheroid formation. Increased spheroid formation and growth were associated with persistent activation of EGFR and its downstream signalling component (MAPK/ERK). Importantly, HNSCC cells derived from spheroid cultures retained their clonogenic potential in the absence of cell-matrix contact. Addition of CTX under these conditions strongly inhibited colony formation in CTX-sensitive cell lines but not their resistant subclones. Altogether, EGFR activation was identified as crucial factor for anchorage-independent survival of HNSCC cells. Targeting EGFR in CTC cluster formation might represent an attractive anti-metastatic treatment approach in HNSCC.	[Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Oeztuerk, Merve; Puertolas, Berta Borras; Konschak, Robert; Budach, Volker; Tinhofer, Ingeborg] Charite, Dept Radiooncol & Radiotherapy, Translat Radiooncol & Radiobiol Res Lab, Berlin, Germany; [Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Konschak, Robert; Tinhofer, Ingeborg] Charite, German Canc Consortium DKTK, Deutsch Krebsforschungszentrum DKFZ, Partner Site Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ)	Braunholz, D (corresponding author), Charite, Dept Radiooncol & Radiotherapy, Translat Radiooncol & Radiobiol Res Lab, Berlin, Germany.; Braunholz, D (corresponding author), Charite, German Canc Consortium DKTK, Deutsch Krebsforschungszentrum DKFZ, Partner Site Berlin, Berlin, Germany.	diana.braunholz@charite.de		Tinhofer, Ingeborg/0000-0002-0512-549X; Ozturk, Merve/0000-0003-2898-2176; Budach, Volker/0000-0002-2191-9871				Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Barriere G, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.10.04; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Boeckx C, 2013, ONCOLOGIST, V18, P850, DOI 10.1634/theoncologist.2013-0013; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BUTLER TP, 1975, CANCER RES, V35, P512; Chang MC, 2016, CLIN CHEM; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Denes V, 2015, INT J CANCER, V136, P1528, DOI 10.1002/ijc.29155; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fehm T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2349; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Humtsoe JO, 2010, ONCOGENE, V29, P1214, DOI 10.1038/onc.2009.419; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kari C, 2003, CANCER RES, V63, P1; Krawczyk N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.352; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Lee SH, 2009, CARCINOGENESIS, V30, P1997, DOI 10.1093/carcin/bgp233; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mascalchi M, 2016, J CANCER RES CLIN, V142, P195, DOI 10.1007/s00432-015-2021-3; Moitra K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/635745; Molnar B, 2001, CLIN CANCER RES, V7, P4080; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Park Jae-Yeo, 2014, Evid Based Complement Alternat Med, V2014, P895272, DOI 10.1155/2014/895272; Payne RE, 2009, PHARMACOGENOMICS, V10, P51, DOI 10.2217/14622416.10.1.51; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rybak AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061716; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solic N, 1997, EXP CELL RES, V234, P465, DOI 10.1006/excr.1997.3635; Tinhofer I, 2014, INT J RADIAT BIOL, V90, P622, DOI 10.3109/09553002.2014.886798; Tinhofer I, 2012, INT J RADIAT ONCOL, V83, pE685, DOI 10.1016/j.ijrobp.2012.02.009; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Van Emburgh B.O., 2014, MOL ONCOL; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163149	10.1371/journal.pone.0163149	http://dx.doi.org/10.1371/journal.pone.0163149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643613	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900034
J	Mir, RA; Weppelmann, TA; Johnson, JA; Archer, D; Morris, JG; Jeong, KC				Mir, Raies A.; Weppelmann, Thomas A.; Johnson, Judith A.; Archer, Douglas; Morris, J. Glenn, Jr.; Jeong, KwangCheol Casey			Identification and Characterization of Cefotaxime Resistant Bacteria in Beef Cattle	PLOS ONE			English	Article							ESCHERICHIA-COLI; CTX-M; ENTEROBACTERIACEAE; EPIDEMIOLOGY; EMERGENCE; GENES; FARMS; SOIL	Third-generation cephalosporins are an important class of antibiotics that are widely used in treatment of serious Gram-negative bacterial infections. In this study, we report the isolation of bacteria resistant to the third-generation cephalosporin cefotaxime from cattle with no previous cefotaxime antibiotic exposure. The prevalence of cefotaxime-resistant bacteria was examined by a combination of culture based and molecular typing methods in beef cattle (n = 1341) from 8 herds located in North Central Florida. The overall prevalence of cefotaxime- resistant bacteria was 15.8% (95% CI: 13.9, 17.8), varied between farms, and ranged from 5.2% to 100%. A subset of isolates (n = 23) was further characterized for the cefotaxime minimum inhibitory concentration (MIC) and antibiotic susceptibility against 10 different antibiotics, sequencing of nine beta- lactamase genes, and species identification by 16S rRNA sequencing. Most of the bacterial isolates were resistant to cefotaxime (concentrations, > 64 mu g/mL) and showed high levels of multi-drug resistance. Full length 16S rRNA sequences (similar to 1300 bp) revealed that most of the isolates were not primary human or animal pathogens; rather were more typical of commensal, soil, or other environmental origin. Six extended spectrum beta-lactamase (ESBL) genes identical to those in clinical human isolates were identified. Our study highlights the potential for carriage of cefotaxime resistance (including "human" ESBL genes) by the bacterial flora of food animals with no history of cefotaxime antibiotic exposure. A better understanding of the origin and transmission of resistance genes in these pre-harvest settings will be critical to development of strategies to prevent the spread of antimicrobial resistant microorganisms to hospitals and communities.	[Mir, Raies A.; Jeong, KwangCheol Casey] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Mir, Raies A.; Weppelmann, Thomas A.; Johnson, Judith A.; Morris, J. Glenn, Jr.; Jeong, KwangCheol Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Weppelmann, Thomas A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Johnson, Judith A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Archer, Douglas] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA.; Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	kcjeong@ufl.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2015-68003-22971]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under the award number 2015-68003-22971 to KCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the farmers and livestock managers for the permission to collect fecal swab samples from the cattle housed on their farms for the purposes of scientific research. This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under the award number 2015-68003-22971 to KCJ.	[Anonymous], 2011, M2A9 CLSI, V32, P1; Anukool U, 2004, APPL ENVIRON MICROB, V70, P5222, DOI 10.1128/AEM.70.9.5222-5228.2004; Blossom D., 2008, INFECT DIS CLIN PRAC, V16, P1, DOI DOI 10.1097/IPC.0B013E3181635DEF; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Doi Y, 2012, DIAGN MICR INFEC DIS, V74, P34, DOI 10.1016/j.diagmicrobio.2012.05.020; Enoch DA, 2012, J HOSP INFECT, V81, P270, DOI 10.1016/j.jhin.2012.05.006; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Glupczynski Y, 2007, J CLIN MICROBIOL, V45, P501, DOI 10.1128/JCM.02221-06; Hiroi M, 2012, J VET MED SCI, V74, P1635, DOI 10.1292/jvms.11-0479; Johnson JR, 2009, J CLIN MICROBIOL, V47, P3721, DOI 10.1128/JCM.01581-09; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Mollenkopf DF, 2012, APPL ENVIRON MICROB, V78, P4552, DOI 10.1128/AEM.00373-12; Mollenkopf DF, 2011, FOODBORNE PATHOG DIS, V8, P333, DOI 10.1089/fpd.2010.0701; PAGE CP, 1993, ARCH SURG-CHICAGO, V128, P410; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Reglier-Poupet H, 2008, J MED MICROBIOL, V57, P310, DOI 10.1099/jmm.0.47625-0; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; STOUTENBEEK CP, 1987, J ANTIMICROB CHEMOTH, V19, P513, DOI 10.1093/jac/19.4.513; Sylvia L, 2010, CANVETJ, V51, P853; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian GB, 2009, FOODBORNE PATHOG DIS, V6, P297, DOI 10.1089/fpd.2008.0164; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Walsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065567; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1	30	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163279	10.1371/journal.pone.0163279	http://dx.doi.org/10.1371/journal.pone.0163279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642751	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900041
J	Duarte, JD; Desai, AA; Sysol, JR; Abbasi, T; Patel, AR; Lang, RM; Gupta, A; Garcia, JGN; Gordeuk, VR; Machado, RF				Duarte, Julio D.; Desai, Ankit A.; Sysol, Justin R.; Abbasi, Taimur; Patel, Amit R.; Lang, Roberto M.; Gupta, Akash; Garcia, Joe G. N.; Gordeuk, Victor R.; Machado, Roberto F.			Genome-Wide Analysis Identifies IL-18 and FUCA2 as Novel Genes Associated with Diastolic Function in African Americans with Sickle Cell Disease	PLOS ONE			English	Article							TISSUE DOPPLER; INTERLEUKIN-18; DYSFUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; EXPRESSION; ANEMIA	Background Diastolic dysfunction is common in sickle cell disease (SCD), and is associated with an increased risk of mortality. However, the molecular pathogenesis underlying this development is poorly understood. The aim of this study was to identify a gene expression profile that is associated with diastolic function in SCD, potentially elucidating molecular mechanisms behind diastolic dysfunction development. Methods Diastolic function was measured via echocardiography in 65 patients with SCD from two independent study populations. Gene expression microarray data was compared with diastolic function in both study cohorts. Candidate genes that associated in both analyses were tested for validation in a murine SCD model. Lastly, genotyping array data from the replication cohort was used to derive cis-expression quantitative trait loci (cis-eQTLs) and genetic associations within the candidate gene regions. Results Transcriptome data from both patient cohorts implicated 7 genes associated with diastolic function, and mouse SCD myocardial expression validated 3 of these genes. Genetic associations and eQTLs were detected in 2 of the 3 genes, FUCA2 and IL18. Conclusions FUCA2 and IL18 are associated with diastolic function in SCD patients, and may be involved in the pathogenesis of the disease. Genetic polymorphisms within the FUCA2 and IL18 gene regions are also associated with diastolic function in SCD, likely by affecting expression levels of the genes.	[Duarte, Julio D.] Univ Illinois, Dept Pharm Practice, Chicago, IL 60607 USA; [Desai, Ankit A.] Univ Arizona, Sarver Heart Ctr, Div Cardiol, Tucson, AZ USA; [Sysol, Justin R.; Gupta, Akash; Gordeuk, Victor R.; Machado, Roberto F.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Abbasi, Taimur] Mercy Hosp, Ctr Med, Dept Med, Chicago, IL USA; [Patel, Amit R.; Lang, Roberto M.] Univ Chicago, Dept Med, Chicago, IL USA; [Garcia, Joe G. N.] Univ Arizona, Dept Med, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Arizona	Duarte, JD (corresponding author), Univ Illinois, Dept Pharm Practice, Chicago, IL 60607 USA.; Machado, RF (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	juliod@cop.ufl.edu; machador@uic.edu	Gordeuk, Victor/AAG-6577-2019; Patel, Amit/B-2464-2014	Gupta, Akash/0000-0001-7305-055X; Patel, Amit/0000-0001-7621-6463; Desai, Ankit/0000-0001-6427-616X; Machado, Roberto/0000-0002-3722-5954	National Institute of General Medical Sciences [K23 GM112014]; American Heart Association [14CRP18910051]; PHA Research Fellowship /ATS Foundation; National Heart, Lung, and Blood Institute [F30 HL128034, R01 HL111656, R01 HL127342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM112014] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); PHA Research Fellowship /ATS Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the following funding sources: National Institute of General Medical Sciences (https://www.nigms.nih.gov/) K23 GM112014 (JDD), American Heart Association (http://www.heart.org) 14CRP18910051 (AAD), PHA Research Fellowship (https://www.phassociation.org/) /ATS Foundation (http://foundation.thoracic.org) (AAD), National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov/) F30 HL128034 (JRS), National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov/) R01 HL111656 and R01 HL127342 (RFM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondi B, 2000, J CLIN ENDOCR METAB, V85, P4701, DOI 10.1210/jc.85.12.4701; Caldas MC, 2008, J AM SOC ECHOCARDIOG, V21, P1163, DOI 10.1016/j.echo.2007.06.001; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cordero OJ, 2001, EUR J BIOCHEM, V268, P3321, DOI 10.1046/j.1432-1327.2001.02237.x; Desai AA, 2014, CIRC-CARDIOVASC IMAG, V7, P431, DOI 10.1161/CIRCIMAGING.113.001420; Desai AA, 2012, AM J RESP CRIT CARE, V186, P359, DOI 10.1164/rccm.201201-0057OC; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Hartford M, 2010, ARTERIOSCL THROM VAS, V30, P2039, DOI 10.1161/ATVBAHA.109.202697; Hillestad V, 2015, ACTA PHYSIOL, V213, P492, DOI 10.1111/apha.12376; Intra J, 2007, GENE, V392, P34, DOI 10.1016/j.gene.2006.11.002; Johnson MC, 2010, BLOOD, V116, P16, DOI 10.1182/blood-2009-06-227447; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; R Core Team, 2013, R LANG ENV STAT COMP; Sachdev V, 2007, J AM COLL CARDIOL, V49, P472, DOI 10.1016/j.jacc.2006.09.038; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Sobkowicz AD, 2014, MOL CELL BIOCHEM, V390, P101, DOI 10.1007/s11010-014-1961-2; Toldo S, 2014, AM J PHYSIOL-HEART C, V306, pH1025, DOI 10.1152/ajpheart.00795.2013; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; WEMEAU JL, 2008, THE JOURNAL OF CLINI, V93, P2084, DOI DOI 10.1210/JC.2007-2719; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517; Zhang X, 2014, CIRCULATION, V129, P1650, DOI 10.1161/CIRCULATIONAHA.113.005296	29	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163013	10.1371/journal.pone.0163013	http://dx.doi.org/10.1371/journal.pone.0163013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636371	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700026
J	Alotaibi, NAS; Slater, NKH; Rahmoune, H				Alotaibi, Noha A. S.; Slater, Nigel K. H.; Rahmoune, Hassan			Salidroside as a Novel Protective Agent to Improve Red Blood Cell Cryopreservation	PLOS ONE			English	Article							HUMAN ERYTHROCYTES; OXIDATIVE STRESS; TREHALOSE; FROZEN; HEMOGLOBIN; SURVIVAL; ACP-215; STORAGE; RBCS	Glycerol and trehalose have been widely examined as protective agents in the cryopreservation of red blood cells (RBCs). However, the effectiveness of these reagents alone on cell viability is moderate. Here, the addition of salidroside attenuated oxidative damage of sheep RBCs prior to and post cryostorage. The supplementation of salidroside to the cryopreservation media containing 10% glycerol improved RBC survival by approximately 61.1+/-4.8% vs 37.9+/-4.6%. A smaller effect was seen in RBCs cryopreserved in 300 mM trehalose where the addition of salidroside improved survival by 7.6+/-0.3%. Furthermore, the addition of salidroside to cold storage solution demonstrated a significant reduction of haemolysis after 4 days for RBCs loaded with either glycerol or trehalose, compared to cells incubated without salidroside. RBCs survival was 2-fold greater following freezing in trehalose, compared with glycerol. After 10 days, salidroside enabled a lower haemolysis of 16.7+/-1.3% compared to 29.0+/-8.4% for cells incubated without salidroside. However, salidroside had no effect on RBCs which had been frozen in glycerol as the resulting haemolysis rate by day 10 was approximately 60%. Salidroside increased glutathione reductase activity and decreased lactate dehydrogenase activity. Furthermore, it led to reduced carbonylation of proteins in both glycerol and trehalose loaded cells. Finally, no effect on lipid peroxidation was found in the glycerol loaded RBCs although this was reduced in RBCs loaded with trehalose and salidroside. The present findings confirm the potential use of salidroside as a novel protective agent in cryopreservation and refrigerated storage of sheep RBCs.	[Alotaibi, Noha A. S.; Slater, Nigel K. H.; Rahmoune, Hassan] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England; [Alotaibi, Noha A. S.] King Abdulaziz City Sci & Technol Kingdom Saudi A, POB 6086, Riyadh 11442, Saudi Arabia	University of Cambridge	Rahmoune, H (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	hr228@cam.ac.uk			King AbdulAziz City for Science and Technology (KACST)	King AbdulAziz City for Science and Technology (KACST)	King AbdulAziz City for Science and Technology (KACST) funded NASA. The funder provided support in the form of salaries for authors [NASA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Acker J.P, 2006, ADV BIOPRESERVATION, P291; Baust JG, 2009, ORGANOGENESIS, V5, P90, DOI 10.4161/org.5.3.10021; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bhowmick P, 2002, CRYOBIOLOGY, V45, P183, DOI 10.1016/S0011-2240(02)00126-8; Bosman GJCGM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00376; CHAO ES, 1988, CELL BIOL TOXICOL, V4, P1, DOI 10.1007/BF00141283; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; D'Alessandro A, 2013, MOL BIOSYST, V9, P1196, DOI 10.1039/c3mb25575a; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Henkelman S, 2015, VOX SANG, V108, P103, DOI 10.1111/vox.12218; Hess JR, 2004, TRANSFUSION MED, V14, P1, DOI 10.1111/j.0958-7578.2004.00472.x; Holovati JL, 2009, CRYOBIOLOGY, V58, P75, DOI 10.1016/j.cryobiol.2008.11.002; Kanias T, 2010, FEBS J, V277, P343, DOI 10.1111/j.1742-4658.2009.07472.x; Kelly G., 2001, ALTERN MED REV, V3, P293; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Kucherenko YV, 2015, CELL PHYSIOL BIOCHEM, V35, P2055, DOI 10.1159/000374012; Lynch AL, 2010, ALTERN MED REV, V31, P6069, DOI [10.1016/j.biomaterials.2010.04.020, DOI 10.1016/J.BIOMATERIALS.2010.04.020]; Lynch AL, 2011, BIOMATERIALS, V32, P4443, DOI 10.1016/j.biomaterials.2011.02.062; Lynch AL, 2010, BIOMATERIALS, V31, P6096, DOI 10.1016/j.biomaterials.2010.04.020; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; Reed B.M., 2012, CRYOBIOLOGY, V65, P340, DOI [10.1016/j.cryobiol.2012.07.005, DOI 10.1016/J.CRYOBIOL.2012.07.005]; Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001; Scott K, 2004, CRYOBIOLOGY, V49, P304; Singbartl K, 1998, CRYOBIOLOGY, V36, P115, DOI 10.1006/cryo.1997.2072; Uchida T, 2012, CRYSTALLIZATION MAT, P203; Valeri CR, 2005, TRANSFUSION, V45, P1621, DOI 10.1111/j.1537-2995.2005.00588.x; Valeri CR, 2001, TRANSFUSION, V41, P933, DOI 10.1046/j.1537-2995.2001.41070933.x; Zhang XG, 2015, CRYOBIOLOGY, V70, P246, DOI 10.1016/j.cryobiol.2015.03.004; Zolla L, 2013, J INTEGRATED OMICS, V3, P11; Zolla L, 2015, BLOOD TRANSFUS-ITALY, V13, P21, DOI 10.2450/2014.0053-14	31	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162748	10.1371/journal.pone.0162748	http://dx.doi.org/10.1371/journal.pone.0162748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631782	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900073
J	Hilbert, A				Hilbert, Anja			Weight Stigma Reduction and Genetic Determinism	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; ANTI-FAT PREJUDICE; OVERWEIGHT INDIVIDUALS; OBESITY; ATTITUDES; BIAS; BELIEFS; HEALTH; IMPACT; PEOPLE	One major approach to weight stigma reduction consists of decreasing beliefs about the personal controllability of-and responsibility for-obesity by educating about its biogenetic causes. Evidence on the efficacy of this approach is mixed, and it remains unclear whether this would create a deterministic view, potentially leading to detrimental side-effects. Two independent studies from Germany using randomized designs with delayed-intervention control groups served to (1) develop and pilot a brief, interactive stigma reduction intervention to educate N = 128 university students on gene x environment interactions in the etiology of obesity; and to (2) evaluate this intervention in the general population (N = 128) and determine mechanisms of change. The results showed (1) decreased weight stigma and controllability beliefs two weeks post-intervention in a student sample; and (2) decreased internal attributions and increased genetic attributions, knowledge, and deterministic beliefs four weeks post-intervention in a population sample. Lower weight stigma was longitudinally predicted by a decrease in controllability beliefs and an increase in the belief in genetic determinism, especially in women. The results underline the usefulness of a brief, interactive intervention promoting an interactionist view of obesity to reduce weight stigma, at least in the short term, lending support to the mechanisms of change derived from attribution theory. The increase in genetic determinism that occurred despite the intervention's gene x environment focus had no detrimental side-effect on weight stigma, but instead contributed to its reduction. Further research is warranted on the effects of how biogenetic causal information influences weight management behavior of individuals with obesity.	[Hilbert, Anja] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany	Leipzig University	Hilbert, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany.	anja.hilbert@medizin.uni-leipzig.de			Bundesministerium fur Bildung und Forschung [01EO1501, 01GP0491]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/): Grants 01EO1501 and 01GP0491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1991, INT J EAT DISORDER, V10, P599; Bannon KL, 2009, INT J EAT DISORDER, V42, P118, DOI 10.1002/eat.20588; Brauhardt A, 2014, J BEHAV THER EXP PSY, V45, P285, DOI 10.1016/j.jbtep.2014.01.001; Brewis AA, 2014, SOC SCI MED, V118, P152, DOI 10.1016/j.socscimed.2014.08.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Danielsdottir S, 2010, OBESITY FACTS, V3, P47, DOI 10.1159/000277067; Dar-Nimrod I, 2014, APPETITE, V81, P269, DOI 10.1016/j.appet.2014.06.109; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; Diedrichs PC, 2011, BRIT J HEALTH PSYCH, V16, P846, DOI 10.1111/j.2044-8287.2011.02022.x; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hague AL, 2005, J NUTR EDUC BEHAV, V37, P58, DOI 10.1016/S1499-4046(06)60017-1; Hilbert A, 2010, ESSANFALLE UND ADIPO; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Hilbert A, 2014, OBESITY, V22, P79, DOI 10.1002/oby.20561; Hoyt C.L., 2017, STIGMA HEALTH, V2, P53, DOI [10.1037/sah0000026, DOI 10.1037/SAH0000026]; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Lebowitz MS, 2014, P NATL ACAD SCI USA, V111, P17786, DOI 10.1073/pnas.1414058111; Lee M, 2014, BODY IMAGE, V11, P251, DOI 10.1016/j.bodyim.2014.03.003; Lewis RJ, 1997, OBES RES, V5, P297, DOI 10.1002/j.1550-8528.1997.tb00555.x; Lippa NC, 2013, HUM HERED, V75, P186, DOI 10.1159/000353712; Lippa NC, 2012, OBESITY, V20, P2367, DOI 10.1038/oby.2012.144; Nelkin D., 2004, DNA MYSTIQUE GENE CU; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; O'Brien KS, 2010, OBESITY, V18, P2138, DOI 10.1038/oby.2010.79; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Pearl RL, 2014, PSYCHOL HEALTH, V29, P1176, DOI 10.1080/08870446.2014.916807; Persky S, 2011, ANN BEHAV MED, V41, P363, DOI 10.1007/s12160-010-9242-0; Phelan JC, 2005, J HEALTH SOC BEHAV, V46, P307, DOI 10.1177/002214650504600401; Puhl RM, 2015, INT J OBESITY, V39, P1166, DOI 10.1038/ijo.2015.32; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Puhl RM, 2005, HEALTH PSYCHOL, V24, P517, DOI 10.1037/0278-6133.24.5.517; Ruscio John, 2011, J Exp Psychopathol, V2, P170; Sheeran P, 2013, HEALTH PSYCHOL, V32, P460, DOI 10.1037/a0029203; Sikorski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046924; Stober J, 1999, DIAGNOSTICA, V45, P173, DOI 10.1026//0012-1924.45.4.173; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Swift JA, 2013, OBESITY FACTS, V6, P91, DOI 10.1159/000348714; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; WIESE HJC, 1992, INT J OBESITY, V16, P859; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162993	10.1371/journal.pone.0162993	http://dx.doi.org/10.1371/journal.pone.0162993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631384	Green Published, gold			2022-12-27	WOS:000383706900110
J	Liu, YL; Zhang, S; Zhao, YL; Du, J; Jin, GH; Shao, S; Lu, XQ				Liu, Yanli; Zhang, Sai; Zhao, Yali; Du, Juan; Jin, Guanghui; Shao, Shuang; Lu, Xiaoqin			Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							C VIRUS-INFECTION; GENERAL-PRACTITIONERS; EPIDEMIOLOGY; PREVENTION	Objective To develop the Chinese (Mainland) version of Chronic Liver Disease Questionnaire (CLDQ) and use it to assess the health-related quality of life (HRQoL) of chronic hepatitis B (CHB) patients in China and identify the determinants of HRQoL. Methods The Chinese (Mainland) CLDQ was developed by expert consultation, focus group interviews with patients, and pilot study. The final version of questionnaire was adopted to assess the HRQoL of chronic hepatitis B outpatients enrolled from two largest infectious hospitals in Beijing. Cronbach's alpha was used to measure the internal consistency reliability. The construct validity was measured by factor analysis. T-test, one-way analysis of variance (ANOVA), and multi-variable linear regression were used to analyze the data. Results Cronbach's alpha of the overall CLDQ is 0.935, ranging from 0.628 to 0.881 among six sub-scales. Six factors were identified via factor analysis, including a new factor sleeping(SL). A total of 519 patients with CHB were included in the investigation with the final version of questionnaire, 405 of them were only with CHB, 53 with compensated cirrhosis, and 61 with decompensated cirrhosis. The CHB group scored the highest in the overall score of CLDQ (p<0.05). The score of worry (WO) domain was significantly lower in the compensated group than the CHB group (p<0.05). Decompensated cirrhosis patients scored lower than the CHB group in all CLDQ domains and the overall score (p<0.05). Stages of illness, gender, regular visits to specialized hospitals, and work status in last year were determinants of HRQoL. Conclusion The psychometric properties of the Chinese(Mainland) CLDQ is acceptable. The HRQoL of CHB patients deteriorated with disease progression. Advanced stages of CHB, female, long time absence from work after illness, and no job or retirement were determinants of poor HRQoL. Regular visits to specialized hospitals was a positive determinant of HRQoL.	[Liu, Yanli; Zhang, Sai; Zhao, Yali; Du, Juan; Jin, Guanghui; Shao, Shuang; Lu, Xiaoqin] Capital Med Univ, Dept Gen Practice, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China; [Zhang, Sai] Cent S Univ, Xiangya Hosp, Inst Med Sci, Changsha 410008, Hunan, Peoples R China	Capital Medical University; Central South University	Lu, XQ (corresponding author), Capital Med Univ, Dept Gen Practice, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China.	xq6518@163.com		Liu, Yanli/0000-0003-3066-3668				Chang SC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-97; Chinese Society Of Hepatology CMAC, 2011, CHINESE J EXPT CLIN, V5, P50; de Franchis R, 2003, COMMUNICATION; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Gao F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-131; Giannini EG, 2009, J CLIN GASTROENTEROL, V43, P1001, DOI 10.1097/MCG.0b013e31818e876f; Gutteling JJ, 2006, ALIMENT PHARM THER, V23, P1629, DOI 10.1111/j.1365-2036.2006.02934.x; Hu M, 2009, VALUE HEALTH, V12, pS89, DOI 10.1111/j.1524-4733.2009.00636.x; Lam ETP, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-52; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; Nokhodian Z, 2009, INDIAN J GASTROENTER, V28, P116, DOI 10.1007/s12664-009-0041-0; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ren JJ, 2014, HEPATOB PANCREAT DIS, V13, P495, DOI 10.1016/S1499-3872(14)60313-1; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Wai CT, 2005, ALIMENT PHARM THER, V21, P1255, DOI 10.1111/j.1365-2036.2005.02497.x; Wallace J, 2013, AUST NZ J PUBL HEAL, V37, P405, DOI 10.1111/1753-6405.12127; World Health Organization, 2014, HEP B FACT SHEETS; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295; Zhuang GH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-101	22	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162763	10.1371/journal.pone.0162763	http://dx.doi.org/10.1371/journal.pone.0162763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631983	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900074
J	Lv, YY; Zhang, SB; Wang, JS; Hu, YS				Lv, Yangyong; Zhang, Shuaibing; Wang, Jinshui; Hu, Yuansen			Quantitative Proteomic Analysis of Wheat Seeds during Artificial Ageing and Priming Using the Isobaric Tandem Mass Tag Labeling	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; LIPID-TRANSFER PROTEINS; TRITICUM-AESTIVUM L.; FUSARIUM HEAD BLIGHT; POSTTRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; ANALYSIS REVEALS; GENE FAMILY; FATTY-ACID; GERMINATION	Wheat (Triticum aestivum L.) is an important crop worldwide. The physiological deterioration of seeds during storage and seed priming is closely associated with germination, and thus contributes to plant growth and subsequent grain yields. In this study, wheat seeds during different stages of artificial ageing (45 degrees C; 50% relative humidity; 98%, 50%, 20%, and 1% Germination rates) and priming (hydro-priming treatment) were subjected to proteomics analysis through a proteomic approach based on the isobaric tandem mass tag labeling. A total of 162 differentially expressed proteins (DEPs) mainly involved in metabolism, energy supply, and defense/stress responses, were identified during artificial ageing and thus validated previous physiological and biochemical studies. These DEPs indicated that the inability to protect against ageing leads to the incremental decomposition of the stored substance, impairment of metabolism and energy supply, and ultimately resulted in seed deterioration. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed that the up-regulated proteins involved in seed ageing were mainly enriched in ribosome, whereas the down-regulated proteins were mainly accumulated in energy supply (starch and sucrose metabolism) and stress defense (ascorbate and aldarate metabolism). Proteins, including hemoglobin 1, oleosin, agglutinin, and non-specific lipid-transfer proteins, were first identified in aged seeds and might be regarded as new markers of seed deterioration. Of the identified proteins, 531 DEPs were recognized during seed priming compared with unprimed seeds. In contrast to the up-regulated DEPs in seed ageing, several up-regulated DEPs in priming were involved in energy supply (tricarboxylic acid cycle, glycolysis, and fatty acid oxidation), anabolism (amino acids, and fatty acid synthesis), and cell growth/division. KEGG and protein-protein interaction analysis indicated that the up-regulated proteins in seed priming were mainly enriched in amino acid synthesis, stress defense (plant-pathogen interactions, and ascorbate and aldarate metabolism), and energy supply (oxidative phosphorylation and carbonmetabolism). Therefore, DEPs associated with seed ageing and priming can be used to characterize seed vigor and optimize germination enhancement treatments. This work reveals new proteomic insights into protein changes that occur during seed deterioration and priming.	[Lv, Yangyong; Zhang, Shuaibing; Wang, Jinshui; Hu, Yuansen] Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China	Henan University of Technology	Hu, YS (corresponding author), Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China.	hys308@126.com	Lv, Yangyong/HDN-1832-2022		Natural Science Foundation of China [31371850, 31501575, 31401542]; Natural Science Foundation of Henan Provincial Education Department [13A210164]; Natural Science Foundation of Youth Support Plan of Henan University of Technology [2015QNJH06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan Provincial Education Department; Natural Science Foundation of Youth Support Plan of Henan University of Technology	This research was financially supported by grants from the Natural Science Foundation of China grants (31371850, 31501575, and 31401542), Natural Science Foundation of Henan Provincial Education Department (13A210164) and Natural Science Foundation of Youth Support Plan of Henan University of Technology (2015QNJH06).	Abid G, 2009, GENE, V439, P1, DOI 10.1016/j.gene.2009.03.007; Bailly C, 2011, METHODS MOL BIOL, V773, P343, DOI 10.1007/978-1-61779-231-1_20; Bellani LM, 2012, ACTA PHYSIOL PLANT, V34, P1789, DOI 10.1007/s11738-012-0976-0; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; CAMMUE BRUNO PA, 1995, PLANT PHYSIOL, V109, P445, DOI 10.1104/pp.109.2.445; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Caruso C, 1996, J PROTEIN CHEM, V15, P35, DOI 10.1007/BF01886809; Carvalho AO, 2001, PLANT PHYSIOL BIOCH, V39, P137, DOI 10.1016/S0981-9428(00)01230-4; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; CHHETRI DR, 1993, SEED SCI TECHNOL, V21, P31; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Christov NK, 2008, CELL BIOL INT, V32, P574, DOI 10.1016/j.cellbi.2007.11.014; Christova PK, 2006, PLANTA, V223, P1207, DOI 10.1007/s00425-005-0169-9; DAS G, 1988, PLANT PHYSIOL, V88, P983, DOI 10.1104/pp.88.4.983; Dell'Aquila A, 1994, SEED SCI RES, V4, P293, DOI 10.1017/S0960258500002324; Dong K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01017; Dong K, 2012, J CEREAL SCI, V56, P615, DOI 10.1016/j.jcs.2012.08.016; Dupont FM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-39; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Farajalla MR, 2007, GENOME, V50, P502, DOI 10.1139/G07-027; Feldman-Salit A, 2012, STRUCTURE, V20, P292, DOI 10.1016/j.str.2011.11.019; Ford KL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00044; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Garcia-Olmedo Francisco, 1995, Trends in Microbiology, V3, P72, DOI 10.1016/S0966-842X(00)88879-4; Ge P, 2013, PROTEOMICS, V13, P3046, DOI 10.1002/pmic.201300042; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Goel A, 2003, J PLANT PHYSIOL, V160, P1093, DOI 10.1078/0176-1617-00881; Han J, 2014, J MICROBIOL BIOTECHN, V24, P1162, DOI 10.4014/jmb.1312.12076; He AY, 2014, GENE, V545, P30, DOI 10.1016/j.gene.2014.05.010; HEYDECKER W, 1973, NATURE, V246, P42, DOI 10.1038/246042a0; Hohm T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145247; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Jin WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147586; Jones R., 2000, BIOCH MOL BIOL PLANT, P930; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Khlestkina EK, 2013, CEREAL RES COMMUN, V41, P185, DOI 10.1556/CRC.2013.0004; Kibinza S, 2011, PLANT SCI, V181, P309, DOI 10.1016/j.plantsci.2011.06.003; Kim ST, 2009, J PROTEOME RES, V8, P3598, DOI 10.1021/pr900358s; Kimura S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0460-2; Kondoh H, 2005, CANCER RES, V65, P177; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Lee J, 2012, PLANT BIOTECHNOL J, V10, P164, DOI 10.1111/j.1467-7652.2011.00650.x; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Lehninger AL, 2005, PRINCIPLES BIOCH; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073330; Li X, 2010, PHYTOPATHOLOGY, V100, P183, DOI 10.1094/PHYTO-100-2-0183; Lin XQ, 2013, J PROTEOMICS, V91, P58, DOI 10.1016/j.jprot.2013.06.031; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Liu ZH, 2013, BIOTECHNOL LETT, V35, P1765, DOI 10.1007/s10529-013-1277-4; Lucyshyn D, 2007, MOL GENET GENOMICS, V277, P507, DOI 10.1007/s00438-006-0201-1; Ma CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1029; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Mak Y, 2009, CEREAL CHEM, V86, P281, DOI 10.1094/CCHEM-86-3-0281; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; MATHUR M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P161, DOI 10.1016/0167-4838(91)99005-D; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Miller J. David, 1997, Natural Toxins, V5, P234, DOI 10.1002/(SICI)1522-7189(1997)5:6<234::AID-NT3>3.0.CO;2-Q; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; MIRELMAN D, 1975, NATURE, V256, P414, DOI 10.1038/256414a0; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; Morscher F, 2015, ANN BOT-LONDON, V116, P669, DOI 10.1093/aob/mcv108; Nair RB, 1997, PLANT SCI, V122, P153, DOI 10.1016/S0168-9452(96)04543-8; Neal AL, 2013, J BIOL INORG CHEM, V18, P557, DOI 10.1007/s00775-013-1000-x; NI WT, 1991, PLANT CELL, V3, P737, DOI 10.1105/tpc.3.7.737; O'Sullivan NC, 2012, HUM MOL GENET, V21, P3356, DOI 10.1093/hmg/dds167; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Olea F, 2004, PLANT CELL PHYSIOL, V45, P770, DOI 10.1093/pcp/pch092; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Permyakova MD, 2010, APPL BIOCHEM MICRO+, V46, P87, DOI 10.1134/S0003683810010151; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Powell AA, 2000, J EXP BOT, V51, P2031, DOI 10.1093/jexbot/51.353.2031; Qin DD, 2015, PLANT MOL BIOL, V87, P31, DOI 10.1007/s11103-014-0259-9; Qu ZL, 2005, BBA-GENE STRUCT EXPR, V1730, P103, DOI 10.1016/j.bbaexp.2005.06.009; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; REBEILLE F, 1994, BIOCHEM J, V302, P223, DOI 10.1042/bj3020223; Seebauer JR, 2004, PLANT PHYSIOL, V136, P4326, DOI 10.1104/pp.104.043778; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoeva OY, 2014, GENE, V538, P334, DOI 10.1016/j.gene.2014.01.008; Song YH, 2007, TRENDS FOOD SCI TECH, V18, P132, DOI 10.1016/j.tifs.2006.11.003; Sramkova Z., 2009, ACTA CHIM SLOVACA, V2, P115; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; Uematsu K, 2012, J EXP BOT, V63, P3001, DOI 10.1093/jxb/ers004; Van den Ende W, 2003, PLANT PHYSIOL, V131, P621, DOI 10.1104/pp.015305; van Ulsen P, 2009, PROTEOMICS, V9, P1771, DOI 10.1002/pmic.200800642; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walters C, 1998, SEED SCI RES, V8, P223, DOI 10.1017/S096025850000413X; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Weyler C, 2016, BIOTECHNOL LETT, V38, P477, DOI 10.1007/s10529-015-1995-x; Whittle E, 2005, J BIOL CHEM, V280, P28169, DOI 10.1074/jbc.M504205200; WONG YS, 1981, PHYTOCHEMISTRY, V20, P1831, DOI 10.1016/0031-9422(81)84014-9; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xin X, 2014, J PLANT PHYSIOL, V171, P140, DOI 10.1016/j.jplph.2013.09.016; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yacoubi R, 2011, J PROTEOME RES, V10, P3891, DOI 10.1021/pr101274f; Yan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076914; Yang P, 2007, PLANT J, V51, P441, DOI 10.1111/j.1365-313X.2007.03154.x; [杨伟飞 Yang Weifei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1878; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yu YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2416-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng J, 2011, MOLECULES, V16, P10570, DOI 10.3390/molecules161210570	112	33	34	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162851	10.1371/journal.pone.0162851	http://dx.doi.org/10.1371/journal.pone.0162851			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632285	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900086
J	Ogita, M; Miyauchi, K; Onishi, A; Tsuboi, S; Wada, H; Konishi, H; Naito, R; Dohi, T; Kasai, T; Kojima, Y; Schwartz, RS; Daida, H				Ogita, Manabu; Miyauchi, Katsumi; Onishi, Akira; Tsuboi, Shuta; Wada, Hideki; Konishi, Hirokazu; Naito, Ryo; Dohi, Tomotaka; Kasai, Takatoshi; Kojima, Yuko; Schwartz, Robert S.; Daida, Hiroyuki			Development of Accelerated Coronary Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-Out Swine with Balloon Injury	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FAMILIAL HYPERCHOLESTEROLEMIA; INTERVENTIONAL RESEARCH; VULNERABLE PLAQUE; APOLIPOPROTEIN-B; PORCINE MODEL; PIG; LESIONS; CHOLESTEROL; ALLELES	Background Several animal models have facilitated the evaluation and pathological understanding of atherosclerosis, but a definitive animal model of coronary atherosclerosis is not available. We therefore developed low density lipoprotein receptor knockout (LDLR-KO) pigs with hypercholesterolemia, a model which rapidly developed coronary atherosclerosis following balloon injury. Methods and Results We deleted LDLR exon regions from cultured porcine fetal fibroblasts and cloned LDLR knockout (LDLR-KO) embryos microinjecting fetal fibroblast nuclei into enucleated oocytes. Twelve LDLR-KO pigs were fed a 2.0% cholesterol and 20% fat diet. Baseline serum LDL cholesterol level was 510.0 +/- 86.1 mg/dL. Balloon injury was created in 46 coronary segments and necropsy were obtained 2, 4, 8 and 12 weeks later. Coronary artery sections were reviewed to evaluate lesion progression. We found lipid accumulation with foam cells and inflammatory cells beginning four weeks after balloon injury. The mean ratio of macrophages to plaque area was significantly higher in the four-weeks and eight-week animals compared with those at 2-weeks (8.79% +/- 5.98% and 17.00% +/- 10.38% vs. 1.14% +/- 1.88%, P < 0.0001). At 12 weeks the ratio decreased toward the level at 2 week level (4.00% +/- 4.56%, P = 0.66 vs. baseline). Advanced coronary atherosclerotic lesions contained lipid pools at eight-weeks with fibrous components beginning at 12 weeks. Conclusions We developed a model of rapid coronary atherosclerosis using LDLR KO pigs with balloon injury. This model may be useful for preclinical evaluation of medication or devices, and may also help investigate mechanisms of plaque progression.	[Ogita, Manabu; Miyauchi, Katsumi; Tsuboi, Shuta; Wada, Hideki; Konishi, Hirokazu; Naito, Ryo; Dohi, Tomotaka; Kasai, Takatoshi; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Onishi, Akira] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki, Japan; [Kojima, Yuko] Juntendo Univ, Div Biomed Imaging Res, Biomed Res Ctr, Grad Sch Med, Tokyo, Japan; [Schwartz, Robert S.] Minneapolis Heart Inst & Fdn, Minneapolis, MN USA	Juntendo University; National Institute of Agrobiological Sciences - Japan; Juntendo University; Minneapolis Heart Institute Foundation	Miyauchi, K (corresponding author), Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan.	ktmmy@juntendo.ac.jp	Dohi, Tomotaka/ABH-3047-2021	Dohi, Tomotaka/0000-0002-6646-468X				Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Davis BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093457; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Gradada JF, 2007, ARTERIOSCLER THROMB, V27, P387; Granada JF, 2005, CORONARY ARTERY DIS, V16, P217, DOI 10.1097/00019501-200506000-00002; Granada JF, 2009, EUROINTERVENTION, V5, P140, DOI 10.4244/EIJV5I1A22; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; Jensen TW, 2010, ANIM BIOTECHNOL, V21, P179, DOI 10.1080/10495398.2010.490693; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Li Y, 2016, J AM HEART ASS, V5; Maeng M, 2001, CORONARY ARTERY DIS, V12, P285, DOI 10.1097/00019501-200106000-00004; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ozawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132155; PRESCOTT MF, 1995, ANN NY ACAD SCI, V748, P283; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; REITMAN JS, 1982, ATHEROSCLEROSIS, V43, P119, DOI 10.1016/0021-9150(82)90104-6; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Suzuki Y, 2009, JACC-CARDIOVASC INTE, V2, P373, DOI 10.1016/j.jcin.2009.03.004; Thim Troels, 2010, Dan Med Bull, V57, pB4161; Thim T, 2010, EUROINTERVENTION, V6, P261, DOI 10.4244/; Thorpe PE, 1996, ANGIOLOGY, V47, P849, DOI 10.1177/000331979604700903; Virmani R, 2007, ARTERIOSCL THROM VAS, V27, P1666, DOI 10.1161/ATVBAHA.107.143198; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870	29	9	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163055	10.1371/journal.pone.0163055	http://dx.doi.org/10.1371/journal.pone.0163055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631974	gold, Green Submitted, Green Published			2022-12-27	WOS:000383706900124
J	Park, S; Han, S; Choi, I; Kim, B; Park, SP; Joe, EH; Suh, YH				Park, Sangwook; Han, Seulki; Choi, Insup; Kim, Beomsue; Park, Seung Pyo; Joe, Eun-Hye; Suh, Young Ho			Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy	PLOS ONE			English	Article							PROTEIN-DEGRADATION PATHWAYS; PARKINSONS-DISEASE; RECEPTOR OPTINEURIN; ALPHA-SYNUCLEIN; CELL-DEATH; P62; PHOSPHORYLATION; CLEARANCE; ADAPTER; UBIQUITINATION	The deposit of polyubiquitinated aggregates has been implicated in the pathophysiology of Parkinson's disease (PD), and growing evidence indicates that selective autophagy plays a critical role in the clearance of ubiquitin-positive protein aggregates by autophagosomes. The selective autophagic receptor p62/SQSTM-1, which associates directly with both ubiquitin and LC3, transports ubiquitin conjugates to autophagosomes for degradation. Leucine-rich repeat kinase 2 (LRRK2), a PD-associated protein kinase, is tightly controlled by autophagy-lysosome degradation as well as by the ubiquitin-proteasome pathway. However, little is known about the degradation of ubiquitinated LRRK2 via selective autophagy. In the present study, we found that p62/SQSTM-1 physically interacts with LRRK2 as a selective autophagic receptor. The overexpression of p62 leads to the robust degradation of LRRK2 through the autophagy-lysosome pathway. In addition, LRRK2 indirectly regulates Ser351 and Ser403 phosphorylation of p62. Of particular interest, the interaction between phosphorylated p62 and Keap1 is reduced by LRRK2 overexpression. Therefore, we propose that the interplay between LRRK2 and p62 may contribute to the pathophysiological function and homeostasis of LRRK2 protein.	[Park, Sangwook] Kyungwoon Univ, Coll Hlth, Dept Biomed Lab Sci, Gumi 39160, South Korea; [Choi, Insup; Kim, Beomsue; Joe, Eun-Hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 16499, South Korea; [Choi, Insup; Kim, Beomsue; Joe, Eun-Hye] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 16499, South Korea; [Han, Seulki; Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea; [Han, Seulki; Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul 03080, South Korea	Kyungwoon University; Ajou University; Ajou University; Seoul National University (SNU); Seoul National University (SNU)	Park, S (corresponding author), Kyungwoon Univ, Coll Hlth, Dept Biomed Lab Sci, Gumi 39160, South Korea.; Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea.; Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul 03080, South Korea.	spark367@iikw.ac.kr; suhyho@snu.ac.kr	Suh, Young Ho/AAJ-6405-2021; Kim, Beomsue/X-3045-2019	Suh, Young Ho/0000-0003-3979-1615; Kim, Beomsue/0000-0003-1207-7876; CHOI, INSUP/0000-0001-8314-8067	National Research Foundation of Korea (NRF) [2013R1A1A2058079, NRF-2011-0011694, 2015048055]; Brain Korea 21 PLUS program; Seoul National University Hospital	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea 21 PLUS program; Seoul National University Hospital	This study was supported by the National Research Foundation of Korea (NRF) grant (http://nrf.re.kr/) to S.P. (2013R1A1A2058079) and to Y.H.S. (NRF-2011-0011694, 2015048055); by the Brain Korea 21 PLUS program (https://bkplus.nrf.re.kr/) to S.H.; and by a grant from Seoul National University Hospital (2016) (http://www.snuh.org/) to Y.H.S.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Esteves AR, 2014, EXP NEUROL, V261, P206, DOI 10.1016/j.expneurol.2014.05.025; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lichtenberg M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.81; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pan JA, 2013, J BIOL CHEM, V288, P2952, DOI 10.1074/jbc.M112.441063; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012	43	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163029	10.1371/journal.pone.0163029	http://dx.doi.org/10.1371/journal.pone.0163029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631370	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900120
J	Tan, PY; Chang, CW; Duan, KB; Poidinger, M; Ng, KL; Chong, YS; Gluckman, PD; Stunkel, W				Tan, Peck Yean; Chang, Cheng Wei; Duan, Kaibo; Poidinger, Michael; Kai Lyn Ng; Chong, Yap Seng; Gluckman, Peter D.; Stunkel, Walter			E2F1 Orchestrates Transcriptomics and Oxidative Metabolism in Wharton's Jelly-Derived Mesenchymal Stem Cells from Growth-Restricted Infants	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH; HISTONE MODIFICATIONS; CANCER-CELLS; HUMAN GENOME; DISEASE; HEALTH; LIFE; RETARDATION; APPROPRIATE	Wharton's jelly-derived Mesenchymal Stem Cells (MSCs) isolated from newborns with intrauterine fetal growth restriction were previously shown to exert anabolic features including insulin hypersensitivity. Here, we extend these observations and demonstrate that MSCs from small for gestational age (SGA) individuals have decreased mitochondrial oxygen consumption rates. Comparing normally grown and SGA MSCs using next generation sequencing studies, we measured global transcriptomic and epigenetic profiles and identified E2F1 as an over-expressed transcription factor regulating oxidative metabolism in the SGA group. We further show that E2F1 regulates the differential transcriptome found in SGA derived MSCs and is associated with the activating histone marks H3K27ac and H3K4me3. One of the key genes regulated by E2F1 was found to be the fatty acid elongase ELOVL2, a gene involved in the endogenous synthesis of docosahexaenoic acid (DHA). Finally, we shed light on how the E2F1-ELOVL2 pathway may alter oxidative respiration in the SGA condition by contributing to the maintenance of cellular metabolic homeostasis.	[Tan, Peck Yean; Chang, Cheng Wei; Chong, Yap Seng; Gluckman, Peter D.; Stunkel, Walter] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Duan, Kaibo; Poidinger, Michael] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Kai Lyn Ng; Chong, Yap Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland, New Zealand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Auckland	Stunkel, W (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	walter_stunkel@sics.a-star.edu.sg		Chong, Yap Seng/0000-0002-7232-8473; Poidinger, Michael/0000-0002-1047-2277	Singapore National Research Foundation under Translational and Clinical Research (TCR) Flagship Programme; Agency for Science Technology and Research (A*STAR);  [NMRC/TCR/004-NUS/2008];  [NMRC/TCR/012-NUHS/ 2014]	Singapore National Research Foundation under Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); ; 	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC; www.nmrc.gov.sg), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/ 2014. SICS Investigators are supported through Agency for Science Technology and Research (A*STAR; www.a-star.edu.sg) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Beauchamp B, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150007; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bol VV, 2008, OBESITY, V16, P2760, DOI 10.1038/oby.2008.417; Budden DM, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-36; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; Dogan N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0009-5; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jorgensen SW, 2015, DIABETOLOGIA, V58, P178, DOI 10.1007/s00125-014-3406-6; Joseph R, 2015, MOL ENDOCRINOL, V29, P909, DOI 10.1210/me.2015-1020; Joung KE, 2015, METABOLISM, V64, P1507, DOI 10.1016/j.metabol.2015.07.019; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Minjong, 2015, World J Biol Chem, V6, P148, DOI 10.4331/wjbc.v6.i3.148; Llanos A, 2005, PEDIATR RES, V58, P735, DOI 10.1203/01.PDR.0000180542.68526.A2; McCarthy F, 2015, LANCET, V385, P67, DOI 10.1016/S0140-6736(15)60382-8; McLeay RC, 2012, BIOINFORMATICS, V28, P2789, DOI 10.1093/bioinformatics/bts529; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Mericq V, 2009, J PEDIATR ENDOCR MET, V22, P1041; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Padmanabhan V, 2016, ENDOCRINOLOGY, V157, P1328, DOI 10.1210/en.2016-1003; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Salama GSA, 2015, CLIN MED INSIGHTS-PE, V9, P25, DOI 10.4137/CMPed.S21161; Gonzalez RS, 2014, GENE, V549, P7, DOI 10.1016/j.gene.2014.06.057; Sukarieh R, 2014, HUM REPROD, V29, P2287, DOI 10.1093/humrep/deu209; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; WARBURG O, 1956, SCIENCE, V124, P269; Wu MH, 2015, ONCOTARGET, V6, P11252, DOI 10.18632/oncotarget.3594; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163035	10.1371/journal.pone.0163035	http://dx.doi.org/10.1371/journal.pone.0163035			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631473	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900121
J	Tao, X; Xu, ZW; Men, XM				Tao, Xin; Xu, Ziwei; Men, Xiaoming			Analysis of Serum microRNA Expression Profiles and Comparison with Small Intestinal microRNA Expression Profiles in Weaned Piglets	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CIRCULATING MICRORNAS; OXIDATIVE STRESS; BIOMARKERS; DISEASE; PLASMA; DIAGNOSIS; CANCER; CHALLENGE; DISORDERS	Weaning stress induces tissue injuries and impairs health and growth in piglets, especially during the first week post-weaning. MicroRNAs (miRNAs) play vital roles in regulating stresses and diseases. Our previous study found multiple differentially expressed miRNAs in small intestine of piglets at four days post-weaning. To better understand the roles of miRNAs during weaning stress, we analyzed the serum miRNA expressional profile in weaned piglets (at four days post-weaning) and in suckling piglets (control) of the same age using miRNA microarray technology. We detected a total of 300 expressed miRNAs, 179 miRNAs of which were differentially expressed between the two groups. The miRNA microarray results were validated by RT-qPCR. The biological functions of these differentially expressed miRNAs were predicted by GO terms and KEGG pathway annotations. We identified 10 highly expressed miRNAs in weaned piglets including miR-31, miR-205, and miR21 (upregulated) and miR-144, miR-30c-5p, miR-363, miR-194a, miR-186, miR-150, and miR-194b-5p (downregulated). Additionally, miR-194b-5p expression was significantly downregulated in serum and small intestine of weaned piglets. Our results suggest that weaning stress affects serum miRNA profiles in piglets. And serum miR-194b-5p levels can reflect its expressional changes in small intestine of piglets by weaning stress.	[Tao, Xin; Xu, Ziwei; Men, Xiaoming] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Xu, ZW (corresponding author), Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou, Zhejiang, Peoples R China.	xzwfyz@sina.com			Zhejiang Provincial Natural Science Foundation [LY15C170004]; National Natural Science Foundation of China [31101725]; Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research System of China [CARS-36]; National Key Technology R D Program [2012BAD39B03-04]; Agro-scientific Research in the Public Interest [201403047]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Modern Agro-industry Technology Research System of China; National Key Technology R D Program(National Key Technology R&D Program); Agro-scientific Research in the Public Interest	This work was supported by grants from the Zhejiang Provincial Natural Science Foundation (LY15C170004), the National Natural Science Foundation of China (31101725), the Science Technology Department of Zhejiang Province, the Modern Agro-industry Technology Research System of China (CARS-36), National Key Technology R & D Program (2012BAD39B03-04), and Agro-scientific Research in the Public Interest (201403047). The funders had no role in study collection, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Bao LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116067; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Campbell JM, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-19; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Ignacio C, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0195-x; Khan IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135440; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu YL, 2013, J NUTR, V143, P1799, DOI 10.3945/jn.113.179960; Madhavan Dharanija, 2013, Frontiers in Genetics, V4, P116, DOI 10.3389/fgene.2013.00116; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Murugaiyan G, 2015, ONCOTARGET, V6, P9644, DOI 10.18632/oncotarget.3928; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sugiharto S, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-17; Tang WB, 2014, J CELL MOL MED, V18, P1580, DOI 10.1111/jcmm.12348; Tao X, 2016, CZECH J ANIM SCI, V61, P82, DOI 10.17221/8731-CJAS; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang JQ, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0285-6; Wang X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0099-8; Wang XC, 2014, WORLD J GASTROENTERO, V20, P17914, DOI 10.3748/wjg.v20.i47.17914; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wozniak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125026; Yang CH, 2015, PHARMACEUTICALS, V8, P836, DOI 10.3390/ph8040836; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Yao LQ, 2015, INT J CLIN EXP PATHO, V8, P7675; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	54	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162776	10.1371/journal.pone.0162776	http://dx.doi.org/10.1371/journal.pone.0162776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632531	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900078
J	Yadav, G; Goldberg, HR; Barense, MD; Bell, CM				Yadav, Geeta; Goldberg, Hanna R.; Barense, Morgan D.; Bell, Chaim M.			A Cross-Sectional Survey of Population-Wide Wait Times for Patients Seeking Medical vs. Cosmetic Dermatologic Care	PLOS ONE			English	Article							WORKFORCE SHORTAGE; SERVICES; CANADA; ACCESS; LONG; TOO	Background Though previous work has examined some aspects of the dermatology workforce shortage and access to dermatologic care, little research has addressed the effect of rising interest in cosmetic procedures on access to medical dermatologic care. Our objective was to determine the wait times for Urgent and Non-Urgent medical dermatologic care and Cosmetic dermatology services at a population level and to examine whether wait times for medical care are affected by offering cosmetic services. Methods A population-wide survey of dermatology practices using simulated calls asking for the earliest appointment for a Non-Urgent, Urgent and Cosmetic service. Results Response rates were greater than 89% for all types of care. Wait times across all types of care were significantly different from each other (all P < 0.05). Cosmetic care was associated with the shortestwait times (3.0 weeks; Interquartile Range (IQR) = 0.4-3.4), followed by Urgent care (9.0 weeks; IQR = 2.1-12.9), then Non-Urgent Care (12.7 weeks; IQR = 4.4-16.4). Wait times for practices offering only Urgent care were not different from practices offering both Urgent and Cosmetic care (10.3 vs. 7.0 weeks). Interpretation Longer wait times and greater variation for Urgent and Non-Urgent dermatologic care and shorter wait times and less variation for Cosmetic care. Wait times were significantly longer in regions with lower dermatologist density. Provision of Cosmetic services did not increase wait times for Urgent care. These findings suggest an overall dermatology workforce shortage and a need for a more streamlined referral system for dermatologic care.	[Yadav, Geeta; Goldberg, Hanna R.; Bell, Chaim M.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Yadav, Geeta] Womens Coll Hosp, Div Dermatol, Toronto, ON, Canada; [Barense, Morgan D.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Bell, Chaim M.] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bell, CM (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Bell, CM (corresponding author), Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada.; Bell, CM (corresponding author), Univ Toronto, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Bell, CM (corresponding author), Mt Sinai Hosp, Dept Med, Toronto, ON, Canada.	cbell@mtsinai.on.ca	Bell, Chaim/C-4611-2015; Barense, Morgan/H-7451-2019; Yadav, Geeta/HHZ-1529-2022	Bell, Chaim/0000-0002-3778-9469; Barense, Morgan/0000-0002-4008-9201; 				[Anonymous], 2014, POSITION PAPER OCCAS; Bercovici Eduard, 2008, Healthc Policy, V4, P59; Burton A, 2008, LANCET ONCOL, V9, P825, DOI 10.1016/S1470-2045(08)70225-0; Campbell RJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P1384, DOI 10.1001/archophthalmol.2009.275; Canadian Medical Association, 2010, 2010 NAT PHYS SURV; Canadian Skin Patient Alliance, 2012, SKIN DEEP REP CARD A; Cancer Care Ontario, 2014, SKIN SYST WAIT TIM R; Chow EY, 2010, J CUTAN MED SURG, V14, P71, DOI 10.2310/7750.2010.09025; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Esmail N, 2008, FRASER FORUM     DEC, P22; Health Council of Canada, 2014, CANADIAN HLTH CARE M, V8; Heughan C, 2008, J CUTAN MED SURG, V12, P217, DOI 10.2310/7750.2008.07071; Kimball AB, 2008, J AM ACAD DERMATOL, V59, P741, DOI 10.1016/j.jaad.2008.06.037; Maguiness S, 2004, J CUTAN MED SURG, V8, P141, DOI 10.1007/s10227-004-0107-7; Martin AR, 2011, CAN J SURG, V54, P154, DOI 10.1503/cjs.048909; Piggott Katrina L, 2013, Healthc Policy, V9, P65; Pong RW, 2005, OTTAWA CAN I HLTH IN, P11; Resneck J, 2004, J AM ACAD DERMATOL, V50, P50, DOI 10.1016/j.jaad.2003.07.001; Resneck J, 2001, ARCH DERMATOL, V137, P1295; Resneck JS, 2008, J AM ACAD DERMATOL, V58, P211, DOI 10.1016/j.jaad.2007.09.032; Resneck JS, 2007, J AM ACAD DERMATOL, V57, P985, DOI 10.1016/j.jaad.2007.07.020; Revah Giselle, 2007, Healthc Policy, V2, P49; Robert JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035179; Salsberg E, 2006, ACAD MED, V81, P782, DOI 10.1097/00001888-200609000-00003; Sibley LM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-20; Siciliani L, 2009, HEALTH ECON, V18, P1295, DOI 10.1002/hec.1429; Suneja T, 2001, ARCH DERMATOL, V137, P1303; Tsang MW, 2006, J AM ACAD DERMATOL, V55, P54, DOI 10.1016/j.jaad.2006.04.001	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162767	10.1371/journal.pone.0162767	http://dx.doi.org/10.1371/journal.pone.0162767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632206	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900076
J	Yamaguchi, N; Sekine, S; Naguro, I; Sekine, Y; Ichijo, H				Yamaguchi, Namiko; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori			KLHDC10 Deficiency Protects Mice against TNF alpha-Induced Systemic Inflammation	PLOS ONE			English	Article							KINASE DOMAIN-LIKE; NONAPOPTOTIC CELL-DEATH; ISCHEMIC BRAIN-INJURY; INDUCED LETHAL SHOCK; REACTIVE OXYGEN; NADPH OXIDASE; INDUCED ACTIVATION; RESPONSE SYNDROME; OXIDATIVE STRESS; INDUCED NECROSIS	Systemic inflammatory response syndrome (SIRS) is a form of fatal acute inflammation for which there is no effective treatment. Here, we revealed that the ablation of Kelch domain containing 10 (KLHDC10), which we had originally identified as an activator of Apoptosis Signal-regulating Kinase 1 (ASK1), protects mice against TNF alpha-induced SIRS. The disease development of SIRS is mainly divided into two stages. The early stage is characterized by TNF alpha-induced systemic necroptosis, a regulated form of necrosis mediated by Receptor-interacting protein (RIP) 1/3 kinases. The later stage presents with an over-production of inflammatory cytokines induced by damage-associated molecular patterns (DAMPs), which are immunogenic cellular contents released from cells that underwent necroptosis. Analysis of TNF alpha-challenged mice revealed that KLHDC10-deficient mice show a reduction in the inflammatory response, but not in early systemic necroptosis. In vitro analysis suggested that the reduced inflammatory response observed in KLHDC10-deficient mice might be caused, in part, by enhanced necroptosis of inflammatory cells encountering DAMPs. Interestingly, the enhancement of necroptosis induced by KLHDC10 deficiency was selectively observed in inflammatory cells. Our results suggest that KLHDC10 is a cell-type specific regulator of necroptosis that ultimately contributes to the development of TNF alpha-induced SIRS.	[Yamaguchi, Namiko; Sekine, Shiori; Naguro, Isao; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Sekine, Yusuke] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	University of Tokyo; University of Cambridge	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Sekine, Yusuke/AHI-8340-2022; Naguro, Isao/P-1337-2019	Ichijo, Hidenori/0000-0002-5005-6438; Naguro, Isao/0000-0002-0338-8026; Sekine, Yusuke/0000-0003-0345-1416	KAKENHI from Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25221302]; Grants-in-Aid for Scientific Research [26114009] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Grant number; 25221302 to H. Ichijo). URL; https://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cauwels A, 2000, IMMUNITY, V13, P223, DOI 10.1016/S1074-7613(00)00022-4; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; EVERAERDT B, 1994, J IMMUNOL, V152, P5041; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Maruyama J, 2016, SCI REP-UK, V6, DOI 10.1038/srep18710; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; STARNES HF, 1990, J IMMUNOL, V145, P4185; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	42	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163118	10.1371/journal.pone.0163118	http://dx.doi.org/10.1371/journal.pone.0163118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631783	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900133
J	Greendale, GA; Wilhalme, H; Huang, MH; Cauley, JA; Karlamangla, AS				Greendale, Gail A.; Wilhalme, Holly; Huang, Mei-Hua; Cauley, Jane A.; Karlamangla, Arun S.			Prevalent and Incident Vertebral Deformities in Midlife Women: Results from the Study of Women's Health Across the Nation (SWAN)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; BODY-MASS INDEX; FRACTURE RISK; OSTEOPOROTIC FRACTURES; MEN; EPIDEMIOLOGY; PREDICTION; TRANSITION; IMPACT	Background Vertebral fractures are the most common type of osteoporotic fracture among women, but estimates of their prevalence and incidence during middle-age are limited. The development of vertebral morphometry (VM) using dual energy X-ray absorptiometry (DXA) makes it more feasible to measure VM in large, longitudinal, observational studies. We conducted this study to: 1) contribute to the scant knowledge of the prevalence, incidence and risk factors for vertebral deformities in middle-aged women; and 2) to evaluate the performance of DXA-based VM measurement in a large, community based sample. Methods The sample is derived from the Study of Women's Health Across the Nation (SWAN), a multi-site, community-based, longitudinal cohort study of the MT. Using Hologic QDR 4500A instruments, we acquired initial VM measurements in 1446 women during calendar years 2004-2007; in 2012-2013, a follow-up VM was obtained in 1108. Annually, lumbar spine (LS) and femoral neck (FN) bone mineral density (BMD) were measured and participant characteristics were assessed with standardized instruments. Multivariable logistic regression models examined the relations between prevalent deformity and relevant characteristics. Analyses of characteristics associated with prevalent deformity were restricted to 824 women who had not taken bone active medications since SWAN baseline. We calculated incident deformity per person year (PY) of observation, standardized to 1000 person-years. Results The cranial portion of the VM image yielded the lowest proportions of readable vertebrae: from T4 through T6, between 43% and 63% of vertebral bodies were evaluable. Greater BMI was associated with fewer readable levels (B = -0.088, p<0.0001). In the baseline sample of 1446 women, the prevalence of vertebral deformity was 3.2% (95% CI: 2.3, 4.1). The relative odds of deformity increased by 61% per SD decrement in baseline LS BMD (p = 0.02) and were 67% greater per SD decrement in baseline FN BMD (p = 0.04). Odds of prevalent deformity increased by 21% per year increment in age (p = 0.02). On average, 1108 women were followed for 6.8 years (SD 0.5 years, range 5.1-8.3 years) and we observed an incidence of 1.98 vertebral deformities per 1000 PY. In the longitudinal sample, 628 participants had never used bone active medications; their vertebral deformity incidence was 2.8 per 1000 PY. Conclusion Prevalence of vertebral deformity in SWAN participants aged 50-60 years was low and lower bone density at the LS and FN was strongly related to greater risk of prevalent deformity. Only about half of the vertebral levels between T4-T6 could be adequately imaged by DXA. Greater BMI is associated with fewer readable vertebral levels.	[Greendale, Gail A.; Huang, Mei-Hua; Karlamangla, Arun S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wilhalme, Holly] Univ Calif Los Angeles, Dept Med Stat Core, Los Angeles, CA USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greendale, GA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	GGreenda@mednet.ucla.edu		Cauley, Jane A/0000-0003-0752-4408	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA); National Institute of Nursing Research (NINR); NIH Office of Research on Women's Health (ORWH) [U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495]; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG012531, U01AG012495, U01AG012553, U01AG012505, U01AG012554, U01AG012546, U01AG012539, U01AG012535, R01AG026463] Funding Source: NIH RePORTER	National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research (NINR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NIH Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH or the NIH.	Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Cauley JA, 2008, J BONE MINER RES, V23, P1458, DOI 10.1359/JBMR.080411; Cauley JA, 2012, MENOPAUSE, V19, P1200, DOI 10.1097/gme.0b013e31825ae17e; COOPER C, 1992, BRIT MED J, V304, P793, DOI 10.1136/bmj.304.6830.793; COOPER C, 1992, BRIT MED J, V304, P1634, DOI 10.1136/bmj.304.6842.1634-b; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Hosmer D. W., 2000, MULTIPLE LOGISTIC RE; Ishii S, 2014, J BONE MINER RES, V29, P2561, DOI 10.1002/jbmr.2303; JONES G, 1995, J RHEUMATOL, V22, P932; Kadowaki E, 2010, OSTEOPOROSIS INT, V21, P1513, DOI 10.1007/s00198-009-1113-9; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; Looker AC, 2007, OSTEOPOROSIS INT, V18, P307, DOI 10.1007/s00198-006-0241-8; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; ONeill TW, 1996, J BONE MINER RES, V11, P1010; Rea JA, 2000, OSTEOPOROSIS INT, V11, P660, DOI 10.1007/s001980070063; Ross PD, 1995, INT J EPIDEMIOL, V24, P1171, DOI 10.1093/ije/24.6.1171; Sanfelix-Gimeno G, 2013, BONE, V52, P393, DOI 10.1016/j.bone.2012.10.022; Schousboe JT, 2008, J CLIN DENSITOM, V11, P92, DOI 10.1016/j.jocd.2007.12.008; Sowers MF, 2000, MENOPAUSE BIOL PATHO, P175; Tsai KS, 1996, CALCIFIED TISSUE INT, V59, P249, DOI 10.1007/s002239900118; vonderRecke P, 1996, OSTEOPOROSIS INT, V6, P43; Waterloo S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-3; Xu L, 2000, J BONE MINER RES, V15, P2019, DOI 10.1359/jbmr.2000.15.10.2019	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162664	10.1371/journal.pone.0162664	http://dx.doi.org/10.1371/journal.pone.0162664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657693	Green Submitted, gold, Green Published			2022-12-27	WOS:000383893200029
J	Balaban, C; Hoffer, ME; Szczupak, M; Snapp, H; Crawford, J; Murphy, S; Marshall, K; Pelusso, C; Knowles, S; Kiderman, A				Balaban, Carey; Hoffer, Michael E.; Szczupak, Mikhaylo; Snapp, Hillary; Crawford, James; Murphy, Sara; Marshall, Kathryn; Pelusso, Constanza; Knowles, Sean; Kiderman, Alex			Oculomotor, Vestibular, and Reaction Time Tests in Mild Traumatic Brain Injury	PLOS ONE			English	Article							ERROR SCORING SYSTEM; COGNITIVE RESERVE; BALANCE; CONCUSSION; DIZZINESS; NEURITIS; STROKE; GAIN; TBI	Objective Mild traumatic brain injury is a major public health issue and is a particular concern in sports. One of the most difficult issues with respect to mild traumatic brain injury involves the diagnosis of the disorder. Typically, diagnosis is made by a constellation of physical exam findings. However, in order to best manage mild traumatic brain injury, it is critically important to develop objective tests that substantiate the diagnosis. With objective tests the disorder can be better characterized, more accurately diagnosed, and studied more effectively. In addition, prevention and treatments can be applied where necessary. Methods Two cohorts each of fifty subjects with mild traumatic brain injury and one hundred controls were evaluated with a battery of oculomotor, vestibular and reaction time related tests applied to a population of individuals with mild traumatic brain injury as compared to controls. Results We demonstrated pattern differences between the two groups and showed how three of these tests yield an 89% sensitivity and 95% specificity for confirming a current diagnosis of mild traumatic brain injury. Interpretation These results help better characterize the oculomotor, vestibular, and reaction time differences between those the mild traumatic brain injury and non-affected individuals. This characterization will allow for the development of more effective point of care neurologic diagnostic techniques and allow for more targeted treatment which may allow for quicker return to normal activity.	[Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Murphy, Sara; Knowles, Sean] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Hoffer, Michael E.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Hoffer, Michael E.; Szczupak, Mikhaylo; Pelusso, Constanza] Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA; [Crawford, James; Marshall, Kathryn] Madigan Army Med Ctr, Dept Otolaryngol, Tacoma, WA 98431 USA; [Murphy, Sara] Naval Med Ctr, San Diego, CA USA; [Kiderman, Alex] Neurokinet Inc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Miami; University of Miami; Madigan Army Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Hoffer, ME (corresponding author), Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Hoffer, ME (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.; Hoffer, ME (corresponding author), Univ Miami, Sports Performance & Wellness Inst, Miami, FL USA.	michael.hoffer@miami.edu	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017; Murphy, Sara/GRJ-1785-2022	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Szczupak, Mikhaylo/0000-0002-2569-2184; Snapp, Hillary/0000-0002-2000-5357; Murphy, Sara/0000-0003-3197-2649	Head Health Challenge II grant (National Football League, Underarmor, General Electric); Department of Defense [W81XWH-12-C-0205]; Neuro-Kinetics, Inc.	Head Health Challenge II grant (National Football League, Underarmor, General Electric); Department of Defense(United States Department of Defense); Neuro-Kinetics, Inc.	This work was supported by Head Health Challenge II grant (National Football League, Underarmor, General Electric) and Department of Defense grant W81XWH-12-C-0205. These sponsors provided funding to conduct the study, only. The funder provided support in the form of salaries for authors (MEH, MS, CB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Alex Kiderman is employed by Neuro-Kinetics, Inc. Neuro-Kinetics, Inc. provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by Head Health Challenge II grant (National Football League, Underarmor, General Electric) and Department of Defense grant W81XWH-12-C-0205. These sponsors provided funding to conduct the study, only. The funder provided support in the form of salaries for authors (MEH, MS, CB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Alex Kiderman is employed by Neuro-Kinetics, Inc. Neuro-Kinetics, Inc. provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, PREVENTION INJURY CO; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Chandrasekhar SS, 2013, NEUROREHABILITATION, V32, P445, DOI 10.3233/NRE-130867; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chen L, 2014, NEUROLOGY, V83, P1513, DOI 10.1212/WNL.0000000000000906; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hosek J., 2011, IS DEPLOYMENT IRAQ A; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Mantokoudis G, 2015, OTOL NEUROTOL, V36, P457, DOI 10.1097/MAO.0000000000000638; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Plog BA, 2015, EXPERT REV NEUROTHER, V15, P465, DOI 10.1586/14737175.2015.1031112; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	22	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162168	10.1371/journal.pone.0162168	http://dx.doi.org/10.1371/journal.pone.0162168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27654131	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700017
J	Domingos, MAM; Moreira, SR; Gomez, L; Goulart, A; Lotufo, PA; Bensenor, I; Titan, S				Muniz Domingos, Maria Alice; Moreira, Silvia Regina; Gomez, Luz; Goulart, Alessandra; Lotufo, Paulo Andrade; Bensenor, Isabela; Titan, Silvia			Urinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETIC SUBJECTS; SERUM; RETINOL-BINDING-PROTEIN-4; DYSFUNCTION; MARKER	The role of urinary retinol-binding protein (RBP) as a biomarker of CKD in proximal tubular diseases, glomerulopathies and in transplantation is well established. However, whether urinary RBP is also a biomarker of renal damage and CKD progression in general CKD is not known. In this study, we evaluated the association of urinary RBP with renal function and cardiovascular risk factors in the baseline data of the Progredir Study, a CKD cohort in Sao Paulo, Brazil, comprising 454 participants with stages 3 and 4 CKD. In univariate analysis, urinary RBP was inversely related to estimated glomerular filtration rate (CKD-EPI eGFR) and several cardiovascular risk factors. After adjustments, however, only CKD-EPI eGFR, albuminuria, systolic blood pressure, anemia, acidosis, and left atrium diameter remained significantly related to urinary RBP. The inverse relationship of eGFR to urinary RBP (beta-0.02 +/- 95CI -0.02; -0.01, p<0.0001 for adjusted model) remained in all strata of albuminuria, even after adjustments: in normoalbuminuria (beta-0.008 +/- 95CI (-0.02; -0.001, p = 0.03), in microalbuminuria (beta-0.02 +/- 95CI (-0.03; -0.02, p<0,0001) and in macroalbuminuria (beta-0.02 +/- 95CI (-0.03; -0.01, p<0,0001). Lastly, urinary RBP was able to significantly increase the accuracy of a logistic regression model (adjusted for sex, age, SBP, diabetes and albuminuria) in diagnosing eGFR<35 ml/min/1.73m(2) (AUC 0,77, 95% CI 0,72-0,81 versus AUC 0,71, 95% CI 0,65-0,75, respectively; p = 0,05). Our results suggest that urinary RBP is significantly associated to renal function in CKD in general, a finding that expands the interest in this biomarker beyond the context of proximal tubulopathies, glomerulopathies or transplantation. Urinary RBP should be further explored as a predictive marker of CKD progression.	[Muniz Domingos, Maria Alice; Titan, Silvia] Univ Sao Paulo, Fac Med, Dept Clin Med, Div Nephrol, Sao Paulo, Brazil; [Moreira, Silvia Regina] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil; [Gomez, Luz] Univ Sao Paulo, Fac Med, Hearts Inst, Genet Cardiovasc Lab, Sao Paulo, Brazil; [Goulart, Alessandra; Lotufo, Paulo Andrade; Bensenor, Isabela] Univ Sao Paulo, Fac Med, Univ Hosp, Clin Res Ctr, Sao Paulo, Brazil; [Titan, Silvia] Univ Sao Paulo, Fac Med, Hosp Clin, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Domingos, MAM (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Div Nephrol, Sao Paulo, Brazil.	mariaalice.md@gmail.com	Joukar, Farahnaz/GMW-7238-2022; Lotufo, Paulo/A-9843-2008; Bensenor, Isabela Judith Martins/L-3306-2017; Goulart, Alessandra C/J-2845-2014	Joukar, Farahnaz/0000-0003-0102-0575; Lotufo, Paulo/0000-0002-4856-8450; Goulart, Alessandra C/0000-0003-1076-5210	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) [2011/17341-0]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)- 2011/17341-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Agatston AS, 1990, J AM COLL CARDIOL, P15; BERNARD A, 1988, CLIN CHIM ACTA, V171, P85, DOI 10.1016/0009-8981(88)90293-8; Camara NOS, 2001, TRANSPLANT P, V33, P2129, DOI 10.1016/S0041-1345(01)01971-6; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Cruz DN, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/351291; Donadio C, 2010, AM J PHYSIOL-RENAL, V299, pF1407, DOI 10.1152/ajprenal.00507.2009; Flower DR, 1996, BIOCHEM J, V318, P1; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hebert K, 2010, EUR J HEART FAIL, V12, P861, DOI 10.1093/eurjhf/hfq077; HOLM J, 1993, CLIN CHEM, V39, P517; HOLM J, 1994, KIDNEY INT, pS105; Hosaka B, 2003, TRANSPLANT P, V35, P1341, DOI 10.1016/S0041-1345(03)00380-4; Kirsztajn GM, 2002, NEPHRON, V90, P424; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Pallet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084708; PEREIRA AB, 1993, CLIN CHEM, V39, P472; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Ronco C, 2009, BLOOD PURIFICAT, V27, P114, DOI 10.1159/000167018; Salem Mona A K, 2002, Pediatr Diabetes, V3, P37, DOI 10.1034/j.1399-5448.2002.30107.x; SESSO R, 1992, ANN INTERN MED, V116, P905, DOI 10.7326/0003-4819-116-11-905; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	26	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162782	10.1371/journal.pone.0162782	http://dx.doi.org/10.1371/journal.pone.0162782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655369	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700030
J	Qiao, T; King, B; Long, JA; Ahlberg, PE; Zhu, M				Qiao, Tuo; King, Benedict; Long, John A.; Ahlberg, Per E.; Zhu, Min			Early Gnathostome Phylogeny Revisited: Multiple Method Consensus	PLOS ONE			English	Article							LOPHOSTEUS-SUPERBUS PANDER; NEW-SOUTH-WALES; BAYESIAN-INFERENCE; MAXIMUM-LIKELIHOOD; COMMON ANCESTOR; DEVONIAN FISH; SHEDS LIGHT; ORIGIN; PLACODERM; PARSIMONY	A series of recent studies recovered consistent phylogenetic scenarios of jawed vertebrates, such as the paraphyly of placoderms with respect to crown gnathostomes, and antiarchs as the sister group of all other jawed vertebrates. However, some of the phylogenetic relationships within the group have remained controversial, such as the positions of Entelognathus, ptyctodontids, and the Guiyu-lineage that comprises Guiyu, Psarolepis and Achoania. The revision of the dataset in a recent study reveals a modified phylogenetic hypothesis, which shows that some of these phylogenetic conflicts were sourced from a few inadvertent miscodings. The interrelationships of early gnathostomes are addressed based on a combined new dataset with 103 taxa and 335 characters, which is the most comprehensive morphological dataset constructed to date. This dataset is investigated in a phylogenetic context using maximum parsimony (MP), Bayesian inference (BI) and maximum likelihood (ML) approaches in an attempt to explore the consensus and incongruence between the hypotheses of early gnathostome interrelationships recovered from different methods. Our findings consistently corroborate the paraphyly of placoderms, all 'acanthodians' as a paraphyletic stem group of chondrichthyans, Entelognathus as a stem gnathostome, and the Guiyu-lineage as stem sarcopterygians. The incongruence using different methods is less significant than the consensus, and mainly relates to the positions of the placoderm Wuttagoonaspis, the stem chondrichthyan Ramirosuarezia, and the stem osteichthyan Lophosteus D the taxa that are either poorly known or highly specialized in character complement. Given that the different performances of each phylogenetic approach, our study provides an empirical case that the multiple phylogenetic analyses of morphological data are mutually complementary rather than redundant.	[Qiao, Tuo; Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [King, Benedict; Long, John A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Flinders University South Australia; Uppsala University	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	zhumin@ivpp.ac.cn	Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Qiao, Tuo/AAJ-6317-2021	Zhu, Min/0000-0002-4786-0898; Qiao, Tuo/0000-0002-0488-7265; Long, John/0000-0001-8012-0114; Ahlberg, Per/0000-0001-9054-2900	MST of China [2012CB821902]; National Natural Science Foundation of China [41202016, 41472016, 41530102]; National Science Fund for Talent Training in Basic Science [J1210008]; State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [133109]; Australian Research Council [DP14014161]	MST of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Talent Training in Basic Science; State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS); Australian Research Council(Australian Research Council)	This work was supported by Major State Basic Research Projects (2012CB821902) of MST of China, National Natural Science Foundation of China (41202016, 41472016, and 41530102), the National Science Fund for Talent Training in Basic Science (J1210008), and the State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (133109) and Australian Research Council Grant DP14014161.	AHLBERG PE, 1989, ZOOL J LINN SOC-LOND, V96, P119, DOI 10.1111/j.1096-3642.1989.tb01824.x; ANDERSON ME, 1994, S AFR J SCI, V90, P397; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; Asher RJ, 2008, SYST BIOL, V57, P311, DOI 10.1080/10635150802033022; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2015, NATURE, V520, P490, DOI 10.1038/nature14438; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Chang M., 1981, SCI SINICA, V24, P89; Chang M-M, 1993, MEM ASS AUSTRALAS PA, V15, P16; Chang M-M, 1982, BRAINCASE YOUNGOLEPI; Chang M-M, 2004, RECENT ADV ORIGIN EA, P665; Chang MM, 1992, J VERTEBR PALEONTOL, V12, P294, DOI 10.1080/02724634.1992.10011461; Chang Mee-mann, 1991, P355; Clement Gael, 2010, P363; Clement Gael, 2004, Fossils and Strata, V50, P92; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Coates MI, 2010, J VERT PALEO S, V30, p74A; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Denison, 1979, ACANTHODII; Denison RH, 1978, HDB PALEOICHTHYOLOGY, V2, P128; Duchene S, 2015, J EXP ZOOL PART B, V324, P517, DOI 10.1002/jez.b.22638; Dupret V, 2008, GEOL MAG, V145, P257, DOI 10.1017/S0016756807004207; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2010, GEODIVERSITAS, V32, P5, DOI 10.5252/g2010n1a1; Forey P.L., 1998, HIST COELACANTH FISH; Forey PL, 2000, J VERTEBR PALEONTOL, V20, P243, DOI 10.1671/0272-4634(2000)020[0243:ANCFTM]2.0.CO;2; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Garcia-Comas Carmen, 2016, P ROY SOC B-BIOL SCI, V283, P20152129, DOI [10.1098/rspb.2015.2129, DOI 10.1098/RSPB.2015.2129, DOI 10.HTTP://DX.D0I.0RG/10.1098/RSPB.2015.2210.D0I:10.1098/RSPB.2015.2210]; GARDINER BG, 1994, ZOOL J LINN SOC-LOND, V112, P443, DOI 10.1006/zjls.1994.1053; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Giles S, 2013, J MORPHOL, V274, P627, DOI 10.1002/jmor.20119; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goujet D., 1973, Palaeontographica Abt A, V143, P73; Goujet D, 1984, POISSONS PLACODERMES; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Goujet DF, 1975, PROBLEMES ACTUELS PA, V218, P81; Greenwood P.H., 1973, Zoological J Linn Soc, V53, P1; GROSS W, 1971, LETHAIA, V4, P131, DOI 10.1111/j.1502-3931.1971.tb01285.x; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; Gross W., 1963, Notizblatt des Hessischen Landesamtes fuer Bodenforschung zu Wiesbaden, V91, P36; HALSTEAD LB, 1979, NATURE, V282, P833, DOI 10.1038/282833a0; Hemmings S.K., 1978, Palaeontographical Society Monographs (London), V131, P1; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JANVIER P, 1981, Journal of Vertebrate Paleontology, V1, P121; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P773, DOI 10.1671/0272-4634(2004)024[0773:CCITPF]2.0.CO;2; Janvier P, 1985, CAHIERS PALEONTOLOGI; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1977, PROBLEMS VERTEBRATE, P199; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JARVIK ERIK, 1948, ARKIV ZOOL, V41 A, P1; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; Jessen HL, 1975, C INT CTR NATIONAL R, V218, P213; Johanson Z, 1997, GEOL MAG, V134, P813, DOI 10.1017/S0016756897007838; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lee M, 2011, BEHAV COGN PSYCHOTH, V39, P413, DOI 10.1017/S1352465810000925; Lewis PO, 2001, TRENDS ECOL EVOL, V16, P30, DOI 10.1016/S0169-5347(00)02025-5; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liu T-S, 1958, PALAEONTOL SINICA, V141, P1; LIU Y-H, 1973, Vertebrata Palasiatica, V11, P132; Liu Yu-hai, 1991, P139; Long J.A., 1984, Proceedings of the Linnean Society of New South Wales, V107, P263; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lu J, 2016, CURR BIOL, V26, P1602, DOI 10.1016/j.cub.2016.04.045; Maddison W.P., 2008, MESQUITE MODULAR SYS; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Miles R. S., 1968, P109; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; Miles R. S., 1971, PALAEOZOIC FISHES; MILES RS, 1971, PHILOS T R SOC B, V263, P101, DOI 10.1098/rstb.1971.0111; Miles RS., 1973, B BR MUS NAT HIS G, V24, P111; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Moy-Thomas J.A., 1936, GEOL MAG, V73, P488, DOI [10.1017/S0016756800095212, DOI 10.1017/S0016756800095212]; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; OTTO M, 1991, Palaeontologische Zeitschrift, V65, P345; PAN J, 1980, ACTA GEOL SIN-ENGL, V54, P176; Pan J, 1992, NEW GALEASPIDS AGNAT; Pan J., 1987, CONTINENTAL DEVONIAN; Pan K., 1978, P298; Pander CH., 1856, MONOGRAPHIE FOSSILEN; Pickett KM, 2005, MOL PHYLOGENET EVOL, V34, P203, DOI 10.1016/j.ympev.2004.09.001; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Pradel A, 2009, ACTA ZOOL-STOCKHOLM, V90, P123, DOI 10.1111/j.1463-6395.2008.00350.x; Qiao T, 2010, SCI CHINA EARTH SCI, V53, P1836, DOI 10.1007/s11430-010-4089-6; Qu QM, 2015, NATURE, V526, P108, DOI 10.1038/nature15259; RADE J, 1964, J PALEONTOL, V38, P929; Rambaut A., TRACER V 1 5; Rayner DH, 1951, T ROY SOC EDINBURGH, V62, P53; Rindal E, 2011, CLADISTICS, V27, P331, DOI 10.1111/j.1096-0031.2010.00342.x; Ritchie A., 1992, Records of the Australian Museum, V44, P319; RITCHIE A, 1975, NATURE, V254, P569, DOI 10.1038/254569a0; Ritchie A., 1973, Palaeontographica Abt A, V143, P58; Rohon JV, 1893, MEMOIRES ACAD IMPERI, V41, P1; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ronquist F, 2011, MRBAYES VER IN PRESS, P172; SCHULTZE H-P, 1982, Palaeontologische Zeitschrift, V56, P95; Schultze H-P, 2004, ACTA U LATV, V679, P57; Schultze HP, 2016, CR PALEVOL, V15, P83, DOI 10.1016/j.crpv.2015.04.001; Shultze H. P., 1973, Palaeontographica Abt A, V143, P188; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Taverne L., 1997, SCI TERRE, V67, P57; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Traquair RH, 1888, GEOLOGICAL MAGAZINE, V5, P507; Trinajstic K, 2015, BIOL REV, V90, P467, DOI 10.1111/brv.12118; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Turner S, 2005, PALAEONTOLOGY, V48, P963, DOI 10.1111/j.1475-4983.2005.00479.x; Wang Nian-zhong, 1991, P41; Warren A, 2000, J VERTEBR PALEONTOL, V20, P225, DOI 10.1671/0272-4634(2000)020[0225:ARAROG]2.0.CO;2; WHITE E I, 1978, Transactions of the Zoological Society of London, V34, P149; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Xu X, 2013, J SYST PALAEONTOL, V2013, P1, DOI [DOI 10.1080/14772019.2013, 10.1080/14772019.2013]; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Young G.C., 2003, Records of the Western Australian Museum Supplement, V65, P1; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; ZHANG MM, 1980, VERTEBRAT PALASIATIC, V18, P179; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271; Zhu Min, 1991, P179; Zhu M, 2014, NATL SCI REV, V1, P490, DOI 10.1093/nsr/nwu062; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu Min, 2010, P199; Zhu Min, 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P233; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	148	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163157	10.1371/journal.pone.0163157	http://dx.doi.org/10.1371/journal.pone.0163157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649538	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100059
J	Savill, SA; Leitch, HF; Harvey, JN; Thomas, TH				Savill, Stuart A.; Leitch, Helen F.; Harvey, John N.; Thomas, Trevor H.			Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients	PLOS ONE			English	Article							INSULIN; ATHEROSCLEROSIS	Cardiovascular disease and cancer are increased in Type 2 diabetes. TPM1 and TPM4 genes encode proteins associated with cardiovascular and neoplastic disease. High (HMW) and low (LMW) molecular weight isoforms from TPM1 and TPM4 are altered in several cancer cells and the 3'UTR of TPM1 mRNA is tumour suppressive. Leukocytes influence cardiovascular and neoplastic disease by immunosurveillance for cancer and by chronic inflammation in Type 2 diabetes and cardiovascular disease. The aim was to determine changes in expression of isoforms from TPM1 and TPM4 genes in leukocytes from Type 2 diabetic patients and to use the leukocyte cell line THP1 to identify possible mediators of changes in the patients. Gene expression was determined by RT-qPCR. In diabetes, expression of HMW isoforms from TPM1 were markedly decreased (0.55 v 1.00; p = 0.019) but HMW isoforms from TPM4 were not significantly different (0.76 v 1.00; p = 0.205). Within individual variance in expression of HMW isoforms was very high. The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNF alpha (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1 alpha (0.17 and 0.14 v 1.00 respectively). Increased insulin or glucose concentrations had no substantial effects on TPM1 or TPM4 expression. Decreased TPM1 mRNA resulted in decreases in HMW protein levels. Expression of HMW isoforms from TPM1 is decreased in Type 2 diabetes. This is probably due to increased levels of inflammatory cytokines TNF alpha and IL-1 alpha in Type 2 diabetes. Lower levels of TPM1 mRNA reduce tumour suppression and could contribute to increased cancer risk in Type 2 diabetes. Decreased HMW tropomyosin isoforms are associated with cancer. Decreased HMW isoforms give rise to cells that are more plastic, motile, invasive and prone to dedifferentiation resulting in leukocytes that are more invasive but less functionally effective.	[Savill, Stuart A.; Leitch, Helen F.; Harvey, John N.; Thomas, Trevor H.] Betsi Cadwaladr Univ Hlth Board, Croesnewydd Rd, Wrexham, Wales; [Harvey, John N.] Bangor Univ, Wrexham Acad Unit, Sch Med Sci, Bangor, Gwynedd, Wales	Bangor University	Savill, SA (corresponding author), Betsi Cadwaladr Univ Hlth Board, Croesnewydd Rd, Wrexham, Wales.	stuart.savill@wales.nhs.uk			North Wales Research Grants Committee	North Wales Research Grants Committee	This work was supported by SAS: North Wales Research Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2003, EUR J CELL BIOL, V82, P473, DOI 10.1078/0171-9335-00333; Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Barua B, 2014, BIOCHEMISTRY-US, V53, P4015, DOI 10.1021/bi500162z; Bigornia SJ, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chow MT, 2012, SEMIN CANCER BIOL, V22, P23, DOI 10.1016/j.semcancer.2011.12.004; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jin SY, 2014, BBA-MOL BASIS DIS, V1842, P1539, DOI 10.1016/j.bbadis.2014.06.003; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lomnytska MI, 2011, BRIT J CANCER, V104, P110, DOI 10.1038/sj.bjc.6605992; Milioli HH, 2015, CANCER GENOM PROTEOM, V12, P89; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Strissel KJ, 2014, CURR OPIN ENDOCRINOL, V21, P330, DOI 10.1097/MED.0000000000000085; Tang HY, 2013, J PROTEOMICS, V89, P165, DOI 10.1016/j.jprot.2013.06.016; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162908	10.1371/journal.pone.0162908	http://dx.doi.org/10.1371/journal.pone.0162908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649540	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100041
J	Wang, P; Yang, J; Zhang, JP				Wang, Peng; Yang, Jing; Zhang, Jian-Pei			Protection of Location Privacy Based on Distributed Collaborative Recommendations	PLOS ONE			English	Article								In the existing centralized location services system structure, the server is easily attracted and be the communication bottleneck. It caused the disclosure of users' location. For this, we presented a new distributed collaborative recommendation strategy that is based on the distributed system. In this strategy, each node establishes profiles of their own location information. When requests for location services appear, the user can obtain the corresponding location services according to the recommendation of the neighboring users' location information profiles. If no suitable recommended location service results are obtained, then the user can send a service request to the server according to the construction of a k-anonymous data set with a centroid position of the neighbors. In this strategy, we designed a new model of distributed collaborative recommendation location service based on the users' location information profiles and used generalization and encryption to ensure the safety of the user's location information privacy. Finally, we used the real location data set to make theoretical and experimental analysis. And the results show that the strategy proposed in this paper is capable of reducing the frequency of access to the location server, providing better location services and protecting better the user's location privacy.	[Wang, Peng; Yang, Jing; Zhang, Jian-Pei] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Wang, Peng] Suihua Univ, Coll Informat Engn, Suihua, Heilongjiang, Peoples R China	Harbin Engineering University; Suihua University	Yang, J (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	yangjing@hrbeu.edu.cn			National Natural Science Foundation of China [61672179, 61370083, 61402126]; National Research Foundation for the Doctoral Program of Higher Education of China [20122304110012]; Youths Science Foundation of Heilongjiang Province of China [QC2016083]; Heilongjiang Postdoctoral Science Foundation [LBH-Z14071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Youths Science Foundation of Heilongjiang Province of China; Heilongjiang Postdoctoral Science Foundation	We acknowledge the support of the National Natural Science Foundation of China under grant nos. 61672179, 61370083, 61402126; the National Research Foundation for the Doctoral Program of Higher Education of China no. 20122304110012; the Youths Science Foundation of Heilongjiang Province of China under grant no. QC2016083; the Heilongjiang Postdoctoral Science Foundation no. LBH-Z14071.	Amini Shahriyar, 2011, INT C MOB SYST APPL, V14, P19; Baccour E., 2015, 2015 49 ANN C INF SC, P1, DOI DOI 10.1109/GLOCOMW.2015.7414102; Chow C, 2009, SIGSPATIAL SPECIAL, V1, P23, DOI [10.1145/1567253.1567258, DOI 10.1145/1567253.1567258]]; Chow CY, 2011, GEOINFORMATICA, V15, P351, DOI 10.1007/s10707-009-0099-y; Chow CY., 2006, P 14 ANN ACM INT S A, P171, DOI DOI 10.1145/1183471.1183500; Cottrill CD, 2015, TRANSPORT RES C-EMER, V56, P132, DOI 10.1016/j.trc.2015.04.005; Domingo-Ferrer J, 2012, INFORM SCIENCES, V208, P55, DOI 10.1016/j.ins.2012.04.015; Gedik B, 2008, IEEE T MOBILE COMPUT, V7, P1, DOI 10.1109/TMC.2007.1062; Ghinita G, 2010, INFORM SYST, V35, P299, DOI 10.1016/j.is.2009.10.001; Gruteser BM, 2010, ANONYMOUS USAGE LOCA; Ilarri S, 2010, ACM COMPUTING SURVEY, V42; Jiang Y., 2014, 2014 Communications Security Conference (CSC 2014); Junglas IA, 2008, COMMUN ACM, V51, P65, DOI 10.1145/1325555.1325568; Khoshgozaran A, 2011, KNOWL INF SYST, V26, P435, DOI 10.1007/s10115-010-0286-z; Li S, 2015, INT J DISTRIB SENS N, V11, P1; Lin C., 2016, ANN TELECOMMUN, p1 ; Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Pan J, 2014, ADV COMPUTER SCI ITS, V279, P877; Pan X, 2012, IEEE T KNOWL DATA EN, V24, P1506, DOI 10.1109/TKDE.2011.105; Piorkowski M., 2009, P 1 INT C COMM SYST, P1, DOI [DOI 10.1109/COMSNETS.2009.4808865, 10.1109/COMSNETS.2009.4808865]; Shao F, 2014, LECT NOTES COMPUT SC, V8407, P596, DOI 10.1007/978-3-642-55032-4_61; Shengnan L, IEEE ACCESS, VPP, P1; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shokri R., 2011, 2011 IEEE 8th International Conference on Mobile Ad-Hoc and Sensor Systems, P500, DOI 10.1109/MASS.2011.55; Shokri R, 2014, IEEE T DEPEND SECURE, V11, P266, DOI 10.1109/TDSC.2013.57; Xu JL, 2010, IEEE T PARALL DISTR, V21, P313, DOI 10.1109/TPDS.2009.65; Xu Q, 2016, IEEE ACCESS, V4, P2840, DOI 10.1109/ACCESS.2016.2575863; Yang J, 2016, MULTIMEDIA RECOMMEND; Zhu TQ, 2014, FUTURE GENER COMP SY, V36, P142, DOI 10.1016/j.future.2013.07.019	30	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163053	10.1371/journal.pone.0163053	http://dx.doi.org/10.1371/journal.pone.0163053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649308	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100047
J	Benso, B; Franchin, M; Massarioli, AP; Paschoal, JAR; Alencar, SM; Franco, GCN; Rosalen, PL				Benso, Bruna; Franchin, Marcelo; Massarioli, Adna Prado; Rizzato Paschoal, Jonas Augusto; Alencar, Severino Matias; Nobre Franco, Gilson Cesar; Rosalen, Pedro Luiz			Anti-Inflammatory, Anti-Osteoclastogenic and Antioxidant Effects of Malva sylvestris Extract and Fractions: In Vitro and In Vivo Studies	PLOS ONE			English	Article							RANKL-INDUCED OSTEOCLASTOGENESIS; PAW EDEMA; FREE-RADICALS; RAT; INFLAMMATION; INHIBITION; DECREASES; IL-1-BETA; MECHANISM; MIGRATION	Given their medical importance, natural products represent a tremendous source of drug discovery. The aim of this study was to investigate Malva sylvestris L. extract and fractions and their pharmacological activities followed by chemical identification. The aqueous fraction (AF) was identified as the bioactive fraction in the in vitro and in vivo assays. The AF controlled the neutrophil migration to the peritoneal cavity by 66%, inhibited the antiedematogenic activity by 58.8%, and controlled IL-1 beta cytokine expression by 54%. The in vitro viability tests showed a concentration-dependent effect, where the MSE and fractions at concentrations under 10 mu g/ mL were non-toxic to cells. Transcriptional factors of carbonic anhydrase II (CAII), cathepsin K (Ctsk) and tartrate-resistant acid phosphatase (TRAP) were analyzed by qPCR in RAW 264.7 cell lines. The gene expression analysis showed that the AF was the only treatment that could downregulate all the study genes: CAII, Ctsk and TRAP (p<0.05). TRAP staining was used to evaluate osteoclast formation. AF treatments reduced the number of osteoclastogenesis 2.6-fold compared to the vehicle control group. Matrix metalloproteinase 9 (MMP-9) activity decreased 75% with the AF treatment. Moreover, the bioactive fraction had the ability to regulate the oxidation pathway in the ABTS (2,2-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) assay with an activity equivalent to 1.30 mu mol Trolox/g and DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals 1.01 g/L. Positive ion ESI-mass spectrometry for molecular ions at m/z 611 and 633 confirmed rutin as the major compound in the AF. The AF of M. sylvestris presented anti-inflammatory, controlled osteoclastogenic mechanisms and antioxidant abilities in different in vitro and in vivo methods. In addition, we suggest that given its multi-target activity the bioactive fraction may be a good candidate in the therapy of chronic inflammatory diseases.	[Benso, Bruna; Franchin, Marcelo; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Benso, Bruna] Univ Austral Chile, Fac Med, Sch Dent, Valdivia, Chile; [Massarioli, Adna Prado; Alencar, Severino Matias] Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Rizzato Paschoal, Jonas Augusto] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Ribeirao Preto, SP, Brazil; [Nobre Franco, Gilson Cesar] Univ Estadual Ponta Grossa, Dept Gen Biol, Lab Physiol & Pathophysiol, Ponta Grossa, PR, Brazil	Universidade Estadual de Campinas; Universidad Austral de Chile; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa	Benso, B; Rosalen, PL (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil.; Benso, B (corresponding author), Univ Austral Chile, Fac Med, Sch Dent, Valdivia, Chile.	bruna.benso@uach.cl; rosalen@fop.unicamp.br	Paschoal, Jonas Augusto Rizzato/F-4260-2012; Franchin, Marcelo/M-7636-2017; Benso, Bruna/L-1010-2015; Massarioli, Adna Prado/I-4840-2013; Rosalen, Pedro Luiz/I-3718-2012; Alencar, Severino Matias/B-7743-2012	Paschoal, Jonas Augusto Rizzato/0000-0002-7372-0936; Franchin, Marcelo/0000-0001-5613-2756; Benso, Bruna/0000-0002-4425-5174; Massarioli, Adna Prado/0000-0002-2747-0788; Rosalen, Pedro Luiz/0000-0003-0812-4027; Alencar, Severino Matias/0000-0002-6637-7973	Sao Paulo Research Foundation (FAPESP) [2011/23980-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Grant #2011/23980-5, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Sao Paulo Research Foundation (FAPESP) (Grant #2011/23980-5) for financial support. We also would like to thank Dr. Helen Lowry for the very careful review of the English in this work.	Al Mamun MA, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0043-6, 10.1186/S40659-015-0043-6]; Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Bocci V, 2013, CURR MED CHEM, V20, P3397, DOI 10.2174/0929867311320270005; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Bruna Benso, 2015, PLOS ONE; Cataldo DD, 2003, CELL MOL BIOL, V49, P875; Choi KS, 2014, ARCH BIOCHEM BIOPHYS, V559, P38, DOI 10.1016/j.abb.2014.05.016; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Coxon A, 2002, ARTHRITIS RHEUM, V46, P2604, DOI 10.1002/art.10546; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Crotti TN, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/281287; Dal Secco D, 2006, NITRIC OXIDE-BIOL CH, V15, P77, DOI 10.1016/j.niox.2006.02.004; Franchin M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/907041; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Georgakopoulou EA, 2014, ORAL DIS, V20, P127, DOI 10.1111/odi.12132; Hardy RS, 2014, ANN NY ACAD SCI, V1318, P18, DOI 10.1111/nyas.12389; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Ishtiaq Muhammad, 2007, Pak J Biol Sci, V10, P2241, DOI 10.3923/pjbs.2007.2241.2256; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; Kauss T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2372; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Kim HS, 2012, INT J MOL MED, V29, P169, DOI 10.3892/ijmm.2011.822; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Rainsford K. D., 2007, V42, P3; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Seleem D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157188; Shim KS, 2011, J MED FOOD, V14, P1439, DOI 10.1089/jmf.2010.1502; Syggelos SA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/230805; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tiveron AP, 2012, INT J MOL SCI, V13, P8943, DOI 10.3390/ijms13078943; van den Berg WB, 2001, SEMIN ARTHRITIS RHEU, V30, P7, DOI 10.1053/sarh.2001.23704; WARD PA, 1974, ANN NY ACAD SCI, V221, P290, DOI 10.1111/j.1749-6632.1974.tb28228.x; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Wu CL, 2015, BIOCHEM PHARMACOL, V93, P59, DOI 10.1016/j.bcp.2014.10.019; Yan B, 2014, J IMMUNOL, V192, P5998, DOI 10.4049/jimmunol.1301645; Zhang F, 2011, BIOCHIMIE, V93, P296, DOI 10.1016/j.biochi.2010.10.001	48	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162728	10.1371/journal.pone.0162728	http://dx.doi.org/10.1371/journal.pone.0162728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643502	Green Published, Green Submitted, gold			2022-12-27	WOS:000383891900015
J	Fregin, T; Bickmeyer, U				Fregin, Torsten; Bickmeyer, Ulf			Electrophysiological Investigation of Different Methods of Anesthesia in Lobster and Crayfish	PLOS ONE			English	Article							CARBON-DIOXIDE; CRUSTACEANS; BEHAVIOR; TEMPERATURE; NEURONS; CRABS; MODULATION; ANIMALS; CIRCUIT; PAIN	Objectives In search for methods of anesthesia of crustaceans, an implanted electrode into lobster and crayfish CNS enabled us to monitor signal propagation in the nerve system of animals undergoing different protocols. Results Cooling (tap water 0 degrees C, sea water -1,8 degrees C) and anesthesia with MgCl2 (10%) were both discarded as anesthetic procedures because responses to external stimuli were still detectable under treatment. Contrarily, bubbling the aquarium water with CO2 can be considered a "partially successful" anesthesia, because signal propagation is inhibited but before that the animals show discomfort. The procedure of "electro-stunning" induces epileptic-form seizures in the crustacean CNS (lobster, crayfish), which overlay but do not mitigate the response to external stimuli. After several minutes the activity declines before the nervous system starts to recover. A feasible way to sacrifice lobsters is to slowly raise the water temperature (1 degrees C min(-1)), as all electrical activities in the CNS cease at temperatures above similar to 30 degrees C, whereas below this temperature the animals do not show signs of stress or escape behavior (e.g. tail flips) in the warming water. Conclusion CO2 is efficient to anaesthetize lobster and crayfish but due to low pH in water is stressful to the animals previous to anesthesia. Electrical stunning induces epileptiform seizures but paralyses the animals and leads to a reversible decline of nerve system activity after seizure. Electric stunning or slowly warming just before preparation may meet ethical expectations regarding anaesthesia and to sacrifice crustaceans.	[Fregin, Torsten; Bickmeyer, Ulf] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Bickmeyer, U (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany.	Ulf.Bickmeyer@awi.de		Bickmeyer, Ulf/0000-0002-5351-2902	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE) [2812HS009]	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE)	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE), grant number 2812HS009.	Aaser CS, 1949, NORDISK VET MEDISIN, V1, P221; BAKER JR, 1955, J MAR BIOL ASSOC UK, V34, P15, DOI 10.1017/S0025315400008572; BAKER JR, 1962, SCIENCE, V135, P587, DOI 10.1126/science.135.3503.587-a; Barr S, 2008, ANIM BEHAV, V75, P745, DOI 10.1016/j.anbehav.2007.07.004; BENARDE MA, 1962, SCIENCE, V135, P587, DOI 10.1126/science.135.3503.587; Bickmeyer U, 2012, MAR DRUGS, V10, P223, DOI 10.3390/md10010223; Bierbower SM, 2010, J EXP ZOOL PART A, V313A, P484, DOI 10.1002/jez.620; Bierbower SM, 2013, J EXP ZOOL PART A, V319A, P340, DOI 10.1002/jez.1798; Chung Y.S., 2012, OPEN J MOL INTEGR PH, V2, P75, DOI DOI 10.4236/OJMIP.2012.23011; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Elwood RW, 2012, ANIM WELFARE, V21, P23, DOI 10.7120/096272812X13353700593365; Fish F. R., 1943, Transactions of the American Fisheries Society, V1942, P25; FORWARD RB, 1990, BIOL BULL-US, V178, P195, DOI 10.2307/1541819; GREGORY NG, 1988, BRIT VET J, V144, P573, DOI 10.1016/0007-1935(88)90027-9; GREGORY NG, 1987, BRIT VET J, V143, P175, DOI 10.1016/0007-1935(87)90009-1; Gruhn M, 2002, J NEUROSCI METH, V118, P33, DOI 10.1016/S0165-0270(02)00127-9; GUNTER G, 1962, SCIENCE, V135, P588, DOI 10.1126/science.135.3503.588; GUNTER G, 1961, SCIENCE, V133, P327, DOI 10.1126/science.133.3449.327; Hamilton JL, 2007, J EXP BIOL, V210, P1025, DOI 10.1242/jeb.02717; HOBBS H H JR, 1981, Smithsonian Contributions to Zoology, P1; Hoenderken R, 1978, ELEKT BEDWELMING SLA, VXI; KERKUT G. A., 1958, BEHAVIOR, V13, P259, DOI 10.1163/156853957X00047; KERKUT GA, 1956, NATURE, V178, P426, DOI 10.1038/178426a0; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Lagerspetz KYH, 2006, BIOL REV, V81, P237, DOI 10.1017/S1464793105006998; Liu YC, 2010, J NEUROPHYSIOL, V104, P675, DOI 10.1152/jn.00391.2010; Makowska IJ, 2009, APPL ANIM BEHAV SCI, V121, P230, DOI 10.1016/j.applanim.2009.10.001; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; MESSENGER JB, 1985, COMP BIOCHEM PHYS C, V82, P203, DOI 10.1016/0742-8413(85)90230-0; Pantin C. F. A., 1962, NOTES MICROSCOPICAL; Payette AL, 2003, COMP BIOCHEM PHYS A, V136, P539, DOI 10.1016/S1095-6433(03)00203-4; POST G, 1979, PROG FISH CULT, V41, P142, DOI 10.1577/1548-8659(1979)41[142:CAAFAO]2.0.CO;2; Reimers U., 2008, THESIS; Roth B, 2010, ANIM WELFARE, V19, P287; RUNHAM N. W., 1965, MALCOLOGIA, V2, P231; Smaldon G., 1979, SYNOPSIS METHODS NAR; Sneddon LU, 2015, J EXP BIOL, V218, P967, DOI 10.1242/jeb.088823; Southward A.J., 1963, CATALOGUE MAIN MARIN; Steneck RS, 2013, CAN J FISH AQUAT SCI, V70, P1612, DOI 10.1139/cjfas-2013-0094; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Tani M, 1998, COMP BIOCHEM PHYS A, V119, P845, DOI 10.1016/S1095-6433(98)01025-3; Wiese KE., 2002, CRUSTACEAN NERVOUS S, Vxxi; Wiese KE, 2002, CRUSTACEAN EXPT SYST, Vxiv	45	18	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162894	10.1371/journal.pone.0162894	http://dx.doi.org/10.1371/journal.pone.0162894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642755	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900023
J	Park, SJ; Yoon, DM; Yoon, KB; Moon, JA; Kim, SH				Park, Sang Jun; Yoon, Duck Mi; Yoon, Kyung Bong; Moon, Ji Ae; Kim, Shin Hyung			Factors Associated with Higher Reported Pain Levels in Patients with Chronic Musculoskeletal Pain: A Cross-Sectional, Correlational Analysis	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL-PROCESSES; INSOMNIA SEVERITY INDEX; POOR SLEEP; NECK PAIN; BACK-PAIN; DEPRESSION; POPULATION; QUALITY; OSTEOARTHRITIS; HYPERALGESIA	Background Chronic musculoskeletal pain is highly prevalent, disabling, and costly, and has many negative effects on quality of life. The aim of this study was to investigate factors associated with higher reported pain levels in patients with chronic musculoskeletal pain among demographic, clinical, and psychological factors, and to evaluate whether insomnia is independently associated with pain intensity in this population. Methods A total of 357 patients with chronic musculoskeletal pain (pain duration >= six months) satisfied the study inclusion criteria and were included in the analyses. Patient demographics, clinical, and psychological factors were evaluated with hierarchical multivariate logistic analysis to identify factors associated with severe pain (NRS [numeric rating scale] >= 7). Hierarchical linear regression analysis also performed to identify factors associated with pain intensity (0 to 10 NRS). Results Multivariate logistic analyses revealed older age (OR [odds ratio] = 1.017, 95% CI [confidence interval] 1.001-1.032, P = 0.034), high anxiety level (OR = 1.162, 95% CI 1.020-1.324, P = 0.024), high pain catastrophizing (OR = 1.043, 95% CI 1.007-1.081, P = 0.018), and severe insomnia (OR = 1.112, 95% CI 1.057-1.170, P < 0.001) were significantly associated with severe pain. Hierarchical linear regression analysis showed age (beta = 0.106, P = 0.041), pain catastrophizing (beta = 0.249, P< 0.001), and insomnia (beta = 0.286, P < 0.001) were significantly associated with pain intensity. The variance in pain intensity explained by the final model was 32.2%. Conclusions Older age, severe insomnia, and high pain catastrophizing were significantly associated with higher reported pain levels. Insomnia was independently associated with pain intensity, even after controlling for various demographic and clinical factors. These factors should be considered when devising pain management strategies for this population.	[Park, Sang Jun; Yoon, Duck Mi; Yoon, Kyung Bong; Moon, Ji Ae; Kim, Shin Hyung] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	tessar@yuhs.ac		Park, Sang Jun/0000-0002-2496-7764; Yoon, Kyung Bong/0000-0002-4167-1375; Kim, Shin Hyung/0000-0003-4058-7697				Artner J, 2013, J PAIN RES, V6, P1, DOI 10.2147/JPR.S36386; Asih S, 2014, SPINE J, V14, P2000, DOI 10.1016/j.spinee.2013.11.052; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Buenaver LF, 2012, PAIN, V153, P1159, DOI 10.1016/j.pain.2012.01.023; Byers HD, 2016, J BEHAV MED, V39, P233, DOI 10.1007/s10865-015-9687-5; Campbell CM, 2015, ARTHRIT CARE RES, V67, P1387, DOI 10.1002/acr.22609; Chiu YH, 2005, PAIN, V115, P316, DOI 10.1016/j.pain.2005.03.009; Chung KF, 2010, SLEEP MED, V11, P752, DOI 10.1016/j.sleep.2009.09.005; Farrell M, 2007, PAIN MED, V8, P514, DOI 10.1111/j.1526-4637.2007.00282.x; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Fishbain DA, 2008, J PAIN SYMPTOM MANAG, V36, P639, DOI 10.1016/j.jpainsymman.2007.12.012; Frondini C, 2007, ARCH GERONTOL GERIAT, V44, P167, DOI 10.1016/j.archger.2007.01.024; Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004; Gustavsson C, 2006, J REHABIL MED, V38, P100, DOI 10.1080/16501970510044025; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Jourdan D, 2000, EUR J PAIN, V4, P291, DOI 10.1053/eujp.2000.0188; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kim SH, 2015, KOREAN J PAIN, V28, P137, DOI 10.3344/kjp.2015.28.2.137; Kovacs FM, 2015, CLIN J PAIN, V31, P713, DOI 10.1097/AJP.0000000000000147; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; MacDonald S, 2008, INT J BEHAV MED, V15, P201, DOI 10.1080/10705500802222675; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Palermo TM, 2011, PAIN, V152, P89, DOI 10.1016/j.pain.2010.09.035; Power JD, 2005, ARTHRIT RHEUM-ARTHR, V53, P911, DOI 10.1002/art.21584; Quartana PJ, 2015, BRAIN BEHAV IMMUN, V47, P228, DOI 10.1016/j.bbi.2014.12.010; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Sayar K, 2002, CAN J PSYCHIAT, V47, P844, DOI 10.1177/070674370204700905; Schuh-Hofer S, 2013, PAIN, V154, P1613, DOI 10.1016/j.pain.2013.04.046; Smith MT, 2004, CLIN J PAIN, V20, P111, DOI 10.1097/00002508-200403000-00008; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; Sturgeon JA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0317-4; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tang Nicole K Y, 2008, Rev Pain, V2, P2, DOI 10.1177/204946370800200102; Tang NKY, 2012, CLIN J PAIN, V28, P428, DOI 10.1097/AJP.0b013e31823711bc; Vitiello MV, 2014, PAIN, V155, P1547, DOI 10.1016/j.pain.2014.04.032; Wong WS, 2014, QUAL LIFE RES, V23, P2333, DOI 10.1007/s11136-014-0683-y; Zheng Z, 2000, PAIN, V85, P51, DOI 10.1016/S0304-3959(99)00247-X	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163132	10.1371/journal.pone.0163132	http://dx.doi.org/10.1371/journal.pone.0163132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636367	gold, Green Submitted, Green Published			2022-12-27	WOS:000383723700035
J	Qian, T; Masino, AJ				Qian, Ting; Masino, Aaron J.			Latent Patient Cluster Discovery for Robust Future Forecasting and New-Patient Generalization	PLOS ONE			English	Article							MISSING DATA; CONCEPT DRIFT; MODEL; MIXTURE	Commonly referred to as predictive modeling, the use of machine learning and statistical methods to improve healthcare outcomes has recently gained traction in biomedical informatics research. Given the vast opportunities enabled by large Electronic Health Records (EHR) data and powerful resources for conducting predictive modeling, we argue that it is yet crucial to first carefully examine the prediction task and then choose predictive methods accordingly. Specifically, we argue that there are at least three distinct prediction tasks that are often conflated in biomedical research: 1) data imputation, where a model fills in the missing values in a dataset, 2) future forecasting, where a model projects the development of a medical condition for a known patient based on existing observations, and 3) newpatient generalization, where a model transfers the knowledge learned from previously observed patients to newly encountered ones. Importantly, the latter two tasks-future forecasting and new-patient generalizations-tend to be more difficult than data imputation as they require predictions to be made on potentially out-of-sample data (i.e., data following a different predictable pattern from what has been learned by the model). Using hearing loss progression as an example, we investigate three regression models and show that the modeling of latent clusters is a robust method for addressing the more challenging prediction scenarios. Overall, our findings suggest that there exist significant differences between various kinds of prediction tasks and that it is important to evaluate the merits of a predictive model relative to the specific purpose of a prediction task.	[Qian, Ting; Masino, Aaron J.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Qian, T (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	qiant@email.chop.edu						Bach S., 2010, ADV NEURAL INFORM, V23, P127; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Carpenter J, 2002, STAT MED, V21, P1043, DOI 10.1002/sim.1065; Chao TK, 2009, J EVAL CLIN PRACT, V15, P32, DOI 10.1111/j.1365-2753.2008.00949.x; Davis SE, 2016, AMIA 7 ANN JOINT SUM; Fong A, 2015, J BIOMED INFORM, V58, P89, DOI 10.1016/j.jbi.2015.09.011; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Grun B, 2007, COMPUT STAT DATA AN, V51, P5247, DOI 10.1016/j.csda.2006.08.014; HALL JW, 1981, EAR HEARING, V2, P156, DOI 10.1097/00003446-198107000-00004; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Huang ZX, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9915-2; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Jung K, 2015, J BIOMED INFORM, V58, P168, DOI 10.1016/j.jbi.2015.10.006; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; MacEachern SN, 1998, J COMPUT GRAPH STAT, V7, P223, DOI 10.2307/1390815; R Core Team, 2021, R LANGUAGE ENV STAT; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Roberts SJ, 1998, IEEE T PATTERN ANAL, V20, P1133, DOI 10.1109/34.730550; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin DB., 2004, MULTIPLE IMPUTATION; Sajda P, 2006, ANNU REV BIOMED ENG, V8, P537, DOI 10.1146/annurev.bioeng.8.061505.095802; Speier W, 2016, J BIOMED INFORM, V61, P260, DOI 10.1016/j.jbi.2016.04.005; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Taslimitehrani V, 2016, J BIOMED INFORM, V60, P260, DOI 10.1016/j.jbi.2016.01.009; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; Tsymbal A, 2006, COMP MED SY, P679, DOI 10.1109/CBMS.2006.94; Wang TT, 2016, J BIOMED INFORM, V61, P247, DOI 10.1016/j.jbi.2016.04.008; Widmer G, 1996, MACH LEARN, V23, P69, DOI 10.1007/BF00116900; Zliobaite I, 2010, ABS10104784 ARXIV CO, P1	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162812	10.1371/journal.pone.0162812	http://dx.doi.org/10.1371/journal.pone.0162812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636203	Green Submitted, Green Published, gold			2022-12-27	WOS:000383723700016
J	Guven, G; Lohmann, E; Bras, J; Gibbs, JR; Gurvit, H; Bilgic, B; Hanagasi, H; Rizzu, P; Heutink, P; Emre, M; Erginel-Unaltuna, N; Just, W; Hardy, J; Singleton, A; Guerreiro, R				Guven, Gamze; Lohmann, Ebba; Bras, Jose; Gibbs, J. Raphael; Gurvit, Hakan; Bilgic, Basar; Hanagasi, Hasmet; Rizzu, Patrizia; Heutink, Peter; Emre, Murat; Erginel-Unaltuna, Nihan; Just, Walter; Hardy, John; Singleton, Andrew; Guerreiro, Rita			Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; LOBAR DEGENERATION; NULL MUTATIONS; TAU-MUTATIONS; PROGRANULIN; RECOMMENDATIONS; ASSOCIATION; GUIDELINES; DIAGNOSIS; DISEASE	'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) genemutations are the major known genetic causes of frontotemporal dementia (FTD). Recent studies suggest that mutations in these genes may also be associated with other forms of dementia. Therefore we investigated whether MAPT, GRN and C9ORF72 genemutations are major contributors to dementia in a random, unselected Turkish cohort of dementia patients. A combination of whole-exome sequencing, Sanger sequencing and fragment analysis/Southern blot was performed in order to identify pathogenic mutations and novel variants in these genes as well as other FTD-related genes such as the 'charged multivesicular body protein 2B' (CHMP2B), the 'FUS RNA binding protein' (FUS),the 'TAR DNA binding protein' (TARDBP), the 'sequestosome1' (SQSTM1), and the 'valosin containing protein' (VCP). We determined one pathogenic MAPT mutation (c. 1906C> T, p. P636L) and one novel missense variant (c. 38A> G, p. D13G). In GRN we identified a probably pathogenic TGAG deletion in the splice donor site of exon 6. Three patients were found to carry the GGGGCC expansions in the non-coding region of the C9ORF72 gene. In summary, a complete screening for mutations in MAPT, GRN and C9ORF72 genes revealed a frequency of 5.4% of pathogenicmutations in a random cohort of 93 Turkish index patients with dementia.	[Guven, Gamze; Erginel-Unaltuna, Nihan] Istanbul Univ, Inst Expt Med, Dept Genet, Istanbul, Turkey; [Lohmann, Ebba; Gurvit, Hakan; Bilgic, Basar; Hanagasi, Hasmet; Emre, Murat] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav Neurol & Movement Disorders Unit, Istanbul, Turkey; [Lohmann, Ebba; Heutink, Peter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Lohmann, Ebba; Rizzu, Patrizia; Heutink, Peter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Bras, Jose; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Bras, Jose; Guerreiro, Rita] Univ Aveiro, Dept Med Sci, P-3810193 Aveiro, Portugal; [Bras, Jose; Guerreiro, Rita] Univ Aveiro, Inst Biomed iBiMED, P-3810193 Aveiro, Portugal; [Gibbs, J. Raphael; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Just, Walter] Univ Ulm, Inst Human Genet, Ulm, Germany	Istanbul University; Istanbul University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; University College London; Universidade de Aveiro; Universidade de Aveiro; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Ulm University	Lohmann, E (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav Neurol & Movement Disorders Unit, Istanbul, Turkey.; Lohmann, E (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany.; Lohmann, E (corresponding author), German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany.	ebbalohmann@gmx.net	Gurvit, Hakan/A-7646-2019; Hanagasi, Hasmet A./AAT-9501-2020; Hardy, John/C-2451-2009; Guven, Gamze/AAB-7548-2020; Gibbs, J. Raphael/A-3984-2010; Erginel-Unaltuna, Nihan/A-4885-2018; Singleton, Andrew B/C-3010-2009; Guerreiro, Rita J L/A-1327-2011; Bilgic, Basar/E-4821-2012; Bras, Jose MT/A-1428-2011; Guven, Gamze/Q-4560-2016	Gurvit, Hakan/0000-0003-2908-8475; Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Erginel-Unaltuna, Nihan/0000-0003-0562-0455; Bilgic, Basar/0000-0001-6032-0856; Heutink, Peter/0000-0001-5218-1737; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Alzheimer's Research UK (ARUK); Wellcome Trust/MRC [WT089698]; National Institute on Aging; National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services [ZO1 AG000950-10]; ARUK Alzheimer's Society; European Social Fund; Ministry of Science Research and the Arts Baden-Wurttemberg; Alzheimer's Society; Alzheimer's Research UK; National Institute on Aging, National Institutes of Health, Department of Health and Human Services; MRC [G0701075, G0901254] Funding Source: UKRI; Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000951, ZIAAG000957] Funding Source: NIH RePORTER	Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services; ARUK Alzheimer's Society; European Social Fund(European Social Fund (ESF)); Ministry of Science Research and the Arts Baden-Wurttemberg; Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Alzheimer's Research UK (ARUK) by an anonymous donor, by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee; by the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services, Project number ZO1 AG000950-10; and by Research Fellowships from ARUK Alzheimer's Society to Dr. Guerreiro and Dr Bras. This project was supported by the European Social Fund and by the Ministry of Science Research and the Arts Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all patients and their families for taking part in this study. Ebru Ozer and Meltem Pak helped with obtaining the samples. Jose Bras and Rita Guerreiro are supported by Fellowships from the Alzheimer's Society. This work was partially funded by Alzheimer's Research UK, Alzheimer's Society and by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services and the European Social Fund and the Ministry of Science Research and the Arts Baden-Wurttemberg.	Bernardi L, 2009, NEUROBIOL AGING, V30, P1825, DOI 10.1016/j.neurobiolaging.2008.01.005; Bit-Ivan EN, 2014, J NEUROPATH EXP NEUR, V73, P467, DOI 10.1097/NEN.0000000000000070; Bronner IF, 2007, EUR J HUM GENET, V15, P369, DOI 10.1038/sj.ejhg.5201772; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Fabre SF, 2001, EXP NEUROL, V168, P413, DOI 10.1006/exnr.2000.7613; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Galimberti D, 2015, BIOL PSYCHIAT, V78, P684, DOI 10.1016/j.biopsych.2015.03.028; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.009; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Huey ED, 2006, ANN NEUROL, V60, P374, DOI 10.1002/ana.20969; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Kertesz A, 2003, NEUROLOGIST, V9, P311, DOI 10.1097/01.nrl.0000094943.84390.cf; Kowalska A, 2001, DEMENT GERIATR COGN, V12, P387, DOI 10.1159/000051285; Le Ber I, 2007, HUM MUTAT, V28, P846, DOI 10.1002/humu.20520; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmann E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.020; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Skoglund L, 2011, ALZ DIS ASSOC DIS, V25, P173, DOI 10.1097/WAD.0b013e3181fbc22c; Stanford PM, 2004, J NEUROL, V251, P1098, DOI 10.1007/s00415-004-0489-x; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wojtas Aleksandra, 2012, Am J Neurodegener Dis, V1, P107; Zekanowski C, 2003, DEMENT GERIATR COGN, V16, P126, DOI 10.1159/000070999	49	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162592	10.1371/journal.pone.0162592	http://dx.doi.org/10.1371/journal.pone.0162592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632209	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900056
J	Kite, J; Foley, BC; Grunseit, AC; Freeman, B				Kite, James; Foley, Bridget C.; Grunseit, Anne C.; Freeman, Becky			Please Like Me: Facebook and Public Health Communication	PLOS ONE			English	Article							SOCIAL NETWORKING SITES; MASS-MEDIA CAMPAIGNS; INFORMATION; BEHAVIOR; SMOKING; EXPOSURE; IMPACT	Facebook, the most widely used social media platform, has been adopted by public health organisations for health promotion and behaviour change campaigns and activities. However, limited information is available on the most effective and efficient use of Facebook for this purpose. This study sought to identify the features of Facebook posts that are associated with higher user engagement on Australian public health organisations' Facebook pages. We selected 20 eligible pages through a systematic search and coded 360-days of posts for each page. Posts were coded by: post type (e.g., photo, text only etc.), communication technique employed (e.g. testimonial, informative etc.) and use of marketing elements (e.g., branding, use of mascots). A series of negative binomial regressions were used to assess associations between post characteristics and user engagement as measured by the number of likes, shares and comments. Our results showed that video posts attracted the greatest amount of user engagement, although an analysis of a subset of the data suggested this may be a reflection of the Facebook algorithm, which governs what is and is not shown in user newsfeeds and appear to preference videos over other post types. Posts that featured a positive emotional appeal or provided factual information attracted higher levels of user engagement, while conventional marketing elements, such as sponsorships and the use of persons of authority, generally discouraged user engagement, with the exception of posts that included a celebrity or sportsperson. Our results give insight into post content that maximises user engagement and begins to fill the knowledge gap on effective use of Facebook by public health organisations.	[Kite, James] Univ Sydney, Prevent Res Collaborat, Charles Perkins Ctr, Sydney, NSW, Australia; Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney	Kite, J (corresponding author), Univ Sydney, Prevent Res Collaborat, Charles Perkins Ctr, Sydney, NSW, Australia.	james.kite@sydney.edu.au	Grunseit, Anne/AAF-2675-2020; Foley, Bridget Clare/T-1909-2019	Kite, James/0000-0001-5500-2538; Foley, Bridget/0000-0002-0148-7872; Grunseit, Anne/0000-0003-1250-3265				Australian Institute of Health and Welfare, 2016, AUSTR BURD DIS STUD; Backstrom Lars, 2013, NEWS FEED FYI WINDOW; Brettel M, 2015, J ADVERTISING RES, V55, P162, DOI 10.2501/JAR-55-2-162-175; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Carah N., 2014, COMMENT SHARE ALCOHO; Cisco, 2015, CISC VIS NETW IND FO; Duggan M, 2015, SOCIAL MEDIA UPDATE; Dunlop S, 2013, AM J PUBLIC HEALTH, V103, pE66, DOI 10.2105/AJPH.2012.301079; Dunlop SM, 2014, J HEALTH COMMUN, V19, P41, DOI 10.1080/10810730.2013.798375; Dunlop SM, 2012, TOBACCO CONTROL; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Erdogan, 1999, J MARK MANAG, V15, P291, DOI [DOI 10.1362/026725799784870379, 10.1362/026725799784870379]; Freeman B, 2008, J EPIDEMIOL COMMUN H, V62, P778, DOI 10.1136/jech.2008.073759; Freeman B, 2015, PUBLIC HLTH RES PRAC, V25; Freeman B, 2014, AM J PUBLIC HEALTH, V104, pE56, DOI 10.2105/AJPH.2014.302167; Goh KY, 2013, INFORM SYST RES, V24, P88, DOI 10.1287/isre.1120.0469; Hastings G., 2007, SOCIAL MARKETING WHY; Hutchinson MK, 2005, RES NURS HEALTH, V28, P408, DOI 10.1002/nur.20093; Jansen BJ, 2011, J INF SCI, V37, P120, DOI 10.1177/0165551510396975; Kaplan AM, 2011, BUS HORIZONS, V54, P253, DOI 10.1016/j.bushor.2011.01.006; Kumar V, 2013, MARKET SCI, V32, P194, DOI 10.1287/mksc.1120.0768; LANG A, 1995, J BROADCAST ELECTRON, V39, P313, DOI 10.1080/08838159509364309; Lang B., 2013, J CONSUMER SATISFACT, V26, P3; Lang B, 2013, J NONPROFIT PUBLIC S, V25, P374, DOI 10.1080/10495142.2013.845419; Lee D., 2014, WORKING PAPERS FACUL, P1; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952; McGee Matt, 2013, MARTECH; McNab C, 2009, B WORLD HEALTH ORGAN, V87, P566, DOI 10.2471/BLT.09.066712; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Nielsen, 2013, INFL CONS TRUST ADV; Park H, 2011, J INTERACT ADVERT, V13, P62, DOI DOI 10.1080/15252019.2011.10722191; Perez D, 2015, HEALTH EDUC RES, V30, P336, DOI 10.1093/her/cyv002; Perrin A, 2015, SOCIAL MEDIA USAGE 2; Safko L., 2010, SOCIAL MEDIA BIBLE T; Sensis, 2015, SENS SOC MED REP MAY; Stead M, 2007, HEALTH EDUC, V107, P126, DOI 10.1108/09654280710731548; Syn SY, 2015, J INF SCI, V41, P553, DOI 10.1177/0165551515585717; Tantiseneepong N, 2012, QUAL MARK RES, V15, P57, DOI 10.1108/13522751211191991; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Trimble C., WHY ONLINE VIDEO IS; Uhrig J, 2010, SOC MARK Q, V16, P2, DOI 10.1080/15245000903528365; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Waters RD, 2009, PUBLIC RELAT REV, V35, P102, DOI 10.1016/j.pubrev.2009.01.006	45	94	97	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162765	10.1371/journal.pone.0162765	http://dx.doi.org/10.1371/journal.pone.0162765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632172	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900075
J	Ring, T; Kellum, JA				Ring, Troels; Kellum, John A.			Strong Relationships in Acid-Base Chemistry - Modeling Protons Based on Predictable Concentrations of Strong Ions, Total Weak Acid Concentrations, and pCO(2)	PLOS ONE			English	Article							METABOLIC-ACIDOSIS; RENAL-RESPONSE; EXTRAPOLATION; UNCERTAINTY; BALANCE; ANIONS	Understanding acid-base regulation is often reduced to pigeonholing clinical states into categories of disorders based on arterial blood sampling. An earlier ambition to quantitatively explain disorders by measuring production and elimination of acid has not become standard clinical practice. Seeking back to classical physical chemistry we propose that in any compartment, the requirement of electroneutrality leads to a strong relationship between charged moieties. This relationship is derived in the form of a general equation stating charge balance, making it possible to calculate [H+] and pH based on all other charged moieties. Therefore, to validate this construct we investigated a large number of blood samples from intensive care patients, where both data and pathology is plentiful, by comparing the measured pH to the modeled pH. We were able to predict both the mean pattern and the individual fluctuation in pH based on all other measured charges with a correlation of approximately 90% in individual patient series. However, there was a shift in pH so that fitted pH in general is overestimated (95% confidence interval -0.072-0.210) and we examine some explanations for this shift. Having confirmed the relationship between charged species we then examine some of the classical and recent literature concerning the importance of charge balance. We conclude that focusing on the charges which are predictable such as strong ions and total concentrations of weak acids leads to new insights with important implications for medicine and physiology. Importantly this construct should pave the way for quantitative acid-base models looking into the underlying mechanisms of disorders rather than just classifying them.	[Ring, Troels] Aalborg Univ Hospital, Dept Nephrol, DK-9000 Aalborg, Denmark; [Kellum, John A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA; [Kellum, John A.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ring, T (corresponding author), Aalborg Univ Hospital, Dept Nephrol, DK-9000 Aalborg, Denmark.	tring@gvdnet.dk	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK070910, R01DK083961]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070910, R01DK083961] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by R01DK070910 and R01DK083961 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to JAK. No other funding was provided or needed.; This work was supported in part by R01DK070910 and R01DK083961 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to JAK. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of NIDDK, or NIH.	[Anonymous], 2014, R LANG ENV STAT COMP; BROWN JC, 1989, AM J PHYSIOL, V257, pF170, DOI 10.1152/ajprenal.1989.257.2.F170; Brown RJC, 2013, MEASUREMENT, V46, P1726, DOI 10.1016/j.measurement.2013.01.007; Carroll RJ, 2009, J AM STAT ASSOC, V104, P993, DOI 10.1198/jasa.2009.tm07543; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Cohen RM, 1997, KIDNEY INT, V52, P287, DOI 10.1038/ki.1997.334; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Davies CW, 1938, J CHEM SOC, P2093, DOI 10.1039/jr9380002093; DuBose TD., 2012, BRENNER RECTORS KIDN, V9th edn, P595; Eisenberg B, 2013, PHYSIOLOGY, V28, P28, DOI 10.1152/physiol.00041.2012; Forni LG, 2005, CRIT CARE, V9, pR591, DOI 10.1186/cc3806; Frassetto LA, 2007, AM J PHYSIOL-RENAL, V293, pF521, DOI 10.1152/ajprenal.00048.2007; Gelman A., 2007, DATA ANAL USING REGR; Giebisch G, 2004, AM J PHYSIOL-RENAL, V287, pF864, DOI 10.1152/classicessays.00005.2004; GIEBISCH G, 1955, J CLIN INVEST, V34, P231, DOI 10.1172/JCI103076; Gunnerson KJ, 2010, J CRIT CARE, V25, P520, DOI 10.1016/j.jcrc.2009.11.001; Hamm LL, 2015, CLIN J AM SOC NEPHRO, V10, P2232, DOI 10.2215/CJN.07400715; Hayfield T., 2008, J STAT SOFTWARE, V27; HERMAN DP, 1990, J CHEM EDUC, V67, P501, DOI 10.1021/ed067p501; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; K?chenhoff H., 2006, R NEWS, V6, P26; Kellum JA, 1998, SHOCK, V9, P364, DOI 10.1097/00024382-199805000-00009; LEMANN J, 1965, J CLIN INVEST, V44, P507, DOI 10.1172/JCI105164; Lemann J, 2003, AM J PHYSIOL-RENAL, V285, pF811, DOI 10.1152/ajprenal.00115.2003; LINDINGER MI, 1992, AM J PHYSIOL, V262, pR126, DOI 10.1152/ajpregu.1992.262.1.R126; Linnet K, 1998, CLIN CHEM, V44, P1024; Maribo-Mogensen B, 2012, IND ENG CHEM RES, V51, P5353, DOI 10.1021/ie2029943; Oh MS, 2011, HENRYS CLIN DIAGNOSI, V2011, P169; PITTS RF, 1945, AM J PHYSIOL, V144, P239, DOI 10.1152/ajplegacy.1945.144.2.239; Rees SE, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.011; RING T, 1995, CLIN NEPHROL, V43, P332; Ring T, 2010, AM J PHYSIOL-RENAL, V298, pF472, DOI 10.1152/ajprenal.00219.2009; Ring T, 2009, INTENS CARE MED, V35, P2183, DOI 10.1007/s00134-009-1668-0; ROOS A, 1980, RESP PHYSIOL, V40, P1, DOI 10.1016/0034-5687(80)90002-X; SCHMITZ G, 1994, J CHEM EDUC, V71, P117, DOI 10.1021/ed071p117; SCHWARTZ WB, 1978, AM J MED, V64, P417, DOI 10.1016/0002-9343(78)90227-9; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P123, DOI 10.1111/j.1399-6576.1995.tb04346.x; Spitzer P, 2011, J SOLID STATE ELECTR, V15, P69, DOI 10.1007/s10008-010-1106-9; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; STONE DK, 1983, J CLIN INVEST, V71, P1505, DOI 10.1172/JCI110905; Vaughan-Jones RD, 2015, NEW ENGL J MED, V372, P389, DOI 10.1056/NEJMc1414731; Watson PD, 1999, J APPL PHYSIOL, V61, P1444; Zuur Alain F., 2009, P1	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162872	10.1371/journal.pone.0162872	http://dx.doi.org/10.1371/journal.pone.0162872			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631369	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900090
J	Botticelli, A; Borro, M; Onesti, CE; Strigari, L; Gentile, G; Cerbelli, B; Romiti, A; Occhipinti, M; Sebastiani, C; Lionetto, L; Marchetti, L; Simmaco, M; Marchetti, P; Mazzuca, F				Botticelli, Andrea; Borro, Marina; Onesti, Concetta Elisa; Strigari, Lidia; Gentile, Giovanna; Cerbelli, Bruna; Romiti, Adriana; Occhipinti, Mario; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Luca; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica			Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?	PLOS ONE			English	Article							REDUCTASE GENE POLYMORPHISMS; FLUOROURACIL-BASED TREATMENT; THYMIDYLATE SYNTHASE; FOLFOX CHEMOTHERAPY; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; TOXICITY; CAPECITABINE; DPYD; VARIANTS	Background 5-FU based chemotherapy is the most common first line regimen used for metastatic colorectal cancer (mCRC). Identification of predictive markers of response to chemotherapy is a challenging approach for drug selection. The present study analyzes the predictive role of 5-FU degradation rate (5-FUDR) and genetic polymorphisms (MTHFR, TSER, DPYD) on survival. Materials and Methods Genetic polymorphisms of MTHFR, TSER and DPYD, and the 5-FUDR of homogenous patients with mCRC were retrospectively studied. Genetic markers and the 5-FUDR were correlated with clinical outcome. Results 133 patients affected by mCRC, treated with fluoropyrimidine-based chemotherapy from 2009 to 2014, were evaluated. Patients were classified into three metabolic classes, according to normal distribution of 5-FUDR in more than 1000 patients, as previously published: poor-metabolizer (PM) with 5-FU-DR <= 0,85 ng/ml/10(6) cells/min (8 pts); normal metabolizer with 0,85 < 5-FU-DR < 2,2 ng/ml/10(6) cells/min (119 pts); ultra-rapid metabolizer (UM) with 5-FU-DR >= 2,2 ng/ml/10(6) cells/min (6 pts). PM and UM groups showed a longer PFS respect to normal metabolizer group (14.5 and 11 months respectively vs 8 months; p = 0.029). A higher G3-4 toxicity rate was observed in PM and UM, respect to normal metabolizer (50% in both PM and UM vs 18%; p = 0.019). No significant associations between genes polymorphisms and outcomes or toxicities were observed. Conclusion 5-FUDR seems to be significantly involved in predicting survival of patients who underwent 5-FU based CHT for mCRC. Although our findings require confirmation in large prospective studies, they reinforce the concept that individual genetic variation may allow personalized selection of chemotherapy to optimize clinical outcomes.	[Botticelli, Andrea; Romiti, Adriana; Marchetti, Paolo; Mazzuca, Federica] Sapienza Univ Rome, Dept Clin & Mol Med, Rome, Italy; [Borro, Marina; Simmaco, Maurizio] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Rome, Italy; [Onesti, Concetta Elisa; Occhipinti, Mario; Marchetti, Paolo; Mazzuca, Federica] St Andrea Hosp, Med Oncol Unit, Rome, Italy; [Strigari, Lidia] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Rome, Italy; [Gentile, Giovanna; Sebastiani, Claudia; Lionetto, Luana; Marchetti, Paolo] Ist Dermopat Immacolata IRCCS, Rome, Italy; [Cerbelli, Bruna] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Marchetti, Luca] Policlin Umberto 1, Dept Med Oncol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome	Onesti, CE (corresponding author), St Andrea Hosp, Med Oncol Unit, Rome, Italy.	elisaonesti@gmail.com	Simmaco, Maurizio/AAC-2870-2019; gentile, giovanna/M-3565-2016; Marchetti, Paolo/J-9890-2018; Borro, Marina/Q-1190-2016; Strigari, Lidia/B-9352-2017; Botticelli, Andrea/J-9926-2018; BORRO, Marina/AAF-3773-2020; Onesti, Concetta Elisa/N-1027-2019	Simmaco, Maurizio/0000-0003-4164-1472; gentile, giovanna/0000-0001-8667-3094; Marchetti, Paolo/0000-0002-9064-8761; Borro, Marina/0000-0002-7839-9125; Strigari, Lidia/0000-0003-4293-2298; Botticelli, Andrea/0000-0002-6425-9893; BORRO, Marina/0000-0002-7839-9125; Onesti, Concetta Elisa/0000-0002-8360-5026; Occhipinti, Mario/0000-0002-7169-5343; Onesti, Emanuela/0000-0003-4041-2248				Afzal S, 2011, CLIN CANCER RES, V17, P3822, DOI 10.1158/1078-0432.CCR-11-0304; Capitain O, 2008, PHARMACOGENOMICS J, V8, P256, DOI 10.1038/sj.tpj.6500476; Cassidy J, 2004, J CLIN ONCOL, V22, P2084, DOI 10.1200/JCO.2004.11.069; Chua W, 2009, BRIT J CANCER, V101, P998, DOI 10.1038/sj.bjc.6605239; Ciccolini J, 2004, J CLIN PHARM THER, V29, P307, DOI 10.1111/j.1365-2710.2004.00569.x; Colucci G, 2005, J CLIN ONCOL, V23, P4866, DOI 10.1200/JCO.2005.07.113; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Deenen MJ, 2016, J CLIN ONCOL, V34, P227, DOI 10.1200/JCO.2015.63.1325; Deenen MJ, 2013, J CHROMATOGR B, V913, P30, DOI 10.1016/j.jchromb.2012.11.033; Deenen MJ, 2011, CLIN CANCER RES, V17, P3455, DOI 10.1158/1078-0432.CCR-10-2209; Etienne MC, 2004, PHARMACOGENETICS, V14, P785, DOI 10.1097/00008571-200412000-00001; Etienne-Grimaldi MC, 2007, PHARMACOGENOMICS, V8, P1561, DOI 10.2217/14622416.8.11.1561; Etienne-Grimaldi MC, 2012, BRIT J CLIN PHARMACO, V73, P776, DOI 10.1111/j.1365-2125.2011.04141.x; Fernandez-Peralta AM, 2010, INT J COLORECTAL DIS, V25, P141, DOI 10.1007/s00384-009-0779-y; Furuse H, 2009, ANTICANCER RES, V29, P1001; Gentile G, 2016, PHARMACOGENOMICS J, V16, P320, DOI 10.1038/tpj.2015.56; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; HEGGIE GD, 1987, CANCER RES, V47, P2203; Huang KD, 2016, ONCOL LETT, V11, P3477, DOI 10.3892/ol.2016.4423; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; Jang MJ, 2014, GENE, V533, P558, DOI 10.1016/j.gene.2013.09.056; Joerger M, 2015, CANCER CHEMOTH PHARM, V75, P763, DOI 10.1007/s00280-015-2698-7; Kumamoto K, 2013, ONCOL LETT, V6, P648, DOI 10.3892/ol.2013.1467; Lee AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju298; Leung HWC, 2015, BIOMED REP, V3, P879, DOI 10.3892/br.2015.513; Loganayagam A, 2013, BRIT J CANCER, V108, P2505, DOI 10.1038/bjc.2013.262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lostia AM, 2009, THER DRUG MONIT, V31, P482, DOI 10.1097/FTD.0b013e3181ae4516; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; Mazzuca F, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7991; Meulendijks D, 2015, LANCET ONCOL, V16, P1639, DOI 10.1016/S1470-2045(15)00286-7; Negandhi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061469; Ochiai T, 2014, ONCOL REP, V32, P887, DOI 10.3892/or.2014.3299; Rosmarin D, 2015, GUT, V64, P111, DOI 10.1136/gutjnl-2013-306571; Rosmarin D, 2014, J CLIN ONCOL, V32, P1031, DOI 10.1200/JCO.2013.51.1857; Ruzzo A, 2008, PHARMACOGENOMICS J, V8, P278, DOI 10.1038/sj.tpj.6500463; Ruzzo A, 2007, J CLIN ONCOL, V25, P1247, DOI 10.1200/JCO.2006.08.1844; Sakamoto E, 2007, BIOCHEM BIOPH RES CO, V363, P216, DOI 10.1016/j.bbrc.2007.08.164; Seck K, 2005, CLIN CANCER RES, V11, P5886, DOI 10.1158/1078-0432.CCR-04-1784; Sharma R, 2008, CLIN CANCER RES, V14, P817, DOI 10.1158/1078-0432.CCR-07-0425; Suh KW, 2006, ANN SURG ONCOL, V13, P1379, DOI 10.1245/s10434-006-9112-y; Sulzyc-Bielicka V, 2013, GENET TEST MOL BIOMA, V17, P799, DOI 10.1089/gtmb.2013.0171; Sun WH, 2014, INT J CLIN EXP MED, V7, P5857; Teh LK, 2013, THER DRUG MONIT, V35, P624, DOI 10.1097/FTD.0b013e318290acd2; Thomas F, 2011, BRIT J CANCER, V105, P1654, DOI 10.1038/bjc.2011.442; Toffoli G, 2015, INT J CANCER, V137, P2971, DOI 10.1002/ijc.29654; Tsunoda A, 2011, ANN ONCOL, V22, P355, DOI 10.1093/annonc/mdq358; Wang YC, 2013, MOL BIOL REP, V40, P4637, DOI 10.1007/s11033-013-2557-8; Wu NC, 2015, ANTI-CANCER DRUG, V26, P888, DOI 10.1097/CAD.0000000000000261; Yhim HY, 2015, ONCOL REP, V34, P155, DOI 10.3892/or.2015.3954; Zhang W, 2007, J CLIN ONCOL, V25, P3726, DOI 10.1200/JCO.2007.11.4710; Zhao J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0802-6; Zhu L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0467-1	53	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163105	10.1371/journal.pone.0163105	http://dx.doi.org/10.1371/journal.pone.0163105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656891	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200067
J	Delva, W; Helleringer, S				Delva, Wim; Helleringer, Stephane			Beyond Risk Compensation: Clusters of Antiretroviral Treatment (ART) Users in Sexual Networks Can Modify the Impact of ART on HIV Incidence	PLOS ONE			English	Article							IMPLEMENTATION SCIENCE; TRANSMISSION RISK; PREVENTION; MEN; THERAPY; PREVALENCE; BEHAVIOR; INFECTION; PARTNERS; COUNTRIES	Introduction Concerns about risk compensation-increased risk behaviours in response to a perception of reduced HIV transmission risk-after the initiation of ART have largely been dispelled in empirical studies, but other changes in sexual networking patterns may still modify the effects of ART on HIV incidence. Methods We developed an exploratory mathematical model of HIV transmission that incorporates the possibility of ART clusters, i.e. subsets of the sexual network in which the density of ART patients is much higher than in the rest of the network. Such clusters may emerge as a result of ART homophily-a tendency for ART patients to preferentially form and maintain relationships with other ART patients. We assessed whether ART clusters may affect the impact of ART on HIV incidence, and how the influence of this effect-modifying variable depends on contextual variables such as HIV prevalence, HIV serosorting, coverage of HIV testing and ART, and adherence to ART. Results ART homophily can modify the impact of ART on HIV incidence in both directions. In concentrated epidemics and generalized epidemics with moderate HIV prevalence (approximate to 10%), ART clusters can enhance the impact of ART on HIV incidence, especially when adherence to ART is poor. In hyperendemic settings (approximate to 35% HIV prevalence), ART clusters can reduce the impact of ART on HIV incidence when adherence to ART is high but few people living with HIV (PLWH) have been diagnosed. In all contexts, the effects of ART clusters on HIV epidemic dynamics are distinct from those of HIV serosorting. Conclusions Depending on the programmatic and epidemiological context, ART clusters may enhance or reduce the impact of ART on HIV incidence, in contrast to serosorting, which always leads to a lower impact of ART on HIV incidence. ART homophily and the emergence of ART clusters should be measured empirically and incorporated into more refined models used to plan and evaluate ART programmes.	[Delva, Wim] Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn DST NRF, South African Dept Sci & Technol, Stellenbosch, South Africa; [Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Delva, Wim] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium; [Delva, Wim] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Delva, Wim] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Helleringer, Stephane] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Stellenbosch University; Ghent University; Hasselt University; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Delva, W (corresponding author), Univ Stellenbosch, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn DST NRF, South African Dept Sci & Technol, Stellenbosch, South Africa.; Delva, W (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium.; Delva, W (corresponding author), Hasselt Univ, Ctr Stat, Diepenbeek, Belgium.; Delva, W (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium.; Delva, W (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	DelvaW@sun.ac.za		Delva, Wim/0000-0001-8054-1904	Canadian International Development Agency (CIDA); Dutch Postcode Lottery through the MaxART programme (Maximizing ART for Better Health and Zero New HIV Infections); Research Foundation - Flanders (FWO); National Institutes of Health [R03HD0177722]; National Institutes of Health through the Johns Hopkins University Center for AIDS Research [P30AI094189]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Canadian International Development Agency (CIDA); Dutch Postcode Lottery through the MaxART programme (Maximizing ART for Better Health and Zero New HIV Infections); Research Foundation - Flanders (FWO)(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the Johns Hopkins University Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WD received funding from the Canadian International Development Agency (CIDA), the Dutch Postcode Lottery through the MaxART programme (Maximizing ART for Better Health and Zero New HIV Infections), and the Research Foundation - Flanders (FWO). SH received funding from the National Institutes of Health through grant R03HD0177722 (RI: Helleringer) and through the Johns Hopkins University Center for AIDS Research P30AI094189 (PI: Chaisson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; WD received funding from the Canadian International Development Agency (CIDA), the Dutch Postcode Lottery through the MaxART programme (Maximizing ART for Better Health and Zero New HIV Infections), and the Research Foundation - Flanders (FWO). SH received funding from the National Institutes of Health through grant R03HD0177722 (PI: Helleringer) and through the Johns Hopkins University Center for AIDS Research P30AI094189 (PI: Chaisson).	[Anonymous], 2004, AIDS Alert, V19, P55; Apondi R, 2011, AIDS, V25, P1317, DOI 10.1097/QAD.0b013e328347f775; Aral SO, 2012, SEX TRANSM INFECT, V88, P157, DOI 10.1136/sextrans-2011-050389; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Beyrer C, 2015, LANCET, V386, P505, DOI 10.1016/S0140-6736(15)61458-1; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Blanchard JF, 2011, SEX TRANSM INFECT, V87, P2, DOI 10.1136/sti.2010.047555; Bohl DD, 2011, SEX TRANSM INFECT, V87, P616, DOI 10.1136/sextrans-2011-050103; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cassels S, 2009, AIDS, V23, P2497, DOI 10.1097/QAD.0b013e328330ed8a; Coburn BJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-224; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton L, 2008, ANN BEHAV MED, V35, pS207; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Eaton LA, 2007, AM J PREV MED, V33, P479, DOI 10.1016/j.amepre.2007.08.004; Eaton LA, 2009, AIDS CARE, V21, P1279, DOI 10.1080/09540120902803208; Frost DM, 2008, CULT HEALTH SEX, V10, P513, DOI 10.1080/13691050801905631; Fujimoto K, 2015, AIDS BEHAV, V19, P996, DOI 10.1007/s10461-014-0842-8; Glasgow RE, 2013, JAIDS-J ACQ IMM DEF, V63, pS26, DOI 10.1097/QAI.0b013e3182920286; Golden MR, 2012, SEX TRANSM DIS, V39, P659, DOI 10.1097/OLQ.0b013e31825727cb; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Goosby E, 2012, HEALTH AFFAIR, V31, P1593, DOI 10.1377/hlthaff.2012.0241; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hamilton DT, 2015, EPIDEMICS-NETH, V11, P56, DOI 10.1016/j.epidem.2015.02.003; Hayes R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-57; Hill A, 2015, AIDS, V29, P2523, DOI 10.1097/QAD.0000000000000864; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jean K, 2014, J INFECT DIS, V209, P431, DOI 10.1093/infdis/jit470; Kandala NB, 2012, HIV AIDS-RES PALLIAT, V4, P95, DOI 10.2147/HIV.S30537; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; King R, 2009, SOC SCI MED, V68, P749, DOI 10.1016/j.socscimed.2008.11.008; Knapp H, 2013, INT J STD AIDS, V24, P5, DOI 10.1258/ijsa.2012.012140; Lambdin BH, 2015, CURR HIV RES, V13, P244, DOI 10.2174/1570162X1303150506185423; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Liu CL, 2011, AIDS BEHAV, V15, P9, DOI 10.1007/s10461-010-9710-3; MacPhail CL, 2012, QUAL HEALTH RES, V22, P668, DOI 10.1177/1049732311431944; Marcus U, 2011, SEX HEALTH, V8, P184, DOI 10.1071/SH10053; McGrath N, 2013, AIDS, V27, P2461, DOI 10.1097/01.aids.0000432473.69250.19; McMahon JH, 2014, LANCET HIV, V1, pE10, DOI 10.1016/S2352-3018(14)70017-7; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Miller AN, 2007, AIDS BEHAV, V11, P687, DOI 10.1007/s10461-006-9198-z; Norton WE, 2009, AIDS BEHAV, V13, P424, DOI 10.1007/s10461-009-9556-8; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Pinkerton SD, 2001, RISK ANAL, V21, P727, DOI 10.1111/0272-4332.214146; Poon CM, 2013, SEX TRANSM DIS, V40, P933, DOI 10.1097/OLQ.0000000000000052; Ramjee G, 2015, FUTURE VIROL, V10, P271, DOI 10.2217/FVL.14.116; Reniers G, 2011, AIDS BEHAV, V15, P1, DOI 10.1007/s10461-010-9774-0; Schackman BR, 2010, JAIDS-J ACQ IMM DEF, V55, pS27, DOI 10.1097/QAI.0b013e3181f9c1da; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Sharma M, 2012, THEORETICAL FOUNDATI; Shisana O., 6TH SOUTH AFRICAN AI; Sibbald B, 2013, LANCET, V381, P103, DOI 10.1016/S0140-6736(13)60033-1; Stanley AHV, 2009, AIDS IMPACT CONFEREN; van den Boom W, 2014, JAIDS-J ACQ IMM DEF, V65, P375, DOI 10.1097/QAI.0000000000000051; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4	69	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163159	10.1371/journal.pone.0163159	http://dx.doi.org/10.1371/journal.pone.0163159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657492	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200076
J	Hrdinka, M; Sudan, K; Just, S; Drobek, A; Stepanek, O; Schluter, D; Reinhold, D; Jordan, BA; Gintschel, P; Schraven, B; Kreutz, MR				Hrdinka, Matous; Sudan, Kritika; Just, Sissy; Drobek, Ales; Stepanek, Ondrej; Schlueter, Dirk; Reinhold, Dirk; Jordan, Bryen A.; Gintschel, Patricia; Schraven, Burkhart; Kreutz, Michael R.			Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice	PLOS ONE			English	Article							TRANSMEMBRANE ADAPTER PROTEINS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; LISTERIA-MONOCYTOGENES; LYMPHOCYTE DEVELOPMENT; NEGATIVE REGULATION; ACTIVATION; RECEPTOR; NEURODEGENERATION; APOPTOSIS	Transmembrane adaptor proteins (TRAPs) are important organisers for the transduction of immunoreceptor-mediated signals. Prr7 is a TRAP that regulates T cell receptor (TCR) signalling and potently induces cell death when overexpressed in human Jurkat T cells. Whether endogenous Prr7 has a similar functional role is currently unknown. To address this issue, we analysed the development and function of the immune system in Prr7 knockout mice. We found that loss of Prr7 partially impairs development of single positive CD4(+) T cells in the thymus but has no effect on the development of other T cell subpopulations, B cells, NK cells, or NKT cells. Moreover, Prr7 does not affect the TCR signalling pathway as T cells derived from Prr7 knockout and wild-type animals and stimulated in vitro express the same levels of the activation marker CD69, and retain their ability to proliferate and activate induced cell death programs. Importantly, Prr7 knockout mice retained the capacity to mount a protective immune response when challenged with Listeria monocytogenes infection in vivo. In addition, T cell effector functions (activation, migration, and reactivation) were normal following induction of experimental autoimmune encephalomyelitis (EAE) in Prr7 knockout mice. Collectively, our work shows that loss of Prr7 does not result in a major immune system phenotype and suggests that Prr7 has a dispensable function for TCR signalling.	[Hrdinka, Matous; Sudan, Kritika; Kreutz, Michael R.] Leibniz Inst Neurobiol, RG Neuroplast, Magdeburg, Germany; [Hrdinka, Matous; Reinhold, Dirk; Gintschel, Patricia; Schraven, Burkhart] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Just, Sissy; Schlueter, Dirk] Otto Von Guericke Univ, Inst Med Microbiol, Magdeburg, Germany; [Drobek, Ales; Stepanek, Ondrej] CAS, Inst Mol Genet, Grp Adapt Immun, Prague, Czech Republic; [Schlueter, Dirk] Helmholtz Ctr Infect Res HZI, Organ Specif Immune Regulat, Braunschweig, Germany; [Jordan, Bryen A.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Schraven, Burkhart] Helmholtz Ctr Infect Res HZI, Dept Immune Control, Braunschweig, Germany; [Kreutz, Michael R.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Leibniz Grp Dendrit Organelles & Synapt Funct, Hamburg, Germany; [Hrdinka, Matous] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England; [Sudan, Kritika] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Helmholtz Association; Helmholtz-Center for Infection Research; Yeshiva University; Albert Einstein College of Medicine; Helmholtz Association; Helmholtz-Center for Infection Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwig Institute for Cancer Research; University of Oxford; Hannover Medical School	Hrdinka, M; Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, RG Neuroplast, Magdeburg, Germany.; Hrdinka, M; Schraven, B (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany.; Schraven, B (corresponding author), Helmholtz Ctr Infect Res HZI, Dept Immune Control, Braunschweig, Germany.; Kreutz, MR (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Leibniz Grp Dendrit Organelles & Synapt Funct, Hamburg, Germany.; Hrdinka, M (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England.	matous.hrdinka@ludwig.ox.ac.uk; schraven@med.ovgu.de; Kreutz@lin-magdeburg.de	Hrdinka, Matous/B-9187-2011; Stepanek, Ondrej/AAG-3180-2020; Stepanek, Ondrej/F-8882-2013; Sudan, Kritika/AAW-9282-2021; Drobek, Aleš/T-3994-2017	Hrdinka, Matous/0000-0002-2981-2825; Stepanek, Ondrej/0000-0002-2735-3311; Stepanek, Ondrej/0000-0002-2735-3311; Jordan, Bryen/0000-0002-4967-444X	Deutsche Forschungsgemeinschaft [DFG Kr1879 / 5-1, DFG Kr1879 / 6-1, CRC854 TP7]; WGL Pakt f. Forschung; JPND (STAD); BMBF Energl; State of Saxony-Anhalt [XN005KL/026]; Czech Science Foundation [16-09208Y];  [CRC854 TP5];  [CRC854 TP12]; NATIONAL INSTITUTE ON AGING [R01AG039521] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); WGL Pakt f. Forschung; JPND (STAD); BMBF Energl; State of Saxony-Anhalt; Czech Science Foundation(Grant Agency of the Czech Republic); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG Kr1879 / 5-1, 6-1; CRC854 TP7), WGL Pakt f. Forschung, JPND (STAD) and BMBF Energl to M.R.K.; CRC854 TP5 to D.S.; CRC854 TP12 and funds of the State of Saxony-Anhalt (XN005KL/026) to B.S. and the Czech Science Foundation, grant number 16-09208Y to O.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Fuller DM, 2009, IMMUNOL REV, V232, P72, DOI 10.1111/j.1600-065X.2009.00828.x; Gregoire C, 2007, EUR J IMMUNOL, V37, P3259, DOI 10.1002/eji.200737563; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hrdinka M, 2014, ONCOGENE, V33, P4881, DOI 10.1038/onc.2013.485; Hrdinka M, 2011, J BIOL CHEM, V286, P19617, DOI 10.1074/jbc.M110.175117; Kamm C, 2003, FEMS IMMUNOL MED MIC, V35, P235, DOI 10.1016/S0928-8244(02)00450-9; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Koelsch U, 2008, J IMMUNOL, V181, P5930, DOI 10.4049/jimmunol.181.9.5930; Kolsch U, 2006, MOL CELL BIOL, V26, P3639, DOI 10.1128/MCB.26.9.3639-3648.2006; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kravchick DO, 2016, EMBO J; Lara-Tejero M, 2004, CURR OPIN MICROBIOL, V7, P45, DOI 10.1016/j.mib.2003.12.002; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Murata Y, 2005, BIOCHEM BIOPH RES CO, V327, P183, DOI 10.1016/j.bbrc.2004.11.154; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Peterson LK, 2007, J NEUROIMMUNOL, V184, P37, DOI 10.1016/j.jneuroim.2006.11.015; Procaccini C, 2015, EUR J PHARMACOL, V759, P182, DOI 10.1016/j.ejphar.2015.03.042; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Riera-Sans L, 2007, J IMMUNOL, V178, P5690, DOI 10.4049/jimmunol.178.9.5690; Simeoni L, 2005, MOL CELL BIOL, V25, P7557, DOI 10.1128/MCB.25.17.7557-7568.2005; Simeoni L, 2008, IMMUNOL REV, V224, P215, DOI 10.1111/j.1600-065X.2008.00656.x; Stepanek O, 2014, CELL SIGNAL, V26, P895, DOI 10.1016/j.cellsig.2014.01.007; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang N, 2005, CELL RES, V15, P749, DOI 10.1038/sj.cr.7290345; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223; Zhu MH, 2005, J IMMUNOL, V174, P5612, DOI 10.4049/jimmunol.174.9.5612	36	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162863	10.1371/journal.pone.0162863	http://dx.doi.org/10.1371/journal.pone.0162863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657535	gold, Green Published, Green Submitted			2022-12-27	WOS:000383893200036
J	Pallin, DJ; Bry, L; Dwyer, RC; Lipworth, AD; Leung, DY; Camargo, CA; Kupper, TS; Filbin, MR; Murphy, GF				Pallin, Daniel J.; Bry, Lynn; Dwyer, Richard C.; Lipworth, Adam D.; Leung, Donald Y.; Camargo, Carlos A., Jr.; Kupper, Thomas S.; Filbin, Michael R.; Murphy, George F.			Toward an Objective Diagnostic Test for Bacterial Cellulitis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; DERMATOLOGY CONSULTATION; SKIN INFECTIONS; PROCALCITONIN; EMERGENCE; OFFICES	Background Prior studies repeatedly showed that cultures of skin lesions diagnosed as "cellulitis" are usually negative. However, lack of a gold standard for diagnosis (against which culture might be judged) and failure to assess the human immune response are important limitations of prior work. In this pilot study, we aimed to develop a criterion standard for research on bacterial cellulitis, to evaluate the sensitivity of procalcitonin for bacterial cellulitis, and to use gene expression analysis to find other candidate diagnostic markers. Methods We classified lesions via biopsies, 16s rRNA gene detection, culture, and histopathology. We quantified procalcitonin expression in blood. We also used Nanostring technology to quantify transcription of immunomodulators that may distinguish cases from inflamed controls. Results Of 28 participants, 15 had a clinical diagnosis of cellulitis, six had a diagnosis of non-infectious dermatitis, and seven were normal volunteers. Of the "cellulitis'' patients, three (20%) had pathogens isolated, and were designated confirmed cases. Procalcitonin was undetectable in all three. HLA-DQA1 was expressed 34-fold more in confirmed cases vs. controls (fold change of geometric mean). Heat maps depicting multiplex gene expression analysis revealed a distinct profile of gene expression in confirmed cases relative to comparators. Conclusions Most ''cellulitis'' patients had microbiologically-negative biopsies. Procalcitonin was undetectable, and HLA-DQA1 elevated, in confirmed bacterial cases. Multivariable transcriptomic profiling results supported our algorithm's ability to identify patients with true bacterial cellulitis. A larger sample may allow discovery of an immunological signature capable of distinguishing bacterial cellulitis from its mimics in clinical practice.	[Pallin, Daniel J.; Dwyer, Richard C.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Bry, Lynn; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Lipworth, Adam D.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Leung, Donald Y.] Natl Jewish Med Hlth, Dept Pediat, Denver, CO USA; [Camargo, Carlos A., Jr.; Filbin, Michael R.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Pallin, DJ (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	dpallin@partners.org	Pallin, Daniel J/H-6382-2013; Kupper, Thomas/O-4962-2019; Camargo, Carlos A./C-2145-2008	Pallin, Daniel J/0000-0002-8517-9702; Camargo, Carlos A./0000-0002-5071-7654; Bry, Lynn/0000-0002-8792-8527	BioMerieux Inc.;  [P30-DK034854]	BioMerieux Inc.; 	This work was funded by BioMerieux Inc. and P30-DK034854 (Bry). P30-DK034854 (Bry) provided support to the BWH Center for Clinical and Translational Metagenomics for microbiologic studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DRG HDB COMP CLIN FI; Arakaki RY, 2014, JAMA DERMATOL, V150, P1056, DOI 10.1001/jamadermatol.2014.1085; BERNARD P, 1989, ARCH DERMATOL, V125, P779, DOI 10.1001/archderm.125.6.779; BERNARD P, 1987, ARCH DERMATOL, V123, P468, DOI 10.1001/archderm.123.4.468; Chambers HF, 2013, CLIN INFECT DIS, V56, P1763, DOI 10.1093/cid/cit126; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Crisp JG, 2015, POLYMERASE CHAIN REA; David Consuelo V, 2011, Dermatol Online J, V17, P1; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Karppelin M, 2015, EUR J CLIN MICROBIOL, V34, P669, DOI 10.1007/s10096-014-2274-9; Laborde RR, 2012, MAYO CLIN PROC, V87, P226, DOI 10.1016/j.mayocp.2011.10.008; Matwiyoff GN, 2012, INFLAMM RES, V61, P401, DOI 10.1007/s00011-012-0439-5; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Pallin DJ, 2014, WEST J EMERG MED, V15, P282, DOI 10.5811/westjem.2013.8.18040; Pallin DJ, 2009, CLIN INFECT DIS, V49, P901, DOI 10.1086/605434; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Soni NJ, 2012, AHRQ COMP EFFECTIVEN; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Strazzula L, 2015, J AM ACAD DERMATOL, V73, P70, DOI 10.1016/j.jaad.2014.11.012; Swartz MN, 2004, NEW ENGL J MED, V350, P904, DOI 10.1056/NEJMcp031807; Toleman MS, 2015, J MED MICROBIOLOGY; Witten DM, 2009, J R STAT SOC B, V71, P615, DOI 10.1111/j.1467-9868.2009.00699.x	26	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162947	10.1371/journal.pone.0162947	http://dx.doi.org/10.1371/journal.pone.0162947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656884	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200043
J	McKinstry, JL; Fleischer, JG; Chen, YQ; Gall, WE; Edelman, GM				McKinstry, Jeffrey L.; Fleischer, Jason G.; Chen, Yanqing; Gall, W. Einar; Edelman, Gerald M.			Imagery May Arise from Associations Formed through Sensory Experience: A Network of Spiking Neurons Controlling a Robot Learns Visual Sequences in Order to Perform a Mental Rotation Task	PLOS ONE			English	Article							REPRESENTATION; ARCHITECTURE; SYSTEMS; MODEL	Mental imagery occurs "when a representation of the type created during the initial phases of perception is present but the stimulus is not actually being perceived." How does the capability to perform mental imagery arise? Extending the idea that imagery arises from learned associations, we propose that mental rotation, a specific form of imagery, could arise through the mechanism of sequence learning-that is, by learning to regenerate the sequence of mental images perceived while passively observing a rotating object. To demonstrate the feasibility of this proposal, we constructed a simulated nervous system and embedded it within a behaving humanoid robot. By observing a rotating object, the system learns the sequence of neural activity patterns generated by the visual system in response to the object. After learning, it can internally regenerate a similar sequence of neural activations upon briefly viewing the static object. This system learns to perform a mental rotation task in which the subject must determine whether two objects are identical despite differences in orientation. As with human subjects, the time taken to respond is proportional to the angular difference between the two stimuli. Moreover, as reported in humans, the system fills in intermediate angles during the task, and this putative mental rotation activates the same pathways that are activated when the system views physical rotation. This work supports the proposal that mental rotation arises through sequence learning and the idea that mental imagery aids perception through learned associations, and suggests testable predictions for biological experiments.	[McKinstry, Jeffrey L.; Fleischer, Jason G.; Chen, Yanqing; Gall, W. Einar; Edelman, Gerald M.] Inst Neurosci, La Jolla, CA 92037 USA; [McKinstry, Jeffrey L.] IBM Res Almaden, San Jose, CA 95120 USA	International Business Machines (IBM)	McKinstry, JL (corresponding author), Inst Neurosci, La Jolla, CA 92037 USA.; McKinstry, JL (corresponding author), IBM Res Almaden, San Jose, CA 95120 USA.	jlmckins@us.ibm.com		Chen, Yanqing/0000-0002-9534-6199; Fleischer, Jason/0000-0001-9462-9333	DARPA through ONR Grant [N00014-08-1-0728]; AFRL Cooperative Agreement [FA8750-11-2-0255]	DARPA through ONR Grant; AFRL Cooperative Agreement	This work was supported in part by DARPA through ONR Grant N00014-08-1-0728 and by AFRL Cooperative Agreement FA8750-11-2-0255 to Neurosciences Research Foundation. For support of later developments we are grateful to The G. Harold and Leila Y. Mathers Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bor D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07089; Bruner J.S., 1957, CONT APPROACHES COGN, P41; Burmann B, 2005, BRAIN BEHAV EVOLUT, V65, P168, DOI 10.1159/000083626; Chen YQ, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00016; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COOPER LA, 1976, PERCEPT PSYCHOPHYS, V19, P296, DOI 10.3758/BF03204234; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Di Nuovo A, 2013, ADAPT BEHAV, V21, P217, DOI 10.1177/1059712313488964; Di Nuovo AG, 2013, NEURAL NETWORKS, V41, P147, DOI 10.1016/j.neunet.2012.09.019; Edelman G.M., 1989, REMEMBERED PRESENT B; Edelman GM, 2007, SCIENCE, V318, P1103, DOI 10.1126/science.1148677; Fleischer JG, 2011, NEUROMORPHIC BRAIN B, P303; Ganis G., 2006, CASE MENTAL IMAGERY; Gaona W, 2014, CONN SCI, V27, P1; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Held R, 2011, NAT NEUROSCI, V14, P551, DOI 10.1038/nn.2795; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Keele SW, 2003, PSYCHOL REV, V110, P316, DOI 10.1037/0033-295X.110.2.316; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kourtzi Z, 1999, ACTA PSYCHOL, V102, P265, DOI 10.1016/S0001-6918(98)00056-0; McKinstry JL, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00010; Mohring W, 2013, CHILD DEV, V84, P1554, DOI 10.1111/cdev.12065; Sakai K, 1998, J NEUROSCI, V18, P1827; Seepanomwan K, 2015, NEURAL NETWORKS, V72, P31, DOI 10.1016/j.neunet.2015.09.010; Seepanomwan K, 2013, ADAPT BEHAV, V21, P299, DOI 10.1177/1059712313488782; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SHEPARD RN, 1976, SCIENCE, V191, P952, DOI 10.1126/science.1251207; Skosnik PD, 2002, NEUROIMAGE, V17, P1306, DOI 10.1006/nimg.2002.1291; Vernon D, 2015, FRONT ROBOT AI, DOI 10.3389/frobt.2.015.00019; Weigelt S, 2007, J NEUROSCI, V27, P3864, DOI 10.1523/JNEUROSCI.0340-07.2007; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	36	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162155	10.1371/journal.pone.0162155	http://dx.doi.org/10.1371/journal.pone.0162155			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27653977	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700016
J	Moreau, C; Devos, D; Baille, G; Delval, A; Tard, C; Perez, T; Danel-Buhl, N; Seguy, D; Labreuche, J; Duhamel, A; Delliaux, M; Dujardin, K; Defebvre, L				Moreau, Caroline; Devos, David; Baille, Guillaume; Delval, Arnaud; Tard, Celine; Perez, Thierry; Danel-Buhl, Nicolas; Seguy, David; Labreuche, Julien; Duhamel, Alain; Delliaux, Marie; Dujardin, Kathy; Defebvre, Luc			Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?	PLOS ONE			English	Article							CLINICAL-ASSESSMENT; DYSARTHRIA; PERFORMANCE; PROGRESSION; FREQUENCY; DYSPHAGIA; DYSPNEA; SCALE; VOICE	Background Axial disorders are considered to appear late in the course of Parkinson's disease (PD). The associated impact on quality of life (QoL) and survival and the lack of an effective treatment mean that understanding and treating axial disorders is a key challenge. However, upper-body axial disorders (namely dysarthria, swallowing and breathing disorders) have never been prospectively assessed in early-stagePD patients. Objectives To characterize upper-body axial symptoms and QoL in consecutive patients with early-stage PD. Methods We prospectively enrolled 66 consecutive patients with early-stagePD (less than 3 years of disease progression) and assessed dysarthria, dysphagia and respiratory function (relative to 36 controls) using both objective and patient-reported outcomes. Results The mean disease duration was 1.26 years and the mean UPDRS motor score was 19.4 out of 108. 74% of the patients presented slight dysarthria (primarily dysprosodia). Men appeared to be more severely affected (i.e. dysphonia). This dysfunction was strongly correlated with low swallowing speed (despite the absence of complaints about dysphagia), respiratory insufficiency and poor QoL. Videofluorography showed that oral-phase swallowing disorders affected 60% of the 31 tested patients and that pharyngeal-phase disorders affected 21%. 24% of the patients reported occasional dyspnea, which was correlated with anxiety in women but not in men. Marked diaphragmatic dysfunction was suspected in 42% of the patients (predominantly in men). Conclusion Upper body axial symptoms were frequent in men with early-stage PD, whereas women presented worst non-motor impairments. New assessment methods are required because currently available tools do not reliably detect these upper-body axial disorders.	[Moreau, Caroline; Devos, David; Baille, Guillaume; Delliaux, Marie; Dujardin, Kathy; Defebvre, Luc] CHU Lille, Dept Neurol & Movement Disorders, Lille, France; [Devos, David] CHU Lille, Dept Med Pharmacol Disorders, Lille, France; [Delval, Arnaud; Tard, Celine] CHU Lille, Dept Clin Neurophysiol Disorders, Lille, France; [Perez, Thierry] CHU Lille, Dept Pulmonol, Lille, France; [Danel-Buhl, Nicolas; Seguy, David] CHU Lille, Dept Nutr, Lille, France; [Labreuche, Julien; Duhamel, Alain] CHU Lille, Dept Biostat, Lille, France; [Moreau, Caroline; Devos, David; Baille, Guillaume; Delval, Arnaud; Tard, Celine; Delliaux, Marie; Dujardin, Kathy; Defebvre, Luc] INSERM, UMR S 1171, Lille, France; [Moreau, Caroline; Devos, David; Baille, Guillaume; Delval, Arnaud; Tard, Celine; Perez, Thierry; Danel-Buhl, Nicolas; Seguy, David; Labreuche, Julien; Duhamel, Alain; Delliaux, Marie; Dujardin, Kathy; Defebvre, Luc] Univ Lille, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Moreau, C (corresponding author), CHU Lille, Dept Neurol & Movement Disorders, Lille, France.; Moreau, C (corresponding author), INSERM, UMR S 1171, Lille, France.; Moreau, C (corresponding author), Univ Lille, Lille, France.	caroline.moreau@chru-lille.fr	Tard, Céline/GRR-8269-2022; Dujardin, Kathy/H-5037-2011; Thierry, PEREZ/AAB-4853-2020; Seguy, David/R-7001-2018; Devos, David/E-4059-2013	Dujardin, Kathy/0000-0002-0110-574X; Seguy, David/0000-0002-5529-8719; Delval, Arnaud/0000-0003-0642-3541; Devos, David/0000-0002-2417-799X	France Parkinson charity	France Parkinson charity	The "Prodigy park I" study was funded by the France Parkinson charity in 2011 ((sic)21,217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Francine Niset and the Federation de la Recherche Clinique du CHU de Lille for collecting the data, and Dr. David Fraser (Biotech Communication, Damery, France) for copy-editing the manuscript. The present research has received funding from the France Parkinson charity. Lastly, we thank all the patients and their physicians for participating in the study.	Auzou P, 1998, REV NEUROL-FRANCE, V154, P523; Baijens LWJ, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/380682; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Correa-Flores M, 2012, CIR CIR, V80, P30; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; DEBRUIN PFC, 1993, AM REV RESPIR DIS, V148, P1576, DOI 10.1164/ajrccm/148.6_Pt_1.1576; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Lim A, 2008, DYSPHAGIA, V23, P76, DOI 10.1007/s00455-007-9100-9; Mehanna R, 2010, PARKINSONISM RELAT D, V16, P628, DOI 10.1016/j.parkreldis.2010.07.004; Miller N, 2009, J NEUROL NEUROSUR PS, V80, P1047, DOI 10.1136/jnnp.2008.157701; Monteiro L, 2014, J NEUROL SCI, V339, P149, DOI 10.1016/j.jns.2014.02.004; Moreau C, 2007, MOVEMENT DISORD, V22, P1503, DOI 10.1002/mds.21549; Moreau C, 2011, MOVEMENT DISORD, V26, P659, DOI 10.1002/mds.23538; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; Nagaya M, 1998, DYSPHAGIA, V13, P95, DOI 10.1007/PL00009562; NATHADWARAWALA KM, 1992, J NEUROL NEUROSUR PS, V55, P822, DOI 10.1136/jnnp.55.9.822; Pal PK, 2007, MOVEMENT DISORD, V22, P420, DOI 10.1002/mds.21330; Picillo M, 2016, PARKINSONISM RELAT D; Pinto S, 2004, LANCET NEUROL, V3, P547, DOI 10.1016/S1474-4422(04)00854-3; Pinto S, 2010, REV NEUROL-FRANCE, V166, P800, DOI 10.1016/j.neurol.2010.07.005; Plowman-Prine EK, 2009, MOVEMENT DISORD, V24, P1352, DOI 10.1002/mds.22617; Seccombe LM, 2011, RESP PHYSIOL NEUROBI, V179, P300, DOI 10.1016/j.resp.2011.09.012; Silbergleit AK, 2015, J PARKINSON DIS, V5, P517, DOI 10.3233/JPD-140526; Skodda S, 2011, MOVEMENT DISORD, V26, P59, DOI 10.1002/mds.23382; Sunwoo MK, 2014, J NEUROL SCI, V346, P112, DOI 10.1016/j.jns.2014.08.003; Troche MS, 2011, DYSPHAGIA, V26, P218, DOI 10.1007/s00455-010-9289-x; Troussiere AC, 2014, J NEUROL NEUROSUR PS, V85, P1405, DOI 10.1136/jnnp-2013-307544; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Volonte MA, 2002, NEUROL SCI, V23, pS121, DOI 10.1007/s100720200099; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Weiner P, 2002, CAN J NEUROL SCI, V29, P68, DOI 10.1017/S031716710000175X; Woisard V, 2004, Rev Laryngol Otol Rhinol (Bord), V125, P307; Woisard V, 2010, Rev Laryngol Otol Rhinol (Bord), V131, P19	37	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162904	10.1371/journal.pone.0162904	http://dx.doi.org/10.1371/journal.pone.0162904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654040	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700031
J	Gomez, O; Neumann, H				Gomez, Olman; Neumann, Heiko			Biologically Inspired Model for Inference of 3D Shape from Texture	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; NEURAL MECHANISMS; 3-DIMENSIONAL SHAPE; SURFACE ORIENTATION; SPATIAL-FREQUENCY; CURVED SURFACES; HUMAN BRAIN; PERCEPTION; MACAQUE; FORM	A biologically inspired model architecture for inferring 3D shape from texture is proposed. The model is hierarchically organized into modules roughly corresponding to visual cortical areas in the ventral stream. Initial orientation selective filtering decomposes the input into low-level orientation and spatial frequency representations. Grouping of spatially anisotropic orientation responses builds sketch-like representations of surface shape. Gradients in orientation fields and subsequent integration infers local surface geometry and globally consistent 3D depth. From the distributions in orientation responses summed in frequency, an estimate of the tilt and slant of the local surface can be obtained. The model suggests how 3D shape can be inferred from texture patterns and their image appearance in a hierarchically organized processing cascade along the cortical ventral stream. The proposed model integrates oriented texture gradient information that is encoded in distributed maps of orientation-frequency representations. The texture energy gradient information is defined by changes in the grouped summed normalized orientation-frequency response activity extracted from the textured object image. This activity is integrated by directed fields to generate a 3D shape representation of a complex object with depth ordering proportional to the fields output, with higher activity denoting larger distance in relative depth away from the viewer.	[Gomez, Olman; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, Ulm, Germany; [Gomez, Olman] UNITEC, Tegucigalpa, Honduras	Ulm University	Gomez, O (corresponding author), Univ Ulm, Inst Neural Informat Proc, Ulm, Germany.; Gomez, O (corresponding author), UNITEC, Tegucigalpa, Honduras.	ogs01hn@gmail.com			German Academic Exchange Service DAAD [A/10/90029]; German DAAD [A/10/90029]	German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	For Olman Gomez, this research was supported by a scholarship of the German Academic Exchange Service DAAD, ref.no. A/10/90029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Olman Gomez was supported by a scholarship of the German DAAD, ref. no. A/10/90029.	Aloimonos J, 1985, P IJCAI 85 LOS ANGEL, P926; Arcizet F, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-140; Bajcsy R., 1976, COMPUT GRAPHICS IMAG, V5, P52, DOI DOI 10.1016/S0146-664X(76)80005-6; Brosch T, 2014, COMPUTING CANONICAL; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cavanagh P., 1985, MODELS VISUAL CORTEX, P85; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; De Valois R. L., 1988, OXFORD PSYCHOL SERIE; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Egan EJL, 2011, J VISION, V11, DOI 10.1167/11.12.15; Fleming RW, 2011, P NATL ACAD SCI USA, V108, P20438, DOI 10.1073/pnas.1114619109; Fujita I, 2002, J NEUROCYTOL, V31, P359, DOI 10.1023/A:1024138413082; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1950, PERCEPTION VISUAL WO; Goodale MA, 1995, VISUAL BRAIN ACTION, V27, P134; Gross CG, 1972, J NEUROPHYSIOLOGY; GROSSBERG S, 1987, COMPUT VISION GRAPH, V37, P116, DOI 10.1016/S0734-189X(87)80015-4; Grossberg S, 2007, VISION RES, V47, P634, DOI 10.1016/j.visres.2006.10.024; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; Hansen T, 2004, NEURAL COMPUT, V16, P1013, DOI 10.1162/089976604773135087; Kafaligonul H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00279; Knill DC, 2001, J OPT SOC AM A, V18, P12, DOI 10.1364/JOSAA.18.000012; Li A, 2004, J VISION, V4, P860, DOI 10.1167/4.10.3; Li A, 2000, VISION RES, V40, P217, DOI 10.1016/S0042-6989(99)00169-8; Liu Y, 2004, J NEUROSCI, V24, P3795, DOI 10.1523/JNEUROSCI.0150-04.2004; Malik J, 1997, INT J COMPUT VISION, V23, P149, DOI 10.1023/A:1007958829620; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Neumann H, 2001, ADV PSYCHOL, V130, P353; Neumann H, 2012, LECT NOTES COMPUT SC, V7583, P468, DOI 10.1007/978-3-642-33863-2_47; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; PETERHANS E, 1989, J NEUROSCI, V9, P1749; PETKOV N, 1995, FUTURE GENER COMP SY, V11, P451, DOI 10.1016/0167-739X(95)00015-K; Sakai K, 1997, NETWORK-COMP NEURAL, V8, P335, DOI 10.1088/0954-898X/8/3/007; SUPER BJ, 1995, IEEE T PATTERN ANAL, V17, P333, DOI 10.1109/34.385983; Thielscher A, 2003, NEUROSCIENCE, V122, P921, DOI 10.1016/j.neuroscience.2003.08.050; Todd JT, 2004, PSYCHOL SCI, V15, P40, DOI 10.1111/j.0963-7214.2004.01501007.x; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; TODD JT, 1987, J EXP PSYCHOL HUMAN, V13, P242, DOI 10.1037/0096-1523.13.2.242; Todd JT, 2005, VISION RES, V45, P1501, DOI 10.1016/j.visres.2005.01.003; Todd JT, 2002, VISION RES, V42, P837, DOI 10.1016/S0042-6989(01)00234-6; Tschechne S, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00093; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Warren WH, 2012, PERCEPTION, V41, P1053, DOI 10.1068/p7327; Weidenbacher U, 2006, ACM T APPL PERCEPT, V3, P262, DOI [10.1145/1166087.1166094, DOI 10.1145/1166087.1166094]; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0160868	10.1371/journal.pone.0160868	http://dx.doi.org/10.1371/journal.pone.0160868			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649387	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100003
J	Li, J; Chen, XL; Yi, J; Liu, YC; Li, DM; Wang, JF; Hou, DX; Jiang, XH; Zhang, JF; Wang, J; Zen, K; Yang, FQ; Zhang, CY; Zhang, YJ				Li, Jing; Chen, Xiulan; Yi, Jiao; Liu, Yuchen; Li, Dameng; Wang, Jifeng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Wang, Jin; Zen, Ke; Yang, Fuquan; Zhang, Chen-Yu; Zhang, Yujing			Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components	PLOS ONE			English	Article							DRUG-DELIVERY VEHICLES; HUMAN URINARY EXOSOME; MEMBRANE-VESICLES; MICROVESICLES; BIOGENESIS; MOLECULES; MECHANISM; GRANULES; PLATFORM; RELEASE	Cell-derived exosomes are leading candidates for in vivo drug delivery carriers. In particular, exosomes derived from 293T cells are used most frequently, although exosome dosing has varied greatly among studies. Considering their biological origin, it is crucial to characterize the molecular composition of exosomes if large doses are to be administered in clinical settings. In this study, we present the first comprehensive analysis of the protein, messenger RNA and microRNA profiles of 293T cell-derived exosomes; then, we characterized these data using Gene Ontology annotation and Kyoto Encyclopedia for Genes and Genomes pathway analysis. Our study will provide the basis for the selection of 293T cell-derived exosome drug delivery systems. Profiling the exosomal signatures of 293T cells will lead to a better understanding of 293T exosome biology and will aid in the identification of any harmful factors in exosomes that could cause adverse clinical effects.	[Li, Jing; Yi, Jiao; Liu, Yuchen; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Wang, Jin; Zen, Ke; Zhang, Chen-Yu; Zhang, Yujing] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, NJU Adv Inst Life Sci,Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Xiulan; Wang, Jifeng; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China; [Chen, Xiulan; Wang, Jifeng; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing, Peoples R China	Nanjing University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, CY; Zhang, YJ (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, NJU Adv Inst Life Sci,Sch Life Sci, Nanjing, Jiangsu, Peoples R China.; Yang, FQ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China.; Yang, FQ (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing, Peoples R China.	fqyang@sun5.ibp.ac.cn; cyzhang@nju.edu.cn; yjzhang@nju.edu.cn		Liu, Yuchen/0000-0001-8922-9976	National Basic Research Program of China (973 Program) [2011CB504803]; Natural Science Foundation of Jiangsu Province, China [BK20130890, BK2011013, BK2012014]; National Natural Science Foundation of China [31200969, 31200874, 81101330, 31271378, 81250044]; National Science Fund for Distinguished Young Scholars [81025019]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); program for New Century Excellent Talents in University from the Ministry of Education, China	National Basic Research Program of China (973 Program) (No. 2011CB504803), Natural Science Foundation of Jiangsu Province, China (BK20130890, BK2011013 and BK2012014), the National Natural Science Foundation of China (31200969, 31200874, 81101330, 31271378 and 81250044), the National Science Fund for Distinguished Young Scholars (81025019) and the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Aryani A, 2016, MOL NEUROBIOL, V53, P818, DOI 10.1007/s12035-014-9054-5; Bruschi M, 2016, J PROTEOMICS, V136, P25, DOI 10.1016/j.jprot.2016.02.001; Bruschi M, 2015, EXPERT REV PROTEOMIC, V12, P425, DOI 10.1586/14789450.2015.1055324; Chen XL, 2014, THERANOSTICS, V4, P1164, DOI 10.7150/thno.8502; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Lee C, 2015, NANOSCALE, V7, P9290, DOI 10.1039/c5nr01333j; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Panfoli I, 2016, FASEB J, V30, P1416, DOI 10.1096/fj.15-279679; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Romana R, 2011, PLOS ONE, V6, P965; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tan A, 2013, ADV DRUG DELIVER REV, V65, P357, DOI 10.1016/j.addr.2012.06.014; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	38	66	69	8	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163043	10.1371/journal.pone.0163043	http://dx.doi.org/10.1371/journal.pone.0163043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649079	gold, Green Submitted, Green Published			2022-12-27	WOS:000383892100046
J	Ma, DY; Ding, HN; Wang, CY; Qin, HX; Han, QX; Hou, JF; Lu, HF; Xie, YX; Guo, TC				Ma, Dongyun; Ding, Huina; Wang, Chenyang; Qin, Haixia; Han, Qiaoxia; Hou, Junfeng; Lu, Hongfang; Xie, Yingxin; Guo, Tiancai			Alleviation of Drought Stress by Hydrogen Sulfide Is Partially Related to the Abscisic Acid Signaling Pathway in Wheat	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; TOLERANCE; BIOSYNTHESIS; ENZYME; RESPONSES; SALINITY	Little information is available describing the effects of exogenous H2S on the ABA pathway in the acquisition of drought tolerance in wheat. In this study, we investigated the physiological parameters, the transcription levels of several genes involved in the abscisic acid (ABA) metabolism pathway, and the ABA and H2S contents in wheat leaves and roots under drought stress in response to exogenous NaHS treatment. The results showed that pretreatment with NaHS significantly increased plant height and the leaf relative water content of seedlings under drought stress. Compared with drought stress treatment alone, H2S application increased antioxidant enzyme activities and reduced MDA and H2O2 contents in both leaves and roots. NaHS pretreatment increased the expression levels of ABA biosynthesis and ABA reactivation genes in leaves; whereas the expression levels of ABA biosynthesis and ABA catabolism genes were up-regulated in roots. These results indicated that ABA participates in drought tolerance induced by exogenous H2S, and that the responses in leaves and roots are different. The transcription levels of genes encoding ABA receptors were up-regulated in response to NaHS pretreatment under drought conditions in both leaves and roots. Correspondingly, the H2S contents in leaves and roots were increased by NaHS pretreatment, while the ABA contents of leaves and roots decreased. This implied that there is complex crosstalk between these two signal molecules, and that the alleviation of drought stress by H2S, at least in part, involves the ABA signaling pathway.	[Ma, Dongyun; Ding, Huina; Wang, Chenyang; Qin, Haixia; Han, Qiaoxia; Hou, Junfeng; Lu, Hongfang; Xie, Yingxin; Guo, Tiancai] Henan Agr Univ, Agron, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China; [Ma, Dongyun; Wang, Chenyang] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Lu, Hongfang; Xie, Yingxin; Guo, Tiancai] Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 45002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Guo, TC (corresponding author), Henan Agr Univ, Agron, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China.; Guo, TC (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 45002, Peoples R China.	tcguo88@163.com			Science and Technology Support Program [2015BAD26B00]; Key Scientific Research Project of Higher Education Insitution [15A210004]	Science and Technology Support Program; Key Scientific Research Project of Higher Education Insitution	This project was funded by the Science and Technology Support Program (2015BAD26B00), and the Key Scientific Research Project of Higher Education Insitution (15A210004).	Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Christou A, 2013, J EXP BOT, V64, P1953, DOI 10.1093/jxb/ert055; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Guo HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2038-x; Guoth A, 2009, J PLANT GROWTH REGUL, V28, P167, DOI 10.1007/s00344-009-9085-8; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Kettlewell P., 2011, INT J AGR MANAGEMENT, V1, P43; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Li ZG, 2015, PLANT CELL TISSUE OR; Lisjak M, 2011, PLANT SIGNAL BEHAV, V6, P1444, DOI 10.4161/psb.6.10.17104; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Scuffi D, 2014, PLANT PHYSIOL, V166, P2065, DOI 10.1104/pp.114.245373; Shi HT, 2013, PLANT PHYSIOL BIOCH, V71, P226, DOI 10.1016/j.plaphy.2013.07.021; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Wang YS, 2004, ACTA BOT SIN, V46, P819; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1	34	62	67	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163082	10.1371/journal.pone.0163082	http://dx.doi.org/10.1371/journal.pone.0163082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649534	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100050
J	Pereira-Gomez, M; Bou, JV; Andreu, I; Sanjuan, R				Pereira-Gomez, Marianoel; Bou, Juan-Vicente; Andreu, Ivaan; Sanjuan, Rafael			Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients	PLOS ONE			English	Article							EVOLUTIONARY RATE; ERROR CATASTROPHE; POLYMERASE; RIBAVIRIN; FIDELITY; REPLICATION; MANAGEMENT; INFECTION; VARIANTS; GENOTYPE	The high levels of genetic diversity shown by hepatitis B virus (HBV) are commonly attributed to the low fidelity of its polymerase. However, the rate of spontaneous mutation of human HBV in vivo is currently unknown. Here, based on the evolutionary principle that the population frequency of lethal mutations equals the rate at which they are produced, we have estimated the mutation rate of HBV in vivo by scoring premature stop codons in 621 publicly available, full-length, molecular clone sequences derived from patients. This yielded an estimate of 8.7 x 10(-5) spontaneous mutations per nucleotide per cell infection in untreated patients, which should be taken as an upper limit estimate because PCR errors and/or lack of effective lethality may inflate observed mutation frequencies. We found that, in patients undergoing lamivudine/adefovir treatment, the HBV mutation rate was elevated by more than sixfold, revealing a mutagenic effect of this treatment. Genome-wide analysis of single-nucleotide polymorphisms indicated that lamivudine/adefovir treatment increases the fraction of A/T-to-G/C base substitutions, consistent with recent work showing similar effects of lamivudine in cellular DNA. Based on these data, the rate at which HBV produces new genetic variants in treated patients is similar to or even higher than in RNA viruses.	[Pereira-Gomez, Marianoel; Bou, Juan-Vicente; Andreu, Ivaan; Sanjuan, Rafael] Univ Valencia, Inst Integrat Syst Biol I2SysBio, Valencia, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain	University of Valencia; University of Valencia	Sanjuan, R (corresponding author), Univ Valencia, Inst Integrat Syst Biol I2SysBio, Valencia, Spain.; Sanjuan, R (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	rafael.sanjuan@uv.es	Pereira-Gómez, Marianoel/AAG-8725-2021	Pereira-Gómez, Marianoel/0000-0003-3665-392X; Bou-Prados, Juan-Vicente/0000-0002-9572-0822; Sanjuan, Rafael/0000-0002-1844-545X; Andreu-Moreno, Ivan/0000-0002-0146-7839	Spanish Ministerio de Economia y Competitividad [BFU2011-25271]; European Research Council [ERC-2011-StG-281191-VIRMUT]; Spanish Ministerio de Educacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Spanish Ministerio de Educacion(Spanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (BFU2011-25271) and the European Research Council (ERC-2011-StG-281191-VIRMUT) to R.S., and by a Ph.D. fellowship from the Spanish Ministerio de Educacion to M.P.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08; Cheung PPH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5794; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dapp MJ, 2013, J MOL BIOL, V425, P41, DOI 10.1016/j.jmb.2012.10.009; Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gao S, 2015, WORLD J HEPATOL, V7, P1086, DOI 10.4254/wjh.v7.i8.1086; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Guimaraes NN, 2010, EXPERT OPIN DRUG SAF, V9, P771, DOI 10.1517/14740331003702384; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Hao R, 2015, INFECT GENET EVOL, V33, P261, DOI 10.1016/j.meegid.2015.05.013; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Hong YB, 2004, J BIOCHEM MOL BIOL, V37, P167; Huang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089753; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kanda T, 2015, WORLD J HEPATOL, V7, P1913, DOI [10.4254/wjh.v7.i15.1913, 10.4254/wjh.v7.i11.1541]; Lai MW, 2008, ANTIVIR THER, V13, P875; Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163; Li ZX, 2014, J CLIN VIROL, V61, P47, DOI 10.1016/j.jcv.2014.06.010; Lin Xu, 2001, Journal of Medical Virology, V64, P299, DOI 10.1002/jmv.1050; Lin YY, 2015, J VIROL, V89, P3512, DOI 10.1128/JVI.03131-14; Mansky LM, 2002, J VIROL, V76, P9253, DOI 10.1128/JVI.76.18.9253-9259.2002; Marzio DHD, 2014, WORLD J GASTROENTERO, V20, P401, DOI 10.3748/wjg.v20.i2.401; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Menendez-Arias L, 2009, VIRUSES-BASEL, V1, P1137, DOI 10.3390/v1031137; Meng T, 2014, J VIROL, V88, P5803, DOI 10.1128/JVI.00289-14; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pult I, 2001, J VIROL, V75, P9623, DOI 10.1128/JVI.75.20.9623-9632.2001; Ribeiro RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002881; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Shen Tao, 2011, Hepat Res Treat, V2011, P939148, DOI 10.1155/2011/939148; Su HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021125; Suppiah J, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22565; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Zhang YL, 2015, J NEUROVIROL, V21, P500, DOI 10.1007/s13365-015-0347-x; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163363	10.1371/journal.pone.0163363	http://dx.doi.org/10.1371/journal.pone.0163363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649318	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100083
J	Stacey, AF; Gill, TK; Price, K; Warmington, R; Taylor, AW				Stacey, Anne F.; Gill, Tiffany K.; Price, Kay; Warmington, Rosemary; Taylor, Anne W.			Unpaid Informal Caregivers in South Australia: Population Characteristics, Prevalence and Age-Period-Cohort Effects 1994-2014	PLOS ONE			English	Article							CARE; HEALTH	Background The ongoing need for an availability of informal carers is taking on greater relevance as the global burden of disease transitions from acute fatal diseases to long termmorbidity. Growing evidence suggests that extra burden on family carers may further impact on their health and ability to provide care. Importantas it is to monitor the prevalence of those conditions which influence the burden of disease, it is also important to monitor the prevalence and health profiles of those who provide the informal care. The aim of this study was to demonstrate the prevalence and demographics of adult carers aged 15 and over in the state of South Australia over 20 years between 1994 and 2014. Methods Data from nine representative, cross-sectional population surveys, conducted in South Australia, Australia were used, (total N = 26,788 and n = 1,504 carers). The adjusted prevalence estimate of carers and their demographic characteristics were determined. So as to examine whether there were any generational effects on the prevalence of carers, an Age-Period Cohort (APC) analysis was undertaken. Results The prevalence estimates of carers increased during the two decades from 3.7% in 1994 to 6.7% by 2014. Large increases in the proportion of retired carers, those aged 70 years and over, those carers employed, and those with higher educational qualifications were observed. There were also larger proportions of respondents with a country of birth other than Australia, UK, Ireland and European counties. The APC analysis illustrated an increasing prevalence rate over each decade for carers aged 20-80 years, especially for those over the age of 60 years. Conclusions The results illustrate changing carer characteristics and carer prevalence estimates in South Australia as new generations of carers take on the caring role. There is a need to include questions regarding informal carers within ongoing mainstream population surveys, particularly at state levels, so as to plan for their future health care and home support.	[Stacey, Anne F.; Gill, Tiffany K.; Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Price, Kay] Univ South Australia, Sch Nursing & Midwifery, Adelaide, SA, Australia; [Warmington, Rosemary] Carers SA, Adelaide, SA, Australia	University of Adelaide; Flinders University South Australia; University of South Australia	Stacey, AF (corresponding author), Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	anne.stacey@adelaide.edu.au	Gill, Tiffany/F-9042-2010; Taylor, Anne w/F-5708-2010	Gill, Tiffany/0000-0002-2822-2436; Taylor, Anne w/0000-0002-4422-7974	Carers SA	Carers SA	Funding was received from Carers SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2000, DIS AG AUSTR POP PAT; [Anonymous], 2015, EC VAL INF CAR AUSTR; Australian Bureau of Statistics, 2018, DISABILITY AGEING CA; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Bureau of Statistics (ABS), 2012, DIS AG CAR AUSTR SUM; Australian Bureau of Statistics (ABS), 2015, AUSTR DEM STAT COUNT; Australian Institute of Health and Welfare, 2018, CDK16 AUSTR I HLTH W; Australian Institute of Health and Welfare, 2015, AUSTR BURD DIS STUD, V1; Australian Institute of Health and Welfare (AIHW), 2015, AUSTR WELF 2015 BRIE; Australian Institute of Health and Welfare (AIHW). Australia's Health, 2014, LEAD TYP ILL HLTH; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Bloch B. S, 1998, INT TECHNICAL C ENHA; Borowski A, 1997, AGEING SOCIAL POLICY, P37; Brehaut JC, 2009, AM J PUBLIC HEALTH, V99, P1254, DOI 10.2105/AJPH.2007.129817; Bruhn JG, 2014, CLIN SOCIOL RES PRAC, P1, DOI 10.1007/978-94-017-8857-1; Bryant L, 2013, AGEING SOC, V33, P1401, DOI 10.1017/S0144686X12000657; Carers V, 2015, RISING VALUE CARERS; Colombo F, 2011, OECD HLTH POLICY STU, DOI [10.1787/9789264097759-en+-, DOI 10.1757/9789264097759-44+-]; Day C, 2015, J YOUTH STUD, V18, P855, DOI 10.1080/13676261.2014.1001826; Farfan-Portet MI, 2010, EUR J PUBLIC HEALTH, V20, P52, DOI 10.1093/eurpub/ckp045; Grady PA, 2014, NURS OUTLOOK, V62, P362, DOI 10.1016/j.outlook.2014.05.007; Hastrup LH, 2011, SCAND J PUBLIC HEALT, V39, P598, DOI 10.1177/1403494811414247; Hirst M, 2005, SOC SCI MED, V61, P697, DOI 10.1016/j.socscimed.2005.01.001; Hirst M, 2002, J EPIDEMIOL COMMUN H, V56, P579, DOI 10.1136/jech.56.8.579; Hosseinpoor AR, 2013, AGE AGEING, V42, P330, DOI 10.1093/ageing/afs196; Hsu HC, 2001, GERONTOLOGIST, V41, P742, DOI 10.1093/geront/41.6.742; Hugo G., 2014, DEMOGRAPHIC FACTS AG; Hugo G, 2009, OLDER CARERS CARERS, P233; Jenkins A., 2003, FUTURE SUPPLY INFORM; Jowsey T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-374; Kaambwa B, 2015, SOC SCI MED, V140, P81, DOI 10.1016/j.socscimed.2015.06.034; Knight BG, 2010, J GERONTOL B-PSYCHOL, V65, P5, DOI 10.1093/geronb/gbp096; Levine C, 2005, AM J PUBLIC HEALTH, V95, P2071, DOI 10.2105/AJPH.2005.067702; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Park HJ, 2015, J AGING SOC POLICY, V27, P280, DOI 10.1080/08959420.2015.1024536; Prince M, 2007, AM J PUBLIC HEALTH, V97, P224; Public Policy Institute, 2015, RES REPORT; Reinhard S., 2012, HOME ALONE FAMILY CA; Reither EN, 2009, SOC SCI MED, V69, P1439, DOI 10.1016/j.socscimed.2009.08.040; Rutherford MJ, 2010, STATA J, V10, P606, DOI 10.1177/1536867X1101000405; SA Health Health Omnibus Survey, 2002, METH BRIEF REP S AUS; Schofield D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-561; Sinha M, 2012, SPOTLIGHT CANADIANS; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P393, DOI 10.2105/AJPH.2004.059337; Taylor AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125233; Trivedi R, 2014, CHRONIC ILLN, V10, P167, DOI 10.1177/1742395313506947; Turcotte M, FAMILY CAREGIVING WH; Twigg Julia, 1996, CARERS PERCEIVED POL; van den Berg B, 2014, J HEALTH ECON, V35, P123, DOI 10.1016/j.jhealeco.2014.01.008; Viana MC, 2013, REV BRAS PSIQUIATR, V35, P115, DOI 10.1590/1516-4446-2012-0919; Yeandle S, 2007, 2 CES CAR UK	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161994	10.1371/journal.pone.0161994	http://dx.doi.org/10.1371/journal.pone.0161994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649074	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000383892100010
J	Salk, HM; Simon, WL; Lambert, ND; Kennedy, RB; Grill, DE; Kabat, BF; Poland, GA				Salk, Hannah M.; Simon, Whitney L.; Lambert, Nathaniel D.; Kennedy, Richard B.; Grill, Diane E.; Kabat, Brian F.; Poland, Gregory A.			Taxa of the Nasal Microbiome Are Associated with Influenza-SpecificIgA Response to Live Attenuated Influenza Vaccine	PLOS ONE			English	Article							UPPER RESPIRATORY TRACTS; VIRUS-INFECTION; GUT MICROBIOTA; IMMUNE-RESPONSES; INTESTINAL MICROBIOTA; SPECIES RICHNESS; NATURAL ADJUVANT; DOUBLE-BLIND; ADULTS; PROBIOTICS	Live attenuated influenza vaccine (LAIV) has demonstrated varying levels of efficacy against seasonal influenza; however, LAIV may be used as a tool to measure interactions between the human microbiome and a live, replicating virus. To increase our knowledge of this interaction, we measured changes to the nasal microbiome in subjects who received LAIV to determine if associations between influenza-specific IgA production and the nasal microbiome exist after immunization with a live virus vaccine. The anterior nares of 47 healthy subjects were swabbed pre- (Day 0) and post- (Days 7 and 28) LAIV administration, and nasal washes were conducted on Days 0 and 28. We performed next-generation sequencing on amplified 16s rRNA genes and measured mucosal influenza-specific IgA titers via enzyme-linked immunosorbent assay (ELISA). A significant increase in alpha diversity was identified (Observed, CHAO, and ACE) between Days 7 vs 0 (p-values = 0.017, 0.005, 0.005, respectively) and between Days 28 vs 0 (p-values = 0.054, 0.030, 0.050, respectively). Several significant associations between the presence of different microbial species, including Lactobacillus helveticus, Prevotella melaninogenica, Streptococcus infantis, Veillonella dispar, and Bacteroides ovatus, and influenza-specific H1 and H3 IgA antibody response were demonstrated. These data suggest that LAIV alters the nasal microbiome, allowing several less-abundant OTUs to establish a community niche. Additionally, specific alterations in the nasal microbiome are significantly associated with variations in influenza-specific IgA antibody production and could be clinically relevant.	[Salk, Hannah M.; Simon, Whitney L.; Lambert, Nathaniel D.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Grill, Diane E.; Kabat, Brian F.] Mayo Clin, Div Biostat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967	Mayo Clinic Center for Individualized Medicine	Mayo Clinic Center for Individualized Medicine	Research reported in this publication was supported by The Mayo Clinic Center for Individualized Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Akatsu H, 2016, GERIATR GERONTOL INT, V16, P205, DOI 10.1111/ggi.12454; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Bek-Thomsen M, 2008, INFECT IMMUN, V76, P1889, DOI 10.1128/IAI.01511-07; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chiu CH, 2014, BIOMETRICS, V70, P671, DOI 10.1111/biom.12200; Chowdhury MYE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094051; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Diaz-Ropero MP, 2007, J APPL MICROBIOL, V102, P337, DOI 10.1111/j.1365-2672.2006.03102.x; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Koeppel AF, 2013, NUCLEIC ACIDS RES, V41, P5175, DOI 10.1093/nar/gkt241; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li R, 2015, VET MICROBIOL, V179, P250, DOI 10.1016/j.vetmic.2015.07.020; MacDonald TT, 2010, P NUTR SOC, V69, P442, DOI 10.1017/S0029665110001758; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mina MJ, 2014, MBIO, V5, P5; Minton K, 2014, NAT REV IMMUNOL, V14, P650, DOI 10.1038/nri3745; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; O'Hara RB, 2005, J ANIM ECOL, V74, P375, DOI 10.1111/j.1365-2656.2005.00940.x; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pabst O, 2014, IMMUNITY, V41, P349, DOI 10.1016/j.immuni.2014.09.002; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; Planet PJ, 2016, MBIO, V7, DOI 10.1128/mBio.01939-15; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Rizzardini G, 2012, BRIT J NUTR, V107, P876, DOI 10.1017/S000711451100420X; Samuelson DR, 2015, FRONT MICROBIOL, V6, DOI [10.5389/fmicb.2015.01085, 10.3389/fmicb.2015.01085]; Seto CT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-42; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Tarabichi Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0133-2; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Yaqoob P, 2014, P NUTR SOC, V73, P309, DOI 10.1017/S0029665113003777; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501	53	52	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162803	10.1371/journal.pone.0162803	http://dx.doi.org/10.1371/journal.pone.0162803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643883	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900019
J	Tukenmez, H; Magnussen, HM; Kovermann, M; Bystrom, A; Wolf-Watz, M				Tukenmez, Hasan; Magnussen, Helge Magnus; Kovermann, Michael; Bystrom, Anders; Wolf-Watz, Magnus			Linkage between Fitness of Yeast Cells and Adenylate Kinase Catalysis	PLOS ONE			English	Article							DYNAMICS; MOTIONS; INHIBITOR; STABILITY; COMPLEX; RESOLUTION; PATHWAY; DOMAIN	Enzymes have evolved with highly specific values of their catalytic parameters kcat and KM. This poses fundamental biological questions about the selection pressures responsible for evolutionary tuning of these parameters. Here we are address these questions for the enzyme adenylate kinase (Adk) in eukaryotic yeast cells. A plasmid shuffling system was developed to allow quantification of relative fitness (calculated from growth rates) of yeast in response to perturbations of Adk activity introduced through mutations. Biophysical characterization verified that all variants studied were properly folded and that the mutations did not cause any substantial differences to thermal stability. We found that cytosolic Adk is essential for yeast viability in our strain background and that viability could not be restored with a catalytically dead, although properly folded Adk variant. There exist a massive overcapacity of Adk catalytic activity and only 12% of the wild type kcat is required for optimal growth at the stress condition 20 degrees C. In summary, the approach developed here has provided new insights into the evolutionary tuning of kcat for Adk in a eukaryotic organism. The developed methodology may also become useful for uncovering new aspects of active site dynamics and also in enzyme design since a large library of enzyme variants can be screened rapidly by identifying viable colonies.	[Tukenmez, Hasan; Bystrom, Anders] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Magnussen, Helge Magnus; Kovermann, Michael; Wolf-Watz, Magnus] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Kovermann, Michael] Univ Konstanz, Dept Chem, D-78457 Constance, Germany	Umea University; Umea University; University of Konstanz	Bystrom, A (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.; Wolf-Watz, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	anders.bystrom@umu.se; magnus.wolf-watz@umu.se		Bystrom, Anders/0000-0003-1281-3888; Magnussen, Helge Magnus/0000-0002-1104-2973	Swedish Research Council [621-2013-5954, 621-2012-3576]; Swedish Cancer Foundation [13 0301]; Karin and Harald Silvanders Foundation [223-2808-12]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karin and Harald Silvanders Foundation	This work was financially supported by the Swedish Research Council (grants 621-2013-5954 to M.W.W. and 621-2012-3576 to A.B.). A.B. was also supported by the Swedish Cancer Foundation (13 0301) and Karin and Harald Silvanders Foundation (223-2808-12).; This work was financially supported by the Swedish Research Council (grants 621-2013-5954 to M.W.W. and 621-2012-3576 to A.B.). A.B. was also supported by the Swedish Cancer Foundation (13 0301) and Karin and Harald Silvanders Foundation (223-2808-12). The NMR experiments were conducted at NMR4life and we thank the Wallenberg and Kempe foundations for supporting this infrastructure. Parts of this work were planned and performed by the Ume Protein Expertise Platform.	ABELE U, 1995, PROTEIN SCI, V4, P1262, DOI 10.1002/pro.5560040702; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; Aden J, 2012, J AM CHEM SOC, V134, P16562, DOI 10.1021/ja3032482; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bearne SL, 1997, BIOCHEMISTRY-US, V36, P1646, DOI 10.1021/bi9620722; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; BRINDLE K, 1990, BIOCHEMISTRY-US, V29, P3295, DOI 10.1021/bi00465a021; Burke D., 2000, METHODS YEAST GENETI; Cheng X, 2010, J BIOL CHEM, V285, P29974, DOI 10.1074/jbc.M110.161455; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Eames M, 2012, SCIENCE, V336, P911, DOI 10.1126/science.1219083; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fersht A. K, 2000, STRUCTURE MECH PROTE; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; KONRAD M, 1988, J BIOL CHEM, V263, P19468; Kovermann M, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000019; Kovermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8644; Lee SY, 2014, J MOL BIOL, V426, P1377, DOI 10.1016/j.jmb.2013.10.042; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Olsson U, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1106; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; REINSTEIN J, 1988, BIOCHEMISTRY-US, V27, P4712, DOI 10.1021/bi00413a020; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thongwichian R, 2015, J AM CHEM SOC, V137, P6468, DOI 10.1021/jacs.5b02987; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163115	10.1371/journal.pone.0163115	http://dx.doi.org/10.1371/journal.pone.0163115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642758	Green Published, gold, Green Submitted			2022-12-27	WOS:000383891900032
J	Obert, D; Helms, G; Sattler, MB; Jung, K; Kretzschmar, B; Bahr, M; Dechent, P; Diem, R; Hein, K				Obert, Dorothea; Helms, Gunther; Saettler, Muriel B.; Jung, Klaus; Kretzschmar, Benedikt; Baehr, Mathias; Dechent, Peter; Diem, Ricarda; Hein, Katharina			Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; APPEARING WHITE-MATTER; AXONAL DAMAGE; H-1-MRS QUANTIFICATION; MR SPECTROSCOPY; LESIONS; DISABILITY; DISEASE; NEURODEGENERATION; DEMYELINATION	Magnetic resonance spectroscopy (MRS) provides the unique ability to monitor several disease-related pathological processes via their characteristic metabolic markers in vivo. In the present study metabolic compositions were assessed every six months over the period of two years in 36 patients with Multiple Sclerosis (MS) including 21 relapsing-remitting (RR), 15 secondary progressive (SP) patients and 12 normal subjects. The concentrations of the main MRS-detectable metabolites N-acetylaspartate and N-acetylaspartylglutamate (tNAA), creatine and phosphocreatine (tCr), choline containing compounds (Cho), myo-Inositol (Ins), glutamine and glutamate (Glx) and their ratios were calculated in the normal appearing white matter (NAWM) and in selected non-enhancing white matter (WM) lesions. Association between metabolic concentrations in the NAWM and disability were investigated. Concentration of tNAA, a marker for neuroaxonal integrity, did not show any difference between the investigated groups. However, the patients with SPMS showed significant reduction of tNAA in the NAWM over the investigation period of two years indicating diffuse neuroaxonal loss during the disease course. Furthermore, we found a significant increase of Ins, Ins/tCr and Ins/tNAA in WM lesions independently from the course of the disease suggesting ongoing astrogliosis in silent-appearing WM lesions. Analyzing correlations between MRS metabolites in the NAWM and patients clinical status we found the positive correlation of Ins/tNAA with disability in patients with RRMS. In SPMS positive correlation of Cho with disability was found.	[Obert, Dorothea; Saettler, Muriel B.; Kretzschmar, Benedikt; Baehr, Mathias; Hein, Katharina] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Helms, Gunther; Dechent, Peter] Univ Med Ctr Gottingen, Dept Cognit Neurol, Gottingen, Germany; [Jung, Klaus] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Diem, Ricarda] Univ Clin Heidelberg, Dept Neurol, Heidelberg, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Veterinary Medicine Hannover, Foundation; Ruprecht Karls University Heidelberg	Hein, K (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.	k.hein@uni-goettingen.de	; Helms, Gunther/A-9114-2010	Jung, Klaus/0000-0001-9955-748X; Helms, Gunther/0000-0002-1371-5123	Bayer Vital GmbH, Leverkusen, Germany; Merck Serono GmbH, Darmstadt	Bayer Vital GmbH, Leverkusen, Germany(Bayer AG); Merck Serono GmbH, Darmstadt	This study was supported by research grants from Bayer Vital GmbH, Leverkusen, Germany, and Merck Serono GmbH, Darmstadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagory M, 2012, IEEE T BIO-MED ENG, V59, P2687, DOI 10.1109/TBME.2011.2161609; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brex PA, 2000, J NEUROL NEUROSUR PS, V68, P627, DOI 10.1136/jnnp.68.5.627; Caramanos Z, 2005, BRAIN, V128, P2483, DOI 10.1093/brain/awh640; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Griffin JL, 2001, FEBS LETT, V509, P263, DOI 10.1016/S0014-5793(01)03175-1; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Llufriu S, 2014, JAMA NEUROL, V71, P840, DOI 10.1001/jamaneurol.2014.895; Ludwin SK, 2000, NEUROIMAG CLIN N AM, V10, P625; Matthews PM, 1998, SEMIN NEUROL, V18, P327, DOI 10.1055/s-2008-1040884; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; Narayana PA, 2004, MULT SCLER J, V10, pS73, DOI 10.1191/1352458504ms1035oa; Natt O, 2005, MAGN RESON MED, V53, P3, DOI 10.1002/mrm.20337; Pan JW, 2002, MULT SCLER J, V8, P200, DOI 10.1191/1352458502ms802oa; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rovaris M, 2001, J NEUROL SCI, V186, pS3, DOI 10.1016/S0022-510X(01)00485-3; Sastre-Garriga J, 2005, NEUROLOGY, V65, P633, DOI 10.1212/01.wnl.0000173061.12776.1f; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vigeveno RM, 2012, J MAGN RESON IMAGING, V36, P1, DOI 10.1002/jmri.23578; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366	40	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162583	10.1371/journal.pone.0162583	http://dx.doi.org/10.1371/journal.pone.0162583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636543	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700009
J	Fukada, I; Araki, K; Kobayashi, K; Shibayama, T; Takahashi, S; Horii, R; Akiyama, F; Iwase, T; Ohno, S; Hatake, K; Hozumi, Y; Sata, N; Ito, Y				Fukada, Ippei; Araki, Kazuhiro; Kobayashi, Kokoro; Shibayama, Tomoko; Takahashi, Shunji; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji; Ohno, Shinji; Hatake, Kiyohiko; Hozumi, Yasuo; Sata, Naohiro; Ito, Yoshinori			Predictive Factors and Value of ypN plus after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PREOPERATIVE CHEMOTHERAPY; PRIMARY THERAPY; RECOMMENDATIONS; PACLITAXEL; HIGHLIGHTS; DOCETAXEL; SUBTYPES; UPDATE; TRIAL	Background Pathological complete response (pCR) with neoadjuvant chemotherapy (NAC) has been regarded as a surrogate endpoint for disease-free survival (DFS) and overall survival (OS) of patients with breast cancer. No consensus regarding the definition of pCR has been established; there are several definitions according to a variety of classifications. Eradication of cancer cells in both breast and lymph nodes has been better associated with improved prognosis than in the breast alone. Even in patients diagnosed as having clinically node-negative cancer before NAC, postoperative pathological examination often shows axillary lymph node metastases. Patients and Methods Of the 771 patients with breast cancer who underwent NAC in the Cancer Institute Hospital between January 2000 and May 2009, 146 patients preoperatively diagnosed as having node-negative breast cancer were retrospectively evaluated. We have made the definition of clinically lymph node-negative (N0) as follows: first, ultrasonography before NAC did not show any lymphadenopathy. Second, a cytological procedure confirmed negative study for each patient when ultrasonography suggested lymphadenopathy. Results The median observation period was 79.7 months, and the median age of the subjects was 51 years. Pathological examination at the time of the surgery showed lymph node metastases (ypN+) in 46 patients (31.5%). Histological therapeutic effects revealed ypT0/is in 9 patients (6.2%) and ypTinv in 137 (93.8%). Multivariate analysis demonstrated that younger age (49>), large tumor size, NG3, and ypN+ were significant poor prognostic factors for DFS (p = 0.020, p = 0.008, P = 0.022 and p = 0.010, respectively). Moreover, ypN+ was the only significant poor prognostic factor for OS (p = 0.022). The predictive factors of ypN+ in clinically lymph node-negative breast cancer were ypTinv (p = 0.036) and the luminal type (HR+ and HER2-) (p = 0.029). Conclusion The prognosis of clinically lymph node negative breast cancer depended on ypN+, which was associated with ypTinv and luminal subtype.	[Fukada, Ippei; Araki, Kazuhiro; Kobayashi, Kokoro; Shibayama, Tomoko; Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Med Oncol, Tokyo, Japan; [Horii, Rie] Japanese Fdn Canc Res, Canc Inst Hosp, Div Pathol, Tokyo, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Breast Surg Oncol, Tokyo, Japan; [Ohno, Shinji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Hatake, Kiyohiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hematol & Oncol, Tokyo, Japan; [Hozumi, Yasuo] Ibaraki Cent Hosp, Dept Surg, Ibaraki, Japan; [Sata, Naohiro] Jichi Med Univ, Dept Gastrointestinal Surg, Shimotsuke, Tochigi, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Jichi Medical University	Fukada, I (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan.	ippei.fukada@jfcr.or.jp	Araki, kazuhiro/AAD-5658-2019	Araki, kazuhiro/0000-0001-7623-7715				Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.2214/AJR.05.0936; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Green MC, 2005, J CLIN ONCOL, V23, P5983, DOI 10.1200/JCO.2005.06.232; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Kobayashi K, 2016, PATHOL INT, V66, P8, DOI 10.1111/pin.12365; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Loo CE, 2011, J CLIN ONCOL, V29, P660, DOI 10.1200/JCO.2010.31.1258; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Sakamoto G, 2005, BREAST CANC, V12, P1, DOI DOI 10.1007/BF02967379; Sparano JA, 2015, J CLIN ONCOL, V33, P2353, DOI 10.1200/JCO.2015.60.9271; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162616	10.1371/journal.pone.0162616	http://dx.doi.org/10.1371/journal.pone.0162616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631393	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900060
J	McNamara, J; Rowcliffe, M; Cowlishaw, G; Alexander, JS; Ntiamoa-Baidu, Y; Brenya, A; Milner-Gulland, EJ				McNamara, J.; Rowcliffe, M.; Cowlishaw, G.; Alexander, J. S.; Ntiamoa-Baidu, Y.; Brenya, A.; Milner-Gulland, E. J.			Characterising Wildlife Trade Market Supply-Demand Dynamics	PLOS ONE			English	Article							BUSHMEAT CONSUMPTION; WEST; SUSTAINABILITY; CONSERVATION; DRIVERS; POLICY	The trade in wildlife products can represent an important source of income for poor people, but also threaten wildlife locally, regionally and internationally. Bushmeat provides livelihoods for hunters, traders and sellers, protein to rural and urban consumers, and has depleted the populations of many tropical forest species. Management interventions can be targeted towards the consumers or suppliers of wildlife products. There has been a general assumption in the bushmeat literature that the urban trade is driven by consumer demand with hunters simply fulfilling this demand. Using the urban bushmeat trade in the city of Kumasi, Ghana, as a case study, we use a range of datasets to explore the processes driving the urban bushmeat trade. We characterise the nature of supply and demand by explicitly considering three market attributes: resource condition, hunter behaviour, and consumer behaviour. Our results suggest that bushmeat resources around Kumasi are becoming increasingly depleted and are unable to meet demand, that hunters move in and out of the trade independently of price signals generated by the market, and that, for the Kumasi bushmeat system, consumption levels are driven not by consumer choice but by shortfalls in supply and consequent price responses. Together, these results indicate that supply-side processes dominate the urban bushmeat trade in Kumasi. This suggests that future management interventions should focus on changing hunter behaviour, although complementary interventions targeting consumer demand are also likely to be necessary in the long term. Our approach represents a structured and repeatable method to assessing market dynamics in information-poor systems. The findings serve as a caution against assuming that wildlife markets are demand driven, and highlight the value of characterising market dynamics to informappropriate management.	[McNamara, J.; Alexander, J. S.; Milner-Gulland, E. J.] Imperial Coll London, Div Biol, Silwood Pk Campus, Ascot, Berks, England; [McNamara, J.; Rowcliffe, M.; Cowlishaw, G.] Zool Soc London, Inst Zool, Regents Pk, London, England; [Ntiamoa-Baidu, Y.] Univ Ghana, Ctr African Wetlands, Legon, Ghana; [Brenya, A.] Forestry Commiss, Ghana Wildlife Div, Accra, Ghana; [Milner-Gulland, E. J.] Univ Oxford, Dept Zool, Oxford, England	Imperial College London; Zoological Society of London; University of Ghana; University of Oxford	Milner-Gulland, EJ (corresponding author), Imperial Coll London, Div Biol, Silwood Pk Campus, Ascot, Berks, England.; Milner-Gulland, EJ (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	ej.milner-gulland@zoo.ox.ac.uk	Rowcliffe, Marcus/G-3713-2018	Rowcliffe, Marcus/0000-0002-4286-6887; Alexander, Justine Shanti/0000-0002-7474-9247	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Biotechnology and Biological Sciences Research Council as part of JM's PhD research grant. www.bbsrc.ac.uk.; J.M. acknowledges support from the Biotechnology and Biological Sciences Research Council, and thanks John Fa and Douglas MacMillan for valuable comments. We thank the Ghana Wildlife Division, James Oppong and Mark Owusu for their help and support in Ghana.	Alexander J, 2014, ORYX; Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; Angrist JD, 2000, REV ECON STUD, V67, P499, DOI 10.1111/1467-937X.00141; Annor SY, 2008, LIVESTOCK RES RURAL, V20, P2008; [Anonymous], 2014, GLSS 6 GHAN LIV STAN; [Anonymous], 2014, GHANA TRADE UNIONS C; [Anonymous], 1999, GLSS 4 GHAN LIV STAN; Asibey EOA, 1987, 97 AS EOA, P4; Badiane O, 1998, J DEV ECON, V56, P411, DOI 10.1016/S0304-3878(98)00072-8; Barnes RFW, 2002, ORYX, V36, P236, DOI 10.1017/S0030605302000443; BESANKO D. A., 2010, MICROECONOMICS, V4; Blanchard O, 2012, 1003 IMF; Bowen-Jones E., 2002, ASSESSMENT SOLUTION; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown D, 2003, INT FOREST REV, V5, P148, DOI 10.1505/IFOR.5.2.148.17414; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Crookes D, 2007, S AFR J ECON MANAG S, V10, P457; DEI GJS, 1989, ECOL FOOD NUTR, V22, P225, DOI 10.1080/03670244.1989.9991071; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Endamana D, 2010, TROP CONSERV SCI, V3, P262, DOI 10.1177/194008291000300303; Fa JE, 2002, HUM ECOL, V30, P397, DOI 10.1023/A:1016524703607; Falconer J., 1992, NONTIMBER FOREST PRO; [FAOSTAT Food and Agriculture Organization of the United Nations], 2015, FAOSTAT DAT; GHOSH A, 1958, ECONOMICA, V25, P58, DOI 10.2307/2550694; Gill DJC, 2012, CONSERV BIOL, V26, P1052, DOI 10.1111/j.1523-1739.2012.01876.x; GTZ, 2009, GRASSC PROD HDB; Hofmann T., 1999, BUSHMEAT NATURAL RES; Illukpitiya P, 2010, ECOL ECON, V69, P1952, DOI 10.1016/j.ecolecon.2010.05.007; Jones-Bowen E., 1999, ORYX, V33, P233, DOI [10.1046/J.1365-3008.1999.00066.X, DOI 10.1046/J.1365-3008.1999.00066.X]; JORI F, 1995, BIODIVERS CONSERV, V4, P257, DOI 10.1007/BF00055972; Ling S, 2006, CONSERV BIOL, V20, P1294, DOI 10.1111/j.1523-1739.2006.00414.x; McGraw WS, 2002, ORYX, V36, P223, DOI 10.1017/S003060530200042X; McNamara J, 2015, CONSERV BIOL, V29, P1446, DOI 10.1111/cobi.12545; McNamara J., 2014, THESIS; Milner-Gulland EJ, 2002, ECOL ECON, V42, P165, DOI 10.1016/S0921-8009(02)00047-2; Moro M, 2015, ANIM CONSERV, V18, P377, DOI 10.1111/acv.12184; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newing H, 2001, BIODIVERS CONSERV, V10, P99, DOI 10.1023/A:1016671524034; Ntiamoa-Baidu Y., 1998, WILDLIFE DEV PLAN 19, V6; Ntiamoa-Baidu Y, 1998, WILDLIFE UTILIZATION; Oates JF, 2000, CONSERV BIOL, V14, P1526, DOI 10.1046/j.1523-1739.2000.99230.x; Owen O. J., 2012, Journal of Environmental issues and Agriculture in Developing Countries, V4, P104; Rentsch D, 2013, ECOL ECON, V91, P1, DOI 10.1016/j.ecolecon.2013.03.021; Robinson JG, 2002, ORYX, V36, P332, DOI 10.1017/S0030605302000662; Schenck M, 2006, HUM ECOL, V34, P433, DOI 10.1007/s10745-006-9025-1; Schulte-Herbruggen B, 2013, HUM ECOL, V41, P795, DOI 10.1007/s10745-013-9609-5; Struhsaker Thomas T., 1995, African Primates, V1, P5; Tutu K., 1993, EC LIVING WILDLIFE G, P85; Wright JH, 2016, CONSERV BIOL, V30, P7, DOI 10.1111/cobi.12607	52	34	34	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162972	10.1371/journal.pone.0162972	http://dx.doi.org/10.1371/journal.pone.0162972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632169	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900105
J	Min, JW; Kim, KW; Kim, BM; Doh, KC; Choi, MS; Choi, BS; Park, CW; Yang, CW; Kim, YS; Oh, EJ; Chung, BH				Min, Ji Won; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Choi, Min Seok; Choi, Bum Soon; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Oh, Eun-Jee; Chung, Byung Ha			Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients	PLOS ONE			English	Article							CELL ACTIVATING FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELLS; RITUXIMAB THERAPY; SURVIVAL; REJECTION; ANTIBODY; EXPRESSION; ALLOGRAFT; APRIL	It is well known that pre-transplant B cell activating factor (BAFF) levels are associated with the development of de novo anti-HLA antibodies and antibody mediated rejection post-transplant. However, the clinical significance of BAFF values at allograft rejection has not been determined. In this study, we investigated the clinical significance of pre-transplant BAFF level as well as post-transplant BAFF levels measured when indication biopsy was done. We checked for anti-HLA antibodies in 115 kidney transplant recipients who required allograft biopsy due to an increase in serum creatinine. With the same serum specimen, we measured BAFF levels, and in 78 of these patients, pre-transplant BAFF and anti-HLA antibody levels were detected as well. Patients in each group were divided into tertiles according to BAFF levels. We investigated the relationship between BAFF levels and the occurrence of anti-HLA antibodies. Pre-transplant BAFF levels showed significant association with pre-transplant sensitization, and also with early rejection (Tertile 3, 26.9% vs. Tertile 1, 11.5%; P<0.05). Post-transplant BAFF levels showed significant association with pre-transplant sensitization, but did not show association with anti-HLA antibodies and positive donor-specific antibodies at the time of biopsy. We did not find any association between post-transplant BAFF levels and allograft biopsy results, Banff scores and microvascular inflammation scores. In conclusion, pre-transplant BAFF levels are associated with pre-transplant sensitization and are useful in predicting allograft rejection. But post-transplant BAFF levels measured at the time of indication biopsy are not associated with the appearance of de novo HLA-DSA, allograft rejection, biopsy findings and other allograft outcomes.	[Min, Ji Won; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Choi, Min Seok; Choi, Bum Soon; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Chung, Byung Ha] Catholic Univ Korea, Transplant Res Ctr, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; [Min, Ji Won; Choi, Bum Soon; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Chung, Byung Ha] Catholic Univ Korea, Div Nephrol, Seoul St Marys Hosp, Dept Internal Med,Coll Med, Seoul, South Korea; [Oh, Eun-Jee] Catholic Univ Korea, Dept Lab Med, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Chung, BH (corresponding author), Catholic Univ Korea, Transplant Res Ctr, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.; Chung, BH (corresponding author), Catholic Univ Korea, Div Nephrol, Seoul St Marys Hosp, Dept Internal Med,Coll Med, Seoul, South Korea.; Oh, EJ (corresponding author), Catholic Univ Korea, Dept Lab Med, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	ejoh@catholic.ac.kr; chungbh@catholic.ac.kr		Oh, Eun-Jee/0000-0001-5870-915X; Min, Ji-Won/0000-0001-6295-8095	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant (HI13C1232) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant (HI13C1232) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	Banham G, 2013, TRANSPLANTATION, V96, P413, DOI 10.1097/TP.0b013e318298dd65; Bloom D, 2009, AM J TRANSPLANT, V9, P1835, DOI 10.1111/j.1600-6143.2009.02710.x; Chung BH, 2011, RENAL FAILURE, V33, P150, DOI 10.3109/0886022X.2011.552149; Clatworthy MR, 2011, AM J TRANSPLANT, V11, P1359, DOI 10.1111/j.1600-6143.2011.03554.x; Comoli P, 2015, TRANSPLANTATION, V99, P243, DOI 10.1097/TP.0000000000000276; Eilertsen GO, 2014, LUPUS, V23, P1383, DOI 10.1177/0961203314543914; Gloor JM, 2006, AM J TRANSPLANT, V6, P1841, DOI 10.1111/j.1600-6143.2006.01416.x; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Ishida H, 2014, TRANSPL INT, V27, P371, DOI 10.1111/tri.12267; Kirk AD, 2010, NAT REV NEPHROL, V6, P584, DOI 10.1038/nrneph.2010.111; Lehnhardt AM, 2015, CLIN TRANSPLANT, V29, P359, DOI 10.1111/ctr.12523; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Pers JO, 2005, ANN NY ACAD SCI, V1050, P34, DOI 10.1196/annals.1313.004; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Stohl W, 2014, EXPERT OPIN THER TAR, V18, P473, DOI 10.1517/14728222.2014.888415; Thaunat O, 2008, TRANSPLANTATION, V85, P1648, DOI 10.1097/TP.0b013e3181735723; Thibault-Espitia A, 2012, AM J TRANSPLANT, V12, P2754, DOI 10.1111/j.1600-6143.2012.04194.x; Xu H, 2009, TRANSPL P, V41, P1552, DOI 10.1016/j.transproceed.2008.10.024; Xu H, 2009, TRANSPL P, V41, P112, DOI 10.1016/j.transproceed.2008.10.037; Zarkhin V, 2009, TRANSPLANTATION, V88, P1229, DOI 10.1097/TP.0b013e3181bbba1a	23	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162964	10.1371/journal.pone.0162964	http://dx.doi.org/10.1371/journal.pone.0162964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631619	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900102
J	Tomotsune, D; Hirashima, K; Fujii, M; Yue, FM; Matsumoto, K; Takizawa-Shirasawa, S; Yokoyama, T; Sasaki, K				Tomotsune, Daihachiro; Hirashima, Kanji; Fujii, Masako; Yue, Fengming; Matsumoto, Ken; Takizawa-Shirasawa, Sakiko; Yokoyama, Tadayuki; Sasaki, Katsunori			Enrichment of Pluripotent Stem Cell-Derived Hepatocyte-Like Cells by Ammonia Treatment	PLOS ONE			English	Article							HUMAN ES CELLS; GLUTAMINE-SYNTHETASE; MOUSE; LIVER; DIFFERENTIATION; EXPRESSION; COLONIES; CULTURE	Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are potential resources for the regeneration of defective organs, including the liver. However, some obstaclesmust be overcome before this becomes reality. Undifferentiated cells that remain following differentiation have teratoma-forming potential. Additionally, practical applications require a large quantity of differentiated cells, so the differentiation processmust be economical. Here we describe a DNA microarray-based global analysis of the gene expression profiles of differentiating human pluripotent stem cells. We identified differences and commonalities among six human pluripotent stem cell lines: the hESCs KhES1, KhES2, KhES3, and H1, and the iPSCs 201B7 and 243G1. Embryoid bodies (EBs) formed without requiring supplementation with inducing factors. EBs also expressed some liver-specific metabolic genes including the ammonia-metabolizing enzymes glutamine synthetase and carbamoyl-phosphate synthase 1. Real-time PCR analysis revealed hepatocyte-like differentiation of EBs treated with ammonia in Lanford medium. Analysis of DNA microarray data suggested that hepatocyte-like cells were the most abundant population in ammonia-treated cells. Furthermore, expression levels of undifferentiated pluripotent stem cell markers were drastically reduced, suggesting a reduced teratoma-forming capacity. These results indicate that treatment of EBs with ammonia in Lanford medium may be an effective inducer of hepatic differentiation in absence of expensive inducing factors.	[Tomotsune, Daihachiro; Yue, Fengming; Sasaki, Katsunori] Shinshu Univ Matsumoto, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Dept Biotechnol & Biomed Engn, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Hirashima, Kanji; Fujii, Masako; Yue, Fengming; Sasaki, Katsunori] Shinshu Univ, Sch Med, Dept Histol & Embryol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Matsumoto, Ken] Nissui Pharmaceut Co Ltd, 1075-2 Hokunanmoro, Yuki, Ibaraki 3070036, Japan; [Takizawa-Shirasawa, Sakiko; Yokoyama, Tadayuki] Bourbon Corp, 4-2-14 Matsunami, Kashiwazaki, Niigata 9458611, Japan	Shinshu University; Shinshu University	Tomotsune, D (corresponding author), Shinshu Univ Matsumoto, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Dept Biotechnol & Biomed Engn, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	dtomo@shinshu-u.ac.jp; katsmd@shinshu-u.ac.jp	Hirashima, Kanji/AAX-1696-2020		Ministry of Education, Culture, Sports, Science and Technology [22500425, 15K01280, 24240076, 15H01803]; Nissui Pharmaceutical Co., Ltd.; Bourbon Corporation; JSPS KAKENHI [JP22500425, JP24240076, JP15H01803, JP15K01280]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nissui Pharmaceutical Co., Ltd.; Bourbon Corporation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Daihachiro Tomotsune received Grant-in-Aid for Scientific Research (c) 22500425 and 15K01280 from The Ministry of Education, Culture, Sports, Science and Technology. (https://kaken.nii.ac.jp/d/p/22500425.ja.html, https://kaken.nii.ac.jp/d/p/15K01280.ja.html). Katsunori Sasaki received Grant-in-Aid for Scientific Research(A) 24240076 and 15H01803 from The Ministry of Education, Culture, Sports, Science and Technology. (https://kaken.nii.ac.jp/d/p/24240076.ja.html, https://kaken.nii.ac.jp/d/p/15H01803.ja.html). Ken Matsumoto is employed by Nissui Pharmaceutical Co., Ltd. and Sakiko Takizawa-Shirasawa and Tadayuki Yokoyama are employed by Bourbon Corporation. Nissui Pharmaceutical Co., Ltd. and Bourbon Corporation provided support in the form of salaries for authors KM, ST-S, and TY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We gratefully thank Akiko Yoshitome for assistance with real-time PCR analysis. We also thank Yumi Uedai and Ikuei Hiraka at DNA Chip Research, Inc., for supporting the processing of microarray data. This work was supported by JSPS KAKENHI Grant Number JP22500425 and JP24240076, JP15H01803 and JP15K01280.	Bartlett DC, 2015, EXPERT REV GASTROENT, V9, P1261, DOI 10.1586/17474124.2015.1073106; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; CAMPBELL JW, 1985, SCIENCE, V228, P349, DOI 10.1126/science.228.4697.349; Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; Hirschi KK, 2014, ANNU REV BIOMED ENG, V16, P277, DOI 10.1146/annurev-bioeng-071813-105108; Ichikawa H, 2011, CRYOPRESERVATION PLU, P1; Ichikawa H, 2013, ANN ANAT, V195, P50, DOI 10.1016/j.aanat.2012.05.004; Ichikawa H, 2012, CRYOBIOLOGY, V64, P12, DOI 10.1016/j.cryobiol.2011.11.005; Johkura K, 2004, J ANAT, V205, P247, DOI 10.1111/j.0021-8782.2004.00336.x; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P407, DOI 10.2133/dmpk.DMPK-14-RG-022; LANFORD RE, 1989, IN VITRO CELL DEV B, V25, P174; Lee SY, 2015, INT J STEM CELLS, V8, P36, DOI 10.15283/ijsc.2015.8.1.36; Mogi A, 2009, TISSUE CELL, V41, P79, DOI 10.1016/j.tice.2008.06.005; Mogi A, 2014, J MED BIOL ENG, V34, P101, DOI [10.5405/jmbe.2225, 10.5405/jmbe.1356]; Notenboom RGE, 1997, MICROSC RES TECHNIQ, V39, P413, DOI 10.1002/(SICI)1097-0029(19971201)39:5<413::AID-JEMT4>3.0.CO;2-H; PACKARD GC, 1983, SCIENCE, V221, P1049, DOI 10.1126/science.221.4615.1049; Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651; Sasaki K, 2009, THESCIENTIFICWORLDJO, V9, P884, DOI 10.1100/tsw.2009.97; Sauer V, 2014, CURR PATHOBIOL REP, V1, P11; Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4; SCHUMPP B, 1992, CYTOTECHNOLOGY, V8, P39, DOI 10.1007/BF02540028; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Takizawa-Shirasawa S, 2013, CELL TISSUE RES, V354, P751, DOI 10.1007/s00441-013-1695-6; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tomizawa Minoru, 2015, World J Methodol, V5, P108, DOI 10.5662/wjm.v5.i3.108; Tomizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071897; Tomotsune D, 2011, ADVANCES IN REGENERATIVE MEDICINE, P145; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Vermeulen T, 2008, ARCH BIOCHEM BIOPHYS, V478, P96, DOI 10.1016/j.abb.2008.07.009; Yoshie S, 2010, BIOCHEM BIOPH RES CO, V391, P1477, DOI 10.1016/j.bbrc.2009.12.097; Yue FM, 2013, REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P117, DOI 10.5772/56000	35	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162693	10.1371/journal.pone.0162693	http://dx.doi.org/10.1371/journal.pone.0162693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632182	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900065
J	Alemany, S; Vilor-Tejedor, N; Bustamante, M; Pujol, J; Macia, D; Martinez-Vilavella, G; Fenoll, R; Alvarez-Pedrerol, M; Forns, J; Julvez, J; Suades-Gonzalez, E; Llop, S; Rebagliato, M; Sunyer, J				Alemany, Silvia; Vilor-Tejedor, Natalia; Bustamante, Mariona; Pujol, Jesus; Macia, Didac; Martinez-Vilavella, Gerard; Fenoll, Raquel; Alvarez-Pedrerol, Mar; Forns, Joan; Julvez, Jordi; Suades-Gonzalez, Elisabet; Llop, Sabrina; Rebagliato, Marisa; Sunyer, Jordi			A Genome-Wide Association Study of Attention Function in a Population-Based Sample of Children	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; ALZHEIMERS-DISEASE; DEFICIT/HYPERACTIVITY DISORDER; SELECTIVE ATTENTION; INSULIN-RESISTANCE; HUMAN BRAIN; EXPRESSION; NETWORKS; PATHWAY; PROTEIN	Background Attention function filters and selects behaviorally relevant information. This capacity is impaired in some psychiatric disorders and has been proposed as an endophenotype for Attention-Deficit/Hyperactivity Disorder; however, its genetic basis remains largely unknown. This study aimed to identify single nucleotide polymorphism (SNPs) associated with attention function. Materials and Methods The discovery sample included 1655 children (7-12 years) and the replication sample included 546 children (5-8 years). Five attention outcomes were assessed using the computerized Attentional Network Test (ANT): alerting, orienting, executive attention, Hit Reaction time (HRT) and the standard error of HRT (HRTSE). A Genome-wide Association Study was conducted for each outcome. Gene set enrichment analyses were performed to detect biological pathways associated with attention outcomes. Additional neuroimaging analyses were conducted to test neural effects of detected SNPs of interest. Results Thirteen loci showed suggestive evidence of association with attention function (P<10(-5)) in the discovery sample. One of them, the rs4321351 located in the PID1 gene, was nominally significant in the replication sample although it did not survive multiple testing correction. Neuroimaging analysis revealed a significant association between this SNP and brain structure and function involving the frontal-basal ganglia circuits. The mTOR signaling and Alzheimer disease-amyloid secretase pathways were significantly enriched for alerting, orienting and HRT respectively (FDR<5%). Conclusion These results suggest for the first time the involvement of the PID1 gene, mTOR signaling and Alzheimer disease-amyloid secretase pathways, in attention function during childhood. These genes and pathways have been proposed to play a role in neuronal plasticity, memory and neurodegenerative disease.	[Alemany, Silvia; Vilor-Tejedor, Natalia; Bustamante, Mariona; Alvarez-Pedrerol, Mar; Forns, Joan; Julvez, Jordi; Suades-Gonzalez, Elisabet; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain; [Alemany, Silvia; Vilor-Tejedor, Natalia; Bustamante, Mariona; Alvarez-Pedrerol, Mar; Forns, Joan; Julvez, Jordi; Suades-Gonzalez, Elisabet; Sunyer, Jordi] Univ Pompeu Fabra, Barcelona, Spain; [Alemany, Silvia; Vilor-Tejedor, Natalia; Bustamante, Mariona; Alvarez-Pedrerol, Mar; Forns, Joan; Julvez, Jordi; Suades-Gonzalez, Elisabet; Llop, Sabrina; Rebagliato, Marisa; Sunyer, Jordi] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Bustamante, Mariona] Barcelona Inst Sci & Technol, CRG, Barcelona, Spain; [Pujol, Jesus; Macia, Didac; Martinez-Vilavella, Gerard; Fenoll, Raquel] Hosp del Mar, Dept Radiol, MRI Res Unit, Barcelona, Spain; [Pujol, Jesus] CIBERSAM G21, Ctr Invest Biomed Red Salud Mental, Barcelona, Spain; [Forns, Joan] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Genes & Environm, Oslo, Norway; [Suades-Gonzalez, Elisabet] Univ Barcelona, Learning Disabil Unit UTAE, Barcelona, Spain; [Suades-Gonzalez, Elisabet] Univ Barcelona, Neuropediat Dept, Hosp Sant Joan de Deu, Barcelona, Spain; [Llop, Sabrina; Rebagliato, Marisa] Univ Valencia, Univ Jaume 1, FISABIO, Epidemiol & Environm Hlth Joint Res Unit, Valencia, Spain; [Rebagliato, Marisa] Univ Jaime I, Castellon de La Plana, Spain; [Sunyer, Jordi] IMIM Hosp del Mar Med Res Inst, Barcelona, Spain	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Norwegian Institute of Public Health (NIPH); University of Barcelona; University of Barcelona; Universitat Jaume I; University of Valencia; Universitat Jaume I; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Alemany, S (corresponding author), Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain.; Alemany, S (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Alemany, S (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain.	silvia.alemany@isglobal.org	Julvez, Jordi/R-4531-2017; Macia, Didac/AAB-5182-2021; Sierra, Silvia Alemany/J-7419-2013; Sunyer, Jordi/G-6909-2014; Bustamante, Mariona/ABB-9142-2021; Llop, Sabrina/L-2122-2015; Martínez-Vilavella, Gerard/ABG-6267-2020; Rebagliato, Marisa/L-6116-2018	Julvez, Jordi/0000-0003-0818-4003; Macia, Didac/0000-0003-3315-7293; Sierra, Silvia Alemany/0000-0002-7925-6767; Sunyer, Jordi/0000-0002-2602-4110; Bustamante, Mariona/0000-0003-0127-2860; Llop, Sabrina/0000-0002-6784-4211; Rebagliato, Marisa/0000-0001-5825-0190; Forns, Joan/0000-0002-1066-0358; Vilor-Tejedor, Natalia/0000-0003-4935-6721	European Research Council under the ERC Grant [268479]; Institute de Salud Carlos III [Red INMA G03/176, CB06/02/0041, FIS-FEDER: PI041436, PI081151, FIS-FEDER: 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/0178, 11/01007, 11/02591, 11/02038, 13/1944, 13/2032, 14/00891, 14/01687, Miguel Servet-FEDER MS15/0025, CD14/00214]; Generalitat de Catalunya [CIRIT 1999SGR 00241]; EU [FP6-2003-Food-3-A-016320]; UE [282957, HEALTH.2010.2.4.5-1]; Conselleria de Sanitat, Generalitat Valenciana; Agenda de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya - Fons Social Europeu [2015 FI_B 00636]; Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness) [MS14/00108]	European Research Council under the ERC Grant; Institute de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); EU(European Commission); UE; Conselleria de Sanitat, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Agenda de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya - Fons Social Europeu; Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness)	The research leading to these results has received funding from the European Research Council under the ERC Grant Agreement number 268479 - the BREATHE project. The INMA project was funded by grants from Institute de Salud Carlos III (Red INMA G03/176 and CB06/02/0041). The INMA-Sabadell cohort received funding from Institute de Salud Carlos III (FIS-FEDER: PI041436 and PI081151), Generalitat de Catalunya-CIRIT 1999SGR 00241, and EU sixth framework project NEWGENERIS FP6-2003-Food-3-A-016320. The INMA-Valencia cohort received funding from UE (FP7-ENV-2011 cod 282957 and HEALTH.2010.2.4.5-1), and from Institute de Salud Carlos III (FIS-FEDER: 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/0178, 11/01007, 11/02591, 11/02038, 13/1944, 13/2032, 14/00891, 14/01687 and Miguel Servet-FEDER MS15/0025) and the Conselleria de Sanitat, Generalitat Valenciana. SA is supported by a Sara Borrell grant from the Institute de Salud Carlos III (CD14/00214). NV-T is funded by a pre-doctoral grant from the Agenda de Gestio d'Ajuts Universitaris i de Recerca (2015 FI_B 00636) Generalitat de Catalunya - Fons Social Europeu. JJ is supported by a Miguel Servet (MS) Fellowship (MS14/00108) awarded by the Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2011, NEUROSCIENCE, V199, P1, DOI 10.1016/j.neuroscience.2011.10.044; Alemany S, 2015, AM J MED GENET B; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anney RJL, 2008, AM J MED GENET B, V147B, P1369, DOI 10.1002/ajmg.b.30871; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Bonala S, 2013, MOL ENDOCRINOL, V27, P1518, DOI 10.1210/me.2013-1048; Cai Z, 2012, J NEUROSCI RES, V90, P1105, DOI 10.1002/jnr.23011; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Davies G, 2016, MOL PSYCHIATR, V21, P758, DOI 10.1038/mp.2016.45; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Egeland J, 2007, ARCH CLIN NEUROPSYCH, V22, P763, DOI 10.1016/j.acn.2007.06.004; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Forns J, 2014, NEUROPSYCHOLOGY, V28, P519, DOI 10.1037/neu0000085; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franke B, 2012, MOL PSYCHIATR, V17, P960, DOI 10.1038/mp.2011.138; Gallagher R, 2001, ANN NY ACAD SCI, V931, P148; Giubilei F, 2008, AGE AGEING, V37, P640, DOI 10.1093/ageing/afn132; Goi T, 1999, MOL CELL BIOL, V19, P1731; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Holmboe K, 2010, DEV PSYCHOL, V46, P404, DOI 10.1037/a0018180; Holscher C, 2014, ACTA PHYSL SINICA, V66, P497; Kajiwara Y, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-1; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liang HM, 2014, NEURAL REGEN RES, V9, P1297, DOI 10.4103/1673-5374.137577; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; McKenna BS, 2013, PSYCHIAT RES-NEUROIM, V212, P183, DOI 10.1016/j.pscychresns.2013.01.005; Mulet B, 2007, EUR PSYCHIAT, V22, P171, DOI 10.1016/j.eurpsy.2006.07.005; Oguro-Ando A, 2014, MOL PSYCHIAT; Palmfeldt J, 2011, J PROTEOME RES, V10, P2389, DOI 10.1021/pr101218d; Posner MI, 2009, PHYS LIFE REV, V6, P103, DOI 10.1016/j.plrev.2009.02.001; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pujol J, 2016, NEUROIMAGE, V129, P175, DOI 10.1016/j.neuroimage.2016.01.036; Pujol J, 2015, CORTEX, V64, P148, DOI 10.1016/j.cortex.2014.10.012; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Saito SY, 2006, CEREBELLUM, V5, P227, DOI 10.1080/14734220600632564; Sherva R, 2014, ALZHEIMERS DEMENT, V10, P45, DOI 10.1016/j.jalz.2013.01.008; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; Tohgo A, 2006, MOL CELL NEUROSCI, V31, P326, DOI 10.1016/j.mcn.2005.10.003; Vagelatos NT, 2013, EPIDEMIOL REV; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Wang B, 2006, GENE, V379, P132, DOI 10.1016/j.gene.2006.05.008; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wu WL, 2011, MOL GENET METAB, V102, P374, DOI 10.1016/j.ymgme.2010.11.165; Xu CS, 2015, AGE AGEING, V44, P452, DOI 10.1093/ageing/afv015; Zhang CM, 2009, ACTA PHARMACOL SIN, V30, P120, DOI 10.1038/aps.2008.9; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	62	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163048	10.1371/journal.pone.0163048	http://dx.doi.org/10.1371/journal.pone.0163048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656889	Green Published, Green Accepted, gold			2022-12-27	WOS:000383893200059
J	Chang, CH; Tang, CH; Kang, CK; Lo, WY; Lee, TH				Chang, Chia-Hao; Tang, Cheng-Hao; Kang, Chao-Kai; Lo, Wan-Yu; Lee, Tsung-Han			Comparison of Integrated Responses to Nonlethal and Lethal Hypothermal Stress in Milkfish (Chanos chanos): A Proteomics Study	PLOS ONE			English	Article							BREAM SPARUS-AURATA; GENE-EXPRESSION; SEA BREAM; MOLECULAR CHARACTERIZATION; AMBIENT-TEMPERATURE; PROTEIN WAP65; COLD; ACCLIMATION; TOLERANCE; PEROXIREDOXIN	Milkfish is an important aquaculture species in Taiwan, and its high mortality during cold snaps in winter usually causes huge economic losses. To understand the effect of hypothermal stress and the corresponding compensatory stress response in milkfish, this study aimed to compare liver and gill protein levels between milkfish exposed to nonlethal (18 degrees C), lethal (16 degrees C), and control (28 degrees C) temperatures. Using a proteomics approach based on two-dimensional electrophoresis and nano-LC-MS/MS analysis, this study identified thirty unique protein spots from milkfish livers and gills for which protein abundance was significantly different between nonlethal, lethal, and control temperature groups. Proteins identified in the liver were classified into three different categories according to their cellular function: (1) anti-oxidative stress, (2) apoptotic pathway, and (3) cytoskeleton. Similarly, proteins identified in the gill were sorted in five different functional categories: (1) cytoskeleton, (2) immune response, (3) protein quality control, (4) energy production, and (5) intracellular homeostasis. Based on functional information derived from the identified proteins, we assumed that different levels of hypothermal stress had a different effect and induced a different cellular response. Upon nonlethal hypothermal stress, the identified proteins were involved in anti-oxidative stress and anti-inflammation pathways, suggesting that milkfish had high levels of oxidative stress in the liver and exhibited inflammation response in the gill. Upon lethal hypothermal stress, however, identified proteins were associated with apoptosis in the liver and regulation of intracellular homeostasis in the gill. The present study provided evidence to illustrate different multi-physiological responses to nonlethal and lethal hypothermal stress in milkfish livers and gills.	[Chang, Chia-Hao; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Tang, Cheng-Hao] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 804, Taiwan; [Kang, Chao-Kai] Natl Cheng Kung Univ, Tainan Hydraul Lab, Tainan 709, Taiwan; [Lo, Wan-Yu] Hung Kuang Univ, Dept Biotechnol, Taichung 433, Taiwan; [Lee, Tsung-Han] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan	National Chung Hsing University; National Sun Yat Sen University; National Cheng Kung University; Hungkuang University; National Chung Hsing University	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.; Lo, WY (corresponding author), Hung Kuang Univ, Dept Biotechnol, Taichung 433, Taiwan.; Lee, TH (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan.	drwanyu@gmail.com; thlee@email.nchu.edu.tw	Chang, Chia-Hao/AAW-2598-2020	Chang, Chia-Hao/0000-0002-7583-4291; Lee, Tsung-Han/0000-0002-3542-4335	Ministry of Science and Technology (MOST) of Taiwan [NSC 99-2321-B-005-013-MY3, 104-2321-B-005-004]; Taiwan Comprehensive University System [103TCUS03]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Comprehensive University System	This study was supported by grants to THL from the Ministry of Science and Technology (MOST) of Taiwan (NSC 99-2321-B-005-013-MY3 and 104-2321-B-005-004; https://www.most.gov.tw/en/public) and the Taiwan Comprehensive University System (103TCUS03; http://www.tcus.edu.tw/English).	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Bai ZY, 2012, ANIMAL, V6, P887, DOI 10.1017/S1751731111002199; Barnabe G., 1990, AQUACULTURE, P647; Barnes KR, 2014, COMP BIOCHEM PHYS A, V168, P50, DOI 10.1016/j.cbpa.2013.11.004; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P727, DOI 10.1016/j.dci.2003.11.005; Baumgarner BL, 2013, COMP BIOCHEM PHYS D, V8, P58, DOI 10.1016/j.cbd.2012.11.001; Bermejo-Nogales A, 2008, COMP BIOCHEM PHYS B, V149, P428, DOI 10.1016/j.cbpb.2007.11.003; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; Bucci B, 2006, ANTICANCER RES, V26, P4549; Cattiaux J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044613; Chang CH, 2016, COMP BIOCHEM PHYS A, V194, P19, DOI 10.1016/j.cbpa.2016.01.013; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Cheng SY, 2013, FISH PHYSIOL BIOCHEM, V39, P277, DOI 10.1007/s10695-012-9698-x; Choi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085509; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Crockett EL, 2005, PHYSL FISHES; De Zoysa M, 2012, FISH SHELLFISH IMMUN, V33, P28, DOI 10.1016/j.fsi.2012.03.029; Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1; Donaldson MR, 2008, J FISH BIOL, V73, P1491, DOI 10.1111/j.1095-8649.2008.02061.x; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; FitzGerald WJ, 2004, MILKFISH AQUACULTURE; Fujisawa K, 2011, BIOCHEM BIOPH RES CO, V414, P331, DOI 10.1016/j.bbrc.2011.09.067; Gilmour KM, 2012, RESP PHYSIOL NEUROBI, V184, P223, DOI 10.1016/j.resp.2012.06.001; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Hagen S, 2012, CELL CALCIUM, V51, P411, DOI 10.1016/j.ceca.2012.01.004; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hsieh SL, 2007, COMP BIOCHEM PHYS B, V147, P438, DOI 10.1016/j.cbpb.2007.02.010; Hu MY, 2010, FISHERIES SCI, V76, P267, DOI 10.1007/s12562-010-0214-x; Huang CY, 2015, COMP BIOCHEM PHYS A, V179, P25, DOI 10.1016/j.cbpa.2014.09.001; Huang H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0748-8; Huang QY, 2011, PROTEOMICS, V11, P3743, DOI 10.1002/pmic.201100084; Huntingford C, 2013, NATURE, V500, P327, DOI 10.1038/nature12310; Huusko A, 2007, RIVER RES APPL, V23, P469, DOI 10.1002/rra.999; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Ibarz A, 2010, REV FISH BIOL FISHER, V20, P539, DOI 10.1007/s11160-010-9159-5; Ibarz A, 2010, PROTEOMICS, V10, P963, DOI 10.1002/pmic.200900528; Jian CY, 2003, AQUAC RES, V34, P175, DOI 10.1046/j.1365-2109.2003.00800.x; Ju ZL, 2007, COMP BIOCHEM PHYS C, V145, P134, DOI 10.1016/j.cbpc.2006.06.012; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Kikuchi K, 1997, FISH PHYSIOL BIOCHEM, V17, P423, DOI 10.1023/A:1007768531655; Kim HE, 2013, INT J BIOCHEM CELL B, V45, P1217, DOI 10.1016/j.biocel.2013.03.006; Kinoshita S, 2001, FISH PHYSIOL BIOCHEM, V24, P125, DOI 10.1023/A:1011939321298; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kyprianou TD, 2010, J COMP PHYSIOL B, V180, P1005, DOI 10.1007/s00360-010-0481-y; Laitusis AL, 1999, J BIOL CHEM, V274, P486, DOI 10.1074/jbc.274.1.486; Lee S, 2012, CELL DEATH DIFFER, V19, P1613, DOI 10.1038/cdd.2012.40; Li S, 2014, FISH SHELLFISH IMMUN, V40, P120, DOI 10.1016/j.fsi.2014.06.027; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Machado JP, 2014, J HERED, V105, P237, DOI 10.1093/jhered/est087; Martin SAM, 2007, PROTEOMICS, V7, P2275, DOI 10.1002/pmic.200700020; Mu YN, 2013, FISH PHYSIOL BIOCHEM, V39, P1267, DOI 10.1007/s10695-013-9781-y; Noyola J, 2013, J THERM BIOL, V38, P14, DOI 10.1016/j.jtherbio.2012.09.001; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Perez-Sanchez J, 2011, FISH SHELLFISH IMMUN, V31, P294, DOI 10.1016/j.fsi.2011.05.015; PICKETT MH, 1983, J BIOL CHEM, V258, P4762; Ramana Kota V, 2011, Biomol Concepts, V2, P103; Rees BB, 2009, COMP BIOCHEM PHYS A, V154, P70, DOI 10.1016/j.cbpa.2009.05.001; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Rufino-Palomares E, 2011, PROTEOMICS, V11, P3312, DOI 10.1002/pmic.201000271; Salas-Leiton E, 2009, MAR BIOTECHNOL, V11, P473, DOI 10.1007/s10126-008-9168-8; Sandbichler AM, 2011, J EXP BIOL, V214, P1473, DOI 10.1242/jeb.050062; Shi YH, 2010, MOL BIOL REP, V37, P1523, DOI 10.1007/s11033-009-9551-1; Silva LD, 2009, J PHYSL, V587, P655, DOI [10.1113/jphysiol.2008.164947, DOI 10.1113/JPHYSIOL.2008.164947]; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3; Srivastava SK, 2011, CHEM-BIOL INTERACT, V191, P330, DOI 10.1016/j.cbi.2011.02.023; Tang CH, 2009, ZOOL STUD, V48, P435; TORRES JJ, 1988, MAR BIOL, V98, P169, DOI 10.1007/BF00391192; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Viitaniemi HM, 2011, J PROTEOME RES, V10, P4033, DOI 10.1021/pr200234a; Visudtiphole V, 2010, AQUACULTURE, V308, pS100, DOI 10.1016/j.aquaculture.2010.06.040; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wawrowski A, 2011, J COMP PHYSIOL B, V181, P199, DOI 10.1007/s00360-010-0518-2; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274; Yang N, 2013, GENE, V521, P32, DOI 10.1016/j.gene.2013.03.048; Yang WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055470, 10.1371/journal.pone.0076447]; Zhu YJ, 2013, FISH SHELLFISH IMMUN, V34, P617, DOI 10.1016/j.fsi.2012.12.005	84	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163538	10.1371/journal.pone.0163538	http://dx.doi.org/10.1371/journal.pone.0163538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657931	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200142
J	Hanschmidt, F; Lehnig, F; Riedel-Heller, SG; Kersting, A				Hanschmidt, Franz; Lehnig, Franziska; Riedel-Heller, Steffi G.; Kersting, Anette			The Stigma of Suicide Survivorship and Related Consequences-A Systematic Review	PLOS ONE			English	Review							GRIEF REACTIONS; BEREAVEMENT DIFFERENT; MENTAL-ILLNESS; DEATH; EXPERIENCES; HEALTH; SCALE; FRAMEWORK; SYMPTOMS; CONTEXT	Background considerable proportion of the population experiences major life disruptions after losing a loved one to suicide. Social stigma attached to suicide survivors adds to complications occurring in the course of suicide bereavement. Despite its known risks, stigma related to suicide survivors has been sparsely investigated. Methods We conducted a systematic literature search in PubMed, Web of Science, PsycInfo and PsyArticles, of studies indexed up through August 2015. Articles were eligible for inclusion if they addressed experiences of stigma in suicide survivors, compared them to other bereavement populations, or investigated stigmatizing attitudes within the public. The search was restricted to English-language studies. Results 25 records matched inclusion criteria. Study designs were heterogeneous, making comparisons difficult. Results demonstrated that suicide survivors experience stigma in the form of shame, blame, and avoidance. Suicide survivors showed higher levels of stigma than natural death survivors. Stigma was linked to concealment of the death, social withdrawal, reduced psychological and somatic functioning, and grief difficulties. Only one study investigated stigmatizing attitudes towards suicide survivors among the general population. Limitations Internal and external validity of the studies was restricted by a lack of valid measures and selection bias. Conclusions More methodologically sound research is needed to understand the impact of stigma on suicide survivors' grief trajectories and to separate it from other grief aspects. Clinicians and grief-counselors as well as the public should be educated about the persistent stigma experienced by suicide survivors.	[Hanschmidt, Franz; Lehnig, Franziska; Kersting, Anette] Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany; [Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany	Leipzig University; Leipzig University	Hanschmidt, F (corresponding author), Univ Leipzig, Dept Psychosomat Med, Leipzig, Germany.	franz.hanschmidt@medizin.uni-leipzig.de	Riedel-Heller, Steffi/ABG-1537-2021					[Anonymous], 2009, SYSTEMATIC REV CRDS; Armour M, 2007, J HUM BEHAV SOC ENVI, V14, P53, DOI 10.1300/J137v14n04_04; Avrami S, 2005, OMEGA-J DEATH DYING, V51, P65, DOI 10.2190/DGWU-PMLM-5J3Y-J7LL; Bailley SE, 2000, DEATH STUD, V24, P721, DOI 10.1080/074811800750036596; BARRETT TW, 1990, SUICIDE LIFE-THREAT, V20, P1; BARRETT TW, 1989, SUICIDE LIFE-THREAT, V19, P201; Batterham PJ, 2013, CRISIS, V34, P13, DOI 10.1027/0227-5910/a000156; Biddle L, 2003, SOC SCI MED, V56, P1033, DOI 10.1016/S0277-9536(02)00097-7; CALHOUN LG, 1991, OMEGA-J DEATH DYING, V23, P95, DOI 10.2190/5BMQ-AWHG-79KN-T619; CALHOUN LG, 1985, OMEGA-J DEATH DYING, V16, P283, DOI 10.2190/V4FW-PF4K-MRPK-15FW; Chambers SK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-184; Chapple A, 2015, SOCIOL HEALTH ILL, V37, P610, DOI 10.1111/1467-9566.12224; Clark S E, 1995, Crisis, V16, P27; Cleiren M, 1994, Crisis, V15, P22; Corrigan PW, 2005, APPL PREV PSYCHOL, V11, P179, DOI 10.1016/j.appsy.2005.07.001; Cvinar JG, 2005, PERSPECT PSYCHIATR C, V41, P14, DOI 10.1111/j.0031-5990.2005.00004.x; Demi A S, 1991, Arch Psychiatr Nurs, V5, P350; Drapeau CW, 2015, US SUICIDE 2014 OFFI; DUNN RG, 1987, OMEGA-J DEATH DYING, V18, P175, DOI 10.2190/6K91-GN16-0DF6-5FUE; Feigelman W, 2008, OMEGA-J DEATH DYING, V57, P217, DOI 10.2190/OM.57.3.a; Feigelman W, 2011, OMEGA-J DEATH DYING, V63, P291, DOI 10.2190/OM.63.4.a; Feigelman W, 2009, DEATH STUD, V33, P591, DOI 10.1080/07481180902979973; Fielden JM, 2003, INT J MENT HEALTH NU, V12, P74, DOI 10.1046/j.1440-0979.2003.00271.x; Frost DM, 2007, J HEALTH PSYCHOL, V12, P636, DOI 10.1177/1359105307078170; GIBSON JA, 1986, J DIVORCE, V10, P163; Harwood D, 2002, J AFFECT DISORDERS, V72, P185, DOI 10.1016/S0165-0327(01)00462-1; Herek G.M., 2015, STIGMA HEALTH, V1, P18, DOI [10.1037/2376-6972.1.S.18, DOI 10.1037/2376-6972.1.S.18]; Houck JA, 2007, J HIV-AIDS SOC SERV, V6, P97, DOI 10.1300/J187v06n03_07; Isaac M, 2009, CAN J PSYCHIAT, V54, P260, DOI 10.1177/070674370905400407; Jordan JR, 2011, SER DEATH DYING, P19; Jordan JR, 2001, SUICIDE LIFE-THREAT, V31, P91, DOI 10.1521/suli.31.1.91.21310; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735; McIntosh J, 1992, CRISIS, V13, P82; MCINTOSH JL, 1988, DEATH STUD, V12, P21, DOI 10.1080/07481188808252217; McMenamy JM, 2008, SUICIDE LIFE-THREAT, V38, P375, DOI 10.1521/suli.2008.38.4.375; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NESS DE, 1990, AM J PSYCHIAT, V147, P279; Oulanova O, 2014, OMEGA-J DEATH DYING, V69, P151, DOI 10.2190/OM.69.2.d; Pachankis JE, 2007, PSYCHOL BULL, V133, P328, DOI 10.1037/0033-2909.133.2.328; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Pitman A, 2014, LANCET PSYCHIAT, V1, P86, DOI 10.1016/S2215-0366(14)70224-X; Pompili M, 2003, BRIT J PSYCHIAT, V183, P173, DOI 10.1192/S0007125000162774; Pompili M, 2013, INDIAN J PSYCHIAT, V55, P256, DOI 10.4103/0019-5545.117145; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Range LM, 1998, PERSPECTIVES LOSS SO, P213; Reed MD, 1998, SUICIDE LIFE-THREAT, V28, P285; Robinson J, 2013, CRISIS, V34, P164, DOI 10.1027/0227-5910/a000168; Rudestam K E, 1992, Crisis, V13, P41; Rudestam Kjell E., 1987, SUICIDE ITS AFTERMAT, P31; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Scocco P, 2012, PSYCHIAT RES, V200, P872, DOI 10.1016/j.psychres.2012.06.033; Seguin M, 1995, SUICIDE LIFE-THREAT, V25, P489; Silverman E, 1994, OMEGA, V30, P41, DOI DOI 10.2190/BPLN-DAG8-7F07-0BKP; SOLOMON MI, 1983, OMEGA-J DEATH DYING, V13, P377, DOI 10.2190/8ATQ-A38A-5HTL-G8TT; Sudak H, 2008, ACAD PSYCHIATR, V32, P136, DOI 10.1176/appi.ap.32.2.136; Sveen CA, 2008, SUICIDE LIFE-THREAT, V38, P13, DOI 10.1521/suli.2008.38.1.13; Tadros G, 2001, BRIT J PSYCHIAT, V179, P178, DOI 10.1192/bjp.179.2.178; Tal Young Ilanit, 2012, Dialogues Clin Neurosci, V14, P177; Thrift O, 2005, COUNS PSYCHOL, V20, P18; Tzeng WC, 2010, QUAL HEALTH RES, V20, P999, DOI 10.1177/1049732310365503; VANDONGEN CJ, 1993, DEATH STUD, V17, P125, DOI 10.1080/07481189308252610; VANDONGEN CJ, 1990, NURS RES, V39, P224; Wilson A, 2010, DEATH STUD, V34, P625, DOI 10.1080/07481181003761567; Wojtkowiak J, 2012, SUICIDE LIFE-THREAT, V42, P56, DOI 10.1111/j.1943-278X.2011.00070.x; World Health Organization, 2014, GLOB HLTH EST 2013 D; Yamanaka A, 2015, OMEGA-J DEATH DYING, V71, P82, DOI 10.1177/0030222814568290	71	81	82	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162688	10.1371/journal.pone.0162688	http://dx.doi.org/10.1371/journal.pone.0162688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GO	27657887	Green Submitted, Green Published, gold			2022-12-27	WOS:000383893200030
J	Antunes, A; Derkaoui, M; Terrade, A; Denizon, M; Deghmane, AE; Deutscher, J; Delany, I; Taha, MK				Antunes, Ana; Derkaoui, Meriem; Terrade, Aude; Denizon, Melanie; Deghmane, Ala-Eddine; Deutscher, Josef; Delany, Isabel; Taha, Muhamed-Kheir			The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection	PLOS ONE			English	Article							FACTOR-H-BINDING; NEISSERIA-MENINGITIDIS; ALTERNATIVE PATHWAY; NITRIC-OXIDE; COMPLEMENT; METABOLISM; PHOSPHORYLATION; VIRULENCE; DISEASE; GENOME	Neisseria meningitidis is an exclusively human pathogen frequently carried asymptomatically in the nasopharynx but it can also provoke invasive infections such as meningitis and septicemia. N. meningitidis uses a limited range of carbon sources during infection, such as glucose, that is usually transported into bacteria via the phosphoenolpyruvate (PEP): sugar phosphotransferase system (PTS), in which the phosphocarrier protein HPr (encoded by the ptsH gene) plays a central role. Although N. meningitidis possesses an incomplete PTS, HPr was found to be required for its virulence. We explored the role of HPr using bioluminescent wild-type and Delta ptsH strains in experimental infection in transgenic mice expressing the human transferrin. The wild-type MC58 strain was recovered at higher levels from the peritoneal cavity and particularly from blood compared to the Delta ptsH strain. The Delta ptsH strain provoked lower levels of septicemia in mice and was more susceptible to complement- mediated killing than the wild-type strain. We tested whether meningococcal structures impacted complement resistance and observed that only the capsule level was decreased in the Delta ptsH mutant. We therefore compared the transcriptomic profiles of wildtype and Delta ptsH strains and identified 49 differentially expressed genes. The HPr regulon contains mainly hypothetical proteins (43%) and several membrane-associated proteins that could play a role during host interaction. Some other genes of the HPr regulon are involved in stress response. Indeed, the Delta ptsH strain showed increased susceptibility to environmental stress conditions. Our data suggest that HPr plays a pleiotropic role in host-bacteria interactions most likely through the innate immune response that may be responsible for the enhanced clearance of the Delta ptsH strain from blood.	[Antunes, Ana; Terrade, Aude; Denizon, Melanie; Deghmane, Ala-Eddine; Taha, Muhamed-Kheir] Inst Pasteur, Unite Infect Bacteriennes Invas, F-75724 Paris 15, France; [Derkaoui, Meriem; Deutscher, Josef] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Deutscher, Josef] Univ Paris Diderot, Sorbonne Paris Cite, CNRS,UMR8261, Express Genet Microbienne,Inst Biol Physicochim, F-75005 Paris, France; [Delany, Isabel] Novartis Vaccines & Diagnost Srl GSK Co, Via Fiorentina 1, I-53100 Siena, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; GlaxoSmithKline	Antunes, A; Taha, MK (corresponding author), Inst Pasteur, Unite Infect Bacteriennes Invas, F-75724 Paris 15, France.	anasofia_antunes@yahoo.com.br; mktaha@pasteur.fr	Deghmane, Ala-Eddine/CAF-2140-2022		Agence National pour la Recherhce [ANR-05-MIIM-031]; Intiative d'Exellence (DYNAMO) [ANR-11-LABX-0011]; Institut Pasteur [E 024519]; ANR [ANR-05-MIIM-031]; "Initiative d'Excellence" program of the French government (grant DYNAMO) [ANR-11-LABX-0011]	Agence National pour la Recherhce(French National Research Agency (ANR)); Intiative d'Exellence (DYNAMO); Institut Pasteur(European Commission); ANR(French National Research Agency (ANR)); "Initiative d'Excellence" program of the French government (grant DYNAMO)	This study was supported by the Agence National pour la Recherhce (ANR-05-MIIM-031), recipient Josef Deutscher; Intiative d'Exellence (DYNAMO, ANR-11-LABX-0011), recipient Ana Antunes; Institut Pasteur (E 024519), recipient Muhamed-Kheir Taha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was supported by a grant from the ANR (ANR-05-MIIM-031) to JD and MKT, the "Initiative d'Excellence" program of the French government (grant DYNAMO, ANR-11-LABX-0011) to AA and The Institut Pasteur to MKT. We thank Dario Giorgini and Marco Spinsanti for their precious technical assistance and Philippe Joyet for fruitful discussions. The dynamic imaging was performed using the facilities of the Imagopole of the Institut Pasteur. We also thank Marie-Noelle Ungeheuer and Vesna Mellon (Institut Pasteur-ICAReB)	ABDILLAHI H, 1988, MICROB PATHOGENESIS, V4, P27, DOI 10.1016/0882-4010(88)90045-9; Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Del Tordello E, 2014, P NATL ACAD SCI USA, V111, P427, DOI 10.1073/pnas.1321556111; Derkaoui M, 2016, MOL MICROBIOL, V100, P788, DOI 10.1111/mmi.13349; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; Giuntini S, 2013, VACCINE, V31, P4192, DOI 10.1016/j.vaccine.2013.06.009; Guiddir T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-276; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hong E, 2012, VACCINE, V31, P183, DOI 10.1016/j.vaccine.2012.10.072; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Laver JR, 2010, FASEB J, V24, P286, DOI 10.1096/fj.08-128330; Leighton MP, 2001, MICROBIOL-SGM, V147, P1473, DOI 10.1099/00221287-147-6-1473; Lewis LA, 2014, INFECT IMMUN, V82, P2574, DOI 10.1128/IAI.01517-14; Lewis LA, 2014, VIRULENCE, V5, P98, DOI 10.4161/viru.26515; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madico G, 2007, J IMMUNOL, V178, P4489, DOI 10.4049/jimmunol.178.7.4489; MALLAVIA LP, 1970, J BACTERIOL, V101, P127, DOI 10.1128/JB.101.1.127-132.1970; Miller JH., 1972, EXPT MOL GENETICS; Pizza M, 2015, CURR OPIN MICROBIOL, V23, P68, DOI 10.1016/j.mib.2014.11.006; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schoen C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00114; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Smith H, 2007, INFECT IMMUN, V75, P4190, DOI 10.1128/IAI.00117-07; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; Szatanik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022210; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zarantonelli ML, 2003, FEMS MICROBIOL LETT, V226, P51, DOI 10.1016/S0378-1097(03)00558-5	51	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162434	10.1371/journal.pone.0162434	http://dx.doi.org/10.1371/journal.pone.0162434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655040	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700023
J	Boulin, M; Diaby, V; Tannenbaum, C				Boulin, Mathieu; Diaby, Vakaramoko; Tannenbaum, Cara			Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada	PLOS ONE			English	Article							MELLITUS; EVENTS; RISK; US; THIAZOLIDINEDIONES; INSULIN; PEOPLE	Background The costs of drug-induced hypoglycemia are a critical but often neglected component of value-based arguments to reduce tight glycemic control in older adults with type 2 diabetes. Methods An economic (decision-tree) analysis compared rates, costs, quality-adjusted life-years, and incremental costs per quality-adjusted life-year gained associated with mild, moderate and severe hypoglycemic events for 6 glucose-lowering medication classes in type 2 diabetic adults aged 65-79 versus those 80 years and older. The national U.S. (Center for Medicare Services) and Canadian public health payer perspectives were adopted. Findings Incidence rates of drug-induced hypoglycemia were the highest for basal insulin and sulfonylureas: 8.64 and 4.32 events per person-year in 65-79 year olds, and 12.06 and 6.03 events per person-year for 80 years and older. In both the U.S. and Canada, metformin dominated sulfonylureas, basal insulin and glucagon-like peptide1 receptor agonists. Relative to sulfonylureas, thiazolidinediones had the lowest incremental cost-effectiveness ratios in the U.S. and dominated sulfonylureas in Canada for adults 80 years and older. Relative to sulfonylureas, dipeptidyl peptidase4 inhibitors were cost-effective for adults 80 years and older in both countries, and for 65-79 year olds in Canada. Annual costs of hypoglycemia for older adults attaining very tight glycemic control with the use of insulin or sulfonylureas were estimated at U.S.$509,214,473 in the U.S. and CAN$65,497,849 in Canada. Conclusions Optimizing drug therapy for older type 2 diabetic adults through the avoidance of drug-induced hypoglycemia will dramatically improve patient health while also generating millions of dollars by saving unnecessary medical costs.	[Boulin, Mathieu; Tannenbaum, Cara] Inst Univ Geriatriede Montreal, Montreal, PQ, Canada; [Diaby, Vakaramoko] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Tannenbaum, Cara] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Tannenbaum, Cara] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	State University System of Florida; Florida A&M University; Universite de Montreal; Universite de Montreal	Tannenbaum, C (corresponding author), Inst Univ Geriatriede Montreal, Montreal, PQ, Canada.; Tannenbaum, C (corresponding author), Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada.; Tannenbaum, C (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	cara.tannenbaum@umontreal.ca	Diaby, Vakaramoko/AAH-4029-2020		Canadian MITACS Accelerate program [IT04775]; National Institute on Minority Health and Health Disparities [P20MD006738, G12MD007582] Funding Source: NIH RePORTER	Canadian MITACS Accelerate program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	MB was supported by the Canadian MITACS Accelerate program (postdoctoral fellowship bursary IT04775) for this study (https://www.mitacs.ca/en/programs/accelerate). MITACS had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.	American Diabetes Association, STAT DIAB; American Diabetes Association, 2014, STAT DIAB; American Geriatrics Society, 2015, CHOOS WISELY; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; [Anonymous], 2008, GUID METH TECHN APPR; [Anonymous], 2013, FDA DRUG SAF COMM FD; [Anonymous], 2015, SING CIT AG GROUP ET; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bordier L, 2015, DIABETES METAB, V41, P301, DOI 10.1016/j.diabet.2015.03.001; Boye KS, 2011, EUR J HEALTH ECON, V12, P219, DOI 10.1007/s10198-010-0224-8; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Bullano MF, 2006, AM J HEALTH-SYST PH, V63, P2473, DOI 10.2146/ajhp050552; Caverly TJ, 2015, JAMA INTERN MED, V175, P1994, DOI 10.1001/jamainternmed.2015.5950; Clemens KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137596; Evans M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-90; Farmer AJ, 2012, DIABETIC MED, V29, P1447, DOI 10.1111/j.1464-5491.2012.03657.x; Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777; Fu HD, 2014, CURR MED RES OPIN, V30, P1787, DOI 10.1185/03007995.2014.922944; Gangji AS, 2007, DIABETES CARE, V30, P389, DOI 10.2337/dc06-1789; GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697; Gomes T, 2010, CAN MED ASSOC J, V182, P35, DOI 10.1503/cmaj.091017; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Leiter LA., 2005, CAN J DIABETES, V29, P186; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Meneilly GS, 2013, CAN J DIABETES, V37, pS184, DOI [10.1016/j.jcjd.2013.01.045, 10.1007/s12170-010-0117-5]; Nicolucci A, 2015, ACTA DIABETOL, V52, P677, DOI 10.1007/s00592-015-0717-0; Ontario Ministry of Health and Long-term Care, 2015, EXC ACC PROGR 2015; Ozieh M. N., 2015, DIABETES CARE; Public Health Agency of Canada, DIAB CAN FACTS FIG P; Rowe BH, 2015, CAN J DIABETES, V39, P55, DOI [10.1016/j.jcjd.2014.04.001, 10.1016/j.jcjd.2015.09.084]; Samuel S, 2015, CURR MED RES OPIN, V31, P633, DOI 10.1185/03007995.2015.1020363; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Slabaugh SL, 2015, DRUG AGING, V32, P169, DOI 10.1007/s40266-014-0235-8; The World Bank, 2015, GROSS DOM PROD PER C; Thompson Angela, 2013, Consult Pharm, V28, P296, DOI 10.4140/TCP.n.2013.296; U.S. Census Bureau Population Division, 2014, ANN EST RES POP SEL; U.S. Departmentof Health and Human Services Office of Disease Prevention and Health Promotion, 2014, NAT ACT PLAN ADV DRU; World Health Organization, 2015, CHOOS INT AR COST EF	46	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162951	10.1371/journal.pone.0162951	http://dx.doi.org/10.1371/journal.pone.0162951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648831	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892100044
J	Ma, HM; Song, T; Wang, TH; Wang, S				Ma, Huimin; Song, Teng; Wang, Tianhua; Wang, Shui			Influence of Human p53 on Plant Development	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; HUMAN RAD51; GENE-TRANSCRIPTION; HUMAN FIBROBLASTS; ARABIDOPSIS SNI1; BRC REPEATS	Mammalian p53 is a super tumor suppressor and plays a key role in guarding genome from DNA damage. However, p53 has not been found in plants which do not bear cancer although they constantly expose to ionizing radiation of ultraviolet light. Here we introduced p53 into the model plant Arabidopsis and examined p53-conferred phenotype in plant. Most strikingly, p53 caused early senescence and fasciation. In plants, fasciation has been shown as a result of the elevated homologous DNA recombination. Consistently, a reporter with overlapping segments of the GUS gene (1445) showed that the frequency of homologous recombination was highly induced in p53-transgenic plants. In contrast to p53, SUPPRESSOR OF NPR1-1 INDUCIBLE 1 (SNI1), as a negative regulator of homologous recombination in plants, is not present in mammals. Comet assay and clonogenic survival assay demonstrated that SNI1 inhibited DNA damage repair caused by either ionizing radiation or hydroxyurea in human osteosarcoma U2OS cancer cells. RAD51D is a recombinase in homologous recombination and functions downstream of SNI1 in plants. Interestingly, p53 rendered the sni1 mutants madly branching of inflorescence, a phenotype of fasciation, whereas rad51d mutant fully suppressed the p53-induced phenotype, indicating that human p53 action in plant is mediated by the SNI1-RAD51D signaling pathway. The reciprocal species-swap tests of p53 and SNI1 in human and Arabidopsis manifest that these species-specific proteins play a common role in homologous recombination across kingdoms of animals and plants.	[Ma, Huimin; Song, Teng; Wang, Tianhua; Wang, Shui] Shanghai Normal Univ, Dev Ctr Plant Germplasm Resources, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	Shanghai Normal University	Wang, S (corresponding author), Shanghai Normal Univ, Dev Ctr Plant Germplasm Resources, Coll Life & Environm Sci, Shanghai 200234, Peoples R China.	shuiwang@shnu.edu.cn	Wang, Shui/GLU-0896-2022		National Natural Science Foundation of China [31571254]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 31571254 from National Natural Science Foundation of China (http://www.nsfc.gov.cn).	Amor IYH, 2008, FEMS YEAST RES, V8, P1254, DOI 10.1111/j.1567-1364.2008.00445.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baumann C, 2006, NUCLEIC ACIDS RES, V34, P1036, DOI 10.1093/nar/gkj509; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BISCHOFF JR, 1992, MOL CELL BIOL, V12, P1405, DOI 10.1128/MCB.12.4.1405; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; CLARK SE, 1993, DEVELOPMENT, V119, P397; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Doonan J, 1996, NATURE, V380, P481, DOI 10.1038/380481a0; Doonan JH, 2010, NAT REV CANCER, V10, P793, DOI 10.1038/nrc2942; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hartung F., 2004, Current Genomics, V5, P109, DOI 10.2174/1389202043489917; Heitzeberg F, 2004, PLANT J, V38, P954, DOI 10.1111/j.1365-313X.2004.02097.x; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hisanaga T, 2013, PLANT PHYSIOL, V162, P831, DOI 10.1104/pp.113.216796; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jensen RB, 2013, DNA REPAIR, V12, P306, DOI 10.1016/j.dnarep.2012.12.007; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Linke SP, 2003, CANCER RES, V63, P2596; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Missirian Victor, 2014, Front Plant Sci, V5, P364, DOI 10.3389/fpls.2014.00364; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ridgway P, 2000, J CELL SCI, V113, P2647; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Rutkowski R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001131; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Song JQ, 2011, CELL HOST MICROBE, V9, P115, DOI 10.1016/j.chom.2011.01.011; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 2014, CELL HOST MICROBE, V16, P787, DOI 10.1016/j.chom.2014.10.005; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Yan SP, 2013, MOL CELL, V52, P602, DOI 10.1016/j.molcel.2013.09.019; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Yoon D, 2004, J MOL BIOL, V336, P639, DOI 10.1016/j.jmb.2003.12.050; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	78	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162840	10.1371/journal.pone.0162840	http://dx.doi.org/10.1371/journal.pone.0162840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648563	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100034
J	Bastos, HN; Osorio, NS; Castro, AG; Ramos, A; Carvalho, T; Meira, L; Araujo, D; Almeida, L; Boaventura, R; Fragata, P; Chaves, C; Costa, P; Portela, M; Ferreira, I; Magalhaes, SP; Rodrigues, F; Sarmento-Castro, R; Duarte, R; Guimaraes, JT; Saraiva, M				Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Ramos, Angelica; Carvalho, Teresa; Meira, Leonor; Araujo, David; Almeida, Leonor; Boaventura, Rita; Fragata, Patricia; Chaves, Catarina; Costa, Patricio; Portela, Miguel; Ferreira, Ivo; Magalhaes, Sara Pinto; Rodrigues, Fernando; Sarmento-Castro, Rui; Duarte, Raquel; Guimaraes, Joao Tiago; Saraiva, Margarida			A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DIABETES-MELLITUS; VALIDATION; INPATIENTS; COHORT; ADULTS	Tuberculosis imposes high human and economic tolls, including in Europe. This study was conducted to develop a severity assessment tool for stratifying mortality risk in pulmonary tuberculosis (PTB) patients. A derivation cohort of 681 PTB cases was retrospectively reviewed to generate a model based on multiple logistic regression analysis of prognostic variables with 6-month mortality as the outcome measure. A clinical scoring system was developed and tested against a validation cohort of 103 patients. Five risk features were selected for the prediction model: hypoxemic respiratory failure (OR 4.7, 95% CI 2.8-7.9), age >= 50 years (OR 2.9, 95% CI 1.7-4.8), bilateral lung involvement (OR 2.5, 95% CI 1.44.4), >= 1 significant comorbidity-HIV infection, diabetes mellitus, liver failure or cirrhosis, congestive heart failure and chronic respiratory disease-(OR 2.3, 95% CI 1.3-3.8), and hemoglobin < 12 g/dL (OR 1.8, 95% CI 1.1-3.1). A tuberculosis risk assessment tool (TReAT) was developed, stratifying patients with low (score <= 2), moderate (score 3-5) and high (score >= 6) mortality risk. The mortality associated with each group was 2.9%, 22.9% and 53.9%, respectively. The model performed equally well in the validation cohort. We provide a new, easy-to-use clinical scoring system to identify PTB patients with high-mortality risk in settings with good healthcare access, helping clinicians to decide which patients are in need of closer medical care during treatment.	[Bastos, Helder Novais; Meira, Leonor; Araujo, David; Almeida, Leonor; Boaventura, Rita] Ctr Hosp Sao Joao, Dept Pneumol, Oporto, Portugal; [Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Chaves, Catarina; Costa, Patricio; Rodrigues, Fernando; Sarmento-Castro, Rui; Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Costa, Patricio; Rodrigues, Fernando; Sarmento-Castro, Rui; Saraiva, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Ramos, Angelica; Carvalho, Teresa; Guimaraes, Joao Tiago] Ctr Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal; [Ramos, Angelica; Carvalho, Teresa; Guimaraes, Joao Tiago] Univ Porto, Inst Publ Hlth, Oporto, Portugal; [Fragata, Patricia] Hosp Santo Espirito Ilha Terceira, Dept Internal Med, Angra Do Heroismo, Portugal; [Costa, Patricio] Univ Porto, Fac Psychol & Educ Sci, Oporto, Portugal; [Portela, Miguel] Univ Minho, Sch Econ & Management, Braga, Portugal; [Ferreira, Ivo; Magalhaes, Sara Pinto] Ctr Hosp Porto, Dept Radiol, Oporto, Portugal; [Sarmento-Castro, Rui] Ctr Hosp Porto, Hosp Joaquim Urbano Unit, Dept Infect Dis, Oporto, Portugal; [Duarte, Raquel] Ctr Hosp Vila Nova De Gaia Espinho, Dept Pneumol, Vila Nova De Gaia, Portugal; [Duarte, Raquel] Chest Dis Ctr Vila Nova Gaia, Referral Ctr Multidrug Resistant TB Northern Reg, Vila Nova De Gaia, Portugal; [Duarte, Raquel] Gen Directorate Hlth, Lisbon, Portugal; [Guimaraes, Joao Tiago] Univ Porto, Fac Med, Dept Biochem, Oporto, Portugal; [Saraiva, Margarida] Univ Porto, I3S Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Saraiva, Margarida] Univ Porto, IBMC, Oporto, Portugal	Sao Joao Hospital; Universidade do Minho; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Universidade do Minho; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Bastos, HN (corresponding author), Ctr Hosp Sao Joao, Dept Pneumol, Oporto, Portugal.; Bastos, HN (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.; Bastos, HN (corresponding author), ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.	hnovaisbastos@ecsaude.uminho.pt	Rodrigues, Fernando/T-5299-2018; Costa, Patrício/A-3072-2013; Novais e Bastos, Helder/F-5722-2011; Osório, Nuno S./D-4773-2013; Portela, Miguel/C-4509-2008; Chaves, Catarina/AAM-9455-2020; Guimarães, João Tiago/T-3079-2017; Osório, Nuno S./AAF-4307-2020; Castro, Gil/T-7584-2018; Saraiva, Margarida/E-8781-2011; Novais Bastos, Helder/E-5191-2017	Rodrigues, Fernando/0000-0001-8436-9398; Costa, Patrício/0000-0002-1201-9177; Novais e Bastos, Helder/0000-0002-1412-4202; Osório, Nuno S./0000-0003-0949-5399; Portela, Miguel/0000-0002-4721-2081; Chaves, Catarina/0000-0003-0131-5728; Guimarães, João Tiago/0000-0003-4836-6311; Osório, Nuno S./0000-0003-0949-5399; Castro, Gil/0000-0002-4684-4183; Saraiva, Margarida/0000-0002-8180-1293; Novais Bastos, Helder/0000-0002-1412-4202; Duarte, Raquel/0000-0003-2257-3099; da Costa Ramos, Angelica/0000-0002-0763-7843; Mendonca Almeida, Leonor/0000-0002-9235-9453	Sociedade Portuguesa de Pneumologia (SPP); Northern Portugal Regional Operational Programme (NORTE), under European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013]; Fundacao Amelia de Mello/Jose de Mello Saude	Sociedade Portuguesa de Pneumologia (SPP); Northern Portugal Regional Operational Programme (NORTE), under European Regional Development Fund (FEDER); Fundacao Amelia de Mello/Jose de Mello Saude	This work was supported by Fundacao Amelia de Mello/Jose de Mello Saude and Sociedade Portuguesa de Pneumologia (SPP). This work was developed under the scope of the project NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). NSO is a FCT (Fundacao para a Ciencia e Tecnologia) investigator. MS is an Associate FCT Investigator. The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Balkema CA, 2014, INT J TUBERC LUNG D, V18, P824, DOI 10.5588/ijtld.13.0044; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004; Franco I, 2016, REV PORT PNEUMOL, V22, P50, DOI 10.1016/j.rppnen.2015.08.006; Horita N, 2013, INT J TUBERC LUNG D, V17, P54, DOI 10.5588/ijtld.12.0476; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Lanoix JP, 2014, INT J TUBERC LUNG D, V18, P581, DOI 10.5588/ijtld.13.0901; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092623; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; MacIntyre CR, 2001, INT J TUBERC LUNG D, V5, P266; Marcy O, 2014, CLIN INFECT DIS, V59, P435, DOI 10.1093/cid/ciu283; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Millet JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025315; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Pontali E, 2015, REV PORT PNEUMOL, V21, P295, DOI 10.1016/j.rppnen.2015.10.007; Reina S, 2015, INT J TUBERC LUNG D, V19, P1554, DOI 10.5588/ijtld.0632; Sales Anne E, 2004, Health Qual Life Outcomes, V2, P49, DOI 10.1186/1477-7525-2-49; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; Perrechi MCT, 2011, J BRAS PNEUMOL, V37, P783, DOI 10.1590/S1806-37132011000600012; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Valade S, 2012, CAN J INFECT DIS MED, V23, P173, DOI 10.1155/2012/361292; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; WHO, 2010, GUID TREATM TUB; Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453; World Health Organization, 2015, GLOB TUB REP 2015; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011	40	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162797	10.1371/journal.pone.0162797	http://dx.doi.org/10.1371/journal.pone.0162797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636095	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700015
J	Afzal, SM; Razvi, MAN; Khan, SA; Osman, OI; Bakry, AH; Asiri, AM				Afzal, S. M.; Razvi, M. A. N.; Khan, Salman A.; Osman, Osman I.; Bakry, Ahmed H.; Asiri, Abdullah M.			Physicochemical and Nonlinear Optical Properties of Novel Environmentally Benign Heterocyclic Azomethine Dyes: Experimental and Theoretical Studies	PLOS ONE			English	Article							STATE DIPOLE-MOMENTS; REVERSE SATURABLE ABSORPTION; MICROWAVE-ASSISTED SYNTHESIS; SOLVENT POLARITY PARAMETER; Z-SCAN; EXCITED-STATE; SCHIFF-BASE; MOLECULAR-STRUCTURE; LIMITING PROPERTIES; HYPERPOLARIZABILITIES	Novel heterocyclic azomethine dyes were prepared by the reaction of anthracene-9-carbaldehyde with different heterocyclic amines under microwave irradiation. Structures of the azomethine dyes were confirmed by the elemental analysis, mass spectrometry and several spectroscopic techniques. We studied absorbance and fluorescence spectra of the azomethine dyes in various solvents. They are found to be good absorbers and emitters. We also report photophysical properties like, extinction coefficient, oscillator strength, stokes shift and transition dipole moment. This reflects physicochemical behaviors of synthesized dyes. In addition, their intramolecular charge transfer and nonlinear optical properties, supported by natural bond orbital technique, were also studied computationally by density functional theory. The negative nonlinear refractive index and nonlinear absorption coefficient were measured for these dyes using the closed and open aperture Z-scan technique with a continuous wave helium-neon laser. These are found to vary linearly with solution concentration.	[Afzal, S. M.; Razvi, M. A. N.; Bakry, Ahmed H.] King Abdulaziz Univ, Fac Sci, Dept Phys, POB 80203, Jeddah 21589, Saudi Arabia; [Khan, Salman A.; Osman, Osman I.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, POB 80203, Jeddah 21589, Saudi Arabia; [Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat, POB 80203, Jeddah 21589, Saudi Arabia; [Afzal, S. M.] Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India; [Osman, Osman I.] Univ Khartoum, Fac Sci, Dept Chem, POB 321, Khartoum 11111, Sudan	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Aligarh Muslim University; University of Khartoum	Afzal, SM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Phys, POB 80203, Jeddah 21589, Saudi Arabia.; Afzal, SM (corresponding author), Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India.	drsmafzal62@gmail.com	Asiri, Abdullah M./C-3458-2009; RAZVI, MIR ALI NAQI/D-5601-2013; I.Osman, Osman/F-1032-2010	Asiri, Abdullah M./0000-0001-7905-3209; RAZVI, MIR ALI NAQI/0000-0003-2729-0813; I.Osman, Osman/0000-0003-4436-276X; Khan, Salman Ahmad/0000-0002-3892-2241	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-857-D1435]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. (130-857-D1435). The authors, therefore, acknowledge the DSR technical and financial support (SMA).	ACREE WE, 1994, J PHYS CHEM-US, V98, P2537, DOI 10.1021/j100061a007; Afzal SM, 2016, J FLUORESC, V26, P559, DOI 10.1007/s10895-015-1740-9; Asiri A.M., 2010, ORG CHEM INSIGHT, V3, P1; Asiri AM, 2012, B KOREAN CHEM SOC, V33, P1900, DOI 10.5012/bkcs.2012.33.6.1900; Asiri AM, 2010, MOLECULES, V15, P6850, DOI 10.3390/molecules15106850; Aurell MJ, 2004, TETRAHEDRON, V60, P11503, DOI 10.1016/j.tet.2004.09.057; BIONDIC MC, 1994, J PHOTOCH PHOTOBIO A, V77, P149, DOI 10.1016/1010-6030(94)80038-3; Chattaraj PK, 2003, J AM CHEM SOC, V125, P2705, DOI 10.1021/ja0276063; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Dworczak R, 1997, DYES PIGMENTS, V34, P13, DOI 10.1016/S0143-7208(96)00055-1; Frisch G. W., 2013, GAUSSIAN 09; Frisch MJ, 2007, GAUSSVIEW REFERENCE; Gao Y, 2007, APPL PHYS B-LASERS O, V88, P255, DOI 10.1007/S00340-007-2687-6; Garza AJ, 2015, J PHYS CHEM B, V119, P1202, DOI 10.1021/jp507226v; Garza AJ, 2013, THEOR CHEM ACC, V132, DOI 10.1007/s00214-013-1384-2; Gayathri C, 2008, SPECTROCHIM ACTA A, V69, P980, DOI 10.1016/j.saa.2007.05.060; Geethakrishnan T, 2007, OPT COMMUN, V270, P424, DOI 10.1016/j.optcom.2006.09.035; Geronikaki Athina, 2003, Farmaco (Lausanne), V58, P489, DOI 10.1016/S0014-827X(03)00065-X; Grivani G, 2012, INORG CHEM COMMUN, V18, P15, DOI 10.1016/j.inoche.2011.12.044; Hamryszak L, 2012, J MOL LIQ, V165, P12, DOI 10.1016/j.molliq.2011.10.001; IIJIMA T, 1973, B CHEM SOC JPN, V46, P2311, DOI 10.1246/bcsj.46.2311; Iwan A, 2011, PROG POLYM SCI, V36, P1277, DOI 10.1016/j.progpolymsci.2011.05.001; Jacquemin D, 2007, J MOL STRUC-THEOCHEM, V804, P31, DOI 10.1016/j.theochem.2006.10.012; Jeux V, 2015, DYES PIGMENTS, V113, P402, DOI 10.1016/j.dyepig.2014.09.012; Jiao T, 2006, J COLLOID INTERF SCI, V299, P815, DOI 10.1016/j.jcis.2006.02.037; Kaatz P, 1998, J CHEM PHYS, V108, P849, DOI 10.1063/1.475448; Karabacak M, 2012, SPECTROCHIM ACTA A, V86, P590, DOI 10.1016/j.saa.2011.11.022; Kaya I, 2010, SYNTHETIC MET, V160, P911, DOI 10.1016/j.synthmet.2010.01.044; Khan S.A., 2013, EUR J MED CHEM, V4, P454, DOI [10.5155/eurjchem.4.4.454-458.784, DOI 10.5155/EURJCHEM.4.4.454-458.784]; Khan SA, 2015, SPECTROCHIM ACTA A, V137, P1100, DOI 10.1016/j.saa.2014.08.065; Khanmohammadi H, 2012, DYES PIGMENTS, V94, P163, DOI 10.1016/j.dyepig.2011.12.013; Kiran AJ, 2006, J PHYS B-AT MOL OPT, V39, P3747, DOI 10.1088/0953-4075/39/18/005; Kong LY, 2005, CHEM PHYS LETT, V416, P176, DOI 10.1016/j.cplett.2005.09.074; Krawczyk P, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2651-z; Kumar S, 2001, SPECTROCHIM ACTA A, V57, P41, DOI 10.1016/S1386-1425(00)00330-9; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LI CF, 1994, PHYS REV A, V49, P1149, DOI 10.1103/PhysRevA.49.1149; Liu XD, 2001, OPT COMMUN, V197, P431, DOI 10.1016/S0030-4018(01)01406-7; MANCINI PME, 1995, J PHYS ORG CHEM, V8, P617, DOI 10.1002/poc.610080908; Mendis BAS, 2004, J MOL STRUC-THEOCHEM, V678, P31, DOI 10.1016/j.theochem.2004.02.027; Nalwa H.S, 1997, HDB ORGANIC CONDUCTI, V1st ed.; NISHIKAWA T, 1955, J CHEM PHYS, V23, P1735, DOI 10.1063/1.1742444; Niu HJ, 2004, MATER LETT, V58, P2979, DOI 10.1016/j.matlet.2004.05.007; Patel NB, 2010, ACTA POL PHARM, V67, P45; Pearson RG, 2005, J CHEM SCI, V117, P369, DOI 10.1007/BF02708340; Pramodini S, 2014, OPT LASER TECHNOL, V62, P12, DOI 10.1016/j.optlastec.2014.02.003; RAVI M, 1995, J CHEM SOC FARADAY T, V91, P2739, DOI 10.1039/ft9959102739; RAVI M, 1994, J PHYS CHEM-US, V98, P9133, DOI 10.1021/j100088a007; Razvi MAN, 2015, MATER LETT, V144, P131, DOI 10.1016/j.matlet.2015.01.036; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; Reis H, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2211611; Ronchi A, 2003, SYNTHETIC MET, V139, P831, DOI 10.1016/S0379-6779(03)00274-1; SAID AA, 1992, J OPT SOC AM B, V9, P405, DOI 10.1364/JOSAB.9.000405; Sendhil K, 2006, OPT LASER TECHNOL, V38, P512, DOI 10.1016/j.optlastec.2004.12.005; Sharbati MT, 2011, J LUMIN, V131, P553, DOI 10.1016/j.jlumin.2010.10.016; SHEIKBAHAE M, 1989, OPT LETT, V14, P955, DOI 10.1364/OL.14.000955; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Sheikhshoaie I, 2006, DYES PIGMENTS, V70, P91, DOI 10.1016/j.dyepig.2005.04.011; Shin CK, 2000, J KOREAN PHYS SOC, V36, P356; Silverstein R., 1977, SPECTROMETRIC IDENTI; Solomon VR, 2009, BIOORGAN MED CHEM, V17, P7585, DOI 10.1016/j.bmc.2009.08.068; Souza RF, 2006, ADV MAT STRUCTURES; Sriram D, 2006, BIOORG MED CHEM LETT, V16, P2127, DOI 10.1016/j.bmcl.2006.01.050; STAHELIN M, 1993, J CHEM PHYS, V98, P5595, DOI 10.1063/1.464904; Sukumaran VS, 2006, PHYS LETT A, V359, P467, DOI 10.1016/j.physleta.2006.06.079; Sun WF, 2000, P SOC PHOTO-OPT INS, V4106, P280, DOI 10.1117/12.408515; Thanthiriwatte KS, 2002, J MOL STRUC-THEOCHEM, V617, P169, DOI 10.1016/S0166-1280(02)00419-0; Turro NJ, 1965, MOL PHOTOCHEMISTRY F; Vydrov OA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2409292; WILLETTS A, 1992, J CHEM PHYS, V97, P7590, DOI 10.1063/1.463479; Yu BL, 1997, OPT MATER, V7, P103, DOI 10.1016/S0925-3467(96)00067-5	72	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161613	10.1371/journal.pone.0161613	http://dx.doi.org/10.1371/journal.pone.0161613			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631371	Green Submitted, gold, Green Published			2022-12-27	WOS:000383706900020
J	Butler, J; Stewart, CR; Layton, DS; Phommachanh, P; Harper, J; Payne, J; Evans, RM; Valdeter, S; Walker, S; Harvey, G; Shan, SH; Bruce, MP; Rootes, CL; Gough, TJ; Rohringer, A; Peck, GR; Fardy, SJ; Karpala, AJ; Johnson, D; Wang, JN; Douangngeun, B; Morrissy, C; Wong, FYK; Bean, AGD; Bingham, J; Williams, DT				Butler, Jeffrey; Stewart, Cameron R.; Layton, Daniel S.; Phouvong Phommachanh; Harper, Jennifer; Payne, Jean; Evans, Ryan M.; Valdeter, Stacey; Walker, Som; Harvey, Gemma; Shan, Songhua; Bruce, Matthew P.; Rootes, Christina L.; Gough, Tamara J.; Rohringer, Andreas; Peck, Grantley R.; Fardy, Sarah J.; Karpala, Adam J.; Johnson, Dayna; Wang, Jianning; Douangngeun, Bounlom; Morrissy, Christopher; Wong, Frank Y. K.; Bean, Andrew G. D.; Bingham, John; Williams, David T.			Novel Reassortant H5N6 Influenza A Virus from the Lao People's Democratic Republic Is Highly Pathogenic in Chickens	PLOS ONE			English	Article							AVIAN INFLUENZA; CHINA; HEMAGGLUTININ; INFECTION; FERRETS; DUCKS; PATHOBIOLOGY; TRANSMISSION; SUBLINEAGES; APOPTOSIS	Avian influenza viruses of H5 subtype can cause highly pathogenic disease in poultry. In March 2014, a new reassortant H5N6 subtype highly pathogenic avian influenza virus emerged in Lao People's Democratic Republic. We have assessed the pathogenicity, pathobiology and immunological responses associated with this virus in chickens. Infection caused moderate to advanced disease in 6 of 6 chickens within 48 h of mucosal inoculation. High virus titers were observed in blood and tissues (kidney, spleen, liver, duodenum, heart, brain and lung) taken at euthanasia. Viral antigen was detected in endothelium, neurons, myocardium, lymphoid tissues and other cell types. Pro-inflammatory cytokines were elevated compared to non-infected birds. Our study confirmed that this new H5N6 reassortant is highly pathogenic, causing disease in chickens similar to that of Asian H5N1 viruses, and demonstrated the ability of such clade 2.3.4-originH5 viruses to reassort with non-N1 subtype viruses while maintaining a fit and infectious phenotype. Recent detection of influenza H5N6 poultry infections in Lao PDR, China and Viet Nam, as well as six fatal human infections in China, demonstrate that these emergent highly pathogenic H5N6 viruses may be widely established in several countries and represent an emerging threat to poultry and human populations.	[Butler, Jeffrey; Stewart, Cameron R.; Layton, Daniel S.; Harper, Jennifer; Payne, Jean; Evans, Ryan M.; Valdeter, Stacey; Walker, Som; Harvey, Gemma; Shan, Songhua; Bruce, Matthew P.; Rootes, Christina L.; Gough, Tamara J.; Rohringer, Andreas; Peck, Grantley R.; Fardy, Sarah J.; Karpala, Adam J.; Johnson, Dayna; Wang, Jianning; Morrissy, Christopher; Wong, Frank Y. K.; Bean, Andrew G. D.; Bingham, John; Williams, David T.] CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia; [Phouvong Phommachanh; Douangngeun, Bounlom] Natl Anim Hlth Lab, Viangchan, Laos	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Williams, DT (corresponding author), CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia.	d.williams@csiro.au	Stewart, Cameron R/E-6823-2011; Rootes, Christina/AAS-6972-2021; Gough, Tamara/P-2107-2015; Layton, Daniel S/J-6117-2017; Bean, Andrew G/H-8664-2013; Williams, David T/H-6750-2013; Bingham, John/H-8591-2013; shan, songhua/H-8650-2013; Bruce, Matthew/AAU-5684-2021; Rootes, Christina L/H-4905-2013; Wong, Frank/H-1950-2013	Rootes, Christina/0000-0002-7448-8307; Bean, Andrew G/0000-0002-4585-3811; Williams, David T/0000-0002-7169-149X; Bingham, John/0000-0003-2360-3827; Rootes, Christina L/0000-0002-7448-8307; Wong, Frank/0000-0003-2471-9549; Stewart, Cameron/0000-0002-3395-7859; Butler, Jeff/0000-0001-7971-9904; Rohringer, Andreas/0000-0003-4351-7184	Australian Government Department of Agriculture; Commonwealth Scientific and Industrial Research Organisation; National CollaborativeResearch Infrastructure Strategy through the AAHL Collaborative Biosecurity Research Facility	Australian Government Department of Agriculture(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); National CollaborativeResearch Infrastructure Strategy through the AAHL Collaborative Biosecurity Research Facility	This study was funded by the Australian Government Department of Agriculture (http://www.agriculture.gov.au; JB, JH, JP, RME, SV, SW, GH, SS, DJ, JW, CM, FYKW, JB, DTW), the Commonwealth Scientific and Industrial Research Organisation (http://www.csiro.au; CRS, DSL, CLR, TJG, AR, SJF, AJK, AGDB) and the National CollaborativeResearch Infrastructure Strategy (https://www.education.gov.au/national-collaborative-research-infrastructure-strategy-ncris) through the AAHL Collaborative Biosecurity Research Facility (MPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bi YH, 2015, J GEN VIROL, V96, P975, DOI 10.1099/vir.0.000056; Boonnak K, 2014, J IMMUNOL, V192, P5906, DOI 10.4049/jimmunol.1302992; Burggraaf S, 2014, VIRUS RES, V185, P23, DOI 10.1016/j.virusres.2014.03.012; Burggraaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014561; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Curran JM, 2014, AVIAN DIS, V58, P53, DOI 10.1637/10531-031513-Reg.1; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Food and Agricultural Organization of the United Nations, 2014, AV INFL H5N6 LAT ADD; Food and Agriculture Organization of the United Nations, 2011, 171 FAO UN; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Kim YI, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.75; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; NHMRC, 2013, AUSTR COD CAR US AN, V8th; OIE, 2015, AVIAN INFLUENZA; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Qi X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00706-14; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shen HQ, 2015, EMERG INFECT DIS, V21, P1261, DOI 10.3201/eid2107.140838; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; VANCAMPEN H, 1989, J GEN VIROL, V70, P467, DOI 10.1099/0022-1317-70-2-467; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; Wibawa H, 2013, COMP IMMUNOL MICROB, V36, P175, DOI 10.1016/j.cimid.2012.12.001; Wong FYK, 2015, EMERG INFECT DIS, V21, P511, DOI 10.3201/eid2103.141488; World Health Organization, INFL HUM AN INT SUMM; World Health Organization, 2016, INFL HUM AN INT SUMM; World Organization for Animal Health, UPD HIGHL PATH AV IN; Wu HB, 2015, INFECT GENET EVOL, V31, P64, DOI 10.1016/j.meegid.2015.01.019; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025	41	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162375	10.1371/journal.pone.0162375	http://dx.doi.org/10.1371/journal.pone.0162375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631618	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900042
J	Modjeski, KL; Ture, SK; Field, DJ; Cameron, SJ; Morrell, CN				Modjeski, Kristina L.; Ture, Sara K.; Field, David J.; Cameron, Scott J.; Morrell, Craig N.			Glutamate Receptor Interacting Protein 1 Mediates Platelet Adhesion and Thrombus Formation	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FRASER-SYNDROME; AMPA RECEPTORS; MICE LACKING; GRIP1; GPIB; IDENTIFICATION; TRAFFICKING; ACTIVATION; MECHANISMS	Thrombosis-associated pathologies, such as myocardial infarction and stroke, are major causes of morbidity and mortality worldwide. Because platelets are necessary for hemostasis and thrombosis, platelet directed therapies must balance inhibiting platelet function with bleeding risk. Glutamate receptor interacting protein 1 (GRIP1) is a large scaffolding protein that localizes and organizes interacting proteins in other cells, such as neurons. We have investigated the role of GRIP1 in platelet function to determine its role as a molecular scaffold in thrombus formation. Platelet-specific GRIP1(-/-) mice were used to determine the role of GRIP1 in platelets. GRIP1(-/-) mice had normal platelet counts, but a prolonged bleeding time and delayed thrombus formation in a FeCl3-induced vessel injury model. In vitro stimulation of WT and GRIP1(-/-) platelets with multiple agonists showed no difference in platelet activation. However, in vivo platelet rolling velocity after endothelial stimulation was significantly greater in GRIP1(-/-) platelets compared to WT platelets, indicating a potential platelet adhesion defect. Mass spectrometry analysis of GRIP1 platelet immunoprecipitation revealed enrichment of GRIP1 binding to GPIb-IX complex proteins. Western blots confirmed the mass spectrometry findings that GRIP1 interacts with GPIb alpha, GPIb beta, and 14-3-3. Additionally, in resting GRIP1(-/-) platelets, GPIba and 14-3-3 have increased interaction compared to WT platelets. GRIP1 interactions with the GPIb-IX binding complex are necessary for normal platelet adhesion to a stimulated endothelium.	[Modjeski, Kristina L.; Ture, Sara K.; Field, David J.; Cameron, Scott J.; Morrell, Craig N.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Modjeski, Kristina L.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Morrell, CN (corresponding author), Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	Craig_Morrell@urmc.rochester.edu	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540	American Heart Association [13EIA14250023]; National Institutes of Health [R01HL124018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124018] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (13EIA14250023) and the National Institutes of Health (R01HL124018).	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Baier PC, 2009, J PSYCHIATR RES, V43, P585, DOI 10.1016/j.jpsychires.2008.07.005; Baig A, 2009, PLATELETS, V20, P446, DOI 10.3109/09537100903137314; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Charych EI, 2006, J NEUROCHEM, V97, P884, DOI 10.1111/j.1471-4159.2006.03795.x; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Estevez B, 2016, BLOOD, V127, P626, DOI 10.1182/blood-2015-04-638387; Geiger JC, 2014, DEV CELL, V28, P381, DOI 10.1016/j.devcel.2014.01.018; Gitz E, 2013, HAEMATOLOGICA, V98, P1810, DOI 10.3324/haematol.2013.087221; Goubau C, 2014, DEV MED CHILD NEUROL, V56, P724, DOI 10.1111/dmcn.12421; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; HARDISTY RM, 1955, J PHYSIOL-LONDON, V130, P711, DOI 10.1113/jphysiol.1955.sp005437; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Mangin P, 2004, BLOOD, V104, P420, DOI 10.1182/blood-2003-08-2881; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Polgar J, 1999, BLOOD, V94, P1313, DOI 10.1182/blood.V94.4.1313.416k27_1313_1318; Schanze D, 2014, AM J MED GENET A, V164, P837, DOI 10.1002/ajmg.a.36343; Sun H, 2009, CIRC RES, V105, P595, DOI 10.1161/CIRCRESAHA.109.198861; Swaim AF, 2010, J IMMUNOL, V185, P6999, DOI 10.4049/jimmunol.1000929; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Vogel MJ, 2012, J MED GENET, V49, P303, DOI 10.1136/jmedgenet-2011-100590; Wang L, 2014, THROMB HAEMOSTASIS, V111, P873, DOI 10.1160/TH13-09-0738; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160638	10.1371/journal.pone.0160638	http://dx.doi.org/10.1371/journal.pone.0160638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631377	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900010
J	Sun, XL; Yang, LL; Yan, XF; Sun, YY; Zhao, DL; Ji, Y; Wang, K; Chen, XY; Shen, BZ				Sun, Xilin; Yang, Lili; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Chen, Xiaoyuan; Shen, Baozhong			DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin	PLOS ONE			English	Article							ALBUMIN-BOUND PACLITAXEL; METASTATIC BREAST-CANCER; SQUAMOUS-CELL CARCINOMA; NAB-PACLITAXEL; ANTIANGIOGENIC THERAPY; LUNG-CANCER; CHEMOTHERAPY; EFFICACY; STAGE; ANTITUMOR	Our previous studies revealed molecular alterations of tumor vessels, varying from immature to mature alterations, resulting from Abraxane, and demonstrated that the integrin-specific PET tracer F-18-FPPRGD2 can be used to noninvasively monitor such changes. However, changes in the tumor vasculature at functional levels such as perfusion and permeability are also important for monitoring Abraxane treatment outcomes in patients with cancer. The purpose of this study is to further investigate the vascular response during Abraxane therapy and the effectiveness of its synergistic interaction with cisplatin using Dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI). Thirty MDA-MB-435 tumor mice were randomized into three groups: PBS control (C group), Abraxane only (A group), and sequential treatment with Abraxane followed by cisplatin (A-P group). Tumor volume was monitored based on caliper measurements. A DCE-MRI protocol was performed at baseline and day 3. The K-trans, K-ep and V-e were calculated and compared with CD31, alpha-SMA, and Ki67 histology data. Sequential treatment with Abraxane followed by cis-platin produced a significantly greater inhibition of tumor growth during the three weeks of the observation period. Decreases in K-trans and K-ep for the A and A-P groups were observed on day 3. Immunohistological staining suggested vascular remodeling during the Abraxane therapy. The changes in K-trans and K-ep values were correlated with alterations in the permeability of the tumor vasculature induced by the Abraxane treatment. In conclusion, Abraxane- mediated permeability variations in tumor vasculature can be quantitatively visualized by DCE-MRI, making this a useful method for studying the effects of early cancer treatment, especially the early vascular response. Vascular remodeling by Abraxane improves the efficiency of cisplatin delivery and thus results in a favorable treatment outcome.	[Sun, Xilin; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Sun, Xilin; Yang, Lili; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Shen, Baozhong] Harbin Med Univ, Mol Imaging Res Ctr, Harbin, Heilongjiang, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Harbin Medical University; Harbin Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Shen, BZ (corresponding author), Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China.; Shen, BZ (corresponding author), Harbin Med Univ, Mol Imaging Res Ctr, Harbin, Heilongjiang, Peoples R China.	shenbzh@vip.sina.com	chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Yan, Xuefeng/I-9936-2019	Yan, Xuefeng/0000-0002-9803-5222	National Basic Research Program of China [2015CB931800]; National Natural Science Foundation of China [81101088, 81471724, 81130028, 31210103913]; Natural Science Foundation of Heilongjiang Province of China [LC2013C26]; Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province; Heilongjiang Province Department of Education Science and Technology Research Projects [12521184]; Innovation Talents Foundation of Harbin Science and Technology Bureau [2014RFQGJ011]; Youth Science WU LIANDE Foundation of Harbin Medical University [WLD-QN1119]; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province; Heilongjiang Province Department of Education Science and Technology Research Projects; Innovation Talents Foundation of Harbin Science and Technology Bureau; Youth Science WU LIANDE Foundation of Harbin Medical University; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Basic Research Program of China (2015CB931800), the National Natural Science Foundation of China (81101088, 81471724,81130028, 31210103913), Natural Science Foundation of Heilongjiang Province of China (LC2013C26), Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province, Heilongjiang Province Department of Education Science and Technology Research Projects (12521184), Innovation Talents Foundation of Harbin Science and Technology Bureau (2014RFQGJ011), The Youth Science WU LIANDE Foundation of Harbin Medical University (WLD-QN1119), and the Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fang Y, 2014, ASIAN PAC J CANCER P, V15, P7453, DOI 10.7314/APJCP.2014.15.17.7453; Gambini D, 2009, TUMORI, V95, P828, DOI 10.1177/030089160909500631; Harries M, 2005, J CLIN ONCOL, V23, P7768, DOI 10.1200/JCO.2005.08.002; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen LR, 2010, NMR BIOMED, V23, P56, DOI 10.1002/nbm.1426; Kaiser CG, 2015, EUR RADIOL, V25, P1793, DOI 10.1007/s00330-014-3580-4; Loong HH, 2014, EUR J CANCER, V50, P2263, DOI 10.1016/j.ejca.2014.05.021; Loveless ME, 2012, NEOPLASIA, V14, P54, DOI 10.1593/neo.111478; Myoung H, 2001, CANCER LETT, V163, P191, DOI 10.1016/S0304-3835(00)00701-1; O'Shaughnessy J, 2013, BREAST CANCER RES TR, V138, P829, DOI 10.1007/s10549-013-2447-8; Riham H, 2011, AM J ROENTGENOL, V197, P1498; Rizvi NA, 2008, J CLIN ONCOL, V26, P639, DOI 10.1200/JCO.2007.10.8605; Sun S, 2014, INT J NANOMED, V9, P1443, DOI 10.2147/IJN.S58275; Sun XL, 2011, J NUCL MED, V52, P140, DOI 10.2967/jnumed.110.080606; Volk LD, 2008, NEOPLASIA, V10, P613, DOI 10.1593/neo.08302; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Yang Q, 2015, MED PHYS, V42, P103, DOI 10.1118/1.4903280; Yardley DA, 2013, J CONTROL RELEASE, V170, P365, DOI 10.1016/j.jconrel.2013.05.041; Zheng DC, 2014, J MAGN RESON IMAGING, V39, P940, DOI 10.1002/jmri.24249	21	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162601	10.1371/journal.pone.0162601	http://dx.doi.org/10.1371/journal.pone.0162601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632532	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900058
J	Chodrow, PS; al-Awwad, Z; Jiang, S; Gonzalez, MC				Chodrow, Philip S.; al-Awwad, Zeyad; Jiang, Shan; Gonzalez, Marta C.			Demand and Congestion in Multiplex Transportation Networks	PLOS ONE			English	Article							TRAVEL	Urban transportation systems are multimodal, sociotechnical systems; however, while their multimodal aspect has received extensive attention in recent literature on multiplex networks, their sociotechnical aspect has been largely neglected. We present the first study of an urban transportation system using multiplex network analysis and validated Origin- Destination travel demand, with Riyadh's planned metro as a case study. We develop methods for analyzing the impact of additional transportation layers on existing dynamics, and show that demand structure plays key quantitative and qualitative roles. There exist fundamental geometrical limits to the metro's impact on traffic dynamics, and the bulk of environmental accrue at metro speeds only slightly faster than those planned. We develop a simple model for informing the use of additional, "feeder" layers to maximize reductions in global congestion. Our techniques are computationally practical, easily extensible to arbitrary transportation layers with complex transfer logic, and implementable in open-source software.	[Chodrow, Philip S.] MIT, Ctr Operat Res, Cambridge, MA 02139 USA; [al-Awwad, Zeyad] King Abdulaziz City Sci & Technol, Ctr Complex Engn Syst, Riyadh 11442, Saudi Arabia; [Jiang, Shan; Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chodrow, PS (corresponding author), MIT, Ctr Operat Res, Cambridge, MA 02139 USA.	pchodrow@mit.edu	Jiang, Shan/P-7677-2014; Gonzalez, Marta C./E-9456-2011	Jiang, Shan/0000-0002-3483-5132; Gonzalez, Marta C./0000-0002-8482-0318; /0000-0001-5667-490X; Awwad, Zeyad/0000-0002-6860-8149	Center for Complex Engineering Systems; U.S. Department of Transportation's University Transportation Centers Program; Singapore-MIT Alliance for Research and Technology (SMART); Samuel Tak Lee Real Estate Entrepreneurship Lab	Center for Complex Engineering Systems; U.S. Department of Transportation's University Transportation Centers Program; Singapore-MIT Alliance for Research and Technology (SMART)(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Samuel Tak Lee Real Estate Entrepreneurship Lab	The research was supported in part by grants from the Center for Complex Engineering Systems (http://cces-kacst-mit.org/), the U.S. Department of Transportation's University Transportation Centers Program (http://www.rita.dot.gov/utc/home), Singapore-MIT Alliance for Research and Technology (SMART) (http://smart.mit.edu/), and The Samuel Tak Lee Real Estate Entrepreneurship Lab (https://stl.mit.edu/). Grant numbers not available.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported in part by grants from the Center for Complex Engineering Systems, the U.S. Department of Transportation's University Transportation Centers Program, Singapore-MIT Alliance for Research and Technology (SMART), and The Samuel Tak Lee Real Estate Entrepreneurship Lab.	Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Clark WAV, 2003, REG SCI URBAN ECON, V33, P199, DOI 10.1016/S0166-0462(02)00012-1; Colak S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10793; Colak S, 2015, TRANSPORT RES REC, P126, DOI 10.3141/2526-14; Colak S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113037; De Domenico M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7868; De Domenico M, 2014, P NATL ACAD SCI USA, V111, P8351, DOI 10.1073/pnas.1318469111; Gallotti R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06911; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Jiang Shan, 2013, P 2 ACM SIGKDD INT W; KOUSHKI PA, 1988, J TRANSP ENG-ASCE, V114, P735, DOI 10.1061/(ASCE)0733-947X(1988)114:6(735); Ledraa TA, 2015, EMIRATES J ENG RES, V20, P1; Lee KM, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-50742-1; LLORENTE A, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0128692; Louail T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7007; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Louf R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.198702; Menichetti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097857; Min B, 2014, PHYS REV E, V89; Morris RG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128703; Shai S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042812; Sole-Ribalta A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032807; Sole-Ribalta A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.108701; Strano E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0651; Sun L., 2012, P ACM SIGKDD INT WOR, P142, DOI [10.1145/2346496.2346519, DOI 10.1145/2346496.2346519]; Toole JL, 2015, TRANSPORT RES C-EMER, V58, P162, DOI 10.1016/j.trc.2015.04.022; Wang FL, 2015, EPL-EUROPHYS LETT, V112, DOI 10.1209/0295-5075/112/38001; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Zhao K, 2015, SCI REPORTS, V5	32	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0161738	10.1371/journal.pone.0161738	http://dx.doi.org/10.1371/journal.pone.0161738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657738	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200013
J	Schob, S; Lobsien, D; Friedrich, B; Bernhard, MK; Gebauer, C; Dieckow, J; Gawlitza, M; Pirlich, M; Saur, D; Brauer, L; Bechmann, I; Hoffmann, KT; Mahr, CV; Nestler, U; Preuss, M				Schob, Stefan; Lobsien, Donald; Friedrich, Benjamin; Bernhard, Matthias K.; Gebauer, Corinna; Dieckow, Julia; Gawlitza, Matthias; Pirlich, Mandy; Saur, Dorothee; Braeuer, Lars; Bechmann, Ingo; Hoffmann, Karl-Titus; Mahr, Cynthia V.; Nestler, Ulf; Preuss, Matthias			The Cerebral Surfactant System and Its Alteration in Hydrocephalic Conditions	PLOS ONE			English	Article							PROTEIN-A; MECHANICAL FORCES; COLLECTINS; RELEASE; INNATE; ROLES; FLUID	Introduction Pulmonary Surfactant reduces surface tension in the terminal airways thus facilitating breathing and contributes to host's innate immunity. Surfactant Proteins (SP) A, B, C and D were recently identified as inherent proteins of the CNS. Aim of the study was to investigate cerebrospinal fluid (CSF) SP levels in hydrocephalus patients compared to normal subjects. Patients and Methods CSF SP A-D levels were quantified using commercially available ELISA kits in 126 patients (0-84 years, mean 39 years). 60 patients without CNS pathologies served as a control group. Hydrocephalus patients were separated in aqueductal stenosis (AQS, n = 24), acute hydrocephalus without aqueductal stenosis (acute HC w/o AQS, n = 16) and idiopathic normal pressure hydrocephalus (NPH, n = 20). Furthermore, six patients with pseudotumor cerebri were investigated. Results SP A D D are present under physiological conditions in human CSF. SP-A is elevated in diseases accompanied by ventricular enlargement (AQS, acute HC w/o AQS) in a significant manner (0.67, 1.21 vs 0.38 ng/ml in control, p<0.001). SP-C is also elevated in hydrocephalic conditions (AQS, acute HC w/o AQS; 0.87, 1.71 vs. 0.48 ng/ml in controls, p<0.001) and in Pseudotumor cerebri (1.26 vs. 0.48 ng/ml in controls, p<0.01). SP-B and SP-D did not show significant alterations. Conclusion The present study confirms the presence of SPs in human CSF. There are significant changes of SP-A and SP-C levels in diseases affecting brain water circulation and elevation of intracranial pressure. Cause of the alterations, underlying regulatory mechanisms, as well as diagnostic and therapeutic consequences of cerebral SP's requires further thorough investigations.	[Schob, Stefan; Lobsien, Donald; Gawlitza, Matthias; Hoffmann, Karl-Titus] Univ Leipzig, Dept Neuroradiol, D-04109 Leipzig, Germany; [Mahr, Cynthia V.; Nestler, Ulf; Preuss, Matthias] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Friedrich, Benjamin] Univ Leipzig, Dept Diagnost & Intervent Radiol, D-04109 Leipzig, Germany; [Bernhard, Matthias K.] Univ Leipzig, Div Neuropediat, D-04109 Leipzig, Germany; [Gebauer, Corinna] Univ Leipzig, Dept Neonatol, D-04109 Leipzig, Germany; [Dieckow, Julia] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Pirlich, Mandy; Saur, Dorothee] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Bechmann, Ingo] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat, Erlangen, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Erlangen Nuremberg	Schob, S (corresponding author), Univ Leipzig, Dept Neuroradiol, D-04109 Leipzig, Germany.	Stefan.Schob@medizin.uni-leipzig.de	Saur, Dorothee/C-5900-2019; Saur, Dorothee/Q-1684-2017; Nestler, Ulf/D-6503-2014	Saur, Dorothee/0000-0002-1808-0913; Saur, Dorothee/0000-0002-1808-0913; Nestler, Ulf/0000-0002-2963-4344; Friedrich, Benjamin/0000-0002-2198-9925; Schob, Julia/0000-0001-9710-3038; Krause, Matthias/0000-0002-7026-2837; Hoffmann, Karl-Titus/0000-0001-7693-887X; schob, stefan/0000-0003-2846-5443				Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Arold SP, 2003, AM J PHYSIOL-LUNG C, V285, pL370, DOI 10.1152/ajplung.00036.2003; Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; Bradley WG, 2015, AM J NEURORADIOL, V36, P831, DOI 10.3174/ajnr.A4124; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Cinalli G, 2011, CHILD NERV SYST, V27, P1621, DOI 10.1007/s00381-011-1546-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; HAAGSMAN HP, 1991, BIOCHEM J, V275, P273, DOI 10.1042/bj2750273; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Hamilton R, 2012, J APPL PHYSIOL, V113, P1560, DOI 10.1152/japplphysiol.00357.2012; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Kerr MH, 1999, AM J RESP CRIT CARE, V159, P1115, DOI 10.1164/ajrccm.159.4.9709065; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Lee WJ, 2010, J NEUROL, V257, P1675, DOI 10.1007/s00415-010-5602-8; Lieb JM, 2015, RADIOLOGE, V55, P389, DOI 10.1007/s00117-014-2797-1; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Palaniyar N, 2010, INNATE IMMUN-LONDON, V16, P131, DOI 10.1177/1753425910370498; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Preuss M, 2013, CHILD NERV SYST, V29, P1263, DOI 10.1007/s00381-013-2159-8; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Schicht M, 2015, ANN ANAT, V199, P92, DOI 10.1016/j.aanat.2014.05.040; Schob S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074412; Singer W, 2003, BIOPHYS J, V84, P1344, DOI 10.1016/S0006-3495(03)74950-9; Sorensen GL, 2007, IMMUNOBIOLOGY, V212, P381, DOI 10.1016/j.imbio.2007.01.003; Veldhuizen EJA, 2000, BIOPHYS J, V79, P3164, DOI 10.1016/S0006-3495(00)76550-7; VOORHOUT WF, 1991, J HISTOCHEM CYTOCHEM, V39, P1331, DOI 10.1177/39.10.1940306; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wang JY, 2007, IMMUNOBIOLOGY, V212, P417, DOI 10.1016/j.imbio.2007.01.002; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; Weerakkody RA, 2011, ACTA NEUROL SCAND, V124, P85, DOI 10.1111/j.1600-0404.2010.01467.x; Whitsett JA, 2014, NEONATOLOGY, V105, P337, DOI 10.1159/000360649; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	39	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0160680	10.1371/journal.pone.0160680	http://dx.doi.org/10.1371/journal.pone.0160680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656877	Green Published, Green Submitted, gold			2022-12-27	WOS:000383893200003
J	Tkachyova, I; Fan, XL; LamHonWah, AM; Fedyshyn, B; Tein, I; Don, JM; Schulze, A				Tkachyova, Ilona; Fan, Xiaolian; LamHonWah, Anne-Marie; Fedyshyn, Bohdana; Tein, Ingrid; Mahuran, Don J.; Schulze, Andreas			NDST1 Preferred Promoter Confirmation and Identification of Corresponding Transcriptional Inhibitors as Substrate Reduction Agents for Multiple Mucopolysaccharidosis Disorders	PLOS ONE			English	Article							HEPARAN-SULFATE; PHARMACOLOGICAL CHAPERONE; N-SULFOTRANSFERASE; THERAPY; DISEASE; BIOLOGY; DEFECT; MICE	The stepwise degradation of glycosaminoglycans (GAGs) is accomplished by twelve lysosomal enzymes. Deficiency in any of these enzymes will result in the accumulation of the intermediate substrates on the pathway to the complete turnover of GAGs. The accumulation of these undegraded substrates in almost any tissue is a hallmark of all Mucopolysaccharidoses (MPS). Present therapeutics based on enzyme replacement therapy and bone marrow transplantation have low effectiveness for the treatment of MPS with neurological complications since enzymes used in these therapies are unable to cross the blood brain barrier. Small molecule-based approaches are more promising in addressing neurological manifestations. In this report we identify a target for developing a substrate reduction therapy (SRT) for six MPS resulting from the abnormal degradation of heparan sulfate (HS). Using the minimal promoter of NDST1, one of the first modifying enzymes of HS precursors, we established a luciferase based reporter gene assay capable of identifying small molecules that could potentially reduce HS maturation and therefore lessen HS accumulation in certain MPS. From the screen of 1,200 compounds comprising the Prestwick Chemical library we identified SAHA, a histone deacetylase inhibitor, as the drug that produced the highest inhibitory effects in the reporter assay. More importantly SAHA treated fibroblasts expressed lower levels of endogenous NDST1 and accumulated less S-35 GAGs in patient cells. Thus, by using our simple reporter gene assay we have demonstrated that by inhibiting the transcription of NDST1 with small molecules, identified by high throughput screening, we can also reduce the level of sulfated HS substrate in MPS patient cells, potentially leading to SRT.	[Tkachyova, Ilona; Fan, Xiaolian; LamHonWah, Anne-Marie; Fedyshyn, Bohdana; Tein, Ingrid; Mahuran, Don J.; Schulze, Andreas] Hosp Sick Children, Res Inst, Genet & Genome Biol, Toronto, ON, Canada; [Tkachyova, Ilona; LamHonWah, Anne-Marie; Tein, Ingrid; Mahuran, Don J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Tein, Ingrid; Schulze, Andreas] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Schulze, A (corresponding author), Hosp Sick Children, Res Inst, Genet & Genome Biol, Toronto, ON, Canada.; Schulze, A (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.	andreas.schulze@sickkids.ca	Schulze, Andreas/I-5706-2019	Schulze, Andreas/0000-0001-8491-1095	Sanfilippo Children's Research Foundation, Canada	Sanfilippo Children's Research Foundation, Canada	This work was supported by The Sanfilippo Children's Research Foundation, Canada.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bennett Lunawati L, 2015, Drug Des Devel Ther, V9, P4639, DOI 10.2147/DDDT.S77760; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Ford-Perriss M, 2002, GLYCOBIOLOGY, V12, P721, DOI 10.1093/glycob/cwf072; FRATANTO.JC, 1969, P NATL ACAD SCI USA, V64, P360, DOI 10.1073/pnas.64.1.360; Garner OB, 2008, IMMUNOLOGY, V125, P420, DOI 10.1111/j.1365-2567.2008.02856.x; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; Lamanna WC, 2012, J BIOL CHEM, V287, P36283, DOI 10.1074/jbc.M112.403360; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; McCarty DM, 2011, METAB BRAIN DIS, V26, P9, DOI 10.1007/s11011-010-9230-x; Parenti G, 2015, MOL THER, V23, P1138, DOI 10.1038/mt.2015.62; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Wraith JE, 2009, INT J CLIN PHARM TH, V47, pS63; Wraith JE, 2013, HAND CLINIC, V113, P1723, DOI 10.1016/B978-0-444-59565-2.00042-3	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0162145	10.1371/journal.pone.0162145	http://dx.doi.org/10.1371/journal.pone.0162145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27657498	Green Published, gold, Green Submitted			2022-12-27	WOS:000383893200020
J	Goates, S; Du, K; Braunschweig, CA; Arensberg, MB				Goates, Scott; Du, Kristy; Braunschweig, Carol A.; Arensberg, Mary Beth			Economic Burden of Disease-Associated Malnutrition at the State Level	PLOS ONE			English	Article							MEDICAL NUTRITION; HOSPITALIZED-PATIENTS; IMPACT; CARE; SUPPLEMENTATION; CANCER; PREVALENCE; MANAGEMENT; OUTCOMES; COSTS	Background Disease-associated malnutrition has been identified as a prevalent condition, particularly for the elderly, which has often been overlooked in the U.S. healthcare system. The state-level burden of community-based disease-associated malnutrition is unknown and there have been limited efforts by state policy makers to identify, quantify, and address malnutrition. The objective of this study was to examine and quantify the state-level economic burden of disease-associated malnutrition. Methods Direct medical costs of disease-associated malnutrition were calculated for 8 diseases: Stroke, Chronic Obstructive Pulmonary Disease, Coronary Heart Failure, Breast Cancer, Dementia, Musculoskeletal Disorders, Depression, and Colorectal Cancer. National disease and malnutrition prevalence rates were estimated for subgroups defined by age, race, and sex using the National Health and Nutrition Examination Survey and the National Health Interview Survey. State prevalence of disease-associated malnutrition was estimated by combining national prevalence estimates with states' demographic data from the U.S. Census. Direct medical cost for each state was estimated as the increased expenditures incurred as a result of malnutrition. Principal Findings Direct medical costs attributable to disease-associated malnutrition vary among states from an annual cost of $ 36 per capita in Utah to $ 65 per capita in Washington, D.C. Nationally the annual cost of disease-associated malnutrition is over $ 15.5 billion. The elderly bear a disproportionate share of this cost on both the state and national level. Conclusions Additional action is needed to reduce the economic impact of disease-associated malnutrition, particularly at the state level. Nutrition may be a cost-effective way to help address high health care costs.	[Goates, Scott] Abbott Nutr, Res & Dev, Columbus, OH USA; [Du, Kristy; Braunschweig, Carol A.] Univ Illinois, Div Nutr Sci, Champaign, IL 61820 USA; [Du, Kristy] Univ Illinois, Abbott Nutr, Res Pk, Champaign, IL 61820 USA; [Braunschweig, Carol A.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Arensberg, Mary Beth] Abbott, Abbott Nutr Prod Div, Columbus, OH 43215 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Arensberg, MB (corresponding author), Abbott, Abbott Nutr Prod Div, Columbus, OH 43215 USA.	mary.arensberg@abbott.com						Agarwal E, 2013, CLIN NUTR, V32, P737, DOI 10.1016/j.clnu.2012.11.021; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Braunschweig C, 2000, J AM DIET ASSOC, V100, P1316, DOI 10.1016/S0002-8223(00)00373-4; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; de Aguilar-Nascimento JE, 2011, NUTRITION, V27, P440, DOI 10.1016/j.nut.2010.02.013; De Hoyos R, 2005, STAT SOFTWARE COMPON; Deutz NE, 2016, CLIN NUTR, V35, P18, DOI 10.1016/j.clnu.2015.12.010; Edington J, 1999, P NUTR SOC, V58, P655, DOI 10.1017/S0029665199000853; Elia M, 2016, CLIN NUTR, V35, P370, DOI 10.1016/j.clnu.2015.05.010; Elia M, 2016, CLIN NUTR, V35, P125, DOI 10.1016/j.clnu.2015.07.012; FORSE RA, 1980, JPEN-PARENTER ENTER, V4, P450, DOI 10.1177/0148607180004005450; Freijer K, 2014, J AM MED DIR ASSOC, V15, P17, DOI 10.1016/j.jamda.2013.09.005; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Guenter P, 2015, JT COMM J QUAL PATIE, V41, P469, DOI 10.1016/S1553-7250(15)41061-X; Hamwi GJ, 1964, DIABETES MELLITUS DI, P73; Heys SD, 1999, ANN SURG, V229, P467, DOI 10.1097/00000658-199904000-00004; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Inotai A., 2012, e-SPEN Journal, V7, pe196; Jena AB, 2014, J GEN INTERN MED, V29, P1065, DOI 10.1007/s11606-014-2779-z; Jensen GL, 2010, JPEN-PARENTER ENTER, V34, P156, DOI 10.1177/0148607110361910; Kenler AS, 1996, ANN SURG, V223, P316, DOI 10.1097/00000658-199603000-00013; May PE, 2002, AM J SURG, V183, P471, DOI 10.1016/S0002-9610(02)00823-1; Meehan A, 2016, J NURS CARE QUAL, V31, P217, DOI 10.1097/NCQ.0000000000000177; Milte RK, 2013, EUR J CLIN NUTR, V67, P1243, DOI 10.1038/ejcn.2013.206; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Naberhuis JK, 2015, VALUE HEALTH, V18, pA553, DOI 10.1016/j.jval.2015.09.1780; National Health Interview Survey, 2014, AD SAMPL; Neelemaat F, 2012, J AM GERIATR SOC, V60, P691, DOI 10.1111/j.1532-5415.2011.03888.x; Pagotto V, 2014, SCI WORLD J, V2014, DOI [10.1155/2014/231312, DOI 10.1155/2014/231312]; Philipson TJ, 2013, AM J MANAG CARE, V19, P121; REILLY JJ, 1988, JPEN-PARENTER ENTER, V12, P371, DOI 10.1177/0148607188012004371; Russell CA, 2007, CLIN NUTR, P25, DOI 10.1016/j.clnu.2007.04.002; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schols AM, 2014, EUR RESPIR J, V44, P1504, DOI 10.1183/09031936.00070914; Shah Bhumika, 2006, Nutr Clin Pract, V21, P312, DOI 10.1177/0115426506021003312; Sheean PM, 2014, JPEN-PARENTER ENTER, V38, P873, DOI 10.1177/0148607113500308; Snider JT, 2014, JPEN-PARENTER ENTER, V38, p77S, DOI 10.1177/0148607114550000; Somanchi M, 2011, JPEN-PARENTER ENTER, V35, P209, DOI 10.1177/0148607110392234; StataCorp, 2013, STAT REL 13; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Tappenden KA, 2013, JPEN-PARENTER ENTER, V37, P482, DOI 10.1177/0148607113484066; Van Cutsem Eric, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS51, DOI 10.1016/j.ejon.2005.09.007; Van Kan GA, 2009, J NUTR HEALTH AGING, V13, P708, DOI 10.1007/s12603-009-0201-z; van Wetering CR, 2010, J AM MED DIR ASSOC, V11, P179, DOI 10.1016/j.jamda.2009.12.083; Walzer S, 2014, CLINICOECONOMIC OUTC, V6, P241, DOI 10.2147/CEOR.S58852; Watson K, 2014, J NURS CARE, V4	48	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161833	10.1371/journal.pone.0161833	http://dx.doi.org/10.1371/journal.pone.0161833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655372	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700009
J	Kroll, ME; Carson, C; Redshaw, M; Quigley, MA				Kroll, Mary E.; Carson, Claire; Redshaw, Maggie; Quigley, Maria A.			Early Father Involvement and Subsequent Child Behaviour at Ages 3, 5 and 7 Years: Prospective Analysis of the UK Millennium Cohort Study	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; PROSOCIAL BEHAVIOR; MOTHER-CHILD; STRENGTHS; PARENTS; AGGRESSION; DISTRESS; OUTCOMES	Objective Fathers are increasingly involved in care of their babies and young children. We assessed the association of resident fathers' involvement with subsequent behaviour of their children, examining boys and girls separately. Methods We used longitudinal data from the UK Millennium Cohort Study for children born in 20002001, divided into three separate analysis periods: ages 9 months to 3 years, 3 to 5 years, and 5 to 7 years. By exploratory factor analysis of self-reported attitudes and engagement in caring activities, we derived composite measures of various types of father involvement at 9 months, 3 and 5 years. Where possible we created equivalent measures of mother involvement. Child behaviour was assessed by the Strengths and Difficulties Questionnaire (SDQ), which was completed by the mother when the child was aged 3, 5 and 7 years. We estimated gender-specific odds ratios for behaviour problems per quintile of father involvement, using separate logistic regression models for boys and girls in each analysis period. We controlled for a wide range of potential confounders: characteristics of the child (temperament and development at 9 months, and illness and exact age at outcome), equivalent mother involvement where appropriate, and factors related to socioeconomic status, household change, and parental well-being, where statistically significant. Results Paternal positive parenting beliefs at age 9 months and increased frequency of creative play at age 5 years were significantly associated with lower risk of subsequent behaviour problems (SDQ total difficulties) in both boys and girls (p<0.05), odds ratios ranging between 0.81 and 0.89 per quintile of involvement. No associations were observed for other composite measures of caring activity by the father at 9 months, 3 years or 5 years. Conclusion Quality of parenting, rather than the division of routine care between parents, was associated with child behavioural outcomes.	[Kroll, Mary E.; Carson, Claire; Redshaw, Maggie; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England	University of Oxford	Kroll, ME (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England.	mary.kroll@npeu.ox.ac.uk		Quigley, Maria/0000-0002-8058-6181	Policy Research Programme in the UK Department of Health [108/0001]	Policy Research Programme in the UK Department of Health	This paper reports on an independent study which is funded by the Policy Research Programme in the UK Department of Health (http://prp-ccf.org.uk/, grant number 108/0001). The views expressed are not necessarily those of the Department. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PATERNITY PAY LEAVE; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Baumrind D, 2010, PARENT-SCI PRACT, V10, P157, DOI 10.1080/15295190903290790; Baxter J. A., 2011, FATHERING AUSTR COUP; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Carey W. B., 1995, CAREY TEMPERAMENT SC; Centre for Longitudinal Studies, 2017, MILL COH STUD 3 SURV, V7th ed., DOI [10.5255/UKDA-SN-5795-4, DOI 10.5255/UKDA-SN-5795-4]; Crick NR, 1996, CHILD DEV, V67, P2317, DOI 10.1111/j.1467-8624.1996.tb01859.x; Croft S, 2015, PEDIATRICS, V135, pE1210, DOI 10.1542/peds.2014-2920; Davidov M, 2006, CHILD DEV, V77, P44, DOI 10.1111/j.1467-8624.2006.00855.x; Deater-Deckard K, 2004, J ABNORM CHILD PSYCH, V32, P609, DOI 10.1023/B:JACP.0000047210.81880.14; Fagan J, 2014, J FAM THEOR REV, V6, P390, DOI 10.1111/jftr.12044; Fenson L., 1993, MACARTHUR COMMUNICAT; Fisher K., 1999, BRIT FATHERS CHILDRE; Flouri E, 2002, J FAM PSYCHOL, V16, P186, DOI 10.1037//0893-3200.16.2.186; Flouri E, 2012, INT J LONGITUDINAL L; Flouri E, 2016, J ABNORM CHILD PSYCH, V44, P1011, DOI 10.1007/s10802-015-0077-9; Flouri E, 2010, CLIN PSYCHOL REV, V30, P363, DOI 10.1016/j.cpr.2010.01.004; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Garner PW, 2008, SOC DEV, V17, P259, DOI 10.1111/j.1467-9507.2007.00424.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hansen K., 2014, MILLENNIUM COHORT ST; Hines M, 2010, TRENDS COGN SCI, V14, P448, DOI 10.1016/j.tics.2010.07.005; Hogg S, 2014, ALL BABIES COUNT DAD; Huerta MC, 2013, DELSAELSAWDSEM201211; Jones E, 2013, DFERB254 CHILDH WELL; Kersten P, 2016, INT J BEHAV DEV, V40, P64, DOI 10.1177/0165025415570647; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lamb M. E., 2010, ROLE FATHER CHILD DE, V4th, P94; Lansford JE, 2006, J FAM PSYCHOL, V20, P292, DOI 10.1037/0893-3200.20.2.292; Luoma I, 1999, EUR CHILD ADOLES PSY, V8, P29; McMunn A, 2017, J FAM ISSUES, V38, P1109, DOI 10.1177/0192513X15622415; Mulligan K, 2013, 18893 NAT BUR EC RES; Pawlak, 2011, MEN FAMILIES FAMILY; Pleck J.H., 2010, ROLE FATHER CHILD DE, P58, DOI DOI 10.2307/583508; Ramchandani P, 2009, LANCET, V374, P646, DOI 10.1016/S0140-6736(09)60238-5; Ramchandani PG, 2013, J CHILD PSYCHOL PSYC, V54, P56, DOI 10.1111/j.1469-7610.2012.02583.x; Rutter M., 1970, ED HLTH BEHAV; Sarkadi A, 2008, ACTA PAEDIATR, V97, P153, DOI 10.1111/j.1651-2227.2007.00572.x; Smeaton D, 2006, 50 DTI ERRS; StataCorp, 2013, STAT REL 13; Stern D. N., 2004, 1 RELATIONSHIP INFAN; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; TREMBLAY RE, 1992, INT J BEHAV DEV, V15, P227, DOI 10.1177/016502549201500204; University Of London IOE, 2017, MILL COH STUD 4 SURV, DOI 10.5255/ukda-sn-6411-7; University of London IoE Centre for Longitudinal Studies, 2001, MILL COH STUD 1 SURV; University of London IoE Centre for Longitudinal Studies, 2003, MILL COH STUD 2 SURV	48	24	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0162339	10.1371/journal.pone.0162339	http://dx.doi.org/10.1371/journal.pone.0162339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GK	27654635	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700019
J	Sureda, A; Batle, JM; Martorell, M; Capo, X; Tejada, S; Tur, JA; Pons, A				Sureda, Antoni; Batle, Juan M.; Martorell, Miquel; Capo, Xavier; Tejada, Silvia; Tur, Josep A.; Pons, Antoni			Antioxidant Response of Chronic Wounds to Hyperbaric Oxygen Therapy	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; MYOCARDIAL-INFARCTION; FOOT; EXPRESSION; DEFENSES; TISSUE; INFLAMMATION; ULCERS; INJURY	We analyzed the effects of the clinical hyperbaric oxygen therapy (HBOT) on the plasma antioxidant response and levels of endothelin-1, Interleukine-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with chronic wounds (20.2 +/- 10.0 months without healing). They received 20 HBOT sessions (five sessions/week), and blood samples were obtained at sessions 1, 5 and 20 before and 2 hours after the HBOT. An additional blood sample was collected 1 month after wound recovery. Serum creatine kinase activity decreased progressively in accordance with the wound healing. Plasma catalase activity significantly increased after the first and fifth sessions of HBOT. Plasma myeloperoxidase activity reported significantly lower values after sessions. Plasma VEGF and IL-6 increased after sessions. Endothelin-1 levels were progressively decreasing during the HBOT, being significant at the session 20. Plasma malondialdehyde concentration was significantly reduced at the last session. Both creatine kinase activity and malondialdehyde levels were maintained lower 1 month after wound recovery respect to initial values. In conclusion, HBOT enhanced the plasma antioxidant defenses and may contribute to activate the healing resolution, angiogenesis and vascular tone regulation by increasing the VEGF and IL-6 release and the endothelin-1 decrease, which may be significant factors in stimulating wound healing.	[Sureda, Antoni; Batle, Juan M.; Martorell, Miquel; Capo, Xavier; Tur, Josep A.; Pons, Antoni] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma de Mallorca, Balearic Island, Spain; [Sureda, Antoni; Batle, Juan M.; Martorell, Miquel; Capo, Xavier; Tur, Josep A.; Pons, Antoni] CIBEROBN Physiopathol Obes & Nutr, E-07122 Palma de Mallorca, Balearic Island, Spain; [Martorell, Miquel] Univ Concepcion, Fac Farm, Dept Nutr & Dietet, E-4070386 Concepcion, Chile; [Tejada, Silvia] Son Llatzer Hosp, IUNICS, Expt Lab, Res Unit, Ctra Manacor Km 4, E-07198 Palma de Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad de Concepcion; Hospital Universitari Son Llatzer; Universitat de les Illes Balears	Pons, A (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma de Mallorca, Balearic Island, Spain.; Pons, A (corresponding author), CIBEROBN Physiopathol Obes & Nutr, E-07122 Palma de Mallorca, Balearic Island, Spain.	antonipons@uib.es	Pons, Antoni/L-4844-2014; , Antoni/AAB-5250-2019; Capò, Xavier/AAL-4246-2020; Tur, Josep/AAE-5748-2020; Sureda, Antoni/N-9588-2019; Capó, Xavier/AAD-6322-2022; Martorell, Miquel/H-8490-2014; Tejada, Silvia/L-7297-2014; Gomila, Antonio Sureda/L-7191-2014	Pons, Antoni/0000-0003-2447-3868; , Antoni/0000-0001-8656-6838; Tur, Josep/0000-0002-6940-0761; Sureda, Antoni/0000-0001-8656-6838; Capó, Xavier/0000-0002-3499-5494; Martorell, Miquel/0000-0003-3183-7623; Tejada, Silvia/0000-0002-7498-6090; Gomila, Antonio Sureda/0000-0003-2101-616X	Spanish Ministry of Health and Consumption Affairs [05/1276, 08/1259, 11/01791, RD06/0045/1004, CB12/03/30038]; Balearic Islands Gov. [35/2011, 23/2012]; EU FEDER funds [35/2011, 23/2012]	Spanish Ministry of Health and Consumption Affairs(Spanish Government); Balearic Islands Gov.; EU FEDER funds(European Commission)	The study was supported by the Spanish Ministry of Health and Consumption Affairs (Programme of Promotion of Biomedical Research and Health Sciences, Projects 05/1276, 08/1259, and 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBERobn CB12/03/30038), Grants of support to research groups no. 35/2011 and 23/2012 (Balearic Islands Gov. and EU FEDER funds).r The study was supported by the Spanish Ministry of Health and Consumption Affairs (Programme of Promotion of Biomedical Research and Health Sciences, Projects 05/1276, 08/1259, and 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038), Grants of support to research groups no. 35/2011 and 23/2012 (Balearic Islands Gov. and EU FEDER funds).	Alonso D, 2003, HEART FAIL REV, V8, P47, DOI 10.1023/A:1022194921040; Aydin F, 2014, ACTA ORTHOP TRAUMATO, V48, P649, DOI 10.3944/AOTT.2014.3225; Barnes RC, 2006, CLIN INFECT DIS, V43, P188, DOI 10.1086/505207; Bescos R, 2012, MED SCI SPORT EXER, V44, P2400, DOI 10.1249/MSS.0b013e3182687e5c; Boykin Joseph V Jr, 2007, Adv Skin Wound Care, V20, P382, DOI 10.1097/01.ASW.0000280198.81130.d5; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Chen QP, 1996, J PHARMACOL EXP THER, V276, P929; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Dekleva M, 2004, AM HEART J, V148, DOI 10.1016/j.ahj.2004.03.031; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Frangogiannis NG, 2014, J CARDIOVASC PHARM, V63, P185, DOI 10.1097/FJC.0000000000000003; Game FL, 2012, DIABETES-METAB RES, V28, P119, DOI 10.1002/dmrr.2246; Garcia-Covarrubias L, 2000, Gac Med Mex, V136, P45; Gasier HG, 2013, UNDERSEA HYPERBAR M, V40, P125; Godman CA, 2010, ANN NY ACAD SCI, V1197, P178, DOI 10.1111/j.1749-6632.2009.05393.x; Gole Y, 2011, EUR J APPL PHYSIOL, V111, P937, DOI 10.1007/s00421-010-1711-4; Gordillo GM, 2008, CLIN EXP PHARMACOL P, V35, P957, DOI 10.1111/j.1440-1681.2008.04934.x; Goudable J, 1996, CLIN NUTR S1, V15, P10; Gurdol F, 2008, PHYSIOL RES, V57, P41, DOI 10.33549/physiolres.931139; Handy RD, 2005, UNDERSEA HYPERBAR M, V32, P327; Jung S, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-29; Juttner B, 2003, UNDERSEA HYPERBAR M, V30, P305; Kendall AC, 2013, WOUND REPAIR REGEN, V21, P860, DOI 10.1111/wrr.12108; Kendall AC, 2012, EXP CELL RES, V318, P207, DOI 10.1016/j.yexcr.2011.10.014; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Luo JD, 2005, ACTA PHARMACOL SIN, V26, P259, DOI 10.1111/j.1745-7254.2005.00058.x; Ma L, 2013, OSTOMY WOUND MANAG, V59, P18; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Serhan C.N., 2015, SEMIN IMMUNOL; Shah Jayesh B, 2011, J Am Col Certif Wound Spec, V3, P26, DOI 10.1016/j.jcws.2011.09.001; Sheffield PJ, 1998, UNDERSEA HYPERBAR M, V25, P179; Sheikh AY, 2005, WOUND REPAIR REGEN, V13, P303, DOI 10.1111/j.1067-1927.2005.130313.x; Stoekenbroek RM, 2014, EUR J VASC ENDOVASC, V47, P647, DOI 10.1016/j.ejvs.2014.03.005; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Sureda A, 2004, FREE RADICAL BIO MED, V37, P1744, DOI 10.1016/j.freeradbiomed.2004.07.033; Sureda A, 2009, MED SCI SPORT EXER, V41, P1271, DOI 10.1249/MSS.0b013e3181951069; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Vince RV, 2011, CELL STRESS CHAPERON, V16, P339, DOI 10.1007/s12192-010-0246-2; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Wang CJ, 2011, DIABETES RES CLIN PR, V94, P105, DOI 10.1016/j.diabres.2011.06.016; Warriner RA, 2012, UNDERSEA HYPERBAR M, V39, P923; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Yildirim AO, 2014, ULUS TRAVMA ACIL CER, V20, P167, DOI 10.5505/tjtes.2014.09465; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zgheib C, 2014, ADV WOUND CARE, V3, P344, DOI 10.1089/wound.2013.0456; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	57	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163371	10.1371/journal.pone.0163371	http://dx.doi.org/10.1371/journal.pone.0163371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654305	Green Submitted, Green Published, gold			2022-12-27	WOS:000383892700052
J	Wei, Y; Zhou, XR; Liu, SY; Wang, H; Liu, LM; Liu, RZ; Kang, JS; Hong, K; Wang, DW; Yuan, G				Wei, Ying; Zhou, Xinrong; Liu, Siyue; Wang, Hong; Liu, Limin; Liu, Renze; Kang, Jinsong; Hong, Kai; Wang, Daowen; Yuan, Gang			Novel and Practical Scoring Systems for the Diagnosis of Thyroid Nodules	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BRAF(V600E) MUTATION; MOLECULAR ANALYSIS; BETHESDA SYSTEM; BRAF MUTATION; CYTOLOGY; CANCER; CYTOPATHOLOGY; MALIGNANCY; MANAGEMENT	Objective The clinical management of patients with thyroid nodules that are biopsied by fine-needle aspiration cytology and yield indeterminate results remains unsettled. The BRAF V600E mutation has dubious diagnostic value due to its low sensitivity. Novel strategies are urgently needed to distinguish thyroid malignancies from thyroid nodules. Design This prospective study included 504 thyroid nodules diagnosed by ultrasonography from 468 patients, and fine-needle aspiration cytology was performed under ultrasound guidance. Cytology and molecular analysis, including BRAF V600E, RET/PTC1 and RET/PTC3, were conducted simultaneously. The cytology, ultrasonography results, and mutational status were gathered and analyzed together. Predictive scoring systems were designed using a combination of diagnostic parameters for ultrasonography, cytology and genetic analysis. The utility of the scoring systems was analyzed and compared to detection using the individual methods alone or combined. Result The sensitivity of scoring system(a) (ultrasonography, cytology, BRAF V600E, RET/PTC) was nearly identical to that of scoring system(b) (ultrasonography, cytology, BRAF V600E); these were 91.0% and 90.2%, respectively. These sensitivities were significantly higher than those obtained using FNAC, genetic analysis and US alone or combined; their sensitivities were 63.9%, 70.7% and 87.2%, respectively. Scoring system(c) (ultrasonography, cytology) was slightly inferior to the former two scoring systems but still had relatively high sensitivity and specificity (80.5% and 95.1%, respectively), which were significantly superior to those of single cytology, ultrasonography or genetic analysis. In nodules with uncertainty cytology, scoring system a, scoring system(b) and scoring system(c) could elevate the malignancy detection rates to 69.7%, 69.7% and 63.6%, respectively. Conclusion These three scoring systems were quick for clinicians to master and could provide quantified information to predict the probability of malignant nodules. Scoring system(b) is recommended for improving the detection rate among nodules of uncertain cytology.	[Wei, Ying; Zhou, Xinrong; Liu, Siyue; Wang, Daowen; Yuan, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Wuhan, Hubei, Peoples R China; [Wang, Hong; Wang, Daowen] Huazhong Univ Sci & Technol, Mol Diagnost Lab, Tongji Hosp, Wuhan, Hubei, Peoples R China; [Liu, Limin; Liu, Renze; Kang, Jinsong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg Cytol, Wuhan, Hubei, Peoples R China; [Hong, Kai] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Ultrason, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, DW; Yuan, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Wuhan, Hubei, Peoples R China.	dwwang@tjh.tjmu.edu.cn; yuangang88@hotmail.com	liu, li/HGC-0900-2022		National Natural Science Foundation of China [81370941]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (No.: 81370941, Gang Yuan, http//npd.nsfc.gov.Cn/fundingProjectSearchAction!search.action).	Agretti P, 2014, J ENDOCRINOL INVEST, V37, P1009, DOI 10.1007/s40618-014-0166-6; Alexander EK, 2008, J CLIN ENDOCR METAB, V93, P4175, DOI 10.1210/jc.2008-1328; Aragon Han P, 2014, ANN SURG ONCOL, DOI 10.1245/s10434-014-3508-x; Bongiovanni M, 2012, ACTA CYTOL, V56, P333, DOI 10.1159/000339959; Buryk MA, 2013, INT J PEDIATR OTORHI, V77, P1697, DOI 10.1016/j.ijporl.2013.07.029; Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cohen Y, 2004, CLIN CANCER RES, V10, P2761, DOI 10.1158/1078-0432.CCR-03-0273; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Faam B, 2015, BIOMED REP, V3, P3, DOI 10.3892/br.2014.375; Fallahi P, 2014, CURR GENOMICS, V15, P171, DOI 10.2174/1389202915999140404100347; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Guan HX, 2009, J CLIN ENDOCR METAB, V94, P1612, DOI 10.1210/jc.2008-2390; Guerra A, 2014, THYROID, V24, P254, DOI 10.1089/thy.2013.0235; Hassell LA, 2012, CANCER CYTOPATHOL, V120, P7, DOI 10.1002/cncy.20186; Haugen BR, 2016, THYROID, V26, P1, DOI [DOI 10.1089/THY.2015.0020, 10.1089/thy.2015.0020]; Illouz F, 2007, EUR J ENDOCRINOL, V156, P303, DOI 10.1530/EJE-06-0616; Jia YS, 2014, DIAGN CYTOPATHOL, V42, P94, DOI 10.1002/dc.23044; Kim SK, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000760; Kim SY, 2015, SURGERY, V157, P354, DOI 10.1016/j.surg.2014.09.003; Krane JF, 2015, CANCER CYTOPATHOL, V123, P356, DOI 10.1002/cncy.21546; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Lee EJ, 2011, CLIN ENDOCRINOL, V75, P844, DOI 10.1111/j.1365-2265.2011.04154.x; Lee MJ, 2011, YONSEI MED J, V52, P838, DOI 10.3349/ymj.2011.52.5.838; Li F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531; Liu S, 2014, EXP MOL PATHOL, V97, P292, DOI 10.1016/j.yexmp.2014.08.005; Melck AL, 2010, ONCOLOGIST, V15, P1285, DOI 10.1634/theoncologist.2010-0156; Moon HJ, 2009, ANN SURG ONCOL, V16, P3125, DOI 10.1245/s10434-009-0644-9; Nacamulli D, 2012, CLIN ENDOCRINOL, V77, P608, DOI 10.1111/j.1365-2265.2012.04427.x; Nikiforov YE, 2014, CANCER-AM CANCER SOC, V120, P3627, DOI 10.1002/cncr.29038; Nikiforov YE, 2011, MODERN PATHOL, V24, pS34, DOI 10.1038/modpathol.2010.167; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; Ohori NP, 2013, CANCER CYTOPATHOL, V121, P197, DOI 10.1002/cncy.21229; Orlandi A, 2005, THYROID, V15, P274, DOI 10.1089/thy.2005.15.274; Pompili G, 2013, ULTRASOUND MED BIOL, V39, P1350, DOI 10.1016/j.ultrasmedbio.2013.02.464; Rabaglia JL, 2010, SURGERY, V148, P1267, DOI 10.1016/j.surg.2010.09.017; Rago T, 2014, J CLIN ENDOCR METAB, V99, P3700, DOI 10.1210/jc.2013-4401; Rossi M, 2015, THYROID, V25, P221, DOI 10.1089/thy.2014.0338; Rossi M, 2012, J CLIN ENDOCR METAB, V97, P2354, DOI 10.1210/jc.2011-3494; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Yoon JH, 2016, RADIOLOGY, V278, P917, DOI 10.1148/radiol.2015150056; Zhao H, 2015, DIAGN CYTOPATHOL, V43, P786, DOI 10.1002/dc.23302	44	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163039	10.1371/journal.pone.0163039	http://dx.doi.org/10.1371/journal.pone.0163039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654865	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892700035
J	Arruda, MB; Campagnari, F; de Almeida, TB; Couto-Fernandez, JC; Tanuri, A; Cardoso, CC				Arruda, Monica Barcellos; Campagnari, Francine; de Almeida, Tailah Bernardo; Couto-Fernandez, Jose Carlos; Tanuri, Amilcar; Cardoso, Cynthia Chester			Single Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive Individuals	PLOS ONE			English	Article							RIO-DE-JANEIRO; INFECTED PATIENTS; PLASMA-CONCENTRATIONS; PROTEASE INHIBITORS; HAART REGIMEN; OATP-B; P-GP; AIDS; PHARMACOGENETICS; EFAVIRENZ	Adverse reactions are the main cause of treatment discontinuation among HIV+ individuals. Genes related to drug absorption, distribution, metabolism and excretion (ADME) influence drug bioavailability and treatment response. We have investigated the association between single nucleotide polymorphisms (SNPs) in 29 ADME genes and intolerance to therapy in a case-control study including 764 individuals. Results showed that 15 SNPs were associated with intolerance to nucleoside and 11 to non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs), and 8 to protease inhibitors (PIs) containing regimens under alpha = 0.05. After Bonferroni adjustment, two associations remained statistically significant. SNP rs2712816, at SLCO2B1 was associated to intolerance to NRTIs (ORGA/AA = 2.37; p = 0.0001), while rs4148396, at ABCC2, conferred risk of intolerance to PIs containing regimens (ORCT/TT = 2.64; p = 0.00009). Accordingly, haplotypes carrying rs2712816A and rs4148396T alleles were also associated to risk of intolerance to NRTIs and PIs, respectively. Our data reinforce the role of drug transporters in response to HIV therapy and may contribute to a future development of personalized therapies.	[Arruda, Monica Barcellos; de Almeida, Tailah Bernardo; Tanuri, Amilcar; Cardoso, Cynthia Chester] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Mol Virol Lab, Rio De Janeiro, Brazil; [Campagnari, Francine] Deoxi Biotecnol, Aracatuba, SP, Brazil; [Couto-Fernandez, Jose Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Aids & Imunol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Mol Virol Lab, Rio De Janeiro, Brazil.	cynthiac@biologia.ufrj.br	Tanuri, Amilcar/AAM-8601-2021; Cardoso, Cynthia/K-5824-2012	Cardoso, Cynthia/0000-0003-0565-7047; Couto-Fernandez, Jose Carlos/0000-0001-7091-9774	Brazilian Ministry of Science and Technology [03.12.0057.00, FINEP 01/2010]; Deoxi Biotecnologia	Brazilian Ministry of Science and Technology; Deoxi Biotecnologia	This work was supported by the "Brazilian Ministry of Science and Technology" [FINEP 01/2010 - contact number 03.12.0057.00]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Deoxi Biotecnologia provided support in the form of salaries for authors [FC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Agarwal S, 2007, INT J PHARMACEUT, V339, P139, DOI 10.1016/j.ijpharm.2007.02.036; Ammassari A, 2001, J ACQ IMMUN DEF SYND, P445; Bonolo PD, 2005, AIDS, V19, pS5; Brasil, 2015, B EPIDEMIOLOGICO HIV, P1; Cardoso SW, 2010, AIDS RES HUM RETROV, V26, P865, DOI 10.1089/aid.2009.0274; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Coelho AVC, 2013, J CLIN PHARMACOL, V53, P1286, DOI 10.1002/jcph.165; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; Guimaraes MDC, 2008, CLINICS, V63, P165, DOI 10.1590/S1807-59322008000200003; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2004, AIDS, V18, P2391; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Janneh O, 2005, AIDS, V19, P2097, DOI 10.1097/01.aids.0000194793.36175.40; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2015, JC25711E UNAIDS, P1; Kis O, 2010, J PHARMACOL EXP THER, V334, P1009, DOI 10.1124/jpet.110.166314; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kohlrausch FB, 2010, BRIT J CLIN PHARMACO, V69, P95, DOI 10.1111/j.1365-2125.2009.03551.x; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lazzaretti RK, 2013, SCI WORLD J, DOI 10.1155/2013/608415; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4; de Padua CA, 2007, BRAZ J INFECT DIS, V11, P20, DOI 10.1590/S1413-86702007000100007; Michaud V, 2012, PHARMACOL REV, V64, P803, DOI 10.1124/pr.111.005553; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Ribeiro FA, 2012, BRAZ J INFECT DIS, V16, P27, DOI 10.1590/S1413-86702012000100005; Rodriguez-Novoa S, 2007, AIDS, V21, P41, DOI 10.1097/QAD.0b013e328011d7c1; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Rotger M, 2009, CIRC-CARDIOVASC GENE, V2, P621, DOI 10.1161/CIRCGENETICS.109.874412; Saves M, 2002, CLIN INFECT DIS, V34, P1396, DOI 10.1086/339866; Tarr PE, 2005, J INFECT DIS, V191, P1419, DOI 10.1086/429295; Tsamandouras N, 2014, CLIN PHARMACOL THER, V96, P90, DOI 10.1038/clpt.2014.55; Turatti L, 2012, AIDS RES HUM RETROV, V28, P815, DOI [10.1089/aid.2011.0261, 10.1089/AID.2011.0261]; Weiss J, 2009, J PHARMACOL SCI, V109, P242, DOI 10.1254/jphs.08209FP; Williams GC, 2002, ANTIMICROB AGENTS CH, V46, P3456, DOI 10.1128/AAC.46.11.3456-3462.2002; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163170	10.1371/journal.pone.0163170	http://dx.doi.org/10.1371/journal.pone.0163170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648838	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100062
J	Kim, D; Kim, HE; Kim, CH				Kim, Doory; Kim, Han-Eol; Kim, Chang-Hong			Development of a Blue Emitting Calcium-Aluminate Phosphor	PLOS ONE			English	Article							PERSISTENT LUMINESCENCE; DY3+; MECHANISM; EU2+; SRAL2O4-EU2+; SR; BA	We report methodological advances that enhance the phosphorescence efficiency of a blue-emitting calcium aluminate phosphor (CaAl2O4: Eu2+, Nd3+). The investigation of long-persistence blue-emitting phosphors is highly desirable due to their promising applications, such as white LEDs; however, the development of highly efficient blue-emitting phosphors is still challenging. Here, we have quantitatively characterized the phosphorescence properties of the blue-emitting phosphor CaAl2O4: Eu2+, Nd3+ with various compositions and directly related these properties to the quality of its luminescence. We optimized the composition of the activator Eu2+ and the co-activator Nd3+, the doping conditions with alkaline earth metals, alkali metals, and Si to create crystallographic distortions and, finally, the flux conditions to find the best parameters for bright and persistent blue-emitting phosphors. Our research has identified several doping compositions with good to excellent performance, with which we have demonstrated bright and persistent phosphors with afterglow characteristics superior to those of conventional phosphors.	[Kim, Doory] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kim, Han-Eol] Gwangju Inst Sci & Technol, Gwangju, South Korea; [Kim, Chang-Hong] Korea Inst Sci & Technol, Seoul, South Korea	University of California System; University of California Berkeley; Gwangju Institute of Science & Technology (GIST); Korea Institute of Science & Technology (KIST)	Kim, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	kim33@berkeley.edu		Kim, Doory/0000-0002-2675-106X				ABBRUSCATO V, 1971, J ELECTROCHEM SOC, V118, P930, DOI 10.1149/1.2408226; Aitasalo T, 2003, J SOLID STATE CHEM, V171, P114, DOI 10.1016/S0022-4596(02)00194-9; Aitasalo T, 2002, J ALLOY COMPD, V341, P76, DOI 10.1016/S0925-8388(02)00068-3; Clabau F, 2005, CHEM MATER, V17, P3904, DOI 10.1021/cm050763r; Clabau F, 2007, SOLID STATE SCI, V9, P608, DOI 10.1016/j.solidstatesciences.2007.03.020; Garlick GFJ, 1949, LUMINESCENT MAT, DOI [10.1039/c4dt03999h, DOI 10.1039/C4DT03999H]; Goldberg P., 1966, LUMINESCENCE INORGAN, Vfirst; Holsa J, 2001, J ALLOY COMPD, V323, P326, DOI 10.1016/S0925-8388(01)01084-2; Jia D, 2002, APPL PHYS LETT, V80, P1535, DOI 10.1063/1.1456955; Jia DD, 2007, J ELECTROCHEM SOC, V154, pJ1, DOI 10.1149/1.2372589; Katsumata T, 1997, J ELECTROCHEMICAL SO; Kim D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145434; Kinoshita T, 1999, J APPL PHYS, V86, P3729, DOI 10.1063/1.371243; Li K, 2016, J MATER CHEM C, V4, P5507, DOI 10.1039/c6tc00436a; Li YQ, 2005, CHEM MATER, V17, P3242, DOI 10.1021/cm050175d; Liang C, 2015, DALTON T, V44, P8100, DOI 10.1039/c4dt03999h; Lima NBD, 2013, SCI REPORTS, P3; Lin YH, 2003, J ALLOY COMPD, V348, P76, DOI 10.1016/S0925-8388(02)00796-X; Liu ZF, 2004, MICROELECTRON J, V35, P375, DOI 10.1016/s0026-2692(03)00249-0; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Palilla FC, 1968, J ELECTROCHEMICAL SO, V115; Shi YF, 2012, CELL STEM CELL, V10, P6, DOI 10.1016/j.stem.2011.12.010; Tanner PA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/21/216213; Vishwakarma AK, 2015, DALTON T, V44, P17166, DOI 10.1039/c5dt02436f; Wang D, 2002, J LUMIN, V97, P1, DOI 10.1016/S0022-2313(01)00413-6; Yamamoto H, 1997, J LUMIN, V72-4, P287, DOI 10.1016/S0022-2313(97)00012-4; Zhang SY, 2011, INORG CHEM, V50, P2897, DOI 10.1021/ic102504x	27	3	3	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162920	10.1371/journal.pone.0162920	http://dx.doi.org/10.1371/journal.pone.0162920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648560	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892100043
J	Portis, E; Portis, F; Valente, L; Moglia, A; Barchi, L; Lanteri, S; Acquadro, A				Portis, Ezio; Portis, Flavio; Valente, Luisa; Moglia, Andrea; Barchi, Lorenzo; Lanteri, Sergio; Acquadro, Alberto			A Genome-Wide Survey of the Microsatellite Content of the Globe Artichoke Genome and the Development of a Web-Based Database	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; NEUROLOGICAL DISEASE; MEDICAGO-TRUNCATULA; GENETIC DIVERSITY; VAR. SCOLYMUS; M-AFLP; MARKERS; L.; IDENTIFICATION; INSTABILITY	The recently acquired genome sequence of globe artichoke (Cynara cardunculus var. scolymus) has been used to catalog the genome's content of simple sequence repeat (SSR) markers. More than 177,000 perfect SSRs were revealed, equivalent to an overall density across the genome of 244.5 SSRs/Mbp, but some 224,000 imperfect SSRs were also identified. About 21% of these SSRs were complex (two stretches of repeats separated by <100 nt). Some 73% of the SSRs were composed of dinucleotide motifs. The SSRs were categorized for the numbers of repeats present, their overall length and were allocated to their linkage group. A total of 4,761 perfect and 6,583 imperfect SSRs were present in 3,781 genes (14.11% of the total), corresponding to an overall density across the gene space of 32,5 and 44,9 SSRs/Mbp for perfect and imperfect motifs, respectively. A putative function has been assigned, using the gene ontology approach, to the set of genes harboring at least one SSR. The same search parameters were applied to reveal the SSR content of 14 other plant species for which genome sequence is available. Certain species-specific SSR motifs were identified, along with a hexa-nucleotide motif shared only with the other two Compositae species (sunflower (Helianthus annuus) and horseweed (Conyza canadensis)) included in the study. Finally, a database, called "Cynara cardunculus MicroSatellite DataBase" (CyMSatDB) was developed to provide a searchable interface to the SSR data. CyMSatDB facilitates the retrieval of SSR markers, as well as suggested forward and reverse primers, on the basis of genomic location, genomic vs genic context, perfect vs imperfect repeat, motif type, motif sequence and repeat number. The SSR markers were validated via an in silico based PCR analysis adopting two available assembled transcriptomes, derived from contrasting globe artichoke accessions, as templates.	[Portis, Ezio; Moglia, Andrea; Barchi, Lorenzo; Lanteri, Sergio; Acquadro, Alberto] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, Plant Genet & Breeding, I-10095 Turin, Italy; [Portis, Flavio; Valente, Luisa] Yebokey User Experience Design & Web Dev, I-10134 Turin, Italy	University of Turin	Acquadro, A (corresponding author), Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, Plant Genet & Breeding, I-10095 Turin, Italy.	alberto.acquadro@unito.it	BARCHI, Lorenzo/ABC-4206-2020	BARCHI, Lorenzo/0000-0001-6414-4239; MOGLIA, Andrea/0000-0001-7431-844X; ACQUADRO, Alberto/0000-0002-5322-9701; PORTIS, Ezio/0000-0002-1548-6096	Yebokey	Yebokey	The authors received no specific funding for this work. Yebokey provided support in the form of salary for the author Luisa Valente. Flavio Portis is a consultant of Yebokey who took part in the research for free to gain professional exposure. Yebokey provided logistic support and shared professional knowledge to Flavio Portis. Yebokey played a role in the study design, data collection and analysis, web development and decision to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acquadro A, 2003, MOL ECOL NOTES, V3, P37, DOI 10.1046/j.1471-8286.2003.00343.x; Acquadro A, 2005, MOL ECOL NOTES, V5, P272, DOI 10.1111/j.1471-8286.2005.00897.x; Acquadro A, 2005, GENOME, V48, P217, DOI [10.1139/G04-111, 10.1139/g04-111]; Acquadro A, 2009, THEOR APPL GENET, V118, P1573, DOI 10.1007/s00122-009-1005-6; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18919; Golubov A, 2010, PLANT PHYSIOL, V154, P1415, DOI 10.1104/pp.110.162933; Iquebal MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-197; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Lanteri S, 2006, THEOR APPL GENET, V112, P1532, DOI 10.1007/s00122-006-0256-8; Liu WX, 2015, MOLECULES, V20, P8759, DOI 10.3390/molecules20058759; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Mauro R, 2009, CONSERV GENET, V10, P431, DOI 10.1007/s10592-008-9621-2; Mondal TK, 2014, GENE, V535, P204, DOI 10.1016/j.gene.2013.11.033; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Portis E, 2005, PLANT SCI, V168, P1591, DOI 10.1016/j.plantsci.2005.02.009; Portis E, 2005, PLANT BREEDING, V124, P299, DOI 10.1111/j.1439-0523.2005.01098.x; Portis E, 2015, EUPHYTICA, V206, P523, DOI 10.1007/s10681-015-1521-1; Portis E, 2014, MOL BREEDING, V34, P615, DOI 10.1007/s11032-014-0061-z; Portis Ezio, 2012, BMC Res Notes, V5, P252, DOI 10.1186/1756-0500-5-252; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Whittaker JC, 2003, GENETICS, V164, P781; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yu JK, 2010, PLANT MOL BIOL REP, V28, P352, DOI 10.1007/s11105-009-0154-8; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]	37	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162841	10.1371/journal.pone.0162841	http://dx.doi.org/10.1371/journal.pone.0162841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648830	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100035
J	Alnazzawi, N; Thompson, P; Ananiadou, S				Alnazzawi, Noha; Thompson, Paul; Ananiadou, Sophia			Mapping Phenotypic Information in Heterogeneous Textual Sources to a Domain-Specific Terminological Resource	PLOS ONE			English	Article							OF-THE-ART; CONCEPT RECOGNITION; CLINICAL TEXT; NORMALIZATION; EXTRACTION; ONTOLOGY; CORPUS; GENES; UMLS; TASK	Biomedical literature articles and narrative content from Electronic Health Records (EHRs) both constitute rich sources of disease-phenotype information. Phenotype concepts may be mentioned in text in multiple ways, using phrases with a variety of structures. This variability stems partly from the different backgrounds of the authors, but also from the different writing styles typically used in each text type. Since EHR narrative reports and literature articles contain different but complementary types of valuable information, combining details from each text type can help to uncover new disease-phenotype associations. However, the alternative ways in which the same concept may be mentioned in each source constitutes a barrier to the automatic integration of information. Accordingly, identification of the unique concepts represented by phrases in text can help to bridge the gap between text types. We describe our development of a novel method, PhenoNorm, which integrates a number of different similarity measures to allow automatic linking of phenotype concept mentions to known concepts in the UMLS Metathesaurus, a biomedical terminological resource. PhenoNorm was developed using the PhenoCHF corpus D a collection of literature articles and narratives in EHRs, annotated for phenotypic information relating to congestive heart failure (CHF). We evaluate the performance of PhenoNorm in linking CHF-related phenotype mentions to Metathesaurus concepts, using a newly enriched version of PhenoCHF, in which each phenotype mention has an expert-verified link to a concept in the UMLS Metathesaurus. We show that PhenoNorm outperforms a number of alternative methods applied to the same task. Furthermore, we demonstrate PhenoNorm's wider utility, by evaluating its ability to link mentions of various other types of medically-related information, occurring in texts covering wider subject areas, to concepts in different terminological resources. We show that PhenoNorm can maintain performance levels, and that its accuracy compares favourably to other methods applied to these tasks.	[Alnazzawi, Noha; Thompson, Paul; Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester	Alnazzawi, N (corresponding author), Univ Manchester, Natl Ctr Text Min, Manchester Inst Biotechnol, Manchester, Lancs, England.	alnazzan@cs.man.ac.uk	Alnazzaawi, Noha/ABG-9130-2021	Alnazzaawi, Noha/0000-0003-3265-0297	Medical Research Council [MR/L01078X/1]; Defense Advanced Research Projects Agency [DARPA-BAA-14-14]; MRC [MR/N00583X/1, MR/L01078X/1] Funding Source: UKRI; Medical Research Council [MR/N00583X/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (Supporting Evidence-based Public Health Interventions using Text Mining [Grant MR/L01078X/1]) and by the Defense Advanced Research Projects Agency (Big Mechanism [Grant DARPA-BAA-14-14]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnazzawi N, 2014, P 5 INT WORKSH HLTH, P69; Alnazzawi N, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S2-S3; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Baumgartner WA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S9; Bello S, 2015, P PHEN DAY ISMB 2015, P16; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Chapman WW, 2011, J AM MED INFORM ASSN, V18, P540, DOI 10.1136/amiajnl-2011-000465; Cohen William W., 2003, P IJCAI 03 WORKSH IN, P73; Collier N, 2015, P PHEN DAY 2015 ISMB; Collier N, 2014, P PHEN DAY ISMB 2014; Collier N, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0019-z; Dai M, 2008, P AMIA SUMM TRANSL B; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; de Bruijn B, 2011, J AM MED INFORM ASSN, V18, P557, DOI 10.1136/amiajnl-2011-000150; De La Higuera C, 2008, 1 INT WORKSH SIM SEA; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Donnelly K, 2006, STUD HEALTH TECHNOL, V121, P279; Elhadad N, 2015, P 9 INT WORKSH SEM E, P303; Fan J, 2013, P SHARE CLEF EV LAB; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Franz P, 2000, J AM MED INFORM ASSN, P250; Friedman C, 2000, P AMIA S; Friedman C, 1996, P AMIA ANN FALL S, P938; Fu X, 2014, PROCEED PHENOTYPE DA, V2014, P1; Garla VN, 2013, J AM MED INFORM ASSN, V20, P882, DOI 10.1136/amiajnl-2012-001350; Goeuriot L, 2015, LECT NOTES COMPUT SC, V9283, P429, DOI 10.1007/978-3-319-24027-5_44; Golbeck J, 2011, WEB SEMANTICS SCI SE, V1; Goudey B, 2007, P AUSTR LANG TECHN W, P143; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HERSH WR, 1990, COMPUT BIOMED RES, V23, P410, DOI 10.1016/0010-4809(90)90031-7; Hettne K, 2015, P PHEN DAY ISMB 2015, P36; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Islamaj Dogan R, 2012, P 2012 AAAI FALL S S; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jaro MA, 1995, J AM MED INFORM ASSN, V14, DOI DOI 10.1136/AMIAJNL-2011-000203; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kate RJ, 2016, J AM MED INFORM ASSN, V23, P380, DOI 10.1093/jamia/ocv108; Kessler JS, 2010, P INT AAAI C WEBL SO; Khordad M, 2012, P COLING, P1425; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim J-D, 2004, P INT JOINT WORKSH N, P70; Kim JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S1; Kim JD, 2011, COMPUT INTELL-US, V27, P513, DOI 10.1111/j.1467-8640.2011.00398.x; Kondrak G, 2005, LECT NOTES COMPUT SC, V3772, P115; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Leaman R, 2013, P SHARE CLEF EV LAB; Leaman R, 2009, P 2009 S LANG BIOL M; Leaman Robert, 2008, Pac Symp Biocomput, P652; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Lu ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S2; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Man, 2014, P 8 INT WORKSH SEM E, P54, DOI DOI 10.3115/V1/S14-2007; Miller R A, 1992, Proc Annu Symp Comput Appl Med Care, P86; Moreau E, 2008, P 22 INT C COMP LING, P593, DOI DOI 10.3115/1599081.1599156; Myers EW, 1986, ALGORITHMICA, V1, P251, DOI 10.1007/BF01840446; Nunes T, 2013, BIOINFORMATICS, V29, P1915, DOI 10.1093/bioinformatics/btt317; Oellrich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116040; Orly A, 2015, P PHEN DAY ISMB 2015, P35; Patrick J, 2007, P 5 AUSTR S ACSW FRO, P219; Patrick J, 2006, P 2006 AUSTR LANG TE, P75; Pradhan S, 2015, J AM MED INFORM ASSN, V22, P143, DOI 10.1136/amiajnl-2013-002544; Pyysalo S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S2; Ramanan S, 2013, P SHARE CLEF EV LAB; Richesson R, 2015, ELECT HLTH RECORDS B; Rudniy A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-187; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Simpson Matthew S, 2012, MINING TEXT DATA, P465, DOI DOI 10.1007/978-1-4614-3223-4_14; Suominen H, 2013, LECT NOTES COMPUT SC, V8138, P212, DOI 10.1007/978-3-642-40802-1_24; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tseytlin E, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0871-y; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2007, J AM MED INFORM ASSN, V14, P550, DOI 10.1197/jamia.M2444; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Vasant D, 2014, P PHEN DAY ISMB 2014, P49; Vasant D, 2015, P PHEN DAY ISMB 2015, P24; Wang CX, 2013, SCI WORLD J, DOI 10.1155/2013/968432; Wang LQ, 2016, ARTIF INTELL MED, V68, P47, DOI 10.1016/j.artmed.2016.02.003; Wei Q, P 5 BIOCREATIVE CHAL, P327; Winkler WE, 1999, STATE RECORD LINKAGE; Winnenburg R, 2014, JOINT BIOONT BIOLINK, P41; Woo H, 2015, INT J MOL SCI, V16, P9017, DOI 10.3390/ijms16049017; Zhou XH, 2006, LECT NOTES ARTIF INT, V4099, P1145, DOI 10.1007/978-3-540-36668-3_150; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763; Zuccon G, 2013, P SHARE CLEF EV LAB	91	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162287	10.1371/journal.pone.0162287	http://dx.doi.org/10.1371/journal.pone.0162287			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643689	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900008
J	Chung, SD; Huang, CY; Wu, ST; Lin, HC; Huang, CC; Kao, LT				Chung, Shiu-Dong; Huang, Chao-Yuan; Wu, Sheng-Tang; Lin, Herng-Ching; Huang, Chung-Chien; Kao, Li-Ting			Nephrectomy Type Was Not Associated with a Subsequent Risk of Coronary Heart Disease: A Population-Based Study	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; RADICAL NEPHRECTOMY; FUNCTIONAL OUTCOMES; SURVIVAL BENEFIT; ARTERY-DISEASE; KIDNEY-DISEASE; TUMORS; CM; EPIDEMIOLOGY; MORTALITY	Previous studies investigated the impacts of a partial nephrectomy (PN) or radical nephrectomy (RN) on cardiovascular events and death. However, the association between the type of nephrectomy (PN vs. RN) and cardiovascular disease is still equivocal. This retrospective cohort study aimed to compare the risk of coronary heart disease (CHD) between patients who underwent a PN and those who underwent an RN. We used data from the Taiwan Longitudinal Health Insurance Database 2005. In total, 60 patients who underwent a PN and 545 patients who underwent an RN were included. Each patient was tracked for 1-, 2-, 3-, and 5-year periods to identify those who were subsequently diagnosed with CHD. Cox proportional hazard regression analyses were used to calculate hazard ratios (HRs) for CHD during 1-, 2-, 3-, and 5-year follow-up periods between these two cohorts. For the 1-year follow-up period, the adjusted HR was 0.39 (95% CI: 0.05 similar to 2.90, p = 0.355) for patients who underwent a PN compared to those who underwent an RN. Additionally, the adjusted HRs of CHD in patients who underwent a PN for 2-, 3-and 5-year follow-up periods were 1.40 (95% CI: 0.62 similar to 3.16, p = 0.417), 1.09 (95% CI: 0.52 similar to 2.31, p = 0.814), and 1.02 (95% CI: 0.48 similar to 2.18, p = 0.961), respectively, compared to those who underwent an RN. We concluded that there was no significant difference in the risk of CHD between patients who underwent a PN and those who underwent an RN.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, Banciao, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching; Kao, Li-Ting] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Huang, Chao-Yuan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Urol, Taipei, Taiwan; [Wu, Sheng-Tang] Triserv Gen Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Wu, Sheng-Tang] Natl Def Med Ctr, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center	Kao, LT (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.; Kao, LT (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	kaoliting@gmail.com	Huang, CC/AAX-5872-2021; Kao, Li-Ting/W-9287-2018	Huang, CC/0000-0003-0818-7175; Kao, Li-Ting/0000-0003-0692-7408; HUANG, CHAO-YUAN/0000-0002-9322-6062				Cai QJ, 2013, CURR CARDIOL REV, V9, P331, DOI 10.2174/1573403X10666140214122234; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Daugherty M, 2014, UROL ONCOL-SEMIN ORI, V32, P549, DOI 10.1016/j.urolonc.2013.11.009; Edwards L, 2016, KIDNEY CANC NURSE PR, P333; Eskicorapci SY, 2007, THESCIENTIFICWORLDJO, V7, P825, DOI 10.1100/tsw.2007.153; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; Kates M, 2011, J UROLOGY, V186, P1247, DOI 10.1016/j.juro.2011.05.054; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Kopp RP, 2015, UROLOGY, V86, P312, DOI 10.1016/j.urology.2015.02.067; Krabbe L-M, 2016, COCHRANE DATABASE SY; Lane BR, 2008, J UROLOGY, V180, P2363, DOI 10.1016/j.juro.2008.08.036; Lane BR, 2011, J UROLOGY, V186, P1229, DOI 10.1016/j.juro.2011.05.081; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Mack M, 2014, CARDIOL CLIN, V32, P323, DOI 10.1016/j.ccl.2014.04.003; McCullough PA, 2007, CLIN J AM SOC NEPHRO, V2, P611, DOI 10.2215/CJN.03871106; Miller DC, 2008, CANCER-AM CANCER SOC, V112, P511, DOI 10.1002/cncr.23218; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Silberstein JL, 2012, J UROLOGY, V187, P429, DOI 10.1016/j.juro.2011.09.150; Smaldone MC, 2012, J UROLOGY, V188, P2089, DOI 10.1016/j.juro.2012.07.099; Sun M, 2012, EUR UROL, V61, P725, DOI 10.1016/j.eururo.2011.11.047; Takagi T, 2015, BJU INT; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Weight CJ, 2010, UROLOGY, V76, P631, DOI 10.1016/j.urology.2009.11.087; Weight CJ, 2010, EUR UROL, V58, P293, DOI 10.1016/j.eururo.2010.04.033; Weight CJ, 2010, J UROLOGY, V183, P1317, DOI 10.1016/j.juro.2009.12.030; Yokoyama M, 2011, J UROLOGY, V185, P2066, DOI 10.1016/j.juro.2011.02.005	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163253	10.1371/journal.pone.0163253	http://dx.doi.org/10.1371/journal.pone.0163253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636094	gold, Green Published, Green Submitted			2022-12-27	WOS:000383723700042
J	Shin, SH; Kim, SC; Song, KB; Hwang, DW; Lee, JH; Park, KM; Lee, YJ				Shin, Sang Hyun; Kim, Song Cheol; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Park, Kwang-Min; Lee, Young-Joo			Appraisal of Laparoscopic Distal Pancreatectomy for Left-Sided Pancreatic Cancer: A Large Volume Cohort Study of 152 Consecutive Patients	PLOS ONE			English	Article							ANTEGRADE MODULAR PANCREATOSPLENECTOMY; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; RANDOMIZED CONTROLLED-TRIAL; INTERNATIONAL STUDY-GROUP; DUCTAL ADENOCARCINOMA; CLINICAL-OUTCOMES; ADJUVANT CHEMOTHERAPY; SINGLE-INSTITUTION; RESECTION; SURGERY	Background The aim of this study was to appraise the value of laparoscopic distal pancreatectomy (LDP) for left-sided pancreatic cancer based on a large volume cohort study. Methods We reviewed data for all consecutive patients undergoing LDP for left-sided pancreatic cancer at Asan Medical Center (Seoul, Korea) between December 2006 and December 2014. Results A total of 91 male and 61 female patients, with a median age of 62.7 years were included in this study. The median operative duration was 234 minutes. Pathological reports revealed the following: a median tumor size of 3.0 cm (range, 0.4-10.0), T stages (T1 in 7.9%, T2 in 5.3%, T3 in 86.8%, and no T4), the tumor differentiation (well differentiated in 16.4%, moderately differentiated in 75.4%, and poorly differentiated in 8.2%), and R0 resection in 126 patients (82.9%). After pancreatectomy, 96 patients (63.2%) received adjuvant chemotherapy, and the median time to chemotherapy was 30 days. The median length of hospital stay was 8 days (range, 5-31), and the median time to diet resumption was 1 day. Grade B or C postoperative pancreatic fistula occurred in 14 patients (9.2%) and grade II or III complications occurred in 27 (17.7%). The median overall survival was 43.0 months. A Cox proportional hazards model showed that tumor size, N1 stage, combined resection, and incompleteness of planned adjuvant chemotherapy affect patient survival. Conclusions LDP for left-sided pancreatic cancer is reasonable within selected indications. An international consensus on laparoscopic surgery for pancreatic cancer would be desirable and timely.	[Shin, Sang Hyun; Kim, Song Cheol; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Park, Kwang-Min; Lee, Young-Joo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Hepato Biliary & Pancreat Surg,Dept Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, SC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Hepato Biliary & Pancreat Surg,Dept Surg, Seoul, South Korea.	drksc@amc.seoul.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2640]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (grant number: HI14C2640)	Asbun HJ, 2012, J AM COLL SURGEONS, V215, P810, DOI 10.1016/j.jamcollsurg.2012.08.006; Ashfaq A, 2014, J GASTROINTEST SURG, V18, P1929, DOI 10.1007/s11605-014-2566-5; BARKUN JS, 1992, LANCET, V340, P1116, DOI 10.1016/0140-6736(92)93148-G; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Correa-Gallego C, 2014, J AM COLL SURGEONS, V218, P129, DOI 10.1016/j.jamcollsurg.2013.09.005; Croome KP, 2014, ANN SURG, V260, P633, DOI 10.1097/SLA.0000000000000937; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eom BW, 2008, SURG ENDOSC, V22, P1334, DOI 10.1007/s00464-007-9660-7; Gagner M, 1996, SURGERY, V120, P1051, DOI 10.1016/S0039-6060(96)80054-7; Gagner M, 1997, ANN SURG, V226, P238, DOI 10.1097/00000658-199709000-00003; Giessing M, 2005, TRANSPLANT P, V37, P2011, DOI 10.1016/j.transproceed.2005.03.007; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/00000658-200207000-00014; Hofstetter G, 2013, GYNECOL ONCOL, V131, P15, DOI 10.1016/j.ygyno.2013.07.086; Kawaguchi Y, 2015, SURGERY, V157, P1106, DOI 10.1016/j.surg.2014.12.015; Kim SC, 2008, SURG ENDOSC, V22, P2261, DOI 10.1007/s00464-008-9973-1; Kim SC, 2013, SURG ENDOSC, V27, P95, DOI 10.1007/s00464-012-2427-9; Kooby DA, 2010, J AM COLL SURGEONS, V210, P779, DOI 10.1016/j.jamcollsurg.2009.12.033; Kooby DA, 2010, SURG CLIN N AM, V90, P427, DOI 10.1016/j.suc.2009.12.011; Latorre M, 2013, AM SURGEON, V79, P1154; Limongelli P, 2012, SURG ENDOSC, V26, P1830, DOI 10.1007/s00464-011-2141-z; Mabrut JY, 2005, SURGERY, V137, P597, DOI 10.1016/j.surg.2005.02.002; Magge D, 2013, JAMA SURG, V148, P525, DOI 10.1001/jamasurg.2013.1673; Melotti G, 2007, ANN SURG, V246, P77, DOI 10.1097/01.sla.0000258607.17194.2b; Mitchem JB, 2012, J AM COLL SURGEONS, V214, P46, DOI 10.1016/j.jamcollsurg.2011.10.008; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Park HJ, 2014, WORLD J SURG, V38, P186, DOI 10.1007/s00268-013-2254-8; Paye F, 2015, BRIT J SURG, V102, P229, DOI 10.1002/bjs.9708; Rehman S, 2014, WORLD J SURG, V38, P476, DOI 10.1007/s00268-013-2268-2; Sharpe SM, 2015, AM J SURG, V209, P557, DOI 10.1016/j.amjsurg.2014.11.001; Shin SH, 2015, J AM COLL SURGEONS, V220, P177, DOI 10.1016/j.jamcollsurg.2014.10.014; Song KB, 2015, ANN SURG, V262, P146, DOI 10.1097/SLA.0000000000001079; Song KB, 2011, SURG ENDOSC, V25, P3364, DOI 10.1007/s00464-011-1727-9; Strasberg SM, 2003, SURGERY, V133, P521, DOI 10.1067/msy.2003.146; Tol JAMG, 2014, SURGERY, V156, P591, DOI 10.1016/j.surg.2014.06.016; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Veldkamp R, 2004, SURG ENDOSC, V18, P1163, DOI 10.1007/s00464-003-8253-3; Vijan SS, 2010, ARCH SURG-CHICAGO, V145, P616, DOI 10.1001/archsurg.2010.120; Yamamoto J, 2010, JPN J CLIN ONCOL, V40, P530, DOI 10.1093/jjco/hyq015	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163266	10.1371/journal.pone.0163266	http://dx.doi.org/10.1371/journal.pone.0163266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636547	Green Published, gold, Green Submitted			2022-12-27	WOS:000383723700045
J	Astolfi, L; Simoni, E; Valente, F; Ghiselli, S; Hatzopoulos, S; Chicca, M; Martini, A				Astolfi, Laura; Simoni, Edi; Valente, Filippo; Ghiselli, Sara; Hatzopoulos, Stavros; Chicca, Milvia; Martini, Alessandro			Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats	PLOS ONE			English	Article							INDUCED HEARING-LOSS; HAIR CELL LOSS; OXIDATIVE STRESS; GUINEA-PIG; D-METHIONINE; IN-VIVO; MICE; PROTECTS; NEPHROTOXICITY; MECHANISMS	Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to evaluate the ototoxic effects of two different protocols of Cpt administration in a Sprague-Dawley rat model, and to test in the same model the synergic protective effects of a solution of coenzyme Q10 terclatrate and Acuval 4001, a multivitamin supplement containing antioxidant agents and minerals (Acu-Qter). The Cpt was administered intraperitoneally in a single dose (14 mg/kg) or in three daily doses (4.6 mg/kg/day) to rats orally treated or untreated with Acu-Qter for 5 days. The auditory function was assessed by measuring auditory brainstem responses from 2 to 32 kHz at day 0 and 5 days after treatment. Similar hearing threshold and body weight alterations were observed in both Cpt administration protocols, but mortality reduced to zero when Cpt was administered in three daily doses. The Acu-Qter treatment was able to prevent and completely neutralize ototoxicity in rats treated with three daily Cpt doses, supporting the synergic protective effects of coenzyme Q terclatrate and Acuval 4001 against Cpt-induced oxidative stress. The administration protocol involving three Cpt doses is more similar to common human chemotherapy protocols, therefore it appears more useful for long-term preclinical studies on ototoxicity prevention.	[Astolfi, Laura; Simoni, Edi; Valente, Filippo; Martini, Alessandro] Univ Padua, Bioacoust Res Lab, Dept Neurosci, Padua, Italy; [Astolfi, Laura; Martini, Alessandro] Fdn Onlus Staminali & Vita, Padua, Italy; [Ghiselli, Sara; Martini, Alessandro] Univ Padua, ENT Surg Dept Neurosci, Padua, Italy; [Hatzopoulos, Stavros] Univ Ferrara, Clin ENT, Ferrara, Italy; [Chicca, Milvia] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy	University of Padua; University of Padua; University of Ferrara; University of Ferrara	Astolfi, L (corresponding author), Univ Padua, Bioacoust Res Lab, Dept Neurosci, Padua, Italy.; Astolfi, L (corresponding author), Fdn Onlus Staminali & Vita, Padua, Italy.	laura.astolfi@unipd.it	Astolfi, Laura/H-2846-2012; Astolfi, Laura/GLU-1045-2022; Hatzopoulos, Stavros/B-6999-2016; Ghiselli, Sara/D-8042-2016; Martini, Alessandro/K-2513-2018	Astolfi, Laura/0000-0002-3291-8567; Astolfi, Laura/0000-0002-3291-8567; Hatzopoulos, Stavros/0000-0002-9509-9722; Ghiselli, Sara/0000-0002-1214-0807; Valente, Filippo/0000-0001-5760-5949; SIMONI, EDI/0000-0001-7336-5041; Martini, Alessandro/0000-0002-2003-6348	Scharper Healthcare Srl. (Milan, Italy)	Scharper Healthcare Srl. (Milan, Italy)	The work was supported by the Scharper Healthcare Srl. (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi L., 2008, AUDIOL MED, V6, P251, DOI [10.1080/16513860802527930, DOI 10.1080/16513860802527930]; Astolfi L, 2013, ONCOL REP, V29, P1285, DOI 10.3892/or.2013.2279; Bhadri N, 2013, SCI WORLD J, DOI 10.1155/2013/565813; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cardinaal RM, 2000, HEARING RES, V144, P135, DOI 10.1016/S0378-5955(00)00059-9; Cascella V, 2012, MED SCI MONITOR, V18, pBR1, DOI 10.12659/MSM.882180; Chirtes F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925485; Choi SJ, 2013, NEUROSCIENCE, V244, P49, DOI 10.1016/j.neuroscience.2013.04.001; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; Corvi Mora P, 2005, OXYGEN SOCIETY OF CA, P97; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Ding DL, 2012, ANAT REC, V295, P1851, DOI 10.1002/ar.22577; Ekborn A, 2003, HEARING RES, V181, P109, DOI 10.1016/S0378-5955(03)00181-3; Ekborn A, 2002, HEARING RES, V165, P53, DOI 10.1016/S0378-5955(02)00277-0; Fang B, 2014, BIOCHEM BIOPH RES CO, V448, P443, DOI 10.1016/j.bbrc.2014.04.123; Fetoni AR, 2014, OTOL NEUROTOL, V35, pE169, DOI 10.1097/MAO.0000000000000302; Fetoni AR, 2009, BRAIN RES, V1257, P108, DOI 10.1016/j.brainres.2008.12.027; Fetoni AR, 2004, ACTA OTO-LARYNGOL, V124, P421, DOI 10.1080/00016480410016559; Fouad AA, 2010, TOXICOLOGY, V274, P49, DOI 10.1016/j.tox.2010.05.007; Giordano P, 2006, Acta Otorhinolaryngol Ital, V26, P198; Guthrie OW, 2008, HEARING RES, V239, P79, DOI 10.1016/j.heares.2008.01.013; Harrison RT, 2015, LARYNGOSCOPE, V125, pE78, DOI 10.1002/lary.24948; He JC, 2009, ACTA OTO-LARYNGOL, V129, P1359, DOI 10.3109/00016480902856604; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jun HJ, 2009, J PHARM PHARMACOL, V61, P1391, DOI 10.1211/jpp/61.10.0017; Karasawa T, 2015, TOXICOL LETT, V237, P219, DOI 10.1016/j.toxlet.2015.06.012; Li GM, 2002, LAB INVEST, V82, P585, DOI 10.1038/labinvest.3780453; Li GM, 2001, NEUROTOXICOLOGY, V22, P163, DOI 10.1016/S0161-813X(00)00010-3; Li YQ, 2011, NEUROTOX RES, V20, P307, DOI 10.1007/s12640-011-9244-0; Lorito G, 2011, MED SCI MONITOR, V17, pBR179, DOI 10.12659/MSM.881894; Ma WJ, 2015, CANCER CHEMOTH PHARM, V75, P949, DOI 10.1007/s00280-015-2716-9; Melamed SB, 2000, AUDIOLOGY, V39, P24; MORA PC, 2007, Patent No. 2007009997; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Rybak LP, 2000, AM J OTOL, V21, P513; Salami A, 2010, ACTA OTO-LARYNGOL, V130, P1154, DOI 10.3109/00016481003727590; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Sun CL, 2015, INT J NANOMED, V10, P3567, DOI 10.2147/IJN.S77912; Teranishi M, 2003, INT J PEDIATR OTORHI, V67, P133, DOI 10.1016/S0165-5876(02)00353-1; Tokgoz SA, 2012, J LARYNGOL OTOL, V126, P464, DOI 10.1017/S0022215112000382; Tsuneki H, 2007, EUR J PHARMACOL, V566, P1, DOI 10.1016/j.ejphar.2007.03.006; Yazici ZM, 2012, EUR ARCH OTO-RHINO-L, V269, P45, DOI 10.1007/s00405-011-1582-2; Youn CK, 2015, INT J PEDIATR OTORHI, V79, P1814, DOI 10.1016/j.ijporl.2015.08.012	44	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162106	10.1371/journal.pone.0162106	http://dx.doi.org/10.1371/journal.pone.0162106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632426	Green Published, gold			2022-12-27	WOS:000383706900028
J	Fitneva, SA; Ho, EP; Hatayama, M				Fitneva, Stanka A.; Ho, Elizabeth Pile; Hatayama, Misako			Japanese and Canadian Children's Beliefs about Child and Adult Knowledge: A Case for Developmental Equifinality?	PLOS ONE			English	Article							FALSE-BELIEF; INTERPRETIVE DIVERSITY; CULTURAL-DIFFERENCES; EXECUTIVE FUNCTION; MIND DEVELOPMENT; UNITED-STATES; SELF; AGE; MOTHER; MEMORY	Children do not know everything that adults know, nor do adults know everything that children know. The present research examined the universality of beliefs about child and adult knowledge and their development with 4- and 7-year-old Canadian and Japanese children (N = 96). In both countries, all children were able to identify adult-specific knowledge and only older children displayed beliefs about child-specific knowledge. However, Japanese and Canadian children differed in whether they used their own knowledge in deciding whether a person who knew an item was a child or an adult. In addition, parental and child beliefs were related in Japan but not in Canada. These findings indicate that children growing up in different cultures may take different paths in developing beliefs about age-related knowledge. Implications for theories of socio-cognitive development and learning are discussed.	[Fitneva, Stanka A.; Ho, Elizabeth Pile] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Hatayama, Misako] Miyagi Gakuin Womens Univ, Dept Dev & Clin Studies, Aoba Ku, Sendai, Miyagi 9818557, Japan	Queens University - Canada	Fitneva, SA (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	fitneva@queensu.ca			CSSI, Tohoku University; CSSI, Tohoku University, Japan	CSSI, Tohoku University; CSSI, Tohoku University, Japan	The research was partially supported by funds from CSSI, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The assistance of Drs. Y. Akinaga, M. Koizumi, Y. Sato, and N. Yusa in making this research possible, and funding from CSSI, Tohoku University, Japan to SAF is gratefully acknowledged.	Aguiar NR, 2012, CHILD DEV, V83, P1368, DOI 10.1111/j.1467-8624.2012.01782.x; [Anonymous], 2006, ALWAYS SEPARATE ALWA; Astington JW, 2004, BEHAV BRAIN SCI, V27, P96; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P289, DOI 10.1177/016502549001300303; Bornstein MH, 2004, CHILD DEV, V75, P221, DOI 10.1111/j.1467-8624.2004.00665.x; BROOKS J, 1976, CHILD DEV, V47, P323, DOI 10.2307/1128785; Burton S, 2003, CHILD DEV, V74, P426, DOI 10.1111/1467-8624.7402007; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Carlson SM, 2015, J COGN DEV, V16, P186, DOI 10.1080/15248372.2013.824883; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; CECI SJ, 1987, J EXP PSYCHOL GEN, V116, P38, DOI 10.1037/0096-3445.116.1.38; Chen XY, 2006, CAMB ST SOC, P3, DOI 10.1017/CBO9780511499739.001; Cicchetti D, 1996, DEV PSYCHOPATHOL, V8, P597, DOI 10.1017/S0954579400007318; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Danovitch JH, 2004, CHILD DEV, V75, P918, DOI 10.1111/j.1467-8624.2004.00714.x; Dennis TA, 2002, CHILD DEV, V73, P1803, DOI 10.1111/1467-8624.00507; Diesendruck G, 2013, CHILD DEV, V84, P1906, DOI 10.1111/cdev.12108; EDWARDS CP, 1984, CHILD DEV, V55, P440, DOI 10.2307/1129955; Fiske A. P., 1998, HDB SOCIAL PSYCHOL, V2, P915; Fitneva SA, 2010, J COGN DEV, V11, P458, DOI 10.1080/15248371003700023; FOGEL A, 1979, INFANT BEHAV DEV, V2, P215, DOI 10.1016/S0163-6383(79)80027-2; Frazier BN, 2012, DEVELOPMENTAL SCI, V15, P87, DOI 10.1111/j.1467-7687.2011.01106.x; Freud Sigmund, 1927, FUTURE ILLUSION; GELMAN SA, 1986, CHILD DEV, V57, P396, DOI 10.2307/1130595; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Grossmann I, 2012, PSYCHOL SCI, V23, P1059, DOI 10.1177/0956797612446025; HARRIS P. L., 2012, TRUSTING WHAT YOURE; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; HOGREFE GJ, 1986, CHILD DEV, V57, P567, DOI 10.2307/1130337; Hughes D, 2006, DEV PSYCHOL, V42, P747, DOI 10.1037/0012-1649.42.5.747; Jaswal VK, 2006, PSYCHOL SCI, V17, P757, DOI 10.1111/j.1467-9280.2006.01778.x; Keller H, 2004, CHILD DEV, V75, P1745, DOI 10.1111/j.1467-8624.2004.00814.x; Keller H., 2007, CULTURES INFANCY, Vxix, P318; Killen M, 2000, New Dir Child Adolesc Dev, P5; Kohlberg L., 1966, DEV SEX DIFFERENCES, P82, DOI DOI 10.1111/1467-8624.EP10400221; Lebra TS., 1994, CROSS CULTURAL ROOTS, P275; Lewis C., 1995, ED HEARTS MINDS REFL; Lillard A, 1998, PSYCHOL BULL, V123, P3, DOI 10.1037/0033-2909.123.1.3; Liu D, 2008, DEV PSYCHOL, V44, P523, DOI 10.1037/0012-1649.44.2.523; Lutz DJ, 2002, CHILD DEV, V73, P1073, DOI 10.1111/1467-8624.00458; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MAYR E, 1964, P NATL ACAD SCI USA, V51, P934, DOI 10.1073/pnas.51.5.934; Meins E, 2003, CHILD DEV, V74, P1194, DOI 10.1111/1467-8624.00601; Mills CM, 2004, J EXP CHILD PSYCHOL, V87, P1, DOI 10.1016/j.jecp.2003.09.003; MONTGOMERY DE, 1993, DEV PSYCHOL, V29, P337, DOI 10.1037/0012-1649.29.2.337; Na J, 2010, P NATL ACAD SCI USA, V107, P6192, DOI 10.1073/pnas.1001911107; Naito M, 2003, J EXP CHILD PSYCHOL, V85, P312, DOI 10.1016/S0022-0965(03)00075-4; Naito M, 2006, INT J BEHAV DEV, V30, P290, DOI 10.1177/0165025406063622; Naito M, 2009, DEVELOPMENTAL SCI, V12, P150, DOI 10.1111/j.1467-7687.2008.00748.x; Packer DJ, 2006, SOC COGNITION, V24, P218, DOI 10.1521/soco.2006.24.3.218; Piaget J, 1959, LANGUAGE THOUGHT CHI; POVINELLI DJ, 1992, J COMP PSYCHOL, V106, P228, DOI 10.1037/0735-7036.106.3.228; Rakoczy H, 2010, BRIT J DEV PSYCHOL, V28, P785, DOI 10.1348/026151009X479178; Robinson EJ, 2003, CHILD DEV, V74, P48, DOI 10.1111/1467-8624.t01-1-00520; Rogoff B., 2003, CULTURAL NATURE HUMA; Rogoff B, 2010, PERSPECT PSYCHOL SCI, V5, P431, DOI 10.1177/1745691610375558; Rothbaum F, 2000, AM PSYCHOL, V55, P1093, DOI 10.1037//0003-066X.55.10.1093; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Sabbagh MA, 2008, DEVELOPMENTAL SCI, V11, P354, DOI 10.1111/j.1467-7687.2008.00680.x; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Shweder R.A., 1998, HDB CHILD PSYCHOL, V1, P865, DOI DOI 10.1002/9780470147658.CHPSY0113; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; TAYLOR M, 1994, CHILD DEV, V65, P1581, DOI 10.2307/1131282; TAYLOR M, 1991, CHILD DEV, V62, P1334, DOI 10.1111/j.1467-8624.1991.tb01609.x; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; Tobin JJ, 1989, CHILDHOOD 3 CULTURES; Tobin JJ, 2004, CONT ISSUES EARLY CH, V5, P128, DOI DOI 10.2304/CIEC.2004.5.2.2; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; VanderBorght M, 2009, INFANT CHILD DEV, V18, P61, DOI 10.1002/icd.591; Vinden PG, 2001, COGNITIVE DEV, V16, P793, DOI 10.1016/S0885-2014(01)00059-4; Wang Q, 2008, COGNITION, V108, P117, DOI 10.1016/j.cognition.2008.02.002; Wellman H.M., 1998, HDB CHILD PSYCHOL VO, P523, DOI DOI 10.1002/9780470147658; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wood LA, 2012, EVOL HUM BEHAV, V33, P387, DOI 10.1016/j.evolhumbehav.2011.11.010; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x; Zmyj N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00252	78	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163018	10.1371/journal.pone.0163018	http://dx.doi.org/10.1371/journal.pone.0163018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632387	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900117
J	Zhou, BY; Wu, XP; Lv, Z; Zhang, L; Guo, XJ				Zhou, Bangyan; Wu, Xiaopei; Lv, Zhao; Zhang, Lei; Guo, Xiaojin			A Fully Automated Trial Selection Method for Optimization of Motor Imagery Based Brain-Computer Interface	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; EEG; CLASSIFICATION; ARTIFACT; REMOVAL; ICA	Independent component analysis (ICA) as a promising spatial filtering method can separate motor-related independent components (MRICs) from the multichannel electroencephalogram (EEG) signals. However, the unpredictable burst interferences may significantly degrade the performance of ICA-based brain-computer interface (BCI) system. In this study, we proposed a new algorithm frame to address this issue by combining the single-trial-based ICA filter with zero-training classifier. We developed a two-round data selection method to identify automatically the badly corrupted EEG trials in the training set. The "high quality" training trials were utilized to optimize the ICA filter. In addition, we proposed an accuracy-matrix method to locate the artifact data segments within a single trial and investigated which types of artifacts can influence the performance of the ICA-based MIBCIs. Twenty-six EEG datasets of three-class motor imagery were used to validate the proposed methods, and the classification accuracies were compared with that obtained by frequently used common spatial pattern (CSP) spatial filtering algorithm. The experimental results demonstrated that the proposed optimizing strategy could effectively improve the stability, practicality and classification performance of ICA-based MIBCI. The study revealed that rational use of ICA method may be crucial in building a practical ICA-based MIBCI system.	[Zhou, Bangyan; Wu, Xiaopei; Lv, Zhao; Zhang, Lei; Guo, Xiaojin] Anhui Univ, Minist Educ, Key Lab Intelligent Comp & Signal Proc, Hefei, Peoples R China; [Zhou, Bangyan; Wu, Xiaopei; Lv, Zhao; Zhang, Lei; Guo, Xiaojin] Anhui Univ, Sch Comp Sci & Technol, Hefei, Peoples R China	Anhui University; Anhui University	Wu, XP (corresponding author), Anhui Univ, Minist Educ, Key Lab Intelligent Comp & Signal Proc, Hefei, Peoples R China.; Wu, XP (corresponding author), Anhui Univ, Sch Comp Sci & Technol, Hefei, Peoples R China.	wxp2001@ahu.edu.cn			National Natural Science Foundation of China [61271352, 61401002]; Anhui Province Natural Science Foundation [1408085QF125]; Anhui University Center of Information Support & Assurance Technology Open Foundation [ADXXBZ2014-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Province Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui University Center of Information Support & Assurance Technology Open Foundation	This work was supported by the National Natural Science Foundation of China (61271352; 61401002), Anhui Province Natural Science Foundation (1408085QF125), and Anhui University Center of Information Support & Assurance Technology Open Foundation (ADXXBZ2014-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Meanwhile, we declare that no competing interests exist. And all EEG dataset files are available from the figshare database.(DOI:10.6084/m9.figshare.2061654).	Amari S, 1999, NEURAL COMPUT, V11, P1875, DOI 10.1162/089976699300015990; Ang KK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00039; Bai O, 2007, CLIN NEUROPHYSIOL, V118, P2637, DOI 10.1016/j.clinph.2007.08.025; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Brunner C, 2007, PATTERN RECOGN LETT, V28, P957, DOI 10.1016/j.patrec.2007.01.002; Chin ZY, 2009, IEEE ENG MED BIO, P571, DOI 10.1109/IEMBS.2009.5332383; Chuang CH, 2014, IEEE T NEUR SYS REH, V22, P230, DOI 10.1109/TNSRE.2013.2293139; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Ghaderi F, 2014, J NEUROSCI METH, V221, P41, DOI 10.1016/j.jneumeth.2013.08.025; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; Hung CI, 2005, ANN BIOMED ENG, V33, P1053, DOI 10.1007/s10439-005-5772-1; Hyvarinen A., 1999, Neural Computing Surveys, V2; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kachenoura A, 2008, IEEE SIGNAL PROC MAG, V25, P57, DOI 10.1109/MSP.2008.4408442; Kindermans PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102504; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Lan T, 2005, P ANN INT IEEE EMBS, P7064; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Li YD, 2006, PHYSIOL MEAS, V27, P425, DOI 10.1088/0967-3334/27/4/008; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1996, ADV NEUR IN, V8, P145; Makeig S, 2012, P IEEE, V100, P1567, DOI 10.1109/JPROC.2012.2185009; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Qin L, 2004, J NEURAL ENG, V1, P135, DOI 10.1088/1741-2560/1/3/002; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Wang T, 2004, CLIN NEUROPHYSIOL, V115, P2744, DOI 10.1016/j.clinph.2004.06.022; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037665; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu W., 2006, DROP, P2387; [吴小培 Wu Xiaopei], 2014, [生物物理学报, Acta Biophysica Sinica], V30, P540; Zhou BY, 2014, 8TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2014), P173; Zou Y, 2016, IEEE J BIOMED HEALTH, V20, P73, DOI 10.1109/JBHI.2014.2370646	43	20	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162657	10.1371/journal.pone.0162657	http://dx.doi.org/10.1371/journal.pone.0162657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631789	gold, Green Published, Green Submitted			2022-12-27	WOS:000383706900063
J	Hurley, SM; Lutay, N; Holmqvist, B; Shannon, O				Hurley, Sinead M.; Lutay, Nataliya; Holmqvist, Bo; Shannon, Oonagh			The Dynamics of Platelet Activation during the Progression of Streptococcal Sepsis	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; SURFACE P-SELECTIN; M-PROTEIN; BACTERIA; THROMBOCYTOPENIA; INFECTION; MARKER	Platelets contribute to inflammation however, the role of platelet activation during the pathophysiological response to invasive bacterial infection and sepsis is not clear. Herein, we have investigated platelet activation in a mouse model of invasive Streptococcus pyogenes infection at 5, 12, and 18 hours post infection and correlated this to parameters of infection. The platelet population in ex-vivo blood samples showed no increased integrin activation or surface presentation of CD62P, however platelet-neutrophil complex formation and plasma levels of CD62P were increased during bacterial dissemination and the progression of sepsis, indicating that platelet activation had occurred in vivo. Platelet-neutrophil complex formation was the most discriminatory marker of platelet activation. Platelet-neutrophil complexes were increased above baseline levels during early sepsis but decreased to significantly lower levels than baseline during late sepsis. The removal of these complexes from the circulation coincided with a significant increase in organ damage and the accumulation of platelets in the liver sinusoids, suggesting that platelet activation in the circulation precedes accumulation of platelets in damaged organs. The results demonstrate that monitoring platelet activation using complementary methods may provide prognostic information during the pathogenesis of invasive S. pyogenes infection.	[Hurley, Sinead M.; Shannon, Oonagh] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Lutay, Nataliya; Holmqvist, Bo] Imagene IT AB, SE-22381 Lund, Sweden	Lund University	Shannon, O (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.	oonagh.shannon@med.lu.se	Lutay, Nataliya/K-1733-2014	Lutay, Nataliya/0000-0003-1852-1288; Shannon, Oonagh/0000-0001-8291-8189	Swedish Research Council [21112, 21587]; Royal Physiographic Society in Lund; foundation of Crafoord; foundation of Osterlund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; foundation of Crafoord; foundation of Osterlund	This work was supported in part by the Swedish Research Council (projects 21112 and 21587), The Royal Physiographic Society in Lund, and the foundations of Crafoord, and Osterlund.; We thank Gisela Hakansson for excellent technical assistance. This work was supported in part by the Swedish Research Council (projects 21112 and 21587), The Royal Physiographic Society in Lund, and the foundations of Crafoord, and Osterlund. The authors have no competing financial interests.	Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cohen J., 2002, INSIDE APPELLATE COU, P1; de Stoppelaar SF, 2015, J THROMB HAEMOST, V13, P1709, DOI 10.1111/jth.13048; De Stoppelaar SF, 2015, J THROMB HAEMOST, V13, P1128, DOI 10.1111/jth.12893; Ferroni P, 2009, CLIN CHIM ACTA, V399, P88, DOI 10.1016/j.cca.2008.09.018; Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081; Foltz C, 1999, LAB ANIMAL, P5; Gafter-Gvili A, 2011, MAYO CLIN PROC, V86, P389, DOI 10.4065/mcp.2010.0705; GAWAZ M, 1995, EUR J CLIN INVEST, V25, P843, DOI 10.1111/j.1365-2362.1995.tb01694.x; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hurley SM, 2015, INFECT IMMUN, V83, P3515, DOI 10.1128/IAI.00508-15; Johansson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026928; Kahn F, 2013, MICROBES INFECT, V15, P669, DOI 10.1016/j.micinf.2013.05.003; Kerrigan SW, 2015, PLATELETS, V26, P293, DOI 10.3109/09537104.2014.997690; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Oehmcke S, 2009, BLOOD, V114, P444, DOI 10.1182/blood-2008-10-182527; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Sandrini MPB, 2007, ANTIMICROB AGENTS CH, V51, P2726, DOI 10.1128/AAC.00081-07; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Shannon O, 2007, MOL MICROBIOL, V65, P1147, DOI 10.1111/j.1365-2958.2007.05841.x; Sharma B, 2008, ANAESTHESIA INTENSIV, V35, P1; Svensson L, 2014, INFECT IMMUN, V82, P4307, DOI 10.1128/IAI.02020-14; Vandijck DM, 2010, HEART LUNG, V39, P21, DOI 10.1016/j.hrtlng.2009.07.005; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x	33	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2016	11	9							e0163531	10.1371/journal.pone.0163531	http://dx.doi.org/10.1371/journal.pone.0163531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GO	27656898	gold, Green Submitted, Green Published			2022-12-27	WOS:000383893200139
J	Brottet, E; Jaffar-Bandjee, MC; Li-Pat-Yuen, G; Filleul, L				Brottet, Elise; Jaffar-Bandjee, Marie-Christine; Li-Pat-Yuen, Ghislaine; Filleul, Laurent			Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in Reunion Island, 2011-2012	PLOS ONE			English	Article							VIRAL-INFECTIONS; PERFORMANCE; RESPIFINDER	In Reunion Island, despite an influenza surveillance established since 1996 by the sentinel general practitioner's network, little is known about the etiology of Influenza like-illness (ILI) that differs from influenza viruses in a tropical area. We set up a retrospective study using nasal swabs collected by sentinel GPs from ILI patients in 2011 and 2012. A total of 250 swabs were randomly selected and analyzed by multiplex reverse transcriptase polymerase chain reaction (RT-PCR) including research of 18 viruses and 4 bacteria. We detected respiratory viruses in 169/222 (76.1%) samples, mostly rhinovirus (23.4%), influenza A virus (21.2%), influenza B virus (12.6%), coronavirus (4.9%) and Human metapneumovirus (3.6%). Nine swabs (5.3% of positive swabs) revealed co-infections with two viruses identified, among which six concerned co-infections with influenza viruses. We observed important seasonal differences, with circulation of Human Metapneumoviruses, RSV A and B and coronavirus only during summer; whereas parainfluenza viruses were identified only during winter. In conclusion, this study highlights a substantial circulation of multiple respiratory pathogens in Re A union Island throughout the year. It shows that ILI are not only attributable to influenza and underlines the need for biological surveillance. As the use of multiplex RT-PCR showed its efficacy, it is now used routinely in the surveillance of ILI.	[Brottet, Elise; Filleul, Laurent] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire, Ocean Indien, Reunion, France; [Jaffar-Bandjee, Marie-Christine; Li-Pat-Yuen, Ghislaine] Ctr Hosp Univ, Virol Lab, St Denis, Reunion, France	Institute of Public Health Surveillance; CHU Reunion	Brottet, E (corresponding author), Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire, Ocean Indien, Reunion, France.	elise.brottet@ars.sante.fr			Indian Ocean Regional Healthcare Agency (ARS-OI)	Indian Ocean Regional Healthcare Agency (ARS-OI)	This research was funded by the Indian Ocean Regional Healthcare Agency (ARS-OI) for paying virological analyses and RT-PCR kits of detection.	Brottet E, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.39.20916; Brottet E, 2015, MED MAL INFECT; D'Ortenzio E, 2009, EUROSURVEILLANCE, V14; Dabisch-Ruthe M, 2012, BMC INFECT DIS, P12; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Filleul L, 2012, EURO SURVEILL, V17; Greenberg SB, 2002, CURR OPIN PULM MED, V8, P201, DOI 10.1097/00063198-200205000-00009; Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043666; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Pascalis H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044755; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Raymaekers M, 2011, J CLIN VIROL, V52, P314, DOI 10.1016/j.jcv.2011.08.017; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10; Sapin G, 2001, B SOC PATHOL EXOT, V94, P3; Thiberville SD, 2012, J MED VIROL, V84, P1071, DOI 10.1002/jmv.23265; Vijgen L, 2005, J CLIN MICROBIOL, V43, P5452, DOI 10.1128/JCM.43.11.5452-5456.2005	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163377	10.1371/journal.pone.0163377	http://dx.doi.org/10.1371/journal.pone.0163377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654509	Green Published, gold, Green Submitted			2022-12-27	WOS:000383892700053
J	Yeh, JJ; Wang, YC; Chen, JH; Hsu, WH				Yeh, Jun-Jun; Wang, Yu-Chiao; Chen, Jiunn-Horng; Hsu, Wu-Huei			Effect of Systemic Lupus Erythematosus on the Risk of Incident Respiratory Failure: A National Cohort Study	PLOS ONE			English	Article							OF-DEATH ANALYSIS; ANTIPHOSPHOLIPID SYNDROME; RETROSPECTIVE COHORT; ORGAN INVOLVEMENT; CLINICAL-PICTURE; ISCHEMIC-STROKE; ICD-9-CM CODES; POPULATION; MORTALITY; PNEUMONIA	Purpose We conducted a nationwide cohort study to investigate the relationship between systemic lupus erythematosus (SLE) and the risk of incident respiratory failure. Methods From the National Health Insurance Research Database, we identified 11 533 patients newly diagnosed with SLE and 46 132 controls without SLE who were randomly selected through frequency-matching according to age, sex, and index year. Both cohorts were followed until the end of 2011 to measure the incidence of incident respiratory failure, which was compared between the 2 cohorts through a Cox proportional hazards regression analysis. Results The adjusted hazard ratio (aHR) of incident respiratory failure was 5.80 (95% confidence interval [CI] = 5.15-6.52) for the SLE cohort after we adjusted for sex, age, and comorbidities. Both men (aHR = 3.44, 95% CI = 2.67-4.43) and women (aHR = 6.79, 95% CI = 5.93-7.77) had a significantly higher rate of incident respiratory failure in the SLE cohort than in the non-SLE cohort. Both men and women aged < 35 years (aHR = 31.2, 95% CI = 21.6-45.2), 35-65 years; (aHR = 6.19, 95% CI = 5.09-7.54) and >= 65 years (aHR = 2.35, 95% CI = 1.92-2.87) had a higher risk of incident respiratory failure in the SLE cohort. Moreover, the risk of incident respiratory failure was higher in the SLE cohort than the non-SLE cohort, for subjects with (aHR = 2.65, 95% CI = 2.22-3.15) or without (aHR = 9.08, 95% CI = 7.72-10.7) pre-existing comorbidities. In the SLE cohort, subjects with >24 outpatient visits and hospitalizations per year had a higher incident respiratory failure risk (aHR = 21.7, 95% CI = 18.0-26.1) compared with the non-SLE cohort. Conclusion Patients with SLE are associated with an increased risk of incident respiratory failure, regardless of their age, sex, and pre-existing comorbidities; especially medical services with higher frequency.	[Yeh, Jun-Jun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ, Coll Med, Taichung, Taiwan; [Chen, Jiunn-Horng; Hsu, Wu-Huei] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, Jiunn-Horng] China Med Univ Hosp, Dept Internal Med, Div Rheumatol, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hsu, WH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Hsu, WH (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	pccm.hsu@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B- 039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B- 039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afessa B, 2004, CHEST, V126, P1905, DOI 10.1378/chest.126.6.1905; Al Sawah S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000066; Al-Abbad AJ, 2001, LUPUS, V10, P32, DOI 10.1191/096120301669980721; Sinicato NA, 2013, CURR CARDIOL REV, V9, P15, DOI 10.2174/1573403X11309010003; Asherson RA, 2005, IMMUNOBIOLOGY, V210, P727, DOI 10.1016/j.imbio.2005.10.002; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Ballocca F, 2015, EUR J PREV CARDIOL, V22, P1435, DOI 10.1177/2047487314546826; Baty F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063285; Booth CM, 2011, CURR ONCOL, V18, P105; Carmier D, 2010, Rev Mal Respir, V27, pe66, DOI 10.1016/j.rmr.2010.01.003; Cartin-Ceba R, 2016, ARTHRITIS RHEUMATOL, V68, P1467, DOI 10.1002/art.39562; Catoggio LJ, 2015, LUPUS, V24, P788, DOI 10.1177/0961203314563134; Celinska-Lowenhoff Magdalena, 2015, Pol Arch Med Wewn, V125, P497; Chen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139144; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chung WS, 2014, J THROMB HAEMOST, V12, P452, DOI 10.1111/jth.12518; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000755; Dharmarajan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078222; Drahos J, 2013, ANN EPIDEMIOL, V23, P291, DOI 10.1016/j.annepidem.2013.02.005; FESSLER BJ, 1995, RHEUM DIS CLIN N AM, V21, P81; Goss LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128920; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Gunning JE, 2003, SURGERY, V21, P72; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Hsu YH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000936; Huang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141547; Huang WS, 2014, QJM-INT J MED, V107, P969, DOI 10.1093/qjmed/hcu117; Huang WC, 2015, INT J CHRONIC OBSTR, V10, P2121, DOI 10.2147/COPD.S92062; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Jeleniewicz R, 2015, POL ARCH MED WEWN, V125, P538, DOI 10.20452/pamw.2963; Johnson AE, 1996, LANCET, V347, P367, DOI 10.1016/S0140-6736(96)90539-5; Kao AH, 2014, TRANSL STROKE RES, V5, P510, DOI 10.1007/s12975-013-0295-9; Kazzaz NM, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000117; Keane MP, 2000, THORAX, V55, P159, DOI 10.1136/thorax.55.2.159; Lai NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101485; Lin CY, 2014, INT J CARDIOL, V176, P847, DOI 10.1016/j.ijcard.2014.08.006; Mackie FE, 2015, LUPUS, V24, P66, DOI 10.1177/0961203314552118; Murray SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144918; Nan-Ping Y, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-152; Narata Roongtiva, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P528; Pardos-Gea J, 2015, INT J RHEUM DIS, V18, P76, DOI 10.1111/1756-185X.12191; Piga M, 2016, LUPUS, V25, P28, DOI 10.1177/0961203315596597; Roussos C, 2003, EUR RESPIR J, V22, p3S, DOI 10.1183/09031936.03.00038503; Santos MJ, 2009, ACTA REUMATOL PORT, V34, P590; Schneider F, 2012, ARCH PATHOL LAB MED, V136, P1242, DOI 10.5858/arpa.2012-0248-SA; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Shen TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091821; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; SILBERSTEIN SL, 1980, J RHEUMATOL, V7, P187; Somers EC, 2014, ARTHRITIS RHEUMATOL, V66, P369, DOI 10.1002/art.38238; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Souza DCC, 2012, J RHEUMATOL, V39, P496, DOI 10.3899/jrheum.110241; Tektonidou MG, 2015, ARTHRIT CARE RES, V67, P1078, DOI 10.1002/acr.22575; Thomas G, 2014, ARTHRITIS RHEUMATOL, V66, P2503, DOI 10.1002/art.38731; Tien YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150816; Urowitz MB, 2010, ARTHRIT CARE RES, V62, P881, DOI 10.1002/acr.20122; Wiedermann FJ, 2000, J INTERN MED, V247, P723, DOI 10.1046/j.1365-2796.2000.00687.x; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093847; Yeh KW, 2013, RHEUMATOL INT, V33, P1805, DOI 10.1007/s00296-012-2643-6; Yu KH, 2016, INT J RHEUM DIS, V19, P1175, DOI 10.1111/1756-185X.12828; Zuily S, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-014-0478-8	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163382	10.1371/journal.pone.0163382	http://dx.doi.org/10.1371/journal.pone.0163382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27654828	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700054
J	Zhou, KL; Wang, MX; Sun, S				Zhou, Konglin; Wang, Minxiao; Sun, Song			Effects of Elevated Temperature and Food Supply on the Termination of Over-Summering and Subsequent Development of the Calanoid Copepod Calanus sinicus: Morphology, Physiology and Gene Expression	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; SOUTHERN YELLOW SEA; COLD BOTTOM WATER; VITELLOGENIN-RECEPTOR; MARINE COPEPOD; LIPID STORAGE; MOLECULAR CHARACTERIZATION; ECDYSONE RECEPTOR; GONAD DEVELOPMENT; LOCH ENVIRONMENT	The copepod Calanus sinicus Brodsky dominates the zooplankton in the Yellow Sea, China, and undergoes over-summering within the Yellow Sea Cold Water Mass (YSCWM). Termination of over-summering and subsequent development are regarded as key processes in population recruitment, and are probably linked to environmental variations in the YSCWM. In this study, we examined the effects of temperature (9 and 18 degrees C) and food conditions (0.1 mu g C mL(-1) and unfed) on metabolic rates, morphological characteristics, and relative gene expressions of six genes involved in molting, gonad development, lipid catabolism, and stress tolerance processes of C. sinicus during termination of over-summering and subsequent development. Both elevated temperature and external food supply rapidly ended over-summering of C. sinicus, accompanied by up-regulation of the ecdysteroid receptor (EcR) gene expression and increased metabolic rates. These environmental conditions resulted in irreversible termination of over-summering and ensure the success of molting. During subsequent development, the lipid reserve in oil sacs could permit only early gonad development. The food supply might be a trigger to activate the final maturity of gonad by up-regulating expression of the vitellogenin receptor (VgR) gene. Thus, food played an indispensable role in population recruitment after termination of over-summering, whereas the elevated temperature accelerated these physiological processes. This study revealed the first dynamic profiles of physiological processes involved in over-summering termination and the subsequent development of C. sinicus using morphological, physiological and molecular methods simultaneously, confirmed the quiescent state of over-summering C5 copepodites, detected the effects of environmental changes on over-summering termination and subsequent development, and provided a foundation for future investigations of the mechanisms involved in over-summering in YSCWM.	[Zhou, Konglin; Wang, Minxiao; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Zhou, Konglin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Konglin; Wang, Minxiao; Sun, Song] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Sun, Song] Chinese Acad Sci, Inst Oceanol, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China; [Zhou, Konglin] State Ocean Adm, Inst Oceanog 2, Key Lab Marine Ecosyst & Biogeochem, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; State Oceanic Administration	Sun, S (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Sun, S (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.; Sun, S (corresponding author), Chinese Acad Sci, Inst Oceanol, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China.	sunsong@qdio.ac.cn	Zhou, Konglin/GZB-1439-2022	Minxiao, Wang/0000-0002-6567-3295; Zhou, Konglin/0000-0002-2162-2859	National Natural Science Foundation of China [41230963, 41106133]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11020305]; National Natural Science Foundation of China - Shandong Joint Fund for Marine Ecology and Environmental Sciences [U1406403]; National Program on Basic Research of China [2014FY110500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China - Shandong Joint Fund for Marine Ecology and Environmental Sciences; National Program on Basic Research of China	This work was supported by the National Natural Science Foundation of China No. 41230963 (SS) and No. 41106133 (MW), the Strategic Priority Research Program of the Chinese Academy of Sciences No. XDA11020305 (SS), the National Natural Science Foundation of China - Shandong Joint Fund for Marine Ecology and Environmental Sciences No. U1406403 (SS) and National Program on Basic Research of China No. 2014FY110500 (MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUD J, 1982, REPROD NUTR DEV, V22, P537, DOI 10.1051/rnd:19820410; Chen T, 2003, EUR J BIOCHEM, V270, P137, DOI 10.1046/j.1432-1033.2003.03373.x; Clark KAJ, 2012, LIMNOL OCEANOGR, V57, P65, DOI 10.4319/lo.2012.57.1.0065; Clark KAJ, 2013, GEN COMP ENDOCR, V189, P66, DOI 10.1016/j.ygcen.2013.04.002; Crain JA, 2000, ICES J MAR SCI, V57, P1773, DOI 10.1006/jmsc.2000.0979; Crain JA, 2001, DEEP-SEA RES PT II, V48, P551, DOI 10.1016/S0967-0645(00)00078-3; DAHMS HU, 1995, HYDROBIOLOGIA, V306, P199, DOI 10.1007/BF00017691; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; Goepfert S, 2005, PLANT PHYSIOL, V138, P1947, DOI 10.1104/pp.105.064311; Gunawardene YINS, 2001, INSECT BIOCHEM MOLEC, V31, P1115, DOI 10.1016/S0965-1748(01)00060-1; Hansen BH, 2008, GEN COMP ENDOCR, V158, P115, DOI 10.1016/j.ygcen.2008.05.013; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HIRCHE HJ, 1983, MAR ECOL PROG SER, V11, P281, DOI 10.3354/meps011281; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; Huang Jiaqi, 1986, Oceanologia et Limnologia Sinica, V17, P161; Hwang DS, 2010, COMP BIOCHEM PHYS C, V151, P303, DOI 10.1016/j.cbpc.2009.12.003; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Ji RB, 2011, MAR ECOL PROG SER, V440, P105, DOI 10.3354/meps09342; Johnson CL, 2004, PROG OCEANOGR, V62, P15, DOI 10.1016/j.pocean.2004.08.002; Johnson CL, 2003, MAR ECOL PROG SER, V257, P159, DOI 10.3354/meps257159; Jonasdottir Sigrun H., 1999, Fisheries Oceanography, V8, P61, DOI 10.1046/j.1365-2419.1999.00003.x; Kattner G, 2007, CAN J FISH AQUAT SCI, V64, P1628, DOI 10.1139/F07-122; Klinbunga S, 2015, AQUACULTURE, V435, P18, DOI 10.1016/j.aquaculture.2014.09.013; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Krishnan M., 2008, Journal of Endocrinology and Reproduction, V12, P13; Kuballa AV, 2007, GEN COMP ENDOCR, V150, P48, DOI 10.1016/j.ygcen.2006.07.020; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Lenz PH, 2012, COMP BIOCHEM PHYS D, V7, P110, DOI 10.1016/j.cbd.2011.12.001; Li C, 2004, MAR BIOL, V145, P149, DOI 10.1007/s00227-004-1306-x; Liu GM, 2003, FISH OCEANOGR, V12, P291, DOI 10.1046/j.1365-2419.2003.00253.x; [刘梦坛 Liu Mengtan], 2011, [生态学报, Acta Ecologica Sinica], V31, P933; Madsen ML, 2008, ICES J MAR SCI, V65, P1112, DOI 10.1093/icesjms/fsn097; Maps F, 2014, J PLANKTON RES, V36, P18, DOI 10.1093/plankt/fbt100; Miller CB, 2000, ICES J MAR SCI, V57, P1786, DOI 10.1006/jmsc.2000.0975; Niehoff B, 2005, MAR ECOL PROG SER, V285, P107, DOI 10.3354/meps285107; Niehoff B, 2004, J EXP MAR BIOL ECOL, V307, P237, DOI 10.1016/j.jembe.2004.02.006; Niehoff B, 2003, J PLANKTON RES, V25, P1581, DOI 10.1093/plankt/fbg104; Niehoff B, 2002, MAR BIOL, V140, P567, DOI 10.1007/s00227-001-0731-3; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; Nilsson B, 2014, J PLANKTON RES, V36, P513, DOI 10.1093/plankt/fbt099; Ning J, 2013, DEEP-SEA RES PT II, V97, P109, DOI 10.1016/j.dsr2.2013.05.019; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Pu XM, 2004, J PLANKTON RES, V26, P1059, DOI 10.1093/plankt/fbh101; Pu XM, 2004, J PLANKTON RES, V26, P1049, DOI 10.1093/plankt/fbh097; Rey-Rassat C, 2002, MAR ECOL PROG SER, V238, P301, DOI 10.3354/meps238301; Roth Z, 2012, MOL REPROD DEV, V79, P478, DOI 10.1002/mrd.22055; SANTER B, 1995, J ANIM ECOL, V64, P600, DOI 10.2307/5803; Speirs DC, 2006, MAR ECOL PROG SER, V313, P173, DOI 10.3354/meps313173; STEWART JM, 1994, INVERTEBR REPROD DEV, V25, P73, DOI 10.1080/07924259.1994.9672370; Strickland J.D.H., 1972, B FISH RES BOARD CAN, V167, P1; Sun Song, 2011, Oceanologia et Limnologia Sinica, V42, P165; Sun S, 2010, DEEP-SEA RES PT II, V57, P1006, DOI 10.1016/j.dsr2.2010.02.002; Sun Song, 2005, GLOBEC International Newsletter, V11, P34; Svetlichny LS, 2006, J MARINE SYST, V59, P52, DOI 10.1016/j.jmarsys.2005.09.003; Swalethorp R, 2011, MAR ECOL PROG SER, V429, P125, DOI 10.3354/meps09065; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Tarrant AM, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0091-8; Tiu SHK, 2008, BIOL REPROD, V79, P66, DOI 10.1095/biolreprod.107.066258; Unal E, 2013, J EXP MAR BIOL ECOL, V446, P76, DOI 10.1016/j.jembe.2013.04.020; UYE S, 1988, HYDROBIOLOGIA, V167, P285, DOI 10.1007/BF00026316; Uye S, 2000, ICES J MAR SCI, V57, P1850, DOI 10.1006/jmsc.2000.0965; Wang R, 2003, J PLANKTON RES, V25, P169, DOI 10.1093/plankt/25.2.169; Wang S., 2009, THESIS; Wang SW, 2009, MAR ECOL PROG SER, V379, P123, DOI 10.3354/meps07902; Weng X C, 1982, HYDROMETEOLOGY, P61; Zhang DY, 2001, J BIOL CHEM, P276; Zhang GT, 2007, J PLANKTON RES, V29, P179, DOI 10.1093/plankt/fbm005; Zhou KL, 2016, J PLANKTON RES, V38, P551, DOI 10.1093/plankt/fbw011	71	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0161838	10.1371/journal.pone.0161838	http://dx.doi.org/10.1371/journal.pone.0161838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27652608	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892700011
J	Hu, W; Mi, L; Yang, Z; Tao, S; Li, MS; Wang, WJ; Dong, Q; Liu, C				Hu, Wei; Mi, Lin; Yang, Zhen; Tao, Sha; Li, Mingshuang; Wang, Wenjing; Dong, Qi; Liu, Chang			Shifting Perceptual Weights in L2 Vowel Identification after Training	PLOS ONE			English	Article							AMERICAN ENGLISH VOWELS; FORMANT DISCRIMINATION; JAPANESE LISTENERS; CROSS-LANGUAGE; INTELLIGIBILITY; ACQUISITION; FREQUENCY; SPEAKERS; CONTEXT; SPEECH	Difficulties with second-language vowel perception may be related to the significant challenges in using acoustic-phonetic cues. This study investigated the effects of perception training with duration-equalized vowels on native Chinese listeners' English vowel perception and their use of acoustic-phonetic cues. Seventeen native Chinese listeners were perceptually trained with duration-equalized English vowels, and another 17 native Chinese listeners watched English videos as a control group. Both groups were tested with English vowel identification and vowel formant discrimination before training, immediately after training, and three months later. The results showed that the training effect was greater for the vowel training group than for the control group, while both groups improved their English vowel identification and vowel formant discrimination after training. Moreover, duration-equalized vowel perception training significantly reduced listeners' reliance on duration cues and improved their use of spectral cues in identifying English vowels, but video-watching did not help. The results suggest that duration-equalized English vowel perception training may improve non-native listeners' English vowel perception by changing their perceptual weights of acoustic-phonetic cues.	[Hu, Wei; Mi, Lin; Yang, Zhen; Tao, Sha; Li, Mingshuang; Wang, Wenjing; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Hu, Wei; Mi, Lin; Yang, Zhen; Tao, Sha; Li, Mingshuang; Wang, Wenjing; Dong, Qi] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Dong, Qi] Beijing Normal Univ, Natl Innovat Ctr Assessment Basic Educ Qual, Beijing, Peoples R China; [Liu, Chang] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Hu, Wei] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; University of Texas System; University of Texas Austin; Tianjin Normal University	Tao, S (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Tao, S (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Liu, C (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.	taosha@bnu.edu.cn; changliu@mail.utexas.edu		Tao, Sha/0000-0002-0928-0681; Mi, Lin/0000-0001-6547-7000	National Natural Science Foundation of China [31521063]; 973 Program of China [2014CB846103]; 111 project [B070008]; Open Research Funds of the State Key Laboratory of Cognitive Neuroscience and Learning at Beijing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); Open Research Funds of the State Key Laboratory of Cognitive Neuroscience and Learning at Beijing Normal University	This study was supported by National Natural Science Foundation of China (No.31521063) (http://www.nsfc.gov.cn/), 973 Program of China (2014CB846103) (http://www.most.gov.cn/), the 111 project (B070008) (http://www.safea.gov.cn/), and the Open Research Funds of the State Key Laboratory of Cognitive Neuroscience and Learning at Beijing Normal University (http://www.bnu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSI, 2010, S362010 ANSI; Antoniou M, 2015, J ACOUST SOC AM, V138, P571, DOI 10.1121/1.4923362; BEDDOR PS, 1982, J ACOUST SOC AM, V71, P1551, DOI 10.1121/1.387809; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giannakopoulou A, 2013, CHILD LANG TEACH THE, V29, P201, DOI 10.1177/0265659012467473; GOTO H, 1971, NEUROPSYCHOLOGIA, V9, P317, DOI 10.1016/0028-3932(71)90027-3; GOTTFRIED TL, 1984, J PHONETICS, V12, P91, DOI 10.1016/S0095-4470(19)30858-7; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Jin SH, 2014, J SPEECH LANG HEAR R, V57, P583, DOI 10.1044/2014_JSLHR-H-13-0047; Kewley-Port D, 2001, J ACOUST SOC AM, V110, P2141, DOI 10.1121/1.1400737; Kewley-Port D., 2005, J ACOUST SOC AM, V117, P2399, DOI [10.1121/1.4785992, DOI 10.1121/1.4785992]; KEWLEYPORT D, 1994, J ACOUST SOC AM, V95, P485, DOI 10.1121/1.410024; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu C, 2004, J ACOUST SOC AM, V116, P3119, DOI 10.1121/1.1802671; Liu C, 2004, J ACOUST SOC AM, V116, P1224, DOI 10.1121/1.1768958; Liu C, 2014, LANG SPEECH, V57, P238, DOI 10.1177/0023830913507692; Liu C, 2012, J ACOUST SOC AM, V132, pEL189, DOI 10.1121/1.4742318; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; MACKAIN KS, 1981, APPL PSYCHOLINGUIST, V2, P369, DOI 10.1017/S0142716400009796; Mi L, 2016, HEARING RES, V333, P58, DOI 10.1016/j.heares.2015.12.024; Mi L, 2013, J ACOUST SOC AM, V133, pEL391, DOI 10.1121/1.4800191; MILLER JD, 1989, J ACOUST SOC AM, V85, P2114, DOI 10.1121/1.397862; MINES MA, 1978, LANG SPEECH, V21, P221, DOI 10.1177/002383097802100302; Morrison G.S., 2002, EFFECTS L1 DURATION; MUNRO MJ, 1993, LANG SPEECH, V36, P39, DOI 10.1177/002383099303600103; Nishi K, 2007, J SPEECH LANG HEAR R, V50, P1496, DOI 10.1044/1092-4388(2007/103); Rato A., 2014, CONCORDIA WORKING PA, V5, P529; Sha Tao, 2014, Journal of the Acoustical Society of America, V136, DOI 10.1121/1.4899577; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; WANG H.R., 2007, THESIS; Wayland RP, 2008, J PHONETICS, V36, P250, DOI 10.1016/j.wocn.2007.06.004; Ylinen S, 2010, J COGNITIVE NEUROSCI, V22, P1319, DOI 10.1162/jocn.2009.21272	36	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162876	10.1371/journal.pone.0162876	http://dx.doi.org/10.1371/journal.pone.0162876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649413	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100039
J	Uyeda, JC; Harmon, LJ; Blank, CE				Uyeda, Josef C.; Harmon, Luke J.; Blank, Carrine E.			A Comprehensive Study of Cyanobacterial Morphological and Ecological Evolutionary Dynamics through Deep Geologic Time	PLOS ONE			English	Article							MESOPROTEROZOIC GAOYUZHUANG FORMATION; PRECAMBRIAN ORGANIC WORLD; RIBOSOMAL-RNA GENE; BIOGEOCHEMICAL PROCESSES; MOLECULAR EVOLUTION; SEQUENCE-ANALYSIS; DIVERGENCE TIMES; PRINCIPAL STAGES; ABSOLUTE RATES; DIVERSIFICATION	Cyanobacteria have exerted a profound influence on the progressive oxygenation of Earth. As a complementary approach to examining the geologic record D phylogenomic and trait evolutionary analyses of extant species can lead to new insights. We constructed new phylogenomic trees and analyzed phenotypic trait data using novel phylogenetic comparative methods. We elucidated the dynamics of trait evolution in Cyanobacteria over billion-year timescales, and provide evidence that major geologic events in early Earth's history have shaped D and been shaped by D evolution in Cyanobacteria. We identify a robust core cyanobacterial phylogeny and a smaller set of taxa that exhibit long-branch attraction artifacts. We estimated the age of nodes and reconstruct the ancestral character states of 43 phenotypic characters. We find high levels of phylogenetic signal for nearly all traits, indicating the phylogeny carries substantial predictive power. The earliest cyanobacterial lineages likely lived in freshwater habitats, had small cell diameters, were benthic or sessile, and possibly epilithic/ endolithic with a sheath. We jointly analyzed a subset of 25 binary traits to determine whether rates of trait evolution have shifted over time in conjunction with major geologic events. Phylogenetic comparative analysis reveal an overriding signal of decreasing rates of trait evolution through time. Furthermore, the data suggest two major rate shifts in trait evolution associated with bursts of evolutionary innovation. The first rate shift occurs in the aftermath of the Great Oxidation Event and broken vertical bar Snowball Earth - glaciations and is associated with decrease in the evolutionary rates around 1.8 +/- 1.6 Ga. This rate shift seems to indicate the end of a major diversification of cyanobacterial phenotypes - particularly related to traits associated with filamentous morphology, heterocysts and motility in freshwater ecosystems. Another burst appears around the time of the Neoproterozoic Oxidation Event in the Neoproterozoic, and is associated with the acquisition of traits involved in planktonic growth in marine habitats. Our results demonstrate how uniting genomic and phenotypic datasets in extant bacterial species can shed light on billion-year old events in Earth's history.	[Uyeda, Josef C.; Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Blank, Carrine E.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA	Idaho; University of Idaho; University of Montana System; University of Montana	Uyeda, JC (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	josef.uyeda@gmail.com		Uyeda, Josef/0000-0003-4624-9680; Harmon, Luke/0000-0002-4985-5750	National Science Foundation [DEB-1208912, DEB-1208534]	National Science Foundation(National Science Foundation (NSF))	DEB-1208912 (https://www.risf.govi awardsearch/showAward?AWD_ID=12085348&HistoricalAwards=false) supported the work of LJH and postdoctoral funding for JCU. DEB-1208534 (https://www.nst.gov/ awardsearch/showAward?AWD_ID=1208534&HistoricalAwards=false) supported CEB.; This work was funded by grants from the National Science Foundation (award DEB-1208534 to C.E.B. and DEB-1208912 to L.J.H.). We would like to thank Matt Pennell, Lisa Moore, Daniel Caetano, and several anonymous reviewers for helpful feedback on earlier versions of this manuscript.	Altermann W, 2001, J AFR EARTH SCI, V33, P427, DOI 10.1016/S0899-5362(01)00089-6; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; [Anonymous], 2001, BERGEYS MANUAL SYSTE; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Blank CE, 2013, J PHYCOL, V49, P1040, DOI 10.1111/jpy.12111; Blank CE, 2012, ARCHAEA, V2012, DOI 10.1155/2012/843539; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; Blank CE, 2002, THESIS; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Bressan A, 2012, MICROB ECOL, V63, P628, DOI 10.1007/s00248-011-9933-5; Bryant WA, 2013, J COMPUT BIOL, V20, P755, DOI 10.1089/cmb.2013.0079; Butterfield NJ, 2015, PALAEONTOLOGY, V58, P953, DOI 10.1111/pala.12211; Castenholz R. W., 2001, BERGEYS MANUAL SYSTE, P539; Castenholz RW, 2001, BERGEYS MANUAL SYSTE; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dvorak P, 2015, BIODIVERS CONSERV, V24, P739, DOI 10.1007/s10531-015-0888-6; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Goode M, 2008, GENOME INFORM SER, V21, P150; Gubry-Rangin C, 2015, P NATL ACAD SCI USA, V112, P9370, DOI 10.1073/pnas.1419329112; Gugger MF, 2004, INT J SYST EVOL MICR, V54, P349, DOI 10.1099/ijs.0.02744-0; Guilbaud R, 2015, NAT GEOSCI, V8, P466, DOI 10.1038/NGEO2434; Hardisty DS, 2014, GEOLOGY, V42, P619, DOI 10.1130/G35439.1; Harmon LJ, 2013, PLOS CURRENTS, P5, DOI [10.1371/currents.tol, DOI 10.1371/CURRENTS.TOL]; Herdman M, 2001, BERGEYS MANUAL SYSTE; Hoffmann L., 2005, ALGOL STUD, V117, P95, DOI DOI 10.1127/1864-1318/2005/0117-0095; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; Hofmann HJ, 1994, MEMOIR PALEONTOLOGIC, P1; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Howard-Azzeh M, 2014, PHOTOSYNTH RES, V122, P171, DOI 10.1007/s11120-014-0020-x; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Kaplan-Levy RN, 2010, TOP CURR GENET, V21, P5, DOI 10.1007/978-3-642-12422-8_2; Katz LA, 2015, SYST BIOL, V64, P406, DOI 10.1093/sysbio/syu126; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Leigh JW, 2011, MOL BIOL EVOL; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li HK, 2013, J ASIAN EARTH SCI, V72, P216, DOI 10.1016/j.jseaes.2013.02.020; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Maddison WP., 2021, MESQUITE MODULAR SYS; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P119; MITRA AK, 1950, ANN BOT-LONDON, V14, P457, DOI 10.1093/oxfordjournals.aob.a083258; Muhlsteinova R, 2014, PHYTOTAXA, V163, P216; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petitjean C, 2015, MOL BIOL EVOL, V32, P1242, DOI 10.1093/molbev/msv015; Pietrasiak N, 2014, PHYCOLOGIA, V53, P529, DOI 10.2216/14-029.1; Ramulu HG, 2014, MOL PHYLOGENET EVOL, V75, P103, DOI 10.1016/j.ympev.2014.02.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosen MJ, 2015, SCIENCE, V348, P1019, DOI 10.1126/science.aaa4456; Sachs JL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2146; Sanchez-Baracaldo P, 2005, GEOBIOLOGY, V3, P145, DOI 10.1111/j.1472-4669.2005.00050.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Schopf J.W., 1992, PROTEROZOIC BIOSPHER, P195, DOI DOI 10.1017/CBO9780511601064; Schopf JW, 2011, PHOTOSYNTH RES, V107, P87, DOI 10.1007/s11120-010-9577-1; Seong-Joo L, 1999, PRECAMBRIAN RES, V96, P183, DOI 10.1016/S0301-9268(99)00004-2; Seong-Joo L, 1998, LETHAIA, V31, P169; Sergeev VN, 2007, STRATIGR GEO CORREL+, V15, P141, DOI 10.1134/S0869593807020025; Sergeev VN, 2010, STRATIGR GEO CORREL+, V18, P561, DOI 10.1134/S0869593810060018; Sergeev VN, 2009, PRECAMBRIAN RES, V173, P212, DOI 10.1016/j.precamres.2009.04.002; Sergeev VN, 1997, PRECAMBRIAN RES, V85, P201, DOI 10.1016/S0301-9268(97)00035-1; Sharma M, 2004, PRECAMBRIAN RES, V134, P317, DOI 10.1016/j.precamres.2004.07.001; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; SINGH S, 1988, NEW PHYTOL, V110, P97, DOI 10.1111/j.1469-8137.1988.tb00241.x; Staley JT, 2009, J IND MICROBIOL BIOT, V36, P1331, DOI 10.1007/s10295-009-0642-8; Swithers KS, 2012, GENOME BIOL EVOL, V4, P842, DOI 10.1093/gbe/evs057; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wagner A, 2008, MOL GENET GENOMICS, V280, P397, DOI 10.1007/s00438-008-0373-y; Waldbauer JR, 2011, P NATL ACAD SCI USA, V108, P13409, DOI 10.1073/pnas.1104160108; WILDON DC, 1963, ARCH MIKROBIOL, V47, P19, DOI 10.1007/BF00408286; Wilmotte A, 2001, BERGEYS MAN SYST BAC, P487; Xu Zl, ACTA BOT SINICA, V26, P216; Young GM, 2013, GEOSCI FRONT, V4, P247, DOI 10.1016/j.gsf.2012.07.003; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	94	42	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162539	10.1371/journal.pone.0162539	http://dx.doi.org/10.1371/journal.pone.0162539			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649395	gold, Green Published, Green Submitted			2022-12-27	WOS:000383892100021
J	Wei, XD; Liu, Z; Li, M; Yang, CH; Wang, WM; Li, XL; Zhang, SP; Li, XR; Tian, G; Bergquist, J; Wang, B; Mi, J				Wei, Xiaodan; Liu, Zhuang; Li, Min; Yang, Chunhua; Wang, Wenming; Li, Xianglin; Zhang, Shuping; Li, Xuri; Tian, Geng; Bergquist, Jonas; Wang, Bin; Mi, Jia			The Number of Stenotic Intracranial Arteries Is Independently Associated with Ischemic Stroke Severity	PLOS ONE			English	Article							CAROTID-ENDARTERECTOMY; CIRCULATION; OCCLUSION; STENOSIS; DENSITY; IMPACT; SCORE; FLOW	Background The severity of ischemic stroke symptoms varies among patients and is a critical determinant of patient outcome. To date, the association between the number of stenotic intracranial arteries and stroke severity remains unclear. Aims We aimed to investigate the association between the number of stenotic major intracranial arteries (NSMIA) and ischemic stroke severity, as well as the degree of stenosis and common stroke risk factors. Methods We performed a retrospective analysis of patients with digital subtraction angiography (DSA)-confirmed ischemic stroke. Clinical stroke severity was measured using the National Institutes of Health Stroke Scale (NIHSS). The number of stenotic vessels was counted from the internal carotid arteries and vertebral arteries, bilaterally. Results Eighty three patients were recruited from a single center and included in the study. NSMIA was significantly correlated with stroke severity (Pearson Correlation Coefficient = 0.485, P < 0.001), but not with the degree of stenosis (Pearson Correlation Coefficient = 0.01, P = 0.90). Multivariate regression analysis revealed that NSMIA was significantly associated with the NIHSS score after adjusting for stroke risk factors. The adjusted odds ratio (per lateral) was 2.092 (95% CI, 0.865 to 3.308, P = 0.001). The degree of stenosis was also significantly associated with the NIHSS score after adjusting for common risk factors. The odds ratio (per 10%) was 0.712 (95% CI, 0.202 to 1.223, P = 0.007). Conclusions The number of stenotic intracranial major arteries is associated with the severity of ischemic stroke independent of the degree of stenosis and other stroke risk factors. To the best of our knowledge, this has not been previosuly studied in great detail using DSA. Our data highlight the importance of examining all major arteries in stroke patients.	[Wei, Xiaodan; Li, Min; Yang, Chunhua; Li, Xianglin; Zhang, Shuping; Li, Xuri; Tian, Geng; Wang, Bin; Mi, Jia] Binzhou Med Univ, Med & Pharmaceut Res Ctr, Yantai, Shandong, Peoples R China; [Liu, Zhuang; Wang, Wenming] Binzhou Med Univ, Affiliated Hosp, Dept Clin Imaging, Binzhou, Shandong, Peoples R China; [Bergquist, Jonas; Mi, Jia] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden; [Bergquist, Jonas; Mi, Jia] Uppsala Univ, SciLifeLab, Analyt Chem, Uppsala, Sweden	Binzhou Medical University; Binzhou Medical University; Uppsala University; SciLifeLab; Uppsala University	Yang, CH; Wang, B; Mi, J (corresponding author), Binzhou Med Univ, Med & Pharmaceut Res Ctr, Yantai, Shandong, Peoples R China.; Mi, J (corresponding author), Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden.; Mi, J (corresponding author), Uppsala Univ, SciLifeLab, Analyt Chem, Uppsala, Sweden.	yangchunhua08@126.com; wangbinbzmc@163.com; Jiajiami@gmail.com		Bergquist, Jonas/0000-0002-4597-041X	National Natural Science Foundation of China [81171303, 81400771, 31170321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China 81400771 (GT, http://www.nsfc.gov.cn/, study design), National Natural Science Foundation of China 81171303 (BW, http://www.nsfc.gov.cn/, decision to publish), and National Natural Science Foundation of China 31170321 (SZ, http://www.nsfc.gov.cn/, study design).	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Adla T, 2015, INT J ANGIOL, V24, P179, DOI 10.1055/s-0035-1556056; Albright K, 2014, STROKE S1, V45; [Anonymous], 1991, STROKE, V22, P816; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cloud GC, 2003, QJM-INT J MED, V96, P27, DOI 10.1093/qjmed/hcg003; Cuadrado-Godia E, 2013, J NEUROL NEUROSUR PS, V84, P305, DOI 10.1136/jnnp-2012-303638; FABRIS F, 1994, STROKE, V25, P1133, DOI 10.1161/01.STR.25.6.1133; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Kawano H, 2016, STROKE, V47, P742, DOI 10.1161/STROKEAHA.115.011320; Kim A, 2015, ANN SURG TREAT RES, V89, P261, DOI 10.4174/astr.2015.89.5.261; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Marquardt L, BRAIN; Melnikova E A, 2015, Vopr Kurortol Fizioter Lech Fiz Kult, V92, P4, DOI 10.17116/kurort201554-11; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; Nicolau C, 2001, J ULTRAS MED, V20, P105; Putaala J, 2013, ACTA NEUROL SCAND, V127, P61, DOI 10.1111/j.1600-0404.2012.01683.x; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Romero JR, 2009, CURR CARDIOL REV, V5, P279, DOI 10.2174/157340309789317887; Sachar R, 2004, J AM COLL CARDIOL, V43, P1358, DOI 10.1016/j.jacc.2003.11.049; Shin HK, 1999, ARCH NEUROL-CHICAGO, V56, P1353, DOI 10.1001/archneur.56.11.1353; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Soderholm M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124957; van Dijk AC, 2014, STROKE, V45, P728, DOI 10.1161/STROKEAHA.113.003197; Yeh PS, 2013, ATHEROSCLEROSIS, V228, P472, DOI 10.1016/j.atherosclerosis.2013.03.015	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163356	10.1371/journal.pone.0163356	http://dx.doi.org/10.1371/journal.pone.0163356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649086	Green Published, Green Submitted, gold			2022-12-27	WOS:000383892100082
J	Lee, YT; Chiang, MC; Kuo, SC; Wang, YC; Lee, IH; Chen, TL; Yang, YS				Lee, Yi-Tzu; Chiang, Mei-Chun; Kuo, Shu-Chen; Wang, Yung-Chih; Lee, I-Hsin; Chen, Te-Li; Yang, Ya-Sung			Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia	PLOS ONE			English	Article							BORNE BLA(OXA-58) GENE; SUSCEPTIBILITY BREAKPOINTS; IDENTIFICATION; RESISTANCE; EMERGENCE; INFECTION; COMPLEX; TAIWAN; SPACER; LEVEL	The carbapenem breakpoints set by different organizations for Acinetobacter are discordant, but supporting clinical data are lacking. This study aimed to provide the first clinical outcome data to support the carbapenem breakpoints for Acinetobacter baumannii (Ab) group in patients with bacteremia. This study included 117 adults who received carbapenems for treatment of Ab group bacteremia in Taipei Veterans General Hospital over an 8-year period. We analyzed 30-day mortality rates among patient groups acquiring isolates with different carbapenem minimal inhibitory concentrations (MICs). The carbapenem MIC breakpoint derived from classification and regression tree (CART) analysis to delineate the risk of 30-day mortality was between MICs of <= 4 mg/L and >= 8 mg/L. Mortality rate was higher in patients acquiring isolates with carbapenem MIC >= 8 mg/L than <= 4 mg/L, by bivariate (54.9% [28/51] vs 25.8% [17/66]; P = 0.003) and survival analysis (P = 0.001 by log-rank test). Multivariate analysis using logistic regression and Cox regression models including severity of illness indices demonstrated that treating patients with Ab group bacteremia caused by isolates with a carbapenem MIC >= 8 mg/L with carbapenem was an independent predictor of 30-day mortality (odds ratio, 5.125; 95% confidence interval [CI], 1.946-13.498; P = 0.001, and hazard ratio, 2.630; 95% CI, 1.431-4.834; P = 0.002, respectively). The clinical outcome data confirmed that isolates with MIC <= 4 mg/L were susceptible to carbapenem, and those with MIC >= 8 mg/L were resistant in patients with Ab group bacteremia.	[Lee, Yi-Tzu; Lee, I-Hsin] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Lee, Yi-Tzu; Lee, I-Hsin] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chiang, Mei-Chun] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Div Prevent Med, Taipei, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Maoli County, Taiwan; [Wang, Yung-Chih; Yang, Ya-Sung] Triserv Gen Hosp, Div Infect Dis & Trop Med, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Wang, Yung-Chih] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Lee, I-Hsin] Natl Yang Ming Univ, Inst Biomed Informat, Sch Med, Taipei, Taiwan; [Chen, Te-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Te-Li] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Defense Medical Center; Taipei Veterans General Hospital	Yang, YS (corresponding author), Triserv Gen Hosp, Div Infect Dis & Trop Med, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.	ysyoung4097@gmail.com	Kuo, Shu-Chen/U-6115-2019; Wang, Yung-Chih/ABE-9069-2020	Kuo, Shu-Chen/0000-0002-6940-6450; Wang, Yung-Chih/0000-0002-8491-8972	Tri-Service General Hospital, National Defense Medical Center [TSGH-C104-119, TSGH-105-113, TSGH-C106-096, DV104-09]; Taipei Veterans General Hospital [V104B-017, V105B-005]; Ministry of Science and Technology [MOST 104-2314-B-016-051, MOST 104-2314-B-075-043-MY3, MOST 105-2628-B-016-003-MY2]	Tri-Service General Hospital, National Defense Medical Center; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from Tri-Service General Hospital, National Defense Medical Center (TSGH-C104-119, TSGH-105-113, TSGH-C106-096, and DV104-09), Taipei Veterans General Hospital (V104B-017 and V105B-005), and the Ministry of Science and Technology (MOST 104-2314-B-016-051, MOST 104-2314-B-075-043-MY3, and MOST 105-2628-B-016-003-MY2).	[Anonymous], 2015, M100S25 CLSI; Aronoff GR, 2007, DRUG PRESCRIBING REN, V5th; Bhat SV, 2007, ANTIMICROB AGENTS CH, V51, P4390, DOI 10.1128/AAC.01487-06; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen LY, 2011, J MICROBIOL IMMUNOL, V44, P358, DOI 10.1016/j.jmii.2011.01.032; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P4575, DOI 10.1128/AAC.00764-10; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P3107, DOI 10.1128/AAC.00128-10; Chiang MC, 2012, INFECTION, V40, P19, DOI 10.1007/s15010-011-0187-4; Dalhoff A, 2009, INFECTION, V37, P296, DOI 10.1007/s15010-009-7108-9; DeRyke CA, 2007, DIAGN MICR INFEC DIS, V58, P337, DOI 10.1016/j.diagmicrobio.2007.01.004; Frei CR, 2008, J ANTIMICROB CHEMOTH, V61, P621, DOI 10.1093/jac/dkm536; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Huang LY, 2008, CLIN MICROBIOL INFEC, V14, P1010, DOI 10.1111/j.1469-0691.2008.02077.x; Jean SS, 2013, INT J ANTIMICROB AG, V41, P457, DOI 10.1016/j.ijantimicag.2013.02.001; Koomanachai P, 2010, CLIN THER, V32, P766, DOI 10.1016/j.clinthera.2010.04.003; Lee NY, 2010, J INFECTION, V61, P219, DOI 10.1016/j.jinf.2010.07.002; Lee YT, 2012, CLIN INFECT DIS, V55, P209, DOI 10.1093/cid/cis385; Lee YT, 2009, J CHEMOTHERAPY, V21, P514, DOI 10.1179/joc.2009.21.5.514; Lee YT, 2009, INT J ANTIMICROB AG, V34, P580, DOI 10.1016/j.ijantimicag.2009.06.027; MacVane SH, 2014, ANTIMICROB AGENTS CH, V58, P599, DOI 10.1128/AAC.02029-13; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163271	10.1371/journal.pone.0163271	http://dx.doi.org/10.1371/journal.pone.0163271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644087	Green Submitted, Green Published, gold			2022-12-27	WOS:000383891900040
J	Vieira, BA; Luft, VC; Schmidt, MI; Chambless, LE; Chor, D; Barreto, SM; Duncan, BB				Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Chambless, Lloyd Ellwood; Chor, Dora; Barreto, Sandhi Maria; Duncan, Bruce Bartholow			Timing and Type of Alcohol Consumption and the Metabolic Syndrome - ELSA-Brasil	PLOS ONE			English	Article							KOREAN NATIONAL-HEALTH; DRINKING PATTERNS; RISK-FACTOR; RED WINE; ASSOCIATION; METAANALYSIS; BEER; ORGANIZATION; PREVALENCE; BIOMARKERS	The prevalence of the metabolic syndrome is rising worldwide. Its association with alcohol intake, a major lifestyle factor, is unclear, particularly with respect to the influence of drinking with as opposed to outside of meals. We investigated the associations of different aspects of alcohol consumption with the metabolic syndrome and its components. In cross-sectional analyses of 14,375 active or retired civil servants (aged 35-74 years) participating in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), we fitted logistic regression models to investigate interactions between the quantity of alcohol, the timing of its consumption with respect to meals, and the predominant beverage type in the association of alcohol consumption with the metabolic syndrome. In analyses adjusted for age, sex, educational level, income, socioeconomic status, ethnicity, smoking, body mass index, and physical activity, light consumption of alcoholic beverages with meals was inversely associated with the metabolic syndrome (<= 4 drinks/week: OR = 0.85, 95% CI 0.74-0.97; 4 to 7 drinks/week: OR = 0.75, 95% CI 0.61-0.92), compared to abstention/occasional drinking. On the other hand, greater consumption of alcohol consumed outside of meals was significantly associated with the metabolic syndrome (7 to 14 drinks/week: OR = 1.32, 95% CI 1.11-1.57; >= 14 drinks/week: OR = 1.60, 95% CI 1.29-1.98). Drinking predominantly wine, which occurred mostly with meals, was significantly related to a lower syndrome prevalence; drinking predominantly beer, most notably when outside of meals and in larger quantity, was frequently associated with a greater prevalence. In conclusion, the alcohol-metabolic syndrome association differs markedly depending on the relationship of intake to meals. Beverage preference-wine or beer-appears to underlie at least part of this difference. Notably, most alcohol was consumed in metabolically unfavorable type and timing. If further investigations extend these findings to clinically relevant endpoints, public policies should recommend that alcohol, when taken, should be preferably consumed with meals.	[Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Duncan, Bruce Bartholow] Fed Univ Rio Grande Sul UFRGS, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Duncan, Bruce Bartholow] Fed Univ Rio Grande Sul UFRGS, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Luft, Vivian Cristine] HCPA UFRGS, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil; [Chambless, Lloyd Ellwood] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Chor, Dora] Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Dept Epidemiol, Rio De Janeiro, Brazil; [Barreto, Sandhi Maria] Fed Univ Minas Gerais UFMG, Grad Studies Program Publ Hlth, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Luft, VC (corresponding author), Fed Univ Rio Grande Sul UFRGS, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.; Luft, VC (corresponding author), Fed Univ Rio Grande Sul UFRGS, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.; Luft, VC (corresponding author), HCPA UFRGS, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil.	vcluft@hcpa.edu.br	Schmidt, Maria Inês/AGT-5691-2022; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria/V-3196-2019; Barreto, Sandhi M/D-2855-2014; Vieira, Bruna/AAA-2594-2020; Luft, Vivian/U-2141-2019; Duncan, Bruce B/L-4140-2016	Schmidt, Maria Inês/0000-0002-3837-0731; Barreto, Sandhi M/0000-0001-7383-7811; Duncan, Bruce B/0000-0002-7491-2630; Angelo Vieira, Bruna/0000-0002-7078-6251	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]; Brazilian Ministry of Science and Technology (National Council for Scientific and Technological Development - CNPq) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); Brazilian Ministry of Science and Technology (National Council for Scientific and Technological Development - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian Ministry of Health (Science and Technology Department -http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/sctie/decit-departamento-de-ciencia-e-tecnologia) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos - http://www.finep.gov.br/- and the National Council for Scientific and Technological Development - CNPq - http://cnpq.br/) [grant numbers 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Augustin LSA, 2004, EPIDEMIOLOGY, V15, P767, DOI 10.1097/01.ede.0000142146.36594.9a; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Barrio-Lopez MT, 2013, CLIN NUTR, V32, P797, DOI 10.1016/j.clnu.2012.12.002; Bendsen NT, 2013, NUTR REV, V71, P67, DOI 10.1111/j.1753-4887.2012.00548.x; Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Brand-Miller JC, 2007, AM J CLIN NUTR, V85, P1545, DOI 10.1093/ajcn/85.6.1545; Brinton EA, 2012, CURR ATHEROSCLER REP, V14, P108, DOI 10.1007/s11883-012-0230-7; Canadian Centre on Substance Abuse (CCSA), CAN LOW RISK ALC DRI; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen CC, 2012, NUTR RES, V32, P24, DOI 10.1016/j.nutres.2011.11.004; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835; Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0; Della Valle E, 2009, NUTR METAB CARDIOVAS, V19, P115, DOI 10.1016/j.numecd.2008.03.006; Dima-Cozma C, 2014, EUR J SCI THEOL, V10, P111; DUNCAN BB, 1995, AM J EPIDEMIOL, V142, P1034, DOI 10.1093/oxfordjournals.aje.a117556; Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807; Foppa M, 2002, J STUD ALCOHOL, V63, P247, DOI 10.15288/jsa.2002.63.247; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Fujita N, 2011, HEPATOL RES, V41, P287, DOI 10.1111/j.1872-034X.2011.00787.x; Galan I, 2014, NUTR METAB CARDIOVAS, V24, P189, DOI 10.1016/j.numecd.2013.07.002; Government Australian. Department of Health and Ageing, NEW NAT GUID ALC CON; Hampton SM, 2010, J HUM NUTR DIET, V23, P120, DOI 10.1111/j.1365-277X.2009.01021.x; Huang C, 2014, MAYO CLIN PROC, V89, P1201, DOI 10.1016/j.mayocp.2014.05.014; Imhof A, 2004, EUR HEART J, V25, P2092, DOI 10.1016/j.ehj.2004.09.032; IPAQ-International Physical Activity Questionnaire, GUID DAT PROC AN INT; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Lee KW, 2011, ALCOHOL, V45, P499, DOI 10.1016/j.alcohol.2011.01.001; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Munoz A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/610950; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Sacanella E, 2003, ADDICT BIOL, V8, P371, DOI 10.1080/13556210310001656376; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889; Schrieks IC, 2013, ALCOHOL ALCOHOLISM, V48, P153, DOI 10.1093/alcalc/ags086; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stoutenberg M, 2013, BRIT J NUTR, V110, P901, DOI 10.1017/S0007114512005764; Sun K, 2014, CLIN NUTR, V33, P596, DOI 10.1016/j.clnu.2013.10.003; Toda N, 2010, ALCOHOL ALCOHOLISM, V45, P347, DOI 10.1093/alcalc/agq028; Trevisan M, 2001, ANN EPIDEMIOL, V11, P312, DOI 10.1016/S1047-2797(00)00183-6; US Department of Health and Human Services and US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wakabayashi I, 2011, J ATHEROSCLER THROMB, V18, P684, DOI 10.5551/jat.7435; Wandler A, 2008, MOL CELL ENDOCRINOL, V296, P26, DOI 10.1016/j.mce.2008.09.006; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yokoyama H, 2007, INTERNAL MED, V46, P1345, DOI 10.2169/internalmedicine.46.6196; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhang C., 2014, P 51 ANN DES AUT C D, P1, DOI [DOI 10.1145/2593069.2593124, 10.1109/BTAS.2014.6996295]	55	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163044	10.1371/journal.pone.0163044	http://dx.doi.org/10.1371/journal.pone.0163044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643787	gold, Green Published, Green Submitted			2022-12-27	WOS:000383891900027
J	Li, XJ; Augustine, A; Chen, S; Fliegel, L				Li, Xiuju; Augustine, Aruna; Chen, Shuo; Fliegel, Larry			Stop Codon Polymorphisms in the Human SLC9A1 Gene Disrupt or Compromise Na+/H+ Exchanger Function	PLOS ONE			English	Article							TRANSMEMBRANE SEGMENT-IV; AMINO-ACIDS SER(770); NHE1 ISOFORM; PHOSPHORYLATION; REGION; IDENTIFICATION; KINASE; ATAXIA; TAIL	The NHE1 isoform of the mammalian Na+/H+ exchanger is a ubiquitous plasma membrane protein that regulates intracellular pH in mammalian cells by removing one intracellular proton in exchange for one extracellular sodium. Deletion of the NHE1 gene (SLC9A1) affects the growth and motor ability of mice and humans but mutations and polymorphisms of the gene are only beginning to be characterized. NHE1 has a cytosolic C-terminal regulatory tail of approximately 315 amino acids and a 500 amino acid membrane domain. We examined the functional effects of three human stop codon mutations at amino acids 321, 449 and 735 in comparison with a mutant that had a shortened tail region (543 stop codon). The short mutants, 321, 449 and 543 stop codon mutant proteins, lost NHE1 activity and expression, and did not target to the plasma membrane. Protein for these short mutants was more rapidly degraded than the wild type and 735 ending proteins. The 735 terminating mutant, with the membrane domain and much of the cytosolic tail, had reduced protein expression and activity. The results demonstrate that early stop codon polymorphisms have significant and deleterious effects on the activity of the SLC9A1 protein product. The 735-NHE1 mutant, without the last 80 amino acids, had more minor defects. Surprisingly, retention of a proximal 43 amino acids adjacent to the membrane domain did little to maintain NHE1 expression, targeting and activity.	[Li, Xiuju; Augustine, Aruna; Chen, Shuo; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			Canadian Institute of Health Research [MOP 97816]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research MOP 97816.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves C, 2014, BIOCHEM CELL BIOL, V92, P524, DOI 10.1139/bcb-2014-0071; Amith SR, 2015, INT J DEV BIOL, V59, P367, DOI 10.1387/ijdb.140336lf; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Amith SR, 2016, ONCOTARGET, V7, P21091, DOI 10.18632/oncotarget.8520; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; FLIEGEL L, 1993, BIOCHEM J, V289, P101, DOI 10.1042/bj2890101; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Guissart C, 2015, HUM MOL GENET, V24, P463, DOI 10.1093/hmg/ddu461; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; Hendus-Altenburger R, 2014, CURR TOP MEMBR, V73, P69, DOI 10.1016/B978-0-12-800223-0.00002-5; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; Karki P, 2011, J BIOL CHEM, V286, P13096, DOI 10.1074/jbc.M110.165134; Karmazyn M, 2008, J MOL CELL CARDIOL, V44, P647, DOI 10.1016/j.yjmcc.2008.01.005; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Lee YCG, 2012, GENOME BIOL EVOL, V4, P533, DOI 10.1093/gbe/evr113; Li XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119453; Li XJ, 2013, J MOL CELL CARDIOL, V61, P153, DOI 10.1016/j.yjmcc.2013.04.007; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Liu YS, 2015, BBA-BIOMEMBRANES, V1848, P2385, DOI 10.1016/j.bbamem.2015.07.011; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162902	10.1371/journal.pone.0162902	http://dx.doi.org/10.1371/journal.pone.0162902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636896	Green Submitted, gold, Green Published			2022-12-27	WOS:000383723700020
J	Sansoe, G; Aragno, M; Mastrocola, R; Mengozzi, G; Novo, E; Parola, M				Sansoe, Giovanni; Aragno, Manuela; Mastrocola, Raffaella; Mengozzi, Giulio; Novo, Erica; Parola, Maurizio			Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; RENIN-ANGIOTENSIN SYSTEM; RENAL-FUNCTION; PORTAL-HYPERTENSION; CONVERTING ENZYME; VASCULAR TISSUES; RECEPTOR BLOCKER; CARDIAC-FUNCTION; FIBROSIS; CALCIUM	Background Tissue Angiotensin II (Ang-II), produced through local non ACE-dependent pathways, stimulates liver fibrogenesis, renal vasoconstriction and sodium retention. Aim To highlight chymase-dependent pathway of Ang-II production in liver and kidney during cirrhosis development. Methods Liver histology, portal pressure, liver and kidney function, and hormonal status were investigated in rat liver cirrhosis induced through 13 weeks of CCl4, with or without chymase inhibitor SF2809E, administered between 4th and 13th CCl4 weeks; liver and kidney chymase immunolocation and Ang-II content were assessed. Chymase immunohistochemistry was also assessed in normal and cirrhotic human liver, and chymase mRNA transcripts were measured in human HepG2 cells and activated hepatic stellate cells (HSC/MFs) in vitro. Results Rats receiving both CCl4 and SF2809E showed liver fibrotic septa focally linking portal tracts but no cirrhosis, as compared to ascitic cirrhotic rats receiving CCl4. SF2809E reduced portal pressure, plasma bilirubin, tissue content of Ang-II, plasma renin activity, norepinephrine and vasopressin, and increased glomerular filtration rate, water clearance, urinary sodium excretion. Chymase tissue content was increased and detected in alpha-SMA-positive liver myofibroblasts and in kidney tubular cells of cirrhotic rats. In human cirrhosis, chymase was located in hepatocytes of regenerative nodules. Human HepG2 cells and HSC/MFs responded to TGF-beta 1 by up-regulating chymase mRNA transcription. Conclusions Chymase, through synthesis of Ang-II and other mediators, plays a role in the derangement of liver and kidney function in chronic liver diseases. In human cirrhosis, chymase is well-represented and apt to become a future target of pharmacological treatment.	[Sansoe, Giovanni] Humanitas Gradenigo Hosp, Div Gastroenterol, Turin, Italy; [Aragno, Manuela; Mastrocola, Raffaella; Novo, Erica; Parola, Maurizio] Univ Torino, Dept Clin & Biol Sci, Turin, Italy; [Mengozzi, Giulio] San Giovanni Battista Hosp, Clin Biochem Lab, Turin, Italy	Humanitas Hospital Gradenigo; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Sansoe, G (corresponding author), Humanitas Gradenigo Hosp, Div Gastroenterol, Turin, Italy.	giovannisan@iol.it	Mengozzi, Giulio/AAY-5322-2020	Mengozzi, Giulio/0000-0003-0431-8369; ARAGNO, Manuela/0000-0002-0453-5235; novo, erica/0000-0003-2586-4246; Sansoe', Giovanni/0000-0003-2328-1768	Italian Ministry of University and of Scientific Research	Italian Ministry of University and of Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Italian Ministry of University and of Scientific Research (60%), 2011.	Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bernardi M, 1996, J HEPATOL, V24, P161, DOI 10.1016/S0168-8278(96)80025-0; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Chappell MC, 2001, NEPHROL DIAL TRANSPL, V16, P22, DOI 10.1093/ndt/16.suppl_1.22; COLE BR, 1972, NEW ENGL J MED, V287, P1109, DOI 10.1056/NEJM197211302872202; Dostal DE, 1999, CIRC RES, V85, P643, DOI 10.1161/01.RES.85.7.643; GANDHI CR, 1995, LIFE SCI, V58, P55, DOI 10.1016/0024-3205(95)02255-4; GENTILINI P, 1993, GASTROENTEROLOGY, V104, P588, DOI 10.1016/0016-5085(93)90431-B; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Huss S, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-10; ICHIKAWA I, 1984, CIRC RES, V55, P669, DOI 10.1161/01.RES.55.5.669; Jin D, 2003, CARDIOVASC RES, V60, P413, DOI 10.1016/S0008-6363(03)00535-2; Jin D, 1998, J HYPERTENS, V16, P657, DOI 10.1097/00004872-199816050-00013; Jonsson JR, 2001, GASTROENTEROLOGY, V121, P148, DOI 10.1053/gast.2001.25480; Kamada Y, 2003, HEPATOL RES, V25, P296, DOI 10.1016/S1386-6346(02)00306-6; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; Komeda K, 2008, HEPATOL RES, V38, P501, DOI 10.1111/j.1872-034X.2007.00271.x; Komeda K, 2010, HEPATOL RES, V40, P832, DOI 10.1111/j.1872-034X.2010.00672.x; Miyazaki MA, 2001, HYPERTENS RES, V24, P189, DOI 10.1291/hypres.24.189; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Nishiyama A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026610.48842.CB; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Parola M, 1996, FREE RADICAL BIO MED, V20, P351, DOI 10.1016/0891-5849(96)02055-2; PINZANI M, 1992, J CLIN INVEST, V90, P642, DOI 10.1172/JCI115905; Rockey DC, 1996, J CLIN INVEST, V98, P1381, DOI 10.1172/JCI118925; ROSE BD, 2001, CLIN PHYSL ACID BASE, P285; Sansoe G, 2007, GUT, V56, P1117, DOI 10.1136/gut.2006.109728; Sansoe G, 2006, AM J PHYSIOL-RENAL, V290, pF1337, DOI 10.1152/ajprenal.00435.2005; Sansoe G, 2005, J HEPATOL, V43, P791, DOI 10.1016/j.jhep.2005.04.017; Sansoe G, 2010, J HEPATOL, V53, P856, DOI 10.1016/j.jhep.2010.05.021; Schepke M, 2001, GASTROENTEROLOGY, V121, P389, DOI 10.1053/gast.2001.26295; SCHEUER PJ, 1995, J HEPATOL, V22, P112, DOI 10.1016/0168-8278(95)80269-X; Sheehan D.C., 1987, THEORY PRACTICE HIST; Simard E, 2009, J PHARMACOL EXP THER, V328, P540, DOI 10.1124/jpet.108.142992; Takai S, 2001, CLIN CHIM ACTA, V305, P191, DOI 10.1016/S0009-8981(01)00379-5; Takai S, 2012, J PHARMACOL SCI, V118, P311, DOI 10.1254/jphs.11R11CP; Tani M, 2004, J ANTIBIOT, V57, P83, DOI 10.7164/antibiotics.57.83; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162644	10.1371/journal.pone.0162644	http://dx.doi.org/10.1371/journal.pone.0162644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637026	Green Published, Green Submitted, gold			2022-12-27	WOS:000383723700012
J	Arango-Argoty, G; Singh, G; Heath, LS; Pruden, A; Xiao, WD; Zhang, LQ				Arango-Argoty, Gustavo; Singh, Gargi; Heath, Lenwood S.; Pruden, Amy; Xiao, Weidong; Zhang, Liqing			MetaStorm: A Public Resource for Customizable Metagenomics Annotation	PLOS ONE			English	Article							RNA GENE DATABASE; MICROBIAL COMMUNITY; DIVERSITY; ALIGNMENT; ECOLOGY; SEA	Metagenomics is a trending research area, calling for the need to analyze large quantities of data generated from next generation DNA sequencing technologies. The need to store, retrieve, analyze, share, and visualize such data challenges current online computational systems. Interpretationand annotation of specific information is especially a challenge for metagenomic data sets derived from environmental samples, because current annotation systems only offer broad classification of microbial diversity and function. Moreover, existing resources are not configured to readily address common questions relevant to environmental systems. Here we developed a new online user-friendly metagenomic analysis server called MetaStorm(http://bench.cs.vt.edu/MetaStorm/), which facilitates customization of computational analysis for metagenomic data sets. Users can upload their own reference databases to tailor the metagenomics annotation to focus on various taxonomic and functional gene markers of interest. MetaStorm offers two major analysis pipelines: an assembly-based annotation pipeline and the standard read annotation pipeline used by existing web servers. These pipelines can be selected individually or together. Overall, MetaStorm provides enhanced interactive visualization to allow researchers to explore and manipulate taxonomy and functional annotation at various levels of resolution.	[Arango-Argoty, Gustavo; Heath, Lenwood S.; Zhang, Liqing] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Pruden, Amy] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA USA; [Xiao, Weidong] Temple Univ, Dept Microbiol & Immunol, Sch Med, Philadelphia, PA 19122 USA; [Singh, Gargi] Indian Inst Technol Roorkee, Dept Civil Engn, Roorkee, Uttarakhand, India	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Zhang, LQ (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA USA.	lqzhang@vt.edu	Heath, Lenwood Scott/A-5861-2008	Heath, Lenwood Scott/0000-0003-1608-431X	Interdisciplinary Graduate Education Program (IGEP) at Virginia Tech; National Science Foundation (NSF) [1402651, 1545756, 1236005, 1438328]; US Department of Agriculture NIFA [2014-05280]; Alfred P. Sloan Foundation; Virginia Tech Interdisciplinary Graduate Education Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080789, R01HL084381, R01HL130871, R01HL114152] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1438328] Funding Source: National Science Foundation; Office Of The Director [1545756] Funding Source: National Science Foundation	Interdisciplinary Graduate Education Program (IGEP) at Virginia Tech; National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Agriculture NIFA; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Virginia Tech Interdisciplinary Graduate Education Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work is supported by the Interdisciplinary Graduate Education Program (IGEP) at Virginia Tech, National Science Foundation (NSF) awards 1402651, 1545756, 1236005, and 1438328, US Department of Agriculture NIFA award #2014-05280, and the Alfred P. Sloan Foundation Microbiology of the Built Environment program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received input and was pilot tested in collaboration with several grants; including National Science Foundation (NSF) Awards 1402651, 1545756, 1236005, and 1438328, US Department of Agriculture NIFA Award #2014-05280, and the Alfred P. Sloan Foundation Microbiology of the Built Environment program. Additional financial support was provided by the Virginia Tech Interdisciplinary Graduate Education Program.	Abbas MM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S10; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Dupre J, 2007, STUD HIST PHI PART C, V38, P834, DOI 10.1016/j.shpsc.2007.09.001; Ehrlich SD, 2011, METAGENOMICS OF THE HUMAN BODY, P307, DOI 10.1007/978-1-4419-7089-3_15; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haft DH, 2012, NAT METHODS, V9, P793, DOI 10.1038/nmeth.2080; Holden, 2005, SCIENCE, V307, P155; Hunter S, 2014, NUCLEIC ACIDS RES, V42, pD600, DOI 10.1093/nar/gkt961; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59; Luo C, 2014, NUCLEIC ACIDS RES; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Parthasarathy H, 2007, PLOS BIOL, V5, P369, DOI 10.1371/journal.pbio.0050083; Pearson W. R, 2013, CURRENT PROTOCOLS BI; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schluter A, 2008, J BIOTECHNOL, V136, P65, DOI 10.1016/j.jbiotec.2008.03.017; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Wilke A, MG RAST TECHNICAL RE; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang Y, 2014, APPL MICROBIOL BIOT, V98, P5709, DOI 10.1007/s00253-014-5648-0	48	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162442	10.1371/journal.pone.0162442	http://dx.doi.org/10.1371/journal.pone.0162442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632579	Green Submitted, Green Published, gold			2022-12-27	WOS:000383706900048
J	Di Pasquale, G; Alaux, C; Le Conte, Y; Odoux, JF; Pioz, M; Vaissiere, BE; Belzunces, LP; Decourtye, A				Di Pasquale, Garance; Alaux, Cedric; Le Conte, Yves; Odoux, Jean-Francois; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.; Decourtye, Axel			Variations in the Availability of Pollen Resources Affect Honey Bee Health	PLOS ONE			English	Article							MELLIFERA L HYMENOPTERA; APIS-MELLIFERA; NUTRITIVE-VALUE; BOMBUS-TERRESTRIS; JUVENILE-HORMONE; APIDAE; WORKERS; LARVAE; DIET; VITELLOGENIN	Intensive agricultural systems often expose honey bees (Apis mellifera L.) to large temporal variations in the availability (quantity, quality and diversity) of nutritional resources. Such nutritional irregularity is expected to affect honey bee health. We therefore tested under laboratory conditions the effect of such variation in pollen availability on honey bee health (survival and nursing physiology-hypopharyngeal gland development and vitellogenin expression). We fed honey bees with different diets composed of pollen pellets collected by honey bees in an agricultural landscape of western France. Slight drops (5-10%) in the availability of oilseed rape (Brassica napus L.) pollen resulted in significant reductions of all tested variables. Despite some variations in taxonomic diversity and nutritional quality, the pollen mixes harvested over the season had a similar positive influence on honey bee health, except for the one collected in late July that induced poor survival and nursing physiology. This period coincided with the mass-flowering of maize (Zea mays L.), an anemophilous crop which produces poor-quality pollen. Therefore, changes in bee health were not connected to variations in pollen diversity but rather to variations in pollen depletion and quality, such as can be encountered in an intensive agricultural system of western France. Finally, even though pollen can be available ad libitum during the mass-flowering of some crops (e.g. maize), it can fail to provide bees with diet adequate for their development.	[Di Pasquale, Garance; Alaux, Cedric; Le Conte, Yves; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.; Decourtye, Axel] UMT PrADE, Avignon, France; [Di Pasquale, Garance; Decourtye, Axel] ACTA, Avignon, France; [Alaux, Cedric; Le Conte, Yves; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.] INRA, UR Abeilles & Environm 406, Avignon, France; [Odoux, Jean-Francois] INRA, Unite Expt Entomol, Le Magneraud, France; [Decourtye, Axel] ITSAP Inst Abeille, Avignon, France	INRAE; INRAE	Di Pasquale, G (corresponding author), UMT PrADE, Avignon, France.; Di Pasquale, G (corresponding author), ACTA, Avignon, France.	garancedipasquale@gmail.com	, Belzunces/P-7061-2019; Le Conte, Yves/M-4442-2018; Alaux, Cedric/B-4667-2013; Le Conte, Yves M/B-3246-2016; ODOUX, Jean-François/AAB-3596-2019; Pioz, Maryline/AAI-3325-2020; Le Conte, Yves/AAP-2379-2021	, Belzunces/0000-0003-1798-9962; Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599; Le Conte, Yves M/0000-0002-8466-5370; ODOUX, Jean-François/0000-0002-6264-4376; Le Conte, Yves/0000-0002-8466-5370; Pioz, Maryline/0000-0003-0331-4403	European Agricultural Guarantee Fund [797/2004]; Conventions Industrielles de Formation par la Recherche (ANRT)	European Agricultural Guarantee Fund; Conventions Industrielles de Formation par la Recherche (ANRT)(French National Research Agency (ANR))	This work was funded by a grant from the European Agricultural Guarantee Fund (797/2004) and GDP was supported by a fellowship from the Conventions Industrielles de Formation par la Recherche (ANRT).	Alaux C, 2014, J EXP BIOL, V217, P3416, DOI 10.1242/jeb.105783; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; [Anonymous], ISO5983; [Anonymous], 2009, AFNOR15662; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bitondi MMG, 1996, J APICULT RES, V35, P27, DOI 10.1080/00218839.1996.11100910; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; COX DR, 1972, J R STAT SOC B, V34, P187; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; DIETZ A, 1980, APIDOLOGIE, V11, P143, DOI 10.1051/apido:19800204; Dimou M, 2009, APIDOLOGIE, V40, P124, DOI 10.1051/apido/2008066; FERNANDESDASILVA PG, 1993, APIDOLOGIE, V24, P73, DOI 10.1051/apido:19930109; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hocherl N, 2012, J INSECT PHYSIOL, V58, P278, DOI 10.1016/j.jinsphys.2011.12.001; Jacobs F, 2004, COMPT REND 1 C TECHN, P57; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; LOPER GM, 1980, APIDOLOGIE, V11, P351, DOI 10.1051/apido:19800403; LOPER GM, 1980, APIDOLOGIE, V11, P181, DOI 10.1051/apido:19800208; Louveaux J, 1959, ANN ABEILLE, V2; Manning R, 2001, BEE WORLD, V82, P60, DOI 10.1080/0005772X.2001.11099504; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Odoux JF, 2012, APIDOLOGIE, V43, P561, DOI 10.1007/s13592-012-0125-1; Otis GW, 2007, AM BEE J, V147, P1033; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Ravoet J, 2015, B ENVIRON CONTAM TOX, V94, P543, DOI 10.1007/s00128-015-1511-y; Requier F, 2015, ECOL APPL, V25, P881, DOI 10.1890/14-1011.1; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; SCHMIDT JO, 1984, J KANSAS ENTOMOL SOC, V57, P323; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Shannon C. E., 1949, MATH THEORY COMMUNIC; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; VAISSIERE BE, 1994, GRANA, V33, P128, DOI 10.1080/00173139409428989; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Wang H, 2014, APIDOLOGIE, V45, P618, DOI 10.1007/s13592-014-0276-3; Willard LE, 2011, APIDOLOGIE, V42, P508, DOI 10.1007/s13592-011-0006-z; Winston M., 1987, The biology of the honey bee.; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	67	85	87	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162818	10.1371/journal.pone.0162818	http://dx.doi.org/10.1371/journal.pone.0162818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631605	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900082
J	Dong, CJ; Wu, AM; Du, SJ; Tang, K; Wang, Y; Liu, JY				Dong, Chun-Juan; Wu, Ai-Min; Du, Shao-Jun; Tang, Kai; Wang, Yun; Liu, Jin-Yuan			GhMCS1, the Cotton Orthologue of Human GRIM-19, Is a Subunit of Mitochondrial Complex I and Associated with Cotton Fibre Growth	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED PROTEINS; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; CELLULOSE SYNTHASE; CELL ELONGATION; EAR-MOTIF; MYB GENE; IDENTIFICATION; INSIGHTS	GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a subunit of mitochondrial respiratory complex I in mammalian systems, and it has been demonstrated to be a multifunctional protein involved in the cell cycle, cell motility and innate immunity. However, little is known about the molecular functions of its homologues in plants. Here, we characterised GhMCS1, an orthologue of human GRIM-19 from cotton (Gossypium hirsutum L.), and found that it was essential for maintaining complex integrity and mitochondrial function in cotton. GhMCS1 was detected in various cotton tissues, with high levels expressed in developing fibres and flowers and lower levels in leaves, roots and ovules. In fibres at different developmental stages, GhMCS1 expression peaked at 5-15 days post anthesis (dpa) and then decreased at 20 dpa and diminished at 25 dpa. By Western blot analysis, GhMCS1 was observed to be localised to the mitochondria of cotton leaves and to colocalise with complex I. In Arabidopsis, GhMCS1 overexpression enhanced the assembly of complex I and thus respiratory activity, whereas the GhMCS1 homologue (At1g04630) knockdown mutants showed significantly decreased respiratory activities. Furthermore, the mutants presented with some phenotypic changes, such as smaller whole-plant architecture, poorly developed seeds and fewer trichomes. More importantly, in the cotton fibres, both the GhMCS1 transcript and protein levels were correlated with respiratory activity and fibre developmental phase. Our results suggest that GhMCS1, a functional ortholog of the human GRIM-19, is an essential subunit of mitochondrial complex I and is involved in cotton fibre development. The present data may deepen our knowledge on the potential roles of mitochondria in fibre morphogenesis.	[Dong, Chun-Juan; Wu, Ai-Min; Du, Shao-Jun; Tang, Kai; Wang, Yun; Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing, Peoples R China	Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing, Peoples R China.	liujy@mail.tsinghua.edu.cn	Wu, Aimin/AAG-9747-2020	Wu, Aimin/0000-0001-8322-8833	State Key Basic Research and Development Plan [2010CB126003]; National Transgenic Animals and Plants Research Project [2009ZX08005-026B, 2011ZX08005-003, 2011ZX08009-003]	State Key Basic Research and Development Plan; National Transgenic Animals and Plants Research Project	This work was supported by the State Key Basic Research and Development Plan (2010CB126003) and the National Transgenic Animals and Plants Research Project (2009ZX08005-026B, 2011ZX08005-003 and 2011ZX08009-003).	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Chen Y, 2007, MOL CELL BIOL, V27, P6420, DOI 10.1128/MCB.01946-06; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26829; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Dong CJ, 2010, FUNCT PLANT BIOL, V37, P64, DOI 10.1071/FP09100; Dong DJ, 2012, AMINO ACIDS, V42, P1297, DOI 10.1007/s00726-010-0824-8; Du SJ, 2013, J PROTEOMICS, V82, P113, DOI 10.1016/j.jprot.2013.02.020; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; GABRIDGE MG, 1976, INFECT IMMUN, V13, P84, DOI 10.1128/IAI.13.1.84-91.1976; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.107; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kalvakolanu DV, 2010, CYTOKINE, V52, P128, DOI 10.1016/j.cyto.2010.03.009; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li T, 2016, MOL PLANT, V9, P650, DOI 10.1016/j.molp.2016.02.010; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116272; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lu SY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P85, DOI 10.1134/S0006297910010116; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Pang Y, 2010, PLANT BIOLOGY, V12, P903, DOI 10.1111/j.1438-8677.2009.00313.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Shangguan XX, 2008, J EXP BOT, V59, P3533, DOI 10.1093/jxb/ern204; Shi Y, 2013, FISH SHELLFISH IMMUN, V34, P273, DOI 10.1016/j.fsi.2012.11.017; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Tang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156281; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Whittaker DJ, 1999, PLANT PHYSIOL, V121, P181, DOI 10.1104/pp.121.1.181; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; Yang XD, 2006, PLANT MOL BIOL, V62, P951, DOI 10.1007/s11103-006-9068-0; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117049; Zhang B, 2013, PROTEOMICS, V13, P1159, DOI 10.1002/pmic.201200176; Zhang HM, 2005, J INTEGR PLANT BIOL, V47, P223, DOI 10.1111/j.1744-7909.2005.00019.x; Zhao GR, 2001, BIOSCI BIOTECH BIOCH, V65, P2789, DOI 10.1271/bbb.65.2789; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t; Zhou L, 2011, J INTEGR PLANT BIOL, V53, P347, DOI 10.1111/j.1744-7909.2011.01034.x	59	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162928	10.1371/journal.pone.0162928	http://dx.doi.org/10.1371/journal.pone.0162928			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632161	Green Published, Green Submitted, gold			2022-12-27	WOS:000383706900095
J	Harms, FA; Stolker, RJ; Mik, EG				Harms, Floor Anneleen; Stolker, Robert Jan; Mik, Egbert Gezinus			Cutaneous Respirometry as Novel Technique to Monitor Mitochondrial Function: A Feasibility Study in Healthy Volunteers (vol 11, e0159544, 2016)	PLOS ONE			English	Correction																		Harms F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159544	1	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163399	10.1371/journal.pone.0163399	http://dx.doi.org/10.1371/journal.pone.0163399			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631969	Green Published, gold			2022-12-27	WOS:000383706900144
J	Khan, AA; Qureshi, JA; Afzal, M; Stansly, PA				Khan, Azhar A.; Qureshi, Jawwad A.; Afzal, Muhammad; Stansly, Philip A.			Two-Spotted Ladybeetle Adalia bipunctata L. (Coleoptera: Coccinellidae): A Commercially Available Predator to Control Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							SAO-PAULO-STATE; SUITABILITY; DISEASE; BEETLE; BRAZIL; EGGS; PREY	The Asian citrus psyllid Diaphorina citri Kuwayama (Hemiptera: Liviidae) is an economically important pest of citrus because it serves as a vector of the causal pathogens of huanglongbing (HLB) also known as citrus greening disease. The increased use of insecticides for control of D. citri negatively impacts several natural enemies including some effective ladybeetle species which are not available commercially. The two-spotted ladybeetle, Adalia bipunctata (Coleoptera: Coccinellidae) is found in some crop and forest ecosystems of Asia, Europe and North America and available commercially. It is known to attack aphids and mealybugs but there are no published records of feeding on psyllids. We evaluated suitability and preference of A. bipunctata for nymphs of D. citri compared to corn leaf aphid Rhopalosiphum maidis (Hemiptera: Aphididae) a global pest of cereal crops and prey for many predaceous insects. We also compared development and reproduction of A. bipunctata on these two species with frozen eggs of the Mediterranean flour moth Ephestia kuehniella (Lepidoptera: Pyralidae) at 25 degrees C. Initially, more D. citri than R. maidis nymphs were consumed in the no-choice tests although final consumption by larva and adult of A. bipunctata did not differ in the choice and no-choice tests. Larval development was prolonged by one day on D. citri compared to R. maidis nymphs but did not differ between either of these diets and E. kuehniella. Larval survival to adult averaged 93-100% and was not impacted by diet. Adult life span did not differ between diets although those on D. citri and R. maidis nymphs weighed less and produced fewer but more fertile eggs than on E. kuehniella eggs. Significant reduction of D. citri nymphs averaging 54% was observed in colonies caged with adult A. bipunctata on field planted citrus. R degrees (net reproductive rate) was least for beetles fed R. maidis, but otherwise there were no significant differences in demographic parameters. Successful feeding, development and reproductive performance of A. bipunctata suggest its usefulness as biological control agent of D. citri as well as aphid species exemplified by R. maidis.	[Khan, Azhar A.; Qureshi, Jawwad A.; Stansly, Philip A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA; [Khan, Azhar A.; Afzal, Muhammad] Univ Sargodha, Dept Entomol, Sargodha, Pakistan; [Khan, Azhar A.] Bahauddin Zakariya Univ, Coll Agr, Bahadur Campus, Layyah, Pakistan; [Qureshi, Jawwad A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA	State University System of Florida; University of Florida; University of Sargodha; State University System of Florida; University of Florida	Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA.; Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA.	jawwadq@ufl.edu	Alotaibi, Majed/GZG-1828-2022; Khan, Azhar/AAQ-6876-2020; Khan, Azhar Abbas/ABH-1865-2020; Afzal, Muhammad/G-2699-2011	Khan, Azhar Abbas/0000-0002-3227-5186; Afzal, Muhammad/0000-0003-1511-816X	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Higher Education Commission of Pakistan, for funding the PhD research work of Azhar A Khan part of which was conducted at UF-SWFREC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the Higher Education Commission of Pakistan, for funding the PhD research work of Azhar A. Khan part of which was conducted at UF-SWFREC.	[Anonymous], 1925, J ECON ENTOMOL; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; De Clercq P, 2005, PEST MANAG SCI, V61, P1129, DOI 10.1002/ps.1111; FRAZER B D, 1976, Journal of the Entomological Society of British Columbia, V73, P33; Halbert S.E., 2005, PEST ALERT CITRUS GR; HALBERT SE, 1998, TRIOLOGY, V37, P6; Hodek I, 1973, BIOL COCCINELLIDAE; Hodek I., 1996, ECOLOGY COCCINELLIDA, V54; Hussain MA, 1927, ENTOMOLOGICAL SERIES, V10, P1; Juan-Blasco M, 2012, FLA ENTOMOL, V95, P543, DOI 10.1653/024.095.0302; Kanga LHB, 2016, J ECON ENTOMOL, V109, P832, DOI 10.1093/jee/tov348; Khan I, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0701; Kuwayama S., 1908, T SOPPORO NAT HIST S, V2, P149; Lanzoni A, 2004, J APPL ENTOMOL, V128, P298, DOI 10.1111/j.1439-0418.2004.00847.x; Lima AC, 1947, SER DIDAT ESC NAC AG, V3, P327; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Majerus M. E. N, 1994, LADYBIRDS; McCoy C. W., 1985, Biological control in agricultural IPM systems, P481; Michaud JP, 2004, BIOCONTROL, V49, P417, DOI 10.1023/B:BICO.0000034605.53030.db; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Monzo C, 2015, ACTA HORTIC, V1065, P1137; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2011, ENVIRON ENTOMOL, V40, P1503, DOI 10.1603/EN11171; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Wyss E, 1999, ENTOMOL EXP APPL, V90, P167, DOI 10.1023/A:1003564714363; Zahoor M. Kashif, 2003, International Journal of Agriculture and Biology, V5, P555	30	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162843	10.1371/journal.pone.0162843	http://dx.doi.org/10.1371/journal.pone.0162843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631730	Green Published, gold, Green Submitted			2022-12-27	WOS:000383706900083
